data_2jt2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jt2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.16 139.71 34.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 108.54 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HZ3' ' CB ' ' A' ' 116' ' ' ASN . 7.4 mptt -123.26 145.9 48.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -0.853 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 t -143.2 -169.76 3.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -100.51 137.94 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.915 -1.115 . . . . 0.0 109.092 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.683 ' HZ2' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -68.33 -19.42 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.972 . . . . 0.0 109.954 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.5 OUTLIER -152.72 157.47 40.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.08 -1.013 . . . . 0.0 109.705 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 138.67 58.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.161 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.46 166.44 13.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.54 144.3 34.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.898 -1.126 . . . . 0.0 110.396 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 81.2 m-85 -138.23 152.08 48.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 6.8 pt-20 -158.99 150.06 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.956 -1.09 . . . . 0.0 110.146 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.33 174.79 36.76 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.2 151.05 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -1.09 . . . . 0.0 110.058 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.61 140.27 16.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 tt -59.22 -38.88 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 110.321 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.415 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 72.2 m-70 -88.75 -50.1 6.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.629 -1.294 . . . . 0.0 111.183 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 -25.06 64.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 111.819 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.88 14.41 23.28 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.319 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -110.32 157.67 19.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.464 -1.021 . . . . 0.0 109.564 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 77.7 t80 -76.02 135.17 39.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -137.27 143.22 42.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.317 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -112.52 156.93 21.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.417 -0.802 . . . . 0.0 109.952 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.5 mt -136.05 146.42 47.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.52 -0.738 . . . . 0.0 109.82 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.59 106.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 108.691 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -91.64 114.83 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.0 110.979 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -108.79 137.03 19.95 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.523 -0.736 . . . . 0.0 109.544 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -52.27 168.41 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.941 1.761 . . . . 0.0 111.993 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -141.95 173.68 11.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.577 ' N ' ' HG1' ' A' ' 35' ' ' THR . 5.6 mttt -83.51 154.29 23.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.96 147.57 3.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.102 -0.999 . . . . 0.0 109.783 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 70.31 0.19 28.26 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.819 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.671 ' N ' HD21 ' A' ' 86' ' ' ASN . 53.8 m -66.03 -44.7 83.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.565 -1.55 . . . . 0.0 109.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.603 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 99.34 178.81 31.36 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.743 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -98.96 117.79 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -144.33 155.96 44.04 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.12 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -101.89 158.7 15.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -128.56 111.45 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 0.0 108.718 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HZ2' ' ND2' ' A' ' 42' ' ' ASN . 20.8 tttp -135.62 132.6 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' HD21 ' A' ' 42' ' ' ASN . 2.0 m120 55.09 28.25 10.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 111.334 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.85 19.42 73.03 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.773 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.15 121.13 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.537 -0.978 . . . . 0.0 109.217 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 46.2 m-85 -83.1 127.58 33.71 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -0.904 . . . . 0.0 109.05 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.44 90.75 35.74 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.625 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.02 148.78 6.41 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.497 2.131 . . . . 0.0 112.075 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.68 70.23 10.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -122.76 170.36 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.49 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p-80 -72.35 -51.67 19.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.363 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.566 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -43.59 -16.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.41 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.5 m-85 -96.47 -0.34 49.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.906 -1.121 . . . . 0.0 110.142 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.46 130.75 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 108.72 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.2 -30.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.415 ' HD1' ' N ' ' A' ' 56' ' ' THR . 2.0 t-80 -147.18 127.0 13.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.968 -1.082 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.415 ' N ' ' HD1' ' A' ' 55' ' ' HIS . 38.6 p -120.56 96.23 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 59' ' ' SER . 8.7 t-20 -160.35 129.01 4.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.036 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.9 m-70 48.94 11.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 108.928 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.567 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.52 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.75 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.4 m -86.81 128.03 35.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 109.293 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.06 147.18 45.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.655 0.74 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -121.92 149.55 43.26 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.74 156.49 28.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -163.52 150.88 12.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -1.102 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 50.1 21.64 0.79 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.299 -0.876 . . . . 0.0 109.399 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.85 -34.0 6.12 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.489 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 76.5 mm-40 -59.04 149.42 27.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.283 . . . . 0.0 109.656 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -143.87 137.61 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 110.809 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 69' ' ' ILE . 71.5 mt -129.25 124.8 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -102.21 157.82 16.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.073 . . . . 0.0 111.461 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.1 m 50.0 73.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.62 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -107.34 -9.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 0.0 108.804 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.4 pm0 -61.2 -26.24 67.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.558 -0.714 . . . . 0.0 110.472 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.413 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.3 m170 -69.1 -68.12 0.42 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.966 -1.084 . . . . 0.0 109.312 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.27 -48.83 43.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.294 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 mt -54.16 -46.39 72.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.022 -1.049 . . . . 0.0 110.184 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.4 t -60.72 -42.25 96.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.016 -1.053 . . . . 0.0 109.889 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.77 -44.98 87.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.024 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.9 -34.79 78.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.282 -0.886 . . . . 0.0 109.119 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.458 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 5.1 t-160 -62.31 -38.12 88.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.495 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 58.7 mt -77.11 -38.0 53.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.695 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.51 -0.79 51.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 109.703 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 5.3 mp0 56.6 43.22 25.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.814 . . . . 0.0 111.506 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 33.4 mm -87.06 144.86 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.81 -1.182 . . . . 0.0 107.952 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.6 p -130.0 -22.01 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.086 -1.009 . . . . 0.0 111.995 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.671 HD21 ' N ' ' A' ' 35' ' ' THR . 13.8 m120 -127.72 107.2 9.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.191 . . . . 0.0 110.607 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.4 m -166.01 152.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.512 0.672 . . . . 0.0 109.861 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.8 m -116.57 113.11 22.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -94.89 100.56 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -75.33 126.74 31.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.42 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.28 127.31 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.899 0.856 . . . . 0.0 111.913 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 92' ' ' ILE . 17.7 mm -109.34 96.88 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.55 -155.14 24.0 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 -8.36 8.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.183 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -141.82 149.64 40.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 109.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.11 121.81 86.08 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.969 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -41.17 127.9 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.774 1.649 . . . . 0.0 111.366 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 tp -79.42 -11.88 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.516 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.7 mt 56.07 -121.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.052 -1.03 . . . . 0.0 109.6 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.33 9.14 43.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.001 -1.062 . . . . 0.0 111.056 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.54 -3.47 61.28 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.249 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -128.66 -171.95 2.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.887 . . . . 0.0 109.537 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.34 15.6 10.76 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -58.78 -42.43 89.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -1.131 . . . . 0.0 110.493 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.03 -58.04 7.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 7.9 m-85 -51.15 -45.65 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.351 -0.843 . . . . 0.0 109.633 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -60.52 -48.97 79.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.623 -0.673 . . . . 0.0 110.974 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.34 -42.6 83.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.087 -1.008 . . . . 0.0 111.701 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.36 -50.36 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 110.395 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.31 -31.92 51.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.989 -1.069 . . . . 0.0 109.291 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -62.96 -42.1 99.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -77.64 12.74 1.52 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.571 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 3.9 m-80 -143.86 31.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.883 -1.136 . . . . 0.0 110.457 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.683 ' N ' ' HZ2' ' A' ' 8' ' ' LYS . 84.0 mt -79.62 141.3 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.957 -1.089 . . . . 0.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.0 tp -129.92 122.46 28.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.711 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -79.23 141.53 37.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.145 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -110.17 -174.59 2.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.504 -0.748 . . . . 0.0 109.595 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.23 68.84 0.68 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 110.678 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -167.16 130.38 1.79 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.91 143.81 55.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.22 149.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.11 78.13 5.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -58.65 142.72 48.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 110.041 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -89.44 101.59 14.26 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.88 134.16 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.461 0.648 . . . . 0.0 111.061 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.57 111.91 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.437 ' C ' ' OE1' ' A' ' 128' ' ' GLU . 81.3 mt-10 -90.35 -27.66 19.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -134.21 154.75 80.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.497 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.76 148.11 45.98 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.551 2.167 . . . . 0.0 112.199 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 tt -152.0 149.05 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mp -140.3 143.37 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 109.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.38 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -133.05 159.63 39.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.15 -0.969 . . . . 0.0 110.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -175.44 105.94 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 52.11 54.95 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -0.813 . . . . 0.0 110.715 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.19 -31.18 3.19 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.109 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.4 HH11 ' HG3' ' A' ' 137' ' ' ARG . 44.4 mtt85 -63.09 135.39 57.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.267 . . . . 0.0 108.52 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.48 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.1 tt -146.03 136.61 24.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.897 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.41 121.64 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.229 -0.919 . . . . 0.0 109.207 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -112.16 131.82 55.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.487 0.66 . . . . 0.0 109.98 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.15 138.47 54.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.83 153.42 33.45 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 109.524 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -49.19 142.38 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.401 2.067 . . . . 0.0 113.49 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 t -154.15 142.44 20.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 146' ' ' THR . 55.8 m-20 -60.59 -4.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.314 -0.866 . . . . 0.0 110.726 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 145' ' ' ASP . 17.4 p -157.96 -171.07 3.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.872 -1.143 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.98 120.57 34.41 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.118 -0.989 . . . . 0.0 109.018 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -136.77 113.01 9.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.36 122.0 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.9 m -112.91 152.31 29.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.96 131.61 27.26 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.938 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.28 140.26 52.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.64 138.67 8.27 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.969 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.36 99.29 9.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -84.42 167.22 16.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.853 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -100.67 -12.07 19.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 159' ' ' LEU . 35.9 p-10 -102.69 -172.63 2.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.934 -1.104 . . . . 0.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -49.18 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.466 -0.771 . . . . 0.0 111.532 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 157' ' ' ASN . 18.3 mt -77.31 -27.19 52.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.379 -1.45 . . . . 0.0 108.311 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.46 -139.18 31.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -97.36 134.07 41.12 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.169 -1.194 . . . . 0.0 109.513 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -141.23 152.86 44.92 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 152.76 32.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.214 -0.929 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 53.8 t80 -148.53 146.53 28.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -110.3 124.57 51.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.516 -0.74 . . . . 0.0 110.468 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.888 . . . . 0.0 110.012 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 t -109.75 156.26 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -50.65 123.37 8.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.973 . . . . 0.0 109.19 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.475 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 103.92 5.95 43.64 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.453 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 82.8 m-20 -119.75 19.03 12.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.367 -1.078 . . . . 0.0 109.212 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 173' ' ' GLU . 1.9 pm0 -59.8 -43.9 94.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.419 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 9.4 mt-10 -53.89 -6.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 110.021 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 171' ' ' GLU . 89.3 mt-10 -104.8 -8.96 18.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.348 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 pt -123.85 -27.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.231 -0.918 . . . . 0.0 110.575 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.18 -29.23 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.795 -1.191 . . . . 0.0 108.611 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.58 -7.53 56.48 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.447 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.28 119.15 12.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.314 -0.866 . . . . 0.0 109.172 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.511 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 72.8 mtm180 -83.25 172.29 12.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.914 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.3 t -77.06 162.37 27.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -147.65 145.17 28.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.302 -1.499 . . . . 0.0 111.333 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.16 45.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.54 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.6 m-85 -98.72 142.28 30.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 0.0 109.514 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.15 -37.66 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.314 -0.866 . . . . 0.0 109.748 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.0 -27.25 63.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.472 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 7.1 mt-10 -78.61 -40.07 35.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 185' ' ' GLU . 13.2 mt -43.22 -54.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 186' ' ' ILE . 1.0 OUTLIER -43.21 -43.12 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.942 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -74.27 -50.08 20.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 56.0 mt -52.08 -28.97 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -85.3 -53.32 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.74 -1.225 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -51.77 -33.68 36.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.6 m -83.07 7.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 0.0 109.819 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.67 39.38 55.87 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.4 mt -129.48 171.56 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.204 . . . . 0.0 110.134 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.67 24.0 56.28 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -58.22 -19.33 32.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.67 -1.488 . . . . 0.0 110.387 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.454 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.44 6.51 28.31 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.723 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.32 126.19 27.79 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 120.903 -1.351 . . . . 0.0 110.297 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.567 ' HG ' ' H ' ' A' ' 201' ' ' LYS . 0.3 OUTLIER -139.58 167.03 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.246 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.5 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 78.5 mt -68.75 -8.59 44.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 108.395 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.567 ' H ' ' HG ' ' A' ' 199' ' ' SER . 2.1 mttp -98.06 -11.17 23.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.712 -0.618 . . . . 0.0 109.54 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.2 p30 -133.21 7.66 3.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.64 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -148.43 149.56 31.94 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.6 tp -99.73 93.99 6.11 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.6 129.06 38.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.779 0.8 . . . . 0.0 109.094 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 40.9 mt -123.08 170.87 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.651 -0.656 . . . . 0.0 109.562 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.76 -166.22 11.71 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -64.48 -29.66 70.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -1.148 . . . . 0.0 109.611 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -153.26 24.45 0.54 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 111.061 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -149.17 156.82 42.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.515 -1.366 . . . . 0.0 110.925 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.6 t -104.67 112.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -57.04 -49.32 76.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.902 -1.123 . . . . 0.0 109.856 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.83 112.26 4.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -57.3 -17.94 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 112.598 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.12 -16.34 60.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.915 -1.116 . . . . 0.0 109.98 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.43 -171.96 50.9 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mt -91.17 137.3 32.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -1.085 . . . . 0.0 109.674 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -74.41 -16.45 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 108.74 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.99 169.36 17.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.495 ' N ' ' OE2' ' A' ' 220' ' ' GLU . 2.1 mm-40 -84.56 3.68 35.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.141 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.519 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -151.38 43.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.186 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -56.24 -47.21 99.31 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.2 Cg_exo -50.57 -68.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.447 2.098 . . . . 0.0 112.193 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.13 -35.3 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.012 -1.055 . . . . 0.0 109.644 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.566 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 76.9 mtt-85 -60.7 -41.24 94.79 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.449 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.0 t60 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.986 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -37.06 78.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.552 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.7 t80 -65.33 -50.98 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.051 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.11 -30.53 71.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.3 tp -75.49 -32.8 60.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.034 -1.041 . . . . 0.0 108.579 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.27 -39.66 83.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.7 -56.15 16.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.41 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 49.6 m-20 -54.82 -33.98 62.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.18 -24.01 66.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.467 -0.771 . . . . 0.0 110.444 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.586 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -72.63 -22.1 61.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.892 -1.13 . . . . 0.0 108.611 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 63.4 mt -50.78 -2.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.0 110.621 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.586 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.5 mt -76.76 -13.38 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.147 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.01 -0.38 58.97 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.04 155.16 8.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.318 . . . . 0.0 108.814 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.53 150.67 5.62 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.745 1.63 . . . . 0.0 109.6 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 145.54 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.076 -1.015 . . . . 0.0 112.361 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -126.25 121.32 32.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.3 -175.55 31.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.556 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 26.9 tttt -114.59 147.47 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.075 . . . . 0.0 109.263 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 6.8 m-85 -142.92 140.48 31.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.56 122.12 34.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -114.7 135.25 54.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 111.112 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -118.52 109.68 16.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 54.15 26.82 6.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.69 158.74 52.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.02 168.14 24.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.41 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 68.5 m-70 -47.19 -41.29 17.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -1.187 . . . . 0.0 109.695 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' A' ' 254' ' ' SER . 0.8 OUTLIER -55.27 -57.98 9.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.045 -1.034 . . . . 0.0 109.293 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.15 -44.82 88.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 256' ' ' ASN . 2.7 m-20 -47.95 -50.48 26.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.057 . . . . 0.0 109.391 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.15 -51.12 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.594 -0.691 . . . . 0.0 109.704 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -53.0 -51.32 62.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 109.286 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 42.7 tp -51.57 -57.79 8.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.161 -0.962 . . . . 0.0 108.434 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.2 t -50.78 -56.23 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 108.899 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -49.04 20.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.525 -0.734 . . . . 0.0 109.398 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.07 -48.27 80.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.36 -50.54 71.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.96 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.44 -27.0 65.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.0 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.908 . . . . 0.0 110.267 -179.276 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.589 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 2.0 mt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -51.76 143.29 13.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.589 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.55 146.61 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.091 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.96 -168.82 3.03 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -99.56 134.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 109.526 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -63.9 -16.73 62.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -152.71 -171.63 3.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.381 -0.824 . . . . 0.0 109.246 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 144.01 25.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.5 mt -120.97 163.31 18.45 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.44 140.41 46.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.6 m-85 -138.48 148.28 44.16 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.13 152.2 26.05 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.809 -1.182 . . . . 0.0 110.209 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.12 173.24 35.9 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.08 150.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.393 -1.063 . . . . 0.0 110.17 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.58 136.63 15.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.52 -37.78 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 110.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -90.68 -51.45 5.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.588 -1.32 . . . . 0.0 111.044 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.7 p -70.54 -22.03 62.65 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.6 -0.688 . . . . 0.0 111.232 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.25 21.37 47.11 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.731 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -110.64 153.07 25.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 109.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -74.86 130.13 38.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.46 -0.775 . . . . 0.0 109.562 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 16.5 t -135.41 145.86 47.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.235 -0.916 . . . . 0.0 110.057 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -112.0 156.52 22.02 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.416 0.627 . . . . 0.0 109.333 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' PHE . 10.8 mt -135.61 144.92 46.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -140.19 110.22 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 108.79 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.3 113.62 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 111.094 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.475 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 45.4 m-70 -108.32 138.14 20.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.073 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -51.37 167.98 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.853 1.702 . . . . 0.0 112.279 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 5.2 mm-40 -140.92 176.21 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 35' ' ' THR . 3.5 mtpp -85.31 152.83 22.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.856 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 146.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.925 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.68 6.32 42.44 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.039 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 24.6 m -69.08 -43.7 74.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.631 -1.511 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.55 -175.67 31.82 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.458 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mm -98.45 117.92 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.03 140.7 38.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.57 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -129.11 110.8 12.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.031 -1.043 . . . . 0.0 109.084 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.19 134.14 39.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.32 28.33 7.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.03 75.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.806 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.49 121.19 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -1.012 . . . . 0.0 108.951 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.5 m-85 -84.34 127.11 33.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.6 mt -115.72 92.65 34.63 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -49.66 144.99 18.33 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.2 67.5 7.15 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -122.16 163.79 18.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -65.63 -52.87 48.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 5.4 mm-40 -43.25 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.724 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' HIS . 15.9 m-85 -95.7 1.73 53.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -70.58 130.35 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 108.874 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.46 -31.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 109.744 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.7 136.53 17.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -125.35 96.3 4.77 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -162.24 129.49 3.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.808 . . . . 0.0 108.949 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 51.98 7.9 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.104 -0.998 . . . . 0.0 108.759 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.9 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.0 m -93.88 126.49 39.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 109.384 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.94 149.02 42.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.612 0.72 . . . . 0.0 110.868 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.86 149.07 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.73 153.74 24.43 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.98 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -163.12 148.79 11.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 0.0 109.174 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.89 23.79 4.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.15 -31.72 7.4 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.38 144.55 50.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.235 . . . . 0.0 109.262 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -140.04 139.02 35.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.675 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 69' ' ' ILE . 51.3 mt -130.4 123.02 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -101.36 157.33 16.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.95 -1.094 . . . . 0.0 111.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.8 m 49.91 74.57 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.545 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.65 -9.81 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.938 . . . . 0.0 109.31 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -61.74 -26.09 67.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 110.46 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -66.78 -69.23 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.932 -1.105 . . . . 0.0 109.242 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -52.02 -48.57 40.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.013 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.8 mt -51.55 -49.27 62.34 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.038 -1.039 . . . . 0.0 110.3 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -42.68 96.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.988 -1.07 . . . . 0.0 110.295 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -56.74 -45.41 82.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.075 -1.015 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.3 -34.69 78.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -61.62 -35.84 79.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 109.035 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 65.1 mt -80.23 -37.65 32.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.257 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.0 9.29 5.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 109.781 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 3.3 mp0 50.2 36.77 13.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.34 136.82 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.034 -1.041 . . . . 0.0 108.282 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -127.1 -19.81 4.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 111.595 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 72.7 m-20 -124.38 107.59 11.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.876 -1.14 . . . . 0.0 110.423 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.8 m -163.94 148.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.408 -0.808 . . . . 0.0 110.282 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.8 m -114.69 111.5 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.68 100.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.07 127.69 33.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.3 t -111.9 119.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.937 0.875 . . . . 0.0 111.905 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.505 ' O ' ' OG ' ' A' ' 24' ' ' SER . 13.7 mt -109.04 93.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.2 160.4 8.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -7.54 59.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 111.292 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -138.96 147.89 42.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 110.676 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.0 mm -73.86 125.96 89.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.457 -0.777 . . . . 0.0 108.917 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -44.61 134.2 9.88 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.775 1.65 . . . . 0.0 111.075 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.7 tp -88.17 -14.66 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 110.61 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.7 mt 55.78 -121.98 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -95.82 7.6 45.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.939 -1.101 . . . . 0.0 111.17 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.52 -3.73 63.61 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.281 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.9 p -123.88 -172.65 2.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.724 -0.868 . . . . 0.0 109.556 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.98 10.18 11.14 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.448 ' CZ2' ' CG ' ' A' ' 108' ' ' GLU . 55.5 t-105 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -1.121 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.31 -58.98 6.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.028 -1.045 . . . . 0.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -51.18 -43.77 61.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.83 0.824 . . . . 0.0 108.885 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.464 ' CE2' ' OE1' ' A' ' 171' ' ' GLU . 56.4 t80 -62.27 -52.19 64.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.663 -0.648 . . . . 0.0 111.18 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.448 ' CG ' ' CZ2' ' A' ' 104' ' ' TRP . 19.5 mm-40 -61.89 -43.2 99.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.956 -1.09 . . . . 0.0 111.195 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.12 2.63 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 110.363 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.44 -35.42 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.635 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 41.8 ttt85 -64.78 -43.55 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.762 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -72.59 10.76 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 111' ' ' ARG . 22.9 m-80 -145.73 36.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.948 -1.095 . . . . 0.0 110.448 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.7 mt -83.44 139.91 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.98 119.5 23.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.744 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -76.3 143.56 40.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.722 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.19 -175.96 2.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 109.592 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.518 ' H ' ' ND2' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -106.91 67.99 0.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.235 -0.915 . . . . 0.0 110.514 -179.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -164.93 129.64 2.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.22 140.77 57.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 121' ' ' ILE . 37.4 mt -81.47 147.0 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.77 88.78 4.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -0.872 . . . . 0.0 108.657 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.71 143.77 56.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -88.47 102.2 14.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.24 134.12 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.556 -0.715 . . . . 0.0 110.792 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.27 117.22 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.463 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 7.3 tp10 -89.69 -31.62 17.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.961 -1.087 . . . . 0.0 109.99 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.11 154.28 80.06 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.41 158.39 44.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.557 2.172 . . . . 0.0 112.35 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 tt -165.09 154.67 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.76 147.06 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.96 147.28 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -132.84 161.56 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -173.66 102.17 0.11 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 0.0 109.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.17 59.25 4.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.436 -0.79 . . . . 0.0 111.002 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.02 -35.56 3.25 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.448 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -63.94 131.38 47.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.265 . . . . 0.0 108.89 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.465 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -143.3 139.25 30.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 109.999 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.5 mt -137.29 128.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.387 -0.821 . . . . 0.0 109.876 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 142' ' ' GLU . 10.7 tttm -117.94 132.77 56.37 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.514 0.673 . . . . 0.0 110.146 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.83 134.95 54.89 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 140' ' ' LYS . 14.8 pt-20 -146.46 147.68 31.59 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.54 143.52 8.45 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.617 2.211 . . . . 0.0 113.458 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.73 147.38 18.55 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.77 -37.55 82.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.325 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -120.46 -169.86 1.88 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.9 tp -100.08 122.94 43.72 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.36 130.2 36.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.73 121.45 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.4 m -112.43 151.99 29.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.594 -0.691 . . . . 0.0 109.433 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -140.52 131.4 25.98 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.145 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -121.67 125.42 46.61 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.91 138.87 10.7 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.345 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -102.87 103.14 13.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -93.31 167.44 11.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.664 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -103.65 -12.27 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 110.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.2 p-10 -97.88 -167.13 1.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 110.378 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -53.48 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.259 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 157' ' ' ASN . 13.5 mt -85.59 -30.53 23.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.545 -1.347 . . . . 0.0 109.102 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.85 -140.25 38.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 161' ' ' ARG . 11.5 ttp-105 -98.82 135.91 39.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.193 -1.181 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -137.89 149.72 46.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.484 -0.76 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -140.86 143.99 35.05 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -145.47 140.3 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.2 m -108.14 123.85 49.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.527 -0.733 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -102.91 111.73 24.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.959 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 44.5 t -99.8 146.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.954 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -48.25 134.21 14.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.29 -0.881 . . . . 0.0 108.987 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.92 -6.0 43.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -114.03 25.61 11.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -1.132 . . . . 0.0 109.27 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.464 ' OE1' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -53.09 -51.69 61.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.429 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 171' ' ' GLU . 82.3 mt-10 -50.56 -21.28 1.47 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.12 -0.988 . . . . 0.0 110.177 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.26 -7.9 59.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 111.619 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.58 -25.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.852 -1.155 . . . . 0.0 111.121 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.9 m -63.7 -24.44 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.438 -1.414 . . . . 0.0 109.005 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.66 -5.62 58.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.468 -0.77 . . . . 0.0 108.99 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.57 115.52 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.173 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.409 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 49.8 mtm180 -79.41 172.51 13.7 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.201 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.4 t -77.86 163.23 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -147.1 144.46 29.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.207 -1.558 . . . . 0.0 111.716 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.01 156.7 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.86 147.29 25.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 109.662 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -52.94 -35.97 59.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.429 -0.794 . . . . 0.0 109.698 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.2 p90 -72.91 -31.44 64.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.578 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.2 mm-40 -75.36 -35.74 61.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.017 -1.052 . . . . 0.0 109.375 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.404 ' O ' ' C ' ' A' ' 187' ' ' GLU . 77.1 mt -46.46 -55.61 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 109.786 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -43.8 -42.0 5.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.858 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -74.44 -48.4 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.988 . . . . 0.0 109.046 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.1 mt -51.09 -30.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.336 -0.852 . . . . 0.0 109.302 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -82.35 -52.02 7.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.782 -1.199 . . . . 0.0 109.143 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -47.29 -47.12 25.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.425 -0.797 . . . . 0.0 110.158 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.67 8.17 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.79 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.08 39.9 62.52 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 44.8 mt -126.45 170.91 11.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -1.082 . . . . 0.0 109.676 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.8 21.22 58.16 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -57.2 -21.67 35.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.557 -1.555 . . . . 0.0 109.807 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -113.48 25.19 11.38 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.36 127.53 8.4 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.458 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -141.18 169.4 17.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.124 . . . . 0.0 109.519 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 63.5 mt -70.7 -8.64 53.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -97.38 -12.66 22.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.609 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.458 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 17.9 p30 -132.71 8.67 4.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.89 149.76 30.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.967 -1.083 . . . . 0.0 110.481 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.0 tp -97.45 93.36 6.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.22 130.34 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.554 -0.716 . . . . 0.0 109.152 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 12.5 mt -124.15 166.26 16.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.159 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.08 -166.15 12.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -1.12 . . . . 0.0 109.366 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 209' ' ' ASP . 47.9 t0 -153.9 24.32 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -143.02 150.6 39.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 79.7 t -103.23 113.32 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -58.61 -49.76 76.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.012 -1.055 . . . . 0.0 110.04 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -58.1 111.81 4.03 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.231 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.54 -12.98 12.35 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.541 1.494 . . . . 0.0 111.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -17.54 59.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 110.035 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.7 -173.78 49.29 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -91.02 136.14 33.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -1.209 . . . . 0.0 109.462 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -75.32 -20.12 59.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 108.824 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.43 159.07 42.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.555 -0.716 . . . . 0.0 109.12 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.5 -12.79 61.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.82 51.17 1.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.28 -47.03 99.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 0.0 109.795 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 63.6 Cg_exo -49.9 -67.08 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.453 2.102 . . . . 0.0 112.342 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 m -59.16 -35.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.121 . . . . 0.0 109.571 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -60.66 -41.1 94.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 108.457 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.2 t60 -68.19 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.301 -0.874 . . . . 0.0 108.947 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -64.45 -37.63 88.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.07 -36.11 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.59 -57.37 9.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.532 -0.73 . . . . 0.0 109.137 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -61.58 -26.01 67.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.354 -0.841 . . . . 0.0 109.885 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 57.7 tp -78.2 -35.08 48.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 0.0 108.69 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.8 mt -66.0 -36.51 77.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.79 -59.76 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 99.4 m-20 -48.09 -36.1 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.274 . . . . 0.0 108.992 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.83 -22.78 66.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.547 -0.721 . . . . 0.0 110.317 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.604 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.27 -22.63 61.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.777 -1.202 . . . . 0.0 108.999 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.36 -3.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.688 -1.257 . . . . 0.0 110.204 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.604 ' H ' ' C ' ' A' ' 236' ' ' TYR . 10.5 mt -78.87 -16.34 57.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.906 -1.121 . . . . 0.0 109.695 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 2.63 56.37 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.172 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.66 154.54 9.13 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.747 -1.443 . . . . 0.0 109.287 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.16 128.77 31.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.91 1.74 . . . . 0.0 109.682 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 151.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 112.524 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -131.9 124.74 30.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.48 -158.41 27.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -129.08 132.89 47.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -1.155 . . . . 0.0 108.713 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.5 m-85 -131.92 140.09 48.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -126.76 125.34 41.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 m -120.93 135.44 55.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 111.015 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.403 ' C ' ' N ' ' A' ' 251' ' ' GLY . 30.4 t80 -116.1 114.84 25.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 17.38 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.092 -1.005 . . . . 0.0 109.007 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 249' ' ' PHE . . . -55.68 140.89 40.06 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.2 179.45 17.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.7 m-70 -62.21 -42.26 99.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.203 -1.174 . . . . 0.0 109.875 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.0 t -55.62 -58.92 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.07 -1.019 . . . . 0.0 109.572 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.99 -44.56 78.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 34.9 m-20 -47.59 -50.77 23.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.965 -1.085 . . . . 0.0 108.962 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.98 -49.55 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.524 -0.735 . . . . 0.0 109.84 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -54.88 -51.93 64.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.029 -1.044 . . . . 0.0 109.311 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.9 tp -50.06 -52.79 31.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 108.549 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.41 -51.45 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 108.746 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -50.16 -47.01 54.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 109.552 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -64.45 -48.95 73.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.957 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.42 -51.81 67.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.44 -27.3 65.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 110.251 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.445 ' CD ' ' OG1' ' A' ' 85' ' ' THR . 13.5 mm-40 -53.94 137.01 40.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.511 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 143.86 48.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -140.87 -171.96 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -97.05 133.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.998 -1.064 . . . . 0.0 109.397 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -64.68 -18.02 64.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.252 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -155.99 163.99 39.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.287 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 139.36 51.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.45 166.85 11.85 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -140.33 142.97 35.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 110.253 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' LEU . 91.6 m-85 -140.11 151.07 45.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.479 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.2 pt-20 -157.12 150.83 24.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.893 -1.129 . . . . 0.0 110.036 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.34 175.42 36.63 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.08 154.47 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -1.107 . . . . 0.0 110.003 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.01 140.15 15.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 tt -59.33 -38.67 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 110.396 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.4 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 59.7 m-70 -89.42 -50.49 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.784 -1.198 . . . . 0.0 111.067 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 p -70.41 -23.08 62.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.634 -0.666 . . . . 0.0 111.758 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.2 15.55 15.57 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.63 153.44 22.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.479 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 24.9 t80 -74.38 135.53 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.354 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.2 m -139.7 144.77 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -110.95 156.23 21.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.0 mt -135.53 147.67 48.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.42 -0.8 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.525 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 11.6 mt -143.81 114.11 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 108.882 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mt -98.41 114.61 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.372 -0.83 . . . . 0.0 110.774 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.525 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 9.3 m-70 -108.49 138.13 20.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -53.23 168.43 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.81 1.674 . . . . 0.0 111.65 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.556 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 58.9 mm-40 -141.22 177.54 8.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.031 -1.043 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.56 ' N ' ' HG1' ' A' ' 35' ' ' THR . 21.0 mttt -84.48 152.44 23.96 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.692 0.758 . . . . 0.0 110.161 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.16 142.82 2.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.167 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.436 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 69.53 10.26 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.258 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.56 ' HG1' ' N ' ' A' ' 32' ' ' LYS . 33.5 m -69.98 -42.43 73.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.573 -1.545 . . . . 0.0 109.798 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 178.95 35.58 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.351 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 37' ' ' ILE . 41.0 mm -95.44 116.32 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.407 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 7.1 ptm180 -141.14 150.26 42.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 110.582 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.31 157.03 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -128.41 111.82 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 108.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 44.4 tttm -134.68 132.62 39.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.534 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.5 m120 52.58 28.27 5.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.795 . . . . 0.0 111.372 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.07 19.64 69.34 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.187 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.81 122.6 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -1.063 . . . . 0.0 109.174 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.407 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 64.5 m-85 -84.73 127.19 33.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 109.729 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.9 mt -116.96 93.88 43.04 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.386 -0.822 . . . . 0.0 109.386 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.95 149.83 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.637 2.224 . . . . 0.0 112.105 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.05 68.48 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.421 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 3.9 mmt85 -123.08 175.69 6.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.276 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.8 p-80 -77.78 -51.65 10.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 110.28 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -43.06 -16.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 110.759 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.0 m-85 -98.11 2.96 49.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 110.295 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.46 128.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.001 -1.062 . . . . 0.0 108.896 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -31.65 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.131 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -151.52 132.01 13.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 p -120.88 96.02 4.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.6 t30 -162.65 128.9 3.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.916 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 83.8 m-70 52.72 5.37 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 0.0 109.02 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 165.14 155.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.588 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.432 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 55.1 m -94.64 126.76 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 109.2 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -119.0 148.02 43.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.507 -0.746 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.51 149.87 44.65 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.78 157.58 28.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.848 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -166.03 143.65 5.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 108.738 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.36 22.13 2.67 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.31 -32.04 7.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.452 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 80.4 mm-40 -59.81 148.31 34.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.312 . . . . 0.0 109.613 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.52 138.5 30.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 110.53 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.3 mt -129.67 123.89 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -99.93 155.95 17.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 111.259 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.9 m 49.96 74.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.59 -8.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 108.71 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 14.3 pm0 -60.86 -28.46 68.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 110.623 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.25 -68.76 0.35 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -51.98 -47.56 41.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.156 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.32 -47.32 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.84 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 48.5 t -61.13 -42.23 98.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.097 -1.002 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.24 -43.41 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.993 -1.067 . . . . 0.0 109.133 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.3 -34.99 78.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.159 -0.963 . . . . 0.0 109.167 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.18 -38.27 90.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.429 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.1 mt -77.59 -38.87 47.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.855 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.5 mt -81.81 0.08 40.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 109.411 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 55.93 42.72 28.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.645 -0.66 . . . . 0.0 111.365 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.34 145.32 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.782 -1.198 . . . . 0.0 108.192 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.445 ' OG1' ' CD ' ' A' ' 4' ' ' GLU . 82.7 p -129.35 -25.61 2.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.0 111.574 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.508 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 83.2 m-20 -124.26 106.87 10.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.867 -1.146 . . . . 0.0 110.362 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.0 m -164.36 148.49 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.415 -0.803 . . . . 0.0 110.289 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.556 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 88.8 m -115.88 109.38 17.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.71 100.15 10.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 109.859 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.17 125.89 28.42 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.94 123.55 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.707 0.765 . . . . 0.0 111.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 91.7 mt -110.25 96.36 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.25 -156.62 25.73 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -119.67 -11.03 9.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -1.149 . . . . 0.0 110.041 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -141.46 149.65 41.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.977 -1.077 . . . . 0.0 109.661 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.52 119.55 75.66 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.037 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -40.32 119.89 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.778 1.652 . . . . 0.0 111.378 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 tp -76.02 -13.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 110.098 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.7 mt 56.86 -118.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.25 -0.907 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 1.9 t0 -95.31 6.08 49.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.121 -0.987 . . . . 0.0 110.682 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.08 -0.91 60.62 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -127.52 -172.53 2.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.698 -0.884 . . . . 0.0 109.627 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.92 17.23 10.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.516 ' H ' ' HG ' ' A' ' 102' ' ' SER . 4.3 t-105 -59.57 -43.53 93.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.456 -1.026 . . . . 0.0 110.08 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 -57.87 8.24 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.062 -1.024 . . . . 0.0 109.852 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.47 -46.69 63.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -61.37 -49.3 77.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.0 -43.83 86.6 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.969 -1.082 . . . . 0.0 111.579 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.84 45.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 110.454 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.53 -31.97 56.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.968 -1.082 . . . . 0.0 109.161 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -63.2 -42.38 99.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.576 ' C ' HD21 ' A' ' 113' ' ' ASN . 7.4 pttp -79.15 10.44 3.56 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.983 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.576 HD21 ' C ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -138.23 32.25 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.55 137.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 110.855 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.28 118.6 21.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.566 -0.708 . . . . 0.0 109.274 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.628 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -79.88 145.8 32.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.028 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.22 -170.74 1.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.775 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.46 68.97 0.69 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 110.361 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.34 128.6 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.152 -0.967 . . . . 0.0 109.207 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.28 142.51 56.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.0 109.506 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.9 mt -84.39 149.33 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.2 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.58 87.68 3.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -66.52 145.36 55.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.184 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -88.22 101.41 13.81 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.88 133.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.456 0.646 . . . . 0.0 111.027 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.51 112.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.22 -30.12 17.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.959 -1.088 . . . . 0.0 110.534 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.42 81.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.86 148.69 41.26 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.562 2.174 . . . . 0.0 112.083 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 tt -156.8 148.93 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -0.833 . . . . 0.0 109.124 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.27 146.23 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.362 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.8 m -132.57 148.93 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.19 161.16 35.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.869 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -170.28 101.94 0.27 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 109.731 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 48.43 58.02 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.38 -35.52 3.31 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.584 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -62.18 136.3 57.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.339 . . . . 0.0 108.778 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tt -144.53 139.1 27.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.863 -1.148 . . . . 0.0 110.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.85 134.02 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.415 -0.803 . . . . 0.0 109.982 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -122.23 132.64 54.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.455 0.645 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.18 53.98 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.85 151.68 42.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 110.143 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.95 141.88 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.583 2.189 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.11 147.62 19.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -36.46 81.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.3 p -121.9 -169.22 1.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.846 . . . . 0.0 109.956 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.76 123.71 43.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 108.67 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -136.33 128.09 29.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.2 t -128.3 121.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.843 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.7 m -110.84 151.1 28.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.451 -0.781 . . . . 0.0 109.07 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -139.15 130.22 26.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -120.99 131.05 54.07 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.18 140.0 11.31 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.534 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -106.22 101.12 10.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.55 167.15 13.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.935 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -99.14 -15.56 18.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.624 -0.672 . . . . 0.0 110.911 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.1 p-10 -96.09 -168.63 1.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.803 -1.185 . . . . 0.0 110.084 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -55.85 2.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.0 111.446 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.9 mt -77.61 -27.34 51.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.408 -1.433 . . . . 0.0 108.13 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.38 29.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.4 135.64 42.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -1.123 . . . . 0.0 109.339 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -140.82 158.9 43.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.429 -0.794 . . . . 0.0 109.363 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -147.44 146.23 29.48 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.216 -0.927 . . . . 0.0 109.828 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -145.41 140.13 27.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 110.08 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.9 m -108.21 123.54 48.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 110.03 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.22 115.46 30.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.56 147.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -48.73 135.04 15.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.196 -0.94 . . . . 0.0 108.897 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.07 -10.23 36.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 0.6 OUTLIER -116.97 25.85 10.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -1.125 . . . . 0.0 109.15 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.45 -15.87 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 176' ' ' LEU . 1.9 tt0 -78.28 -8.11 57.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 110.887 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG3' HH21 ' A' ' 225' ' ' ARG . 1.0 OUTLIER -104.79 -5.07 21.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.993 -1.067 . . . . 0.0 111.302 -178.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 41.7 pt -115.65 -30.05 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.192 -0.942 . . . . 0.0 110.355 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.3 m -60.44 -18.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.017 -1.052 . . . . 0.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 172' ' ' GLU . 1.4 mp -93.92 0.85 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.008 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.55 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.05 117.39 11.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.922 . . . . 0.0 108.774 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 87.4 mtm180 -80.29 171.72 14.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.1 t -79.04 163.02 25.49 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -148.2 144.55 27.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.269 -1.519 . . . . 0.0 111.565 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.4 157.73 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.511 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.5 m-85 -99.35 146.56 26.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 109.558 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.99 -35.19 23.54 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.352 -0.842 . . . . 0.0 109.647 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.2 p90 -74.83 -30.32 61.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.983 -1.073 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.8 OUTLIER -73.56 -37.53 65.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.922 . . . . 0.0 109.967 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 187' ' ' GLU . 84.2 mt -48.93 -55.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.037 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -41.53 -41.73 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.062 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -75.62 -47.31 27.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 109.148 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.17 -25.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.845 . . . . 0.0 109.566 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -85.64 -55.19 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.874 -1.141 . . . . 0.0 109.335 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -48.63 -41.74 32.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.4 m -76.38 7.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.062 -1.024 . . . . 0.0 110.462 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.71 61.48 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.212 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.3 mt -128.33 171.96 11.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 109.372 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 59.16 21.98 54.57 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -59.99 -21.16 60.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.476 -1.603 . . . . 0.0 108.945 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -108.6 25.62 18.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.41 7.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' THR . 35.7 m -143.94 165.56 27.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -1.114 . . . . 0.0 109.582 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 27.8 mt -66.51 -8.68 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 17.7 ttpt -95.08 -17.2 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 15.8 p30 -132.24 8.75 4.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.64 149.48 31.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.976 -1.077 . . . . 0.0 110.405 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.8 tp -100.61 93.45 5.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.43 131.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.828 0.823 . . . . 0.0 108.914 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 60.2 mt -123.25 161.7 24.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.556 -0.715 . . . . 0.0 109.464 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.82 -166.23 12.61 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -64.67 -29.55 70.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 110.051 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.28 24.23 0.63 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.999 . . . . 0.0 111.208 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -150.93 159.3 44.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.309 -1.494 . . . . 0.0 110.839 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.36 111.86 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -54.83 -48.32 72.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.991 -1.068 . . . . 0.0 109.444 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.43 112.22 5.21 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -57.96 -19.84 41.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.823 1.682 . . . . 0.0 112.69 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.53 -15.49 61.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.056 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.67 -175.58 46.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 217' ' ' LEU . 7.2 mt -84.84 144.26 28.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -76.15 -18.06 59.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 108.759 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.84 -170.26 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.191 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.73 -7.33 37.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.114 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.68 48.84 1.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.246 -0.909 . . . . 0.0 109.612 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.95 -45.47 98.94 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.321 -0.862 . . . . 0.0 110.548 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.2 Cg_exo -54.62 -55.7 3.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.329 2.019 . . . . 0.0 112.876 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -68.31 -39.73 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.883 -1.135 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.41 HH21 ' HG3' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -68.89 -32.24 71.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.238 -1.539 . . . . 0.0 108.526 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.55 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 21.8 t60 -66.47 -35.46 80.32 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -64.41 -35.04 79.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.94 -35.67 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.59 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -68.21 -52.24 36.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.76 -30.8 71.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.816 . . . . 0.0 109.642 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.62 -32.44 58.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.135 -0.978 . . . . 0.0 108.755 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.78 -37.35 78.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.82 -55.96 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.555 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -54.36 -35.99 63.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.237 . . . . 0.0 108.936 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.08 -23.13 63.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.474 -0.766 . . . . 0.0 110.03 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.59 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.8 -21.77 61.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.043 -1.036 . . . . 0.0 108.659 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 79.6 mt -49.87 -4.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.641 -1.287 . . . . 0.0 110.329 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.59 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.4 mt -76.88 -17.25 59.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.974 -1.078 . . . . 0.0 109.861 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.421 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 100.23 2.17 55.78 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.943 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.47 153.91 10.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.42 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.91 128.54 30.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.013 1.809 . . . . 0.0 110.035 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 t -86.95 152.01 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 112.217 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -135.79 127.67 29.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.76 -158.37 27.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.486 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.4 ttmt -127.29 140.73 52.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 109.137 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.4 m-85 -138.91 140.69 38.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.059 -1.025 . . . . 0.0 110.394 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -124.3 132.58 53.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -129.59 136.1 49.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.062 . . . . 0.0 111.154 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 250' ' ' ARG . 39.3 t80 -117.33 116.81 27.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.1 mtt-85 45.03 48.16 9.53 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.055 -1.028 . . . . 0.0 108.516 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.29 143.94 24.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -124.33 160.96 18.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.432 ' ND1' ' HG1' ' A' ' 60' ' ' THR . 76.6 m-70 -46.4 -36.34 6.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -1.22 . . . . 0.0 109.492 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -58.11 9.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 108.986 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.5 tp -59.14 -44.21 92.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 0.0 109.239 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.3 m-20 -47.63 -54.31 12.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.555 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 258' ' ' LYS . 74.9 t -61.0 -56.84 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.424 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.0 OUTLIER -44.53 -49.68 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.96 . . . . 0.0 108.93 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.09 -61.59 2.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.896 -1.128 . . . . 0.0 108.605 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.8 t -47.2 -54.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -47.2 -52.83 14.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.345 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -59.1 -49.92 76.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.782 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 16.0 mt -53.15 -52.86 57.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.59 66.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.213 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -57.55 138.62 55.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.296 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 145.39 48.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.487 -0.758 . . . . 0.0 109.541 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -141.37 -173.95 3.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 m -96.19 135.69 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 0.0 109.212 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -66.49 -23.0 66.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.482 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 9.9 pt-20 -150.83 156.08 40.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 142.09 58.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 110.249 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -119.73 163.35 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 p -134.55 142.0 46.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.0 110.183 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 26' ' ' LEU . 96.8 m-85 -139.21 146.32 40.35 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -153.06 150.63 29.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.354 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.16 174.79 36.65 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.06 154.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.254 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.81 139.94 15.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tt -60.82 -37.0 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -1.168 . . . . 0.0 110.558 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.406 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 78.0 m-70 -89.58 -51.72 5.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.631 -1.293 . . . . 0.0 111.396 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 p -70.0 -23.25 63.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.701 -0.624 . . . . 0.0 111.653 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.78 20.14 46.34 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.182 -1.485 . . . . 0.0 109.6 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -111.83 154.03 25.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -1.118 . . . . 0.0 109.563 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.24 135.59 42.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.169 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.3 m -139.37 144.52 38.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.03 . . . . 0.0 109.845 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.96 155.7 23.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.448 -0.782 . . . . 0.0 109.668 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.6 mt -135.74 148.26 48.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.523 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 11.9 mt -143.58 112.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 108.928 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.86 114.91 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.42 -0.8 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.523 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 16.3 m-70 -107.83 139.17 20.36 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -52.82 168.23 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.849 1.699 . . . . 0.0 111.822 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.436 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 20.1 mm-40 -142.23 174.74 10.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.541 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -85.91 155.11 21.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -49.62 146.95 3.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.961 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.03 -0.54 29.72 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.978 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.8 m -65.43 -42.39 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.556 -1.555 . . . . 0.0 109.481 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.754 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 93.6 -177.36 37.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 37' ' ' ILE . 20.6 mm -99.52 115.31 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -137.5 151.5 48.51 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.993 -1.067 . . . . 0.0 110.498 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.17 157.57 16.48 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -129.99 110.69 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.853 . . . . 0.0 108.995 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HZ1' ' H ' ' A' ' 68' ' ' ARG . 19.3 tttm -134.69 133.81 40.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.596 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 48.38 34.31 4.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.59 -0.694 . . . . 0.0 111.59 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 17.04 80.26 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.472 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.89 120.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.105 . . . . 0.0 108.836 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 39.8 m-85 -86.84 129.14 35.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.187 -0.946 . . . . 0.0 109.734 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.43 96.97 50.48 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.647 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.25 146.43 31.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.229 1.953 . . . . 0.0 111.623 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.97 70.28 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.982 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.423 ' CG ' HH11 ' A' ' 49' ' ' ARG . 6.7 mtt-85 -127.22 171.55 11.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 0.0 109.003 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -73.25 -49.17 29.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.591 ' OE1' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mp0 -43.53 -17.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.889 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.4 m-85 -97.89 2.96 49.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.208 . . . . 0.0 109.938 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.06 129.07 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.372 -0.83 . . . . 0.0 108.781 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.74 -25.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.885 . . . . 0.0 110.281 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 t-80 -150.37 130.02 13.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.692 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.3 p -123.79 96.04 4.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.1 t-20 -158.42 128.49 5.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.5 m-70 46.54 13.12 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.89 152.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.796 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.8 m -96.24 128.16 42.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 55' ' ' HIS . 0.9 OUTLIER -120.28 148.67 43.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.652 0.739 . . . . 0.0 110.878 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -125.54 146.81 49.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.84 151.12 22.06 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.01 -1.567 . . . . 0.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -160.0 148.89 17.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.981 . . . . 0.0 109.145 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.09 26.39 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.858 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.53 -32.5 6.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.539 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 2.8 mm100 -57.38 140.25 50.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.149 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.667 ' H ' ' HZ1' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -134.65 134.09 40.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.849 . . . . 0.0 110.305 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.53 120.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -100.94 157.11 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.046 . . . . 0.0 111.119 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.0 m 48.97 75.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.72 -10.56 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 109.318 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.0 pm0 -60.79 -24.3 65.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.556 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -68.68 -68.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.126 -0.984 . . . . 0.0 109.232 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.1 tp -52.1 -48.11 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -52.79 -46.92 67.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 22.5 t -61.91 -43.24 99.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.432 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.82 -46.76 83.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.021 -1.05 . . . . 0.0 109.071 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.39 -34.42 78.26 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -63.29 -34.78 78.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.631 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.3 mt -81.6 -38.82 25.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 110.289 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.13 -0.39 39.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 0.0 110.005 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 61.53 39.84 14.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 111.383 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 84' ' ' ILE . 17.7 mm -85.81 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.698 -1.251 . . . . 0.0 108.026 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -123.73 -24.1 4.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 0.0 111.792 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.754 HD21 ' H ' ' A' ' 36' ' ' GLY . 27.7 m120 -123.84 107.18 11.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.917 -1.115 . . . . 0.0 110.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.6 m -164.35 148.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 110.468 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 99.3 m -115.54 113.04 23.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -95.36 100.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.184 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.6 126.73 30.95 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.54 128.21 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.98 0.895 . . . . 0.0 111.895 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.81 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.11 -159.78 27.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 -11.3 10.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.25 149.88 41.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.995 -1.066 . . . . 0.0 109.535 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.96 120.93 83.56 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 108.712 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -40.51 120.45 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.782 1.655 . . . . 0.0 111.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.62 -14.21 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.913 . . . . 0.0 110.476 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 mt 56.84 -118.43 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.029 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.86 6.75 47.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.23 59.48 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 p -128.76 -172.25 2.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.666 -0.902 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.3 15.2 9.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 2.7 t-105 -57.59 -42.44 83.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.272 -1.134 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.11 -57.2 9.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 110.122 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.42 -46.33 62.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.09 -54.08 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 0.0 110.821 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.44 -43.76 96.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.02 . . . . 0.0 111.53 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.67 -56.91 8.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.252 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.73 -32.83 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.158 -0.963 . . . . 0.0 109.383 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER -64.18 -42.72 96.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.6 13.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 110.041 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' OE2' ' A' ' 9' ' ' GLU . 15.7 m-80 -144.58 33.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 0.0 110.336 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.2 mt -79.81 138.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.28 123.35 29.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.23 148.3 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.62 -171.82 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -111.67 69.0 0.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -165.32 130.92 2.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.003 -1.061 . . . . 0.0 109.691 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.53 144.46 53.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.528 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.16 149.37 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.568 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -93.09 78.17 4.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.4 m-85 -58.1 140.67 52.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 109.409 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -88.87 101.44 14.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.68 134.3 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.528 0.68 . . . . 0.0 110.772 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.52 116.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.42 -27.01 16.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.528 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -130.74 149.76 74.53 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.15 150.0 41.91 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.589 2.192 . . . . 0.0 112.017 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 tt -157.37 151.01 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 142.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 0.0 109.513 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.93 145.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -133.25 156.72 47.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.002 . . . . 0.0 110.459 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -166.04 98.91 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.485 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 46.02 65.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 110.848 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.2 -38.02 3.0 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.89 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.9 mtt85 -65.44 133.67 51.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.862 -1.375 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.499 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.7 tt -146.58 138.92 24.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.053 -1.029 . . . . 0.0 109.973 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 139' ' ' ILE . 69.2 mt -135.57 125.87 42.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.458 -0.776 . . . . 0.0 109.523 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -114.3 133.44 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.532 0.682 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.29 133.61 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.08 151.56 48.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.787 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -50.14 143.23 25.94 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.382 2.055 . . . . 0.0 113.392 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.41 145.78 20.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -68.61 -5.01 17.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 110.488 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 p -148.45 -175.24 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.069 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 tp -98.32 120.06 38.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.084 -1.01 . . . . 0.0 108.702 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -137.27 122.84 19.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 108.553 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.37 122.58 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.723 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -113.52 152.22 30.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.494 ' HH ' ' N ' ' A' ' 251' ' ' GLY . 32.9 t80 -139.64 130.47 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.964 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.56 129.95 54.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.53 141.2 12.52 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.266 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -105.64 104.11 13.77 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -93.65 166.95 11.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -14.89 17.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.734 . . . . 0.0 110.485 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 159' ' ' LEU . 29.9 p-10 -93.96 -171.38 2.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.869 -1.144 . . . . 0.0 110.265 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -52.91 3.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.449 -0.782 . . . . 0.0 111.704 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.9 mt -83.35 -29.36 28.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.321 -1.487 . . . . 0.0 109.06 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.43 -140.67 36.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 134.41 38.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -1.145 . . . . 0.0 109.491 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.03 148.72 45.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -141.26 145.05 35.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.934 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -144.63 139.34 27.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.7 m -109.78 124.63 51.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 110.156 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -104.08 113.07 26.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.273 -0.892 . . . . 0.0 109.961 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.53 156.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -50.86 133.12 26.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.266 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.83 3.76 60.62 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 170' ' ' ASN . 3.4 m-20 -117.53 20.25 13.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 109.153 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -55.89 -56.57 18.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.291 -0.881 . . . . 0.0 110.017 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 171' ' ' GLU . 1.8 mt-10 -42.52 -25.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.545 ' O ' ' CZ ' ' A' ' 225' ' ' ARG . 12.5 mt-10 -80.74 -7.85 59.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 111.924 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.74 -25.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.663 -1.273 . . . . 0.0 111.817 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.77 -15.88 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.456 -1.403 . . . . 0.0 109.175 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.4 mt -92.27 -6.43 50.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.46 -0.775 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.448 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -67.43 116.19 7.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.173 -0.954 . . . . 0.0 108.847 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.507 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 74.5 mtm180 -77.57 172.84 12.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.516 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 t -77.25 162.28 27.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -146.81 149.07 32.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.21 -1.556 . . . . 0.0 111.493 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.06 43.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -98.97 146.97 25.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.537 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.11 -38.11 16.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.488 -0.757 . . . . 0.0 109.86 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -72.29 -28.9 63.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.827 -1.171 . . . . 0.0 109.605 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.0 mt-10 -71.93 -39.9 69.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.638 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 25.6 mt -47.37 -59.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.553 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 7.7 tp10 -41.81 -40.02 1.94 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.514 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 189' ' ' ILE . 13.3 t-160 -75.28 -60.89 2.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 108.887 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 188' ' ' HIS . 93.7 mt -41.85 -32.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.625 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -80.13 -52.07 8.22 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.764 -1.21 . . . . 0.0 109.193 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -48.17 -40.05 22.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 110.518 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.0 8.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.036 . . . . 0.0 110.522 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.74 39.65 54.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.406 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 mt -129.64 172.81 11.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -1.111 . . . . 0.0 109.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.65 20.57 56.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -57.56 -20.55 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.365 -1.668 . . . . 0.0 109.878 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.431 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.55 25.18 11.33 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.22 129.38 9.64 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.99 -1.3 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -143.88 172.75 12.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 109.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.9 mt -71.26 -7.8 49.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -99.35 -11.54 21.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 17.0 p30 -133.53 8.49 3.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 109.999 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -150.28 151.52 33.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.0 tp -99.5 93.93 6.14 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -85.34 128.96 38.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.832 0.825 . . . . 0.0 109.119 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.6 mt -123.53 162.81 22.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.615 -0.678 . . . . 0.0 109.289 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.33 -166.73 13.03 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.77 71.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.491 -1.005 . . . . 0.0 109.458 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.83 21.66 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -147.58 155.88 42.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.64 -1.287 . . . . 0.0 110.355 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.82 114.56 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -57.97 -47.02 84.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.046 -1.034 . . . . 0.0 109.904 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.86 121.83 61.12 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.139 -0.976 . . . . 0.0 109.768 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.87 -16.22 45.29 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.437 1.424 . . . . 0.0 111.794 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -15.12 59.54 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.63 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.47 -170.32 50.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 217' ' ' LEU . 6.3 mt -86.78 131.12 34.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -1.213 . . . . 0.0 109.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -63.15 -17.78 62.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.122 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CD2' ' CZ ' ' A' ' 225' ' ' ARG . 62.3 m-85 -144.73 -168.88 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -100.65 -0.24 37.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.247 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 30.49 1.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.034 -1.041 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 mt-10 -46.26 -51.17 35.35 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.026 -1.047 . . . . 0.0 110.013 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 76.4 Cg_exo -47.4 -68.01 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.118 1.878 . . . . 0.0 112.278 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 m -57.33 -34.84 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.963 -1.086 . . . . 0.0 109.991 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' CZ ' ' CD2' ' A' ' 219' ' ' TYR . 5.0 mtp180 -60.53 -42.85 97.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 108.381 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 6.9 t60 -65.78 -33.02 74.9 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.88 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.75 -36.77 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.4 t80 -65.98 -48.82 69.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.562 -0.711 . . . . 0.0 109.147 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -65.0 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.804 . . . . 0.0 109.776 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.5 tp -75.02 -31.77 61.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.816 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.84 -39.37 81.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.95 -54.79 19.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.36 -35.62 67.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.055 -1.262 . . . . 0.0 109.279 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -22.79 64.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 110.414 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.598 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.8 -22.28 60.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.164 . . . . 0.0 109.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.9 mt -50.93 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.639 -1.288 . . . . 0.0 110.6 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -77.46 -14.85 59.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.831 -1.168 . . . . 0.0 109.643 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.78 57.67 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.563 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.16 155.07 10.23 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.374 . . . . 0.0 108.937 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.1 Cg_endo -50.02 151.02 9.25 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.825 1.684 . . . . 0.0 109.566 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.43 140.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 112.044 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -121.86 119.12 30.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.9 -163.56 30.95 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.142 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.514 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -123.77 141.64 51.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -1.032 . . . . 0.0 109.078 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -139.6 139.64 36.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -127.02 118.38 24.35 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 133.83 53.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.005 -1.059 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -115.47 112.16 21.84 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.36 28.68 2.44 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.494 ' N ' ' HH ' ' A' ' 151' ' ' TYR . . . -72.61 149.13 42.99 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -121.78 -174.2 14.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.463 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.2 m-70 -63.74 -41.38 98.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.094 . . . . 0.0 109.741 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -58.63 6.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.032 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.402 HD12 ' HZ1' ' A' ' 258' ' ' LYS . 5.7 tp -55.29 -45.07 76.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.202 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 22.2 m-20 -47.73 -51.56 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.432 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.18 -42.27 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.402 ' HZ1' HD12 ' A' ' 255' ' ' LEU . 28.2 ttmt -61.41 -52.86 62.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -50.34 -49.63 53.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.091 -1.006 . . . . 0.0 108.423 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.03 -52.18 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -50.76 -49.52 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -61.54 -51.24 69.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.791 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.98 -48.45 75.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 109.738 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.34 71.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 109.801 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 108.954 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.288 0.566 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.596 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -53.18 129.02 29.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 142.07 50.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.182 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 t -141.94 -170.57 3.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.66 136.45 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -62.85 -20.48 65.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -152.15 -171.12 3.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.222 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 142.14 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.09 160.23 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.14 145.2 41.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.996 -1.065 . . . . 0.0 110.698 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 73.3 m-85 -139.83 155.09 47.43 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.05 151.69 19.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.809 -1.182 . . . . 0.0 110.319 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.43 174.77 36.1 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.85 151.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 110.128 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.63 137.98 16.38 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.95 -39.06 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.105 -1.232 . . . . 0.0 110.452 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -90.74 -50.65 5.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.724 -1.235 . . . . 0.0 110.966 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -70.31 -22.68 62.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.68 -0.638 . . . . 0.0 111.091 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.75 17.48 21.22 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.686 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -105.26 151.25 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -1.151 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -74.77 132.87 41.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.177 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 145.31 40.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 5.7 ttmt -113.02 156.42 23.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.0 mt -133.4 147.01 51.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.491 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.2 mt -141.38 108.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.917 . . . . 0.0 108.738 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.25 115.44 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 111.122 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.491 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 33.3 m-70 -111.12 139.81 22.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.578 -0.701 . . . . 0.0 109.689 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -52.57 168.33 0.46 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.048 1.832 . . . . 0.0 111.854 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 16.4 mm-40 -141.02 -178.97 5.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.162 -0.961 . . . . 0.0 109.798 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.6 mttm -89.45 154.4 20.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -47.62 142.46 4.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.329 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.11 11.22 63.44 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.466 -0.874 . . . . 0.0 110.949 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -72.02 -44.87 62.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.605 -1.526 . . . . 0.0 109.752 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -179.88 33.77 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.379 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mm -95.67 117.97 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 148.24 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.86 158.87 15.5 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -129.9 110.58 11.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 0.0 108.874 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' NZ ' ' H ' ' A' ' 93' ' ' GLY . 64.6 tttp -135.06 134.6 40.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 110.737 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.05 29.52 10.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.784 . . . . 0.0 111.341 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.56 17.27 77.94 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.355 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -1.126 . . . . 0.0 109.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -83.66 127.36 33.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.0 mt -115.48 93.81 37.76 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 109.436 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.55 145.8 16.07 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.412 2.075 . . . . 0.0 111.948 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.38 79.76 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -134.18 -179.89 5.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -74.99 -55.25 5.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 110.01 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 33.4 mt-10 -43.55 -17.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.795 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' HIS . 35.5 m-85 -95.17 0.62 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.884 -1.135 . . . . 0.0 110.104 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.8 t -68.48 129.46 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.415 -0.803 . . . . 0.0 109.173 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -112.38 -29.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.322 -0.861 . . . . 0.0 109.977 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -152.26 132.98 14.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.036 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.8 p -123.65 95.46 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 59' ' ' SER . 47.7 t-20 -162.95 129.21 3.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 108.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 84.6 m-70 48.97 10.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.056 -1.027 . . . . 0.0 108.711 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 163.0 157.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.9 m -102.86 127.76 49.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -121.33 152.37 39.05 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 111.024 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -128.14 152.18 48.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.31 151.86 21.96 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 118.824 -1.655 . . . . 0.0 110.956 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CD2' ' CD ' ' A' ' 65' ' ' LYS . 9.4 t80 -156.51 146.29 20.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -1.03 . . . . 0.0 109.676 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CD ' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 54.73 21.79 3.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.528 -0.732 . . . . 0.0 109.638 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.88 8.17 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.96 145.24 55.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.318 . . . . 0.0 109.343 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.91 142.86 34.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 110.333 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.13 125.94 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -100.21 156.67 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.081 . . . . 0.0 111.217 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m 49.27 73.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.071 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.78 -8.46 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.4 pm0 -61.02 -26.66 67.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.599 -0.688 . . . . 0.0 110.539 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.1 m170 -68.07 -68.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.941 -1.099 . . . . 0.0 109.46 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.14 -47.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.4 -48.33 68.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.6 t -59.66 -41.99 91.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.058 -1.026 . . . . 0.0 110.244 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.8 -44.02 89.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 109.168 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.29 -34.92 79.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -62.91 -38.88 92.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.72 -38.07 58.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.22 -1.46 53.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.978 . . . . 0.0 109.891 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 41.5 mt-10 55.75 42.24 29.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.385 -0.822 . . . . 0.0 111.121 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.414 HD12 HG21 ' A' ' 84' ' ' ILE . 46.0 mm -84.87 141.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.946 -1.096 . . . . 0.0 108.096 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.5 p -123.79 -23.71 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 0.0 112.027 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.493 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 80.4 m-20 -125.98 107.66 10.66 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.698 -1.251 . . . . 0.0 110.688 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.5 m -162.95 149.14 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.829 0.824 . . . . 0.0 110.442 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 45.2 m -116.71 113.77 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.65 100.92 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.467 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -70.24 124.57 24.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.96 119.0 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.587 0.708 . . . . 0.0 111.507 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mt -108.85 93.38 2.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.468 ' H ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.63 160.52 8.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -81.05 -5.55 57.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.914 -1.345 . . . . 0.0 111.091 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -142.06 149.11 39.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.602 -1.311 . . . . 0.0 110.276 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.89 121.82 86.1 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -41.52 127.81 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.585 1.523 . . . . 0.0 111.282 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 tp -81.76 -15.94 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.8 mt 58.1 -120.62 1.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.12 -0.988 . . . . 0.0 110.081 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 46.4 t0 -97.49 5.81 49.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.62 60.11 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.384 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.4 p -127.86 -172.62 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.896 . . . . 0.0 109.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.1 15.83 10.14 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CH2' ' CD ' ' A' ' 108' ' ' GLU . 6.1 t-105 -60.26 -43.56 96.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.48 -1.012 . . . . 0.0 110.317 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.71 -58.59 6.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.024 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.29 -45.16 62.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -61.9 -49.29 76.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 111.22 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CD ' ' CH2' ' A' ' 104' ' ' TRP . 1.6 mm-40 -65.5 -42.36 92.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.019 -1.05 . . . . 0.0 111.236 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.92 -54.2 24.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.017 -1.052 . . . . 0.0 110.286 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.29 -32.56 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -64.42 -42.55 95.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -76.16 12.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.74 32.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.165 . . . . 0.0 110.545 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -80.32 138.96 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.932 -1.105 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.52 125.53 34.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.546 -0.721 . . . . 0.0 109.157 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -78.27 145.42 35.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.352 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -115.06 -173.53 2.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.688 -0.632 . . . . 0.0 109.404 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.55 65.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.293 -0.879 . . . . 0.0 111.268 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.502 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -161.49 129.31 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 0.0 109.043 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -68.38 141.1 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 109.163 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.427 HD12 HG23 ' A' ' 121' ' ' ILE . 85.4 mt -82.16 147.77 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 110.427 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -95.66 84.12 3.88 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 55.1 m-85 -62.82 143.93 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -90.43 101.96 14.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -93.05 133.62 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.699 . . . . 0.0 111.193 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.47 115.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -98.78 -26.81 14.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 110.576 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.02 148.43 65.72 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.36 148.35 38.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.493 2.129 . . . . 0.0 111.899 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.29 152.27 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.957 . . . . 0.0 109.363 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.83 146.45 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.212 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.18 147.09 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -135.19 162.63 31.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.984 -1.072 . . . . 0.0 110.515 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -173.9 103.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 50.58 58.66 5.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 110.725 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.44 -32.59 2.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.421 HH21 ' H ' ' A' ' 252' ' ' GLY . 42.7 mtp180 -61.91 134.12 56.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.245 . . . . 0.0 108.26 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -146.1 137.79 24.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.77 -1.206 . . . . 0.0 110.446 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 79.6 mt -135.62 131.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.476 -0.765 . . . . 0.0 109.353 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -121.37 131.09 53.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.369 0.604 . . . . 0.0 109.839 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.88 134.62 54.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 151.07 47.31 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.131 -0.981 . . . . 0.0 109.659 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.71 143.27 12.87 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.481 2.121 . . . . 0.0 113.22 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.32 147.08 20.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.61 -6.6 26.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -148.66 178.68 8.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.942 -1.098 . . . . 0.0 109.741 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.98 120.8 32.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.996 . . . . 0.0 108.709 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.73 129.72 33.07 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.87 120.73 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -112.3 152.29 28.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.461 -0.774 . . . . 0.0 109.358 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.46 130.74 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.458 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 23.2 tt0 -120.84 130.36 53.92 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.22 137.79 9.57 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.465 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -103.06 100.14 10.06 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.21 166.93 13.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.008 . . . . 0.0 110.833 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -99.67 -18.56 17.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.563 -0.711 . . . . 0.0 110.652 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.4 p-10 -92.3 -170.0 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.227 . . . . 0.0 110.22 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -52.77 0.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 111.398 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.543 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.1 mt -79.02 -28.01 43.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.401 -1.437 . . . . 0.0 108.734 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.66 -138.48 33.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -101.93 134.64 44.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.233 -1.157 . . . . 0.0 109.671 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -138.53 151.72 47.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -141.09 144.8 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.76 135.29 27.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.3 m -105.03 121.93 44.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.698 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.415 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 7.7 t80 -102.66 113.12 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.22 148.75 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.767 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -49.36 131.26 20.35 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.261 -0.899 . . . . 0.0 109.026 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.7 -3.63 39.33 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 1.3 m-20 -114.6 24.46 11.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 0.0 109.183 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 173' ' ' GLU . 1.1 mt-10 -50.87 -56.48 12.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.293 -0.88 . . . . 0.0 109.882 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -44.62 -23.45 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.306 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' GLU . 6.6 mt-10 -83.24 -12.72 56.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 111.537 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.9 pt -121.44 -28.26 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.862 -1.149 . . . . 0.0 111.2 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.66 -27.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.556 -1.34 . . . . 0.0 109.395 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.52 -6.0 54.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.66 24.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.684 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.475 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -88.71 172.17 9.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -78.57 162.32 26.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.55 146.07 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.125 -1.609 . . . . 0.0 111.836 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.5 157.72 44.1 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.453 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 77.3 m-85 -100.96 147.77 25.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.414 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 22.8 p30 -54.23 -33.29 58.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 110.022 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.551 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 7.0 p90 -72.35 -28.76 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.818 -1.176 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.525 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -81.84 -37.33 27.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.099 -1.001 . . . . 0.0 109.985 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 94.3 mt -45.53 -59.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.966 -1.084 . . . . 0.0 109.475 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 14.9 tt0 -41.32 -39.4 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 109.763 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -73.94 -44.38 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.769 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 189' ' ' ILE . 98.2 mt -57.72 -27.59 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.555 -0.716 . . . . 0.0 109.579 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -84.67 -53.59 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.883 -1.136 . . . . 0.0 109.317 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -49.24 -42.48 40.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.1 m -75.68 6.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.978 -1.076 . . . . 0.0 110.294 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.41 39.65 50.32 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.0 mt -128.77 172.09 11.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.225 -1.162 . . . . 0.0 109.855 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.79 61.53 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -54.17 -21.51 9.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.636 -1.508 . . . . 0.0 109.85 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -115.35 25.8 9.56 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.07 124.31 7.1 Favored Glycine 0 N--CA 1.491 2.362 0 O-C-N 120.819 -1.401 . . . . 0.0 109.703 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.28 172.74 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.8 mt -69.13 -7.91 40.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 6.2 mmmt -91.58 -12.17 35.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.832 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -143.46 13.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.917 -1.114 . . . . 0.0 110.421 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -148.39 149.65 32.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.857 -1.152 . . . . 0.0 110.82 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 26.0 tp -99.11 93.51 6.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.81 129.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.868 0.842 . . . . 0.0 109.336 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.26 164.76 18.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.19 -166.45 12.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -26.44 68.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.499 -1.0 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.64 21.89 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -143.33 150.82 39.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.755 -1.215 . . . . 0.0 110.518 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.26 111.72 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -57.79 -51.37 69.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 110.236 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -57.62 111.66 3.75 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -58.36 -11.77 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.699 1.599 . . . . 0.0 111.772 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -17.28 59.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 110.2 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.7 -177.79 46.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.9 mt -88.81 143.28 27.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.767 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.596 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 37.1 mtp85 -73.46 -20.01 60.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.602 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 17.2 m-85 -146.83 169.81 18.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -82.28 10.77 6.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 38.11 0.49 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.407 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -55.08 -47.42 98.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.94 -1.1 . . . . 0.0 109.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 54.3 Cg_exo -50.53 -65.37 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.3 m -58.7 -36.34 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.602 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 60.7 mtt180 -60.48 -42.85 97.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.2 t60 -66.42 -32.48 73.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.355 -0.841 . . . . 0.0 108.964 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -65.66 -35.49 80.93 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.64 -36.73 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 61.6 t80 -65.24 -52.6 53.48 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.93 -29.7 70.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.842 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.79 -32.85 62.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.029 -1.044 . . . . 0.0 108.536 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.53 -40.85 85.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.41 -53.92 32.72 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.459 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 24.7 m-20 -56.79 -30.57 63.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.062 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.11 -24.44 65.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.66 -22.36 60.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.813 -1.18 . . . . 0.0 109.095 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 83.2 mt -49.16 -6.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.516 -1.365 . . . . 0.0 110.063 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.4 mt -72.28 -16.12 61.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.908 -1.12 . . . . 0.0 109.63 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.63 2.24 60.04 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.794 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.39 153.88 9.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.779 -1.424 . . . . 0.0 108.984 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.34 150.5 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.787 1.658 . . . . 0.0 109.618 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.48 148.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.009 -1.057 . . . . 0.0 111.861 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -128.92 122.95 31.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.34 -163.86 31.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -126.07 139.62 53.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 109.652 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 35.1 m-85 -136.4 139.43 42.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.458 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 56.8 t80 -126.19 125.36 42.31 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.3 m -120.36 136.77 54.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 0.0 111.579 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -118.28 113.14 21.02 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 47.59 47.35 17.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.13 150.57 23.95 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -122.66 178.53 16.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.459 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.9 m-70 -61.92 -38.26 87.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -1.19 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 11.0 m -60.08 -60.01 4.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.023 -1.048 . . . . 0.0 109.004 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.41 ' H ' ' NH2' ' A' ' 137' ' ' ARG . 24.4 tp -52.0 -47.59 64.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.09 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 19.7 m-20 -48.02 -50.9 26.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.84 -54.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.997 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -45.33 59.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.668 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.12 -55.44 27.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.02 . . . . 0.0 108.56 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 261' ' ' LYS . 15.2 t -56.81 -55.32 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.077 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 260' ' ' VAL . 0.1 OUTLIER -44.95 -48.51 11.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.1 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.22 -52.76 63.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.403 -0.811 . . . . 0.0 109.485 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.09 -50.09 59.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.28 -27.03 63.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.507 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 110.663 -178.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -52.5 142.27 18.19 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -123.05 144.73 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.33 -170.55 3.3 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.49 136.63 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.89 -1.131 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -19.68 65.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 110.078 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -154.23 156.33 36.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 138.06 58.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 109.809 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -118.77 163.99 16.05 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.48 142.23 48.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.91 150.18 46.85 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 9.6 pt-20 -158.91 151.28 21.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.926 -1.109 . . . . 0.0 109.923 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.55 173.66 35.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.44 148.34 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.232 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.67 137.07 16.21 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tt -59.09 -37.84 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.052 -1.263 . . . . 0.0 110.298 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.423 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 70.5 m-70 -88.85 -50.17 6.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.687 -1.258 . . . . 0.0 110.925 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 p -69.69 -20.76 63.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 111.544 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.36 12.88 6.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.15 156.61 18.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -1.018 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 67.4 t80 -74.39 135.11 42.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -138.41 144.09 40.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.88 155.16 24.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -135.87 146.41 47.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.35 -0.844 . . . . 0.0 109.953 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.509 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 mt -141.43 112.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 108.638 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.91 113.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 110.466 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.7 m-70 -107.47 137.72 19.74 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -54.77 168.73 1.02 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.685 1.59 . . . . 0.0 111.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 77.6 mm-40 -141.04 176.09 9.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.955 . . . . 0.0 109.769 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 18.6 mmtp -87.08 155.18 20.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -46.46 141.69 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.712 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 70.85 9.2 65.54 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.27 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.7 ' H ' HD21 ' A' ' 86' ' ' ASN . 53.5 m -71.53 -44.16 65.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.476 -1.602 . . . . 0.0 109.461 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.28 -179.87 35.1 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.512 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 mm -97.69 115.63 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -139.92 154.45 47.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.914 -1.116 . . . . 0.0 110.333 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -102.79 158.36 16.32 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -129.68 111.73 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.296 -0.878 . . . . 0.0 108.981 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -135.41 134.75 40.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.839 . . . . 0.0 110.621 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.495 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.7 m120 50.37 32.74 6.67 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 111.47 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 17.39 79.95 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.427 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -123.22 120.94 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.055 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -82.41 126.81 32.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.443 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.42 92.07 31.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.458 -0.777 . . . . 0.0 109.201 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.81 146.14 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.502 2.135 . . . . 0.0 112.287 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.35 70.24 10.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -122.86 166.89 14.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 109.448 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.615 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.6 p-80 -68.94 -53.85 18.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.615 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -44.99 -16.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' HIS . 41.1 m-85 -95.44 3.4 54.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.47 129.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 108.719 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.53 -29.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.841 . . . . 0.0 110.225 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.12 131.53 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.9 p -123.18 95.12 4.48 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.568 ' ND2' ' CD2' ' A' ' 58' ' ' HIS . 1.1 t-20 -163.33 130.68 3.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.568 ' CD2' ' ND2' ' A' ' 57' ' ' ASN . 73.7 m-70 50.46 8.8 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.041 -1.037 . . . . 0.0 108.848 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.9 157.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.54 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.415 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 36.2 m -100.55 127.71 46.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 109.254 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.78 151.85 41.23 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.799 0.809 . . . . 0.0 111.171 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mt -126.42 151.21 48.01 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.37 156.56 28.4 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.568 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -164.7 151.89 11.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -1.069 . . . . 0.0 109.273 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 53.1 21.66 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.256 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.09 7.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 85.7 mm-40 -60.64 148.15 39.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -1.209 . . . . 0.0 109.451 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.44 ' NH1' HD22 ' A' ' 94' ' ' ASN . 9.6 ttp-105 -144.48 140.81 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.478 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.82 126.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -101.47 156.19 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.898 -1.126 . . . . 0.0 111.299 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.2 m 50.93 74.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.2 -10.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.579 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.34 -28.56 69.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -64.8 -68.88 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.886 -1.134 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.39 -48.12 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.12 -0.987 . . . . 0.0 109.28 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.1 mt -50.88 -50.3 57.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.953 -1.092 . . . . 0.0 110.286 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 9.4 t -60.48 -42.81 97.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 110.164 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.71 -45.32 79.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.4 mt -68.16 -35.0 77.35 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.082 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.1 -31.77 72.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.848 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.2 mt -83.34 -36.92 24.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.29 4.44 17.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.733 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 53.8 38.76 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.957 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.0 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.496 ' OG1' ' OD1' ' A' ' 86' ' ' ASN . 72.6 p -126.13 -18.9 4.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.181 -0.949 . . . . 0.0 111.762 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.712 HD22 ' N ' ' A' ' 34' ' ' GLY . 3.0 m120 -126.98 107.9 10.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.843 -1.161 . . . . 0.0 110.956 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 6.7 m -163.95 148.18 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.377 -0.827 . . . . 0.0 109.971 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 27.9 m -117.06 110.04 17.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -94.08 103.73 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -77.33 127.51 32.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.41 128.99 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.98 0.895 . . . . 0.0 111.734 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mm -112.2 95.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.44 -155.83 24.89 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.44 HD22 ' NH1' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -120.18 -10.45 9.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -1.107 . . . . 0.0 110.13 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -141.06 149.91 42.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.926 -1.109 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.5 mm -72.68 121.66 85.52 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 109.182 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -41.15 127.26 2.83 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.641 1.561 . . . . 0.0 111.175 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 tp -81.27 -12.61 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.5 mt 55.25 -121.15 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.4 9.32 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.927 -1.108 . . . . 0.0 111.192 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.49 -2.98 65.5 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.242 -1.456 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -172.09 2.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.625 -0.926 . . . . 0.0 109.628 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.1 15.72 12.11 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -56.39 -43.83 79.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -1.088 . . . . 0.0 110.232 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -57.46 8.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.089 -1.007 . . . . 0.0 110.143 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -51.68 -47.95 63.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 109.871 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.59 -49.18 77.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 111.214 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.92 -43.02 89.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 111.368 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.77 -54.95 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.939 -1.101 . . . . 0.0 110.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.1 mt -63.45 -34.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 109.477 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -62.81 -41.72 99.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -78.07 12.83 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.822 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -142.54 31.17 1.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.971 -1.08 . . . . 0.0 110.327 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.409 HG22 HD12 ' A' ' 114' ' ' ILE . 78.3 mt -80.05 138.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 110.478 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -129.76 122.49 28.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 147.86 42.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.93 -174.87 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -110.62 66.36 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.137 -0.977 . . . . 0.0 111.222 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.4 129.52 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.865 -1.147 . . . . 0.0 109.379 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.42 141.55 56.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.783 -1.198 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.2 150.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 110.266 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -97.46 81.89 3.03 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 31.2 m-85 -59.33 142.04 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -88.06 101.3 13.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.01 132.65 35.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.412 0.625 . . . . 0.0 110.643 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.93 111.17 2.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.56 -31.67 26.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.02 -1.05 . . . . 0.0 110.323 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 155.47 75.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.627 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.05 153.5 57.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.529 2.153 . . . . 0.0 112.103 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 tt -159.59 153.07 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -0.789 . . . . 0.0 109.273 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.36 141.89 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.92 150.05 33.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -135.76 158.93 43.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.61 106.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.929 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.9 51.55 15.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.25 3.32 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.146 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -61.61 137.4 58.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.963 -1.316 . . . . 0.0 108.639 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.9 tt -145.03 138.11 26.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 110.251 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mt -134.97 132.54 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.569 -0.707 . . . . 0.0 109.556 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -121.39 130.82 53.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.696 -0.628 . . . . 0.0 109.948 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.06 137.14 54.92 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -149.28 149.63 29.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.47 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 40.6 Cg_exo -47.74 143.73 12.26 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.491 2.127 . . . . 0.0 113.572 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.4 144.32 19.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -5.4 2.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.61 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -154.04 -174.89 5.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.1 tp -93.76 122.04 35.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.132 -0.98 . . . . 0.0 108.933 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -135.86 126.63 27.38 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.82 123.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 m -113.68 152.62 30.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.684 -0.635 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -138.95 131.78 29.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.123 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -120.91 135.23 55.24 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 137.06 8.59 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.633 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.81 97.91 7.99 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.95 167.09 16.22 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 110.937 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' NZ ' ' A' ' 208' ' ' LYS . 16.5 mtpp -100.01 -15.25 18.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.6 p-10 -95.01 -168.18 1.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.125 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -57.16 2.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -0.787 . . . . 0.0 111.296 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.5 mt -79.03 -26.63 43.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.455 -1.403 . . . . 0.0 108.28 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.3 -137.53 37.68 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 131.25 45.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.4 -1.059 . . . . 0.0 109.295 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.22 146.23 44.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -0.792 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.667 ' CB ' ' HZ2' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -142.26 148.01 37.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.371 -0.83 . . . . 0.0 110.366 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -146.53 140.39 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 110.044 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.1 m -107.21 123.41 48.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 109.732 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -103.06 112.8 25.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.902 . . . . 0.0 110.312 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.69 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.875 . . . . 0.0 109.673 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -48.16 134.38 14.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.413 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 107.58 -9.12 37.86 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -120.84 26.43 9.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.8 OUTLIER -68.25 -16.01 63.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.74 -8.84 57.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 0.0 109.894 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -106.15 -5.5 19.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.37 -33.38 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.32 -0.862 . . . . 0.0 109.632 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.4 m -64.11 -23.67 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 108.395 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.75 -7.2 59.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.05 119.47 12.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 108.963 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -80.62 173.01 13.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 109.514 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.5 t -77.18 162.01 27.74 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -148.25 141.65 25.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.312 -1.492 . . . . 0.0 111.71 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -139.32 156.72 46.84 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -98.2 143.64 28.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.264 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 183' ' ' ASP . 3.3 t0 -47.7 -35.32 9.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -0.85 . . . . 0.0 109.59 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.545 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -73.13 -29.87 63.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.883 -1.136 . . . . 0.0 109.681 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.545 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 4.6 tt0 -75.38 -41.21 56.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.447 ' O ' ' C ' ' A' ' 187' ' ' GLU . 49.5 mt -46.17 -56.71 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -0.983 . . . . 0.0 110.031 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.6 -40.08 1.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -76.19 -53.79 7.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.875 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.86 -26.8 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.452 -0.78 . . . . 0.0 109.624 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.98 -53.64 5.17 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.785 -1.197 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -47.58 -44.9 26.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 110.217 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.99 8.67 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.9 54.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.818 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.402 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 50.9 mt -128.04 172.03 11.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -1.196 . . . . 0.0 109.687 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.423 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 57.39 24.83 53.41 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -60.14 -19.62 54.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.714 -1.462 . . . . 0.0 110.304 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -106.43 4.33 37.53 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.05 129.99 41.54 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.107 -1.231 . . . . 0.0 110.307 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.63 165.13 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.997 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.81 -8.4 43.1 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -97.09 -10.41 26.11 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.455 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 19.1 p-10 -140.3 9.82 2.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 m -145.27 147.09 31.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.106 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.4 tp -97.8 93.86 6.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -88.45 130.51 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.569 0.7 . . . . 0.0 109.281 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 18.3 mt -123.33 -178.46 4.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 109.605 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.95 -166.13 10.54 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 156' ' ' LYS . 8.2 mmtt -64.59 -20.75 66.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -1.104 . . . . 0.0 109.401 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.34 22.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.848 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -140.78 148.51 40.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.046 -1.033 . . . . 0.0 110.34 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.38 110.55 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -57.74 -45.22 86.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.987 -1.071 . . . . 0.0 109.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.8 118.82 45.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.642 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.23 -14.52 43.34 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.401 1.401 . . . . 0.0 112.017 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.85 -14.73 60.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.057 -1.027 . . . . 0.0 108.78 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.04 52.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.5 mt -86.14 134.99 33.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -1.206 . . . . 0.0 109.617 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -64.17 -19.58 65.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 108.824 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.663 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.5 m-85 -139.89 -164.16 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.118 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.65 -21.41 17.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.12 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 48.38 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.448 -0.783 . . . . 0.0 109.463 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.515 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -53.8 -47.92 95.19 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.995 . . . . 0.0 109.992 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.7 Cg_exo -48.67 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.164 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.87 -36.76 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.976 -1.078 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.663 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 74.8 mtt180 -60.09 -41.74 93.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 108.267 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -68.02 -30.56 69.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.905 . . . . 0.0 108.859 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.75 -36.0 82.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -68.48 -37.72 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.54 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.8 t80 -64.1 -52.1 60.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.546 -0.721 . . . . 0.0 109.175 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.25 -27.31 68.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.74 -33.2 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.161 -0.962 . . . . 0.0 108.57 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.66 -38.81 79.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -57.58 9.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.492 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.4 m-20 -54.35 -37.26 64.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -1.211 . . . . 0.0 109.06 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mt -61.99 -24.68 67.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 0.0 110.271 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.617 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.2 t80 -72.85 -20.85 61.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.162 . . . . 0.0 109.35 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 83.8 mt -50.67 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.858 -1.151 . . . . 0.0 110.591 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.617 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.9 mt -74.59 -14.23 60.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.779 -1.2 . . . . 0.0 109.854 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.17 1.69 59.41 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.575 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.1 m -164.94 153.11 10.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.259 . . . . 0.0 108.751 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.6 Cg_endo -50.06 150.4 10.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.806 1.671 . . . . 0.0 109.48 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.66 142.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.812 -1.18 . . . . 0.0 112.056 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -124.05 119.82 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.96 -165.94 32.33 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.525 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.2 tmtt? -123.39 142.06 51.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -1.022 . . . . 0.0 108.581 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 9.7 m-85 -139.52 142.16 37.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.981 -1.074 . . . . 0.0 110.63 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -126.28 132.56 51.64 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -126.93 137.7 53.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 111.145 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -119.32 116.83 27.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 47.09 28.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.182 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.0 153.31 52.89 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -134.52 170.39 22.71 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.579 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -49.92 -36.52 27.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -1.166 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 254' ' ' SER . 0.3 OUTLIER -58.84 -58.19 9.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.701 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.21 -45.02 92.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.071 -1.018 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.5 m-20 -47.77 -51.39 22.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.566 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.94 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.339 -0.85 . . . . 0.0 109.404 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -50.97 -51.07 56.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 109.209 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.0 tp -51.26 -51.62 52.44 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 108.487 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.14 -53.86 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.948 . . . . 0.0 109.104 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -46.78 -41.66 15.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -70.98 -50.32 35.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.905 . . . . 0.0 109.802 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 38.2 mt -57.28 -47.64 80.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.05 75.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.968 179.799 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.11 137.52 51.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.088 -1.008 . . . . 0.0 108.473 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -123.23 144.89 49.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -143.41 -168.85 2.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.97 136.31 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -12.96 56.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.39 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 8.5 pt-20 -156.15 -172.71 4.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 141.92 28.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 mt -119.15 166.15 13.3 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.8 144.54 37.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 110.328 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 76.1 m-85 -140.0 156.23 46.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -163.59 149.23 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 109.581 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.95 173.35 35.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 p -79.32 150.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -1.074 . . . . 0.0 110.518 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.63 141.18 15.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -60.67 -39.66 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -1.154 . . . . 0.0 111.189 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 75.2 m-70 -88.14 -49.44 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 111.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -72.18 -21.68 61.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.664 . . . . 0.0 111.842 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.27 16.88 22.29 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.08 -1.533 . . . . 0.0 109.558 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.48 156.14 20.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -1.152 . . . . 0.0 109.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.39 136.68 39.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.88 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -135.64 141.12 45.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.36 155.71 21.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 109.723 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' PHE . 7.3 mt -137.89 149.38 46.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.519 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -141.71 109.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.54 116.65 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.165 -0.96 . . . . 0.0 111.049 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.519 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 21.4 m-70 -112.77 139.75 23.19 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.442 -0.786 . . . . 0.0 109.542 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -54.26 168.59 0.91 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.895 1.73 . . . . 0.0 111.916 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 14.4 mm-40 -138.0 178.18 7.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.593 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.505 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.9 mtmm -87.16 152.76 22.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.981 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -48.36 146.21 2.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.642 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.751 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 68.35 8.49 55.44 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.729 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.67 ' H ' HD21 ' A' ' 86' ' ' ASN . 26.4 m -73.42 -45.84 52.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.608 -1.525 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.66 -178.92 30.2 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.662 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.4 mm -97.9 117.18 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -142.07 150.14 40.84 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.7 157.12 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -129.69 110.72 12.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 108.974 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.666 ' NZ ' ' NE2' ' A' ' 67' ' ' GLN . 17.5 tttm -135.96 135.97 40.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.582 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m120 51.03 28.17 3.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 111.183 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.23 74.76 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.024 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.95 120.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -1.065 . . . . 0.0 108.946 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 29.3 m-85 -86.86 129.0 35.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.066 -1.021 . . . . 0.0 109.169 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 52.8 mt -120.12 96.95 49.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.238 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -53.07 149.3 27.71 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.081 1.854 . . . . 0.0 111.101 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.7 72.16 10.36 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -127.55 175.61 8.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -73.19 -50.74 20.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -43.72 -17.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.184 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' HIS . 54.2 m-85 -98.2 0.07 45.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.128 . . . . 0.0 110.258 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.81 130.91 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 108.722 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 m -114.3 -28.7 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.326 -0.859 . . . . 0.0 110.088 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -152.81 131.62 12.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.956 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.3 p -121.75 95.09 4.53 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.602 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.3 t-20 -163.11 128.74 3.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.399 -0.813 . . . . 0.0 109.064 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 76.9 m-70 50.25 6.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.962 . . . . 0.0 109.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.602 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.1 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.7 m -81.38 129.18 34.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 0.0 109.247 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.92 150.43 42.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.357 -0.839 . . . . 0.0 111.172 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -126.0 147.66 49.48 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.69 160.41 32.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.248 -1.453 . . . . 0.0 110.243 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.24 149.58 10.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -1.123 . . . . 0.0 109.329 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.65 21.47 3.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.411 -0.805 . . . . 0.0 109.938 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.53 -30.94 8.95 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.681 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.693 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.78 145.06 50.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.763 -1.433 . . . . 0.0 108.855 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 4.7 mtt180 -137.46 149.76 47.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.019 -1.051 . . . . 0.0 111.874 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.29 128.45 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -105.14 155.28 19.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.892 -1.13 . . . . 0.0 111.338 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.2 m 51.5 74.57 0.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.894 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -108.24 -9.58 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.037 -1.039 . . . . 0.0 109.63 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.0 pm0 -61.13 -26.8 67.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 110.689 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 25.4 m170 -66.88 -68.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.958 -1.089 . . . . 0.0 109.375 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -51.84 -47.64 40.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.048 -1.033 . . . . 0.0 109.058 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.9 mt -54.13 -47.42 71.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.889 -1.132 . . . . 0.0 110.478 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 25.2 t -60.23 -41.75 93.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.004 -1.06 . . . . 0.0 109.817 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -57.5 -45.81 85.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 108.955 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.97 -35.0 79.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 109.247 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.05 -40.25 97.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 0.0 109.202 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.0 mt -75.68 -38.48 58.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.22 -0.48 45.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.842 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 56.42 41.97 28.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 111.303 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 84' ' ' ILE . 37.1 mm -88.33 138.47 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.741 -1.224 . . . . 0.0 108.158 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.491 ' OG1' ' OD1' ' A' ' 86' ' ' ASN . 70.7 p -126.56 -20.62 4.31 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.213 -0.929 . . . . 0.0 111.451 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.751 HD22 ' N ' ' A' ' 34' ' ' GLY . 3.3 m120 -124.2 106.45 10.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.02 -1.05 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.6 m -166.07 150.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.654 0.74 . . . . 0.0 110.2 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.464 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 55.8 m -117.11 114.61 23.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mt -95.69 100.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.432 -0.792 . . . . 0.0 109.988 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -74.27 122.88 23.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.69 124.75 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.845 0.831 . . . . 0.0 111.906 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.4 96.22 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.52 -158.51 27.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -122.19 -11.68 8.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -1.111 . . . . 0.0 110.196 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -140.63 149.38 42.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 96' ' ' ILE . 41.2 mm -73.06 127.24 89.69 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.06 132.32 14.5 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.033 1.822 . . . . 0.0 111.276 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.91 -20.85 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.12 -0.987 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.9 mt 58.64 -119.69 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.91 4.71 49.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.908 -1.12 . . . . 0.0 110.95 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.78 0.04 56.45 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.332 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -172.28 2.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.718 -0.872 . . . . 0.0 109.676 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.84 13.17 9.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 47.9 t-105 -56.0 -40.54 73.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 110.742 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.44 -59.28 4.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 11.0 m-85 -51.3 -45.56 62.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.68 -49.99 75.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.772 -0.58 . . . . 0.0 110.806 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.99 -43.36 99.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.245 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.05 6.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.703 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.1 -30.28 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.212 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -66.11 -44.37 84.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.412 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.406 ' HG3' HD21 ' A' ' 113' ' ' ASN . 15.0 ptpt -76.36 8.72 3.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.882 -1.136 . . . . 0.0 110.431 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' OD1' ' OE1' ' A' ' 9' ' ' GLU . 8.0 m-80 -140.58 35.87 1.83 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.945 -1.097 . . . . 0.0 110.267 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.65 143.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.12 . . . . 0.0 110.88 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 tp -133.51 129.68 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.429 -0.795 . . . . 0.0 109.431 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.75 138.81 31.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -108.48 -173.53 2.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.73 . . . . 0.0 109.108 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.62 70.66 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.958 . . . . 0.0 110.685 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -167.4 129.68 1.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -65.96 140.54 58.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.086 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.3 mt -84.42 150.25 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 109.894 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -93.24 76.67 4.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.858 . . . . 0.0 108.792 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -58.21 142.79 46.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.3 101.97 14.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.22 133.64 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.686 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.77 116.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -92.0 -28.71 17.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.65 156.99 78.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.943 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.56 150.15 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.913 2.409 . . . . 0.0 112.39 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.21 151.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.828 . . . . 0.0 109.323 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.82 145.91 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 109.366 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.12 147.98 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -131.78 161.32 33.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.137 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -170.35 102.21 0.27 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 110.082 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 47.6 59.26 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.805 . . . . 0.0 110.677 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.78 -35.86 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.456 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -62.94 135.98 57.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.362 . . . . 0.0 109.132 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.2 tt -143.08 139.36 30.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 110.148 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 91.4 mt -137.47 134.13 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 0.0 109.734 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.75 131.48 53.61 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.53 0.681 . . . . 0.0 109.998 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.37 55.22 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.01 150.47 45.84 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.103 -0.998 . . . . 0.0 110.197 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -48.37 142.51 17.02 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.566 2.177 . . . . 0.0 113.35 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.76 147.24 18.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -69.84 -18.07 63.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.3 p -133.51 -173.33 3.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.49 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 16.3 tp -102.43 123.02 45.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.83 129.04 29.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.632 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.09 121.34 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.557 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.1 m -112.27 152.15 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.488 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 37.6 t80 -138.83 129.72 26.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.965 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -120.57 131.91 54.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.0 132.3 6.21 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.701 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.24 97.59 9.29 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.57 166.98 19.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.368 -0.832 . . . . 0.0 111.169 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -105.87 23.6 13.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.752 -0.593 . . . . 0.0 110.034 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.4 p-10 -140.53 -169.74 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.053 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -47.15 -4.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.618 -0.676 . . . . 0.0 111.664 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 17.5 mt -85.27 -28.63 25.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.334 -1.479 . . . . 0.0 109.111 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.14 -132.47 41.83 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.615 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 4.4 ttm105 -97.02 129.84 44.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.302 . . . . 0.0 109.8 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.628 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -132.81 139.36 47.47 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -137.57 144.05 41.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -143.56 136.12 27.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.724 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.3 m -106.98 124.53 49.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.417 -0.802 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -105.8 118.48 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.0 t -113.59 158.42 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.75 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 30.9 mt-10 -50.18 125.15 11.71 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 108.92 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.89 6.59 39.94 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -120.31 15.81 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.245 . . . . 0.0 108.698 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -49.63 73.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.404 -0.81 . . . . 0.0 110.034 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -51.2 -22.33 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.12 -6.99 58.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 0.0 111.441 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 8.9 pt -124.95 -27.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.888 -1.133 . . . . 0.0 111.552 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.98 -24.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.528 -1.358 . . . . 0.0 108.694 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -5.54 58.64 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.407 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.32 118.5 11.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.189 -0.944 . . . . 0.0 109.005 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 41.3 mtm180 -81.21 171.8 14.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.197 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -77.94 164.16 25.36 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -149.3 146.03 27.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.168 -1.582 . . . . 0.0 111.629 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.81 158.93 43.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -101.24 146.03 28.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 9.9 p30 -52.08 -32.91 36.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.233 -0.917 . . . . 0.0 109.935 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.1 p90 -71.8 -26.16 62.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.756 -1.215 . . . . 0.0 109.645 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.449 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 tt0 -83.81 -40.29 18.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.101 -1.0 . . . . 0.0 110.049 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 67.2 mt -43.17 -59.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.614 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.8 tp10 -42.1 -38.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.85 -42.81 38.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.137 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.97 -27.6 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.579 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.64 -53.15 5.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.666 -1.271 . . . . 0.0 109.143 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -50.99 -41.17 59.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 110.172 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.56 4.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.82 38.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.2 mt -129.89 171.36 12.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -1.141 . . . . 0.0 109.684 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.94 24.82 58.59 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.487 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.6 -18.48 41.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.425 -1.633 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.24 25.22 10.02 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.09 130.18 9.96 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.8 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.6 t -144.42 171.2 14.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.679 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.426 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 59.5 mt -69.78 -8.41 47.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -98.69 -13.75 20.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.642 -0.661 . . . . 0.0 109.696 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 18.7 p30 -130.33 7.1 4.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -149.19 150.13 32.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.96 95.26 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.05 127.87 40.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.985 0.898 . . . . 0.0 109.497 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 mt -123.28 164.89 17.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.613 -0.68 . . . . 0.0 109.303 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.04 -166.63 11.98 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -34.79 73.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.507 -0.996 . . . . 0.0 109.325 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -153.41 23.76 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.926 -1.109 . . . . 0.0 110.74 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -142.12 149.04 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.614 -1.304 . . . . 0.0 110.702 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.4 t -101.49 111.05 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.19 -46.41 85.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.977 -1.077 . . . . 0.0 110.148 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.1 118.28 31.48 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.927 . . . . 0.0 109.827 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -67.6 -17.2 48.15 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.85 -14.32 61.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.296 -0.878 . . . . 0.0 108.99 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.8 -176.98 45.28 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 217' ' ' LEU . 6.4 mt -84.37 153.05 23.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -1.208 . . . . 0.0 109.558 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.564 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -82.2 -18.4 42.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.0 m-85 -145.53 -165.14 2.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -0.751 . . . . 0.0 108.998 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.19 -4.84 28.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.309 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.675 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -141.91 40.86 1.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.85 -47.36 97.09 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.876 -1.14 . . . . 0.0 109.584 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.7 Cg_exo -51.8 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.375 2.05 . . . . 0.0 112.076 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.9 m -58.86 -35.06 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 109.624 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NH1' ' CD2' ' A' ' 219' ' ' TYR . 58.2 mtt180 -60.21 -40.66 90.92 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.9 t60 -69.43 -32.1 70.85 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.162 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 7.2 mmtp -64.88 -35.73 82.08 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.72 -40.85 84.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.539 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.5 t80 -61.78 -51.46 68.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.611 0.719 . . . . 0.0 109.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.6 -27.48 68.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.6 tp -77.46 -34.24 54.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.094 -1.004 . . . . 0.0 108.777 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 57.9 mt -68.31 -38.5 79.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.92 -56.8 11.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 2.2 m-20 -53.16 -35.06 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.238 . . . . 0.0 108.671 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.01 -23.51 66.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.639 -0.663 . . . . 0.0 110.325 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.04 -21.8 61.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 108.821 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 53.3 mt -51.22 -1.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.619 -1.3 . . . . 0.0 110.416 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.9 mt -77.86 -15.61 58.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.903 -1.123 . . . . 0.0 109.526 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.68 58.01 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.14 -1.029 . . . . 0.0 110.605 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.64 153.88 10.13 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.901 -1.352 . . . . 0.0 109.127 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.66 130.22 39.14 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.904 1.736 . . . . 0.0 109.939 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 68.5 t -86.22 147.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 122.204 1.002 . . . . 0.0 112.558 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -131.34 124.71 30.96 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.28 -155.58 26.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -131.8 133.77 45.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.315 -1.109 . . . . 0.0 109.119 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.8 m-85 -135.09 140.01 45.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.459 ' CD1' ' C ' ' A' ' 247' ' ' TYR . 4.1 t80 -125.34 132.23 52.87 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.2 t -127.62 136.85 52.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.25 112.97 20.8 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 53.41 24.91 4.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.97 153.0 48.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.49 177.5 18.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.585 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 74.8 m-70 -57.72 -36.25 71.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -1.187 . . . . 0.0 109.427 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 29.6 t -58.97 -58.62 7.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.0 tp -59.53 -44.6 93.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.501 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -47.94 -50.62 26.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 109.286 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.18 -50.44 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.16 -50.9 63.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.06 -1.025 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 28.8 tp -52.22 -59.36 4.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 108.447 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.1 t -48.39 -55.58 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.032 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -46.39 -47.53 18.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.17 -47.02 78.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -59.51 -49.79 76.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.13 69.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 4.3 mmtp . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.435 ' CD ' HD22 ' A' ' 86' ' ' ASN . 70.8 mt-10 -55.22 139.85 40.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 108.833 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.81 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.907 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -140.55 -172.71 3.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -97.93 136.38 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.003 -1.06 . . . . 0.0 109.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -23.29 65.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.549 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 2.5 pt-20 -146.92 170.04 17.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 141.08 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.3 mt -120.03 166.47 13.33 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 143.18 41.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.071 -1.018 . . . . 0.0 110.418 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -139.24 154.15 47.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.98 150.8 15.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.875 -1.141 . . . . 0.0 110.019 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.22 174.98 36.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 p -82.81 153.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.115 . . . . 0.0 110.183 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.86 140.11 16.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.52 -37.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.916 -1.344 . . . . 0.0 110.379 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 45.8 m-70 -86.77 -51.07 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 111.096 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -73.47 -20.93 60.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.741 -0.599 . . . . 0.0 111.706 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.33 16.41 14.73 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.492 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.22 154.07 21.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 109.598 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.9 134.53 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -138.61 143.03 39.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.398 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -110.87 157.74 19.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.299 -0.876 . . . . 0.0 109.728 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mt -138.2 147.77 44.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.515 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.9 mt -142.55 112.69 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 108.825 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.09 114.57 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 111.123 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.515 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 24.5 m-70 -109.4 139.3 20.97 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 109.669 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -55.12 168.6 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.828 1.686 . . . . 0.0 111.758 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 64.2 mm-40 -141.72 178.22 7.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.993 . . . . 0.0 109.816 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 35' ' ' THR . 23.9 mmtm -85.72 152.49 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -46.07 145.08 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.78 9.17 55.52 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -70.03 -41.67 73.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.63 -1.512 . . . . 0.0 109.49 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.99 179.69 37.14 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.539 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mm -96.61 116.26 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -138.8 144.43 39.34 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.511 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.59 158.34 15.48 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -131.02 110.18 11.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 109.222 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -136.63 134.97 37.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 110.558 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.14 26.95 10.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 111.275 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 17.95 78.49 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.81 122.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -83.98 127.46 33.89 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.191 -0.943 . . . . 0.0 109.243 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.71 94.4 40.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.422 -0.799 . . . . 0.0 109.446 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.12 145.71 33.14 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.0 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.6 65.58 5.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -119.49 153.24 35.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.407 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.521 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 1.8 p-80 -57.71 -53.67 55.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 109.985 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.521 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.0 mm-40 -43.84 -17.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 111.043 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' HIS . 16.0 m-85 -94.13 5.11 52.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.664 -1.272 . . . . 0.0 109.79 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 50' ' ' HIS . 79.8 t -72.66 130.87 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.53 -29.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.345 -0.847 . . . . 0.0 109.894 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.4 t-80 -150.13 131.22 14.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.046 -1.034 . . . . 0.0 109.915 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -121.98 95.84 4.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.38 128.56 3.53 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 59' ' ' SER . 72.6 m-70 52.79 5.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.082 -1.011 . . . . 0.0 109.047 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m 165.16 151.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.521 ' HG1' ' CG ' ' A' ' 234' ' ' ASP . 31.1 m -91.12 126.54 36.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.241 -0.912 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD2' ' NZ ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -120.29 149.57 42.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.449 -0.782 . . . . 0.0 111.12 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mt -126.28 147.54 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.52 155.91 27.25 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 118.961 -1.59 . . . . 0.0 110.587 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -160.42 147.64 15.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -1.047 . . . . 0.0 109.095 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 24.18 4.77 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.283 -0.885 . . . . 0.0 109.647 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.52 -31.35 7.89 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 8.3 mm-40 -60.34 144.25 51.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.245 . . . . 0.0 108.916 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -143.06 141.38 31.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 110.475 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.09 123.32 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 13.2 mtpp -99.36 154.63 18.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.966 -1.083 . . . . 0.0 111.128 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.5 m 50.79 74.38 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.338 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.92 -10.08 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.236 -0.915 . . . . 0.0 108.927 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.9 pm0 -61.34 -26.3 67.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 110.353 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -66.58 -69.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.91 -1.119 . . . . 0.0 109.47 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.01 -47.37 42.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 108.979 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.401 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 16.8 mt -52.1 -49.22 64.03 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.04 -1.038 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 t -60.65 -42.82 97.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.105 -0.997 . . . . 0.0 110.247 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -56.04 -48.37 78.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.05 -1.031 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.04 -33.9 76.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.165 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.4 -37.17 86.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.912 . . . . 0.0 109.268 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.29 -38.76 34.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.414 -0.804 . . . . 0.0 109.648 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.36 -0.48 37.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.132 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 56.89 42.38 26.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.666 -0.646 . . . . 0.0 111.622 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mm -89.41 144.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.697 -1.252 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.5 p -127.88 -20.81 3.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.192 -0.943 . . . . 0.0 111.815 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 35' ' ' THR . 33.6 m-80 -124.99 108.12 11.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.838 -1.164 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.75 148.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.363 -0.836 . . . . 0.0 110.421 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.477 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 94.3 m -114.71 113.53 24.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mt -97.27 100.77 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 110.412 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.63 124.83 27.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.96 131.93 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 122.048 0.928 . . . . 0.0 111.707 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mm -116.15 95.9 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.67 -156.9 26.07 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -121.37 -9.51 9.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.439 -1.036 . . . . 0.0 109.999 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -140.53 148.81 41.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.648 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.07 119.37 74.16 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 108.987 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -39.94 120.09 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.739 1.626 . . . . 0.0 111.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 tp -75.04 -10.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 110.774 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.9 mt 54.7 -120.7 1.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.091 -1.006 . . . . 0.0 109.995 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.6 8.22 44.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.66 67.36 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.197 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -172.54 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.768 -0.842 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.0 9.0 9.76 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -55.49 -39.52 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -1.135 . . . . 0.0 110.452 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.12 -59.31 4.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -50.84 -44.83 59.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.209 -0.932 . . . . 0.0 109.38 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.92 -48.05 83.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 110.786 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.82 -42.47 90.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.009 -1.057 . . . . 0.0 111.28 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.49 -52.06 43.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.913 -1.117 . . . . 0.0 110.356 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.05 -32.86 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.943 -1.098 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -63.79 -43.44 96.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 109.822 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.586 ' C ' HD21 ' A' ' 113' ' ' ASN . 1.3 ptpm? -77.81 11.1 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.017 -1.052 . . . . 0.0 109.852 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.586 HD21 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.92 33.23 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.29 138.82 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.864 -1.147 . . . . 0.0 111.212 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.75 123.56 26.45 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.65 145.15 31.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.343 -0.848 . . . . 0.0 110.221 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -112.61 -173.19 2.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.763 . . . . 0.0 109.352 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -109.34 68.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -164.09 128.76 2.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.007 . . . . 0.0 109.315 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.69 140.58 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.069 . . . . 0.0 109.667 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -83.94 150.47 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.843 . . . . 0.0 109.906 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.64 85.94 3.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 108.876 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -63.52 142.79 58.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.545 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -87.54 101.38 13.57 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.43 134.16 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.663 -0.648 . . . . 0.0 110.75 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.97 111.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -83.74 -33.5 25.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.944 -1.098 . . . . 0.0 110.725 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.25 156.93 78.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 109.784 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.09 149.0 45.63 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.791 2.327 . . . . 0.0 112.241 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 tt -159.01 151.48 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.19 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 143.51 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.76 148.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.89 157.38 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.15 106.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 109.796 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 49.58 53.43 12.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 110.803 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.57 -35.68 3.17 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.416 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.589 HH22 ' HG ' ' A' ' 254' ' ' SER . 0.9 OUTLIER -63.48 131.81 49.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.932 -1.334 . . . . 0.0 108.906 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.98 139.79 29.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.986 -1.071 . . . . 0.0 109.891 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.9 127.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.783 . . . . 0.0 109.59 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -112.49 131.76 55.42 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.411 0.624 . . . . 0.0 109.752 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 135.37 54.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.88 149.19 32.44 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.128 -0.983 . . . . 0.0 109.648 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -46.35 143.53 7.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.661 2.241 . . . . 0.0 113.272 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.92 145.62 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -65.34 -4.71 5.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 110.541 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 244' ' ' GLY . 21.8 p -155.66 -177.78 6.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -92.26 119.35 31.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.16 110.32 8.91 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.29 122.09 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.7 m -112.32 151.98 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.624 -0.673 . . . . 0.0 109.229 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -139.62 131.71 27.98 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.128 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -122.0 132.98 54.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.4 144.67 16.2 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.747 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.82 105.97 15.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -95.18 166.86 11.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -98.07 -16.69 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.576 -0.703 . . . . 0.0 110.9 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.7 p-10 -94.79 -173.14 2.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.751 -1.218 . . . . 0.0 110.217 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -50.35 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 0.0 111.642 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.57 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.2 mt -77.74 -27.8 50.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.343 -1.473 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.76 -140.5 34.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -104.16 137.89 41.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.302 -1.116 . . . . 0.0 109.691 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -143.89 159.14 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.497 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -146.67 147.68 31.27 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -142.86 135.65 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 109.645 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 98.6 m -104.56 122.87 46.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.894 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -104.46 112.34 25.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.9 t -106.38 152.36 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.758 0.79 . . . . 0.0 109.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -49.28 127.04 14.14 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 108.808 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.57 27.35 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -116.69 20.72 13.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.162 -1.199 . . . . 0.0 108.962 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.04 -22.78 11.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.445 -0.784 . . . . 0.0 110.542 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -18.21 48.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.041 -1.037 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -84.2 -6.37 59.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 111.476 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 pt -125.19 -26.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.865 -1.147 . . . . 0.0 111.221 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.5 m -60.5 -24.01 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.623 -1.298 . . . . 0.0 108.716 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.56 -3.23 57.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.518 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.99 113.5 7.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.569 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 73.0 mtm180 -79.31 172.36 13.9 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.6 t -77.26 161.13 28.37 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.39 146.06 32.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.282 -1.512 . . . . 0.0 111.439 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.55 42.71 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.422 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 70.2 m-85 -98.09 145.82 26.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.018 -1.051 . . . . 0.0 109.362 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.61 -36.97 37.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.3 p90 -71.42 -27.19 63.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.843 -1.161 . . . . 0.0 110.039 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.1 tt0 -78.97 -43.18 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.979 -1.076 . . . . 0.0 110.137 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 21.3 mt -41.0 -61.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.903 . . . . 0.0 110.145 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.7 tt0 -40.49 -41.37 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 0.0 110.193 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -76.24 -46.22 29.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.942 . . . . 0.0 109.402 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.5 -30.86 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -80.65 -52.23 7.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.883 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -48.61 -44.56 37.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 110.334 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 m -74.86 6.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 0.0 110.326 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.41 41.79 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.584 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.4 mt -127.73 178.39 6.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -1.185 . . . . 0.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 50.83 24.28 7.95 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -61.23 -19.3 61.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.624 -1.516 . . . . 0.0 110.59 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -107.27 4.82 35.49 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.57 125.03 30.44 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 121.136 -1.214 . . . . 0.0 110.296 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 202' ' ' ASN . 3.5 t -135.99 174.22 10.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -1.028 . . . . 0.0 109.456 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.91 -9.14 58.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -102.78 -17.67 15.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.642 -0.662 . . . . 0.0 110.289 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.538 HD22 ' N ' ' A' ' 199' ' ' SER . 18.9 p30 -120.04 7.91 10.93 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -150.84 151.25 31.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.872 -1.143 . . . . 0.0 110.556 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.2 tp -98.99 93.54 6.06 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.7 t -86.08 129.19 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.687 0.756 . . . . 0.0 109.277 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 mt -123.48 162.95 21.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.611 -0.68 . . . . 0.0 109.454 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.41 -166.38 12.91 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -28.26 66.5 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.384 -1.068 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.44 20.98 1.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 111.153 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.6 160.99 43.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.465 -1.397 . . . . 0.0 110.823 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.59 116.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -60.28 -42.93 96.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.06 115.61 22.71 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -64.69 -10.53 25.09 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.16 1.24 . . . . 0.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -20.13 59.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.408 -0.807 . . . . 0.0 109.286 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.24 -179.5 45.53 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.5 mt -86.1 133.51 33.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.073 -1.251 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.99 -17.71 64.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.318 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 39.2 m-85 -143.33 -170.46 3.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.71 -4.37 44.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.79 43.61 1.26 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 109.649 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.86 -47.84 95.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.997 -1.065 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.5 Cg_exo -51.37 -65.33 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.487 2.124 . . . . 0.0 112.31 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.39 -35.19 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.986 -1.071 . . . . 0.0 109.461 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -62.72 -39.44 94.07 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 8.5 t60 -68.02 -32.68 73.22 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -64.17 -35.72 81.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.88 -35.48 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.97 -53.01 44.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 109.172 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -63.98 -28.86 70.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.457 -0.777 . . . . 0.0 109.797 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.12 -34.97 49.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.085 -1.01 . . . . 0.0 109.018 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.55 -38.53 81.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.5 -54.87 17.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.521 ' CG ' ' HG1' ' A' ' 60' ' ' THR . 97.3 m-20 -55.27 -30.19 59.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.0 108.825 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.86 -24.23 66.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.529 -0.732 . . . . 0.0 110.442 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.78 -21.8 61.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.855 -1.153 . . . . 0.0 108.54 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 38.9 mt -48.19 -7.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.762 -1.211 . . . . 0.0 109.905 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 236' ' ' TYR . 7.2 mt -74.03 -16.6 61.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.767 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 95.77 3.83 60.68 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.823 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.79 152.99 10.6 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.763 -1.433 . . . . 0.0 109.301 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -53.91 127.22 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.956 1.771 . . . . 0.0 110.002 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.8 t -86.43 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 112.289 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.57 125.86 29.72 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.51 -160.59 29.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 133.56 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -1.107 . . . . 0.0 108.951 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.8 m-85 -132.92 141.65 48.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 110.945 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -124.76 124.94 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.2 t -118.83 135.69 54.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.946 -1.096 . . . . 0.0 111.28 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -116.87 114.75 24.33 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 48.41 25.77 0.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.57 164.11 12.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -145.01 173.94 25.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 77.4 m-70 -54.41 -43.52 71.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.589 ' HG ' HH22 ' A' ' 137' ' ' ARG . 9.4 p -55.37 -58.6 7.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.88 -46.23 74.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 109.383 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.0 m-20 -47.43 -48.11 26.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.942 -1.099 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -50.03 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 109.96 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -56.31 -50.27 71.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.961 -1.087 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.6 tp -52.58 -50.53 62.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.063 -1.023 . . . . 0.0 108.636 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.79 -55.28 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.274 -0.891 . . . . 0.0 109.165 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.69 -49.08 14.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.82 -49.53 72.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.278 -0.889 . . . . 0.0 110.109 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.17 -50.94 71.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 0.0 110.38 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -33.16 75.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.123 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 109.374 179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 73.8 mt-10 -56.04 135.04 52.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.123 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.38 142.67 48.97 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -139.46 -170.34 2.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 137.55 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.33 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -64.88 -19.87 66.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.857 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.95 157.42 36.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.113 -0.992 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 140.36 58.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.946 . . . . 0.0 109.805 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.07 157.08 28.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 p -127.67 140.13 52.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.2 m-85 -138.04 147.67 44.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.543 ' CD ' ' HH ' ' A' ' 23' ' ' TYR . 4.4 pt-20 -156.8 151.98 26.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.16 175.66 36.72 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.06 152.93 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 110.222 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.67 140.07 15.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 tt -59.31 -39.05 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.039 -1.271 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.407 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 34.0 m-70 -88.43 -50.05 6.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.688 -1.258 . . . . 0.0 110.77 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 22' ' ' GLU . 2.6 p -70.45 -22.95 62.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.716 . . . . 0.0 111.297 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.24 10.92 4.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.0 mt-10 -103.64 156.18 17.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.636 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.543 ' HH ' ' CD ' ' A' ' 14' ' ' GLU . 32.2 t80 -74.82 136.25 41.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -141.04 143.51 34.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -109.77 159.02 17.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.999 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.9 mt -138.29 145.12 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.472 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 9.3 mt -142.18 107.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.976 . . . . 0.0 108.867 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mt -90.85 113.77 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.366 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.472 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 57.2 m-70 -107.74 137.26 19.69 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 109.4 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -50.1 167.72 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.847 1.698 . . . . 0.0 111.532 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 28.0 mm-40 -144.99 160.48 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.886 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.8 mttp -68.0 149.1 50.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -48.41 151.05 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.141 -0.974 . . . . 0.0 110.093 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 68.63 -2.12 8.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.66 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 24.6 m -62.21 -42.75 99.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.467 . . . . 0.0 109.558 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.678 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 95.86 179.45 36.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.415 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.58 116.81 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -140.91 147.68 39.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 0.0 110.215 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.34 157.42 15.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -129.06 112.17 13.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 108.976 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -135.58 133.43 38.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.636 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 53.5 26.82 5.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 111.313 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.43 20.26 64.67 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.097 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.5 t -124.46 124.49 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -1.093 . . . . 0.0 109.322 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -86.37 126.75 34.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.78 93.03 36.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.188 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.12 145.5 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.298 1.999 . . . . 0.0 112.044 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.93 70.57 8.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 109.403 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -120.52 174.73 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.159 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -78.31 -46.37 20.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.695 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -49.95 -16.62 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -93.15 3.97 54.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.754 -1.216 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.95 127.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.32 -31.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.405 ' HD1' ' H ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -155.12 139.83 17.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.811 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.405 ' H ' ' HD1' ' A' ' 55' ' ' HIS . 39.2 p -126.25 95.82 4.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.5 t30 -161.39 128.91 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.769 . . . . 0.0 108.95 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 82.2 m-70 52.95 5.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.247 -0.908 . . . . 0.0 109.178 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.11 142.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 m -81.87 127.3 32.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 108.837 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.82 148.24 43.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.859 0.837 . . . . 0.0 111.071 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.84 150.06 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.36 155.73 27.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.756 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.92 153.55 12.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -1.012 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 50.75 21.59 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.8 -33.25 6.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.99 141.86 57.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.245 . . . . 0.0 109.245 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.33 139.69 41.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 110.364 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.3 mt -129.23 121.3 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -99.64 157.54 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 110.926 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.9 m 51.23 73.73 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.932 -0.48 . . . . 0.0 110.694 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.7 -9.29 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.0 108.9 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 18.2 pm0 -61.04 -28.86 69.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 110.75 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -66.83 -67.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.868 -1.145 . . . . 0.0 109.56 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -52.15 -46.73 44.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.271 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.0 mt -53.61 -46.91 70.58 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.899 -1.126 . . . . 0.0 110.136 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.87 -43.18 99.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -0.989 . . . . 0.0 110.063 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.88 -46.05 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.05 -34.47 77.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -62.58 -37.34 85.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.8 mt -78.78 -38.73 37.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.9 -1.03 37.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.383 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 57.7 43.01 22.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 111.339 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 mm -88.22 143.74 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.887 -1.133 . . . . 0.0 108.688 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -127.4 -23.44 3.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 111.822 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 36' ' ' GLY . 29.4 m120 -124.73 107.49 11.01 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.723 -1.235 . . . . 0.0 110.412 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.3 m -163.64 147.0 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 37.9 m -114.23 109.48 18.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.06 100.52 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 126.15 30.11 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.4 t -111.74 122.42 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.964 0.887 . . . . 0.0 111.58 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.94 96.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.39 -156.78 26.34 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -120.66 -10.04 9.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -1.095 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -142.82 150.63 40.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.01 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.9 mm -72.76 120.94 83.53 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 109.117 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -41.85 123.81 2.5 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.517 1.478 . . . . 0.0 110.987 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 tp -76.91 -12.43 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.369 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 mt 56.48 -121.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.29 8.89 40.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 110.666 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.41 -1.96 67.35 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.436 -1.364 . . . . 0.0 109.696 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -172.46 2.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.841 -0.8 . . . . 0.0 109.401 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.74 16.02 9.61 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.55 -43.47 93.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.409 -1.054 . . . . 0.0 110.28 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.8 -57.61 10.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -51.21 -44.87 61.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.078 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 62.2 t80 -61.81 -52.42 64.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.633 -0.667 . . . . 0.0 110.674 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.53 -44.88 95.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 0.0 111.319 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.71 -58.6 4.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.918 -1.114 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.22 -33.73 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.452 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 13.1 ttt180 -62.37 -43.71 98.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.26 12.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.951 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -143.24 34.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.097 . . . . 0.0 110.329 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.75 138.55 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 tp -132.3 128.87 38.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.331 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -87.87 140.5 29.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.694 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.72 -170.85 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.9 69.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.24 -0.913 . . . . 0.0 110.599 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.01 130.12 2.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.959 -1.088 . . . . 0.0 109.708 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.76 145.97 51.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.984 . . . . 0.0 109.817 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 121' ' ' ILE . 35.4 mt -90.87 151.48 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -94.06 79.8 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 50.0 m-85 -59.93 143.01 52.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.483 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.1 101.5 14.16 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.78 132.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.707 -0.62 . . . . 0.0 110.785 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -70.12 111.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -88.49 -30.48 19.35 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.104 -0.998 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -133.06 149.29 72.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 109.663 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.32 155.66 55.64 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.372 2.048 . . . . 0.0 112.118 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.71 153.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -139.33 141.04 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.835 . . . . 0.0 109.257 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.42 148.85 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.72 158.28 44.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 135' ' ' GLU . 43.4 t0 -174.51 105.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.933 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 134' ' ' ASP . 5.5 mt-10 49.7 54.74 10.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.7 -36.31 3.14 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.448 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.55 134.36 56.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 108.657 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -147.79 138.52 23.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.5 mt -135.69 132.13 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.662 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' NZ ' ' HZ1' ' A' ' 245' ' ' LYS . 19.0 tttm -117.72 131.05 56.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.707 -0.621 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.79 55.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.29 151.65 37.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.774 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -49.42 142.68 22.36 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.439 2.093 . . . . 0.0 113.445 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.44 141.35 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.03 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -60.98 -6.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.836 . . . . 0.0 110.602 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.4 p -152.79 -173.52 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.926 -1.109 . . . . 0.0 109.546 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.8 tp -96.29 120.45 36.61 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -136.57 129.41 30.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.21 123.61 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.43 HG21 ' HZ2' ' A' ' 163' ' ' LYS . 95.9 m -113.51 152.35 30.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.749 -0.594 . . . . 0.0 109.481 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -141.85 132.39 25.37 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.31 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.18 132.72 54.59 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.27 147.16 19.04 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.184 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.28 98.28 6.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -85.57 167.84 15.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.632 0.729 . . . . 0.0 110.894 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -97.55 -9.94 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 111.302 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' LEU . 30.7 p-10 -102.76 -170.94 1.87 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 111.036 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -48.2 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.806 -0.559 . . . . 0.0 111.509 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.7 mt -80.29 -29.75 38.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.479 -1.388 . . . . 0.0 108.534 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.41 -133.73 46.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.0 ttp-105 -107.88 136.27 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -1.075 . . . . 0.0 109.391 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.694 -0.629 . . . . 0.0 109.303 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.43 ' HZ2' HG21 ' A' ' 150' ' ' THR . 0.0 OUTLIER -148.13 147.84 29.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.44 -0.788 . . . . 0.0 109.604 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.495 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 9.8 t80 -147.9 143.18 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.084 -1.01 . . . . 0.0 110.3 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.458 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 89.4 m -110.17 123.81 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.798 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.21 116.93 33.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 109.961 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.57 149.4 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.011 0.91 . . . . 0.0 110.405 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.61 134.44 24.36 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.385 -0.822 . . . . 0.0 109.197 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.11 -9.18 42.68 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.09 28.19 8.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.199 -1.177 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -60.41 -36.67 78.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 110.262 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.56 -17.0 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.86 -5.99 46.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.835 -1.166 . . . . 0.0 111.517 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.2 pt -121.21 -29.82 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.061 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.99 -15.81 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.626 -1.296 . . . . 0.0 108.803 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.98 -2.85 55.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.48 114.49 7.76 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -77.58 172.93 12.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.3 t -77.25 162.49 27.31 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.2 143.85 30.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.366 -1.459 . . . . 0.0 111.427 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.79 155.78 44.87 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.44 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 71.4 m-85 -99.38 140.41 33.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.494 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.07 -37.54 9.7 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.369 -0.832 . . . . 0.0 110.345 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.3 p90 -70.16 -26.81 64.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.734 -1.229 . . . . 0.0 110.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.7 OUTLIER -88.5 -35.05 17.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.94 -1.1 . . . . 0.0 110.441 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 187' ' ' GLU . 73.5 mt -48.23 -58.18 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 0.0 109.708 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.9 OUTLIER -42.92 -36.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.16 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -72.63 -50.22 26.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.752 . . . . 0.0 109.136 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 81.7 mt -52.17 -29.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -80.87 -53.04 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.798 -1.189 . . . . 0.0 109.022 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -48.55 -40.45 27.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.62 6.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.026 -1.046 . . . . 0.0 110.364 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.18 38.79 38.73 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.228 -0.986 . . . . 0.0 110.655 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.407 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.6 mt -130.91 -179.71 5.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -1.155 . . . . 0.0 109.515 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 54.64 23.44 28.68 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.578 -0.701 . . . . 0.0 111.488 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -57.06 -21.13 29.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.602 -1.528 . . . . 0.0 110.435 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.92 5.47 34.49 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.985 -1.103 . . . . 0.0 110.559 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.74 129.3 41.73 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 120.925 -1.338 . . . . 0.0 110.451 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.14 167.0 25.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.353 -1.086 . . . . 0.0 108.822 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 75.4 mt -71.03 -7.71 48.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.492 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.83 -11.46 21.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.528 -0.733 . . . . 0.0 110.309 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.501 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 11.7 p-10 -130.94 9.77 4.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -151.82 152.22 32.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 110.416 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.4 tp -99.2 95.46 7.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.6 t -87.49 129.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.672 0.749 . . . . 0.0 109.606 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.5 mt -123.82 164.16 19.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.55 -0.719 . . . . 0.0 109.306 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.55 -166.36 11.97 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . 0.419 ' HZ1' ' HB2' ' A' ' 208' ' ' LYS . 1.1 tppp? -57.02 -36.83 70.91 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.555 -0.968 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.89 26.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 110.57 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.29 148.44 39.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.696 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.28 112.94 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.69 -49.93 75.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.972 -1.08 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.4 m120 -58.92 112.29 4.84 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 0.0 110.193 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -58.44 -11.73 11.86 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.576 1.517 . . . . 0.0 111.501 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 -18.53 57.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.381 -0.825 . . . . 0.0 109.92 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.32 -173.63 50.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.18 140.35 29.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -1.222 . . . . 0.0 109.803 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -78.06 -21.17 51.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.416 -0.803 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -138.58 154.77 48.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.177 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -67.09 -1.88 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.744 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.536 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -148.48 46.14 1.04 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.128 -0.983 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.17 -46.56 99.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.697 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -52.55 -66.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.371 2.047 . . . . 0.0 112.044 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.41 -35.9 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.976 -1.077 . . . . 0.0 109.439 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.536 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 68.4 mtt-85 -60.67 -41.48 95.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -67.1 -31.77 72.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.766 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -65.21 -36.9 85.61 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.55 -35.5 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.568 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 73.1 t80 -66.32 -54.14 28.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.88 -27.08 68.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.933 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.26 -33.76 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 33.7 mt -68.23 -38.93 80.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.76 -57.33 12.67 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.55 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.6 m-20 -54.24 -34.42 60.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 109.274 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.4 mt -60.88 -23.8 65.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 110.219 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.613 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.18 -22.31 61.3 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.902 -1.124 . . . . 0.0 108.91 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.58 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.712 -1.243 . . . . 0.0 110.629 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.05 -13.0 60.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.744 -1.223 . . . . 0.0 109.66 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.84 -0.79 57.83 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.503 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.57 156.28 10.34 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.914 -1.345 . . . . 0.0 108.829 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.6 Cg_endo -49.93 150.68 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.892 1.728 . . . . 0.0 109.552 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.08 148.36 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.988 -1.07 . . . . 0.0 112.125 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -130.97 124.17 30.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.97 -157.32 27.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -131.85 145.11 51.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -1.074 . . . . 0.0 108.951 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.2 m-85 -141.51 142.44 33.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.485 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.34 123.15 37.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.3 m -115.85 134.81 54.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 250' ' ' ARG . 60.5 t80 -116.54 117.01 28.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.3 OUTLIER 45.4 24.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.161 -0.962 . . . . 0.0 109.425 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.57 164.74 45.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.491 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -142.73 171.52 24.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.55 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 60.9 m-70 -51.01 -34.87 31.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -1.225 . . . . 0.0 109.635 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.7 m -60.03 -57.82 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 256' ' ' ASN . 7.0 tp -61.57 -43.8 98.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.008 . . . . 0.0 109.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.5 m-20 -47.33 -46.84 25.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.88 -1.138 . . . . 0.0 108.577 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.15 -50.46 76.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.59 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -55.32 -51.18 67.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.997 -1.065 . . . . 0.0 109.285 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 46.9 tp -51.07 -50.7 58.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.152 -0.967 . . . . 0.0 108.588 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.9 t -57.06 -54.79 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.89 -55.07 8.65 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 109.597 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.57 -51.29 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.95 -51.91 59.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.81 -25.51 65.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.34 -179.232 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.219 0.533 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.57 ' CD ' HD22 ' A' ' 86' ' ' ASN . 1.6 mm-40 -56.43 136.14 53.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.087 -1.008 . . . . 0.0 108.579 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 143.23 49.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.8 t -141.69 -170.46 3.12 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 m -101.6 138.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.483 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.566 ' NZ ' ' OE1' ' A' ' 9' ' ' GLU . 7.8 ptmm? -66.96 -25.37 66.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.566 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 8.2 pt-20 -148.14 158.4 44.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.993 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 142.32 57.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.481 -0.762 . . . . 0.0 110.133 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -120.68 167.07 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -137.13 142.25 42.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 26' ' ' LEU . 95.0 m-85 -139.26 151.7 46.69 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.48 153.44 19.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.0 110.023 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.44 177.02 36.77 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.83 153.7 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -1.047 . . . . 0.0 110.025 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.97 140.36 15.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tt -60.46 -38.44 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -1.152 . . . . 0.0 110.807 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -90.02 -51.26 5.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.564 -1.335 . . . . 0.0 110.963 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.1 p -70.11 -22.25 63.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.774 -0.579 . . . . 0.0 111.237 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.6 19.44 27.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -111.44 155.06 23.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -1.059 . . . . 0.0 109.788 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -74.34 137.0 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.647 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -143.16 143.59 31.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.064 -1.022 . . . . 0.0 109.594 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -108.14 160.06 16.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.9 mt -139.84 145.13 37.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.731 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.46 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 11.8 mt -140.33 116.26 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 108.972 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.14 111.89 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.46 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 61.5 m-70 -107.46 139.89 20.97 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.81 168.15 1.26 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.836 1.691 . . . . 0.0 111.495 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.479 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -142.12 178.93 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.611 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' N ' ' HG1' ' A' ' 35' ' ' THR . 12.4 mmtm -87.7 153.32 21.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 118' ' ' ASN . 63.1 mt-10 -47.51 146.43 2.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.496 -0.752 . . . . 0.0 109.939 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 69.26 4.71 45.09 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.032 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.586 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -67.92 -44.56 76.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.618 -1.519 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -179.26 32.14 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.471 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.76 115.74 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.408 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 6.8 ptm180 -140.3 152.09 45.59 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.951 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.03 157.81 16.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.9 111.09 12.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -134.7 133.51 40.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.73 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 53.16 28.33 6.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.577 -0.702 . . . . 0.0 111.401 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 18.88 69.95 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.399 -1.382 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 122.05 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -1.069 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.5 m-85 -83.82 127.07 33.56 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 mt -116.54 92.93 38.86 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.242 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.5 149.0 18.85 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.504 2.136 . . . . 0.0 112.086 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 69.4 9.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -121.31 170.95 9.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -74.18 -48.58 28.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.622 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.56 -16.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.47 4.33 53.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.73 -1.231 . . . . 0.0 109.92 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.51 141.68 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.17 -29.26 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -0.847 . . . . 0.0 110.114 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -151.67 129.84 11.93 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 109.965 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -120.63 95.36 4.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.7 t-20 -163.28 129.41 3.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 73.3 m-70 49.9 9.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.177 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER 162.48 150.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.706 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.536 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -91.22 124.42 35.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 109.288 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.13 148.59 42.9 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.651 0.739 . . . . 0.0 110.637 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -125.48 153.2 43.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.35 154.55 25.35 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 118.974 -1.584 . . . . 0.0 110.747 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -161.37 149.83 15.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -1.017 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.8 mttt 46.36 24.18 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.621 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -34.45 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -54.87 145.57 19.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.255 . . . . 0.0 109.045 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -145.36 135.39 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 110.613 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.16 120.28 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.8 159.11 15.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 0.0 111.193 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.7 m 46.52 74.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.37 -8.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -60.61 -25.19 66.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.152 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -67.97 -69.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.049 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.4 -47.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.099 -1.001 . . . . 0.0 109.129 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.08 -50.18 62.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.026 . . . . 0.0 110.137 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 39.2 t -60.32 -41.55 93.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.113 -0.992 . . . . 0.0 110.071 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -56.88 -44.95 83.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.051 -1.031 . . . . 0.0 109.217 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.72 -33.76 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -62.89 -40.86 98.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 109.179 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.38 -39.09 59.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.852 . . . . 0.0 109.702 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.42 -1.07 35.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.94 42.1 26.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 111.414 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 23.1 mm -90.69 139.91 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 108.226 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.449 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 73.3 p -126.9 -19.15 4.51 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.745 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 35' ' ' THR . 70.2 m-80 -124.98 106.25 9.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.827 -1.171 . . . . 0.0 110.274 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.1 m -165.86 150.67 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.729 0.776 . . . . 0.0 109.916 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.479 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.0 m -116.17 117.84 31.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.19 100.36 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.352 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -71.77 126.08 28.8 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -112.55 121.02 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.949 0.88 . . . . 0.0 111.807 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mm -107.77 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.72 160.05 8.2 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -83.05 -7.45 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.267 . . . . 0.0 111.219 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -139.35 147.59 41.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.725 -1.234 . . . . 0.0 110.36 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.18 121.28 84.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -41.82 123.83 2.48 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.665 1.577 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 tp -76.58 -15.4 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.678 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.7 mt 57.0 -122.09 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 27.0 t70 -93.36 7.3 45.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.024 -1.048 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.84 -3.9 62.94 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.243 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.94 -172.0 2.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.911 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.39 14.53 9.36 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -57.94 -41.76 83.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 0.0 110.284 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.89 -55.7 17.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.019 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -51.4 -45.81 62.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 108.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.96 -54.18 48.12 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.268 0.556 . . . . 0.0 110.62 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.98 -43.69 98.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 111.508 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.408 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . . . -65.59 -56.83 10.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.961 -1.087 . . . . 0.0 110.363 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.12 -30.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 109.355 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -65.26 -43.36 91.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.307 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HZ2' ' HA ' ' A' ' 109' ' ' ALA . 3.7 pttm -76.41 9.88 2.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.892 -1.13 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -140.89 36.45 1.77 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 0.0 109.926 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -85.29 140.68 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 111.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -131.42 122.0 25.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.584 -0.697 . . . . 0.0 109.129 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -79.37 146.32 32.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -111.26 -174.45 2.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.447 -0.783 . . . . 0.0 109.42 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 26.8 t-20 -111.69 70.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.852 . . . . 0.0 110.579 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -168.41 134.69 1.9 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.355 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.39 143.98 51.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.065 -1.022 . . . . 0.0 110.15 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.11 151.43 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 0.0 110.233 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.53 83.78 3.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 108.872 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -63.12 142.13 58.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -86.94 101.36 13.34 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.7 133.47 33.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 110.75 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.29 111.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.45 -30.1 23.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.138 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.92 155.34 77.89 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.01 149.87 53.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.536 2.158 . . . . 0.0 112.234 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 tt -152.77 149.83 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 108.942 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.75 140.93 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.78 145.96 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.63 156.95 47.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -174.3 107.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.851 . . . . 0.0 109.929 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 53.33 52.86 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.51 -31.66 3.22 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -61.77 134.91 57.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.242 . . . . 0.0 108.52 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tt -147.5 137.12 22.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.854 -1.154 . . . . 0.0 109.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 139' ' ' ILE . 75.4 mt -136.41 125.51 37.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.454 -0.779 . . . . 0.0 109.451 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -114.21 132.08 56.24 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.511 0.672 . . . . 0.0 109.932 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.05 134.66 54.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.69 149.18 32.94 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.921 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -45.87 143.04 7.22 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.62 2.213 . . . . 0.0 113.447 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.2 t -156.61 144.82 19.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 145' ' ' ASP . 53.5 t0 -62.75 -5.6 2.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.898 . . . . 0.0 110.332 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 145' ' ' ASP . 24.6 p -156.15 -167.43 2.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.359 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.0 tp -102.51 121.49 42.47 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -134.5 108.24 8.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.68 122.79 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.07 -1.019 . . . . 0.0 110.206 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 m -112.76 151.13 30.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 38.9 t80 -141.64 130.47 22.97 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.126 -1.029 . . . . 0.0 111.234 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -120.98 133.96 55.29 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.08 142.11 13.49 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.601 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -104.06 99.41 9.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -87.87 167.41 13.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.558 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -105.55 -11.53 16.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.471 -0.768 . . . . 0.0 110.72 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 159' ' ' LEU . 31.1 p-10 -98.53 -164.83 1.17 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.789 -1.195 . . . . 0.0 110.456 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -55.41 0.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 111.161 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 157' ' ' ASN . 16.5 mt -83.61 -30.4 26.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.504 -1.372 . . . . 0.0 108.565 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.27 -138.67 42.8 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -99.91 135.87 40.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -1.151 . . . . 0.0 109.306 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -144.8 159.03 43.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.435 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 149.85 33.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 110.159 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -143.63 140.67 30.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.8 m -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.705 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -105.2 114.39 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.44 152.95 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -49.8 126.11 13.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.175 -0.953 . . . . 0.0 108.975 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.503 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 106.24 2.11 38.49 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -121.02 21.54 11.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.248 -1.148 . . . . 0.0 109.718 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.534 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.1 pm0 -59.32 -54.7 43.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 4.3 mt-10 -41.42 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 0.0 110.085 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 171' ' ' GLU . 67.3 mm-40 -87.59 -6.99 58.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 111.731 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.56 -27.73 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.863 -1.148 . . . . 0.0 111.282 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.32 -17.27 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mt -90.02 -5.89 56.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.266 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.87 119.07 13.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -79.94 173.06 12.97 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.442 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -76.37 162.51 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -146.19 146.87 30.97 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.237 -1.539 . . . . 0.0 111.421 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.78 157.8 43.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 81.3 m-85 -100.04 146.48 26.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.94 -1.1 . . . . 0.0 109.092 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -50.14 -33.73 19.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.109 -0.995 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.6 p90 -74.33 -28.31 61.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.786 -1.197 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -75.21 -35.58 61.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 65.0 mt -52.34 -49.93 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -47.34 -41.66 19.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 110.079 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -74.34 -48.34 28.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.131 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.2 mt -52.38 -30.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.44 -53.77 5.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 0.0 109.365 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -48.88 -32.59 9.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.487 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.8 m -87.16 7.66 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.02 . . . . 0.0 110.506 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.73 39.88 54.38 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.083 -1.01 . . . . 0.0 110.725 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.53 174.75 9.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -1.216 . . . . 0.0 109.808 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.7 22.13 52.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -57.97 -19.91 34.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.679 -1.483 . . . . 0.0 109.63 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.32 10.34 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 125.47 7.76 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 120.859 -1.377 . . . . 0.0 109.72 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.4 t -143.27 169.47 17.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -1.146 . . . . 0.0 109.806 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.56 -8.73 36.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -13.26 25.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -136.18 11.32 3.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.14 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -150.06 149.28 30.09 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 110.275 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.3 tp -98.94 93.32 5.96 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.1 130.03 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.738 0.78 . . . . 0.0 109.019 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.41 164.92 18.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.632 -0.667 . . . . 0.0 109.365 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -127.03 -166.6 12.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -61.69 -32.43 72.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 109.552 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.6 22.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -142.09 149.17 39.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.808 -1.183 . . . . 0.0 110.688 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.6 t -101.96 111.32 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -58.23 -47.01 84.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 110.063 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.16 124.17 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 109.787 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -67.09 -18.07 51.16 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.57 1.514 . . . . 0.0 111.965 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 -15.34 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.923 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.13 -163.53 53.99 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.55 148.35 22.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.207 . . . . 0.0 109.833 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -87.0 -18.36 30.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 108.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.499 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 60.2 m-85 -137.73 178.69 6.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -82.88 -14.18 54.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.68 52.25 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.514 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -58.18 -48.19 97.47 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.039 -1.038 . . . . 0.0 109.89 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.8 Cg_exo -49.79 -68.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.7 m -58.77 -34.71 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.005 -1.059 . . . . 0.0 109.604 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.499 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 56.2 mtt180 -61.23 -41.18 96.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -67.26 -31.65 72.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.326 -0.95 . . . . 0.0 108.692 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 12.8 mmtp -66.07 -37.33 85.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.3 -35.87 75.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.1 t80 -65.84 -54.77 22.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.554 0.693 . . . . 0.0 109.236 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.11 -27.91 69.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.753 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.67 -34.08 58.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 108.394 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.79 -39.45 85.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -57.88 8.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.411 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 78.6 m-20 -51.4 -34.65 35.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -1.23 . . . . 0.0 109.001 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.6 mt -62.52 -22.76 66.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.038 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.08 -22.97 60.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.857 -1.152 . . . . 0.0 108.919 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.15 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.699 -1.251 . . . . 0.0 109.909 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.478 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 1.42 59.33 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.485 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.95 156.93 10.08 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.012 -1.287 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -49.36 150.35 8.09 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.966 1.778 . . . . 0.0 109.655 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.07 143.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 112.133 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.01 121.53 33.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.49 175.27 23.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -101.9 135.26 43.77 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.203 -1.175 . . . . 0.0 109.276 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.8 m-85 -130.76 136.52 48.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.288 -0.882 . . . . 0.0 109.596 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -126.17 126.15 43.64 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 m -119.42 133.08 55.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.853 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.539 ' CZ ' ' NE ' ' A' ' 250' ' ' ARG . 74.8 t80 -115.34 112.83 22.96 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.539 ' NE ' ' CZ ' ' A' ' 249' ' ' PHE . 71.4 mtt180 48.41 32.48 3.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.81 165.26 54.71 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -140.33 179.64 18.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.588 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.4 m-70 -59.64 -41.62 90.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -1.203 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.091 -1.006 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.94 -45.13 87.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 11.0 m-20 -47.42 -51.25 20.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.989 -1.07 . . . . 0.0 109.077 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.91 -44.71 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -0.793 . . . . 0.0 109.849 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -58.75 -50.08 75.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 0.0 109.292 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.86 -49.18 69.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 108.695 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 17.2 t -60.43 -58.2 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.077 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -43.32 17.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 109.061 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.24 -47.12 74.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.32 -49.63 76.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.48 -28.6 65.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.023 -1.048 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.468 ' OE1' ' OG1' ' A' ' 85' ' ' THR . 9.4 mm-40 -54.45 139.65 36.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 108.71 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -122.66 146.27 47.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 110.234 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -143.61 -171.62 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.35 135.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.971 -1.081 . . . . 0.0 109.378 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -65.19 -21.61 66.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.778 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -152.86 158.72 42.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 140.46 58.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.288 -0.883 . . . . 0.0 110.055 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -118.22 164.8 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -131.32 139.87 49.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 110.18 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -138.05 146.23 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.1 154.05 24.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 110.349 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.87 175.21 36.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.33 151.68 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -1.07 . . . . 0.0 110.069 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.75 138.66 15.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tt -59.73 -37.21 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -1.22 . . . . 0.0 110.403 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 29.6 m-70 -89.66 -50.66 5.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.66 -1.275 . . . . 0.0 111.08 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.474 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 3.8 p -70.66 -24.26 62.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.797 -0.565 . . . . 0.0 111.822 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.21 14.64 26.7 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.146 -1.502 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.07 155.38 19.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -1.142 . . . . 0.0 109.407 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -75.24 134.53 41.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m -137.55 145.84 43.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -114.54 155.26 26.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.451 -0.78 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.1 mt -136.25 144.19 44.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.643 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.513 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 4.7 mp -139.49 112.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.81 115.76 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.349 -0.845 . . . . 0.0 110.858 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 19.6 m-70 -106.96 139.68 20.64 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.495 -0.753 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -56.46 168.24 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.533 1.489 . . . . 0.0 111.238 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 50.1 mm-40 -144.51 163.39 34.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 109.629 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.1 pttm -74.55 155.42 37.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 118' ' ' ASN . 5.2 mt-10 -49.96 149.88 2.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.174 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.26 19.52 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.042 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.448 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 90.0 m -58.0 -48.53 79.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.555 -1.556 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.68 178.42 35.17 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mm -92.97 116.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -1.033 . . . . 0.0 108.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 35' ' ' THR . 14.1 ptp180 -144.18 151.01 38.92 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.456 -1.297 . . . . 0.0 110.883 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.97 157.06 16.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -129.87 111.83 12.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.413 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -135.19 134.88 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 110.735 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.2 27.39 2.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.608 -0.682 . . . . 0.0 111.247 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.72 66.2 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.04 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.23 120.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 108.808 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -84.77 126.06 33.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.12 -0.987 . . . . 0.0 109.192 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.1 mt -117.01 91.45 36.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.13 148.06 14.4 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.667 2.245 . . . . 0.0 112.077 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.13 70.38 9.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -128.54 174.44 9.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 109.186 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.7 p-80 -71.52 -49.58 39.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -43.19 -17.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 111.496 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.4 m-85 -100.2 -2.47 33.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.684 -1.26 . . . . 0.0 110.163 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.92 121.13 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.185 -0.947 . . . . 0.0 108.576 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.99 -30.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.275 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.32 136.24 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.254 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -123.75 95.96 4.78 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.569 ' C ' ' H ' ' A' ' 59' ' ' SER . 15.0 t-20 -162.47 129.05 3.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 108.882 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 91.6 m-70 50.19 8.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 108.983 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.569 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.26 147.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.851 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 m -90.13 128.29 36.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.322 -0.861 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.75 150.6 41.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.478 -0.763 . . . . 0.0 111.056 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -123.89 149.49 45.78 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.02 150.31 20.42 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -162.82 148.17 12.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.423 -1.045 . . . . 0.0 108.965 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.452 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.06 25.93 2.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 109.677 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.92 5.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.549 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 5.3 mm-40 -57.45 145.1 34.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -1.221 . . . . 0.0 109.152 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.58 137.71 26.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 110.407 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 55.5 mt -131.18 125.94 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -101.08 156.21 17.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.023 -1.048 . . . . 0.0 111.294 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.0 m 51.79 75.29 0.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.52 -9.06 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.11 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pm0 -61.4 -26.34 67.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 0.0 110.361 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 30.8 m170 -68.2 -69.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.068 -1.02 . . . . 0.0 109.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -51.88 -48.42 39.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.197 -0.939 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 mt -51.86 -48.8 63.87 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.006 -1.058 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -60.26 -43.09 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.119 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.67 -45.69 82.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 109.193 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.97 -34.37 77.96 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.212 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -63.37 -37.0 85.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.316 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.13 -38.91 51.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.64 6.53 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 110.034 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 52.36 39.73 27.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 110.07 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.69 141.66 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 108.267 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.468 ' OG1' ' OE1' ' A' ' 4' ' ' GLU . 54.9 p -128.98 -22.6 3.17 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.114 -0.991 . . . . 0.0 111.873 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.493 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 76.9 m-20 -124.0 107.72 11.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.874 -1.141 . . . . 0.0 110.278 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.8 142.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.519 -0.738 . . . . 0.0 110.138 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 96.0 m -109.42 111.46 23.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.97 100.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 110.311 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.08 125.46 28.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -114.75 118.39 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.947 0.879 . . . . 0.0 111.675 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.4 98.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.84 -159.23 27.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 -13.63 8.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -1.135 . . . . 0.0 110.421 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.474 ' OE1' ' OG1' ' A' ' 20' ' ' THR . 69.9 tt0 -138.73 146.99 42.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.979 -1.076 . . . . 0.0 109.676 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.5 mm -70.08 119.83 74.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 108.706 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.27 124.49 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.88 1.72 . . . . 0.0 111.62 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 tp -76.39 -15.42 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 110.206 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.7 mt 55.36 -123.14 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -92.66 8.97 36.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.15 -7.87 69.63 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.47 -1.348 . . . . 0.0 109.973 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.2 p -124.02 -172.1 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.61 -0.936 . . . . 0.0 109.16 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.62 13.71 11.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -56.08 -42.33 76.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -1.125 . . . . 0.0 110.001 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.27 -54.78 31.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -54.85 -46.49 74.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.118 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -60.69 -56.54 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.731 -0.606 . . . . 0.0 110.718 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -58.88 -44.01 91.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.145 -0.972 . . . . 0.0 111.337 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.6 -51.79 46.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.964 -1.085 . . . . 0.0 110.719 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.7 mt -69.31 -31.87 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.155 . . . . 0.0 109.344 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.46 -43.22 94.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 110.258 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.23 17.05 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -144.05 29.04 1.35 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -0.999 . . . . 0.0 110.169 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 114' ' ' ILE . 71.7 mt -79.61 141.35 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.58 123.47 33.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.612 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.97 141.0 37.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.94 . . . . 0.0 110.314 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.85 -175.74 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.394 -0.816 . . . . 0.0 109.26 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.487 ' OD1' ' OE2' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -109.66 70.09 0.72 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -169.22 134.03 1.48 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.082 -1.011 . . . . 0.0 109.503 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.13 142.56 54.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.79 150.16 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 110.024 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.74 90.0 4.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -68.94 148.03 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.94 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -90.12 101.98 14.69 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.22 134.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.612 -0.68 . . . . 0.0 111.204 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.21 118.72 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.51 -27.04 15.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.522 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.18 152.5 79.66 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 151.52 46.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.64 2.226 . . . . 0.0 112.286 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.9 tt -160.04 153.15 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.336 -0.853 . . . . 0.0 109.29 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.11 145.31 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.84 149.29 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -139.85 157.86 45.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.132 -0.98 . . . . 0.0 110.196 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.86 111.35 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.252 -0.905 . . . . 0.0 109.93 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 52.47 48.19 23.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.541 -0.724 . . . . 0.0 110.833 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.6 -33.59 3.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.366 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -64.31 131.95 48.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.915 -1.344 . . . . 0.0 108.528 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.49 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -145.03 141.63 29.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 110.357 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 92.4 mt -136.88 132.18 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.779 . . . . 0.0 109.859 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.43 133.04 56.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.413 0.625 . . . . 0.0 110.007 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.71 135.33 53.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.727 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.02 149.62 39.51 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.868 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -48.48 142.4 17.73 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.523 2.149 . . . . 0.0 113.382 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.12 145.19 19.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.97 -30.43 70.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -127.01 -171.14 2.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.74 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.15 123.46 44.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.163 -0.96 . . . . 0.0 108.675 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.28 118.03 15.07 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.233 -0.917 . . . . 0.0 108.555 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.84 122.2 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.47 ' OG1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 m -113.15 152.05 30.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.479 -0.763 . . . . 0.0 109.679 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.78 130.79 28.08 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.948 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -119.98 130.44 54.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.78 135.64 8.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.645 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -98.55 100.39 11.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.79 167.02 13.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 110.66 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -102.84 -22.53 13.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.912 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.0 p-10 -88.05 -171.42 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.701 -1.249 . . . . 0.0 109.986 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -52.23 1.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 111.458 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.567 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -79.44 -28.58 41.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.353 -1.467 . . . . 0.0 108.71 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.05 -142.55 35.15 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -99.6 135.65 40.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -138.26 153.5 49.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.812 . . . . 0.0 109.41 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -141.22 144.85 34.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.288 -0.882 . . . . 0.0 109.754 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.583 ' CE1' ' NH2' ' A' ' 225' ' ' ARG . 49.2 t80 -142.05 132.89 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.661 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 86.9 m -103.78 122.68 45.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -103.83 114.06 28.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.9 152.79 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.737 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -49.96 128.19 18.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.69 1.81 43.1 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -117.83 20.29 13.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -60.15 -51.47 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.443 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 5.0 mt-10 -47.76 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 171' ' ' GLU . 9.3 mm-40 -102.94 -6.11 22.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.123 -0.985 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.7 pt -125.16 -26.84 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.959 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.2 m -62.13 -10.66 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.815 -1.178 . . . . 0.0 109.106 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -98.46 -2.17 39.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 0.0 109.078 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.462 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -65.44 122.2 16.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 0.0 109.283 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.566 HH12 ' CD ' ' A' ' 215' ' ' GLU . 52.5 mtm180 -94.23 128.27 40.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.869 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 12.5 t -36.53 158.67 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -145.2 150.0 35.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.51 -1.369 . . . . 0.0 111.49 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.39 157.05 43.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.6 m-85 -97.7 145.52 26.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.442 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.97 -37.11 8.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.363 -0.835 . . . . 0.0 109.278 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -74.29 -29.56 61.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.1 mm-40 -71.52 -31.64 67.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 59.6 mt -57.24 -55.07 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.669 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.8 tt0 -42.85 -38.74 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.13 -0.981 . . . . 0.0 109.302 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 189' ' ' ILE . 9.3 t60 -76.3 -59.34 2.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.051 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 188' ' ' HIS . 82.9 mt -41.75 -36.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.698 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -79.43 -51.83 8.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.875 -1.141 . . . . 0.0 109.226 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -49.35 -27.17 3.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 110.709 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.51 11.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.746 -1.221 . . . . 0.0 110.086 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.44 39.54 69.35 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.429 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.1 mt -129.61 172.59 11.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -1.179 . . . . 0.0 109.998 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.99 21.84 59.54 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -58.93 -21.19 57.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.463 -1.61 . . . . 0.0 109.749 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.405 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.56 25.51 11.03 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -87.49 132.94 11.48 Favored Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.923 -1.34 . . . . 0.0 109.921 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.9 174.39 11.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -1.095 . . . . 0.0 109.564 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.18 -7.52 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 108.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -97.51 -19.97 18.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.603 -0.686 . . . . 0.0 110.003 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 21.8 p30 -125.68 3.35 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -144.54 145.35 31.79 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.996 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.8 tp -96.35 96.13 8.54 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.53 128.22 39.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.9 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.38 162.99 21.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.539 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.2 -166.28 12.74 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -24.54 66.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.457 -1.025 . . . . 0.0 109.966 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.6 24.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -151.97 160.47 43.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.515 -1.365 . . . . 0.0 110.643 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.5 t -106.08 114.01 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -57.56 -46.94 83.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 110.46 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 213' ' ' ASN . 1.3 m-20 -59.31 130.39 87.21 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.17 -0.956 . . . . 0.0 110.53 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -67.88 -21.62 43.77 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.682 1.588 . . . . 0.0 111.688 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.566 ' CD ' HH12 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -80.71 -15.46 56.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.957 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.404 ' O ' ' OE2' ' A' ' 215' ' ' GLU . . . 71.51 -157.5 53.29 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.262 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.19 154.44 20.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -1.138 . . . . 0.0 110.138 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -90.14 -19.54 24.14 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -138.75 -176.5 4.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 19.2 mp0 -83.6 -20.16 34.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 109.529 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.649 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -136.12 54.7 1.89 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -57.59 -46.31 99.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.893 -1.13 . . . . 0.0 109.848 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.6 Cg_exo -52.67 -66.26 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.221 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.69 -36.07 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 109.512 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.583 ' NH2' ' CE1' ' A' ' 164' ' ' PHE . 74.6 mtt-85 -59.79 -41.21 90.67 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.462 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 7.5 t60 -68.17 -31.64 71.34 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.1 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.17 -38.37 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.53 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.3 t80 -62.56 -51.34 67.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 108.892 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.76 -29.51 70.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.526 -0.733 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.87 -33.77 51.97 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.3 mt -65.76 -37.81 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.22 -56.1 11.29 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.425 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 92.4 m-20 -52.67 -37.14 58.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.246 . . . . 0.0 109.309 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.04 -24.04 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 110.497 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.631 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -70.66 -21.58 62.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.783 -1.198 . . . . 0.0 108.792 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.13 3.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.56 -1.338 . . . . 0.0 110.318 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.631 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.7 mt -82.98 -16.47 47.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 0.0 109.585 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.17 44.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.913 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.75 158.69 11.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.428 . . . . 0.0 109.297 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.15 128.3 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.874 1.716 . . . . 0.0 109.456 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.1 t -87.86 154.56 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.992 -1.068 . . . . 0.0 112.387 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -136.26 127.57 28.3 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.38 -155.0 25.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.47 ' NZ ' ' OG1' ' A' ' 150' ' ' THR . 19.9 tptt -133.49 127.49 33.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 108.697 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -127.82 140.76 51.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.313 -0.867 . . . . 0.0 110.572 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -123.65 133.91 53.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.5 t -127.26 134.89 50.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.952 -1.092 . . . . 0.0 110.95 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -116.91 115.82 26.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 47.44 24.37 0.47 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.168 -0.957 . . . . 0.0 109.248 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 152.92 37.45 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.58 166.6 22.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.592 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 60.0 m-70 -48.77 -40.68 29.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.131 -1.217 . . . . 0.0 109.531 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -54.91 -58.53 7.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.54 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.14 -45.48 83.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.646 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.2 m-20 -47.51 -51.26 21.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.361 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.72 -50.55 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.928 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -52.05 -52.2 52.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.008 . . . . 0.0 109.356 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 37.0 tp -51.28 -51.33 55.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 108.533 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 69.0 t -53.93 -50.07 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.918 . . . . 0.0 108.828 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -51.23 -55.16 19.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.515 -0.74 . . . . 0.0 109.732 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.19 -49.91 75.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 110.022 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.7 -52.11 66.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.1 67.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.272 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.196 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -58.0 136.62 57.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 109.063 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.632 ' HZ1' ' ND2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -120.96 141.58 50.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 109.54 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -139.19 -170.12 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.57 136.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -66.47 -16.67 64.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -156.18 159.85 39.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 139.21 57.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 110.228 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt -117.66 165.41 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.66 144.51 39.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.957 -1.089 . . . . 0.0 110.483 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.7 m-85 -140.41 155.35 46.77 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -162.11 152.81 17.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.782 -1.199 . . . . 0.0 110.275 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.4 176.83 36.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.53 153.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.179 . . . . 0.0 110.424 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.62 141.13 16.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.51 -41.29 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 111.026 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.41 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 59.5 m-70 -87.1 -50.49 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.534 -1.354 . . . . 0.0 111.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -70.24 -22.82 62.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 111.363 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.0 20.65 35.01 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.931 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -110.86 154.1 24.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.65 135.4 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -139.67 143.37 37.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -112.38 154.39 25.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.324 -0.86 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' PHE . 7.9 mt -132.43 148.98 52.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.367 -0.833 . . . . 0.0 110.312 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.426 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.0 mt -143.58 110.78 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.52 117.44 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 111.032 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.426 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 22.0 m-70 -110.65 138.84 21.14 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.458 -0.776 . . . . 0.0 109.701 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -54.28 168.58 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.958 1.772 . . . . 0.0 111.79 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 50.3 mm-40 -140.86 177.49 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.918 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.0 mttt -86.02 153.0 22.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.393 -0.817 . . . . 0.0 110.136 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -47.25 145.67 2.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.089 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.3 7.33 51.58 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.128 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.6 m -69.56 -43.68 72.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.659 -1.495 . . . . 0.0 109.56 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.73 -178.96 32.72 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.359 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.15 116.52 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -140.26 150.86 44.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.822 -1.174 . . . . 0.0 110.382 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.66 157.4 16.71 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -129.43 110.97 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.181 -0.949 . . . . 0.0 108.877 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.565 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 32.7 tttm -135.64 135.26 40.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.534 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.565 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 15.2 m120 52.85 28.88 6.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 111.19 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.27 18.1 78.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.958 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -122.7 122.22 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -1.028 . . . . 0.0 108.808 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 42.1 m-85 -83.84 126.5 33.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.089 -1.007 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -115.39 95.64 43.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.31 145.04 22.04 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.427 2.085 . . . . 0.0 112.081 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.24 74.8 10.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -132.79 -179.91 5.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.381 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.6 p-80 -75.78 -53.26 8.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.129 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -43.28 -17.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.232 -0.918 . . . . 0.0 110.963 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.2 m-85 -97.63 1.31 48.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.735 -1.228 . . . . 0.0 109.837 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.54 131.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.099 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -30.05 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -151.08 133.49 15.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -124.38 95.44 4.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.207 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 59' ' ' SER . 46.0 t-20 -162.97 128.86 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 47.4 11.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 108.969 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 163.37 141.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.344 -0.847 . . . . 0.0 110.098 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.557 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -90.62 127.97 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.376 -0.828 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.42 151.75 39.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.664 0.745 . . . . 0.0 111.002 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -126.23 148.23 49.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.63 154.14 25.12 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.088 -1.529 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -165.31 152.95 11.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt 50.69 22.26 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.13 -33.48 6.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.546 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 9.0 mm-40 -56.22 147.34 21.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.229 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.9 135.55 26.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.272 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.36 126.11 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -103.29 156.23 17.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.968 -1.082 . . . . 0.0 111.078 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.8 m 51.64 75.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.943 -0.473 . . . . 0.0 110.818 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.07 -10.32 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.5 pm0 -61.45 -26.8 68.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.906 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.0 m170 -66.35 -68.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 tp -52.07 -47.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 109.161 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.5 mt -52.33 -49.15 64.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 17.5 t -59.73 -43.17 94.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.35 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.71 -44.6 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.975 -1.078 . . . . 0.0 109.101 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.56 -36.07 80.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.964 . . . . 0.0 109.588 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.72 -35.58 78.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.47 -36.93 37.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.38 -0.825 . . . . 0.0 109.843 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -83.52 4.12 29.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.084 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 53.59 40.62 31.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.556 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 27.3 mm -85.33 142.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 42.5 p -129.81 -22.61 2.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.186 -0.946 . . . . 0.0 111.612 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.9 OUTLIER -125.2 107.03 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.744 -1.223 . . . . 0.0 110.035 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.9 m -164.3 148.55 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.616 0.722 . . . . 0.0 110.008 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 57.4 m -117.19 108.19 15.37 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.18 100.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.804 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -73.78 125.14 27.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.99 119.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.815 0.817 . . . . 0.0 111.542 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -105.94 97.75 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.56 -158.77 27.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -120.49 -13.03 8.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -139.56 148.23 42.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 109.707 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -71.66 120.76 81.81 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 108.943 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.05 120.23 1.45 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.733 1.622 . . . . 0.0 111.629 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 tp -78.38 -15.8 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.8 mt 55.76 -115.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.267 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.82 5.6 50.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.032 -1.043 . . . . 0.0 110.797 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.96 0.7 61.83 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.147 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -126.7 -172.87 2.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.661 -0.905 . . . . 0.0 109.629 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.33 16.7 8.02 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -57.77 -41.73 82.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -1.08 . . . . 0.0 110.086 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -64.54 -57.15 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.105 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 14.7 m-85 -51.57 -46.55 63.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.97 . . . . 0.0 109.348 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -61.03 -51.04 70.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.667 -0.646 . . . . 0.0 110.941 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.18 -42.45 96.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.002 -1.061 . . . . 0.0 111.245 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.91 -58.49 4.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.5 -34.4 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.099 -1.001 . . . . 0.0 109.577 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -63.25 -42.21 99.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.98 . . . . 0.0 109.26 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 11.86 0.81 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 8' ' ' LYS . 3.5 m-80 -146.24 33.64 0.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.595 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 70.2 mt -78.19 139.59 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.742 -1.224 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.8 tp -127.7 121.96 31.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -0.779 . . . . 0.0 108.998 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.632 ' ND2' ' HZ1' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -79.04 142.59 36.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.144 -0.972 . . . . 0.0 110.354 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -111.56 -170.61 1.68 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.358 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -116.64 71.22 0.78 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.144 -0.972 . . . . 0.0 111.713 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.572 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 9.4 ttt180 -170.02 132.11 1.07 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.959 -1.088 . . . . 0.0 109.31 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.32 142.11 57.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.959 -1.088 . . . . 0.0 110.238 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 121' ' ' ILE . 89.5 mt -87.6 151.74 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.35 79.3 3.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.284 -0.885 . . . . 0.0 108.813 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.466 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 36.4 m-85 -58.78 146.67 36.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.294 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -93.11 101.91 14.22 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.75 132.68 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.359 0.599 . . . . 0.0 110.918 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.3 117.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.06 -27.57 15.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 110.662 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -134.36 150.78 74.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.549 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.98 151.42 62.12 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.401 HG12 ' N ' ' A' ' 131' ' ' ILE . 1.9 tt -157.22 150.69 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.416 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.401 ' N ' HG12 ' A' ' 130' ' ' ILE . 2.7 mp -138.68 136.44 43.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 108.965 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.64 147.48 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -130.0 164.71 23.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 0.0 110.263 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 258' ' ' LYS . 0.9 OUTLIER -171.82 102.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.841 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 48.05 57.43 6.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 110.731 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.05 -34.51 3.57 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -63.25 138.28 58.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.252 . . . . 0.0 109.133 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.46 137.89 28.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.082 -1.011 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.2 mt -135.75 121.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.399 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -110.99 131.69 54.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.436 0.636 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.87 132.88 55.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.55 146.92 34.21 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 110.258 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -47.11 141.78 12.37 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.654 2.236 . . . . 0.0 113.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.02 144.35 19.98 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 146' ' ' THR . 4.0 t0 -66.16 0.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.792 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 244' ' ' GLY . 27.9 p -157.13 173.6 16.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.841 -1.162 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 tp -85.11 118.3 24.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -137.45 126.17 23.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 108.764 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.41 121.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.9 m -111.62 151.7 28.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.642 -0.661 . . . . 0.0 109.292 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.03 130.25 26.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.721 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -120.88 131.66 54.52 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.24 133.91 7.46 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.584 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -100.98 97.72 8.26 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -88.57 167.13 13.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.983 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -98.99 -17.05 18.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.76 -0.587 . . . . 0.0 110.697 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.0 p-10 -92.62 -168.59 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.825 -1.172 . . . . 0.0 110.386 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -55.08 0.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.362 -0.836 . . . . 0.0 111.472 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.2 mt -78.55 -27.65 45.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.443 -1.411 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.8 -137.96 34.96 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -100.4 132.3 45.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.202 -1.175 . . . . 0.0 109.682 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.5 155.52 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.125 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -147.93 149.5 32.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.113 -0.992 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -143.46 139.32 29.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.512 -0.742 . . . . 0.0 109.41 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.29 124.82 51.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -105.12 113.77 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.848 . . . . 0.0 110.327 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.0 153.06 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.316 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.01 125.61 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.248 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 102.73 3.59 49.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -120.24 19.9 12.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.307 -1.114 . . . . 0.0 109.278 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 173' ' ' GLU . 2.2 pm0 -64.88 -46.49 81.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.642 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -47.8 -7.52 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 171' ' ' GLU . 75.0 mt-10 -103.58 -5.89 22.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.482 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.4 pt -123.29 -26.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.217 -0.927 . . . . 0.0 110.558 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -60.79 -23.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.569 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.9 mt -85.27 -2.2 57.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.417 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -71.49 119.09 15.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.417 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 42.5 mtm180 -83.53 172.97 11.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.4 163.38 25.7 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -147.78 147.91 30.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.22 -1.55 . . . . 0.0 111.786 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.87 157.88 43.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.443 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.0 m-85 -97.85 146.94 24.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.901 -1.124 . . . . 0.0 109.78 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.52 -37.31 26.22 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.304 -0.872 . . . . 0.0 109.176 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.443 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.0 p90 -71.05 -25.56 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.13 -0.981 . . . . 0.0 109.947 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.434 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 mt-10 -82.39 -22.93 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.977 . . . . 0.0 109.742 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.85 -53.67 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.639 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.88 -38.02 9.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -76.54 -53.78 7.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.122 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.82 -32.3 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.788 . . . . 0.0 109.533 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -52.61 6.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.039 -1.038 . . . . 0.0 109.226 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -49.84 -40.43 42.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 110.265 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.55 5.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.006 -1.059 . . . . 0.0 110.218 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.96 37.21 56.71 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.4 mt -125.39 168.89 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.41 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.51 21.77 58.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.74 -20.27 5.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.571 -1.547 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.447 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.67 26.32 9.05 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 128.53 9.19 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.946 -1.326 . . . . 0.0 110.034 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.8 p -144.93 171.97 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -1.056 . . . . 0.0 109.422 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.47 -8.14 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -97.06 -12.73 22.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.772 -0.58 . . . . 0.0 109.515 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.0 p30 -133.13 7.54 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 109.882 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -149.88 151.0 32.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.15 95.4 7.4 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.3 t -85.87 127.76 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.788 0.804 . . . . 0.0 109.28 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 52.9 mt -123.24 161.47 24.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.647 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.94 -166.65 12.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -29.73 70.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -1.099 . . . . 0.0 109.672 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.66 23.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -0.944 . . . . 0.0 110.856 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -146.78 154.12 41.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.51 -1.369 . . . . 0.0 110.708 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 45.3 t -104.44 113.45 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -58.69 -45.62 89.06 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 109.832 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.15 116.61 18.2 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.224 -0.923 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.95 -15.4 43.51 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.475 1.45 . . . . 0.0 111.641 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -75.01 -15.82 60.64 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.231 -0.918 . . . . 0.0 108.702 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.23 -178.12 47.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mt -83.92 145.75 28.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -1.106 . . . . 0.0 109.639 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -77.79 -18.79 56.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 108.811 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.638 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 76.0 m-85 -141.8 178.74 7.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -85.92 -3.49 58.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.678 HD21 ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -146.77 45.55 1.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -55.58 -47.18 99.24 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.861 -1.149 . . . . 0.0 109.756 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.6 Cg_exo -51.37 -66.77 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.429 2.086 . . . . 0.0 112.157 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.97 -36.79 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.936 -1.102 . . . . 0.0 109.63 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.678 ' NE ' HD21 ' A' ' 221' ' ' ASN . 75.3 mtt180 -59.77 -42.18 92.76 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.417 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 19.2 t60 -67.09 -31.66 72.29 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.06 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -66.57 -35.76 81.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.73 -37.73 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.9 t80 -64.01 -50.61 67.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.46 -28.02 67.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.3 tp -75.92 -33.02 59.87 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 28.2 mt -67.52 -39.54 82.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.28 -58.2 9.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.438 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 53.8 m-20 -51.55 -40.84 60.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -1.226 . . . . 0.0 109.249 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.18 -22.97 44.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.533 -0.729 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.6 -22.26 61.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.841 -1.162 . . . . 0.0 108.721 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.4 mt -53.08 -1.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.727 -1.233 . . . . 0.0 110.122 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.6 mt -75.68 -14.45 60.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.052 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.91 57.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.594 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.3 m -166.52 157.2 10.96 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.867 -1.372 . . . . 0.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -49.84 150.55 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.956 1.771 . . . . 0.0 109.712 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.7 147.95 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 111.515 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.466 ' NZ ' ' CE2' ' A' ' 123' ' ' TYR . 1.7 tppt? -130.34 123.97 31.19 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.51 -158.77 28.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -129.55 139.82 51.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -1.128 . . . . 0.0 109.087 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 22.7 m-85 -134.74 139.84 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 110.426 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -123.39 123.29 40.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.6 m -120.54 134.36 55.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.942 -1.099 . . . . 0.0 111.074 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -115.73 115.74 26.86 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 49.71 20.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.972 -1.08 . . . . 0.0 109.054 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -50.28 156.23 2.4 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -139.7 157.28 25.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.557 ' ND1' ' HG1' ' A' ' 60' ' ' THR . 80.9 m-70 -45.32 -43.36 10.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -1.118 . . . . 0.0 110.032 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.9 p -58.46 -41.05 84.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 26.0 tp -74.2 -43.61 56.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 108.538 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 256' ' ' ASN . 0.8 OUTLIER -50.98 -45.73 61.13 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.092 -1.005 . . . . 0.0 109.051 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.13 -57.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 134' ' ' ASP . 2.6 ttpt -47.41 -46.16 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.839 -1.163 . . . . 0.0 108.614 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 44.1 tp -55.04 -53.48 55.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.051 . . . . 0.0 108.791 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.6 t -54.49 -53.75 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -49.32 -46.69 47.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.83 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -64.92 -52.77 54.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.957 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.6 mt -53.87 -51.82 62.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 110.196 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.14 -27.2 65.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.963 -1.086 . . . . 0.0 110.304 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 110.149 -179.314 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -55.74 129.12 38.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 108.97 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.9 144.27 48.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.501 -0.749 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -143.83 -173.28 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 m -95.44 135.01 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.087 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -20.43 66.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -154.62 156.12 35.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.435 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.78 139.85 58.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.78 168.29 10.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 p -143.64 146.53 33.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.1 m-85 -140.12 150.24 44.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -152.97 148.18 26.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.965 -1.084 . . . . 0.0 109.703 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.58 173.1 36.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.42 153.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.12 . . . . 0.0 110.311 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.57 140.76 15.51 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 197' ' ' GLY . 15.4 tt -60.15 -41.52 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 110.659 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.403 ' N ' HG22 ' A' ' 18' ' ' ILE . 88.6 m-70 -86.64 -50.8 6.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.686 -1.259 . . . . 0.0 110.875 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 p -70.96 -22.57 62.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.67 -0.644 . . . . 0.0 111.526 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.51 15.61 12.52 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -106.82 154.99 20.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 109.76 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.23 135.44 42.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 3.5 t -138.9 145.43 39.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -111.04 155.21 23.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.616 -0.677 . . . . 0.0 110.019 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.7 mt -135.4 147.11 48.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 109.969 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 mt -143.45 109.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 108.864 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.68 113.75 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -106.76 140.0 20.92 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.489 -0.757 . . . . 0.0 109.265 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.55 165.77 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.752 1.635 . . . . 0.0 111.952 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.6 mm-40 -141.39 174.39 10.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 35' ' ' THR . 75.2 mttt -82.68 152.26 25.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 35' ' ' THR . 11.7 mt-10 -48.7 151.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.81 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.56 -6.94 3.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 32.7 m -59.62 -44.9 93.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.784 -1.421 . . . . 0.0 109.705 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.15 -176.31 30.38 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.57 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 mm -102.52 116.79 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.93 155.13 47.31 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.608 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -102.99 158.67 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -128.88 109.14 11.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 108.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HZ2' HD21 ' A' ' 42' ' ' ASN . 45.5 tttm -135.53 134.5 39.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.333 -0.854 . . . . 0.0 110.995 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.59 HD21 ' HZ2' ' A' ' 41' ' ' LYS . 19.3 m-80 52.7 29.14 7.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.775 . . . . 0.0 111.325 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.0 18.41 76.84 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.909 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.65 123.26 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -1.062 . . . . 0.0 109.08 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -85.49 127.59 34.46 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.0 mt -116.91 93.7 42.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.69 151.42 19.37 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 111.897 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.42 70.74 10.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.759 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.952 . . . . 0.0 109.035 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -69.51 -54.12 15.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.56 -17.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 111.087 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.5 m-85 -94.96 3.4 54.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.936 -1.102 . . . . 0.0 109.912 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -72.24 138.94 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.19 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.76 -28.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.395 -0.815 . . . . 0.0 109.639 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.37 133.61 12.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -124.03 95.6 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.124 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.0 t-20 -163.09 128.71 3.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.798 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.9 m-70 45.64 13.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.32 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.963 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.468 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 45.2 m -78.68 125.17 29.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 108.869 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 147.73 44.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.841 0.829 . . . . 0.0 111.206 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -123.77 150.26 44.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.88 151.36 21.09 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.731 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -163.36 152.21 14.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.533 -0.981 . . . . 0.0 109.27 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt 51.3 21.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.89 6.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 13.6 mm-40 -59.26 146.39 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -1.229 . . . . 0.0 109.332 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -142.13 137.31 30.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 110.663 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 122.96 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -101.13 155.16 18.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 111.312 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 m 49.18 73.89 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.78 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -107.78 -8.33 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.05 -27.61 68.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.495 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 29.1 m170 -64.49 -69.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.923 -1.111 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.49 -47.59 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.23 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.5 mt -52.58 -48.28 66.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 109.985 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.6 t -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.04 -45.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 108.981 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.09 -34.98 78.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.255 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -61.52 -36.4 80.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -79.75 -37.02 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.5 mt -79.33 2.07 22.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.015 -1.053 . . . . 0.0 109.802 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 54.48 39.4 31.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.513 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 2.8 mm -86.21 141.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 108.25 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.0 p -124.49 -21.44 4.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.028 -1.045 . . . . 0.0 111.753 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.487 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 38.8 m-80 -127.24 108.06 10.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.887 -1.133 . . . . 0.0 111.048 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 7.0 m -162.61 146.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 89.5 m -115.85 113.75 23.79 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mt -95.9 107.4 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.693 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -76.75 127.15 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.38 117.51 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.742 0.782 . . . . 0.0 111.442 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.497 ' O ' ' OG ' ' A' ' 24' ' ' SER . 26.1 mm -104.51 95.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.19 -155.4 24.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.21 -10.5 8.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -1.175 . . . . 0.0 110.379 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -139.82 148.95 42.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.8 mm -72.85 126.41 90.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 108.735 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -45.9 121.18 4.03 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 121.845 1.697 . . . . 0.0 111.004 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 tp -75.25 -15.64 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 110.551 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.6 mt 57.33 -120.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.96 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -96.29 6.61 48.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.062 -1.024 . . . . 0.0 110.821 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.3 61.12 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.077 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 p -128.31 -172.31 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.634 -0.921 . . . . 0.0 109.524 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.66 15.5 10.53 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -58.53 -43.27 89.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -1.098 . . . . 0.0 110.003 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.85 -59.19 4.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.008 -1.057 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -51.56 -46.29 63.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.762 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.56 -51.99 66.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 110.974 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.36 -43.26 95.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 111.375 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -55.92 13.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 110.611 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.74 -31.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 0.0 109.446 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -65.0 -41.15 95.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.069 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.566 ' C ' HD21 ' A' ' 113' ' ' ASN . 6.0 pttt -75.55 11.06 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.566 HD21 ' C ' ' A' ' 112' ' ' LYS . 1.5 m-80 -139.91 34.6 1.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 110.507 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.15 139.85 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.8 -1.187 . . . . 0.0 110.949 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.74 126.62 34.91 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.487 ' H ' ' ND2' ' A' ' 116' ' ' ASN . 2.1 p30 -82.81 146.91 28.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.156 -0.965 . . . . 0.0 110.569 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -114.2 -169.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.121 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -112.65 69.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 111.22 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 21.3 ttm-85 -164.89 132.23 3.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.993 -1.067 . . . . 0.0 109.267 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.82 141.52 55.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.066 -1.021 . . . . 0.0 109.456 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.9 mt -81.34 146.26 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.333 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.74 81.04 4.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 43.0 m-85 -60.41 140.03 57.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -86.97 100.91 12.94 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.4 t -92.41 134.56 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.418 0.628 . . . . 0.0 111.073 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.84 114.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.7 -25.99 15.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.93 149.21 71.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.19 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.4 152.01 48.8 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.377 2.051 . . . . 0.0 111.942 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -155.2 151.58 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.361 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.54 139.23 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.1 m -125.78 148.13 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.92 159.03 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.7 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.38 105.42 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.442 -0.786 . . . . 0.0 109.666 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 47.82 56.85 6.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.373 -0.83 . . . . 0.0 110.827 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.09 -36.84 2.87 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.464 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -61.56 129.48 41.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.964 -1.315 . . . . 0.0 108.449 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -143.57 141.01 30.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.864 -1.147 . . . . 0.0 110.242 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.62 132.36 44.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -120.47 130.76 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.373 0.606 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.64 135.76 54.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -145.29 152.63 50.85 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.078 -1.014 . . . . 0.0 109.52 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -49.95 143.17 24.82 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.412 2.075 . . . . 0.0 113.506 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.45 144.0 20.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -4.53 4.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.273 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.5 p -151.9 -172.08 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.5 tp -100.54 121.4 41.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 108.845 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -135.05 128.82 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.76 122.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 109.966 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 39.6 m -113.71 151.92 31.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.429 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -139.69 131.12 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.938 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -120.94 133.42 55.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.93 138.49 9.84 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.649 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.03 98.04 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -84.97 167.18 16.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.576 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -104.07 -17.57 14.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 110.64 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.3 p-10 -92.17 -166.65 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.779 -1.2 . . . . 0.0 110.01 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.29 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 111.151 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.4 mt -78.68 -27.11 45.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.459 -1.4 . . . . 0.0 108.2 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.03 -141.52 33.14 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -100.27 134.99 42.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.332 -1.099 . . . . 0.0 109.275 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.4 153.89 47.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.661 ' HZ1' ' HG1' ' A' ' 165' ' ' THR . 0.0 OUTLIER -144.23 145.75 32.25 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.41 -0.806 . . . . 0.0 109.545 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.564 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 16.4 t80 -145.03 140.19 27.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.173 -0.955 . . . . 0.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.661 ' HG1' ' HZ1' ' A' ' 163' ' ' LYS . 90.2 m -109.06 123.37 49.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 110.093 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -102.98 114.06 28.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.01 147.53 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.11 132.34 19.23 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.312 -0.867 . . . . 0.0 108.838 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.4 -9.58 30.78 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.47 25.53 10.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.209 -1.171 . . . . 0.0 109.288 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.0 OUTLIER -61.33 -15.65 38.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.0 110.496 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -81.54 -10.42 59.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.038 -1.039 . . . . 0.0 110.668 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' CZ ' ' A' ' 164' ' ' PHE . 1.5 pp20? -101.11 -5.26 25.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.052 -1.03 . . . . 0.0 110.623 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 pt -115.99 -31.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -61.7 -15.45 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.842 -1.161 . . . . 0.0 108.776 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.1 mt -94.74 -4.81 46.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.561 -0.712 . . . . 0.0 109.451 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.02 120.52 14.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.006 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -81.07 172.16 14.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.74 163.66 25.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.64 145.44 27.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.252 -1.53 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.03 44.01 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.51 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -99.44 143.94 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.002 -1.061 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.38 -36.47 6.46 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.9 p90 -73.35 -29.81 62.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.947 -1.095 . . . . 0.0 109.889 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.5 tt0 -74.54 -27.64 60.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 109.938 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.31 -48.76 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -47.77 -40.76 21.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.168 -0.957 . . . . 0.0 109.995 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -77.25 -52.92 8.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.275 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.6 mt -49.42 -27.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.418 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -85.61 -54.74 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.001 -1.062 . . . . 0.0 109.35 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -50.76 -33.78 24.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.3 m -84.66 7.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.0 -1.063 . . . . 0.0 110.08 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.93 61.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 46.1 mt -129.39 171.36 12.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -1.168 . . . . 0.0 110.145 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.39 29.14 62.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 198' ' ' GLY . 29.8 mttt -58.2 -56.33 23.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.388 -1.654 . . . . 0.0 109.683 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -67.1 4.68 3.19 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.725 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 196' ' ' LYS . . . -61.99 124.82 34.94 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.876 -1.367 . . . . 0.0 110.523 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.1 t -145.91 164.23 32.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.438 -1.036 . . . . 0.0 109.101 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.513 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 70.7 mt -67.92 -8.01 33.24 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.5 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -98.77 -9.31 24.62 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.758 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 23.6 p30 -134.54 9.66 3.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -150.72 150.05 30.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.86 93.18 5.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.85 130.56 36.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.716 0.769 . . . . 0.0 108.973 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 35.2 mt -124.78 165.11 18.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.656 -0.652 . . . . 0.0 109.576 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.19 -166.4 12.23 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -25.21 67.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.747 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -163.21 23.15 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.385 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 146.67 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.016 -1.053 . . . . 0.0 110.342 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.73 109.99 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.48 -49.11 75.63 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.078 -1.014 . . . . 0.0 109.826 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.8 m120 -60.28 112.48 5.55 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.832 . . . . 0.0 110.279 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.26 -23.2 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.796 1.664 . . . . 0.0 112.783 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.61 -14.71 62.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.834 -1.166 . . . . 0.0 109.919 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.24 -168.55 52.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.28 138.67 31.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 109.763 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -75.32 -17.25 60.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.174 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.3 -173.61 3.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.7 -22.43 23.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.51 HD21 ' NH1' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -136.94 53.25 1.9 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.543 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -54.63 -47.82 96.92 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.3 Cg_exo -48.45 -64.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.391 2.061 . . . . 0.0 112.102 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.5 m -60.64 -35.8 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.793 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.51 ' NH1' HD21 ' A' ' 221' ' ' ASN . 4.0 mtt85 -60.89 -41.56 96.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.046 -1.033 . . . . 0.0 108.468 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.4 t60 -67.45 -32.3 73.07 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -66.53 -36.45 82.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.53 -37.37 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.508 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.6 t80 -64.98 -51.48 61.51 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -64.55 -28.26 69.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 109.844 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 36.0 tp -75.06 -34.13 61.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.072 -1.018 . . . . 0.0 108.492 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.77 -39.84 84.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.04 -56.0 18.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 26.7 m-20 -54.63 -32.72 59.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.096 -1.238 . . . . 0.0 109.178 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.68 -23.77 67.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.475 -0.766 . . . . 0.0 110.653 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.73 -21.79 61.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.749 -1.219 . . . . 0.0 109.105 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 83.9 mt -50.46 -1.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.31 . . . . 0.0 110.607 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.44 -15.26 58.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.771 -1.205 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.19 2.93 59.02 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.574 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.8 m -166.46 155.45 10.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.362 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.0 Cg_endo -49.63 150.55 8.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.952 1.768 . . . . 0.0 109.608 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.83 145.96 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 0.0 112.124 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -127.81 121.98 31.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.91 -179.27 30.29 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -109.43 140.7 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -1.131 . . . . 0.0 109.198 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 17.2 m-85 -135.05 138.76 44.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 110.34 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -125.0 124.75 42.67 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 m -120.19 135.78 54.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.971 -1.081 . . . . 0.0 111.429 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 251' ' ' GLY . 75.8 t80 -115.28 117.06 29.41 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' PHE . 63.3 mtp180 45.98 22.37 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.065 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -51.9 159.41 2.61 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -139.1 164.3 25.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 34.1 m-70 -50.28 -42.76 52.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.149 -1.206 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.543 ' H ' ' HG ' ' A' ' 254' ' ' SER . 1.1 m -56.98 -59.2 5.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 26.4 tp -53.51 -45.64 69.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.381 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -49.54 -50.53 41.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 0.0 109.666 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.41 -55.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.805 . . . . 0.0 110.197 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -45.2 64.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 108.79 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.99 -54.47 34.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.488 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.6 t -55.86 -54.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.37 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -43.98 33.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.35 -49.99 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 109.861 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 13.9 mt -56.94 -47.59 80.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.34 -30.77 69.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 109.568 -179.674 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.291 0.567 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -54.62 137.35 43.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 142.72 49.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.495 -0.753 . . . . 0.0 109.717 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -141.51 -171.63 3.35 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -96.86 135.15 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.049 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CB ' ' HZ2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -65.91 -21.26 66.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.585 -179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -153.0 160.76 43.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 0.0 109.275 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 140.59 54.48 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 0.0 110.022 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.14 163.93 15.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 141.9 46.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.091 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 98.0 m-85 -139.84 146.24 39.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' CG ' ' OH ' ' A' ' 23' ' ' TYR . 3.8 pt-20 -151.88 149.35 28.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 109.908 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.87 172.27 35.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.28 151.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -1.087 . . . . 0.0 110.357 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.37 137.1 15.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.26 -38.74 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -91.07 -49.21 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.845 -1.159 . . . . 0.0 111.105 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.498 ' HG1' ' CB ' ' A' ' 95' ' ' GLU . 2.9 p -69.49 -21.76 63.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 111.416 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.03 8.31 3.05 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 20' ' ' THR . 3.4 mm-40 -102.69 157.34 17.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -1.108 . . . . 0.0 109.672 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' OH ' ' CG ' ' A' ' 14' ' ' GLU . 81.8 t80 -74.66 136.58 41.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.466 -0.771 . . . . 0.0 109.734 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -137.67 142.66 41.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -108.39 151.91 25.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.7 mt -134.74 144.29 47.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.493 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -142.45 110.48 2.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.607 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -94.95 115.92 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 111.168 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.493 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 27.8 m-70 -109.41 139.73 21.38 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.482 -0.761 . . . . 0.0 109.585 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -54.43 168.13 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.662 1.574 . . . . 0.0 111.434 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 73.4 mm-40 -139.99 173.35 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.001 . . . . 0.0 110.04 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.9 mtmt -81.98 149.78 27.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.493 -0.754 . . . . 0.0 109.742 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -46.79 145.43 1.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.341 -0.849 . . . . 0.0 109.823 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.77 8.22 60.19 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.312 -0.947 . . . . 0.0 110.878 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.5 m -73.61 -43.47 59.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.598 -1.531 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.46 -177.61 33.5 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.603 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.11 117.1 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -140.42 151.69 45.1 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.212 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.62 157.38 16.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.56 110.87 12.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 42.5 tttm -135.23 133.95 39.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.7 29.44 4.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.47 -0.769 . . . . 0.0 111.213 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.84 19.14 73.69 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.144 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.9 t -122.47 120.98 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -1.08 . . . . 0.0 109.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 18.7 m-85 -84.61 127.59 34.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.086 -1.008 . . . . 0.0 109.401 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -117.18 93.99 43.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.523 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.72 148.31 16.24 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.558 2.172 . . . . 0.0 112.206 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 69.08 10.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -0.952 . . . . 0.0 109.175 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -118.94 163.98 16.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -0.812 . . . . 0.0 109.291 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.546 ' CD2' ' CD ' ' A' ' 51' ' ' GLU . 1.2 p-80 -68.85 -50.07 53.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 0.0 109.578 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.546 ' CD ' ' CD2' ' A' ' 50' ' ' HIS . 42.8 mp0 -46.19 -16.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.632 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.6 m-85 -95.79 3.53 53.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.851 -1.156 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.15 128.73 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 108.735 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.38 -21.73 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.389 -0.819 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -156.26 125.89 6.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.907 -1.12 . . . . 0.0 110.009 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.5 p -121.03 95.56 4.75 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.3 t-20 -162.78 128.74 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 87.9 m-70 51.91 7.22 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.97 . . . . 0.0 108.854 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.574 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m 164.22 153.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.0 109.786 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.418 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 30.1 m -94.05 127.37 39.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.21 -0.931 . . . . 0.0 109.215 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.36 149.67 41.96 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.758 0.79 . . . . 0.0 111.064 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.35 151.81 45.59 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.68 148.0 15.55 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.802 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -159.27 145.67 16.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.972 . . . . 0.0 108.976 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER 52.94 28.01 6.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.394 -0.817 . . . . 0.0 109.473 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.12 -32.61 5.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.567 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -56.62 143.93 34.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 108.952 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.87 137.02 29.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.268 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.33 123.45 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -98.81 157.19 16.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.95 -1.093 . . . . 0.0 110.94 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m 50.77 74.61 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.55 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.02 -10.39 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.197 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -61.63 -27.41 68.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 110.627 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.5 m170 -65.78 -68.6 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.976 -1.078 . . . . 0.0 109.352 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.44 -47.13 47.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.004 . . . . 0.0 109.312 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -52.59 -48.7 66.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.968 -1.082 . . . . 0.0 110.189 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 0.8 OUTLIER -61.0 -43.35 99.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.941 . . . . 0.0 110.241 -179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.69 -44.81 78.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 108.843 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.08 -34.85 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.09 -32.03 73.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -83.74 -36.97 23.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.283 -0.886 . . . . 0.0 109.363 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.81 5.01 12.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.056 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 52.84 39.38 28.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 110.188 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.78 138.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 108.493 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.585 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 72.6 p -123.77 -18.19 6.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 111.716 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.585 ' ND2' ' OG1' ' A' ' 85' ' ' THR . 0.8 OUTLIER -126.7 107.8 10.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.864 -1.147 . . . . 0.0 111.134 -179.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 7.9 m -163.5 148.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.285 -0.885 . . . . 0.0 110.054 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 18.9 m -116.38 109.1 16.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -91.86 100.88 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.333 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.41 127.18 31.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.48 126.1 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.98 0.895 . . . . 0.0 111.925 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.94 95.84 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 141.59 -156.7 25.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -120.67 -10.77 9.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -1.151 . . . . 0.0 110.449 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.498 ' CB ' ' HG1' ' A' ' 20' ' ' THR . 86.8 tt0 -140.39 148.89 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 109.47 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.0 mm -72.59 121.38 84.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.18 -0.95 . . . . 0.0 108.927 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.96 121.97 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.624 1.549 . . . . 0.0 111.206 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.0 tp -78.66 -12.08 13.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.2 mt 56.04 -118.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -97.87 7.29 46.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.3 -0.47 61.88 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.819 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -127.08 -172.26 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.799 -0.824 . . . . 0.0 109.535 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.56 15.04 9.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -57.59 -42.86 84.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 110.095 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.1 -57.75 8.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.103 -0.998 . . . . 0.0 110.19 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.39 -44.99 62.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.442 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 54.0 t80 -63.58 -51.26 66.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 111.261 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.67 -44.41 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.816 -1.177 . . . . 0.0 111.06 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.49 7.29 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.155 -0.966 . . . . 0.0 110.16 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 mt -62.55 -35.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 57.5 ttt-85 -60.82 -41.72 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.592 ' C ' HD21 ' A' ' 113' ' ' ASN . 2.8 mmmp? -74.87 9.45 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.884 . . . . 0.0 109.89 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.592 HD21 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.56 33.76 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -83.57 138.01 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.63 -1.294 . . . . 0.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.25 127.08 37.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.767 . . . . 0.0 109.206 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.92 144.91 27.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.076 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -112.23 -169.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -111.87 68.8 0.67 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.761 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -163.3 127.91 2.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 109.127 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.75 141.35 56.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.886 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 121' ' ' ILE . 94.0 mt -87.71 152.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -102.23 90.84 4.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 14.4 m-85 -65.33 148.14 52.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.552 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -92.58 101.79 14.22 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.79 134.33 31.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 110.74 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.05 116.2 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -92.52 -29.13 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.017 -1.052 . . . . 0.0 110.369 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.91 150.04 75.44 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.36 152.11 43.79 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.551 2.168 . . . . 0.0 112.343 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.24 152.62 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.08 147.35 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.61 148.03 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -131.59 162.43 30.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 258' ' ' LYS . 0.3 OUTLIER -172.41 103.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 50.76 54.89 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.333 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.54 -32.64 3.6 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.451 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.56 ' NH1' ' O ' ' A' ' 250' ' ' ARG . 88.1 mtt-85 -62.52 139.74 58.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.925 -1.338 . . . . 0.0 108.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -145.37 138.89 26.6 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.131 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 78.8 mt -137.56 125.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.579 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -113.41 132.86 55.46 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.393 0.616 . . . . 0.0 109.995 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 130.21 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.0 149.09 47.96 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.028 -1.045 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.59 142.88 9.35 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.677 2.251 . . . . 0.0 113.546 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.18 146.15 19.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.39 -3.36 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 p -149.08 -179.16 6.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.967 -1.083 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 tp -97.32 120.38 37.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -136.77 134.59 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.37 123.43 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.071 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.1 m -112.63 151.67 29.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.767 . . . . 0.0 109.743 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -138.17 129.37 27.37 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.653 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -120.74 131.06 54.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.22 141.6 12.51 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.753 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -106.38 101.16 10.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.94 167.1 15.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 110.964 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -99.55 -16.25 18.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.627 -0.671 . . . . 0.0 110.706 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.5 p-10 -98.53 -169.25 1.76 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.994 -1.067 . . . . 0.0 110.611 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -52.09 -0.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.502 -0.749 . . . . 0.0 111.531 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -78.04 -26.63 48.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.431 -1.418 . . . . 0.0 108.903 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.96 -140.83 34.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -104.9 134.23 48.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.067 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -138.68 158.76 43.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 109.375 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.04 145.43 31.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.383 -0.823 . . . . 0.0 109.471 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -143.74 137.17 27.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.53 124.88 51.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 110.038 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.77 117.78 34.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.79 153.14 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -50.71 126.35 15.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.94 -2.86 28.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -117.76 22.94 12.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.173 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.43 -29.95 62.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.86 -19.7 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.0 -6.5 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 111.241 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.79 -26.33 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.906 -1.122 . . . . 0.0 111.314 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -60.34 -20.8 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.594 -1.316 . . . . 0.0 109.123 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.9 -2.75 58.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.518 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.2 116.48 8.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 108.881 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.521 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.8 mtm180 -81.15 172.06 14.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.8 t -80.66 162.14 24.33 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -147.49 147.08 29.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.246 -1.534 . . . . 0.0 111.527 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.22 158.05 43.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.531 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.4 m-85 -99.55 144.25 28.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.992 -1.067 . . . . 0.0 109.981 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.95 -38.87 53.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.531 -0.73 . . . . 0.0 109.895 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.531 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.3 p90 -66.81 -27.46 67.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 0.0 110.034 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.8 mt-10 -84.05 -43.61 14.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.097 -1.002 . . . . 0.0 109.835 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 185' ' ' GLU . 61.8 mt -40.8 -44.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.245 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.75 -37.72 76.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.995 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 185' ' ' GLU . 4.6 t-80 -76.68 -43.6 37.08 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.66 -29.57 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.504 -0.748 . . . . 0.0 109.036 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -80.98 -52.08 7.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -48.86 -45.67 41.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 110.282 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -74.89 6.49 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.03 . . . . 0.0 110.216 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.78 39.24 48.41 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.126 -0.984 . . . . 0.0 110.726 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 44.6 mt -126.53 176.1 7.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -1.168 . . . . 0.0 109.56 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 54.43 24.25 30.0 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -58.51 -20.89 49.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.662 -1.493 . . . . 0.0 110.306 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.11 1.74 31.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.46 126.2 35.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.963 -1.316 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' THR . 1.6 t -146.31 167.31 23.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.379 -1.071 . . . . 0.0 109.506 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.589 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 0.6 OUTLIER -68.57 -8.76 44.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 7.6 mmtp -96.67 -13.13 23.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.6 p30 -135.83 7.43 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.627 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -151.72 152.98 33.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 15.3 tp -100.21 97.98 8.72 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.403 HG13 ' CG ' ' A' ' 212' ' ' TYR . 53.4 t -85.49 126.86 40.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.0 mt -122.26 161.99 22.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.548 -0.72 . . . . 0.0 109.875 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.85 -166.39 12.38 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -62.89 -26.23 68.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -1.13 . . . . 0.0 109.735 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -161.29 22.77 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 110.565 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.04 147.62 40.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.865 -1.147 . . . . 0.0 110.393 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.32 112.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.403 ' CG ' HG13 ' A' ' 205' ' ' VAL . 10.8 m-85 -60.29 -45.46 93.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 110.103 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.9 m120 -61.91 121.58 66.16 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 109.792 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.66 -12.62 36.19 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.486 1.457 . . . . 0.0 111.817 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.69 -16.81 56.83 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.273 -0.892 . . . . 0.0 108.945 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.26 -169.21 54.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.25 145.57 25.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -1.2 . . . . 0.0 109.781 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -79.42 -19.26 50.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.499 ' C ' ' H ' ' A' ' 221' ' ' ASN . 71.2 m-85 -146.85 152.14 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.467 -0.771 . . . . 0.0 108.987 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.64 6.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -151.11 40.62 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -58.27 -47.24 99.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 109.734 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.3 Cg_exo -51.43 -67.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.3 m -58.4 -37.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 109.858 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -59.96 -41.44 91.93 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.071 -1.018 . . . . 0.0 108.446 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.6 t60 -67.0 -31.8 72.6 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -66.77 -36.44 82.44 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.15 -39.1 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.9 t80 -61.6 -52.36 64.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.44 -28.37 69.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.06 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.2 -33.54 49.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.945 -1.097 . . . . 0.0 108.738 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.86 -37.69 79.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.37 -55.86 11.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 29.1 m-20 -53.95 -35.48 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -1.174 . . . . 0.0 109.086 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.96 -24.64 67.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.478 -0.764 . . . . 0.0 110.512 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.606 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.3 t80 -75.44 -21.66 57.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.918 -1.114 . . . . 0.0 109.361 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.79 -3.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.711 -1.243 . . . . 0.0 110.203 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.606 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -72.1 -12.85 61.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.94 -1.1 . . . . 0.0 109.962 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 0.51 59.66 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.915 -1.135 . . . . 0.0 110.824 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 154.54 11.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.872 -1.369 . . . . 0.0 108.816 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.4 Cg_endo -47.94 150.04 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.622 1.548 . . . . 0.0 109.416 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.72 146.85 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.979 -1.075 . . . . 0.0 112.056 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.88 124.33 30.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.8 179.22 29.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.87 132.53 54.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.6 m-85 -132.9 140.38 47.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 247' ' ' TYR . 4.3 t80 -125.0 137.44 54.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.3 t -130.62 137.29 49.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 111.343 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -117.5 115.9 26.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.56 ' O ' ' NH1' ' A' ' 137' ' ' ARG . 5.3 mtp85 47.57 30.41 1.69 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.05 146.12 44.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.75 169.6 15.92 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 59.5 m-70 -52.94 -37.85 61.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.061 -1.258 . . . . 0.0 109.531 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -57.98 8.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.005 . . . . 0.0 109.127 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.75 -43.17 99.38 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -47.7 -51.61 21.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.133 . . . . 0.0 109.139 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 85.3 t -62.6 -52.16 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 134' ' ' ASP . 10.1 ttmt -51.31 -51.34 55.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 109.083 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 39.8 tp -50.78 -54.82 20.37 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.702 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 49.7 t -55.39 -51.16 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 108.895 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -47.77 -50.5 25.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.08 -48.28 79.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.814 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.1 -49.58 76.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.82 -32.99 71.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.292 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.264 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.81 138.93 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 108.996 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -122.58 144.9 48.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.21 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.93 -172.72 3.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.1 m -99.03 137.89 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.865 -1.147 . . . . 0.0 109.132 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -18.24 65.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 109.898 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -155.27 156.25 35.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 109.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.08 139.54 58.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 110.234 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -117.4 160.39 21.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.89 141.98 47.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 110.232 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -140.34 150.76 44.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -161.61 151.98 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.912 -1.117 . . . . 0.0 109.848 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.62 175.71 37.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.57 152.46 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -1.181 . . . . 0.0 110.243 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' C ' ' OE2' ' A' ' 95' ' ' GLU . . . -88.24 140.29 16.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.496 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 6.2 tt -59.99 -38.39 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 111.041 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 72.2 m-70 -91.52 -46.95 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.402 -1.436 . . . . 0.0 111.039 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.601 ' HG1' ' CD ' ' A' ' 95' ' ' GLU . 3.5 p -72.15 -23.23 61.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.211 -0.931 . . . . 0.0 111.557 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.64 15.67 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.284 -1.436 . . . . 0.0 109.553 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.94 155.24 20.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -1.091 . . . . 0.0 109.748 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.69 134.98 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.429 -0.794 . . . . 0.0 109.466 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 m -137.01 144.24 43.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.37 155.98 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.453 -0.78 . . . . 0.0 109.866 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.9 mt -138.64 143.89 39.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.544 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -139.35 114.56 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 108.667 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.18 115.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 0.0 111.006 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 15.6 m-70 -108.42 137.06 19.85 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.517 -0.739 . . . . 0.0 109.788 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -51.62 168.13 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.032 1.821 . . . . 0.0 111.604 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 66.9 mm-40 -146.52 155.23 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.938 . . . . 0.0 109.975 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -67.39 154.16 42.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.781 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 149.23 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 110.824 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.645 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 75.18 -7.45 22.92 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.26 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.723 ' N ' HD21 ' A' ' 86' ' ' ASN . 93.0 m -59.33 -44.97 92.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.557 -1.555 . . . . 0.0 109.861 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.474 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 95.65 -175.82 33.15 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -100.42 116.54 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -141.23 150.97 43.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.764 -1.21 . . . . 0.0 110.983 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.16 157.42 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.17 114.29 15.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.93 . . . . 0.0 109.248 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 45.4 tttm -134.2 134.38 42.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.486 ' CG ' ' O ' ' A' ' 41' ' ' LYS . 7.5 p-10 44.08 42.37 4.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.877 -0.514 . . . . 0.0 112.193 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.93 15.7 78.33 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 120.695 -1.253 . . . . 0.0 110.549 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -121.43 120.65 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -1.141 . . . . 0.0 109.311 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 36.1 m-85 -86.11 127.72 34.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.481 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.87 93.43 41.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.506 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.99 145.99 17.98 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.656 2.237 . . . . 0.0 112.39 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.01 4.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.98 166.69 12.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p-80 -72.94 -49.96 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.476 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -44.11 -16.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.2 m-85 -96.84 1.94 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.24 130.36 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 108.7 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.0 m -111.74 -28.94 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -152.1 130.31 11.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.911 -1.118 . . . . 0.0 110.176 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -120.87 94.6 4.4 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.6 t-20 -163.74 129.15 2.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 108.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' SER . 86.5 m-70 52.52 6.15 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.128 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.81 143.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.851 . . . . 0.0 109.683 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.454 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 37.6 m -84.72 128.08 34.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -120.73 149.46 42.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.429 -0.794 . . . . 0.0 110.751 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.74 154.59 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.98 22.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.976 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -161.78 145.79 12.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.413 -1.051 . . . . 0.0 109.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt 51.61 21.7 1.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.86 . . . . 0.0 109.323 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.26 -33.59 6.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.513 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 2.8 mm100 -55.96 149.16 15.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -1.217 . . . . 0.0 109.51 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -145.89 136.32 24.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.553 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.97 128.15 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -101.27 155.51 17.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 111.605 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.8 m 50.35 74.95 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.746 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.8 m -108.4 -11.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.99 . . . . 0.0 109.566 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.4 pm0 -60.44 -26.46 66.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -66.32 -68.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.324 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.72 -48.03 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.072 -1.018 . . . . 0.0 109.107 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 mt -52.33 -50.18 62.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.024 -1.048 . . . . 0.0 110.371 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.564 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.7 t -59.22 -41.54 88.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.9 t -56.36 -47.1 81.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.121 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.67 -34.05 77.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.323 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -61.95 -39.19 91.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -77.84 -38.51 46.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.68 -1.17 41.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 109.392 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 56.87 42.12 26.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.733 -0.604 . . . . 0.0 111.386 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 84' ' ' ILE . 38.1 mm -87.17 140.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.854 -1.154 . . . . 0.0 107.968 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.8 p -124.57 -22.47 4.61 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.126 -0.984 . . . . 0.0 111.799 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.723 HD21 ' N ' ' A' ' 35' ' ' THR . 18.0 m120 -125.46 107.13 10.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.868 -1.145 . . . . 0.0 110.666 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.3 m -164.69 148.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.771 0.796 . . . . 0.0 110.151 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 93.5 m -114.49 113.26 24.22 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.29 100.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' OE2' ' NE2' ' A' ' 29' ' ' HIS . 33.4 mt-10 -73.41 124.84 26.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.108 -0.995 . . . . 0.0 108.361 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.94 123.79 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 121.677 0.751 . . . . 0.0 111.172 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mm -109.18 96.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.52 -156.04 23.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -123.08 -12.28 7.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.319 -1.107 . . . . 0.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.601 ' CD ' ' HG1' ' A' ' 20' ' ' THR . 29.3 tt0 -132.85 140.19 47.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 109.944 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.6 mm -70.24 119.32 71.32 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 108.417 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -40.74 122.58 1.45 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.887 1.725 . . . . 0.0 111.466 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 tp -79.0 -12.0 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.711 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.3 mt 56.42 -119.61 1.34 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 110.01 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 27.6 t0 -96.53 10.02 39.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.923 -1.111 . . . . 0.0 111.126 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.26 -1.41 62.55 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.43 -1.367 . . . . 0.0 109.843 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.02 -172.06 2.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.799 -0.824 . . . . 0.0 109.483 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.18 16.08 10.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -57.83 -42.84 85.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.429 -1.042 . . . . 0.0 110.464 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.46 -58.96 5.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.167 -0.958 . . . . 0.0 110.092 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -51.03 -45.96 61.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.37 -50.36 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.554 -0.716 . . . . 0.0 111.059 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.47 -44.46 94.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.946 -1.096 . . . . 0.0 111.377 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.85 -53.56 38.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 0.0 110.646 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -65.04 -30.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.918 -1.114 . . . . 0.0 109.287 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -65.68 -43.89 87.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.407 -0.808 . . . . 0.0 110.274 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -77.78 14.22 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.957 -1.089 . . . . 0.0 110.019 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -144.13 32.47 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.8 mt -80.87 139.89 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.928 -1.107 . . . . 0.0 110.272 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.14 125.08 32.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.766 . . . . 0.0 109.128 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -80.57 142.29 34.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.334 -0.854 . . . . 0.0 110.169 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -110.36 -172.75 2.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.408 -0.807 . . . . 0.0 109.448 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -110.43 68.27 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 110.58 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.7 131.16 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 109.531 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.24 142.42 54.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.064 -1.022 . . . . 0.0 109.691 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.9 mt -85.44 151.34 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.815 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.71 83.42 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 108.817 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 28.6 m-85 -61.44 143.09 56.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -90.32 101.83 14.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.17 133.73 32.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.62 . . . . 0.0 110.857 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.13 112.45 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.91 -34.18 21.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.979 -1.076 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.9 149.88 72.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.5 147.93 71.89 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.318 2.012 . . . . 0.0 112.089 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -154.27 152.3 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.67 144.73 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.227 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.95 147.68 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -132.83 159.77 38.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 258' ' ' LYS . 0.1 OUTLIER -172.33 101.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.241 -0.912 . . . . 0.0 109.995 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 45.97 59.26 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.753 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.31 -37.92 3.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.485 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -63.75 130.89 46.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CD2' ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -144.14 139.85 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.992 -1.067 . . . . 0.0 109.769 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 98.5 mt -137.62 129.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 109.693 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -115.56 131.67 56.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.49 135.88 55.0 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -149.52 148.54 26.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 109.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -46.04 142.17 8.58 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.508 2.139 . . . . 0.0 113.326 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.48 143.3 19.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.75 -5.17 2.52 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.503 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 244' ' ' GLY . 30.4 p -154.96 179.1 9.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.949 -1.095 . . . . 0.0 109.859 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.25 120.19 29.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.208 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.6 123.58 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 108.646 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -124.41 122.02 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.1 m -112.25 151.94 29.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.369 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -139.5 130.67 26.59 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.106 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 28.4 tt0 -121.18 131.7 54.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.43 139.19 10.45 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.469 -1.348 . . . . 0.0 111.577 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -103.0 100.66 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -86.33 167.03 15.15 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 110.6 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.57 -15.55 18.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 110.589 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 159' ' ' LEU . 23.0 p-10 -95.21 -168.12 1.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.832 -1.168 . . . . 0.0 110.131 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -56.58 3.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 111.26 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.8 mt -79.67 -28.28 40.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.454 -1.404 . . . . 0.0 108.423 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.01 -138.69 34.56 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 3.9 ttm180 -97.0 131.84 43.41 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.275 -1.133 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.467 ' OE1' ' O ' ' A' ' 161' ' ' ARG . 29.1 mm100 -136.63 147.29 46.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.765 . . . . 0.0 109.108 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -140.52 145.05 36.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.856 . . . . 0.0 110.093 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.515 ' CZ ' ' NH2' ' A' ' 225' ' ' ARG . 89.3 t80 -144.26 140.38 29.19 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 76.8 m -110.82 124.3 51.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 110.295 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -103.89 117.26 33.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.409 -0.807 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.31 154.64 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.097 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -50.63 125.22 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 108.977 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.24 -2.44 26.75 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -119.81 21.74 11.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.14 -1.212 . . . . 0.0 109.186 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -54.46 -32.12 56.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.379 -0.825 . . . . 0.0 110.621 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.24 -17.47 62.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 110.183 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.554 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 23.2 mm-40 -86.79 -6.83 58.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.172 -0.955 . . . . 0.0 111.495 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 40.2 pt -123.68 -26.05 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.919 -1.113 . . . . 0.0 110.845 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 15.1 m -65.21 -26.77 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.553 -1.342 . . . . 0.0 109.382 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.54 -5.54 56.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.0 109.335 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.468 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.09 123.43 21.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.977 . . . . 0.0 109.205 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -84.54 172.93 11.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -77.32 161.48 28.04 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -147.04 144.38 29.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.191 -1.568 . . . . 0.0 111.427 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.08 45.02 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 90.6 m-85 -97.66 146.89 24.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.602 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.56 -38.71 21.32 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.399 -0.813 . . . . 0.0 109.741 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.13 -25.18 62.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.0 109.644 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.7 mm-40 -79.82 -25.64 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.0 110.044 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 187' ' ' GLU . 22.6 mt -60.93 -54.82 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 110.017 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 186' ' ' ILE . 10.9 tt0 -42.1 -39.88 2.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.887 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -78.76 -54.31 6.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 194' ' ' LEU . 29.1 mt -48.35 -29.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.663 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -85.34 -54.38 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.769 -1.207 . . . . 0.0 109.194 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -50.09 -42.52 50.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.066 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.65 5.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.995 . . . . 0.0 109.854 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.31 37.28 54.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' ILE . 36.0 mt -125.61 166.04 17.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -1.126 . . . . 0.0 109.591 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.41 ' N ' ' ND1' ' A' ' 19' ' ' HIS . . . 64.5 22.98 68.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -56.18 -23.65 36.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.432 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.5 25.91 12.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.24 125.12 7.88 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.945 -1.327 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -145.1 168.07 21.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.064 . . . . 0.0 109.708 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.1 -8.72 25.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 ttmm -93.89 -14.31 26.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 14.7 p30 -136.07 8.14 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.792 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -147.34 149.28 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.047 -1.033 . . . . 0.0 110.702 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.87 94.61 6.68 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.2 t -86.81 129.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.635 0.731 . . . . 0.0 109.225 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.07 173.9 6.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.369 -0.832 . . . . 0.0 109.53 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -134.64 -166.41 11.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.95 70.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -1.047 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -158.91 26.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.061 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -145.36 153.27 41.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.841 -1.162 . . . . 0.0 110.421 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.0 t -104.4 113.32 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -57.99 -48.34 80.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.051 -1.03 . . . . 0.0 109.854 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -63.0 112.51 6.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 110.313 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -57.85 -11.12 8.82 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.697 1.598 . . . . 0.0 112.165 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.18 -18.91 58.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.436 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.24 179.65 50.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 217' ' ' LEU . 5.7 mt -83.23 121.93 27.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -1.217 . . . . 0.0 109.64 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.0 OUTLIER -49.52 -22.48 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 108.661 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 56.0 m-85 -148.42 178.96 8.15 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -86.87 2.95 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.755 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 45.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.543 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -61.76 -42.69 84.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.911 -1.118 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.6 Cg_exo -58.76 -60.04 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.585 2.19 . . . . 0.0 112.596 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 28.2 m -66.96 -39.34 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.064 -1.023 . . . . 0.0 111.448 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.554 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 3.3 ptm85 -67.51 -35.52 79.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.561 -1.337 . . . . 0.0 108.595 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.468 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 23.3 t60 -66.02 -34.56 78.37 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -64.59 -35.08 79.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.01 -35.99 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.564 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.5 t80 -67.41 -50.93 57.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.2 -33.14 72.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.355 -0.84 . . . . 0.0 109.808 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.1 tp -74.97 -32.74 61.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.096 -1.003 . . . . 0.0 108.736 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.4 mt -65.76 -38.6 82.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -53.97 22.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.497 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 6.7 m-20 -56.15 -29.53 60.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -1.201 . . . . 0.0 109.09 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.09 -23.27 65.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.529 -0.732 . . . . 0.0 110.581 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.591 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.47 -22.51 60.15 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.743 -1.223 . . . . 0.0 109.374 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 91.7 mt -50.09 -4.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.599 -1.313 . . . . 0.0 110.411 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.591 ' H ' ' C ' ' A' ' 236' ' ' TYR . 10.6 mt -75.52 -15.46 60.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 109.681 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.02 58.14 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.659 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.36 155.04 9.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.875 -1.368 . . . . 0.0 109.106 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.4 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.1 Cg_endo -49.33 150.62 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.956 1.771 . . . . 0.0 109.869 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -109.42 145.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.023 -1.048 . . . . 0.0 111.881 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -130.25 125.18 34.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.47 -160.3 29.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -130.49 140.43 50.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 109.153 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.8 m-85 -138.62 142.14 39.12 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.175 -0.953 . . . . 0.0 110.331 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.7 t80 -124.91 124.66 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.0 m -117.76 135.0 54.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -115.36 114.92 25.75 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 49.87 20.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.02 -1.05 . . . . 0.0 109.074 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -53.34 156.53 5.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.489 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -138.35 163.0 25.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.577 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 48.4 m-70 -48.68 -40.11 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.187 -1.184 . . . . 0.0 109.817 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -58.4 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.127 -0.983 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' ASN . 13.8 tp -59.63 -44.02 93.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.077 -1.014 . . . . 0.0 109.519 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.2 m-20 -47.73 -48.12 29.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.885 -1.135 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.89 -52.37 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.584 -0.698 . . . . 0.0 109.573 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 134' ' ' ASP . 31.0 ttmt -52.86 -48.79 66.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 42.7 tp -52.94 -51.75 60.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 108.7 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.82 -53.75 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.21 -0.932 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -49.64 -48.23 49.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.91 -48.47 81.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.64 -49.76 74.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.877 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.47 -26.35 66.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.831 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 110.097 -179.531 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 85' ' ' THR . 3.0 mm-40 -56.88 138.57 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 108.846 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.593 ' HZ1' ' CB ' ' A' ' 116' ' ' ASN . 8.3 mptt -121.61 144.59 48.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.0 110.272 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -142.5 -174.63 4.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.0 m -98.6 136.96 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.249 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.41 -23.03 66.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 109.945 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.51 159.35 44.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.719 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 139.68 58.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.18 164.39 15.24 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.32 142.65 45.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.85 -1.156 . . . . 0.0 110.566 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.3 m-85 -139.3 154.01 47.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.1 152.6 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.856 -1.153 . . . . 0.0 110.091 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.79 176.49 36.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.7 154.6 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -1.099 . . . . 0.0 110.369 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.64 140.45 15.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 tt -58.83 -40.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -1.169 . . . . 0.0 110.679 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -89.53 -49.67 6.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.663 -1.273 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 p -69.6 -23.1 63.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.662 -0.649 . . . . 0.0 111.262 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.48 15.94 13.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.39 154.37 21.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 109.607 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 14.1 t80 -75.98 135.93 40.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 109.766 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 m -139.39 145.28 38.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.43 154.87 24.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.7 mt -135.71 148.58 48.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.204 -0.935 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.502 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 14.6 mt -143.37 113.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.18 115.22 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 110.992 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.502 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 18.0 m-70 -107.71 135.95 19.73 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.476 -0.765 . . . . 0.0 109.692 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -52.32 168.18 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.004 1.803 . . . . 0.0 111.94 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.443 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 12.7 mm-40 -144.63 177.52 8.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.35 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.11 156.07 19.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 35' ' ' THR . 1.4 mt-10 -49.6 151.28 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.711 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 70.29 -11.1 2.28 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.997 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.68 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 62.1 m -55.81 -46.65 78.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.652 -1.499 . . . . 0.0 109.986 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.439 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 96.97 -177.71 32.89 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.204 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.66 117.0 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -138.44 147.7 43.57 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.67 156.86 16.35 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -129.08 111.27 12.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 16.2 tttp -135.65 134.97 39.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 110.851 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 49.92 26.59 2.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.969 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.11 19.54 62.6 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.298 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.7 120.45 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.099 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -87.14 129.14 35.06 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.093 -1.004 . . . . 0.0 108.42 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.514 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 73.5 mt -121.31 95.64 48.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 110.466 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.45 150.19 16.12 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.93 1.754 . . . . 0.0 110.995 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.66 72.1 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.642 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -123.86 163.38 21.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.774 . . . . 0.0 109.043 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.3 p-80 -66.04 -52.12 52.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 110.141 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -43.83 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.777 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' HIS . 28.3 m-85 -95.2 5.44 51.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.789 -1.194 . . . . 0.0 109.936 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 50' ' ' HIS . 75.3 t -76.69 129.82 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.0 108.611 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.74 -24.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 0.0 110.303 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.67 125.18 10.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.012 -1.055 . . . . 0.0 110.009 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -119.58 95.98 5.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.9 t-20 -162.66 128.54 3.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 88.0 m-70 48.02 9.79 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.15 -0.969 . . . . 0.0 109.263 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 165.8 147.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.905 . . . . 0.0 109.868 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.0 m -90.06 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 109.149 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.11 149.49 42.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.465 -0.772 . . . . 0.0 110.788 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.37 163.17 18.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.117 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.62 151.19 15.58 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.619 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.33 145.41 14.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.669 -0.901 . . . . 0.0 108.691 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 21.35 7.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.04 -28.14 15.22 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.804 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.23 147.46 49.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.699 -1.471 . . . . 0.0 109.402 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 47.2 ttp180 -140.51 147.03 38.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.071 -1.018 . . . . 0.0 111.498 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.23 137.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -105.87 156.07 18.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 112.322 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.0 m 50.18 78.3 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.439 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.33 -8.2 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.005 . . . . 0.0 109.363 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.8 pm0 -62.74 -27.13 69.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 111.106 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -66.81 -69.09 0.33 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.802 -1.186 . . . . 0.0 109.256 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 7.1 tp -51.87 -47.7 40.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 11.8 mt -52.29 -49.12 64.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.937 -1.102 . . . . 0.0 110.384 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 36.1 t -60.56 -42.12 95.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.19 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.3 t -57.25 -46.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.942 -1.099 . . . . 0.0 109.194 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.63 -34.2 77.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -64.09 -37.95 89.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.85 -39.58 43.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.72 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.41 -2.53 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.009 . . . . 0.0 109.226 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 58.32 42.44 21.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 111.311 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.1 mm -86.01 146.59 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.871 -1.143 . . . . 0.0 108.169 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.416 ' CB ' ' OE2' ' A' ' 4' ' ' GLU . 61.3 p -128.93 -23.84 3.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 111.514 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 34' ' ' GLY . 27.6 m120 -124.61 107.85 11.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.851 -1.156 . . . . 0.0 110.75 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.89 147.14 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.851 0.834 . . . . 0.0 110.256 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 24.7 m -114.82 112.04 22.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.82 100.32 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.421 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.55 125.94 29.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.3 t -107.16 130.01 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.921 0.867 . . . . 0.0 111.998 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.3 mm -110.69 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.82 -154.76 23.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.44 -10.44 8.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.385 -1.068 . . . . 0.0 110.049 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -138.83 148.31 43.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.041 -1.037 . . . . 0.0 109.347 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.8 mm -74.44 122.17 86.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.317 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -41.82 122.05 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.975 1.783 . . . . 0.0 111.501 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 tp -74.82 -13.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.101 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 mt 57.27 -122.45 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.496 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.49 8.74 43.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.588 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.52 -3.66 72.06 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.514 -1.327 . . . . 0.0 109.819 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.21 -173.03 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.495 -1.003 . . . . 0.0 109.135 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.24 16.2 11.83 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -58.24 -45.09 88.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.907 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.95 -57.42 9.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.011 . . . . 0.0 109.655 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -51.58 -46.03 63.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.058 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 59.6 t80 -61.17 -52.93 62.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.646 . . . . 0.0 111.058 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.1 -43.08 99.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.139 -0.976 . . . . 0.0 111.376 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -56.63 9.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 110.572 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.7 mt -63.54 -32.24 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.97 -1.081 . . . . 0.0 109.661 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.2 ttt180 -65.09 -43.62 91.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -75.83 11.39 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.018 -1.051 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -143.98 35.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.914 -1.116 . . . . 0.0 110.435 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -82.02 141.19 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 0.0 110.57 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.69 120.52 22.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.599 HD21 ' H ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -81.78 140.68 34.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -106.11 -168.57 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.785 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 118' ' ' ASN . 16.3 p30 -111.54 71.52 0.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 0.0 110.65 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -170.5 133.77 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.995 . . . . 0.0 109.547 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -69.71 147.68 50.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.707 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.72 151.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 110.113 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -97.99 88.05 4.14 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.3 m-85 -66.46 144.27 56.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.848 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -88.31 100.98 13.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -90.78 132.61 34.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.657 -0.652 . . . . 0.0 110.799 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.45 114.06 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.87 -30.18 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.961 -1.087 . . . . 0.0 110.313 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.76 149.95 73.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.831 . . . . 0.0 109.463 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.28 149.72 45.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.492 2.128 . . . . 0.0 111.456 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 tt -157.37 153.82 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.055 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.63 144.51 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.322 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.39 148.24 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -134.96 161.83 34.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -174.8 105.81 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 52.26 53.57 12.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.442 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 -33.0 3.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -60.32 135.51 57.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.019 -1.283 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.466 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -145.41 137.72 25.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 110.333 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 90.4 mt -137.04 130.39 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -117.8 132.09 56.49 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.362 0.601 . . . . 0.0 109.896 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.26 134.21 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.57 153.15 46.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -50.79 143.19 30.49 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.379 2.052 . . . . 0.0 113.428 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.5 143.8 19.03 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.12 -9.66 11.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 110.463 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' GLY . 82.1 p -144.7 -175.29 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 109.547 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.19 123.56 44.56 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.198 -0.939 . . . . 0.0 108.567 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -138.9 135.41 34.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 108.751 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.9 t -134.48 123.67 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.711 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 90.9 m -113.75 152.32 30.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -0.775 . . . . 0.0 109.846 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.949 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.97 132.43 54.92 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.03 141.2 11.33 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.338 -1.41 . . . . 0.0 112.07 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.11 101.92 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.43 167.03 13.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 111.144 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -104.54 30.97 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.594 -0.691 . . . . 0.0 110.726 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' LEU . 27.5 p-10 -148.53 -168.35 3.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.771 -1.206 . . . . 0.0 110.118 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -48.22 -4.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 0.0 111.374 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.7 mt -82.99 -31.01 27.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.521 -1.362 . . . . 0.0 108.708 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.55 -135.53 41.48 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.69 132.27 45.14 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.154 -1.203 . . . . 0.0 109.146 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -137.92 149.98 46.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -140.66 144.11 35.5 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -141.78 132.62 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 109.775 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -105.89 123.98 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -105.22 115.74 30.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.49 151.53 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.69 129.63 23.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.01 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.09 -1.99 38.06 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -119.18 23.23 11.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -1.123 . . . . 0.0 109.39 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.583 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -56.03 -56.05 25.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 171' ' ' GLU . 3.8 mt-10 -41.81 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.407 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.572 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 2.3 mt-10 -85.11 -7.35 59.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.067 -1.021 . . . . 0.0 111.463 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.36 -27.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.864 -1.147 . . . . 0.0 110.906 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.89 -17.37 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.739 -1.226 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.4 -3.52 55.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.409 ' HB1' ' HD1' ' A' ' 226' ' ' HIS . . . -68.6 126.32 29.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 179' ' ' THR . 62.4 mtm180 -94.04 130.36 40.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 10.1 t -37.11 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.52 154.24 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.544 -1.348 . . . . 0.0 111.578 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.16 156.36 39.65 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.1 m-85 -97.66 145.49 26.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.83 -1.169 . . . . 0.0 109.692 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.447 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 4.0 t0 -48.8 -37.9 20.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.251 -0.905 . . . . 0.0 109.084 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.532 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.8 p90 -70.16 -25.82 63.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.987 -1.071 . . . . 0.0 109.331 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.3 mm-40 -75.68 -35.66 60.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.92 -42.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.681 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -58.84 -41.7 87.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 0.0 109.538 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 189' ' ' ILE . 11.7 t60 -75.85 -58.31 3.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.013 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 188' ' ' HIS . 94.4 mt -43.79 -33.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -79.4 -52.51 7.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.1 . . . . 0.0 109.069 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -47.33 -44.82 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.22 7.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.054 -1.029 . . . . 0.0 110.531 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.02 40.0 57.67 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.081 -1.012 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 44.0 mt -127.72 173.82 9.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.219 -1.166 . . . . 0.0 109.93 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.16 26.58 50.11 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -60.26 -19.69 55.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.0 109.868 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.84 3.34 33.92 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.68 128.07 40.14 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.462 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 11.5 p -146.44 164.65 31.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.9 mt -66.72 -7.93 24.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 108.607 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . 0.414 ' H ' ' HG ' ' A' ' 199' ' ' SER . 2.4 mtmt -96.83 -19.09 19.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.601 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.462 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 21.5 p30 -128.04 3.98 5.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.5 m -144.47 146.72 32.59 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.688 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 13.7 tp -96.79 96.3 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.09 127.67 39.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.893 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.5 160.95 24.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.577 -0.702 . . . . 0.0 109.438 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.43 -166.15 13.04 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -30.47 70.61 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.134 -1.215 . . . . 0.0 109.658 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.97 23.38 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.089 -1.007 . . . . 0.0 111.264 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -149.97 157.76 43.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.449 -1.407 . . . . 0.0 110.724 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.9 t -105.24 115.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -61.63 -44.06 97.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.387 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.3 m120 -62.43 126.01 87.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.889 -1.132 . . . . 0.0 110.334 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -67.08 -17.17 50.7 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.689 1.593 . . . . 0.0 112.246 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -15.82 56.28 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.964 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.33 -164.93 54.45 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.7 mt -91.83 129.55 37.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -1.208 . . . . 0.0 109.463 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 3.3 mmt85 -67.02 -17.08 64.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.995 -1.066 . . . . 0.0 108.193 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 40.6 m-85 -145.53 160.67 41.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.433 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.9 mp0 -77.86 15.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.708 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.538 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -154.28 39.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.781 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.4 tt0 -57.95 -43.81 98.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.903 -1.123 . . . . 0.0 109.793 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 33.2 Cg_exo -59.59 -66.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.833 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.37 -40.19 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.133 -0.979 . . . . 0.0 111.428 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.572 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 4.3 ptm180 -67.77 -34.72 77.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.615 -1.303 . . . . 0.0 109.006 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.409 ' HD1' ' HB1' ' A' ' 177' ' ' ALA . 27.9 t60 -66.61 -32.35 73.62 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -65.59 -37.61 87.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.7 -37.2 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.59 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 46.1 t80 -64.04 -52.07 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.705 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.51 -33.58 54.32 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 mt -67.41 -38.06 80.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -54.4 22.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 95.4 m-20 -56.52 -33.04 65.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -1.197 . . . . 0.0 109.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.1 mt -68.09 -25.15 65.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.544 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.597 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.4 t80 -75.06 -21.48 58.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.921 -1.112 . . . . 0.0 109.528 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -50.71 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.705 -1.247 . . . . 0.0 110.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.597 ' H ' ' C ' ' A' ' 236' ' ' TYR . 4.3 mt -70.67 -13.55 62.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.048 . . . . 0.0 109.857 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.74 0.91 60.34 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.609 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.05 152.5 11.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.345 . . . . 0.0 108.86 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.9 Cg_endo -53.59 128.04 27.83 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.795 1.663 . . . . 0.0 109.942 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 t -87.48 153.16 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 112.266 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -134.94 126.15 28.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.7 -157.15 27.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.1 OUTLIER -131.2 136.17 48.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 108.87 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.0 m-85 -135.52 140.54 44.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.155 -0.965 . . . . 0.0 110.484 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -126.09 132.15 51.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -125.32 136.37 53.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.121 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -117.3 113.37 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.19 24.43 1.99 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 109.037 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.45 154.08 42.38 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -131.09 178.18 17.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 75.5 m-70 -59.78 -40.92 89.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -1.226 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -58.96 5.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.1 tp -55.74 -46.38 77.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.3 -51.73 18.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.889 -1.132 . . . . 0.0 109.323 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.53 -50.26 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.428 -0.795 . . . . 0.0 109.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -54.09 -52.05 62.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.988 -1.07 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.1 tp -49.79 -50.92 43.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.17 -0.956 . . . . 0.0 108.486 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.65 -53.16 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -46.9 -49.77 19.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.82 -48.4 74.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.8 mt -55.95 -51.99 65.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.72 -26.44 63.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.397 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.514 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.34 138.49 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.957 . . . . 0.0 108.862 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.85 145.77 47.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -141.77 -174.83 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.18 136.95 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.115 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -65.47 -29.82 70.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -144.42 156.15 44.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -63.69 141.21 58.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.428 -0.795 . . . . 0.0 110.356 -179.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.94 166.22 13.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -137.76 143.18 41.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.085 -1.01 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.1 m-85 -139.37 154.52 47.86 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -163.28 152.59 14.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.837 -1.165 . . . . 0.0 110.177 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.13 176.66 36.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.19 153.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -1.144 . . . . 0.0 110.01 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.28 139.97 15.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tt -58.54 -41.09 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.249 . . . . 0.0 110.472 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 73.4 m-70 -88.09 -50.52 6.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.694 -1.254 . . . . 0.0 111.116 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 p -66.07 -27.92 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.781 -0.575 . . . . 0.0 111.801 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.74 16.63 46.66 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 118.888 -1.625 . . . . 0.0 109.226 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.85 156.04 22.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -1.058 . . . . 0.0 109.487 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.84 134.45 41.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.5 m -138.21 143.86 40.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.132 -0.98 . . . . 0.0 109.499 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -113.03 156.59 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.255 -0.903 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt -136.08 146.94 47.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 110.236 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.529 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 2.3 mp -140.85 115.43 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.93 114.99 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.493 -0.755 . . . . 0.0 110.967 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.529 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 13.2 m-70 -109.34 138.06 20.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.427 -0.796 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -52.15 168.87 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.959 1.772 . . . . 0.0 111.704 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 71.9 mm-40 -141.91 173.91 11.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.037 -1.039 . . . . 0.0 109.973 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' OG1' ' A' ' 35' ' ' THR . 31.1 mmtp -83.51 152.26 25.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.769 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.11 146.1 2.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 110.073 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.7 46.27 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.83 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 29.0 m -68.51 -42.66 78.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.702 -1.469 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.756 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 96.6 -176.62 32.58 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.367 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.12 118.32 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -141.64 155.95 45.68 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.933 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -104.31 156.91 17.51 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -129.5 109.94 11.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 108.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -135.4 134.97 40.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.422 -0.799 . . . . 0.0 111.006 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.69 32.63 7.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 111.578 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.75 17.37 80.12 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.2 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.12 120.81 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.44 -1.036 . . . . 0.0 108.854 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 31.8 m-85 -84.96 128.28 34.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -117.78 93.44 43.9 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.389 -0.819 . . . . 0.0 109.283 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.78 146.7 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.324 2.016 . . . . 0.0 111.925 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.99 70.93 9.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -122.34 174.82 6.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.2 p-80 -78.1 -52.57 8.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.997 . . . . 0.0 109.61 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -43.7 -16.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' HIS . 39.8 m-85 -96.18 2.74 53.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.06 . . . . 0.0 110.029 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -73.12 132.76 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 108.664 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.64 -30.83 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 110.336 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.68 134.91 18.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -123.75 96.07 4.82 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -162.84 128.7 3.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.3 -0.875 . . . . 0.0 109.121 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.578 ' C ' ' HG ' ' A' ' 59' ' ' SER . 33.6 m-70 48.41 9.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.118 -0.989 . . . . 0.0 109.15 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.07 141.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.692 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.617 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 85.1 m -86.22 127.68 34.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.366 -0.834 . . . . 0.0 109.158 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -120.29 149.59 42.06 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.67 0.748 . . . . 0.0 110.944 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -122.16 150.38 42.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.72 151.89 22.7 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.06 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -161.68 147.09 13.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 52.35 21.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.09 6.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -58.42 146.09 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 136.28 34.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.579 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.2 126.47 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -102.96 157.85 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.097 . . . . 0.0 111.582 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.3 m 49.93 74.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 m -108.01 -10.86 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 6.7 pm0 -61.71 -25.79 67.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 110.706 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -66.13 -68.91 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 109.083 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -52.15 -47.66 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.006 -1.059 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -52.73 -50.03 64.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 110.201 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.579 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.9 t -59.75 -42.76 93.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.943 -1.098 . . . . 0.0 110.195 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.06 -48.08 76.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.026 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.49 -33.49 76.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.191 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -62.6 -38.77 91.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 109.416 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.9 mt -76.47 -39.25 53.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 110.155 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.8 0.5 38.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.985 -1.072 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.38 43.28 26.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.556 -0.715 . . . . 0.0 111.185 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mm -87.69 146.52 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 108.082 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.0 p -130.53 -20.46 2.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.116 -0.99 . . . . 0.0 111.385 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.756 HD21 ' H ' ' A' ' 36' ' ' GLY . 11.5 m120 -125.74 107.09 10.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.054 -1.028 . . . . 0.0 110.614 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.8 m -165.75 148.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.618 0.723 . . . . 0.0 110.053 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.1 m -115.87 111.47 20.49 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.3 101.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.976 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -72.95 126.36 29.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.68 120.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.892 0.854 . . . . 0.0 111.285 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.2 mt -108.37 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.22 -158.27 27.18 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -118.95 -12.43 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -1.101 . . . . 0.0 110.059 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -141.43 150.77 42.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 109.509 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 121.26 84.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.991 . . . . 0.0 108.964 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -41.12 122.02 1.5 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.751 1.634 . . . . 0.0 111.345 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.95 -15.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.536 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt 57.25 -117.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 100' ' ' ASP . 9.4 t70 -98.25 5.72 48.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.037 -1.039 . . . . 0.0 110.731 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.97 0.9 58.6 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.143 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.0 -172.45 2.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.703 -0.881 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.59 16.64 7.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.554 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 68.8 t-105 -58.38 -42.15 86.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -1.101 . . . . 0.0 110.292 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.0 -56.39 17.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.905 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 12.8 m-85 -51.38 -44.09 62.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 108.783 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.415 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 36.3 t80 -62.41 -53.91 48.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.702 -0.624 . . . . 0.0 110.801 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 4.2 mt-10 -59.31 -44.5 92.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 111.133 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.38 -54.87 19.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.992 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.1 mt -67.09 -33.63 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.761 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.8 ttm-85 -62.87 -43.71 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -77.8 14.01 1.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -144.53 32.2 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.964 -1.085 . . . . 0.0 110.333 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.76 138.34 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tp -128.87 120.03 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -80.2 142.99 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.272 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.57 -174.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.66 68.95 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -164.77 129.42 2.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.099 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -67.96 141.9 56.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.107 . . . . 0.0 109.478 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.37 150.86 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.128 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' ' OG ' ' A' ' 240' ' ' SER . 12.7 p30 -97.76 85.16 3.5 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 32.7 m-85 -62.32 143.49 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.588 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -89.48 101.6 14.28 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.2 133.46 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.43 0.634 . . . . 0.0 110.768 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.16 116.56 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -92.62 -29.93 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.957 -1.089 . . . . 0.0 110.607 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.67 149.7 73.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 109.793 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.17 149.56 46.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.62 2.213 . . . . 0.0 111.779 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -157.02 152.43 7.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.155 -0.966 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.51 141.17 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 109.007 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.83 147.22 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -138.49 157.08 46.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.996 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -175.3 108.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.318 -0.864 . . . . 0.0 109.779 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 53.44 51.53 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -0.828 . . . . 0.0 110.614 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.02 -32.53 3.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -59.16 136.9 58.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -1.232 . . . . 0.0 108.133 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.3 135.64 19.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.77 -1.206 . . . . 0.0 109.709 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 87.4 mt -137.27 128.57 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -114.13 131.88 56.27 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.412 0.625 . . . . 0.0 109.886 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.0 134.26 54.81 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.91 152.86 45.04 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.004 -1.06 . . . . 0.0 110.018 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.68 142.57 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.529 2.153 . . . . 0.0 113.889 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -156.83 147.01 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.3 -29.42 68.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.122 -0.986 . . . . 0.0 110.869 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.534 ' O ' ' OG ' ' A' ' 144' ' ' SER . 12.6 p -119.67 -165.52 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.358 -0.838 . . . . 0.0 109.23 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 tp -107.42 122.38 46.5 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -138.65 126.25 22.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.979 . . . . 0.0 109.098 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.96 122.2 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 109.83 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.0 m -112.98 151.77 30.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.613 -0.68 . . . . 0.0 109.61 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.76 130.18 25.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.669 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -122.47 135.13 54.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.44 143.13 12.73 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.7 100.64 10.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.11 167.82 13.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.846 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -103.82 24.93 10.49 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.632 -0.668 . . . . 0.0 110.257 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 158' ' ' PHE . 22.6 p-10 -137.71 -170.53 2.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.037 -1.04 . . . . 0.0 110.36 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.59 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 21.2 p90 -49.55 -5.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.608 -0.683 . . . . 0.0 111.638 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.601 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 73.6 mt -82.35 -30.31 30.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.176 -1.578 . . . . 0.0 108.349 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.59 -132.26 43.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 131.04 43.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.158 -1.201 . . . . 0.0 109.192 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 1.6 tp-100 -138.29 144.7 40.59 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.465 -0.772 . . . . 0.0 109.259 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.83 36.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 110.361 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -146.74 141.66 26.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.927 . . . . 0.0 109.942 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 58.5 m -110.49 124.59 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.491 -0.755 . . . . 0.0 109.822 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -105.37 115.91 31.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 110.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.51 151.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.737 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.33 131.56 24.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.167 -0.958 . . . . 0.0 109.166 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.28 -3.03 43.53 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -117.35 22.57 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -1.183 . . . . 0.0 109.002 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -50.97 -54.87 20.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.738 . . . . 0.0 110.011 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 171' ' ' GLU . 71.6 mt-10 -41.79 -23.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' GLU . 64.6 mt-10 -81.54 -12.77 58.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.028 -1.045 . . . . 0.0 111.754 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.15 -28.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.866 -1.146 . . . . 0.0 111.355 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.58 -26.84 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.519 -1.363 . . . . 0.0 108.972 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -84.71 -3.61 58.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.427 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -69.46 116.82 10.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 108.915 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 54.4 mtm180 -79.95 172.35 13.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.143 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -78.54 162.51 26.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.37 149.17 32.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.218 -1.551 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.24 156.7 43.57 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.441 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 89.9 m-85 -98.15 146.2 25.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.0 109.314 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.44 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.37 -38.3 12.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.897 . . . . 0.0 109.479 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -72.33 -29.37 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 0.0 109.597 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.7 mt-10 -73.16 -33.95 65.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.8 -54.25 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.792 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.3 -41.93 9.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -74.42 -47.99 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.466 -0.771 . . . . 0.0 109.615 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 92.9 mt -53.97 -30.56 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -84.36 -53.52 5.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.885 -1.135 . . . . 0.0 109.477 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -49.87 -36.54 27.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.9 m -81.61 8.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.022 . . . . 0.0 109.892 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.2 39.95 71.53 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 57.5 mt -128.99 172.31 11.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -1.143 . . . . 0.0 109.989 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.5 25.23 57.8 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -58.89 -20.02 47.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.478 -1.601 . . . . 0.0 109.987 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.46 5.47 31.46 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.69 130.71 34.09 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.315 . . . . 0.0 110.437 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.641 ' N ' HD22 ' A' ' 202' ' ' ASN . 8.2 t -144.08 160.9 40.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.44 -1.035 . . . . 0.0 109.235 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 31.8 mt -66.92 -8.99 33.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.419 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -98.15 -13.05 21.13 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.641 HD22 ' N ' ' A' ' 199' ' ' SER . 10.0 p30 -128.66 8.79 5.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 109.256 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.97 153.91 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 110.377 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.9 tp -101.3 110.65 22.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.79 128.85 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.773 0.797 . . . . 0.0 109.281 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.83 165.79 17.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.706 . . . . 0.0 109.639 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -166.73 11.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -30.44 69.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -1.049 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 209' ' ' ASP . 23.0 p-10 -158.34 21.88 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.274 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -138.15 145.19 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.907 -1.12 . . . . 0.0 110.535 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.3 108.41 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -54.84 -50.58 68.27 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 110.043 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.61 115.29 13.0 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.66 -12.28 35.01 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.418 1.412 . . . . 0.0 111.9 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.72 -15.95 60.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 108.664 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.73 178.27 46.05 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -82.62 150.12 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -1.08 . . . . 0.0 109.576 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -79.02 -19.0 52.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.15 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -141.94 -165.53 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.6 -8.21 29.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.191 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.07 45.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.914 . . . . 0.0 109.35 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.18 -46.92 99.6 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.925 -1.109 . . . . 0.0 109.86 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 55.4 Cg_exo -51.18 -68.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.42 2.08 . . . . 0.0 112.179 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.6 -35.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.95 -1.094 . . . . 0.0 109.674 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -61.69 -40.7 95.94 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.9 t60 -68.02 -31.41 71.06 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.664 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -65.33 -36.25 83.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -38.14 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 67.5 t80 -64.42 -50.23 68.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 109.17 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.65 -28.35 68.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . 0.495 ' CD2' ' HG ' ' A' ' 248' ' ' SER . 31.9 tp -76.06 -32.91 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.104 -0.998 . . . . 0.0 108.391 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 34.4 mt -68.97 -38.9 79.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.58 -53.49 31.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.449 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 80.6 m-20 -56.74 -38.2 72.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.234 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mt -58.59 -21.12 52.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.505 -0.747 . . . . 0.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.625 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -75.02 -22.32 58.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.824 -1.172 . . . . 0.0 109.454 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.18 1.08 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.49 -1.381 . . . . 0.0 110.292 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.625 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.4 mt -77.93 -16.29 58.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.911 -1.118 . . . . 0.0 109.569 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.9 -0.23 51.88 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.867 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.472 ' OG ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -166.79 157.41 10.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.736 -1.449 . . . . 0.0 109.118 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.8 Cg_endo -50.22 150.79 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.805 1.67 . . . . 0.0 109.322 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.67 145.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.873 -1.142 . . . . 0.0 112.108 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 122.44 33.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.66 -160.5 30.7 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.444 -1.033 . . . . 0.0 108.888 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -140.66 141.26 35.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 110.401 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -125.52 122.96 38.08 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' SER . . . . . 0.495 ' HG ' ' CD2' ' A' ' 231' ' ' LEU . 3.8 m -115.22 136.11 53.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 111.198 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 250' ' ' ARG . 91.7 t80 -117.81 116.04 26.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 249' ' ' PHE . 38.0 mtp85 43.55 43.54 4.66 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.219 -0.926 . . . . 0.0 109.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.35 165.42 35.62 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -138.83 -174.57 13.51 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.617 ' ND1' ' HG1' ' A' ' 60' ' ' THR . 61.4 m-70 -63.01 -39.14 93.86 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER -55.27 -58.68 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.088 -1.007 . . . . 0.0 108.999 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.449 ' N ' ' OG ' ' A' ' 254' ' ' SER . 4.1 tp -56.27 -45.08 80.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 109.461 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.46 -50.5 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 109.35 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.95 -39.23 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -63.97 -51.41 64.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.87 -49.13 66.44 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 108.545 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.01 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -49.29 -48.68 45.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -61.32 -49.07 78.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 109.705 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -57.3 -45.77 83.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 109.641 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.55 63.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.914 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 109.76 -179.644 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -57.59 141.57 47.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 108.731 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -125.59 147.09 49.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.4 t -141.93 -173.03 3.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.35 136.84 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.868 -1.145 . . . . 0.0 109.035 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -67.27 -21.77 65.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.572 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE2' ' O ' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -152.31 157.82 41.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' O ' ' OE2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -65.8 139.99 58.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.312 -0.867 . . . . 0.0 110.368 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 mt -115.95 163.55 15.72 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.51 142.06 43.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 110.344 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -141.21 161.01 38.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -167.15 152.75 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 109.768 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.27 176.11 36.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.34 155.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -1.128 . . . . 0.0 110.062 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 139.14 15.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tt -58.98 -38.33 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.265 . . . . 0.0 110.354 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.401 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 80.2 m-70 -90.86 -50.82 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.674 -1.266 . . . . 0.0 111.026 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.3 p -68.65 -23.64 64.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.76 -0.587 . . . . 0.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.95 17.2 21.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -108.28 153.34 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -1.025 . . . . 0.0 109.651 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -73.3 134.64 44.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.0 109.41 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -140.49 143.83 35.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -108.28 158.58 17.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -137.6 144.61 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.54 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.5 mt -143.43 110.91 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.9 . . . . 0.0 108.852 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.43 115.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 111.057 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.49 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 30.1 m-70 -108.5 138.57 20.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 109.422 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.82 168.37 0.81 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.753 1.635 . . . . 0.0 111.728 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.94 173.75 11.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 39.7 mttm -85.08 153.06 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.284 -0.885 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.17 147.21 3.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.645 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 71.82 -0.33 37.24 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.903 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.704 ' H ' HD21 ' A' ' 86' ' ' ASN . 51.6 m -67.21 -45.42 76.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.615 -1.52 . . . . 0.0 109.536 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.75 -179.34 31.52 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.774 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.87 117.66 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH2' ' CE1' ' A' ' 45' ' ' TYR . 21.7 ptt180 -144.49 157.73 44.1 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.839 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -103.64 157.86 16.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -128.07 110.83 12.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 108.772 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 15.9 tttp -135.27 132.81 38.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.579 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.17 28.3 6.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.464 -0.772 . . . . 0.0 111.628 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.44 19.67 68.34 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.211 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -124.28 123.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.278 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.447 ' CE1' ' NH2' ' A' ' 38' ' ' ARG . 98.9 m-85 -84.78 127.62 34.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.4 90.99 40.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.69 150.22 4.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.549 2.166 . . . . 0.0 111.926 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.11 75.99 9.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.982 . . . . 0.0 109.775 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -129.35 173.66 10.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 109.211 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.2 p-80 -71.81 -52.43 17.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -45.48 -16.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.758 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' HIS . 21.0 m-85 -94.9 0.37 54.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.722 -1.236 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -72.82 128.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.04 -28.94 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -151.07 133.03 15.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.8 p -123.93 95.91 4.74 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.554 ' C ' ' H ' ' A' ' 59' ' ' SER . 5.7 t-20 -162.61 128.76 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.852 . . . . 0.0 108.805 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' SER . 50.9 m-70 50.17 9.45 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.97 146.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.801 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.434 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 31.0 m -89.9 126.92 35.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 0.0 109.174 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.04 150.35 41.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.328 -0.857 . . . . 0.0 111.059 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.5 150.11 47.68 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.51 154.82 25.91 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.894 -1.622 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -163.22 150.39 12.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -1.033 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt 52.31 22.2 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.13 -32.5 7.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -59.83 145.74 44.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.287 . . . . 0.0 109.478 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.25 139.51 35.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.407 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -130.15 121.96 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -99.04 156.99 16.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.1 m 49.14 74.52 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.879 -0.513 . . . . 0.0 110.739 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -108.0 -9.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.117 -0.989 . . . . 0.0 109.274 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.1 pm0 -60.86 -26.28 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.493 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -66.01 -69.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.56 -47.48 48.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.4 mt -52.02 -48.75 64.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.954 -1.091 . . . . 0.0 110.026 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.541 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 26.2 t -61.18 -42.46 98.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.166 -0.959 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.8 t -56.64 -44.88 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.093 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.24 -35.19 75.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.33 -0.856 . . . . 0.0 109.288 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -62.48 -34.36 76.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 109.189 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 52.2 mt -82.03 -37.97 25.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.619 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.62 0.26 30.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.409 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 4.1 mp0 57.13 41.13 27.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.326 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.07 143.67 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.703 -1.248 . . . . 0.0 108.043 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.484 ' OG1' ' OD1' ' A' ' 86' ' ' ASN . 51.5 p -127.52 -21.04 3.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.103 -0.998 . . . . 0.0 111.703 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.704 HD21 ' H ' ' A' ' 35' ' ' THR . 5.4 m120 -127.18 107.0 9.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.937 -1.102 . . . . 0.0 110.609 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.8 m -164.94 149.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 109.917 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.45 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 41.7 m -117.21 111.66 19.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -92.61 100.92 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.917 . . . . 0.0 110.269 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.95 127.51 33.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.9 124.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.04 0.924 . . . . 0.0 112.261 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.5 mm -109.48 98.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.548 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 144.36 -159.05 27.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.02 -10.93 9.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -1.163 . . . . 0.0 110.075 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -141.62 150.2 41.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.981 -1.074 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.27 120.35 79.91 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.702 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -41.09 120.83 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.69 1.593 . . . . 0.0 111.145 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 tp -78.25 -15.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 110.754 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt 57.1 -117.78 1.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.051 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 10.3 t0 -97.04 4.48 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 110.588 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.63 1.57 58.87 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.104 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 p -127.58 -172.68 2.73 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.811 . . . . 0.0 109.563 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.7 15.84 7.94 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 42.1 t-105 -56.09 -42.43 76.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -1.046 . . . . 0.0 110.5 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.9 -59.1 5.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.322 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -51.16 -45.18 61.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.149 -0.969 . . . . 0.0 109.288 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.521 ' HH ' HH11 ' A' ' 111' ' ' ARG . 48.8 t80 -60.12 -50.72 72.57 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -63.78 -43.85 95.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.17 -0.956 . . . . 0.0 111.23 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.45 -60.01 2.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.945 -1.097 . . . . 0.0 110.095 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.49 -36.8 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.192 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.521 HH11 ' HH ' ' A' ' 107' ' ' TYR . 39.9 ttt180 -62.12 -43.44 98.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 109.249 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -76.33 13.93 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.614 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 111' ' ' ARG . 6.5 m-80 -146.08 31.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.069 -1.02 . . . . 0.0 110.453 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.1 mt -80.75 139.12 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.902 -1.124 . . . . 0.0 110.35 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -128.06 119.25 25.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.529 -0.732 . . . . 0.0 109.041 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.62 140.68 48.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -109.54 -178.26 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.701 . . . . 0.0 109.186 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -108.85 68.4 0.68 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.949 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -165.91 131.58 2.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 0.0 109.255 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -67.49 139.02 57.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 109.666 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.2 mt -81.35 147.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.103 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.73 84.74 3.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 108.856 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.2 m-85 -64.14 143.84 57.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.438 -0.789 . . . . 0.0 109.851 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -88.27 101.56 13.98 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.17 132.19 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.7 . . . . 0.0 110.777 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.0 114.65 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -86.64 -29.1 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.959 -1.088 . . . . 0.0 110.907 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.77 162.33 51.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.963 -1.086 . . . . 0.0 109.766 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.34 145.56 27.14 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.857 2.371 . . . . 0.0 112.777 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -154.31 149.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.33 143.49 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 109.37 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.5 149.29 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.13 164.72 27.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.4 -0.812 . . . . 0.0 109.859 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.578 ' CG ' HH21 ' A' ' 137' ' ' ARG . 57.6 t0 -173.87 111.77 0.18 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 109.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 58.18 9.54 1.02 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.619 -0.675 . . . . 0.0 109.865 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 134' ' ' ASP . . . 117.18 -26.63 8.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.578 HH21 ' CG ' ' A' ' 134' ' ' ASP . 1.2 mpp_? -58.42 144.12 43.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.482 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.3 tt -148.94 139.51 22.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.093 -1.443 . . . . 0.0 111.03 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.23 125.6 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -111.71 131.0 55.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.436 0.636 . . . . 0.0 109.838 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.97 132.37 54.88 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 154.02 52.26 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.995 -1.066 . . . . 0.0 109.959 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.3 139.76 43.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.276 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.93 147.13 22.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.9 -37.54 82.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.4 p -117.75 -171.55 2.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.0 110.051 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 tp -100.95 126.15 47.58 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.98 137.23 34.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.8 t -133.98 121.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.0 m -111.29 151.96 27.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.465 -0.772 . . . . 0.0 109.265 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.581 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 34.0 t80 -140.75 130.94 24.88 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.181 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.83 131.66 54.17 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.83 141.33 12.29 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.583 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -103.89 100.81 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.28 167.3 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -100.94 -14.99 17.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.821 . . . . 0.0 110.774 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 p-10 -95.31 -173.56 2.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.784 -1.198 . . . . 0.0 110.587 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.47 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 8.4 p90 -49.3 -0.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.812 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.6 mt -80.76 -28.63 36.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.31 -1.494 . . . . 0.0 108.803 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.12 -137.09 45.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -99.85 135.85 40.65 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -1.188 . . . . 0.0 109.625 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -139.03 146.88 41.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -138.18 144.65 40.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.493 -0.755 . . . . 0.0 109.756 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -143.22 136.16 27.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.7 m -105.85 122.76 46.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CD1' ' OD1' ' A' ' 170' ' ' ASN . 7.2 t80 -101.73 110.24 22.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.271 -0.893 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.589 ' H ' HD22 ' A' ' 170' ' ' ASN . 3.7 t -105.76 141.02 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 110.054 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 167' ' ' VAL . 9.8 mm-40 -44.06 131.58 5.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 108.819 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.85 -16.52 18.45 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.589 HD22 ' H ' ' A' ' 167' ' ' VAL . 1.9 p30 -115.16 29.36 8.07 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.074 -1.25 . . . . 0.0 109.916 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -38.32 64.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.07 -1.019 . . . . 0.0 109.806 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.3 -18.65 50.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -85.66 -7.57 58.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 111.179 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.73 -28.49 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.114 -0.991 . . . . 0.0 110.963 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.5 -24.95 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.736 -1.227 . . . . 0.0 108.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.59 -4.72 58.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.471 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.13 120.17 13.9 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 82.3 mtm180 -83.4 172.47 12.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.9 t -79.14 161.48 26.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -147.85 145.45 28.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.234 -1.541 . . . . 0.0 111.859 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.49 157.43 44.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.5 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.5 m-85 -98.95 145.54 26.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 109.626 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.06 -35.79 26.58 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.344 -0.847 . . . . 0.0 109.864 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -72.8 -28.16 62.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.963 -1.086 . . . . 0.0 109.862 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.6 mm-40 -79.11 -40.62 30.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 110.085 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 77.5 mt -44.73 -55.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 19.3 tt0 -42.13 -41.73 2.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.26 -55.55 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 189' ' ' ILE . 88.5 mt -45.4 -26.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.368 -0.832 . . . . 0.0 109.407 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -85.75 -53.71 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.819 -1.176 . . . . 0.0 108.921 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -49.09 -26.77 2.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 m -96.1 18.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 59.25 39.83 95.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.401 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 62.4 mt -125.45 171.97 10.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -1.071 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.49 51.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -58.28 -22.79 54.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.7 -1.471 . . . . 0.0 109.534 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -110.28 25.56 15.52 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.33 125.01 7.61 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.416 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -143.89 169.49 17.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -1.118 . . . . 0.0 109.847 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.554 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 55.8 mt -69.08 -8.74 48.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.5 -10.64 24.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.722 -0.611 . . . . 0.0 109.762 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.44 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 13.5 p30 -138.27 8.76 2.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 109.866 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -148.72 149.56 31.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.932 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.8 tp -97.95 93.65 6.44 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.41 130.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.279 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.3 mt -123.35 163.05 21.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.528 -0.733 . . . . 0.0 109.164 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.52 -166.79 13.22 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -68.45 -25.74 65.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.261 -1.14 . . . . 0.0 109.665 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.16 21.47 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 0.0 110.778 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -150.1 157.92 43.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.411 -1.43 . . . . 0.0 110.68 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.01 113.94 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -57.38 -50.86 71.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.897 -1.127 . . . . 0.0 109.99 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.34 111.21 3.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.56 -16.47 30.15 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.747 1.631 . . . . 0.0 112.677 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.65 -15.7 60.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.901 -1.125 . . . . 0.0 109.923 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.4 -178.37 47.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.31 151.41 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 109.735 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.5 OUTLIER -78.55 -18.97 53.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.187 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 52.9 m-85 -144.72 -172.0 3.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.542 -0.724 . . . . 0.0 109.103 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.3 -5.08 53.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.6 43.28 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.196 -0.94 . . . . 0.0 109.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -54.82 -47.52 98.02 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 109.948 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -50.82 -68.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.463 2.108 . . . . 0.0 112.079 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.7 m -58.22 -36.3 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -60.88 -40.88 94.66 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.223 -0.923 . . . . 0.0 108.555 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 15.3 t60 -68.47 -32.19 72.01 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.253 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . 0.581 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 6.0 mmtp -66.04 -36.03 82.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.63 -37.49 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.541 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.2 t80 -64.03 -52.11 61.01 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 87.4 m-20 -65.38 -27.01 68.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.681 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.92 -32.77 57.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.084 -1.01 . . . . 0.0 108.588 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.85 -38.53 78.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.15 -54.36 24.57 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -56.96 -35.43 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 109.293 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.72 -24.83 67.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 110.512 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.2 t80 -74.98 -21.46 59.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.884 -1.135 . . . . 0.0 109.388 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 65.0 mt -48.54 -6.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.86 -1.15 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -69.33 -13.03 62.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.945 -1.097 . . . . 0.0 109.85 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.85 2.92 64.44 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.715 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.74 149.87 11.02 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.872 -1.369 . . . . 0.0 108.904 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.401 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 6.9 Cg_endo -53.04 130.0 35.95 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.639 1.559 . . . . 0.0 110.076 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.88 150.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 112.216 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -130.64 123.37 29.28 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.82 -157.43 27.59 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.8 OUTLIER -129.35 137.03 50.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -1.042 . . . . 0.0 108.857 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.0 m-85 -133.54 140.03 46.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -126.97 123.24 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.06 132.99 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.735 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -114.92 110.79 20.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 56.6 mtp180 46.57 41.25 9.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.249 -0.907 . . . . 0.0 109.087 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.8 163.98 50.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -131.76 -179.05 15.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.519 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 30.7 m-70 -65.15 -46.72 79.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -1.229 . . . . 0.0 110.034 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.6 OUTLIER -53.45 -60.61 3.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.971 -1.081 . . . . 0.0 108.782 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 254' ' ' SER . 12.5 tp -47.76 -49.5 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.03 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 25.8 m-20 -47.74 -49.5 28.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.988 -1.07 . . . . 0.0 109.098 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.94 -44.29 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.473 -0.767 . . . . 0.0 109.755 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -59.4 -49.21 78.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.218 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 32.4 tp -54.19 -49.85 68.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.63 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.5 t -58.47 -57.43 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.003 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -47.74 -45.33 28.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.133 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -62.48 -57.4 11.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.365 -0.834 . . . . 0.0 109.213 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.5 mt -48.4 -48.7 36.86 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.141 -0.975 . . . . 0.0 109.512 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.58 67.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 109.859 -179.537 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.266 0.555 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 119' ' ' ARG . 27.9 mt-10 -54.0 142.45 24.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -125.7 142.73 51.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.351 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -142.62 -168.55 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.22 141.19 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.005 -1.059 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -69.92 -26.03 63.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.982 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -145.44 161.79 38.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 110.161 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 139.18 55.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.07 161.27 20.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 p -131.96 141.66 49.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.73 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 91.9 m-85 -138.17 152.5 48.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.24 151.9 19.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.743 -1.223 . . . . 0.0 110.157 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.72 174.28 35.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 151.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.0 136.14 14.81 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tt -56.55 -39.05 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 75.8 m-70 -92.35 -49.26 6.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.757 -1.214 . . . . 0.0 111.008 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -28.38 69.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 111.245 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.87 17.63 55.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -112.7 155.12 25.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -1.012 . . . . 0.0 109.325 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.28 135.2 44.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.0 109.421 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 m -138.11 144.34 40.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.784 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.18 154.38 25.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.027 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.7 mt -135.74 147.44 48.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 110.162 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.546 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 7.8 mt -143.87 109.43 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.4 115.15 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.449 -0.782 . . . . 0.0 110.575 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.546 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.2 m-70 -109.46 141.81 24.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.79 168.89 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.824 1.683 . . . . 0.0 111.477 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 70.7 mm-40 -141.74 175.44 9.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.93 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' OG1' ' A' ' 35' ' ' THR . 13.8 mttt -82.37 152.09 26.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 145.13 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.19 5.06 52.59 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.107 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 35.2 m -67.31 -44.37 79.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.526 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.752 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 97.36 -179.69 33.54 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.547 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -96.29 116.58 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -143.02 148.84 37.41 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.69 -1.204 . . . . 0.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.82 156.94 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -129.3 109.38 11.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.236 -0.915 . . . . 0.0 108.934 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 tttp -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m120 53.61 27.7 7.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 111.101 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.25 19.67 71.43 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.463 -1.351 . . . . 0.0 109.859 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 t -123.28 123.2 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -85.87 127.46 34.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.04 -1.038 . . . . 0.0 109.287 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mt -118.23 95.03 47.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 109.724 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.4 148.24 11.18 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.476 2.118 . . . . 0.0 112.179 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.59 78.38 8.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.761 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -134.85 -179.94 5.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 0.0 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.597 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.4 p-80 -74.52 -54.76 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.986 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.597 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.4 OUTLIER -43.5 -17.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.845 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 67.2 m-85 -97.23 -0.52 46.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 109.655 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.94 122.36 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.4 -0.813 . . . . 0.0 108.831 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -100.3 -34.11 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -151.21 138.66 19.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.144 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.2 p -125.02 95.86 4.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 59' ' ' SER . 28.0 t-20 -162.53 129.5 3.66 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.4 m-70 49.43 9.57 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.091 -1.006 . . . . 0.0 108.969 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.61 143.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 109.646 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.8 m -88.66 129.56 35.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 109.011 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.16 152.34 41.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.288 -0.883 . . . . 0.0 111.164 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mt -126.11 151.77 46.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.04 165.54 34.25 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.021 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -168.71 141.74 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 108.806 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? 52.27 28.59 5.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.741 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.63 5.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -57.64 148.75 23.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.006 -1.291 . . . . 0.0 109.343 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.28 139.99 26.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.699 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.9 mt -130.24 124.62 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -98.45 154.19 18.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.272 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.2 m 51.89 75.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.88 -9.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.138 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.58 -27.96 69.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.517 -0.739 . . . . 0.0 110.559 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -65.08 -69.37 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.988 -1.07 . . . . 0.0 109.498 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.0 tp -51.57 -47.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.154 -0.966 . . . . 0.0 109.023 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -52.12 -48.37 64.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.076 -1.015 . . . . 0.0 110.134 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 40.5 t -60.87 -42.77 98.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.45 -44.59 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.0 109.086 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.05 -34.48 77.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -61.96 -40.43 95.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.8 mt -75.0 -37.9 61.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.718 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.23 0.82 34.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 109.543 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 54.41 42.25 31.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 0.0 110.139 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -90.36 137.04 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 108.557 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.4 p -124.53 -19.01 5.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.191 -0.943 . . . . 0.0 112.018 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.752 HD21 ' H ' ' A' ' 36' ' ' GLY . 19.2 m120 -124.61 107.16 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.806 -1.184 . . . . 0.0 110.407 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.3 m -165.9 147.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.738 0.78 . . . . 0.0 109.913 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.462 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.3 m -114.03 110.97 20.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.18 100.31 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 110.16 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.92 125.7 28.2 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.79 120.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.762 0.791 . . . . 0.0 111.725 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt -107.52 96.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.84 -156.61 26.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -121.83 -10.55 8.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -1.169 . . . . 0.0 110.443 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -140.33 148.86 41.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.0 -1.063 . . . . 0.0 109.973 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 97' ' ' PRO . 43.7 mm -72.99 117.17 57.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.892 . . . . 0.0 108.804 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' ILE . 75.3 Cg_exo -39.31 130.26 1.57 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.586 1.524 . . . . 0.0 111.418 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 tp -86.21 -14.12 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.08 -117.47 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 0.0 109.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 4.47 51.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.024 -1.047 . . . . 0.0 110.75 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.71 58.77 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.182 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.1 p -126.54 -172.82 2.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.558 -0.966 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.7 15.99 9.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -59.67 -42.73 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -1.064 . . . . 0.0 110.299 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.55 -57.06 11.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.095 -1.003 . . . . 0.0 109.996 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -51.33 -44.92 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.865 . . . . 0.0 109.048 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 46.4 t80 -62.55 -52.51 63.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.726 -0.608 . . . . 0.0 110.931 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.71 -44.13 96.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.08 . . . . 0.0 111.144 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.85 3.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.088 -1.007 . . . . 0.0 110.51 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.25 -33.75 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.506 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 36.2 ttt180 -64.64 -41.81 95.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' C ' HD21 ' A' ' 113' ' ' ASN . 20.3 mmtt -75.86 11.97 1.23 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 110.024 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.43 HD21 ' C ' ' A' ' 112' ' ' LYS . 2.7 m-80 -142.84 35.68 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.284 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.3 mt -81.41 140.12 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.225 -0.922 . . . . 0.0 110.953 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.9 tp -132.21 126.94 34.73 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.15 146.03 33.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.02 -175.85 2.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.272 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -113.27 67.02 0.66 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.232 -0.917 . . . . 0.0 111.175 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 4' ' ' GLU . 7.6 ttt180 -164.89 128.31 2.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 109.529 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -68.24 142.77 55.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.89 -1.131 . . . . 0.0 109.99 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.95 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -95.94 83.46 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 108.794 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.501 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 44.1 m-85 -61.66 145.27 52.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 110.14 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -92.6 102.31 14.74 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.22 133.89 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.384 0.611 . . . . 0.0 110.843 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.69 118.96 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.62 -28.31 16.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.979 -1.075 . . . . 0.0 110.736 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 154.54 80.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.48 151.68 47.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.684 2.256 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 tt -160.23 154.21 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.595 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.37 144.67 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.49 148.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -134.88 159.9 39.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.45 107.9 0.12 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 54.66 49.35 18.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.442 -0.786 . . . . 0.0 110.488 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.65 -29.36 3.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -61.8 137.97 58.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -1.216 . . . . 0.0 108.116 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.473 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -146.71 139.38 25.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.691 -1.256 . . . . 0.0 110.223 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 126.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.375 -0.828 . . . . 0.0 109.767 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -113.34 133.26 55.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.392 0.615 . . . . 0.0 109.999 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.11 136.2 54.89 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.81 150.73 40.3 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.61 141.88 14.57 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.693 2.262 . . . . 0.0 113.62 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 144.89 20.16 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.19 -20.51 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.296 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.9 p -137.45 -174.13 3.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 tp -94.39 121.19 35.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -134.74 120.46 19.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.52 121.45 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.805 . . . . 0.0 109.993 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.0 m -111.31 151.84 27.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.631 -0.668 . . . . 0.0 109.199 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -139.21 130.05 26.22 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -121.23 131.67 54.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.65 138.5 9.49 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.32 -1.419 . . . . 0.0 112.053 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 99.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -83.66 167.01 17.65 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 111.359 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -100.44 23.61 10.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.712 -0.617 . . . . 0.0 110.649 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.0 p-10 -140.08 -172.91 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -49.34 -2.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 111.417 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -77.94 -27.74 49.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.361 -1.462 . . . . 0.0 108.375 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.84 -135.1 43.14 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 133.25 44.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -1.204 . . . . 0.0 109.302 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -135.31 141.4 45.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -136.8 144.11 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.012 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -144.91 137.06 25.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.3 m -105.5 123.55 48.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.701 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.56 109.0 20.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.984 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.76 149.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.07 131.39 23.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -0.958 . . . . 0.0 109.02 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.53 43.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -115.97 22.95 12.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -1.085 . . . . 0.0 109.226 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 173' ' ' GLU . 4.9 pt-20 -58.11 -47.24 83.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.376 -0.827 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 171' ' ' GLU . 22.8 mt-10 -52.85 -6.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 110.258 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 171' ' ' GLU . 23.7 mt-10 -102.71 -6.94 22.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.033 . . . . 0.0 110.952 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.1 pt -123.73 -26.46 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.996 -1.065 . . . . 0.0 110.849 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.65 -29.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mt -77.39 -5.65 50.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.537 -0.727 . . . . 0.0 109.165 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.51 124.51 24.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.113 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -86.13 172.72 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.778 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -79.0 162.55 25.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.36 145.63 27.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.216 -1.552 . . . . 0.0 111.875 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.14 157.94 44.06 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.593 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.5 m-85 -98.61 142.11 30.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.652 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 183' ' ' ASP . 2.9 t0 -49.22 -35.61 17.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.205 -0.935 . . . . 0.0 109.409 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.593 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.2 p90 -70.55 -26.16 63.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.023 -1.048 . . . . 0.0 109.553 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -86.3 -27.3 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.758 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.14 -43.81 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.999 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.6 -39.8 65.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.998 -1.064 . . . . 0.0 109.261 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -75.92 -56.22 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.8 mt -44.74 -33.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.451 ' HZ1' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -80.29 -52.54 7.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.827 -1.171 . . . . 0.0 108.869 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -46.73 -48.33 20.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 110.455 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.6 m -74.24 7.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.002 -1.061 . . . . 0.0 110.409 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 37.85 45.69 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.8 mt -126.07 169.5 12.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.3 25.38 57.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -61.76 -21.76 64.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.675 -1.486 . . . . 0.0 109.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.44 24.22 22.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.35 124.92 7.43 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.9 OUTLIER -138.64 163.38 32.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -1.154 . . . . 0.0 109.539 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.8 mt -66.91 -8.6 30.49 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.59 -11.83 20.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 8.3 p30 -133.36 6.4 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.31 149.64 32.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.597 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 tp -98.63 95.89 7.58 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.23 127.83 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.717 0.77 . . . . 0.0 109.323 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 28.1 mt -122.27 173.98 7.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.602 -0.686 . . . . 0.0 109.322 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.58 -166.39 10.84 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -30.79 70.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.48 -1.012 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -157.85 25.22 0.27 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -144.21 150.75 38.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.922 -1.111 . . . . 0.0 110.677 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -103.75 112.31 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -58.89 -45.31 90.54 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.056 -1.027 . . . . 0.0 110.071 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.6 m120 -59.86 117.14 20.61 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.9 -15.3 46.7 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.391 1.394 . . . . 0.0 111.702 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.08 -14.83 60.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.352 -0.842 . . . . 0.0 109.089 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.82 -176.39 51.02 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.8 mt -86.72 140.95 29.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 109.671 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 7.3 ttp180 -71.29 -18.08 62.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.67 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 57.1 m-85 -147.26 165.09 31.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.58 -12.69 60.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.078 . . . . 0.0 109.355 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.433 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -131.9 43.63 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -60.62 -46.39 97.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.3 Cg_exo -51.37 -67.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.326 2.018 . . . . 0.0 112.295 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.74 -36.26 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.032 -1.042 . . . . 0.0 109.579 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.67 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 58.5 mtt180 -58.67 -42.08 87.61 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -69.08 -30.94 69.36 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.404 -0.81 . . . . 0.0 109.302 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -65.77 -36.37 83.36 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.49 -39.25 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.584 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 57.6 t80 -62.82 -50.48 70.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.28 -29.4 69.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.057 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.42 -31.16 62.2 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.022 -1.049 . . . . 0.0 108.177 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.4 mt -69.56 -40.17 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.88 47.99 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 m-20 -58.62 -40.81 84.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.262 . . . . 0.0 109.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.09 -21.45 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.683 . . . . 0.0 110.15 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.95 -22.19 60.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.087 . . . . 0.0 108.73 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.31 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.649 -1.282 . . . . 0.0 110.208 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.9 mt -76.21 -15.51 60.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.941 -1.099 . . . . 0.0 109.781 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.0 -1.21 55.06 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.48 156.74 9.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.368 . . . . 0.0 108.671 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.8 Cg_endo -47.88 150.49 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.637 1.558 . . . . 0.0 109.461 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.68 144.92 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.074 -1.016 . . . . 0.0 111.935 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . 0.501 ' NZ ' ' CD2' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -125.78 120.34 30.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 -166.8 34.49 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.476 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 2.0 ttmt -126.34 139.25 53.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.405 -1.056 . . . . 0.0 108.934 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -139.26 140.58 37.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 110.546 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.88 124.81 42.86 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 m -116.43 136.39 53.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 111.314 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 250' ' ' ARG . 51.8 t80 -116.54 114.5 24.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 249' ' ' PHE . 5.1 mtp180 44.4 46.8 8.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.021 -1.05 . . . . 0.0 108.836 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -84.99 158.8 33.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -132.15 176.85 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.583 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 55.9 m-70 -58.89 -40.34 84.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.2 t -55.55 -59.53 4.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.833 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.33 -47.26 66.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.56 -49.87 25.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.62 -51.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 109.805 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.06 -51.56 61.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.045 . . . . 0.0 109.312 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.04 -50.2 61.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 108.525 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.65 -53.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 108.82 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -48.31 -47.06 36.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.742 . . . . 0.0 109.311 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.24 -51.43 60.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 109.813 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.06 -50.89 69.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.62 -29.46 69.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.083 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.88 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.8 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 69.0 mt-10 -54.22 141.26 30.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 143.57 50.89 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 109.76 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -142.16 -168.61 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.4 139.32 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -66.91 -30.07 70.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 109.825 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.43 160.11 41.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.73 140.72 56.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.433 -0.792 . . . . 0.0 110.137 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 mt -117.75 166.79 12.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.18 35.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.952 -1.092 . . . . 0.0 110.404 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' LEU . 85.6 m-85 -142.17 158.83 43.29 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -163.32 151.13 13.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.953 -1.092 . . . . 0.0 109.492 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.99 175.24 36.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.85 153.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -1.079 . . . . 0.0 110.266 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.21 140.72 15.6 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.32 -38.23 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 110.862 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 70.4 m-70 -90.8 -49.93 6.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.496 -1.378 . . . . 0.0 111.237 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.8 p -72.55 -20.44 61.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 0.0 111.233 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.43 15.6 12.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -105.5 154.27 20.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 109.909 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 31.2 t80 -75.57 136.04 40.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -0.76 . . . . 0.0 109.557 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -138.52 145.55 40.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 109.906 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -108.7 154.67 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' PHE . 10.1 mt -134.64 146.8 49.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.514 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.8 mt -143.72 111.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.808 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.87 115.04 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.189 -0.945 . . . . 0.0 110.668 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.514 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 25.5 m-70 -110.82 138.55 21.13 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 109.669 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.47 168.42 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.917 1.744 . . . . 0.0 111.627 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 9.3 mm-40 -140.19 173.2 11.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 109.826 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.3 mmtt -83.04 150.95 26.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.584 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -49.11 146.67 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.937 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 67.14 6.68 40.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -71.78 -47.14 55.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.809 -1.407 . . . . 0.0 109.606 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.16 -174.76 24.41 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.771 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -102.33 118.34 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -139.54 151.91 46.48 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.574 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.81 158.09 16.22 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -130.4 113.82 14.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -135.14 133.16 38.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 110.472 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 42' ' ' ASN . 1.7 m-80 48.98 34.92 5.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.379 -0.825 . . . . 0.0 111.561 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.71 17.43 80.11 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.233 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.18 121.24 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.102 . . . . 0.0 108.901 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.8 m-85 -86.76 128.01 35.01 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.025 -1.047 . . . . 0.0 109.913 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.4 mt -116.39 92.15 35.64 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.54 -0.725 . . . . 0.0 109.044 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.94 144.99 10.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.47 2.114 . . . . 0.0 112.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.87 63.65 4.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 108.995 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.29 169.88 8.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -75.14 -44.32 47.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 -16.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -95.09 2.05 55.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.815 -1.178 . . . . 0.0 109.949 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.02 126.49 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 108.927 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.4 -30.82 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.888 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.83 141.56 19.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.048 -1.032 . . . . 0.0 109.94 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.0 p -128.56 95.72 4.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.86 129.44 3.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 109.061 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 96.3 m-70 50.82 8.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.047 -1.033 . . . . 0.0 108.875 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.575 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.13 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 109.591 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.585 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 33.8 m -91.44 126.95 36.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.026 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.59 149.85 42.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.712 0.768 . . . . 0.0 111.14 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 mt -125.54 149.13 48.58 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.55 151.52 21.43 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 118.767 -1.682 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -158.36 149.46 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.5 -1.0 . . . . 0.0 109.231 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 59.7 mttt 46.38 33.92 2.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 109.781 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.76 -33.25 4.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.559 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -55.58 139.76 43.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -1.19 . . . . 0.0 108.886 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -139.94 135.14 32.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 110.517 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.84 117.17 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -97.27 155.42 16.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.896 -1.127 . . . . 0.0 111.118 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 m 52.62 72.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.221 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.41 -10.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 2.5 pm0 -60.91 -31.47 70.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -0.786 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -61.87 -68.39 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.983 -1.073 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.39 -48.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 109.314 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.15 -47.61 62.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.875 -1.141 . . . . 0.0 109.744 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.9 t -62.09 -43.31 99.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.54 -45.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 108.937 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 mt -66.79 -34.67 78.34 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 108.916 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -63.21 -34.48 77.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.203 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.42 -38.45 34.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.764 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.13 3.1 21.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.64 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 5.9 mt-10 55.51 40.19 31.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mm -90.26 134.39 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 108.696 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.7 ' HG1' ' ND2' ' A' ' 86' ' ' ASN . 26.5 p -120.96 -16.16 8.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.367 -0.833 . . . . 0.0 111.718 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.7 ' ND2' ' HG1' ' A' ' 85' ' ' THR . 0.0 OUTLIER -127.64 108.15 10.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.876 -1.14 . . . . 0.0 111.242 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.3 m -165.36 150.7 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.356 -0.84 . . . . 0.0 110.404 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 35.7 m -118.67 109.67 16.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.3 102.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -71.42 124.49 24.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 t -108.66 113.95 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.529 0.681 . . . . 0.0 110.709 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.7 mm -102.08 97.7 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.65 -156.31 25.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.31 -12.32 9.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 109.827 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -138.5 148.86 44.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 109.404 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.17 128.16 86.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 121.95 4.81 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.709 1.606 . . . . 0.0 111.39 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 202' ' ' ASN . 2.4 tp -77.98 -14.83 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.3 mt 57.38 -120.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.275 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 15.7 t70 -95.05 9.0 41.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.983 -1.073 . . . . 0.0 111.117 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.3 64.64 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.148 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -171.62 2.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.812 -0.817 . . . . 0.0 109.43 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.47 15.11 10.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.99 -42.63 85.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.342 -1.093 . . . . 0.0 110.665 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.47 -58.48 7.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.124 -0.985 . . . . 0.0 110.017 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -51.05 -44.03 61.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.19 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 64.6 t80 -60.88 -50.91 71.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.933 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.33 -43.61 90.42 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.967 -1.083 . . . . 0.0 111.469 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.01 -59.52 3.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.958 -1.088 . . . . 0.0 110.277 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.23 -36.17 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 71.6 ttt180 -63.27 -41.52 99.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.595 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -74.13 9.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -143.76 38.65 1.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.148 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 114' ' ' ILE . 89.4 mt -88.08 141.72 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.097 -1.002 . . . . 0.0 111.585 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.401 ' N ' HG23 ' A' ' 114' ' ' ILE . 5.5 tp -132.87 134.72 44.97 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -85.4 150.31 24.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 109.931 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -115.98 -173.95 2.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.408 -0.808 . . . . 0.0 109.81 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.426 ' C ' ' ND2' ' A' ' 118' ' ' ASN . 0.9 OUTLIER -113.97 66.8 0.67 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 -178.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.6 128.61 2.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.051 -1.031 . . . . 0.0 109.291 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.05 139.18 58.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.732 -1.23 . . . . 0.0 109.572 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.1 mt -82.62 149.31 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.8 81.38 3.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.68 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.493 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 51.4 m-85 -60.28 143.53 52.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.672 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -89.36 101.33 14.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -93.39 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.367 0.603 . . . . 0.0 110.778 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.54 114.69 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.89 -28.43 15.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.978 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -129.58 150.18 74.97 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.84 149.59 37.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.478 2.119 . . . . 0.0 112.207 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.95 150.94 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.954 . . . . 0.0 109.265 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.29 143.44 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.58 147.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.24 162.21 35.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' HZ3' ' A' ' 258' ' ' LYS . 2.2 t0 -178.07 113.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 54.58 47.38 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 0.0 110.717 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 -30.88 4.26 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -61.55 137.66 58.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.91 -1.347 . . . . 0.0 108.469 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.1 138.18 28.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.011 -1.056 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 78.8 mt -138.85 127.3 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.312 -0.867 . . . . 0.0 110.067 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -117.09 132.01 56.78 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.454 0.645 . . . . 0.0 109.887 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.75 133.66 54.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.72 153.05 46.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.88 -1.138 . . . . 0.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -48.43 141.87 18.48 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.859 2.373 . . . . 0.0 113.836 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.26 148.75 20.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -37.83 82.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.501 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.4 p -124.91 -174.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.317 -0.864 . . . . 0.0 110.385 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.86 121.2 32.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.9 . . . . 0.0 109.065 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -134.79 121.7 21.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.67 120.97 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -110.6 151.45 27.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.196 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.81 130.18 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.4 ' CB ' ' HH ' ' A' ' 247' ' ' TYR . 24.2 tt0 -121.68 130.79 53.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.13 135.11 7.69 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.623 -1.275 . . . . 0.0 111.682 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -101.91 102.34 12.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -86.18 166.95 15.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 111.141 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -103.96 23.36 13.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.771 -0.581 . . . . 0.0 110.294 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.5 p-10 -138.81 -170.7 2.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 110.115 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -50.67 -4.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 111.163 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' ASN . 13.0 mt -78.51 -26.92 46.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.463 -1.398 . . . . 0.0 108.556 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.84 -139.54 32.31 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -99.71 134.76 42.13 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -136.19 144.62 45.04 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.552 -0.717 . . . . 0.0 109.116 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.508 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.21 145.15 38.93 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 110.036 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 165' ' ' THR . 10.1 t80 -147.41 146.11 29.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 92.1 m -113.53 125.39 54.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 110.582 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -105.01 118.95 37.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.371 -0.83 . . . . 0.0 109.997 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 65.0 t -109.84 150.5 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 134.26 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.35 -7.46 51.25 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -118.95 28.02 8.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.183 -1.187 . . . . 0.0 109.365 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -15.4 57.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.438 -0.789 . . . . 0.0 110.647 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.46 -13.19 61.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 0.0 110.622 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.02 -6.07 36.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.834 -1.167 . . . . 0.0 111.51 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.42 -30.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.149 -0.969 . . . . 0.0 110.426 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 m -61.1 -20.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.772 -1.205 . . . . 0.0 108.683 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.98 -3.35 58.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 0.0 108.969 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.4 117.41 11.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.581 ' NE ' ' OE2' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -82.2 173.22 12.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.665 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.67 162.91 25.88 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -147.8 143.93 27.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.313 -1.492 . . . . 0.0 111.38 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.09 158.63 43.53 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.488 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.1 m-85 -101.03 146.07 27.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.584 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 7.8 p30 -51.18 -37.7 48.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.102 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.488 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.1 p90 -67.87 -26.1 65.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.788 -1.195 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.6 mm-40 -82.43 -25.5 33.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.943 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 37.2 mt -58.22 -55.34 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.963 . . . . 0.0 109.659 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -45.3 -39.59 6.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.085 -1.01 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 189' ' ' ILE . 16.1 t-160 -76.49 -57.46 3.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.151 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 188' ' ' HIS . 84.3 mt -42.04 -32.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.46 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -82.13 -51.31 8.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.071 -1.018 . . . . 0.0 109.102 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -48.35 -45.07 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.89 . . . . 0.0 110.376 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.6 m -76.95 8.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.039 -1.038 . . . . 0.0 110.558 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.76 39.74 59.41 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.403 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 51.7 mt -126.43 170.79 11.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -1.107 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.49 22.28 58.78 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -55.78 -21.6 20.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.641 -1.505 . . . . 0.0 110.231 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.5 3.63 32.72 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.55 124.86 34.14 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.125 -1.221 . . . . 0.0 110.092 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.0 m -145.57 167.4 23.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.267 -1.137 . . . . 0.0 108.956 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.517 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.2 mt -69.94 -8.26 47.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.464 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -95.16 -10.67 29.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.912 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.516 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 12.2 p-10 -138.38 9.81 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.926 -1.109 . . . . 0.0 110.215 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -148.89 149.3 31.02 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.358 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.6 tp -99.79 93.68 5.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.7 130.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 66.2 mt -123.05 168.53 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.39 -166.06 11.82 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -63.44 -21.08 66.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -1.107 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.34 22.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -136.66 144.81 44.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.286 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.42 110.25 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -59.76 -47.02 87.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.605 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -62.5 121.28 66.18 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 0.0 109.733 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -67.65 -14.74 42.91 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.474 1.45 . . . . 0.0 112.016 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.2 -16.73 59.78 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.113 -0.992 . . . . 0.0 108.714 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.38 -169.97 54.88 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.247 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 217' ' ' LEU . 7.3 mt -88.98 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 0.0 110.117 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -69.03 -21.34 64.12 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.582 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.8 m-85 -147.03 148.01 31.23 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.17 7.6 0.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.201 -0.937 . . . . 0.0 109.769 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.659 ' ND2' ' NE ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -148.34 37.05 0.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.581 ' OE2' ' NE ' ' A' ' 178' ' ' ARG . 1.1 tt0 -54.92 -47.08 99.26 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.95 -66.98 0.1 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.435 2.09 . . . . 0.0 112.102 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.02 -37.12 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 109.969 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.659 ' NE ' ' ND2' ' A' ' 221' ' ' ASN . 56.9 mtt180 -60.95 -40.64 94.11 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.0 t60 -67.47 -32.05 72.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.696 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.87 -35.52 80.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.14 -37.57 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.59 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 49.8 t80 -64.51 -50.69 66.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.15 -28.74 69.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.9 tp -76.03 -33.66 59.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 108.732 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.34 -40.74 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.85 -52.88 38.16 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.23 -31.8 69.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -1.187 . . . . 0.0 109.314 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.86 -24.56 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.61 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -76.51 -21.79 55.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.918 -1.114 . . . . 0.0 109.394 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.2 mt -51.23 -0.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.793 -1.192 . . . . 0.0 110.606 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.6 mt -76.59 -11.92 59.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 109.955 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.32 0.6 59.59 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.836 -1.174 . . . . 0.0 110.724 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.56 152.67 13.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.928 -1.337 . . . . 0.0 108.859 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 130.17 39.13 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.869 1.712 . . . . 0.0 110.032 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.55 151.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 112.042 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -136.39 128.82 30.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.21 -156.78 26.86 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.453 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.4 OUTLIER -128.9 139.98 51.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -1.102 . . . . 0.0 109.169 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.0 m-85 -139.04 140.04 37.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.104 -0.998 . . . . 0.0 110.329 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.4 ' HH ' ' CB ' ' A' ' 152' ' ' GLU . 40.0 t80 -125.56 123.09 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.8 m -118.28 136.55 53.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 111.303 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 250' ' ' ARG . 47.8 t80 -117.32 117.27 29.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 249' ' ' PHE . 10.4 mtp180 45.02 42.49 6.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 108.562 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.08 153.09 35.48 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.13 178.89 17.64 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 86.2 m-70 -59.72 -40.09 86.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -1.044 . . . . 0.0 109.77 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 83.4 p -59.48 -38.78 81.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.798 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 256' ' ' ASN . 2.1 tp -76.15 -47.18 25.22 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.038 . . . . 0.0 108.984 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . 9.0 m-20 -47.59 -44.5 26.44 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.987 -1.07 . . . . 0.0 108.457 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.71 -54.23 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.541 -0.724 . . . . 0.0 109.321 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 134' ' ' ASP . 11.0 ttpt -49.59 -51.67 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.946 -1.096 . . . . 0.0 109.435 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 37.2 tp -53.37 -52.88 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.214 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.4 -54.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.034 -1.041 . . . . 0.0 109.229 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.02 -52.63 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.96 -50.93 72.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 109.738 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.86 -49.87 64.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.29 -26.98 66.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.658 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -55.13 138.62 44.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 108.777 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.25 143.43 49.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 110.048 -179.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -141.23 -174.28 3.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 m -96.81 136.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.878 -1.139 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HZ3' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -67.34 -21.43 65.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.422 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -151.52 156.91 41.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.63 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 141.91 58.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.825 . . . . 0.0 110.297 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.77 164.98 15.77 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.44 140.52 48.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 26' ' ' LEU . 90.6 m-85 -136.92 148.36 46.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.28 150.23 25.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.923 -1.11 . . . . 0.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.39 171.38 34.99 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.47 151.17 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.404 -1.056 . . . . 0.0 109.893 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.15 137.85 15.94 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.64 -38.52 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -1.222 . . . . 0.0 110.316 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 69.5 m-70 -90.94 -50.26 5.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.701 -1.25 . . . . 0.0 110.804 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.3 p -66.93 -24.79 66.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.708 -0.62 . . . . 0.0 111.265 -178.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.17 18.97 29.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -112.69 155.45 24.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -1.059 . . . . 0.0 109.446 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.91 132.18 43.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.242 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -134.9 143.22 46.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.494 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.75 156.62 21.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.421 -0.8 . . . . 0.0 109.728 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.3 mt -138.46 147.45 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 9.0 mt -141.75 113.34 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 mt -96.34 113.16 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.609 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.492 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 18.0 m-70 -106.33 138.9 19.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -55.29 168.12 1.55 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.652 1.568 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.552 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 37.0 mm-40 -142.31 171.5 13.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.369 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.0 mttp -83.58 155.82 23.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.73 150.38 4.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.74 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 72.34 -7.63 8.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.629 ' N ' HD21 ' A' ' 86' ' ' ASN . 95.8 m -62.19 -46.26 89.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.602 -1.528 . . . . 0.0 109.773 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 -179.64 35.59 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.34 115.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.78 151.29 46.95 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.54 158.27 16.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -129.26 108.94 10.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.245 -0.91 . . . . 0.0 108.602 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -135.27 135.55 40.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 53.7 26.78 6.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.49 17.0 78.53 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.19 122.47 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.443 -1.034 . . . . 0.0 108.706 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.48 128.0 33.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.79 93.64 41.83 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 0.0 109.533 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.61 145.71 16.58 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.407 2.071 . . . . 0.0 111.905 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.86 76.25 10.26 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -132.63 -179.66 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.532 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.9 p-80 -76.0 -55.67 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.008 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -43.75 -16.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.934 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.8 m-85 -98.16 3.62 49.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.74 -1.225 . . . . 0.0 110.337 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.78 138.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 108.607 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.92 -28.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.387 -0.821 . . . . 0.0 110.307 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -150.68 129.08 12.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.012 -1.055 . . . . 0.0 109.612 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 p -121.74 95.35 4.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.581 ' OD1' ' CD2' ' A' ' 58' ' ' HIS . 64.9 t-20 -163.09 129.82 3.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 108.935 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.581 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 99.7 m-70 52.01 7.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.025 . . . . 0.0 108.883 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.562 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 161.54 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.0 109.689 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.418 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 85.9 m -85.42 129.1 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.177 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.8 m-20 -121.38 150.38 41.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.79 0.805 . . . . 0.0 110.814 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 mt -125.66 148.63 48.94 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.72 158.35 30.81 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.027 -1.559 . . . . 0.0 110.415 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -165.75 153.06 10.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -1.012 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt 51.29 21.3 1.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.78 -33.03 6.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 2.1 mm100 -58.99 148.23 31.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -146.47 140.18 26.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.525 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.01 123.34 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -99.32 153.95 18.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.83 -1.169 . . . . 0.0 111.154 -178.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.7 m 50.82 75.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.82 -9.14 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 109.082 178.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -60.86 -25.35 66.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.531 -0.731 . . . . 0.0 110.464 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -68.26 -69.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 0.0 109.36 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -51.87 -47.34 40.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.018 -1.051 . . . . 0.0 109.07 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.95 -49.27 66.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.475 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 32.8 t -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.077 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.78 -46.26 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.174 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.88 -34.28 78.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -63.29 -39.18 93.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.2 -40.43 45.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.788 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.8 mt -77.89 0.04 25.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.998 -1.064 . . . . 0.0 109.357 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 56.9 41.64 27.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.585 -0.697 . . . . 0.0 111.283 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.5 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 17.2 mm -88.53 144.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.773 -1.205 . . . . 0.0 108.434 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.9 p -126.98 -23.25 3.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.29 -0.881 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.74 HD22 ' N ' ' A' ' 34' ' ' GLY . 8.9 m120 -125.08 108.16 11.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.866 -1.147 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.8 m -163.26 150.11 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.0 110.549 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.552 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 52.0 m -117.46 114.12 23.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.93 103.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -74.41 124.68 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.16 120.7 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.792 0.806 . . . . 0.0 111.23 -178.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.77 96.13 4.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.07 -158.67 27.5 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -119.37 -11.95 9.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -1.177 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.15 148.26 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.017 -1.052 . . . . 0.0 109.726 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.79 119.04 71.93 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 128.45 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.66 1.574 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 tp -82.05 -13.27 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.562 -179.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 mt 55.84 -121.92 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.71 7.61 44.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.45 -10.87 61.41 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.435 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.93 -171.58 2.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.696 -0.885 . . . . 0.0 109.434 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.25 13.59 12.4 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CE3' ' CD2' ' A' ' 176' ' ' LEU . 44.1 t-105 -58.34 -42.22 86.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -1.01 . . . . 0.0 110.635 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.88 -56.05 23.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.849 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -51.47 -42.96 61.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.011 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.49 ' OH ' ' OE2' ' A' ' 171' ' ' GLU . 44.8 t80 -62.62 -53.48 54.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.7 . . . . 0.0 110.558 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -44.52 92.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.67 -59.82 3.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.051 -1.031 . . . . 0.0 110.402 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mt -59.45 -33.34 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.52 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 113' ' ' ASN . 30.8 ttt180 -64.03 -43.68 94.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -73.73 15.98 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.576 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 5.8 m-80 -149.25 34.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.904 -1.122 . . . . 0.0 110.941 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.624 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 65.8 mt -81.88 136.72 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.763 -1.211 . . . . 0.0 110.294 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -130.37 116.27 18.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.37 150.18 45.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -114.84 -174.51 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.545 -0.722 . . . . 0.0 109.422 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.67 67.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 111.118 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -168.52 135.25 1.94 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.048 . . . . 0.0 109.776 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -69.85 142.14 53.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.647 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.8 mt -83.14 148.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.16 87.14 3.85 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 47.9 m-85 -65.91 144.35 56.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.891 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -87.64 101.94 14.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.66 131.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.642 -0.661 . . . . 0.0 110.724 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.93 113.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.52 -31.06 22.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.74 156.84 75.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.018 . . . . 0.0 109.796 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.93 148.61 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.613 2.209 . . . . 0.0 112.149 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.0 tt -157.08 149.29 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.073 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.65 142.77 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.355 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.11 149.64 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -134.53 161.55 34.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.655 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -173.61 108.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.334 -0.854 . . . . 0.0 109.709 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 54.91 49.51 17.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.68 -30.35 3.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.57 HH21 ' CA ' ' A' ' 252' ' ' GLY . 19.3 mtp85 -60.79 140.17 57.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -1.224 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tt -145.33 137.08 25.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.981 -1.074 . . . . 0.0 109.953 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 83.2 mt -136.66 128.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.662 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -117.12 133.28 56.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.482 0.658 . . . . 0.0 110.263 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.08 135.64 54.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -149.05 149.46 29.91 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.932 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -48.23 143.8 14.06 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.507 2.138 . . . . 0.0 113.519 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.93 148.6 19.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -36.37 78.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.344 -0.848 . . . . 0.0 110.111 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.1 p -123.89 -165.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 109.67 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.46 124.54 48.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.941 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -135.81 109.52 8.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.088 -1.007 . . . . 0.0 108.711 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.7 t -109.5 121.69 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.237 -0.914 . . . . 0.0 109.82 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.0 m -112.82 152.03 29.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 109.631 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -139.85 130.47 25.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.959 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -120.56 131.37 54.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.01 136.96 8.76 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.57 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 155' ' ' PHE . 10.7 tm-20 -101.93 100.95 11.3 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.405 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 79.9 m-85 -89.44 167.64 12.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.614 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -11.31 19.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.533 -0.73 . . . . 0.0 110.64 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 159' ' ' LEU . 46.5 p-10 -98.0 -166.54 1.39 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.845 -1.159 . . . . 0.0 110.445 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -55.67 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.488 -0.758 . . . . 0.0 111.654 -178.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.522 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 30.8 mt -82.49 -29.26 30.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.384 -1.447 . . . . 0.0 108.789 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.72 -135.22 42.51 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.5 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 5.5 ttm-85 -96.64 131.41 43.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -1.196 . . . . 0.0 109.559 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.522 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.43 143.69 41.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -143.26 135.92 27.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.269 -0.894 . . . . 0.0 109.822 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -105.34 122.56 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -103.68 112.74 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.139 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.13 152.73 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -49.0 123.77 7.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 108.757 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.76 5.26 36.17 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -117.11 18.32 14.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -1.058 . . . . 0.0 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.49 ' OE2' ' OH ' ' A' ' 107' ' ' TYR . 0.2 OUTLIER -52.75 -56.39 15.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.838 . . . . 0.0 110.079 -179.66 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 171' ' ' GLU . 48.1 mt-10 -42.67 -24.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 171' ' ' GLU . 54.9 mt-10 -82.67 -11.38 58.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 111.77 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.9 pt -124.21 -28.12 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.0 111.415 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.15 -29.34 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.427 -1.421 . . . . 0.0 108.942 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.409 ' CD2' ' CE3' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -78.31 -0.6 29.48 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.037 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.419 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -75.01 113.61 12.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.758 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.575 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -78.97 173.3 12.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.37 -0.831 . . . . 0.0 109.064 179.657 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.3 t -77.62 161.86 27.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -147.67 143.94 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.239 -1.538 . . . . 0.0 111.667 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.03 157.49 44.49 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 83.8 m-85 -97.41 147.15 24.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.467 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.87 -36.38 16.9 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.683 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -74.85 -28.31 60.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 0.0 109.934 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 9.4 tt0 -77.26 -26.23 52.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.103 -0.998 . . . . 0.0 110.339 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 187' ' ' GLU . 81.1 mt -60.43 -56.08 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.937 -1.102 . . . . 0.0 110.033 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.18 -41.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 110.144 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -73.56 -48.1 35.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 108.801 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.53 -28.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . 0.411 ' HZ1' HG21 ' A' ' 186' ' ' ILE . 4.2 mmtm -85.21 -52.73 5.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 109.281 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -46.98 -35.01 6.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.7 m -88.54 17.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.57 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 60.26 40.4 97.33 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 39.0 mt -125.74 170.76 11.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 61.04 21.94 59.8 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . 0.57 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 27.9 mttp -54.5 -20.65 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.598 -1.53 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.83 26.04 9.14 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.01 125.31 7.71 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 120.781 -1.423 . . . . 0.0 109.932 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.66 170.44 16.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.698 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.582 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 38.6 mt -68.68 -8.42 42.3 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -96.46 -13.21 23.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 109.658 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.2 p30 -135.1 7.96 3.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 109.852 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -148.5 149.99 32.62 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.017 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.09 93.6 6.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.7 t -87.06 129.9 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.64 0.733 . . . . 0.0 109.347 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.35 170.55 9.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.37 -166.36 11.78 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -63.98 -30.37 71.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.55 24.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.672 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.95 153.2 40.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.257 . . . . 0.0 110.561 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.19 112.23 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.99 -50.19 71.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.015 -1.053 . . . . 0.0 109.965 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.03 111.51 4.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.458 -0.776 . . . . 0.0 110.425 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -59.83 -13.95 24.9 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.732 1.621 . . . . 0.0 112.467 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -76.31 -18.09 59.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.062 -1.024 . . . . 0.0 109.723 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.31 -179.08 53.27 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.438 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.0 mt -85.65 149.28 25.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.08 . . . . 0.0 109.852 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.44 -21.36 49.26 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -142.27 170.82 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.7 pm0 -77.21 -12.33 59.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.142 -0.974 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.526 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -135.1 44.16 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.176 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.7 OUTLIER -54.11 -46.91 98.59 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.944 -1.097 . . . . 0.0 109.41 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.64 -67.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.386 2.057 . . . . 0.0 111.996 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.56 -35.57 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.526 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 59.6 mtt-85 -61.45 -40.15 93.43 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.575 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.3 t60 -68.02 -32.85 73.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.002 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -65.47 -36.5 84.08 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -66.06 -39.14 83.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.475 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.0 t80 -63.23 -51.58 65.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.83 -27.74 69.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.31 -35.85 47.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.13 -0.981 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -65.18 -38.61 83.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.83 -54.54 17.85 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.477 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 48.0 m-20 -55.59 -31.35 62.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.079 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.55 -23.81 66.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.697 . . . . 0.0 110.299 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.595 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.23 -21.94 61.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.762 -1.211 . . . . 0.0 108.865 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.71 -3.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.623 -1.298 . . . . 0.0 110.381 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.595 ' H ' ' C ' ' A' ' 236' ' ' TYR . 13.6 mt -78.37 -16.77 57.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.18 2.92 56.82 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.08 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.43 153.31 8.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.62 -1.517 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.7 Cg_endo -53.95 129.31 33.61 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.895 1.73 . . . . 0.0 109.938 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.1 t -88.74 153.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.121 0.962 . . . . 0.0 112.295 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -133.34 125.82 30.02 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.32 -154.82 25.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 133.12 43.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -1.152 . . . . 0.0 108.873 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.2 m-85 -131.46 138.12 48.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 110.026 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -124.47 128.1 48.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.8 t -122.72 135.07 54.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.063 . . . . 0.0 111.364 -178.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -115.61 116.23 27.78 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 46.15 28.61 0.68 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.93 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.82 154.5 31.68 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.57 ' CA ' HH21 ' A' ' 137' ' ' ARG . . . -130.48 172.51 20.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 35.9 m-70 -59.13 -40.68 86.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.24 . . . . 0.0 109.547 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.5 t -56.43 -59.28 5.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 108.958 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.34 -47.3 62.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 109.207 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.6 m-20 -48.26 -51.01 27.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.58 -54.17 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.794 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -51.27 -50.01 60.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 109.061 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 50.4 tp -51.8 -50.16 61.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 77.4 t -59.12 -53.81 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.182 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -49.35 -43.18 43.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.436 -0.79 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.59 -50.64 64.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.4 mt -57.77 -45.72 85.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.821 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.49 -31.01 65.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.31 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.222 -179.237 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.594 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 19.7 mt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.304 0.573 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 70.8 mt-10 -54.89 136.74 46.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.035 -1.041 . . . . 0.0 108.542 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -120.19 142.42 49.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.456 -0.778 . . . . 0.0 109.572 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.28 -168.4 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.81 139.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.988 -1.07 . . . . 0.0 109.4 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -67.46 -23.68 65.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -150.02 158.38 44.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.013 . . . . 0.0 109.833 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 141.51 58.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.448 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.43 168.6 10.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -139.63 144.79 37.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.965 -1.085 . . . . 0.0 110.674 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 77.8 m-85 -139.77 156.44 46.76 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -163.35 152.3 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.95 174.94 35.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.18 152.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -1.102 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 139.07 15.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.75 -40.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 110.354 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -89.37 -49.2 6.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 111.181 -178.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -69.92 -23.85 63.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.547 -0.721 . . . . 0.0 111.692 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.68 11.47 7.9 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.17 -1.49 . . . . 0.0 109.517 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -104.29 155.32 18.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.68 136.49 40.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.845 . . . . 0.0 109.67 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.0 m -137.07 142.73 42.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.562 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.32 151.27 26.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 mt -132.71 147.59 52.33 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.462 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -143.12 110.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 108.755 178.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mt -96.35 116.21 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 110.721 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.462 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 67.7 m-70 -110.64 141.55 24.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.537 -0.727 . . . . 0.0 109.781 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -53.97 168.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.868 1.712 . . . . 0.0 111.479 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 14.3 mm-40 -140.1 176.27 8.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 30.2 mttp -84.76 151.02 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.94 143.88 2.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.51 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.1 9.39 57.01 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.99 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -71.31 -44.95 64.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.563 -1.551 . . . . 0.0 109.502 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.99 -176.2 29.26 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.69 117.25 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH2' ' CE2' ' A' ' 45' ' ' TYR . 13.3 ptt180 -142.47 155.72 45.1 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.836 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.84 157.45 17.08 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -128.35 110.94 12.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 108.996 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -135.11 133.83 39.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 52.43 26.84 4.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 111.238 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.69 66.41 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.038 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.5 123.88 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -1.083 . . . . 0.0 109.096 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.477 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 16.3 m-85 -88.31 128.81 35.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.174 -0.954 . . . . 0.0 109.797 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.43 112.97 35.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.86 155.96 57.3 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.81 1.673 . . . . 0.0 112.322 -179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.91 63.68 7.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.58 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.3 mtt85 -116.84 169.2 9.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.3 p-80 -74.04 -49.89 22.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.517 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -45.93 -16.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' HIS . 55.7 m-85 -97.85 3.93 49.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.872 -1.143 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.7 126.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.29 -30.35 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.34 131.3 13.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.061 -1.024 . . . . 0.0 110.112 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.7 p -120.52 95.09 4.59 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' SER . 35.3 t30 -163.36 130.17 3.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.544 ' O ' ' CB ' ' A' ' 59' ' ' SER . 76.8 m-70 51.66 7.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.1 -1.0 . . . . 0.0 109.266 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 161.03 140.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.2 m -80.42 127.36 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.291 -0.881 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -120.77 147.73 44.94 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.861 0.839 . . . . 0.0 111.113 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.95 148.21 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.44 153.83 24.78 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.252 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -164.75 150.12 9.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -1.083 . . . . 0.0 109.285 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.3 mttt 51.63 23.9 2.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -33.04 6.32 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -60.49 148.36 37.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.041 -1.27 . . . . 0.0 109.565 -179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -144.12 139.79 29.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.57 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.65 122.69 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -97.95 155.8 16.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 111.22 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 m 49.12 75.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.094 0.473 . . . . 0.0 110.747 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.78 -8.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.268 -0.895 . . . . 0.0 109.006 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 7.6 pm0 -60.84 -27.25 67.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.67 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.413 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.9 m170 -65.78 -69.03 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.907 -1.12 . . . . 0.0 109.281 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.09 -47.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.59 -49.27 62.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 110.157 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 19.5 t -60.99 -42.87 99.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.03 -1.044 . . . . 0.0 110.382 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.89 -47.54 79.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.96 -34.59 78.46 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.3 -34.95 77.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -80.83 -38.01 29.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.045 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.27 5.58 12.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.026 -1.046 . . . . 0.0 109.581 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 53.87 39.14 30.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.4 mm -89.79 134.48 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 108.716 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.8 p -123.39 -18.68 6.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.259 -0.901 . . . . 0.0 111.686 -178.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.509 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 3.1 m120 -124.09 106.9 10.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.868 -1.145 . . . . 0.0 110.351 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.9 m -166.41 147.54 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.666 0.746 . . . . 0.0 110.056 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 22.2 m -115.76 110.2 18.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.29 100.33 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.028 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.0 128.58 35.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.098 -1.001 . . . . 0.0 108.417 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.1 128.67 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.06 0.933 . . . . 0.0 111.927 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.2 mm -109.66 96.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.28 -153.15 21.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -9.27 8.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -1.087 . . . . 0.0 110.072 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.93 148.31 41.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.042 -1.036 . . . . 0.0 109.727 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.9 mm -73.48 120.02 78.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 108.772 179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -40.0 125.25 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.515 1.477 . . . . 0.0 111.105 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.425 HG22 HD21 ' A' ' 202' ' ' ASN . 2.5 tp -78.16 -11.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.3 mt 54.34 -119.73 1.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.21 7.8 45.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.83 -0.63 64.93 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.765 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.72 -172.66 2.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.801 -0.823 . . . . 0.0 109.315 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.4 16.08 8.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -59.56 -42.86 93.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -1.086 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.74 -56.88 13.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.544 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 9.9 m-85 -51.67 -44.54 63.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.847 . . . . 0.0 109.108 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 72.1 t80 -61.72 -50.63 71.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.577 -0.702 . . . . 0.0 110.916 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.59 -43.0 95.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.091 -1.006 . . . . 0.0 111.24 -178.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.77 -55.68 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 110.735 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.11 -30.82 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 51.5 ttt180 -66.76 -43.43 84.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.842 . . . . 0.0 110.52 -179.141 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -75.72 11.61 1.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 110.196 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.471 ' OD1' ' CG ' ' A' ' 9' ' ' GLU . 2.6 m-80 -142.75 35.01 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.992 -1.068 . . . . 0.0 110.198 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 114' ' ' ILE . 83.7 mt -83.02 142.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.949 -1.094 . . . . 0.0 111.186 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -132.98 129.39 38.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -83.79 149.07 26.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -116.47 -174.58 2.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.15 68.3 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.35 -0.844 . . . . 0.0 110.807 -178.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -163.73 129.82 3.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.0 109.298 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.82 138.94 56.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.844 -1.16 . . . . 0.0 109.685 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 121' ' ' ILE . 96.5 mt -83.37 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 110.191 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.15 79.53 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.414 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 42.5 m-85 -59.92 142.76 53.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -88.87 101.93 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.716 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.35 133.31 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.71 -0.619 . . . . 0.0 110.561 -177.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.1 t -70.6 114.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.5 mp0 -82.42 -29.98 30.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.044 -1.035 . . . . 0.0 110.695 -178.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 172.99 5.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.754 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.55 149.47 12.92 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.846 2.364 . . . . 0.0 112.848 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.3 tt -157.0 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.79 140.56 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.98 147.59 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' O ' ' NZ ' ' A' ' 258' ' ' LYS . 3.5 mp0 -136.54 160.99 37.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.014 -1.054 . . . . 0.0 110.523 -178.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -174.13 105.48 0.11 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.367 -0.833 . . . . 0.0 109.741 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.09 57.7 6.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.496 -0.752 . . . . 0.0 110.676 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.9 2.83 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.402 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.557 ' NH2' ' H ' ' A' ' 255' ' ' LEU . 46.5 mtp180 -61.96 130.85 47.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.023 -1.281 . . . . 0.0 108.219 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 3.2 tt -143.12 137.15 28.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 109.984 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.44 127.21 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 109.418 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.91 131.46 56.93 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.514 0.673 . . . . 0.0 109.926 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.98 136.07 54.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.58 149.28 36.52 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.015 -1.053 . . . . 0.0 109.874 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.41 141.42 51.01 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.426 2.084 . . . . 0.0 113.187 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.84 147.46 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.4 -3.91 7.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.299 -0.876 . . . . 0.0 110.619 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.1 p -150.84 -175.61 5.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.872 -1.143 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.2 tp -96.4 122.63 39.5 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.064 -1.022 . . . . 0.0 108.875 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -137.13 127.14 25.92 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.331 -0.856 . . . . 0.0 108.768 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 65.7 t -126.89 120.68 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 46.5 m -112.15 152.11 28.72 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.583 -0.698 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -139.69 130.71 26.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.933 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.38 132.86 54.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.37 141.18 12.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.802 -178.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.41 ' O ' ' NH1' ' A' ' 250' ' ' ARG . 5.6 tt0 -105.54 100.1 9.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.31 167.0 15.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -102.5 5.08 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 110.91 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.8 p-10 -119.46 -171.0 2.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.0 110.424 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -47.8 -3.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.595 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -80.24 -29.11 38.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.359 -1.463 . . . . 0.0 109.073 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.95 -139.02 33.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -97.23 131.79 43.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.218 -1.166 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -138.01 147.69 44.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.87 . . . . 0.0 109.456 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.5 146.15 36.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -143.83 137.9 28.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -107.18 123.34 48.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.224 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.477 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 6.3 t80 -102.69 109.64 21.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 154.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.05 126.79 19.54 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.83 2.49 42.78 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -115.37 20.58 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -1.153 . . . . 0.0 109.079 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 173' ' ' GLU . 1.4 pm0 -58.14 -52.15 66.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 1.2 mt-10 -48.6 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 110.499 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 171' ' ' GLU . 12.6 mm-40 -103.47 -7.16 21.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.957 -1.089 . . . . 0.0 110.552 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.35 -26.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.125 -0.984 . . . . 0.0 110.942 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.1 m -60.84 -22.13 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.646 -1.284 . . . . 0.0 108.76 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.87 -2.74 58.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 109.222 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.15 116.41 10.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 108.764 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -79.65 172.76 13.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.401 HG21 ' HG1' ' A' ' 203' ' ' THR . 9.4 t -78.53 163.57 25.43 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -147.51 144.98 28.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.28 -1.512 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.77 157.41 44.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.423 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.2 m-85 -98.98 144.43 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.992 -1.068 . . . . 0.0 109.53 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 183' ' ' ASP . 3.9 t0 -53.07 -35.96 60.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.38 -0.825 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.2 p90 -69.36 -25.38 64.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.77 -1.206 . . . . 0.0 109.902 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.436 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -83.43 -31.14 26.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.032 -1.043 . . . . 0.0 109.92 -179.652 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 189' ' ' ILE . 55.7 mt -50.98 -58.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.532 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.0 tp10 -40.82 -40.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.937 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -74.68 -35.39 62.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.017 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.49 ' N ' ' O ' ' A' ' 186' ' ' ILE . 91.1 mt -58.92 -38.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.354 -0.841 . . . . 0.0 109.024 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -75.71 -52.52 10.3 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -49.07 -43.12 40.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.433 -0.792 . . . . 0.0 110.678 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.53 5.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.388 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 40.08 50.64 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.8 178.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.0 mt -128.13 173.91 9.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.098 -1.236 . . . . 0.0 110.013 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.03 58.58 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -54.7 -20.64 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.479 -1.601 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -117.04 26.02 8.52 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.815 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.5 127.05 8.41 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.665 -1.491 . . . . 0.0 109.886 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.4 m -144.43 174.84 10.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -1.09 . . . . 0.0 109.332 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.5 mt -72.15 -7.77 50.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 108.872 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -96.28 -11.36 26.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.27 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.505 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 8.3 p-10 -134.75 9.88 3.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.008 . . . . 0.0 110.034 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.401 ' HG1' HG21 ' A' ' 179' ' ' THR . 1.2 m -150.65 150.94 31.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 110.339 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.0 tp -100.4 93.88 5.88 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.0 t -86.07 130.12 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.781 0.801 . . . . 0.0 109.318 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.99 165.08 18.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.651 -0.656 . . . . 0.0 109.343 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.31 -166.61 12.05 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.68 73.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.482 -1.011 . . . . 0.0 109.338 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.38 23.71 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.026 -1.046 . . . . 0.0 110.469 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -139.0 146.91 41.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 0.0 110.552 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -100.58 111.26 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -57.54 -52.37 65.68 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.322 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -56.16 111.11 2.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.045 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.55 -14.85 17.99 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.741 1.627 . . . . 0.0 111.962 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -15.86 59.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.126 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.28 -173.17 49.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -89.69 148.05 23.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.17 -1.194 . . . . 0.0 109.843 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.29 -18.15 37.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 108.851 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 59.5 m-85 -139.47 173.71 11.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 220' ' ' GLU . 5.8 mp0 -80.09 -14.42 58.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.48 48.38 1.84 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.253 -0.904 . . . . 0.0 109.596 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -56.54 -46.52 99.81 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 109.808 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.1 Cg_exo -51.5 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.452 2.101 . . . . 0.0 112.108 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.1 -35.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.028 -1.045 . . . . 0.0 109.575 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 18.5 mtt180 -60.19 -41.5 93.08 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -68.04 -31.87 71.83 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.828 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -64.56 -37.16 86.59 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.42 -35.18 65.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.525 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.4 t80 -65.22 -55.27 19.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -63.64 -26.19 68.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.0 tp -77.81 -35.03 51.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.021 -1.049 . . . . 0.0 108.609 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.1 mt -67.14 -36.42 76.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.86 -59.31 6.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -51.67 -34.86 40.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -1.231 . . . . 0.0 108.873 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.67 -23.0 64.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.983 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.614 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.44 -21.64 61.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.088 . . . . 0.0 108.743 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.3 mt -55.16 3.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.677 -1.264 . . . . 0.0 110.521 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.1 mt -80.12 -16.24 55.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.856 -1.152 . . . . 0.0 109.729 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.88 43.4 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.114 -1.041 . . . . 0.0 110.629 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.38 158.14 9.94 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.395 . . . . 0.0 108.921 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.414 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -48.74 150.94 5.71 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 121.848 1.699 . . . . 0.0 109.429 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.72 145.35 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 0.0 112.181 -177.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.5 122.2 32.76 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 148.62 174.8 20.62 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.519 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 18.3 tttt -102.02 146.98 27.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.255 . . . . 0.0 109.986 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 18.3 m-85 -140.56 140.27 35.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 109.927 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -127.12 126.0 42.17 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.0 m -119.62 135.53 54.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 0.0 111.331 -178.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 250' ' ' ARG . 90.9 t80 -116.78 115.22 25.17 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 249' ' ' PHE . 78.3 mtp85 45.14 47.82 9.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.01 -1.056 . . . . 0.0 108.726 -179.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.83 159.53 28.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.52 -174.56 13.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -60.75 -47.92 84.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -1.125 . . . . 0.0 109.642 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.25 -59.08 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.557 ' H ' ' NH2' ' A' ' 137' ' ' ARG . 1.3 tp -52.73 -48.39 66.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.731 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 7.2 m-20 -47.41 -45.29 25.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 109.192 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 59.1 t -66.96 -40.14 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 109.986 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 133' ' ' GLU . 8.3 ttpt -63.74 -51.75 63.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 109.378 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 47.6 tp -53.95 -48.8 69.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.81 -53.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.372 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 265' ' ' LYS . 10.7 mtmt -51.1 -40.44 58.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.688 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.82 -50.45 42.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.949 . . . . 0.0 109.841 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.75 -48.7 80.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.82 73.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 110.114 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 7.7 mmtm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.0 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -55.95 137.61 50.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.959 . . . . 0.0 108.93 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.57 144.19 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.439 -0.788 . . . . 0.0 110.024 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -141.53 -171.34 3.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 m -99.49 137.09 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.013 -1.055 . . . . 0.0 109.437 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.43 -25.18 67.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.667 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.28 162.5 40.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 139.97 54.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.92 166.18 12.81 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -136.72 141.7 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.086 -1.009 . . . . 0.0 110.305 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 26' ' ' LEU . 93.4 m-85 -139.25 153.65 47.86 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.52 152.33 21.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.836 -1.165 . . . . 0.0 110.283 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.57 175.71 36.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.4 153.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.551 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 140.98 17.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 tt -61.48 -37.92 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -1.217 . . . . 0.0 111.117 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.4 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 92.3 m-70 -90.52 -49.45 6.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.292 -1.505 . . . . 0.0 110.938 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.422 ' HG1' ' CB ' ' A' ' 95' ' ' GLU . 1.8 p -68.66 -25.71 64.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 111.853 -178.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.71 16.78 47.12 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.065 -1.54 . . . . 0.0 109.456 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.69 153.69 23.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -1.085 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -76.31 135.53 39.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.773 . . . . 0.0 109.602 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 22.1 t -138.23 145.72 41.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.43 154.44 22.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' PHE . 10.1 mt -134.12 144.13 48.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.74 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -140.03 114.31 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mt -99.3 114.59 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.461 -0.775 . . . . 0.0 110.501 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.58 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 2.9 m-70 -109.41 140.23 21.87 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.42 -0.8 . . . . 0.0 109.682 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -55.35 168.61 1.36 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.767 1.645 . . . . 0.0 111.183 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.481 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 42.0 mm-40 -140.5 179.72 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.0 110.026 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.0 mttt -86.36 152.68 22.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.761 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.14 143.83 2.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.22 7.87 60.9 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.322 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 44.0 m -69.7 -45.22 68.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.533 -1.569 . . . . 0.0 109.802 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.751 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 99.39 -179.9 30.88 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.613 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 HG23 HD13 ' A' ' 37' ' ' ILE . 19.9 mm -96.86 118.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -142.65 153.7 43.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.716 -1.24 . . . . 0.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -102.43 158.78 15.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -130.94 108.32 9.74 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.445 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 30.1 tttm -135.58 137.04 41.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 111.004 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.492 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 16.5 m120 52.25 31.22 8.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 111.279 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.42 80.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.569 -1.3 . . . . 0.0 109.97 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 121.24 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -1.06 . . . . 0.0 109.108 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.69 129.81 34.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.92 93.45 44.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.843 . . . . 0.0 109.618 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -49.04 148.82 9.0 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.317 2.011 . . . . 0.0 111.897 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 69.88 10.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.183 -0.948 . . . . 0.0 109.965 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -122.54 173.95 7.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 108.957 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 237' ' ' LEU . 1.3 p-80 -74.71 -48.21 27.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.465 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.9 mm-40 -47.75 -16.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.807 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' HIS . 27.4 m-85 -95.6 -0.86 51.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.756 -1.215 . . . . 0.0 109.705 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.7 129.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.08 -27.78 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 110.258 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -151.02 131.79 14.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.4 p -124.5 95.44 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.569 ' C ' ' H ' ' A' ' 59' ' ' SER . 1.9 t-20 -163.01 128.8 3.25 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.4 m-70 50.4 8.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.132 -0.98 . . . . 0.0 109.027 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.569 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER 162.64 140.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.883 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.44 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 63.7 m -85.51 126.29 33.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -119.83 148.84 42.97 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.65 0.738 . . . . 0.0 110.75 -179.168 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.92 147.25 46.82 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.97 152.89 23.62 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.561 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -160.59 148.35 16.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -1.023 . . . . 0.0 109.108 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.36 21.68 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.552 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.83 -32.34 7.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.492 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 28.1 mm-40 -60.36 144.64 50.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.071 -1.252 . . . . 0.0 109.469 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -141.64 140.89 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -131.3 122.72 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -90.8 158.69 16.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.036 -1.04 . . . . 0.0 111.365 -179.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 m 41.58 79.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.426 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.34 -9.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.6 pm0 -61.7 -26.58 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.674 . . . . 0.0 110.443 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.407 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -66.06 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 0.0 108.998 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.34 -49.87 40.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.119 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.14 -51.19 33.68 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.976 -1.078 . . . . 0.0 110.233 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -59.61 -41.63 90.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.16 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.05 -44.54 78.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.038 -1.039 . . . . 0.0 108.912 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.32 -35.21 78.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.362 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -62.78 -35.79 80.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.63 -38.21 34.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 109.845 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.14 1.71 30.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.1 -1.0 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 54.79 40.51 31.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 110.113 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.26 140.47 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.1 p -126.34 -21.4 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.16 -0.963 . . . . 0.0 111.753 -178.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.751 HD21 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -126.02 107.25 10.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.942 -1.099 . . . . 0.0 110.351 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.1 m -164.56 147.07 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.16 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.481 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 72.3 m -116.29 110.46 18.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.95 101.58 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.35 129.01 35.27 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 108.539 179.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.41 123.38 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.918 0.866 . . . . 0.0 111.823 -177.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.493 ' O ' ' OG ' ' A' ' 24' ' ' SER . 3.6 mt -104.6 96.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.55 -155.32 24.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -122.22 -9.04 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CB ' ' HG1' ' A' ' 20' ' ' THR . 44.2 tt0 -138.86 148.13 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 110.0 -179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.7 mm -71.94 122.81 88.3 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.187 -1.005 . . . . 0.0 108.383 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -42.46 117.4 0.82 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.637 1.558 . . . . 0.0 110.937 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -72.45 -14.38 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 75.1 mt 56.98 -120.41 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.121 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.99 8.45 44.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.868 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.28 62.4 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.901 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -172.1 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.901 . . . . 0.0 109.57 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.23 17.31 8.54 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 57.7 t-105 -57.12 -43.76 82.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 0.0 110.197 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.88 -55.91 16.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.08 -45.94 61.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 0.0 109.604 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.427 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 44.6 t80 -62.69 -52.87 61.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.0 110.829 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.436 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 2.0 mm-40 -61.21 -44.63 96.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.116 -0.99 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.99 19.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.219 -0.926 . . . . 0.0 110.351 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.2 mt -65.11 -32.11 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.423 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 53.2 ttt180 -63.29 -42.31 99.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -76.46 7.39 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 110.134 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -137.36 33.97 2.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.024 . . . . 0.0 110.509 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.68 138.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.945 -1.097 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -129.41 124.97 35.49 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 142.6 31.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.1 -172.27 2.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.239 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -113.93 69.61 0.71 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.286 -0.884 . . . . 0.0 110.716 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -168.59 131.28 1.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 109.255 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE2' ' C ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -69.8 151.05 46.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 110.08 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.45 ' C ' ' OE2' ' A' ' 120' ' ' GLU . 45.4 mt -95.25 152.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.107 -0.996 . . . . 0.0 110.096 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.32 83.83 4.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 48.0 m-85 -62.5 147.01 50.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.071 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -93.68 102.04 14.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.9 133.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 0.0 110.647 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.91 116.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -84.63 -29.95 25.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.064 -1.022 . . . . 0.0 110.889 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.25 168.73 13.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 109.901 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 147.92 24.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.862 2.374 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -157.36 149.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -0.834 . . . . 0.0 109.043 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.95 146.4 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.93 148.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -133.56 160.72 36.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.71 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -175.1 105.71 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.301 -0.875 . . . . 0.0 109.823 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.32 51.33 15.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 110.199 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.78 -30.65 3.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -62.13 136.89 58.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.262 . . . . 0.0 108.229 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.1 tt -145.57 140.09 27.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 110.534 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 71.2 mt -136.91 127.03 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.717 . . . . 0.0 109.66 179.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -114.22 134.03 55.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 135.64 54.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.42 150.2 39.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -47.22 142.53 11.86 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.684 2.256 . . . . 0.0 113.409 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.581 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -159.0 147.87 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.689 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -66.39 -32.49 73.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 110.53 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.581 ' O ' ' OG ' ' A' ' 144' ' ' SER . 72.5 p -120.25 -163.23 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.327 -0.858 . . . . 0.0 109.308 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.7 tp -109.25 123.98 50.15 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -135.37 125.25 25.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 108.466 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.87 121.5 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 152.03 27.66 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.623 -0.673 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -140.01 130.59 25.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -122.41 133.86 54.62 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.9 140.81 11.91 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.651 -178.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -101.54 100.47 10.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.71 166.95 13.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 110.707 -178.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -104.29 -20.51 13.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 110.484 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 159' ' ' LEU . 32.4 p-10 -89.08 -171.01 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.761 -1.212 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -52.63 2.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.277 -0.889 . . . . 0.0 111.501 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' H ' ' C ' ' A' ' 157' ' ' ASN . 14.6 mt -82.25 -28.63 31.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.388 -1.445 . . . . 0.0 108.493 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.5 -141.56 38.35 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -100.44 136.23 40.64 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.256 -1.143 . . . . 0.0 109.13 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -143.73 160.81 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.374 -0.829 . . . . 0.0 109.597 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 150.54 31.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -144.66 140.78 28.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -107.06 122.93 47.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 109.985 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.484 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 6.0 t80 -102.76 111.61 24.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 110.022 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.446 ' H ' HD21 ' A' ' 170' ' ' ASN . 13.1 t -103.15 150.74 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.73 138.13 6.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.202 -0.936 . . . . 0.0 108.826 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.09 3.83 69.6 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.446 HD21 ' H ' ' A' ' 167' ' ' VAL . 98.7 m-20 -113.83 20.97 15.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.18 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -58.96 -50.86 72.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.361 -0.837 . . . . 0.0 109.196 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 2.4 mt-10 -50.6 -5.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.491 -0.756 . . . . 0.0 109.774 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 171' ' ' GLU . 39.3 mt-10 -104.91 -9.81 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 110.3 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.0 pt -126.85 -27.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.191 -0.943 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.0 m -60.98 -22.88 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.679 -1.263 . . . . 0.0 108.524 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.93 -2.62 58.75 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.35 115.93 10.11 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.355 -0.841 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.3 mtm180 -79.53 172.76 13.35 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 0.0 109.255 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.404 HG21 ' HG1' ' A' ' 203' ' ' THR . 10.1 t -79.71 163.87 24.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -148.71 144.46 27.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.244 -1.535 . . . . 0.0 111.37 -179.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.06 158.84 43.29 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.3 m-85 -99.46 144.75 28.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.35 -36.2 20.79 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.31 -0.869 . . . . 0.0 109.578 -179.477 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 8.5 p90 -73.67 -26.38 60.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 109.842 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.3 OUTLIER -76.65 -38.66 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 109.998 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 187' ' ' GLU . 62.6 mt -48.51 -51.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 186' ' ' ILE . 8.6 tt0 -42.95 -45.38 5.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.953 . . . . 0.0 110.303 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.26 -57.35 3.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 194' ' ' LEU . 45.6 mt -44.74 -27.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -54.37 4.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.772 -1.205 . . . . 0.0 109.506 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -51.91 -40.22 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.929 . . . . 0.0 110.034 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.3 m -75.37 3.37 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.927 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.24 37.72 31.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 189' ' ' ILE . 57.0 mt -128.52 169.53 14.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -1.144 . . . . 0.0 109.865 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.42 24.11 61.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -60.4 -21.23 61.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.623 -1.516 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -111.24 24.95 14.76 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.2 125.45 7.79 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.885 -1.362 . . . . 0.0 109.744 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -144.11 164.5 30.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -1.112 . . . . 0.0 110.03 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.568 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 25.3 mt -64.47 -8.99 15.64 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -93.09 -15.99 25.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -136.84 10.99 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 110.17 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -149.16 149.99 31.92 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.043 -1.035 . . . . 0.0 110.287 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.6 tp -100.24 93.34 5.64 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.12 131.33 34.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.768 0.794 . . . . 0.0 109.031 -179.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.14 162.66 23.13 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.31 -166.73 12.68 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -31.59 71.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -1.05 . . . . 0.0 109.569 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -153.9 23.79 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.21 -0.931 . . . . 0.0 110.678 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -144.24 151.73 39.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.748 -1.22 . . . . 0.0 110.516 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.56 112.25 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -57.17 -51.88 67.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.015 . . . . 0.0 110.328 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 8.0 m120 -58.0 111.66 3.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.5 -12.42 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.596 1.531 . . . . 0.0 111.821 179.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -17.2 59.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.048 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.3 -175.79 48.26 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.81 142.07 28.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -1.2 . . . . 0.0 109.86 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -19.92 60.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -142.9 -179.05 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.389 -0.82 . . . . 0.0 109.297 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.567 ' N ' ' OE2' ' A' ' 220' ' ' GLU . 1.9 pm0 -87.17 3.42 46.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.608 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.474 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -154.04 47.57 0.62 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.818 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.561 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -58.88 -46.02 99.57 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.011 -1.055 . . . . 0.0 109.933 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 50.7 Cg_exo -52.19 -66.44 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.069 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 -35.94 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 109.568 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -59.27 -41.64 89.33 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 18.1 t60 -68.3 -32.13 72.05 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.147 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.81 -35.5 81.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.35 -37.85 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -63.33 -49.79 72.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.458 -0.776 . . . . 0.0 108.961 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -67.78 -27.82 67.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 109.755 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.1 tp -77.33 -34.03 55.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.002 -1.061 . . . . 0.0 108.359 179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.1 mt -67.95 -37.74 78.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.22 -56.06 13.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 21.8 m-20 -52.45 -38.36 59.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -1.219 . . . . 0.0 108.982 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.23 -23.47 55.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.629 -0.669 . . . . 0.0 110.48 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.603 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.83 -22.36 60.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.692 -1.255 . . . . 0.0 108.758 -179.666 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 94.0 mt -52.71 -0.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.635 -1.291 . . . . 0.0 110.356 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.9 mt -77.96 -14.48 59.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.799 -1.188 . . . . 0.0 109.756 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.39 -1.53 55.97 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.844 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.05 156.7 9.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.742 -1.446 . . . . 0.0 109.174 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.75 150.23 9.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.852 1.701 . . . . 0.0 109.518 178.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.42 149.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.999 -1.063 . . . . 0.0 112.115 -177.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -129.77 123.55 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . 0.533 ' C ' ' HG ' ' A' ' 144' ' ' SER . . . 157.58 -160.86 30.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.14 46.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -1.085 . . . . 0.0 108.76 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -133.1 138.22 46.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 110.145 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -123.55 129.72 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 t -123.83 136.24 54.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.378 -177.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.36 111.47 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 50.0 45.05 25.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.17 -0.957 . . . . 0.0 108.465 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.78 141.73 17.33 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -115.8 178.75 17.74 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 52.0 m-70 -59.33 -39.14 82.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.137 -1.213 . . . . 0.0 109.595 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -54.74 -58.79 6.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.224 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.65 ' CD1' ' HZ3' ' A' ' 258' ' ' LYS . 11.8 tp -56.69 -45.7 81.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.563 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.5 m-20 -47.46 -54.76 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 109.634 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.89 -50.71 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . 0.65 ' HZ3' ' CD1' ' A' ' 255' ' ' LEU . 22.2 ttmt -50.49 -52.35 39.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.978 -1.076 . . . . 0.0 108.963 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.5 tp -50.4 -50.85 50.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.27 -52.94 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.09 -50.16 29.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.148 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.48 -49.32 77.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.1 mt -56.12 -52.47 64.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -26.29 67.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.79 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.935 . . . . 0.0 110.072 -179.442 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.371 0.605 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 94.6 mt-10 -57.67 137.83 56.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 146.98 47.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.49 -0.756 . . . . 0.0 109.996 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -141.16 -171.7 3.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.64 135.35 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.036 -1.04 . . . . 0.0 109.269 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.07 -20.75 65.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.16 160.66 40.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 139.11 57.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 109.869 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -117.44 163.01 17.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.17 141.02 48.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 26' ' ' LEU . 99.0 m-85 -139.56 147.72 41.56 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.93 151.84 22.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.839 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.14 173.95 36.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.56 149.25 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -1.039 . . . . 0.0 110.108 -179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 140.09 16.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 tt -58.91 -39.15 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.126 -1.22 . . . . 0.0 110.327 -179.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.404 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 78.3 m-70 -90.21 -50.38 6.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.718 -1.239 . . . . 0.0 111.168 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -66.6 -23.93 66.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.762 . . . . 0.0 111.242 -178.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.69 16.71 17.85 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -112.56 157.93 20.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -1.012 . . . . 0.0 109.401 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.82 134.7 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -136.34 145.29 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.57 157.62 20.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.978 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.3 mt -138.59 145.02 40.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.491 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.493 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -140.56 108.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 108.416 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -92.28 115.24 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 0.0 110.621 -178.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.493 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 47.5 m-70 -108.67 139.77 21.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 0.0 109.393 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -52.57 168.34 0.46 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.828 1.686 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -142.84 174.56 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.668 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.7 mttt -82.05 149.38 28.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -47.05 149.03 0.98 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.15 -0.969 . . . . 0.0 109.821 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 66.66 4.01 23.62 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.75 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.8 m -67.53 -41.69 83.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.774 -1.427 . . . . 0.0 109.238 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.67 -179.91 34.58 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.398 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 37' ' ' ILE . 24.4 mm -98.92 116.5 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -139.62 155.31 47.51 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.772 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -103.58 156.8 17.5 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -128.69 111.8 13.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.0 108.657 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -135.66 134.35 39.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.699 -178.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 42' ' ' ASN . 1.0 OUTLIER 53.74 28.31 8.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 111.362 178.455 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.05 18.23 75.16 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.074 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.56 122.99 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.415 -1.05 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -84.39 128.26 34.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.111 -0.993 . . . . 0.0 109.466 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.7 mt -118.13 91.09 39.37 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.36 152.24 8.75 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.519 2.146 . . . . 0.0 111.826 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 67.4 9.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -121.55 161.86 21.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.83 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.1 p-80 -65.17 -51.6 60.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -43.44 -16.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 110.879 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.1 m-85 -98.56 0.58 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.867 -1.145 . . . . 0.0 110.105 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.98 131.0 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.63 -30.27 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 110.35 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -151.75 133.3 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.952 -1.093 . . . . 0.0 109.992 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.2 p -123.29 95.51 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 59' ' ' SER . 13.9 t-20 -163.03 129.1 3.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.972 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 80.7 m-70 50.83 8.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.065 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.571 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.19 144.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.754 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m -87.09 127.18 35.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 109.18 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.78 150.33 42.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.81 0.814 . . . . 0.0 111.046 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mt -126.27 149.71 48.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.23 151.91 23.04 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.193 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -158.04 144.13 17.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -1.092 . . . . 0.0 109.215 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.86 22.04 2.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 109.839 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.14 -33.37 6.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -57.55 141.56 47.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.241 . . . . 0.0 109.153 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -133.89 134.3 42.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.486 -0.758 . . . . 0.0 110.336 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.8 mt -127.05 122.02 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -102.78 156.17 17.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.0 -1.063 . . . . 0.0 111.357 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.1 m 50.31 73.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.11 -9.22 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.21 -26.2 67.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.537 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.66 -69.02 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -52.64 -48.02 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.054 -1.029 . . . . 0.0 109.107 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.1 mt -51.76 -49.19 63.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.0 109.93 -179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 t -60.95 -42.5 98.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.82 -44.87 79.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 108.823 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -67.74 -34.44 76.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -61.92 -36.81 82.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 108.872 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.1 mt -78.86 -38.14 38.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt -80.45 -0.52 37.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 55.0 40.37 32.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 110.922 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 84' ' ' ILE . 45.5 mm -85.82 141.77 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 69.0 p -127.23 -23.18 3.6 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.182 -0.949 . . . . 0.0 111.582 -178.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.59 ' OD1' ' N ' ' A' ' 34' ' ' GLY . 3.4 m-80 -124.33 106.53 10.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.828 -1.17 . . . . 0.0 110.164 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.9 148.27 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.625 0.726 . . . . 0.0 110.295 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.8 m -116.33 114.53 24.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mt -94.97 100.4 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.367 -179.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.55 124.72 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.39 126.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.82 0.819 . . . . 0.0 111.583 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.7 mt -111.03 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.39 -156.24 25.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -121.68 -10.68 8.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.11 149.25 42.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 0.0 109.564 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -73.43 121.33 84.86 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.042 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.71 124.03 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.76 1.64 . . . . 0.0 111.405 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 tp -81.19 -12.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mt 56.05 -116.83 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.84 8.13 45.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.012 -1.055 . . . . 0.0 110.743 -178.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.2 65.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 -172.27 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.741 -0.858 . . . . 0.0 109.339 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.96 14.58 8.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.582 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 52.3 t-105 -56.3 -42.8 78.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 3.8 mp0 -64.96 -57.32 9.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 0.0 110.171 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -51.02 -46.2 61.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.223 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.581 ' OH ' ' NH1' ' A' ' 111' ' ' ARG . 89.4 t80 -60.97 -52.35 65.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.669 -0.644 . . . . 0.0 110.884 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.582 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 4.0 mm-40 -62.03 -45.24 94.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.142 -0.974 . . . . 0.0 111.726 -178.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.1 -55.64 17.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.996 -1.065 . . . . 0.0 110.548 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.47 -32.46 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.383 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.581 ' NH1' ' OH ' ' A' ' 107' ' ' TYR . 59.1 ttt85 -63.3 -41.86 98.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.0 109.933 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.475 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 27.6 pttt -77.58 13.37 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 112' ' ' LYS . 1.7 m-80 -143.11 31.32 1.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.898 -1.126 . . . . 0.0 110.79 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.6 mt -79.07 138.79 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.759 -1.213 . . . . 0.0 109.718 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -129.24 125.32 36.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.32 143.51 35.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.573 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.92 -175.6 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 109.303 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -110.03 67.33 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.633 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.3 ttt85 -162.91 129.55 3.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 109.335 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.96 142.61 52.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.959 -1.088 . . . . 0.0 109.661 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.0 mt -88.83 151.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.651 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.42 84.88 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 70.9 m-85 -61.71 146.69 48.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.517 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -91.63 101.64 14.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -93.63 134.44 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.442 0.639 . . . . 0.0 111.058 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.7 t -73.89 112.93 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.65 -26.94 16.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.277 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.04 150.3 76.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.825 . . . . 0.0 109.278 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.5 149.35 55.78 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.432 2.088 . . . . 0.0 112.037 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.7 tt -152.41 150.65 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 108.965 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.43 141.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.38 146.73 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -135.9 159.22 42.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 109.485 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.57 108.05 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.169 -0.957 . . . . 0.0 110.161 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 48.61 52.94 12.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 110.754 178.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.4 -36.85 3.17 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.484 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.85 126.16 26.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.93 -1.335 . . . . 0.0 108.634 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.71 138.85 38.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 110.138 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.97 130.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.475 -0.766 . . . . 0.0 109.76 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.465 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 29.5 tttm -119.24 132.1 55.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.689 -0.632 . . . . 0.0 109.887 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.81 133.82 54.43 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.465 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 4.2 pt-20 -145.89 149.11 38.24 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.016 -1.053 . . . . 0.0 109.729 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.0 140.95 9.77 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.561 2.174 . . . . 0.0 113.158 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.57 142.8 20.4 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.97 -7.1 3.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.437 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.9 p -149.91 -174.62 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 109.605 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.75 123.16 42.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.137 -0.977 . . . . 0.0 108.737 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -139.28 126.99 21.92 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 108.651 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.24 123.7 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.421 -0.799 . . . . 0.0 109.864 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m -113.8 152.73 30.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.608 -0.682 . . . . 0.0 109.849 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -140.44 131.09 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.854 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 10.1 tt0 -122.47 133.75 54.59 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.99 140.76 10.66 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.482 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 97.56 7.03 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.51 167.36 21.4 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.713 . . . . 0.0 110.673 -178.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.89 25.3 9.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.507 -0.746 . . . . 0.0 111.092 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 157' ' ' ASN . 20.5 p-10 -137.19 -164.66 1.62 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.864 -1.147 . . . . 0.0 109.996 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -56.62 -4.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.429 -0.794 . . . . 0.0 110.968 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.2 mt -76.39 -27.01 56.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.59 -1.319 . . . . 0.0 108.036 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.57 -139.49 39.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.2 136.78 41.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -142.75 154.18 44.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.614 -0.679 . . . . 0.0 109.519 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 148.96 31.52 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -145.37 139.01 26.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -0.841 . . . . 0.0 109.836 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 m -107.1 123.87 48.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.474 -0.767 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -103.17 109.04 20.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.415 ' H ' HD21 ' A' ' 170' ' ' ASN . 2.4 t -100.35 150.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 109.676 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -49.5 128.21 16.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 108.787 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . 0.463 ' N ' ' OE1' ' A' ' 171' ' ' GLU . . . 106.31 0.97 38.06 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.55 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 91.4 m-20 -116.62 20.75 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 109.022 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 170' ' ' ASN . 1.1 pm0 -55.62 -49.08 73.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.396 -0.815 . . . . 0.0 110.205 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -50.27 -22.22 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 110.46 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.71 -7.13 58.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.002 -1.061 . . . . 0.0 111.899 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.5 pt -125.51 -28.16 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.84 -1.163 . . . . 0.0 111.247 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.62 -17.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.593 -1.317 . . . . 0.0 109.022 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.56 -4.03 55.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.45 -0.781 . . . . 0.0 108.945 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.465 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.29 115.82 8.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.86 . . . . 0.0 108.937 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.525 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 88.5 mtm180 -78.59 172.7 13.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.232 -0.918 . . . . 0.0 109.264 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.6 t -79.36 163.3 24.96 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -147.85 148.78 31.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.141 -1.599 . . . . 0.0 111.666 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -145.65 156.7 43.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.402 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 80.3 m-85 -99.75 144.37 28.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.041 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.444 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.35 -36.04 5.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 110.169 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -75.55 -29.27 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.906 -1.121 . . . . 0.0 110.387 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.7 tt0 -75.23 -29.0 60.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.3 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.9 -47.75 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.297 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.29 -41.56 19.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . 0.42 ' CE1' ' CG1' ' A' ' 192' ' ' VAL . 8.6 t60 -74.82 -52.18 12.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 43.1 mt -48.5 -29.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -85.13 -53.54 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.792 -1.192 . . . . 0.0 109.737 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -49.81 -34.76 20.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.385 -179.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.42 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 15.9 m -85.51 8.87 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.895 -1.128 . . . . 0.0 110.36 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.4 39.71 56.38 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.63 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 46.3 mt -128.47 171.12 12.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -1.177 . . . . 0.0 109.835 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.19 23.22 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -57.92 -19.65 31.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.598 -1.531 . . . . 0.0 110.031 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.38 3.47 34.85 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.58 125.46 35.41 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.082 -1.246 . . . . 0.0 110.466 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.7 p -147.61 165.24 31.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.373 -1.075 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 24.0 mt -67.85 -8.2 34.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -96.36 -11.91 25.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.793 -0.567 . . . . 0.0 109.702 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.512 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 8.5 p-10 -137.93 8.89 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.046 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -147.57 149.08 31.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.071 -1.018 . . . . 0.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.1 tp -99.58 93.79 6.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.22 131.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.86 0.838 . . . . 0.0 109.109 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.23 165.82 16.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.22 -166.38 11.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -58.56 -36.16 73.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -1.072 . . . . 0.0 109.604 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.62 25.44 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.693 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.59 148.92 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.872 -1.142 . . . . 0.0 110.537 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.24 110.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.52 -46.85 73.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.11 -0.993 . . . . 0.0 109.516 -178.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -66.57 117.42 44.17 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.03 -11.13 29.75 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.362 1.375 . . . . 0.0 111.37 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.55 -17.77 61.69 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.376 -0.827 . . . . 0.0 109.031 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.57 -177.73 46.37 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.6 mt -86.58 136.94 32.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -1.227 . . . . 0.0 109.644 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -20.29 65.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.3 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . 0.467 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.8 m-85 -138.31 -164.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.203 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -97.63 -17.02 19.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -138.5 48.52 1.93 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -53.11 -48.29 92.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 109.806 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.1 Cg_exo -48.24 -67.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.14 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.2 m -59.59 -36.61 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 93.2 mtt180 -60.84 -40.52 93.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.975 -1.078 . . . . 0.0 108.411 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 13.8 t60 -67.6 -30.87 70.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.251 -0.906 . . . . 0.0 108.732 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -66.11 -36.86 84.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.4 -37.97 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -63.24 -53.68 49.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.52 -0.737 . . . . 0.0 109.067 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.41 -28.77 70.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 33.1 tp -76.76 -34.29 58.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.988 -1.07 . . . . 0.0 108.565 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.6 mt -65.29 -38.33 82.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.36 -56.81 10.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.431 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 46.0 m-20 -53.11 -30.95 39.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.203 . . . . 0.0 109.191 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.17 -23.61 67.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 110.339 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.63 -22.37 60.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.744 -1.223 . . . . 0.0 108.96 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -49.76 -5.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.373 -1.454 . . . . 0.0 109.974 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -74.51 -15.85 60.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.42 0.31 61.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.293 178.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -167.14 146.95 4.66 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.557 -1.554 . . . . 0.0 110.007 179.471 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.468 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 58.7 Cg_exo -34.66 147.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.699 2.266 . . . . 0.0 111.339 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 83.1 t -115.03 147.76 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.603 -178.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -131.77 124.03 28.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.68 174.99 23.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 13.9 tttt -103.89 142.2 34.82 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.8 m-85 -137.41 138.93 40.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.216 -0.927 . . . . 0.0 109.761 -179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 59.7 t80 -125.69 128.26 47.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -124.7 136.23 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 -177.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -118.96 113.91 21.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 55.13 18.89 2.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.353 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.32 155.41 17.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.65 176.36 20.66 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.5 m-70 -58.9 -37.7 77.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.251 . . . . 0.0 109.534 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -58.27 9.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.319 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.94 -43.24 98.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 18.4 m-20 -47.57 -54.07 12.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 109.417 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.4 -46.38 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.596 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -54.27 -52.08 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.013 -1.054 . . . . 0.0 108.961 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.8 tp -50.65 -58.49 5.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.0 t -49.27 -52.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.196 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -49.18 -49.19 43.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.761 . . . . 0.0 109.704 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -61.83 -48.2 81.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 109.699 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.0 -47.97 79.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.01 -29.72 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 110.08 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 -179.603 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 mt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 26.6 mt-10 -53.18 135.19 38.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.173 -0.954 . . . . 0.0 108.783 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 144.55 46.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.618 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -141.86 -169.78 2.99 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.83 137.33 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.324 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.35 -27.96 68.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.695 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.42 158.19 43.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.812 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 141.1 58.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -120.39 165.18 15.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.64 143.11 43.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 110.177 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.0 m-85 -139.82 150.73 45.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -158.65 151.57 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 0.0 109.999 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.85 174.06 36.45 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.73 149.01 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.431 -1.041 . . . . 0.0 110.256 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.46 137.86 16.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 tt -59.2 -38.15 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.243 . . . . 0.0 110.272 -179.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.426 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 85.2 m-70 -89.8 -50.63 5.94 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.724 -1.235 . . . . 0.0 111.376 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 p -69.03 -21.62 64.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 111.547 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.56 19.2 26.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -112.41 155.46 24.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.523 -0.987 . . . . 0.0 109.569 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -76.53 134.45 39.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 m -138.36 146.12 41.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.726 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 3.4 ttpp -112.6 157.79 20.77 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.41 -0.806 . . . . 0.0 109.923 -179.347 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.4 mt -136.86 145.14 44.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.457 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -138.74 115.85 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.02 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.62 114.38 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.873 . . . . 0.0 110.994 -178.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.457 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 50.7 m-70 -109.58 138.16 20.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 109.808 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.0 Cg_exo -51.99 168.38 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.942 1.761 . . . . 0.0 111.399 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 30' ' ' PRO . 15.1 mm-40 -142.91 168.97 18.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 110.131 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 1.6 mttp -76.82 150.76 36.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.464 -0.773 . . . . 0.0 109.72 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -46.92 146.16 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.867 . . . . 0.0 110.209 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.74 6.04 48.7 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.955 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.536 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 28.5 m -68.66 -43.29 76.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.597 -1.531 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.97 178.2 36.25 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.3 mm -96.07 117.23 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.72 149.83 42.67 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.603 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -100.18 158.26 15.98 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -129.61 112.27 13.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 108.624 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -135.64 132.88 37.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.463 -0.773 . . . . 0.0 110.5 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 42' ' ' ASN . 2.8 m120 53.16 31.24 11.09 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 0.0 111.639 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.3 17.8 78.94 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.153 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.6 121.75 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -1.015 . . . . 0.0 109.19 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.6 m-85 -84.19 128.51 34.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mt -117.61 92.64 41.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.26 145.75 14.64 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.462 2.108 . . . . 0.0 111.984 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.99 71.41 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 6.0 mmt85 -126.23 172.43 10.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.5 p-80 -73.64 -48.67 30.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 110.195 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -43.6 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 0.0 111.25 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 37.4 m-85 -96.92 1.78 50.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.725 -1.234 . . . . 0.0 110.105 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.66 123.59 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.043 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 m -106.55 -29.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 109.979 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -154.11 132.49 11.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.049 -1.032 . . . . 0.0 109.805 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.3 p -123.6 95.23 4.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 45.6 t-20 -163.66 129.01 3.0 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.395 -0.815 . . . . 0.0 108.894 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 71.4 m-70 47.76 11.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.065 -1.022 . . . . 0.0 108.973 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.36 141.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.872 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.42 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 34.2 m -90.36 127.76 36.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 109.131 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.71 152.82 38.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.413 -0.805 . . . . 0.0 111.067 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt -128.44 149.01 50.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.76 156.77 28.76 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 118.886 -1.626 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -163.82 151.47 12.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.026 . . . . 0.0 108.849 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 52.53 23.85 2.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.971 . . . . 0.0 109.375 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.96 -31.25 7.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -58.3 145.94 36.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -1.17 . . . . 0.0 108.827 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -145.28 140.04 27.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 110.693 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.26 123.08 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 12.8 mtpp -101.43 158.47 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.074 -1.016 . . . . 0.0 111.408 -177.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 m 48.45 72.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.253 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -107.16 -9.4 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.174 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -60.47 -25.33 65.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 110.025 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.6 m170 -67.33 -68.48 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 109.181 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.14 -47.18 44.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 109.192 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.67 -47.57 67.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.948 -1.095 . . . . 0.0 110.1 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.1 t -61.65 -43.53 98.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.943 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.19 -44.75 80.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.14 -35.25 77.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.284 -0.885 . . . . 0.0 109.208 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -62.39 -33.76 75.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.883 . . . . 0.0 109.269 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.3 mt -82.13 -38.37 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.5 mt -80.74 4.18 19.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 54.22 39.11 30.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.07 139.38 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.63 ' HG1' HD21 ' A' ' 86' ' ' ASN . 56.6 p -126.02 -20.57 4.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.151 -0.968 . . . . 0.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.63 HD21 ' HG1' ' A' ' 85' ' ' THR . 1.1 m-80 -128.5 108.25 10.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.884 -1.135 . . . . 0.0 111.0 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 12.7 m -162.76 147.17 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 178.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 17.5 m -112.76 113.74 25.98 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -97.7 101.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 110.648 -178.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.93 124.26 25.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -104.94 129.42 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.87 0.843 . . . . 0.0 111.836 -177.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 33.3 mm -111.7 91.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.7 163.6 10.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -84.51 -3.36 58.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.321 . . . . 0.0 110.852 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -140.01 147.09 39.89 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.836 -1.165 . . . . 0.0 110.214 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.0 mm -74.35 122.2 86.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 109.02 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -41.4 127.17 3.09 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.762 1.641 . . . . 0.0 111.394 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -80.18 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.274 -179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.9 mt 58.74 -122.67 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.067 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -95.07 8.3 43.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.926 . . . . 0.0 110.464 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.85 -3.63 65.16 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.119 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.45 -172.44 2.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.792 -0.828 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.06 14.3 10.38 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.549 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 4.7 t-105 -56.98 -42.15 79.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.18 -57.83 7.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.097 -1.002 . . . . 0.0 110.261 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.43 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.45 -45.93 62.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.356 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.22 -53.93 50.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.665 . . . . 0.0 110.905 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 1.5 mm-40 -60.99 -43.54 98.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 111.473 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -54.74 20.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.013 -1.054 . . . . 0.0 110.449 -179.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.6 mt -66.43 -32.83 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 109.645 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 113' ' ' ASN . 5.5 ttt180 -63.61 -42.45 98.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -77.06 15.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.654 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 111' ' ' ARG . 7.0 m-80 -146.31 31.18 1.01 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.659 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.9 mt -79.29 138.86 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.776 -1.202 . . . . 0.0 110.328 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.05 120.87 25.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.435 -0.791 . . . . 0.0 109.058 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 142.41 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 0.0 110.148 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -110.37 -170.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 109.48 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.516 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.3 OUTLIER -111.53 67.84 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.232 -0.918 . . . . 0.0 110.588 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -164.01 128.7 2.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.044 -1.035 . . . . 0.0 109.314 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.92 142.59 54.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mt -86.79 151.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.841 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.03 79.99 3.27 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -58.08 143.41 43.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.557 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -90.08 101.67 14.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.45 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.639 -0.663 . . . . 0.0 110.902 -177.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.12 117.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -97.99 -26.73 14.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.456 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.59 149.66 74.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 149.1 56.48 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.41 2.073 . . . . 0.0 112.096 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 tt -153.09 149.75 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.03 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.22 143.46 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.94 147.61 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -134.44 161.52 34.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.076 -1.015 . . . . 0.0 110.181 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -168.65 101.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.357 -0.839 . . . . 0.0 109.804 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 47.32 62.54 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.528 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.86 -37.29 3.09 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.578 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -61.03 137.72 58.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.888 -1.36 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -146.96 136.78 23.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.935 -1.103 . . . . 0.0 110.082 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 92.9 mt -136.13 134.48 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.455 -0.778 . . . . 0.0 109.46 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 tttp -124.16 131.63 53.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.504 0.669 . . . . 0.0 109.957 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 137.39 54.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.96 155.86 40.59 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.091 -1.006 . . . . 0.0 109.765 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -50.53 142.21 31.43 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.496 2.131 . . . . 0.0 113.421 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -156.69 139.38 15.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.91 -5.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 0.0 110.462 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 p -154.18 -177.54 6.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.884 -1.135 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.64 120.55 34.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.0 -1.062 . . . . 0.0 109.341 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.49 115.7 14.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.94 121.81 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.4 m -112.82 152.22 29.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.714 -0.616 . . . . 0.0 109.452 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -139.6 131.06 26.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.138 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -121.47 130.52 53.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.25 139.11 10.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.682 -1.246 . . . . 0.0 111.556 -178.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -104.33 101.9 11.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -88.46 167.42 13.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.852 -178.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -100.69 -12.86 18.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 159' ' ' LEU . 39.9 p-10 -97.77 -170.8 2.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.979 -1.076 . . . . 0.0 110.355 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -52.86 0.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.492 -0.755 . . . . 0.0 112.019 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.545 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 28.5 mt -81.87 -28.03 33.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.241 -1.537 . . . . 0.0 108.772 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.16 -136.97 41.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -97.48 130.69 44.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 109.791 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -132.96 142.91 49.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.4 pttm -138.09 144.03 40.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.406 -0.809 . . . . 0.0 109.826 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' PHE . . . . . 0.508 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 61.0 t80 -144.99 138.02 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 59.8 m -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.419 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 8.2 t80 -102.8 110.91 23.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.99 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.06 152.14 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.836 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -49.51 124.24 9.07 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.336 -0.853 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 0.75 31.08 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -116.93 21.66 13.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.195 -1.179 . . . . 0.0 109.268 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -55.44 -52.74 62.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 109.942 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.585 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.8 mt-10 -44.54 -22.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 0.0 110.11 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 171' ' ' GLU . 42.0 mt-10 -86.15 -8.95 57.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 111.753 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.5 pt -123.73 -29.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.801 -1.187 . . . . 0.0 111.225 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.41 -20.75 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.586 -1.321 . . . . 0.0 109.025 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.31 -1.79 57.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.49 120.44 16.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.031 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.444 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 83.6 mtm180 -84.45 172.6 11.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.487 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 163.37 25.06 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -148.7 146.01 27.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.303 -1.498 . . . . 0.0 111.628 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.25 157.76 44.11 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 79.5 m-85 -99.19 147.54 25.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.076 -1.015 . . . . 0.0 109.389 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 2.3 p30 -53.27 -33.2 52.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 109.686 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' TRP . . . . . 0.501 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.5 p90 -73.53 -26.36 60.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.906 -1.121 . . . . 0.0 109.55 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.8 mm-40 -77.82 -40.65 39.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.953 . . . . 0.0 109.698 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 76.4 mt -45.69 -51.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.136 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -42.65 -45.16 4.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -77.1 -50.93 11.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 109.71 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.5 mt -47.37 -32.24 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -85.04 -52.7 5.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.69 -1.256 . . . . 0.0 108.744 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -50.65 -32.16 18.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.331 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 m -86.62 6.27 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.941 -1.1 . . . . 0.0 110.116 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.49 37.55 40.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.71 171.85 11.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -1.11 . . . . 0.0 109.798 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.55 22.38 52.11 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.78 -19.42 16.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.661 -1.494 . . . . 0.0 110.521 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.27 5.55 28.49 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.36 125.15 26.18 Favored Glycine 0 N--CA 1.491 2.337 0 O-C-N 121.052 -1.263 . . . . 0.0 110.571 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' SER . . . . . 0.455 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -147.04 169.46 19.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.562 -0.964 . . . . 0.0 109.421 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 35.2 mt -67.97 -8.36 36.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -93.09 -13.05 29.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 23.8 p30 -139.64 10.72 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.041 -1.037 . . . . 0.0 110.33 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -148.06 148.49 30.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.911 -1.118 . . . . 0.0 110.49 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.69 93.41 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.1 t -85.88 129.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.4 mt -124.1 164.18 19.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.635 -0.665 . . . . 0.0 109.625 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.25 -166.24 12.55 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -23.25 65.8 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.639 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -157.02 21.77 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.042 -1.036 . . . . 0.0 111.255 -179.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -147.37 156.04 42.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.529 -1.357 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.87 112.79 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -59.21 -51.16 71.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 110.58 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -59.6 112.71 5.66 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -58.05 -11.07 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.704 1.603 . . . . 0.0 112.162 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -19.03 59.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.237 -179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.42 -178.04 50.37 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.8 mt -87.88 131.53 34.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -1.126 . . . . 0.0 109.73 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -61.14 -20.97 63.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.833 . . . . 0.0 108.875 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -143.43 -173.31 3.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.49 -0.757 . . . . 0.0 109.246 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.05 -16.84 30.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' ASN . . . . . 0.729 HD21 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -134.55 46.25 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.303 -179.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.73 -47.11 99.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.751 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 60.2 Cg_exo -50.42 -66.3 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.511 2.141 . . . . 0.0 112.177 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.04 -35.62 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 109.636 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . 0.729 ' HE ' HD21 ' A' ' 221' ' ' ASN . 60.8 mtt-85 -60.91 -40.62 93.85 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.6 t60 -67.89 -31.99 72.17 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.561 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -65.03 -36.0 82.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.54 -34.52 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.2 t80 -66.14 -52.49 47.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.44 -27.76 68.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.776 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.2 tp -77.76 -33.99 52.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.107 -0.995 . . . . 0.0 108.591 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.9 mt -67.65 -38.11 79.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -55.37 15.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' ASP . . . . . 0.432 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 9.7 m-20 -55.24 -36.82 66.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.293 . . . . 0.0 109.114 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.27 -24.92 67.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.514 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' TYR . . . . . 0.6 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -73.95 -21.5 60.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.825 -1.172 . . . . 0.0 109.376 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 93.2 mt -49.16 -4.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.572 -1.33 . . . . 0.0 110.501 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 236' ' ' TYR . 11.1 mt -74.09 -14.36 60.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 109.998 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.402 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 96.53 3.19 59.84 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.989 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.59 152.18 11.76 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.489 . . . . 0.0 109.06 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.33 129.36 34.25 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.706 1.604 . . . . 0.0 109.668 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -89.39 151.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.033 -1.042 . . . . 0.0 112.435 -176.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.64 126.65 31.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.77 -165.55 32.61 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.631 ' N ' ' OG ' ' A' ' 144' ' ' SER . 11.9 tptm -124.55 133.71 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -1.092 . . . . 0.0 108.639 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.2 m-85 -132.25 138.05 47.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -125.77 118.21 25.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -112.49 135.31 53.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 111.023 -178.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -117.36 107.73 14.72 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 54.39 31.02 13.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.77 157.56 52.62 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.97 -179.91 16.48 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 54.6 m-70 -60.06 -40.15 88.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -58.88 6.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 tp -56.68 -44.77 81.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.025 . . . . 0.0 109.283 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 256' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 19.9 m-20 -47.64 -52.09 19.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.933 -1.104 . . . . 0.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 81.4 t -61.54 -45.24 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.07 -49.2 77.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -54.61 -51.2 66.09 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.972 . . . . 0.0 108.779 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 11.5 t -57.87 -54.37 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.896 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -48.67 -45.53 38.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.678 . . . . 0.0 109.517 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.02 -51.68 63.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.862 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.88 -46.86 71.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.908 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.84 66.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 110.41 -179.274 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.79 149.86 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.16 139.71 34.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 108.54 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.495 ' HZ3' ' CB ' ' A' ' 116' ' ' ASN . 7.4 mptt -123.26 145.9 48.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -0.853 . . . . 0.0 110.217 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 t -143.2 -169.76 3.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.3 m -100.51 137.94 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.915 -1.115 . . . . 0.0 109.092 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.683 ' HZ2' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -68.33 -19.42 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.972 . . . . 0.0 109.954 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.5 OUTLIER -152.72 157.47 40.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.08 -1.013 . . . . 0.0 109.705 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 138.67 58.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.161 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.46 166.44 13.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.54 144.3 34.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.898 -1.126 . . . . 0.0 110.396 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 81.2 m-85 -138.23 152.08 48.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 6.8 pt-20 -158.99 150.06 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.956 -1.09 . . . . 0.0 110.146 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.33 174.79 36.76 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.2 151.05 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -1.09 . . . . 0.0 110.058 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.61 140.27 16.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 tt -59.22 -38.88 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 110.321 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.415 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 72.2 m-70 -88.75 -50.1 6.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.629 -1.294 . . . . 0.0 111.183 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 -25.06 64.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 111.819 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.88 14.41 23.28 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.319 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -110.32 157.67 19.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.464 -1.021 . . . . 0.0 109.564 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 77.7 t80 -76.02 135.17 39.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -137.27 143.22 42.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.317 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -112.52 156.93 21.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.417 -0.802 . . . . 0.0 109.952 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.5 mt -136.05 146.42 47.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.52 -0.738 . . . . 0.0 109.82 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.59 106.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 108.691 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -91.64 114.83 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.0 110.979 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -108.79 137.03 19.95 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.523 -0.736 . . . . 0.0 109.544 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -52.27 168.41 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.941 1.761 . . . . 0.0 111.993 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -141.95 173.68 11.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.577 ' N ' ' HG1' ' A' ' 35' ' ' THR . 5.6 mttt -83.51 154.29 23.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.96 147.57 3.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.102 -0.999 . . . . 0.0 109.783 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 70.31 0.19 28.26 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.819 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.671 ' N ' HD21 ' A' ' 86' ' ' ASN . 53.8 m -66.03 -44.7 83.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.565 -1.55 . . . . 0.0 109.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.603 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 99.34 178.81 31.36 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.743 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -98.96 117.79 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -144.33 155.96 44.04 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.12 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -101.89 158.7 15.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -128.56 111.45 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 0.0 108.718 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.453 ' HZ2' ' ND2' ' A' ' 42' ' ' ASN . 20.8 tttp -135.62 132.6 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.511 ' N ' HD21 ' A' ' 42' ' ' ASN . 2.0 m120 55.09 28.25 10.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 111.334 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.85 19.42 73.03 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.773 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.15 121.13 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.537 -0.978 . . . . 0.0 109.217 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 46.2 m-85 -83.1 127.58 33.71 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -0.904 . . . . 0.0 109.05 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.44 90.75 35.74 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.625 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.02 148.78 6.41 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.497 2.131 . . . . 0.0 112.075 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.68 70.23 10.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -122.76 170.36 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.49 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.566 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p-80 -72.35 -51.67 19.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.363 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -43.59 -16.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.41 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.5 m-85 -96.47 -0.34 49.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.906 -1.121 . . . . 0.0 110.142 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.3 t -68.46 130.75 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 108.72 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.2 -30.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.415 ' HD1' ' N ' ' A' ' 56' ' ' THR . 2.0 t-80 -147.18 127.0 13.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.968 -1.082 . . . . 0.0 109.608 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.415 ' N ' ' HD1' ' A' ' 55' ' ' HIS . 38.6 p -120.56 96.23 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 59' ' ' SER . 8.7 t-20 -160.35 129.01 4.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.036 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.9 m-70 48.94 11.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 108.928 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.567 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.52 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.75 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.4 m -86.81 128.03 35.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 109.293 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.06 147.18 45.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.655 0.74 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mt -121.92 149.55 43.26 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.74 156.49 28.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -163.52 150.88 12.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -1.102 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 50.1 21.64 0.79 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.299 -0.876 . . . . 0.0 109.399 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.85 -34.0 6.12 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.489 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 76.5 mm-40 -59.04 149.42 27.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.283 . . . . 0.0 109.656 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -143.87 137.61 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 110.809 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 69' ' ' ILE . 71.5 mt -129.25 124.8 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -102.21 157.82 16.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.073 . . . . 0.0 111.461 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.1 m 50.0 73.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.62 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.1 m -107.34 -9.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 0.0 108.804 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.4 pm0 -61.2 -26.24 67.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.558 -0.714 . . . . 0.0 110.472 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.413 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.3 m170 -69.1 -68.12 0.42 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.966 -1.084 . . . . 0.0 109.312 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.27 -48.83 43.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.294 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.3 mt -54.16 -46.39 72.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.022 -1.049 . . . . 0.0 110.184 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.4 t -60.72 -42.25 96.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.016 -1.053 . . . . 0.0 109.889 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.77 -44.98 87.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.024 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.9 -34.79 78.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.282 -0.886 . . . . 0.0 109.119 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.458 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 5.1 t-160 -62.31 -38.12 88.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.495 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 58.7 mt -77.11 -38.0 53.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.695 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.51 -0.79 51.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 109.703 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 5.3 mp0 56.6 43.22 25.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.814 . . . . 0.0 111.506 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 33.4 mm -87.06 144.86 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.81 -1.182 . . . . 0.0 107.952 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.6 p -130.0 -22.01 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.086 -1.009 . . . . 0.0 111.995 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.671 HD21 ' N ' ' A' ' 35' ' ' THR . 13.8 m120 -127.72 107.2 9.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.191 . . . . 0.0 110.607 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.4 m -166.01 152.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.512 0.672 . . . . 0.0 109.861 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.8 m -116.57 113.11 22.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -94.89 100.56 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -75.33 126.74 31.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.42 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.8 t -110.28 127.31 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.899 0.856 . . . . 0.0 111.913 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 92' ' ' ILE . 17.7 mm -109.34 96.88 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.55 -155.14 24.0 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 -8.36 8.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.183 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -141.82 149.64 40.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 109.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.9 mm -74.11 121.81 86.08 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.969 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -41.17 127.9 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.774 1.649 . . . . 0.0 111.366 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.6 tp -79.42 -11.88 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.516 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 70.7 mt 56.07 -121.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.052 -1.03 . . . . 0.0 109.6 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.33 9.14 43.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.001 -1.062 . . . . 0.0 111.056 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.54 -3.47 61.28 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.249 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -128.66 -171.95 2.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.887 . . . . 0.0 109.537 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.34 15.6 10.76 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 15.7 t-105 -58.78 -42.43 89.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -1.131 . . . . 0.0 110.493 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.03 -58.04 7.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 7.9 m-85 -51.15 -45.65 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.351 -0.843 . . . . 0.0 109.633 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -60.52 -48.97 79.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.623 -0.673 . . . . 0.0 110.974 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -67.34 -42.6 83.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.087 -1.008 . . . . 0.0 111.701 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.36 -50.36 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 110.395 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.31 -31.92 51.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.989 -1.069 . . . . 0.0 109.291 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -62.96 -42.1 99.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.0 pttp -77.64 12.74 1.52 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.571 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 3.9 m-80 -143.86 31.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.883 -1.136 . . . . 0.0 110.457 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.683 ' N ' ' HZ2' ' A' ' 8' ' ' LYS . 84.0 mt -79.62 141.3 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.957 -1.089 . . . . 0.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.0 tp -129.92 122.46 28.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.711 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -79.23 141.53 37.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.145 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -110.17 -174.59 2.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.504 -0.748 . . . . 0.0 109.595 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.23 68.84 0.68 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 110.678 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -167.16 130.38 1.79 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.91 143.81 55.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 55.2 mt -86.22 149.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.11 78.13 5.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -58.65 142.72 48.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 110.041 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -89.44 101.59 14.26 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.8 t -93.88 134.16 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.461 0.648 . . . . 0.0 111.061 -177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.57 111.91 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.437 ' C ' ' OE1' ' A' ' 128' ' ' GLU . 81.3 mt-10 -90.35 -27.66 19.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -134.21 154.75 80.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.497 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.76 148.11 45.98 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.551 2.167 . . . . 0.0 112.199 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 tt -152.0 149.05 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mp -140.3 143.37 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 109.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.38 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -133.05 159.63 39.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.15 -0.969 . . . . 0.0 110.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -175.44 105.94 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 52.11 54.95 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -0.813 . . . . 0.0 110.715 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.19 -31.18 3.19 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.109 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.4 HH11 ' HG3' ' A' ' 137' ' ' ARG . 44.4 mtt85 -63.09 135.39 57.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.267 . . . . 0.0 108.52 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.48 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.1 tt -146.03 136.61 24.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.897 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.41 121.64 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.229 -0.919 . . . . 0.0 109.207 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -112.16 131.82 55.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.487 0.66 . . . . 0.0 109.98 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.15 138.47 54.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.83 153.42 33.45 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 109.524 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -49.19 142.38 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.401 2.067 . . . . 0.0 113.49 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.5 t -154.15 142.44 20.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.422 ' O ' ' CG2' ' A' ' 146' ' ' THR . 55.8 m-20 -60.59 -4.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.314 -0.866 . . . . 0.0 110.726 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 145' ' ' ASP . 17.4 p -157.96 -171.07 3.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.872 -1.143 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.98 120.57 34.41 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.118 -0.989 . . . . 0.0 109.018 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -136.77 113.01 9.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.36 122.0 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.9 m -112.91 152.31 29.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.96 131.61 27.26 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.938 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.28 140.26 52.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.64 138.67 8.27 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.969 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.36 99.29 9.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -84.42 167.22 16.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.853 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -100.67 -12.07 19.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 159' ' ' LEU . 35.9 p-10 -102.69 -172.63 2.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.934 -1.104 . . . . 0.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -49.18 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.466 -0.771 . . . . 0.0 111.532 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 157' ' ' ASN . 18.3 mt -77.31 -27.19 52.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.379 -1.45 . . . . 0.0 108.311 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.46 -139.18 31.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -97.36 134.07 41.12 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.169 -1.194 . . . . 0.0 109.513 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -141.23 152.86 44.92 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 152.76 32.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.214 -0.929 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 53.8 t80 -148.53 146.53 28.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -110.3 124.57 51.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.516 -0.74 . . . . 0.0 110.468 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.888 . . . . 0.0 110.012 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 t -109.75 156.26 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -50.65 123.37 8.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.973 . . . . 0.0 109.19 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.475 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 103.92 5.95 43.64 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.453 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 82.8 m-20 -119.75 19.03 12.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.367 -1.078 . . . . 0.0 109.212 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.5 ' C ' ' H ' ' A' ' 173' ' ' GLU . 1.9 pm0 -59.8 -43.9 94.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.419 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 9.4 mt-10 -53.89 -6.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 110.021 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 171' ' ' GLU . 89.3 mt-10 -104.8 -8.96 18.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.348 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 pt -123.85 -27.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.231 -0.918 . . . . 0.0 110.575 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.18 -29.23 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.795 -1.191 . . . . 0.0 108.611 179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.58 -7.53 56.48 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.447 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.28 119.15 12.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.314 -0.866 . . . . 0.0 109.172 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.511 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 72.8 mtm180 -83.25 172.29 12.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.914 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.472 ' HG1' HN17 ' A' ' 501' ' ' C90 . 8.3 t -77.06 162.37 27.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -147.65 145.17 28.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.302 -1.499 . . . . 0.0 111.333 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.16 45.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.54 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.6 m-85 -98.72 142.28 30.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 0.0 109.514 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.15 -37.66 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.314 -0.866 . . . . 0.0 109.748 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.0 -27.25 63.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.472 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 7.1 mt-10 -78.61 -40.07 35.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 185' ' ' GLU . 13.2 mt -43.22 -54.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 186' ' ' ILE . 1.0 OUTLIER -43.21 -43.12 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.942 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -74.27 -50.08 20.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 0.0 109.598 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 56.0 mt -52.08 -28.97 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -85.3 -53.32 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.74 -1.225 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -51.77 -33.68 36.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.6 m -83.07 7.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 0.0 109.819 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.67 39.38 55.87 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 54.4 mt -129.48 171.56 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.204 . . . . 0.0 110.134 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.67 24.0 56.28 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -58.22 -19.33 32.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.67 -1.488 . . . . 0.0 110.387 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.454 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.44 6.51 28.31 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.723 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.32 126.19 27.79 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 120.903 -1.351 . . . . 0.0 110.297 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.567 ' HG ' ' H ' ' A' ' 201' ' ' LYS . 0.3 OUTLIER -139.58 167.03 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.246 179.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.5 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 78.5 mt -68.75 -8.59 44.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 108.395 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.567 ' H ' ' HG ' ' A' ' 199' ' ' SER . 2.1 mttp -98.06 -11.17 23.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.712 -0.618 . . . . 0.0 109.54 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.2 p30 -133.21 7.66 3.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.64 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -148.43 149.56 31.94 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.6 tp -99.73 93.99 6.11 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.6 129.06 38.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.779 0.8 . . . . 0.0 109.094 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 40.9 mt -123.08 170.87 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.651 -0.656 . . . . 0.0 109.562 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.76 -166.22 11.71 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -64.48 -29.66 70.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -1.148 . . . . 0.0 109.611 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -153.26 24.45 0.54 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 111.061 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -149.17 156.82 42.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.515 -1.366 . . . . 0.0 110.925 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.6 t -104.67 112.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -57.04 -49.32 76.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.902 -1.123 . . . . 0.0 109.856 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.83 112.26 4.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -57.3 -17.94 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 112.598 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.12 -16.34 60.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.915 -1.116 . . . . 0.0 109.98 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.43 -171.96 50.9 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.0 mt -91.17 137.3 32.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -1.085 . . . . 0.0 109.674 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -74.41 -16.45 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 108.74 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.99 169.36 17.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.495 ' N ' ' OE2' ' A' ' 220' ' ' GLU . 2.1 mm-40 -84.56 3.68 35.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.141 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.519 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -151.38 43.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.186 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -56.24 -47.21 99.31 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.2 Cg_exo -50.57 -68.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.447 2.098 . . . . 0.0 112.193 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 28.1 m -57.13 -35.3 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.012 -1.055 . . . . 0.0 109.644 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.566 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 76.9 mtt-85 -60.7 -41.24 94.79 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.449 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.0 t60 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.986 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.64 -37.06 78.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.552 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.7 t80 -65.33 -50.98 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.051 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.539 ' OD2' ' C22' ' A' ' 501' ' ' C90 . 91.8 m-20 -64.11 -30.53 71.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 109.997 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.3 tp -75.49 -32.8 60.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.034 -1.041 . . . . 0.0 108.579 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.27 -39.66 83.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.7 -56.15 16.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.41 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 49.6 m-20 -54.82 -33.98 62.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.7 mt -61.18 -24.01 66.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.467 -0.771 . . . . 0.0 110.444 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.586 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -72.63 -22.1 61.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.892 -1.13 . . . . 0.0 108.611 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 63.4 mt -50.78 -2.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.0 110.621 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.586 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.5 mt -76.76 -13.38 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.147 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.01 -0.38 58.97 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.04 155.16 8.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.318 . . . . 0.0 108.814 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.53 150.67 5.62 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.745 1.63 . . . . 0.0 109.6 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 145.54 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.076 -1.015 . . . . 0.0 112.361 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.6 mmmp? -126.25 121.32 32.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.3 -175.55 31.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.556 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 26.9 tttt -114.59 147.47 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.075 . . . . 0.0 109.263 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 6.8 m-85 -142.92 140.48 31.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.56 122.12 34.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -114.7 135.25 54.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 111.112 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -118.52 109.68 16.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 54.15 26.82 6.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.69 158.74 52.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.02 168.14 24.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.41 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 68.5 m-70 -47.19 -41.29 17.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -1.187 . . . . 0.0 109.695 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.435 ' H ' ' HG ' ' A' ' 254' ' ' SER . 0.8 OUTLIER -55.27 -57.98 9.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.045 -1.034 . . . . 0.0 109.293 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.15 -44.82 88.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 256' ' ' ASN . 2.7 m-20 -47.95 -50.48 26.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.057 . . . . 0.0 109.391 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.15 -51.12 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.594 -0.691 . . . . 0.0 109.704 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -53.0 -51.32 62.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 109.286 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 42.7 tp -51.57 -57.79 8.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.161 -0.962 . . . . 0.0 108.434 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.2 t -50.78 -56.23 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 108.899 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -49.04 20.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.525 -0.734 . . . . 0.0 109.398 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.07 -48.27 80.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.36 -50.54 71.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.96 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.44 -27.0 65.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.0 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -77.11 -40.3 46.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.908 . . . . 0.0 110.267 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -19.5 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 0.0 109.972 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.83 -47.29 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.052 -1.03 . . . . 0.0 109.739 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 -162.99 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.982 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 109.399 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' C90 . . . . . 0.539 ' C22' ' OD2' ' A' ' 230' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.589 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 2.0 mt -84.28 156.49 21.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.18 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -51.76 143.29 13.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.589 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.55 146.61 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.091 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.96 -168.82 3.03 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -99.56 134.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 109.526 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -63.9 -16.73 62.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -152.71 -171.63 3.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.381 -0.824 . . . . 0.0 109.246 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 144.01 25.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 43.5 mt -120.97 163.31 18.45 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.44 140.41 46.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.6 m-85 -138.48 148.28 44.16 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.13 152.2 26.05 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.809 -1.182 . . . . 0.0 110.209 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.12 173.24 35.9 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.08 150.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.393 -1.063 . . . . 0.0 110.17 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.58 136.63 15.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.6 tt -60.52 -37.78 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 110.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -90.68 -51.45 5.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.588 -1.32 . . . . 0.0 111.044 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.7 p -70.54 -22.03 62.65 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.6 -0.688 . . . . 0.0 111.232 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.25 21.37 47.11 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.731 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -110.64 153.07 25.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 109.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -74.86 130.13 38.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.46 -0.775 . . . . 0.0 109.562 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 16.5 t -135.41 145.86 47.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.235 -0.916 . . . . 0.0 110.057 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -112.0 156.52 22.02 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.416 0.627 . . . . 0.0 109.333 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 13' ' ' PHE . 10.8 mt -135.61 144.92 46.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -140.19 110.22 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 108.79 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.3 113.62 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 111.094 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.475 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 45.4 m-70 -108.32 138.14 20.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.073 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -51.37 167.98 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.853 1.702 . . . . 0.0 112.279 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 5.2 mm-40 -140.92 176.21 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 35' ' ' THR . 3.5 mtpp -85.31 152.83 22.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.856 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 146.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.925 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.68 6.32 42.44 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.039 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.501 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 24.6 m -69.08 -43.7 74.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.631 -1.511 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.55 -175.67 31.82 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.458 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mm -98.45 117.92 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.03 140.7 38.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.57 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -129.11 110.8 12.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.031 -1.043 . . . . 0.0 109.084 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.19 134.14 39.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.32 28.33 7.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.03 75.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.806 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.49 121.19 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -1.012 . . . . 0.0 108.951 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.5 m-85 -84.34 127.11 33.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.6 mt -115.72 92.65 34.63 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -49.66 144.99 18.33 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.2 67.5 7.15 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -122.16 163.79 18.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -65.63 -52.87 48.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 5.4 mm-40 -43.25 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.724 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' HIS . 15.9 m-85 -95.7 1.73 53.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.8 t -70.58 130.35 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 108.874 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.46 -31.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 109.744 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.7 136.53 17.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 35.8 p -125.35 96.3 4.77 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.5 OUTLIER -162.24 129.49 3.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.808 . . . . 0.0 108.949 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 51.98 7.9 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.104 -0.998 . . . . 0.0 108.759 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.9 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.0 m -93.88 126.49 39.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 109.384 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.94 149.02 42.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.612 0.72 . . . . 0.0 110.868 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -124.86 149.07 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.73 153.74 24.43 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.98 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -163.12 148.79 11.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 0.0 109.174 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.89 23.79 4.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.15 -31.72 7.4 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.38 144.55 50.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.235 . . . . 0.0 109.262 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -140.04 139.02 35.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.675 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.446 HD13 HG21 ' A' ' 69' ' ' ILE . 51.3 mt -130.4 123.02 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -101.36 157.33 16.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.95 -1.094 . . . . 0.0 111.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.8 m 49.91 74.57 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.545 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.5 m -107.65 -9.81 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.938 . . . . 0.0 109.31 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.6 pm0 -61.74 -26.09 67.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 110.46 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.0 m170 -66.78 -69.23 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.932 -1.105 . . . . 0.0 109.242 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -52.02 -48.57 40.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.013 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.8 mt -51.55 -49.27 62.34 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.038 -1.039 . . . . 0.0 110.3 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -42.68 96.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.988 -1.07 . . . . 0.0 110.295 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -56.74 -45.41 82.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.075 -1.015 . . . . 0.0 109.048 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.3 -34.69 78.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -61.62 -35.84 79.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 109.035 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 65.1 mt -80.23 -37.65 32.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.257 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.0 9.29 5.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 109.781 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 3.3 mp0 50.2 36.77 13.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.34 136.82 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.034 -1.041 . . . . 0.0 108.282 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 p -127.1 -19.81 4.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 111.595 -178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.498 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 72.7 m-20 -124.38 107.59 11.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.876 -1.14 . . . . 0.0 110.423 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.8 m -163.94 148.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.408 -0.808 . . . . 0.0 110.282 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.8 m -114.69 111.5 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -95.68 100.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -72.07 127.69 33.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 83.3 t -111.9 119.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.937 0.875 . . . . 0.0 111.905 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.505 ' O ' ' OG ' ' A' ' 24' ' ' SER . 13.7 mt -109.04 93.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.2 160.4 8.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -7.54 59.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 111.292 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -138.96 147.89 42.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 110.676 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.0 mm -73.86 125.96 89.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.457 -0.777 . . . . 0.0 108.917 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -44.61 134.2 9.88 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.775 1.65 . . . . 0.0 111.075 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.7 tp -88.17 -14.66 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 110.61 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.7 mt 55.78 -121.98 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -95.82 7.6 45.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.939 -1.101 . . . . 0.0 111.17 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.52 -3.73 63.61 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.281 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.9 p -123.88 -172.65 2.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.724 -0.868 . . . . 0.0 109.556 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.98 10.18 11.14 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.448 ' CZ2' ' CG ' ' A' ' 108' ' ' GLU . 55.5 t-105 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -1.121 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.31 -58.98 6.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.028 -1.045 . . . . 0.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -51.18 -43.77 61.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.83 0.824 . . . . 0.0 108.885 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.464 ' CE2' ' OE1' ' A' ' 171' ' ' GLU . 56.4 t80 -62.27 -52.19 64.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.663 -0.648 . . . . 0.0 111.18 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.448 ' CG ' ' CZ2' ' A' ' 104' ' ' TRP . 19.5 mm-40 -61.89 -43.2 99.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.956 -1.09 . . . . 0.0 111.195 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.12 2.63 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 110.363 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.44 -35.42 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.635 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 41.8 ttt85 -64.78 -43.55 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.762 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -72.59 10.76 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 111' ' ' ARG . 22.9 m-80 -145.73 36.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.948 -1.095 . . . . 0.0 110.448 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.7 mt -83.44 139.91 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.98 119.5 23.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.744 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.5 OUTLIER -76.3 143.56 40.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.722 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.19 -175.96 2.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 109.592 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.518 ' H ' ' ND2' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -106.91 67.99 0.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.235 -0.915 . . . . 0.0 110.514 -179.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -164.93 129.64 2.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.22 140.77 57.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 121' ' ' ILE . 37.4 mt -81.47 147.0 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.77 88.78 4.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -0.872 . . . . 0.0 108.657 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.71 143.77 56.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -88.47 102.2 14.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.24 134.12 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.556 -0.715 . . . . 0.0 110.792 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.27 117.22 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 7.3 tp10 -89.69 -31.62 17.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.961 -1.087 . . . . 0.0 109.99 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.11 154.28 80.06 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.41 158.39 44.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.557 2.172 . . . . 0.0 112.35 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.537 ' CG1' ' HZ3' ' A' ' 266' ' ' LYS . 3.0 tt -165.09 154.67 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.76 147.06 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.96 147.28 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -132.84 161.56 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -173.66 102.17 0.11 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 0.0 109.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.17 59.25 4.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.436 -0.79 . . . . 0.0 111.002 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.02 -35.56 3.25 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.448 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -63.94 131.38 47.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.265 . . . . 0.0 108.89 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.465 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -143.3 139.25 30.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 109.999 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.5 mt -137.29 128.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.387 -0.821 . . . . 0.0 109.876 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' NZ ' ' OE2' ' A' ' 142' ' ' GLU . 10.7 tttm -117.94 132.77 56.37 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.514 0.673 . . . . 0.0 110.146 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.83 134.95 54.89 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.468 ' OE2' ' NZ ' ' A' ' 140' ' ' LYS . 14.8 pt-20 -146.46 147.68 31.59 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.54 143.52 8.45 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.617 2.211 . . . . 0.0 113.458 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.73 147.38 18.55 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.77 -37.55 82.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.325 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -120.46 -169.86 1.88 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.9 tp -100.08 122.94 43.72 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.36 130.2 36.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 54.9 t -128.73 121.45 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.4 m -112.43 151.99 29.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.594 -0.691 . . . . 0.0 109.433 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -140.52 131.4 25.98 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.145 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -121.67 125.42 46.61 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.91 138.87 10.7 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.345 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -102.87 103.14 13.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -93.31 167.44 11.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.664 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -103.65 -12.27 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 110.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.2 p-10 -97.88 -167.13 1.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 110.378 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -53.48 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.259 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.568 ' H ' ' C ' ' A' ' 157' ' ' ASN . 13.5 mt -85.59 -30.53 23.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.545 -1.347 . . . . 0.0 109.102 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.85 -140.25 38.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 161' ' ' ARG . 11.5 ttp-105 -98.82 135.91 39.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.193 -1.181 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -137.89 149.72 46.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.484 -0.76 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -140.86 143.99 35.05 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -145.47 140.3 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 32.2 m -108.14 123.85 49.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.527 -0.733 . . . . 0.0 109.998 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -102.91 111.73 24.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.959 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 44.5 t -99.8 146.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.954 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -48.25 134.21 14.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.29 -0.881 . . . . 0.0 108.987 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.92 -6.0 43.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -114.03 25.61 11.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -1.132 . . . . 0.0 109.27 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.464 ' OE1' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -53.09 -51.69 61.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.429 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.424 ' H ' ' HG3' ' A' ' 171' ' ' GLU . 82.3 mt-10 -50.56 -21.28 1.47 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.12 -0.988 . . . . 0.0 110.177 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.26 -7.9 59.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 111.619 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.58 -25.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.852 -1.155 . . . . 0.0 111.121 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.9 m -63.7 -24.44 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.438 -1.414 . . . . 0.0 109.005 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.66 -5.62 58.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.468 -0.77 . . . . 0.0 108.99 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.57 115.52 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.173 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.409 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 49.8 mtm180 -79.41 172.51 13.7 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.201 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.524 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.4 t -77.86 163.23 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -147.1 144.46 29.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.207 -1.558 . . . . 0.0 111.716 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.01 156.7 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.86 147.29 25.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 109.662 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.454 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -52.94 -35.97 59.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.429 -0.794 . . . . 0.0 109.698 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.2 p90 -72.91 -31.44 64.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.578 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.2 mm-40 -75.36 -35.74 61.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.017 -1.052 . . . . 0.0 109.375 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.404 ' O ' ' C ' ' A' ' 187' ' ' GLU . 77.1 mt -46.46 -55.61 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 109.786 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -43.8 -42.0 5.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.858 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -74.44 -48.4 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.988 . . . . 0.0 109.046 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.1 mt -51.09 -30.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.336 -0.852 . . . . 0.0 109.302 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -82.35 -52.02 7.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.782 -1.199 . . . . 0.0 109.143 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -47.29 -47.12 25.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.425 -0.797 . . . . 0.0 110.158 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.67 8.17 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.79 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.08 39.9 62.52 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 44.8 mt -126.45 170.91 11.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -1.082 . . . . 0.0 109.676 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.8 21.22 58.16 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -57.2 -21.67 35.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.557 -1.555 . . . . 0.0 109.807 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -113.48 25.19 11.38 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.36 127.53 8.4 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.458 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -141.18 169.4 17.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.124 . . . . 0.0 109.519 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 63.5 mt -70.7 -8.64 53.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -97.38 -12.66 22.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.609 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.458 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 17.9 p30 -132.71 8.67 4.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.89 149.76 30.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.967 -1.083 . . . . 0.0 110.481 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.0 tp -97.45 93.36 6.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 45.1 t -87.22 130.34 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.554 -0.716 . . . . 0.0 109.152 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 12.5 mt -124.15 166.26 16.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.159 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.08 -166.15 12.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -1.12 . . . . 0.0 109.366 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 209' ' ' ASP . 47.9 t0 -153.9 24.32 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -143.02 150.6 39.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 79.7 t -103.23 113.32 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -58.61 -49.76 76.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.012 -1.055 . . . . 0.0 110.04 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -58.1 111.81 4.03 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.231 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.54 -12.98 12.35 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.541 1.494 . . . . 0.0 111.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -17.54 59.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 110.035 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.7 -173.78 49.29 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -91.02 136.14 33.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -1.209 . . . . 0.0 109.462 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -75.32 -20.12 59.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 108.824 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.43 159.07 42.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.555 -0.716 . . . . 0.0 109.12 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.5 -12.79 61.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.82 51.17 1.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.28 -47.03 99.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 0.0 109.795 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 63.6 Cg_exo -49.9 -67.08 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.453 2.102 . . . . 0.0 112.342 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 m -59.16 -35.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.121 . . . . 0.0 109.571 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -60.66 -41.1 94.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 108.457 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.2 t60 -68.19 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.301 -0.874 . . . . 0.0 108.947 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -64.45 -37.63 88.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.07 -36.11 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.59 -57.37 9.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.532 -0.73 . . . . 0.0 109.137 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -61.58 -26.01 67.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.354 -0.841 . . . . 0.0 109.885 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 57.7 tp -78.2 -35.08 48.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 0.0 108.69 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.8 mt -66.0 -36.51 77.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.79 -59.76 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 99.4 m-20 -48.09 -36.1 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.274 . . . . 0.0 108.992 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.9 mt -62.83 -22.78 66.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.547 -0.721 . . . . 0.0 110.317 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.604 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.27 -22.63 61.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.777 -1.202 . . . . 0.0 108.999 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.36 -3.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.688 -1.257 . . . . 0.0 110.204 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.604 ' H ' ' C ' ' A' ' 236' ' ' TYR . 10.5 mt -78.87 -16.34 57.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.906 -1.121 . . . . 0.0 109.695 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 2.63 56.37 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.172 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.66 154.54 9.13 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.747 -1.443 . . . . 0.0 109.287 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.16 128.77 31.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.91 1.74 . . . . 0.0 109.682 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 151.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 112.524 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -131.9 124.74 30.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.48 -158.41 27.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -129.08 132.89 47.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -1.155 . . . . 0.0 108.713 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.5 m-85 -131.92 140.09 48.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -126.76 125.34 41.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 m -120.93 135.44 55.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 111.015 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.403 ' C ' ' N ' ' A' ' 251' ' ' GLY . 30.4 t80 -116.1 114.84 25.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 17.38 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.092 -1.005 . . . . 0.0 109.007 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 249' ' ' PHE . . . -55.68 140.89 40.06 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.2 179.45 17.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.7 m-70 -62.21 -42.26 99.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.203 -1.174 . . . . 0.0 109.875 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.0 t -55.62 -58.92 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.07 -1.019 . . . . 0.0 109.572 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.8 tp -55.99 -44.56 78.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 109.313 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 34.9 m-20 -47.59 -50.77 23.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.965 -1.085 . . . . 0.0 108.962 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 86.3 t -61.98 -49.55 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.524 -0.735 . . . . 0.0 109.84 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -54.88 -51.93 64.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.029 -1.044 . . . . 0.0 109.311 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 51.9 tp -50.06 -52.79 31.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 108.549 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 34.5 t -55.41 -51.45 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 108.746 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -50.16 -47.01 54.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 109.552 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -64.45 -48.95 73.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.957 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 14.9 mt -57.42 -51.81 67.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.3 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.44 -27.3 65.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 110.251 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -63.44 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.537 ' HZ3' ' CG1' ' A' ' 130' ' ' ILE . 3.1 pttt -71.17 -15.41 62.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.473 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 266' ' ' LYS . 5.6 tp-100 -34.59 -35.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 266' ' ' LYS . 7.7 mmtp -87.37 85.49 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.475 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.506 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.524 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt -100.05 152.55 20.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.445 ' CD ' ' OG1' ' A' ' 85' ' ' THR . 13.5 mm-40 -53.94 137.01 40.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.511 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 143.86 48.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -140.87 -171.96 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 m -97.05 133.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.998 -1.064 . . . . 0.0 109.397 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -64.68 -18.02 64.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.252 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -155.99 163.99 39.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.287 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 139.36 51.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.45 166.85 11.85 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -140.33 142.97 35.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 110.253 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' LEU . 91.6 m-85 -140.11 151.07 45.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.2 pt-20 -157.12 150.83 24.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.893 -1.129 . . . . 0.0 110.036 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.34 175.42 36.63 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.08 154.47 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -1.107 . . . . 0.0 110.003 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.01 140.15 15.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 tt -59.33 -38.67 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 110.396 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.4 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 59.7 m-70 -89.42 -50.49 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.784 -1.198 . . . . 0.0 111.067 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 p -70.41 -23.08 62.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.634 -0.666 . . . . 0.0 111.758 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.2 15.55 15.57 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.63 153.44 22.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.479 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 24.9 t80 -74.38 135.53 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.354 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.2 m -139.7 144.77 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 ttpp -110.95 156.23 21.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.434 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.0 mt -135.53 147.67 48.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.42 -0.8 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.525 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 11.6 mt -143.81 114.11 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 108.882 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mt -98.41 114.61 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.372 -0.83 . . . . 0.0 110.774 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.525 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 9.3 m-70 -108.49 138.13 20.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -53.23 168.43 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.81 1.674 . . . . 0.0 111.65 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.556 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 58.9 mm-40 -141.22 177.54 8.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.031 -1.043 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.56 ' N ' ' HG1' ' A' ' 35' ' ' THR . 21.0 mttt -84.48 152.44 23.96 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.692 0.758 . . . . 0.0 110.161 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.16 142.82 2.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.167 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.436 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 69.53 10.26 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.258 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.56 ' HG1' ' N ' ' A' ' 32' ' ' LYS . 33.5 m -69.98 -42.43 73.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.573 -1.545 . . . . 0.0 109.798 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 178.95 35.58 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.351 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 37' ' ' ILE . 41.0 mm -95.44 116.32 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.407 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 7.1 ptm180 -141.14 150.26 42.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 110.582 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.31 157.03 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -128.41 111.82 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 108.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 44.4 tttm -134.68 132.62 39.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.534 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.5 m120 52.58 28.27 5.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.795 . . . . 0.0 111.372 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.07 19.64 69.34 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.187 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.81 122.6 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -1.063 . . . . 0.0 109.174 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.407 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 64.5 m-85 -84.73 127.19 33.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 109.729 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.9 mt -116.96 93.88 43.04 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.386 -0.822 . . . . 0.0 109.386 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.95 149.83 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.637 2.224 . . . . 0.0 112.105 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.05 68.48 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.421 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 3.9 mmt85 -123.08 175.69 6.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.276 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.8 p-80 -77.78 -51.65 10.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 110.28 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -43.06 -16.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 110.759 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.0 m-85 -98.11 2.96 49.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 110.295 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.46 128.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.001 -1.062 . . . . 0.0 108.896 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -31.65 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.131 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -151.52 132.01 13.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.4 p -120.88 96.02 4.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.6 t30 -162.65 128.9 3.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.916 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 83.8 m-70 52.72 5.37 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 0.0 109.02 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 165.14 155.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.588 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.432 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 55.1 m -94.64 126.76 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 109.2 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -119.0 148.02 43.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.507 -0.746 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.51 149.87 44.65 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.78 157.58 28.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.848 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -166.03 143.65 5.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 108.738 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.36 22.13 2.67 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.31 -32.04 7.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 80.4 mm-40 -59.81 148.31 34.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.312 . . . . 0.0 109.613 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.52 138.5 30.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 110.53 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.3 mt -129.67 123.89 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -99.93 155.95 17.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 111.259 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.9 m 49.96 74.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.4 m -107.59 -8.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 108.71 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 14.3 pm0 -60.86 -28.46 68.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 110.623 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.25 -68.76 0.35 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -51.98 -47.56 41.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.156 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.9 mt -52.32 -47.32 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.84 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 48.5 t -61.13 -42.23 98.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.097 -1.002 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.24 -43.41 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.993 -1.067 . . . . 0.0 109.133 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.3 -34.99 78.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.159 -0.963 . . . . 0.0 109.167 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.18 -38.27 90.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.429 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.1 mt -77.59 -38.87 47.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.855 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 68.5 mt -81.81 0.08 40.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 109.411 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 55.93 42.72 28.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.645 -0.66 . . . . 0.0 111.365 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.34 145.32 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.782 -1.198 . . . . 0.0 108.192 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.445 ' OG1' ' CD ' ' A' ' 4' ' ' GLU . 82.7 p -129.35 -25.61 2.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.0 111.574 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.508 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 83.2 m-20 -124.26 106.87 10.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.867 -1.146 . . . . 0.0 110.362 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.0 m -164.36 148.49 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.415 -0.803 . . . . 0.0 110.289 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.556 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 88.8 m -115.88 109.38 17.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -91.71 100.15 10.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 109.859 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.17 125.89 28.42 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 92.3 t -107.94 123.55 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.707 0.765 . . . . 0.0 111.364 -178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 91.7 mt -110.25 96.36 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.25 -156.62 25.73 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -119.67 -11.03 9.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -1.149 . . . . 0.0 110.041 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -141.46 149.65 41.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.977 -1.077 . . . . 0.0 109.661 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.3 mm -72.52 119.55 75.66 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.037 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -40.32 119.89 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.778 1.652 . . . . 0.0 111.378 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 tp -76.02 -13.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 110.098 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.7 mt 56.86 -118.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.25 -0.907 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 1.9 t0 -95.31 6.08 49.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.121 -0.987 . . . . 0.0 110.682 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.08 -0.91 60.62 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.516 ' HG ' ' H ' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -127.52 -172.53 2.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.698 -0.884 . . . . 0.0 109.627 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.92 17.23 10.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.516 ' H ' ' HG ' ' A' ' 102' ' ' SER . 4.3 t-105 -59.57 -43.53 93.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.456 -1.026 . . . . 0.0 110.08 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 -57.87 8.24 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.062 -1.024 . . . . 0.0 109.852 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.47 -46.69 63.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -61.37 -49.3 77.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.0 -43.83 86.6 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.969 -1.082 . . . . 0.0 111.579 -178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.84 45.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 110.454 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.53 -31.97 56.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.968 -1.082 . . . . 0.0 109.161 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -63.2 -42.38 99.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.576 ' C ' HD21 ' A' ' 113' ' ' ASN . 7.4 pttp -79.15 10.44 3.56 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.983 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.576 HD21 ' C ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -138.23 32.25 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.55 137.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 110.855 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.28 118.6 21.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.566 -0.708 . . . . 0.0 109.274 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.628 HD21 ' H ' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -79.88 145.8 32.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.028 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.22 -170.74 1.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.775 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.46 68.97 0.69 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 110.361 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.34 128.6 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.152 -0.967 . . . . 0.0 109.207 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.28 142.51 56.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.0 109.506 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 65.9 mt -84.39 149.33 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.2 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.58 87.68 3.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -66.52 145.36 55.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.184 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -88.22 101.41 13.81 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.88 133.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.456 0.646 . . . . 0.0 111.027 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.51 112.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.22 -30.12 17.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.959 -1.088 . . . . 0.0 110.534 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.42 81.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.86 148.69 41.26 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.562 2.174 . . . . 0.0 112.083 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 tt -156.8 148.93 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -0.833 . . . . 0.0 109.124 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.27 146.23 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.362 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.8 m -132.57 148.93 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.19 161.16 35.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.869 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -170.28 101.94 0.27 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 109.731 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 48.43 58.02 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.38 -35.52 3.31 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.584 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -62.18 136.3 57.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.339 . . . . 0.0 108.778 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.4 tt -144.53 139.1 27.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.863 -1.148 . . . . 0.0 110.062 -179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 23.3 mt -137.85 134.02 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.415 -0.803 . . . . 0.0 109.982 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -122.23 132.64 54.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.455 0.645 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.18 53.98 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.85 151.68 42.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 110.143 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.95 141.88 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.583 2.189 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.11 147.62 19.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -36.46 81.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.3 p -121.9 -169.22 1.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.846 . . . . 0.0 109.956 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.0 tp -98.76 123.71 43.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 108.67 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -136.33 128.09 29.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.2 t -128.3 121.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.843 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.7 m -110.84 151.1 28.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.451 -0.781 . . . . 0.0 109.07 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -139.15 130.22 26.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -120.99 131.05 54.07 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.18 140.0 11.31 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.534 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -106.22 101.12 10.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.55 167.15 13.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.935 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -99.14 -15.56 18.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.624 -0.672 . . . . 0.0 110.911 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.1 p-10 -96.09 -168.63 1.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.803 -1.185 . . . . 0.0 110.084 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -55.85 2.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.0 111.446 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.9 mt -77.61 -27.34 51.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.408 -1.433 . . . . 0.0 108.13 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.38 29.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.4 135.64 42.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -1.123 . . . . 0.0 109.339 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -140.82 158.9 43.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.429 -0.794 . . . . 0.0 109.363 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -147.44 146.23 29.48 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.216 -0.927 . . . . 0.0 109.828 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -145.41 140.13 27.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 110.08 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.9 m -108.21 123.54 48.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 110.03 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.22 115.46 30.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.56 147.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -48.73 135.04 15.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.196 -0.94 . . . . 0.0 108.897 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.07 -10.23 36.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 0.6 OUTLIER -116.97 25.85 10.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -1.125 . . . . 0.0 109.15 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.45 -15.87 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 176' ' ' LEU . 1.9 tt0 -78.28 -8.11 57.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 110.887 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.41 ' HG3' HH21 ' A' ' 225' ' ' ARG . 1.0 OUTLIER -104.79 -5.07 21.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.993 -1.067 . . . . 0.0 111.302 -178.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 41.7 pt -115.65 -30.05 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.192 -0.942 . . . . 0.0 110.355 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 10.3 m -60.44 -18.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.017 -1.052 . . . . 0.0 109.25 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.486 ' CD1' ' O ' ' A' ' 172' ' ' GLU . 1.4 mp -93.92 0.85 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.008 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.55 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.05 117.39 11.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.922 . . . . 0.0 108.774 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 87.4 mtm180 -80.29 171.72 14.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.548 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.1 t -79.04 163.02 25.49 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -148.2 144.55 27.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.269 -1.519 . . . . 0.0 111.565 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.4 157.73 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.511 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.5 m-85 -99.35 146.56 26.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 109.558 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.99 -35.19 23.54 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.352 -0.842 . . . . 0.0 109.647 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.2 p90 -74.83 -30.32 61.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.983 -1.073 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.8 OUTLIER -73.56 -37.53 65.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.922 . . . . 0.0 109.967 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 187' ' ' GLU . 84.2 mt -48.93 -55.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.037 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -41.53 -41.73 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.062 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -75.62 -47.31 27.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 109.148 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.17 -25.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.845 . . . . 0.0 109.566 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -85.64 -55.19 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.874 -1.141 . . . . 0.0 109.335 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -48.63 -41.74 32.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.4 m -76.38 7.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.062 -1.024 . . . . 0.0 110.462 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.71 61.48 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.212 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 51.3 mt -128.33 171.96 11.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 109.372 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 59.16 21.98 54.57 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -59.99 -21.16 60.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.476 -1.603 . . . . 0.0 108.945 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -108.6 25.62 18.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.41 7.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' THR . 35.7 m -143.94 165.56 27.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -1.114 . . . . 0.0 109.582 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 27.8 mt -66.51 -8.68 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 17.7 ttpt -95.08 -17.2 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.444 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 15.8 p30 -132.24 8.75 4.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.64 149.48 31.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.976 -1.077 . . . . 0.0 110.405 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.8 tp -100.61 93.45 5.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 44.2 t -85.43 131.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.828 0.823 . . . . 0.0 108.914 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 60.2 mt -123.25 161.7 24.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.556 -0.715 . . . . 0.0 109.464 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.82 -166.23 12.61 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -64.67 -29.55 70.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 110.051 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.28 24.23 0.63 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.999 . . . . 0.0 111.208 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -150.93 159.3 44.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.309 -1.494 . . . . 0.0 110.839 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 43.1 t -104.36 111.86 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -54.83 -48.32 72.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.991 -1.068 . . . . 0.0 109.444 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.43 112.22 5.21 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -57.96 -19.84 41.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.823 1.682 . . . . 0.0 112.69 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.53 -15.49 61.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.056 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.67 -175.58 46.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.411 HD21 ' N ' ' A' ' 217' ' ' LEU . 7.2 mt -84.84 144.26 28.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -76.15 -18.06 59.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 108.759 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.84 -170.26 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.191 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.73 -7.33 37.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.114 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.68 48.84 1.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.246 -0.909 . . . . 0.0 109.612 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.95 -45.47 98.94 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.321 -0.862 . . . . 0.0 110.548 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.2 Cg_exo -54.62 -55.7 3.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.329 2.019 . . . . 0.0 112.876 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -68.31 -39.73 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.883 -1.135 . . . . 0.0 111.749 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.41 HH21 ' HG3' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -68.89 -32.24 71.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.238 -1.539 . . . . 0.0 108.526 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.55 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 21.8 t60 -66.47 -35.46 80.32 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -64.41 -35.04 79.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.94 -35.67 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.59 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -68.21 -52.24 36.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.76 -30.8 71.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.816 . . . . 0.0 109.642 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.62 -32.44 58.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.135 -0.978 . . . . 0.0 108.755 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.78 -37.35 78.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.82 -55.96 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.555 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -54.36 -35.99 63.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.237 . . . . 0.0 108.936 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.08 -23.13 63.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.474 -0.766 . . . . 0.0 110.03 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.59 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.8 -21.77 61.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.043 -1.036 . . . . 0.0 108.659 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 79.6 mt -49.87 -4.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.641 -1.287 . . . . 0.0 110.329 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.59 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.4 mt -76.88 -17.25 59.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.974 -1.078 . . . . 0.0 109.861 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.421 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 100.23 2.17 55.78 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.943 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.47 153.91 10.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.42 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.91 128.54 30.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.013 1.809 . . . . 0.0 110.035 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 t -86.95 152.01 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 112.217 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -135.79 127.67 29.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.76 -158.37 27.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.486 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.4 ttmt -127.29 140.73 52.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 109.137 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.4 m-85 -138.91 140.69 38.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.059 -1.025 . . . . 0.0 110.394 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -124.3 132.58 53.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -129.59 136.1 49.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.062 . . . . 0.0 111.154 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 250' ' ' ARG . 39.3 t80 -117.33 116.81 27.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.1 mtt-85 45.03 48.16 9.53 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.055 -1.028 . . . . 0.0 108.516 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.29 143.94 24.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -124.33 160.96 18.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.432 ' ND1' ' HG1' ' A' ' 60' ' ' THR . 76.6 m-70 -46.4 -36.34 6.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -1.22 . . . . 0.0 109.492 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -58.11 9.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 108.986 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.5 tp -59.14 -44.21 92.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 0.0 109.239 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.3 m-20 -47.63 -54.31 12.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.555 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 258' ' ' LYS . 74.9 t -61.0 -56.84 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.424 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.0 OUTLIER -44.53 -49.68 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.96 . . . . 0.0 108.93 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.09 -61.59 2.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.896 -1.128 . . . . 0.0 108.605 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 23.8 t -47.2 -54.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -47.2 -52.83 14.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.345 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -59.1 -49.92 76.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.782 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.411 HD22 ' HZ2' ' A' ' 266' ' ' LYS . 16.0 mt -53.15 -52.86 57.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.59 66.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -76.34 -42.38 45.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 268' ' ' LYS . 3.2 pptp? -87.28 -19.64 27.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.84 30.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 109.382 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 266' ' ' LYS . 11.9 ptmt -177.76 48.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.622 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.441 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.548 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.68 154.94 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -1.111 . . . . 0.0 109.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -57.55 138.62 55.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.296 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 145.39 48.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.487 -0.758 . . . . 0.0 109.541 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -141.37 -173.95 3.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 m -96.19 135.69 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 0.0 109.212 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -66.49 -23.0 66.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.482 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 9.9 pt-20 -150.83 156.08 40.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 142.09 58.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 110.249 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -119.73 163.35 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 p -134.55 142.0 46.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.0 110.183 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 26' ' ' LEU . 96.8 m-85 -139.21 146.32 40.35 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -153.06 150.63 29.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.354 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.16 174.79 36.65 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.06 154.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.254 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.81 139.94 15.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tt -60.82 -37.0 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -1.168 . . . . 0.0 110.558 -179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.406 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 78.0 m-70 -89.58 -51.72 5.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.631 -1.293 . . . . 0.0 111.396 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 p -70.0 -23.25 63.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.701 -0.624 . . . . 0.0 111.653 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.78 20.14 46.34 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.182 -1.485 . . . . 0.0 109.6 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -111.83 154.03 25.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -1.118 . . . . 0.0 109.563 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.24 135.59 42.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.169 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.3 m -139.37 144.52 38.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.03 . . . . 0.0 109.845 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.96 155.7 23.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.448 -0.782 . . . . 0.0 109.668 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.6 mt -135.74 148.26 48.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.523 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 11.9 mt -143.58 112.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 108.928 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.86 114.91 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.42 -0.8 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.523 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 16.3 m-70 -107.83 139.17 20.36 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -52.82 168.23 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.849 1.699 . . . . 0.0 111.822 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.436 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 20.1 mm-40 -142.23 174.74 10.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.541 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -85.91 155.11 21.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -49.62 146.95 3.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.961 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 71.03 -0.54 29.72 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.978 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.8 m -65.43 -42.39 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.556 -1.555 . . . . 0.0 109.481 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.754 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 93.6 -177.36 37.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 37' ' ' ILE . 20.6 mm -99.52 115.31 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -137.5 151.5 48.51 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.993 -1.067 . . . . 0.0 110.498 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.17 157.57 16.48 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -129.99 110.69 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.853 . . . . 0.0 108.995 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.667 ' HZ1' ' H ' ' A' ' 68' ' ' ARG . 19.3 tttm -134.69 133.81 40.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.596 -178.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 48.38 34.31 4.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.59 -0.694 . . . . 0.0 111.59 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 17.04 80.26 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.472 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.89 120.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.105 . . . . 0.0 108.836 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 39.8 m-85 -86.84 129.14 35.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.187 -0.946 . . . . 0.0 109.734 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.43 96.97 50.48 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.647 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.25 146.43 31.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.229 1.953 . . . . 0.0 111.623 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.97 70.28 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.982 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.423 ' CG ' HH11 ' A' ' 49' ' ' ARG . 6.7 mtt-85 -127.22 171.55 11.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 0.0 109.003 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -73.25 -49.17 29.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.591 ' OE1' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mp0 -43.53 -17.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.889 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.4 m-85 -97.89 2.96 49.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.208 . . . . 0.0 109.938 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.9 t -74.06 129.07 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.372 -0.83 . . . . 0.0 108.781 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.74 -25.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.885 . . . . 0.0 110.281 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 t-80 -150.37 130.02 13.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.692 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.3 p -123.79 96.04 4.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.1 t-20 -158.42 128.49 5.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.5 m-70 46.54 13.12 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.89 152.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.796 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.8 m -96.24 128.16 42.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 55' ' ' HIS . 0.9 OUTLIER -120.28 148.67 43.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.652 0.739 . . . . 0.0 110.878 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -125.54 146.81 49.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.84 151.12 22.06 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.01 -1.567 . . . . 0.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -160.0 148.89 17.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.981 . . . . 0.0 109.145 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.09 26.39 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.858 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.53 -32.5 6.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.539 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 2.8 mm100 -57.38 140.25 50.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.149 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.667 ' H ' ' HZ1' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -134.65 134.09 40.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.849 . . . . 0.0 110.305 -179.323 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.53 120.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -100.94 157.11 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.046 . . . . 0.0 111.119 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.0 m 48.97 75.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.7 m -107.72 -10.56 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 109.318 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.0 pm0 -60.79 -24.3 65.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.556 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -68.68 -68.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.126 -0.984 . . . . 0.0 109.232 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.1 tp -52.1 -48.11 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -52.79 -46.92 67.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.543 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 22.5 t -61.91 -43.24 99.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.432 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.82 -46.76 83.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.021 -1.05 . . . . 0.0 109.071 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.39 -34.42 78.26 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -63.29 -34.78 78.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.631 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 59.3 mt -81.6 -38.82 25.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 110.289 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.13 -0.39 39.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 0.0 110.005 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 61.53 39.84 14.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 111.383 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 84' ' ' ILE . 17.7 mm -85.81 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.698 -1.251 . . . . 0.0 108.026 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -123.73 -24.1 4.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 0.0 111.792 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.754 HD21 ' H ' ' A' ' 36' ' ' GLY . 27.7 m120 -123.84 107.18 11.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.917 -1.115 . . . . 0.0 110.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.6 m -164.35 148.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 110.468 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 99.3 m -115.54 113.04 23.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -95.36 100.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.184 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -73.6 126.73 30.95 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.54 128.21 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.98 0.895 . . . . 0.0 111.895 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.81 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.11 -159.78 27.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 -11.3 10.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.25 149.88 41.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.995 -1.066 . . . . 0.0 109.535 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.9 mm -72.96 120.93 83.56 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 108.712 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -40.51 120.45 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.782 1.655 . . . . 0.0 111.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 tp -76.62 -14.21 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.913 . . . . 0.0 110.476 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 mt 56.84 -118.43 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.029 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.86 6.75 47.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.23 59.48 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 p -128.76 -172.25 2.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.666 -0.902 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.3 15.2 9.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 2.7 t-105 -57.59 -42.44 83.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.272 -1.134 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.11 -57.2 9.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 110.122 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.42 -46.33 62.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.09 -54.08 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 0.0 110.821 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -60.44 -43.76 96.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.02 . . . . 0.0 111.53 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.67 -56.91 8.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.252 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.73 -32.83 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.158 -0.963 . . . . 0.0 109.383 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER -64.18 -42.72 96.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.6 13.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 110.041 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' OE2' ' A' ' 9' ' ' GLU . 15.7 m-80 -144.58 33.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 0.0 110.336 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.2 mt -79.81 138.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.28 123.35 29.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.23 148.3 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.62 -171.82 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -111.67 69.0 0.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -165.32 130.92 2.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.003 -1.061 . . . . 0.0 109.691 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.53 144.46 53.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.528 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.16 149.37 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.568 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -93.09 78.17 4.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.4 m-85 -58.1 140.67 52.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 109.409 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -88.87 101.44 14.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.0 t -92.68 134.3 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.528 0.68 . . . . 0.0 110.772 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.52 116.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.42 -27.01 16.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.528 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -130.74 149.76 74.53 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.15 150.0 41.91 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.589 2.192 . . . . 0.0 112.017 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.493 ' CD1' ' HZ3' ' A' ' 266' ' ' LYS . 1.4 tt -157.37 151.01 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 142.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 0.0 109.513 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.93 145.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -133.25 156.72 47.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.002 . . . . 0.0 110.459 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -166.04 98.91 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.485 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 46.02 65.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 110.848 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.2 -38.02 3.0 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.89 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.9 mtt85 -65.44 133.67 51.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.862 -1.375 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.499 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.7 tt -146.58 138.92 24.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.053 -1.029 . . . . 0.0 109.973 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.414 HG22 HD13 ' A' ' 139' ' ' ILE . 69.2 mt -135.57 125.87 42.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.458 -0.776 . . . . 0.0 109.523 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -114.3 133.44 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.532 0.682 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.29 133.61 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.08 151.56 48.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.787 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -50.14 143.23 25.94 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.382 2.055 . . . . 0.0 113.392 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.41 145.78 20.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -68.61 -5.01 17.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 110.488 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 p -148.45 -175.24 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.069 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.2 tp -98.32 120.06 38.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.084 -1.01 . . . . 0.0 108.702 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -137.27 122.84 19.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 108.553 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 76.7 t -122.37 122.58 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.723 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -113.52 152.22 30.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.494 ' HH ' ' N ' ' A' ' 251' ' ' GLY . 32.9 t80 -139.64 130.47 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.964 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.56 129.95 54.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.53 141.2 12.52 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.266 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -105.64 104.11 13.77 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -93.65 166.95 11.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -14.89 17.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.734 . . . . 0.0 110.485 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 159' ' ' LEU . 29.9 p-10 -93.96 -171.38 2.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.869 -1.144 . . . . 0.0 110.265 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -52.91 3.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.449 -0.782 . . . . 0.0 111.704 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.9 mt -83.35 -29.36 28.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.321 -1.487 . . . . 0.0 109.06 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.43 -140.67 36.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 134.41 38.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -1.145 . . . . 0.0 109.491 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.03 148.72 45.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -141.26 145.05 35.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.934 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -144.63 139.34 27.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.7 m -109.78 124.63 51.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 110.156 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -104.08 113.07 26.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.273 -0.892 . . . . 0.0 109.961 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.53 156.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -50.86 133.12 26.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.266 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.83 3.76 60.62 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 170' ' ' ASN . 3.4 m-20 -117.53 20.25 13.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 109.153 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.566 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -55.89 -56.57 18.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.291 -0.881 . . . . 0.0 110.017 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 171' ' ' GLU . 1.8 mt-10 -42.52 -25.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.545 ' O ' ' CZ ' ' A' ' 225' ' ' ARG . 12.5 mt-10 -80.74 -7.85 59.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 111.924 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.74 -25.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.663 -1.273 . . . . 0.0 111.817 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.77 -15.88 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.456 -1.403 . . . . 0.0 109.175 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.4 mt -92.27 -6.43 50.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.46 -0.775 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.448 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -67.43 116.19 7.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.173 -0.954 . . . . 0.0 108.847 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.507 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 74.5 mtm180 -77.57 172.84 12.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.516 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.522 ' HG1' HN17 ' A' ' 500' ' ' C90 . 5.4 t -77.25 162.28 27.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -146.81 149.07 32.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.21 -1.556 . . . . 0.0 111.493 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.06 43.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -98.97 146.97 25.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.537 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.11 -38.11 16.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.488 -0.757 . . . . 0.0 109.86 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -72.29 -28.9 63.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.827 -1.171 . . . . 0.0 109.605 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.0 mt-10 -71.93 -39.9 69.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.638 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 25.6 mt -47.37 -59.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.553 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 7.7 tp10 -41.81 -40.02 1.94 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.514 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 189' ' ' ILE . 13.3 t-160 -75.28 -60.89 2.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 108.887 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 188' ' ' HIS . 93.7 mt -41.85 -32.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.625 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -80.13 -52.07 8.22 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.764 -1.21 . . . . 0.0 109.193 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -48.17 -40.05 22.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 110.518 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.0 8.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.036 . . . . 0.0 110.522 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.74 39.65 54.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.406 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 69.3 mt -129.64 172.81 11.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -1.111 . . . . 0.0 109.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.65 20.57 56.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -57.56 -20.55 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.365 -1.668 . . . . 0.0 109.878 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.431 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.55 25.18 11.33 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.22 129.38 9.64 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.99 -1.3 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -143.88 172.75 12.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 109.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.9 mt -71.26 -7.8 49.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -99.35 -11.54 21.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.442 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 17.0 p30 -133.53 8.49 3.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 109.999 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -150.28 151.52 33.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.0 tp -99.5 93.93 6.14 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -85.34 128.96 38.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.832 0.825 . . . . 0.0 109.119 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.6 mt -123.53 162.81 22.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.615 -0.678 . . . . 0.0 109.289 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.33 -166.73 13.03 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.77 71.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.491 -1.005 . . . . 0.0 109.458 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.83 21.66 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -147.58 155.88 42.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.64 -1.287 . . . . 0.0 110.355 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.82 114.56 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -57.97 -47.02 84.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.046 -1.034 . . . . 0.0 109.904 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.86 121.83 61.12 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.139 -0.976 . . . . 0.0 109.768 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.87 -16.22 45.29 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.437 1.424 . . . . 0.0 111.794 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -15.12 59.54 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.63 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.47 -170.32 50.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 217' ' ' LEU . 6.3 mt -86.78 131.12 34.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -1.213 . . . . 0.0 109.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -63.15 -17.78 62.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.122 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CD2' ' CZ ' ' A' ' 225' ' ' ARG . 62.3 m-85 -144.73 -168.88 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -100.65 -0.24 37.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.247 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 30.49 1.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.034 -1.041 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 mt-10 -46.26 -51.17 35.35 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.026 -1.047 . . . . 0.0 110.013 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 76.4 Cg_exo -47.4 -68.01 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.118 1.878 . . . . 0.0 112.278 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.4 m -57.33 -34.84 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.963 -1.086 . . . . 0.0 109.991 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' CZ ' ' CD2' ' A' ' 219' ' ' TYR . 5.0 mtp180 -60.53 -42.85 97.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 108.381 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 6.9 t60 -65.78 -33.02 74.9 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.88 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.9 t -69.75 -36.77 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.4 t80 -65.98 -48.82 69.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.562 -0.711 . . . . 0.0 109.147 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.551 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 86.6 m-20 -65.0 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.804 . . . . 0.0 109.776 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.5 tp -75.02 -31.77 61.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.816 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.84 -39.37 81.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.95 -54.79 19.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.36 -35.62 67.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.055 -1.262 . . . . 0.0 109.279 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.11 -22.79 64.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 110.414 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.598 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.8 -22.28 60.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.164 . . . . 0.0 109.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.9 mt -50.93 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.639 -1.288 . . . . 0.0 110.6 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.598 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -77.46 -14.85 59.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.831 -1.168 . . . . 0.0 109.643 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.78 57.67 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.563 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.16 155.07 10.23 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.374 . . . . 0.0 108.937 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.1 Cg_endo -50.02 151.02 9.25 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.825 1.684 . . . . 0.0 109.566 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.43 140.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 112.044 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -121.86 119.12 30.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.9 -163.56 30.95 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.142 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.514 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -123.77 141.64 51.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -1.032 . . . . 0.0 109.078 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -139.6 139.64 36.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -127.02 118.38 24.35 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 133.83 53.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.005 -1.059 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -115.47 112.16 21.84 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.36 28.68 2.44 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.494 ' N ' ' HH ' ' A' ' 151' ' ' TYR . . . -72.61 149.13 42.99 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -121.78 -174.2 14.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.552 ' HE2' HN23 ' A' ' 500' ' ' C90 . 68.2 m-70 -63.74 -41.38 98.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.094 . . . . 0.0 109.741 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -58.63 6.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.032 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.402 HD12 ' HZ1' ' A' ' 258' ' ' LYS . 5.7 tp -55.29 -45.07 76.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.202 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 22.2 m-20 -47.73 -51.56 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.432 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 90.8 t -63.18 -42.27 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.402 ' HZ1' HD12 ' A' ' 255' ' ' LEU . 28.2 ttmt -61.41 -52.86 62.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -50.34 -49.63 53.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.091 -1.006 . . . . 0.0 108.423 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.1 t -58.03 -52.18 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -50.76 -49.52 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -61.54 -51.24 69.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.791 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.98 -48.45 75.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 109.738 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.34 71.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 109.801 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -67.35 -40.26 85.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 108.954 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.493 ' HZ3' ' CD1' ' A' ' 130' ' ' ILE . 0.1 OUTLIER -67.79 -66.21 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.449 -0.782 . . . . 0.0 109.028 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -42.93 -46.27 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.403 -0.811 . . . . 0.0 109.507 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 265' ' ' LYS . 10.4 mmmt -94.07 110.83 22.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 109.529 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.552 HN23 ' HE2' ' A' ' 253' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.2 mt -101.67 153.81 19.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -1.11 . . . . 0.0 109.578 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.596 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -53.18 129.02 29.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 142.07 50.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.182 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 t -141.94 -170.57 3.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.66 136.45 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -62.85 -20.48 65.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -152.15 -171.12 3.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.222 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 142.14 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.09 160.23 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.14 145.2 41.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.996 -1.065 . . . . 0.0 110.698 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 73.3 m-85 -139.83 155.09 47.43 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.05 151.69 19.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.809 -1.182 . . . . 0.0 110.319 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.43 174.77 36.1 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.85 151.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 110.128 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.63 137.98 16.38 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.0 tt -58.95 -39.06 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.105 -1.232 . . . . 0.0 110.452 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -90.74 -50.65 5.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.724 -1.235 . . . . 0.0 110.966 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -70.31 -22.68 62.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.68 -0.638 . . . . 0.0 111.091 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.75 17.48 21.22 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.686 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -105.26 151.25 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -1.151 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -74.77 132.87 41.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.177 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 145.31 40.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 5.7 ttmt -113.02 156.42 23.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.0 mt -133.4 147.01 51.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.491 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.2 mt -141.38 108.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.917 . . . . 0.0 108.738 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.25 115.44 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 111.122 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.491 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 33.3 m-70 -111.12 139.81 22.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.578 -0.701 . . . . 0.0 109.689 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -52.57 168.33 0.46 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.048 1.832 . . . . 0.0 111.854 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 16.4 mm-40 -141.02 -178.97 5.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.162 -0.961 . . . . 0.0 109.798 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.6 mttm -89.45 154.4 20.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -47.62 142.46 4.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.329 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.11 11.22 63.44 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.466 -0.874 . . . . 0.0 110.949 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -72.02 -44.87 62.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.605 -1.526 . . . . 0.0 109.752 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -179.88 33.77 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.379 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mm -95.67 117.97 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 148.24 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.86 158.87 15.5 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -129.9 110.58 11.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 0.0 108.874 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' NZ ' ' H ' ' A' ' 93' ' ' GLY . 64.6 tttp -135.06 134.6 40.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 110.737 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.05 29.52 10.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.784 . . . . 0.0 111.341 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.56 17.27 77.94 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.355 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -1.126 . . . . 0.0 109.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -83.66 127.36 33.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.0 mt -115.48 93.81 37.76 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 109.436 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.55 145.8 16.07 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.412 2.075 . . . . 0.0 111.948 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.38 79.76 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -134.18 -179.89 5.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -74.99 -55.25 5.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 110.01 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 33.4 mt-10 -43.55 -17.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.795 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' HIS . 35.5 m-85 -95.17 0.62 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.884 -1.135 . . . . 0.0 110.104 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.8 t -68.48 129.46 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.415 -0.803 . . . . 0.0 109.173 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -112.38 -29.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.322 -0.861 . . . . 0.0 109.977 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -152.26 132.98 14.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.036 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 47.8 p -123.65 95.46 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 59' ' ' SER . 47.7 t-20 -162.95 129.21 3.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 108.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 84.6 m-70 48.97 10.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.056 -1.027 . . . . 0.0 108.711 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 163.0 157.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.9 m -102.86 127.76 49.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -121.33 152.37 39.05 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 111.024 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.9 mt -128.14 152.18 48.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.31 151.86 21.96 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 118.824 -1.655 . . . . 0.0 110.956 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CD2' ' CD ' ' A' ' 65' ' ' LYS . 9.4 t80 -156.51 146.29 20.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -1.03 . . . . 0.0 109.676 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CD ' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 54.73 21.79 3.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.528 -0.732 . . . . 0.0 109.638 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.88 8.17 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.96 145.24 55.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.318 . . . . 0.0 109.343 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.91 142.86 34.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 110.333 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.13 125.94 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -100.21 156.67 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.081 . . . . 0.0 111.217 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m 49.27 73.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.071 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.78 -8.46 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 108.957 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.4 pm0 -61.02 -26.66 67.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.599 -0.688 . . . . 0.0 110.539 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.1 m170 -68.07 -68.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.941 -1.099 . . . . 0.0 109.46 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.0 tp -52.14 -47.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.4 -48.33 68.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.6 t -59.66 -41.99 91.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.058 -1.026 . . . . 0.0 110.244 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.8 -44.02 89.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 109.168 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.29 -34.92 79.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -62.91 -38.88 92.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.72 -38.07 58.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.547 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.22 -1.46 53.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.978 . . . . 0.0 109.891 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 41.5 mt-10 55.75 42.24 29.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.385 -0.822 . . . . 0.0 111.121 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.414 HD12 HG21 ' A' ' 84' ' ' ILE . 46.0 mm -84.87 141.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.946 -1.096 . . . . 0.0 108.096 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.5 p -123.79 -23.71 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 0.0 112.027 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.493 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 80.4 m-20 -125.98 107.66 10.66 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.698 -1.251 . . . . 0.0 110.688 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.5 m -162.95 149.14 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.829 0.824 . . . . 0.0 110.442 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 45.2 m -116.71 113.77 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.65 100.92 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.467 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -70.24 124.57 24.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.2 t -107.96 119.0 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.587 0.708 . . . . 0.0 111.507 -178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mt -108.85 93.38 2.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.468 ' H ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.63 160.52 8.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -81.05 -5.55 57.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.914 -1.345 . . . . 0.0 111.091 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -142.06 149.11 39.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.602 -1.311 . . . . 0.0 110.276 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 46.4 mm -73.89 121.82 86.1 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -41.52 127.81 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.585 1.523 . . . . 0.0 111.282 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 tp -81.76 -15.94 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.879 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.8 mt 58.1 -120.62 1.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.12 -0.988 . . . . 0.0 110.081 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 46.4 t0 -97.49 5.81 49.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.62 60.11 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.384 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.4 p -127.86 -172.62 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.896 . . . . 0.0 109.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.1 15.83 10.14 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CH2' ' CD ' ' A' ' 108' ' ' GLU . 6.1 t-105 -60.26 -43.56 96.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.48 -1.012 . . . . 0.0 110.317 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.71 -58.59 6.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.024 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.29 -45.16 62.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -61.9 -49.29 76.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 111.22 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CD ' ' CH2' ' A' ' 104' ' ' TRP . 1.6 mm-40 -65.5 -42.36 92.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.019 -1.05 . . . . 0.0 111.236 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.92 -54.2 24.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.017 -1.052 . . . . 0.0 110.286 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.29 -32.56 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -64.42 -42.55 95.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -76.16 12.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.74 32.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.165 . . . . 0.0 110.545 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -80.32 138.96 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.932 -1.105 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.52 125.53 34.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.546 -0.721 . . . . 0.0 109.157 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -78.27 145.42 35.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.352 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -115.06 -173.53 2.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.688 -0.632 . . . . 0.0 109.404 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.55 65.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.293 -0.879 . . . . 0.0 111.268 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.502 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -161.49 129.31 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 0.0 109.043 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -68.38 141.1 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 109.163 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.427 HD12 HG23 ' A' ' 121' ' ' ILE . 85.4 mt -82.16 147.77 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 110.427 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -95.66 84.12 3.88 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 55.1 m-85 -62.82 143.93 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -90.43 101.96 14.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 55.1 t -93.05 133.62 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.699 . . . . 0.0 111.193 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.47 115.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -98.78 -26.81 14.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 110.576 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.02 148.43 65.72 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.36 148.35 38.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.493 2.129 . . . . 0.0 111.899 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.29 152.27 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.957 . . . . 0.0 109.363 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.83 146.45 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.212 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.18 147.09 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -135.19 162.63 31.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.984 -1.072 . . . . 0.0 110.515 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -173.9 103.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 50.58 58.66 5.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 110.725 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.44 -32.59 2.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.421 HH21 ' H ' ' A' ' 252' ' ' GLY . 42.7 mtp180 -61.91 134.12 56.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.245 . . . . 0.0 108.26 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -146.1 137.79 24.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.77 -1.206 . . . . 0.0 110.446 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 79.6 mt -135.62 131.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.476 -0.765 . . . . 0.0 109.353 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -121.37 131.09 53.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.369 0.604 . . . . 0.0 109.839 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.88 134.62 54.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 151.07 47.31 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.131 -0.981 . . . . 0.0 109.659 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.71 143.27 12.87 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.481 2.121 . . . . 0.0 113.22 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.32 147.08 20.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.61 -6.6 26.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -148.66 178.68 8.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.942 -1.098 . . . . 0.0 109.741 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.98 120.8 32.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.996 . . . . 0.0 108.709 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -135.73 129.72 33.07 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.4 t -129.87 120.73 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 47.6 m -112.3 152.29 28.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.461 -0.774 . . . . 0.0 109.358 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.46 130.74 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.458 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 23.2 tt0 -120.84 130.36 53.92 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.22 137.79 9.57 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.465 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -103.06 100.14 10.06 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.21 166.93 13.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.008 . . . . 0.0 110.833 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -99.67 -18.56 17.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.563 -0.711 . . . . 0.0 110.652 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.4 p-10 -92.3 -170.0 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.227 . . . . 0.0 110.22 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -52.77 0.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 111.398 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.543 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.1 mt -79.02 -28.01 43.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.401 -1.437 . . . . 0.0 108.734 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.66 -138.48 33.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -101.93 134.64 44.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.233 -1.157 . . . . 0.0 109.671 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -138.53 151.72 47.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -141.09 144.8 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.76 135.29 27.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.3 m -105.03 121.93 44.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.698 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.415 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 7.7 t80 -102.66 113.12 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -104.22 148.75 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.767 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -49.36 131.26 20.35 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.261 -0.899 . . . . 0.0 109.026 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.7 -3.63 39.33 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 1.3 m-20 -114.6 24.46 11.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 0.0 109.183 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.407 ' O ' ' N ' ' A' ' 173' ' ' GLU . 1.1 mt-10 -50.87 -56.48 12.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.293 -0.88 . . . . 0.0 109.882 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -44.62 -23.45 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.306 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' GLU . 6.6 mt-10 -83.24 -12.72 56.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 111.537 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.9 pt -121.44 -28.26 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.862 -1.149 . . . . 0.0 111.2 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.1 m -63.66 -27.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.556 -1.34 . . . . 0.0 109.395 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.52 -6.0 54.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.66 24.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.684 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.475 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -88.71 172.17 9.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.528 ' HG1' HN17 ' A' ' 500' ' ' C90 . 5.8 t -78.57 162.32 26.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.55 146.07 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.125 -1.609 . . . . 0.0 111.836 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.5 157.72 44.1 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.453 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 77.3 m-85 -100.96 147.77 25.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.414 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 22.8 p30 -54.23 -33.29 58.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 110.022 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.551 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 7.0 p90 -72.35 -28.76 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.818 -1.176 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.525 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -81.84 -37.33 27.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.099 -1.001 . . . . 0.0 109.985 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 94.3 mt -45.53 -59.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.966 -1.084 . . . . 0.0 109.475 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 14.9 tt0 -41.32 -39.4 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 109.763 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 12.7 t-160 -73.94 -44.38 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.769 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.422 HG23 HD13 ' A' ' 189' ' ' ILE . 98.2 mt -57.72 -27.59 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.555 -0.716 . . . . 0.0 109.579 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -84.67 -53.59 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.883 -1.136 . . . . 0.0 109.317 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -49.24 -42.48 40.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.1 m -75.68 6.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.978 -1.076 . . . . 0.0 110.294 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.41 39.65 50.32 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 55.0 mt -128.77 172.09 11.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.225 -1.162 . . . . 0.0 109.855 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 62.41 20.79 61.53 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -54.17 -21.51 9.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.636 -1.508 . . . . 0.0 109.85 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -115.35 25.8 9.56 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.07 124.31 7.1 Favored Glycine 0 N--CA 1.491 2.362 0 O-C-N 120.819 -1.401 . . . . 0.0 109.703 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.28 172.74 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.8 mt -69.13 -7.91 40.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 6.2 mmmt -91.58 -12.17 35.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.832 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -143.46 13.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.917 -1.114 . . . . 0.0 110.421 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -148.39 149.65 32.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.857 -1.152 . . . . 0.0 110.82 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 26.0 tp -99.11 93.51 6.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 47.5 t -86.81 129.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.868 0.842 . . . . 0.0 109.336 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.26 164.76 18.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.19 -166.45 12.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -26.44 68.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.499 -1.0 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.64 21.89 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -143.33 150.82 39.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.755 -1.215 . . . . 0.0 110.518 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.26 111.72 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -57.79 -51.37 69.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 110.236 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -57.62 111.66 3.75 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -58.36 -11.77 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.699 1.599 . . . . 0.0 111.772 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -17.28 59.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 110.2 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.7 -177.79 46.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.9 mt -88.81 143.28 27.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.767 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.596 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 37.1 mtp85 -73.46 -20.01 60.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.602 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 17.2 m-85 -146.83 169.81 18.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -82.28 10.77 6.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 38.11 0.49 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.407 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -55.08 -47.42 98.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.94 -1.1 . . . . 0.0 109.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 54.3 Cg_exo -50.53 -65.37 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.3 m -58.7 -36.34 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.602 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 60.7 mtt180 -60.48 -42.85 97.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.2 t60 -66.42 -32.48 73.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.355 -0.841 . . . . 0.0 108.964 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -65.66 -35.49 80.93 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.6 t -68.64 -36.73 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.463 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 61.6 t80 -65.24 -52.6 53.48 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.501 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 88.1 m-20 -62.93 -29.7 70.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.842 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.7 tp -74.79 -32.85 62.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.029 -1.044 . . . . 0.0 108.536 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.53 -40.85 85.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.41 -53.92 32.72 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.459 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 24.7 m-20 -56.79 -30.57 63.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.062 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.5 mt -67.11 -24.44 65.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.66 -22.36 60.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.813 -1.18 . . . . 0.0 109.095 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 83.2 mt -49.16 -6.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.516 -1.365 . . . . 0.0 110.063 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.4 mt -72.28 -16.12 61.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.908 -1.12 . . . . 0.0 109.63 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.63 2.24 60.04 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.794 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.39 153.88 9.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.779 -1.424 . . . . 0.0 108.984 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -49.34 150.5 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.787 1.658 . . . . 0.0 109.618 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.48 148.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.009 -1.057 . . . . 0.0 111.861 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -128.92 122.95 31.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.34 -163.86 31.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ttpt -126.07 139.62 53.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 109.652 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 35.1 m-85 -136.4 139.43 42.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.458 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 56.8 t80 -126.19 125.36 42.31 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.3 m -120.36 136.77 54.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 0.0 111.579 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -118.28 113.14 21.02 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 47.59 47.35 17.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.13 150.57 23.95 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.441 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -122.66 178.53 16.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.459 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.9 m-70 -61.92 -38.26 87.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -1.19 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 11.0 m -60.08 -60.01 4.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.023 -1.048 . . . . 0.0 109.004 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.41 ' H ' ' NH2' ' A' ' 137' ' ' ARG . 24.4 tp -52.0 -47.59 64.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.09 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 19.7 m-20 -48.02 -50.9 26.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 73.9 t -60.84 -54.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.997 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -45.33 59.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.668 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.12 -55.44 27.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.02 . . . . 0.0 108.56 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 261' ' ' LYS . 15.2 t -56.81 -55.32 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.077 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 260' ' ' VAL . 0.1 OUTLIER -44.95 -48.51 11.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.1 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.22 -52.76 63.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.403 -0.811 . . . . 0.0 109.485 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.09 -50.09 59.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.28 -27.03 63.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.507 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -73.54 -58.45 3.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 110.663 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -62.45 -37.58 86.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.92 -1.112 . . . . 0.0 109.744 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -48.75 -13.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 266' ' ' LYS . 0.3 OUTLIER -132.79 120.49 21.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 109.372 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.528 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.63 146.73 40.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.199 -1.177 . . . . 0.0 109.33 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -52.5 142.27 18.19 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -123.05 144.73 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.33 -170.55 3.3 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.49 136.63 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.89 -1.131 . . . . 0.0 109.314 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -19.68 65.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 110.078 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -154.23 156.33 36.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 138.06 58.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 109.809 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -118.77 163.99 16.05 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.48 142.23 48.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.91 150.18 46.85 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 9.6 pt-20 -158.91 151.28 21.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.926 -1.109 . . . . 0.0 109.923 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.55 173.66 35.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.44 148.34 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.232 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.67 137.07 16.21 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.1 tt -59.09 -37.84 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.052 -1.263 . . . . 0.0 110.298 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.423 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 70.5 m-70 -88.85 -50.17 6.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.687 -1.258 . . . . 0.0 110.925 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 p -69.69 -20.76 63.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 111.544 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.36 12.88 6.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.15 156.61 18.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -1.018 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 67.4 t80 -74.39 135.11 42.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -138.41 144.09 40.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.88 155.16 24.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.0 mt -135.87 146.41 47.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.35 -0.844 . . . . 0.0 109.953 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.509 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 mt -141.43 112.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 108.638 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.91 113.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 110.466 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.7 m-70 -107.47 137.72 19.74 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -54.77 168.73 1.02 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.685 1.59 . . . . 0.0 111.515 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 77.6 mm-40 -141.04 176.09 9.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.955 . . . . 0.0 109.769 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 18.6 mmtp -87.08 155.18 20.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -46.46 141.69 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.712 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 70.85 9.2 65.54 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.27 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.7 ' H ' HD21 ' A' ' 86' ' ' ASN . 53.5 m -71.53 -44.16 65.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.476 -1.602 . . . . 0.0 109.461 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.28 -179.87 35.1 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.512 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 mm -97.69 115.63 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -139.92 154.45 47.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.914 -1.116 . . . . 0.0 110.333 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -102.79 158.36 16.32 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -129.68 111.73 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.296 -0.878 . . . . 0.0 108.981 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -135.41 134.75 40.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.839 . . . . 0.0 110.621 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.495 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.7 m120 50.37 32.74 6.67 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 111.47 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 17.39 79.95 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.427 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -123.22 120.94 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.055 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -82.41 126.81 32.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.443 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.42 92.07 31.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.458 -0.777 . . . . 0.0 109.201 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.81 146.14 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.502 2.135 . . . . 0.0 112.287 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.35 70.24 10.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -122.86 166.89 14.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 109.448 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.615 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.6 p-80 -68.94 -53.85 18.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.615 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -44.99 -16.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' HIS . 41.1 m-85 -95.44 3.4 54.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -70.47 129.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 108.719 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.53 -29.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.841 . . . . 0.0 110.225 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.12 131.53 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.9 p -123.18 95.12 4.48 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.568 ' ND2' ' CD2' ' A' ' 58' ' ' HIS . 1.1 t-20 -163.33 130.68 3.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.568 ' CD2' ' ND2' ' A' ' 57' ' ' ASN . 73.7 m-70 50.46 8.8 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.041 -1.037 . . . . 0.0 108.848 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.9 157.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.54 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.415 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 36.2 m -100.55 127.71 46.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 109.254 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.78 151.85 41.23 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.799 0.809 . . . . 0.0 111.171 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mt -126.42 151.21 48.01 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.37 156.56 28.4 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.568 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -164.7 151.89 11.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -1.069 . . . . 0.0 109.273 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 53.1 21.66 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.256 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.09 7.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 85.7 mm-40 -60.64 148.15 39.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -1.209 . . . . 0.0 109.451 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.44 ' NH1' HD22 ' A' ' 94' ' ' ASN . 9.6 ttp-105 -144.48 140.81 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.478 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.82 126.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -101.47 156.19 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.898 -1.126 . . . . 0.0 111.299 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.2 m 50.93 74.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.2 -10.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.579 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.34 -28.56 69.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -64.8 -68.88 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.886 -1.134 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.39 -48.12 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.12 -0.987 . . . . 0.0 109.28 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.1 mt -50.88 -50.3 57.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.953 -1.092 . . . . 0.0 110.286 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.54 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 9.4 t -60.48 -42.81 97.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 110.164 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.71 -45.32 79.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.4 mt -68.16 -35.0 77.35 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.082 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.1 -31.77 72.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.848 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 72.2 mt -83.34 -36.92 24.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.3 mt -80.29 4.44 17.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.733 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 53.8 38.76 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.957 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.0 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.496 ' OG1' ' OD1' ' A' ' 86' ' ' ASN . 72.6 p -126.13 -18.9 4.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.181 -0.949 . . . . 0.0 111.762 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.712 HD22 ' N ' ' A' ' 34' ' ' GLY . 3.0 m120 -126.98 107.9 10.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.843 -1.161 . . . . 0.0 110.956 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 6.7 m -163.95 148.18 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.377 -0.827 . . . . 0.0 109.971 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 27.9 m -117.06 110.04 17.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -94.08 103.73 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -77.33 127.51 32.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.41 128.99 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.98 0.895 . . . . 0.0 111.734 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mm -112.2 95.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.44 -155.83 24.89 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.44 HD22 ' NH1' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -120.18 -10.45 9.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -1.107 . . . . 0.0 110.13 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -141.06 149.91 42.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.926 -1.109 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.5 mm -72.68 121.66 85.52 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 109.182 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -41.15 127.26 2.83 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.641 1.561 . . . . 0.0 111.175 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 tp -81.27 -12.61 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.5 mt 55.25 -121.15 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.4 9.32 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.927 -1.108 . . . . 0.0 111.192 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.49 -2.98 65.5 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.242 -1.456 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -172.09 2.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.625 -0.926 . . . . 0.0 109.628 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.1 15.72 12.11 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -56.39 -43.83 79.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -1.088 . . . . 0.0 110.232 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -57.46 8.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.089 -1.007 . . . . 0.0 110.143 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -51.68 -47.95 63.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 109.871 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -61.59 -49.18 77.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 111.214 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.92 -43.02 89.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 111.368 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.77 -54.95 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.939 -1.101 . . . . 0.0 110.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.1 mt -63.45 -34.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 109.477 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -62.81 -41.72 99.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -78.07 12.83 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.822 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -142.54 31.17 1.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.971 -1.08 . . . . 0.0 110.327 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.409 HG22 HD12 ' A' ' 114' ' ' ILE . 78.3 mt -80.05 138.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 110.478 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 tp -129.76 122.49 28.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 147.86 42.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.93 -174.87 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -110.62 66.36 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.137 -0.977 . . . . 0.0 111.222 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.4 129.52 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.865 -1.147 . . . . 0.0 109.379 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.42 141.55 56.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.783 -1.198 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 85.4 mt -84.2 150.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 110.266 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -97.46 81.89 3.03 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 31.2 m-85 -59.33 142.04 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -88.06 101.3 13.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.01 132.65 35.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.412 0.625 . . . . 0.0 110.643 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.93 111.17 2.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.56 -31.67 26.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.02 -1.05 . . . . 0.0 110.323 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 155.47 75.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.627 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.05 153.5 57.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.529 2.153 . . . . 0.0 112.103 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 tt -159.59 153.07 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -0.789 . . . . 0.0 109.273 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.36 141.89 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.92 150.05 33.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -135.76 158.93 43.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.61 106.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.929 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.9 51.55 15.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.25 3.32 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.146 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -61.61 137.4 58.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.963 -1.316 . . . . 0.0 108.639 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.502 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.9 tt -145.03 138.11 26.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 110.251 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mt -134.97 132.54 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.569 -0.707 . . . . 0.0 109.556 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -121.39 130.82 53.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.696 -0.628 . . . . 0.0 109.948 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.06 137.14 54.92 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -149.28 149.63 29.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.47 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 40.6 Cg_exo -47.74 143.73 12.26 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.491 2.127 . . . . 0.0 113.572 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.4 144.32 19.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.85 -5.4 2.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.61 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.6 p -154.04 -174.89 5.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 109.628 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 13.1 tp -93.76 122.04 35.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.132 -0.98 . . . . 0.0 108.933 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -135.86 126.63 27.38 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.82 123.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 m -113.68 152.62 30.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.684 -0.635 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -138.95 131.78 29.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.123 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -120.91 135.23 55.24 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 137.06 8.59 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.633 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.81 97.91 7.99 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.95 167.09 16.22 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 110.937 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.422 ' O ' ' NZ ' ' A' ' 208' ' ' LYS . 16.5 mtpp -100.01 -15.25 18.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.6 p-10 -95.01 -168.18 1.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.125 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -57.16 2.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -0.787 . . . . 0.0 111.296 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.507 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.5 mt -79.03 -26.63 43.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.455 -1.403 . . . . 0.0 108.28 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.3 -137.53 37.68 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 131.25 45.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.4 -1.059 . . . . 0.0 109.295 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.22 146.23 44.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -0.792 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.667 ' CB ' ' HZ2' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -142.26 148.01 37.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.371 -0.83 . . . . 0.0 110.366 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -146.53 140.39 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 110.044 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.1 m -107.21 123.41 48.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 109.732 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -103.06 112.8 25.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.902 . . . . 0.0 110.312 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.69 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.875 . . . . 0.0 109.673 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -48.16 134.38 14.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.413 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 107.58 -9.12 37.86 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -120.84 26.43 9.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.575 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.8 OUTLIER -68.25 -16.01 63.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.74 -8.84 57.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 0.0 109.894 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -106.15 -5.5 19.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.37 -33.38 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.32 -0.862 . . . . 0.0 109.632 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.4 m -64.11 -23.67 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 108.395 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.75 -7.2 59.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.05 119.47 12.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 108.963 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -80.62 173.01 13.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 109.514 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.539 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.5 t -77.18 162.01 27.74 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -148.25 141.65 25.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.312 -1.492 . . . . 0.0 111.71 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -139.32 156.72 46.84 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -98.2 143.64 28.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.264 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.486 ' OD1' ' O ' ' A' ' 183' ' ' ASP . 3.3 t0 -47.7 -35.32 9.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -0.85 . . . . 0.0 109.59 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.545 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -73.13 -29.87 63.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.883 -1.136 . . . . 0.0 109.681 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.545 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 4.6 tt0 -75.38 -41.21 56.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.447 ' O ' ' C ' ' A' ' 187' ' ' GLU . 49.5 mt -46.17 -56.71 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -0.983 . . . . 0.0 110.031 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.6 -40.08 1.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -76.19 -53.79 7.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.875 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.86 -26.8 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.452 -0.78 . . . . 0.0 109.624 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.98 -53.64 5.17 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.785 -1.197 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -47.58 -44.9 26.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 110.217 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.99 8.67 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.9 54.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.818 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.402 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 50.9 mt -128.04 172.03 11.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -1.196 . . . . 0.0 109.687 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.423 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 57.39 24.83 53.41 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -60.14 -19.62 54.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.714 -1.462 . . . . 0.0 110.304 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -106.43 4.33 37.53 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.05 129.99 41.54 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.107 -1.231 . . . . 0.0 110.307 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.63 165.13 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.997 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.81 -8.4 43.1 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -97.09 -10.41 26.11 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.455 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 19.1 p-10 -140.3 9.82 2.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 m -145.27 147.09 31.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.106 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 19.4 tp -97.8 93.86 6.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -88.45 130.51 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.569 0.7 . . . . 0.0 109.281 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 18.3 mt -123.33 -178.46 4.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 109.605 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.95 -166.13 10.54 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.422 ' NZ ' ' O ' ' A' ' 156' ' ' LYS . 8.2 mmtt -64.59 -20.75 66.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -1.104 . . . . 0.0 109.401 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.34 22.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.848 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -140.78 148.51 40.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.046 -1.033 . . . . 0.0 110.34 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.38 110.55 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -57.74 -45.22 86.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.987 -1.071 . . . . 0.0 109.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.8 118.82 45.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.642 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.23 -14.52 43.34 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.401 1.401 . . . . 0.0 112.017 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.85 -14.73 60.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.057 -1.027 . . . . 0.0 108.78 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.04 52.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.5 mt -86.14 134.99 33.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -1.206 . . . . 0.0 109.617 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -64.17 -19.58 65.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 108.824 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.663 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.5 m-85 -139.89 -164.16 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.118 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.65 -21.41 17.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.12 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 48.38 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.448 -0.783 . . . . 0.0 109.463 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.515 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -53.8 -47.92 95.19 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.995 . . . . 0.0 109.992 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.7 Cg_exo -48.67 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.164 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.87 -36.76 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.976 -1.078 . . . . 0.0 109.666 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.663 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 74.8 mtt180 -60.09 -41.74 93.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 108.267 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -68.02 -30.56 69.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.905 . . . . 0.0 108.859 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.515 ' HZ3' HO20 ' A' ' 500' ' ' C90 . 13.3 mmtt -65.75 -36.0 82.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -68.48 -37.72 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.54 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.8 t80 -64.1 -52.1 60.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.546 -0.721 . . . . 0.0 109.175 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.25 -27.31 68.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.74 -33.2 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.161 -0.962 . . . . 0.0 108.57 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.66 -38.81 79.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -57.58 9.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.492 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.4 m-20 -54.35 -37.26 64.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -1.211 . . . . 0.0 109.06 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mt -61.99 -24.68 67.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 0.0 110.271 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.617 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.2 t80 -72.85 -20.85 61.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.162 . . . . 0.0 109.35 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 83.8 mt -50.67 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.858 -1.151 . . . . 0.0 110.591 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.617 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.9 mt -74.59 -14.23 60.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.779 -1.2 . . . . 0.0 109.854 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.17 1.69 59.41 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.575 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.1 m -164.94 153.11 10.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.259 . . . . 0.0 108.751 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.6 Cg_endo -50.06 150.4 10.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.806 1.671 . . . . 0.0 109.48 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.66 142.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.812 -1.18 . . . . 0.0 112.056 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -124.05 119.82 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.96 -165.94 32.33 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.525 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.2 tmtt? -123.39 142.06 51.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -1.022 . . . . 0.0 108.581 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 9.7 m-85 -139.52 142.16 37.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.981 -1.074 . . . . 0.0 110.63 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -126.28 132.56 51.64 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -126.93 137.7 53.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 111.145 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -119.32 116.83 27.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 47.09 28.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.182 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.0 153.31 52.89 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -134.52 170.39 22.71 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.579 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -49.92 -36.52 27.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -1.166 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.45 ' H ' ' HG ' ' A' ' 254' ' ' SER . 0.3 OUTLIER -58.84 -58.19 9.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.701 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 8.6 tp -59.21 -45.02 92.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.071 -1.018 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.5 m-20 -47.77 -51.39 22.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.566 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 84.8 t -62.94 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.339 -0.85 . . . . 0.0 109.404 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -50.97 -51.07 56.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 109.209 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 33.0 tp -51.26 -51.62 52.44 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 108.487 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 71.2 t -57.14 -53.86 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.948 . . . . 0.0 109.104 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -46.78 -41.66 15.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -70.98 -50.32 35.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.905 . . . . 0.0 109.802 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 38.2 mt -57.28 -47.64 80.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.05 75.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -68.75 -36.59 78.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.968 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.07 -64.4 0.86 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.327 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.67 -40.92 60.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.56 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 102.06 14.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.539 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.05 159.75 18.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -1.131 . . . . 0.0 109.489 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.11 137.52 51.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.088 -1.008 . . . . 0.0 108.473 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -123.23 144.89 49.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -143.41 -168.85 2.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.97 136.31 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.05 -12.96 56.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.39 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 8.5 pt-20 -156.15 -172.71 4.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 141.92 28.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 mt -119.15 166.15 13.3 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.8 144.54 37.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 110.328 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 76.1 m-85 -140.0 156.23 46.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -163.59 149.23 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 109.581 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.95 173.35 35.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 p -79.32 150.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -1.074 . . . . 0.0 110.518 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.63 141.18 15.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.0 tt -60.67 -39.66 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -1.154 . . . . 0.0 111.189 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 75.2 m-70 -88.14 -49.44 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 111.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -72.18 -21.68 61.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.664 . . . . 0.0 111.842 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.27 16.88 22.29 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.08 -1.533 . . . . 0.0 109.558 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.48 156.14 20.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -1.152 . . . . 0.0 109.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.39 136.68 39.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.88 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -135.64 141.12 45.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -110.36 155.71 21.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 109.723 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' PHE . 7.3 mt -137.89 149.38 46.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.519 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -141.71 109.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.54 116.65 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.165 -0.96 . . . . 0.0 111.049 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.519 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 21.4 m-70 -112.77 139.75 23.19 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.442 -0.786 . . . . 0.0 109.542 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -54.26 168.59 0.91 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.895 1.73 . . . . 0.0 111.916 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 14.4 mm-40 -138.0 178.18 7.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.593 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.505 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.9 mtmm -87.16 152.76 22.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.981 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -48.36 146.21 2.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.642 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.751 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 68.35 8.49 55.44 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.729 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.67 ' H ' HD21 ' A' ' 86' ' ' ASN . 26.4 m -73.42 -45.84 52.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.608 -1.525 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.66 -178.92 30.2 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.662 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.4 mm -97.9 117.18 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -142.07 150.14 40.84 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -99.7 157.12 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -129.69 110.72 12.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 108.974 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.666 ' NZ ' ' NE2' ' A' ' 67' ' ' GLN . 17.5 tttm -135.96 135.97 40.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.582 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m120 51.03 28.17 3.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 111.183 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.23 74.76 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.024 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.95 120.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -1.065 . . . . 0.0 108.946 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 29.3 m-85 -86.86 129.0 35.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.066 -1.021 . . . . 0.0 109.169 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 52.8 mt -120.12 96.95 49.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.238 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -53.07 149.3 27.71 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.081 1.854 . . . . 0.0 111.101 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.7 72.16 10.36 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -127.55 175.61 8.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -73.19 -50.74 20.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -43.72 -17.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.184 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' HIS . 54.2 m-85 -98.2 0.07 45.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.128 . . . . 0.0 110.258 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -68.81 130.91 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 108.722 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.4 m -114.3 -28.7 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.326 -0.859 . . . . 0.0 110.088 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -152.81 131.62 12.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.956 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.3 p -121.75 95.09 4.53 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.602 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.3 t-20 -163.11 128.74 3.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.399 -0.813 . . . . 0.0 109.064 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 76.9 m-70 50.25 6.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.962 . . . . 0.0 109.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.602 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.1 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.7 m -81.38 129.18 34.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 0.0 109.247 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.92 150.43 42.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.357 -0.839 . . . . 0.0 111.172 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -126.0 147.66 49.48 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.69 160.41 32.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.248 -1.453 . . . . 0.0 110.243 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.24 149.58 10.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -1.123 . . . . 0.0 109.329 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.65 21.47 3.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.411 -0.805 . . . . 0.0 109.938 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.53 -30.94 8.95 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.681 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.693 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.78 145.06 50.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.763 -1.433 . . . . 0.0 108.855 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 4.7 mtt180 -137.46 149.76 47.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.019 -1.051 . . . . 0.0 111.874 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.29 128.45 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -105.14 155.28 19.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.892 -1.13 . . . . 0.0 111.338 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.2 m 51.5 74.57 0.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.894 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -108.24 -9.58 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.037 -1.039 . . . . 0.0 109.63 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.0 pm0 -61.13 -26.8 67.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 110.689 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 25.4 m170 -66.88 -68.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.958 -1.089 . . . . 0.0 109.375 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -51.84 -47.64 40.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.048 -1.033 . . . . 0.0 109.058 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.9 mt -54.13 -47.42 71.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.889 -1.132 . . . . 0.0 110.478 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.539 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 25.2 t -60.23 -41.75 93.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.004 -1.06 . . . . 0.0 109.817 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -57.5 -45.81 85.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 108.955 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.97 -35.0 79.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 109.247 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.05 -40.25 97.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 0.0 109.202 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.0 mt -75.68 -38.48 58.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.22 -0.48 45.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.842 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 56.42 41.97 28.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 111.303 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 84' ' ' ILE . 37.1 mm -88.33 138.47 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.741 -1.224 . . . . 0.0 108.158 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.491 ' OG1' ' OD1' ' A' ' 86' ' ' ASN . 70.7 p -126.56 -20.62 4.31 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.213 -0.929 . . . . 0.0 111.451 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.751 HD22 ' N ' ' A' ' 34' ' ' GLY . 3.3 m120 -124.2 106.45 10.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.02 -1.05 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.6 m -166.07 150.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.654 0.74 . . . . 0.0 110.2 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.464 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 55.8 m -117.11 114.61 23.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mt -95.69 100.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.432 -0.792 . . . . 0.0 109.988 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -74.27 122.88 23.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.3 t -108.69 124.75 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.845 0.831 . . . . 0.0 111.906 -177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.1 mt -108.4 96.22 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.52 -158.51 27.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -122.19 -11.68 8.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -1.111 . . . . 0.0 110.196 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -140.63 149.38 42.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.442 HG23 HD11 ' A' ' 96' ' ' ILE . 41.2 mm -73.06 127.24 89.69 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.06 132.32 14.5 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.033 1.822 . . . . 0.0 111.276 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.91 -20.85 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.12 -0.987 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.9 mt 58.64 -119.69 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.91 4.71 49.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.908 -1.12 . . . . 0.0 110.95 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.78 0.04 56.45 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.332 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -172.28 2.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.718 -0.872 . . . . 0.0 109.676 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.84 13.17 9.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 47.9 t-105 -56.0 -40.54 73.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 110.742 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.44 -59.28 4.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 11.0 m-85 -51.3 -45.56 62.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.68 -49.99 75.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.772 -0.58 . . . . 0.0 110.806 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -62.99 -43.36 99.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.245 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.05 6.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.703 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.1 -30.28 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.212 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -66.11 -44.37 84.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.412 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.406 ' HG3' HD21 ' A' ' 113' ' ' ASN . 15.0 ptpt -76.36 8.72 3.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.882 -1.136 . . . . 0.0 110.431 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' OD1' ' OE1' ' A' ' 9' ' ' GLU . 8.0 m-80 -140.58 35.87 1.83 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.945 -1.097 . . . . 0.0 110.267 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.65 143.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.12 . . . . 0.0 110.88 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.9 tp -133.51 129.68 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.429 -0.795 . . . . 0.0 109.431 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.75 138.81 31.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -108.48 -173.53 2.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.73 . . . . 0.0 109.108 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.62 70.66 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.958 . . . . 0.0 110.685 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -167.4 129.68 1.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -65.96 140.54 58.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.086 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 56.3 mt -84.42 150.25 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 109.894 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -93.24 76.67 4.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.858 . . . . 0.0 108.792 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -58.21 142.79 46.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.596 ' CZ ' ' NE2' ' A' ' 267' ' ' GLN . 51.8 t80 -87.3 101.97 14.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.22 133.64 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.686 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.77 116.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -92.0 -28.71 17.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.65 156.99 78.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.943 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.56 150.15 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.913 2.409 . . . . 0.0 112.39 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.21 151.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.828 . . . . 0.0 109.323 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.82 145.91 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 109.366 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.12 147.98 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -131.78 161.32 33.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.137 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -170.35 102.21 0.27 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 110.082 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 47.6 59.26 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.805 . . . . 0.0 110.677 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.78 -35.86 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.456 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -62.94 135.98 57.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.362 . . . . 0.0 109.132 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.2 tt -143.08 139.36 30.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 110.148 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 91.4 mt -137.47 134.13 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 0.0 109.734 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.75 131.48 53.61 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.53 0.681 . . . . 0.0 109.998 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.37 55.22 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.01 150.47 45.84 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.103 -0.998 . . . . 0.0 110.197 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -48.37 142.51 17.02 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.566 2.177 . . . . 0.0 113.35 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.76 147.24 18.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -69.84 -18.07 63.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.3 p -133.51 -173.33 3.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.49 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 16.3 tp -102.43 123.02 45.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -136.83 129.04 29.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.632 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.09 121.34 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.557 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.1 m -112.27 152.15 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.488 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 37.6 t80 -138.83 129.72 26.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.965 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -120.57 131.91 54.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.0 132.3 6.21 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.701 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.24 97.59 9.29 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.57 166.98 19.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.368 -0.832 . . . . 0.0 111.169 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -105.87 23.6 13.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.752 -0.593 . . . . 0.0 110.034 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.4 p-10 -140.53 -169.74 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.053 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -47.15 -4.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.618 -0.676 . . . . 0.0 111.664 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 17.5 mt -85.27 -28.63 25.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.334 -1.479 . . . . 0.0 109.111 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.14 -132.47 41.83 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.615 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 4.4 ttm105 -97.02 129.84 44.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.302 . . . . 0.0 109.8 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.628 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -132.81 139.36 47.47 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -137.57 144.05 41.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -143.56 136.12 27.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.724 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.3 m -106.98 124.53 49.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.417 -0.802 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -105.8 118.48 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.0 t -113.59 158.42 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.75 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 30.9 mt-10 -50.18 125.15 11.71 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 108.92 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.89 6.59 39.94 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -120.31 15.81 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.245 . . . . 0.0 108.698 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -49.63 73.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.404 -0.81 . . . . 0.0 110.034 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -51.2 -22.33 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.12 -6.99 58.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 0.0 111.441 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 8.9 pt -124.95 -27.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.888 -1.133 . . . . 0.0 111.552 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.98 -24.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.528 -1.358 . . . . 0.0 108.694 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.31 -5.54 58.64 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.407 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.32 118.5 11.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.189 -0.944 . . . . 0.0 109.005 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 41.3 mtm180 -81.21 171.8 14.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.197 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.458 ' HG1' HN17 ' A' ' 500' ' ' C90 . 8.8 t -77.94 164.16 25.36 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -149.3 146.03 27.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.168 -1.582 . . . . 0.0 111.629 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.81 158.93 43.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -101.24 146.03 28.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 9.9 p30 -52.08 -32.91 36.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.233 -0.917 . . . . 0.0 109.935 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.1 p90 -71.8 -26.16 62.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.756 -1.215 . . . . 0.0 109.645 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.449 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 tt0 -83.81 -40.29 18.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.101 -1.0 . . . . 0.0 110.049 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 67.2 mt -43.17 -59.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.614 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.8 tp10 -42.1 -38.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -76.85 -42.81 38.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.137 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.97 -27.6 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.579 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.64 -53.15 5.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.666 -1.271 . . . . 0.0 109.143 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -50.99 -41.17 59.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 110.172 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.8 m -74.56 4.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.82 38.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.2 mt -129.89 171.36 12.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -1.141 . . . . 0.0 109.684 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.94 24.82 58.59 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.487 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.6 -18.48 41.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.425 -1.633 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.24 25.22 10.02 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.09 130.18 9.96 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.8 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.6 t -144.42 171.2 14.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.679 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.426 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 59.5 mt -69.78 -8.41 47.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -98.69 -13.75 20.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.642 -0.661 . . . . 0.0 109.696 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 18.7 p30 -130.33 7.1 4.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -149.19 150.13 32.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.96 95.26 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.05 127.87 40.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.985 0.898 . . . . 0.0 109.497 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 34.3 mt -123.28 164.89 17.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.613 -0.68 . . . . 0.0 109.303 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.04 -166.63 11.98 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -34.79 73.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.507 -0.996 . . . . 0.0 109.325 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -153.41 23.76 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.926 -1.109 . . . . 0.0 110.74 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -142.12 149.04 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.614 -1.304 . . . . 0.0 110.702 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.4 t -101.49 111.05 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.19 -46.41 85.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.977 -1.077 . . . . 0.0 110.148 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.1 118.28 31.48 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.927 . . . . 0.0 109.827 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -67.6 -17.2 48.15 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.85 -14.32 61.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.296 -0.878 . . . . 0.0 108.99 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.8 -176.98 45.28 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.401 HD21 ' N ' ' A' ' 217' ' ' LEU . 6.4 mt -84.37 153.05 23.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -1.208 . . . . 0.0 109.558 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.564 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -82.2 -18.4 42.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.0 m-85 -145.53 -165.14 2.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -0.751 . . . . 0.0 108.998 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.19 -4.84 28.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.309 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.675 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -141.91 40.86 1.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.85 -47.36 97.09 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.876 -1.14 . . . . 0.0 109.584 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.7 Cg_exo -51.8 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.375 2.05 . . . . 0.0 112.076 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.9 m -58.86 -35.06 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 109.624 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NH1' ' CD2' ' A' ' 219' ' ' TYR . 58.2 mtt180 -60.21 -40.66 90.92 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.9 t60 -69.43 -32.1 70.85 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.162 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 7.2 mmtp -64.88 -35.73 82.08 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.72 -40.85 84.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.539 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.5 t80 -61.78 -51.46 68.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.611 0.719 . . . . 0.0 109.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.548 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 92.0 m-20 -65.6 -27.48 68.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 110.016 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.6 tp -77.46 -34.24 54.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.094 -1.004 . . . . 0.0 108.777 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 57.9 mt -68.31 -38.5 79.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.92 -56.8 11.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 2.2 m-20 -53.16 -35.06 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.238 . . . . 0.0 108.671 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.0 mt -62.01 -23.51 66.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.639 -0.663 . . . . 0.0 110.325 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.607 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.04 -21.8 61.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 108.821 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 53.3 mt -51.22 -1.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.619 -1.3 . . . . 0.0 110.416 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.607 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.9 mt -77.86 -15.61 58.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.903 -1.123 . . . . 0.0 109.526 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.68 58.01 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.14 -1.029 . . . . 0.0 110.605 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.64 153.88 10.13 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.901 -1.352 . . . . 0.0 109.127 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.66 130.22 39.14 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.904 1.736 . . . . 0.0 109.939 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 68.5 t -86.22 147.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 122.204 1.002 . . . . 0.0 112.558 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -131.34 124.71 30.96 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.28 -155.58 26.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -131.8 133.77 45.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.315 -1.109 . . . . 0.0 109.119 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.8 m-85 -135.09 140.01 45.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.459 ' CD1' ' C ' ' A' ' 247' ' ' TYR . 4.1 t80 -125.34 132.23 52.87 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.2 t -127.62 136.85 52.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.25 112.97 20.8 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 53.41 24.91 4.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.97 153.0 48.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.49 177.5 18.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.585 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 74.8 m-70 -57.72 -36.25 71.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -1.187 . . . . 0.0 109.427 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 29.6 t -58.97 -58.62 7.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 9.0 tp -59.53 -44.6 93.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.501 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -47.94 -50.62 26.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 109.286 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.18 -50.44 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.16 -50.9 63.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.06 -1.025 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 28.8 tp -52.22 -59.36 4.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 108.447 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 43.1 t -48.39 -55.58 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.032 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -46.39 -47.53 18.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.17 -47.02 78.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -59.51 -49.79 76.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.76 -32.13 69.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 4.3 mmtp -69.8 -46.84 64.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.945 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 268' ' ' LYS . 17.2 mtpp -67.1 -52.51 41.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.596 ' NE2' ' CZ ' ' A' ' 124' ' ' PHE . 4.9 tt0 -55.94 -8.93 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.807 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 269' ' ' LEU . 0.0 OUTLIER -81.69 114.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 268' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.548 ' C22' ' OD2' ' A' ' 230' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.1 mt -98.05 155.25 17.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.435 ' CD ' HD22 ' A' ' 86' ' ' ASN . 70.8 mt-10 -55.22 139.85 40.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 108.833 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.81 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.907 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -140.55 -172.71 3.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.4 m -97.93 136.38 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.003 -1.06 . . . . 0.0 109.074 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -23.29 65.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.549 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 2.5 pt-20 -146.92 170.04 17.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 141.08 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.3 mt -120.03 166.47 13.33 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 143.18 41.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.071 -1.018 . . . . 0.0 110.418 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -139.24 154.15 47.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.98 150.8 15.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.875 -1.141 . . . . 0.0 110.019 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.22 174.98 36.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 p -82.81 153.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.115 . . . . 0.0 110.183 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.86 140.11 16.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.52 -37.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.916 -1.344 . . . . 0.0 110.379 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 45.8 m-70 -86.77 -51.07 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 111.096 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -73.47 -20.93 60.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.741 -0.599 . . . . 0.0 111.706 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.33 16.41 14.73 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.492 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.22 154.07 21.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 109.598 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.9 134.53 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -138.61 143.03 39.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.398 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -110.87 157.74 19.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.299 -0.876 . . . . 0.0 109.728 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mt -138.2 147.77 44.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.447 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.515 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.9 mt -142.55 112.69 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 108.825 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.2 mt -96.09 114.57 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 111.123 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.515 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 24.5 m-70 -109.4 139.3 20.97 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 109.669 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -55.12 168.6 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.828 1.686 . . . . 0.0 111.758 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 64.2 mm-40 -141.72 178.22 7.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.993 . . . . 0.0 109.816 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.501 ' O ' ' OG1' ' A' ' 35' ' ' THR . 23.9 mmtm -85.72 152.49 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -46.07 145.08 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.78 9.17 55.52 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.169 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -70.03 -41.67 73.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.63 -1.512 . . . . 0.0 109.49 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.99 179.69 37.14 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.539 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mm -96.61 116.26 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -138.8 144.43 39.34 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.511 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.59 158.34 15.48 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -131.02 110.18 11.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 109.222 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -136.63 134.97 37.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 110.558 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.14 26.95 10.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 111.275 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 17.95 78.49 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.81 122.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -83.98 127.46 33.89 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.191 -0.943 . . . . 0.0 109.243 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.71 94.4 40.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.422 -0.799 . . . . 0.0 109.446 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.12 145.71 33.14 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.0 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.6 65.58 5.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -119.49 153.24 35.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.407 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.521 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 1.8 p-80 -57.71 -53.67 55.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 109.985 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.521 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.0 mm-40 -43.84 -17.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 111.043 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' HIS . 16.0 m-85 -94.13 5.11 52.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.664 -1.272 . . . . 0.0 109.79 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 50' ' ' HIS . 79.8 t -72.66 130.87 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.53 -29.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.345 -0.847 . . . . 0.0 109.894 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.4 t-80 -150.13 131.22 14.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.046 -1.034 . . . . 0.0 109.915 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -121.98 95.84 4.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.38 128.56 3.53 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 59' ' ' SER . 72.6 m-70 52.79 5.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.082 -1.011 . . . . 0.0 109.047 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m 165.16 151.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.521 ' HG1' ' CG ' ' A' ' 234' ' ' ASP . 31.1 m -91.12 126.54 36.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.241 -0.912 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD2' ' NZ ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -120.29 149.57 42.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.449 -0.782 . . . . 0.0 111.12 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.4 mt -126.28 147.54 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.52 155.91 27.25 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 118.961 -1.59 . . . . 0.0 110.587 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -160.42 147.64 15.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -1.047 . . . . 0.0 109.095 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 24.18 4.77 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.283 -0.885 . . . . 0.0 109.647 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.52 -31.35 7.89 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 8.3 mm-40 -60.34 144.25 51.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.245 . . . . 0.0 108.916 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -143.06 141.38 31.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 110.475 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.09 123.32 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 13.2 mtpp -99.36 154.63 18.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.966 -1.083 . . . . 0.0 111.128 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.5 m 50.79 74.38 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.338 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.92 -10.08 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.236 -0.915 . . . . 0.0 108.927 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.9 pm0 -61.34 -26.3 67.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 110.353 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -66.58 -69.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.91 -1.119 . . . . 0.0 109.47 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.01 -47.37 42.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 108.979 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.401 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 16.8 mt -52.1 -49.22 64.03 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.04 -1.038 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 t -60.65 -42.82 97.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.105 -0.997 . . . . 0.0 110.247 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -56.04 -48.37 78.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.05 -1.031 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.04 -33.9 76.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.165 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.4 -37.17 86.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.912 . . . . 0.0 109.268 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.29 -38.76 34.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.414 -0.804 . . . . 0.0 109.648 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.8 mt -80.36 -0.48 37.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.132 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 56.89 42.38 26.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.666 -0.646 . . . . 0.0 111.622 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mm -89.41 144.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.697 -1.252 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.5 p -127.88 -20.81 3.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.192 -0.943 . . . . 0.0 111.815 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.58 ' OD1' ' N ' ' A' ' 35' ' ' THR . 33.6 m-80 -124.99 108.12 11.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.838 -1.164 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.75 148.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.363 -0.836 . . . . 0.0 110.421 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.477 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 94.3 m -114.71 113.53 24.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 5.5 mt -97.27 100.77 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 110.412 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.63 124.83 27.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 20.0 t -109.96 131.93 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 122.048 0.928 . . . . 0.0 111.707 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mm -116.15 95.9 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.67 -156.9 26.07 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -121.37 -9.51 9.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.439 -1.036 . . . . 0.0 109.999 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -140.53 148.81 41.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.648 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.2 mm -72.07 119.37 74.16 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 108.987 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -39.94 120.09 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.739 1.626 . . . . 0.0 111.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 tp -75.04 -10.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 110.774 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.9 mt 54.7 -120.7 1.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.091 -1.006 . . . . 0.0 109.995 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.6 8.22 44.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.66 67.36 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.197 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -172.54 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.768 -0.842 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.0 9.0 9.76 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -55.49 -39.52 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -1.135 . . . . 0.0 110.452 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.12 -59.31 4.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -50.84 -44.83 59.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.209 -0.932 . . . . 0.0 109.38 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -60.92 -48.05 83.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 110.786 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.82 -42.47 90.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.009 -1.057 . . . . 0.0 111.28 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.49 -52.06 43.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.913 -1.117 . . . . 0.0 110.356 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.05 -32.86 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.943 -1.098 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -63.79 -43.44 96.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 109.822 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.586 ' C ' HD21 ' A' ' 113' ' ' ASN . 1.3 ptpm? -77.81 11.1 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.017 -1.052 . . . . 0.0 109.852 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.586 HD21 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.92 33.23 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.29 138.82 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.864 -1.147 . . . . 0.0 111.212 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.75 123.56 26.45 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.65 145.15 31.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.343 -0.848 . . . . 0.0 110.221 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -112.61 -173.19 2.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.763 . . . . 0.0 109.352 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -109.34 68.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -164.09 128.76 2.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.007 . . . . 0.0 109.315 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.69 140.58 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.069 . . . . 0.0 109.667 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.3 mt -83.94 150.47 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.843 . . . . 0.0 109.906 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.64 85.94 3.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 108.876 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -63.52 142.79 58.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.545 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -87.54 101.38 13.57 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.43 134.16 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.663 -0.648 . . . . 0.0 110.75 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.97 111.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -83.74 -33.5 25.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.944 -1.098 . . . . 0.0 110.725 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.25 156.93 78.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 109.784 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.09 149.0 45.63 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.791 2.327 . . . . 0.0 112.241 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 tt -159.01 151.48 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.19 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 143.51 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.76 148.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.89 157.38 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -174.15 106.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 109.796 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 49.58 53.43 12.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 110.803 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.57 -35.68 3.17 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.416 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.589 HH22 ' HG ' ' A' ' 254' ' ' SER . 0.9 OUTLIER -63.48 131.81 49.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.932 -1.334 . . . . 0.0 108.906 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.98 139.79 29.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.986 -1.071 . . . . 0.0 109.891 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 62.6 mt -136.9 127.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.783 . . . . 0.0 109.59 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -112.49 131.76 55.42 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.411 0.624 . . . . 0.0 109.752 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 135.37 54.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.88 149.19 32.44 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.128 -0.983 . . . . 0.0 109.648 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -46.35 143.53 7.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.661 2.241 . . . . 0.0 113.272 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.92 145.62 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -65.34 -4.71 5.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 110.541 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 244' ' ' GLY . 21.8 p -155.66 -177.78 6.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -92.26 119.35 31.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -135.16 110.32 8.91 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.29 122.09 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.7 m -112.32 151.98 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.624 -0.673 . . . . 0.0 109.229 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -139.62 131.71 27.98 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.128 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -122.0 132.98 54.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.4 144.67 16.2 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.747 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.82 105.97 15.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -95.18 166.86 11.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -98.07 -16.69 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.576 -0.703 . . . . 0.0 110.9 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.7 p-10 -94.79 -173.14 2.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.751 -1.218 . . . . 0.0 110.217 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -50.35 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 0.0 111.642 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.57 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.2 mt -77.74 -27.8 50.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.343 -1.473 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.76 -140.5 34.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -104.16 137.89 41.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.302 -1.116 . . . . 0.0 109.691 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -143.89 159.14 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.497 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -146.67 147.68 31.27 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -142.86 135.65 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 109.645 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 98.6 m -104.56 122.87 46.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.894 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -104.46 112.34 25.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.9 t -106.38 152.36 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.758 0.79 . . . . 0.0 109.901 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -49.28 127.04 14.14 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 108.808 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.57 27.35 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -116.69 20.72 13.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.162 -1.199 . . . . 0.0 108.962 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.04 -22.78 11.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.445 -0.784 . . . . 0.0 110.542 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -18.21 48.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.041 -1.037 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -84.2 -6.37 59.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 111.476 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 pt -125.19 -26.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.865 -1.147 . . . . 0.0 111.221 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.5 m -60.5 -24.01 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.623 -1.298 . . . . 0.0 108.716 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -83.56 -3.23 57.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.518 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.99 113.5 7.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.569 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 73.0 mtm180 -79.31 172.36 13.9 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.542 ' HG1' HN17 ' A' ' 500' ' ' C90 . 5.6 t -77.26 161.13 28.37 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.39 146.06 32.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.282 -1.512 . . . . 0.0 111.439 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.55 42.71 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.422 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 70.2 m-85 -98.09 145.82 26.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.018 -1.051 . . . . 0.0 109.362 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.61 -36.97 37.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.3 p90 -71.42 -27.19 63.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.843 -1.161 . . . . 0.0 110.039 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.1 tt0 -78.97 -43.18 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.979 -1.076 . . . . 0.0 110.137 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 21.3 mt -41.0 -61.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.903 . . . . 0.0 110.145 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.7 tt0 -40.49 -41.37 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 0.0 110.193 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -76.24 -46.22 29.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.942 . . . . 0.0 109.402 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.5 -30.86 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -80.65 -52.23 7.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.883 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -48.61 -44.56 37.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 110.334 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 m -74.86 6.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 0.0 110.326 -179.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.41 41.79 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.584 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.4 mt -127.73 178.39 6.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -1.185 . . . . 0.0 109.455 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.414 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 50.83 24.28 7.95 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -61.23 -19.3 61.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.624 -1.516 . . . . 0.0 110.59 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -107.27 4.82 35.49 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.57 125.03 30.44 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 121.136 -1.214 . . . . 0.0 110.296 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.538 ' N ' HD22 ' A' ' 202' ' ' ASN . 3.5 t -135.99 174.22 10.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -1.028 . . . . 0.0 109.456 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.91 -9.14 58.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -102.78 -17.67 15.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.642 -0.662 . . . . 0.0 110.289 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.538 HD22 ' N ' ' A' ' 199' ' ' SER . 18.9 p30 -120.04 7.91 10.93 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -150.84 151.25 31.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.872 -1.143 . . . . 0.0 110.556 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.2 tp -98.99 93.54 6.06 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.7 t -86.08 129.19 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.687 0.756 . . . . 0.0 109.277 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 11.9 mt -123.48 162.95 21.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.611 -0.68 . . . . 0.0 109.454 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.41 -166.38 12.91 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -28.26 66.5 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.384 -1.068 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.44 20.98 1.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 111.153 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.6 160.99 43.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.465 -1.397 . . . . 0.0 110.823 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 86.9 t -107.59 116.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -60.28 -42.93 96.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -65.06 115.61 22.71 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -64.69 -10.53 25.09 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.16 1.24 . . . . 0.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -20.13 59.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.408 -0.807 . . . . 0.0 109.286 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.24 -179.5 45.53 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.5 mt -86.1 133.51 33.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.073 -1.251 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.99 -17.71 64.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.318 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 39.2 m-85 -143.33 -170.46 3.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.71 -4.37 44.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.79 43.61 1.26 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 109.649 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.86 -47.84 95.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.997 -1.065 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.5 Cg_exo -51.37 -65.33 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.487 2.124 . . . . 0.0 112.31 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.39 -35.19 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.986 -1.071 . . . . 0.0 109.461 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -62.72 -39.44 94.07 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 8.5 t60 -68.02 -32.68 73.22 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -64.17 -35.72 81.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.88 -35.48 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.97 -53.01 44.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 109.172 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.437 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 93.1 m-20 -63.98 -28.86 70.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.457 -0.777 . . . . 0.0 109.797 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.12 -34.97 49.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.085 -1.01 . . . . 0.0 109.018 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.55 -38.53 81.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.5 -54.87 17.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.521 ' CG ' ' HG1' ' A' ' 60' ' ' THR . 97.3 m-20 -55.27 -30.19 59.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.0 108.825 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.86 -24.23 66.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.529 -0.732 . . . . 0.0 110.442 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.78 -21.8 61.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.855 -1.153 . . . . 0.0 108.54 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 38.9 mt -48.19 -7.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.762 -1.211 . . . . 0.0 109.905 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 236' ' ' TYR . 7.2 mt -74.03 -16.6 61.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.767 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 95.77 3.83 60.68 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.823 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.79 152.99 10.6 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.763 -1.433 . . . . 0.0 109.301 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -53.91 127.22 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.956 1.771 . . . . 0.0 110.002 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.8 t -86.43 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 112.289 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.57 125.86 29.72 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.51 -160.59 29.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.6 133.56 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -1.107 . . . . 0.0 108.951 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.8 m-85 -132.92 141.65 48.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 110.945 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -124.76 124.94 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.2 t -118.83 135.69 54.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.946 -1.096 . . . . 0.0 111.28 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -116.87 114.75 24.33 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 48.41 25.77 0.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.57 164.11 12.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -145.01 173.94 25.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.427 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 77.4 m-70 -54.41 -43.52 71.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.589 ' HG ' HH22 ' A' ' 137' ' ' ARG . 9.4 p -55.37 -58.6 7.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 109.489 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.9 tp -54.88 -46.23 74.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 109.383 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.0 m-20 -47.43 -48.11 26.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.942 -1.099 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.85 -50.03 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 109.96 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -56.31 -50.27 71.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.961 -1.087 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.6 tp -52.58 -50.53 62.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.063 -1.023 . . . . 0.0 108.636 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.4 t -57.79 -55.28 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.274 -0.891 . . . . 0.0 109.165 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.69 -49.08 14.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.82 -49.53 72.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.278 -0.889 . . . . 0.0 110.109 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.17 -50.94 71.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 0.0 110.38 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -33.16 75.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.123 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -67.6 -38.06 83.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -71.91 -65.28 0.79 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.282 -0.886 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.469 ' O ' ' CB ' ' A' ' 268' ' ' LYS . 11.2 tt0 -59.06 -92.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.771 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 267' ' ' GLN . 10.8 ttpt 166.35 123.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.261 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.542 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.6 mt -98.16 155.61 17.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -1.162 . . . . 0.0 109.574 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 73.8 mt-10 -56.04 135.04 52.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.123 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.38 142.67 48.97 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -139.46 -170.34 2.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.8 m -100.32 137.55 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.33 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -64.88 -19.87 66.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.857 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.95 157.42 36.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.113 -0.992 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 140.36 58.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.946 . . . . 0.0 109.805 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.07 157.08 28.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 p -127.67 140.13 52.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.2 m-85 -138.04 147.67 44.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.543 ' CD ' ' HH ' ' A' ' 23' ' ' TYR . 4.4 pt-20 -156.8 151.98 26.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.16 175.66 36.72 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.06 152.93 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 110.222 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.67 140.07 15.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.4 tt -59.31 -39.05 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.039 -1.271 . . . . 0.0 110.269 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.407 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 34.0 m-70 -88.43 -50.05 6.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.688 -1.258 . . . . 0.0 110.77 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 22' ' ' GLU . 2.6 p -70.45 -22.95 62.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.716 . . . . 0.0 111.297 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.24 10.92 4.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 20' ' ' THR . 2.0 mt-10 -103.64 156.18 17.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.636 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.543 ' HH ' ' CD ' ' A' ' 14' ' ' GLU . 32.2 t80 -74.82 136.25 41.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -141.04 143.51 34.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -109.77 159.02 17.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.999 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.9 mt -138.29 145.12 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.472 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 9.3 mt -142.18 107.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.976 . . . . 0.0 108.867 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mt -90.85 113.77 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.366 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.472 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 57.2 m-70 -107.74 137.26 19.69 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 109.4 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -50.1 167.72 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.847 1.698 . . . . 0.0 111.532 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 28.0 mm-40 -144.99 160.48 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.886 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.497 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.8 mttp -68.0 149.1 50.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -48.41 151.05 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.141 -0.974 . . . . 0.0 110.093 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 68.63 -2.12 8.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.66 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 24.6 m -62.21 -42.75 99.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.467 . . . . 0.0 109.558 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.678 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 95.86 179.45 36.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.415 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 14.6 mm -96.58 116.81 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -140.91 147.68 39.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 0.0 110.215 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.34 157.42 15.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -129.06 112.17 13.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 108.976 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -135.58 133.43 38.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.636 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 53.5 26.82 5.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 111.313 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.43 20.26 64.67 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.097 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.5 t -124.46 124.49 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -1.093 . . . . 0.0 109.322 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -86.37 126.75 34.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.78 93.03 36.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.188 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.12 145.5 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.298 1.999 . . . . 0.0 112.044 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.93 70.57 8.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 109.403 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -120.52 174.73 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.159 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -78.31 -46.37 20.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.695 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -49.95 -16.62 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -93.15 3.97 54.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.754 -1.216 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.95 127.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.9 m -106.32 -31.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.405 ' HD1' ' H ' ' A' ' 56' ' ' THR . 0.7 OUTLIER -155.12 139.83 17.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.811 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.405 ' H ' ' HD1' ' A' ' 55' ' ' HIS . 39.2 p -126.25 95.82 4.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.5 t30 -161.39 128.91 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.769 . . . . 0.0 108.95 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 82.2 m-70 52.95 5.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.247 -0.908 . . . . 0.0 109.178 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.584 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.11 142.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 m -81.87 127.3 32.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 108.837 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.82 148.24 43.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.859 0.837 . . . . 0.0 111.071 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.84 150.06 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.36 155.73 27.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.756 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.92 153.55 12.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -1.012 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 50.75 21.59 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.8 -33.25 6.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.99 141.86 57.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.245 . . . . 0.0 109.245 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.33 139.69 41.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 110.364 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.3 mt -129.23 121.3 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -99.64 157.54 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 110.926 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.9 m 51.23 73.73 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.932 -0.48 . . . . 0.0 110.694 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.2 m -107.7 -9.29 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.0 108.9 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 18.2 pm0 -61.04 -28.86 69.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 110.75 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -66.83 -67.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.868 -1.145 . . . . 0.0 109.56 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -52.15 -46.73 44.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.271 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.0 mt -53.61 -46.91 70.58 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.899 -1.126 . . . . 0.0 110.136 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.87 -43.18 99.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -0.989 . . . . 0.0 110.063 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.88 -46.05 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.05 -34.47 77.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -62.58 -37.34 85.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.8 mt -78.78 -38.73 37.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 72.8 mt -79.9 -1.03 37.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.383 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 57.7 43.01 22.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 111.339 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 mm -88.22 143.74 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.887 -1.133 . . . . 0.0 108.688 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.0 p -127.4 -23.44 3.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 111.822 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.678 HD21 ' H ' ' A' ' 36' ' ' GLY . 29.4 m120 -124.73 107.49 11.01 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.723 -1.235 . . . . 0.0 110.412 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.3 m -163.64 147.0 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 37.9 m -114.23 109.48 18.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mt -92.06 100.52 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -74.48 126.15 30.11 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.4 t -111.74 122.42 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.964 0.887 . . . . 0.0 111.58 -178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.94 96.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.39 -156.78 26.34 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -120.66 -10.04 9.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -1.095 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -142.82 150.63 40.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.01 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.9 mm -72.76 120.94 83.53 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 109.117 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -41.85 123.81 2.5 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.517 1.478 . . . . 0.0 110.987 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.4 tp -76.91 -12.43 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.369 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 mt 56.48 -121.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.29 8.89 40.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 110.666 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.41 -1.96 67.35 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.436 -1.364 . . . . 0.0 109.696 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -172.46 2.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.841 -0.8 . . . . 0.0 109.401 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.74 16.02 9.61 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.55 -43.47 93.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.409 -1.054 . . . . 0.0 110.28 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.8 -57.61 10.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -51.21 -44.87 61.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.078 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 62.2 t80 -61.81 -52.42 64.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.633 -0.667 . . . . 0.0 110.674 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -60.53 -44.88 95.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 0.0 111.319 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.71 -58.6 4.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.918 -1.114 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.22 -33.73 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.452 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 13.1 ttt180 -62.37 -43.71 98.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.26 12.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.951 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -143.24 34.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.097 . . . . 0.0 110.329 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.9 mt -80.75 138.55 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 tp -132.3 128.87 38.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.331 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -87.87 140.5 29.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.694 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.72 -170.85 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.9 69.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.24 -0.913 . . . . 0.0 110.599 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.01 130.12 2.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.959 -1.088 . . . . 0.0 109.708 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.76 145.97 51.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.984 . . . . 0.0 109.817 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 121' ' ' ILE . 35.4 mt -90.87 151.48 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -94.06 79.8 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 50.0 m-85 -59.93 143.01 52.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.483 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.553 ' CE1' ' OE1' ' A' ' 267' ' ' GLN . 83.6 t80 -89.1 101.5 14.16 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.78 132.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.707 -0.62 . . . . 0.0 110.785 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -70.12 111.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -88.49 -30.48 19.35 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.104 -0.998 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -133.06 149.29 72.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 109.663 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.32 155.66 55.64 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.372 2.048 . . . . 0.0 112.118 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.71 153.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -139.33 141.04 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.835 . . . . 0.0 109.257 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.42 148.85 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.72 158.28 44.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 135' ' ' GLU . 43.4 t0 -174.51 105.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.933 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 134' ' ' ASP . 5.5 mt-10 49.7 54.74 10.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.7 -36.31 3.14 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.448 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -61.55 134.36 56.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 108.657 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -147.79 138.52 23.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 75.5 mt -135.69 132.13 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.662 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' NZ ' ' HZ1' ' A' ' 245' ' ' LYS . 19.0 tttm -117.72 131.05 56.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.707 -0.621 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.79 55.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -148.29 151.65 37.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.774 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -49.42 142.68 22.36 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.439 2.093 . . . . 0.0 113.445 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.44 141.35 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.03 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -60.98 -6.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.836 . . . . 0.0 110.602 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.4 p -152.79 -173.52 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.926 -1.109 . . . . 0.0 109.546 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.8 tp -96.29 120.45 36.61 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 108.865 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -136.57 129.41 30.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.21 123.61 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.43 HG21 ' HZ2' ' A' ' 163' ' ' LYS . 95.9 m -113.51 152.35 30.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.749 -0.594 . . . . 0.0 109.481 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -141.85 132.39 25.37 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.31 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.18 132.72 54.59 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.27 147.16 19.04 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.184 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.28 98.28 6.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -85.57 167.84 15.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.632 0.729 . . . . 0.0 110.894 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -97.55 -9.94 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 111.302 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' LEU . 30.7 p-10 -102.76 -170.94 1.87 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 111.036 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -48.2 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.806 -0.559 . . . . 0.0 111.509 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.7 mt -80.29 -29.75 38.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.479 -1.388 . . . . 0.0 108.534 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.41 -133.73 46.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 13.0 ttp-105 -107.88 136.27 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -1.075 . . . . 0.0 109.391 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.694 -0.629 . . . . 0.0 109.303 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.43 ' HZ2' HG21 ' A' ' 150' ' ' THR . 0.0 OUTLIER -148.13 147.84 29.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.44 -0.788 . . . . 0.0 109.604 179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.495 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 9.8 t80 -147.9 143.18 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.084 -1.01 . . . . 0.0 110.3 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.458 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 89.4 m -110.17 123.81 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.798 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -104.21 116.93 33.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 109.961 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.57 149.4 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.011 0.91 . . . . 0.0 110.405 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.61 134.44 24.36 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.385 -0.822 . . . . 0.0 109.197 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.11 -9.18 42.68 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.09 28.19 8.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.199 -1.177 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -60.41 -36.67 78.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 110.262 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.56 -17.0 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.86 -5.99 46.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.835 -1.166 . . . . 0.0 111.517 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.2 pt -121.21 -29.82 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.061 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.99 -15.81 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.626 -1.296 . . . . 0.0 108.803 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.98 -2.85 55.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.48 114.49 7.76 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -77.58 172.93 12.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.534 ' HG1' HN17 ' A' ' 500' ' ' C90 . 5.3 t -77.25 162.49 27.31 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.2 143.85 30.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.366 -1.459 . . . . 0.0 111.427 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.79 155.78 44.87 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.44 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 71.4 m-85 -99.38 140.41 33.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.494 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.07 -37.54 9.7 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.369 -0.832 . . . . 0.0 110.345 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.3 p90 -70.16 -26.81 64.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.734 -1.229 . . . . 0.0 110.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.7 OUTLIER -88.5 -35.05 17.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.94 -1.1 . . . . 0.0 110.441 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 187' ' ' GLU . 73.5 mt -48.23 -58.18 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 0.0 109.708 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.9 OUTLIER -42.92 -36.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.16 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -72.63 -50.22 26.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.752 . . . . 0.0 109.136 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 81.7 mt -52.17 -29.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -80.87 -53.04 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.798 -1.189 . . . . 0.0 109.022 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -48.55 -40.45 27.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.4 m -77.62 6.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.026 -1.046 . . . . 0.0 110.364 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.18 38.79 38.73 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.228 -0.986 . . . . 0.0 110.655 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.407 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.6 mt -130.91 -179.71 5.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -1.155 . . . . 0.0 109.515 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 54.64 23.44 28.68 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.578 -0.701 . . . . 0.0 111.488 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -57.06 -21.13 29.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.602 -1.528 . . . . 0.0 110.435 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.92 5.47 34.49 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.985 -1.103 . . . . 0.0 110.559 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.74 129.3 41.73 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 120.925 -1.338 . . . . 0.0 110.451 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.14 167.0 25.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.353 -1.086 . . . . 0.0 108.822 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 75.4 mt -71.03 -7.71 48.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.492 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.83 -11.46 21.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.528 -0.733 . . . . 0.0 110.309 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.501 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 11.7 p-10 -130.94 9.77 4.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -151.82 152.22 32.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 110.416 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.4 tp -99.2 95.46 7.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.6 t -87.49 129.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.672 0.749 . . . . 0.0 109.606 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.5 mt -123.82 164.16 19.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.55 -0.719 . . . . 0.0 109.306 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.55 -166.36 11.97 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . 0.419 ' HZ1' ' HB2' ' A' ' 208' ' ' LYS . 1.1 tppp? -57.02 -36.83 70.91 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.555 -0.968 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.89 26.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 110.57 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.29 148.44 39.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.696 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.28 112.94 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.69 -49.93 75.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.972 -1.08 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.4 m120 -58.92 112.29 4.84 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 0.0 110.193 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -58.44 -11.73 11.86 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.576 1.517 . . . . 0.0 111.501 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 -18.53 57.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.381 -0.825 . . . . 0.0 109.92 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.32 -173.63 50.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -89.18 140.35 29.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -1.222 . . . . 0.0 109.803 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -78.06 -21.17 51.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.416 -0.803 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -138.58 154.77 48.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.177 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -67.09 -1.88 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.744 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.536 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -148.48 46.14 1.04 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.128 -0.983 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.17 -46.56 99.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.697 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -52.55 -66.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.371 2.047 . . . . 0.0 112.044 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.41 -35.9 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.976 -1.077 . . . . 0.0 109.439 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.536 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 68.4 mtt-85 -60.67 -41.48 95.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -67.1 -31.77 72.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.766 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -65.21 -36.9 85.61 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.6 t -68.55 -35.5 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.568 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 73.1 t80 -66.32 -54.14 28.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.88 -27.08 68.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.933 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.26 -33.76 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 33.7 mt -68.23 -38.93 80.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.76 -57.33 12.67 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.55 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.6 m-20 -54.24 -34.42 60.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 109.274 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.4 mt -60.88 -23.8 65.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 110.219 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.613 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.18 -22.31 61.3 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.902 -1.124 . . . . 0.0 108.91 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.8 mt -52.58 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.712 -1.243 . . . . 0.0 110.629 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.613 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.05 -13.0 60.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.744 -1.223 . . . . 0.0 109.66 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.84 -0.79 57.83 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.503 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.57 156.28 10.34 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.914 -1.345 . . . . 0.0 108.829 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.6 Cg_endo -49.93 150.68 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.892 1.728 . . . . 0.0 109.552 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.08 148.36 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.988 -1.07 . . . . 0.0 112.125 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -130.97 124.17 30.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.97 -157.32 27.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -131.85 145.11 51.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -1.074 . . . . 0.0 108.951 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.2 m-85 -141.51 142.44 33.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.485 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.34 123.15 37.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.3 m -115.85 134.81 54.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 250' ' ' ARG . 60.5 t80 -116.54 117.01 28.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.3 OUTLIER 45.4 24.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.161 -0.962 . . . . 0.0 109.425 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.57 164.74 45.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.491 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -142.73 171.52 24.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.55 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 60.9 m-70 -51.01 -34.87 31.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -1.225 . . . . 0.0 109.635 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.7 m -60.03 -57.82 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 256' ' ' ASN . 7.0 tp -61.57 -43.8 98.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.008 . . . . 0.0 109.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.5 m-20 -47.33 -46.84 25.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.88 -1.138 . . . . 0.0 108.577 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.15 -50.46 76.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.59 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -55.32 -51.18 67.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.997 -1.065 . . . . 0.0 109.285 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 46.9 tp -51.07 -50.7 58.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.152 -0.967 . . . . 0.0 108.588 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 37.9 t -57.06 -54.79 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.89 -55.07 8.65 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 109.597 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.57 -51.29 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.95 -51.91 59.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.81 -25.51 65.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.29 -60.83 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.34 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -44.96 80.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.08 . . . . 0.0 109.713 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.553 ' OE1' ' CE1' ' A' ' 124' ' ' PHE . 5.3 tt0 -67.72 -75.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 54.7 tttt 52.28 27.45 4.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.537 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.534 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.9 mt -90.5 156.55 18.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -1.163 . . . . 0.0 109.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.57 ' CD ' HD22 ' A' ' 86' ' ' ASN . 1.6 mm-40 -56.43 136.14 53.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.087 -1.008 . . . . 0.0 108.579 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.96 143.23 49.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.8 t -141.69 -170.46 3.12 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.8 m -101.6 138.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.483 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.566 ' NZ ' ' OE1' ' A' ' 9' ' ' GLU . 7.8 ptmm? -66.96 -25.37 66.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.566 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 8.2 pt-20 -148.14 158.4 44.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.993 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 142.32 57.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.481 -0.762 . . . . 0.0 110.133 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 20.7 mt -120.68 167.07 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -137.13 142.25 42.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 26' ' ' LEU . 95.0 m-85 -139.26 151.7 46.69 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.48 153.44 19.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.0 110.023 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.44 177.02 36.77 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.83 153.7 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -1.047 . . . . 0.0 110.025 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.97 140.36 15.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tt -60.46 -38.44 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -1.152 . . . . 0.0 110.807 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -90.02 -51.26 5.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.564 -1.335 . . . . 0.0 110.963 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.1 p -70.11 -22.25 63.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.774 -0.579 . . . . 0.0 111.237 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.6 19.44 27.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -111.44 155.06 23.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -1.059 . . . . 0.0 109.788 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -74.34 137.0 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.647 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -143.16 143.59 31.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.064 -1.022 . . . . 0.0 109.594 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -108.14 160.06 16.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.9 mt -139.84 145.13 37.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.731 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.46 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 11.8 mt -140.33 116.26 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 108.972 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.14 111.89 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.46 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 61.5 m-70 -107.46 139.89 20.97 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -54.81 168.15 1.26 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.836 1.691 . . . . 0.0 111.495 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.479 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -142.12 178.93 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.611 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' N ' ' HG1' ' A' ' 35' ' ' THR . 12.4 mmtm -87.7 153.32 21.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 118' ' ' ASN . 63.1 mt-10 -47.51 146.43 2.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.496 -0.752 . . . . 0.0 109.939 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.402 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 69.26 4.71 45.09 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.032 178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.586 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -67.92 -44.56 76.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.618 -1.519 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -179.26 32.14 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.471 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.76 115.74 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.408 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 6.8 ptm180 -140.3 152.09 45.59 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.951 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.03 157.81 16.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.9 111.09 12.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -134.7 133.51 40.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.73 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 53.16 28.33 6.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.577 -0.702 . . . . 0.0 111.401 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 18.88 69.95 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.399 -1.382 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 122.05 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -1.069 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.5 m-85 -83.82 127.07 33.56 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 mt -116.54 92.93 38.86 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.242 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.5 149.0 18.85 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.504 2.136 . . . . 0.0 112.086 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.44 69.4 9.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -121.31 170.95 9.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -74.18 -48.58 28.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.622 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.56 -16.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.47 4.33 53.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.73 -1.231 . . . . 0.0 109.92 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.51 141.68 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.17 -29.26 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -0.847 . . . . 0.0 110.114 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -151.67 129.84 11.93 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 109.965 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -120.63 95.36 4.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.7 t-20 -163.28 129.41 3.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 73.3 m-70 49.9 9.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.177 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER 162.48 150.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.706 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.536 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -91.22 124.42 35.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 109.288 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.13 148.59 42.9 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.651 0.739 . . . . 0.0 110.637 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -125.48 153.2 43.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.35 154.55 25.35 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 118.974 -1.584 . . . . 0.0 110.747 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -161.37 149.83 15.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -1.017 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.8 mttt 46.36 24.18 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.621 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -34.45 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -54.87 145.57 19.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.255 . . . . 0.0 109.045 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -145.36 135.39 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 110.613 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.16 120.28 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.8 159.11 15.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 0.0 111.193 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 91.7 m 46.52 74.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -107.37 -8.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -60.61 -25.19 66.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.152 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -67.97 -69.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.049 . . . . 0.0 109.415 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.4 -47.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.099 -1.001 . . . . 0.0 109.129 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.08 -50.18 62.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.026 . . . . 0.0 110.137 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 39.2 t -60.32 -41.55 93.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.113 -0.992 . . . . 0.0 110.071 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -56.88 -44.95 83.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.051 -1.031 . . . . 0.0 109.217 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.72 -33.76 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -62.89 -40.86 98.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 109.179 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 37.5 mt -75.38 -39.09 59.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.852 . . . . 0.0 109.702 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -79.42 -1.07 35.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.94 42.1 26.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 111.414 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.422 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 23.1 mm -90.69 139.91 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 108.226 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.449 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 73.3 p -126.9 -19.15 4.51 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.745 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 35' ' ' THR . 70.2 m-80 -124.98 106.25 9.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.827 -1.171 . . . . 0.0 110.274 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.1 m -165.86 150.67 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.729 0.776 . . . . 0.0 109.916 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.479 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.0 m -116.17 117.84 31.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mt -100.19 100.36 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.352 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -71.77 126.08 28.8 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.2 t -112.55 121.02 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.949 0.88 . . . . 0.0 111.807 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mm -107.77 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.72 160.05 8.2 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -83.05 -7.45 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.267 . . . . 0.0 111.219 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -139.35 147.59 41.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.725 -1.234 . . . . 0.0 110.36 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.18 121.28 84.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -41.82 123.83 2.48 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.665 1.577 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.2 tp -76.58 -15.4 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.678 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.7 mt 57.0 -122.09 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 27.0 t70 -93.36 7.3 45.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.024 -1.048 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.84 -3.9 62.94 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.243 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.94 -172.0 2.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.911 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.39 14.53 9.36 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -57.94 -41.76 83.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 0.0 110.284 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.89 -55.7 17.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.019 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -51.4 -45.81 62.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 108.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.96 -54.18 48.12 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.268 0.556 . . . . 0.0 110.62 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.98 -43.69 98.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 111.508 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.408 ' HA ' ' HZ2' ' A' ' 112' ' ' LYS . . . -65.59 -56.83 10.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.961 -1.087 . . . . 0.0 110.363 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.12 -30.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 109.355 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -65.26 -43.36 91.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.307 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HZ2' ' HA ' ' A' ' 109' ' ' ALA . 3.7 pttm -76.41 9.88 2.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.892 -1.13 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -140.89 36.45 1.77 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 0.0 109.926 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -85.29 140.68 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 111.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -131.42 122.0 25.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.584 -0.697 . . . . 0.0 109.129 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -79.37 146.32 32.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -111.26 -174.45 2.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.447 -0.783 . . . . 0.0 109.42 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 26.8 t-20 -111.69 70.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.852 . . . . 0.0 110.579 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -168.41 134.69 1.9 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.355 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.39 143.98 51.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.065 -1.022 . . . . 0.0 110.15 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.11 151.43 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 0.0 110.233 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.53 83.78 3.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 108.872 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -63.12 142.13 58.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -86.94 101.36 13.34 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.7 133.47 33.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 110.75 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.29 111.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.45 -30.1 23.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.138 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.92 155.34 77.89 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.01 149.87 53.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.536 2.158 . . . . 0.0 112.234 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.2 tt -152.77 149.83 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 108.942 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.75 140.93 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.78 145.96 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.63 156.95 47.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -174.3 107.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.851 . . . . 0.0 109.929 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 53.33 52.86 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.51 -31.66 3.22 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -61.77 134.91 57.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.242 . . . . 0.0 108.52 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.1 tt -147.5 137.12 22.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.854 -1.154 . . . . 0.0 109.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 139' ' ' ILE . 75.4 mt -136.41 125.51 37.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.454 -0.779 . . . . 0.0 109.451 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -114.21 132.08 56.24 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.511 0.672 . . . . 0.0 109.932 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.05 134.66 54.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.69 149.18 32.94 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.921 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -45.87 143.04 7.22 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.62 2.213 . . . . 0.0 113.447 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.2 t -156.61 144.82 19.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 145' ' ' ASP . 53.5 t0 -62.75 -5.6 2.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.898 . . . . 0.0 110.332 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 145' ' ' ASP . 24.6 p -156.15 -167.43 2.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.359 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.0 tp -102.51 121.49 42.47 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -134.5 108.24 8.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.68 122.79 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.07 -1.019 . . . . 0.0 110.206 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 m -112.76 151.13 30.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 38.9 t80 -141.64 130.47 22.97 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.126 -1.029 . . . . 0.0 111.234 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -120.98 133.96 55.29 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.08 142.11 13.49 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.601 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -104.06 99.41 9.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -87.87 167.41 13.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.558 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -105.55 -11.53 16.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.471 -0.768 . . . . 0.0 110.72 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 159' ' ' LEU . 31.1 p-10 -98.53 -164.83 1.17 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.789 -1.195 . . . . 0.0 110.456 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -55.41 0.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 111.161 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 157' ' ' ASN . 16.5 mt -83.61 -30.4 26.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.504 -1.372 . . . . 0.0 108.565 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.27 -138.67 42.8 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -99.91 135.87 40.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -1.151 . . . . 0.0 109.306 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -144.8 159.03 43.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.435 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 149.85 33.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 110.159 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -143.63 140.67 30.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.8 m -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.705 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -105.2 114.39 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.44 152.95 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -49.8 126.11 13.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.175 -0.953 . . . . 0.0 108.975 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.503 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 106.24 2.11 38.49 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -121.02 21.54 11.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.248 -1.148 . . . . 0.0 109.718 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.534 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.1 pm0 -59.32 -54.7 43.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 4.3 mt-10 -41.42 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 0.0 110.085 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 171' ' ' GLU . 67.3 mm-40 -87.59 -6.99 58.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 111.731 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.56 -27.73 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.863 -1.148 . . . . 0.0 111.282 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.32 -17.27 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 108.669 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mt -90.02 -5.89 56.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.266 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.87 119.07 13.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -79.94 173.06 12.97 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.442 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.473 ' HG1' HN17 ' A' ' 500' ' ' C90 . 9.2 t -76.37 162.51 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -146.19 146.87 30.97 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.237 -1.539 . . . . 0.0 111.421 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.78 157.8 43.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 81.3 m-85 -100.04 146.48 26.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.94 -1.1 . . . . 0.0 109.092 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -50.14 -33.73 19.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.109 -0.995 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.6 p90 -74.33 -28.31 61.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.786 -1.197 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -75.21 -35.58 61.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 65.0 mt -52.34 -49.93 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -47.34 -41.66 19.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 110.079 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -74.34 -48.34 28.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.131 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.2 mt -52.38 -30.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.44 -53.77 5.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 0.0 109.365 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -48.88 -32.59 9.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.487 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.8 m -87.16 7.66 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.02 . . . . 0.0 110.506 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.73 39.88 54.38 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.083 -1.01 . . . . 0.0 110.725 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.53 174.75 9.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -1.216 . . . . 0.0 109.808 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.7 22.13 52.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -57.97 -19.91 34.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.679 -1.483 . . . . 0.0 109.63 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.32 10.34 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 125.47 7.76 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 120.859 -1.377 . . . . 0.0 109.72 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.4 t -143.27 169.47 17.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -1.146 . . . . 0.0 109.806 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.56 -8.73 36.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -13.26 25.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -136.18 11.32 3.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.14 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -150.06 149.28 30.09 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 110.275 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.3 tp -98.94 93.32 5.96 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.1 130.03 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.738 0.78 . . . . 0.0 109.019 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.41 164.92 18.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.632 -0.667 . . . . 0.0 109.365 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -127.03 -166.6 12.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -61.69 -32.43 72.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 109.552 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.6 22.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -142.09 149.17 39.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.808 -1.183 . . . . 0.0 110.688 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.6 t -101.96 111.32 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -58.23 -47.01 84.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 110.063 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.16 124.17 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 109.787 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -67.09 -18.07 51.16 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.57 1.514 . . . . 0.0 111.965 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 -15.34 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.923 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.13 -163.53 53.99 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mt -91.55 148.35 22.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.207 . . . . 0.0 109.833 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -87.0 -18.36 30.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 108.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.499 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 60.2 m-85 -137.73 178.69 6.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -82.88 -14.18 54.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.68 52.25 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.514 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -58.18 -48.19 97.47 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.039 -1.038 . . . . 0.0 109.89 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.8 Cg_exo -49.79 -68.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.7 m -58.77 -34.71 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.005 -1.059 . . . . 0.0 109.604 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.499 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 56.2 mtt180 -61.23 -41.18 96.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -67.26 -31.65 72.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.326 -0.95 . . . . 0.0 108.692 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 12.8 mmtp -66.07 -37.33 85.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.3 -35.87 75.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.1 t80 -65.84 -54.77 22.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.554 0.693 . . . . 0.0 109.236 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.11 -27.91 69.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.753 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.67 -34.08 58.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 108.394 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.79 -39.45 85.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -57.88 8.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.411 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 78.6 m-20 -51.4 -34.65 35.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -1.23 . . . . 0.0 109.001 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.6 mt -62.52 -22.76 66.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.038 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.08 -22.97 60.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.857 -1.152 . . . . 0.0 108.919 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.15 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.699 -1.251 . . . . 0.0 109.909 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.478 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 1.42 59.33 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.485 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.95 156.93 10.08 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.012 -1.287 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -49.36 150.35 8.09 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.966 1.778 . . . . 0.0 109.655 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.07 143.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 112.133 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.01 121.53 33.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.49 175.27 23.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -101.9 135.26 43.77 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.203 -1.175 . . . . 0.0 109.276 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.8 m-85 -130.76 136.52 48.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.288 -0.882 . . . . 0.0 109.596 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -126.17 126.15 43.64 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 m -119.42 133.08 55.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.853 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.539 ' CZ ' ' NE ' ' A' ' 250' ' ' ARG . 74.8 t80 -115.34 112.83 22.96 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.539 ' NE ' ' CZ ' ' A' ' 249' ' ' PHE . 71.4 mtt180 48.41 32.48 3.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.81 165.26 54.71 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -140.33 179.64 18.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.588 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.4 m-70 -59.64 -41.62 90.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -1.203 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.091 -1.006 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.8 tp -57.94 -45.13 87.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.424 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 11.0 m-20 -47.42 -51.25 20.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.989 -1.07 . . . . 0.0 109.077 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.91 -44.71 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -0.793 . . . . 0.0 109.849 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -58.75 -50.08 75.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 0.0 109.292 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.86 -49.18 69.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 108.695 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 17.2 t -60.43 -58.2 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.077 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -43.32 17.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 109.061 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -66.24 -47.12 74.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.32 -49.63 76.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 268' ' ' LYS . . . -70.48 -28.6 65.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.78 -50.7 48.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.023 -1.048 . . . . 0.0 109.859 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -69.97 -45.95 66.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.538 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.74 23.27 3.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 264' ' ' ALA . 24.7 mmtm 48.92 -150.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.302 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.473 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.16 159.66 14.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.601 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.468 ' OE1' ' OG1' ' A' ' 85' ' ' THR . 9.4 mm-40 -54.45 139.65 36.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 108.71 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -122.66 146.27 47.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 110.234 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -143.61 -171.62 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.0 m -99.35 135.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.971 -1.081 . . . . 0.0 109.378 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -65.19 -21.61 66.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.778 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -152.86 158.72 42.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 140.46 58.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.288 -0.883 . . . . 0.0 110.055 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -118.22 164.8 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -131.32 139.87 49.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 110.18 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -138.05 146.23 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.1 154.05 24.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 110.349 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.87 175.21 36.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.33 151.68 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -1.07 . . . . 0.0 110.069 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.75 138.66 15.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.7 tt -59.73 -37.21 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -1.22 . . . . 0.0 110.403 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 29.6 m-70 -89.66 -50.66 5.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.66 -1.275 . . . . 0.0 111.08 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.474 ' OG1' ' OE1' ' A' ' 95' ' ' GLU . 3.8 p -70.66 -24.26 62.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.797 -0.565 . . . . 0.0 111.822 -177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.21 14.64 26.7 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.146 -1.502 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.07 155.38 19.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -1.142 . . . . 0.0 109.407 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -75.24 134.53 41.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m -137.55 145.84 43.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -114.54 155.26 26.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.451 -0.78 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.1 mt -136.25 144.19 44.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.643 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.513 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 4.7 mp -139.49 112.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.81 115.76 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.349 -0.845 . . . . 0.0 110.858 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 19.6 m-70 -106.96 139.68 20.64 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.495 -0.753 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -56.46 168.24 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.533 1.489 . . . . 0.0 111.238 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 50.1 mm-40 -144.51 163.39 34.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 109.629 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.1 pttm -74.55 155.42 37.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 118' ' ' ASN . 5.2 mt-10 -49.96 149.88 2.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.174 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.26 19.52 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.042 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.448 ' O ' ' NH2' ' A' ' 38' ' ' ARG . 90.0 m -58.0 -48.53 79.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.555 -1.556 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.68 178.42 35.17 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mm -92.97 116.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -1.033 . . . . 0.0 108.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 35' ' ' THR . 14.1 ptp180 -144.18 151.01 38.92 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.456 -1.297 . . . . 0.0 110.883 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.97 157.06 16.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -129.87 111.83 12.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.413 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -135.19 134.88 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 110.735 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.2 27.39 2.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.608 -0.682 . . . . 0.0 111.247 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.72 66.2 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.04 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.23 120.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 108.808 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -84.77 126.06 33.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.12 -0.987 . . . . 0.0 109.192 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.1 mt -117.01 91.45 36.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.13 148.06 14.4 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.667 2.245 . . . . 0.0 112.077 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.13 70.38 9.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.494 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -128.54 174.44 9.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 109.186 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.7 p-80 -71.52 -49.58 39.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -43.19 -17.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 111.496 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.4 m-85 -100.2 -2.47 33.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.684 -1.26 . . . . 0.0 110.163 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.4 t -66.92 121.13 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.185 -0.947 . . . . 0.0 108.576 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.99 -30.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.275 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.32 136.24 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.254 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.9 p -123.75 95.96 4.78 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.569 ' C ' ' H ' ' A' ' 59' ' ' SER . 15.0 t-20 -162.47 129.05 3.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 108.882 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 91.6 m-70 50.19 8.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 108.983 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.569 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.26 147.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.851 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 m -90.13 128.29 36.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.322 -0.861 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.75 150.6 41.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.478 -0.763 . . . . 0.0 111.056 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.0 mt -123.89 149.49 45.78 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.02 150.31 20.42 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -162.82 148.17 12.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.423 -1.045 . . . . 0.0 108.965 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.452 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.06 25.93 2.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 109.677 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.92 5.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.549 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 5.3 mm-40 -57.45 145.1 34.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -1.221 . . . . 0.0 109.152 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.58 137.71 26.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 110.407 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 55.5 mt -131.18 125.94 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -101.08 156.21 17.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.023 -1.048 . . . . 0.0 111.294 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.0 m 51.79 75.29 0.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.9 m -107.52 -9.06 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.11 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pm0 -61.4 -26.34 67.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 0.0 110.361 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 30.8 m170 -68.2 -69.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.068 -1.02 . . . . 0.0 109.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.405 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -51.88 -48.42 39.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.197 -0.939 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 mt -51.86 -48.8 63.87 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.006 -1.058 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.53 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -60.26 -43.09 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.119 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -56.67 -45.69 82.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 109.193 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.6 mt -65.97 -34.37 77.96 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.212 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -63.37 -37.0 85.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.316 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.3 mt -77.13 -38.91 51.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.1 mt -80.64 6.53 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 110.034 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 52.36 39.73 27.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 110.07 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.69 141.66 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 108.267 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.468 ' OG1' ' OE1' ' A' ' 4' ' ' GLU . 54.9 p -128.98 -22.6 3.17 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.114 -0.991 . . . . 0.0 111.873 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.493 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 76.9 m-20 -124.0 107.72 11.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.874 -1.141 . . . . 0.0 110.278 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.8 142.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.519 -0.738 . . . . 0.0 110.138 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 96.0 m -109.42 111.46 23.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.97 100.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 110.311 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -75.08 125.46 28.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -114.75 118.39 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.947 0.879 . . . . 0.0 111.675 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 mt -105.4 98.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.84 -159.23 27.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 -13.63 8.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -1.135 . . . . 0.0 110.421 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.474 ' OE1' ' OG1' ' A' ' 20' ' ' THR . 69.9 tt0 -138.73 146.99 42.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.979 -1.076 . . . . 0.0 109.676 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.5 mm -70.08 119.83 74.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 108.706 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.27 124.49 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.88 1.72 . . . . 0.0 111.62 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 tp -76.39 -15.42 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 110.206 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.7 mt 55.36 -123.14 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -92.66 8.97 36.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.15 -7.87 69.63 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.47 -1.348 . . . . 0.0 109.973 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.2 p -124.02 -172.1 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.61 -0.936 . . . . 0.0 109.16 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.62 13.71 11.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 48.3 t-105 -56.08 -42.33 76.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -1.125 . . . . 0.0 110.001 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.27 -54.78 31.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.445 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -54.85 -46.49 74.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.118 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -60.69 -56.54 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.731 -0.606 . . . . 0.0 110.718 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -58.88 -44.01 91.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.145 -0.972 . . . . 0.0 111.337 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.6 -51.79 46.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.964 -1.085 . . . . 0.0 110.719 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.7 mt -69.31 -31.87 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.155 . . . . 0.0 109.344 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.46 -43.22 94.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 110.258 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.23 17.05 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -144.05 29.04 1.35 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -0.999 . . . . 0.0 110.169 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 114' ' ' ILE . 71.7 mt -79.61 141.35 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.607 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.58 123.47 33.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.612 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.97 141.0 37.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.94 . . . . 0.0 110.314 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.85 -175.74 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.394 -0.816 . . . . 0.0 109.26 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.487 ' OD1' ' OE2' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -109.66 70.09 0.72 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.085 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -169.22 134.03 1.48 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.082 -1.011 . . . . 0.0 109.503 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.13 142.56 54.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 35.0 mt -84.79 150.16 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 110.024 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.74 90.0 4.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -68.94 148.03 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.94 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -90.12 101.98 14.69 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.22 134.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.612 -0.68 . . . . 0.0 111.204 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.21 118.72 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' HG3' HE22 ' A' ' 267' ' ' GLN . 2.6 mt-10 -96.51 -27.04 15.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.522 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.18 152.5 79.66 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 151.52 46.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.64 2.226 . . . . 0.0 112.286 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.9 tt -160.04 153.15 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.336 -0.853 . . . . 0.0 109.29 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.11 145.31 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.84 149.29 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -139.85 157.86 45.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.132 -0.98 . . . . 0.0 110.196 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.86 111.35 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.252 -0.905 . . . . 0.0 109.93 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 52.47 48.19 23.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.541 -0.724 . . . . 0.0 110.833 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.6 -33.59 3.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.366 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -64.31 131.95 48.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.915 -1.344 . . . . 0.0 108.528 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.49 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -145.03 141.63 29.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 110.357 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 92.4 mt -136.88 132.18 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.779 . . . . 0.0 109.859 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.43 133.04 56.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.413 0.625 . . . . 0.0 110.007 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.71 135.33 53.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.727 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.02 149.62 39.51 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.868 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -48.48 142.4 17.73 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.523 2.149 . . . . 0.0 113.382 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.12 145.19 19.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.97 -30.43 70.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -127.01 -171.14 2.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.74 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.15 123.46 44.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.163 -0.96 . . . . 0.0 108.675 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -136.28 118.03 15.07 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.233 -0.917 . . . . 0.0 108.555 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.84 122.2 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.47 ' OG1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 m -113.15 152.05 30.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.479 -0.763 . . . . 0.0 109.679 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -138.78 130.79 28.08 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.948 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -119.98 130.44 54.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.78 135.64 8.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.645 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -98.55 100.39 11.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.79 167.02 13.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 110.66 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -102.84 -22.53 13.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.912 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.0 p-10 -88.05 -171.42 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.701 -1.249 . . . . 0.0 109.986 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -52.23 1.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 111.458 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.567 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -79.44 -28.58 41.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.353 -1.467 . . . . 0.0 108.71 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.05 -142.55 35.15 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -99.6 135.65 40.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -138.26 153.5 49.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.812 . . . . 0.0 109.41 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -141.22 144.85 34.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.288 -0.882 . . . . 0.0 109.754 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.583 ' CE1' ' NH2' ' A' ' 225' ' ' ARG . 49.2 t80 -142.05 132.89 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.661 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 86.9 m -103.78 122.68 45.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -103.83 114.06 28.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.9 152.79 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.737 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -49.96 128.19 18.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.69 1.81 43.1 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -117.83 20.29 13.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.586 ' O ' ' N ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -60.15 -51.47 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.443 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 5.0 mt-10 -47.76 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 171' ' ' GLU . 9.3 mm-40 -102.94 -6.11 22.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.123 -0.985 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.7 pt -125.16 -26.84 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.959 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.2 m -62.13 -10.66 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.815 -1.178 . . . . 0.0 109.106 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -98.46 -2.17 39.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 0.0 109.078 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.462 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -65.44 122.2 16.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 0.0 109.283 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.566 HH12 ' CD ' ' A' ' 215' ' ' GLU . 52.5 mtm180 -94.23 128.27 40.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.869 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 12.5 t -36.53 158.67 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -145.2 150.0 35.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.51 -1.369 . . . . 0.0 111.49 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.39 157.05 43.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.6 m-85 -97.7 145.52 26.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.442 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.97 -37.11 8.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.363 -0.835 . . . . 0.0 109.278 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -74.29 -29.56 61.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.1 mm-40 -71.52 -31.64 67.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 59.6 mt -57.24 -55.07 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.669 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.8 tt0 -42.85 -38.74 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.13 -0.981 . . . . 0.0 109.302 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 189' ' ' ILE . 9.3 t60 -76.3 -59.34 2.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.051 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 188' ' ' HIS . 82.9 mt -41.75 -36.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.698 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -79.43 -51.83 8.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.875 -1.141 . . . . 0.0 109.226 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -49.35 -27.17 3.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 110.709 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.51 11.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.746 -1.221 . . . . 0.0 110.086 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.44 39.54 69.35 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.429 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.1 mt -129.61 172.59 11.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -1.179 . . . . 0.0 109.998 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.99 21.84 59.54 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -58.93 -21.19 57.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.463 -1.61 . . . . 0.0 109.749 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.56 25.51 11.03 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -87.49 132.94 11.48 Favored Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.923 -1.34 . . . . 0.0 109.921 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.9 174.39 11.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -1.095 . . . . 0.0 109.564 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.18 -7.52 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 108.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -97.51 -19.97 18.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.603 -0.686 . . . . 0.0 110.003 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 21.8 p30 -125.68 3.35 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -144.54 145.35 31.79 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.996 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.8 tp -96.35 96.13 8.54 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.53 128.22 39.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.9 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.38 162.99 21.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.539 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.2 -166.28 12.74 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -24.54 66.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.457 -1.025 . . . . 0.0 109.966 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.6 24.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -151.97 160.47 43.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.515 -1.365 . . . . 0.0 110.643 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.5 t -106.08 114.01 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -57.56 -46.94 83.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 110.46 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 213' ' ' ASN . 1.3 m-20 -59.31 130.39 87.21 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.17 -0.956 . . . . 0.0 110.53 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -67.88 -21.62 43.77 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.682 1.588 . . . . 0.0 111.688 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.566 ' CD ' HH12 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -80.71 -15.46 56.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.957 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.404 ' O ' ' OE2' ' A' ' 215' ' ' GLU . . . 71.51 -157.5 53.29 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.262 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.19 154.44 20.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -1.138 . . . . 0.0 110.138 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -90.14 -19.54 24.14 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -138.75 -176.5 4.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.534 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 19.2 mp0 -83.6 -20.16 34.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 109.529 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.649 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -136.12 54.7 1.89 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -57.59 -46.31 99.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.893 -1.13 . . . . 0.0 109.848 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.6 Cg_exo -52.67 -66.26 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.221 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 21.9 m -59.69 -36.07 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 109.512 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.583 ' NH2' ' CE1' ' A' ' 164' ' ' PHE . 74.6 mtt-85 -59.79 -41.21 90.67 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.462 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 7.5 t60 -68.17 -31.64 71.34 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.1 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.9 mmtt -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.17 -38.37 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.53 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.3 t80 -62.56 -51.34 67.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 108.892 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 91.9 m-20 -64.76 -29.51 70.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.526 -0.733 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.87 -33.77 51.97 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.3 mt -65.76 -37.81 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.22 -56.1 11.29 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.425 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 92.4 m-20 -52.67 -37.14 58.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.246 . . . . 0.0 109.309 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.2 mt -60.04 -24.04 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 110.497 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.631 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -70.66 -21.58 62.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.783 -1.198 . . . . 0.0 108.792 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.13 3.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.56 -1.338 . . . . 0.0 110.318 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.631 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.7 mt -82.98 -16.47 47.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 0.0 109.585 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.17 44.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.913 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.75 158.69 11.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.428 . . . . 0.0 109.297 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.15 128.3 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.874 1.716 . . . . 0.0 109.456 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.1 t -87.86 154.56 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.992 -1.068 . . . . 0.0 112.387 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -136.26 127.57 28.3 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.38 -155.0 25.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.47 ' NZ ' ' OG1' ' A' ' 150' ' ' THR . 19.9 tptt -133.49 127.49 33.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 108.697 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -127.82 140.76 51.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.313 -0.867 . . . . 0.0 110.572 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -123.65 133.91 53.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.5 t -127.26 134.89 50.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.952 -1.092 . . . . 0.0 110.95 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -116.91 115.82 26.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 47.44 24.37 0.47 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.168 -0.957 . . . . 0.0 109.248 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 152.92 37.45 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.58 166.6 22.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.592 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 60.0 m-70 -48.77 -40.68 29.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.131 -1.217 . . . . 0.0 109.531 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -54.91 -58.53 7.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.54 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 7.8 tp -57.14 -45.48 83.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.646 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.2 m-20 -47.51 -51.26 21.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.361 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 87.9 t -62.72 -50.55 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.928 . . . . 0.0 109.547 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -52.05 -52.2 52.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.008 . . . . 0.0 109.356 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 37.0 tp -51.28 -51.33 55.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 108.533 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 69.0 t -53.93 -50.07 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.918 . . . . 0.0 108.828 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -51.23 -55.16 19.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.515 -0.74 . . . . 0.0 109.732 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.19 -49.91 75.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 110.022 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.7 -52.11 66.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.1 67.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.272 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -69.03 -57.41 5.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 267' ' ' GLN . 31.5 pttt -69.43 -36.05 76.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 268' ' ' LYS . 2.6 mm-40 -71.07 -9.01 57.31 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.066 -1.021 . . . . 0.0 110.099 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 267' ' ' GLN . 5.8 ptmt 35.39 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.688 -0.632 . . . . 0.0 110.123 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.3 tp . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.542 ' C22' ' OD2' ' A' ' 230' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mt -101.1 160.23 14.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.437 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -58.0 136.62 57.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 109.063 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.632 ' HZ1' ' ND2' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -120.96 141.58 50.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 109.54 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -139.19 -170.12 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.8 m -99.57 136.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.595 ' NZ ' ' O ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -66.47 -16.67 64.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -156.18 159.85 39.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 139.21 57.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 110.228 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 57.2 mt -117.66 165.41 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.66 144.51 39.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.957 -1.089 . . . . 0.0 110.483 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.7 m-85 -140.41 155.35 46.77 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -162.11 152.81 17.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.782 -1.199 . . . . 0.0 110.275 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.4 176.83 36.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.53 153.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.179 . . . . 0.0 110.424 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.62 141.13 16.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.1 tt -61.51 -41.29 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 111.026 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.41 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 59.5 m-70 -87.1 -50.49 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.534 -1.354 . . . . 0.0 111.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -70.24 -22.82 62.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 111.363 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.0 20.65 35.01 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.931 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -110.86 154.1 24.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.65 135.4 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -139.67 143.37 37.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -112.38 154.39 25.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.324 -0.86 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 13' ' ' PHE . 7.9 mt -132.43 148.98 52.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.367 -0.833 . . . . 0.0 110.312 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.426 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.0 mt -143.58 110.78 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.52 117.44 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 111.032 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.426 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 22.0 m-70 -110.65 138.84 21.14 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.458 -0.776 . . . . 0.0 109.701 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -54.28 168.58 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.958 1.772 . . . . 0.0 111.79 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 50.3 mm-40 -140.86 177.49 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.918 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.0 mttt -86.02 153.0 22.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.393 -0.817 . . . . 0.0 110.136 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -47.25 145.67 2.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.089 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.3 7.33 51.58 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.128 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.6 m -69.56 -43.68 72.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.659 -1.495 . . . . 0.0 109.56 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.73 -178.96 32.72 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.359 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.15 116.52 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -140.26 150.86 44.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.822 -1.174 . . . . 0.0 110.382 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.66 157.4 16.71 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -129.43 110.97 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.181 -0.949 . . . . 0.0 108.877 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.565 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 32.7 tttm -135.64 135.26 40.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.534 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.565 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 15.2 m120 52.85 28.88 6.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 111.19 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.27 18.1 78.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.958 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -122.7 122.22 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -1.028 . . . . 0.0 108.808 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 42.1 m-85 -83.84 126.5 33.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.089 -1.007 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -115.39 95.64 43.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.31 145.04 22.04 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.427 2.085 . . . . 0.0 112.081 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.24 74.8 10.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -132.79 -179.91 5.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.381 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.6 p-80 -75.78 -53.26 8.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.129 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -43.28 -17.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.232 -0.918 . . . . 0.0 110.963 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.2 m-85 -97.63 1.31 48.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.735 -1.228 . . . . 0.0 109.837 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.54 131.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.099 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -30.05 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -151.08 133.49 15.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -124.38 95.44 4.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.207 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 59' ' ' SER . 46.0 t-20 -162.97 128.86 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 47.4 11.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 108.969 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 163.37 141.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.344 -0.847 . . . . 0.0 110.098 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.557 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -90.62 127.97 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.376 -0.828 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.42 151.75 39.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.664 0.745 . . . . 0.0 111.002 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mt -126.23 148.23 49.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.63 154.14 25.12 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.088 -1.529 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -165.31 152.95 11.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt 50.69 22.26 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.13 -33.48 6.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 9.0 mm-40 -56.22 147.34 21.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.229 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.9 135.55 26.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.272 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.36 126.11 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -103.29 156.23 17.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.968 -1.082 . . . . 0.0 111.078 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.8 m 51.64 75.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.943 -0.473 . . . . 0.0 110.818 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.07 -10.32 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.5 pm0 -61.45 -26.8 68.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.906 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.416 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.0 m170 -66.35 -68.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 tp -52.07 -47.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 109.161 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.5 mt -52.33 -49.15 64.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.519 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 17.5 t -59.73 -43.17 94.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.35 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.71 -44.6 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.975 -1.078 . . . . 0.0 109.101 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.56 -36.07 80.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.964 . . . . 0.0 109.588 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.72 -35.58 78.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.47 -36.93 37.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.38 -0.825 . . . . 0.0 109.843 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.8 mt -83.52 4.12 29.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.084 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 53.59 40.62 31.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.556 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.46 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 27.3 mm -85.33 142.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 42.5 p -129.81 -22.61 2.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.186 -0.946 . . . . 0.0 111.612 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 86' ' ' ASN . 0.9 OUTLIER -125.2 107.03 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.744 -1.223 . . . . 0.0 110.035 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.9 m -164.3 148.55 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.616 0.722 . . . . 0.0 110.008 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 57.4 m -117.19 108.19 15.37 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -90.18 100.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.804 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -73.78 125.14 27.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.99 119.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.815 0.817 . . . . 0.0 111.542 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -105.94 97.75 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.56 -158.77 27.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -120.49 -13.03 8.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -139.56 148.23 42.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 109.707 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -71.66 120.76 81.81 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 108.943 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.05 120.23 1.45 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.733 1.622 . . . . 0.0 111.629 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.2 tp -78.38 -15.8 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.8 mt 55.76 -115.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.267 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.82 5.6 50.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.032 -1.043 . . . . 0.0 110.797 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.96 0.7 61.83 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.147 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -126.7 -172.87 2.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.661 -0.905 . . . . 0.0 109.629 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.33 16.7 8.02 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -57.77 -41.73 82.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -1.08 . . . . 0.0 110.086 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -64.54 -57.15 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.105 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 14.7 m-85 -51.57 -46.55 63.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.97 . . . . 0.0 109.348 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -61.03 -51.04 70.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.667 -0.646 . . . . 0.0 110.941 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.18 -42.45 96.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.002 -1.061 . . . . 0.0 111.245 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.91 -58.49 4.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.5 -34.4 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.099 -1.001 . . . . 0.0 109.577 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -63.25 -42.21 99.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.98 . . . . 0.0 109.26 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 11.86 0.81 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 8' ' ' LYS . 3.5 m-80 -146.24 33.64 0.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.595 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 70.2 mt -78.19 139.59 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.742 -1.224 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 31.8 tp -127.7 121.96 31.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -0.779 . . . . 0.0 108.998 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.632 ' ND2' ' HZ1' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -79.04 142.59 36.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.144 -0.972 . . . . 0.0 110.354 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -111.56 -170.61 1.68 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.358 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -116.64 71.22 0.78 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.144 -0.972 . . . . 0.0 111.713 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.572 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 9.4 ttt180 -170.02 132.11 1.07 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.959 -1.088 . . . . 0.0 109.31 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.32 142.11 57.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.959 -1.088 . . . . 0.0 110.238 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.456 HD13 HG22 ' A' ' 121' ' ' ILE . 89.5 mt -87.6 151.74 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.35 79.3 3.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.284 -0.885 . . . . 0.0 108.813 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.466 ' CE2' ' NZ ' ' A' ' 243' ' ' LYS . 36.4 m-85 -58.78 146.67 36.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.294 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -93.11 101.91 14.22 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.75 132.68 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.359 0.599 . . . . 0.0 110.918 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.3 117.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.06 -27.57 15.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 110.662 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -134.36 150.78 74.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.549 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.98 151.42 62.12 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.481 ' CD1' ' NZ ' ' A' ' 266' ' ' LYS . 1.9 tt -157.22 150.69 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.416 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.401 ' N ' HG12 ' A' ' 130' ' ' ILE . 2.7 mp -138.68 136.44 43.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 108.965 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.64 147.48 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -130.0 164.71 23.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 0.0 110.263 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.428 ' OD2' ' NZ ' ' A' ' 258' ' ' LYS . 0.9 OUTLIER -171.82 102.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.841 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 48.05 57.43 6.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 110.731 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.05 -34.51 3.57 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -63.25 138.28 58.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.252 . . . . 0.0 109.133 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.46 137.89 28.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.082 -1.011 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 46.2 mt -135.75 121.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.399 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -110.99 131.69 54.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.436 0.636 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -119.87 132.88 55.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.55 146.92 34.21 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 110.258 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -47.11 141.78 12.37 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.654 2.236 . . . . 0.0 113.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.02 144.35 19.98 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' O ' ' CG2' ' A' ' 146' ' ' THR . 4.0 t0 -66.16 0.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.792 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.491 ' O ' ' O ' ' A' ' 244' ' ' GLY . 27.9 p -157.13 173.6 16.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.841 -1.162 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 tp -85.11 118.3 24.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -137.45 126.17 23.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 108.764 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.41 121.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.9 m -111.62 151.7 28.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.642 -0.661 . . . . 0.0 109.292 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.03 130.25 26.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.721 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -120.88 131.66 54.52 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.24 133.91 7.46 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.584 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -100.98 97.72 8.26 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -88.57 167.13 13.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.983 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -98.99 -17.05 18.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.76 -0.587 . . . . 0.0 110.697 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.0 p-10 -92.62 -168.59 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.825 -1.172 . . . . 0.0 110.386 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -55.08 0.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.362 -0.836 . . . . 0.0 111.472 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.2 mt -78.55 -27.65 45.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.443 -1.411 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.8 -137.96 34.96 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -100.4 132.3 45.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.202 -1.175 . . . . 0.0 109.682 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -139.5 155.52 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.125 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -147.93 149.5 32.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.113 -0.992 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -143.46 139.32 29.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.512 -0.742 . . . . 0.0 109.41 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.29 124.82 51.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -105.12 113.77 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.848 . . . . 0.0 110.327 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.0 153.06 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.316 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.01 125.61 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.248 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 102.73 3.59 49.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -120.24 19.9 12.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.307 -1.114 . . . . 0.0 109.278 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' A' ' 173' ' ' GLU . 2.2 pm0 -64.88 -46.49 81.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.642 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -47.8 -7.52 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 171' ' ' GLU . 75.0 mt-10 -103.58 -5.89 22.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.482 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.4 pt -123.29 -26.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.217 -0.927 . . . . 0.0 110.558 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -60.79 -23.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.569 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.9 mt -85.27 -2.2 57.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.417 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -71.49 119.09 15.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.417 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 42.5 mtm180 -83.53 172.97 11.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.523 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.2 t -78.4 163.38 25.7 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -147.78 147.91 30.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.22 -1.55 . . . . 0.0 111.786 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.87 157.88 43.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.443 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.0 m-85 -97.85 146.94 24.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.901 -1.124 . . . . 0.0 109.78 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.52 -37.31 26.22 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.304 -0.872 . . . . 0.0 109.176 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.443 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.0 p90 -71.05 -25.56 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.13 -0.981 . . . . 0.0 109.947 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.434 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 mt-10 -82.39 -22.93 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.977 . . . . 0.0 109.742 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.85 -53.67 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.639 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.88 -38.02 9.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -76.54 -53.78 7.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.122 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.82 -32.3 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.788 . . . . 0.0 109.533 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -52.61 6.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.039 -1.038 . . . . 0.0 109.226 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -49.84 -40.43 42.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 110.265 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.55 5.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.006 -1.059 . . . . 0.0 110.218 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.96 37.21 56.71 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 35.4 mt -125.39 168.89 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 109.433 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.51 21.77 58.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.74 -20.27 5.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.571 -1.547 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.447 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.67 26.32 9.05 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 128.53 9.19 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.946 -1.326 . . . . 0.0 110.034 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.8 p -144.93 171.97 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -1.056 . . . . 0.0 109.422 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.47 -8.14 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -97.06 -12.73 22.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.772 -0.58 . . . . 0.0 109.515 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.0 p30 -133.13 7.54 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 109.882 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -149.88 151.0 32.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.15 95.4 7.4 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.3 t -85.87 127.76 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.788 0.804 . . . . 0.0 109.28 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 52.9 mt -123.24 161.47 24.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.647 -178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.94 -166.65 12.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -29.73 70.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -1.099 . . . . 0.0 109.672 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.66 23.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -0.944 . . . . 0.0 110.856 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -146.78 154.12 41.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.51 -1.369 . . . . 0.0 110.708 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 45.3 t -104.44 113.45 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -58.69 -45.62 89.06 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 109.832 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.15 116.61 18.2 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.224 -0.923 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.95 -15.4 43.51 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.475 1.45 . . . . 0.0 111.641 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -75.01 -15.82 60.64 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.231 -0.918 . . . . 0.0 108.702 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.23 -178.12 47.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mt -83.92 145.75 28.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -1.106 . . . . 0.0 109.639 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -77.79 -18.79 56.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 108.811 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.638 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 76.0 m-85 -141.8 178.74 7.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -85.92 -3.49 58.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.678 HD21 ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -146.77 45.55 1.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -55.58 -47.18 99.24 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.861 -1.149 . . . . 0.0 109.756 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.6 Cg_exo -51.37 -66.77 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.429 2.086 . . . . 0.0 112.157 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.97 -36.79 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.936 -1.102 . . . . 0.0 109.63 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.678 ' NE ' HD21 ' A' ' 221' ' ' ASN . 75.3 mtt180 -59.77 -42.18 92.76 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.417 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 19.2 t60 -67.09 -31.66 72.29 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.06 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -66.57 -35.76 81.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.73 -37.73 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.519 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.9 t80 -64.01 -50.61 67.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.46 -28.02 67.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.3 tp -75.92 -33.02 59.87 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 28.2 mt -67.52 -39.54 82.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.28 -58.2 9.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.438 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 53.8 m-20 -51.55 -40.84 60.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -1.226 . . . . 0.0 109.249 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.0 mt -57.18 -22.97 44.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.533 -0.729 . . . . 0.0 110.282 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.6 -22.26 61.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.841 -1.162 . . . . 0.0 108.721 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.4 mt -53.08 -1.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.727 -1.233 . . . . 0.0 110.122 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.6 mt -75.68 -14.45 60.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.052 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.91 57.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.594 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.3 m -166.52 157.2 10.96 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.867 -1.372 . . . . 0.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -49.84 150.55 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.956 1.771 . . . . 0.0 109.712 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.7 147.95 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 111.515 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.466 ' NZ ' ' CE2' ' A' ' 123' ' ' TYR . 1.7 tppt? -130.34 123.97 31.19 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.51 -158.77 28.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 11.6 ttmt -129.55 139.82 51.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -1.128 . . . . 0.0 109.087 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 22.7 m-85 -134.74 139.84 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 110.426 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -123.39 123.29 40.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.6 m -120.54 134.36 55.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.942 -1.099 . . . . 0.0 111.074 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -115.73 115.74 26.86 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 49.71 20.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.972 -1.08 . . . . 0.0 109.054 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -50.28 156.23 2.4 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -139.7 157.28 25.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.557 ' ND1' ' HG1' ' A' ' 60' ' ' THR . 80.9 m-70 -45.32 -43.36 10.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -1.118 . . . . 0.0 110.032 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.9 p -58.46 -41.05 84.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 26.0 tp -74.2 -43.61 56.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 108.538 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 256' ' ' ASN . 0.8 OUTLIER -50.98 -45.73 61.13 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.092 -1.005 . . . . 0.0 109.051 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 77.7 t -66.13 -57.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.428 ' NZ ' ' OD2' ' A' ' 134' ' ' ASP . 2.6 ttpt -47.41 -46.16 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.839 -1.163 . . . . 0.0 108.614 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 44.1 tp -55.04 -53.48 55.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.051 . . . . 0.0 108.791 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.6 t -54.49 -53.75 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.528 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -49.32 -46.69 47.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.83 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -64.92 -52.77 54.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.957 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 267' ' ' GLN . 22.6 mt -53.87 -51.82 62.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 110.196 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.14 -27.2 65.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.963 -1.086 . . . . 0.0 110.304 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -64.77 -59.36 4.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 110.149 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.481 ' NZ ' ' CD1' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -81.48 -28.81 33.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.321 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.558 ' O ' ' CG ' ' A' ' 268' ' ' LYS . 1.6 tp-100 -86.02 56.67 4.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.03 -1.043 . . . . 0.0 109.242 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.592 ' O ' ' NZ ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 160.57 11.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 0.0 109.445 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.523 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.5 mt -117.51 162.35 18.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.988 . . . . 0.0 109.635 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -55.74 129.12 38.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 108.97 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.9 144.27 48.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.501 -0.749 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -143.83 -173.28 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.1 m -95.44 135.01 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.087 . . . . 0.0 109.503 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.36 -20.43 66.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -154.62 156.12 35.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.435 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.78 139.85 58.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 56.4 mt -118.78 168.29 10.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 p -143.64 146.53 33.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.1 m-85 -140.12 150.24 44.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -152.97 148.18 26.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.965 -1.084 . . . . 0.0 109.703 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.58 173.1 36.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.42 153.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.12 . . . . 0.0 110.311 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.57 140.76 15.51 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' A' ' 197' ' ' GLY . 15.4 tt -60.15 -41.52 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 110.659 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.403 ' N ' HG22 ' A' ' 18' ' ' ILE . 88.6 m-70 -86.64 -50.8 6.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.686 -1.259 . . . . 0.0 110.875 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 p -70.96 -22.57 62.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.67 -0.644 . . . . 0.0 111.526 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.51 15.61 12.52 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -106.82 154.99 20.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 109.76 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.23 135.44 42.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.497 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 3.5 t -138.9 145.43 39.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -111.04 155.21 23.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.616 -0.677 . . . . 0.0 110.019 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.7 mt -135.4 147.11 48.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 109.969 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 mt -143.45 109.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 108.864 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.68 113.75 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -106.76 140.0 20.92 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.489 -0.757 . . . . 0.0 109.265 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.55 165.77 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.752 1.635 . . . . 0.0 111.952 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 5.6 mm-40 -141.39 174.39 10.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 35' ' ' THR . 75.2 mttt -82.68 152.26 25.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 35' ' ' THR . 11.7 mt-10 -48.7 151.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.81 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.56 -6.94 3.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 32.7 m -59.62 -44.9 93.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.784 -1.421 . . . . 0.0 109.705 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.15 -176.31 30.38 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.57 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 mm -102.52 116.79 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.93 155.13 47.31 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.608 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -102.99 158.67 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -128.88 109.14 11.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 108.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.59 ' HZ2' HD21 ' A' ' 42' ' ' ASN . 45.5 tttm -135.53 134.5 39.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.333 -0.854 . . . . 0.0 110.995 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.59 HD21 ' HZ2' ' A' ' 41' ' ' LYS . 19.3 m-80 52.7 29.14 7.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.775 . . . . 0.0 111.325 178.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.0 18.41 76.84 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.909 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.65 123.26 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -1.062 . . . . 0.0 109.08 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -85.49 127.59 34.46 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.0 mt -116.91 93.7 42.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.69 151.42 19.37 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 111.897 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.42 70.74 10.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.759 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.952 . . . . 0.0 109.035 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -69.51 -54.12 15.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.56 -17.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 111.087 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.5 m-85 -94.96 3.4 54.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.936 -1.102 . . . . 0.0 109.912 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -72.24 138.94 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.19 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.76 -28.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.395 -0.815 . . . . 0.0 109.639 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.37 133.61 12.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -124.03 95.6 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.124 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.0 t-20 -163.09 128.71 3.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.798 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.9 m-70 45.64 13.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.32 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.963 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.468 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 45.2 m -78.68 125.17 29.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 108.869 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 147.73 44.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.841 0.829 . . . . 0.0 111.206 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -123.77 150.26 44.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.88 151.36 21.09 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.731 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -163.36 152.21 14.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.533 -0.981 . . . . 0.0 109.27 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt 51.3 21.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.89 6.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 13.6 mm-40 -59.26 146.39 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -1.229 . . . . 0.0 109.332 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -142.13 137.31 30.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 110.663 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 122.96 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -101.13 155.16 18.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 111.312 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 m 49.18 73.89 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.78 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -107.78 -8.33 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.05 -27.61 68.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.495 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 29.1 m170 -64.49 -69.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.923 -1.111 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.49 -47.59 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.23 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.5 mt -52.58 -48.28 66.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 109.985 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.508 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 29.6 t -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.095 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -57.04 -45.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 108.981 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.09 -34.98 78.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.255 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -61.52 -36.4 80.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.3 mt -79.75 -37.02 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.5 mt -79.33 2.07 22.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.015 -1.053 . . . . 0.0 109.802 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 54.48 39.4 31.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.513 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 2.8 mm -86.21 141.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 108.25 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 57.0 p -124.49 -21.44 4.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.028 -1.045 . . . . 0.0 111.753 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.487 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 38.8 m-80 -127.24 108.06 10.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.887 -1.133 . . . . 0.0 111.048 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 7.0 m -162.61 146.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 89.5 m -115.85 113.75 23.79 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.5 mt -95.9 107.4 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.693 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -76.75 127.15 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.38 117.51 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.742 0.782 . . . . 0.0 111.442 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.497 ' O ' ' OG ' ' A' ' 24' ' ' SER . 26.1 mm -104.51 95.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.19 -155.4 24.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.21 -10.5 8.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -1.175 . . . . 0.0 110.379 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -139.82 148.95 42.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.8 mm -72.85 126.41 90.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 108.735 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -45.9 121.18 4.03 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 121.845 1.697 . . . . 0.0 111.004 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.9 tp -75.25 -15.64 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 110.551 -178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.6 mt 57.33 -120.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.96 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -96.29 6.61 48.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.062 -1.024 . . . . 0.0 110.821 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.3 61.12 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.077 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 p -128.31 -172.31 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.634 -0.921 . . . . 0.0 109.524 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.66 15.5 10.53 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -58.53 -43.27 89.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -1.098 . . . . 0.0 110.003 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.85 -59.19 4.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.008 -1.057 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -51.56 -46.29 63.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.762 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -61.56 -51.99 66.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 110.974 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.36 -43.26 95.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 111.375 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -55.92 13.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 110.611 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.6 mt -63.74 -31.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 0.0 109.446 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -65.0 -41.15 95.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.069 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.566 ' C ' HD21 ' A' ' 113' ' ' ASN . 6.0 pttt -75.55 11.06 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.566 HD21 ' C ' ' A' ' 112' ' ' LYS . 1.5 m-80 -139.91 34.6 1.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 110.507 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.15 139.85 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.8 -1.187 . . . . 0.0 110.949 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.2 tp -131.74 126.62 34.91 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.487 ' H ' ' ND2' ' A' ' 116' ' ' ASN . 2.1 p30 -82.81 146.91 28.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.156 -0.965 . . . . 0.0 110.569 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -114.2 -169.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.121 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -112.65 69.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 111.22 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 21.3 ttm-85 -164.89 132.23 3.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.993 -1.067 . . . . 0.0 109.267 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.82 141.52 55.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.066 -1.021 . . . . 0.0 109.456 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.9 mt -81.34 146.26 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.333 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.74 81.04 4.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 43.0 m-85 -60.41 140.03 57.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -86.97 100.91 12.94 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.4 t -92.41 134.56 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.418 0.628 . . . . 0.0 111.073 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.84 114.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.7 -25.99 15.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.93 149.21 71.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.19 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.4 152.01 48.8 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.377 2.051 . . . . 0.0 111.942 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -155.2 151.58 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.361 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.54 139.23 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 23.1 m -125.78 148.13 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.92 159.03 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.7 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.38 105.42 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.442 -0.786 . . . . 0.0 109.666 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 47.82 56.85 6.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.373 -0.83 . . . . 0.0 110.827 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.09 -36.84 2.87 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.464 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -61.56 129.48 41.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.964 -1.315 . . . . 0.0 108.449 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -143.57 141.01 30.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.864 -1.147 . . . . 0.0 110.242 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 68.2 mt -137.62 132.36 44.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.735 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -120.47 130.76 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.373 0.606 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.64 135.76 54.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -145.29 152.63 50.85 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.078 -1.014 . . . . 0.0 109.52 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -49.95 143.17 24.82 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.412 2.075 . . . . 0.0 113.506 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -155.45 144.0 20.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -4.53 4.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.273 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.5 p -151.9 -172.08 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.5 tp -100.54 121.4 41.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 108.845 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -135.05 128.82 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.76 122.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 109.966 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 39.6 m -113.71 151.92 31.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.429 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -139.69 131.12 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.938 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -120.94 133.42 55.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.93 138.49 9.84 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.649 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.03 98.04 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -84.97 167.18 16.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.576 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -104.07 -17.57 14.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 110.64 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.495 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.3 p-10 -92.17 -166.65 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.779 -1.2 . . . . 0.0 110.01 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.29 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 111.151 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.4 mt -78.68 -27.11 45.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.459 -1.4 . . . . 0.0 108.2 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.03 -141.52 33.14 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -100.27 134.99 42.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.332 -1.099 . . . . 0.0 109.275 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.4 153.89 47.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.661 ' HZ1' ' HG1' ' A' ' 165' ' ' THR . 0.0 OUTLIER -144.23 145.75 32.25 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.41 -0.806 . . . . 0.0 109.545 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.564 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 16.4 t80 -145.03 140.19 27.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.173 -0.955 . . . . 0.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.661 ' HG1' ' HZ1' ' A' ' 163' ' ' LYS . 90.2 m -109.06 123.37 49.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 110.093 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -102.98 114.06 28.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.01 147.53 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -49.11 132.34 19.23 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.312 -0.867 . . . . 0.0 108.838 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.4 -9.58 30.78 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.47 25.53 10.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.209 -1.171 . . . . 0.0 109.288 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.0 OUTLIER -61.33 -15.65 38.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.0 110.496 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -81.54 -10.42 59.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.038 -1.039 . . . . 0.0 110.668 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' CZ ' ' A' ' 164' ' ' PHE . 1.5 pp20? -101.11 -5.26 25.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.052 -1.03 . . . . 0.0 110.623 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 16.7 pt -115.99 -31.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -61.7 -15.45 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.842 -1.161 . . . . 0.0 108.776 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.1 mt -94.74 -4.81 46.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.561 -0.712 . . . . 0.0 109.451 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.02 120.52 14.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.006 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -81.07 172.16 14.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.529 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.2 t -78.74 163.66 25.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.64 145.44 27.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.252 -1.53 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.03 44.01 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.51 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -99.44 143.94 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.002 -1.061 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.38 -36.47 6.46 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.9 p90 -73.35 -29.81 62.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.947 -1.095 . . . . 0.0 109.889 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.5 tt0 -74.54 -27.64 60.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 109.938 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.31 -48.76 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -47.77 -40.76 21.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.168 -0.957 . . . . 0.0 109.995 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -77.25 -52.92 8.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.275 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.6 mt -49.42 -27.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.418 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -85.61 -54.74 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.001 -1.062 . . . . 0.0 109.35 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -50.76 -33.78 24.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.3 m -84.66 7.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.0 -1.063 . . . . 0.0 110.08 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.93 61.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 46.1 mt -129.39 171.36 12.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -1.168 . . . . 0.0 110.145 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.39 29.14 62.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 198' ' ' GLY . 29.8 mttt -58.2 -56.33 23.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.388 -1.654 . . . . 0.0 109.683 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -67.1 4.68 3.19 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.725 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 196' ' ' LYS . . . -61.99 124.82 34.94 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.876 -1.367 . . . . 0.0 110.523 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.1 t -145.91 164.23 32.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.438 -1.036 . . . . 0.0 109.101 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.513 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 70.7 mt -67.92 -8.01 33.24 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.5 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -98.77 -9.31 24.62 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.758 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 23.6 p30 -134.54 9.66 3.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -150.72 150.05 30.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.4 tp -99.86 93.18 5.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 43.0 t -85.85 130.56 36.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.716 0.769 . . . . 0.0 108.973 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 35.2 mt -124.78 165.11 18.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.656 -0.652 . . . . 0.0 109.576 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.19 -166.4 12.23 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -25.21 67.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.747 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -163.21 23.15 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.385 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 146.67 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.016 -1.053 . . . . 0.0 110.342 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.73 109.99 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.48 -49.11 75.63 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.078 -1.014 . . . . 0.0 109.826 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.8 m120 -60.28 112.48 5.55 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.832 . . . . 0.0 110.279 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.26 -23.2 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.796 1.664 . . . . 0.0 112.783 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.61 -14.71 62.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.834 -1.166 . . . . 0.0 109.919 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.24 -168.55 52.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.6 mt -90.28 138.67 31.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 109.763 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -75.32 -17.25 60.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.174 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.3 -173.61 3.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.7 -22.43 23.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.51 HD21 ' NH1' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -136.94 53.25 1.9 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.543 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -54.63 -47.82 96.92 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.3 Cg_exo -48.45 -64.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.391 2.061 . . . . 0.0 112.102 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.5 m -60.64 -35.8 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.793 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.51 ' NH1' HD21 ' A' ' 221' ' ' ASN . 4.0 mtt85 -60.89 -41.56 96.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.046 -1.033 . . . . 0.0 108.468 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.4 t60 -67.45 -32.3 73.07 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -66.53 -36.45 82.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.53 -37.37 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.508 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.6 t80 -64.98 -51.48 61.51 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -64.55 -28.26 69.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 109.844 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 36.0 tp -75.06 -34.13 61.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.072 -1.018 . . . . 0.0 108.492 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.77 -39.84 84.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.04 -56.0 18.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 26.7 m-20 -54.63 -32.72 59.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.096 -1.238 . . . . 0.0 109.178 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.6 mt -63.68 -23.77 67.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.475 -0.766 . . . . 0.0 110.653 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.611 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.73 -21.79 61.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.749 -1.219 . . . . 0.0 109.105 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 83.9 mt -50.46 -1.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.31 . . . . 0.0 110.607 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.44 -15.26 58.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.771 -1.205 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.19 2.93 59.02 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.574 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.8 m -166.46 155.45 10.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.362 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.0 Cg_endo -49.63 150.55 8.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.952 1.768 . . . . 0.0 109.608 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.83 145.96 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 0.0 112.124 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -127.81 121.98 31.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.91 -179.27 30.29 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -109.43 140.7 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -1.131 . . . . 0.0 109.198 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 17.2 m-85 -135.05 138.76 44.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 110.34 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -125.0 124.75 42.67 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 m -120.19 135.78 54.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.971 -1.081 . . . . 0.0 111.429 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 251' ' ' GLY . 75.8 t80 -115.28 117.06 29.41 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' PHE . 63.3 mtp180 45.98 22.37 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.065 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -51.9 159.41 2.61 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -139.1 164.3 25.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 34.1 m-70 -50.28 -42.76 52.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.149 -1.206 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.543 ' H ' ' HG ' ' A' ' 254' ' ' SER . 1.1 m -56.98 -59.2 5.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 26.4 tp -53.51 -45.64 69.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.381 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -49.54 -50.53 41.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 0.0 109.666 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 98.5 t -62.41 -55.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.805 . . . . 0.0 110.197 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -52.0 -45.2 64.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 108.79 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 24.6 tp -52.99 -54.47 34.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.488 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 30.6 t -55.86 -54.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.37 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -43.98 33.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.35 -49.99 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 109.861 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 13.9 mt -56.94 -47.59 80.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.34 -30.77 69.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -67.5 -42.8 82.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 109.568 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -78.54 -54.16 6.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.889 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -70.41 53.26 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -60.48 -176.03 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.529 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.4 mt -91.88 157.47 16.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -1.166 . . . . 0.0 109.649 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -54.62 137.35 43.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 142.72 49.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.495 -0.753 . . . . 0.0 109.717 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -141.51 -171.63 3.35 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.3 m -96.86 135.15 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.049 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.501 ' CB ' ' HZ2' ' A' ' 8' ' ' LYS . 0.2 OUTLIER -65.91 -21.26 66.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.585 -179.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -153.0 160.76 43.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 0.0 109.275 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 140.59 54.48 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 0.0 110.022 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.14 163.93 15.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 141.9 46.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.091 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 98.0 m-85 -139.84 146.24 39.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' CG ' ' OH ' ' A' ' 23' ' ' TYR . 3.8 pt-20 -151.88 149.35 28.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 109.908 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.87 172.27 35.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.28 151.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -1.087 . . . . 0.0 110.357 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.37 137.1 15.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 tt -56.26 -38.74 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -91.07 -49.21 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.845 -1.159 . . . . 0.0 111.105 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.498 ' HG1' ' CB ' ' A' ' 95' ' ' GLU . 2.9 p -69.49 -21.76 63.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 111.416 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.03 8.31 3.05 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 20' ' ' THR . 3.4 mm-40 -102.69 157.34 17.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -1.108 . . . . 0.0 109.672 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' OH ' ' CG ' ' A' ' 14' ' ' GLU . 81.8 t80 -74.66 136.58 41.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.466 -0.771 . . . . 0.0 109.734 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -137.67 142.66 41.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -108.39 151.91 25.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.7 mt -134.74 144.29 47.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.493 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -142.45 110.48 2.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.607 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -94.95 115.92 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 111.168 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.493 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 27.8 m-70 -109.41 139.73 21.38 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.482 -0.761 . . . . 0.0 109.585 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -54.43 168.13 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.662 1.574 . . . . 0.0 111.434 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 73.4 mm-40 -139.99 173.35 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.001 . . . . 0.0 110.04 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.9 mtmt -81.98 149.78 27.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.493 -0.754 . . . . 0.0 109.742 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -46.79 145.43 1.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.341 -0.849 . . . . 0.0 109.823 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.77 8.22 60.19 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.312 -0.947 . . . . 0.0 110.878 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.5 m -73.61 -43.47 59.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.598 -1.531 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.46 -177.61 33.5 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.603 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.11 117.1 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -140.42 151.69 45.1 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.212 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.62 157.38 16.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.56 110.87 12.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 42.5 tttm -135.23 133.95 39.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.7 29.44 4.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.47 -0.769 . . . . 0.0 111.213 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.84 19.14 73.69 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.144 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.9 t -122.47 120.98 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -1.08 . . . . 0.0 109.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 18.7 m-85 -84.61 127.59 34.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.086 -1.008 . . . . 0.0 109.401 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -117.18 93.99 43.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.523 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.72 148.31 16.24 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.558 2.172 . . . . 0.0 112.206 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 69.08 10.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -0.952 . . . . 0.0 109.175 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -118.94 163.98 16.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -0.812 . . . . 0.0 109.291 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.546 ' CD2' ' CD ' ' A' ' 51' ' ' GLU . 1.2 p-80 -68.85 -50.07 53.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 0.0 109.578 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.546 ' CD ' ' CD2' ' A' ' 50' ' ' HIS . 42.8 mp0 -46.19 -16.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.632 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.6 m-85 -95.79 3.53 53.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.851 -1.156 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 75.7 t -71.15 128.73 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 108.735 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.38 -21.73 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.389 -0.819 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -156.26 125.89 6.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.907 -1.12 . . . . 0.0 110.009 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.5 p -121.03 95.56 4.75 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.3 t-20 -162.78 128.74 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 87.9 m-70 51.91 7.22 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.97 . . . . 0.0 108.854 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.574 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m 164.22 153.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.0 109.786 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.418 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 30.1 m -94.05 127.37 39.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.21 -0.931 . . . . 0.0 109.215 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.36 149.67 41.96 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.758 0.79 . . . . 0.0 111.064 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -125.35 151.81 45.59 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.68 148.0 15.55 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.802 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -159.27 145.67 16.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.972 . . . . 0.0 108.976 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER 52.94 28.01 6.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.394 -0.817 . . . . 0.0 109.473 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.12 -32.61 5.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.567 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -56.62 143.93 34.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 108.952 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.87 137.02 29.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.268 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.33 123.45 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -98.81 157.19 16.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.95 -1.093 . . . . 0.0 110.94 -178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m 50.77 74.61 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.55 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.02 -10.39 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.197 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -61.63 -27.41 68.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 110.627 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.415 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.5 m170 -65.78 -68.6 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.976 -1.078 . . . . 0.0 109.352 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -52.44 -47.13 47.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.004 . . . . 0.0 109.312 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.5 mt -52.59 -48.7 66.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.968 -1.082 . . . . 0.0 110.189 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 0.8 OUTLIER -61.0 -43.35 99.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.941 . . . . 0.0 110.241 -179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.69 -44.81 78.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 108.843 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.08 -34.85 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.09 -32.03 73.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.7 mt -83.74 -36.97 23.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.283 -0.886 . . . . 0.0 109.363 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.7 mt -78.81 5.01 12.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.056 . . . . 0.0 109.513 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 52.84 39.38 28.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 110.188 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.78 138.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 108.493 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.585 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 72.6 p -123.77 -18.19 6.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 111.716 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.585 ' ND2' ' OG1' ' A' ' 85' ' ' THR . 0.8 OUTLIER -126.7 107.8 10.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.864 -1.147 . . . . 0.0 111.134 -179.168 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 7.9 m -163.5 148.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.285 -0.885 . . . . 0.0 110.054 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 18.9 m -116.38 109.1 16.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -91.86 100.88 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.333 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.41 127.18 31.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.3 t -110.48 126.1 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.98 0.895 . . . . 0.0 111.925 -177.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.94 95.84 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 141.59 -156.7 25.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -120.67 -10.77 9.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -1.151 . . . . 0.0 110.449 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.498 ' CB ' ' HG1' ' A' ' 20' ' ' THR . 86.8 tt0 -140.39 148.89 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 109.47 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.0 mm -72.59 121.38 84.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.18 -0.95 . . . . 0.0 108.927 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.96 121.97 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.624 1.549 . . . . 0.0 111.206 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.0 tp -78.66 -12.08 13.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.2 mt 56.04 -118.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -97.87 7.29 46.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.3 -0.47 61.88 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.819 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -127.08 -172.26 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.799 -0.824 . . . . 0.0 109.535 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.56 15.04 9.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -57.59 -42.86 84.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 110.095 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.1 -57.75 8.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.103 -0.998 . . . . 0.0 110.19 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.39 -44.99 62.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.442 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 54.0 t80 -63.58 -51.26 66.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 111.261 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.67 -44.41 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.816 -1.177 . . . . 0.0 111.06 -178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.49 7.29 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.155 -0.966 . . . . 0.0 110.16 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 mt -62.55 -35.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 57.5 ttt-85 -60.82 -41.72 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.592 ' C ' HD21 ' A' ' 113' ' ' ASN . 2.8 mmmp? -74.87 9.45 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.884 . . . . 0.0 109.89 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.592 HD21 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.56 33.76 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.443 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -83.57 138.01 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.63 -1.294 . . . . 0.0 110.824 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.25 127.08 37.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.767 . . . . 0.0 109.206 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.92 144.91 27.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.076 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -112.23 -169.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -111.87 68.8 0.67 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.761 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -163.3 127.91 2.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 109.127 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.75 141.35 56.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.886 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 121' ' ' ILE . 94.0 mt -87.71 152.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -102.23 90.84 4.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 14.4 m-85 -65.33 148.14 52.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.552 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -92.58 101.79 14.22 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.79 134.33 31.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 110.74 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.05 116.2 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -92.52 -29.13 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.017 -1.052 . . . . 0.0 110.369 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.91 150.04 75.44 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.36 152.11 43.79 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.551 2.168 . . . . 0.0 112.343 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.24 152.62 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.08 147.35 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.61 148.03 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -131.59 162.43 30.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.422 ' OD2' ' NZ ' ' A' ' 258' ' ' LYS . 0.3 OUTLIER -172.41 103.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 50.76 54.89 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.333 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.54 -32.64 3.6 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.451 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.56 ' NH1' ' O ' ' A' ' 250' ' ' ARG . 88.1 mtt-85 -62.52 139.74 58.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.925 -1.338 . . . . 0.0 108.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -145.37 138.89 26.6 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.131 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 78.8 mt -137.56 125.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.579 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -113.41 132.86 55.46 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.393 0.616 . . . . 0.0 109.995 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 130.21 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.0 149.09 47.96 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.028 -1.045 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.59 142.88 9.35 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.677 2.251 . . . . 0.0 113.546 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.18 146.15 19.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.39 -3.36 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 p -149.08 -179.16 6.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.967 -1.083 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.2 tp -97.32 120.38 37.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -136.77 134.59 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -133.37 123.43 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.071 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.1 m -112.63 151.67 29.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.767 . . . . 0.0 109.743 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -138.17 129.37 27.37 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.653 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -120.74 131.06 54.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.22 141.6 12.51 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.753 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -106.38 101.16 10.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.94 167.1 15.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 110.964 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -99.55 -16.25 18.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.627 -0.671 . . . . 0.0 110.706 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.5 p-10 -98.53 -169.25 1.76 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.994 -1.067 . . . . 0.0 110.611 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -52.09 -0.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.502 -0.749 . . . . 0.0 111.531 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.542 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -78.04 -26.63 48.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.431 -1.418 . . . . 0.0 108.903 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.96 -140.83 34.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -104.9 134.23 48.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.067 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -138.68 158.76 43.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 109.375 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.04 145.43 31.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.383 -0.823 . . . . 0.0 109.471 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -143.74 137.17 27.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.53 124.88 51.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 110.038 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -105.77 117.78 34.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.79 153.14 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -50.71 126.35 15.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.94 -2.86 28.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -117.76 22.94 12.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.173 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.43 -29.95 62.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 0.0 110.18 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.86 -19.7 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.0 -6.5 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 111.241 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.79 -26.33 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.906 -1.122 . . . . 0.0 111.314 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -60.34 -20.8 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.594 -1.316 . . . . 0.0 109.123 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.9 -2.75 58.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.518 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.2 116.48 8.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 108.881 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.521 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.8 mtm180 -81.15 172.06 14.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.546 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.8 t -80.66 162.14 24.33 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -147.49 147.08 29.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.246 -1.534 . . . . 0.0 111.527 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.22 158.05 43.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.531 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.4 m-85 -99.55 144.25 28.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.992 -1.067 . . . . 0.0 109.981 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.95 -38.87 53.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.531 -0.73 . . . . 0.0 109.895 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.531 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.3 p90 -66.81 -27.46 67.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 0.0 110.034 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.8 mt-10 -84.05 -43.61 14.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.097 -1.002 . . . . 0.0 109.835 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.439 ' C ' ' O ' ' A' ' 185' ' ' GLU . 61.8 mt -40.8 -44.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.245 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.75 -37.72 76.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.995 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 185' ' ' GLU . 4.6 t-80 -76.68 -43.6 37.08 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.66 -29.57 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.504 -0.748 . . . . 0.0 109.036 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -80.98 -52.08 7.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -48.86 -45.67 41.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 110.282 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.1 m -74.89 6.49 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.03 . . . . 0.0 110.216 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.78 39.24 48.41 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.126 -0.984 . . . . 0.0 110.726 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 44.6 mt -126.53 176.1 7.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -1.168 . . . . 0.0 109.56 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 54.43 24.25 30.0 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -58.51 -20.89 49.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.662 -1.493 . . . . 0.0 110.306 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.11 1.74 31.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.46 126.2 35.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.963 -1.316 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' THR . 1.6 t -146.31 167.31 23.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.379 -1.071 . . . . 0.0 109.506 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.589 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 0.6 OUTLIER -68.57 -8.76 44.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 7.6 mmtp -96.67 -13.13 23.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.6 p30 -135.83 7.43 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.627 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -151.72 152.98 33.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 15.3 tp -100.21 97.98 8.72 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.403 HG13 ' CG ' ' A' ' 212' ' ' TYR . 53.4 t -85.49 126.86 40.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.0 mt -122.26 161.99 22.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.548 -0.72 . . . . 0.0 109.875 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.85 -166.39 12.38 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -62.89 -26.23 68.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -1.13 . . . . 0.0 109.735 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -161.29 22.77 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 110.565 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.04 147.62 40.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.865 -1.147 . . . . 0.0 110.393 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.32 112.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.403 ' CG ' HG13 ' A' ' 205' ' ' VAL . 10.8 m-85 -60.29 -45.46 93.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 110.103 -178.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.9 m120 -61.91 121.58 66.16 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 109.792 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.66 -12.62 36.19 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.486 1.457 . . . . 0.0 111.817 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.69 -16.81 56.83 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.273 -0.892 . . . . 0.0 108.945 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.26 -169.21 54.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.4 mt -89.25 145.57 25.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -1.2 . . . . 0.0 109.781 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -79.42 -19.26 50.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.499 ' C ' ' H ' ' A' ' 221' ' ' ASN . 71.2 m-85 -146.85 152.14 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.467 -0.771 . . . . 0.0 108.987 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.64 6.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -151.11 40.62 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -58.27 -47.24 99.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 109.734 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.3 Cg_exo -51.43 -67.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.3 m -58.4 -37.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 109.858 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 44.4 mtt180 -59.96 -41.44 91.93 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.071 -1.018 . . . . 0.0 108.446 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.6 t60 -67.0 -31.8 72.6 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -66.77 -36.44 82.44 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 92.7 t -67.15 -39.1 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.9 t80 -61.6 -52.36 64.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.559 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 93.7 m-20 -63.44 -28.37 69.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.06 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 40.6 tp -78.2 -33.54 49.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.945 -1.097 . . . . 0.0 108.738 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.86 -37.69 79.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.37 -55.86 11.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 29.1 m-20 -53.95 -35.48 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -1.174 . . . . 0.0 109.086 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 17.0 mt -63.96 -24.64 67.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.478 -0.764 . . . . 0.0 110.512 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.606 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.3 t80 -75.44 -21.66 57.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.918 -1.114 . . . . 0.0 109.361 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 33.0 mt -50.79 -3.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.711 -1.243 . . . . 0.0 110.203 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.606 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -72.1 -12.85 61.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.94 -1.1 . . . . 0.0 109.962 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 0.51 59.66 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.915 -1.135 . . . . 0.0 110.824 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 154.54 11.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.872 -1.369 . . . . 0.0 108.816 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.4 Cg_endo -47.94 150.04 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.622 1.548 . . . . 0.0 109.416 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.72 146.85 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.979 -1.075 . . . . 0.0 112.056 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.88 124.33 30.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.8 179.22 29.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.87 132.53 54.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.6 m-85 -132.9 140.38 47.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.47 ' CD1' ' C ' ' A' ' 247' ' ' TYR . 4.3 t80 -125.0 137.44 54.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.3 t -130.62 137.29 49.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 111.343 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -117.5 115.9 26.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.56 ' O ' ' NH1' ' A' ' 137' ' ' ARG . 5.3 mtp85 47.57 30.41 1.69 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.05 146.12 44.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.75 169.6 15.92 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 59.5 m-70 -52.94 -37.85 61.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.061 -1.258 . . . . 0.0 109.531 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -57.98 8.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.005 . . . . 0.0 109.127 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 15.9 tp -61.75 -43.17 99.38 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -47.7 -51.61 21.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.133 . . . . 0.0 109.139 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 85.3 t -62.6 -52.16 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.422 ' NZ ' ' OD2' ' A' ' 134' ' ' ASP . 10.1 ttmt -51.31 -51.34 55.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 109.083 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 39.8 tp -50.78 -54.82 20.37 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.702 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 49.7 t -55.39 -51.16 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 108.895 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -47.77 -50.5 25.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.08 -48.28 79.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.814 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.1 -49.58 76.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 268' ' ' LYS . . . -69.82 -32.99 71.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.292 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -65.47 -62.98 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.264 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.9 -59.18 3.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -60.61 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.449 -0.782 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 269' ' ' LEU . 19.8 mttt -137.43 93.83 2.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 268' ' ' LYS . 1.2 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.498 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.559 ' C22' ' OD2' ' A' ' 230' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mt -83.39 156.36 23.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -1.097 . . . . 0.0 109.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.81 138.93 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 108.996 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -122.58 144.9 48.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.21 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.93 -172.72 3.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.1 m -99.03 137.89 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.865 -1.147 . . . . 0.0 109.132 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -18.24 65.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 109.898 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -155.27 156.25 35.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 109.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.08 139.54 58.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 110.234 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -117.4 160.39 21.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.89 141.98 47.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 110.232 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -140.34 150.76 44.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -161.61 151.98 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.912 -1.117 . . . . 0.0 109.848 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.62 175.71 37.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.57 152.46 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -1.181 . . . . 0.0 110.243 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' C ' ' OE2' ' A' ' 95' ' ' GLU . . . -88.24 140.29 16.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.496 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 6.2 tt -59.99 -38.39 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 111.041 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 72.2 m-70 -91.52 -46.95 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.402 -1.436 . . . . 0.0 111.039 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.601 ' HG1' ' CD ' ' A' ' 95' ' ' GLU . 3.5 p -72.15 -23.23 61.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.211 -0.931 . . . . 0.0 111.557 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.64 15.67 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.284 -1.436 . . . . 0.0 109.553 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.94 155.24 20.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -1.091 . . . . 0.0 109.748 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.69 134.98 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.429 -0.794 . . . . 0.0 109.466 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 m -137.01 144.24 43.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.37 155.98 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.453 -0.78 . . . . 0.0 109.866 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.9 mt -138.64 143.89 39.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.544 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -139.35 114.56 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 108.667 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.18 115.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 0.0 111.006 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.544 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 15.6 m-70 -108.42 137.06 19.85 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.517 -0.739 . . . . 0.0 109.788 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -51.62 168.13 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.032 1.821 . . . . 0.0 111.604 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 66.9 mm-40 -146.52 155.23 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.938 . . . . 0.0 109.975 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.511 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -67.39 154.16 42.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.781 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 149.23 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 110.824 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.645 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 75.18 -7.45 22.92 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.26 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.723 ' N ' HD21 ' A' ' 86' ' ' ASN . 93.0 m -59.33 -44.97 92.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.557 -1.555 . . . . 0.0 109.861 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.474 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 95.65 -175.82 33.15 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -100.42 116.54 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -141.23 150.97 43.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.764 -1.21 . . . . 0.0 110.983 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.16 157.42 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.17 114.29 15.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.93 . . . . 0.0 109.248 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 45.4 tttm -134.2 134.38 42.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.486 ' CG ' ' O ' ' A' ' 41' ' ' LYS . 7.5 p-10 44.08 42.37 4.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.877 -0.514 . . . . 0.0 112.193 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.93 15.7 78.33 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 120.695 -1.253 . . . . 0.0 110.549 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -121.43 120.65 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -1.141 . . . . 0.0 109.311 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 36.1 m-85 -86.11 127.72 34.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.481 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.87 93.43 41.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.506 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.99 145.99 17.98 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.656 2.237 . . . . 0.0 112.39 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.39 66.01 4.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.98 166.69 12.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p-80 -72.94 -49.96 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.476 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -44.11 -16.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.2 m-85 -96.84 1.94 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.24 130.36 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 108.7 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.0 m -111.74 -28.94 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -152.1 130.31 11.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.911 -1.118 . . . . 0.0 110.176 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.9 p -120.87 94.6 4.4 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.6 t-20 -163.74 129.15 2.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 108.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' SER . 86.5 m-70 52.52 6.15 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.128 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.81 143.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.851 . . . . 0.0 109.683 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.454 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 37.6 m -84.72 128.08 34.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -120.73 149.46 42.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.429 -0.794 . . . . 0.0 110.751 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.2 mt -120.74 154.59 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.98 22.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.976 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -161.78 145.79 12.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.413 -1.051 . . . . 0.0 109.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt 51.61 21.7 1.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.86 . . . . 0.0 109.323 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.26 -33.59 6.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.513 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 2.8 mm100 -55.96 149.16 15.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -1.217 . . . . 0.0 109.51 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -145.89 136.32 24.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.553 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.97 128.15 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -101.27 155.51 17.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 111.605 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.8 m 50.35 74.95 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.746 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.8 m -108.4 -11.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.99 . . . . 0.0 109.566 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.4 pm0 -60.44 -26.46 66.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -66.32 -68.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.324 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.72 -48.03 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.072 -1.018 . . . . 0.0 109.107 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.3 mt -52.33 -50.18 62.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.024 -1.048 . . . . 0.0 110.371 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.564 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 28.7 t -59.22 -41.54 88.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.9 t -56.36 -47.1 81.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.121 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.67 -34.05 77.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.323 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -61.95 -39.19 91.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.1 mt -77.84 -38.51 46.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.4 mt -80.68 -1.17 41.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 109.392 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 56.87 42.12 26.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.733 -0.604 . . . . 0.0 111.386 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.4 HG21 HD11 ' A' ' 84' ' ' ILE . 38.1 mm -87.17 140.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.854 -1.154 . . . . 0.0 107.968 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.8 p -124.57 -22.47 4.61 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.126 -0.984 . . . . 0.0 111.799 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.723 HD21 ' N ' ' A' ' 35' ' ' THR . 18.0 m120 -125.46 107.13 10.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.868 -1.145 . . . . 0.0 110.666 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.3 m -164.69 148.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.771 0.796 . . . . 0.0 110.151 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 93.5 m -114.49 113.26 24.22 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -95.29 100.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' OE2' ' NE2' ' A' ' 29' ' ' HIS . 33.4 mt-10 -73.41 124.84 26.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.108 -0.995 . . . . 0.0 108.361 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.6 t -106.94 123.79 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 121.677 0.751 . . . . 0.0 111.172 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mm -109.18 96.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.52 -156.04 23.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -123.08 -12.28 7.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.319 -1.107 . . . . 0.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.601 ' CD ' ' HG1' ' A' ' 20' ' ' THR . 29.3 tt0 -132.85 140.19 47.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 109.944 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.6 mm -70.24 119.32 71.32 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 108.417 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -40.74 122.58 1.45 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.887 1.725 . . . . 0.0 111.466 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.6 tp -79.0 -12.0 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.711 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.3 mt 56.42 -119.61 1.34 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 110.01 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 27.6 t0 -96.53 10.02 39.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.923 -1.111 . . . . 0.0 111.126 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.26 -1.41 62.55 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.43 -1.367 . . . . 0.0 109.843 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.02 -172.06 2.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.799 -0.824 . . . . 0.0 109.483 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.18 16.08 10.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -57.83 -42.84 85.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.429 -1.042 . . . . 0.0 110.464 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.46 -58.96 5.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.167 -0.958 . . . . 0.0 110.092 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -51.03 -45.96 61.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -61.37 -50.36 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.554 -0.716 . . . . 0.0 111.059 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -63.47 -44.46 94.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.946 -1.096 . . . . 0.0 111.377 -178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.85 -53.56 38.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 0.0 110.646 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -65.04 -30.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.918 -1.114 . . . . 0.0 109.287 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.9 ttt-85 -65.68 -43.89 87.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.407 -0.808 . . . . 0.0 110.274 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -77.78 14.22 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.957 -1.089 . . . . 0.0 110.019 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -144.13 32.47 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.8 mt -80.87 139.89 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.928 -1.107 . . . . 0.0 110.272 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.14 125.08 32.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.766 . . . . 0.0 109.128 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -80.57 142.29 34.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.334 -0.854 . . . . 0.0 110.169 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -110.36 -172.75 2.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.408 -0.807 . . . . 0.0 109.448 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -110.43 68.27 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 110.58 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.7 131.16 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 109.531 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.24 142.42 54.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.064 -1.022 . . . . 0.0 109.691 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.9 mt -85.44 151.34 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.815 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.71 83.42 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 108.817 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 28.6 m-85 -61.44 143.09 56.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -90.32 101.83 14.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.17 133.73 32.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.62 . . . . 0.0 110.857 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.13 112.45 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.91 -34.18 21.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.979 -1.076 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.9 149.88 72.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.5 147.93 71.89 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.318 2.012 . . . . 0.0 112.089 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -154.27 152.3 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.67 144.73 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.227 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.95 147.68 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -132.83 159.77 38.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.53 ' OD1' ' NZ ' ' A' ' 258' ' ' LYS . 0.1 OUTLIER -172.33 101.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.241 -0.912 . . . . 0.0 109.995 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 45.97 59.26 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.753 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.31 -37.92 3.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.485 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -63.75 130.89 46.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.45 ' CD2' ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -144.14 139.85 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.992 -1.067 . . . . 0.0 109.769 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 98.5 mt -137.62 129.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 109.693 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -115.56 131.67 56.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.49 135.88 55.0 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -149.52 148.54 26.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 109.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -46.04 142.17 8.58 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.508 2.139 . . . . 0.0 113.326 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.48 143.3 19.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -62.75 -5.17 2.52 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.503 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 244' ' ' GLY . 30.4 p -154.96 179.1 9.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.949 -1.095 . . . . 0.0 109.859 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.25 120.19 29.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.208 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.6 123.58 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 108.646 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -124.41 122.02 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.1 m -112.25 151.94 29.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.369 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -139.5 130.67 26.59 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.106 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 28.4 tt0 -121.18 131.7 54.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.43 139.19 10.45 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.469 -1.348 . . . . 0.0 111.577 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -103.0 100.66 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -86.33 167.03 15.15 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 110.6 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.57 -15.55 18.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 110.589 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 159' ' ' LEU . 23.0 p-10 -95.21 -168.12 1.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.832 -1.168 . . . . 0.0 110.131 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -56.58 3.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 111.26 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.525 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.8 mt -79.67 -28.28 40.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.454 -1.404 . . . . 0.0 108.423 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.01 -138.69 34.56 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 3.9 ttm180 -97.0 131.84 43.41 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.275 -1.133 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.467 ' OE1' ' O ' ' A' ' 161' ' ' ARG . 29.1 mm100 -136.63 147.29 46.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.765 . . . . 0.0 109.108 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -140.52 145.05 36.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.856 . . . . 0.0 110.093 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.515 ' CZ ' ' NH2' ' A' ' 225' ' ' ARG . 89.3 t80 -144.26 140.38 29.19 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 76.8 m -110.82 124.3 51.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 110.295 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -103.89 117.26 33.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.409 -0.807 . . . . 0.0 109.761 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.31 154.64 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.097 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -50.63 125.22 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 108.977 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.24 -2.44 26.75 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -119.81 21.74 11.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.14 -1.212 . . . . 0.0 109.186 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -54.46 -32.12 56.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.379 -0.825 . . . . 0.0 110.621 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.24 -17.47 62.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 110.183 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.554 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 23.2 mm-40 -86.79 -6.83 58.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.172 -0.955 . . . . 0.0 111.495 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 40.2 pt -123.68 -26.05 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.919 -1.113 . . . . 0.0 110.845 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 15.1 m -65.21 -26.77 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.553 -1.342 . . . . 0.0 109.382 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.54 -5.54 56.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.0 109.335 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.468 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.09 123.43 21.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.977 . . . . 0.0 109.205 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -84.54 172.93 11.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.569 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.2 t -77.32 161.48 28.04 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -147.04 144.38 29.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.191 -1.568 . . . . 0.0 111.427 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.08 45.02 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 90.6 m-85 -97.66 146.89 24.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.602 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.56 -38.71 21.32 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.399 -0.813 . . . . 0.0 109.741 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.13 -25.18 62.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.0 109.644 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.7 mm-40 -79.82 -25.64 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.0 110.044 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 187' ' ' GLU . 22.6 mt -60.93 -54.82 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 110.017 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 186' ' ' ILE . 10.9 tt0 -42.1 -39.88 2.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.887 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -78.76 -54.31 6.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 194' ' ' LEU . 29.1 mt -48.35 -29.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.663 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -85.34 -54.38 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.769 -1.207 . . . . 0.0 109.194 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -50.09 -42.52 50.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.066 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.65 5.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.995 . . . . 0.0 109.854 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.31 37.28 54.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' ILE . 36.0 mt -125.61 166.04 17.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -1.126 . . . . 0.0 109.591 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.41 ' N ' ' ND1' ' A' ' 19' ' ' HIS . . . 64.5 22.98 68.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -56.18 -23.65 36.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.432 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.5 25.91 12.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.24 125.12 7.88 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.945 -1.327 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -145.1 168.07 21.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.064 . . . . 0.0 109.708 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.1 -8.72 25.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 ttmm -93.89 -14.31 26.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 14.7 p30 -136.07 8.14 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.792 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -147.34 149.28 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.047 -1.033 . . . . 0.0 110.702 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 27.1 tp -98.87 94.61 6.68 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.2 t -86.81 129.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.635 0.731 . . . . 0.0 109.225 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.07 173.9 6.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.369 -0.832 . . . . 0.0 109.53 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -134.64 -166.41 11.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.95 70.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -1.047 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -158.91 26.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.061 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -145.36 153.27 41.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.841 -1.162 . . . . 0.0 110.421 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.0 t -104.4 113.32 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -57.99 -48.34 80.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.051 -1.03 . . . . 0.0 109.854 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -63.0 112.51 6.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 110.313 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -57.85 -11.12 8.82 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.697 1.598 . . . . 0.0 112.165 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.18 -18.91 58.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.436 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.24 179.65 50.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 217' ' ' LEU . 5.7 mt -83.23 121.93 27.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -1.217 . . . . 0.0 109.64 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.0 OUTLIER -49.52 -22.48 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 108.661 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 56.0 m-85 -148.42 178.96 8.15 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -86.87 2.95 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.755 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 45.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.543 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -61.76 -42.69 84.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.911 -1.118 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.6 Cg_exo -58.76 -60.04 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.585 2.19 . . . . 0.0 112.596 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 28.2 m -66.96 -39.34 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.064 -1.023 . . . . 0.0 111.448 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.554 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 3.3 ptm85 -67.51 -35.52 79.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.561 -1.337 . . . . 0.0 108.595 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.468 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 23.3 t60 -66.02 -34.56 78.37 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -64.59 -35.08 79.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.9 t -67.01 -35.99 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.564 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.5 t80 -67.41 -50.93 57.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.2 -33.14 72.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.355 -0.84 . . . . 0.0 109.808 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.1 tp -74.97 -32.74 61.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.096 -1.003 . . . . 0.0 108.736 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.4 mt -65.76 -38.6 82.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -53.97 22.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.497 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 6.7 m-20 -56.15 -29.53 60.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -1.201 . . . . 0.0 109.09 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.1 mt -67.09 -23.27 65.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.529 -0.732 . . . . 0.0 110.581 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.591 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.47 -22.51 60.15 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.743 -1.223 . . . . 0.0 109.374 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 91.7 mt -50.09 -4.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.599 -1.313 . . . . 0.0 110.411 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.591 ' H ' ' C ' ' A' ' 236' ' ' TYR . 10.6 mt -75.52 -15.46 60.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 109.681 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.02 58.14 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.659 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.36 155.04 9.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.875 -1.368 . . . . 0.0 109.106 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.4 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.1 Cg_endo -49.33 150.62 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.956 1.771 . . . . 0.0 109.869 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -109.42 145.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.023 -1.048 . . . . 0.0 111.881 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -130.25 125.18 34.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.47 -160.3 29.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.4 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -130.49 140.43 50.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 109.153 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.8 m-85 -138.62 142.14 39.12 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.175 -0.953 . . . . 0.0 110.331 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.7 t80 -124.91 124.66 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.0 m -117.76 135.0 54.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -115.36 114.92 25.75 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 49.87 20.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.02 -1.05 . . . . 0.0 109.074 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -53.34 156.53 5.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.489 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -138.35 163.0 25.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.577 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 48.4 m-70 -48.68 -40.11 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.187 -1.184 . . . . 0.0 109.817 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -58.4 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.127 -0.983 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' ASN . 13.8 tp -59.63 -44.02 93.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.077 -1.014 . . . . 0.0 109.519 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.2 m-20 -47.73 -48.12 29.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.885 -1.135 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.89 -52.37 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.584 -0.698 . . . . 0.0 109.573 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.53 ' NZ ' ' OD1' ' A' ' 134' ' ' ASP . 31.0 ttmt -52.86 -48.79 66.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 42.7 tp -52.94 -51.75 60.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 108.7 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.82 -53.75 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.21 -0.932 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -49.64 -48.23 49.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.91 -48.47 81.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.64 -49.76 74.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.877 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.47 -26.35 66.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.831 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -70.01 -57.29 5.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 110.097 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.486 ' HZ3' ' NE2' ' A' ' 267' ' ' GLN . 0.0 OUTLIER -66.32 -34.65 78.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.744 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.486 ' NE2' ' HZ3' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -64.96 -75.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.331 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -84.52 -166.4 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.317 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.429 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.569 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.34 154.44 19.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 85' ' ' THR . 3.0 mm-40 -56.88 138.57 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 108.846 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.593 ' HZ1' ' CB ' ' A' ' 116' ' ' ASN . 8.3 mptt -121.61 144.59 48.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.0 110.272 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -142.5 -174.63 4.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.0 m -98.6 136.96 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.249 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.41 -23.03 66.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 109.945 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.51 159.35 44.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.719 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 139.68 58.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.18 164.39 15.24 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.32 142.65 45.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.85 -1.156 . . . . 0.0 110.566 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.3 m-85 -139.3 154.01 47.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.1 152.6 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.856 -1.153 . . . . 0.0 110.091 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.79 176.49 36.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.7 154.6 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -1.099 . . . . 0.0 110.369 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.64 140.45 15.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 tt -58.83 -40.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -1.169 . . . . 0.0 110.679 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -89.53 -49.67 6.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.663 -1.273 . . . . 0.0 111.126 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 p -69.6 -23.1 63.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.662 -0.649 . . . . 0.0 111.262 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.48 15.94 13.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.39 154.37 21.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 109.607 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 14.1 t80 -75.98 135.93 40.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 109.766 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 m -139.39 145.28 38.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.43 154.87 24.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.7 mt -135.71 148.58 48.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.204 -0.935 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.502 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 14.6 mt -143.37 113.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.18 115.22 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 110.992 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.502 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 18.0 m-70 -107.71 135.95 19.73 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.476 -0.765 . . . . 0.0 109.692 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -52.32 168.18 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.004 1.803 . . . . 0.0 111.94 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.443 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 12.7 mm-40 -144.63 177.52 8.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.35 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.11 156.07 19.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.411 ' C ' ' H ' ' A' ' 35' ' ' THR . 1.4 mt-10 -49.6 151.28 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.711 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 70.29 -11.1 2.28 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.997 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.68 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 62.1 m -55.81 -46.65 78.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.652 -1.499 . . . . 0.0 109.986 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.439 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 96.97 -177.71 32.89 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.204 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.66 117.0 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -138.44 147.7 43.57 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.67 156.86 16.35 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -129.08 111.27 12.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 16.2 tttp -135.65 134.97 39.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 110.851 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 49.92 26.59 2.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.969 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.11 19.54 62.6 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.298 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.7 120.45 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.099 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -87.14 129.14 35.06 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.093 -1.004 . . . . 0.0 108.42 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.514 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 73.5 mt -121.31 95.64 48.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 110.466 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.45 150.19 16.12 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.93 1.754 . . . . 0.0 110.995 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.66 72.1 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.642 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -123.86 163.38 21.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.774 . . . . 0.0 109.043 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.3 p-80 -66.04 -52.12 52.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 110.141 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -43.83 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.777 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' HIS . 28.3 m-85 -95.2 5.44 51.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.789 -1.194 . . . . 0.0 109.936 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 50' ' ' HIS . 75.3 t -76.69 129.82 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.0 108.611 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.74 -24.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 0.0 110.303 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.67 125.18 10.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.012 -1.055 . . . . 0.0 110.009 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -119.58 95.98 5.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.9 t-20 -162.66 128.54 3.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 88.0 m-70 48.02 9.79 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.15 -0.969 . . . . 0.0 109.263 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 165.8 147.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.905 . . . . 0.0 109.868 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.0 m -90.06 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 109.149 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.11 149.49 42.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.465 -0.772 . . . . 0.0 110.788 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.3 mt -120.37 163.17 18.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.117 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.62 151.19 15.58 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.619 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.33 145.41 14.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.669 -0.901 . . . . 0.0 108.691 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 21.35 7.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.04 -28.14 15.22 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.804 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.23 147.46 49.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.699 -1.471 . . . . 0.0 109.402 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 47.2 ttp180 -140.51 147.03 38.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.071 -1.018 . . . . 0.0 111.498 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.23 137.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -105.87 156.07 18.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 112.322 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.0 m 50.18 78.3 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.439 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.33 -8.2 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.005 . . . . 0.0 109.363 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.8 pm0 -62.74 -27.13 69.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 111.106 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -66.81 -69.09 0.33 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.802 -1.186 . . . . 0.0 109.256 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.418 ' CG2' ' N ' ' A' ' 76' ' ' LEU . 7.1 tp -51.87 -47.7 40.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.418 ' N ' ' CG2' ' A' ' 75' ' ' ILE . 11.8 mt -52.29 -49.12 64.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.937 -1.102 . . . . 0.0 110.384 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 36.1 t -60.56 -42.12 95.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.19 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 82.3 t -57.25 -46.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.942 -1.099 . . . . 0.0 109.194 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.63 -34.2 77.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -64.09 -37.95 89.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.4 mt -77.85 -39.58 43.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.72 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.3 mt -78.41 -2.53 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.009 . . . . 0.0 109.226 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 58.32 42.44 21.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 111.311 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.1 mm -86.01 146.59 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.871 -1.143 . . . . 0.0 108.169 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.416 ' CB ' ' OE2' ' A' ' 4' ' ' GLU . 61.3 p -128.93 -23.84 3.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 111.514 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.711 HD22 ' N ' ' A' ' 34' ' ' GLY . 27.6 m120 -124.61 107.85 11.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.851 -1.156 . . . . 0.0 110.75 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.89 147.14 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.851 0.834 . . . . 0.0 110.256 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 24.7 m -114.82 112.04 22.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.1 mt -93.82 100.32 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.421 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -74.55 125.94 29.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.3 t -107.16 130.01 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.921 0.867 . . . . 0.0 111.998 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.3 mm -110.69 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.82 -154.76 23.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.44 -10.44 8.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.385 -1.068 . . . . 0.0 110.049 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -138.83 148.31 43.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.041 -1.037 . . . . 0.0 109.347 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.8 mm -74.44 122.17 86.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.317 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -41.82 122.05 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.975 1.783 . . . . 0.0 111.501 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.5 tp -74.82 -13.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.101 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.8 mt 57.27 -122.45 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.496 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.49 8.74 43.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.588 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.52 -3.66 72.06 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.514 -1.327 . . . . 0.0 109.819 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.21 -173.03 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.495 -1.003 . . . . 0.0 109.135 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.24 16.2 11.83 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -58.24 -45.09 88.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.907 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.95 -57.42 9.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.011 . . . . 0.0 109.655 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -51.58 -46.03 63.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.058 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 59.6 t80 -61.17 -52.93 62.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.646 . . . . 0.0 111.058 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.1 -43.08 99.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.139 -0.976 . . . . 0.0 111.376 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -56.63 9.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 110.572 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.7 mt -63.54 -32.24 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.97 -1.081 . . . . 0.0 109.661 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.2 ttt180 -65.09 -43.62 91.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -75.83 11.39 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.018 -1.051 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -143.98 35.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.914 -1.116 . . . . 0.0 110.435 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -82.02 141.19 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 0.0 110.57 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.69 120.52 22.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.599 HD21 ' H ' ' A' ' 116' ' ' ASN . 1.0 OUTLIER -81.78 140.68 34.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -106.11 -168.57 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.785 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.444 ' OD1' ' O ' ' A' ' 118' ' ' ASN . 16.3 p30 -111.54 71.52 0.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 0.0 110.65 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -170.5 133.77 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.995 . . . . 0.0 109.547 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -69.71 147.68 50.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.707 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.1 mt -88.72 151.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 110.113 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -97.99 88.05 4.14 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.3 m-85 -66.46 144.27 56.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.848 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.635 ' CZ ' ' NE2' ' A' ' 267' ' ' GLN . 34.5 t80 -88.31 100.98 13.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -90.78 132.61 34.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.657 -0.652 . . . . 0.0 110.799 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.45 114.06 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.87 -30.18 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.961 -1.087 . . . . 0.0 110.313 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.76 149.95 73.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.831 . . . . 0.0 109.463 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.28 149.72 45.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.492 2.128 . . . . 0.0 111.456 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 tt -157.37 153.82 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.055 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.63 144.51 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.322 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.39 148.24 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -134.96 161.83 34.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -174.8 105.81 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.907 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 52.26 53.57 12.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.442 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 -33.0 3.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -60.32 135.51 57.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.019 -1.283 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.466 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -145.41 137.72 25.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 110.333 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 90.4 mt -137.04 130.39 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 0.0 109.51 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -117.8 132.09 56.49 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.362 0.601 . . . . 0.0 109.896 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.26 134.21 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.57 153.15 46.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -50.79 143.19 30.49 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.379 2.052 . . . . 0.0 113.428 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.5 143.8 19.03 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.12 -9.66 11.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 110.463 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' GLY . 82.1 p -144.7 -175.29 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 109.547 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.3 tp -100.19 123.56 44.56 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.198 -0.939 . . . . 0.0 108.567 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -138.9 135.41 34.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 108.751 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 70.9 t -134.48 123.67 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.711 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 90.9 m -113.75 152.32 30.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -0.775 . . . . 0.0 109.846 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.949 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.97 132.43 54.92 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.03 141.2 11.33 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.338 -1.41 . . . . 0.0 112.07 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.11 101.92 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.43 167.03 13.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 111.144 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -104.54 30.97 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.594 -0.691 . . . . 0.0 110.726 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' LEU . 27.5 p-10 -148.53 -168.35 3.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.771 -1.206 . . . . 0.0 110.118 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -48.22 -4.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 0.0 111.374 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.7 mt -82.99 -31.01 27.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.521 -1.362 . . . . 0.0 108.708 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.55 -135.53 41.48 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.69 132.27 45.14 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.154 -1.203 . . . . 0.0 109.146 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -137.92 149.98 46.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -140.66 144.11 35.5 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -141.78 132.62 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 109.775 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -105.89 123.98 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -105.22 115.74 30.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.49 151.53 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.69 129.63 23.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.01 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.09 -1.99 38.06 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -119.18 23.23 11.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -1.123 . . . . 0.0 109.39 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.583 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -56.03 -56.05 25.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 171' ' ' GLU . 3.8 mt-10 -41.81 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.407 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.572 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 2.3 mt-10 -85.11 -7.35 59.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.067 -1.021 . . . . 0.0 111.463 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.2 pt -126.36 -27.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.864 -1.147 . . . . 0.0 110.906 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.89 -17.37 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.739 -1.226 . . . . 0.0 109.346 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.4 -3.52 55.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.409 ' HB1' ' HD1' ' A' ' 226' ' ' HIS . . . -68.6 126.32 29.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 179' ' ' THR . 62.4 mtm180 -94.04 130.36 40.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.548 ' HG1' HN17 ' A' ' 500' ' ' C90 . 10.1 t -37.11 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.52 154.24 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.544 -1.348 . . . . 0.0 111.578 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.16 156.36 39.65 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.1 m-85 -97.66 145.49 26.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.83 -1.169 . . . . 0.0 109.692 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.447 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 4.0 t0 -48.8 -37.9 20.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.251 -0.905 . . . . 0.0 109.084 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.532 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.8 p90 -70.16 -25.82 63.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.987 -1.071 . . . . 0.0 109.331 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.3 mm-40 -75.68 -35.66 60.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.92 -42.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.681 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -58.84 -41.7 87.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 0.0 109.538 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 189' ' ' ILE . 11.7 t60 -75.85 -58.31 3.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.013 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 188' ' ' HIS . 94.4 mt -43.79 -33.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -79.4 -52.51 7.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.1 . . . . 0.0 109.069 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -47.33 -44.82 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.22 7.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.054 -1.029 . . . . 0.0 110.531 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.02 40.0 57.67 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.081 -1.012 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 44.0 mt -127.72 173.82 9.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.219 -1.166 . . . . 0.0 109.93 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.16 26.58 50.11 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -60.26 -19.69 55.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.0 109.868 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.84 3.34 33.92 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.68 128.07 40.14 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.462 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 11.5 p -146.44 164.65 31.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.9 mt -66.72 -7.93 24.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 108.607 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . 0.414 ' H ' ' HG ' ' A' ' 199' ' ' SER . 2.4 mtmt -96.83 -19.09 19.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.601 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.462 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 21.5 p30 -128.04 3.98 5.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.5 m -144.47 146.72 32.59 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.688 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 13.7 tp -96.79 96.3 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.09 127.67 39.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.893 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.5 160.95 24.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.577 -0.702 . . . . 0.0 109.438 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.43 -166.15 13.04 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -30.47 70.61 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.134 -1.215 . . . . 0.0 109.658 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.97 23.38 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.089 -1.007 . . . . 0.0 111.264 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -149.97 157.76 43.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.449 -1.407 . . . . 0.0 110.724 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.9 t -105.24 115.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -61.63 -44.06 97.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.387 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.3 m120 -62.43 126.01 87.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.889 -1.132 . . . . 0.0 110.334 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -67.08 -17.17 50.7 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.689 1.593 . . . . 0.0 112.246 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -15.82 56.28 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.964 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.33 -164.93 54.45 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.7 mt -91.83 129.55 37.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -1.208 . . . . 0.0 109.463 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 3.3 mmt85 -67.02 -17.08 64.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.995 -1.066 . . . . 0.0 108.193 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 40.6 m-85 -145.53 160.67 41.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.433 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.9 mp0 -77.86 15.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.708 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.538 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -154.28 39.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.781 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.4 tt0 -57.95 -43.81 98.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.903 -1.123 . . . . 0.0 109.793 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 33.2 Cg_exo -59.59 -66.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.833 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.37 -40.19 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.133 -0.979 . . . . 0.0 111.428 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.572 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 4.3 ptm180 -67.77 -34.72 77.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.615 -1.303 . . . . 0.0 109.006 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.409 ' HD1' ' HB1' ' A' ' 177' ' ' ALA . 27.9 t60 -66.61 -32.35 73.62 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -65.59 -37.61 87.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 67.8 t -65.7 -37.2 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.59 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 46.1 t80 -64.04 -52.07 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.403 ' OD2' ' N23' ' A' ' 500' ' ' C90 . 82.3 m-20 -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.705 . . . . 0.0 109.565 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.51 -33.58 54.32 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 mt -67.41 -38.06 80.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -54.4 22.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 95.4 m-20 -56.52 -33.04 65.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -1.197 . . . . 0.0 109.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.1 mt -68.09 -25.15 65.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.544 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.597 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.4 t80 -75.06 -21.48 58.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.921 -1.112 . . . . 0.0 109.528 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -50.71 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.705 -1.247 . . . . 0.0 110.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.597 ' H ' ' C ' ' A' ' 236' ' ' TYR . 4.3 mt -70.67 -13.55 62.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.048 . . . . 0.0 109.857 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.74 0.91 60.34 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.609 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.05 152.5 11.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.345 . . . . 0.0 108.86 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.9 Cg_endo -53.59 128.04 27.83 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.795 1.663 . . . . 0.0 109.942 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 t -87.48 153.16 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 112.266 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -134.94 126.15 28.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.7 -157.15 27.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.1 OUTLIER -131.2 136.17 48.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 108.87 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.0 m-85 -135.52 140.54 44.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.155 -0.965 . . . . 0.0 110.484 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -126.09 132.15 51.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -125.32 136.37 53.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.121 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -117.3 113.37 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.19 24.43 1.99 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 109.037 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.45 154.08 42.38 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -131.09 178.18 17.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 75.5 m-70 -59.78 -40.92 89.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -1.226 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -58.96 5.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 6.1 tp -55.74 -46.38 77.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 109.62 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.3 -51.73 18.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.889 -1.132 . . . . 0.0 109.323 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.6 t -61.53 -50.26 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.428 -0.795 . . . . 0.0 109.725 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -54.09 -52.05 62.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.988 -1.07 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.1 tp -49.79 -50.92 43.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.17 -0.956 . . . . 0.0 108.486 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 44.1 t -58.65 -53.16 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -46.9 -49.77 19.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.82 -48.4 74.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.8 mt -55.95 -51.99 65.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.72 -26.44 63.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.397 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -47.78 35.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.514 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' 267' ' ' GLN . 0.3 OUTLIER -71.63 -46.92 57.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 0.0 110.111 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.635 ' NE2' ' CZ ' ' A' ' 124' ' ' PHE . 22.7 tt0 -42.74 -72.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.542 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 150.4 20.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.488 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.466 -179.975 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.548 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mt -99.65 159.43 15.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.34 138.49 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.957 . . . . 0.0 108.862 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.85 145.77 47.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -141.77 -174.83 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.18 136.95 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.115 . . . . 0.0 109.112 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -65.47 -29.82 70.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -144.42 156.15 44.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -63.69 141.21 58.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.428 -0.795 . . . . 0.0 110.356 -179.486 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.94 166.22 13.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -137.76 143.18 41.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.085 -1.01 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.1 m-85 -139.37 154.52 47.86 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -163.28 152.59 14.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.837 -1.165 . . . . 0.0 110.177 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.13 176.66 36.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.19 153.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -1.144 . . . . 0.0 110.01 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.28 139.97 15.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 tt -58.54 -41.09 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.249 . . . . 0.0 110.472 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 73.4 m-70 -88.09 -50.52 6.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.694 -1.254 . . . . 0.0 111.116 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 p -66.07 -27.92 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.781 -0.575 . . . . 0.0 111.801 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.74 16.63 46.66 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 118.888 -1.625 . . . . 0.0 109.226 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.85 156.04 22.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -1.058 . . . . 0.0 109.487 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.84 134.45 41.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.5 m -138.21 143.86 40.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.132 -0.98 . . . . 0.0 109.499 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -113.03 156.59 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.255 -0.903 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.7 mt -136.08 146.94 47.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 110.236 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.529 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 2.3 mp -140.85 115.43 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.93 114.99 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.493 -0.755 . . . . 0.0 110.967 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.529 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 13.2 m-70 -109.34 138.06 20.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.427 -0.796 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -52.15 168.87 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.959 1.772 . . . . 0.0 111.704 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 71.9 mm-40 -141.91 173.91 11.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.037 -1.039 . . . . 0.0 109.973 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.462 ' O ' ' OG1' ' A' ' 35' ' ' THR . 31.1 mmtp -83.51 152.26 25.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.769 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.11 146.1 2.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 110.073 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.7 46.27 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.83 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 29.0 m -68.51 -42.66 78.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.702 -1.469 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.756 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 96.6 -176.62 32.58 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.367 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.12 118.32 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -141.64 155.95 45.68 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.933 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -104.31 156.91 17.51 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -129.5 109.94 11.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 108.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -135.4 134.97 40.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.422 -0.799 . . . . 0.0 111.006 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.69 32.63 7.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 111.578 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.75 17.37 80.12 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.2 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.12 120.81 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.44 -1.036 . . . . 0.0 108.854 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 31.8 m-85 -84.96 128.28 34.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -117.78 93.44 43.9 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.389 -0.819 . . . . 0.0 109.283 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.78 146.7 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.324 2.016 . . . . 0.0 111.925 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.99 70.93 9.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -122.34 174.82 6.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.2 p-80 -78.1 -52.57 8.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.997 . . . . 0.0 109.61 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -43.7 -16.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' HIS . 39.8 m-85 -96.18 2.74 53.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.06 . . . . 0.0 110.029 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -73.12 132.76 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 108.664 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.64 -30.83 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 110.336 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.68 134.91 18.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.3 p -123.75 96.07 4.82 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.592 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -162.84 128.7 3.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.3 -0.875 . . . . 0.0 109.121 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.578 ' C ' ' HG ' ' A' ' 59' ' ' SER . 33.6 m-70 48.41 9.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.118 -0.989 . . . . 0.0 109.15 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.07 141.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.692 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.617 ' HG1' ' ND1' ' A' ' 253' ' ' HIS . 85.1 m -86.22 127.68 34.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.366 -0.834 . . . . 0.0 109.158 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -120.29 149.59 42.06 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.67 0.748 . . . . 0.0 110.944 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.0 mt -122.16 150.38 42.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.72 151.89 22.7 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.06 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -161.68 147.09 13.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 52.35 21.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.09 6.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -58.42 146.09 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 136.28 34.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.579 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.2 126.47 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -102.96 157.85 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.097 . . . . 0.0 111.582 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.3 m 49.93 74.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.4 m -108.01 -10.86 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 6.7 pm0 -61.71 -25.79 67.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 110.706 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -66.13 -68.91 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 109.083 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -52.15 -47.66 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.006 -1.059 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.4 mt -52.73 -50.03 64.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 110.201 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.579 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.9 t -59.75 -42.76 93.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.943 -1.098 . . . . 0.0 110.195 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -55.06 -48.08 76.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.026 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.49 -33.49 76.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.191 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -62.6 -38.77 91.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 109.416 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.9 mt -76.47 -39.25 53.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 110.155 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.5 mt -81.8 0.5 38.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.985 -1.072 . . . . 0.0 109.502 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.38 43.28 26.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.556 -0.715 . . . . 0.0 111.185 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mm -87.69 146.52 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 108.082 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 51.0 p -130.53 -20.46 2.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.116 -0.99 . . . . 0.0 111.385 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.756 HD21 ' H ' ' A' ' 36' ' ' GLY . 11.5 m120 -125.74 107.09 10.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.054 -1.028 . . . . 0.0 110.614 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.8 m -165.75 148.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.618 0.723 . . . . 0.0 110.053 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.48 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.1 m -115.87 111.47 20.49 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.3 101.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.976 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -72.95 126.36 29.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.5 t -108.68 120.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.892 0.854 . . . . 0.0 111.285 -178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 14.2 mt -108.37 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.22 -158.27 27.18 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -118.95 -12.43 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -1.101 . . . . 0.0 110.059 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -141.43 150.77 42.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 109.509 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 121.26 84.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.991 . . . . 0.0 108.964 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -41.12 122.02 1.5 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.751 1.634 . . . . 0.0 111.345 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.3 tp -77.95 -15.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.536 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt 57.25 -117.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 100' ' ' ASP . 9.4 t70 -98.25 5.72 48.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.037 -1.039 . . . . 0.0 110.731 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.97 0.9 58.6 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.143 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.0 -172.45 2.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.703 -0.881 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.59 16.64 7.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.554 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 68.8 t-105 -58.38 -42.15 86.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -1.101 . . . . 0.0 110.292 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.0 -56.39 17.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.905 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 12.8 m-85 -51.38 -44.09 62.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 108.783 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.415 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 36.3 t80 -62.41 -53.91 48.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.702 -0.624 . . . . 0.0 110.801 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 4.2 mt-10 -59.31 -44.5 92.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 111.133 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.38 -54.87 19.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.992 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.1 mt -67.09 -33.63 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.761 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.8 ttm-85 -62.87 -43.71 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -77.8 14.01 1.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -144.53 32.2 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.964 -1.085 . . . . 0.0 110.333 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 79.4 mt -77.76 138.34 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 110.344 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 tp -128.87 120.03 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -80.2 142.99 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.272 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.57 -174.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.66 68.95 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -164.77 129.42 2.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.099 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -67.96 141.9 56.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.107 . . . . 0.0 109.478 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 69.9 mt -85.37 150.86 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.128 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' OD1' ' OG ' ' A' ' 240' ' ' SER . 12.7 p30 -97.76 85.16 3.5 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 32.7 m-85 -62.32 143.49 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.588 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -89.48 101.6 14.28 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.2 133.46 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.43 0.634 . . . . 0.0 110.768 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.16 116.56 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -92.62 -29.93 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.957 -1.089 . . . . 0.0 110.607 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.67 149.7 73.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 109.793 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.17 149.56 46.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.62 2.213 . . . . 0.0 111.779 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -157.02 152.43 7.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.155 -0.966 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.51 141.17 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 109.007 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.83 147.22 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -138.49 157.08 46.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.996 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -175.3 108.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.318 -0.864 . . . . 0.0 109.779 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 53.44 51.53 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -0.828 . . . . 0.0 110.614 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.02 -32.53 3.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -59.16 136.9 58.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -1.232 . . . . 0.0 108.133 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -149.3 135.64 19.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.77 -1.206 . . . . 0.0 109.709 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 87.4 mt -137.27 128.57 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -114.13 131.88 56.27 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.412 0.625 . . . . 0.0 109.886 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.0 134.26 54.81 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.91 152.86 45.04 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.004 -1.06 . . . . 0.0 110.018 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.68 142.57 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.529 2.153 . . . . 0.0 113.889 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -156.83 147.01 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.3 -29.42 68.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.122 -0.986 . . . . 0.0 110.869 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.534 ' O ' ' OG ' ' A' ' 144' ' ' SER . 12.6 p -119.67 -165.52 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.358 -0.838 . . . . 0.0 109.23 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 tp -107.42 122.38 46.5 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -138.65 126.25 22.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.979 . . . . 0.0 109.098 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.96 122.2 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 109.83 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 52.0 m -112.98 151.77 30.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.613 -0.68 . . . . 0.0 109.61 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.76 130.18 25.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.669 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -122.47 135.13 54.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.44 143.13 12.73 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.7 100.64 10.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.11 167.82 13.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.846 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -103.82 24.93 10.49 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.632 -0.668 . . . . 0.0 110.257 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 158' ' ' PHE . 22.6 p-10 -137.71 -170.53 2.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.037 -1.04 . . . . 0.0 110.36 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.59 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 21.2 p90 -49.55 -5.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.608 -0.683 . . . . 0.0 111.638 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.601 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 73.6 mt -82.35 -30.31 30.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.176 -1.578 . . . . 0.0 108.349 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.59 -132.26 43.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 131.04 43.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.158 -1.201 . . . . 0.0 109.192 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 1.6 tp-100 -138.29 144.7 40.59 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.465 -0.772 . . . . 0.0 109.259 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.83 36.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 110.361 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -146.74 141.66 26.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.927 . . . . 0.0 109.942 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 58.5 m -110.49 124.59 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.491 -0.755 . . . . 0.0 109.822 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -105.37 115.91 31.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 110.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.51 151.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.737 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.33 131.56 24.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.167 -0.958 . . . . 0.0 109.166 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.28 -3.03 43.53 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -117.35 22.57 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -1.183 . . . . 0.0 109.002 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.552 ' CD ' ' N ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -50.97 -54.87 20.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.738 . . . . 0.0 110.011 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 171' ' ' GLU . 71.6 mt-10 -41.79 -23.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' GLU . 64.6 mt-10 -81.54 -12.77 58.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.028 -1.045 . . . . 0.0 111.754 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.15 -28.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.866 -1.146 . . . . 0.0 111.355 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.58 -26.84 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.519 -1.363 . . . . 0.0 108.972 179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -84.71 -3.61 58.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.427 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -69.46 116.82 10.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 108.915 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 54.4 mtm180 -79.95 172.35 13.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.143 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.454 ' HG1' HN17 ' A' ' 500' ' ' C90 . 7.0 t -78.54 162.51 26.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.37 149.17 32.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.218 -1.551 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.24 156.7 43.57 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.441 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 89.9 m-85 -98.15 146.2 25.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.0 109.314 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.44 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.37 -38.3 12.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.897 . . . . 0.0 109.479 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -72.33 -29.37 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 0.0 109.597 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.7 mt-10 -73.16 -33.95 65.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.8 -54.25 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.792 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.3 -41.93 9.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -74.42 -47.99 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.466 -0.771 . . . . 0.0 109.615 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 92.9 mt -53.97 -30.56 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -84.36 -53.52 5.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.885 -1.135 . . . . 0.0 109.477 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -49.87 -36.54 27.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.9 m -81.61 8.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.022 . . . . 0.0 109.892 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.2 39.95 71.53 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 57.5 mt -128.99 172.31 11.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -1.143 . . . . 0.0 109.989 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.5 25.23 57.8 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -58.89 -20.02 47.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.478 -1.601 . . . . 0.0 109.987 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.46 5.47 31.46 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.69 130.71 34.09 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.315 . . . . 0.0 110.437 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.641 ' N ' HD22 ' A' ' 202' ' ' ASN . 8.2 t -144.08 160.9 40.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.44 -1.035 . . . . 0.0 109.235 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 31.8 mt -66.92 -8.99 33.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.419 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -98.15 -13.05 21.13 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.641 HD22 ' N ' ' A' ' 199' ' ' SER . 10.0 p30 -128.66 8.79 5.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 109.256 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.97 153.91 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 110.377 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 9.9 tp -101.3 110.65 22.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.79 128.85 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.773 0.797 . . . . 0.0 109.281 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.83 165.79 17.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.706 . . . . 0.0 109.639 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -166.73 11.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -30.44 69.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -1.049 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 209' ' ' ASP . 23.0 p-10 -158.34 21.88 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.274 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -138.15 145.19 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.907 -1.12 . . . . 0.0 110.535 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.3 108.41 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -54.84 -50.58 68.27 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 110.043 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.61 115.29 13.0 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.66 -12.28 35.01 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.418 1.412 . . . . 0.0 111.9 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.72 -15.95 60.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 108.664 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.73 178.27 46.05 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.9 mt -82.62 150.12 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -1.08 . . . . 0.0 109.576 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -79.02 -19.0 52.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.15 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -141.94 -165.53 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.6 -8.21 29.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.191 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.07 45.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.914 . . . . 0.0 109.35 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.18 -46.92 99.6 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.925 -1.109 . . . . 0.0 109.86 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 55.4 Cg_exo -51.18 -68.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.42 2.08 . . . . 0.0 112.179 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.6 -35.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.95 -1.094 . . . . 0.0 109.674 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -61.69 -40.7 95.94 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.9 t60 -68.02 -31.41 71.06 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.664 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -65.33 -36.25 83.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -38.14 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 67.5 t80 -64.42 -50.23 68.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 109.17 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.435 ' OD2' ' N23' ' A' ' 500' ' ' C90 . 89.2 m-20 -66.65 -28.35 68.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . 0.495 ' CD2' ' HG ' ' A' ' 248' ' ' SER . 31.9 tp -76.06 -32.91 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.104 -0.998 . . . . 0.0 108.391 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 34.4 mt -68.97 -38.9 79.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.58 -53.49 31.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.449 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 80.6 m-20 -56.74 -38.2 72.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.234 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 10.6 mt -58.59 -21.12 52.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.505 -0.747 . . . . 0.0 110.36 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.625 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -75.02 -22.32 58.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.824 -1.172 . . . . 0.0 109.454 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.18 1.08 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.49 -1.381 . . . . 0.0 110.292 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.625 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.4 mt -77.93 -16.29 58.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.911 -1.118 . . . . 0.0 109.569 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.9 -0.23 51.88 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.867 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.472 ' OG ' ' OD1' ' A' ' 122' ' ' ASP . 0.4 OUTLIER -166.79 157.41 10.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.736 -1.449 . . . . 0.0 109.118 179.61 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.8 Cg_endo -50.22 150.79 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.805 1.67 . . . . 0.0 109.322 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.67 145.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.873 -1.142 . . . . 0.0 112.108 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 122.44 33.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.66 -160.5 30.7 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.444 -1.033 . . . . 0.0 108.888 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -140.66 141.26 35.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 110.401 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -125.52 122.96 38.08 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.495 ' HG ' ' CD2' ' A' ' 231' ' ' LEU . 3.8 m -115.22 136.11 53.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 111.198 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 250' ' ' ARG . 91.7 t80 -117.81 116.04 26.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 249' ' ' PHE . 38.0 mtp85 43.55 43.54 4.66 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.219 -0.926 . . . . 0.0 109.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.35 165.42 35.62 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -138.83 -174.57 13.51 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.617 ' ND1' ' HG1' ' A' ' 60' ' ' THR . 61.4 m-70 -63.01 -39.14 93.86 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER -55.27 -58.68 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.088 -1.007 . . . . 0.0 108.999 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.449 ' N ' ' OG ' ' A' ' 254' ' ' SER . 4.1 tp -56.27 -45.08 80.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 109.461 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.46 -50.5 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 109.35 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.95 -39.23 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.732 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -63.97 -51.41 64.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.87 -49.13 66.44 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 108.545 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 15.4 t -60.01 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -49.29 -48.68 45.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -61.32 -49.07 78.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 109.705 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . 0.4 HD21 ' HZ3' ' A' ' 266' ' ' LYS . 18.1 mt -57.3 -45.77 83.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 109.641 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.55 63.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.914 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -69.2 -65.62 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 109.76 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 268' ' ' LYS . 4.1 pttm -51.02 -40.19 57.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.074 -1.016 . . . . 0.0 108.97 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -67.63 52.5 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 266' ' ' LYS . 7.2 pttp -39.67 130.21 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.478 -0.763 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.454 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.48 155.01 31.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -57.59 141.57 47.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 108.731 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -125.59 147.09 49.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.4 t -141.93 -173.03 3.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.6 m -97.35 136.84 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.868 -1.145 . . . . 0.0 109.035 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -67.27 -21.77 65.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.572 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE2' ' O ' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -152.31 157.82 41.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' O ' ' OE2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -65.8 139.99 58.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.312 -0.867 . . . . 0.0 110.368 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 mt -115.95 163.55 15.72 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.51 142.06 43.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 110.344 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -141.21 161.01 38.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -167.15 152.75 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 109.768 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.27 176.11 36.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.34 155.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -1.128 . . . . 0.0 110.062 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 139.14 15.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.3 tt -58.98 -38.33 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.265 . . . . 0.0 110.354 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 80.2 m-70 -90.86 -50.82 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.674 -1.266 . . . . 0.0 111.026 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.3 p -68.65 -23.64 64.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.76 -0.587 . . . . 0.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.95 17.2 21.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -108.28 153.34 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -1.025 . . . . 0.0 109.651 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -73.3 134.64 44.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.0 109.41 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -140.49 143.83 35.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -108.28 158.58 17.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -137.6 144.61 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.54 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.49 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 6.5 mt -143.43 110.91 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.9 . . . . 0.0 108.852 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.43 115.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 111.057 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.49 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 30.1 m-70 -108.5 138.57 20.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 109.422 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -53.82 168.37 0.81 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.753 1.635 . . . . 0.0 111.728 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -140.94 173.75 11.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 39.7 mttm -85.08 153.06 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.284 -0.885 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.17 147.21 3.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.645 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 71.82 -0.33 37.24 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.903 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.704 ' H ' HD21 ' A' ' 86' ' ' ASN . 51.6 m -67.21 -45.42 76.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.615 -1.52 . . . . 0.0 109.536 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.75 -179.34 31.52 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.774 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.87 117.66 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH2' ' CE1' ' A' ' 45' ' ' TYR . 21.7 ptt180 -144.49 157.73 44.1 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.839 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -103.64 157.86 16.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -128.07 110.83 12.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 108.772 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 15.9 tttp -135.27 132.81 38.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.579 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.17 28.3 6.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.464 -0.772 . . . . 0.0 111.628 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.44 19.67 68.34 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.211 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -124.28 123.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.278 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.447 ' CE1' ' NH2' ' A' ' 38' ' ' ARG . 98.9 m-85 -84.78 127.62 34.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.4 90.99 40.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.69 150.22 4.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.549 2.166 . . . . 0.0 111.926 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.11 75.99 9.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.982 . . . . 0.0 109.775 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -129.35 173.66 10.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 109.211 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.2 p-80 -71.81 -52.43 17.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -45.48 -16.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.758 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' HIS . 21.0 m-85 -94.9 0.37 54.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.722 -1.236 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -72.82 128.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.04 -28.94 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -151.07 133.03 15.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.8 p -123.93 95.91 4.74 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.554 ' C ' ' H ' ' A' ' 59' ' ' SER . 5.7 t-20 -162.61 128.76 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.852 . . . . 0.0 108.805 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' SER . 50.9 m-70 50.17 9.45 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.554 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.97 146.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.801 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.434 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 31.0 m -89.9 126.92 35.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 0.0 109.174 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -121.04 150.35 41.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.328 -0.857 . . . . 0.0 111.059 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mt -125.5 150.11 47.68 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.51 154.82 25.91 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.894 -1.622 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -163.22 150.39 12.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -1.033 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt 52.31 22.2 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.13 -32.5 7.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -59.83 145.74 44.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.287 . . . . 0.0 109.478 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.25 139.51 35.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.407 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -130.15 121.96 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -99.04 156.99 16.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.1 m 49.14 74.52 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.879 -0.513 . . . . 0.0 110.739 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.6 m -108.0 -9.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.117 -0.989 . . . . 0.0 109.274 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.1 pm0 -60.86 -26.28 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.493 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -66.01 -69.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.56 -47.48 48.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.276 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.4 mt -52.02 -48.75 64.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.954 -1.091 . . . . 0.0 110.026 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.541 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 26.2 t -61.18 -42.46 98.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.166 -0.959 . . . . 0.0 110.118 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.8 t -56.64 -44.88 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.093 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.24 -35.19 75.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.33 -0.856 . . . . 0.0 109.288 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -62.48 -34.36 76.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 109.189 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 52.2 mt -82.03 -37.97 25.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.619 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 70.4 mt -79.62 0.26 30.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.409 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 4.1 mp0 57.13 41.13 27.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.326 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.07 143.67 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.703 -1.248 . . . . 0.0 108.043 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.484 ' OG1' ' OD1' ' A' ' 86' ' ' ASN . 51.5 p -127.52 -21.04 3.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.103 -0.998 . . . . 0.0 111.703 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.704 HD21 ' H ' ' A' ' 35' ' ' THR . 5.4 m120 -127.18 107.0 9.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.937 -1.102 . . . . 0.0 110.609 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.8 m -164.94 149.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 109.917 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.45 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 41.7 m -117.21 111.66 19.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.2 mt -92.61 100.92 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.917 . . . . 0.0 110.269 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.95 127.51 33.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.2 t -115.9 124.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.04 0.924 . . . . 0.0 112.261 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.5 mm -109.48 98.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.548 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 144.36 -159.05 27.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.02 -10.93 9.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -1.163 . . . . 0.0 110.075 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -141.62 150.2 41.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.981 -1.074 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -72.27 120.35 79.91 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.702 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -41.09 120.83 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.69 1.593 . . . . 0.0 111.145 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.3 tp -78.25 -15.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 110.754 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.2 mt 57.1 -117.78 1.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.051 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 10.3 t0 -97.04 4.48 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 110.588 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.63 1.57 58.87 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.104 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 p -127.58 -172.68 2.73 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.811 . . . . 0.0 109.563 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.7 15.84 7.94 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 42.1 t-105 -56.09 -42.43 76.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -1.046 . . . . 0.0 110.5 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.9 -59.1 5.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.322 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -51.16 -45.18 61.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.149 -0.969 . . . . 0.0 109.288 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.521 ' HH ' HH11 ' A' ' 111' ' ' ARG . 48.8 t80 -60.12 -50.72 72.57 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -63.78 -43.85 95.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.17 -0.956 . . . . 0.0 111.23 -178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.45 -60.01 2.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.945 -1.097 . . . . 0.0 110.095 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.49 -36.8 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.192 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.521 HH11 ' HH ' ' A' ' 107' ' ' TYR . 39.9 ttt180 -62.12 -43.44 98.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 109.249 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -76.33 13.93 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.614 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 111' ' ' ARG . 6.5 m-80 -146.08 31.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.069 -1.02 . . . . 0.0 110.453 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.1 mt -80.75 139.12 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.902 -1.124 . . . . 0.0 110.35 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -128.06 119.25 25.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.529 -0.732 . . . . 0.0 109.041 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.62 140.68 48.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -109.54 -178.26 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.701 . . . . 0.0 109.186 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -108.85 68.4 0.68 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.949 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -165.91 131.58 2.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 0.0 109.255 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -67.49 139.02 57.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 109.666 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 47.2 mt -81.35 147.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.103 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.73 84.74 3.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 108.856 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.2 m-85 -64.14 143.84 57.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.438 -0.789 . . . . 0.0 109.851 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -88.27 101.56 13.98 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.17 132.19 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.7 . . . . 0.0 110.777 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.0 114.65 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -86.64 -29.1 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.959 -1.088 . . . . 0.0 110.907 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.77 162.33 51.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.963 -1.086 . . . . 0.0 109.766 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.34 145.56 27.14 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.857 2.371 . . . . 0.0 112.777 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -154.31 149.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.33 143.49 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 109.37 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.5 149.29 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.13 164.72 27.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.4 -0.812 . . . . 0.0 109.859 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.578 ' CG ' HH21 ' A' ' 137' ' ' ARG . 57.6 t0 -173.87 111.77 0.18 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 109.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 58.18 9.54 1.02 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.619 -0.675 . . . . 0.0 109.865 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 134' ' ' ASP . . . 117.18 -26.63 8.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.578 HH21 ' CG ' ' A' ' 134' ' ' ASP . 1.2 mpp_? -58.42 144.12 43.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.482 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.3 tt -148.94 139.51 22.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.093 -1.443 . . . . 0.0 111.03 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.23 125.6 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -111.71 131.0 55.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.436 0.636 . . . . 0.0 109.838 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.97 132.37 54.88 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 154.02 52.26 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.995 -1.066 . . . . 0.0 109.959 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.3 139.76 43.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.276 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.93 147.13 22.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.9 -37.54 82.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.4 p -117.75 -171.55 2.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.0 110.051 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 tp -100.95 126.15 47.58 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.98 137.23 34.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.8 t -133.98 121.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.0 m -111.29 151.96 27.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.465 -0.772 . . . . 0.0 109.265 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.581 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 34.0 t80 -140.75 130.94 24.88 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.181 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.83 131.66 54.17 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.83 141.33 12.29 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.583 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -103.89 100.81 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.28 167.3 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -100.94 -14.99 17.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.821 . . . . 0.0 110.774 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 p-10 -95.31 -173.56 2.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.784 -1.198 . . . . 0.0 110.587 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.47 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 8.4 p90 -49.3 -0.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.812 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.6 mt -80.76 -28.63 36.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.31 -1.494 . . . . 0.0 108.803 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.12 -137.09 45.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -99.85 135.85 40.65 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -1.188 . . . . 0.0 109.625 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -139.03 146.88 41.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -138.18 144.65 40.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.493 -0.755 . . . . 0.0 109.756 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -143.22 136.16 27.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.7 m -105.85 122.76 46.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CD1' ' OD1' ' A' ' 170' ' ' ASN . 7.2 t80 -101.73 110.24 22.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.271 -0.893 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.589 ' H ' HD22 ' A' ' 170' ' ' ASN . 3.7 t -105.76 141.02 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 110.054 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 167' ' ' VAL . 9.8 mm-40 -44.06 131.58 5.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 108.819 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.85 -16.52 18.45 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.589 HD22 ' H ' ' A' ' 167' ' ' VAL . 1.9 p30 -115.16 29.36 8.07 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.074 -1.25 . . . . 0.0 109.916 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -53.75 -38.32 64.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.07 -1.019 . . . . 0.0 109.806 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.3 -18.65 50.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -85.66 -7.57 58.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 111.179 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.73 -28.49 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.114 -0.991 . . . . 0.0 110.963 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 15.8 m -63.5 -24.95 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.736 -1.227 . . . . 0.0 108.882 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.59 -4.72 58.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.471 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.13 120.17 13.9 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 82.3 mtm180 -83.4 172.47 12.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.512 ' HG1' HN17 ' A' ' 500' ' ' C90 . 5.9 t -79.14 161.48 26.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -147.85 145.45 28.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.234 -1.541 . . . . 0.0 111.859 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.49 157.43 44.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.5 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.5 m-85 -98.95 145.54 26.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 109.626 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.06 -35.79 26.58 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.344 -0.847 . . . . 0.0 109.864 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -72.8 -28.16 62.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.963 -1.086 . . . . 0.0 109.862 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.6 mm-40 -79.11 -40.62 30.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 110.085 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 77.5 mt -44.73 -55.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 19.3 tt0 -42.13 -41.73 2.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 48.6 t60 -73.26 -55.55 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 189' ' ' ILE . 88.5 mt -45.4 -26.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.368 -0.832 . . . . 0.0 109.407 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -85.75 -53.71 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.819 -1.176 . . . . 0.0 108.921 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -49.09 -26.77 2.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 m -96.1 18.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 59.25 39.83 95.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.401 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 62.4 mt -125.45 171.97 10.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -1.071 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.37 22.49 51.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -58.28 -22.79 54.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.7 -1.471 . . . . 0.0 109.534 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -110.28 25.56 15.52 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.33 125.01 7.61 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.416 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -143.89 169.49 17.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -1.118 . . . . 0.0 109.847 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.554 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 55.8 mt -69.08 -8.74 48.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.5 -10.64 24.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.722 -0.611 . . . . 0.0 109.762 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.44 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 13.5 p30 -138.27 8.76 2.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 109.866 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -148.72 149.56 31.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.932 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.8 tp -97.95 93.65 6.44 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.41 130.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.279 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 20.3 mt -123.35 163.05 21.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.528 -0.733 . . . . 0.0 109.164 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.52 -166.79 13.22 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -68.45 -25.74 65.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.261 -1.14 . . . . 0.0 109.665 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.16 21.47 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 0.0 110.778 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -150.1 157.92 43.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.411 -1.43 . . . . 0.0 110.68 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.01 113.94 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -57.38 -50.86 71.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.897 -1.127 . . . . 0.0 109.99 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.34 111.21 3.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.56 -16.47 30.15 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.747 1.631 . . . . 0.0 112.677 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.65 -15.7 60.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.901 -1.125 . . . . 0.0 109.923 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.4 -178.37 47.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.31 151.41 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 109.735 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.5 OUTLIER -78.55 -18.97 53.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.187 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 52.9 m-85 -144.72 -172.0 3.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.542 -0.724 . . . . 0.0 109.103 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.3 -5.08 53.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.6 43.28 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.196 -0.94 . . . . 0.0 109.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -54.82 -47.52 98.02 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 109.948 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -50.82 -68.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.463 2.108 . . . . 0.0 112.079 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.7 m -58.22 -36.3 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -60.88 -40.88 94.66 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.223 -0.923 . . . . 0.0 108.555 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 15.3 t60 -68.47 -32.19 72.01 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.253 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . 0.581 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 6.0 mmtp -66.04 -36.03 82.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.63 -37.49 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.541 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.2 t80 -64.03 -52.11 61.01 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 87.4 m-20 -65.38 -27.01 68.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.681 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 59.2 tp -76.92 -32.77 57.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.084 -1.01 . . . . 0.0 108.588 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.85 -38.53 78.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.15 -54.36 24.57 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -56.96 -35.43 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 109.293 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.72 -24.83 67.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 110.512 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.2 t80 -74.98 -21.46 59.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.884 -1.135 . . . . 0.0 109.388 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 65.0 mt -48.54 -6.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.86 -1.15 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -69.33 -13.03 62.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.945 -1.097 . . . . 0.0 109.85 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.85 2.92 64.44 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.715 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.74 149.87 11.02 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.872 -1.369 . . . . 0.0 108.904 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.401 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 6.9 Cg_endo -53.04 130.0 35.95 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.639 1.559 . . . . 0.0 110.076 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.88 150.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 112.216 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -130.64 123.37 29.28 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.82 -157.43 27.59 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.8 OUTLIER -129.35 137.03 50.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -1.042 . . . . 0.0 108.857 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.0 m-85 -133.54 140.03 46.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -126.97 123.24 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.06 132.99 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.735 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -114.92 110.79 20.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 56.6 mtp180 46.57 41.25 9.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.249 -0.907 . . . . 0.0 109.087 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.8 163.98 50.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -131.76 -179.05 15.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.519 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 30.7 m-70 -65.15 -46.72 79.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -1.229 . . . . 0.0 110.034 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.6 OUTLIER -53.45 -60.61 3.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.971 -1.081 . . . . 0.0 108.782 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 254' ' ' SER . 12.5 tp -47.76 -49.5 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.03 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 25.8 m-20 -47.74 -49.5 28.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.988 -1.07 . . . . 0.0 109.098 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.94 -44.29 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.473 -0.767 . . . . 0.0 109.755 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -59.4 -49.21 78.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.218 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 32.4 tp -54.19 -49.85 68.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.63 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 22.5 t -58.47 -57.43 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.003 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -47.74 -45.33 28.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.133 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -62.48 -57.4 11.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.365 -0.834 . . . . 0.0 109.213 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.5 mt -48.4 -48.7 36.86 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.141 -0.975 . . . . 0.0 109.512 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.58 67.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -69.81 -50.61 41.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 109.859 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 266' ' ' LYS . 26.2 mmtt -64.08 -45.87 86.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.966 -1.084 . . . . 0.0 108.533 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -86.94 58.2 4.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 0.0 109.367 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -92.6 5.68 50.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.512 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.91 143.04 57.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -1.132 . . . . 0.0 109.643 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 119' ' ' ARG . 27.9 mt-10 -54.0 142.45 24.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -125.7 142.73 51.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.351 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -142.62 -168.55 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.1 m -103.22 141.19 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.005 -1.059 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -69.92 -26.03 63.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.982 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -145.44 161.79 38.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 110.161 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 139.18 55.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.07 161.27 20.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 p -131.96 141.66 49.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.73 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 91.9 m-85 -138.17 152.5 48.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.24 151.9 19.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.743 -1.223 . . . . 0.0 110.157 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.72 174.28 35.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 151.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.0 136.14 14.81 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.4 tt -56.55 -39.05 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 75.8 m-70 -92.35 -49.26 6.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.757 -1.214 . . . . 0.0 111.008 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -28.38 69.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 111.245 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.87 17.63 55.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -112.7 155.12 25.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -1.012 . . . . 0.0 109.325 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.28 135.2 44.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.0 109.421 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 m -138.11 144.34 40.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.784 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.18 154.38 25.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.027 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.7 mt -135.74 147.44 48.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 110.162 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.546 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 7.8 mt -143.87 109.43 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.4 115.15 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.449 -0.782 . . . . 0.0 110.575 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.546 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.2 m-70 -109.46 141.81 24.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -55.79 168.89 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.824 1.683 . . . . 0.0 111.477 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 70.7 mm-40 -141.74 175.44 9.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.93 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.495 ' O ' ' OG1' ' A' ' 35' ' ' THR . 13.8 mttt -82.37 152.09 26.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 145.13 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.19 5.06 52.59 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.107 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 35.2 m -67.31 -44.37 79.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.526 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.752 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 97.36 -179.69 33.54 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.547 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -96.29 116.58 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -143.02 148.84 37.41 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.69 -1.204 . . . . 0.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.82 156.94 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -129.3 109.38 11.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.236 -0.915 . . . . 0.0 108.934 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 tttp -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m120 53.61 27.7 7.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 111.101 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.25 19.67 71.43 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.463 -1.351 . . . . 0.0 109.859 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 t -123.28 123.2 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -85.87 127.46 34.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.04 -1.038 . . . . 0.0 109.287 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mt -118.23 95.03 47.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 109.724 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.4 148.24 11.18 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.476 2.118 . . . . 0.0 112.179 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -87.59 78.38 8.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.761 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -134.85 -179.94 5.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 0.0 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.597 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.4 p-80 -74.52 -54.76 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.986 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.4 OUTLIER -43.5 -17.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.845 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 67.2 m-85 -97.23 -0.52 46.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 109.655 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.94 122.36 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.4 -0.813 . . . . 0.0 108.831 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -100.3 -34.11 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -151.21 138.66 19.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.144 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.2 p -125.02 95.86 4.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 59' ' ' SER . 28.0 t-20 -162.53 129.5 3.66 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.4 m-70 49.43 9.57 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.091 -1.006 . . . . 0.0 108.969 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.563 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.61 143.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 109.646 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.8 m -88.66 129.56 35.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 109.011 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.16 152.34 41.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.288 -0.883 . . . . 0.0 111.164 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 mt -126.11 151.77 46.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.04 165.54 34.25 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.021 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -168.71 141.74 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 108.806 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? 52.27 28.59 5.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.741 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.63 5.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -57.64 148.75 23.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.006 -1.291 . . . . 0.0 109.343 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.28 139.99 26.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.699 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 7.9 mt -130.24 124.62 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -98.45 154.19 18.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.272 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.2 m 51.89 75.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.88 -9.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.138 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.58 -27.96 69.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.517 -0.739 . . . . 0.0 110.559 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -65.08 -69.37 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.988 -1.07 . . . . 0.0 109.498 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.0 tp -51.57 -47.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.154 -0.966 . . . . 0.0 109.023 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.6 mt -52.12 -48.37 64.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.076 -1.015 . . . . 0.0 110.134 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.584 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 40.5 t -60.87 -42.77 98.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.45 -44.59 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.0 109.086 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.05 -34.48 77.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -61.96 -40.43 95.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 55.8 mt -75.0 -37.9 61.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.718 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.23 0.82 34.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 109.543 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 54.41 42.25 31.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 0.0 110.139 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -90.36 137.04 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 108.557 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.4 p -124.53 -19.01 5.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.191 -0.943 . . . . 0.0 112.018 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.752 HD21 ' H ' ' A' ' 36' ' ' GLY . 19.2 m120 -124.61 107.16 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.806 -1.184 . . . . 0.0 110.407 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.3 m -165.9 147.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.738 0.78 . . . . 0.0 109.913 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.462 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.3 m -114.03 110.97 20.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.18 100.31 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 110.16 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.92 125.7 28.2 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.8 t -110.79 120.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.762 0.791 . . . . 0.0 111.725 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt -107.52 96.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.84 -156.61 26.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -121.83 -10.55 8.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -1.169 . . . . 0.0 110.443 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -140.33 148.86 41.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.0 -1.063 . . . . 0.0 109.973 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 97' ' ' PRO . 43.7 mm -72.99 117.17 57.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.892 . . . . 0.0 108.804 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' ILE . 75.3 Cg_exo -39.31 130.26 1.57 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.586 1.524 . . . . 0.0 111.418 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.6 tp -86.21 -14.12 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.08 -117.47 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 0.0 109.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 4.47 51.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.024 -1.047 . . . . 0.0 110.75 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.71 58.77 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.182 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.1 p -126.54 -172.82 2.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.558 -0.966 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.7 15.99 9.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.5 t-105 -59.67 -42.73 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -1.064 . . . . 0.0 110.299 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.55 -57.06 11.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.095 -1.003 . . . . 0.0 109.996 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -51.33 -44.92 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.865 . . . . 0.0 109.048 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 46.4 t80 -62.55 -52.51 63.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.726 -0.608 . . . . 0.0 110.931 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -60.71 -44.13 96.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.08 . . . . 0.0 111.144 -178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.85 3.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.088 -1.007 . . . . 0.0 110.51 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.25 -33.75 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.506 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 36.2 ttt180 -64.64 -41.81 95.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' C ' HD21 ' A' ' 113' ' ' ASN . 20.3 mmtt -75.86 11.97 1.23 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 110.024 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.43 HD21 ' C ' ' A' ' 112' ' ' LYS . 2.7 m-80 -142.84 35.68 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.284 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.3 mt -81.41 140.12 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.225 -0.922 . . . . 0.0 110.953 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.9 tp -132.21 126.94 34.73 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.15 146.03 33.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.02 -175.85 2.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.272 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -113.27 67.02 0.66 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.232 -0.917 . . . . 0.0 111.175 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 4' ' ' GLU . 7.6 ttt180 -164.89 128.31 2.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 109.529 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -68.24 142.77 55.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.89 -1.131 . . . . 0.0 109.99 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 70.7 mt -85.95 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -95.94 83.46 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 108.794 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.501 ' CD2' ' NZ ' ' A' ' 243' ' ' LYS . 44.1 m-85 -61.66 145.27 52.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 110.14 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -92.6 102.31 14.74 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.22 133.89 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.384 0.611 . . . . 0.0 110.843 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.69 118.96 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.62 -28.31 16.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.979 -1.075 . . . . 0.0 110.736 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 154.54 80.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.48 151.68 47.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.684 2.256 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.5 tt -160.23 154.21 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.595 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.37 144.67 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.49 148.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -134.88 159.9 39.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.45 107.9 0.12 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 54.66 49.35 18.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.442 -0.786 . . . . 0.0 110.488 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.65 -29.36 3.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -61.8 137.97 58.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -1.216 . . . . 0.0 108.116 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.473 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -146.71 139.38 25.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.691 -1.256 . . . . 0.0 110.223 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -137.78 126.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.375 -0.828 . . . . 0.0 109.767 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -113.34 133.26 55.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.392 0.615 . . . . 0.0 109.999 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.11 136.2 54.89 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.81 150.73 40.3 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.61 141.88 14.57 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.693 2.262 . . . . 0.0 113.62 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.21 144.89 20.16 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.19 -20.51 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.296 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.9 p -137.45 -174.13 3.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 tp -94.39 121.19 35.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -134.74 120.46 19.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.52 121.45 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.805 . . . . 0.0 109.993 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.0 m -111.31 151.84 27.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.631 -0.668 . . . . 0.0 109.199 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -139.21 130.05 26.22 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -121.23 131.67 54.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.65 138.5 9.49 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.32 -1.419 . . . . 0.0 112.053 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 99.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -83.66 167.01 17.65 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 111.359 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -100.44 23.61 10.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.712 -0.617 . . . . 0.0 110.649 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.0 p-10 -140.08 -172.91 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -49.34 -2.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 111.417 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -77.94 -27.74 49.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.361 -1.462 . . . . 0.0 108.375 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.84 -135.1 43.14 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 133.25 44.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -1.204 . . . . 0.0 109.302 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -135.31 141.4 45.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -136.8 144.11 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.012 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -144.91 137.06 25.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.3 m -105.5 123.55 48.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.701 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -103.56 109.0 20.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.984 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.76 149.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.07 131.39 23.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -0.958 . . . . 0.0 109.02 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.53 43.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -115.97 22.95 12.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -1.085 . . . . 0.0 109.226 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.501 ' C ' ' H ' ' A' ' 173' ' ' GLU . 4.9 pt-20 -58.11 -47.24 83.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.376 -0.827 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 171' ' ' GLU . 22.8 mt-10 -52.85 -6.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 110.258 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.501 ' H ' ' C ' ' A' ' 171' ' ' GLU . 23.7 mt-10 -102.71 -6.94 22.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.033 . . . . 0.0 110.952 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.1 pt -123.73 -26.46 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.996 -1.065 . . . . 0.0 110.849 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.65 -29.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mt -77.39 -5.65 50.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.537 -0.727 . . . . 0.0 109.165 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.51 124.51 24.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.113 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 63.3 mtm180 -86.13 172.72 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.778 -179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.533 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.3 t -79.0 162.55 25.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.36 145.63 27.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.216 -1.552 . . . . 0.0 111.875 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.14 157.94 44.06 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.593 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.5 m-85 -98.61 142.11 30.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.652 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 183' ' ' ASP . 2.9 t0 -49.22 -35.61 17.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.205 -0.935 . . . . 0.0 109.409 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.593 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.2 p90 -70.55 -26.16 63.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.023 -1.048 . . . . 0.0 109.553 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -86.3 -27.3 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.758 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.14 -43.81 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.999 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.6 -39.8 65.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.998 -1.064 . . . . 0.0 109.261 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -75.92 -56.22 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 47.8 mt -44.74 -33.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.451 ' HZ1' ' CB ' ' A' ' 190' ' ' LYS . 0.7 OUTLIER -80.29 -52.54 7.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.827 -1.171 . . . . 0.0 108.869 179.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -46.73 -48.33 20.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 110.455 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.6 m -74.24 7.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.002 -1.061 . . . . 0.0 110.409 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 37.85 45.69 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 36.8 mt -126.07 169.5 12.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.3 25.38 57.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -61.76 -21.76 64.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.675 -1.486 . . . . 0.0 109.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.44 24.22 22.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.35 124.92 7.43 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.9 OUTLIER -138.64 163.38 32.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -1.154 . . . . 0.0 109.539 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.8 mt -66.91 -8.6 30.49 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.59 -11.83 20.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.451 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 8.3 p30 -133.36 6.4 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.31 149.64 32.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.597 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 21.3 tp -98.63 95.89 7.58 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 62.8 t -86.23 127.83 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.717 0.77 . . . . 0.0 109.323 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 28.1 mt -122.27 173.98 7.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.602 -0.686 . . . . 0.0 109.322 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.58 -166.39 10.84 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -30.79 70.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.48 -1.012 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -157.85 25.22 0.27 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -144.21 150.75 38.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.922 -1.111 . . . . 0.0 110.677 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -103.75 112.31 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -58.89 -45.31 90.54 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.056 -1.027 . . . . 0.0 110.071 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.6 m120 -59.86 117.14 20.61 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.9 -15.3 46.7 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.391 1.394 . . . . 0.0 111.702 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -76.08 -14.83 60.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.352 -0.842 . . . . 0.0 109.089 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.82 -176.39 51.02 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.8 mt -86.72 140.95 29.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 109.671 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 7.3 ttp180 -71.29 -18.08 62.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.67 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 57.1 m-85 -147.26 165.09 31.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.58 -12.69 60.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.078 . . . . 0.0 109.355 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.433 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -131.9 43.63 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -60.62 -46.39 97.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.3 Cg_exo -51.37 -67.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.326 2.018 . . . . 0.0 112.295 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.5 m -58.74 -36.26 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.032 -1.042 . . . . 0.0 109.579 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.67 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 58.5 mtt180 -58.67 -42.08 87.61 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -69.08 -30.94 69.36 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.404 -0.81 . . . . 0.0 109.302 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -65.77 -36.37 83.36 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 58.8 t -68.49 -39.25 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.584 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 57.6 t80 -62.82 -50.48 70.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.28 -29.4 69.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.057 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.42 -31.16 62.2 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.022 -1.049 . . . . 0.0 108.177 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.4 mt -69.56 -40.17 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.88 47.99 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 m-20 -58.62 -40.81 84.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.262 . . . . 0.0 109.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.09 -21.45 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.683 . . . . 0.0 110.15 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.95 -22.19 60.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.087 . . . . 0.0 108.73 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.31 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.649 -1.282 . . . . 0.0 110.208 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.9 mt -76.21 -15.51 60.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.941 -1.099 . . . . 0.0 109.781 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.0 -1.21 55.06 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.48 156.74 9.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.368 . . . . 0.0 108.671 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.8 Cg_endo -47.88 150.49 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.637 1.558 . . . . 0.0 109.461 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.68 144.92 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.074 -1.016 . . . . 0.0 111.935 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . 0.501 ' NZ ' ' CD2' ' A' ' 123' ' ' TYR . 0.2 OUTLIER -125.78 120.34 30.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 -166.8 34.49 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.476 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 2.0 ttmt -126.34 139.25 53.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.405 -1.056 . . . . 0.0 108.934 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -139.26 140.58 37.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 110.546 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.88 124.81 42.86 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 m -116.43 136.39 53.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 111.314 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 250' ' ' ARG . 51.8 t80 -116.54 114.5 24.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 249' ' ' PHE . 5.1 mtp180 44.4 46.8 8.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.021 -1.05 . . . . 0.0 108.836 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -84.99 158.8 33.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -132.15 176.85 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.583 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 55.9 m-70 -58.89 -40.34 84.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.2 t -55.55 -59.53 4.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.833 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.33 -47.26 66.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.56 -49.87 25.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.62 -51.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 109.805 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.06 -51.56 61.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.045 . . . . 0.0 109.312 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 39.7 tp -52.04 -50.2 61.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 108.525 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.65 -53.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 108.82 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -48.31 -47.06 36.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.742 . . . . 0.0 109.311 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.24 -51.43 60.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 109.813 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.06 -50.89 69.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 268' ' ' LYS . . . -66.62 -29.46 69.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.083 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -59.06 3.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.88 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.63 -36.49 84.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.16 -105.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 264' ' ' ALA . 2.6 tttm -106.41 128.11 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.982 . . . . 0.0 109.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.585 179.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.533 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.11 152.33 21.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -1.178 . . . . 0.0 109.596 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 69.0 mt-10 -54.22 141.26 30.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.28 143.57 50.89 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 109.76 -178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -142.16 -168.61 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.4 139.32 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -66.91 -30.07 70.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 109.825 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.43 160.11 41.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.73 140.72 56.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.433 -0.792 . . . . 0.0 110.137 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.0 mt -117.75 166.79 12.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.18 35.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.952 -1.092 . . . . 0.0 110.404 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' LEU . 85.6 m-85 -142.17 158.83 43.29 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -163.32 151.13 13.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.953 -1.092 . . . . 0.0 109.492 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.99 175.24 36.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.85 153.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -1.079 . . . . 0.0 110.266 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.21 140.72 15.6 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.32 -38.23 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 110.862 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 70.4 m-70 -90.8 -49.93 6.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.496 -1.378 . . . . 0.0 111.237 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.8 p -72.55 -20.44 61.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 0.0 111.233 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.43 15.6 12.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -105.5 154.27 20.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 109.909 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 31.2 t80 -75.57 136.04 40.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -0.76 . . . . 0.0 109.557 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -138.52 145.55 40.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 109.906 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -108.7 154.67 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.426 ' N ' ' O ' ' A' ' 13' ' ' PHE . 10.1 mt -134.64 146.8 49.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.514 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.8 mt -143.72 111.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.808 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.87 115.04 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.189 -0.945 . . . . 0.0 110.668 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.514 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 25.5 m-70 -110.82 138.55 21.13 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 109.669 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -50.47 168.42 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.917 1.744 . . . . 0.0 111.627 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 9.3 mm-40 -140.19 173.2 11.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 109.826 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.3 mmtt -83.04 150.95 26.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.584 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -49.11 146.67 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.937 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 67.14 6.68 40.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -71.78 -47.14 55.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.809 -1.407 . . . . 0.0 109.606 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.16 -174.76 24.41 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.771 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.2 mm -102.33 118.34 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -139.54 151.91 46.48 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.574 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.81 158.09 16.22 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -130.4 113.82 14.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -135.14 133.16 38.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 110.472 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' N ' HD21 ' A' ' 42' ' ' ASN . 1.7 m-80 48.98 34.92 5.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.379 -0.825 . . . . 0.0 111.561 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.71 17.43 80.11 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.233 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.18 121.24 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.102 . . . . 0.0 108.901 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.8 m-85 -86.76 128.01 35.01 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.025 -1.047 . . . . 0.0 109.913 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.4 mt -116.39 92.15 35.64 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.54 -0.725 . . . . 0.0 109.044 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.94 144.99 10.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.47 2.114 . . . . 0.0 112.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.87 63.65 4.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 108.995 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.29 169.88 8.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -75.14 -44.32 47.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 -16.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -95.09 2.05 55.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.815 -1.178 . . . . 0.0 109.949 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.02 126.49 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 108.927 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.4 -30.82 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.888 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.83 141.56 19.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.048 -1.032 . . . . 0.0 109.94 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.0 p -128.56 95.72 4.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.86 129.44 3.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 109.061 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 96.3 m-70 50.82 8.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.047 -1.033 . . . . 0.0 108.875 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.575 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.13 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 109.591 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.585 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 33.8 m -91.44 126.95 36.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.026 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.59 149.85 42.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.712 0.768 . . . . 0.0 111.14 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 mt -125.54 149.13 48.58 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.55 151.52 21.43 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 118.767 -1.682 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -158.36 149.46 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.5 -1.0 . . . . 0.0 109.231 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 59.7 mttt 46.38 33.92 2.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 109.781 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.76 -33.25 4.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.559 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -55.58 139.76 43.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -1.19 . . . . 0.0 108.886 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -139.94 135.14 32.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 110.517 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.1 mt -128.84 117.17 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp -97.27 155.42 16.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.896 -1.127 . . . . 0.0 111.118 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 66.1 m 52.62 72.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.221 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.0 m -107.41 -10.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 2.5 pm0 -60.91 -31.47 70.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -0.786 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -61.87 -68.39 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.983 -1.073 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.39 -48.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 109.314 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.15 -47.61 62.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.875 -1.141 . . . . 0.0 109.744 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.9 t -62.09 -43.31 99.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.54 -45.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 108.937 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 mt -66.79 -34.67 78.34 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 108.916 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -63.21 -34.48 77.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.203 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.3 mt -79.42 -38.45 34.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.764 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.13 3.1 21.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.64 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 5.9 mt-10 55.51 40.19 31.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mm -90.26 134.39 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 108.696 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.7 ' HG1' ' ND2' ' A' ' 86' ' ' ASN . 26.5 p -120.96 -16.16 8.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.367 -0.833 . . . . 0.0 111.718 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.7 ' ND2' ' HG1' ' A' ' 85' ' ' THR . 0.0 OUTLIER -127.64 108.15 10.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.876 -1.14 . . . . 0.0 111.242 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.3 m -165.36 150.7 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.356 -0.84 . . . . 0.0 110.404 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 35.7 m -118.67 109.67 16.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.1 mt -93.3 102.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.666 -178.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -71.42 124.49 24.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 t -108.66 113.95 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.529 0.681 . . . . 0.0 110.709 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.7 mm -102.08 97.7 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.65 -156.31 25.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.31 -12.32 9.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 109.827 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -138.5 148.86 44.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 109.404 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.17 128.16 86.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 121.95 4.81 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.709 1.606 . . . . 0.0 111.39 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 202' ' ' ASN . 2.4 tp -77.98 -14.83 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.3 mt 57.38 -120.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.275 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 100' ' ' ASP . 15.7 t70 -95.05 9.0 41.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.983 -1.073 . . . . 0.0 111.117 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.3 64.64 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.148 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -171.62 2.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.812 -0.817 . . . . 0.0 109.43 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.47 15.11 10.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.99 -42.63 85.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.342 -1.093 . . . . 0.0 110.665 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.47 -58.48 7.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.124 -0.985 . . . . 0.0 110.017 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -51.05 -44.03 61.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.19 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 64.6 t80 -60.88 -50.91 71.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.933 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.33 -43.61 90.42 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.967 -1.083 . . . . 0.0 111.469 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.01 -59.52 3.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.958 -1.088 . . . . 0.0 110.277 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.23 -36.17 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 71.6 ttt180 -63.27 -41.52 99.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.595 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -74.13 9.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -143.76 38.65 1.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.148 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 114' ' ' ILE . 89.4 mt -88.08 141.72 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.097 -1.002 . . . . 0.0 111.585 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.401 ' N ' HG23 ' A' ' 114' ' ' ILE . 5.5 tp -132.87 134.72 44.97 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -85.4 150.31 24.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 109.931 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -115.98 -173.95 2.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.408 -0.808 . . . . 0.0 109.81 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.426 ' C ' ' ND2' ' A' ' 118' ' ' ASN . 0.9 OUTLIER -113.97 66.8 0.67 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 -178.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.6 128.61 2.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.051 -1.031 . . . . 0.0 109.291 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.05 139.18 58.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.732 -1.23 . . . . 0.0 109.572 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 68.1 mt -82.62 149.31 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.8 81.38 3.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.68 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.493 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 51.4 m-85 -60.28 143.53 52.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.672 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -89.36 101.33 14.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -93.39 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.367 0.603 . . . . 0.0 110.778 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.54 114.69 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.89 -28.43 15.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.978 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -129.58 150.18 74.97 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.84 149.59 37.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.478 2.119 . . . . 0.0 112.207 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.95 150.94 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.954 . . . . 0.0 109.265 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.29 143.44 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.58 147.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.24 162.21 35.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.412 ' HB2' ' HZ3' ' A' ' 258' ' ' LYS . 2.2 t0 -178.07 113.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 54.58 47.38 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 0.0 110.717 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 -30.88 4.26 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -61.55 137.66 58.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.91 -1.347 . . . . 0.0 108.469 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.1 138.18 28.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.011 -1.056 . . . . 0.0 109.543 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 78.8 mt -138.85 127.3 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.312 -0.867 . . . . 0.0 110.067 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -117.09 132.01 56.78 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.454 0.645 . . . . 0.0 109.887 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.75 133.66 54.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.72 153.05 46.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.88 -1.138 . . . . 0.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -48.43 141.87 18.48 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.859 2.373 . . . . 0.0 113.836 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.26 148.75 20.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -37.83 82.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.501 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.4 p -124.91 -174.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.317 -0.864 . . . . 0.0 110.385 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.5 tp -90.86 121.2 32.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.9 . . . . 0.0 109.065 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -134.79 121.7 21.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 59.9 t -121.67 120.97 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -110.6 151.45 27.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.196 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.81 130.18 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.4 ' CB ' ' HH ' ' A' ' 247' ' ' TYR . 24.2 tt0 -121.68 130.79 53.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.13 135.11 7.69 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.623 -1.275 . . . . 0.0 111.682 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -101.91 102.34 12.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -86.18 166.95 15.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 111.141 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -103.96 23.36 13.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.771 -0.581 . . . . 0.0 110.294 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.5 p-10 -138.81 -170.7 2.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 110.115 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -50.67 -4.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 111.163 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' ASN . 13.0 mt -78.51 -26.92 46.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.463 -1.398 . . . . 0.0 108.556 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.84 -139.54 32.31 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -99.71 134.76 42.13 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -136.19 144.62 45.04 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.552 -0.717 . . . . 0.0 109.116 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.508 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.21 145.15 38.93 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 110.036 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 165' ' ' THR . 10.1 t80 -147.41 146.11 29.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 92.1 m -113.53 125.39 54.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 110.582 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -105.01 118.95 37.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.371 -0.83 . . . . 0.0 109.997 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 65.0 t -109.84 150.5 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 134.26 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.35 -7.46 51.25 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -118.95 28.02 8.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.183 -1.187 . . . . 0.0 109.365 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.55 -15.4 57.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.438 -0.789 . . . . 0.0 110.647 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.46 -13.19 61.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 0.0 110.622 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.02 -6.07 36.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.834 -1.167 . . . . 0.0 111.51 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.42 -30.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.149 -0.969 . . . . 0.0 110.426 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 m -61.1 -20.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.772 -1.205 . . . . 0.0 108.683 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.98 -3.35 58.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 0.0 108.969 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.4 117.41 11.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.581 ' NE ' ' OE2' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -82.2 173.22 12.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.665 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.537 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.2 t -78.67 162.91 25.88 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -147.8 143.93 27.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.313 -1.492 . . . . 0.0 111.38 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.09 158.63 43.53 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.488 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.1 m-85 -101.03 146.07 27.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.584 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 7.8 p30 -51.18 -37.7 48.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.102 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.488 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.1 p90 -67.87 -26.1 65.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.788 -1.195 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.6 mm-40 -82.43 -25.5 33.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.943 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 37.2 mt -58.22 -55.34 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.963 . . . . 0.0 109.659 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -45.3 -39.59 6.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.085 -1.01 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 189' ' ' ILE . 16.1 t-160 -76.49 -57.46 3.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.151 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 188' ' ' HIS . 84.3 mt -42.04 -32.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.46 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -82.13 -51.31 8.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.071 -1.018 . . . . 0.0 109.102 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -48.35 -45.07 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.89 . . . . 0.0 110.376 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 30.6 m -76.95 8.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.039 -1.038 . . . . 0.0 110.558 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.76 39.74 59.41 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.403 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 51.7 mt -126.43 170.79 11.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -1.107 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.49 22.28 58.78 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -55.78 -21.6 20.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.641 -1.505 . . . . 0.0 110.231 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.5 3.63 32.72 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.55 124.86 34.14 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.125 -1.221 . . . . 0.0 110.092 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.0 m -145.57 167.4 23.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.267 -1.137 . . . . 0.0 108.956 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.517 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.2 mt -69.94 -8.26 47.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.464 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -95.16 -10.67 29.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.912 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.516 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 12.2 p-10 -138.38 9.81 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.926 -1.109 . . . . 0.0 110.215 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -148.89 149.3 31.02 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.358 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 12.6 tp -99.79 93.68 5.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -85.7 130.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 66.2 mt -123.05 168.53 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.39 -166.06 11.82 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -63.44 -21.08 66.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -1.107 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.34 22.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -136.66 144.81 44.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.286 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.42 110.25 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -59.76 -47.02 87.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.605 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -62.5 121.28 66.18 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 0.0 109.733 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -67.65 -14.74 42.91 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.474 1.45 . . . . 0.0 112.016 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.2 -16.73 59.78 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.113 -0.992 . . . . 0.0 108.714 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.38 -169.97 54.88 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.247 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 217' ' ' LEU . 7.3 mt -88.98 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 0.0 110.117 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -69.03 -21.34 64.12 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.582 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.8 m-85 -147.03 148.01 31.23 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.17 7.6 0.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.201 -0.937 . . . . 0.0 109.769 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.659 ' ND2' ' NE ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -148.34 37.05 0.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.581 ' OE2' ' NE ' ' A' ' 178' ' ' ARG . 1.1 tt0 -54.92 -47.08 99.26 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.95 -66.98 0.1 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.435 2.09 . . . . 0.0 112.102 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.02 -37.12 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 109.969 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.659 ' NE ' ' ND2' ' A' ' 221' ' ' ASN . 56.9 mtt180 -60.95 -40.64 94.11 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.0 t60 -67.47 -32.05 72.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.696 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.87 -35.52 80.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.14 -37.57 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.59 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 49.8 t80 -64.51 -50.69 66.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.15 -28.74 69.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.9 tp -76.03 -33.66 59.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 108.732 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.34 -40.74 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.85 -52.88 38.16 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.23 -31.8 69.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -1.187 . . . . 0.0 109.314 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.86 -24.56 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.61 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -76.51 -21.79 55.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.918 -1.114 . . . . 0.0 109.394 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.2 mt -51.23 -0.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.793 -1.192 . . . . 0.0 110.606 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.61 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.6 mt -76.59 -11.92 59.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 109.955 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.32 0.6 59.59 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.836 -1.174 . . . . 0.0 110.724 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.56 152.67 13.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.928 -1.337 . . . . 0.0 108.859 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 130.17 39.13 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.869 1.712 . . . . 0.0 110.032 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.55 151.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 112.042 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -136.39 128.82 30.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.21 -156.78 26.86 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.453 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.4 OUTLIER -128.9 139.98 51.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -1.102 . . . . 0.0 109.169 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.0 m-85 -139.04 140.04 37.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.104 -0.998 . . . . 0.0 110.329 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.4 ' HH ' ' CB ' ' A' ' 152' ' ' GLU . 40.0 t80 -125.56 123.09 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.8 m -118.28 136.55 53.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 111.303 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 250' ' ' ARG . 47.8 t80 -117.32 117.27 29.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 249' ' ' PHE . 10.4 mtp180 45.02 42.49 6.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 108.562 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.08 153.09 35.48 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.13 178.89 17.64 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 86.2 m-70 -59.72 -40.09 86.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -1.044 . . . . 0.0 109.77 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 83.4 p -59.48 -38.78 81.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.798 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 256' ' ' ASN . 2.1 tp -76.15 -47.18 25.22 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.038 . . . . 0.0 108.984 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . 9.0 m-20 -47.59 -44.5 26.44 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.987 -1.07 . . . . 0.0 108.457 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 72.1 t -66.71 -54.23 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.541 -0.724 . . . . 0.0 109.321 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.412 ' HZ3' ' HB2' ' A' ' 134' ' ' ASP . 11.0 ttpt -49.59 -51.67 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.946 -1.096 . . . . 0.0 109.435 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 37.2 tp -53.37 -52.88 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.214 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.3 t -56.4 -54.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.034 -1.041 . . . . 0.0 109.229 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.02 -52.63 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.96 -50.93 72.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 109.738 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -52.86 -49.87 64.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.29 -26.98 66.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -71.21 -47.81 55.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -34.94 53.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 109.91 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.63 56.35 3.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -102.95 12.55 35.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.537 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.37 155.61 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -55.13 138.62 44.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 108.777 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.25 143.43 49.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 110.048 -179.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -141.23 -174.28 3.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 m -96.81 136.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.878 -1.139 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HZ3' ' N ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -67.34 -21.43 65.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.422 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -151.52 156.91 41.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.63 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 141.91 58.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.825 . . . . 0.0 110.297 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.77 164.98 15.77 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.44 140.52 48.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 26' ' ' LEU . 90.6 m-85 -136.92 148.36 46.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.28 150.23 25.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.923 -1.11 . . . . 0.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.39 171.38 34.99 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.47 151.17 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.404 -1.056 . . . . 0.0 109.893 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.15 137.85 15.94 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.64 -38.52 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -1.222 . . . . 0.0 110.316 -179.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.404 ' ND1' ' HB3' ' A' ' 194' ' ' LEU . 69.5 m-70 -90.94 -50.26 5.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.701 -1.25 . . . . 0.0 110.804 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.3 p -66.93 -24.79 66.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.708 -0.62 . . . . 0.0 111.265 -178.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.17 18.97 29.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -112.69 155.45 24.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -1.059 . . . . 0.0 109.446 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.91 132.18 43.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.242 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -134.9 143.22 46.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.494 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.75 156.62 21.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.421 -0.8 . . . . 0.0 109.728 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.3 mt -138.46 147.45 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 9.0 mt -141.75 113.34 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 mt -96.34 113.16 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.609 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.492 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 18.0 m-70 -106.33 138.9 19.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -55.29 168.12 1.55 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.652 1.568 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.552 ' CD ' ' HG1' ' A' ' 88' ' ' THR . 37.0 mm-40 -142.31 171.5 13.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.369 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.0 mttp -83.58 155.82 23.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.73 150.38 4.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.74 ' N ' HD22 ' A' ' 86' ' ' ASN . . . 72.34 -7.63 8.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.629 ' N ' HD21 ' A' ' 86' ' ' ASN . 95.8 m -62.19 -46.26 89.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.602 -1.528 . . . . 0.0 109.773 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 -179.64 35.59 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.34 115.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.78 151.29 46.95 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.54 158.27 16.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -129.26 108.94 10.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.245 -0.91 . . . . 0.0 108.602 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -135.27 135.55 40.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 53.7 26.78 6.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.49 17.0 78.53 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.19 122.47 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.443 -1.034 . . . . 0.0 108.706 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.48 128.0 33.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.79 93.64 41.83 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 0.0 109.533 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.61 145.71 16.58 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.407 2.071 . . . . 0.0 111.905 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.86 76.25 10.26 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.731 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -132.63 -179.66 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.532 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.9 p-80 -76.0 -55.67 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.008 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -43.75 -16.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.934 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.8 m-85 -98.16 3.62 49.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.74 -1.225 . . . . 0.0 110.337 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.78 138.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 108.607 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.92 -28.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.387 -0.821 . . . . 0.0 110.307 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -150.68 129.08 12.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.012 -1.055 . . . . 0.0 109.612 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.8 p -121.74 95.35 4.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.581 ' OD1' ' CD2' ' A' ' 58' ' ' HIS . 64.9 t-20 -163.09 129.82 3.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 108.935 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.581 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 99.7 m-70 52.01 7.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.025 . . . . 0.0 108.883 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.562 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 161.54 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.0 109.689 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.418 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 85.9 m -85.42 129.1 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.177 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.8 m-20 -121.38 150.38 41.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.79 0.805 . . . . 0.0 110.814 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 mt -125.66 148.63 48.94 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.72 158.35 30.81 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.027 -1.559 . . . . 0.0 110.415 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -165.75 153.06 10.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -1.012 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt 51.29 21.3 1.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.78 -33.03 6.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 2.1 mm100 -58.99 148.23 31.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -146.47 140.18 26.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.525 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 13.5 mt -129.01 123.34 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp -99.32 153.95 18.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.83 -1.169 . . . . 0.0 111.154 -178.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.7 m 50.82 75.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 m -107.82 -9.14 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 109.082 178.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.7 pm0 -60.86 -25.35 66.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.531 -0.731 . . . . 0.0 110.464 -179.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -68.26 -69.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 0.0 109.36 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 tp -51.87 -47.34 40.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.018 -1.051 . . . . 0.0 109.07 179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.9 mt -52.95 -49.27 66.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 -179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.475 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 32.8 t -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.077 -179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.78 -46.26 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.174 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.88 -34.28 78.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -63.29 -39.18 93.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.2 -40.43 45.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.788 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.8 mt -77.89 0.04 25.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.998 -1.064 . . . . 0.0 109.357 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 56.9 41.64 27.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.585 -0.697 . . . . 0.0 111.283 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.5 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 17.2 mm -88.53 144.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.773 -1.205 . . . . 0.0 108.434 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.9 p -126.98 -23.25 3.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.29 -0.881 . . . . 0.0 111.901 -178.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.74 HD22 ' N ' ' A' ' 34' ' ' GLY . 8.9 m120 -125.08 108.16 11.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.866 -1.147 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 5.8 m -163.26 150.11 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.0 110.549 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.552 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 52.0 m -117.46 114.12 23.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mt -96.93 103.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -74.41 124.68 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.16 120.7 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.792 0.806 . . . . 0.0 111.23 -178.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.77 96.13 4.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.29 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.07 -158.67 27.5 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -119.37 -11.95 9.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -1.177 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.15 148.26 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.017 -1.052 . . . . 0.0 109.726 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.5 mm -71.79 119.04 71.93 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 128.45 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.66 1.574 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.8 tp -82.05 -13.27 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.562 -179.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 mt 55.84 -121.92 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.71 7.61 44.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.45 -10.87 61.41 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.435 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.93 -171.58 2.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.696 -0.885 . . . . 0.0 109.434 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.25 13.59 12.4 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CE3' ' CD2' ' A' ' 176' ' ' LEU . 44.1 t-105 -58.34 -42.22 86.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -1.01 . . . . 0.0 110.635 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.88 -56.05 23.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.849 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -51.47 -42.96 61.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.011 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.49 ' OH ' ' OE2' ' A' ' 171' ' ' GLU . 44.8 t80 -62.62 -53.48 54.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.7 . . . . 0.0 110.558 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -44.52 92.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.67 -59.82 3.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.051 -1.031 . . . . 0.0 110.402 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mt -59.45 -33.34 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.52 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 113' ' ' ASN . 30.8 ttt180 -64.03 -43.68 94.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -73.73 15.98 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.576 ' C ' ' HZ3' ' A' ' 8' ' ' LYS . 5.8 m-80 -149.25 34.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.904 -1.122 . . . . 0.0 110.941 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.624 ' N ' ' HZ3' ' A' ' 8' ' ' LYS . 65.8 mt -81.88 136.72 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.763 -1.211 . . . . 0.0 110.294 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 tp -130.37 116.27 18.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.37 150.18 45.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -114.84 -174.51 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.545 -0.722 . . . . 0.0 109.422 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.67 67.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 111.118 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -168.52 135.25 1.94 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.048 . . . . 0.0 109.776 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -69.85 142.14 53.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.647 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 42.8 mt -83.14 148.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.48 -179.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.16 87.14 3.85 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 47.9 m-85 -65.91 144.35 56.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.891 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -87.64 101.94 14.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.248 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.66 131.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.642 -0.661 . . . . 0.0 110.724 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.93 113.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.52 -31.06 22.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.74 156.84 75.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.018 . . . . 0.0 109.796 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.93 148.61 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.613 2.209 . . . . 0.0 112.149 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.0 tt -157.08 149.29 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.073 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.65 142.77 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.355 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.11 149.64 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -134.53 161.55 34.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.655 -179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -173.61 108.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.334 -0.854 . . . . 0.0 109.709 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 54.91 49.51 17.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.68 -30.35 3.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.57 HH21 ' CA ' ' A' ' 252' ' ' GLY . 19.3 mtp85 -60.79 140.17 57.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -1.224 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tt -145.33 137.08 25.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.981 -1.074 . . . . 0.0 109.953 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 83.2 mt -136.66 128.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.662 179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -117.12 133.28 56.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.482 0.658 . . . . 0.0 110.263 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.08 135.64 54.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -149.05 149.46 29.91 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.932 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -48.23 143.8 14.06 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.507 2.138 . . . . 0.0 113.519 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.93 148.6 19.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -36.37 78.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.344 -0.848 . . . . 0.0 110.111 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.1 p -123.89 -165.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 109.67 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 tp -103.46 124.54 48.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.941 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -135.81 109.52 8.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.088 -1.007 . . . . 0.0 108.711 179.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.7 t -109.5 121.69 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.237 -0.914 . . . . 0.0 109.82 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.0 m -112.82 152.03 29.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 109.631 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -139.85 130.47 25.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.959 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -120.56 131.37 54.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.01 136.96 8.76 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.57 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 155' ' ' PHE . 10.7 tm-20 -101.93 100.95 11.3 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.405 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 79.9 m-85 -89.44 167.64 12.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.614 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -11.31 19.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.533 -0.73 . . . . 0.0 110.64 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 159' ' ' LEU . 46.5 p-10 -98.0 -166.54 1.39 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.845 -1.159 . . . . 0.0 110.445 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -55.67 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.488 -0.758 . . . . 0.0 111.654 -178.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.522 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 30.8 mt -82.49 -29.26 30.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.384 -1.447 . . . . 0.0 108.789 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.72 -135.22 42.51 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.5 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 5.5 ttm-85 -96.64 131.41 43.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -1.196 . . . . 0.0 109.559 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.522 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.43 143.69 41.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -143.26 135.92 27.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.269 -0.894 . . . . 0.0 109.822 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -105.34 122.56 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -103.68 112.74 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.139 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.0 t -105.13 152.73 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -49.0 123.77 7.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 108.757 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.76 5.26 36.17 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -117.11 18.32 14.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -1.058 . . . . 0.0 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.49 ' OE2' ' OH ' ' A' ' 107' ' ' TYR . 0.2 OUTLIER -52.75 -56.39 15.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.838 . . . . 0.0 110.079 -179.66 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 171' ' ' GLU . 48.1 mt-10 -42.67 -24.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 171' ' ' GLU . 54.9 mt-10 -82.67 -11.38 58.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 111.77 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.9 pt -124.21 -28.12 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.0 111.415 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.4 m -62.15 -29.34 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.427 -1.421 . . . . 0.0 108.942 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.409 ' CD2' ' CE3' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -78.31 -0.6 29.48 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.037 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -75.01 113.61 12.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.758 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.575 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -78.97 173.3 12.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.37 -0.831 . . . . 0.0 109.064 179.657 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.536 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.3 t -77.62 161.86 27.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -147.67 143.94 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.239 -1.538 . . . . 0.0 111.667 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.03 157.49 44.49 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 83.8 m-85 -97.41 147.15 24.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.467 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.87 -36.38 16.9 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.683 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -74.85 -28.31 60.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 0.0 109.934 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 9.4 tt0 -77.26 -26.23 52.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.103 -0.998 . . . . 0.0 110.339 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 187' ' ' GLU . 81.1 mt -60.43 -56.08 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.937 -1.102 . . . . 0.0 110.033 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.18 -41.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 110.144 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -73.56 -48.1 35.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 108.801 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.53 -28.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . 0.411 ' HZ1' HG21 ' A' ' 186' ' ' ILE . 4.2 mmtm -85.21 -52.73 5.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 109.281 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -46.98 -35.01 6.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.7 m -88.54 17.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.57 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 60.26 40.4 97.33 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 39.0 mt -125.74 170.76 11.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 61.04 21.94 59.8 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . 0.57 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 27.9 mttp -54.5 -20.65 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.598 -1.53 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.83 26.04 9.14 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.01 125.31 7.71 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 120.781 -1.423 . . . . 0.0 109.932 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.66 170.44 16.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.698 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.582 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 38.6 mt -68.68 -8.42 42.3 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -96.46 -13.21 23.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 109.658 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.2 p30 -135.1 7.96 3.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 109.852 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.1 m -148.5 149.99 32.62 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.017 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 20.6 tp -98.09 93.6 6.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.7 t -87.06 129.9 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.64 0.733 . . . . 0.0 109.347 -179.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.35 170.55 9.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 -179.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.37 -166.36 11.78 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -63.98 -30.37 71.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.55 24.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.672 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.95 153.2 40.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.257 . . . . 0.0 110.561 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.19 112.23 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.99 -50.19 71.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.015 -1.053 . . . . 0.0 109.965 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.03 111.51 4.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.458 -0.776 . . . . 0.0 110.425 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -59.83 -13.95 24.9 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.732 1.621 . . . . 0.0 112.467 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -76.31 -18.09 59.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.062 -1.024 . . . . 0.0 109.723 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.31 -179.08 53.27 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.438 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.0 mt -85.65 149.28 25.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.08 . . . . 0.0 109.852 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.44 -21.36 49.26 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -142.27 170.82 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.7 pm0 -77.21 -12.33 59.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.142 -0.974 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.526 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -135.1 44.16 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.176 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.7 OUTLIER -54.11 -46.91 98.59 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.944 -1.097 . . . . 0.0 109.41 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.64 -67.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.386 2.057 . . . . 0.0 111.996 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.56 -35.57 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.526 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 59.6 mtt-85 -61.45 -40.15 93.43 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.575 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.3 t60 -68.02 -32.85 73.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.002 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -65.47 -36.5 84.08 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -66.06 -39.14 83.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.475 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 48.0 t80 -63.23 -51.58 65.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.454 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.523 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 92.1 m-20 -63.83 -27.74 69.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.31 -35.85 47.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.13 -0.981 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -65.18 -38.61 83.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.83 -54.54 17.85 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.477 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 48.0 m-20 -55.59 -31.35 62.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.079 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.55 -23.81 66.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.697 . . . . 0.0 110.299 -179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.595 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.23 -21.94 61.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.762 -1.211 . . . . 0.0 108.865 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.0 mt -49.71 -3.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.623 -1.298 . . . . 0.0 110.381 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.595 ' H ' ' C ' ' A' ' 236' ' ' TYR . 13.6 mt -78.37 -16.77 57.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.18 2.92 56.82 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.08 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.43 153.31 8.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.62 -1.517 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.7 Cg_endo -53.95 129.31 33.61 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.895 1.73 . . . . 0.0 109.938 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.1 t -88.74 153.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.121 0.962 . . . . 0.0 112.295 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -133.34 125.82 30.02 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.32 -154.82 25.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 133.12 43.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -1.152 . . . . 0.0 108.873 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.2 m-85 -131.46 138.12 48.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 110.026 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -124.47 128.1 48.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.8 t -122.72 135.07 54.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.063 . . . . 0.0 111.364 -178.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -115.61 116.23 27.78 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 46.15 28.61 0.68 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.93 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.82 154.5 31.68 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.57 ' CA ' HH21 ' A' ' 137' ' ' ARG . . . -130.48 172.51 20.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 35.9 m-70 -59.13 -40.68 86.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.24 . . . . 0.0 109.547 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.5 t -56.43 -59.28 5.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 108.958 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 10.0 tp -51.34 -47.3 62.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 109.207 179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.6 m-20 -48.26 -51.01 27.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.58 -54.17 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.794 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -51.27 -50.01 60.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 109.061 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 50.4 tp -51.8 -50.16 61.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 77.4 t -59.12 -53.81 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.182 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -49.35 -43.18 43.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.436 -0.79 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.59 -50.64 64.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.4 mt -57.77 -45.72 85.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.821 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.49 -31.01 65.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.31 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -69.87 -58.95 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.222 -179.237 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -41.83 97.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.916 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -46.2 -27.32 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.404 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -95.23 152.32 18.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.536 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.594 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 19.7 mt -85.31 149.43 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -1.121 . . . . 0.0 109.757 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 70.8 mt-10 -54.89 136.74 46.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.035 -1.041 . . . . 0.0 108.542 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -120.19 142.42 49.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.456 -0.778 . . . . 0.0 109.572 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.28 -168.4 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.81 139.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.988 -1.07 . . . . 0.0 109.4 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ptpm? -67.46 -23.68 65.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -150.02 158.38 44.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.013 . . . . 0.0 109.833 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 141.51 58.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.448 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.43 168.6 10.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -139.63 144.79 37.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.965 -1.085 . . . . 0.0 110.674 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 77.8 m-85 -139.77 156.44 46.76 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -163.35 152.3 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.95 174.94 35.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.18 152.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -1.102 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 139.07 15.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.2 tt -57.75 -40.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 110.354 -179.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -89.37 -49.2 6.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 111.181 -178.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -69.92 -23.85 63.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.547 -0.721 . . . . 0.0 111.692 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.68 11.47 7.9 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.17 -1.49 . . . . 0.0 109.517 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -104.29 155.32 18.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.68 136.49 40.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.845 . . . . 0.0 109.67 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.0 m -137.07 142.73 42.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.562 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.32 151.27 26.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.3 mt -132.71 147.59 52.33 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.462 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -143.12 110.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 108.755 178.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mt -96.35 116.21 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 110.721 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.462 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 67.7 m-70 -110.64 141.55 24.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.537 -0.727 . . . . 0.0 109.781 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -53.97 168.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.868 1.712 . . . . 0.0 111.479 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' CD ' ' OG1' ' A' ' 88' ' ' THR . 14.3 mm-40 -140.1 176.27 8.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 30.2 mttp -84.76 151.02 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.94 143.88 2.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.51 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.1 9.39 57.01 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.99 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -71.31 -44.95 64.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.563 -1.551 . . . . 0.0 109.502 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.99 -176.2 29.26 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.69 117.25 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH2' ' CE2' ' A' ' 45' ' ' TYR . 13.3 ptt180 -142.47 155.72 45.1 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.836 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.84 157.45 17.08 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -128.35 110.94 12.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 108.996 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -135.11 133.83 39.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 52.43 26.84 4.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 111.238 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.69 66.41 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.038 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.5 123.88 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -1.083 . . . . 0.0 109.096 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.477 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 16.3 m-85 -88.31 128.81 35.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.174 -0.954 . . . . 0.0 109.797 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.43 112.97 35.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -71.86 155.96 57.3 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.81 1.673 . . . . 0.0 112.322 -179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.91 63.68 7.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.58 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.3 mtt85 -116.84 169.2 9.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.3 p-80 -74.04 -49.89 22.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.517 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -45.93 -16.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' HIS . 55.7 m-85 -97.85 3.93 49.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.872 -1.143 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.7 126.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.29 -30.35 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.34 131.3 13.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.061 -1.024 . . . . 0.0 110.112 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 56.7 p -120.52 95.09 4.59 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' SER . 35.3 t30 -163.36 130.17 3.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' O ' ' CB ' ' A' ' 59' ' ' SER . 76.8 m-70 51.66 7.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.1 -1.0 . . . . 0.0 109.266 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 161.03 140.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.2 m -80.42 127.36 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.291 -0.881 . . . . 0.0 109.197 179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -120.77 147.73 44.94 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.861 0.839 . . . . 0.0 111.113 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.95 148.21 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.44 153.83 24.78 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.252 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -164.75 150.12 9.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -1.083 . . . . 0.0 109.285 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.3 mttt 51.63 23.9 2.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -33.04 6.32 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -60.49 148.36 37.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.041 -1.27 . . . . 0.0 109.565 -179.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -144.12 139.79 29.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.57 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.65 122.69 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -97.95 155.8 16.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 111.22 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 m 49.12 75.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.094 0.473 . . . . 0.0 110.747 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 m -107.78 -8.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.268 -0.895 . . . . 0.0 109.006 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 7.6 pm0 -60.84 -27.25 67.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.67 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.413 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.9 m170 -65.78 -69.03 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.907 -1.12 . . . . 0.0 109.281 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.09 -47.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 82.0 mt -51.59 -49.27 62.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 110.157 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.525 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 19.5 t -60.99 -42.87 99.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.03 -1.044 . . . . 0.0 110.382 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.2 t -55.89 -47.54 79.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.96 -34.59 78.46 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.3 -34.95 77.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -80.83 -38.01 29.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.045 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.27 5.58 12.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.026 -1.046 . . . . 0.0 109.581 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 53.87 39.14 30.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.4 mm -89.79 134.48 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 108.716 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.8 p -123.39 -18.68 6.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.259 -0.901 . . . . 0.0 111.686 -178.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' O ' ' CG1' ' A' ' 87' ' ' VAL . 3.1 m120 -124.09 106.9 10.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.868 -1.145 . . . . 0.0 110.351 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 3.9 m -166.41 147.54 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.666 0.746 . . . . 0.0 110.056 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 22.2 m -115.76 110.2 18.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.3 mt -91.29 100.33 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.028 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -75.0 128.58 35.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.098 -1.001 . . . . 0.0 108.417 179.143 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.1 128.67 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.06 0.933 . . . . 0.0 111.927 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.2 mm -109.66 96.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.28 -153.15 21.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -9.27 8.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -1.087 . . . . 0.0 110.072 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.93 148.31 41.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.042 -1.036 . . . . 0.0 109.727 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.9 mm -73.48 120.02 78.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 108.772 179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -40.0 125.25 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.515 1.477 . . . . 0.0 111.105 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.425 HG22 HD21 ' A' ' 202' ' ' ASN . 2.5 tp -78.16 -11.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.3 mt 54.34 -119.73 1.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.21 7.8 45.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.83 -0.63 64.93 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.765 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.72 -172.66 2.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.801 -0.823 . . . . 0.0 109.315 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.4 16.08 8.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -59.56 -42.86 93.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -1.086 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.74 -56.88 13.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.544 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 9.9 m-85 -51.67 -44.54 63.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.847 . . . . 0.0 109.108 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 72.1 t80 -61.72 -50.63 71.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.577 -0.702 . . . . 0.0 110.916 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.59 -43.0 95.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.091 -1.006 . . . . 0.0 111.24 -178.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.77 -55.68 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 110.735 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.11 -30.82 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 51.5 ttt180 -66.76 -43.43 84.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.842 . . . . 0.0 110.52 -179.141 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -75.72 11.61 1.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 110.196 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.471 ' OD1' ' CG ' ' A' ' 9' ' ' GLU . 2.6 m-80 -142.75 35.01 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.992 -1.068 . . . . 0.0 110.198 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.403 HD12 HG21 ' A' ' 114' ' ' ILE . 83.7 mt -83.02 142.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.949 -1.094 . . . . 0.0 111.186 -179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -132.98 129.39 38.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -83.79 149.07 26.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -116.47 -174.58 2.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.15 68.3 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.35 -0.844 . . . . 0.0 110.807 -178.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -163.73 129.82 3.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.0 109.298 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.82 138.94 56.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.844 -1.16 . . . . 0.0 109.685 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 HG21 HD13 ' A' ' 121' ' ' ILE . 96.5 mt -83.37 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 110.191 -179.484 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.15 79.53 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.414 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 42.5 m-85 -59.92 142.76 53.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.524 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 38.1 t80 -88.87 101.93 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.35 133.31 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.71 -0.619 . . . . 0.0 110.561 -177.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.1 t -70.6 114.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.5 mp0 -82.42 -29.98 30.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.044 -1.035 . . . . 0.0 110.695 -178.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 172.99 5.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.754 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.55 149.47 12.92 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.846 2.364 . . . . 0.0 112.848 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.432 ' CD1' ' HZ2' ' A' ' 266' ' ' LYS . 11.3 tt -157.0 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.79 140.56 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.98 147.59 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' O ' ' NZ ' ' A' ' 258' ' ' LYS . 3.5 mp0 -136.54 160.99 37.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.014 -1.054 . . . . 0.0 110.523 -178.793 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -174.13 105.48 0.11 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.367 -0.833 . . . . 0.0 109.741 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.09 57.7 6.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.496 -0.752 . . . . 0.0 110.676 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.9 2.83 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.402 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.557 ' NH2' ' H ' ' A' ' 255' ' ' LEU . 46.5 mtp180 -61.96 130.85 47.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.023 -1.281 . . . . 0.0 108.219 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.504 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 3.2 tt -143.12 137.15 28.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 109.984 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 71.2 mt -134.44 127.21 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 109.418 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.91 131.46 56.93 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.514 0.673 . . . . 0.0 109.926 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.98 136.07 54.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.58 149.28 36.52 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.015 -1.053 . . . . 0.0 109.874 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.41 141.42 51.01 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.426 2.084 . . . . 0.0 113.187 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.84 147.46 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.4 -3.91 7.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.299 -0.876 . . . . 0.0 110.619 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.1 p -150.84 -175.61 5.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.872 -1.143 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.2 tp -96.4 122.63 39.5 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.064 -1.022 . . . . 0.0 108.875 179.616 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -137.13 127.14 25.92 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.331 -0.856 . . . . 0.0 108.768 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 65.7 t -126.89 120.68 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 46.5 m -112.15 152.11 28.72 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.583 -0.698 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -139.69 130.71 26.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.933 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.38 132.86 54.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.37 141.18 12.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.802 -178.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.41 ' O ' ' NH1' ' A' ' 250' ' ' ARG . 5.6 tt0 -105.54 100.1 9.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.31 167.0 15.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -102.5 5.08 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 110.91 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.8 p-10 -119.46 -171.0 2.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.0 110.424 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -47.8 -3.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.595 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -80.24 -29.11 38.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.359 -1.463 . . . . 0.0 109.073 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.95 -139.02 33.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -97.23 131.79 43.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.218 -1.166 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -138.01 147.69 44.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.87 . . . . 0.0 109.456 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.5 146.15 36.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -143.83 137.9 28.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 25.4 m -107.18 123.34 48.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.224 -179.497 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.477 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 6.3 t80 -102.69 109.64 21.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.14 154.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.05 126.79 19.54 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.83 2.49 42.78 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -115.37 20.58 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -1.153 . . . . 0.0 109.079 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 173' ' ' GLU . 1.4 pm0 -58.14 -52.15 66.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 1.2 mt-10 -48.6 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 110.499 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 171' ' ' GLU . 12.6 mm-40 -103.47 -7.16 21.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.957 -1.089 . . . . 0.0 110.552 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.35 -26.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.125 -0.984 . . . . 0.0 110.942 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.1 m -60.84 -22.13 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.646 -1.284 . . . . 0.0 108.76 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.87 -2.74 58.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 109.222 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.15 116.41 10.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 108.764 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -79.65 172.76 13.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.464 ' HG1' HN17 ' A' ' 500' ' ' C90 . 9.4 t -78.53 163.57 25.43 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -147.51 144.98 28.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.28 -1.512 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.77 157.41 44.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.423 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.2 m-85 -98.98 144.43 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.992 -1.068 . . . . 0.0 109.53 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 183' ' ' ASP . 3.9 t0 -53.07 -35.96 60.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.38 -0.825 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.2 p90 -69.36 -25.38 64.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.77 -1.206 . . . . 0.0 109.902 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.436 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -83.43 -31.14 26.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.032 -1.043 . . . . 0.0 109.92 -179.652 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.49 ' O ' ' N ' ' A' ' 189' ' ' ILE . 55.7 mt -50.98 -58.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.532 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.0 tp10 -40.82 -40.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.937 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -74.68 -35.39 62.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.017 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.49 ' N ' ' O ' ' A' ' 186' ' ' ILE . 91.1 mt -58.92 -38.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.354 -0.841 . . . . 0.0 109.024 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -75.71 -52.52 10.3 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -49.07 -43.12 40.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.433 -0.792 . . . . 0.0 110.678 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.53 5.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.388 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 40.08 50.64 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.8 178.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 39.0 mt -128.13 173.91 9.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.098 -1.236 . . . . 0.0 110.013 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.03 58.58 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -54.7 -20.64 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.479 -1.601 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -117.04 26.02 8.52 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.815 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.5 127.05 8.41 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.665 -1.491 . . . . 0.0 109.886 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.4 m -144.43 174.84 10.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -1.09 . . . . 0.0 109.332 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.5 mt -72.15 -7.77 50.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 108.872 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -96.28 -11.36 26.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.27 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.505 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 8.3 p-10 -134.75 9.88 3.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.008 . . . . 0.0 110.034 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.401 ' HG1' HG21 ' A' ' 179' ' ' THR . 1.2 m -150.65 150.94 31.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 110.339 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.0 tp -100.4 93.88 5.88 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.0 t -86.07 130.12 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.781 0.801 . . . . 0.0 109.318 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.99 165.08 18.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.651 -0.656 . . . . 0.0 109.343 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.31 -166.61 12.05 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -58.4 -36.68 73.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.482 -1.011 . . . . 0.0 109.338 179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.38 23.71 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.026 -1.046 . . . . 0.0 110.469 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -139.0 146.91 41.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 0.0 110.552 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -100.58 111.26 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -57.54 -52.37 65.68 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.322 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -56.16 111.11 2.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.045 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.55 -14.85 17.99 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.741 1.627 . . . . 0.0 111.962 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -15.86 59.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.126 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.28 -173.17 49.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.3 mt -89.69 148.05 23.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.17 -1.194 . . . . 0.0 109.843 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.29 -18.15 37.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 108.851 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 59.5 m-85 -139.47 173.71 11.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 220' ' ' GLU . 5.8 mp0 -80.09 -14.42 58.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.48 48.38 1.84 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.253 -0.904 . . . . 0.0 109.596 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -56.54 -46.52 99.81 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 109.808 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.1 Cg_exo -51.5 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.452 2.101 . . . . 0.0 112.108 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.1 -35.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.028 -1.045 . . . . 0.0 109.575 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 18.5 mtt180 -60.19 -41.5 93.08 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -68.04 -31.87 71.83 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.828 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -64.56 -37.16 86.59 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.42 -35.18 65.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.525 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.4 t80 -65.22 -55.27 19.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -63.64 -26.19 68.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.0 tp -77.81 -35.03 51.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.021 -1.049 . . . . 0.0 108.609 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.1 mt -67.14 -36.42 76.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.86 -59.31 6.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -51.67 -34.86 40.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -1.231 . . . . 0.0 108.873 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.67 -23.0 64.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.983 -179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.614 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.44 -21.64 61.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.088 . . . . 0.0 108.743 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.3 mt -55.16 3.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.677 -1.264 . . . . 0.0 110.521 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.614 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.1 mt -80.12 -16.24 55.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.856 -1.152 . . . . 0.0 109.729 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.88 43.4 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.114 -1.041 . . . . 0.0 110.629 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.38 158.14 9.94 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.395 . . . . 0.0 108.921 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.414 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -48.74 150.94 5.71 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 121.848 1.699 . . . . 0.0 109.429 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.72 145.35 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 0.0 112.181 -177.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.5 122.2 32.76 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 148.62 174.8 20.62 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.442 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.519 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 18.3 tttt -102.02 146.98 27.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.255 . . . . 0.0 109.986 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 18.3 m-85 -140.56 140.27 35.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 109.927 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -127.12 126.0 42.17 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.0 m -119.62 135.53 54.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 0.0 111.331 -178.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 250' ' ' ARG . 90.9 t80 -116.78 115.22 25.17 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 249' ' ' PHE . 78.3 mtp85 45.14 47.82 9.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.01 -1.056 . . . . 0.0 108.726 -179.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.83 159.53 28.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.52 -174.56 13.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -60.75 -47.92 84.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -1.125 . . . . 0.0 109.642 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.25 -59.08 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.557 ' H ' ' NH2' ' A' ' 137' ' ' ARG . 1.3 tp -52.73 -48.39 66.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.731 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 7.2 m-20 -47.41 -45.29 25.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 109.192 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 59.1 t -66.96 -40.14 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 109.986 -179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 133' ' ' GLU . 8.3 ttpt -63.74 -51.75 63.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 109.378 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 47.6 tp -53.95 -48.8 69.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.81 -53.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.372 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . 0.417 ' O ' ' CG ' ' A' ' 265' ' ' LYS . 10.7 mtmt -51.1 -40.44 58.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.688 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.82 -50.45 42.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.949 . . . . 0.0 109.841 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.75 -48.7 80.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.24 -32.82 73.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 110.114 -179.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 7.7 mmtm -66.13 -43.84 85.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.572 ' C ' ' H ' ' A' ' 268' ' ' LYS . 12.4 mtmt -66.09 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.548 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.524 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 27.1 tt0 -56.59 -0.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.831 . . . . 0.0 109.979 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 266' ' ' LYS . 9.8 tttt -117.83 138.49 52.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.464 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.67 152.26 21.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -1.158 . . . . 0.0 109.501 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -55.95 137.61 50.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.959 . . . . 0.0 108.93 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.57 144.19 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.439 -0.788 . . . . 0.0 110.024 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -141.53 -171.34 3.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 m -99.49 137.09 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.013 -1.055 . . . . 0.0 109.437 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.43 -25.18 67.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.667 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.28 162.5 40.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 139.97 54.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.92 166.18 12.81 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -136.72 141.7 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.086 -1.009 . . . . 0.0 110.305 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' O ' ' N ' ' A' ' 26' ' ' LEU . 93.4 m-85 -139.25 153.65 47.86 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.52 152.33 21.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.836 -1.165 . . . . 0.0 110.283 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.57 175.71 36.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.4 153.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.551 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 140.98 17.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.5 tt -61.48 -37.92 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -1.217 . . . . 0.0 111.117 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.4 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 92.3 m-70 -90.52 -49.45 6.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.292 -1.505 . . . . 0.0 110.938 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.422 ' HG1' ' CB ' ' A' ' 95' ' ' GLU . 1.8 p -68.66 -25.71 64.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 111.853 -178.12 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.71 16.78 47.12 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.065 -1.54 . . . . 0.0 109.456 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.69 153.69 23.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -1.085 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -76.31 135.53 39.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.773 . . . . 0.0 109.602 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 22.1 t -138.23 145.72 41.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.43 154.44 22.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' PHE . 10.1 mt -134.12 144.13 48.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.74 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.58 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -140.03 114.31 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mt -99.3 114.59 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.461 -0.775 . . . . 0.0 110.501 -178.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.58 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 2.9 m-70 -109.41 140.23 21.87 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.42 -0.8 . . . . 0.0 109.682 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -55.35 168.61 1.36 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.767 1.645 . . . . 0.0 111.183 178.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.481 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 42.0 mm-40 -140.5 179.72 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.0 110.026 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.417 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.0 mttt -86.36 152.68 22.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.761 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.14 143.83 2.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.22 7.87 60.9 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.322 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 44.0 m -69.7 -45.22 68.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.533 -1.569 . . . . 0.0 109.802 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.751 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 99.39 -179.9 30.88 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.613 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG23 HD13 ' A' ' 37' ' ' ILE . 19.9 mm -96.86 118.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -142.65 153.7 43.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.716 -1.24 . . . . 0.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -102.43 158.78 15.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -130.94 108.32 9.74 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.445 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 30.1 tttm -135.58 137.04 41.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 111.004 -178.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.492 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 16.5 m120 52.25 31.22 8.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 111.279 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.42 80.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.569 -1.3 . . . . 0.0 109.97 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 121.24 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -1.06 . . . . 0.0 109.108 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.69 129.81 34.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 mt -117.92 93.45 44.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.843 . . . . 0.0 109.618 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -49.04 148.82 9.0 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.317 2.011 . . . . 0.0 111.897 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.29 69.88 10.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.183 -0.948 . . . . 0.0 109.965 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -122.54 173.95 7.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 108.957 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 237' ' ' LEU . 1.3 p-80 -74.71 -48.21 27.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.9 mm-40 -47.75 -16.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.807 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' HIS . 27.4 m-85 -95.6 -0.86 51.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.756 -1.215 . . . . 0.0 109.705 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.7 129.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.08 -27.78 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 110.258 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -151.02 131.79 14.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.4 p -124.5 95.44 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.569 ' C ' ' H ' ' A' ' 59' ' ' SER . 1.9 t-20 -163.01 128.8 3.25 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.4 m-70 50.4 8.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.132 -0.98 . . . . 0.0 109.027 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.569 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER 162.64 140.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.883 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.44 ' C ' ' OD1' ' A' ' 61' ' ' ASP . 63.7 m -85.51 126.29 33.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -119.83 148.84 42.97 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.65 0.738 . . . . 0.0 110.75 -179.168 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mt -122.92 147.25 46.82 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.97 152.89 23.62 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.561 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -160.59 148.35 16.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -1.023 . . . . 0.0 109.108 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.36 21.68 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.552 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.83 -32.34 7.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 28.1 mm-40 -60.36 144.64 50.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.071 -1.252 . . . . 0.0 109.469 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -141.64 140.89 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 56.9 mt -131.3 122.72 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -90.8 158.69 16.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.036 -1.04 . . . . 0.0 111.365 -179.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 m 41.58 79.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.426 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.34 -9.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.6 pm0 -61.7 -26.58 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.674 . . . . 0.0 110.443 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.407 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -66.06 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 0.0 108.998 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.2 tp -52.34 -49.87 40.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.119 179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.8 mt -49.14 -51.19 33.68 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.976 -1.078 . . . . 0.0 110.233 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -59.61 -41.63 90.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.16 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.05 -44.54 78.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.038 -1.039 . . . . 0.0 108.912 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.32 -35.21 78.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.362 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -62.78 -35.79 80.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.63 -38.21 34.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 109.845 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 94.6 mt -81.14 1.71 30.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.1 -1.0 . . . . 0.0 109.633 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 54.79 40.51 31.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 110.113 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.26 140.47 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 64.1 p -126.34 -21.4 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.16 -0.963 . . . . 0.0 111.753 -178.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.751 HD21 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -126.02 107.25 10.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.942 -1.099 . . . . 0.0 110.351 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.1 m -164.56 147.07 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.16 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.481 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 72.3 m -116.29 110.46 18.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.95 101.58 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -77.35 129.01 35.27 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 108.539 179.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.41 123.38 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.918 0.866 . . . . 0.0 111.823 -177.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.493 ' O ' ' OG ' ' A' ' 24' ' ' SER . 3.6 mt -104.6 96.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.55 -155.32 24.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -122.22 -9.04 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.422 ' CB ' ' HG1' ' A' ' 20' ' ' THR . 44.2 tt0 -138.86 148.13 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 110.0 -179.459 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 39.7 mm -71.94 122.81 88.3 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.187 -1.005 . . . . 0.0 108.383 179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -42.46 117.4 0.82 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.637 1.558 . . . . 0.0 110.937 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -72.45 -14.38 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 75.1 mt 56.98 -120.41 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.121 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.99 8.45 44.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.868 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.28 62.4 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.901 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -172.1 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.901 . . . . 0.0 109.57 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.23 17.31 8.54 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 57.7 t-105 -57.12 -43.76 82.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 0.0 110.197 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.88 -55.91 16.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.08 -45.94 61.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 0.0 109.604 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.427 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 44.6 t80 -62.69 -52.87 61.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.0 110.829 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.436 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 2.0 mm-40 -61.21 -44.63 96.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.116 -0.99 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.99 19.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.219 -0.926 . . . . 0.0 110.351 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.2 mt -65.11 -32.11 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.423 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 53.2 ttt180 -63.29 -42.31 99.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -76.46 7.39 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 110.134 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -137.36 33.97 2.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.024 . . . . 0.0 110.509 -179.424 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.9 mt -80.68 138.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.945 -1.097 . . . . 0.0 110.247 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -129.41 124.97 35.49 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 142.6 31.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.1 -172.27 2.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.239 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -113.93 69.61 0.71 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.286 -0.884 . . . . 0.0 110.716 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -168.59 131.28 1.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 109.255 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE2' ' C ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -69.8 151.05 46.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 110.08 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.45 ' C ' ' OE2' ' A' ' 120' ' ' GLU . 45.4 mt -95.25 152.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.107 -0.996 . . . . 0.0 110.096 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.32 83.83 4.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.405 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 48.0 m-85 -62.5 147.01 50.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.071 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -93.68 102.04 14.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 61.4 t -93.9 133.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 0.0 110.647 -177.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.91 116.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -84.63 -29.95 25.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.064 -1.022 . . . . 0.0 110.889 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.25 168.73 13.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 109.901 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 147.92 24.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.862 2.374 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -157.36 149.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -0.834 . . . . 0.0 109.043 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.95 146.4 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.93 148.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -133.56 160.72 36.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.71 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -175.1 105.71 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.301 -0.875 . . . . 0.0 109.823 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.32 51.33 15.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 110.199 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.78 -30.65 3.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -62.13 136.89 58.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.262 . . . . 0.0 108.229 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 1.1 tt -145.57 140.09 27.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 110.534 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 71.2 mt -136.91 127.03 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.717 . . . . 0.0 109.66 179.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -114.22 134.03 55.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 135.64 54.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.42 150.2 39.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -47.22 142.53 11.86 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.684 2.256 . . . . 0.0 113.409 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.581 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -159.0 147.87 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.689 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -66.39 -32.49 73.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 110.53 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.581 ' O ' ' OG ' ' A' ' 144' ' ' SER . 72.5 p -120.25 -163.23 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.327 -0.858 . . . . 0.0 109.308 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.7 tp -109.25 123.98 50.15 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -135.37 125.25 25.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 108.466 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 63.5 t -125.87 121.5 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 152.03 27.66 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.623 -0.673 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -140.01 130.59 25.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -122.41 133.86 54.62 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.9 140.81 11.91 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.651 -178.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -101.54 100.47 10.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.71 166.95 13.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 110.707 -178.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -104.29 -20.51 13.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 110.484 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 159' ' ' LEU . 32.4 p-10 -89.08 -171.01 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.761 -1.212 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -52.63 2.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.277 -0.889 . . . . 0.0 111.501 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' H ' ' C ' ' A' ' 157' ' ' ASN . 14.6 mt -82.25 -28.63 31.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.388 -1.445 . . . . 0.0 108.493 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.5 -141.56 38.35 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -100.44 136.23 40.64 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.256 -1.143 . . . . 0.0 109.13 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -143.73 160.81 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.374 -0.829 . . . . 0.0 109.597 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 150.54 31.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -144.66 140.78 28.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -107.06 122.93 47.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 109.985 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.484 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 6.0 t80 -102.76 111.61 24.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 110.022 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.446 ' H ' HD21 ' A' ' 170' ' ' ASN . 13.1 t -103.15 150.74 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.73 138.13 6.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.202 -0.936 . . . . 0.0 108.826 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.09 3.83 69.6 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.446 HD21 ' H ' ' A' ' 167' ' ' VAL . 98.7 m-20 -113.83 20.97 15.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.18 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' A' ' 173' ' ' GLU . 0.8 OUTLIER -58.96 -50.86 72.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.361 -0.837 . . . . 0.0 109.196 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 171' ' ' GLU . 2.4 mt-10 -50.6 -5.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.491 -0.756 . . . . 0.0 109.774 179.53 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 171' ' ' GLU . 39.3 mt-10 -104.91 -9.81 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 110.3 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.0 pt -126.85 -27.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.191 -0.943 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.0 m -60.98 -22.88 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.679 -1.263 . . . . 0.0 108.524 179.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.93 -2.62 58.75 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.35 115.93 10.11 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.355 -0.841 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.3 mtm180 -79.53 172.76 13.35 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 0.0 109.255 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.439 ' HG1' HN17 ' A' ' 500' ' ' C90 . 10.1 t -79.71 163.87 24.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -148.71 144.46 27.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.244 -1.535 . . . . 0.0 111.37 -179.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.06 158.84 43.29 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.3 m-85 -99.46 144.75 28.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.35 -36.2 20.79 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.31 -0.869 . . . . 0.0 109.578 -179.477 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 8.5 p90 -73.67 -26.38 60.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 109.842 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.3 OUTLIER -76.65 -38.66 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 109.998 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 187' ' ' GLU . 62.6 mt -48.51 -51.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 186' ' ' ILE . 8.6 tt0 -42.95 -45.38 5.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.953 . . . . 0.0 110.303 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -75.26 -57.35 3.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 -179.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 194' ' ' LEU . 45.6 mt -44.74 -27.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.5 -54.37 4.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.772 -1.205 . . . . 0.0 109.506 179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -51.91 -40.22 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.929 . . . . 0.0 110.034 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.3 m -75.37 3.37 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.927 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.24 37.72 31.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 189' ' ' ILE . 57.0 mt -128.52 169.53 14.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -1.144 . . . . 0.0 109.865 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.4 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.42 24.11 61.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -60.4 -21.23 61.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.623 -1.516 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -111.24 24.95 14.76 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.2 125.45 7.79 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.885 -1.362 . . . . 0.0 109.744 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -144.11 164.5 30.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -1.112 . . . . 0.0 110.03 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.568 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 25.3 mt -64.47 -8.99 15.64 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -93.09 -15.99 25.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -136.84 10.99 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 110.17 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -149.16 149.99 31.92 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.043 -1.035 . . . . 0.0 110.287 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.6 tp -100.24 93.34 5.64 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.1 t -86.12 131.33 34.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.768 0.794 . . . . 0.0 109.031 -179.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.14 162.66 23.13 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.31 -166.73 12.68 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -31.59 71.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -1.05 . . . . 0.0 109.569 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -153.9 23.79 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.21 -0.931 . . . . 0.0 110.678 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -144.24 151.73 39.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.748 -1.22 . . . . 0.0 110.516 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.56 112.25 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -57.17 -51.88 67.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.015 . . . . 0.0 110.328 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 8.0 m120 -58.0 111.66 3.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.5 -12.42 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.596 1.531 . . . . 0.0 111.821 179.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -17.2 59.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.048 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.3 -175.79 48.26 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.81 142.07 28.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -1.2 . . . . 0.0 109.86 -179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -19.92 60.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -142.9 -179.05 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.389 -0.82 . . . . 0.0 109.297 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.567 ' N ' ' OE2' ' A' ' 220' ' ' GLU . 1.9 pm0 -87.17 3.42 46.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.608 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.474 ' N ' ' ND2' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -154.04 47.57 0.62 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.818 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.561 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -58.88 -46.02 99.57 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.011 -1.055 . . . . 0.0 109.933 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 50.7 Cg_exo -52.19 -66.44 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.069 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 -35.94 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 109.568 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -59.27 -41.64 89.33 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 18.1 t60 -68.3 -32.13 72.05 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.147 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.81 -35.5 81.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.35 -37.85 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -63.33 -49.79 72.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.458 -0.776 . . . . 0.0 108.961 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -67.78 -27.82 67.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 109.755 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.1 tp -77.33 -34.03 55.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.002 -1.061 . . . . 0.0 108.359 179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.1 mt -67.95 -37.74 78.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.22 -56.06 13.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 21.8 m-20 -52.45 -38.36 59.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -1.219 . . . . 0.0 108.982 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 15.9 mt -58.23 -23.47 55.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.629 -0.669 . . . . 0.0 110.48 -179.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.603 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.83 -22.36 60.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.692 -1.255 . . . . 0.0 108.758 -179.666 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 94.0 mt -52.71 -0.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.635 -1.291 . . . . 0.0 110.356 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.9 mt -77.96 -14.48 59.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.799 -1.188 . . . . 0.0 109.756 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.39 -1.53 55.97 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.844 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.05 156.7 9.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.742 -1.446 . . . . 0.0 109.174 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.405 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.75 150.23 9.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.852 1.701 . . . . 0.0 109.518 178.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.42 149.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.999 -1.063 . . . . 0.0 112.115 -177.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -129.77 123.55 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . 0.533 ' C ' ' HG ' ' A' ' 144' ' ' SER . . . 157.58 -160.86 30.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.26 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.14 46.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -1.085 . . . . 0.0 108.76 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -133.1 138.22 46.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 110.145 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -123.55 129.72 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 t -123.83 136.24 54.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.378 -177.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.36 111.47 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 50.0 45.05 25.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.17 -0.957 . . . . 0.0 108.465 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.78 141.73 17.33 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -115.8 178.75 17.74 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 52.0 m-70 -59.33 -39.14 82.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.137 -1.213 . . . . 0.0 109.595 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -54.74 -58.79 6.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.224 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.65 ' CD1' ' HZ3' ' A' ' 258' ' ' LYS . 11.8 tp -56.69 -45.7 81.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.563 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.5 m-20 -47.46 -54.76 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 109.634 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 99.2 t -60.89 -50.71 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . 0.65 ' HZ3' ' CD1' ' A' ' 255' ' ' LEU . 22.2 ttmt -50.49 -52.35 39.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.978 -1.076 . . . . 0.0 108.963 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.5 tp -50.4 -50.85 50.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.27 -52.94 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.889 179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.09 -50.16 29.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.148 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.48 -49.32 77.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.1 mt -56.12 -52.47 64.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -26.29 67.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.79 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -71.29 -64.68 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.935 . . . . 0.0 110.072 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -54.53 -37.35 65.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.951 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -90.31 32.25 0.95 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.966 -1.083 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.605 ' CG ' ' H ' ' A' ' 269' ' ' LEU . 2.5 tptm -90.44 -134.91 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.605 ' H ' ' CG ' ' A' ' 268' ' ' LYS . 2.1 pp . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.439 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.77 156.65 17.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -1.128 . . . . 0.0 109.654 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.474 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 94.6 mt-10 -57.67 137.83 56.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 146.98 47.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.49 -0.756 . . . . 0.0 109.996 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -141.16 -171.7 3.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 m -97.64 135.35 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.036 -1.04 . . . . 0.0 109.269 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.07 -20.75 65.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.16 160.66 40.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 139.11 57.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 109.869 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -117.44 163.01 17.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.17 141.02 48.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.473 ' O ' ' N ' ' A' ' 26' ' ' LEU . 99.0 m-85 -139.56 147.72 41.56 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.93 151.84 22.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.839 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.14 173.95 36.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.56 149.25 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -1.039 . . . . 0.0 110.108 -179.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 140.09 16.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.0 tt -58.91 -39.15 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.126 -1.22 . . . . 0.0 110.327 -179.179 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.404 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 78.3 m-70 -90.21 -50.38 6.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.718 -1.239 . . . . 0.0 111.168 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -66.6 -23.93 66.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.762 . . . . 0.0 111.242 -178.156 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.69 16.71 17.85 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -112.56 157.93 20.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -1.012 . . . . 0.0 109.401 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.82 134.7 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -136.34 145.29 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.57 157.62 20.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.978 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 13' ' ' PHE . 9.3 mt -138.59 145.02 40.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.491 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.493 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -140.56 108.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 108.416 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -92.28 115.24 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 0.0 110.621 -178.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.493 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 47.5 m-70 -108.67 139.77 21.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 0.0 109.393 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -52.57 168.34 0.46 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.828 1.686 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -142.84 174.56 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.668 179.434 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.7 mttt -82.05 149.38 28.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -47.05 149.03 0.98 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.15 -0.969 . . . . 0.0 109.821 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 66.66 4.01 23.62 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.75 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 19.8 m -67.53 -41.69 83.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.774 -1.427 . . . . 0.0 109.238 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.67 -179.91 34.58 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.398 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.438 HG23 HD11 ' A' ' 37' ' ' ILE . 24.4 mm -98.92 116.5 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -139.62 155.31 47.51 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.772 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -103.58 156.8 17.5 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -128.69 111.8 13.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.0 108.657 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -135.66 134.35 39.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.699 -178.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 42' ' ' ASN . 1.0 OUTLIER 53.74 28.31 8.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 111.362 178.455 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.05 18.23 75.16 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.074 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.56 122.99 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.415 -1.05 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -84.39 128.26 34.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.111 -0.993 . . . . 0.0 109.466 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 55.7 mt -118.13 91.09 39.37 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.526 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.36 152.24 8.75 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.519 2.146 . . . . 0.0 111.826 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 67.4 9.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -121.55 161.86 21.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.83 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.1 p-80 -65.17 -51.6 60.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -43.44 -16.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 110.879 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.1 m-85 -98.56 0.58 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.867 -1.145 . . . . 0.0 110.105 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.3 t -69.98 131.0 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.63 -30.27 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 110.35 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -151.75 133.3 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.952 -1.093 . . . . 0.0 109.992 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.2 p -123.29 95.51 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.571 ' C ' ' H ' ' A' ' 59' ' ' SER . 13.9 t-20 -163.03 129.1 3.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.972 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 80.7 m-70 50.83 8.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.065 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.571 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.19 144.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.754 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m -87.09 127.18 35.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 109.18 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.78 150.33 42.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.81 0.814 . . . . 0.0 111.046 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mt -126.27 149.71 48.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.23 151.91 23.04 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.193 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -158.04 144.13 17.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -1.092 . . . . 0.0 109.215 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.86 22.04 2.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 109.839 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.14 -33.37 6.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -57.55 141.56 47.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.241 . . . . 0.0 109.153 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -133.89 134.3 42.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.486 -0.758 . . . . 0.0 110.336 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.8 mt -127.05 122.02 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -102.78 156.17 17.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.0 -1.063 . . . . 0.0 111.357 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.1 m 50.31 73.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 179.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m -108.11 -9.22 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 179.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.21 -26.2 67.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.537 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.66 -69.02 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -52.64 -48.02 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.054 -1.029 . . . . 0.0 109.107 179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.1 mt -51.76 -49.19 63.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.0 109.93 -179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 t -60.95 -42.5 98.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.82 -44.87 79.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 108.823 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -67.74 -34.44 76.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -61.92 -36.81 82.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 108.872 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.1 mt -78.86 -38.14 38.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt -80.45 -0.52 37.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.744 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 55.0 40.37 32.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 110.922 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.44 HD13 HG23 ' A' ' 84' ' ' ILE . 45.5 mm -85.82 141.77 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 69.0 p -127.23 -23.18 3.6 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.182 -0.949 . . . . 0.0 111.582 -178.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.59 ' OD1' ' N ' ' A' ' 34' ' ' GLY . 3.4 m-80 -124.33 106.53 10.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.828 -1.17 . . . . 0.0 110.164 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.9 148.27 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.625 0.726 . . . . 0.0 110.295 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.8 m -116.33 114.53 24.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.2 mt -94.97 100.4 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.367 -179.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -73.55 124.72 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.1 t -107.39 126.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.82 0.819 . . . . 0.0 111.583 -178.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 27.7 mt -111.03 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.39 -156.24 25.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -121.68 -10.68 8.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.11 149.25 42.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 0.0 109.564 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.1 mm -73.43 121.33 84.86 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.042 179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.71 124.03 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.76 1.64 . . . . 0.0 111.405 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 tp -81.19 -12.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 mt 56.05 -116.83 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.84 8.13 45.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.012 -1.055 . . . . 0.0 110.743 -178.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.2 65.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 -172.27 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.741 -0.858 . . . . 0.0 109.339 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.96 14.58 8.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.582 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 52.3 t-105 -56.3 -42.8 78.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 3.8 mp0 -64.96 -57.32 9.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 0.0 110.171 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -51.02 -46.2 61.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.223 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.581 ' OH ' ' NH1' ' A' ' 111' ' ' ARG . 89.4 t80 -60.97 -52.35 65.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.669 -0.644 . . . . 0.0 110.884 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.582 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 4.0 mm-40 -62.03 -45.24 94.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.142 -0.974 . . . . 0.0 111.726 -178.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.1 -55.64 17.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.996 -1.065 . . . . 0.0 110.548 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.47 -32.46 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.383 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.581 ' NH1' ' OH ' ' A' ' 107' ' ' TYR . 59.1 ttt85 -63.3 -41.86 98.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.0 109.933 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.475 ' O ' ' ND2' ' A' ' 113' ' ' ASN . 27.6 pttt -77.58 13.37 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 112' ' ' LYS . 1.7 m-80 -143.11 31.32 1.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.898 -1.126 . . . . 0.0 110.79 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.6 mt -79.07 138.79 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.759 -1.213 . . . . 0.0 109.718 179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -129.24 125.32 36.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.32 143.51 35.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.573 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.92 -175.6 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 109.303 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -110.03 67.33 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.633 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.3 ttt85 -162.91 129.55 3.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 109.335 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.96 142.61 52.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.959 -1.088 . . . . 0.0 109.661 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 74.0 mt -88.83 151.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.651 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.42 84.88 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.468 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 70.9 m-85 -61.71 146.69 48.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.517 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -91.63 101.64 14.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -93.63 134.44 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.442 0.639 . . . . 0.0 111.058 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.7 t -73.89 112.93 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.65 -26.94 16.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.277 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.04 150.3 76.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.825 . . . . 0.0 109.278 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.5 149.35 55.78 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.432 2.088 . . . . 0.0 112.037 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.7 tt -152.41 150.65 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 108.965 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.43 141.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.38 146.73 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -135.9 159.22 42.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 109.485 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.57 108.05 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.169 -0.957 . . . . 0.0 110.161 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 48.61 52.94 12.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 110.754 178.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.4 -36.85 3.17 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.484 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.85 126.16 26.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.93 -1.335 . . . . 0.0 108.634 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.71 138.85 38.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 110.138 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 83.6 mt -137.97 130.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.475 -0.766 . . . . 0.0 109.76 179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.465 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 29.5 tttm -119.24 132.1 55.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.689 -0.632 . . . . 0.0 109.887 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.81 133.82 54.43 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.465 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 4.2 pt-20 -145.89 149.11 38.24 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.016 -1.053 . . . . 0.0 109.729 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.0 140.95 9.77 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.561 2.174 . . . . 0.0 113.158 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.57 142.8 20.4 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.97 -7.1 3.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.437 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.9 p -149.91 -174.62 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 109.605 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.8 tp -98.75 123.16 42.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.137 -0.977 . . . . 0.0 108.737 179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -139.28 126.99 21.92 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 108.651 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.6 t -125.24 123.7 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.421 -0.799 . . . . 0.0 109.864 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m -113.8 152.73 30.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.608 -0.682 . . . . 0.0 109.849 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -140.44 131.09 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.854 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 10.1 tt0 -122.47 133.75 54.59 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.99 140.76 10.66 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.482 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 97.56 7.03 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.51 167.36 21.4 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.713 . . . . 0.0 110.673 -178.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.89 25.3 9.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.507 -0.746 . . . . 0.0 111.092 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 157' ' ' ASN . 20.5 p-10 -137.19 -164.66 1.62 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.864 -1.147 . . . . 0.0 109.996 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -56.62 -4.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.429 -0.794 . . . . 0.0 110.968 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.2 mt -76.39 -27.01 56.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.59 -1.319 . . . . 0.0 108.036 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.57 -139.49 39.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.2 136.78 41.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -142.75 154.18 44.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.614 -0.679 . . . . 0.0 109.519 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 148.96 31.52 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -145.37 139.01 26.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -0.841 . . . . 0.0 109.836 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 m -107.1 123.87 48.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.474 -0.767 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -103.17 109.04 20.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.415 ' H ' HD21 ' A' ' 170' ' ' ASN . 2.4 t -100.35 150.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 109.676 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -49.5 128.21 16.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 108.787 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . 0.463 ' N ' ' OE1' ' A' ' 171' ' ' GLU . . . 106.31 0.97 38.06 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.55 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 91.4 m-20 -116.62 20.75 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 109.022 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 170' ' ' ASN . 1.1 pm0 -55.62 -49.08 73.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.396 -0.815 . . . . 0.0 110.205 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -50.27 -22.22 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 110.46 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.71 -7.13 58.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.002 -1.061 . . . . 0.0 111.899 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.5 pt -125.51 -28.16 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.84 -1.163 . . . . 0.0 111.247 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.3 m -61.62 -17.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.593 -1.317 . . . . 0.0 109.022 179.627 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.56 -4.03 55.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.45 -0.781 . . . . 0.0 108.945 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.465 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.29 115.82 8.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.86 . . . . 0.0 108.937 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.525 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 88.5 mtm180 -78.59 172.7 13.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.232 -0.918 . . . . 0.0 109.264 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.536 ' HG1' HN17 ' A' ' 500' ' ' C90 . 6.6 t -79.36 163.3 24.96 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.612 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -147.85 148.78 31.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.141 -1.599 . . . . 0.0 111.666 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -145.65 156.7 43.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.402 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 80.3 m-85 -99.75 144.37 28.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.041 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.444 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.35 -36.04 5.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 110.169 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -75.55 -29.27 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.906 -1.121 . . . . 0.0 110.387 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.7 tt0 -75.23 -29.0 60.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.3 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.9 -47.75 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.297 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.29 -41.56 19.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . 0.42 ' CE1' ' CG1' ' A' ' 192' ' ' VAL . 8.6 t60 -74.82 -52.18 12.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 43.1 mt -48.5 -29.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -85.13 -53.54 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.792 -1.192 . . . . 0.0 109.737 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -49.81 -34.76 20.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.385 -179.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.42 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 15.9 m -85.51 8.87 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.895 -1.128 . . . . 0.0 110.36 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.4 39.71 56.38 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.63 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 46.3 mt -128.47 171.12 12.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -1.177 . . . . 0.0 109.835 179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.19 23.22 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -57.92 -19.65 31.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.598 -1.531 . . . . 0.0 110.031 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.38 3.47 34.85 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.58 125.46 35.41 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.082 -1.246 . . . . 0.0 110.466 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.7 p -147.61 165.24 31.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.373 -1.075 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 24.0 mt -67.85 -8.2 34.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -96.36 -11.91 25.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.793 -0.567 . . . . 0.0 109.702 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.512 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 8.5 p-10 -137.93 8.89 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.046 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 m -147.57 149.08 31.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.071 -1.018 . . . . 0.0 110.006 -179.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.1 tp -99.58 93.79 6.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.22 131.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.86 0.838 . . . . 0.0 109.109 -179.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.23 165.82 16.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.22 -166.38 11.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -58.56 -36.16 73.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -1.072 . . . . 0.0 109.604 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.62 25.44 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.693 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.59 148.92 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.872 -1.142 . . . . 0.0 110.537 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.24 110.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.52 -46.85 73.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.11 -0.993 . . . . 0.0 109.516 -178.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -66.57 117.42 44.17 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.03 -11.13 29.75 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.362 1.375 . . . . 0.0 111.37 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.55 -17.77 61.69 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.376 -0.827 . . . . 0.0 109.031 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.57 -177.73 46.37 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.6 mt -86.58 136.94 32.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -1.227 . . . . 0.0 109.644 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -20.29 65.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.3 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . 0.467 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.8 m-85 -138.31 -164.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.203 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -97.63 -17.02 19.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -138.5 48.52 1.93 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -53.11 -48.29 92.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 109.806 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.1 Cg_exo -48.24 -67.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.14 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.2 m -59.59 -36.61 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 93.2 mtt180 -60.84 -40.52 93.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.975 -1.078 . . . . 0.0 108.411 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 13.8 t60 -67.6 -30.87 70.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.251 -0.906 . . . . 0.0 108.732 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -66.11 -36.86 84.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 57.4 t -67.4 -37.97 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.44 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -63.24 -53.68 49.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.52 -0.737 . . . . 0.0 109.067 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 89.6 m-20 -62.41 -28.77 70.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 110.145 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 33.1 tp -76.76 -34.29 58.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.988 -1.07 . . . . 0.0 108.565 179.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.6 mt -65.29 -38.33 82.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.36 -56.81 10.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.431 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 46.0 m-20 -53.11 -30.95 39.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.203 . . . . 0.0 109.191 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 11.2 mt -65.17 -23.61 67.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 110.339 -179.534 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.63 -22.37 60.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.744 -1.223 . . . . 0.0 108.96 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -49.76 -5.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.373 -1.454 . . . . 0.0 109.974 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -74.51 -15.85 60.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.42 0.31 61.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.293 178.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -167.14 146.95 4.66 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.557 -1.554 . . . . 0.0 110.007 179.471 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.468 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 58.7 Cg_exo -34.66 147.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.699 2.266 . . . . 0.0 111.339 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 83.1 t -115.03 147.76 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.603 -178.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -131.77 124.03 28.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.68 174.99 23.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 13.9 tttt -103.89 142.2 34.82 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.8 m-85 -137.41 138.93 40.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.216 -0.927 . . . . 0.0 109.761 -179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 59.7 t80 -125.69 128.26 47.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -124.7 136.23 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 -177.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -118.96 113.91 21.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 55.13 18.89 2.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.353 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.32 155.41 17.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.65 176.36 20.66 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.5 m-70 -58.9 -37.7 77.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.251 . . . . 0.0 109.534 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -58.27 9.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.319 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.94 -43.24 98.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 18.4 m-20 -47.57 -54.07 12.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 109.417 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.4 -46.38 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.596 -179.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -54.27 -52.08 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.013 -1.054 . . . . 0.0 108.961 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 23.8 tp -50.65 -58.49 5.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 14.0 t -49.27 -52.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.196 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -49.18 -49.19 43.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.761 . . . . 0.0 109.704 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -61.83 -48.2 81.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 109.699 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.0 -47.97 79.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.01 -29.72 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 110.08 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -67.39 -53.89 25.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 -179.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -62.32 -49.22 76.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.0 109.484 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.22 47.69 0.47 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.681 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 269' ' ' LEU . 23.2 tttm -117.98 170.37 8.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.403 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.409 ' H ' ' HG2' ' A' ' 268' ' ' LYS . 1.3 mp . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.542 ' C22' ' OD2' ' A' ' 230' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 mt -99.34 153.73 18.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 109.502 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 34' ' ' GLY . 26.6 mt-10 -53.18 135.19 38.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.173 -0.954 . . . . 0.0 108.783 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 144.55 46.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.618 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -141.86 -169.78 2.99 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.7 m -100.83 137.33 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.324 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.35 -27.96 68.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.695 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.42 158.19 43.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.812 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 141.1 58.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -120.39 165.18 15.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.64 143.11 43.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 110.177 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.0 m-85 -139.82 150.73 45.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -158.65 151.57 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 0.0 109.999 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.85 174.06 36.45 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.73 149.01 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.431 -1.041 . . . . 0.0 110.256 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.46 137.86 16.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.8 tt -59.2 -38.15 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.243 . . . . 0.0 110.272 -179.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.426 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 85.2 m-70 -89.8 -50.63 5.94 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.724 -1.235 . . . . 0.0 111.376 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 p -69.03 -21.62 64.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 111.547 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.56 19.2 26.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -112.41 155.46 24.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.523 -0.987 . . . . 0.0 109.569 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -76.53 134.45 39.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 m -138.36 146.12 41.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.726 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 3.4 ttpp -112.6 157.79 20.77 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.41 -0.806 . . . . 0.0 109.923 -179.347 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 ' N ' ' O ' ' A' ' 13' ' ' PHE . 8.4 mt -136.86 145.14 44.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.457 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -138.74 115.85 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.02 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.62 114.38 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.873 . . . . 0.0 110.994 -178.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.457 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 50.7 m-70 -109.58 138.16 20.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 109.808 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 28.0 Cg_exo -51.99 168.38 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.942 1.761 . . . . 0.0 111.399 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' OE1' ' O ' ' A' ' 30' ' ' PRO . 15.1 mm-40 -142.91 168.97 18.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 110.131 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 35' ' ' THR . 1.6 mttp -76.82 150.76 36.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.464 -0.773 . . . . 0.0 109.72 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -46.92 146.16 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.867 . . . . 0.0 110.209 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.74 6.04 48.7 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.955 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.536 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 28.5 m -68.66 -43.29 76.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.597 -1.531 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.97 178.2 36.25 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.3 mm -96.07 117.23 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.72 149.83 42.67 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.603 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -100.18 158.26 15.98 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -129.61 112.27 13.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 108.624 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -135.64 132.88 37.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.463 -0.773 . . . . 0.0 110.5 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.433 ' N ' HD21 ' A' ' 42' ' ' ASN . 2.8 m120 53.16 31.24 11.09 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 0.0 111.639 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.3 17.8 78.94 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.153 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.6 121.75 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -1.015 . . . . 0.0 109.19 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.6 m-85 -84.19 128.51 34.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mt -117.61 92.64 41.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.26 145.75 14.64 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.462 2.108 . . . . 0.0 111.984 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.99 71.41 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.534 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 6.0 mmt85 -126.23 172.43 10.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.5 p-80 -73.64 -48.67 30.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 110.195 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -43.6 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 0.0 111.25 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 37.4 m-85 -96.92 1.78 50.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.725 -1.234 . . . . 0.0 110.105 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -63.66 123.59 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.043 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 m -106.55 -29.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 109.979 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -154.11 132.49 11.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.049 -1.032 . . . . 0.0 109.805 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.3 p -123.6 95.23 4.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 45.6 t-20 -163.66 129.01 3.0 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.395 -0.815 . . . . 0.0 108.894 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 71.4 m-70 47.76 11.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.065 -1.022 . . . . 0.0 108.973 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.36 141.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.872 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.42 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 34.2 m -90.36 127.76 36.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 109.131 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.71 152.82 38.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.413 -0.805 . . . . 0.0 111.067 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.7 mt -128.44 149.01 50.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.76 156.77 28.76 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 118.886 -1.626 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -163.82 151.47 12.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.026 . . . . 0.0 108.849 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 52.53 23.85 2.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.971 . . . . 0.0 109.375 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.96 -31.25 7.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' CD ' ' N ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -58.3 145.94 36.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -1.17 . . . . 0.0 108.827 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -145.28 140.04 27.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 110.693 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.26 123.08 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB3' ' HZ3' ' A' ' 70' ' ' LYS . 12.8 mtpp -101.43 158.47 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.074 -1.016 . . . . 0.0 111.408 -177.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 m 48.45 72.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.253 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.0 m -107.16 -9.4 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.174 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -60.47 -25.33 65.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 110.025 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.6 m170 -67.33 -68.48 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 109.181 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.14 -47.18 44.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 109.192 179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.9 mt -52.67 -47.57 67.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.948 -1.095 . . . . 0.0 110.1 -179.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.516 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.1 t -61.65 -43.53 98.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.943 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.19 -44.75 80.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.14 -35.25 77.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.284 -0.885 . . . . 0.0 109.208 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -62.39 -33.76 75.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.883 . . . . 0.0 109.269 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.3 mt -82.13 -38.37 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.5 mt -80.74 4.18 19.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.547 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 54.22 39.11 30.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.07 139.38 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.63 ' HG1' HD21 ' A' ' 86' ' ' ASN . 56.6 p -126.02 -20.57 4.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.151 -0.968 . . . . 0.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.63 HD21 ' HG1' ' A' ' 85' ' ' THR . 1.1 m-80 -128.5 108.25 10.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.884 -1.135 . . . . 0.0 111.0 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' A' ' 86' ' ' ASN . 12.7 m -162.76 147.17 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 178.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 17.5 m -112.76 113.74 25.98 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mt -97.7 101.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 110.648 -178.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.93 124.26 25.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 98.5 t -104.94 129.42 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.87 0.843 . . . . 0.0 111.836 -177.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 33.3 mm -111.7 91.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.7 163.6 10.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -84.51 -3.36 58.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.321 . . . . 0.0 110.852 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -140.01 147.09 39.89 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.836 -1.165 . . . . 0.0 110.214 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.0 mm -74.35 122.2 86.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 109.02 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -41.4 127.17 3.09 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.762 1.641 . . . . 0.0 111.394 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -80.18 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.274 -179.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.9 mt 58.74 -122.67 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.067 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -95.07 8.3 43.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.926 . . . . 0.0 110.464 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.85 -3.63 65.16 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.119 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.45 -172.44 2.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.792 -0.828 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.06 14.3 10.38 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.549 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 4.7 t-105 -56.98 -42.15 79.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.18 -57.83 7.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.097 -1.002 . . . . 0.0 110.261 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.43 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.45 -45.93 62.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.356 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -61.22 -53.93 50.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.665 . . . . 0.0 110.905 -179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 1.5 mm-40 -60.99 -43.54 98.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 111.473 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -54.74 20.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.013 -1.054 . . . . 0.0 110.449 -179.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.6 mt -66.43 -32.83 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 109.645 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 113' ' ' ASN . 5.5 ttt180 -63.61 -42.45 98.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.656 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -77.06 15.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.654 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 111' ' ' ARG . 7.0 m-80 -146.31 31.18 1.01 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.659 -179.693 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.9 mt -79.29 138.86 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.776 -1.202 . . . . 0.0 110.328 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.05 120.87 25.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.435 -0.791 . . . . 0.0 109.058 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 142.41 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 0.0 110.148 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -110.37 -170.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 109.48 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.516 ' C ' HD21 ' A' ' 118' ' ' ASN . 0.3 OUTLIER -111.53 67.84 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.232 -0.918 . . . . 0.0 110.588 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -164.01 128.7 2.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.044 -1.035 . . . . 0.0 109.314 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.92 142.59 54.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 37.5 mt -86.79 151.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.841 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.03 79.99 3.27 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -58.08 143.41 43.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.557 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -90.08 101.67 14.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.45 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.639 -0.663 . . . . 0.0 110.902 -177.652 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.12 117.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -97.99 -26.73 14.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.456 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.59 149.66 74.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 149.1 56.48 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.41 2.073 . . . . 0.0 112.096 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 6.5 tt -153.09 149.75 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.03 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.22 143.46 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.94 147.61 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -134.44 161.52 34.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.076 -1.015 . . . . 0.0 110.181 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -168.65 101.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.357 -0.839 . . . . 0.0 109.804 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 47.32 62.54 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.528 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.86 -37.29 3.09 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.578 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -61.03 137.72 58.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.888 -1.36 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -146.96 136.78 23.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.935 -1.103 . . . . 0.0 110.082 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 92.9 mt -136.13 134.48 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.455 -0.778 . . . . 0.0 109.46 179.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 tttp -124.16 131.63 53.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.504 0.669 . . . . 0.0 109.957 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 137.39 54.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.96 155.86 40.59 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.091 -1.006 . . . . 0.0 109.765 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -50.53 142.21 31.43 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.496 2.131 . . . . 0.0 113.421 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -156.69 139.38 15.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.91 -5.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 0.0 110.462 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 p -154.18 -177.54 6.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.884 -1.135 . . . . 0.0 109.72 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.64 120.55 34.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.0 -1.062 . . . . 0.0 109.341 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -134.49 115.7 14.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.94 121.81 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 60.4 m -112.82 152.22 29.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.714 -0.616 . . . . 0.0 109.452 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -139.6 131.06 26.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.138 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -121.47 130.52 53.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.25 139.11 10.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.682 -1.246 . . . . 0.0 111.556 -178.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -104.33 101.9 11.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -88.46 167.42 13.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.852 -178.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -100.69 -12.86 18.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 159' ' ' LEU . 39.9 p-10 -97.77 -170.8 2.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.979 -1.076 . . . . 0.0 110.355 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -52.86 0.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.492 -0.755 . . . . 0.0 112.019 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.545 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 28.5 mt -81.87 -28.03 33.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.241 -1.537 . . . . 0.0 108.772 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.16 -136.97 41.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -97.48 130.69 44.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 109.791 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -132.96 142.91 49.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.4 pttm -138.09 144.03 40.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.406 -0.809 . . . . 0.0 109.826 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . 0.508 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 61.0 t80 -144.99 138.02 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 59.8 m -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.419 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 8.2 t80 -102.8 110.91 23.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.99 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.06 152.14 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.836 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -49.51 124.24 9.07 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.336 -0.853 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 0.75 31.08 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -116.93 21.66 13.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.195 -1.179 . . . . 0.0 109.268 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.585 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -55.44 -52.74 62.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 109.942 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.585 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.8 mt-10 -44.54 -22.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 0.0 110.11 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 171' ' ' GLU . 42.0 mt-10 -86.15 -8.95 57.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 111.753 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.5 pt -123.73 -29.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.801 -1.187 . . . . 0.0 111.225 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.41 -20.75 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.586 -1.321 . . . . 0.0 109.025 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.7 mt -90.31 -1.79 57.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.49 120.44 16.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.031 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.444 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 83.6 mtm180 -84.45 172.6 11.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.487 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.461 ' HG1' HN17 ' A' ' 500' ' ' C90 . 8.9 t -79.21 163.37 25.06 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -148.7 146.01 27.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.303 -1.498 . . . . 0.0 111.628 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.25 157.76 44.11 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 79.5 m-85 -99.19 147.54 25.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.076 -1.015 . . . . 0.0 109.389 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 2.3 p30 -53.27 -33.2 52.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 109.686 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' TRP . . . . . 0.501 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.5 p90 -73.53 -26.36 60.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.906 -1.121 . . . . 0.0 109.55 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.8 mm-40 -77.82 -40.65 39.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.953 . . . . 0.0 109.698 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 76.4 mt -45.69 -51.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.136 -179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -42.65 -45.16 4.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -77.1 -50.93 11.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 109.71 -179.639 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.5 mt -47.37 -32.24 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -85.04 -52.7 5.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.69 -1.256 . . . . 0.0 108.744 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -50.65 -32.16 18.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.331 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.7 m -86.62 6.27 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.941 -1.1 . . . . 0.0 110.116 -179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.49 37.55 40.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 58.6 mt -128.71 171.85 11.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -1.11 . . . . 0.0 109.798 179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.55 22.38 52.11 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.78 -19.42 16.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.661 -1.494 . . . . 0.0 110.521 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.27 5.55 28.49 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.36 125.15 26.18 Favored Glycine 0 N--CA 1.491 2.337 0 O-C-N 121.052 -1.263 . . . . 0.0 110.571 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' SER . . . . . 0.455 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -147.04 169.46 19.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.562 -0.964 . . . . 0.0 109.421 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 35.2 mt -67.97 -8.36 36.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -93.09 -13.05 29.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 23.8 p30 -139.64 10.72 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.041 -1.037 . . . . 0.0 110.33 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -148.06 148.49 30.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.911 -1.118 . . . . 0.0 110.49 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.69 93.41 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 42.1 t -85.88 129.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.036 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.4 mt -124.1 164.18 19.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.635 -0.665 . . . . 0.0 109.625 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.25 -166.24 12.55 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -23.25 65.8 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.639 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -157.02 21.77 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.042 -1.036 . . . . 0.0 111.255 -179.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -147.37 156.04 42.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.529 -1.357 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.87 112.79 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -59.21 -51.16 71.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 110.58 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -59.6 112.71 5.66 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -58.05 -11.07 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.704 1.603 . . . . 0.0 112.162 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -19.03 59.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.237 -179.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.42 -178.04 50.37 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.8 mt -87.88 131.53 34.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -1.126 . . . . 0.0 109.73 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -61.14 -20.97 63.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.833 . . . . 0.0 108.875 179.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -143.43 -173.31 3.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.49 -0.757 . . . . 0.0 109.246 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.05 -16.84 30.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' ASN . . . . . 0.729 HD21 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -134.55 46.25 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.303 -179.952 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.73 -47.11 99.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.751 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 60.2 Cg_exo -50.42 -66.3 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.511 2.141 . . . . 0.0 112.177 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.3 m -60.04 -35.62 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 109.636 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . 0.729 ' HE ' HD21 ' A' ' 221' ' ' ASN . 60.8 mtt-85 -60.91 -40.62 93.85 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.6 t60 -67.89 -31.99 72.17 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.561 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -65.03 -36.0 82.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.54 -34.52 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.265 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.516 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.2 t80 -66.14 -52.49 47.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.44 -27.76 68.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.776 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.2 tp -77.76 -33.99 52.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.107 -0.995 . . . . 0.0 108.591 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.9 mt -67.65 -38.11 79.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -55.37 15.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' ASP . . . . . 0.432 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 9.7 m-20 -55.24 -36.82 66.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.293 . . . . 0.0 109.114 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.27 -24.92 67.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.514 -179.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . 0.6 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -73.95 -21.5 60.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.825 -1.172 . . . . 0.0 109.376 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 93.2 mt -49.16 -4.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.572 -1.33 . . . . 0.0 110.501 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 236' ' ' TYR . 11.1 mt -74.09 -14.36 60.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 109.998 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.402 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 96.53 3.19 59.84 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.989 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.59 152.18 11.76 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.489 . . . . 0.0 109.06 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.33 129.36 34.25 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.706 1.604 . . . . 0.0 109.668 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -89.39 151.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.033 -1.042 . . . . 0.0 112.435 -176.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.64 126.65 31.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.77 -165.55 32.61 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.631 ' N ' ' OG ' ' A' ' 144' ' ' SER . 11.9 tptm -124.55 133.71 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -1.092 . . . . 0.0 108.639 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.2 m-85 -132.25 138.05 47.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -125.77 118.21 25.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -112.49 135.31 53.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 111.023 -178.385 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -117.36 107.73 14.72 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 54.39 31.02 13.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.77 157.56 52.62 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.97 -179.91 16.48 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 54.6 m-70 -60.06 -40.15 88.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -58.88 6.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 12.6 tp -56.68 -44.77 81.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.025 . . . . 0.0 109.283 179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 19.9 m-20 -47.64 -52.09 19.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.933 -1.104 . . . . 0.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 81.4 t -61.54 -45.24 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.07 -49.2 77.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -54.61 -51.2 66.09 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.972 . . . . 0.0 108.779 -179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 11.5 t -57.87 -54.37 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.896 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -48.67 -45.53 38.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.678 . . . . 0.0 109.517 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -64.02 -51.68 63.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.862 . . . . 0.0 109.854 -179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.88 -46.86 71.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.908 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.84 66.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -70.29 -59.86 2.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 110.41 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -28.9 69.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.163 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 267' ' ' GLN . . . . . 0.487 ' C ' ' H ' ' A' ' 269' ' ' LEU . 6.3 tt0 -101.27 42.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.966 -1.084 . . . . 0.0 109.583 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -73.61 15.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.454 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.487 ' H ' ' C ' ' A' ' 267' ' ' GLN . 1.6 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 500' ' ' C90 . . . . . 0.461 HN17 ' HG1' ' A' ' 179' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' HD22 ' A' ' 86' ' ' ASN . 33.1 mt-10 -54.16 139.71 34.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 108.54 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -123.26 145.9 48.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -0.853 . . . . 0.0 110.217 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 t -143.2 -169.76 3.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.588 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.3 m -100.51 137.94 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.915 -1.115 . . . . 0.0 109.092 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.669 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -68.33 -19.42 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.972 . . . . 0.0 109.954 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.5 OUTLIER -152.72 157.47 40.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.08 -1.013 . . . . 0.0 109.705 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 138.67 58.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.161 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.46 166.44 13.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.54 144.3 34.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.898 -1.126 . . . . 0.0 110.396 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 81.2 m-85 -138.23 152.08 48.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 6.8 pt-20 -158.99 150.06 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.956 -1.09 . . . . 0.0 110.146 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.33 174.79 36.76 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.2 151.05 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -1.09 . . . . 0.0 110.058 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.61 140.27 16.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 4.2 tt -59.22 -38.88 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 110.321 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 72.2 m-70 -88.75 -50.1 6.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.629 -1.294 . . . . 0.0 111.183 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 -25.06 64.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 111.819 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.88 14.41 23.28 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.319 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -110.32 157.67 19.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.464 -1.021 . . . . 0.0 109.564 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 77.7 t80 -76.02 135.17 39.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -137.27 143.22 42.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.317 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -112.52 156.93 21.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.417 -0.802 . . . . 0.0 109.952 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.627 HD11 HG23 ' A' ' 96' ' ' ILE . 9.5 mt -136.05 146.42 47.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.52 -0.738 . . . . 0.0 109.82 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.59 106.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 108.691 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -91.64 114.83 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.0 110.979 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -108.79 137.03 19.95 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.523 -0.736 . . . . 0.0 109.544 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.8 Cg_exo -52.27 168.41 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.941 1.761 . . . . 0.0 111.993 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.517 ' HB3' HG21 ' A' ' 35' ' ' THR . 35.3 mm-40 -141.95 173.68 11.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.6 mttt -83.51 154.29 23.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.96 147.57 3.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.102 -0.999 . . . . 0.0 109.783 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 70.31 0.19 28.26 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.819 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 31' ' ' GLU . 53.8 m -66.03 -44.7 83.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.565 -1.55 . . . . 0.0 109.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.34 178.81 31.36 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.743 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -98.96 117.79 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -144.33 155.96 44.04 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.12 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -101.89 158.7 15.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -128.56 111.45 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 0.0 108.718 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -135.62 132.6 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.639 ' ND2' ' OE1' ' A' ' 67' ' ' GLN . 21.8 m-20 55.09 28.25 10.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 111.334 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.85 19.42 73.03 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.773 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.15 121.13 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.537 -0.978 . . . . 0.0 109.217 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 46.2 m-85 -83.1 127.58 33.71 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -0.904 . . . . 0.0 109.05 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.44 90.75 35.74 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.625 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.02 148.78 6.41 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.497 2.131 . . . . 0.0 112.075 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.569 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.68 70.23 10.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.064 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -122.76 170.36 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.49 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.573 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p-80 -72.35 -51.67 19.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.363 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -43.59 -16.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.41 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.5 m-85 -96.47 -0.34 49.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.906 -1.121 . . . . 0.0 110.142 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 76.3 t -68.46 130.75 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 108.72 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.2 -30.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -147.18 127.0 13.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.968 -1.082 . . . . 0.0 109.608 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.876 HG21 HG21 ' A' ' 257' ' ' VAL . 38.6 p -120.56 96.23 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 59' ' ' SER . 8.7 t-20 -160.35 129.01 4.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.036 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 59' ' ' SER . 41.8 m80 48.94 11.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 108.928 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.52 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.75 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 237' ' ' LEU . 46.4 m -86.81 128.03 35.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 109.293 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.06 147.18 45.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.655 0.74 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.546 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.5 mt -121.92 149.55 43.26 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.74 156.49 28.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -163.52 150.88 12.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -1.102 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 50.1 21.64 0.79 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.299 -0.876 . . . . 0.0 109.399 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.85 -34.0 6.12 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.639 ' OE1' ' ND2' ' A' ' 42' ' ' ASN . 76.5 mm-40 -59.04 149.42 27.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.283 . . . . 0.0 109.656 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -143.87 137.61 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 110.809 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.25 124.8 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 13.6 mtpp -102.21 157.82 16.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.073 . . . . 0.0 111.461 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.1 m 50.0 73.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.62 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 62' ' ' LEU . 30.1 m -107.34 -9.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 0.0 108.804 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.4 pm0 -61.2 -26.24 67.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.558 -0.714 . . . . 0.0 110.472 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.3 m170 -69.1 -68.12 0.42 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.966 -1.084 . . . . 0.0 109.312 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.27 -48.83 43.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.294 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 75' ' ' ILE . 20.3 mt -54.16 -46.39 72.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.022 -1.049 . . . . 0.0 110.184 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.414 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 29.4 t -60.72 -42.25 96.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.016 -1.053 . . . . 0.0 109.889 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.77 -44.98 87.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.024 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.9 -34.79 78.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.282 -0.886 . . . . 0.0 109.119 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.458 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 5.1 t-160 -62.31 -38.12 88.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' A' ' 171' ' ' GLU . 58.7 mt -77.11 -38.0 53.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.695 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 82' ' ' LEU . 72.6 mt -83.51 -0.79 51.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 109.703 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 5.3 mp0 56.6 43.22 25.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.814 . . . . 0.0 111.506 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 33.4 mm -87.06 144.86 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.81 -1.182 . . . . 0.0 107.952 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.596 HG21 HG12 ' A' ' 121' ' ' ILE . 43.6 p -130.0 -22.01 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.086 -1.009 . . . . 0.0 111.995 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 87' ' ' VAL . 24.1 m-80 -127.72 107.2 9.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.191 . . . . 0.0 110.607 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.4 m -166.01 152.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.512 0.672 . . . . 0.0 109.861 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.8 m -116.57 113.11 22.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -94.89 100.56 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' HD23 ' A' ' 26' ' ' LEU . 16.5 tt0 -75.33 126.74 31.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.42 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 HD21 ' A' ' 26' ' ' LEU . 39.8 t -110.28 127.31 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.899 0.856 . . . . 0.0 111.913 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mm -109.34 96.88 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.55 -155.14 24.0 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 -8.36 8.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.183 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -141.82 149.64 40.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 109.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 26' ' ' LEU . 42.9 mm -74.11 121.81 86.08 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.969 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -41.17 127.9 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.774 1.649 . . . . 0.0 111.366 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.6 tp -79.42 -11.88 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.516 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 106' ' ' PHE . 70.7 mt 56.07 -121.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.052 -1.03 . . . . 0.0 109.6 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.33 9.14 43.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.001 -1.062 . . . . 0.0 111.056 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.54 -3.47 61.28 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.249 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -128.66 -171.95 2.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.887 . . . . 0.0 109.537 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.34 15.6 10.76 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HB2' HD22 ' A' ' 176' ' ' LEU . 15.7 t-105 -58.78 -42.43 89.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -1.131 . . . . 0.0 110.493 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.03 -58.04 7.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' A' ' 99' ' ' LEU . 7.9 m-85 -51.15 -45.65 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.351 -0.843 . . . . 0.0 109.633 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -60.52 -48.97 79.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.623 -0.673 . . . . 0.0 110.974 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 9.1 mm-40 -67.34 -42.6 83.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.087 -1.008 . . . . 0.0 111.701 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.36 -50.36 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 110.395 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.31 -31.92 51.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.989 -1.069 . . . . 0.0 109.291 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -62.96 -42.1 99.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HG3' HD22 ' A' ' 113' ' ' ASN . 12.0 pttp -77.64 12.74 1.52 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.204 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.669 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 3.9 m-80 -143.86 31.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.883 -1.136 . . . . 0.0 110.457 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.515 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 84.0 mt -79.62 141.3 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.957 -1.089 . . . . 0.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LYS . 22.0 tp -129.92 122.46 28.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -79.23 141.53 37.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.145 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -110.17 -174.59 2.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.504 -0.748 . . . . 0.0 109.595 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.23 68.84 0.68 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 110.678 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -167.16 130.38 1.79 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.91 143.81 55.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.596 HG12 HG21 ' A' ' 85' ' ' THR . 55.2 mt -86.22 149.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.11 78.13 5.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -58.65 142.72 48.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 110.041 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -89.44 101.59 14.26 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.8 t -93.88 134.16 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.461 0.648 . . . . 0.0 111.061 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.57 111.91 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.437 ' C ' ' OE1' ' A' ' 128' ' ' GLU . 81.3 mt-10 -90.35 -27.66 19.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -134.21 154.75 80.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.497 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.76 148.11 45.98 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.551 2.167 . . . . 0.0 112.199 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.0 149.05 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mp -140.3 143.37 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 109.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.38 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -133.05 159.63 39.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.15 -0.969 . . . . 0.0 110.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -175.44 105.94 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 52.11 54.95 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -0.813 . . . . 0.0 110.715 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.19 -31.18 3.19 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.109 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -63.09 135.39 57.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.267 . . . . 0.0 108.52 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -146.03 136.61 24.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.897 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.657 HG21 HD22 ' A' ' 259' ' ' LEU . 96.5 mt -135.41 121.64 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.229 -0.919 . . . . 0.0 109.207 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -112.16 131.82 55.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.487 0.66 . . . . 0.0 109.98 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.15 138.47 54.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.83 153.42 33.45 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 109.524 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -49.19 142.38 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.401 2.067 . . . . 0.0 113.49 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.5 t -154.15 142.44 20.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 146' ' ' THR . 55.8 m-20 -60.59 -4.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.314 -0.866 . . . . 0.0 110.726 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 145' ' ' ASP . 17.4 p -157.96 -171.07 3.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.872 -1.143 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 148' ' ' GLU . 14.9 tp -93.98 120.57 34.41 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.118 -0.989 . . . . 0.0 109.018 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.409 ' N ' HD12 ' A' ' 147' ' ' LEU . 77.1 tt0 -136.77 113.01 9.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.36 122.0 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.9 m -112.91 152.31 29.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.96 131.61 27.26 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.938 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.28 140.26 52.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.64 138.67 8.27 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.969 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.36 99.29 9.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -84.42 167.22 16.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.853 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -100.67 -12.07 19.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.9 p-10 -102.69 -172.63 2.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.934 -1.104 . . . . 0.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -49.18 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.466 -0.771 . . . . 0.0 111.532 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' ASN . 18.3 mt -77.31 -27.19 52.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.379 -1.45 . . . . 0.0 108.311 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.46 -139.18 31.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -97.36 134.07 41.12 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.169 -1.194 . . . . 0.0 109.513 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -141.23 152.86 44.92 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 152.76 32.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.214 -0.929 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 53.8 t80 -148.53 146.53 28.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -110.3 124.57 51.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.516 -0.74 . . . . 0.0 110.468 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.456 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.888 . . . . 0.0 110.012 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 t -109.75 156.26 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -50.65 123.37 8.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.973 . . . . 0.0 109.19 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.475 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 103.92 5.95 43.64 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.453 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 82.8 m-20 -119.75 19.03 12.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.367 -1.078 . . . . 0.0 109.212 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.695 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.9 pm0 -59.8 -43.9 94.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -53.89 -6.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 110.021 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 171' ' ' GLU . 89.3 mt-10 -104.8 -8.96 18.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.348 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 pt -123.85 -27.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.231 -0.918 . . . . 0.0 110.575 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.8 m -62.18 -29.23 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.795 -1.191 . . . . 0.0 108.611 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -77.58 -7.53 56.48 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.403 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.28 119.15 12.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.314 -0.866 . . . . 0.0 109.172 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.511 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 72.8 mtm180 -83.25 172.29 12.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.914 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.3 t -77.06 162.37 27.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -147.65 145.17 28.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.302 -1.499 . . . . 0.0 111.333 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.16 45.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.54 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.6 m-85 -98.72 142.28 30.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 0.0 109.514 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.15 -37.66 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.314 -0.866 . . . . 0.0 109.748 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.0 -27.25 63.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.472 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 7.1 mt-10 -78.61 -40.07 35.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 185' ' ' GLU . 13.2 mt -43.22 -54.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 186' ' ' ILE . 1.0 OUTLIER -43.21 -43.12 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.942 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.75 ' O ' HG22 ' A' ' 192' ' ' VAL . 2.3 t60 -74.27 -50.08 20.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 0.0 109.598 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 56.0 mt -52.08 -28.97 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -85.3 -53.32 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.74 -1.225 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -51.77 -33.68 36.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.6 m -83.07 7.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 0.0 109.819 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.67 39.38 55.87 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 54.4 mt -129.48 171.56 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.204 . . . . 0.0 110.134 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.67 24.0 56.28 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -58.22 -19.33 32.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.67 -1.488 . . . . 0.0 110.387 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.454 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.44 6.51 28.31 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.723 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.32 126.19 27.79 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 120.903 -1.351 . . . . 0.0 110.297 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.58 167.03 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.246 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.5 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 78.5 mt -68.75 -8.59 44.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 108.395 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -98.06 -11.17 23.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.712 -0.618 . . . . 0.0 109.54 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.2 p30 -133.21 7.66 3.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.64 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.43 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.43 149.56 31.94 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.645 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.73 93.99 6.11 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.6 129.06 38.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.779 0.8 . . . . 0.0 109.094 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 211' ' ' VAL . 40.9 mt -123.08 170.87 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.651 -0.656 . . . . 0.0 109.562 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.76 -166.22 11.71 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -64.48 -29.66 70.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -1.148 . . . . 0.0 109.611 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -153.26 24.45 0.54 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 111.061 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -149.17 156.82 42.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.515 -1.366 . . . . 0.0 110.925 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 206' ' ' LEU . 84.6 t -104.67 112.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -57.04 -49.32 76.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.902 -1.123 . . . . 0.0 109.856 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.83 112.26 4.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -57.3 -17.94 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 112.598 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.12 -16.34 60.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.915 -1.116 . . . . 0.0 109.98 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.43 -171.96 50.9 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.645 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.0 mt -91.17 137.3 32.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -1.085 . . . . 0.0 109.674 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -74.41 -16.45 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 108.74 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.99 169.36 17.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 2.1 mm-40 -84.56 3.68 35.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.141 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.519 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -151.38 43.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.186 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -56.24 -47.21 99.31 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.2 Cg_exo -50.57 -68.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.447 2.098 . . . . 0.0 112.193 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.1 m -57.13 -35.3 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.012 -1.055 . . . . 0.0 109.644 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.566 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 76.9 mtt-85 -60.7 -41.24 94.79 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.449 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.0 t60 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.986 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.7 t -67.64 -37.06 78.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.414 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 52.7 t80 -65.33 -50.98 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.051 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.11 -30.53 71.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.3 tp -75.49 -32.8 60.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.034 -1.041 . . . . 0.0 108.579 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.27 -39.66 83.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.7 -56.15 16.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.41 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 49.6 m-20 -54.82 -33.98 62.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 235' ' ' LEU . 7.7 mt -61.18 -24.01 66.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.467 -0.771 . . . . 0.0 110.444 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -72.63 -22.1 61.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.892 -1.13 . . . . 0.0 108.611 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 60' ' ' THR . 63.4 mt -50.78 -2.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.0 110.621 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 260' ' ' VAL . 9.5 mt -76.76 -13.38 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.147 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.01 -0.38 58.97 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.04 155.16 8.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.318 . . . . 0.0 108.814 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.53 150.67 5.62 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.745 1.63 . . . . 0.0 109.6 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 145.54 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.076 -1.015 . . . . 0.0 112.361 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.6 mmmp? -126.25 121.32 32.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.3 -175.55 31.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.556 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 26.9 tttt -114.59 147.47 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.075 . . . . 0.0 109.263 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 6.8 m-85 -142.92 140.48 31.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.56 122.12 34.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -114.7 135.25 54.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 111.112 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -118.52 109.68 16.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 54.15 26.82 6.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.69 158.74 52.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.02 168.14 24.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.41 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 68.5 m-70 -47.19 -41.29 17.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -1.187 . . . . 0.0 109.695 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.27 -57.98 9.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.045 -1.034 . . . . 0.0 109.293 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.546 HD23 HG13 ' A' ' 139' ' ' ILE . 6.4 tp -58.15 -44.82 88.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 256' ' ' ASN . 2.7 m-20 -47.95 -50.48 26.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.057 . . . . 0.0 109.391 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 56' ' ' THR . 99.4 t -63.15 -51.12 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.594 -0.691 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -53.0 -51.32 62.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 109.286 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.657 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -51.57 -57.79 8.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.161 -0.962 . . . . 0.0 108.434 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.6 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.2 t -50.78 -56.23 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 108.899 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -49.04 20.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.525 -0.734 . . . . 0.0 109.398 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.435 ' HB3' HD11 ' A' ' 130' ' ' ILE . 1.8 mm-40 -62.07 -48.27 80.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.36 -50.54 71.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.96 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.44 -27.0 65.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.0 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.908 . . . . 0.0 110.267 -179.276 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.569 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 2.0 mt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -51.76 143.29 13.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.55 146.61 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.091 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.96 -168.82 3.03 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.2 m -99.56 134.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 109.526 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -63.9 -16.73 62.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -152.71 -171.63 3.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.381 -0.824 . . . . 0.0 109.246 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 144.01 25.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 11' ' ' LEU . 43.5 mt -120.97 163.31 18.45 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.44 140.41 46.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.6 m-85 -138.48 148.28 44.16 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.13 152.2 26.05 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.809 -1.182 . . . . 0.0 110.209 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.12 173.24 35.9 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.08 150.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.393 -1.063 . . . . 0.0 110.17 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.58 136.63 15.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.6 tt -60.52 -37.78 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 110.445 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.421 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 46.3 m-70 -90.68 -51.45 5.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.588 -1.32 . . . . 0.0 111.044 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.7 p -70.54 -22.03 62.65 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.6 -0.688 . . . . 0.0 111.232 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.25 21.37 47.11 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.731 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -110.64 153.07 25.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 109.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -74.86 130.13 38.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.46 -0.775 . . . . 0.0 109.562 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 t -135.41 145.86 47.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.235 -0.916 . . . . 0.0 110.057 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -112.0 156.52 22.02 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.416 0.627 . . . . 0.0 109.333 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.586 HD11 HG23 ' A' ' 96' ' ' ILE . 10.8 mt -135.61 144.92 46.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.553 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -140.19 110.22 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 108.79 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.3 113.62 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 111.094 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' HG22 ' A' ' 27' ' ' ILE . 45.4 m-70 -108.32 138.14 20.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.073 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HG3' HG23 ' A' ' 7' ' ' VAL . 20.6 Cg_exo -51.37 167.98 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.853 1.702 . . . . 0.0 112.279 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.2 mm-40 -140.92 176.21 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 35' ' ' THR . 3.5 mtpp -85.31 152.83 22.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.856 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 146.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.925 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.68 6.32 42.44 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.039 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 24.6 m -69.08 -43.7 74.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.631 -1.511 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.55 -175.67 31.82 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.458 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mm -98.45 117.92 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.03 140.7 38.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.57 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -129.11 110.8 12.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.031 -1.043 . . . . 0.0 109.084 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.19 134.14 39.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.32 28.33 7.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.03 75.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.806 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.49 121.19 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -1.012 . . . . 0.0 108.951 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.5 m-85 -84.34 127.11 33.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.6 mt -115.72 92.65 34.63 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -49.66 144.99 18.33 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.2 67.5 7.15 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -122.16 163.79 18.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -65.63 -52.87 48.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 5.4 mm-40 -43.25 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.724 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' HIS . 15.9 m-85 -95.7 1.73 53.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 50' ' ' HIS . 86.8 t -70.58 130.35 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 108.874 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.46 -31.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 109.744 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.7 136.53 17.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.884 HG21 HG21 ' A' ' 257' ' ' VAL . 35.8 p -125.35 96.3 4.77 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.4 t-20 -162.24 129.49 3.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.808 . . . . 0.0 108.949 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.6 m80 51.98 7.9 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.104 -0.998 . . . . 0.0 108.759 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.5 OUTLIER 161.9 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 72' ' ' VAL . 88.0 m -93.88 126.49 39.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 109.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.94 149.02 42.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.612 0.72 . . . . 0.0 110.868 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 72' ' ' VAL . 9.0 mt -124.86 149.07 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.73 153.74 24.43 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.98 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -163.12 148.79 11.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 0.0 109.174 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.89 23.79 4.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.15 -31.72 7.4 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.38 144.55 50.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.235 . . . . 0.0 109.262 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -140.04 139.02 35.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.675 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.3 mt -130.4 123.02 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -101.36 157.33 16.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.95 -1.094 . . . . 0.0 111.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.8 m 49.91 74.57 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.545 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 62' ' ' LEU . 30.5 m -107.65 -9.81 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.938 . . . . 0.0 109.31 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 10.6 pm0 -61.74 -26.09 67.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 110.46 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.0 m170 -66.78 -69.23 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.932 -1.105 . . . . 0.0 109.242 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.02 -48.57 40.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.013 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.589 HD21 ' HB1' ' A' ' 48' ' ' ALA . 14.8 mt -51.55 -49.27 62.34 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.038 -1.039 . . . . 0.0 110.3 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -42.68 96.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.988 -1.07 . . . . 0.0 110.295 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.9 t -56.74 -45.41 82.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.075 -1.015 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.3 -34.69 78.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -61.62 -35.84 79.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 109.035 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 65.1 mt -80.23 -37.65 32.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.257 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.0 9.29 5.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 109.781 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 3.3 mp0 50.2 36.77 13.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.34 136.82 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.034 -1.041 . . . . 0.0 108.282 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.484 HG21 HG12 ' A' ' 121' ' ' ILE . 33.0 p -127.1 -19.81 4.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 111.595 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' VAL . 72.7 m-20 -124.38 107.59 11.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.876 -1.14 . . . . 0.0 110.423 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -163.94 148.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.408 -0.808 . . . . 0.0 110.282 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.8 m -114.69 111.5 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.552 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -95.68 100.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -72.07 127.69 33.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 26' ' ' LEU . 83.3 t -111.9 119.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.937 0.875 . . . . 0.0 111.905 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' ILE . 13.7 mt -109.04 93.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.2 160.4 8.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -7.54 59.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 111.292 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -138.96 147.89 42.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 110.676 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 26' ' ' LEU . 42.0 mm -73.86 125.96 89.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.457 -0.777 . . . . 0.0 108.917 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -44.61 134.2 9.88 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.775 1.65 . . . . 0.0 111.075 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.7 tp -88.17 -14.66 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 110.61 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.7 mt 55.78 -121.98 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -95.82 7.6 45.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.939 -1.101 . . . . 0.0 111.17 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.52 -3.73 63.61 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.281 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.9 p -123.88 -172.65 2.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.724 -0.868 . . . . 0.0 109.556 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.98 10.18 11.14 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 55.5 t-105 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -1.121 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.31 -58.98 6.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.028 -1.045 . . . . 0.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HB3' HG11 ' A' ' 78' ' ' VAL . 11.7 m-85 -51.18 -43.77 61.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.83 0.824 . . . . 0.0 108.885 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.464 ' CE2' ' OE1' ' A' ' 171' ' ' GLU . 56.4 t80 -62.27 -52.19 64.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.663 -0.648 . . . . 0.0 111.18 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.448 ' CG ' ' CZ2' ' A' ' 104' ' ' TRP . 19.5 mm-40 -61.89 -43.2 99.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.956 -1.09 . . . . 0.0 111.195 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.12 2.63 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 110.363 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.44 -35.42 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.635 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 41.8 ttt85 -64.78 -43.55 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.762 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -72.59 10.76 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -145.73 36.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.948 -1.095 . . . . 0.0 110.448 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.7 mt -83.44 139.91 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.98 119.5 23.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 5' ' ' LYS . 2.8 m120 -76.3 143.56 40.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.722 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.19 -175.96 2.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 109.592 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.91 67.99 0.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.235 -0.915 . . . . 0.0 110.514 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -164.93 129.64 2.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.22 140.77 57.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 85' ' ' THR . 37.4 mt -81.47 147.0 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.77 88.78 4.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -0.872 . . . . 0.0 108.657 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.71 143.77 56.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -88.47 102.2 14.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.24 134.12 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.556 -0.715 . . . . 0.0 110.792 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.27 117.22 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 127' ' ' GLU . 7.3 tp10 -89.69 -31.62 17.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.961 -1.087 . . . . 0.0 109.99 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.11 154.28 80.06 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.41 158.39 44.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.557 2.172 . . . . 0.0 112.35 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 tt -165.09 154.67 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.76 147.06 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.96 147.28 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -132.84 161.56 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -173.66 102.17 0.11 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 0.0 109.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.17 59.25 4.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.436 -0.79 . . . . 0.0 111.002 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.02 -35.56 3.25 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.448 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -63.94 131.38 47.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.265 . . . . 0.0 108.89 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -143.3 139.25 30.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 109.999 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 259' ' ' LEU . 68.5 mt -137.29 128.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.387 -0.821 . . . . 0.0 109.876 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -117.94 132.77 56.37 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.514 0.673 . . . . 0.0 110.146 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.83 134.95 54.89 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -146.46 147.68 31.59 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.54 143.52 8.45 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.617 2.211 . . . . 0.0 113.458 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.73 147.38 18.55 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.77 -37.55 82.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.325 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -120.46 -169.86 1.88 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.9 tp -100.08 122.94 43.72 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.36 130.2 36.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.459 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.9 t -128.73 121.45 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.541 ' OG1' HG23 ' A' ' 165' ' ' THR . 21.4 m -112.43 151.99 29.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.594 -0.691 . . . . 0.0 109.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -140.52 131.4 25.98 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.145 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -121.67 125.42 46.61 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.91 138.87 10.7 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.345 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -102.87 103.14 13.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -93.31 167.44 11.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.664 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -103.65 -12.27 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 110.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.2 p-10 -97.88 -167.13 1.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 110.378 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -53.48 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.259 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 157' ' ' ASN . 13.5 mt -85.59 -30.53 23.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.545 -1.347 . . . . 0.0 109.102 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.85 -140.25 38.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 161' ' ' ARG . 11.5 ttp-105 -98.82 135.91 39.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.193 -1.181 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -137.89 149.72 46.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.484 -0.76 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -140.86 143.99 35.05 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -145.47 140.3 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.541 HG23 ' OG1' ' A' ' 150' ' ' THR . 32.2 m -108.14 123.85 49.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.527 -0.733 . . . . 0.0 109.998 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -102.91 111.73 24.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.959 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 44.5 t -99.8 146.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.954 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -48.25 134.21 14.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.29 -0.881 . . . . 0.0 108.987 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.92 -6.0 43.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -114.03 25.61 11.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -1.132 . . . . 0.0 109.27 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.464 ' OE1' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -53.09 -51.69 61.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.429 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -50.56 -21.28 1.47 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.12 -0.988 . . . . 0.0 110.177 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.26 -7.9 59.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 111.619 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.58 -25.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.852 -1.155 . . . . 0.0 111.121 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.9 m -63.7 -24.44 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.438 -1.414 . . . . 0.0 109.005 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.4 mm? -81.66 -5.62 58.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.468 -0.77 . . . . 0.0 108.99 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.404 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.57 115.52 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.173 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.409 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 49.8 mtm180 -79.41 172.51 13.7 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.201 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.4 t -77.86 163.23 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -147.1 144.46 29.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.207 -1.558 . . . . 0.0 111.716 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.01 156.7 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.86 147.29 25.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 109.662 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -52.94 -35.97 59.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.429 -0.794 . . . . 0.0 109.698 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.2 p90 -72.91 -31.44 64.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.578 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.2 mm-40 -75.36 -35.74 61.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.017 -1.052 . . . . 0.0 109.375 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 183' ' ' ASP . 77.1 mt -46.46 -55.61 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 109.786 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -43.8 -42.0 5.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.858 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.0 t60 -74.44 -48.4 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.988 . . . . 0.0 109.046 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.1 mt -51.09 -30.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.336 -0.852 . . . . 0.0 109.302 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -82.35 -52.02 7.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.782 -1.199 . . . . 0.0 109.143 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -47.29 -47.12 25.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.425 -0.797 . . . . 0.0 110.158 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.7 m -74.67 8.17 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.79 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.08 39.9 62.52 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 194' ' ' LEU . 44.8 mt -126.45 170.91 11.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -1.082 . . . . 0.0 109.676 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.8 21.22 58.16 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -57.2 -21.67 35.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.557 -1.555 . . . . 0.0 109.807 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -113.48 25.19 11.38 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.36 127.53 8.4 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.458 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -141.18 169.4 17.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.124 . . . . 0.0 109.519 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 63.5 mt -70.7 -8.64 53.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -97.38 -12.66 22.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.609 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.458 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 17.9 p30 -132.71 8.67 4.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.492 HG22 HG23 ' A' ' 205' ' ' VAL . 1.0 OUTLIER -149.89 149.76 30.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.967 -1.083 . . . . 0.0 110.481 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.548 ' CG ' HD21 ' A' ' 206' ' ' LEU . 32.0 tp -97.45 93.36 6.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 203' ' ' THR . 45.1 t -87.22 130.34 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.554 -0.716 . . . . 0.0 109.152 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.548 HD21 ' CG ' ' A' ' 204' ' ' LEU . 12.5 mt -124.15 166.26 16.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.159 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.08 -166.15 12.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -1.12 . . . . 0.0 109.366 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 209' ' ' ASP . 47.9 t0 -153.9 24.32 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -143.02 150.6 39.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 79.7 t -103.23 113.32 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -58.61 -49.76 76.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.012 -1.055 . . . . 0.0 110.04 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -58.1 111.81 4.03 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.231 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.54 -12.98 12.35 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.541 1.494 . . . . 0.0 111.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -17.54 59.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 110.035 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.7 -173.78 49.29 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 204' ' ' LEU . 6.7 mt -91.02 136.14 33.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -1.209 . . . . 0.0 109.462 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -75.32 -20.12 59.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 108.824 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.43 159.07 42.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.555 -0.716 . . . . 0.0 109.12 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.5 -12.79 61.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.82 51.17 1.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.28 -47.03 99.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 0.0 109.795 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 63.6 Cg_exo -49.9 -67.08 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.453 2.102 . . . . 0.0 112.342 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 m -59.16 -35.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.121 . . . . 0.0 109.571 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -60.66 -41.1 94.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 108.457 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.2 t60 -68.19 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.301 -0.874 . . . . 0.0 108.947 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -64.45 -37.63 88.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.07 -36.11 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.59 -57.37 9.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.532 -0.73 . . . . 0.0 109.137 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -61.58 -26.01 67.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.354 -0.841 . . . . 0.0 109.885 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.7 tp -78.2 -35.08 48.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 0.0 108.69 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.8 mt -66.0 -36.51 77.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.79 -59.76 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 99.4 m-20 -48.09 -36.1 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.274 . . . . 0.0 108.992 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.9 mt -62.83 -22.78 66.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.547 -0.721 . . . . 0.0 110.317 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.27 -22.63 61.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.777 -1.202 . . . . 0.0 108.999 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.36 -3.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.688 -1.257 . . . . 0.0 110.204 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.5 mt -78.87 -16.34 57.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.906 -1.121 . . . . 0.0 109.695 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 2.63 56.37 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.172 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.66 154.54 9.13 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.747 -1.443 . . . . 0.0 109.287 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.16 128.77 31.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.91 1.74 . . . . 0.0 109.682 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 151.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 112.524 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -131.9 124.74 30.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.48 -158.41 27.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -129.08 132.89 47.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -1.155 . . . . 0.0 108.713 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.5 m-85 -131.92 140.09 48.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -126.76 125.34 41.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 m -120.93 135.44 55.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 111.015 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.403 ' C ' ' N ' ' A' ' 251' ' ' GLY . 30.4 t80 -116.1 114.84 25.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 17.38 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.092 -1.005 . . . . 0.0 109.007 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 249' ' ' PHE . . . -55.68 140.89 40.06 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.2 179.45 17.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.7 m-70 -62.21 -42.26 99.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.203 -1.174 . . . . 0.0 109.875 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.0 t -55.62 -58.92 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.07 -1.019 . . . . 0.0 109.572 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 255' ' ' LEU . 12.8 tp -55.99 -44.56 78.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 109.313 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 34.9 m-20 -47.59 -50.77 23.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.965 -1.085 . . . . 0.0 108.962 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 56' ' ' THR . 86.3 t -61.98 -49.55 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.524 -0.735 . . . . 0.0 109.84 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -54.88 -51.93 64.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.029 -1.044 . . . . 0.0 109.311 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 139' ' ' ILE . 51.9 tp -50.06 -52.79 31.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 108.549 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.503 HG13 ' HG ' ' A' ' 238' ' ' LEU . 34.5 t -55.41 -51.45 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 108.746 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -50.16 -47.01 54.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 109.552 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -64.45 -48.95 73.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.957 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 14.9 mt -57.42 -51.81 67.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.44 -27.3 65.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 110.251 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' HZ1' ' A' ' 265' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.445 ' CD ' ' OG1' ' A' ' 85' ' ' THR . 13.5 mm-40 -53.94 137.01 40.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.511 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 143.86 48.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -140.87 -171.96 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.502 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.8 m -97.05 133.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.998 -1.064 . . . . 0.0 109.397 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -64.68 -18.02 64.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.252 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.524 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 16.5 pt-20 -155.99 163.99 39.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.287 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 139.36 51.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 113' ' ' ASN . 11.5 mt -117.45 166.85 11.85 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -140.33 142.97 35.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 110.253 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' LEU . 91.6 m-85 -140.11 151.07 45.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.2 pt-20 -157.12 150.83 24.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.893 -1.129 . . . . 0.0 110.036 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.34 175.42 36.63 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.08 154.47 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -1.107 . . . . 0.0 110.003 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.01 140.15 15.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -59.33 -38.67 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 110.396 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.7 m-70 -89.42 -50.49 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.784 -1.198 . . . . 0.0 111.067 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 p -70.41 -23.08 62.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.634 -0.666 . . . . 0.0 111.758 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.2 15.55 15.57 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.63 153.44 22.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 24.9 t80 -74.38 135.53 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.354 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.2 m -139.7 144.77 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.602 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.9 ttpp -110.95 156.23 21.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -135.53 147.67 48.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.42 -0.8 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.6 mt -143.81 114.11 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 108.882 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mt -98.41 114.61 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.372 -0.83 . . . . 0.0 110.774 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 9.3 m-70 -108.49 138.13 20.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.2 Cg_exo -53.23 168.43 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.81 1.674 . . . . 0.0 111.65 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.497 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 58.9 mm-40 -141.22 177.54 8.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.031 -1.043 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' OG1' ' A' ' 35' ' ' THR . 21.0 mttt -84.48 152.44 23.96 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.692 0.758 . . . . 0.0 110.161 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.16 142.82 2.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.167 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 69.53 10.26 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.258 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 33.5 m -69.98 -42.43 73.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.573 -1.545 . . . . 0.0 109.798 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 178.95 35.58 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.351 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 87' ' ' VAL . 41.0 mm -95.44 116.32 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 7.1 ptm180 -141.14 150.26 42.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 110.582 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.31 157.03 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -128.41 111.82 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 108.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 44.4 tttm -134.68 132.62 39.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.534 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.5 m120 52.58 28.27 5.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.795 . . . . 0.0 111.372 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.07 19.64 69.34 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.187 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.81 122.6 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -1.063 . . . . 0.0 109.174 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.453 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 64.5 m-85 -84.73 127.19 33.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 109.729 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.9 mt -116.96 93.88 43.04 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.386 -0.822 . . . . 0.0 109.386 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.95 149.83 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.637 2.224 . . . . 0.0 112.105 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.05 68.48 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 3.9 mmt85 -123.08 175.69 6.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.276 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.8 p-80 -77.78 -51.65 10.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 110.28 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -43.06 -16.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 110.759 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.0 m-85 -98.11 2.96 49.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 110.295 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 50' ' ' HIS . 74.0 t -70.46 128.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.001 -1.062 . . . . 0.0 108.896 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -31.65 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.131 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -151.52 132.01 13.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.733 HG21 HG21 ' A' ' 257' ' ' VAL . 41.4 p -120.88 96.02 4.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.6 t30 -162.65 128.9 3.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.916 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 51.7 m80 52.72 5.37 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 0.0 109.02 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 165.14 155.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.588 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 72' ' ' VAL . 55.1 m -94.64 126.76 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 109.2 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -119.0 148.02 43.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.507 -0.746 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' HG21 ' A' ' 72' ' ' VAL . 11.0 mt -123.51 149.87 44.65 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.78 157.58 28.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.848 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CD2' ' HD3' ' A' ' 65' ' ' LYS . 8.0 t80 -166.03 143.65 5.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 108.738 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HD3' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 53.36 22.13 2.67 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.31 -32.04 7.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.452 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 80.4 mm-40 -59.81 148.31 34.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.312 . . . . 0.0 109.613 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.52 138.5 30.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 110.53 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.3 mt -129.67 123.89 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -99.93 155.95 17.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 111.259 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.9 m 49.96 74.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.4 m -107.59 -8.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 108.71 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 60' ' ' THR . 14.3 pm0 -60.86 -28.46 68.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 110.623 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.25 -68.76 0.35 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -51.98 -47.56 41.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 75' ' ' ILE . 85.9 mt -52.32 -47.32 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.84 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 48.5 t -61.13 -42.23 98.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.097 -1.002 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.24 -43.41 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.993 -1.067 . . . . 0.0 109.133 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.3 -34.99 78.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.159 -0.963 . . . . 0.0 109.167 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.18 -38.27 90.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.429 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.1 mt -77.59 -38.87 47.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.855 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 82' ' ' LEU . 68.5 mt -81.81 0.08 40.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 109.411 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 55.93 42.72 28.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.645 -0.66 . . . . 0.0 111.365 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.34 145.32 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.782 -1.198 . . . . 0.0 108.192 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.667 HG21 HG12 ' A' ' 121' ' ' ILE . 82.7 p -129.35 -25.61 2.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.0 111.574 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 87' ' ' VAL . 83.2 m-20 -124.26 106.87 10.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.867 -1.146 . . . . 0.0 110.362 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.0 m -164.36 148.49 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.415 -0.803 . . . . 0.0 110.289 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.497 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 88.8 m -115.88 109.38 17.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.475 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -91.71 100.15 10.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 109.859 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -72.17 125.89 28.42 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 26' ' ' LEU . 92.3 t -107.94 123.55 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.707 0.765 . . . . 0.0 111.364 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.602 HD12 ' HB3' ' A' ' 25' ' ' LYS . 91.7 mt -110.25 96.36 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.25 -156.62 25.73 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -119.67 -11.03 9.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -1.149 . . . . 0.0 110.041 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -141.46 149.65 41.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.977 -1.077 . . . . 0.0 109.661 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.658 HG23 HD11 ' A' ' 26' ' ' LEU . 44.3 mm -72.52 119.55 75.66 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.037 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -40.32 119.89 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.778 1.652 . . . . 0.0 111.378 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -76.02 -13.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 110.098 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.7 mt 56.86 -118.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.25 -0.907 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 1.9 t0 -95.31 6.08 49.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.121 -0.987 . . . . 0.0 110.682 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.08 -0.91 60.62 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.52 -172.53 2.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.698 -0.884 . . . . 0.0 109.627 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.92 17.23 10.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.546 ' CE3' HD21 ' A' ' 176' ' ' LEU . 4.3 t-105 -59.57 -43.53 93.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.456 -1.026 . . . . 0.0 110.08 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 -57.87 8.24 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.062 -1.024 . . . . 0.0 109.852 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.47 -46.69 63.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -61.37 -49.3 77.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 7.2 mm-40 -66.0 -43.83 86.6 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.969 -1.082 . . . . 0.0 111.579 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.84 45.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 110.454 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.53 -31.97 56.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.968 -1.082 . . . . 0.0 109.161 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -63.2 -42.38 99.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 7.4 pttp -79.15 10.44 3.56 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.983 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.524 ' ND2' ' OE2' ' A' ' 9' ' ' GLU . 9.6 m-20 -138.23 32.25 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.051 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.55 137.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 110.855 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.28 118.6 21.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.566 -0.708 . . . . 0.0 109.274 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -79.88 145.8 32.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.028 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.22 -170.74 1.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.775 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -109.46 68.97 0.69 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 110.361 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.34 128.6 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.152 -0.967 . . . . 0.0 109.207 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.28 142.51 56.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.0 109.506 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.667 HG12 HG21 ' A' ' 85' ' ' THR . 65.9 mt -84.39 149.33 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.2 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.58 87.68 3.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -66.52 145.36 55.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.184 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -88.22 101.41 13.81 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.88 133.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.456 0.646 . . . . 0.0 111.027 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.51 112.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.22 -30.12 17.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.959 -1.088 . . . . 0.0 110.534 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.42 81.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.86 148.69 41.26 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.562 2.174 . . . . 0.0 112.083 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 tt -156.8 148.93 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -0.833 . . . . 0.0 109.124 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.27 146.23 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.362 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.8 m -132.57 148.93 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.19 161.16 35.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.869 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -170.28 101.94 0.27 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 109.731 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 48.43 58.02 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.38 -35.52 3.31 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.584 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -62.18 136.3 57.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.339 . . . . 0.0 108.778 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.4 tt -144.53 139.1 27.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.863 -1.148 . . . . 0.0 110.062 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.801 HG21 HD22 ' A' ' 259' ' ' LEU . 23.3 mt -137.85 134.02 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.415 -0.803 . . . . 0.0 109.982 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -122.23 132.64 54.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.455 0.645 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.18 53.98 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.85 151.68 42.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 110.143 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.95 141.88 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.583 2.189 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.11 147.62 19.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -36.46 81.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.3 p -121.9 -169.22 1.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.846 . . . . 0.0 109.956 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.0 tp -98.76 123.71 43.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 108.67 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -136.33 128.09 29.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.2 t -128.3 121.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.843 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.7 m -110.84 151.1 28.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.451 -0.781 . . . . 0.0 109.07 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -139.15 130.22 26.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -120.99 131.05 54.07 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.18 140.0 11.31 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.534 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -106.22 101.12 10.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.55 167.15 13.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.935 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -99.14 -15.56 18.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.624 -0.672 . . . . 0.0 110.911 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.1 p-10 -96.09 -168.63 1.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.803 -1.185 . . . . 0.0 110.084 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -55.85 2.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.0 111.446 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.9 mt -77.61 -27.34 51.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.408 -1.433 . . . . 0.0 108.13 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.38 29.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.4 135.64 42.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -1.123 . . . . 0.0 109.339 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -140.82 158.9 43.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.429 -0.794 . . . . 0.0 109.363 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -147.44 146.23 29.48 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.216 -0.927 . . . . 0.0 109.828 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -145.41 140.13 27.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 110.08 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.9 m -108.21 123.54 48.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 110.03 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.49 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.22 115.46 30.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.56 147.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 5.6 mm-40 -48.73 135.04 15.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.196 -0.94 . . . . 0.0 108.897 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.07 -10.23 36.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 0.6 OUTLIER -116.97 25.85 10.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -1.125 . . . . 0.0 109.15 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.5 pm0 -62.45 -15.87 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 176' ' ' LEU . 1.9 tt0 -78.28 -8.11 57.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 110.887 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.564 ' HG2' HG23 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -104.79 -5.07 21.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.993 -1.067 . . . . 0.0 111.302 -178.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 173' ' ' GLU . 41.7 pt -115.65 -30.05 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.192 -0.942 . . . . 0.0 110.355 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 171' ' ' GLU . 10.3 m -60.44 -18.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.017 -1.052 . . . . 0.0 109.25 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.546 HD21 ' CE3' ' A' ' 104' ' ' TRP . 1.4 mp -93.92 0.85 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.008 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.492 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -70.05 117.39 11.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.922 . . . . 0.0 108.774 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 87.4 mtm180 -80.29 171.72 14.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.453 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.1 t -79.04 163.02 25.49 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -148.2 144.55 27.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.269 -1.519 . . . . 0.0 111.565 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.4 157.73 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.511 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.5 m-85 -99.35 146.56 26.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 109.558 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.99 -35.19 23.54 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.352 -0.842 . . . . 0.0 109.647 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.2 p90 -74.83 -30.32 61.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.983 -1.073 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.8 OUTLIER -73.56 -37.53 65.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.922 . . . . 0.0 109.967 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 187' ' ' GLU . 84.2 mt -48.93 -55.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.037 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -41.53 -41.73 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.062 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.6 t-160 -75.62 -47.31 27.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 109.148 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.17 -25.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.845 . . . . 0.0 109.566 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -85.64 -55.19 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.874 -1.141 . . . . 0.0 109.335 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -48.63 -41.74 32.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 188' ' ' HIS . 33.4 m -76.38 7.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.062 -1.024 . . . . 0.0 110.462 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.71 61.48 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.212 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 194' ' ' LEU . 51.3 mt -128.33 171.96 11.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 109.372 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 59.16 21.98 54.57 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -59.99 -21.16 60.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.476 -1.603 . . . . 0.0 108.945 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -108.6 25.62 18.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.41 7.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' THR . 35.7 m -143.94 165.56 27.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -1.114 . . . . 0.0 109.582 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 27.8 mt -66.51 -8.68 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 17.7 ttpt -95.08 -17.2 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 15.8 p30 -132.24 8.75 4.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.64 149.48 31.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.976 -1.077 . . . . 0.0 110.405 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.8 tp -100.61 93.45 5.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 203' ' ' THR . 44.2 t -85.43 131.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.828 0.823 . . . . 0.0 108.914 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' A' ' 211' ' ' VAL . 60.2 mt -123.25 161.7 24.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.556 -0.715 . . . . 0.0 109.464 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.82 -166.23 12.61 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -64.67 -29.55 70.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 110.051 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.28 24.23 0.63 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.999 . . . . 0.0 111.208 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -150.93 159.3 44.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.309 -1.494 . . . . 0.0 110.839 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 206' ' ' LEU . 43.1 t -104.36 111.86 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -54.83 -48.32 72.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.991 -1.068 . . . . 0.0 109.444 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.43 112.22 5.21 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -57.96 -19.84 41.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.823 1.682 . . . . 0.0 112.69 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.53 -15.49 61.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.056 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.67 -175.58 46.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.59 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.2 mt -84.84 144.26 28.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -76.15 -18.06 59.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 108.759 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.84 -170.26 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.191 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.73 -7.33 37.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.114 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.68 48.84 1.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.246 -0.909 . . . . 0.0 109.612 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.95 -45.47 98.94 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.321 -0.862 . . . . 0.0 110.548 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.2 Cg_exo -54.62 -55.7 3.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.329 2.019 . . . . 0.0 112.876 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 17.2 m -68.31 -39.73 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.883 -1.135 . . . . 0.0 111.749 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -68.89 -32.24 71.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.238 -1.539 . . . . 0.0 108.526 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 177' ' ' ALA . 21.8 t60 -66.47 -35.46 80.32 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -64.41 -35.04 79.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 166' ' ' PHE . 79.2 t -66.94 -35.67 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -68.21 -52.24 36.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.76 -30.8 71.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.816 . . . . 0.0 109.642 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.62 -32.44 58.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.135 -0.978 . . . . 0.0 108.755 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.78 -37.35 78.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.82 -55.96 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.555 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -54.36 -35.99 63.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.237 . . . . 0.0 108.936 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.0 mt -60.08 -23.13 63.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.474 -0.766 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.8 -21.77 61.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.043 -1.036 . . . . 0.0 108.659 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 60' ' ' THR . 79.6 mt -49.87 -4.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.641 -1.287 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -76.88 -17.25 59.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.974 -1.078 . . . . 0.0 109.861 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.481 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 100.23 2.17 55.78 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.943 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.47 153.91 10.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.42 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.91 128.54 30.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.013 1.809 . . . . 0.0 110.035 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 t -86.95 152.01 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 112.217 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -135.79 127.67 29.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.76 -158.37 27.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.486 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.4 ttmt -127.29 140.73 52.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 109.137 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.4 m-85 -138.91 140.69 38.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.059 -1.025 . . . . 0.0 110.394 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -124.3 132.58 53.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -129.59 136.1 49.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.062 . . . . 0.0 111.154 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 250' ' ' ARG . 39.3 t80 -117.33 116.81 27.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.1 mtt-85 45.03 48.16 9.53 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.055 -1.028 . . . . 0.0 108.516 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.29 143.94 24.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -124.33 160.96 18.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.404 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 76.6 m-70 -46.4 -36.34 6.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -1.22 . . . . 0.0 109.492 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -58.11 9.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 108.986 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.5 tp -59.14 -44.21 92.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 0.0 109.239 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.3 m-20 -47.63 -54.31 12.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.555 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.733 HG21 HG21 ' A' ' 56' ' ' THR . 74.9 t -61.0 -56.84 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.424 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.533 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -44.53 -49.68 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.96 . . . . 0.0 108.93 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.801 HD22 HG21 ' A' ' 139' ' ' ILE . 24.5 tp -54.09 -61.59 2.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.896 -1.128 . . . . 0.0 108.605 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 238' ' ' LEU . 23.8 t -47.2 -54.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -47.2 -52.83 14.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.345 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -59.1 -49.92 76.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.782 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 16.0 mt -53.15 -52.86 57.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.59 66.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.213 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.505 ' CD ' HD22 ' A' ' 86' ' ' ASN . 76.1 mt-10 -57.55 138.62 55.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.296 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 145.39 48.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.487 -0.758 . . . . 0.0 109.541 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -141.37 -173.95 3.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.9 m -96.19 135.69 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 0.0 109.212 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -66.49 -23.0 66.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.482 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 9.9 pt-20 -150.83 156.08 40.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 142.09 58.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 110.249 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -119.73 163.35 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 p -134.55 142.0 46.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.0 110.183 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 26' ' ' LEU . 96.8 m-85 -139.21 146.32 40.35 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -153.06 150.63 29.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.354 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.16 174.79 36.65 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.5 p -84.06 154.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.254 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -88.81 139.94 15.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.2 tt -60.82 -37.0 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -1.168 . . . . 0.0 110.558 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.579 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 78.0 m-70 -89.58 -51.72 5.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.631 -1.293 . . . . 0.0 111.396 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 p -70.0 -23.25 63.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.701 -0.624 . . . . 0.0 111.653 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.78 20.14 46.34 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.182 -1.485 . . . . 0.0 109.6 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -111.83 154.03 25.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -1.118 . . . . 0.0 109.563 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.24 135.59 42.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.169 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.3 m -139.37 144.52 38.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.03 . . . . 0.0 109.845 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.96 155.7 23.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.448 -0.782 . . . . 0.0 109.668 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.667 HD11 HG23 ' A' ' 96' ' ' ILE . 8.6 mt -135.74 148.26 48.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.58 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.9 mt -143.58 112.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 108.928 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.86 114.91 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.42 -0.8 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.58 ' NE2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -107.83 139.17 20.36 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 26.8 Cg_exo -52.82 168.23 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.849 1.699 . . . . 0.0 111.822 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' OE1' HG21 ' A' ' 35' ' ' THR . 20.1 mm-40 -142.23 174.74 10.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.541 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -85.91 155.11 21.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -49.62 146.95 3.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.961 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 71.03 -0.54 29.72 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.978 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.8 m -65.43 -42.39 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.556 -1.555 . . . . 0.0 109.481 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.6 -177.36 37.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mm -99.52 115.31 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -137.5 151.5 48.51 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.993 -1.067 . . . . 0.0 110.498 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.17 157.57 16.48 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -129.99 110.69 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.853 . . . . 0.0 108.995 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -134.69 133.81 40.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.596 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 48.38 34.31 4.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.59 -0.694 . . . . 0.0 111.59 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 17.04 80.26 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.472 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.89 120.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.105 . . . . 0.0 108.836 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 39.8 m-85 -86.84 129.14 35.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.187 -0.946 . . . . 0.0 109.734 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.43 96.97 50.48 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.647 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.25 146.43 31.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.229 1.953 . . . . 0.0 111.623 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -78.97 70.28 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.982 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 49' ' ' ARG . 6.7 mtt-85 -127.22 171.55 11.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 0.0 109.003 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -73.25 -49.17 29.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.591 ' OE1' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mp0 -43.53 -17.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.889 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.4 m-85 -97.89 2.96 49.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.208 . . . . 0.0 109.938 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 50' ' ' HIS . 66.9 t -74.06 129.07 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.372 -0.83 . . . . 0.0 108.781 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.74 -25.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.885 . . . . 0.0 110.281 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 t-80 -150.37 130.02 13.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.692 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.734 HG21 HG21 ' A' ' 257' ' ' VAL . 34.3 p -123.79 96.04 4.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 49.3 t30 -158.42 128.49 5.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 42.1 m80 46.54 13.12 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.89 152.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.796 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.8 m -96.24 128.16 42.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 55' ' ' HIS . 0.9 OUTLIER -120.28 148.67 43.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.652 0.739 . . . . 0.0 110.878 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 72' ' ' VAL . 10.8 mt -125.54 146.81 49.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.84 151.12 22.06 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.01 -1.567 . . . . 0.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -160.0 148.89 17.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.981 . . . . 0.0 109.145 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.09 26.39 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.858 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.53 -32.5 6.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 9.0 mm-40 -57.38 140.25 50.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.149 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 134.09 40.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.849 . . . . 0.0 110.305 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.53 120.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -100.94 157.11 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.046 . . . . 0.0 111.119 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.0 m 48.97 75.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 62' ' ' LEU . 22.7 m -107.72 -10.56 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 109.318 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.0 pm0 -60.79 -24.3 65.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.556 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.414 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -68.68 -68.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.126 -0.984 . . . . 0.0 109.232 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.1 tp -52.1 -48.11 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.7 mt -52.79 -46.92 67.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 22.5 t -61.91 -43.24 99.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.432 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.82 -46.76 83.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.021 -1.05 . . . . 0.0 109.071 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.39 -34.42 78.26 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -63.29 -34.78 78.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.631 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 171' ' ' GLU . 59.3 mt -81.6 -38.82 25.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 110.289 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 82' ' ' LEU . 63.7 mt -81.13 -0.39 39.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 0.0 110.005 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 61.53 39.84 14.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 111.383 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.81 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.698 -1.251 . . . . 0.0 108.026 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -123.73 -24.1 4.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 0.0 111.792 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.708 ' O ' HG13 ' A' ' 87' ' ' VAL . 45.0 m-80 -123.84 107.18 11.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.917 -1.115 . . . . 0.0 110.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -164.35 148.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 110.468 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 99.3 m -115.54 113.04 23.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.481 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -95.36 100.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.184 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' O ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -73.6 126.73 30.95 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.54 128.21 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.98 0.895 . . . . 0.0 111.895 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.81 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.11 -159.78 27.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 -11.3 10.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.25 149.88 41.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.995 -1.066 . . . . 0.0 109.535 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.667 HG23 HD11 ' A' ' 26' ' ' LEU . 43.9 mm -72.96 120.93 83.56 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -40.51 120.45 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.782 1.655 . . . . 0.0 111.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.8 tp -76.62 -14.21 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.913 . . . . 0.0 110.476 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 mt 56.84 -118.43 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.029 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.86 6.75 47.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.23 59.48 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 p -128.76 -172.25 2.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.666 -0.902 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.3 15.2 9.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 2.7 t-105 -57.59 -42.44 83.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.272 -1.134 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.11 -57.2 9.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 110.122 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.42 -46.33 62.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.09 -54.08 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 0.0 110.821 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 2.9 mm-40 -60.44 -43.76 96.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.02 . . . . 0.0 111.53 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.67 -56.91 8.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.252 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.73 -32.83 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.158 -0.963 . . . . 0.0 109.383 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER -64.18 -42.72 96.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.6 13.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 110.041 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' OE2' ' A' ' 9' ' ' GLU . 15.7 m-80 -144.58 33.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 0.0 110.336 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 82' ' ' LEU . 66.2 mt -79.81 138.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.28 123.35 29.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.23 148.3 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.476 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 21.6 mt-30 -115.62 -171.82 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -111.67 69.0 0.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -165.32 130.92 2.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.003 -1.061 . . . . 0.0 109.691 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.53 144.46 53.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.528 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.16 149.37 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.568 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -93.09 78.17 4.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.4 m-85 -58.1 140.67 52.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 109.409 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -88.87 101.44 14.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 243' ' ' LYS . 41.0 t -92.68 134.3 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.528 0.68 . . . . 0.0 110.772 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.52 116.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.42 -27.01 16.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.528 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -130.74 149.76 74.53 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.15 150.0 41.91 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.589 2.192 . . . . 0.0 112.017 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 tt -157.37 151.01 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 142.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 0.0 109.513 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.93 145.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -133.25 156.72 47.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.002 . . . . 0.0 110.459 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -166.04 98.91 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.485 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 46.02 65.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 110.848 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.2 -38.02 3.0 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.89 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.9 mtt85 -65.44 133.67 51.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.862 -1.375 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.734 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.7 tt -146.58 138.92 24.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.053 -1.029 . . . . 0.0 109.973 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 255' ' ' LEU . 69.2 mt -135.57 125.87 42.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.458 -0.776 . . . . 0.0 109.523 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -114.3 133.44 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.532 0.682 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.29 133.61 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.08 151.56 48.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.787 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -50.14 143.23 25.94 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.382 2.055 . . . . 0.0 113.392 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.41 145.78 20.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -68.61 -5.01 17.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 110.488 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 p -148.45 -175.24 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.069 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.2 tp -98.32 120.06 38.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.084 -1.01 . . . . 0.0 108.702 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.404 ' N ' HD12 ' A' ' 147' ' ' LEU . 38.4 tt0 -137.27 122.84 19.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 108.553 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 231' ' ' LEU . 76.7 t -122.37 122.58 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.723 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -113.52 152.22 30.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -139.64 130.47 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.964 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.56 129.95 54.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.53 141.2 12.52 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.266 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -105.64 104.11 13.77 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -93.65 166.95 11.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -14.89 17.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.734 . . . . 0.0 110.485 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 159' ' ' LEU . 29.9 p-10 -93.96 -171.38 2.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.869 -1.144 . . . . 0.0 110.265 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -52.91 3.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.449 -0.782 . . . . 0.0 111.704 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.9 mt -83.35 -29.36 28.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.321 -1.487 . . . . 0.0 109.06 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.43 -140.67 36.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 134.41 38.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -1.145 . . . . 0.0 109.491 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -138.03 148.72 45.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.296 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -141.26 145.05 35.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.934 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -144.63 139.34 27.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.7 m -109.78 124.63 51.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 110.156 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.537 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.5 t80 -104.08 113.07 26.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.273 -0.892 . . . . 0.0 109.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.53 156.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -50.86 133.12 26.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.266 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.83 3.76 60.62 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 170' ' ' ASN . 3.4 m-20 -117.53 20.25 13.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 109.153 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -55.89 -56.57 18.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.291 -0.881 . . . . 0.0 110.017 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 171' ' ' GLU . 1.8 mt-10 -42.52 -25.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.545 ' O ' ' CZ ' ' A' ' 225' ' ' ARG . 12.5 mt-10 -80.74 -7.85 59.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 111.924 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.74 -25.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.663 -1.273 . . . . 0.0 111.817 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 175' ' ' VAL . 4.5 m -62.77 -15.88 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.456 -1.403 . . . . 0.0 109.175 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.4 mt -92.27 -6.43 50.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.46 -0.775 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.448 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -67.43 116.19 7.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.173 -0.954 . . . . 0.0 108.847 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.507 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 74.5 mtm180 -77.57 172.84 12.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.516 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 t -77.25 162.28 27.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -146.81 149.07 32.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.21 -1.556 . . . . 0.0 111.493 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.06 43.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -98.97 146.97 25.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.537 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.11 -38.11 16.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.488 -0.757 . . . . 0.0 109.86 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -72.29 -28.9 63.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.827 -1.171 . . . . 0.0 109.605 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.0 mt-10 -71.93 -39.9 69.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.638 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 25.6 mt -47.37 -59.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.553 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 7.7 tp10 -41.81 -40.02 1.94 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.514 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 189' ' ' ILE . 13.3 t-160 -75.28 -60.89 2.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 108.887 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 188' ' ' HIS . 93.7 mt -41.85 -32.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.625 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -80.13 -52.07 8.22 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.764 -1.21 . . . . 0.0 109.193 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -48.17 -40.05 22.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 110.518 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.0 8.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.036 . . . . 0.0 110.522 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.74 39.65 54.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 194' ' ' LEU . 69.3 mt -129.64 172.81 11.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -1.111 . . . . 0.0 109.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.65 20.57 56.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -57.56 -20.55 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.365 -1.668 . . . . 0.0 109.878 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.431 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.55 25.18 11.33 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.22 129.38 9.64 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.99 -1.3 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -143.88 172.75 12.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 109.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.9 mt -71.26 -7.8 49.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -99.35 -11.54 21.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.442 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 17.0 p30 -133.53 8.49 3.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 109.999 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.1 m -150.28 151.52 33.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.0 tp -99.5 93.93 6.14 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -85.34 128.96 38.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.832 0.825 . . . . 0.0 109.119 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 211' ' ' VAL . 15.6 mt -123.53 162.81 22.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.615 -0.678 . . . . 0.0 109.289 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.33 -166.73 13.03 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.77 71.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.491 -1.005 . . . . 0.0 109.458 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.83 21.66 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -147.58 155.88 42.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.64 -1.287 . . . . 0.0 110.355 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 206' ' ' LEU . 51.3 t -105.82 114.56 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -57.97 -47.02 84.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.046 -1.034 . . . . 0.0 109.904 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.86 121.83 61.12 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.139 -0.976 . . . . 0.0 109.768 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.87 -16.22 45.29 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.437 1.424 . . . . 0.0 111.794 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -15.12 59.54 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.63 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.47 -170.32 50.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.617 ' CD2' HD11 ' A' ' 204' ' ' LEU . 6.3 mt -86.78 131.12 34.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -1.213 . . . . 0.0 109.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -63.15 -17.78 62.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.122 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CD2' ' CZ ' ' A' ' 225' ' ' ARG . 62.3 m-85 -144.73 -168.88 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -100.65 -0.24 37.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.247 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 30.49 1.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.034 -1.041 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 mt-10 -46.26 -51.17 35.35 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.026 -1.047 . . . . 0.0 110.013 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 76.4 Cg_exo -47.4 -68.01 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.118 1.878 . . . . 0.0 112.278 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.4 m -57.33 -34.84 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.963 -1.086 . . . . 0.0 109.991 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' CZ ' ' CD2' ' A' ' 219' ' ' TYR . 5.0 mtp180 -60.53 -42.85 97.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 108.381 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 6.9 t60 -65.78 -33.02 74.9 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.88 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 166' ' ' PHE . 51.9 t -69.75 -36.77 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.531 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.4 t80 -65.98 -48.82 69.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.562 -0.711 . . . . 0.0 109.147 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -65.0 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.804 . . . . 0.0 109.776 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.412 HD23 ' CG1' ' A' ' 149' ' ' VAL . 52.5 tp -75.02 -31.77 61.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.84 -39.37 81.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.95 -54.79 19.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.36 -35.62 67.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.055 -1.262 . . . . 0.0 109.279 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 235' ' ' LEU . 12.1 mt -61.11 -22.79 64.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 110.414 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.8 -22.28 60.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.164 . . . . 0.0 109.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.9 mt -50.93 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.639 -1.288 . . . . 0.0 110.6 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.2 mt -77.46 -14.85 59.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.831 -1.168 . . . . 0.0 109.643 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.78 57.67 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.563 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.16 155.07 10.23 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.374 . . . . 0.0 108.937 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.1 Cg_endo -50.02 151.02 9.25 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.825 1.684 . . . . 0.0 109.566 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.43 140.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 112.044 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.493 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.3 mmtp -121.86 119.12 30.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.9 -163.56 30.95 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.142 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.514 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -123.77 141.64 51.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -1.032 . . . . 0.0 109.078 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -139.6 139.64 36.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -127.02 118.38 24.35 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 133.83 53.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.005 -1.059 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -115.47 112.16 21.84 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.36 28.68 2.44 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.61 149.13 42.99 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -121.78 -174.2 14.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.463 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.2 m-70 -63.74 -41.38 98.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.094 . . . . 0.0 109.741 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -58.63 6.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.032 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.532 HD23 HG13 ' A' ' 139' ' ' ILE . 5.7 tp -55.29 -45.07 76.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.202 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 22.2 m-20 -47.73 -51.56 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.432 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.734 HG21 HG21 ' A' ' 56' ' ' THR . 90.8 t -63.18 -42.27 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -61.41 -52.86 62.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -50.34 -49.63 53.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.091 -1.006 . . . . 0.0 108.423 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.54 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.1 t -58.03 -52.18 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -50.76 -49.52 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -61.54 -51.24 69.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.791 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.98 -48.45 75.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 109.738 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.34 71.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 109.801 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 108.954 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 121' ' ' ILE . 84.2 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.288 0.566 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.596 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -53.18 129.02 29.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -120.91 142.07 50.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.182 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 t -141.94 -170.57 3.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.66 136.45 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -62.85 -20.48 65.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -152.15 -171.12 3.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.222 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 142.14 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.09 160.23 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.14 145.2 41.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.996 -1.065 . . . . 0.0 110.698 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 73.3 m-85 -139.83 155.09 47.43 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.05 151.69 19.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.809 -1.182 . . . . 0.0 110.319 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.43 174.77 36.1 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.85 151.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 110.128 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.63 137.98 16.38 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.0 tt -58.95 -39.06 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.105 -1.232 . . . . 0.0 110.452 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' ILE . 79.8 m-70 -90.74 -50.65 5.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.724 -1.235 . . . . 0.0 110.966 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -70.31 -22.68 62.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.68 -0.638 . . . . 0.0 111.091 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.75 17.48 21.22 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.686 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -105.26 151.25 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -1.151 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -74.77 132.87 41.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.177 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 145.31 40.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 5.7 ttmt -113.02 156.42 23.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -133.4 147.01 51.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.594 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.2 mt -141.38 108.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.917 . . . . 0.0 108.738 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.25 115.44 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 111.122 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.594 ' NE2' HG22 ' A' ' 27' ' ' ILE . 33.3 m-70 -111.12 139.81 22.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.578 -0.701 . . . . 0.0 109.689 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -52.57 168.33 0.46 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.048 1.832 . . . . 0.0 111.854 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 16.4 mm-40 -141.02 -178.97 5.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.162 -0.961 . . . . 0.0 109.798 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.6 mttm -89.45 154.4 20.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -47.62 142.46 4.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.329 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.11 11.22 63.44 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.466 -0.874 . . . . 0.0 110.949 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -72.02 -44.87 62.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.605 -1.526 . . . . 0.0 109.752 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -179.88 33.77 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.379 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mm -95.67 117.97 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 148.24 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.86 158.87 15.5 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -129.9 110.58 11.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 0.0 108.874 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' NZ ' ' H ' ' A' ' 93' ' ' GLY . 64.6 tttp -135.06 134.6 40.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 110.737 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.05 29.52 10.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.784 . . . . 0.0 111.341 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.56 17.27 77.94 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.355 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -1.126 . . . . 0.0 109.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -83.66 127.36 33.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.0 mt -115.48 93.81 37.76 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 109.436 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.55 145.8 16.07 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.412 2.075 . . . . 0.0 111.948 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -89.38 79.76 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -134.18 -179.89 5.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -74.99 -55.25 5.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 110.01 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 33.4 mt-10 -43.55 -17.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.795 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' HIS . 35.5 m-85 -95.17 0.62 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.884 -1.135 . . . . 0.0 110.104 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.8 t -68.48 129.46 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.415 -0.803 . . . . 0.0 109.173 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -112.38 -29.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.322 -0.861 . . . . 0.0 109.977 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -152.26 132.98 14.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.036 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 HG21 ' A' ' 257' ' ' VAL . 47.8 p -123.65 95.46 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 59' ' ' SER . 47.7 t-20 -162.95 129.21 3.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 108.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 84.6 m-70 48.97 10.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.056 -1.027 . . . . 0.0 108.711 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 163.0 157.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.9 m -102.86 127.76 49.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -121.33 152.37 39.05 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 111.024 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.9 mt -128.14 152.18 48.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.31 151.86 21.96 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 118.824 -1.655 . . . . 0.0 110.956 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CD2' ' CD ' ' A' ' 65' ' ' LYS . 9.4 t80 -156.51 146.29 20.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -1.03 . . . . 0.0 109.676 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CD ' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 54.73 21.79 3.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.528 -0.732 . . . . 0.0 109.638 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.88 8.17 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -62.96 145.24 55.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.318 . . . . 0.0 109.343 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.91 142.86 34.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 110.333 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.13 125.94 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -100.21 156.67 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.081 . . . . 0.0 111.217 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m 49.27 73.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.071 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 34.4 m -107.78 -8.46 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 108.957 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.4 pm0 -61.02 -26.66 67.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.599 -0.688 . . . . 0.0 110.539 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.1 m170 -68.07 -68.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.941 -1.099 . . . . 0.0 109.46 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -52.14 -47.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.605 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.2 mt -53.4 -48.33 68.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.461 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.6 t -59.66 -41.99 91.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.058 -1.026 . . . . 0.0 110.244 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.8 -44.02 89.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 109.168 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.29 -34.92 79.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -62.91 -38.88 92.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 171' ' ' GLU . 50.2 mt -75.72 -38.07 58.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 114' ' ' ILE . 80.7 mt -83.22 -1.46 53.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.978 . . . . 0.0 109.891 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 41.5 mt-10 55.75 42.24 29.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.385 -0.822 . . . . 0.0 111.121 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 5' ' ' LYS . 46.0 mm -84.87 141.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.946 -1.096 . . . . 0.0 108.096 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 121' ' ' ILE . 72.5 p -123.79 -23.71 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 0.0 112.027 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.675 ' O ' HG13 ' A' ' 87' ' ' VAL . 80.4 m-20 -125.98 107.66 10.66 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.698 -1.251 . . . . 0.0 110.688 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.5 m -162.95 149.14 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.829 0.824 . . . . 0.0 110.442 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 45.2 m -116.71 113.77 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.497 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.7 mt -96.65 100.92 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.467 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 11.7 mt-10 -70.24 124.57 24.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 44.2 t -107.96 119.0 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.587 0.708 . . . . 0.0 111.507 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mt -108.85 93.38 2.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' H ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.63 160.52 8.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -81.05 -5.55 57.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.914 -1.345 . . . . 0.0 111.091 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -142.06 149.11 39.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.602 -1.311 . . . . 0.0 110.276 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 26' ' ' LEU . 46.4 mm -73.89 121.82 86.1 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -41.52 127.81 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.585 1.523 . . . . 0.0 111.282 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.408 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -81.76 -15.94 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.879 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.8 mt 58.1 -120.62 1.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.12 -0.988 . . . . 0.0 110.081 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 46.4 t0 -97.49 5.81 49.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.62 60.11 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.384 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.4 p -127.86 -172.62 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.896 . . . . 0.0 109.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.1 15.83 10.14 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.533 ' HB2' HD22 ' A' ' 176' ' ' LEU . 6.1 t-105 -60.26 -43.56 96.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.48 -1.012 . . . . 0.0 110.317 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.71 -58.59 6.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.024 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.29 -45.16 62.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -61.9 -49.29 76.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 111.22 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CD ' ' CH2' ' A' ' 104' ' ' TRP . 1.6 mm-40 -65.5 -42.36 92.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.019 -1.05 . . . . 0.0 111.236 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.92 -54.2 24.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.017 -1.052 . . . . 0.0 110.286 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.29 -32.56 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -64.42 -42.55 95.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -76.16 12.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.74 32.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.165 . . . . 0.0 110.545 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 HD22 ' A' ' 82' ' ' LEU . 77.5 mt -80.32 138.96 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.932 -1.105 . . . . 0.0 110.265 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.52 125.53 34.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.546 -0.721 . . . . 0.0 109.157 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -78.27 145.42 35.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.352 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -115.06 -173.53 2.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.688 -0.632 . . . . 0.0 109.404 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.55 65.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.293 -0.879 . . . . 0.0 111.268 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.502 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -161.49 129.31 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 0.0 109.043 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -68.38 141.1 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 109.163 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 3' ' ' LEU . 85.4 mt -82.16 147.77 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 110.427 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -95.66 84.12 3.88 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 55.1 m-85 -62.82 143.93 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -90.43 101.96 14.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 243' ' ' LYS . 55.1 t -93.05 133.62 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.699 . . . . 0.0 111.193 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.47 115.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -98.78 -26.81 14.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 110.576 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.02 148.43 65.72 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.36 148.35 38.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.493 2.129 . . . . 0.0 111.899 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.29 152.27 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.957 . . . . 0.0 109.363 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.83 146.45 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.212 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.18 147.09 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -135.19 162.63 31.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.984 -1.072 . . . . 0.0 110.515 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -173.9 103.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 50.58 58.66 5.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 110.725 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.44 -32.59 2.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.517 HH21 ' H ' ' A' ' 252' ' ' GLY . 42.7 mtp180 -61.91 134.12 56.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.245 . . . . 0.0 108.26 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -146.1 137.79 24.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.77 -1.206 . . . . 0.0 110.446 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.727 HG21 HD22 ' A' ' 259' ' ' LEU . 79.6 mt -135.62 131.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.476 -0.765 . . . . 0.0 109.353 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -121.37 131.09 53.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.369 0.604 . . . . 0.0 109.839 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.88 134.62 54.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 151.07 47.31 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.131 -0.981 . . . . 0.0 109.659 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.71 143.27 12.87 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.481 2.121 . . . . 0.0 113.22 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.407 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -157.32 147.08 20.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.61 -6.6 26.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -148.66 178.68 8.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.942 -1.098 . . . . 0.0 109.741 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.4 tp -91.98 120.8 32.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.996 . . . . 0.0 108.709 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 167' ' ' VAL . 2.0 tt0 -135.73 129.72 33.07 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.4 t -129.87 120.73 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.507 ' OG1' HG23 ' A' ' 165' ' ' THR . 47.6 m -112.3 152.29 28.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.461 -0.774 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 228' ' ' VAL . 38.8 t80 -139.46 130.74 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.176 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.444 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 23.2 tt0 -120.84 130.36 53.92 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.22 137.79 9.57 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.465 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -103.06 100.14 10.06 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.21 166.93 13.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.008 . . . . 0.0 110.833 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -99.67 -18.56 17.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.563 -0.711 . . . . 0.0 110.652 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.4 p-10 -92.3 -170.0 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.227 . . . . 0.0 110.22 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -52.77 0.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 111.398 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.1 mt -79.02 -28.01 43.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.401 -1.437 . . . . 0.0 108.734 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.66 -138.48 33.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -101.93 134.64 44.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.233 -1.157 . . . . 0.0 109.671 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -138.53 151.72 47.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -141.09 144.8 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.76 135.29 27.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.507 HG23 ' OG1' ' A' ' 150' ' ' THR . 57.3 m -105.03 121.93 44.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.698 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.7 t80 -102.66 113.12 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.449 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.9 t -104.22 148.75 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.767 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -49.36 131.26 20.35 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.261 -0.899 . . . . 0.0 109.026 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.7 -3.63 39.33 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 1.3 m-20 -114.6 24.46 11.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 0.0 109.183 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 81' ' ' LEU . 1.1 mt-10 -50.87 -56.48 12.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.293 -0.88 . . . . 0.0 109.882 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -44.62 -23.45 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.306 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' GLU . 6.6 mt-10 -83.24 -12.72 56.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 111.537 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.9 pt -121.44 -28.26 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.862 -1.149 . . . . 0.0 111.2 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.1 m -63.66 -27.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.556 -1.34 . . . . 0.0 109.395 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -78.52 -6.0 54.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.66 24.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.684 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.475 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -88.71 172.17 9.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -78.57 162.32 26.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.55 146.07 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.125 -1.609 . . . . 0.0 111.836 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.5 157.72 44.1 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.453 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 77.3 m-85 -100.96 147.77 25.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.414 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 22.8 p30 -54.23 -33.29 58.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 110.022 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.551 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 7.0 p90 -72.35 -28.76 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.818 -1.176 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.525 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -81.84 -37.33 27.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.099 -1.001 . . . . 0.0 109.985 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 183' ' ' ASP . 94.3 mt -45.53 -59.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.966 -1.084 . . . . 0.0 109.475 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 14.9 tt0 -41.32 -39.4 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 109.763 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.507 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.7 t-160 -73.94 -44.38 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.769 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 98.2 mt -57.72 -27.59 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.555 -0.716 . . . . 0.0 109.579 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -84.67 -53.59 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.883 -1.136 . . . . 0.0 109.317 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -49.24 -42.48 40.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.1 m -75.68 6.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.978 -1.076 . . . . 0.0 110.294 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.41 39.65 50.32 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 55.0 mt -128.77 172.09 11.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.225 -1.162 . . . . 0.0 109.855 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 62.41 20.79 61.53 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -54.17 -21.51 9.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.636 -1.508 . . . . 0.0 109.85 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -115.35 25.8 9.56 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.07 124.31 7.1 Favored Glycine 0 N--CA 1.491 2.362 0 O-C-N 120.819 -1.401 . . . . 0.0 109.703 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.28 172.74 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.8 mt -69.13 -7.91 40.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 6.2 mmmt -91.58 -12.17 35.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.832 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -143.46 13.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.917 -1.114 . . . . 0.0 110.421 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -148.39 149.65 32.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.857 -1.152 . . . . 0.0 110.82 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.445 HD21 HD22 ' A' ' 217' ' ' LEU . 26.0 tp -99.11 93.51 6.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.436 HG23 HG22 ' A' ' 203' ' ' THR . 47.5 t -86.81 129.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.868 0.842 . . . . 0.0 109.336 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.26 164.76 18.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.19 -166.45 12.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -26.44 68.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.499 -1.0 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.64 21.89 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -143.33 150.82 39.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.755 -1.215 . . . . 0.0 110.518 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.26 111.72 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -57.79 -51.37 69.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 110.236 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -57.62 111.66 3.75 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -58.36 -11.77 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.699 1.599 . . . . 0.0 111.772 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -17.28 59.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 110.2 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.7 -177.79 46.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.9 mt -88.81 143.28 27.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.767 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.596 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 37.1 mtp85 -73.46 -20.01 60.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.602 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 17.2 m-85 -146.83 169.81 18.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -82.28 10.77 6.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 38.11 0.49 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.407 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -55.08 -47.42 98.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.94 -1.1 . . . . 0.0 109.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 54.3 Cg_exo -50.53 -65.37 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.3 m -58.7 -36.34 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.602 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 60.7 mtt180 -60.48 -42.85 97.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.2 t60 -66.42 -32.48 73.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.355 -0.841 . . . . 0.0 108.964 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -65.66 -35.49 80.93 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.6 t -68.64 -36.73 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.461 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 61.6 t80 -65.24 -52.6 53.48 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.93 -29.7 70.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.842 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 149' ' ' VAL . 58.7 tp -74.79 -32.85 62.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.029 -1.044 . . . . 0.0 108.536 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.53 -40.85 85.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.41 -53.92 32.72 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.459 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 24.7 m-20 -56.79 -30.57 63.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.062 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.5 mt -67.11 -24.44 65.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 110.481 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.66 -22.36 60.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.813 -1.18 . . . . 0.0 109.095 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.2 mt -49.16 -6.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.516 -1.365 . . . . 0.0 110.063 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.4 mt -72.28 -16.12 61.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.908 -1.12 . . . . 0.0 109.63 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.63 2.24 60.04 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.794 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.39 153.88 9.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.779 -1.424 . . . . 0.0 108.984 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -49.34 150.5 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.787 1.658 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.48 148.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.009 -1.057 . . . . 0.0 111.861 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.439 ' HB2' HG22 ' A' ' 125' ' ' VAL . 29.2 mmtt -128.92 122.95 31.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.34 -163.86 31.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 144' ' ' SER . 10.3 ttpt -126.07 139.62 53.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 109.652 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 35.1 m-85 -136.4 139.43 42.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.444 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 56.8 t80 -126.19 125.36 42.31 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.3 m -120.36 136.77 54.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 0.0 111.579 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -118.28 113.14 21.02 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 47.59 47.35 17.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.13 150.57 23.95 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 137' ' ' ARG . . . -122.66 178.53 16.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.459 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.9 m-70 -61.92 -38.26 87.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -1.19 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 11.0 m -60.08 -60.01 4.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.023 -1.048 . . . . 0.0 109.004 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.613 ' HG ' HD12 ' A' ' 139' ' ' ILE . 24.4 tp -52.0 -47.59 64.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.09 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 19.7 m-20 -48.02 -50.9 26.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 56' ' ' THR . 73.9 t -60.84 -54.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.997 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.474 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -50.8 -45.33 59.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.668 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.727 HD22 HG21 ' A' ' 139' ' ' ILE . 13.9 tp -54.12 -55.44 27.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.02 . . . . 0.0 108.56 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.2 t -56.81 -55.32 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.077 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 260' ' ' VAL . 0.1 OUTLIER -44.95 -48.51 11.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.1 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.22 -52.76 63.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.403 -0.811 . . . . 0.0 109.485 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.09 -50.09 59.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.28 -27.03 63.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.507 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 110.663 -178.866 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.6 mt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -52.5 142.27 18.19 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -123.05 144.73 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.33 -170.55 3.3 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.9 m -98.49 136.63 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.89 -1.131 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -67.57 -19.68 65.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 110.078 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -154.23 156.33 36.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 138.06 58.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 109.809 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -118.77 163.99 16.05 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.48 142.23 48.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.91 150.18 46.85 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 9.6 pt-20 -158.91 151.28 21.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.926 -1.109 . . . . 0.0 109.923 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.55 173.66 35.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.44 148.34 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.232 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.67 137.07 16.21 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' A' ' 98' ' ' ILE . 10.1 tt -59.09 -37.84 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.052 -1.263 . . . . 0.0 110.298 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 70.5 m-70 -88.85 -50.17 6.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.687 -1.258 . . . . 0.0 110.925 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 p -69.69 -20.76 63.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 111.544 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.36 12.88 6.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.15 156.61 18.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -1.018 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 67.4 t80 -74.39 135.11 42.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -138.41 144.09 40.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.88 155.16 24.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG23 ' A' ' 96' ' ' ILE . 9.0 mt -135.87 146.41 47.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.35 -0.844 . . . . 0.0 109.953 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.509 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 mt -141.43 112.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 108.638 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.91 113.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 110.466 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.7 m-70 -107.47 137.72 19.74 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.0 Cg_exo -54.77 168.73 1.02 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.685 1.59 . . . . 0.0 111.515 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 35' ' ' THR . 77.6 mm-40 -141.04 176.09 9.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.955 . . . . 0.0 109.769 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 18.6 mmtp -87.08 155.18 20.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -46.46 141.69 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.769 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 70.85 9.2 65.54 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.27 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.752 ' H ' HD22 ' A' ' 86' ' ' ASN . 53.5 m -71.53 -44.16 65.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.476 -1.602 . . . . 0.0 109.461 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.28 -179.87 35.1 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.512 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 mm -97.69 115.63 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -139.92 154.45 47.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.914 -1.116 . . . . 0.0 110.333 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -102.79 158.36 16.32 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -129.68 111.73 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.296 -0.878 . . . . 0.0 108.981 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -135.41 134.75 40.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.839 . . . . 0.0 110.621 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.495 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.7 m120 50.37 32.74 6.67 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 111.47 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 17.39 79.95 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.427 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -123.22 120.94 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.055 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -82.41 126.81 32.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.443 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.42 92.07 31.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.458 -0.777 . . . . 0.0 109.201 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.81 146.14 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.502 2.135 . . . . 0.0 112.287 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.35 70.24 10.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -122.86 166.89 14.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 109.448 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.6 p-80 -68.94 -53.85 18.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.618 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -44.99 -16.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' HIS . 41.1 m-85 -95.44 3.4 54.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 50' ' ' HIS . 69.1 t -70.47 129.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 108.719 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.53 -29.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.841 . . . . 0.0 110.225 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.12 131.53 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.74 HG21 HG21 ' A' ' 257' ' ' VAL . 45.9 p -123.18 95.12 4.48 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.5 t30 -163.33 130.68 3.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 27.2 m80 50.46 8.8 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.041 -1.037 . . . . 0.0 108.848 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.9 157.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.54 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 36.2 m -100.55 127.71 46.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 109.254 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.78 151.85 41.23 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.799 0.809 . . . . 0.0 111.171 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.4 mt -126.42 151.21 48.01 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.37 156.56 28.4 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.568 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -164.7 151.89 11.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -1.069 . . . . 0.0 109.273 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 53.1 21.66 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.256 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.09 7.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 85.7 mm-40 -60.64 148.15 39.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -1.209 . . . . 0.0 109.451 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' A' ' 70' ' ' LYS . 9.6 ttp-105 -144.48 140.81 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.478 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.82 126.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HD2' HH21 ' A' ' 68' ' ' ARG . 15.1 mtpp -101.47 156.19 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.898 -1.126 . . . . 0.0 111.299 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.2 m 50.93 74.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.4 m -108.2 -10.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.579 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.34 -28.56 69.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -64.8 -68.88 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.886 -1.134 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.39 -48.12 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.12 -0.987 . . . . 0.0 109.28 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.623 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.1 mt -50.88 -50.3 57.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.953 -1.092 . . . . 0.0 110.286 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 9.4 t -60.48 -42.81 97.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 110.164 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.71 -45.32 79.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.4 mt -68.16 -35.0 77.35 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.082 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.1 -31.77 72.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.848 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 171' ' ' GLU . 72.2 mt -83.34 -36.92 24.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 107' ' ' TYR . 87.3 mt -80.29 4.44 17.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.733 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 53.8 38.76 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.957 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.0 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 121' ' ' ILE . 72.6 p -126.13 -18.9 4.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.181 -0.949 . . . . 0.0 111.762 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.769 HD21 ' H ' ' A' ' 34' ' ' GLY . 3.0 m120 -126.98 107.9 10.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.843 -1.161 . . . . 0.0 110.956 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.7 m -163.95 148.18 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.377 -0.827 . . . . 0.0 109.971 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 27.9 m -117.06 110.04 17.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.526 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -94.08 103.73 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.6 tt0 -77.33 127.51 32.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.41 128.99 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.98 0.895 . . . . 0.0 111.734 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mm -112.2 95.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.44 -155.83 24.89 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.18 -10.45 9.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -1.107 . . . . 0.0 110.13 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -141.06 149.91 42.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.926 -1.109 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.697 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -72.68 121.66 85.52 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 109.182 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -41.15 127.26 2.83 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.641 1.561 . . . . 0.0 111.175 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -81.27 -12.61 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.5 mt 55.25 -121.15 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.4 9.32 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.927 -1.108 . . . . 0.0 111.192 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.49 -2.98 65.5 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.242 -1.456 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -172.09 2.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.625 -0.926 . . . . 0.0 109.628 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.1 15.72 12.11 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -56.39 -43.83 79.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -1.088 . . . . 0.0 110.232 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -57.46 8.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.089 -1.007 . . . . 0.0 110.143 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -51.68 -47.95 63.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 109.871 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 82' ' ' LEU . 57.9 t80 -61.59 -49.18 77.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 111.214 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.92 -43.02 89.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 111.368 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.77 -54.95 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.939 -1.101 . . . . 0.0 110.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.1 mt -63.45 -34.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 109.477 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -62.81 -41.72 99.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -78.07 12.83 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.822 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -142.54 31.17 1.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.971 -1.08 . . . . 0.0 110.327 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.3 mt -80.05 138.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 110.478 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 8' ' ' LYS . 8.3 tp -129.76 122.49 28.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 147.86 42.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.93 -174.87 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -110.62 66.36 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.137 -0.977 . . . . 0.0 111.222 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.4 129.52 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.865 -1.147 . . . . 0.0 109.379 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.42 141.55 56.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.783 -1.198 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 85' ' ' THR . 85.4 mt -84.2 150.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 110.266 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -97.46 81.89 3.03 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 31.2 m-85 -59.33 142.04 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -88.06 101.3 13.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.01 132.65 35.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.412 0.625 . . . . 0.0 110.643 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.93 111.17 2.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.56 -31.67 26.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.02 -1.05 . . . . 0.0 110.323 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 155.47 75.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.627 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.05 153.5 57.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.529 2.153 . . . . 0.0 112.103 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 tt -159.59 153.07 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -0.789 . . . . 0.0 109.273 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.36 141.89 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.92 150.05 33.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -135.76 158.93 43.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.61 106.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.929 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.9 51.55 15.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.25 3.32 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.146 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -61.61 137.4 58.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.963 -1.316 . . . . 0.0 108.639 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.9 tt -145.03 138.11 26.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 110.251 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 259' ' ' LEU . 48.3 mt -134.97 132.54 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.569 -0.707 . . . . 0.0 109.556 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -121.39 130.82 53.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.696 -0.628 . . . . 0.0 109.948 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.06 137.14 54.92 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -149.28 149.63 29.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.47 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 40.6 Cg_exo -47.74 143.73 12.26 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.491 2.127 . . . . 0.0 113.572 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.405 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -156.4 144.32 19.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -62.85 -5.4 2.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.61 -178.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 145' ' ' ASP . 12.6 p -154.04 -174.89 5.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 109.628 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.1 tp -93.76 122.04 35.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.132 -0.98 . . . . 0.0 108.933 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 mt-10 -135.86 126.63 27.38 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.1 t -129.82 123.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 m -113.68 152.62 30.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.684 -0.635 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -138.95 131.78 29.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.123 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -120.91 135.23 55.24 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 137.06 8.59 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.633 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.81 97.91 7.99 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.95 167.09 16.22 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 110.937 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -100.01 -15.25 18.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.6 p-10 -95.01 -168.18 1.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.125 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -57.16 2.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -0.787 . . . . 0.0 111.296 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.5 mt -79.03 -26.63 43.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.455 -1.403 . . . . 0.0 108.28 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.3 -137.53 37.68 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 131.25 45.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.4 -1.059 . . . . 0.0 109.295 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.22 146.23 44.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -0.792 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HZ2' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -142.26 148.01 37.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.371 -0.83 . . . . 0.0 110.366 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -146.53 140.39 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 110.044 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.1 m -107.21 123.41 48.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 109.732 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.462 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.4 t80 -103.06 112.8 25.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.902 . . . . 0.0 110.312 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.69 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.875 . . . . 0.0 109.673 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -48.16 134.38 14.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.413 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 107.58 -9.12 37.86 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -120.84 26.43 9.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.8 OUTLIER -68.25 -16.01 63.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.74 -8.84 57.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 0.0 109.894 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -106.15 -5.5 19.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.37 -33.38 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.32 -0.862 . . . . 0.0 109.632 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 171' ' ' GLU . 14.4 m -64.11 -23.67 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 108.395 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.75 -7.2 59.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.421 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.05 119.47 12.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -80.62 173.01 13.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 109.514 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.5 t -77.18 162.01 27.74 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -148.25 141.65 25.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.312 -1.492 . . . . 0.0 111.71 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -139.32 156.72 46.84 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -98.2 143.64 28.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.264 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.3 t0 -47.7 -35.32 9.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -0.85 . . . . 0.0 109.59 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.545 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -73.13 -29.87 63.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.883 -1.136 . . . . 0.0 109.681 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.545 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 4.6 tt0 -75.38 -41.21 56.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.447 ' O ' ' C ' ' A' ' 187' ' ' GLU . 49.5 mt -46.17 -56.71 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -0.983 . . . . 0.0 110.031 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.6 -40.08 1.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -76.19 -53.79 7.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.875 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.86 -26.8 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.452 -0.78 . . . . 0.0 109.624 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.98 -53.64 5.17 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.785 -1.197 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -47.58 -44.9 26.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 110.217 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.99 8.67 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.9 54.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.818 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 194' ' ' LEU . 50.9 mt -128.04 172.03 11.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -1.196 . . . . 0.0 109.687 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 57.39 24.83 53.41 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -60.14 -19.62 54.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.714 -1.462 . . . . 0.0 110.304 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -106.43 4.33 37.53 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.05 129.99 41.54 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.107 -1.231 . . . . 0.0 110.307 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.63 165.13 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.997 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.81 -8.4 43.1 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -97.09 -10.41 26.11 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.455 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 19.1 p-10 -140.3 9.82 2.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 m -145.27 147.09 31.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.106 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 206' ' ' LEU . 19.4 tp -97.8 93.86 6.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -88.45 130.51 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.569 0.7 . . . . 0.0 109.281 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 204' ' ' LEU . 18.3 mt -123.33 -178.46 4.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 109.605 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.95 -166.13 10.54 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -64.59 -20.75 66.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -1.104 . . . . 0.0 109.401 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.34 22.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.848 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -140.78 148.51 40.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.046 -1.033 . . . . 0.0 110.34 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.38 110.55 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -57.74 -45.22 86.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.987 -1.071 . . . . 0.0 109.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.8 118.82 45.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.642 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.23 -14.52 43.34 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.401 1.401 . . . . 0.0 112.017 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.85 -14.73 60.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.057 -1.027 . . . . 0.0 108.78 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.04 52.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.5 mt -86.14 134.99 33.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -1.206 . . . . 0.0 109.617 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -64.17 -19.58 65.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 108.824 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.663 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.5 m-85 -139.89 -164.16 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.118 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.65 -21.41 17.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.12 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 48.38 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.448 -0.783 . . . . 0.0 109.463 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.515 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -53.8 -47.92 95.19 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.995 . . . . 0.0 109.992 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.7 Cg_exo -48.67 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.164 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 225' ' ' ARG . 17.4 m -59.87 -36.76 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.976 -1.078 . . . . 0.0 109.666 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.663 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 74.8 mtt180 -60.09 -41.74 93.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 108.267 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.421 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 17.2 t60 -68.02 -30.56 69.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.905 . . . . 0.0 108.859 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.75 -36.0 82.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -68.48 -37.72 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.471 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.8 t80 -64.1 -52.1 60.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.546 -0.721 . . . . 0.0 109.175 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.25 -27.31 68.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.429 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.2 tp -76.74 -33.2 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.161 -0.962 . . . . 0.0 108.57 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.66 -38.81 79.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -57.58 9.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.492 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.4 m-20 -54.35 -37.26 64.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -1.211 . . . . 0.0 109.06 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 235' ' ' LEU . 10.3 mt -61.99 -24.68 67.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 0.0 110.271 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.2 t80 -72.85 -20.85 61.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.162 . . . . 0.0 109.35 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 237' ' ' LEU . 83.8 mt -50.67 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.858 -1.151 . . . . 0.0 110.591 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.9 mt -74.59 -14.23 60.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.779 -1.2 . . . . 0.0 109.854 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.17 1.69 59.41 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.575 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.1 m -164.94 153.11 10.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.259 . . . . 0.0 108.751 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.6 Cg_endo -50.06 150.4 10.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.806 1.671 . . . . 0.0 109.48 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.66 142.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.812 -1.18 . . . . 0.0 112.056 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -124.05 119.82 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.96 -165.94 32.33 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.525 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.2 tmtt? -123.39 142.06 51.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -1.022 . . . . 0.0 108.581 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 9.7 m-85 -139.52 142.16 37.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.981 -1.074 . . . . 0.0 110.63 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -126.28 132.56 51.64 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -126.93 137.7 53.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 111.145 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -119.32 116.83 27.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 47.09 28.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.182 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.0 153.31 52.89 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -134.52 170.39 22.71 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.579 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -49.92 -36.52 27.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -1.166 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.84 -58.19 9.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.701 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.414 HD23 ' CD1' ' A' ' 139' ' ' ILE . 8.6 tp -59.21 -45.02 92.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.071 -1.018 . . . . 0.0 109.444 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.5 m-20 -47.77 -51.39 22.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.566 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.74 HG21 HG21 ' A' ' 56' ' ' THR . 84.8 t -62.94 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.339 -0.85 . . . . 0.0 109.404 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -50.97 -51.07 56.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 109.209 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 139' ' ' ILE . 33.0 tp -51.26 -51.62 52.44 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 108.487 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.487 HG13 ' HG ' ' A' ' 238' ' ' LEU . 71.2 t -57.14 -53.86 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.948 . . . . 0.0 109.104 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -46.78 -41.66 15.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -70.98 -50.32 35.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.905 . . . . 0.0 109.802 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 38.2 mt -57.28 -47.64 80.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.05 75.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.968 179.799 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.11 137.52 51.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.088 -1.008 . . . . 0.0 108.473 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -123.23 144.89 49.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -143.41 -168.85 2.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.97 136.31 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.05 -12.96 56.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.39 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 8.5 pt-20 -156.15 -172.71 4.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 141.92 28.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 mt -119.15 166.15 13.3 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.8 144.54 37.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 110.328 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 76.1 m-85 -140.0 156.23 46.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -163.59 149.23 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 109.581 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.95 173.35 35.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 p -79.32 150.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -1.074 . . . . 0.0 110.518 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.63 141.18 15.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.0 tt -60.67 -39.66 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -1.154 . . . . 0.0 111.189 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.2 m-70 -88.14 -49.44 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 111.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -72.18 -21.68 61.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.664 . . . . 0.0 111.842 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.27 16.88 22.29 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.08 -1.533 . . . . 0.0 109.558 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.48 156.14 20.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -1.152 . . . . 0.0 109.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.39 136.68 39.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.88 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -135.64 141.12 45.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.5 ttpt -110.36 155.71 21.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 109.723 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.3 mt -137.89 149.38 46.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.607 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -141.71 109.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.54 116.65 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.165 -0.96 . . . . 0.0 111.049 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.607 ' NE2' HG22 ' A' ' 27' ' ' ILE . 21.4 m-70 -112.77 139.75 23.19 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.442 -0.786 . . . . 0.0 109.542 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -54.26 168.59 0.91 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.895 1.73 . . . . 0.0 111.916 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.4 mm-40 -138.0 178.18 7.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.593 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.9 mtmm -87.16 152.76 22.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.981 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -48.36 146.21 2.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.642 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 68.35 8.49 55.44 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.729 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.733 ' H ' HD22 ' A' ' 86' ' ' ASN . 26.4 m -73.42 -45.84 52.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.608 -1.525 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.66 -178.92 30.2 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.662 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.4 mm -97.9 117.18 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -142.07 150.14 40.84 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' HD13 ' A' ' 89' ' ' ILE . 95.6 m-85 -99.7 157.12 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -129.69 110.72 12.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 108.974 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -135.96 135.97 40.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.582 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m120 51.03 28.17 3.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 111.183 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.23 74.76 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.024 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.95 120.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -1.065 . . . . 0.0 108.946 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.3 m-85 -86.86 129.0 35.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.066 -1.021 . . . . 0.0 109.169 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.129 ' CD1' HE21 ' A' ' 67' ' ' GLN . 52.8 mt -120.12 96.95 49.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.238 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -53.07 149.3 27.71 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.081 1.854 . . . . 0.0 111.101 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.7 72.16 10.36 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -127.55 175.61 8.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -73.19 -50.74 20.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -43.72 -17.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.184 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' HIS . 54.2 m-85 -98.2 0.07 45.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.128 . . . . 0.0 110.258 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.3 t -68.81 130.91 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 108.722 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG21 ' HG2' ' A' ' 68' ' ' ARG . 10.4 m -114.3 -28.7 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.326 -0.859 . . . . 0.0 110.088 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -152.81 131.62 12.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.956 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 257' ' ' VAL . 70.3 p -121.75 95.09 4.53 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.3 t-20 -163.11 128.74 3.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.399 -0.813 . . . . 0.0 109.064 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 27.3 m80 50.25 6.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.962 . . . . 0.0 109.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.573 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.1 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.7 m -81.38 129.18 34.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 0.0 109.247 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.92 150.43 42.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.357 -0.839 . . . . 0.0 111.172 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 72' ' ' VAL . 8.0 mt -126.0 147.66 49.48 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.69 160.41 32.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.248 -1.453 . . . . 0.0 110.243 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.24 149.58 10.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -1.123 . . . . 0.0 109.329 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.65 21.47 3.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.411 -0.805 . . . . 0.0 109.938 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.53 -30.94 8.95 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.681 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 1.129 HE21 ' CD1' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -70.78 145.06 50.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.763 -1.433 . . . . 0.0 108.855 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 4.7 mtt180 -137.46 149.76 47.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.019 -1.051 . . . . 0.0 111.874 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.732 ' CG1' HE22 ' A' ' 67' ' ' GLN . 12.9 mt -129.29 128.45 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -105.14 155.28 19.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.892 -1.13 . . . . 0.0 111.338 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.2 m 51.5 74.57 0.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.894 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.8 m -108.24 -9.58 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.037 -1.039 . . . . 0.0 109.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.0 pm0 -61.13 -26.8 67.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 110.689 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.43 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 25.4 m170 -66.88 -68.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.958 -1.089 . . . . 0.0 109.375 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -51.84 -47.64 40.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.048 -1.033 . . . . 0.0 109.058 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.9 mt -54.13 -47.42 71.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.889 -1.132 . . . . 0.0 110.478 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 25.2 t -60.23 -41.75 93.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.004 -1.06 . . . . 0.0 109.817 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -57.5 -45.81 85.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 108.955 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.97 -35.0 79.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 109.247 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.05 -40.25 97.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 0.0 109.202 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.0 mt -75.68 -38.48 58.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.22 -0.48 45.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.842 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 56.42 41.97 28.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 111.303 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.1 mm -88.33 138.47 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.741 -1.224 . . . . 0.0 108.158 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.433 HG21 HG12 ' A' ' 121' ' ' ILE . 70.7 p -126.56 -20.62 4.31 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.213 -0.929 . . . . 0.0 111.451 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.775 HD21 ' N ' ' A' ' 34' ' ' GLY . 3.3 m120 -124.2 106.45 10.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.02 -1.05 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -166.07 150.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.654 0.74 . . . . 0.0 110.2 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 55.8 m -117.11 114.61 23.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.415 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.3 mt -95.69 100.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.432 -0.792 . . . . 0.0 109.988 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -74.27 122.88 23.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 HD21 ' A' ' 26' ' ' LEU . 19.3 t -108.69 124.75 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.845 0.831 . . . . 0.0 111.906 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 25' ' ' LYS . 8.1 mt -108.4 96.22 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.52 -158.51 27.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -122.19 -11.68 8.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -1.111 . . . . 0.0 110.196 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -140.63 149.38 42.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -73.06 127.24 89.69 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.06 132.32 14.5 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.033 1.822 . . . . 0.0 111.276 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.91 -20.85 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.12 -0.987 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.9 mt 58.64 -119.69 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.91 4.71 49.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.908 -1.12 . . . . 0.0 110.95 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.78 0.04 56.45 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.332 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -172.28 2.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.718 -0.872 . . . . 0.0 109.676 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.84 13.17 9.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 47.9 t-105 -56.0 -40.54 73.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.44 -59.28 4.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 11.0 m-85 -51.3 -45.56 62.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CE2' ' HD2' ' A' ' 111' ' ' ARG . 64.7 t80 -60.68 -49.99 75.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.772 -0.58 . . . . 0.0 110.806 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 19.8 mm-40 -62.99 -43.36 99.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.245 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.05 6.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.703 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.1 -30.28 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.212 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.418 ' HD2' ' CE2' ' A' ' 107' ' ' TYR . 57.9 ttt180 -66.11 -44.37 84.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.412 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HG3' HD22 ' A' ' 113' ' ' ASN . 15.0 ptpt -76.36 8.72 3.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.882 -1.136 . . . . 0.0 110.431 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' OD1' ' OE1' ' A' ' 9' ' ' GLU . 8.0 m-80 -140.58 35.87 1.83 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.945 -1.097 . . . . 0.0 110.267 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.65 143.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.12 . . . . 0.0 110.88 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.9 tp -133.51 129.68 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.429 -0.795 . . . . 0.0 109.431 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.75 138.81 31.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -108.48 -173.53 2.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.73 . . . . 0.0 109.108 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -113.62 70.66 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.958 . . . . 0.0 110.685 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -167.4 129.68 1.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -65.96 140.54 58.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.086 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.433 HG12 HG21 ' A' ' 85' ' ' THR . 56.3 mt -84.42 150.25 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 109.894 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -93.24 76.67 4.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.858 . . . . 0.0 108.792 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -58.21 142.79 46.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.3 101.97 14.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.22 133.64 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.686 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.77 116.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -92.0 -28.71 17.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.65 156.99 78.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.943 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.56 150.15 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.913 2.409 . . . . 0.0 112.39 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.21 151.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.828 . . . . 0.0 109.323 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.82 145.91 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 109.366 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.12 147.98 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -131.78 161.32 33.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.137 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 255' ' ' LEU . 6.6 t70 -170.35 102.21 0.27 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 110.082 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 47.6 59.26 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.805 . . . . 0.0 110.677 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.78 -35.86 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.456 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -62.94 135.98 57.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.362 . . . . 0.0 109.132 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.2 tt -143.08 139.36 30.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 110.148 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.649 HG21 HD22 ' A' ' 259' ' ' LEU . 91.4 mt -137.47 134.13 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 0.0 109.734 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.75 131.48 53.61 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.53 0.681 . . . . 0.0 109.998 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.37 55.22 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.01 150.47 45.84 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.103 -0.998 . . . . 0.0 110.197 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -48.37 142.51 17.02 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.566 2.177 . . . . 0.0 113.35 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.76 147.24 18.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -69.84 -18.07 63.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.3 p -133.51 -173.33 3.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.49 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 16.3 tp -102.43 123.02 45.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.6 ' HG3' HG22 ' A' ' 167' ' ' VAL . 11.2 tt0 -136.83 129.04 29.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.632 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.09 121.34 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.557 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.1 m -112.27 152.15 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -138.83 129.72 26.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.965 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -120.57 131.91 54.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.0 132.3 6.21 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.701 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.24 97.59 9.29 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.57 166.98 19.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.368 -0.832 . . . . 0.0 111.169 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -105.87 23.6 13.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.752 -0.593 . . . . 0.0 110.034 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.4 p-10 -140.53 -169.74 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.053 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -47.15 -4.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.618 -0.676 . . . . 0.0 111.664 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 157' ' ' ASN . 17.5 mt -85.27 -28.63 25.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.334 -1.479 . . . . 0.0 109.111 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.14 -132.47 41.83 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.465 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 4.4 ttm105 -97.02 129.84 44.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.302 . . . . 0.0 109.8 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -132.81 139.36 47.47 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -137.57 144.05 41.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -143.56 136.12 27.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.724 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.3 m -106.98 124.53 49.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.417 -0.802 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -105.8 118.48 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 148' ' ' GLU . 26.0 t -113.59 158.42 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.75 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 30.9 mt-10 -50.18 125.15 11.71 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 108.92 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.89 6.59 39.94 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -120.31 15.81 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.245 . . . . 0.0 108.698 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -49.63 73.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.404 -0.81 . . . . 0.0 110.034 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -51.2 -22.33 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.12 -6.99 58.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 0.0 111.441 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 8.9 pt -124.95 -27.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.888 -1.133 . . . . 0.0 111.552 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.98 -24.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.528 -1.358 . . . . 0.0 108.694 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -82.31 -5.54 58.64 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.32 118.5 11.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.189 -0.944 . . . . 0.0 109.005 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 41.3 mtm180 -81.21 171.8 14.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.197 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -77.94 164.16 25.36 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -149.3 146.03 27.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.168 -1.582 . . . . 0.0 111.629 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.81 158.93 43.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -101.24 146.03 28.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 9.9 p30 -52.08 -32.91 36.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.233 -0.917 . . . . 0.0 109.935 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.1 p90 -71.8 -26.16 62.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.756 -1.215 . . . . 0.0 109.645 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.449 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 tt0 -83.81 -40.29 18.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.101 -1.0 . . . . 0.0 110.049 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 67.2 mt -43.17 -59.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.614 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.8 tp10 -42.1 -38.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.597 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.4 t-160 -76.85 -42.81 38.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.137 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.97 -27.6 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.579 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.64 -53.15 5.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.666 -1.271 . . . . 0.0 109.143 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -50.99 -41.17 59.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 110.172 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 188' ' ' HIS . 18.8 m -74.56 4.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.82 38.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 56.2 mt -129.89 171.36 12.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -1.141 . . . . 0.0 109.684 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.94 24.82 58.59 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.487 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.6 -18.48 41.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.425 -1.633 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.24 25.22 10.02 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.09 130.18 9.96 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.8 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.6 t -144.42 171.2 14.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.679 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.426 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 59.5 mt -69.78 -8.41 47.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -98.69 -13.75 20.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.642 -0.661 . . . . 0.0 109.696 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 18.7 p30 -130.33 7.1 4.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -149.19 150.13 32.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 206' ' ' LEU . 12.5 tp -97.96 95.26 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.05 127.87 40.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.985 0.898 . . . . 0.0 109.497 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 204' ' ' LEU . 34.3 mt -123.28 164.89 17.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.613 -0.68 . . . . 0.0 109.303 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.04 -166.63 11.98 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.414 ' HZ2' ' HB2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -60.03 -34.79 73.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.507 -0.996 . . . . 0.0 109.325 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -153.41 23.76 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.926 -1.109 . . . . 0.0 110.74 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -142.12 149.04 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.614 -1.304 . . . . 0.0 110.702 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.4 t -101.49 111.05 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.19 -46.41 85.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.977 -1.077 . . . . 0.0 110.148 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.1 118.28 31.48 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.927 . . . . 0.0 109.827 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -67.6 -17.2 48.15 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.85 -14.32 61.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.296 -0.878 . . . . 0.0 108.99 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.8 -176.98 45.28 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.4 mt -84.37 153.05 23.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -1.208 . . . . 0.0 109.558 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 218' ' ' ARG . 0.0 OUTLIER -82.2 -18.4 42.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.0 m-85 -145.53 -165.14 2.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -0.751 . . . . 0.0 108.998 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.19 -4.84 28.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.309 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.53 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -141.91 40.86 1.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.85 -47.36 97.09 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.876 -1.14 . . . . 0.0 109.584 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.7 Cg_exo -51.8 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.375 2.05 . . . . 0.0 112.076 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.9 m -58.86 -35.06 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 109.624 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NH1' ' CD2' ' A' ' 219' ' ' TYR . 58.2 mtt180 -60.21 -40.66 90.92 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.9 t60 -69.43 -32.1 70.85 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.162 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -64.88 -35.73 82.08 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.72 -40.85 84.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.5 t80 -61.78 -51.46 68.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.611 0.719 . . . . 0.0 109.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.6 -27.48 68.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.6 tp -77.46 -34.24 54.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.094 -1.004 . . . . 0.0 108.777 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 57.9 mt -68.31 -38.5 79.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.92 -56.8 11.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 2.2 m-20 -53.16 -35.06 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.238 . . . . 0.0 108.671 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.0 mt -62.01 -23.51 66.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.639 -0.663 . . . . 0.0 110.325 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.04 -21.8 61.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 108.821 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 237' ' ' LEU . 53.3 mt -51.22 -1.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.619 -1.3 . . . . 0.0 110.416 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.624 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -77.86 -15.61 58.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.903 -1.123 . . . . 0.0 109.526 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.68 58.01 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.14 -1.029 . . . . 0.0 110.605 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.64 153.88 10.13 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.901 -1.352 . . . . 0.0 109.127 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.66 130.22 39.14 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.904 1.736 . . . . 0.0 109.939 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 68.5 t -86.22 147.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 122.204 1.002 . . . . 0.0 112.558 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -131.34 124.71 30.96 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.28 -155.58 26.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -131.8 133.77 45.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.315 -1.109 . . . . 0.0 109.119 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.8 m-85 -135.09 140.01 45.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.459 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.1 t80 -125.34 132.23 52.87 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.2 t -127.62 136.85 52.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.25 112.97 20.8 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 53.41 24.91 4.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.97 153.0 48.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.49 177.5 18.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.585 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 74.8 m-70 -57.72 -36.25 71.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -1.187 . . . . 0.0 109.427 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 29.6 t -58.97 -58.62 7.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 134' ' ' ASP . 9.0 tp -59.53 -44.6 93.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.501 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -47.94 -50.62 26.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 109.286 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 56' ' ' THR . 70.7 t -63.18 -50.44 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.16 -50.9 63.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.06 -1.025 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.649 HD22 HG21 ' A' ' 139' ' ' ILE . 28.8 tp -52.22 -59.36 4.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 108.447 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.624 HG13 ' HG ' ' A' ' 238' ' ' LEU . 43.1 t -48.39 -55.58 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.39 -47.53 18.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.17 -47.02 78.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -59.51 -49.79 76.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -70.76 -32.13 69.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 4.3 mmtp . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' CD ' HD21 ' A' ' 86' ' ' ASN . 70.8 mt-10 -55.22 139.85 40.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 108.833 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.81 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.907 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -140.55 -172.71 3.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.4 m -97.93 136.38 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.003 -1.06 . . . . 0.0 109.074 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -66.97 -23.29 65.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.549 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 2.5 pt-20 -146.92 170.04 17.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 141.08 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.3 mt -120.03 166.47 13.33 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 143.18 41.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.071 -1.018 . . . . 0.0 110.418 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' ILE . 79.1 m-85 -139.24 154.15 47.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.98 150.8 15.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.875 -1.141 . . . . 0.0 110.019 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.22 174.98 36.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 p -82.81 153.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.115 . . . . 0.0 110.183 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.86 140.11 16.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 ' OG1' ' A' ' 203' ' ' THR . 9.6 tt -61.52 -37.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.916 -1.344 . . . . 0.0 110.379 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 45.8 m-70 -86.77 -51.07 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 111.096 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -73.47 -20.93 60.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.741 -0.599 . . . . 0.0 111.706 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.33 16.41 14.73 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.492 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.22 154.07 21.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 109.598 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.9 134.53 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -138.61 143.03 39.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.398 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -110.87 157.74 19.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.299 -0.876 . . . . 0.0 109.728 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.9 mt -138.2 147.77 44.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.447 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.568 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.9 mt -142.55 112.69 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 108.825 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.45 HD12 ' CE1' ' A' ' 13' ' ' PHE . 55.2 mt -96.09 114.57 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 111.123 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.568 ' NE2' HG22 ' A' ' 27' ' ' ILE . 24.5 m-70 -109.4 139.3 20.97 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 109.669 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.7 Cg_exo -55.12 168.6 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.828 1.686 . . . . 0.0 111.758 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 64.2 mm-40 -141.72 178.22 7.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.993 . . . . 0.0 109.816 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' A' ' 35' ' ' THR . 23.9 mmtm -85.72 152.49 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -46.07 145.08 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 67.78 9.17 55.52 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.169 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -70.03 -41.67 73.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.63 -1.512 . . . . 0.0 109.49 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.99 179.69 37.14 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.539 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mm -96.61 116.26 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -138.8 144.43 39.34 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.511 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.59 158.34 15.48 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -131.02 110.18 11.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 109.222 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -136.63 134.97 37.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 110.558 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.14 26.95 10.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 111.275 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 17.95 78.49 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.81 122.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -83.98 127.46 33.89 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.191 -0.943 . . . . 0.0 109.243 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.71 94.4 40.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.422 -0.799 . . . . 0.0 109.446 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.12 145.71 33.14 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.0 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -80.6 65.58 5.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -119.49 153.24 35.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.407 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.508 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 1.8 p-80 -57.71 -53.67 55.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 109.985 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.0 mm-40 -43.84 -17.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 111.043 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' HIS . 16.0 m-85 -94.13 5.11 52.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.664 -1.272 . . . . 0.0 109.79 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' HIS . 79.8 t -72.66 130.87 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.53 -29.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.345 -0.847 . . . . 0.0 109.894 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.4 t-80 -150.13 131.22 14.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.046 -1.034 . . . . 0.0 109.915 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.822 HG21 HG21 ' A' ' 257' ' ' VAL . 67.7 p -121.98 95.84 4.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 11.6 t-20 -162.38 128.56 3.53 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 59' ' ' SER . 34.3 m80 52.79 5.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.082 -1.011 . . . . 0.0 109.047 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m 165.16 151.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.404 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 31.1 m -91.12 126.54 36.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.241 -0.912 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD2' ' NZ ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -120.29 149.57 42.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.449 -0.782 . . . . 0.0 111.12 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.687 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.4 mt -126.28 147.54 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.52 155.91 27.25 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 118.961 -1.59 . . . . 0.0 110.587 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -160.42 147.64 15.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -1.047 . . . . 0.0 109.095 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 24.18 4.77 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.283 -0.885 . . . . 0.0 109.647 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.52 -31.35 7.89 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 8.3 mm-40 -60.34 144.25 51.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.245 . . . . 0.0 108.916 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -143.06 141.38 31.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 110.475 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.09 123.32 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 13.2 mtpp -99.36 154.63 18.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.966 -1.083 . . . . 0.0 111.128 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.5 m 50.79 74.38 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.338 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.687 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.9 m -106.92 -10.08 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.236 -0.915 . . . . 0.0 108.927 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.9 pm0 -61.34 -26.3 67.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 110.353 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.58 -69.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.91 -1.119 . . . . 0.0 109.47 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.01 -47.37 42.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 108.979 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' ILE . 16.8 mt -52.1 -49.22 64.03 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.04 -1.038 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 t -60.65 -42.82 97.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.105 -0.997 . . . . 0.0 110.247 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -56.04 -48.37 78.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.05 -1.031 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.04 -33.9 76.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.165 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.4 -37.17 86.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.912 . . . . 0.0 109.268 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.29 -38.76 34.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.414 -0.804 . . . . 0.0 109.648 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 107' ' ' TYR . 77.8 mt -80.36 -0.48 37.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.132 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 56.89 42.38 26.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.666 -0.646 . . . . 0.0 111.622 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mm -89.41 144.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.697 -1.252 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.571 HG21 HG12 ' A' ' 121' ' ' ILE . 43.5 p -127.88 -20.81 3.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.192 -0.943 . . . . 0.0 111.815 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG13 ' A' ' 87' ' ' VAL . 33.6 m-80 -124.99 108.12 11.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.838 -1.164 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.75 148.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.363 -0.836 . . . . 0.0 110.421 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.47 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 94.3 m -114.71 113.53 24.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 5.5 mt -97.27 100.77 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 110.412 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.1 tt0 -74.63 124.83 27.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 20.0 t -109.96 131.93 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 122.048 0.928 . . . . 0.0 111.707 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mm -116.15 95.9 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.67 -156.9 26.07 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -121.37 -9.51 9.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.439 -1.036 . . . . 0.0 109.999 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -140.53 148.81 41.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.648 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 26' ' ' LEU . 39.2 mm -72.07 119.37 74.16 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 108.987 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -39.94 120.09 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.739 1.626 . . . . 0.0 111.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -75.04 -10.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 110.774 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.9 mt 54.7 -120.7 1.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.091 -1.006 . . . . 0.0 109.995 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.6 8.22 44.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.66 67.36 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.197 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -172.54 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.768 -0.842 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.0 9.0 9.76 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.407 ' HB2' HD22 ' A' ' 176' ' ' LEU . 33.6 t-105 -55.49 -39.52 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -1.135 . . . . 0.0 110.452 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.12 -59.31 4.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -50.84 -44.83 59.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.209 -0.932 . . . . 0.0 109.38 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 82' ' ' LEU . 36.2 t80 -60.92 -48.05 83.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 110.786 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.82 -42.47 90.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.009 -1.057 . . . . 0.0 111.28 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.49 -52.06 43.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.913 -1.117 . . . . 0.0 110.356 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.05 -32.86 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.943 -1.098 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -63.79 -43.44 96.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 109.822 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.623 ' C ' HD22 ' A' ' 113' ' ' ASN . 1.3 ptpm? -77.81 11.1 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.017 -1.052 . . . . 0.0 109.852 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.623 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.92 33.23 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.29 138.82 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.864 -1.147 . . . . 0.0 111.212 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 8' ' ' LYS . 9.0 tp -132.75 123.56 26.45 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.65 145.15 31.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.343 -0.848 . . . . 0.0 110.221 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -112.61 -173.19 2.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.763 . . . . 0.0 109.352 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -109.34 68.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -164.09 128.76 2.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.007 . . . . 0.0 109.315 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.69 140.58 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.069 . . . . 0.0 109.667 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 85' ' ' THR . 69.3 mt -83.94 150.47 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.843 . . . . 0.0 109.906 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.64 85.94 3.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 108.876 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 241' ' ' PRO . 25.1 m-85 -63.52 142.79 58.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.545 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -87.54 101.38 13.57 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.43 134.16 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.663 -0.648 . . . . 0.0 110.75 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.97 111.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -83.74 -33.5 25.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.944 -1.098 . . . . 0.0 110.725 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.25 156.93 78.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 109.784 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.09 149.0 45.63 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.791 2.327 . . . . 0.0 112.241 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 tt -159.01 151.48 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.19 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 143.51 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.76 148.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.89 157.38 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.466 ' HB3' HD13 ' A' ' 255' ' ' LEU . 10.5 t70 -174.15 106.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 109.796 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 49.58 53.43 12.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 110.803 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.57 -35.68 3.17 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.416 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.581 ' HB3' HD22 ' A' ' 255' ' ' LEU . 0.9 OUTLIER -63.48 131.81 49.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.932 -1.334 . . . . 0.0 108.906 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -143.98 139.79 29.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.986 -1.071 . . . . 0.0 109.891 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HD22 ' A' ' 259' ' ' LEU . 62.6 mt -136.9 127.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.783 . . . . 0.0 109.59 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -112.49 131.76 55.42 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.411 0.624 . . . . 0.0 109.752 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 135.37 54.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.88 149.19 32.44 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.128 -0.983 . . . . 0.0 109.648 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -46.35 143.53 7.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.661 2.241 . . . . 0.0 113.272 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.425 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.92 145.62 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 146' ' ' THR . 44.0 t0 -65.34 -4.71 5.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 110.541 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 145' ' ' ASP . 21.8 p -155.66 -177.78 6.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -92.26 119.35 31.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 167' ' ' VAL . 1.1 tt0 -135.16 110.32 8.91 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.29 122.09 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.7 m -112.32 151.98 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.624 -0.673 . . . . 0.0 109.229 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -139.62 131.71 27.98 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.128 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -122.0 132.98 54.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.4 144.67 16.2 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.747 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.82 105.97 15.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -95.18 166.86 11.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -98.07 -16.69 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.576 -0.703 . . . . 0.0 110.9 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.7 p-10 -94.79 -173.14 2.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.751 -1.218 . . . . 0.0 110.217 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -50.35 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 0.0 111.642 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.2 mt -77.74 -27.8 50.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.343 -1.473 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.76 -140.5 34.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -104.16 137.89 41.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.302 -1.116 . . . . 0.0 109.691 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -143.89 159.14 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.497 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -146.67 147.68 31.27 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -142.86 135.65 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 109.645 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 98.6 m -104.56 122.87 46.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.894 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -104.46 112.34 25.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 148' ' ' GLU . 4.9 t -106.38 152.36 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.758 0.79 . . . . 0.0 109.901 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -49.28 127.04 14.14 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 108.808 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.57 27.35 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -116.69 20.72 13.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.162 -1.199 . . . . 0.0 108.962 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -54.04 -22.78 11.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.445 -0.784 . . . . 0.0 110.542 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -18.21 48.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.041 -1.037 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -84.2 -6.37 59.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 111.476 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 pt -125.19 -26.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.865 -1.147 . . . . 0.0 111.221 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 171' ' ' GLU . 6.5 m -60.5 -24.01 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.623 -1.298 . . . . 0.0 108.716 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.2 mm? -83.56 -3.23 57.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.506 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -69.99 113.5 7.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.569 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 73.0 mtm180 -79.31 172.36 13.9 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.6 t -77.26 161.13 28.37 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.39 146.06 32.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.282 -1.512 . . . . 0.0 111.439 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.55 42.71 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.422 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 70.2 m-85 -98.09 145.82 26.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.018 -1.051 . . . . 0.0 109.362 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.61 -36.97 37.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.3 p90 -71.42 -27.19 63.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.843 -1.161 . . . . 0.0 110.039 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.1 tt0 -78.97 -43.18 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.979 -1.076 . . . . 0.0 110.137 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 21.3 mt -41.0 -61.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.903 . . . . 0.0 110.145 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.7 tt0 -40.49 -41.37 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 0.0 110.193 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 192' ' ' VAL . 74.3 t60 -76.24 -46.22 29.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.942 . . . . 0.0 109.402 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.5 -30.86 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -80.65 -52.23 7.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.883 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -48.61 -44.56 37.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 110.334 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.1 m -74.86 6.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 0.0 110.326 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.41 41.79 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.584 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.4 mt -127.73 178.39 6.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -1.185 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 50.83 24.28 7.95 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -61.23 -19.3 61.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.624 -1.516 . . . . 0.0 110.59 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -107.27 4.82 35.49 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.57 125.03 30.44 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 121.136 -1.214 . . . . 0.0 110.296 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.559 ' N ' HD21 ' A' ' 202' ' ' ASN . 3.5 t -135.99 174.22 10.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -1.028 . . . . 0.0 109.456 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 213' ' ' ASN . 2.2 mm? -73.91 -9.14 58.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -102.78 -17.67 15.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.642 -0.662 . . . . 0.0 110.289 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 199' ' ' SER . 18.9 p30 -120.04 7.91 10.93 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.477 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -150.84 151.25 31.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.872 -1.143 . . . . 0.0 110.556 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.2 tp -98.99 93.54 6.06 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -86.08 129.19 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.687 0.756 . . . . 0.0 109.277 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 211' ' ' VAL . 11.9 mt -123.48 162.95 21.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.611 -0.68 . . . . 0.0 109.454 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.41 -166.38 12.91 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -28.26 66.5 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.384 -1.068 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.44 20.98 1.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 111.153 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.6 160.99 43.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.465 -1.397 . . . . 0.0 110.823 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 206' ' ' LEU . 86.9 t -107.59 116.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -60.28 -42.93 96.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.578 ' HA ' HD12 ' A' ' 200' ' ' LEU . 8.9 m120 -65.06 115.61 22.71 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -64.69 -10.53 25.09 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.16 1.24 . . . . 0.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -20.13 59.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.408 -0.807 . . . . 0.0 109.286 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.24 -179.5 45.53 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.5 mt -86.1 133.51 33.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.073 -1.251 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.99 -17.71 64.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.318 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 39.2 m-85 -143.33 -170.46 3.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.71 -4.37 44.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.79 43.61 1.26 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 109.649 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.86 -47.84 95.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.997 -1.065 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.5 Cg_exo -51.37 -65.33 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.487 2.124 . . . . 0.0 112.31 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.39 -35.19 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.986 -1.071 . . . . 0.0 109.461 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -62.72 -39.44 94.07 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 8.5 t60 -68.02 -32.68 73.22 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -64.17 -35.72 81.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.88 -35.48 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.97 -53.01 44.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 109.172 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -63.98 -28.86 70.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.457 -0.777 . . . . 0.0 109.797 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.12 -34.97 49.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.085 -1.01 . . . . 0.0 109.018 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.55 -38.53 81.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.5 -54.87 17.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -55.27 -30.19 59.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.0 108.825 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.6 mt -65.86 -24.23 66.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.529 -0.732 . . . . 0.0 110.442 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.78 -21.8 61.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.855 -1.153 . . . . 0.0 108.54 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 38.9 mt -48.19 -7.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.762 -1.211 . . . . 0.0 109.905 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 236' ' ' TYR . 7.2 mt -74.03 -16.6 61.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.767 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 95.77 3.83 60.68 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.823 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.79 152.99 10.6 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.763 -1.433 . . . . 0.0 109.301 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.413 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 8.1 Cg_endo -53.91 127.22 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.956 1.771 . . . . 0.0 110.002 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.8 t -86.43 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 112.289 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.57 125.86 29.72 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.51 -160.59 29.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -128.6 133.56 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -1.107 . . . . 0.0 108.951 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.8 m-85 -132.92 141.65 48.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 110.945 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -124.76 124.94 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.2 t -118.83 135.69 54.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.946 -1.096 . . . . 0.0 111.28 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -116.87 114.75 24.33 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 48.41 25.77 0.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.57 164.11 12.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -145.01 173.94 25.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.446 ' O ' HG23 ' A' ' 257' ' ' VAL . 77.4 m-70 -54.41 -43.52 71.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 p -55.37 -58.6 7.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 137' ' ' ARG . 5.9 tp -54.88 -46.23 74.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.0 m-20 -47.43 -48.11 26.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.942 -1.099 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.822 HG21 HG21 ' A' ' 56' ' ' THR . 44.9 t -63.85 -50.03 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 109.96 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -56.31 -50.27 71.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.961 -1.087 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 139' ' ' ILE . 35.6 tp -52.58 -50.53 62.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.063 -1.023 . . . . 0.0 108.636 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.4 t -57.79 -55.28 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.274 -0.891 . . . . 0.0 109.165 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.69 -49.08 14.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.82 -49.53 72.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.278 -0.889 . . . . 0.0 110.109 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.17 -50.94 71.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 0.0 110.38 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -33.16 75.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.123 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 109.374 179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.545 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 73.8 mt-10 -56.04 135.04 52.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.123 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.38 142.67 48.97 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -139.46 -170.34 2.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.8 m -100.32 137.55 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -64.88 -19.87 66.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.857 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.95 157.42 36.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.113 -0.992 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 140.36 58.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.946 . . . . 0.0 109.805 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.07 157.08 28.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 p -127.67 140.13 52.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.2 m-85 -138.04 147.67 44.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.4 pt-20 -156.8 151.98 26.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.16 175.66 36.72 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.06 152.93 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 110.222 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.67 140.07 15.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 11.4 tt -59.31 -39.05 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.039 -1.271 . . . . 0.0 110.269 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 34.0 m-70 -88.43 -50.05 6.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.688 -1.258 . . . . 0.0 110.77 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -70.45 -22.95 62.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.716 . . . . 0.0 111.297 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.24 10.92 4.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.64 156.18 17.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 32.2 t80 -74.82 136.25 41.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -141.04 143.51 34.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -109.77 159.02 17.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.999 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.29 145.12 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.3 mt -142.18 107.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.976 . . . . 0.0 108.867 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mt -90.85 113.77 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.366 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.503 ' NE2' HG22 ' A' ' 27' ' ' ILE . 57.2 m-70 -107.74 137.26 19.69 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 109.4 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG3' HG23 ' A' ' 7' ' ' VAL . 33.2 Cg_exo -50.1 167.72 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.847 1.698 . . . . 0.0 111.532 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HB3' HG21 ' A' ' 35' ' ' THR . 28.0 mm-40 -144.99 160.48 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.886 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.8 mttp -68.0 149.1 50.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -48.41 151.05 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.141 -0.974 . . . . 0.0 110.093 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.542 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.63 -2.12 8.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.51 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 24.6 m -62.21 -42.75 99.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.467 . . . . 0.0 109.558 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 179.45 36.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.415 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 87' ' ' VAL . 14.6 mm -96.58 116.81 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -140.91 147.68 39.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 0.0 110.215 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.34 157.42 15.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -129.06 112.17 13.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 108.976 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -135.58 133.43 38.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.636 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 53.5 26.82 5.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 111.313 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.43 20.26 64.67 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.097 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.5 t -124.46 124.49 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -1.093 . . . . 0.0 109.322 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -86.37 126.75 34.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.78 93.03 36.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.188 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.12 145.5 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.298 1.999 . . . . 0.0 112.044 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.93 70.57 8.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 109.403 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -120.52 174.73 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.159 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.485 ' O ' HG23 ' A' ' 53' ' ' VAL . 16.1 p-80 -78.31 -46.37 20.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -49.95 -16.62 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -93.15 3.97 54.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.754 -1.216 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 50' ' ' HIS . 75.2 t -70.95 127.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG21 ' HD2' ' A' ' 68' ' ' ARG . 26.9 m -106.32 -31.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -155.12 139.83 17.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 257' ' ' VAL . 39.2 p -126.25 95.82 4.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.5 t30 -161.39 128.91 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.769 . . . . 0.0 108.95 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 82.2 m-70 52.95 5.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.247 -0.908 . . . . 0.0 109.178 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.11 142.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' VAL . 34.6 m -81.87 127.3 32.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 108.837 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.82 148.24 43.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.859 0.837 . . . . 0.0 111.071 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.1 mt -126.84 150.06 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.36 155.73 27.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.756 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.92 153.55 12.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -1.012 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 50.75 21.59 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.8 -33.25 6.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.99 141.86 57.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.245 . . . . 0.0 109.245 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -137.33 139.69 41.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 110.364 -179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.3 mt -129.23 121.3 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -99.64 157.54 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 110.926 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.9 m 51.23 73.73 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.932 -0.48 . . . . 0.0 110.694 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG21 ' HG ' ' A' ' 62' ' ' LEU . 12.2 m -107.7 -9.29 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.0 108.9 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 18.2 pm0 -61.04 -28.86 69.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 110.75 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -66.83 -67.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.868 -1.145 . . . . 0.0 109.56 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.15 -46.73 44.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.271 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.0 mt -53.61 -46.91 70.58 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.899 -1.126 . . . . 0.0 110.136 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.56 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.87 -43.18 99.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -0.989 . . . . 0.0 110.063 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.88 -46.05 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.05 -34.47 77.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -62.58 -37.34 85.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.408 HD12 ' CG1' ' A' ' 175' ' ' VAL . 54.8 mt -78.78 -38.73 37.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 114' ' ' ILE . 72.8 mt -79.9 -1.03 37.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.383 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 57.7 43.01 22.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 111.339 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 mm -88.22 143.74 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.887 -1.133 . . . . 0.0 108.688 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.477 HG21 HD13 ' A' ' 121' ' ' ILE . 63.0 p -127.4 -23.44 3.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 111.822 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 54.1 m-80 -124.73 107.49 11.01 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.723 -1.235 . . . . 0.0 110.412 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -163.64 147.0 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 37.9 m -114.23 109.48 18.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.8 mt -92.06 100.52 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -74.48 126.15 30.11 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.512 HG22 HD21 ' A' ' 26' ' ' LEU . 29.4 t -111.74 122.42 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.964 0.887 . . . . 0.0 111.58 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.94 96.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.39 -156.78 26.34 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -120.66 -10.04 9.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -1.095 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -142.82 150.63 40.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.01 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 36.9 mm -72.76 120.94 83.53 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -41.85 123.81 2.5 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.517 1.478 . . . . 0.0 110.987 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.4 tp -76.91 -12.43 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.369 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 mt 56.48 -121.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.29 8.89 40.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 110.666 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.41 -1.96 67.35 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.436 -1.364 . . . . 0.0 109.696 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -172.46 2.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.841 -0.8 . . . . 0.0 109.401 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.74 16.02 9.61 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.4 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 67.0 t-105 -59.55 -43.47 93.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.409 -1.054 . . . . 0.0 110.28 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.8 -57.61 10.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -51.21 -44.87 61.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.078 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 62.2 t80 -61.81 -52.42 64.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.633 -0.667 . . . . 0.0 110.674 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.4 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 16.8 mm-40 -60.53 -44.88 95.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 0.0 111.319 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.71 -58.6 4.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.918 -1.114 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.22 -33.73 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.452 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 13.1 ttt180 -62.37 -43.71 98.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.26 12.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.951 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -143.24 34.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.097 . . . . 0.0 110.329 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 82' ' ' LEU . 46.9 mt -80.75 138.55 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 tp -132.3 128.87 38.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.331 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -87.87 140.5 29.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.694 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.72 -170.85 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.9 69.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.24 -0.913 . . . . 0.0 110.599 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.01 130.12 2.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.959 -1.088 . . . . 0.0 109.708 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.76 145.97 51.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.984 . . . . 0.0 109.817 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 85' ' ' THR . 35.4 mt -90.87 151.48 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -94.06 79.8 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 50.0 m-85 -59.93 143.01 52.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.483 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.1 101.5 14.16 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.78 132.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.707 -0.62 . . . . 0.0 110.785 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -70.12 111.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -88.49 -30.48 19.35 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.104 -0.998 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -133.06 149.29 72.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 109.663 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.32 155.66 55.64 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.372 2.048 . . . . 0.0 112.118 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.71 153.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -139.33 141.04 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.835 . . . . 0.0 109.257 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.42 148.85 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.72 158.28 44.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 135' ' ' GLU . 43.4 t0 -174.51 105.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.933 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 134' ' ' ASP . 5.5 mt-10 49.7 54.74 10.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.7 -36.31 3.14 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.448 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.475 ' HB3' HD22 ' A' ' 255' ' ' LEU . 2.4 mpt_? -61.55 134.36 56.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 108.657 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -147.79 138.52 23.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 255' ' ' LEU . 75.5 mt -135.69 132.13 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.662 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 142' ' ' GLU . 19.0 tttm -117.72 131.05 56.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.707 -0.621 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.79 55.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 140' ' ' LYS . 9.7 pt-20 -148.29 151.65 37.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.774 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -49.42 142.68 22.36 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.439 2.093 . . . . 0.0 113.445 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.44 141.35 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.03 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -60.98 -6.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.836 . . . . 0.0 110.602 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.4 p -152.79 -173.52 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.926 -1.109 . . . . 0.0 109.546 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 148' ' ' GLU . 8.8 tp -96.29 120.45 36.61 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 108.865 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.1 tt0 -136.57 129.41 30.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.21 123.61 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 95.9 m -113.51 152.35 30.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.749 -0.594 . . . . 0.0 109.481 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -141.85 132.39 25.37 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.31 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.18 132.72 54.59 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.27 147.16 19.04 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.184 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.28 98.28 6.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -85.57 167.84 15.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.632 0.729 . . . . 0.0 110.894 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -97.55 -9.94 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 111.302 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' LEU . 30.7 p-10 -102.76 -170.94 1.87 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 111.036 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -48.2 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.806 -0.559 . . . . 0.0 111.509 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.7 mt -80.29 -29.75 38.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.479 -1.388 . . . . 0.0 108.534 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.41 -133.73 46.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.425 HH11 ' HB2' ' A' ' 161' ' ' ARG . 13.0 ttp-105 -107.88 136.27 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -1.075 . . . . 0.0 109.391 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.694 -0.629 . . . . 0.0 109.303 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.13 147.84 29.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.44 -0.788 . . . . 0.0 109.604 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.495 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 9.8 t80 -147.9 143.18 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.084 -1.01 . . . . 0.0 110.3 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.458 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 89.4 m -110.17 123.81 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.798 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.21 116.93 33.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.414 HG22 ' CG ' ' A' ' 148' ' ' GLU . 56.0 t -106.57 149.4 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.011 0.91 . . . . 0.0 110.405 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.61 134.44 24.36 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.385 -0.822 . . . . 0.0 109.197 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.11 -9.18 42.68 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.09 28.19 8.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.199 -1.177 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.7 pm0 -60.41 -36.67 78.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.56 -17.0 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.86 -5.99 46.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.835 -1.166 . . . . 0.0 111.517 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.2 pt -121.21 -29.82 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.061 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.9 m -61.99 -15.81 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.626 -1.296 . . . . 0.0 108.803 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.98 -2.85 55.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.48 114.49 7.76 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -77.58 172.93 12.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.4 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.3 t -77.25 162.49 27.31 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.2 143.85 30.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.366 -1.459 . . . . 0.0 111.427 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.79 155.78 44.87 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.44 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 71.4 m-85 -99.38 140.41 33.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.494 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.07 -37.54 9.7 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.369 -0.832 . . . . 0.0 110.345 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.3 p90 -70.16 -26.81 64.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.734 -1.229 . . . . 0.0 110.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.7 OUTLIER -88.5 -35.05 17.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.94 -1.1 . . . . 0.0 110.441 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 205' ' ' VAL . 73.5 mt -48.23 -58.18 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 0.0 109.708 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.9 OUTLIER -42.92 -36.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.16 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.461 ' O ' HG22 ' A' ' 192' ' ' VAL . 19.6 t60 -72.63 -50.22 26.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.752 . . . . 0.0 109.136 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 81.7 mt -52.17 -29.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -80.87 -53.04 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.798 -1.189 . . . . 0.0 109.022 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -48.55 -40.45 27.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.4 m -77.62 6.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.026 -1.046 . . . . 0.0 110.364 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.18 38.79 38.73 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.228 -0.986 . . . . 0.0 110.655 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.413 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.6 mt -130.91 -179.71 5.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -1.155 . . . . 0.0 109.515 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 54.64 23.44 28.68 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.578 -0.701 . . . . 0.0 111.488 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -57.06 -21.13 29.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.602 -1.528 . . . . 0.0 110.435 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.92 5.47 34.49 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.985 -1.103 . . . . 0.0 110.559 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.74 129.3 41.73 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 120.925 -1.338 . . . . 0.0 110.451 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.14 167.0 25.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.353 -1.086 . . . . 0.0 108.822 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 75.4 mt -71.03 -7.71 48.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.492 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.83 -11.46 21.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.528 -0.733 . . . . 0.0 110.309 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.501 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 11.7 p-10 -130.94 9.77 4.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.82 152.22 32.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 110.416 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.4 tp -99.2 95.46 7.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 186' ' ' ILE . 52.6 t -87.49 129.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.672 0.749 . . . . 0.0 109.606 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.5 mt -123.82 164.16 19.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.55 -0.719 . . . . 0.0 109.306 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.55 -166.36 11.97 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.517 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 1.1 tppp? -57.02 -36.83 70.91 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.555 -0.968 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.89 26.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 110.57 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.29 148.44 39.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.696 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.28 112.94 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.69 -49.93 75.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.972 -1.08 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.4 m120 -58.92 112.29 4.84 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 0.0 110.193 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -58.44 -11.73 11.86 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.576 1.517 . . . . 0.0 111.501 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 -18.53 57.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.381 -0.825 . . . . 0.0 109.92 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.32 -173.63 50.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.616 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -89.18 140.35 29.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -1.222 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -78.06 -21.17 51.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.416 -0.803 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -138.58 154.77 48.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.177 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -67.09 -1.88 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.744 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.536 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -148.48 46.14 1.04 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.128 -0.983 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.17 -46.56 99.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.697 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -52.55 -66.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.371 2.047 . . . . 0.0 112.044 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.41 -35.9 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.976 -1.077 . . . . 0.0 109.439 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.536 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 68.4 mtt-85 -60.67 -41.48 95.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -67.1 -31.77 72.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.766 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -65.21 -36.9 85.61 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.6 t -68.55 -35.5 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.56 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 73.1 t80 -66.32 -54.14 28.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.88 -27.08 68.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.933 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.26 -33.76 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 33.7 mt -68.23 -38.93 80.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.76 -57.33 12.67 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.55 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.6 m-20 -54.24 -34.42 60.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 109.274 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.4 mt -60.88 -23.8 65.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 110.219 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.18 -22.31 61.3 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.902 -1.124 . . . . 0.0 108.91 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.424 HD11 HG21 ' A' ' 60' ' ' THR . 95.8 mt -52.58 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.712 -1.243 . . . . 0.0 110.629 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.569 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.05 -13.0 60.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.744 -1.223 . . . . 0.0 109.66 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.84 -0.79 57.83 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.503 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.57 156.28 10.34 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.914 -1.345 . . . . 0.0 108.829 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.6 Cg_endo -49.93 150.68 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.892 1.728 . . . . 0.0 109.552 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.08 148.36 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.988 -1.07 . . . . 0.0 112.125 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -130.97 124.17 30.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.97 -157.32 27.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -131.85 145.11 51.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -1.074 . . . . 0.0 108.951 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.2 m-85 -141.51 142.44 33.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.485 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.34 123.15 37.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.3 m -115.85 134.81 54.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 250' ' ' ARG . 60.5 t80 -116.54 117.01 28.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.3 OUTLIER 45.4 24.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.161 -0.962 . . . . 0.0 109.425 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.57 164.74 45.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.491 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -142.73 171.52 24.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.55 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 60.9 m-70 -51.01 -34.87 31.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -1.225 . . . . 0.0 109.635 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.7 m -60.03 -57.82 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 139' ' ' ILE . 7.0 tp -61.57 -43.8 98.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.008 . . . . 0.0 109.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.5 m-20 -47.33 -46.84 25.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.88 -1.138 . . . . 0.0 108.577 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 56' ' ' THR . 60.5 t -64.15 -50.46 76.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.59 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -55.32 -51.18 67.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.997 -1.065 . . . . 0.0 109.285 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 139' ' ' ILE . 46.9 tp -51.07 -50.7 58.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.152 -0.967 . . . . 0.0 108.588 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.563 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.9 t -57.06 -54.79 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.458 ' NZ ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.89 -55.07 8.65 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 109.597 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.57 -51.29 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.95 -51.91 59.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.81 -25.51 65.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.34 -179.232 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.219 0.533 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' HD21 ' A' ' 86' ' ' ASN . 1.6 mm-40 -56.43 136.14 53.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.087 -1.008 . . . . 0.0 108.579 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HZ1' ' HB3' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -121.96 143.23 49.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.8 t -141.69 -170.46 3.12 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.8 m -101.6 138.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.483 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 9' ' ' GLU . 7.8 ptmm? -66.96 -25.37 66.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 8.2 pt-20 -148.14 158.4 44.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.993 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 142.32 57.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.481 -0.762 . . . . 0.0 110.133 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 11' ' ' LEU . 20.7 mt -120.68 167.07 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -137.13 142.25 42.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 26' ' ' LEU . 95.0 m-85 -139.26 151.7 46.69 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.48 153.44 19.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.0 110.023 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.44 177.02 36.77 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.83 153.7 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -1.047 . . . . 0.0 110.025 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.97 140.36 15.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.483 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.9 tt -60.46 -38.44 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -1.152 . . . . 0.0 110.807 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 73.8 m-70 -90.02 -51.26 5.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.564 -1.335 . . . . 0.0 110.963 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.1 p -70.11 -22.25 63.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.774 -0.579 . . . . 0.0 111.237 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.6 19.44 27.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -111.44 155.06 23.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -1.059 . . . . 0.0 109.788 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -74.34 137.0 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.647 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -143.16 143.59 31.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.064 -1.022 . . . . 0.0 109.594 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -108.14 160.06 16.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -139.84 145.13 37.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.731 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.466 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.8 mt -140.33 116.26 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 108.972 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.14 111.89 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.466 ' NE2' HG22 ' A' ' 27' ' ' ILE . 61.5 m-70 -107.46 139.89 20.97 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.1 Cg_exo -54.81 168.15 1.26 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.836 1.691 . . . . 0.0 111.495 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -142.12 178.93 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.611 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 mmtm -87.7 153.32 21.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' OE2' ' N ' ' A' ' 118' ' ' ASN . 63.1 mt-10 -47.51 146.43 2.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.496 -0.752 . . . . 0.0 109.939 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.26 4.71 45.09 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.032 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.586 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -67.92 -44.56 76.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.618 -1.519 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -179.26 32.14 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.471 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.76 115.74 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 6.8 ptm180 -140.3 152.09 45.59 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.951 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.03 157.81 16.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.9 111.09 12.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -134.7 133.51 40.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.73 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 53.16 28.33 6.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.577 -0.702 . . . . 0.0 111.401 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 18.88 69.95 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.399 -1.382 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 122.05 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -1.069 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 28.5 m-85 -83.82 127.07 33.56 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 mt -116.54 92.93 38.86 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.242 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.5 149.0 18.85 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.504 2.136 . . . . 0.0 112.086 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.44 69.4 9.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -121.31 170.95 9.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.2 p-80 -74.18 -48.58 28.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.622 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.56 -16.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.47 4.33 53.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.73 -1.231 . . . . 0.0 109.92 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -71.51 141.68 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.17 -29.26 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -0.847 . . . . 0.0 110.114 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -151.67 129.84 11.93 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 109.965 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -120.63 95.36 4.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.7 t-20 -163.28 129.41 3.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 73.3 m-70 49.9 9.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.177 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER 162.48 150.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.706 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -91.22 124.42 35.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 109.288 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.13 148.59 42.9 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.651 0.739 . . . . 0.0 110.637 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 72' ' ' VAL . 10.7 mt -125.48 153.2 43.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.35 154.55 25.35 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 118.974 -1.584 . . . . 0.0 110.747 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -161.37 149.83 15.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -1.017 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.8 mttt 46.36 24.18 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.621 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -34.45 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -54.87 145.57 19.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.255 . . . . 0.0 109.045 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -145.36 135.39 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 110.613 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.16 120.28 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -97.8 159.11 15.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 0.0 111.193 -178.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 71' ' ' THR . 91.7 m 46.52 74.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 62' ' ' LEU . 20.6 m -107.37 -8.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -60.61 -25.19 66.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.152 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.1 m170 -67.97 -69.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.049 . . . . 0.0 109.415 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.4 -47.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.099 -1.001 . . . . 0.0 109.129 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' N ' HG23 ' A' ' 75' ' ' ILE . 19.9 mt -52.08 -50.18 62.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.026 . . . . 0.0 110.137 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 39.2 t -60.32 -41.55 93.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.113 -0.992 . . . . 0.0 110.071 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 106' ' ' PHE . 97.4 t -56.88 -44.95 83.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.051 -1.031 . . . . 0.0 109.217 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.72 -33.76 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -62.89 -40.86 98.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 109.179 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD12 ' CG1' ' A' ' 175' ' ' VAL . 37.5 mt -75.38 -39.09 59.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.852 . . . . 0.0 109.702 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 82' ' ' LEU . 67.8 mt -79.42 -1.07 35.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.94 42.1 26.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 111.414 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 23.1 mm -90.69 139.91 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 108.226 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 73.3 p -126.9 -19.15 4.51 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.745 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.73 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.2 m-80 -124.98 106.25 9.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.827 -1.171 . . . . 0.0 110.274 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -165.86 150.67 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.729 0.776 . . . . 0.0 109.916 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.0 m -116.17 117.84 31.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.575 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.9 mt -100.19 100.36 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.352 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.1 mt-10 -71.77 126.08 28.8 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG22 HD21 ' A' ' 26' ' ' LEU . 19.2 t -112.55 121.02 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.949 0.88 . . . . 0.0 111.807 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mm -107.77 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.72 160.05 8.2 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -83.05 -7.45 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.267 . . . . 0.0 111.219 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -139.35 147.59 41.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.725 -1.234 . . . . 0.0 110.36 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 40.3 mm -73.18 121.28 84.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -41.82 123.83 2.48 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.665 1.577 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.2 tp -76.58 -15.4 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.678 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.7 mt 57.0 -122.09 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 27.0 t70 -93.36 7.3 45.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.024 -1.048 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.84 -3.9 62.94 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.243 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.94 -172.0 2.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.911 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.39 14.53 9.36 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -57.94 -41.76 83.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 0.0 110.284 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.89 -55.7 17.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.019 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' A' ' 78' ' ' VAL . 7.2 m-85 -51.4 -45.81 62.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 108.927 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.96 -54.18 48.12 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.268 0.556 . . . . 0.0 110.62 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.98 -43.69 98.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 111.508 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . . . -65.59 -56.83 10.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.961 -1.087 . . . . 0.0 110.363 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.12 -30.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 109.355 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -65.26 -43.36 91.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.307 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ1' ' HA ' ' A' ' 109' ' ' ALA . 3.7 pttm -76.41 9.88 2.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.892 -1.13 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -140.89 36.45 1.77 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 0.0 109.926 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -85.29 140.68 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 111.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -131.42 122.0 25.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.584 -0.697 . . . . 0.0 109.129 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.506 ' HB3' ' HZ1' ' A' ' 5' ' ' LYS . 6.7 m-80 -79.37 146.32 32.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -111.26 -174.45 2.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.447 -0.783 . . . . 0.0 109.42 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 26.8 t-20 -111.69 70.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.852 . . . . 0.0 110.579 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -168.41 134.69 1.9 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.355 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.39 143.98 51.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.065 -1.022 . . . . 0.0 110.15 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.11 151.43 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 0.0 110.233 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.53 83.78 3.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 108.872 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 15.0 m-85 -63.12 142.13 58.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.291 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -86.94 101.36 13.34 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.7 133.47 33.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 110.75 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.29 111.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.45 -30.1 23.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.138 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.92 155.34 77.89 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.01 149.87 53.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.536 2.158 . . . . 0.0 112.234 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.555 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.77 149.83 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 108.942 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.75 140.93 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.78 145.96 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.63 156.95 47.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -174.3 107.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.851 . . . . 0.0 109.929 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 53.33 52.86 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.51 -31.66 3.22 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -61.77 134.91 57.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.242 . . . . 0.0 108.52 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 138' ' ' LEU . 1.1 tt -147.5 137.12 22.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.854 -1.154 . . . . 0.0 109.901 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.551 HG13 HD23 ' A' ' 255' ' ' LEU . 75.4 mt -136.41 125.51 37.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.454 -0.779 . . . . 0.0 109.451 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -114.21 132.08 56.24 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.511 0.672 . . . . 0.0 109.932 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.05 134.66 54.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.69 149.18 32.94 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.921 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -45.87 143.04 7.22 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.62 2.213 . . . . 0.0 113.447 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.2 t -156.61 144.82 19.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 146' ' ' THR . 53.5 t0 -62.75 -5.6 2.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.898 . . . . 0.0 110.332 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' ASP . 24.6 p -156.15 -167.43 2.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.359 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.0 tp -102.51 121.49 42.47 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -134.5 108.24 8.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.68 122.79 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.07 -1.019 . . . . 0.0 110.206 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 m -112.76 151.13 30.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 38.9 t80 -141.64 130.47 22.97 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.126 -1.029 . . . . 0.0 111.234 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -120.98 133.96 55.29 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.08 142.11 13.49 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.601 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -104.06 99.41 9.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -87.87 167.41 13.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.558 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -105.55 -11.53 16.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.471 -0.768 . . . . 0.0 110.72 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 159' ' ' LEU . 31.1 p-10 -98.53 -164.83 1.17 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.789 -1.195 . . . . 0.0 110.456 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -55.41 0.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 111.161 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 157' ' ' ASN . 16.5 mt -83.61 -30.4 26.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.504 -1.372 . . . . 0.0 108.565 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.27 -138.67 42.8 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -99.91 135.87 40.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -1.151 . . . . 0.0 109.306 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -144.8 159.03 43.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.435 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 149.85 33.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 110.159 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -143.63 140.67 30.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.8 m -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.705 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.548 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.6 t80 -105.2 114.39 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.44 152.95 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -49.8 126.11 13.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.175 -0.953 . . . . 0.0 108.975 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.503 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 106.24 2.11 38.49 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -121.02 21.54 11.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.248 -1.148 . . . . 0.0 109.718 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.1 pm0 -59.32 -54.7 43.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 4.3 mt-10 -41.42 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 0.0 110.085 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 171' ' ' GLU . 67.3 mm-40 -87.59 -6.99 58.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 111.731 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.56 -27.73 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.863 -1.148 . . . . 0.0 111.282 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' A' ' 81' ' ' LEU . 5.0 m -63.32 -17.27 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 108.669 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mt -90.02 -5.89 56.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.266 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.87 119.07 13.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -79.94 173.06 12.97 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.442 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -76.37 162.51 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -146.19 146.87 30.97 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.237 -1.539 . . . . 0.0 111.421 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.78 157.8 43.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 81.3 m-85 -100.04 146.48 26.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.94 -1.1 . . . . 0.0 109.092 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -50.14 -33.73 19.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.109 -0.995 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.6 p90 -74.33 -28.31 61.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.786 -1.197 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -75.21 -35.58 61.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 65.0 mt -52.34 -49.93 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -47.34 -41.66 19.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 110.079 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -74.34 -48.34 28.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.131 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.2 mt -52.38 -30.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.44 -53.77 5.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 0.0 109.365 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -48.88 -32.59 9.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.487 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.8 m -87.16 7.66 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.02 . . . . 0.0 110.506 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.73 39.88 54.38 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.083 -1.01 . . . . 0.0 110.725 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.53 174.75 9.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -1.216 . . . . 0.0 109.808 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.7 22.13 52.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -57.97 -19.91 34.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.679 -1.483 . . . . 0.0 109.63 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.32 10.34 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 125.47 7.76 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 120.859 -1.377 . . . . 0.0 109.72 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.4 t -143.27 169.47 17.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -1.146 . . . . 0.0 109.806 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.56 -8.73 36.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -13.26 25.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -136.18 11.32 3.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.14 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.433 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.06 149.28 30.09 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 110.275 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.3 tp -98.94 93.32 5.96 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 203' ' ' THR . 48.8 t -86.1 130.03 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.738 0.78 . . . . 0.0 109.019 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.41 164.92 18.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.632 -0.667 . . . . 0.0 109.365 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -127.03 -166.6 12.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -61.69 -32.43 72.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 109.552 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.6 22.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -142.09 149.17 39.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.808 -1.183 . . . . 0.0 110.688 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.407 HG11 ' HA2' ' A' ' 216' ' ' GLY . 87.6 t -101.96 111.32 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -58.23 -47.01 84.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 110.063 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.16 124.17 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 109.787 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -67.09 -18.07 51.16 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.57 1.514 . . . . 0.0 111.965 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 -15.34 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.923 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.13 -163.53 53.99 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.638 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -91.55 148.35 22.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.207 . . . . 0.0 109.833 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -87.0 -18.36 30.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 108.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.499 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 60.2 m-85 -137.73 178.69 6.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -82.88 -14.18 54.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.68 52.25 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.514 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -58.18 -48.19 97.47 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.039 -1.038 . . . . 0.0 109.89 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.8 Cg_exo -49.79 -68.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 228' ' ' VAL . 20.7 m -58.77 -34.71 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.005 -1.059 . . . . 0.0 109.604 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.499 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 56.2 mtt180 -61.23 -41.18 96.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -67.26 -31.65 72.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.326 -0.95 . . . . 0.0 108.692 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 12.8 mmtp -66.07 -37.33 85.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 166' ' ' PHE . 56.0 t -67.3 -35.87 75.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.1 t80 -65.84 -54.77 22.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.554 0.693 . . . . 0.0 109.236 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.11 -27.91 69.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.753 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.67 -34.08 58.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 108.394 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.79 -39.45 85.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -57.88 8.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.411 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 78.6 m-20 -51.4 -34.65 35.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -1.23 . . . . 0.0 109.001 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.6 mt -62.52 -22.76 66.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.038 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.08 -22.97 60.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.857 -1.152 . . . . 0.0 108.919 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 237' ' ' LEU . 94.6 mt -50.15 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.699 -1.251 . . . . 0.0 109.909 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 236' ' ' TYR . 9.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.478 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 1.42 59.33 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.485 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.95 156.93 10.08 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.012 -1.287 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.36 150.35 8.09 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.966 1.778 . . . . 0.0 109.655 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.07 143.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 112.133 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.01 121.53 33.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.49 175.27 23.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -101.9 135.26 43.77 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.203 -1.175 . . . . 0.0 109.276 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.8 m-85 -130.76 136.52 48.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.288 -0.882 . . . . 0.0 109.596 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -126.17 126.15 43.64 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 m -119.42 133.08 55.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.853 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.539 ' CZ ' ' NE ' ' A' ' 250' ' ' ARG . 74.8 t80 -115.34 112.83 22.96 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.539 ' NE ' ' CZ ' ' A' ' 249' ' ' PHE . 71.4 mtt180 48.41 32.48 3.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.81 165.26 54.71 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -140.33 179.64 18.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.588 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.4 m-70 -59.64 -41.62 90.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -1.203 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.091 -1.006 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 139' ' ' ILE . 5.8 tp -57.94 -45.13 87.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.424 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 11.0 m-20 -47.42 -51.25 20.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.989 -1.07 . . . . 0.0 109.077 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 56' ' ' THR . 71.3 t -62.91 -44.71 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -0.793 . . . . 0.0 109.849 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -58.75 -50.08 75.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 0.0 109.292 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.86 -49.18 69.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 108.695 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 238' ' ' LEU . 17.2 t -60.43 -58.2 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.077 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -43.32 17.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 109.061 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 130' ' ' ILE . 2.8 mm-40 -66.24 -47.12 74.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.32 -49.63 76.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -70.48 -28.6 65.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.023 -1.048 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 85' ' ' THR . 9.4 mm-40 -54.45 139.65 36.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 108.71 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -122.66 146.27 47.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 110.234 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -143.61 -171.62 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.0 m -99.35 135.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.971 -1.081 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -65.19 -21.61 66.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.778 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.591 ' HG2' HD21 ' A' ' 113' ' ' ASN . 18.7 pt-20 -152.86 158.72 42.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 140.46 58.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.288 -0.883 . . . . 0.0 110.055 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -118.22 164.8 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -131.32 139.87 49.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 110.18 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -138.05 146.23 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.1 154.05 24.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 110.349 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.87 175.21 36.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.33 151.68 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -1.07 . . . . 0.0 110.069 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.75 138.66 15.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CG2' HD13 ' A' ' 98' ' ' ILE . 8.7 tt -59.73 -37.21 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -1.22 . . . . 0.0 110.403 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 29.6 m-70 -89.66 -50.66 5.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.66 -1.275 . . . . 0.0 111.08 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 p -70.66 -24.26 62.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.797 -0.565 . . . . 0.0 111.822 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.21 14.64 26.7 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.146 -1.502 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.07 155.38 19.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -1.142 . . . . 0.0 109.407 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -75.24 134.53 41.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m -137.55 145.84 43.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -114.54 155.26 26.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.451 -0.78 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 96' ' ' ILE . 9.1 mt -136.25 144.19 44.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.643 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' NE2' ' A' ' 29' ' ' HIS . 4.7 mp -139.49 112.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.81 115.76 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.349 -0.845 . . . . 0.0 110.858 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.562 ' NE2' HG22 ' A' ' 27' ' ' ILE . 19.6 m-70 -106.96 139.68 20.64 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.495 -0.753 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.3 Cg_exo -56.46 168.24 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.533 1.489 . . . . 0.0 111.238 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 35' ' ' THR . 50.1 mm-40 -144.51 163.39 34.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 109.629 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -74.55 155.42 37.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 118' ' ' ASN . 5.2 mt-10 -49.96 149.88 2.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.174 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.26 19.52 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.042 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.47 HG21 ' HB3' ' A' ' 31' ' ' GLU . 90.0 m -58.0 -48.53 79.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.555 -1.556 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.68 178.42 35.17 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mm -92.97 116.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -1.033 . . . . 0.0 108.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 35' ' ' THR . 14.1 ptp180 -144.18 151.01 38.92 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.456 -1.297 . . . . 0.0 110.883 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.97 157.06 16.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -129.87 111.83 12.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.413 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -135.19 134.88 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 110.735 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.2 27.39 2.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.608 -0.682 . . . . 0.0 111.247 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.72 66.2 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.04 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.23 120.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 108.808 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -84.77 126.06 33.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.12 -0.987 . . . . 0.0 109.192 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.1 mt -117.01 91.45 36.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.13 148.06 14.4 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.667 2.245 . . . . 0.0 112.077 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.13 70.38 9.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -128.54 174.44 9.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 109.186 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.7 p-80 -71.52 -49.58 39.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -43.19 -17.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 111.496 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.4 m-85 -100.2 -2.47 33.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.684 -1.26 . . . . 0.0 110.163 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.4 t -66.92 121.13 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.185 -0.947 . . . . 0.0 108.576 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.99 -30.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.275 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.32 136.24 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.254 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 257' ' ' VAL . 66.9 p -123.75 95.96 4.78 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.0 t-20 -162.47 129.05 3.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 108.882 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 91.6 m-70 50.19 8.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 108.983 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.26 147.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.851 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 m -90.13 128.29 36.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.322 -0.861 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.75 150.6 41.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.478 -0.763 . . . . 0.0 111.056 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.542 HD12 HG11 ' A' ' 72' ' ' VAL . 9.0 mt -123.89 149.49 45.78 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.02 150.31 20.42 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -162.82 148.17 12.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.423 -1.045 . . . . 0.0 108.965 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.452 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.06 25.93 2.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 109.677 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.92 5.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.549 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 5.3 mm-40 -57.45 145.1 34.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -1.221 . . . . 0.0 109.152 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.58 137.71 26.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 110.407 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 96' ' ' ILE . 55.5 mt -131.18 125.94 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -101.08 156.21 17.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.023 -1.048 . . . . 0.0 111.294 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.0 m 51.79 75.29 0.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 HD12 ' A' ' 62' ' ' LEU . 34.9 m -107.52 -9.06 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.11 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pm0 -61.4 -26.34 67.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 0.0 110.361 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 30.8 m170 -68.2 -69.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.068 -1.02 . . . . 0.0 109.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -51.88 -48.42 39.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.197 -0.939 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.605 ' N ' HG23 ' A' ' 75' ' ' ILE . 13.1 mt -51.86 -48.8 63.87 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.006 -1.058 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -60.26 -43.09 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.119 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 106' ' ' PHE . 94.8 t -56.67 -45.69 82.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 109.193 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 89' ' ' ILE . 25.6 mt -65.97 -34.37 77.96 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.212 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -63.37 -37.0 85.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.316 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 171' ' ' GLU . 78.3 mt -77.13 -38.91 51.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 107' ' ' TYR . 96.1 mt -80.64 6.53 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 110.034 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 52.36 39.73 27.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 110.07 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.69 141.66 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 108.267 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.61 HG21 HG12 ' A' ' 121' ' ' ILE . 54.9 p -128.98 -22.6 3.17 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.114 -0.991 . . . . 0.0 111.873 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.681 ' O ' HG13 ' A' ' 87' ' ' VAL . 76.9 m-20 -124.0 107.72 11.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.874 -1.141 . . . . 0.0 110.278 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.8 142.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.519 -0.738 . . . . 0.0 110.138 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 96.0 m -109.42 111.46 23.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 79' ' ' LEU . 6.5 mt -93.97 100.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 110.311 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -75.08 125.46 28.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.612 HG22 HD21 ' A' ' 26' ' ' LEU . 16.1 t -114.75 118.39 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.947 0.879 . . . . 0.0 111.675 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' ILE . 11.0 mt -105.4 98.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.84 -159.23 27.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 -13.63 8.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -1.135 . . . . 0.0 110.421 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -138.73 146.99 42.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.979 -1.076 . . . . 0.0 109.676 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.68 HG23 HD11 ' A' ' 26' ' ' LEU . 43.5 mm -70.08 119.83 74.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 108.706 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.27 124.49 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.88 1.72 . . . . 0.0 111.62 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.497 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.0 tp -76.39 -15.42 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 110.206 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.7 mt 55.36 -123.14 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -92.66 8.97 36.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.15 -7.87 69.63 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.47 -1.348 . . . . 0.0 109.973 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.2 p -124.02 -172.1 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.61 -0.936 . . . . 0.0 109.16 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.62 13.71 11.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 48.3 t-105 -56.08 -42.33 76.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -1.125 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.27 -54.78 31.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 78' ' ' VAL . 10.3 m-85 -54.85 -46.49 74.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.118 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 82' ' ' LEU . 34.5 t80 -60.69 -56.54 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.731 -0.606 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 13.6 mm-40 -58.88 -44.01 91.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.145 -0.972 . . . . 0.0 111.337 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.6 -51.79 46.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.964 -1.085 . . . . 0.0 110.719 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.7 mt -69.31 -31.87 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.155 . . . . 0.0 109.344 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.46 -43.22 94.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 110.258 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.23 17.05 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.591 HD21 ' HG2' ' A' ' 9' ' ' GLU . 2.3 m120 -144.05 29.04 1.35 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -0.999 . . . . 0.0 110.169 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.7 mt -79.61 141.35 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.607 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.58 123.47 33.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.612 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.97 141.0 37.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.94 . . . . 0.0 110.314 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.85 -175.74 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.394 -0.816 . . . . 0.0 109.26 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.487 ' OD1' ' OE2' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -109.66 70.09 0.72 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.085 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -169.22 134.03 1.48 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.082 -1.011 . . . . 0.0 109.503 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.13 142.56 54.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.61 HG12 HG21 ' A' ' 85' ' ' THR . 35.0 mt -84.79 150.16 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 110.024 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.74 90.0 4.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -68.94 148.03 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.94 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -90.12 101.98 14.69 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.22 134.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.612 -0.68 . . . . 0.0 111.204 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.21 118.72 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.51 -27.04 15.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.522 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.18 152.5 79.66 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 151.52 46.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.64 2.226 . . . . 0.0 112.286 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.9 tt -160.04 153.15 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.336 -0.853 . . . . 0.0 109.29 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.11 145.31 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.84 149.29 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 138' ' ' LEU . 28.8 mt-10 -139.85 157.86 45.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.132 -0.98 . . . . 0.0 110.196 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.86 111.35 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.252 -0.905 . . . . 0.0 109.93 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 52.47 48.19 23.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.541 -0.724 . . . . 0.0 110.833 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.6 -33.59 3.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.366 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 1.5 mpt_? -64.31 131.95 48.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.915 -1.344 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -145.03 141.63 29.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 110.357 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 255' ' ' LEU . 92.4 mt -136.88 132.18 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.779 . . . . 0.0 109.859 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.43 133.04 56.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.413 0.625 . . . . 0.0 110.007 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.71 135.33 53.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.727 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.02 149.62 39.51 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.868 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -48.48 142.4 17.73 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.523 2.149 . . . . 0.0 113.382 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.12 145.19 19.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.97 -30.43 70.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -127.01 -171.14 2.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.74 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.467 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 12.3 tp -100.15 123.46 44.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.163 -0.96 . . . . 0.0 108.675 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 tt0 -136.28 118.03 15.07 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.233 -0.917 . . . . 0.0 108.555 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.84 122.2 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.47 ' OG1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 m -113.15 152.05 30.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.479 -0.763 . . . . 0.0 109.679 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 227' ' ' LYS . 39.2 t80 -138.78 130.79 28.08 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.948 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -119.98 130.44 54.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.78 135.64 8.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.645 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -98.55 100.39 11.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.79 167.02 13.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 110.66 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -102.84 -22.53 13.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.912 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' LEU . 26.0 p-10 -88.05 -171.42 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.701 -1.249 . . . . 0.0 109.986 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -52.23 1.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 111.458 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.5 mt -79.44 -28.58 41.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.353 -1.467 . . . . 0.0 108.71 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.05 -142.55 35.15 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -99.6 135.65 40.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -138.26 153.5 49.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.812 . . . . 0.0 109.41 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -141.22 144.85 34.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.288 -0.882 . . . . 0.0 109.754 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.583 ' CE1' ' NH2' ' A' ' 225' ' ' ARG . 49.2 t80 -142.05 132.89 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.661 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 86.9 m -103.78 122.68 45.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.2 t80 -103.83 114.06 28.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.9 152.79 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.737 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 3.2 mm-40 -49.96 128.19 18.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.69 1.81 43.1 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -117.83 20.29 13.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.15 -51.47 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 5.0 mt-10 -47.76 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 171' ' ' GLU . 9.3 mm-40 -102.94 -6.11 22.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.123 -0.985 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.7 pt -125.16 -26.84 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.959 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 175' ' ' VAL . 5.2 m -62.13 -10.66 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.815 -1.178 . . . . 0.0 109.106 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -98.46 -2.17 39.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 0.0 109.078 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.44 122.2 16.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 215' ' ' GLU . 52.5 mtm180 -94.23 128.27 40.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.869 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 12.5 t -36.53 158.67 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -145.2 150.0 35.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.51 -1.369 . . . . 0.0 111.49 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.39 157.05 43.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.6 m-85 -97.7 145.52 26.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.442 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.97 -37.11 8.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.363 -0.835 . . . . 0.0 109.278 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -74.29 -29.56 61.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.1 mm-40 -71.52 -31.64 67.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 59.6 mt -57.24 -55.07 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.669 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.8 tt0 -42.85 -38.74 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.13 -0.981 . . . . 0.0 109.302 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 189' ' ' ILE . 9.3 t60 -76.3 -59.34 2.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.051 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 188' ' ' HIS . 82.9 mt -41.75 -36.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.698 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -79.43 -51.83 8.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.875 -1.141 . . . . 0.0 109.226 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -49.35 -27.17 3.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 110.709 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.51 11.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.746 -1.221 . . . . 0.0 110.086 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.44 39.54 69.35 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.433 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.1 mt -129.61 172.59 11.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -1.179 . . . . 0.0 109.998 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.99 21.84 59.54 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -58.93 -21.19 57.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.463 -1.61 . . . . 0.0 109.749 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.405 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.56 25.51 11.03 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -87.49 132.94 11.48 Favored Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.923 -1.34 . . . . 0.0 109.921 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.9 174.39 11.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -1.095 . . . . 0.0 109.564 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.18 -7.52 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 108.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -97.51 -19.97 18.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.603 -0.686 . . . . 0.0 110.003 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.8 p30 -125.68 3.35 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -144.54 145.35 31.79 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.636 HD11 HD21 ' A' ' 206' ' ' LEU . 25.8 tp -96.35 96.13 8.54 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.53 128.22 39.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.9 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.636 HD21 HD11 ' A' ' 204' ' ' LEU . 29.7 mt -123.38 162.99 21.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.539 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.2 -166.28 12.74 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -24.54 66.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.457 -1.025 . . . . 0.0 109.966 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.6 24.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -151.97 160.47 43.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.515 -1.365 . . . . 0.0 110.643 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.559 HG11 ' HA2' ' A' ' 216' ' ' GLY . 88.5 t -106.08 114.01 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -57.56 -46.94 83.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 110.46 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 213' ' ' ASN . 1.3 m-20 -59.31 130.39 87.21 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.17 -0.956 . . . . 0.0 110.53 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -67.88 -21.62 43.77 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.682 1.588 . . . . 0.0 111.688 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -80.71 -15.46 56.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.957 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.559 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.51 -157.5 53.29 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.262 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.6 mt -89.19 154.44 20.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -1.138 . . . . 0.0 110.138 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -90.14 -19.54 24.14 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -138.75 -176.5 4.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 19.2 mp0 -83.6 -20.16 34.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 109.529 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -136.12 54.7 1.89 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -57.59 -46.31 99.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.893 -1.13 . . . . 0.0 109.848 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.6 Cg_exo -52.67 -66.26 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.221 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 225' ' ' ARG . 21.9 m -59.69 -36.07 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 109.512 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.583 ' NH2' ' CE1' ' A' ' 164' ' ' PHE . 74.6 mtt-85 -59.79 -41.21 90.67 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -68.17 -31.64 71.34 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.1 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.4 ' HB3' ' CD2' ' A' ' 151' ' ' TYR . 16.9 mmtt -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 166' ' ' PHE . 64.3 t -69.17 -38.37 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.3 t80 -62.56 -51.34 67.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 108.892 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.76 -29.51 70.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.526 -0.733 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.87 -33.77 51.97 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.3 mt -65.76 -37.81 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.22 -56.1 11.29 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.425 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 92.4 m-20 -52.67 -37.14 58.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.246 . . . . 0.0 109.309 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.2 mt -60.04 -24.04 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 110.497 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.592 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -70.66 -21.58 62.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.783 -1.198 . . . . 0.0 108.792 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.13 3.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.56 -1.338 . . . . 0.0 110.318 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 260' ' ' VAL . 7.7 mt -82.98 -16.47 47.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 0.0 109.585 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.17 44.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.913 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.75 158.69 11.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.428 . . . . 0.0 109.297 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.15 128.3 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.874 1.716 . . . . 0.0 109.456 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.1 t -87.86 154.56 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.992 -1.068 . . . . 0.0 112.387 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -136.26 127.57 28.3 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.38 -155.0 25.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.47 ' NZ ' ' OG1' ' A' ' 150' ' ' THR . 19.9 tptt -133.49 127.49 33.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 108.697 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -127.82 140.76 51.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.313 -0.867 . . . . 0.0 110.572 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -123.65 133.91 53.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.5 t -127.26 134.89 50.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.952 -1.092 . . . . 0.0 110.95 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -116.91 115.82 26.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 47.44 24.37 0.47 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.168 -0.957 . . . . 0.0 109.248 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 152.92 37.45 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.58 166.6 22.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.592 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 60.0 m-70 -48.77 -40.68 29.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.131 -1.217 . . . . 0.0 109.531 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -54.91 -58.53 7.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.54 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 139' ' ' ILE . 7.8 tp -57.14 -45.48 83.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.646 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.2 m-20 -47.51 -51.26 21.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.361 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 56' ' ' THR . 87.9 t -62.72 -50.55 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.928 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -52.05 -52.2 52.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.008 . . . . 0.0 109.356 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 139' ' ' ILE . 37.0 tp -51.28 -51.33 55.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 108.533 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.609 HG13 ' HG ' ' A' ' 238' ' ' LEU . 69.0 t -53.93 -50.07 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.918 . . . . 0.0 108.828 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -51.23 -55.16 19.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.515 -0.74 . . . . 0.0 109.732 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.19 -49.91 75.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 110.022 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.5 mt -56.7 -52.11 66.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.1 67.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.272 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.196 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.522 ' O ' HD11 ' A' ' 121' ' ' ILE . 6.9 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -58.0 136.62 57.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 109.063 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.675 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -120.96 141.58 50.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 109.54 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -139.19 -170.12 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 29.8 m -99.57 136.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.022 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -66.47 -16.67 64.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -156.18 159.85 39.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 139.21 57.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 110.228 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 11' ' ' LEU . 57.2 mt -117.66 165.41 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.66 144.51 39.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.957 -1.089 . . . . 0.0 110.483 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.7 m-85 -140.41 155.35 46.77 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -162.11 152.81 17.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.782 -1.199 . . . . 0.0 110.275 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.4 176.83 36.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.53 153.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.179 . . . . 0.0 110.424 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.62 141.13 16.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.1 tt -61.51 -41.29 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 111.026 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.5 m-70 -87.1 -50.49 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.534 -1.354 . . . . 0.0 111.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -70.24 -22.82 62.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 111.363 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.0 20.65 35.01 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.931 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -110.86 154.1 24.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.65 135.4 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -139.67 143.37 37.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -112.38 154.39 25.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.324 -0.86 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 96' ' ' ILE . 7.9 mt -132.43 148.98 52.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.367 -0.833 . . . . 0.0 110.312 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.501 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.0 mt -143.58 110.78 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.52 117.44 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 111.032 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.501 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.0 m-70 -110.65 138.84 21.14 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.458 -0.776 . . . . 0.0 109.701 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.4 Cg_exo -54.28 168.58 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.958 1.772 . . . . 0.0 111.79 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 50.3 mm-40 -140.86 177.49 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.918 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.0 mttt -86.02 153.0 22.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.393 -0.817 . . . . 0.0 110.136 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -47.25 145.67 2.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.089 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.3 7.33 51.58 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.128 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.6 m -69.56 -43.68 72.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.659 -1.495 . . . . 0.0 109.56 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.73 -178.96 32.72 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.359 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.15 116.52 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 8.8 ptm180 -140.26 150.86 44.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.822 -1.174 . . . . 0.0 110.382 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.66 157.4 16.71 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -129.43 110.97 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.181 -0.949 . . . . 0.0 108.877 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.555 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 32.7 tttm -135.64 135.26 40.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.534 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 15.2 m120 52.85 28.88 6.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 111.19 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.27 18.1 78.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.958 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -122.7 122.22 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -1.028 . . . . 0.0 108.808 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 42.1 m-85 -83.84 126.5 33.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.089 -1.007 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -115.39 95.64 43.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.31 145.04 22.04 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.427 2.085 . . . . 0.0 112.081 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.24 74.8 10.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -132.79 -179.91 5.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.381 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.6 p-80 -75.78 -53.26 8.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.129 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -43.28 -17.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.232 -0.918 . . . . 0.0 110.963 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.2 m-85 -97.63 1.31 48.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.735 -1.228 . . . . 0.0 109.837 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' HD23 ' A' ' 62' ' ' LEU . 48.8 t -71.54 131.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.099 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -30.05 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -151.08 133.49 15.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.685 HG21 HG21 ' A' ' 257' ' ' VAL . 76.2 p -124.38 95.44 4.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.207 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 59' ' ' SER . 46.0 t-20 -162.97 128.86 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 47.4 11.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 108.969 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 163.37 141.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.344 -0.847 . . . . 0.0 110.098 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.436 HG21 HD11 ' A' ' 237' ' ' LEU . 86.2 m -90.62 127.97 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.376 -0.828 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.42 151.75 39.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.664 0.745 . . . . 0.0 111.002 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 53' ' ' VAL . 10.8 mt -126.23 148.23 49.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.63 154.14 25.12 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.088 -1.529 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -165.31 152.95 11.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt 50.69 22.26 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.13 -33.48 6.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -56.22 147.34 21.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.229 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.9 135.55 26.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.272 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.36 126.11 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -103.29 156.23 17.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.968 -1.082 . . . . 0.0 111.078 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.8 m 51.64 75.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.943 -0.473 . . . . 0.0 110.818 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.3 m -108.07 -10.32 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.5 pm0 -61.45 -26.8 68.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.906 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.427 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.0 m170 -66.35 -68.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.574 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.8 tp -52.07 -47.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 109.161 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 48' ' ' ALA . 17.5 mt -52.33 -49.15 64.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 17.5 t -59.73 -43.17 94.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.35 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.71 -44.6 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.975 -1.078 . . . . 0.0 109.101 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.56 -36.07 80.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.964 . . . . 0.0 109.588 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.72 -35.58 78.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.579 HD13 ' CB ' ' A' ' 171' ' ' GLU . 68.1 mt -79.47 -36.93 37.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.38 -0.825 . . . . 0.0 109.843 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 114' ' ' ILE . 94.8 mt -83.52 4.12 29.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.084 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 53.59 40.62 31.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.556 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 5' ' ' LYS . 27.3 mm -85.33 142.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 42.5 p -129.81 -22.61 2.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.186 -0.946 . . . . 0.0 111.612 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.698 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -125.2 107.03 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.744 -1.223 . . . . 0.0 110.035 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.9 m -164.3 148.55 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.616 0.722 . . . . 0.0 110.008 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.496 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 57.4 m -117.19 108.19 15.37 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.436 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -90.18 100.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.804 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 26' ' ' LEU . 10.6 tt0 -73.78 125.14 27.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.99 119.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.815 0.817 . . . . 0.0 111.542 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -105.94 97.75 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.56 -158.77 27.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -120.49 -13.03 8.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -139.56 148.23 42.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 109.707 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 HD11 ' A' ' 26' ' ' LEU . 45.7 mm -71.66 120.76 81.81 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 108.943 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.05 120.23 1.45 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.733 1.622 . . . . 0.0 111.629 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.459 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.2 tp -78.38 -15.8 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.8 mt 55.76 -115.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.267 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.82 5.6 50.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.032 -1.043 . . . . 0.0 110.797 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.96 0.7 61.83 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.147 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -126.7 -172.87 2.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.661 -0.905 . . . . 0.0 109.629 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.33 16.7 8.02 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -57.77 -41.73 82.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -1.08 . . . . 0.0 110.086 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -64.54 -57.15 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.105 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 14.7 m-85 -51.57 -46.55 63.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.97 . . . . 0.0 109.348 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -61.03 -51.04 70.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.667 -0.646 . . . . 0.0 110.941 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.18 -42.45 96.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.002 -1.061 . . . . 0.0 111.245 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.91 -58.49 4.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.5 -34.4 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.099 -1.001 . . . . 0.0 109.577 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -63.25 -42.21 99.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.98 . . . . 0.0 109.26 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 11.86 0.81 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.465 ' HA ' ' HZ2' ' A' ' 8' ' ' LYS . 3.5 m-80 -146.24 33.64 0.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.557 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 70.2 mt -78.19 139.59 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.742 -1.224 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 8' ' ' LYS . 31.8 tp -127.7 121.96 31.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -0.779 . . . . 0.0 108.998 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.605 ' ND2' ' HZ1' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -79.04 142.59 36.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.144 -0.972 . . . . 0.0 110.354 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -111.56 -170.61 1.68 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.358 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -116.64 71.22 0.78 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.144 -0.972 . . . . 0.0 111.713 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.572 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 9.4 ttt180 -170.02 132.11 1.07 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.959 -1.088 . . . . 0.0 109.31 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.32 142.11 57.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.959 -1.088 . . . . 0.0 110.238 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 3' ' ' LEU . 89.5 mt -87.6 151.74 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.35 79.3 3.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.284 -0.885 . . . . 0.0 108.813 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 36.4 m-85 -58.78 146.67 36.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.294 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -93.11 101.91 14.22 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.75 132.68 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.359 0.599 . . . . 0.0 110.918 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.3 117.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.06 -27.57 15.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 110.662 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -134.36 150.78 74.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.549 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.98 151.42 62.12 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -157.22 150.69 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.416 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 130' ' ' ILE . 2.7 mp -138.68 136.44 43.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 108.965 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 HD11 ' A' ' 255' ' ' LEU . 29.9 m -124.64 147.48 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -130.0 164.71 23.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 0.0 110.263 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -171.82 102.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.841 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 48.05 57.43 6.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 110.731 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.05 -34.51 3.57 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -63.25 138.28 58.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.252 . . . . 0.0 109.133 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.46 137.89 28.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.082 -1.011 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 255' ' ' LEU . 46.2 mt -135.75 121.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.399 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -110.99 131.69 54.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.436 0.636 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -119.87 132.88 55.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.55 146.92 34.21 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 110.258 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -47.11 141.78 12.37 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.654 2.236 . . . . 0.0 113.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.419 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.02 144.35 19.98 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 146' ' ' THR . 4.0 t0 -66.16 0.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.792 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 145' ' ' ASP . 27.9 p -157.13 173.6 16.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.841 -1.162 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 tp -85.11 118.3 24.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -137.45 126.17 23.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 108.764 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.41 121.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.9 m -111.62 151.7 28.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.642 -0.661 . . . . 0.0 109.292 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.03 130.25 26.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.721 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -120.88 131.66 54.52 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.24 133.91 7.46 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.584 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -100.98 97.72 8.26 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -88.57 167.13 13.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.983 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -98.99 -17.05 18.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.76 -0.587 . . . . 0.0 110.697 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.0 p-10 -92.62 -168.59 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.825 -1.172 . . . . 0.0 110.386 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -55.08 0.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.362 -0.836 . . . . 0.0 111.472 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.537 HD22 ' OE1' ' A' ' 162' ' ' GLN . 11.2 mt -78.55 -27.65 45.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.443 -1.411 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.8 -137.96 34.96 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -100.4 132.3 45.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.202 -1.175 . . . . 0.0 109.682 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.537 ' OE1' HD22 ' A' ' 159' ' ' LEU . 56.4 mt-30 -139.5 155.52 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.125 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -147.93 149.5 32.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.113 -0.992 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -143.46 139.32 29.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.512 -0.742 . . . . 0.0 109.41 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.29 124.82 51.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.509 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.8 t80 -105.12 113.77 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.848 . . . . 0.0 110.327 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.0 153.06 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.316 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.01 125.61 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.248 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 102.73 3.59 49.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -120.24 19.9 12.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.307 -1.114 . . . . 0.0 109.278 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 173' ' ' GLU . 2.2 pm0 -64.88 -46.49 81.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.642 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -47.8 -7.52 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 171' ' ' GLU . 75.0 mt-10 -103.58 -5.89 22.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.482 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.4 pt -123.29 -26.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.217 -0.927 . . . . 0.0 110.558 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -60.79 -23.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.569 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.9 mt -85.27 -2.2 57.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.09 15.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.417 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 42.5 mtm180 -83.53 172.97 11.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.4 163.38 25.7 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -147.78 147.91 30.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.22 -1.55 . . . . 0.0 111.786 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.87 157.88 43.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.443 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.0 m-85 -97.85 146.94 24.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.901 -1.124 . . . . 0.0 109.78 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.52 -37.31 26.22 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.304 -0.872 . . . . 0.0 109.176 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.443 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.0 p90 -71.05 -25.56 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.13 -0.981 . . . . 0.0 109.947 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.434 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 mt-10 -82.39 -22.93 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.977 . . . . 0.0 109.742 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.85 -53.67 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.639 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.88 -38.02 9.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.686 ' O ' HG22 ' A' ' 192' ' ' VAL . 71.3 t60 -76.54 -53.78 7.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.122 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.82 -32.3 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.788 . . . . 0.0 109.533 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -52.61 6.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.039 -1.038 . . . . 0.0 109.226 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -49.84 -40.43 42.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 110.265 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 188' ' ' HIS . 28.0 m -78.55 5.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.006 -1.059 . . . . 0.0 110.218 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.96 37.21 56.71 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 194' ' ' LEU . 35.4 mt -125.39 168.89 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 109.433 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.51 21.77 58.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.74 -20.27 5.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.571 -1.547 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.447 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.67 26.32 9.05 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 128.53 9.19 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.946 -1.326 . . . . 0.0 110.034 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.8 p -144.93 171.97 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -1.056 . . . . 0.0 109.422 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.47 -8.14 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -97.06 -12.73 22.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.772 -0.58 . . . . 0.0 109.515 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.0 p30 -133.13 7.54 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 109.882 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -149.88 151.0 32.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.609 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.8 tp -98.15 95.4 7.4 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.3 t -85.87 127.76 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.788 0.804 . . . . 0.0 109.28 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.562 ' CD2' HG13 ' A' ' 211' ' ' VAL . 52.9 mt -123.24 161.47 24.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.647 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.94 -166.65 12.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -29.73 70.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -1.099 . . . . 0.0 109.672 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.66 23.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -0.944 . . . . 0.0 110.856 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -146.78 154.12 41.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.51 -1.369 . . . . 0.0 110.708 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.562 HG13 ' CD2' ' A' ' 206' ' ' LEU . 45.3 t -104.44 113.45 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -58.69 -45.62 89.06 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 109.832 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.15 116.61 18.2 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.224 -0.923 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.95 -15.4 43.51 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.475 1.45 . . . . 0.0 111.641 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.404 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.9 pm0 -75.01 -15.82 60.64 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.231 -0.918 . . . . 0.0 108.702 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.23 -178.12 47.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.609 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -83.92 145.75 28.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -1.106 . . . . 0.0 109.639 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -77.79 -18.79 56.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 108.811 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.638 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 76.0 m-85 -141.8 178.74 7.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -85.92 -3.49 58.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.77 45.55 1.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -55.58 -47.18 99.24 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.861 -1.149 . . . . 0.0 109.756 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.6 Cg_exo -51.37 -66.77 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.429 2.086 . . . . 0.0 112.157 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 225' ' ' ARG . 27.9 m -59.97 -36.79 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.936 -1.102 . . . . 0.0 109.63 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.638 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 75.3 mtt180 -59.77 -42.18 92.76 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.2 t60 -67.09 -31.66 72.29 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.06 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -66.57 -35.76 81.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.0 t -67.73 -37.73 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.449 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 66.9 t80 -64.01 -50.61 67.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.46 -28.02 67.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.3 tp -75.92 -33.02 59.87 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 28.2 mt -67.52 -39.54 82.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.28 -58.2 9.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.438 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 53.8 m-20 -51.55 -40.84 60.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -1.226 . . . . 0.0 109.249 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 235' ' ' LEU . 7.0 mt -57.18 -22.97 44.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.533 -0.729 . . . . 0.0 110.282 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.6 -22.26 61.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.841 -1.162 . . . . 0.0 108.721 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 60' ' ' THR . 92.4 mt -53.08 -1.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.727 -1.233 . . . . 0.0 110.122 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.592 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.6 mt -75.68 -14.45 60.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.052 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.91 57.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.594 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.3 m -166.52 157.2 10.96 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.867 -1.372 . . . . 0.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.5 Cg_endo -49.84 150.55 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.956 1.771 . . . . 0.0 109.712 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.7 147.95 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 111.515 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -130.34 123.97 31.19 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.51 -158.77 28.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.419 ' N ' ' HB2' ' A' ' 144' ' ' SER . 11.6 ttmt -129.55 139.82 51.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -1.128 . . . . 0.0 109.087 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 22.7 m-85 -134.74 139.84 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 110.426 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -123.39 123.29 40.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.6 m -120.54 134.36 55.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.942 -1.099 . . . . 0.0 111.074 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -115.73 115.74 26.86 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 49.71 20.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.972 -1.08 . . . . 0.0 109.054 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -50.28 156.23 2.4 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -139.7 157.28 25.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.468 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -45.32 -43.36 10.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -1.118 . . . . 0.0 110.032 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.9 p -58.46 -41.05 84.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.0 tp -74.2 -43.61 56.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 108.538 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 256' ' ' ASN . 0.8 OUTLIER -50.98 -45.73 61.13 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.092 -1.005 . . . . 0.0 109.051 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 56' ' ' THR . 77.7 t -66.13 -57.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.416 ' HE3' HD12 ' A' ' 255' ' ' LEU . 2.6 ttpt -47.41 -46.16 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.839 -1.163 . . . . 0.0 108.614 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.683 HD22 HG21 ' A' ' 139' ' ' ILE . 44.1 tp -55.04 -53.48 55.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.051 . . . . 0.0 108.791 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.592 HG13 ' HG ' ' A' ' 238' ' ' LEU . 47.6 t -54.49 -53.75 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.528 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -49.32 -46.69 47.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.83 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -64.92 -52.77 54.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.957 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 263' ' ' LEU . 22.6 mt -53.87 -51.82 62.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 110.196 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.14 -27.2 65.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.963 -1.086 . . . . 0.0 110.304 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 110.149 -179.314 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 121' ' ' ILE . 14.5 mt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -55.74 129.12 38.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 108.97 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.9 144.27 48.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.501 -0.749 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -143.83 -173.28 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 30' ' ' PRO . 16.1 m -95.44 135.01 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.087 . . . . 0.0 109.503 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.36 -20.43 66.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -154.62 156.12 35.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.435 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.78 139.85 58.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 11' ' ' LEU . 56.4 mt -118.78 168.29 10.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 p -143.64 146.53 33.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.1 m-85 -140.12 150.24 44.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -152.97 148.18 26.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.965 -1.084 . . . . 0.0 109.703 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.58 173.1 36.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.42 153.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.12 . . . . 0.0 110.311 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.57 140.76 15.51 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.4 tt -60.15 -41.52 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 110.659 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' HG23 ' A' ' 18' ' ' ILE . 88.6 m-70 -86.64 -50.8 6.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.686 -1.259 . . . . 0.0 110.875 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 p -70.96 -22.57 62.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.67 -0.644 . . . . 0.0 111.526 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.51 15.61 12.52 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -106.82 154.99 20.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 109.76 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.23 135.44 42.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 3.5 t -138.9 145.43 39.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -111.04 155.21 23.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.616 -0.677 . . . . 0.0 110.019 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 90' ' ' GLU . 9.7 mt -135.4 147.11 48.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 109.969 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 mt -143.45 109.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 108.864 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.68 113.75 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -106.76 140.0 20.92 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.489 -0.757 . . . . 0.0 109.265 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.625 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.6 Cg_exo -54.55 165.77 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.752 1.635 . . . . 0.0 111.952 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.6 mm-40 -141.39 174.39 10.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' OG1' ' A' ' 35' ' ' THR . 75.2 mttt -82.68 152.26 25.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -48.7 151.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.81 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.56 -6.94 3.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 31' ' ' GLU . 32.7 m -59.62 -44.9 93.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.784 -1.421 . . . . 0.0 109.705 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.15 -176.31 30.38 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.57 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 mm -102.52 116.79 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.93 155.13 47.31 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.608 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -102.99 158.67 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -128.88 109.14 11.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 108.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -135.53 134.5 39.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.333 -0.854 . . . . 0.0 110.995 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.7 29.14 7.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.775 . . . . 0.0 111.325 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.0 18.41 76.84 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.909 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.65 123.26 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -1.062 . . . . 0.0 109.08 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -85.49 127.59 34.46 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.0 mt -116.91 93.7 42.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.69 151.42 19.37 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 111.897 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.42 70.74 10.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.759 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.952 . . . . 0.0 109.035 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.4 p-80 -69.51 -54.12 15.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.56 -17.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 111.087 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.5 m-85 -94.96 3.4 54.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.936 -1.102 . . . . 0.0 109.912 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' HIS . 96.9 t -72.24 138.94 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.19 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.76 -28.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.395 -0.815 . . . . 0.0 109.639 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.37 133.61 12.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.632 HG21 HG21 ' A' ' 257' ' ' VAL . 45.6 p -124.03 95.6 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.124 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.0 t-20 -163.09 128.71 3.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.798 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 59' ' ' SER . 30.4 m80 45.64 13.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.32 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.963 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.468 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 45.2 m -78.68 125.17 29.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 108.869 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 147.73 44.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.841 0.829 . . . . 0.0 111.206 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 15.0 mt -123.77 150.26 44.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.88 151.36 21.09 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.731 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -163.36 152.21 14.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.533 -0.981 . . . . 0.0 109.27 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt 51.3 21.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.89 6.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 13.6 mm-40 -59.26 146.39 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -1.229 . . . . 0.0 109.332 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -142.13 137.31 30.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 110.663 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 122.96 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -101.13 155.16 18.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 111.312 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 m 49.18 73.89 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.78 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 17.2 m -107.78 -8.33 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.05 -27.61 68.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.495 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 29.1 m170 -64.49 -69.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.923 -1.111 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.49 -47.59 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.23 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' N ' HG23 ' A' ' 75' ' ' ILE . 37.5 mt -52.58 -48.28 66.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 109.985 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 t -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.095 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD12 ' A' ' 110' ' ' ILE . 54.0 t -57.04 -45.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 108.981 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.09 -34.98 78.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.255 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -61.52 -36.4 80.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 171' ' ' GLU . 52.3 mt -79.75 -37.02 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.5 mt -79.33 2.07 22.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.015 -1.053 . . . . 0.0 109.802 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 54.48 39.4 31.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.513 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 2.8 mm -86.21 141.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 108.25 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.516 HG21 HG23 ' A' ' 121' ' ' ILE . 57.0 p -124.49 -21.44 4.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.028 -1.045 . . . . 0.0 111.753 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 87' ' ' VAL . 38.8 m-80 -127.24 108.06 10.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.887 -1.133 . . . . 0.0 111.048 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.0 m -162.61 146.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 89.5 m -115.85 113.75 23.79 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.568 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.5 mt -95.9 107.4 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.693 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.4 tt0 -76.75 127.15 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.38 117.51 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.742 0.782 . . . . 0.0 111.442 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.414 ' O ' ' OG ' ' A' ' 24' ' ' SER . 26.1 mm -104.51 95.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.19 -155.4 24.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.21 -10.5 8.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -1.175 . . . . 0.0 110.379 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -139.82 148.95 42.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 26' ' ' LEU . 40.8 mm -72.85 126.41 90.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 108.735 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -45.9 121.18 4.03 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 121.845 1.697 . . . . 0.0 111.004 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.9 tp -75.25 -15.64 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 110.551 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.6 mt 57.33 -120.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.96 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -96.29 6.61 48.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.062 -1.024 . . . . 0.0 110.821 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.3 61.12 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.077 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 p -128.31 -172.31 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.634 -0.921 . . . . 0.0 109.524 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.66 15.5 10.53 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -58.53 -43.27 89.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -1.098 . . . . 0.0 110.003 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.85 -59.19 4.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.008 -1.057 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -51.56 -46.29 63.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.762 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CD1' HG11 ' A' ' 175' ' ' VAL . 53.5 t80 -61.56 -51.99 66.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 110.974 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.36 -43.26 95.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 111.375 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -55.92 13.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 110.611 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.409 HD12 HG11 ' A' ' 78' ' ' VAL . 40.6 mt -63.74 -31.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 0.0 109.446 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -65.0 -41.15 95.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.069 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 113' ' ' ASN . 6.0 pttt -75.55 11.06 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.5 m-80 -139.91 34.6 1.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 110.507 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.15 139.85 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.8 -1.187 . . . . 0.0 110.949 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.2 tp -131.74 126.62 34.91 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.81 146.91 28.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.156 -0.965 . . . . 0.0 110.569 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -114.2 -169.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.121 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -112.65 69.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 111.22 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 21.3 ttm-85 -164.89 132.23 3.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.993 -1.067 . . . . 0.0 109.267 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.82 141.52 55.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.066 -1.021 . . . . 0.0 109.456 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 3' ' ' LEU . 18.9 mt -81.34 146.26 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.333 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.74 81.04 4.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 43.0 m-85 -60.41 140.03 57.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -86.97 100.91 12.94 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.4 t -92.41 134.56 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.418 0.628 . . . . 0.0 111.073 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.84 114.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.7 -25.99 15.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.93 149.21 71.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.19 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.4 152.01 48.8 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.377 2.051 . . . . 0.0 111.942 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -155.2 151.58 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.361 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.54 139.23 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 255' ' ' LEU . 23.1 m -125.78 148.13 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.92 159.03 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.7 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.38 105.42 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.442 -0.786 . . . . 0.0 109.666 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 47.82 56.85 6.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.373 -0.83 . . . . 0.0 110.827 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.09 -36.84 2.87 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.464 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -61.56 129.48 41.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.964 -1.315 . . . . 0.0 108.449 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -143.57 141.01 30.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.864 -1.147 . . . . 0.0 110.242 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 259' ' ' LEU . 68.2 mt -137.62 132.36 44.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.735 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -120.47 130.76 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.373 0.606 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.64 135.76 54.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -145.29 152.63 50.85 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.078 -1.014 . . . . 0.0 109.52 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -49.95 143.17 24.82 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.412 2.075 . . . . 0.0 113.506 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -155.45 144.0 20.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -4.53 4.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.273 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.5 p -151.9 -172.08 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -100.54 121.4 41.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 108.845 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 147' ' ' LEU . 67.5 tt0 -135.05 128.82 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.76 122.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 109.966 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 39.6 m -113.71 151.92 31.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.429 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -139.69 131.12 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.938 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -120.94 133.42 55.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.93 138.49 9.84 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.649 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.03 98.04 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -84.97 167.18 16.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.576 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -104.07 -17.57 14.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 110.64 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.3 p-10 -92.17 -166.65 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.779 -1.2 . . . . 0.0 110.01 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.29 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 111.151 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.4 mt -78.68 -27.11 45.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.459 -1.4 . . . . 0.0 108.2 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.03 -141.52 33.14 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -100.27 134.99 42.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.332 -1.099 . . . . 0.0 109.275 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -139.4 153.89 47.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.51 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -144.23 145.75 32.25 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.41 -0.806 . . . . 0.0 109.545 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.564 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 16.4 t80 -145.03 140.19 27.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.173 -0.955 . . . . 0.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.415 ' OG1' ' NZ ' ' A' ' 163' ' ' LYS . 90.2 m -109.06 123.37 49.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 110.093 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.487 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.4 t80 -102.98 114.06 28.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.01 147.53 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 6.5 mm-40 -49.11 132.34 19.23 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.312 -0.867 . . . . 0.0 108.838 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.4 -9.58 30.78 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.47 25.53 10.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.209 -1.171 . . . . 0.0 109.288 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.665 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.0 OUTLIER -61.33 -15.65 38.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.0 110.496 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -81.54 -10.42 59.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.038 -1.039 . . . . 0.0 110.668 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' CZ ' ' A' ' 164' ' ' PHE . 1.5 pp20? -101.11 -5.26 25.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.052 -1.03 . . . . 0.0 110.623 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.478 HG23 ' OE2' ' A' ' 173' ' ' GLU . 16.7 pt -115.99 -31.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 171' ' ' GLU . 11.7 m -61.7 -15.45 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.842 -1.161 . . . . 0.0 108.776 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.1 mt -94.74 -4.81 46.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.561 -0.712 . . . . 0.0 109.451 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.419 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.02 120.52 14.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.006 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -81.07 172.16 14.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.74 163.66 25.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.64 145.44 27.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.252 -1.53 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.03 44.01 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.51 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -99.44 143.94 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.002 -1.061 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.38 -36.47 6.46 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.9 p90 -73.35 -29.81 62.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.947 -1.095 . . . . 0.0 109.889 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.5 tt0 -74.54 -27.64 60.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 109.938 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.31 -48.76 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -47.77 -40.76 21.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.168 -0.957 . . . . 0.0 109.995 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.1 t60 -77.25 -52.92 8.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.275 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.6 mt -49.42 -27.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.418 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -85.61 -54.74 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.001 -1.062 . . . . 0.0 109.35 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -50.76 -33.78 24.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -84.66 7.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.0 -1.063 . . . . 0.0 110.08 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.93 61.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.1 mt -129.39 171.36 12.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -1.168 . . . . 0.0 110.145 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.39 29.14 62.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -58.2 -56.33 23.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.388 -1.654 . . . . 0.0 109.683 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -67.1 4.68 3.19 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.725 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.99 124.82 34.94 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.876 -1.367 . . . . 0.0 110.523 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.1 t -145.91 164.23 32.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.438 -1.036 . . . . 0.0 109.101 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.513 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 70.7 mt -67.92 -8.01 33.24 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.5 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -98.77 -9.31 24.62 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.758 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 23.6 p30 -134.54 9.66 3.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.72 150.05 30.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.4 tp -99.86 93.18 5.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 203' ' ' THR . 43.0 t -85.85 130.56 36.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.716 0.769 . . . . 0.0 108.973 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 35.2 mt -124.78 165.11 18.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.656 -0.652 . . . . 0.0 109.576 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.19 -166.4 12.23 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -25.21 67.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.747 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -163.21 23.15 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.385 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 146.67 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.016 -1.053 . . . . 0.0 110.342 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.73 109.99 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.48 -49.11 75.63 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.078 -1.014 . . . . 0.0 109.826 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.8 m120 -60.28 112.48 5.55 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.832 . . . . 0.0 110.279 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.26 -23.2 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.796 1.664 . . . . 0.0 112.783 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.61 -14.71 62.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.834 -1.166 . . . . 0.0 109.919 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.24 -168.55 52.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.614 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -90.28 138.67 31.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -75.32 -17.25 60.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.174 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.3 -173.61 3.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.7 -22.43 23.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.94 53.25 1.9 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.543 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -54.63 -47.82 96.92 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.3 Cg_exo -48.45 -64.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.391 2.061 . . . . 0.0 112.102 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.5 m -60.64 -35.8 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.793 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.472 HH11 ' CG ' ' A' ' 225' ' ' ARG . 4.0 mtt85 -60.89 -41.56 96.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.046 -1.033 . . . . 0.0 108.468 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.4 t60 -67.45 -32.3 73.07 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -66.53 -36.45 82.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 166' ' ' PHE . 66.2 t -67.53 -37.37 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.98 -51.48 61.51 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -64.55 -28.26 69.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 109.844 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 36.0 tp -75.06 -34.13 61.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.072 -1.018 . . . . 0.0 108.492 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.77 -39.84 84.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.04 -56.0 18.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 26.7 m-20 -54.63 -32.72 59.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.096 -1.238 . . . . 0.0 109.178 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.6 mt -63.68 -23.77 67.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.475 -0.766 . . . . 0.0 110.653 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.73 -21.79 61.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.749 -1.219 . . . . 0.0 109.105 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.9 mt -50.46 -1.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.31 . . . . 0.0 110.607 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -78.44 -15.26 58.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.771 -1.205 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.19 2.93 59.02 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.574 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.8 m -166.46 155.45 10.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.362 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.0 Cg_endo -49.63 150.55 8.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.952 1.768 . . . . 0.0 109.608 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.83 145.96 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 0.0 112.124 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -127.81 121.98 31.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.91 -179.27 30.29 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -109.43 140.7 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -1.131 . . . . 0.0 109.198 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 17.2 m-85 -135.05 138.76 44.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 110.34 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -125.0 124.75 42.67 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 m -120.19 135.78 54.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.971 -1.081 . . . . 0.0 111.429 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 251' ' ' GLY . 75.8 t80 -115.28 117.06 29.41 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' PHE . 63.3 mtp180 45.98 22.37 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.065 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -51.9 159.41 2.61 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -139.1 164.3 25.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 34.1 m-70 -50.28 -42.76 52.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.149 -1.206 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.1 m -56.98 -59.2 5.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.4 tp -53.51 -45.64 69.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.381 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -49.54 -50.53 41.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 0.0 109.666 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 56' ' ' THR . 98.5 t -62.41 -55.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.805 . . . . 0.0 110.197 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 255' ' ' LEU . 1.0 OUTLIER -52.0 -45.2 64.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 108.79 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 139' ' ' ILE . 24.6 tp -52.99 -54.47 34.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.488 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.564 HG13 ' HG ' ' A' ' 238' ' ' LEU . 30.6 t -55.86 -54.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -43.98 33.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.35 -49.99 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 109.861 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 13.9 mt -56.94 -47.59 80.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.34 -30.77 69.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 109.568 -179.674 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.291 0.567 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -54.62 137.35 43.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 142.72 49.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.495 -0.753 . . . . 0.0 109.717 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -141.51 -171.63 3.35 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 30.3 m -96.86 135.15 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.049 . . . . 0.0 109.162 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -21.26 66.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.585 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -153.0 160.76 43.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 0.0 109.275 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 140.59 54.48 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 0.0 110.022 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.14 163.93 15.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 141.9 46.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.091 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 98.0 m-85 -139.84 146.24 39.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' CG ' ' OH ' ' A' ' 23' ' ' TYR . 3.8 pt-20 -151.88 149.35 28.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 109.908 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.87 172.27 35.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.28 151.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -1.087 . . . . 0.0 110.357 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.37 137.1 15.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' HG21 ' A' ' 179' ' ' THR . 6.7 tt -56.26 -38.74 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 68.8 m-70 -91.07 -49.21 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.845 -1.159 . . . . 0.0 111.105 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 22' ' ' GLU . 2.9 p -69.49 -21.76 63.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 111.416 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.03 8.31 3.05 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 20' ' ' THR . 3.4 mm-40 -102.69 157.34 17.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -1.108 . . . . 0.0 109.672 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' OH ' ' CG ' ' A' ' 14' ' ' GLU . 81.8 t80 -74.66 136.58 41.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.466 -0.771 . . . . 0.0 109.734 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -137.67 142.66 41.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -108.39 151.91 25.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -134.74 144.29 47.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -142.45 110.48 2.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.607 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -94.95 115.92 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 111.168 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.592 ' NE2' HG22 ' A' ' 27' ' ' ILE . 27.8 m-70 -109.41 139.73 21.38 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.482 -0.761 . . . . 0.0 109.585 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.5 Cg_exo -54.43 168.13 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.662 1.574 . . . . 0.0 111.434 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.482 ' HB3' HG21 ' A' ' 35' ' ' THR . 73.4 mm-40 -139.99 173.35 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.001 . . . . 0.0 110.04 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.9 mtmt -81.98 149.78 27.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.493 -0.754 . . . . 0.0 109.742 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -46.79 145.43 1.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.341 -0.849 . . . . 0.0 109.823 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 69.77 8.22 60.19 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.312 -0.947 . . . . 0.0 110.878 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.578 ' H ' HD21 ' A' ' 86' ' ' ASN . 26.5 m -73.61 -43.47 59.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.598 -1.531 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.46 -177.61 33.5 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.603 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.11 117.1 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -140.42 151.69 45.1 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.212 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.62 157.38 16.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.56 110.87 12.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 42.5 tttm -135.23 133.95 39.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 50.7 29.44 4.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.47 -0.769 . . . . 0.0 111.213 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.84 19.14 73.69 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.144 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.9 t -122.47 120.98 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -1.08 . . . . 0.0 109.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.7 m-85 -84.61 127.59 34.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.086 -1.008 . . . . 0.0 109.401 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -117.18 93.99 43.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.523 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.72 148.31 16.24 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.558 2.172 . . . . 0.0 112.206 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.64 69.08 10.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -0.952 . . . . 0.0 109.175 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -118.94 163.98 16.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -0.812 . . . . 0.0 109.291 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.546 ' CD2' ' CD ' ' A' ' 51' ' ' GLU . 1.2 p-80 -68.85 -50.07 53.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 0.0 109.578 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.546 ' CD ' ' CD2' ' A' ' 50' ' ' HIS . 42.8 mp0 -46.19 -16.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.632 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.6 m-85 -95.79 3.53 53.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.851 -1.156 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.7 t -71.15 128.73 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 108.735 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.38 -21.73 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.389 -0.819 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -156.26 125.89 6.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.907 -1.12 . . . . 0.0 110.009 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.836 HG21 HG21 ' A' ' 257' ' ' VAL . 38.5 p -121.03 95.56 4.75 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' SER . 44.7 t30 -162.78 128.74 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 87.9 m-70 51.91 7.22 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.97 . . . . 0.0 108.854 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m 164.22 153.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.0 109.786 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.464 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 30.1 m -94.05 127.37 39.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.21 -0.931 . . . . 0.0 109.215 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.36 149.67 41.96 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.758 0.79 . . . . 0.0 111.064 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.594 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.0 mt -125.35 151.81 45.59 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.68 148.0 15.55 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.802 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -159.27 145.67 16.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.972 . . . . 0.0 108.976 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER 52.94 28.01 6.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.394 -0.817 . . . . 0.0 109.473 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.12 -32.61 5.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.567 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -56.62 143.93 34.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 108.952 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.87 137.02 29.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.268 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.33 123.45 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 70' ' ' LYS . 12.5 mtpp -98.81 157.19 16.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.95 -1.093 . . . . 0.0 110.94 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m 50.77 74.61 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.55 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 62' ' ' LEU . 22.0 m -108.02 -10.39 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.197 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -61.63 -27.41 68.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 110.627 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.5 m170 -65.78 -68.6 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.976 -1.078 . . . . 0.0 109.352 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.44 -47.13 47.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.004 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.602 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.5 mt -52.59 -48.7 66.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.968 -1.082 . . . . 0.0 110.189 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 0.8 OUTLIER -61.0 -43.35 99.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.941 . . . . 0.0 110.241 -179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.69 -44.81 78.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 108.843 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.08 -34.85 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.09 -32.03 73.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' HB2' ' A' ' 171' ' ' GLU . 58.7 mt -83.74 -36.97 23.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.283 -0.886 . . . . 0.0 109.363 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 114' ' ' ILE . 94.7 mt -78.81 5.01 12.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.056 . . . . 0.0 109.513 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 52.84 39.38 28.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 110.188 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.78 138.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 108.493 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.6 p -123.77 -18.19 6.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 111.716 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 87' ' ' VAL . 2.4 m120 -126.7 107.8 10.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.864 -1.147 . . . . 0.0 111.134 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.9 m -163.5 148.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.285 -0.885 . . . . 0.0 110.054 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 18.9 m -116.38 109.1 16.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.51 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -91.86 100.88 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.333 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -73.41 127.18 31.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 26' ' ' LEU . 62.3 t -110.48 126.1 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.98 0.895 . . . . 0.0 111.925 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.6 mt -111.94 95.84 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 141.59 -156.7 25.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -120.67 -10.77 9.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -1.151 . . . . 0.0 110.449 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -140.39 148.89 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 109.47 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 26' ' ' LEU . 45.0 mm -72.59 121.38 84.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.18 -0.95 . . . . 0.0 108.927 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.96 121.97 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.624 1.549 . . . . 0.0 111.206 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.0 tp -78.66 -12.08 13.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.2 mt 56.04 -118.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -97.87 7.29 46.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.3 -0.47 61.88 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.819 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -127.08 -172.26 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.799 -0.824 . . . . 0.0 109.535 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.56 15.04 9.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 27.6 t-105 -57.59 -42.86 84.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 110.095 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.1 -57.75 8.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.103 -0.998 . . . . 0.0 110.19 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.39 -44.99 62.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.442 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 54.0 t80 -63.58 -51.26 66.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 111.261 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 8.0 mm-40 -62.67 -44.41 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.816 -1.177 . . . . 0.0 111.06 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.49 7.29 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.155 -0.966 . . . . 0.0 110.16 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 mt -62.55 -35.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 57.5 ttt-85 -60.82 -41.72 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.628 ' C ' HD22 ' A' ' 113' ' ' ASN . 2.8 mmmp? -74.87 9.45 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.884 . . . . 0.0 109.89 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.628 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.56 33.76 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.443 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 82' ' ' LEU . 66.4 mt -83.57 138.01 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.63 -1.294 . . . . 0.0 110.824 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.25 127.08 37.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.767 . . . . 0.0 109.206 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -85.92 144.91 27.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.076 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -112.23 -169.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -111.87 68.8 0.67 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.761 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -163.3 127.91 2.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 109.127 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.75 141.35 56.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.886 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 122' ' ' ASP . 94.0 mt -87.71 152.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 121' ' ' ILE . 9.1 t70 -102.23 90.84 4.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 14.4 m-85 -65.33 148.14 52.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.552 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.439 ' CD2' HD13 ' A' ' 238' ' ' LEU . 85.1 t80 -92.58 101.79 14.22 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.79 134.33 31.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 110.74 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.05 116.2 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -92.52 -29.13 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.017 -1.052 . . . . 0.0 110.369 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.91 150.04 75.44 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.36 152.11 43.79 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.551 2.168 . . . . 0.0 112.343 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.24 152.62 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.08 147.35 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.61 148.03 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -131.59 162.43 30.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.533 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.3 OUTLIER -172.41 103.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 50.76 54.89 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.333 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.54 -32.64 3.6 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.451 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.56 ' NH1' ' O ' ' A' ' 250' ' ' ARG . 88.1 mtt-85 -62.52 139.74 58.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.925 -1.338 . . . . 0.0 108.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -145.37 138.89 26.6 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.131 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.748 HG21 HD22 ' A' ' 259' ' ' LEU . 78.8 mt -137.56 125.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.579 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -113.41 132.86 55.46 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.393 0.616 . . . . 0.0 109.995 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 130.21 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.0 149.09 47.96 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.028 -1.045 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.59 142.88 9.35 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.677 2.251 . . . . 0.0 113.546 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -157.18 146.15 19.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.39 -3.36 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 p -149.08 -179.16 6.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.967 -1.083 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.2 tp -97.32 120.38 37.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 147' ' ' LEU . 56.1 tt0 -136.77 134.59 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.5 t -133.37 123.43 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.071 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.1 m -112.63 151.67 29.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.767 . . . . 0.0 109.743 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -138.17 129.37 27.37 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.653 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -120.74 131.06 54.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.22 141.6 12.51 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.753 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -106.38 101.16 10.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.94 167.1 15.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 110.964 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -99.55 -16.25 18.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.627 -0.671 . . . . 0.0 110.706 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.5 p-10 -98.53 -169.25 1.76 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.994 -1.067 . . . . 0.0 110.611 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -52.09 -0.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.502 -0.749 . . . . 0.0 111.531 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -78.04 -26.63 48.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.431 -1.418 . . . . 0.0 108.903 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.96 -140.83 34.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -104.9 134.23 48.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.067 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -138.68 158.76 43.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 109.375 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.04 145.43 31.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.383 -0.823 . . . . 0.0 109.471 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -143.74 137.17 27.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.53 124.88 51.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 110.038 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.414 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -105.77 117.78 34.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.79 153.14 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -50.71 126.35 15.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.94 -2.86 28.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -117.76 22.94 12.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.173 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 81' ' ' LEU . 11.2 pt-20 -56.43 -29.95 62.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 0.0 110.18 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.86 -19.7 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.0 -6.5 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 111.241 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.79 -26.33 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.906 -1.122 . . . . 0.0 111.314 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -60.34 -20.8 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.594 -1.316 . . . . 0.0 109.123 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.9 -2.75 58.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.466 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.2 116.48 8.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 108.881 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.521 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.8 mtm180 -81.15 172.06 14.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.8 t -80.66 162.14 24.33 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -147.49 147.08 29.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.246 -1.534 . . . . 0.0 111.527 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.22 158.05 43.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.531 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.4 m-85 -99.55 144.25 28.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.992 -1.067 . . . . 0.0 109.981 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.95 -38.87 53.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.531 -0.73 . . . . 0.0 109.895 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.531 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.3 p90 -66.81 -27.46 67.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 0.0 110.034 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.8 mt-10 -84.05 -43.61 14.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.097 -1.002 . . . . 0.0 109.835 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 205' ' ' VAL . 61.8 mt -40.8 -44.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.245 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.75 -37.72 76.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.995 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 185' ' ' GLU . 4.6 t-80 -76.68 -43.6 37.08 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.66 -29.57 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.504 -0.748 . . . . 0.0 109.036 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -80.98 -52.08 7.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -48.86 -45.67 41.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 110.282 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.415 HG11 ' NE2' ' A' ' 188' ' ' HIS . 19.1 m -74.89 6.49 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.03 . . . . 0.0 110.216 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.78 39.24 48.41 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.126 -0.984 . . . . 0.0 110.726 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.6 mt -126.53 176.1 7.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -1.168 . . . . 0.0 109.56 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 54.43 24.25 30.0 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -58.51 -20.89 49.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.662 -1.493 . . . . 0.0 110.306 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.11 1.74 31.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.46 126.2 35.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.963 -1.316 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' THR . 1.6 t -146.31 167.31 23.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.379 -1.071 . . . . 0.0 109.506 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.589 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 0.6 OUTLIER -68.57 -8.76 44.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 7.6 mmtp -96.67 -13.13 23.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.6 p30 -135.83 7.43 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.627 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.72 152.98 33.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 217' ' ' LEU . 15.3 tp -100.21 97.98 8.72 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 186' ' ' ILE . 53.4 t -85.49 126.86 40.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.0 mt -122.26 161.99 22.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.548 -0.72 . . . . 0.0 109.875 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.85 -166.39 12.38 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -62.89 -26.23 68.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -1.13 . . . . 0.0 109.735 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -161.29 22.77 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 110.565 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.04 147.62 40.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.865 -1.147 . . . . 0.0 110.393 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.32 112.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.29 -45.46 93.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 110.103 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.9 m120 -61.91 121.58 66.16 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 109.792 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.66 -12.62 36.19 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.486 1.457 . . . . 0.0 111.817 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.69 -16.81 56.83 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.273 -0.892 . . . . 0.0 108.945 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.26 -169.21 54.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.58 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -89.25 145.57 25.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -1.2 . . . . 0.0 109.781 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -79.42 -19.26 50.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 221' ' ' ASN . 71.2 m-85 -146.85 152.14 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.467 -0.771 . . . . 0.0 108.987 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.64 6.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -151.11 40.62 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -58.27 -47.24 99.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 109.734 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.3 Cg_exo -51.43 -67.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -58.4 -37.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 109.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 224' ' ' VAL . 44.4 mtt180 -59.96 -41.44 91.93 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.071 -1.018 . . . . 0.0 108.446 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.6 t60 -67.0 -31.8 72.6 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -66.77 -36.44 82.44 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 166' ' ' PHE . 92.7 t -67.15 -39.1 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.9 t80 -61.6 -52.36 64.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.44 -28.37 69.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.06 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.458 HD23 ' CG1' ' A' ' 149' ' ' VAL . 40.6 tp -78.2 -33.54 49.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.945 -1.097 . . . . 0.0 108.738 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.86 -37.69 79.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.37 -55.86 11.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 29.1 m-20 -53.95 -35.48 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -1.174 . . . . 0.0 109.086 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.0 mt -63.96 -24.64 67.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.478 -0.764 . . . . 0.0 110.512 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.3 t80 -75.44 -21.66 57.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.918 -1.114 . . . . 0.0 109.361 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 237' ' ' LEU . 33.0 mt -50.79 -3.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.711 -1.243 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -72.1 -12.85 61.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.94 -1.1 . . . . 0.0 109.962 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 0.51 59.66 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.915 -1.135 . . . . 0.0 110.824 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 154.54 11.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.872 -1.369 . . . . 0.0 108.816 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.4 Cg_endo -47.94 150.04 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.622 1.548 . . . . 0.0 109.416 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.72 146.85 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.979 -1.075 . . . . 0.0 112.056 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.88 124.33 30.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 154.8 179.22 29.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.413 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.5 OUTLIER -110.87 132.53 54.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.6 m-85 -132.9 140.38 47.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.3 t80 -125.0 137.44 54.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.3 t -130.62 137.29 49.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 111.343 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -117.5 115.9 26.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.56 ' O ' ' NH1' ' A' ' 137' ' ' ARG . 5.3 mtp85 47.57 30.41 1.69 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.05 146.12 44.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.75 169.6 15.92 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 59.5 m-70 -52.94 -37.85 61.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.061 -1.258 . . . . 0.0 109.531 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -57.98 8.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.005 . . . . 0.0 109.127 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 134' ' ' ASP . 15.9 tp -61.75 -43.17 99.38 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -47.7 -51.61 21.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.133 . . . . 0.0 109.139 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 56' ' ' THR . 85.3 t -62.6 -52.16 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -51.31 -51.34 55.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 109.083 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 139' ' ' ILE . 39.8 tp -50.78 -54.82 20.37 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.702 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.449 HG13 ' HG ' ' A' ' 238' ' ' LEU . 49.7 t -55.39 -51.16 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 108.895 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -47.77 -50.5 25.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.08 -48.28 79.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.814 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 263' ' ' LEU . 23.4 mt -58.1 -49.58 76.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.415 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -69.82 -32.99 71.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.292 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.264 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.81 138.93 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 108.996 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -122.58 144.9 48.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.21 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.93 -172.72 3.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 30' ' ' PRO . 32.1 m -99.03 137.89 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.865 -1.147 . . . . 0.0 109.132 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -18.24 65.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 109.898 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -155.27 156.25 35.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 109.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.08 139.54 58.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 110.234 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -117.4 160.39 21.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.89 141.98 47.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 110.232 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -140.34 150.76 44.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -161.61 151.98 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.912 -1.117 . . . . 0.0 109.848 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.62 175.71 37.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.57 152.46 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -1.181 . . . . 0.0 110.243 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' C ' ' OE2' ' A' ' 95' ' ' GLU . . . -88.24 140.29 16.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.496 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 6.2 tt -59.99 -38.39 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 111.041 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 72.2 m-70 -91.52 -46.95 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.402 -1.436 . . . . 0.0 111.039 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.594 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 p -72.15 -23.23 61.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.211 -0.931 . . . . 0.0 111.557 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.64 15.67 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.284 -1.436 . . . . 0.0 109.553 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.94 155.24 20.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -1.091 . . . . 0.0 109.748 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.69 134.98 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.429 -0.794 . . . . 0.0 109.466 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 m -137.01 144.24 43.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.37 155.98 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.453 -0.78 . . . . 0.0 109.866 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.64 143.89 39.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -139.35 114.56 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 108.667 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.18 115.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 0.0 111.006 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.567 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.6 m-70 -108.42 137.06 19.85 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.517 -0.739 . . . . 0.0 109.788 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -51.62 168.13 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.032 1.821 . . . . 0.0 111.604 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 66.9 mm-40 -146.52 155.23 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.938 . . . . 0.0 109.975 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -67.39 154.16 42.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.781 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 149.23 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 110.824 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.18 -7.45 22.92 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.26 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 93.0 m -59.33 -44.97 92.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.557 -1.555 . . . . 0.0 109.861 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.65 -175.82 33.15 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -100.42 116.54 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -141.23 150.97 43.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.764 -1.21 . . . . 0.0 110.983 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.16 157.42 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.17 114.29 15.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.93 . . . . 0.0 109.248 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 45.4 tttm -134.2 134.38 42.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.486 ' CG ' ' O ' ' A' ' 41' ' ' LYS . 7.5 p-10 44.08 42.37 4.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.877 -0.514 . . . . 0.0 112.193 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.93 15.7 78.33 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 120.695 -1.253 . . . . 0.0 110.549 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -121.43 120.65 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -1.141 . . . . 0.0 109.311 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 36.1 m-85 -86.11 127.72 34.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.481 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.87 93.43 41.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.506 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.99 145.99 17.98 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.656 2.237 . . . . 0.0 112.39 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.39 66.01 4.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.98 166.69 12.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p-80 -72.94 -49.96 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.476 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -44.11 -16.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.2 m-85 -96.84 1.94 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 50' ' ' HIS . 58.5 t -69.24 130.36 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 108.7 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.0 m -111.74 -28.94 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -152.1 130.31 11.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.911 -1.118 . . . . 0.0 110.176 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.816 HG21 HG21 ' A' ' 257' ' ' VAL . 32.9 p -120.87 94.6 4.4 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 59' ' ' SER . 38.8 t30 -163.74 129.15 2.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 108.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' SER . 37.1 m80 52.52 6.15 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.128 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.81 143.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.851 . . . . 0.0 109.683 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.457 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 37.6 m -84.72 128.08 34.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -120.73 149.46 42.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.429 -0.794 . . . . 0.0 110.751 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 72' ' ' VAL . 12.2 mt -120.74 154.59 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.98 22.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.976 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -161.78 145.79 12.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.413 -1.051 . . . . 0.0 109.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt 51.61 21.7 1.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.86 . . . . 0.0 109.323 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.26 -33.59 6.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -55.96 149.16 15.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -1.217 . . . . 0.0 109.51 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -145.89 136.32 24.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.553 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.97 128.15 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -101.27 155.51 17.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 111.605 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.8 m 50.35 74.95 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.746 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.565 HG21 ' CD1' ' A' ' 62' ' ' LEU . 18.8 m -108.4 -11.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.99 . . . . 0.0 109.566 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.4 pm0 -60.44 -26.46 66.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.406 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.8 m170 -66.32 -68.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.324 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.6 tp -52.72 -48.03 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.072 -1.018 . . . . 0.0 109.107 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.646 HD21 ' HB1' ' A' ' 48' ' ' ALA . 11.3 mt -52.33 -50.18 62.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.024 -1.048 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.7 t -59.22 -41.54 88.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 106' ' ' PHE . 76.9 t -56.36 -47.1 81.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.121 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.67 -34.05 77.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.323 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -61.95 -39.19 91.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 171' ' ' GLU . 51.1 mt -77.84 -38.51 46.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 82' ' ' LEU . 74.4 mt -80.68 -1.17 41.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 56.87 42.12 26.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.733 -0.604 . . . . 0.0 111.386 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.17 140.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.854 -1.154 . . . . 0.0 107.968 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 121' ' ' ILE . 68.8 p -124.57 -22.47 4.61 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.126 -0.984 . . . . 0.0 111.799 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.709 ' O ' HG13 ' A' ' 87' ' ' VAL . 36.5 m-80 -125.46 107.13 10.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.868 -1.145 . . . . 0.0 110.666 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -164.69 148.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.771 0.796 . . . . 0.0 110.151 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 93.5 m -114.49 113.26 24.22 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.462 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -95.29 100.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 110.345 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' OE2' ' NE2' ' A' ' 29' ' ' HIS . 33.4 mt-10 -73.41 124.84 26.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.108 -0.995 . . . . 0.0 108.361 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 26' ' ' LEU . 48.6 t -106.94 123.79 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 121.677 0.751 . . . . 0.0 111.172 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mm -109.18 96.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.52 -156.04 23.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -123.08 -12.28 7.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.319 -1.107 . . . . 0.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 20' ' ' THR . 29.3 tt0 -132.85 140.19 47.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 109.944 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 26' ' ' LEU . 45.6 mm -70.24 119.32 71.32 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 108.417 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -40.74 122.58 1.45 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.887 1.725 . . . . 0.0 111.466 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -79.0 -12.0 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.711 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.3 mt 56.42 -119.61 1.34 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 110.01 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 27.6 t0 -96.53 10.02 39.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.923 -1.111 . . . . 0.0 111.126 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.26 -1.41 62.55 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.43 -1.367 . . . . 0.0 109.843 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.02 -172.06 2.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.799 -0.824 . . . . 0.0 109.483 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.18 16.08 10.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.41 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 54.1 t-105 -57.83 -42.84 85.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.429 -1.042 . . . . 0.0 110.464 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.46 -58.96 5.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.167 -0.958 . . . . 0.0 110.092 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.402 ' HB3' HG11 ' A' ' 78' ' ' VAL . 13.7 m-85 -51.03 -45.96 61.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.382 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.403 ' CE1' ' HD2' ' A' ' 111' ' ' ARG . 36.9 t80 -61.37 -50.36 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.554 -0.716 . . . . 0.0 111.059 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 10.1 mm-40 -63.47 -44.46 94.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.946 -1.096 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.85 -53.56 38.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 0.0 110.646 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -65.04 -30.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.918 -1.114 . . . . 0.0 109.287 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.403 ' HD2' ' CE1' ' A' ' 107' ' ' TYR . 63.9 ttt-85 -65.68 -43.89 87.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.407 -0.808 . . . . 0.0 110.274 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -77.78 14.22 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.957 -1.089 . . . . 0.0 110.019 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -144.13 32.47 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 82' ' ' LEU . 78.8 mt -80.87 139.89 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.928 -1.107 . . . . 0.0 110.272 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.14 125.08 32.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.766 . . . . 0.0 109.128 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -80.57 142.29 34.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.334 -0.854 . . . . 0.0 110.169 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -110.36 -172.75 2.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.408 -0.807 . . . . 0.0 109.448 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -110.43 68.27 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 110.58 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.7 131.16 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 109.531 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.24 142.42 54.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.064 -1.022 . . . . 0.0 109.691 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 85' ' ' THR . 70.9 mt -85.44 151.34 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.815 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.71 83.42 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 108.817 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 28.6 m-85 -61.44 143.09 56.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -90.32 101.83 14.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.17 133.73 32.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.62 . . . . 0.0 110.857 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.13 112.45 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.91 -34.18 21.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.979 -1.076 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.9 149.88 72.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.5 147.93 71.89 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.318 2.012 . . . . 0.0 112.089 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -154.27 152.3 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.67 144.73 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.227 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.95 147.68 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -132.83 159.77 38.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.607 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -172.33 101.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.241 -0.912 . . . . 0.0 109.995 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 45.97 59.26 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.753 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.31 -37.92 3.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.485 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 4.5 mpt_? -63.75 130.89 46.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -144.14 139.85 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.992 -1.067 . . . . 0.0 109.769 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.522 HG21 HD22 ' A' ' 259' ' ' LEU . 98.5 mt -137.62 129.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 109.693 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -115.56 131.67 56.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.49 135.88 55.0 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -149.52 148.54 26.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 109.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -46.04 142.17 8.58 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.508 2.139 . . . . 0.0 113.326 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -155.48 143.3 19.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 146' ' ' THR . 24.7 t0 -62.75 -5.17 2.52 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.503 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 244' ' ' GLY . 30.4 p -154.96 179.1 9.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.949 -1.095 . . . . 0.0 109.859 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.25 120.19 29.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.208 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.6 123.58 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 108.646 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -124.41 122.02 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.1 m -112.25 151.94 29.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.369 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 228' ' ' VAL . 39.1 t80 -139.5 130.67 26.59 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.106 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 28.4 tt0 -121.18 131.7 54.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.43 139.19 10.45 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.469 -1.348 . . . . 0.0 111.577 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -103.0 100.66 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -86.33 167.03 15.15 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 110.6 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.57 -15.55 18.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 110.589 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 159' ' ' LEU . 23.0 p-10 -95.21 -168.12 1.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.832 -1.168 . . . . 0.0 110.131 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -56.58 3.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 111.26 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.8 mt -79.67 -28.28 40.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.454 -1.404 . . . . 0.0 108.423 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.01 -138.69 34.56 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 3.9 ttm180 -97.0 131.84 43.41 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.275 -1.133 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.467 ' OE1' ' O ' ' A' ' 161' ' ' ARG . 29.1 mm100 -136.63 147.29 46.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.765 . . . . 0.0 109.108 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -140.52 145.05 36.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.856 . . . . 0.0 110.093 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.515 ' CZ ' ' NH2' ' A' ' 225' ' ' ARG . 89.3 t80 -144.26 140.38 29.19 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 76.8 m -110.82 124.3 51.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 110.295 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.561 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -103.89 117.26 33.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.409 -0.807 . . . . 0.0 109.761 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.31 154.64 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.097 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -50.63 125.22 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 108.977 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.24 -2.44 26.75 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -119.81 21.74 11.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.14 -1.212 . . . . 0.0 109.186 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.476 ' HB2' HD13 ' A' ' 81' ' ' LEU . 3.6 pm0 -54.46 -32.12 56.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.379 -0.825 . . . . 0.0 110.621 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.24 -17.47 62.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 110.183 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.554 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 23.2 mm-40 -86.79 -6.83 58.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.172 -0.955 . . . . 0.0 111.495 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 40.2 pt -123.68 -26.05 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.919 -1.113 . . . . 0.0 110.845 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.1 m -65.21 -26.77 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.553 -1.342 . . . . 0.0 109.382 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.54 -5.54 56.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.0 109.335 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 225' ' ' ARG . . . -70.09 123.43 21.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.977 . . . . 0.0 109.205 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -84.54 172.93 11.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.2 t -77.32 161.48 28.04 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -147.04 144.38 29.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.191 -1.568 . . . . 0.0 111.427 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.08 45.02 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 90.6 m-85 -97.66 146.89 24.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.602 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.56 -38.71 21.32 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.399 -0.813 . . . . 0.0 109.741 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.13 -25.18 62.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.0 109.644 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.7 mm-40 -79.82 -25.64 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.0 110.044 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 187' ' ' GLU . 22.6 mt -60.93 -54.82 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 110.017 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 186' ' ' ILE . 10.9 tt0 -42.1 -39.88 2.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.887 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.763 ' O ' HG22 ' A' ' 192' ' ' VAL . 5.4 t60 -78.76 -54.31 6.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 194' ' ' LEU . 29.1 mt -48.35 -29.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.663 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -85.34 -54.38 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.769 -1.207 . . . . 0.0 109.194 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -50.09 -42.52 50.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.066 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.5 m -74.65 5.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.995 . . . . 0.0 109.854 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.31 37.28 54.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' ILE . 36.0 mt -125.61 166.04 17.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -1.126 . . . . 0.0 109.591 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 64.5 22.98 68.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -56.18 -23.65 36.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.432 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.5 25.91 12.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.24 125.12 7.88 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.945 -1.327 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -145.1 168.07 21.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.064 . . . . 0.0 109.708 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.1 -8.72 25.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 ttmm -93.89 -14.31 26.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 14.7 p30 -136.07 8.14 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.792 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -147.34 149.28 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.047 -1.033 . . . . 0.0 110.702 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 217' ' ' LEU . 27.1 tp -98.87 94.61 6.68 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 203' ' ' THR . 52.2 t -86.81 129.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.635 0.731 . . . . 0.0 109.225 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.07 173.9 6.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.369 -0.832 . . . . 0.0 109.53 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -134.64 -166.41 11.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.95 70.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -1.047 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -158.91 26.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.061 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -145.36 153.27 41.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.841 -1.162 . . . . 0.0 110.421 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.0 t -104.4 113.32 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -57.99 -48.34 80.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.051 -1.03 . . . . 0.0 109.854 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -63.0 112.51 6.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 110.313 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -57.85 -11.12 8.82 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.697 1.598 . . . . 0.0 112.165 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.18 -18.91 58.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.436 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.24 179.65 50.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.7 mt -83.23 121.93 27.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -1.217 . . . . 0.0 109.64 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.0 OUTLIER -49.52 -22.48 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 108.661 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 56.0 m-85 -148.42 178.96 8.15 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -86.87 2.95 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.755 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 45.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.543 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -61.76 -42.69 84.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.911 -1.118 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.6 Cg_exo -58.76 -60.04 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.585 2.19 . . . . 0.0 112.596 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.2 m -66.96 -39.34 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.064 -1.023 . . . . 0.0 111.448 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.554 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 3.3 ptm85 -67.51 -35.52 79.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.561 -1.337 . . . . 0.0 108.595 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -66.02 -34.56 78.37 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -64.59 -35.08 79.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -67.01 -35.99 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -67.41 -50.93 57.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.2 -33.14 72.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.355 -0.84 . . . . 0.0 109.808 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.1 tp -74.97 -32.74 61.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.096 -1.003 . . . . 0.0 108.736 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.4 mt -65.76 -38.6 82.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -53.97 22.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.497 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 6.7 m-20 -56.15 -29.53 60.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -1.201 . . . . 0.0 109.09 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.1 mt -67.09 -23.27 65.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.529 -0.732 . . . . 0.0 110.581 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.47 -22.51 60.15 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.743 -1.223 . . . . 0.0 109.374 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 237' ' ' LEU . 91.7 mt -50.09 -4.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.599 -1.313 . . . . 0.0 110.411 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.6 mt -75.52 -15.46 60.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 109.681 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.02 58.14 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.659 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.36 155.04 9.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.875 -1.368 . . . . 0.0 109.106 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.1 Cg_endo -49.33 150.62 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.956 1.771 . . . . 0.0 109.869 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -109.42 145.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.023 -1.048 . . . . 0.0 111.881 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -130.25 125.18 34.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.47 -160.3 29.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.417 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -130.49 140.43 50.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 109.153 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.8 m-85 -138.62 142.14 39.12 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.175 -0.953 . . . . 0.0 110.331 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.7 t80 -124.91 124.66 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.0 m -117.76 135.0 54.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -115.36 114.92 25.75 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 49.87 20.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.02 -1.05 . . . . 0.0 109.074 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -53.34 156.53 5.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.489 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -138.35 163.0 25.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.577 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 48.4 m-70 -48.68 -40.11 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.187 -1.184 . . . . 0.0 109.817 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -58.4 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.127 -0.983 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 134' ' ' ASP . 13.8 tp -59.63 -44.02 93.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.077 -1.014 . . . . 0.0 109.519 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.2 m-20 -47.73 -48.12 29.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.885 -1.135 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 56' ' ' THR . 73.2 t -62.89 -52.37 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.584 -0.698 . . . . 0.0 109.573 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.484 ' NZ ' ' OD1' ' A' ' 134' ' ' ASP . 31.0 ttmt -52.86 -48.79 66.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.522 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -52.94 -51.75 60.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 108.7 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.538 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.0 t -56.82 -53.75 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.21 -0.932 . . . . 0.0 109.18 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -49.64 -48.23 49.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.91 -48.47 81.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.64 -49.76 74.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.877 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.47 -26.35 66.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.831 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 110.097 -179.531 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 85' ' ' THR . 3.0 mm-40 -56.88 138.57 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 108.846 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -121.61 144.59 48.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.0 110.272 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -142.5 -174.63 4.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.0 m -98.6 136.96 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.249 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.41 -23.03 66.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 109.945 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.51 159.35 44.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.719 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 139.68 58.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.18 164.39 15.24 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.32 142.65 45.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.85 -1.156 . . . . 0.0 110.566 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.3 m-85 -139.3 154.01 47.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.1 152.6 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.856 -1.153 . . . . 0.0 110.091 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.79 176.49 36.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.7 154.6 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -1.099 . . . . 0.0 110.369 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.64 140.45 15.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.526 ' CD1' HG21 ' A' ' 179' ' ' THR . 4.2 tt -58.83 -40.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -1.169 . . . . 0.0 110.679 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 18' ' ' ILE . 77.9 m-70 -89.53 -49.67 6.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.663 -1.273 . . . . 0.0 111.126 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 p -69.6 -23.1 63.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.662 -0.649 . . . . 0.0 111.262 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.48 15.94 13.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.39 154.37 21.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 109.607 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 14.1 t80 -75.98 135.93 40.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 109.766 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 m -139.39 145.28 38.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.43 154.87 24.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 89' ' ' ILE . 8.7 mt -135.71 148.58 48.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.204 -0.935 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG22 ' NE2' ' A' ' 29' ' ' HIS . 14.6 mt -143.37 113.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.18 115.22 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 110.992 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.546 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -107.71 135.95 19.73 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.476 -0.765 . . . . 0.0 109.692 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 21.0 Cg_exo -52.32 168.18 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.004 1.803 . . . . 0.0 111.94 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 35' ' ' THR . 12.7 mm-40 -144.63 177.52 8.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.35 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.11 156.07 19.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.44 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 1.4 mt-10 -49.6 151.28 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -11.1 2.28 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.997 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 62.1 m -55.81 -46.65 78.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.652 -1.499 . . . . 0.0 109.986 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.97 -177.71 32.89 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.204 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.66 117.0 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -138.44 147.7 43.57 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.67 156.86 16.35 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -129.08 111.27 12.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 16.2 tttp -135.65 134.97 39.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 110.851 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 49.92 26.59 2.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.969 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.11 19.54 62.6 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.298 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.7 120.45 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.099 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -87.14 129.14 35.06 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.093 -1.004 . . . . 0.0 108.42 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.514 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 73.5 mt -121.31 95.64 48.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 110.466 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.45 150.19 16.12 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.93 1.754 . . . . 0.0 110.995 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.66 72.1 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -123.86 163.38 21.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.774 . . . . 0.0 109.043 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.3 p-80 -66.04 -52.12 52.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 110.141 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -43.83 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.777 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' HIS . 28.3 m-85 -95.2 5.44 51.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.789 -1.194 . . . . 0.0 109.936 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.3 t -76.69 129.82 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.0 108.611 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.74 -24.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 0.0 110.303 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.67 125.18 10.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.012 -1.055 . . . . 0.0 110.009 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -119.58 95.98 5.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.9 t-20 -162.66 128.54 3.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 59' ' ' SER . 35.1 m80 48.02 9.79 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.15 -0.969 . . . . 0.0 109.263 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 165.8 147.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.905 . . . . 0.0 109.868 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.41 ' HG1' ' HD1' ' A' ' 253' ' ' HIS . 86.0 m -90.06 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 109.149 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.11 149.49 42.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.465 -0.772 . . . . 0.0 110.788 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 13.3 mt -120.37 163.17 18.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.117 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.62 151.19 15.58 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.619 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.33 145.41 14.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.669 -0.901 . . . . 0.0 108.691 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 21.35 7.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.04 -28.14 15.22 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.804 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.23 147.46 49.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.699 -1.471 . . . . 0.0 109.402 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 47.2 ttp180 -140.51 147.03 38.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.071 -1.018 . . . . 0.0 111.498 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.23 137.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -105.87 156.07 18.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 112.322 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.0 m 50.18 78.3 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.439 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.33 -8.2 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.005 . . . . 0.0 109.363 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.8 pm0 -62.74 -27.13 69.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 111.106 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.81 -69.09 0.33 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.802 -1.186 . . . . 0.0 109.256 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG23 ' N ' ' A' ' 76' ' ' LEU . 7.1 tp -51.87 -47.7 40.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.6 ' N ' HG23 ' A' ' 75' ' ' ILE . 11.8 mt -52.29 -49.12 64.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.937 -1.102 . . . . 0.0 110.384 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 36.1 t -60.56 -42.12 95.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.19 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 106' ' ' PHE . 82.3 t -57.25 -46.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.942 -1.099 . . . . 0.0 109.194 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.63 -34.2 77.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -64.09 -37.95 89.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' A' ' 171' ' ' GLU . 54.4 mt -77.85 -39.58 43.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.72 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 82' ' ' LEU . 69.3 mt -78.41 -2.53 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.009 . . . . 0.0 109.226 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 58.32 42.44 21.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 111.311 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.1 mm -86.01 146.59 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.871 -1.143 . . . . 0.0 108.169 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG12 ' A' ' 121' ' ' ILE . 61.3 p -128.93 -23.84 3.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 111.514 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 87' ' ' VAL . 51.3 m-80 -124.61 107.85 11.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.851 -1.156 . . . . 0.0 110.75 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.89 147.14 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.851 0.834 . . . . 0.0 110.256 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 24.7 m -114.82 112.04 22.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.478 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -93.82 100.32 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.421 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.494 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.4 tt0 -74.55 125.94 29.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.4 HG22 HD21 ' A' ' 26' ' ' LEU . 40.3 t -107.16 130.01 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.921 0.867 . . . . 0.0 111.998 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.3 mm -110.69 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.82 -154.76 23.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.44 -10.44 8.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.385 -1.068 . . . . 0.0 110.049 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -138.83 148.31 43.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.041 -1.037 . . . . 0.0 109.347 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 26' ' ' LEU . 7.8 mm -74.44 122.17 86.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.317 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -41.82 122.05 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.975 1.783 . . . . 0.0 111.501 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.475 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -74.82 -13.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.101 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 106' ' ' PHE . 25.8 mt 57.27 -122.45 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.496 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.49 8.74 43.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.588 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.52 -3.66 72.06 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.514 -1.327 . . . . 0.0 109.819 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.21 -173.03 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.495 -1.003 . . . . 0.0 109.135 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.24 16.2 11.83 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -58.24 -45.09 88.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.907 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.95 -57.42 9.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.011 . . . . 0.0 109.655 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 99' ' ' LEU . 8.8 m-85 -51.58 -46.03 63.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.058 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 59.6 t80 -61.17 -52.93 62.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.646 . . . . 0.0 111.058 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.1 -43.08 99.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.139 -0.976 . . . . 0.0 111.376 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -56.63 9.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 110.572 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.7 mt -63.54 -32.24 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.97 -1.081 . . . . 0.0 109.661 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.2 ttt180 -65.09 -43.62 91.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -75.83 11.39 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.018 -1.051 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -143.98 35.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.914 -1.116 . . . . 0.0 110.435 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -82.02 141.19 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 0.0 110.57 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.69 120.52 22.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -81.78 140.68 34.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -106.11 -168.57 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.785 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.571 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -111.54 71.52 0.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 0.0 110.65 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -170.5 133.77 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.995 . . . . 0.0 109.547 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -69.71 147.68 50.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.707 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.629 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -88.72 151.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -97.99 88.05 4.14 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.3 m-85 -66.46 144.27 56.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.848 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -88.31 100.98 13.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -90.78 132.61 34.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.657 -0.652 . . . . 0.0 110.799 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.45 114.06 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.87 -30.18 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.961 -1.087 . . . . 0.0 110.313 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.76 149.95 73.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.831 . . . . 0.0 109.463 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.28 149.72 45.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.492 2.128 . . . . 0.0 111.456 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 tt -157.37 153.82 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.055 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.63 144.51 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.322 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.39 148.24 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -134.96 161.83 34.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB3' HD13 ' A' ' 255' ' ' LEU . 30.6 t70 -174.8 105.81 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.907 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 52.26 53.57 12.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.442 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 -33.0 3.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -60.32 135.51 57.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.019 -1.283 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -145.41 137.72 25.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 110.333 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.575 ' CD1' HD23 ' A' ' 255' ' ' LEU . 90.4 mt -137.04 130.39 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 0.0 109.51 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -117.8 132.09 56.49 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.362 0.601 . . . . 0.0 109.896 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.26 134.21 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.57 153.15 46.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -50.79 143.19 30.49 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.379 2.052 . . . . 0.0 113.428 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.5 143.8 19.03 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.12 -9.66 11.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 110.463 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' GLY . 82.1 p -144.7 -175.29 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 109.547 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 148' ' ' GLU . 10.3 tp -100.19 123.56 44.56 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.198 -0.939 . . . . 0.0 108.567 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.477 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -138.9 135.41 34.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 108.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 231' ' ' LEU . 70.9 t -134.48 123.67 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 165' ' ' THR . 90.9 m -113.75 152.32 30.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -0.775 . . . . 0.0 109.846 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.949 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.97 132.43 54.92 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.03 141.2 11.33 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.338 -1.41 . . . . 0.0 112.07 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.11 101.92 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.43 167.03 13.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 111.144 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -104.54 30.97 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.594 -0.691 . . . . 0.0 110.726 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' LEU . 27.5 p-10 -148.53 -168.35 3.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.771 -1.206 . . . . 0.0 110.118 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -48.22 -4.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 0.0 111.374 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.7 mt -82.99 -31.01 27.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.521 -1.362 . . . . 0.0 108.708 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.55 -135.53 41.48 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.69 132.27 45.14 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.154 -1.203 . . . . 0.0 109.146 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -137.92 149.98 46.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -140.66 144.11 35.5 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -141.78 132.62 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 109.775 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.455 HG23 ' OG1' ' A' ' 150' ' ' THR . 85.5 m -105.89 123.98 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.549 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.9 t80 -105.22 115.74 30.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.49 151.53 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.69 129.63 23.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.01 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.09 -1.99 38.06 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -119.18 23.23 11.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -1.123 . . . . 0.0 109.39 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -56.03 -56.05 25.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 171' ' ' GLU . 3.8 mt-10 -41.81 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.407 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.572 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 2.3 mt-10 -85.11 -7.35 59.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.067 -1.021 . . . . 0.0 111.463 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.565 HG22 ' HB2' ' A' ' 225' ' ' ARG . 9.2 pt -126.36 -27.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.864 -1.147 . . . . 0.0 110.906 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 81' ' ' LEU . 15.8 m -63.89 -17.37 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.739 -1.226 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.4 -3.52 55.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 225' ' ' ARG . . . -68.6 126.32 29.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 179' ' ' THR . 62.4 mtm180 -94.04 130.36 40.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 10.1 t -37.11 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.52 154.24 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.544 -1.348 . . . . 0.0 111.578 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.16 156.36 39.65 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.1 m-85 -97.66 145.49 26.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.83 -1.169 . . . . 0.0 109.692 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.447 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 4.0 t0 -48.8 -37.9 20.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.251 -0.905 . . . . 0.0 109.084 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.532 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.8 p90 -70.16 -25.82 63.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.987 -1.071 . . . . 0.0 109.331 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.3 mm-40 -75.68 -35.66 60.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.92 -42.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.681 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -58.84 -41.7 87.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 0.0 109.538 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 189' ' ' ILE . 11.7 t60 -75.85 -58.31 3.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.013 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 188' ' ' HIS . 94.4 mt -43.79 -33.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -79.4 -52.51 7.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.1 . . . . 0.0 109.069 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -47.33 -44.82 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.22 7.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.054 -1.029 . . . . 0.0 110.531 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.02 40.0 57.67 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.081 -1.012 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.0 mt -127.72 173.82 9.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.219 -1.166 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.16 26.58 50.11 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -60.26 -19.69 55.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.0 109.868 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.84 3.34 33.92 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.68 128.07 40.14 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.462 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 11.5 p -146.44 164.65 31.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.9 mt -66.72 -7.93 24.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 108.607 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -96.83 -19.09 19.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.601 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.462 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 21.5 p30 -128.04 3.98 5.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.5 m -144.47 146.72 32.59 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.688 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 217' ' ' LEU . 13.7 tp -96.79 96.3 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.09 127.67 39.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.893 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.5 160.95 24.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.577 -0.702 . . . . 0.0 109.438 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.43 -166.15 13.04 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -30.47 70.61 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.134 -1.215 . . . . 0.0 109.658 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.97 23.38 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.089 -1.007 . . . . 0.0 111.264 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -149.97 157.76 43.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.449 -1.407 . . . . 0.0 110.724 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.9 t -105.24 115.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -61.63 -44.06 97.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.387 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.3 m120 -62.43 126.01 87.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.889 -1.132 . . . . 0.0 110.334 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -67.08 -17.17 50.7 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.689 1.593 . . . . 0.0 112.246 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -15.82 56.28 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.964 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.33 -164.93 54.45 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.7 mt -91.83 129.55 37.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -1.208 . . . . 0.0 109.463 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 3.3 mmt85 -67.02 -17.08 64.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.995 -1.066 . . . . 0.0 108.193 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 40.6 m-85 -145.53 160.67 41.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.433 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.9 mp0 -77.86 15.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.708 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.538 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -154.28 39.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.781 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.4 tt0 -57.95 -43.81 98.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.903 -1.123 . . . . 0.0 109.793 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 33.2 Cg_exo -59.59 -66.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.833 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 225' ' ' ARG . 19.6 m -60.37 -40.19 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.133 -0.979 . . . . 0.0 111.428 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.572 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 4.3 ptm180 -67.77 -34.72 77.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.615 -1.303 . . . . 0.0 109.006 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -66.61 -32.35 73.62 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -65.59 -37.61 87.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 166' ' ' PHE . 67.8 t -65.7 -37.2 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 46.1 t80 -64.04 -52.07 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.705 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.557 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.0 tp -77.51 -33.58 54.32 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 mt -67.41 -38.06 80.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -54.4 22.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 95.4 m-20 -56.52 -33.04 65.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -1.197 . . . . 0.0 109.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 235' ' ' LEU . 9.1 mt -68.09 -25.15 65.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.544 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.4 t80 -75.06 -21.48 58.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.921 -1.112 . . . . 0.0 109.528 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -50.71 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.705 -1.247 . . . . 0.0 110.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 4.3 mt -70.67 -13.55 62.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.048 . . . . 0.0 109.857 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.74 0.91 60.34 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.609 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.05 152.5 11.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.345 . . . . 0.0 108.86 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.9 Cg_endo -53.59 128.04 27.83 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.795 1.663 . . . . 0.0 109.942 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 t -87.48 153.16 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 112.266 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -134.94 126.15 28.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.7 -157.15 27.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.1 OUTLIER -131.2 136.17 48.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 108.87 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.0 m-85 -135.52 140.54 44.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.155 -0.965 . . . . 0.0 110.484 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -126.09 132.15 51.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -125.32 136.37 53.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.121 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -117.3 113.37 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.19 24.43 1.99 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 109.037 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.45 154.08 42.38 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -131.09 178.18 17.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 75.5 m-70 -59.78 -40.92 89.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -1.226 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -58.96 5.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.575 HD23 ' CD1' ' A' ' 139' ' ' ILE . 6.1 tp -55.74 -46.38 77.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 109.62 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.3 -51.73 18.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.889 -1.132 . . . . 0.0 109.323 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 56' ' ' THR . 88.6 t -61.53 -50.26 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.428 -0.795 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -54.09 -52.05 62.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.988 -1.07 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.1 tp -49.79 -50.92 43.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.17 -0.956 . . . . 0.0 108.486 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 238' ' ' LEU . 44.1 t -58.65 -53.16 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -46.9 -49.77 19.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.82 -48.4 74.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.8 mt -55.95 -51.99 65.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.72 -26.44 63.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.397 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.514 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.34 138.49 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.957 . . . . 0.0 108.862 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.85 145.77 47.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -141.77 -174.83 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.634 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.3 m -97.18 136.95 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.115 . . . . 0.0 109.112 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' HD13 ' A' ' 115' ' ' LEU . 16.7 ptmt -65.47 -29.82 70.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -144.42 156.15 44.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -63.69 141.21 58.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.428 -0.795 . . . . 0.0 110.356 -179.486 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.94 166.22 13.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -137.76 143.18 41.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.085 -1.01 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.1 m-85 -139.37 154.52 47.86 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -163.28 152.59 14.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.837 -1.165 . . . . 0.0 110.177 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.13 176.66 36.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.19 153.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -1.144 . . . . 0.0 110.01 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.28 139.97 15.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 19' ' ' HIS . 5.9 tt -58.54 -41.09 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.249 . . . . 0.0 110.472 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 73.4 m-70 -88.09 -50.52 6.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.694 -1.254 . . . . 0.0 111.116 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 p -66.07 -27.92 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.781 -0.575 . . . . 0.0 111.801 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.74 16.63 46.66 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 118.888 -1.625 . . . . 0.0 109.226 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.85 156.04 22.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -1.058 . . . . 0.0 109.487 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.84 134.45 41.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.5 m -138.21 143.86 40.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.132 -0.98 . . . . 0.0 109.499 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -113.03 156.59 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.255 -0.903 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -136.08 146.94 47.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 110.236 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.3 mp -140.85 115.43 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.93 114.99 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.493 -0.755 . . . . 0.0 110.967 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.547 ' NE2' HG22 ' A' ' 27' ' ' ILE . 13.2 m-70 -109.34 138.06 20.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.427 -0.796 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.634 ' HG3' HG23 ' A' ' 7' ' ' VAL . 29.6 Cg_exo -52.15 168.87 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.959 1.772 . . . . 0.0 111.704 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 35' ' ' THR . 71.9 mm-40 -141.91 173.91 11.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.037 -1.039 . . . . 0.0 109.973 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' A' ' 35' ' ' THR . 31.1 mmtp -83.51 152.26 25.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.769 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 17.7 mt-10 -48.11 146.1 2.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.7 46.27 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.83 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 31' ' ' GLU . 29.0 m -68.51 -42.66 78.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.702 -1.469 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -176.62 32.58 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.367 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.12 118.32 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -141.64 155.95 45.68 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.933 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -104.31 156.91 17.51 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -129.5 109.94 11.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 108.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -135.4 134.97 40.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.422 -0.799 . . . . 0.0 111.006 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 50.69 32.63 7.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 111.578 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.75 17.37 80.12 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.2 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.12 120.81 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.44 -1.036 . . . . 0.0 108.854 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 31.8 m-85 -84.96 128.28 34.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -117.78 93.44 43.9 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.389 -0.819 . . . . 0.0 109.283 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.78 146.7 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.324 2.016 . . . . 0.0 111.925 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 70.93 9.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -122.34 174.82 6.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.2 p-80 -78.1 -52.57 8.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.997 . . . . 0.0 109.61 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -43.7 -16.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' HIS . 39.8 m-85 -96.18 2.74 53.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.06 . . . . 0.0 110.029 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -73.12 132.76 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 108.664 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.64 -30.83 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 110.336 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.68 134.91 18.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 257' ' ' VAL . 73.3 p -123.75 96.07 4.82 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.0 t-20 -162.84 128.7 3.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.3 -0.875 . . . . 0.0 109.121 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.502 ' O ' ' CB ' ' A' ' 59' ' ' SER . 11.9 m80 48.41 9.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.118 -0.989 . . . . 0.0 109.15 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.07 141.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.692 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.1 m -86.22 127.68 34.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.366 -0.834 . . . . 0.0 109.158 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -120.29 149.59 42.06 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.67 0.748 . . . . 0.0 110.944 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 72' ' ' VAL . 12.0 mt -122.16 150.38 42.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.72 151.89 22.7 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.06 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -161.68 147.09 13.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 52.35 21.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.09 6.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -58.42 146.09 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 136.28 34.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.579 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.2 126.47 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -102.96 157.85 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.097 . . . . 0.0 111.582 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.3 m 49.93 74.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 60' ' ' THR . 24.4 m -108.01 -10.86 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 6.7 pm0 -61.71 -25.79 67.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 110.706 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.13 -68.91 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 109.083 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.15 -47.66 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.006 -1.059 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.579 ' N ' HG23 ' A' ' 75' ' ' ILE . 14.4 mt -52.73 -50.03 64.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 110.201 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.9 t -59.75 -42.76 93.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.943 -1.098 . . . . 0.0 110.195 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.2 t -55.06 -48.08 76.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.026 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.49 -33.49 76.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.191 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -62.6 -38.77 91.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 109.416 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.9 mt -76.47 -39.25 53.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 110.155 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 114' ' ' ILE . 65.5 mt -81.8 0.5 38.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.985 -1.072 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.38 43.28 26.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.556 -0.715 . . . . 0.0 111.185 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mm -87.69 146.52 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 108.082 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.592 HG21 HG12 ' A' ' 121' ' ' ILE . 51.0 p -130.53 -20.46 2.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.116 -0.99 . . . . 0.0 111.385 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.728 ' O ' HG13 ' A' ' 87' ' ' VAL . 57.2 m-20 -125.74 107.09 10.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.054 -1.028 . . . . 0.0 110.614 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -165.75 148.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.618 0.723 . . . . 0.0 110.053 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.1 m -115.87 111.47 20.49 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -94.3 101.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.4 tt0 -72.95 126.36 29.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 HD21 ' A' ' 26' ' ' LEU . 71.5 t -108.68 120.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.892 0.854 . . . . 0.0 111.285 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' ILE . 14.2 mt -108.37 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.22 -158.27 27.18 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -118.95 -12.43 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -1.101 . . . . 0.0 110.059 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -141.43 150.77 42.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 109.509 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -74.09 121.26 84.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.991 . . . . 0.0 108.964 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -41.12 122.02 1.5 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.751 1.634 . . . . 0.0 111.345 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.3 tp -77.95 -15.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.536 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt 57.25 -117.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 9.4 t70 -98.25 5.72 48.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.037 -1.039 . . . . 0.0 110.731 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.97 0.9 58.6 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.143 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.0 -172.45 2.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.703 -0.881 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.59 16.64 7.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.554 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 68.8 t-105 -58.38 -42.15 86.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -1.101 . . . . 0.0 110.292 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.0 -56.39 17.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.905 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 78' ' ' VAL . 12.8 m-85 -51.38 -44.09 62.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 108.783 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.415 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 36.3 t80 -62.41 -53.91 48.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.702 -0.624 . . . . 0.0 110.801 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 4.2 mt-10 -59.31 -44.5 92.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 111.133 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.38 -54.87 19.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.992 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.1 mt -67.09 -33.63 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.761 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.8 ttm-85 -62.87 -43.71 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -77.8 14.01 1.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -144.53 32.2 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.964 -1.085 . . . . 0.0 110.333 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 82' ' ' LEU . 79.4 mt -77.76 138.34 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 110.344 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 8' ' ' LYS . 5.1 tp -128.87 120.03 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -80.2 142.99 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.272 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.57 -174.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -109.66 68.95 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -164.77 129.42 2.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.099 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -67.96 141.9 56.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.107 . . . . 0.0 109.478 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.592 HG12 HG21 ' A' ' 85' ' ' THR . 69.9 mt -85.37 150.86 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.128 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p30 -97.76 85.16 3.5 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 32.7 m-85 -62.32 143.49 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.588 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -89.48 101.6 14.28 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.2 133.46 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.43 0.634 . . . . 0.0 110.768 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.16 116.56 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -92.62 -29.93 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.957 -1.089 . . . . 0.0 110.607 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.67 149.7 73.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 109.793 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.17 149.56 46.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.62 2.213 . . . . 0.0 111.779 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -157.02 152.43 7.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.155 -0.966 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.51 141.17 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 109.007 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.83 147.22 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -138.49 157.08 46.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.996 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -175.3 108.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.318 -0.864 . . . . 0.0 109.779 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 53.44 51.53 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -0.828 . . . . 0.0 110.614 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.02 -32.53 3.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.419 ' HB3' HD22 ' A' ' 255' ' ' LEU . 4.8 mtp180 -59.16 136.9 58.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -1.232 . . . . 0.0 108.133 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -149.3 135.64 19.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.77 -1.206 . . . . 0.0 109.709 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.615 ' CD1' HD23 ' A' ' 255' ' ' LEU . 87.4 mt -137.27 128.57 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -114.13 131.88 56.27 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.412 0.625 . . . . 0.0 109.886 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.0 134.26 54.81 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.91 152.86 45.04 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.004 -1.06 . . . . 0.0 110.018 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.68 142.57 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.529 2.153 . . . . 0.0 113.889 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -156.83 147.01 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.3 -29.42 68.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.122 -0.986 . . . . 0.0 110.869 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.534 ' O ' ' OG ' ' A' ' 144' ' ' SER . 12.6 p -119.67 -165.52 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.358 -0.838 . . . . 0.0 109.23 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 148' ' ' GLU . 7.3 tp -107.42 122.38 46.5 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.7 tt0 -138.65 126.25 22.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.979 . . . . 0.0 109.098 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.96 122.2 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 109.83 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 165' ' ' THR . 52.0 m -112.98 151.77 30.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.613 -0.68 . . . . 0.0 109.61 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.76 130.18 25.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.669 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -122.47 135.13 54.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.44 143.13 12.73 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.7 100.64 10.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.11 167.82 13.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.846 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -103.82 24.93 10.49 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.632 -0.668 . . . . 0.0 110.257 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 158' ' ' PHE . 22.6 p-10 -137.71 -170.53 2.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.037 -1.04 . . . . 0.0 110.36 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.59 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 21.2 p90 -49.55 -5.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.608 -0.683 . . . . 0.0 111.638 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.601 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 73.6 mt -82.35 -30.31 30.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.176 -1.578 . . . . 0.0 108.349 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.59 -132.26 43.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 131.04 43.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.158 -1.201 . . . . 0.0 109.192 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 1.6 tp-100 -138.29 144.7 40.59 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.465 -0.772 . . . . 0.0 109.259 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.83 36.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 110.361 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -146.74 141.66 26.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.927 . . . . 0.0 109.942 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 150' ' ' THR . 58.5 m -110.49 124.59 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.491 -0.755 . . . . 0.0 109.822 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -105.37 115.91 31.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.51 151.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.737 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.33 131.56 24.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.167 -0.958 . . . . 0.0 109.166 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.28 -3.03 43.53 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -117.35 22.57 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -1.183 . . . . 0.0 109.002 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -50.97 -54.87 20.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.738 . . . . 0.0 110.011 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 171' ' ' GLU . 71.6 mt-10 -41.79 -23.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' GLU . 64.6 mt-10 -81.54 -12.77 58.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.028 -1.045 . . . . 0.0 111.754 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.15 -28.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.866 -1.146 . . . . 0.0 111.355 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.58 -26.84 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.519 -1.363 . . . . 0.0 108.972 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -84.71 -3.61 58.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.461 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.46 116.82 10.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 108.915 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 54.4 mtm180 -79.95 172.35 13.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.143 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -78.54 162.51 26.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.37 149.17 32.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.218 -1.551 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.24 156.7 43.57 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.441 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 89.9 m-85 -98.15 146.2 25.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.0 109.314 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.44 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.37 -38.3 12.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.897 . . . . 0.0 109.479 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -72.33 -29.37 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 0.0 109.597 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.7 mt-10 -73.16 -33.95 65.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.8 -54.25 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.792 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.3 -41.93 9.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.5 t-160 -74.42 -47.99 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.466 -0.771 . . . . 0.0 109.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 92.9 mt -53.97 -30.56 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -84.36 -53.52 5.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.885 -1.135 . . . . 0.0 109.477 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -49.87 -36.54 27.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.9 m -81.61 8.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.022 . . . . 0.0 109.892 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.2 39.95 71.53 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.5 mt -128.99 172.31 11.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -1.143 . . . . 0.0 109.989 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.5 25.23 57.8 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -58.89 -20.02 47.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.478 -1.601 . . . . 0.0 109.987 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.46 5.47 31.46 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.69 130.71 34.09 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.315 . . . . 0.0 110.437 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.659 ' N ' HD21 ' A' ' 202' ' ' ASN . 8.2 t -144.08 160.9 40.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.44 -1.035 . . . . 0.0 109.235 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 31.8 mt -66.92 -8.99 33.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.419 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -98.15 -13.05 21.13 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.659 HD21 ' N ' ' A' ' 199' ' ' SER . 10.0 p30 -128.66 8.79 5.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 109.256 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.97 153.91 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 110.377 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 217' ' ' LEU . 9.9 tp -101.3 110.65 22.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.79 128.85 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.773 0.797 . . . . 0.0 109.281 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.83 165.79 17.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.706 . . . . 0.0 109.639 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -166.73 11.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -30.44 69.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -1.049 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 209' ' ' ASP . 23.0 p-10 -158.34 21.88 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.274 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -138.15 145.19 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.907 -1.12 . . . . 0.0 110.535 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.3 108.41 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -54.84 -50.58 68.27 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 110.043 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.61 115.29 13.0 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.66 -12.28 35.01 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.418 1.412 . . . . 0.0 111.9 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.72 -15.95 60.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 108.664 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.73 178.27 46.05 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.592 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -82.62 150.12 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -1.08 . . . . 0.0 109.576 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -79.02 -19.0 52.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.15 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -141.94 -165.53 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.6 -8.21 29.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.191 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.07 45.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.914 . . . . 0.0 109.35 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.18 -46.92 99.6 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.925 -1.109 . . . . 0.0 109.86 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 55.4 Cg_exo -51.18 -68.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.42 2.08 . . . . 0.0 112.179 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.6 -35.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.95 -1.094 . . . . 0.0 109.674 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -61.69 -40.7 95.94 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.9 t60 -68.02 -31.41 71.06 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.664 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -65.33 -36.25 83.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -38.14 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 67.5 t80 -64.42 -50.23 68.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 109.17 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.65 -28.35 68.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.06 -32.91 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.104 -0.998 . . . . 0.0 108.391 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.587 HD11 ' CD2' ' A' ' 166' ' ' PHE . 34.4 mt -68.97 -38.9 79.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.58 -53.49 31.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.449 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 80.6 m-20 -56.74 -38.2 72.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.234 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.6 mt -58.59 -21.12 52.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.505 -0.747 . . . . 0.0 110.36 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -75.02 -22.32 58.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.824 -1.172 . . . . 0.0 109.454 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.18 1.08 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.49 -1.381 . . . . 0.0 110.292 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.4 mt -77.93 -16.29 58.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.911 -1.118 . . . . 0.0 109.569 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.9 -0.23 51.88 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.867 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.79 157.41 10.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.736 -1.449 . . . . 0.0 109.118 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.8 Cg_endo -50.22 150.79 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.805 1.67 . . . . 0.0 109.322 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.67 145.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.873 -1.142 . . . . 0.0 112.108 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 122.44 33.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.66 -160.5 30.7 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.444 -1.033 . . . . 0.0 108.888 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -140.66 141.26 35.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 110.401 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -125.52 122.96 38.08 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.8 m -115.22 136.11 53.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 111.198 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 250' ' ' ARG . 91.7 t80 -117.81 116.04 26.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 249' ' ' PHE . 38.0 mtp85 43.55 43.54 4.66 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.219 -0.926 . . . . 0.0 109.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.35 165.42 35.62 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -138.83 -174.57 13.51 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.552 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.4 m-70 -63.01 -39.14 93.86 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER -55.27 -58.68 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.088 -1.007 . . . . 0.0 108.999 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 139' ' ' ILE . 4.1 tp -56.27 -45.08 80.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 109.461 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.46 -50.5 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 109.35 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 56' ' ' THR . 96.1 t -64.95 -39.23 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.732 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -63.97 -51.41 64.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 139' ' ' ILE . 23.6 tp -52.87 -49.13 66.44 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 108.545 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.471 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.4 t -60.01 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -49.29 -48.68 45.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -61.32 -49.07 78.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 109.705 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -57.3 -45.77 83.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 109.641 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.55 63.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.914 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 109.76 -179.644 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -57.59 141.57 47.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 108.731 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -125.59 147.09 49.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.4 t -141.93 -173.03 3.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.6 m -97.35 136.84 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.868 -1.145 . . . . 0.0 109.035 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -67.27 -21.77 65.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.572 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE2' ' O ' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -152.31 157.82 41.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' O ' ' OE2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -65.8 139.99 58.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.312 -0.867 . . . . 0.0 110.368 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 mt -115.95 163.55 15.72 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.51 142.06 43.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 110.344 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -141.21 161.01 38.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -167.15 152.75 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 109.768 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.27 176.11 36.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.34 155.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -1.128 . . . . 0.0 110.062 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 139.14 15.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 179' ' ' THR . 7.3 tt -58.98 -38.33 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.265 . . . . 0.0 110.354 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 80.2 m-70 -90.86 -50.82 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.674 -1.266 . . . . 0.0 111.026 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.3 p -68.65 -23.64 64.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.76 -0.587 . . . . 0.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.95 17.2 21.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -108.28 153.34 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -1.025 . . . . 0.0 109.651 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -73.3 134.64 44.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.0 109.41 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -140.49 143.83 35.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -108.28 158.58 17.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -137.6 144.61 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.54 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.574 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.5 mt -143.43 110.91 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.9 . . . . 0.0 108.852 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.43 115.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 111.057 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' NE2' HG22 ' A' ' 27' ' ' ILE . 30.1 m-70 -108.5 138.57 20.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 109.422 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -53.82 168.37 0.81 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.753 1.635 . . . . 0.0 111.728 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' OE1' HG21 ' A' ' 35' ' ' THR . 28.1 mm-40 -140.94 173.75 11.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OG1' ' A' ' 35' ' ' THR . 39.7 mttm -85.08 153.06 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.284 -0.885 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.17 147.21 3.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.704 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 71.82 -0.33 37.24 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.903 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.76 ' H ' HD22 ' A' ' 86' ' ' ASN . 51.6 m -67.21 -45.42 76.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.615 -1.52 . . . . 0.0 109.536 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.75 -179.34 31.52 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.774 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.87 117.66 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH2' ' CE1' ' A' ' 45' ' ' TYR . 21.7 ptt180 -144.49 157.73 44.1 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.839 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -103.64 157.86 16.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -128.07 110.83 12.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 108.772 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 15.9 tttp -135.27 132.81 38.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.579 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.17 28.3 6.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.464 -0.772 . . . . 0.0 111.628 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.44 19.67 68.34 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.211 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -124.28 123.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.278 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.447 ' CE1' ' NH2' ' A' ' 38' ' ' ARG . 98.9 m-85 -84.78 127.62 34.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.4 90.99 40.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.69 150.22 4.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.549 2.166 . . . . 0.0 111.926 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.644 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.11 75.99 9.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.982 . . . . 0.0 109.775 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -129.35 173.66 10.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 109.211 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.2 p-80 -71.81 -52.43 17.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -45.48 -16.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.758 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' HIS . 21.0 m-85 -94.9 0.37 54.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.722 -1.236 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -72.82 128.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.04 -28.94 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -151.07 133.03 15.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.945 HG21 HG21 ' A' ' 257' ' ' VAL . 40.8 p -123.93 95.91 4.74 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' SER . 5.7 t-20 -162.61 128.76 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.852 . . . . 0.0 108.805 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' SER . 18.0 m80 50.17 9.45 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.97 146.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.801 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.434 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 31.0 m -89.9 126.92 35.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 0.0 109.174 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.7 m-20 -121.04 150.35 41.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.328 -0.857 . . . . 0.0 111.059 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CG ' HG21 ' A' ' 72' ' ' VAL . 4.5 mt -125.5 150.11 47.68 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.51 154.82 25.91 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.894 -1.622 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -163.22 150.39 12.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -1.033 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt 52.31 22.2 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.13 -32.5 7.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -59.83 145.74 44.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.287 . . . . 0.0 109.478 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.25 139.51 35.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.407 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -130.15 121.96 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -99.04 156.99 16.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.1 m 49.14 74.52 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.879 -0.513 . . . . 0.0 110.739 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.533 HG21 ' CG ' ' A' ' 62' ' ' LEU . 20.6 m -108.0 -9.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.117 -0.989 . . . . 0.0 109.274 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.1 pm0 -60.86 -26.28 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.493 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.01 -69.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -52.56 -47.48 48.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.276 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.644 HD21 ' HB1' ' A' ' 48' ' ' ALA . 26.4 mt -52.02 -48.75 64.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.954 -1.091 . . . . 0.0 110.026 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -61.18 -42.46 98.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.166 -0.959 . . . . 0.0 110.118 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.8 t -56.64 -44.88 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.093 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.24 -35.19 75.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.33 -0.856 . . . . 0.0 109.288 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -62.48 -34.36 76.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 109.189 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 52.2 mt -82.03 -37.97 25.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.619 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 82' ' ' LEU . 70.4 mt -79.62 0.26 30.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.409 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 4.1 mp0 57.13 41.13 27.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.326 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.07 143.67 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.703 -1.248 . . . . 0.0 108.043 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 121' ' ' ILE . 51.5 p -127.52 -21.04 3.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.103 -0.998 . . . . 0.0 111.703 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.76 HD22 ' H ' ' A' ' 35' ' ' THR . 5.4 m120 -127.18 107.0 9.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.937 -1.102 . . . . 0.0 110.609 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -164.94 149.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 109.917 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.45 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 41.7 m -117.21 111.66 19.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.487 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.2 mt -92.61 100.92 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.917 . . . . 0.0 110.269 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.8 tt0 -73.95 127.51 33.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.552 HG22 HD21 ' A' ' 26' ' ' LEU . 21.2 t -115.9 124.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.04 0.924 . . . . 0.0 112.261 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.5 mm -109.48 98.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.548 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 144.36 -159.05 27.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.02 -10.93 9.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -1.163 . . . . 0.0 110.075 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -141.62 150.2 41.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.981 -1.074 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -72.27 120.35 79.91 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.702 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -41.09 120.83 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.69 1.593 . . . . 0.0 111.145 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.3 tp -78.25 -15.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 110.754 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 106' ' ' PHE . 46.2 mt 57.1 -117.78 1.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.051 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 10.3 t0 -97.04 4.48 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 110.588 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.63 1.57 58.87 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.104 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 p -127.58 -172.68 2.73 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.811 . . . . 0.0 109.563 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.7 15.84 7.94 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.403 ' CZ2' ' HG3' ' A' ' 108' ' ' GLU . 42.1 t-105 -56.09 -42.43 76.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -1.046 . . . . 0.0 110.5 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.9 -59.1 5.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.322 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 99' ' ' LEU . 11.2 m-30 -51.16 -45.18 61.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.149 -0.969 . . . . 0.0 109.288 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 48.8 t80 -60.12 -50.72 72.57 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 23.8 mm-40 -63.78 -43.85 95.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.17 -0.956 . . . . 0.0 111.23 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.45 -60.01 2.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.945 -1.097 . . . . 0.0 110.095 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.49 -36.8 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.192 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 39.9 ttt180 -62.12 -43.44 98.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 109.249 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -76.33 13.93 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.614 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -146.08 31.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.069 -1.02 . . . . 0.0 110.453 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.1 mt -80.75 139.12 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.902 -1.124 . . . . 0.0 110.35 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -128.06 119.25 25.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.529 -0.732 . . . . 0.0 109.041 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.62 140.68 48.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -109.54 -178.26 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.701 . . . . 0.0 109.186 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -108.85 68.4 0.68 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.949 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -165.91 131.58 2.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 0.0 109.255 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -67.49 139.02 57.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 109.666 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 HG21 ' A' ' 85' ' ' THR . 47.2 mt -81.35 147.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.103 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.73 84.74 3.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 108.856 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.2 m-85 -64.14 143.84 57.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.438 -0.789 . . . . 0.0 109.851 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -88.27 101.56 13.98 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.17 132.19 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.7 . . . . 0.0 110.777 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.0 114.65 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -86.64 -29.1 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.959 -1.088 . . . . 0.0 110.907 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.77 162.33 51.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.963 -1.086 . . . . 0.0 109.766 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.34 145.56 27.14 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.857 2.371 . . . . 0.0 112.777 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -154.31 149.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.33 143.49 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 109.37 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.5 149.29 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.13 164.72 27.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.4 -0.812 . . . . 0.0 109.859 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.598 ' CG ' HH21 ' A' ' 137' ' ' ARG . 57.6 t0 -173.87 111.77 0.18 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 109.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 58.18 9.54 1.02 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.619 -0.675 . . . . 0.0 109.865 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.18 -26.63 8.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 134' ' ' ASP . 1.2 mpp_? -58.42 144.12 43.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.702 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.3 tt -148.94 139.51 22.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.093 -1.443 . . . . 0.0 111.03 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.23 125.6 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -111.71 131.0 55.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.436 0.636 . . . . 0.0 109.838 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.97 132.37 54.88 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 154.02 52.26 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.995 -1.066 . . . . 0.0 109.959 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.3 139.76 43.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.276 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.93 147.13 22.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.9 -37.54 82.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.4 p -117.75 -171.55 2.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.0 110.051 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 tp -100.95 126.15 47.58 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.98 137.23 34.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.58 ' CG1' HD23 ' A' ' 231' ' ' LEU . 61.8 t -133.98 121.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.0 m -111.29 151.96 27.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.465 -0.772 . . . . 0.0 109.265 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.557 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 34.0 t80 -140.75 130.94 24.88 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.181 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.83 131.66 54.17 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.83 141.33 12.29 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.583 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -103.89 100.81 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.28 167.3 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -100.94 -14.99 17.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.821 . . . . 0.0 110.774 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 p-10 -95.31 -173.56 2.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.784 -1.198 . . . . 0.0 110.587 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.47 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 8.4 p90 -49.3 -0.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.812 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.6 mt -80.76 -28.63 36.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.31 -1.494 . . . . 0.0 108.803 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.12 -137.09 45.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -99.85 135.85 40.65 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -1.188 . . . . 0.0 109.625 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -139.03 146.88 41.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -138.18 144.65 40.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.493 -0.755 . . . . 0.0 109.756 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -143.22 136.16 27.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.7 m -105.85 122.76 46.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.72 ' CD1' ' ND2' ' A' ' 170' ' ' ASN . 7.2 t80 -101.73 110.24 22.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.271 -0.893 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.659 ' O ' ' ND2' ' A' ' 170' ' ' ASN . 3.7 t -105.76 141.02 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 110.054 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 167' ' ' VAL . 9.8 mm-40 -44.06 131.58 5.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 108.819 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.85 -16.52 18.45 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.72 ' ND2' ' CD1' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -115.16 29.36 8.07 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.074 -1.25 . . . . 0.0 109.916 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -53.75 -38.32 64.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.07 -1.019 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.3 -18.65 50.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -85.66 -7.57 58.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 111.179 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.73 -28.49 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.114 -0.991 . . . . 0.0 110.963 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.8 m -63.5 -24.95 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.736 -1.227 . . . . 0.0 108.882 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.59 -4.72 58.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.13 120.17 13.9 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 82.3 mtm180 -83.4 172.47 12.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.501 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.9 t -79.14 161.48 26.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -147.85 145.45 28.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.234 -1.541 . . . . 0.0 111.859 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.49 157.43 44.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.5 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.5 m-85 -98.95 145.54 26.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 109.626 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.06 -35.79 26.58 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.344 -0.847 . . . . 0.0 109.864 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -72.8 -28.16 62.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.963 -1.086 . . . . 0.0 109.862 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.6 mm-40 -79.11 -40.62 30.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 110.085 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 77.5 mt -44.73 -55.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 19.3 tt0 -42.13 -41.73 2.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 192' ' ' VAL . 48.6 t60 -73.26 -55.55 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 88.5 mt -45.4 -26.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.368 -0.832 . . . . 0.0 109.407 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -85.75 -53.71 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.819 -1.176 . . . . 0.0 108.921 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -49.09 -26.77 2.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 188' ' ' HIS . 15.4 m -96.1 18.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 59.25 39.83 95.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 194' ' ' LEU . 62.4 mt -125.45 171.97 10.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -1.071 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.37 22.49 51.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -58.28 -22.79 54.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.7 -1.471 . . . . 0.0 109.534 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -110.28 25.56 15.52 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.33 125.01 7.61 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.416 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -143.89 169.49 17.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -1.118 . . . . 0.0 109.847 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.554 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 55.8 mt -69.08 -8.74 48.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.5 -10.64 24.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.722 -0.611 . . . . 0.0 109.762 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.44 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 13.5 p30 -138.27 8.76 2.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 109.866 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.482 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.72 149.56 31.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.932 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.586 HD11 HD21 ' A' ' 206' ' ' LEU . 21.8 tp -97.95 93.65 6.44 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -87.41 130.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.279 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 204' ' ' LEU . 20.3 mt -123.35 163.05 21.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.528 -0.733 . . . . 0.0 109.164 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.52 -166.79 13.22 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -68.45 -25.74 65.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.261 -1.14 . . . . 0.0 109.665 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.16 21.47 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 0.0 110.778 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -150.1 157.92 43.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.411 -1.43 . . . . 0.0 110.68 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.01 113.94 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -57.38 -50.86 71.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.897 -1.127 . . . . 0.0 109.99 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.34 111.21 3.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.56 -16.47 30.15 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.747 1.631 . . . . 0.0 112.677 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.65 -15.7 60.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.901 -1.125 . . . . 0.0 109.923 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.4 -178.37 47.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.7 mt -84.31 151.41 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 109.735 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.5 OUTLIER -78.55 -18.97 53.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.187 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 52.9 m-85 -144.72 -172.0 3.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.542 -0.724 . . . . 0.0 109.103 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.3 -5.08 53.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.6 43.28 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.196 -0.94 . . . . 0.0 109.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -54.82 -47.52 98.02 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 109.948 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -50.82 -68.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.463 2.108 . . . . 0.0 112.079 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.7 m -58.22 -36.3 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -60.88 -40.88 94.66 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.223 -0.923 . . . . 0.0 108.555 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 15.3 t60 -68.47 -32.19 72.01 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.253 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LYS . . . . . 0.557 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 6.0 mmtp -66.04 -36.03 82.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.9 t -67.63 -37.49 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.03 -52.11 61.01 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 87.4 m-20 -65.38 -27.01 68.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.681 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.58 HD23 ' CG1' ' A' ' 149' ' ' VAL . 59.2 tp -76.92 -32.77 57.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.084 -1.01 . . . . 0.0 108.588 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.85 -38.53 78.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.15 -54.36 24.57 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -56.96 -35.43 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 109.293 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.72 -24.83 67.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 110.512 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.2 t80 -74.98 -21.46 59.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.884 -1.135 . . . . 0.0 109.388 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 237' ' ' LEU . 65.0 mt -48.54 -6.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.86 -1.15 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -69.33 -13.03 62.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.945 -1.097 . . . . 0.0 109.85 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.85 2.92 64.44 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.715 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.74 149.87 11.02 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.872 -1.369 . . . . 0.0 108.904 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.401 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 6.9 Cg_endo -53.04 130.0 35.95 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.639 1.559 . . . . 0.0 110.076 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.88 150.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 112.216 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -130.64 123.37 29.28 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.82 -157.43 27.59 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.8 OUTLIER -129.35 137.03 50.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -1.042 . . . . 0.0 108.857 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.0 m-85 -133.54 140.03 46.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -126.97 123.24 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.06 132.99 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.735 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -114.92 110.79 20.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 56.6 mtp180 46.57 41.25 9.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.249 -0.907 . . . . 0.0 109.087 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.8 163.98 50.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -131.76 -179.05 15.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.519 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 30.7 m-70 -65.15 -46.72 79.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -1.229 . . . . 0.0 110.034 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.6 OUTLIER -53.45 -60.61 3.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.971 -1.081 . . . . 0.0 108.782 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 254' ' ' SER . 12.5 tp -47.76 -49.5 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.03 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 25.8 m-20 -47.74 -49.5 28.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.988 -1.07 . . . . 0.0 109.098 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 56' ' ' THR . 88.2 t -60.94 -44.29 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.473 -0.767 . . . . 0.0 109.755 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -59.4 -49.21 78.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.218 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 32.4 tp -54.19 -49.85 68.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.63 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.555 HG13 ' HG ' ' A' ' 238' ' ' LEU . 22.5 t -58.47 -57.43 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.003 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -47.74 -45.33 28.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.133 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -62.48 -57.4 11.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.365 -0.834 . . . . 0.0 109.213 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.5 mt -48.4 -48.7 36.86 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.141 -0.975 . . . . 0.0 109.512 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.58 67.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 109.859 -179.537 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.3 mt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.266 0.555 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 119' ' ' ARG . 27.9 mt-10 -54.0 142.45 24.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -125.7 142.73 51.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.351 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -142.62 -168.55 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.1 m -103.22 141.19 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.005 -1.059 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -69.92 -26.03 63.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.982 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -145.44 161.79 38.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 110.161 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 139.18 55.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.07 161.27 20.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 p -131.96 141.66 49.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.73 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 91.9 m-85 -138.17 152.5 48.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.24 151.9 19.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.743 -1.223 . . . . 0.0 110.157 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.72 174.28 35.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 151.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.0 136.14 14.81 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.4 tt -56.55 -39.05 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.456 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.8 m-70 -92.35 -49.26 6.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.757 -1.214 . . . . 0.0 111.008 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -28.38 69.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 111.245 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.87 17.63 55.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -112.7 155.12 25.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -1.012 . . . . 0.0 109.325 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.28 135.2 44.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.0 109.421 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 m -138.11 144.34 40.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.784 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.18 154.38 25.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.027 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 7.7 mt -135.74 147.44 48.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 110.162 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.573 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.8 mt -143.87 109.43 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.4 115.15 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.449 -0.782 . . . . 0.0 110.575 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.573 ' NE2' HG22 ' A' ' 27' ' ' ILE . 34.2 m-70 -109.46 141.81 24.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 7' ' ' VAL . 16.5 Cg_exo -55.79 168.89 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.824 1.683 . . . . 0.0 111.477 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' HG21 ' A' ' 35' ' ' THR . 70.7 mm-40 -141.74 175.44 9.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.93 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 13.8 mttt -82.37 152.09 26.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 145.13 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 70.19 5.06 52.59 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.107 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 31' ' ' GLU . 35.2 m -67.31 -44.37 79.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.526 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.36 -179.69 33.54 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.547 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -96.29 116.58 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -143.02 148.84 37.41 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.69 -1.204 . . . . 0.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.82 156.94 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -129.3 109.38 11.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.236 -0.915 . . . . 0.0 108.934 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 tttp -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m120 53.61 27.7 7.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 111.101 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.25 19.67 71.43 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.463 -1.351 . . . . 0.0 109.859 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 t -123.28 123.2 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -85.87 127.46 34.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.04 -1.038 . . . . 0.0 109.287 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mt -118.23 95.03 47.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 109.724 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.4 148.24 11.18 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.476 2.118 . . . . 0.0 112.179 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.674 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.59 78.38 8.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.761 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -134.85 -179.94 5.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 0.0 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.4 p-80 -74.52 -54.76 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.986 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.598 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.4 OUTLIER -43.5 -17.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.845 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 67.2 m-85 -97.23 -0.52 46.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 109.655 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.94 122.36 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.4 -0.813 . . . . 0.0 108.831 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -100.3 -34.11 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -151.21 138.66 19.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.144 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.944 HG21 HG21 ' A' ' 257' ' ' VAL . 55.2 p -125.02 95.86 4.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 59' ' ' SER . 28.0 t-20 -162.53 129.5 3.66 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.4 m-70 49.43 9.57 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.091 -1.006 . . . . 0.0 108.969 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.61 143.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 109.646 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 41.8 m -88.66 129.56 35.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 109.011 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.16 152.34 41.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.288 -0.883 . . . . 0.0 111.164 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.0 mt -126.11 151.77 46.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.04 165.54 34.25 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.021 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -168.71 141.74 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 108.806 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? 52.27 28.59 5.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.741 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.63 5.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -57.64 148.75 23.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.006 -1.291 . . . . 0.0 109.343 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.28 139.99 26.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.699 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.534 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -130.24 124.62 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -98.45 154.19 18.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.272 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.2 m 51.89 75.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.1 m -107.88 -9.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.138 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.58 -27.96 69.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.517 -0.739 . . . . 0.0 110.559 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -65.08 -69.37 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.988 -1.07 . . . . 0.0 109.498 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -51.57 -47.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.154 -0.966 . . . . 0.0 109.023 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.674 HD21 ' HB1' ' A' ' 48' ' ' ALA . 18.6 mt -52.12 -48.37 64.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.076 -1.015 . . . . 0.0 110.134 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.582 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 40.5 t -60.87 -42.77 98.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.45 -44.59 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.0 109.086 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.05 -34.48 77.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -61.96 -40.43 95.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' HB2' ' A' ' 171' ' ' GLU . 55.8 mt -75.0 -37.9 61.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.718 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.23 0.82 34.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 109.543 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 54.41 42.25 31.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 0.0 110.139 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -90.36 137.04 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 108.557 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 HG12 ' A' ' 121' ' ' ILE . 31.4 p -124.53 -19.01 5.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.191 -0.943 . . . . 0.0 112.018 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.732 ' O ' HG13 ' A' ' 87' ' ' VAL . 29.6 m-80 -124.61 107.16 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.806 -1.184 . . . . 0.0 110.407 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.3 m -165.9 147.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.738 0.78 . . . . 0.0 109.913 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 53.3 m -114.03 110.97 20.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.18 100.31 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 110.16 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.92 125.7 28.2 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 69' ' ' ILE . 48.8 t -110.79 120.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.762 0.791 . . . . 0.0 111.725 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt -107.52 96.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.84 -156.61 26.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -121.83 -10.55 8.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -1.169 . . . . 0.0 110.443 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -140.33 148.86 41.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.0 -1.063 . . . . 0.0 109.973 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.7 mm -72.99 117.17 57.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.892 . . . . 0.0 108.804 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' ILE . 75.3 Cg_exo -39.31 130.26 1.57 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.586 1.524 . . . . 0.0 111.418 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.482 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.6 tp -86.21 -14.12 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.08 -117.47 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 0.0 109.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 4.47 51.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.024 -1.047 . . . . 0.0 110.75 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.71 58.77 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.182 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.1 p -126.54 -172.82 2.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.558 -0.966 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.7 15.99 9.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 62.5 t-105 -59.67 -42.73 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -1.064 . . . . 0.0 110.299 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.55 -57.06 11.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.095 -1.003 . . . . 0.0 109.996 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -51.33 -44.92 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.865 . . . . 0.0 109.048 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 46.4 t80 -62.55 -52.51 63.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.726 -0.608 . . . . 0.0 110.931 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 3.8 mm-40 -60.71 -44.13 96.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.08 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.85 3.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.088 -1.007 . . . . 0.0 110.51 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.25 -33.75 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.506 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 36.2 ttt180 -64.64 -41.81 95.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -75.86 11.97 1.23 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 110.024 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -142.84 35.68 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.3 mt -81.41 140.12 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.225 -0.922 . . . . 0.0 110.953 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 8' ' ' LYS . 3.9 tp -132.21 126.94 34.73 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.15 146.03 33.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -117.02 -175.85 2.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.272 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -113.27 67.02 0.66 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.232 -0.917 . . . . 0.0 111.175 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 4' ' ' GLU . 7.6 ttt180 -164.89 128.31 2.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 109.529 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -68.24 142.77 55.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.89 -1.131 . . . . 0.0 109.99 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.528 HG12 HG21 ' A' ' 85' ' ' THR . 70.7 mt -85.95 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -95.94 83.46 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 108.794 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 44.1 m-85 -61.66 145.27 52.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 110.14 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -92.6 102.31 14.74 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.22 133.89 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.384 0.611 . . . . 0.0 110.843 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.69 118.96 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.62 -28.31 16.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.979 -1.075 . . . . 0.0 110.736 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 154.54 80.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.48 151.68 47.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.684 2.256 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -160.23 154.21 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.595 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.37 144.67 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.49 148.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -134.88 159.9 39.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.45 107.9 0.12 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 54.66 49.35 18.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.442 -0.786 . . . . 0.0 110.488 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.65 -29.36 3.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -61.8 137.97 58.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -1.216 . . . . 0.0 108.116 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -146.71 139.38 25.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.691 -1.256 . . . . 0.0 110.223 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.587 ' CD1' HD23 ' A' ' 255' ' ' LEU . 96.7 mt -137.78 126.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.375 -0.828 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -113.34 133.26 55.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.392 0.615 . . . . 0.0 109.999 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.11 136.2 54.89 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.81 150.73 40.3 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.61 141.88 14.57 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.693 2.262 . . . . 0.0 113.62 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.21 144.89 20.16 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.539 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.19 -20.51 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.296 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.9 p -137.45 -174.13 3.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 tp -94.39 121.19 35.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -134.74 120.46 19.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.52 121.45 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.805 . . . . 0.0 109.993 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.0 m -111.31 151.84 27.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.631 -0.668 . . . . 0.0 109.199 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -139.21 130.05 26.22 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -121.23 131.67 54.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.65 138.5 9.49 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.32 -1.419 . . . . 0.0 112.053 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 99.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -83.66 167.01 17.65 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 111.359 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -100.44 23.61 10.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.712 -0.617 . . . . 0.0 110.649 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.0 p-10 -140.08 -172.91 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -49.34 -2.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 111.417 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -77.94 -27.74 49.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.361 -1.462 . . . . 0.0 108.375 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.84 -135.1 43.14 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 133.25 44.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -1.204 . . . . 0.0 109.302 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.31 141.4 45.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -136.8 144.11 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.012 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -144.91 137.06 25.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.3 m -105.5 123.55 48.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.701 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.489 ' HB3' HG11 ' A' ' 228' ' ' VAL . 10.2 t80 -103.56 109.0 20.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.984 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.76 149.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.07 131.39 23.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -0.958 . . . . 0.0 109.02 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.53 43.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -115.97 22.95 12.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -1.085 . . . . 0.0 109.226 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.722 ' HB2' HD13 ' A' ' 81' ' ' LEU . 4.9 pt-20 -58.11 -47.24 83.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.376 -0.827 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 171' ' ' GLU . 22.8 mt-10 -52.85 -6.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 110.258 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 171' ' ' GLU . 23.7 mt-10 -102.71 -6.94 22.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.033 . . . . 0.0 110.952 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.1 pt -123.73 -26.46 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.996 -1.065 . . . . 0.0 110.849 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.1 m -63.65 -29.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mt -77.39 -5.65 50.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.537 -0.727 . . . . 0.0 109.165 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.51 124.51 24.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.113 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.412 HH12 ' HG3' ' A' ' 215' ' ' GLU . 63.3 mtm180 -86.13 172.72 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.778 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.427 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -79.0 162.55 25.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.36 145.63 27.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.216 -1.552 . . . . 0.0 111.875 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.14 157.94 44.06 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.593 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.5 m-85 -98.61 142.11 30.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.652 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 2.9 t0 -49.22 -35.61 17.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.205 -0.935 . . . . 0.0 109.409 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.593 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.2 p90 -70.55 -26.16 63.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.023 -1.048 . . . . 0.0 109.553 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -86.3 -27.3 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.758 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 205' ' ' VAL . 31.5 mt -60.14 -43.81 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.999 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.6 -39.8 65.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.998 -1.064 . . . . 0.0 109.261 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -75.92 -56.22 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 194' ' ' LEU . 47.8 mt -44.74 -33.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -52.54 7.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.827 -1.171 . . . . 0.0 108.869 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -46.73 -48.33 20.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 110.455 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.6 m -74.24 7.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.002 -1.061 . . . . 0.0 110.409 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 37.85 45.69 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 194' ' ' LEU . 36.8 mt -126.07 169.5 12.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.3 25.38 57.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -61.76 -21.76 64.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.675 -1.486 . . . . 0.0 109.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.44 24.22 22.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.35 124.92 7.43 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.9 OUTLIER -138.64 163.38 32.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -1.154 . . . . 0.0 109.539 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.8 mt -66.91 -8.6 30.49 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.59 -11.83 20.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.3 p30 -133.36 6.4 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.31 149.64 32.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.597 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.456 HD11 HD21 ' A' ' 206' ' ' LEU . 21.3 tp -98.63 95.89 7.58 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 186' ' ' ILE . 62.8 t -86.23 127.83 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.717 0.77 . . . . 0.0 109.323 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 211' ' ' VAL . 28.1 mt -122.27 173.98 7.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.602 -0.686 . . . . 0.0 109.322 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.58 -166.39 10.84 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -30.79 70.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.48 -1.012 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -157.85 25.22 0.27 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -144.21 150.75 38.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.922 -1.111 . . . . 0.0 110.677 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.518 HG22 HD22 ' A' ' 206' ' ' LEU . 51.3 t -103.75 112.31 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -58.89 -45.31 90.54 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.056 -1.027 . . . . 0.0 110.071 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.6 m120 -59.86 117.14 20.61 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.9 -15.3 46.7 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.391 1.394 . . . . 0.0 111.702 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.8 pm0 -76.08 -14.83 60.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.352 -0.842 . . . . 0.0 109.089 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.82 -176.39 51.02 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.8 mt -86.72 140.95 29.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 7.3 ttp180 -71.29 -18.08 62.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.67 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 57.1 m-85 -147.26 165.09 31.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.58 -12.69 60.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.078 . . . . 0.0 109.355 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -131.9 43.63 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -60.62 -46.39 97.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.3 Cg_exo -51.37 -67.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.326 2.018 . . . . 0.0 112.295 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.5 m -58.74 -36.26 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.032 -1.042 . . . . 0.0 109.579 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.67 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 58.5 mtt180 -58.67 -42.08 87.61 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -69.08 -30.94 69.36 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.404 -0.81 . . . . 0.0 109.302 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -65.77 -36.37 83.36 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.8 t -68.49 -39.25 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.582 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 57.6 t80 -62.82 -50.48 70.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.28 -29.4 69.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.057 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.42 -31.16 62.2 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.022 -1.049 . . . . 0.0 108.177 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.4 mt -69.56 -40.17 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.88 47.99 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 m-20 -58.62 -40.81 84.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.262 . . . . 0.0 109.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 13.2 mt -55.09 -21.45 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.683 . . . . 0.0 110.15 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.95 -22.19 60.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.087 . . . . 0.0 108.73 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.31 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.649 -1.282 . . . . 0.0 110.208 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.583 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -76.21 -15.51 60.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.941 -1.099 . . . . 0.0 109.781 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.0 -1.21 55.06 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.48 156.74 9.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.368 . . . . 0.0 108.671 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.422 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.8 Cg_endo -47.88 150.49 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.637 1.558 . . . . 0.0 109.461 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.68 144.92 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.074 -1.016 . . . . 0.0 111.935 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.78 120.34 30.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 -166.8 34.49 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.476 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 2.0 ttmt -126.34 139.25 53.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.405 -1.056 . . . . 0.0 108.934 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -139.26 140.58 37.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 110.546 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.88 124.81 42.86 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 m -116.43 136.39 53.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 111.314 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 250' ' ' ARG . 51.8 t80 -116.54 114.5 24.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 249' ' ' PHE . 5.1 mtp180 44.4 46.8 8.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.021 -1.05 . . . . 0.0 108.836 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -84.99 158.8 33.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -132.15 176.85 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.583 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 55.9 m-70 -58.89 -40.34 84.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.2 t -55.55 -59.53 4.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.833 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 139' ' ' ILE . 5.3 tp -52.33 -47.26 66.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.56 -49.87 25.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.944 HG21 HG21 ' A' ' 56' ' ' THR . 85.4 t -63.62 -51.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 109.805 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.06 -51.56 61.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.045 . . . . 0.0 109.312 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 139' ' ' ILE . 39.7 tp -52.04 -50.2 61.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 108.525 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.583 HG13 ' HG ' ' A' ' 238' ' ' LEU . 41.7 t -57.65 -53.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 108.82 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -48.31 -47.06 36.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.742 . . . . 0.0 109.311 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.24 -51.43 60.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 109.813 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.06 -50.89 69.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.448 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -66.62 -29.46 69.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.083 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.88 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.8 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 69.0 mt-10 -54.22 141.26 30.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HG2' HG23 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -125.28 143.57 50.89 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 109.76 -178.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -142.16 -168.61 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -102.4 139.32 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -66.91 -30.07 70.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 109.825 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.43 160.11 41.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.73 140.72 56.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.433 -0.792 . . . . 0.0 110.137 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 11' ' ' LEU . 21.0 mt -117.75 166.79 12.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.18 35.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.952 -1.092 . . . . 0.0 110.404 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' LEU . 85.6 m-85 -142.17 158.83 43.29 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -163.32 151.13 13.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.953 -1.092 . . . . 0.0 109.492 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.99 175.24 36.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.85 153.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -1.079 . . . . 0.0 110.266 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.21 140.72 15.6 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.459 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.5 tt -60.32 -38.23 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 110.862 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 18' ' ' ILE . 70.4 m-70 -90.8 -49.93 6.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.496 -1.378 . . . . 0.0 111.237 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.8 p -72.55 -20.44 61.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 0.0 111.233 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.43 15.6 12.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -105.5 154.27 20.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 109.909 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 31.2 t80 -75.57 136.04 40.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -0.76 . . . . 0.0 109.557 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -138.52 145.55 40.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 109.906 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -108.7 154.67 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.537 HD22 ' CG2' ' A' ' 89' ' ' ILE . 10.1 mt -134.64 146.8 49.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.8 mt -143.72 111.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.808 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.87 115.04 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.189 -0.945 . . . . 0.0 110.668 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 25.5 m-70 -110.82 138.55 21.13 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 109.669 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 7' ' ' VAL . 37.9 Cg_exo -50.47 168.42 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.917 1.744 . . . . 0.0 111.627 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' HG21 ' A' ' 35' ' ' THR . 9.3 mm-40 -140.19 173.2 11.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 109.826 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.3 mmtt -83.04 150.95 26.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.584 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -49.11 146.67 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.937 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 67.14 6.68 40.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -71.78 -47.14 55.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.809 -1.407 . . . . 0.0 109.606 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.16 -174.76 24.41 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.771 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 87' ' ' VAL . 24.2 mm -102.33 118.34 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -139.54 151.91 46.48 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.574 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.81 158.09 16.22 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -130.4 113.82 14.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -135.14 133.16 38.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 110.472 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.98 34.92 5.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.379 -0.825 . . . . 0.0 111.561 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.71 17.43 80.11 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.233 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.18 121.24 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.102 . . . . 0.0 108.901 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.8 m-85 -86.76 128.01 35.01 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.025 -1.047 . . . . 0.0 109.913 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 52' ' ' PHE . 13.4 mt -116.39 92.15 35.64 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.54 -0.725 . . . . 0.0 109.044 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.94 144.99 10.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.47 2.114 . . . . 0.0 112.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.87 63.65 4.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 108.995 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 49' ' ' ARG . 0.3 OUTLIER -114.29 169.88 8.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -75.14 -44.32 47.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 -16.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.436 ' HD2' HG23 ' A' ' 46' ' ' ILE . 24.5 m-85 -95.09 2.05 55.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.815 -1.178 . . . . 0.0 109.949 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.02 126.49 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 108.927 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.4 -30.82 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.888 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.83 141.56 19.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.048 -1.032 . . . . 0.0 109.94 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 HG21 ' A' ' 257' ' ' VAL . 66.0 p -128.56 95.72 4.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 5.9 t-20 -162.86 129.44 3.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 109.061 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 96.3 m-70 50.82 8.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.047 -1.033 . . . . 0.0 108.875 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.13 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 109.591 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.646 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 33.8 m -91.44 126.95 36.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.026 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.59 149.85 42.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.712 0.768 . . . . 0.0 111.14 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CG ' HG21 ' A' ' 72' ' ' VAL . 5.9 mt -125.54 149.13 48.58 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.55 151.52 21.43 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 118.767 -1.682 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -158.36 149.46 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.5 -1.0 . . . . 0.0 109.231 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 59.7 mttt 46.38 33.92 2.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 109.781 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.76 -33.25 4.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -55.58 139.76 43.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -1.19 . . . . 0.0 108.886 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -139.94 135.14 32.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 110.517 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.408 HG23 HG11 ' A' ' 91' ' ' VAL . 51.1 mt -128.84 117.17 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 mtpp -97.27 155.42 16.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.896 -1.127 . . . . 0.0 111.118 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' THR . 66.1 m 52.62 72.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.221 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 62' ' ' LEU . 19.0 m -107.41 -10.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.646 ' CD ' ' H ' ' A' ' 60' ' ' THR . 2.5 pm0 -60.91 -31.47 70.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -0.786 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -61.87 -68.39 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.983 -1.073 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.39 -48.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 109.314 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.4 mt -51.15 -47.61 62.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.875 -1.141 . . . . 0.0 109.744 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.9 t -62.09 -43.31 99.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 106' ' ' PHE . 91.3 t -56.54 -45.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 108.937 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 mt -66.79 -34.67 78.34 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 108.916 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -63.21 -34.48 77.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.203 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 171' ' ' GLU . 66.3 mt -79.42 -38.45 34.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.764 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.13 3.1 21.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.64 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 55.51 40.19 31.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mm -90.26 134.39 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 108.696 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 121' ' ' ILE . 26.5 p -120.96 -16.16 8.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.367 -0.833 . . . . 0.0 111.718 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.64 108.15 10.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.876 -1.14 . . . . 0.0 111.242 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -165.36 150.7 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.356 -0.84 . . . . 0.0 110.404 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 35.7 m -118.67 109.67 16.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.537 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -93.3 102.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.666 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.1 mt-10 -71.42 124.49 24.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.408 HG11 HG23 ' A' ' 69' ' ' ILE . 13.7 t -108.66 113.95 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.529 0.681 . . . . 0.0 110.709 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.7 mm -102.08 97.7 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.65 -156.31 25.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.31 -12.32 9.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 109.827 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -138.5 148.86 44.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 109.404 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.17 128.16 86.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 121.95 4.81 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.709 1.606 . . . . 0.0 111.39 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 202' ' ' ASN . 2.4 tp -77.98 -14.83 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.3 mt 57.38 -120.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.275 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 15.7 t70 -95.05 9.0 41.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.983 -1.073 . . . . 0.0 111.117 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.3 64.64 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.148 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -171.62 2.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.812 -0.817 . . . . 0.0 109.43 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.47 15.11 10.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.99 -42.63 85.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.342 -1.093 . . . . 0.0 110.665 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.47 -58.48 7.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.124 -0.985 . . . . 0.0 110.017 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HG11 ' A' ' 78' ' ' VAL . 21.4 m-85 -51.05 -44.03 61.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.19 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 64.6 t80 -60.88 -50.91 71.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.933 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.33 -43.61 90.42 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.967 -1.083 . . . . 0.0 111.469 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.01 -59.52 3.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.958 -1.088 . . . . 0.0 110.277 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.23 -36.17 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 71.6 ttt180 -63.27 -41.52 99.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.595 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -74.13 9.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -143.76 38.65 1.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.148 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.43 HG23 ' HG2' ' A' ' 5' ' ' LYS . 89.4 mt -88.08 141.72 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.097 -1.002 . . . . 0.0 111.585 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.87 134.72 44.97 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -85.4 150.31 24.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 109.931 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -115.98 -173.95 2.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.408 -0.808 . . . . 0.0 109.81 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -113.97 66.8 0.67 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.6 128.61 2.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.051 -1.031 . . . . 0.0 109.291 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.05 139.18 58.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.732 -1.23 . . . . 0.0 109.572 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -82.62 149.31 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.8 81.38 3.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.68 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -60.28 143.53 52.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.672 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -89.36 101.33 14.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -93.39 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.367 0.603 . . . . 0.0 110.778 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.54 114.69 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.89 -28.43 15.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.978 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -129.58 150.18 74.97 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.84 149.59 37.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.478 2.119 . . . . 0.0 112.207 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.95 150.94 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.954 . . . . 0.0 109.265 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.29 143.44 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.58 147.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.24 162.21 35.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -178.07 113.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 54.58 47.38 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 0.0 110.717 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 -30.88 4.26 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -61.55 137.66 58.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.91 -1.347 . . . . 0.0 108.469 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -144.1 138.18 28.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.011 -1.056 . . . . 0.0 109.543 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.768 ' CD1' HD23 ' A' ' 255' ' ' LEU . 78.8 mt -138.85 127.3 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.312 -0.867 . . . . 0.0 110.067 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -117.09 132.01 56.78 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.454 0.645 . . . . 0.0 109.887 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.75 133.66 54.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.72 153.05 46.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.88 -1.138 . . . . 0.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -48.43 141.87 18.48 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.859 2.373 . . . . 0.0 113.836 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.26 148.75 20.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -37.83 82.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.501 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.4 p -124.91 -174.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.317 -0.864 . . . . 0.0 110.385 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -90.86 121.2 32.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.9 . . . . 0.0 109.065 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.476 ' CG ' HG22 ' A' ' 167' ' ' VAL . 3.7 tt0 -134.79 121.7 21.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.473 ' CG1' HD23 ' A' ' 231' ' ' LEU . 59.9 t -121.67 120.97 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -110.6 151.45 27.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.196 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.81 130.18 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.68 130.79 53.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.13 135.11 7.69 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.623 -1.275 . . . . 0.0 111.682 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -101.91 102.34 12.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -86.18 166.95 15.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 111.141 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -103.96 23.36 13.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.771 -0.581 . . . . 0.0 110.294 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.5 p-10 -138.81 -170.7 2.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 110.115 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -50.67 -4.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 111.163 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' ASN . 13.0 mt -78.51 -26.92 46.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.463 -1.398 . . . . 0.0 108.556 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.84 -139.54 32.31 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -99.71 134.76 42.13 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -136.19 144.62 45.04 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.552 -0.717 . . . . 0.0 109.116 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.508 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.21 145.15 38.93 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 110.036 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 165' ' ' THR . 10.1 t80 -147.41 146.11 29.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 92.1 m -113.53 125.39 54.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 110.582 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.434 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.1 t80 -105.01 118.95 37.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.371 -0.83 . . . . 0.0 109.997 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.476 HG22 ' CG ' ' A' ' 148' ' ' GLU . 65.0 t -109.84 150.5 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 134.26 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.35 -7.46 51.25 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -118.95 28.02 8.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.183 -1.187 . . . . 0.0 109.365 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.634 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -63.55 -15.4 57.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.438 -0.789 . . . . 0.0 110.647 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.46 -13.19 61.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 0.0 110.622 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.02 -6.07 36.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.834 -1.167 . . . . 0.0 111.51 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.42 -30.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.149 -0.969 . . . . 0.0 110.426 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 171' ' ' GLU . 12.3 m -61.1 -20.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.772 -1.205 . . . . 0.0 108.683 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.98 -3.35 58.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 0.0 108.969 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.4 117.41 11.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.581 ' NE ' ' OE2' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -82.2 173.22 12.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.665 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.67 162.91 25.88 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -147.8 143.93 27.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.313 -1.492 . . . . 0.0 111.38 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.09 158.63 43.53 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.488 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.1 m-85 -101.03 146.07 27.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.584 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 7.8 p30 -51.18 -37.7 48.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.102 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.488 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.1 p90 -67.87 -26.1 65.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.788 -1.195 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.6 mm-40 -82.43 -25.5 33.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.943 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 186' ' ' ILE . 37.2 mt -58.22 -55.34 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.963 . . . . 0.0 109.659 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -45.3 -39.59 6.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.085 -1.01 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 16.1 t-160 -76.49 -57.46 3.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.151 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 188' ' ' HIS . 84.3 mt -42.04 -32.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.46 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -82.13 -51.31 8.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.071 -1.018 . . . . 0.0 109.102 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -48.35 -45.07 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.89 . . . . 0.0 110.376 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 30.6 m -76.95 8.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.039 -1.038 . . . . 0.0 110.558 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.76 39.74 59.41 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 194' ' ' LEU . 51.7 mt -126.43 170.79 11.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -1.107 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.49 22.28 58.78 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -55.78 -21.6 20.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.641 -1.505 . . . . 0.0 110.231 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.5 3.63 32.72 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.55 124.86 34.14 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.125 -1.221 . . . . 0.0 110.092 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.0 m -145.57 167.4 23.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.267 -1.137 . . . . 0.0 108.956 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.517 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.2 mt -69.94 -8.26 47.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.464 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -95.16 -10.67 29.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.912 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.516 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 12.2 p-10 -138.38 9.81 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.926 -1.109 . . . . 0.0 110.215 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.89 149.3 31.02 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.79 93.68 5.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 203' ' ' THR . 38.6 t -85.7 130.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 66.2 mt -123.05 168.53 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.39 -166.06 11.82 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -63.44 -21.08 66.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -1.107 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.34 22.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -136.66 144.81 44.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.286 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.42 110.25 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -59.76 -47.02 87.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.605 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -62.5 121.28 66.18 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 0.0 109.733 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -67.65 -14.74 42.91 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.474 1.45 . . . . 0.0 112.016 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.2 -16.73 59.78 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.113 -0.992 . . . . 0.0 108.714 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.38 -169.97 54.88 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.247 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -88.98 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 0.0 110.117 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -69.03 -21.34 64.12 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.8 m-85 -147.03 148.01 31.23 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.17 7.6 0.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.201 -0.937 . . . . 0.0 109.769 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -148.34 37.05 0.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.581 ' OE2' ' NE ' ' A' ' 178' ' ' ARG . 1.1 tt0 -54.92 -47.08 99.26 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.95 -66.98 0.1 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.435 2.09 . . . . 0.0 112.102 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.02 -37.12 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 109.969 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.509 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 56.9 mtt180 -60.95 -40.64 94.11 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.0 t60 -67.47 -32.05 72.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.696 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.87 -35.52 80.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 166' ' ' PHE . 65.1 t -69.14 -37.57 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.575 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 49.8 t80 -64.51 -50.69 66.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.15 -28.74 69.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' CG1' ' A' ' 149' ' ' VAL . 42.9 tp -76.03 -33.66 59.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 108.732 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.34 -40.74 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.85 -52.88 38.16 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.23 -31.8 69.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -1.187 . . . . 0.0 109.314 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 235' ' ' LEU . 6.2 mt -68.86 -24.56 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -76.51 -21.79 55.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.918 -1.114 . . . . 0.0 109.394 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.2 mt -51.23 -0.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.793 -1.192 . . . . 0.0 110.606 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.6 mt -76.59 -11.92 59.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 109.955 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.32 0.6 59.59 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.836 -1.174 . . . . 0.0 110.724 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.56 152.67 13.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.928 -1.337 . . . . 0.0 108.859 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 130.17 39.13 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.869 1.712 . . . . 0.0 110.032 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.55 151.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 112.042 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -136.39 128.82 30.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 151.21 -156.78 26.86 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.453 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.4 OUTLIER -128.9 139.98 51.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -1.102 . . . . 0.0 109.169 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.0 m-85 -139.04 140.04 37.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.104 -0.998 . . . . 0.0 110.329 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -125.56 123.09 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.8 m -118.28 136.55 53.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 111.303 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 250' ' ' ARG . 47.8 t80 -117.32 117.27 29.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 249' ' ' PHE . 10.4 mtp180 45.02 42.49 6.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 108.562 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.08 153.09 35.48 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.13 178.89 17.64 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 86.2 m-70 -59.72 -40.09 86.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -1.044 . . . . 0.0 109.77 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 83.4 p -59.48 -38.78 81.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.798 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.768 HD23 ' CD1' ' A' ' 139' ' ' ILE . 2.1 tp -76.15 -47.18 25.22 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.038 . . . . 0.0 108.984 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . 9.0 m-20 -47.59 -44.5 26.44 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.987 -1.07 . . . . 0.0 108.457 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 56' ' ' THR . 72.1 t -66.71 -54.23 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.541 -0.724 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -49.59 -51.67 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.946 -1.096 . . . . 0.0 109.435 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.723 HD22 HG21 ' A' ' 139' ' ' ILE . 37.2 tp -53.37 -52.88 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.214 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.3 t -56.4 -54.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.034 -1.041 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.02 -52.63 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.96 -50.93 72.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 109.738 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -52.86 -49.87 64.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.29 -26.98 66.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.658 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -55.13 138.62 44.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 108.777 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.25 143.43 49.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 110.048 -179.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -141.23 -174.28 3.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.656 HG23 ' HG3' ' A' ' 30' ' ' PRO . 26.1 m -96.81 136.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.878 -1.139 . . . . 0.0 109.007 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.707 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -67.34 -21.43 65.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.422 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -151.52 156.91 41.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.63 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 141.91 58.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.825 . . . . 0.0 110.297 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.77 164.98 15.77 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.44 140.52 48.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 26' ' ' LEU . 90.6 m-85 -136.92 148.36 46.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.28 150.23 25.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.923 -1.11 . . . . 0.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.39 171.38 34.99 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.47 151.17 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.404 -1.056 . . . . 0.0 109.893 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.15 137.85 15.94 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.0 tt -58.64 -38.52 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -1.222 . . . . 0.0 110.316 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.427 ' N ' HG23 ' A' ' 18' ' ' ILE . 69.5 m-70 -90.94 -50.26 5.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.701 -1.25 . . . . 0.0 110.804 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.3 p -66.93 -24.79 66.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.708 -0.62 . . . . 0.0 111.265 -178.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.17 18.97 29.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -112.69 155.45 24.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -1.059 . . . . 0.0 109.446 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.91 132.18 43.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.242 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -134.9 143.22 46.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.494 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.75 156.62 21.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.421 -0.8 . . . . 0.0 109.728 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.631 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -138.46 147.45 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.509 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.0 mt -141.75 113.34 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 mt -96.34 113.16 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.609 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -106.33 138.9 19.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.656 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.0 Cg_exo -55.29 168.12 1.55 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.652 1.568 . . . . 0.0 111.657 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' OE1' HG21 ' A' ' 35' ' ' THR . 37.0 mm-40 -142.31 171.5 13.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.369 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.0 mttp -83.58 155.82 23.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.73 150.38 4.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 72.34 -7.63 8.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.54 HG21 ' OE1' ' A' ' 31' ' ' GLU . 95.8 m -62.19 -46.26 89.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.602 -1.528 . . . . 0.0 109.773 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 -179.64 35.59 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.34 115.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.78 151.29 46.95 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.54 158.27 16.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -129.26 108.94 10.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.245 -0.91 . . . . 0.0 108.602 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -135.27 135.55 40.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.7 26.78 6.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.49 17.0 78.53 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.19 122.47 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.443 -1.034 . . . . 0.0 108.706 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.48 128.0 33.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.79 93.64 41.83 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 0.0 109.533 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.61 145.71 16.58 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.407 2.071 . . . . 0.0 111.905 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.86 76.25 10.26 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -132.63 -179.66 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.532 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.9 p-80 -76.0 -55.67 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.008 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -43.75 -16.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.934 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.8 m-85 -98.16 3.62 49.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.74 -1.225 . . . . 0.0 110.337 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.78 138.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 108.607 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.92 -28.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.387 -0.821 . . . . 0.0 110.307 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -150.68 129.08 12.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.012 -1.055 . . . . 0.0 109.612 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.83 HG21 HG21 ' A' ' 257' ' ' VAL . 45.8 p -121.74 95.35 4.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.9 t-20 -163.09 129.82 3.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 108.935 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.539 ' O ' ' CB ' ' A' ' 59' ' ' SER . 50.9 m80 52.01 7.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.025 . . . . 0.0 108.883 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 161.54 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.0 109.689 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.9 m -85.42 129.1 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.177 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.8 m-20 -121.38 150.38 41.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.79 0.805 . . . . 0.0 110.814 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.2 mt -125.66 148.63 48.94 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.72 158.35 30.81 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.027 -1.559 . . . . 0.0 110.415 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -165.75 153.06 10.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -1.012 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt 51.29 21.3 1.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.78 -33.03 6.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.1 mm100 -58.99 148.23 31.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -146.47 140.18 26.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.525 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 91' ' ' VAL . 13.5 mt -129.01 123.34 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 12.6 mtpp -99.32 153.95 18.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.83 -1.169 . . . . 0.0 111.154 -178.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.7 m 50.82 75.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 62' ' ' LEU . 14.2 m -107.82 -9.14 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 109.082 178.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.7 pm0 -60.86 -25.35 66.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.531 -0.731 . . . . 0.0 110.464 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -68.26 -69.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 0.0 109.36 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -51.87 -47.34 40.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.018 -1.051 . . . . 0.0 109.07 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.58 HD21 ' HB1' ' A' ' 48' ' ' ALA . 19.9 mt -52.95 -49.27 66.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 t -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.077 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.78 -46.26 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.174 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.88 -34.28 78.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -63.29 -39.18 93.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.2 -40.43 45.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.788 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.536 HD22 HD11 ' A' ' 114' ' ' ILE . 64.8 mt -77.89 0.04 25.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.998 -1.064 . . . . 0.0 109.357 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 56.9 41.64 27.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.585 -0.697 . . . . 0.0 111.283 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.5 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 17.2 mm -88.53 144.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.773 -1.205 . . . . 0.0 108.434 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.699 HG21 HG12 ' A' ' 121' ' ' ILE . 43.9 p -126.98 -23.25 3.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.29 -0.881 . . . . 0.0 111.901 -178.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.5 m-80 -125.08 108.16 11.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.866 -1.147 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -163.26 150.11 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.0 110.549 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.44 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.0 m -117.46 114.12 23.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.479 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -96.93 103.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -178.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 26' ' ' LEU . 40.7 mt-10 -74.41 124.68 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 69' ' ' ILE . 13.4 t -110.16 120.7 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.792 0.806 . . . . 0.0 111.23 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.77 96.13 4.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.29 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.07 -158.67 27.5 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -119.37 -11.95 9.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -1.177 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.15 148.26 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.017 -1.052 . . . . 0.0 109.726 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 26' ' ' LEU . 42.5 mm -71.79 119.04 71.93 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 128.45 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.66 1.574 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -82.05 -13.27 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.562 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 mt 55.84 -121.92 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.71 7.61 44.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.45 -10.87 61.41 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.435 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.93 -171.58 2.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.696 -0.885 . . . . 0.0 109.434 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.25 13.59 12.4 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.522 ' HB2' HD22 ' A' ' 176' ' ' LEU . 44.1 t-105 -58.34 -42.22 86.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -1.01 . . . . 0.0 110.635 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.88 -56.05 23.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.849 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -51.47 -42.96 61.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.011 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.489 ' OH ' ' OE2' ' A' ' 171' ' ' GLU . 44.8 t80 -62.62 -53.48 54.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.7 . . . . 0.0 110.558 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -44.52 92.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.67 -59.82 3.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.051 -1.031 . . . . 0.0 110.402 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mt -59.45 -33.34 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.52 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 30.8 ttt180 -64.03 -43.68 94.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -73.73 15.98 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.707 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 5.8 m-80 -149.25 34.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.904 -1.122 . . . . 0.0 110.941 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 HD22 ' A' ' 82' ' ' LEU . 65.8 mt -81.88 136.72 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.763 -1.211 . . . . 0.0 110.294 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.3 tp -130.37 116.27 18.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -71.37 150.18 45.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -114.84 -174.51 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.545 -0.722 . . . . 0.0 109.422 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -107.67 67.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 111.118 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -168.52 135.25 1.94 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.048 . . . . 0.0 109.776 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -69.85 142.14 53.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.647 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 85' ' ' THR . 42.8 mt -83.14 148.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.48 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.16 87.14 3.85 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 47.9 m-85 -65.91 144.35 56.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.891 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -87.64 101.94 14.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.248 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.66 131.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.642 -0.661 . . . . 0.0 110.724 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.93 113.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.52 -31.06 22.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.74 156.84 75.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.018 . . . . 0.0 109.796 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.93 148.61 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.613 2.209 . . . . 0.0 112.149 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.0 tt -157.08 149.29 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.073 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.65 142.77 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.355 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.11 149.64 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.559 ' OE2' HD12 ' A' ' 138' ' ' LEU . 48.8 mt-10 -134.53 161.55 34.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.655 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.415 ' CB ' HD13 ' A' ' 255' ' ' LEU . 34.5 t0 -173.61 108.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.334 -0.854 . . . . 0.0 109.709 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 54.91 49.51 17.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.68 -30.35 3.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.589 HH21 ' CA ' ' A' ' 252' ' ' GLY . 19.3 mtp85 -60.79 140.17 57.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -1.224 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.559 HD12 ' OE2' ' A' ' 133' ' ' GLU . 1.2 tt -145.33 137.08 25.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.981 -1.074 . . . . 0.0 109.953 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.572 ' CD1' HD23 ' A' ' 255' ' ' LEU . 83.2 mt -136.66 128.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.662 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -117.12 133.28 56.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.482 0.658 . . . . 0.0 110.263 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.08 135.64 54.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -149.05 149.46 29.91 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.932 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -48.23 143.8 14.06 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.507 2.138 . . . . 0.0 113.519 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.93 148.6 19.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -36.37 78.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.344 -0.848 . . . . 0.0 110.111 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.1 p -123.89 -165.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 109.67 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 18.7 tp -103.46 124.54 48.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.941 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.694 ' HG3' HG22 ' A' ' 167' ' ' VAL . 33.6 tt0 -135.81 109.52 8.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.088 -1.007 . . . . 0.0 108.711 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.7 t -109.5 121.69 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.237 -0.914 . . . . 0.0 109.82 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.0 m -112.82 152.03 29.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 109.631 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -139.85 130.47 25.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.959 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -120.56 131.37 54.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.01 136.96 8.76 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.57 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 155' ' ' PHE . 10.7 tm-20 -101.93 100.95 11.3 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.405 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 79.9 m-85 -89.44 167.64 12.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.614 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -11.31 19.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.533 -0.73 . . . . 0.0 110.64 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 159' ' ' LEU . 46.5 p-10 -98.0 -166.54 1.39 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.845 -1.159 . . . . 0.0 110.445 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -55.67 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.488 -0.758 . . . . 0.0 111.654 -178.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.522 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 30.8 mt -82.49 -29.26 30.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.384 -1.447 . . . . 0.0 108.789 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.72 -135.22 42.51 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.5 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 5.5 ttm-85 -96.64 131.41 43.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -1.196 . . . . 0.0 109.559 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.522 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.43 143.69 41.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -143.26 135.92 27.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.269 -0.894 . . . . 0.0 109.822 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -105.34 122.56 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -103.68 112.74 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.139 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.694 HG22 ' HG3' ' A' ' 148' ' ' GLU . 30.0 t -105.13 152.73 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 62.3 mt-10 -49.0 123.77 7.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 108.757 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.76 5.26 36.17 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -117.11 18.32 14.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -1.058 . . . . 0.0 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.489 ' OE2' ' OH ' ' A' ' 107' ' ' TYR . 0.2 OUTLIER -52.75 -56.39 15.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.838 . . . . 0.0 110.079 -179.66 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 171' ' ' GLU . 48.1 mt-10 -42.67 -24.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 171' ' ' GLU . 54.9 mt-10 -82.67 -11.38 58.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 111.77 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.9 pt -124.21 -28.12 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.0 111.415 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.4 m -62.15 -29.34 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.427 -1.421 . . . . 0.0 108.942 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -78.31 -0.6 29.48 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.037 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -75.01 113.61 12.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.758 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.575 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -78.97 173.3 12.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.37 -0.831 . . . . 0.0 109.064 179.657 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.441 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -77.62 161.86 27.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -147.67 143.94 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.239 -1.538 . . . . 0.0 111.667 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.03 157.49 44.49 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 83.8 m-85 -97.41 147.15 24.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.467 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.87 -36.38 16.9 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.683 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -74.85 -28.31 60.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 0.0 109.934 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 9.4 tt0 -77.26 -26.23 52.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.103 -0.998 . . . . 0.0 110.339 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 187' ' ' GLU . 81.1 mt -60.43 -56.08 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.937 -1.102 . . . . 0.0 110.033 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.18 -41.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 110.144 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.689 ' O ' HG22 ' A' ' 192' ' ' VAL . 3.1 t-160 -73.56 -48.1 35.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 108.801 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.53 -28.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.409 ' HZ3' ' CG2' ' A' ' 186' ' ' ILE . 4.2 mmtm -85.21 -52.73 5.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 109.281 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -46.98 -35.01 6.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.7 m -88.54 17.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 -179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.485 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 60.26 40.4 97.33 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 194' ' ' LEU . 39.0 mt -125.74 170.76 11.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 61.04 21.94 59.8 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' LYS . . . . . 0.485 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 27.9 mttp -54.5 -20.65 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.598 -1.53 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.83 26.04 9.14 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.01 125.31 7.71 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 120.781 -1.423 . . . . 0.0 109.932 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.66 170.44 16.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.698 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.582 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 38.6 mt -68.68 -8.42 42.3 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -96.46 -13.21 23.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 109.658 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.2 p30 -135.1 7.96 3.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 109.852 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.438 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.5 149.99 32.62 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.017 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.526 HD11 HD21 ' A' ' 206' ' ' LEU . 20.6 tp -98.09 93.6 6.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 203' ' ' THR . 52.7 t -87.06 129.9 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.64 0.733 . . . . 0.0 109.347 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.526 HD21 HD11 ' A' ' 204' ' ' LEU . 22.7 mt -122.35 170.55 9.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.37 -166.36 11.78 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -63.98 -30.37 71.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.55 24.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.672 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.95 153.2 40.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.257 . . . . 0.0 110.561 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.19 112.23 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.99 -50.19 71.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.015 -1.053 . . . . 0.0 109.965 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.03 111.51 4.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.458 -0.776 . . . . 0.0 110.425 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -59.83 -13.95 24.9 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.732 1.621 . . . . 0.0 112.467 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -76.31 -18.09 59.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.062 -1.024 . . . . 0.0 109.723 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.31 -179.08 53.27 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.438 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.0 mt -85.65 149.28 25.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.08 . . . . 0.0 109.852 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.44 -21.36 49.26 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -142.27 170.82 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.7 pm0 -77.21 -12.33 59.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.142 -0.974 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.526 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -135.1 44.16 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.176 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.7 OUTLIER -54.11 -46.91 98.59 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.944 -1.097 . . . . 0.0 109.41 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.64 -67.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.386 2.057 . . . . 0.0 111.996 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.56 -35.57 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.526 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 59.6 mtt-85 -61.45 -40.15 93.43 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.575 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.3 t60 -68.02 -32.85 73.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.002 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -65.47 -36.5 84.08 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -66.06 -39.14 83.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -63.23 -51.58 65.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.83 -27.74 69.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.31 -35.85 47.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.13 -0.981 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -65.18 -38.61 83.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.83 -54.54 17.85 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.477 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 48.0 m-20 -55.59 -31.35 62.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.079 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.0 mt -65.55 -23.81 66.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.697 . . . . 0.0 110.299 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.23 -21.94 61.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.762 -1.211 . . . . 0.0 108.865 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 237' ' ' LEU . 92.0 mt -49.71 -3.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.623 -1.298 . . . . 0.0 110.381 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.6 mt -78.37 -16.77 57.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.18 2.92 56.82 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.08 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.43 153.31 8.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.62 -1.517 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.7 Cg_endo -53.95 129.31 33.61 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.895 1.73 . . . . 0.0 109.938 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.1 t -88.74 153.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.121 0.962 . . . . 0.0 112.295 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -133.34 125.82 30.02 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.32 -154.82 25.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 133.12 43.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -1.152 . . . . 0.0 108.873 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.2 m-85 -131.46 138.12 48.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 110.026 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -124.47 128.1 48.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.8 t -122.72 135.07 54.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.063 . . . . 0.0 111.364 -178.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -115.61 116.23 27.78 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 46.15 28.61 0.68 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.93 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.82 154.5 31.68 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.589 ' CA ' HH21 ' A' ' 137' ' ' ARG . . . -130.48 172.51 20.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 35.9 m-70 -59.13 -40.68 86.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.24 . . . . 0.0 109.547 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.5 t -56.43 -59.28 5.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 108.958 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.572 HD23 ' CD1' ' A' ' 139' ' ' ILE . 10.0 tp -51.34 -47.3 62.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 109.207 179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.6 m-20 -48.26 -51.01 27.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 56' ' ' THR . 89.9 t -61.58 -54.17 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -51.27 -50.01 60.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 109.061 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 139' ' ' ILE . 50.4 tp -51.8 -50.16 61.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.544 HG13 ' HG ' ' A' ' 238' ' ' LEU . 77.4 t -59.12 -53.81 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.182 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -49.35 -43.18 43.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.436 -0.79 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.59 -50.64 64.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.4 mt -57.77 -45.72 85.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.821 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.49 -31.01 65.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.31 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.222 -179.237 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.594 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 19.7 mt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.304 0.573 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 70.8 mt-10 -54.89 136.74 46.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.035 -1.041 . . . . 0.0 108.542 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -120.19 142.42 49.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.456 -0.778 . . . . 0.0 109.572 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.28 -168.4 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.0 m -103.81 139.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.988 -1.07 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -67.46 -23.68 65.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -150.02 158.38 44.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.013 . . . . 0.0 109.833 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 141.51 58.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.448 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.43 168.6 10.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -139.63 144.79 37.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.965 -1.085 . . . . 0.0 110.674 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 77.8 m-85 -139.77 156.44 46.76 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -163.35 152.3 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.95 174.94 35.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.18 152.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -1.102 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 139.07 15.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 19' ' ' HIS . 7.2 tt -57.75 -40.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 110.354 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.47 ' N ' HG23 ' A' ' 18' ' ' ILE . 81.8 m-70 -89.37 -49.2 6.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 111.181 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -69.92 -23.85 63.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.547 -0.721 . . . . 0.0 111.692 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.68 11.47 7.9 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.17 -1.49 . . . . 0.0 109.517 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -104.29 155.32 18.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.68 136.49 40.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.845 . . . . 0.0 109.67 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.0 m -137.07 142.73 42.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.562 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.32 151.27 26.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 -179.498 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -132.71 147.59 52.33 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -143.12 110.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 108.755 178.322 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mt -96.35 116.21 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 110.721 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' A' ' 27' ' ' ILE . 67.7 m-70 -110.64 141.55 24.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.537 -0.727 . . . . 0.0 109.781 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.5 Cg_exo -53.97 168.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.868 1.712 . . . . 0.0 111.479 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.3 mm-40 -140.1 176.27 8.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 30.2 mttp -84.76 151.02 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.94 143.88 2.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.543 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.1 9.39 57.01 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.99 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 31' ' ' GLU . 22.9 m -71.31 -44.95 64.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.563 -1.551 . . . . 0.0 109.502 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.99 -176.2 29.26 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.69 117.25 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH2' ' CE2' ' A' ' 45' ' ' TYR . 13.3 ptt180 -142.47 155.72 45.1 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.836 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.84 157.45 17.08 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -128.35 110.94 12.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 108.996 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -135.11 133.83 39.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 52.43 26.84 4.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 111.238 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.69 66.41 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.038 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.5 123.88 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -1.083 . . . . 0.0 109.096 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.477 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 16.3 m-85 -88.31 128.81 35.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.174 -0.954 . . . . 0.0 109.797 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.43 112.97 35.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CE1' ' A' ' 52' ' ' PHE . 36.6 Cg_endo -71.86 155.96 57.3 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.81 1.673 . . . . 0.0 112.322 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.91 63.68 7.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.58 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.3 mtt85 -116.84 169.2 9.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.3 p-80 -74.04 -49.89 22.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.517 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -45.93 -16.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' HIS . 55.7 m-85 -97.85 3.93 49.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.872 -1.143 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.7 126.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.29 -30.35 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.34 131.3 13.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.061 -1.024 . . . . 0.0 110.112 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.907 HG21 HG21 ' A' ' 257' ' ' VAL . 56.7 p -120.52 95.09 4.59 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' SER . 35.3 t30 -163.36 130.17 3.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.544 ' O ' ' CB ' ' A' ' 59' ' ' SER . 28.6 m80 51.66 7.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.1 -1.0 . . . . 0.0 109.266 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.3 OUTLIER 161.03 140.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 72' ' ' VAL . 27.2 m -80.42 127.36 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.291 -0.881 . . . . 0.0 109.197 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -120.77 147.73 44.94 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.861 0.839 . . . . 0.0 111.113 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.7 mt -120.95 148.21 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.44 153.83 24.78 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.252 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -164.75 150.12 9.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -1.083 . . . . 0.0 109.285 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.3 mttt 51.63 23.9 2.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -33.04 6.32 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -60.49 148.36 37.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.041 -1.27 . . . . 0.0 109.565 -179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -144.12 139.79 29.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.57 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.65 122.69 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -97.95 155.8 16.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 111.22 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 m 49.12 75.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.094 0.473 . . . . 0.0 110.747 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.5 m -107.78 -8.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.268 -0.895 . . . . 0.0 109.006 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 7.6 pm0 -60.84 -27.25 67.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.67 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.423 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.9 m170 -65.78 -69.03 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.907 -1.12 . . . . 0.0 109.281 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.09 -47.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' N ' HG23 ' A' ' 75' ' ' ILE . 82.0 mt -51.59 -49.27 62.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 110.157 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.49 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 19.5 t -60.99 -42.87 99.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.03 -1.044 . . . . 0.0 110.382 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 106' ' ' PHE . 99.2 t -55.89 -47.54 79.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.96 -34.59 78.46 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.3 -34.95 77.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -80.83 -38.01 29.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.045 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.27 5.58 12.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.026 -1.046 . . . . 0.0 109.581 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 53.87 39.14 30.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.4 mm -89.79 134.48 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 108.716 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.8 p -123.39 -18.68 6.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.259 -0.901 . . . . 0.0 111.686 -178.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.746 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.1 m120 -124.09 106.9 10.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.868 -1.145 . . . . 0.0 110.351 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.9 m -166.41 147.54 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.666 0.746 . . . . 0.0 110.056 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 22.2 m -115.76 110.2 18.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.433 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.3 mt -91.29 100.33 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.028 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' OE2' HD12 ' A' ' 27' ' ' ILE . 2.1 tt0 -75.0 128.58 35.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.098 -1.001 . . . . 0.0 108.417 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.1 128.67 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.06 0.933 . . . . 0.0 111.927 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 31.2 mm -109.66 96.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.28 -153.15 21.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -9.27 8.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -1.087 . . . . 0.0 110.072 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.93 148.31 41.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.042 -1.036 . . . . 0.0 109.727 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 26' ' ' LEU . 45.9 mm -73.48 120.02 78.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -40.0 125.25 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.515 1.477 . . . . 0.0 111.105 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.51 HG21 HD22 ' A' ' 202' ' ' ASN . 2.5 tp -78.16 -11.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.3 mt 54.34 -119.73 1.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.21 7.8 45.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.83 -0.63 64.93 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.765 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.72 -172.66 2.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.801 -0.823 . . . . 0.0 109.315 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.4 16.08 8.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -59.56 -42.86 93.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -1.086 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.74 -56.88 13.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.544 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB3' HG11 ' A' ' 78' ' ' VAL . 9.9 m-85 -51.67 -44.54 63.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.847 . . . . 0.0 109.108 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 72.1 t80 -61.72 -50.63 71.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.577 -0.702 . . . . 0.0 110.916 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.59 -43.0 95.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.091 -1.006 . . . . 0.0 111.24 -178.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.77 -55.68 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 110.735 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.11 -30.82 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 51.5 ttt180 -66.76 -43.43 84.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.842 . . . . 0.0 110.52 -179.141 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -75.72 11.61 1.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 110.196 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.471 ' OD1' ' CG ' ' A' ' 9' ' ' GLU . 2.6 m-80 -142.75 35.01 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.992 -1.068 . . . . 0.0 110.198 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.7 mt -83.02 142.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.949 -1.094 . . . . 0.0 111.186 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 8' ' ' LYS . 6.2 tp -132.98 129.39 38.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -83.79 149.07 26.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -116.47 -174.58 2.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.15 68.3 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.35 -0.844 . . . . 0.0 110.807 -178.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -163.73 129.82 3.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.0 109.298 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.82 138.94 56.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.844 -1.16 . . . . 0.0 109.685 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.5 mt -83.37 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 110.191 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.15 79.53 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 42.5 m-85 -59.92 142.76 53.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -88.87 101.93 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.35 133.31 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.71 -0.619 . . . . 0.0 110.561 -177.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.1 t -70.6 114.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.5 mp0 -82.42 -29.98 30.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.044 -1.035 . . . . 0.0 110.695 -178.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 172.99 5.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.754 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.55 149.47 12.92 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.846 2.364 . . . . 0.0 112.848 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.3 tt -157.0 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.79 140.56 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.98 147.59 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' O ' ' NZ ' ' A' ' 258' ' ' LYS . 3.5 mp0 -136.54 160.99 37.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.014 -1.054 . . . . 0.0 110.523 -178.793 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -174.13 105.48 0.11 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.367 -0.833 . . . . 0.0 109.741 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.09 57.7 6.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.496 -0.752 . . . . 0.0 110.676 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.9 2.83 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.402 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.604 ' NH2' ' H ' ' A' ' 255' ' ' LEU . 46.5 mtp180 -61.96 130.85 47.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.023 -1.281 . . . . 0.0 108.219 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.2 tt -143.12 137.15 28.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 109.984 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.697 ' CD1' HD23 ' A' ' 255' ' ' LEU . 71.2 mt -134.44 127.21 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 109.418 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.91 131.46 56.93 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.514 0.673 . . . . 0.0 109.926 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.98 136.07 54.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.58 149.28 36.52 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.015 -1.053 . . . . 0.0 109.874 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.41 141.42 51.01 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.426 2.084 . . . . 0.0 113.187 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -154.84 147.46 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.925 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.4 -3.91 7.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.299 -0.876 . . . . 0.0 110.619 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.1 p -150.84 -175.61 5.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.872 -1.143 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' A' ' 244' ' ' GLY . 17.2 tp -96.4 122.63 39.5 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.064 -1.022 . . . . 0.0 108.875 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG3' HG13 ' A' ' 167' ' ' VAL . 1.5 mt-10 -137.13 127.14 25.92 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.331 -0.856 . . . . 0.0 108.768 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 65.7 t -126.89 120.68 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 165' ' ' THR . 46.5 m -112.15 152.11 28.72 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.583 -0.698 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -139.69 130.71 26.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.933 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.38 132.86 54.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.37 141.18 12.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.802 -178.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.41 ' O ' ' NH1' ' A' ' 250' ' ' ARG . 5.6 tt0 -105.54 100.1 9.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.31 167.0 15.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -102.5 5.08 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 110.91 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.8 p-10 -119.46 -171.0 2.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.0 110.424 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -47.8 -3.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.595 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -80.24 -29.11 38.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.359 -1.463 . . . . 0.0 109.073 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.95 -139.02 33.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -97.23 131.79 43.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.218 -1.166 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -138.01 147.69 44.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.87 . . . . 0.0 109.456 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.5 146.15 36.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -143.83 137.9 28.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.488 HG23 ' OG1' ' A' ' 150' ' ' THR . 25.4 m -107.18 123.34 48.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.224 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.3 t80 -102.69 109.64 21.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.8 t -102.14 154.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.05 126.79 19.54 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.83 2.49 42.78 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -115.37 20.58 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -1.153 . . . . 0.0 109.079 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 173' ' ' GLU . 1.4 pm0 -58.14 -52.15 66.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.6 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 110.499 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 171' ' ' GLU . 12.6 mm-40 -103.47 -7.16 21.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.957 -1.089 . . . . 0.0 110.552 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.35 -26.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.125 -0.984 . . . . 0.0 110.942 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.1 m -60.84 -22.13 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.646 -1.284 . . . . 0.0 108.76 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.87 -2.74 58.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 109.222 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.15 116.41 10.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 108.764 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -79.65 172.76 13.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.4 t -78.53 163.57 25.43 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -147.51 144.98 28.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.28 -1.512 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.77 157.41 44.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.423 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.2 m-85 -98.98 144.43 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.992 -1.068 . . . . 0.0 109.53 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 t0 -53.07 -35.96 60.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.38 -0.825 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.2 p90 -69.36 -25.38 64.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.77 -1.206 . . . . 0.0 109.902 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.436 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -83.43 -31.14 26.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.032 -1.043 . . . . 0.0 109.92 -179.652 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 189' ' ' ILE . 55.7 mt -50.98 -58.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.532 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.0 tp10 -40.82 -40.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.937 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.2 t60 -74.68 -35.39 62.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 186' ' ' ILE . 91.1 mt -58.92 -38.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.354 -0.841 . . . . 0.0 109.024 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -75.71 -52.52 10.3 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -49.07 -43.12 40.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.433 -0.792 . . . . 0.0 110.678 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 188' ' ' HIS . 21.0 m -79.53 5.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.388 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 40.08 50.64 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.8 178.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 189' ' ' ILE . 39.0 mt -128.13 173.91 9.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.098 -1.236 . . . . 0.0 110.013 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.03 58.58 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -54.7 -20.64 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.479 -1.601 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -117.04 26.02 8.52 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.815 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.5 127.05 8.41 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.665 -1.491 . . . . 0.0 109.886 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.4 m -144.43 174.84 10.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -1.09 . . . . 0.0 109.332 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.5 mt -72.15 -7.77 50.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 108.872 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -96.28 -11.36 26.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.27 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 98' ' ' ILE . 8.3 p-10 -134.75 9.88 3.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.008 . . . . 0.0 110.034 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.444 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -150.65 150.94 31.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 110.339 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.0 tp -100.4 93.88 5.88 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 203' ' ' THR . 52.0 t -86.07 130.12 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.781 0.801 . . . . 0.0 109.318 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.99 165.08 18.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.651 -0.656 . . . . 0.0 109.343 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.31 -166.61 12.05 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -58.4 -36.68 73.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.482 -1.011 . . . . 0.0 109.338 179.8 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.38 23.71 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.026 -1.046 . . . . 0.0 110.469 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -139.0 146.91 41.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 0.0 110.552 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -100.58 111.26 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -57.54 -52.37 65.68 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.322 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -56.16 111.11 2.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.045 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.55 -14.85 17.99 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.741 1.627 . . . . 0.0 111.962 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -15.86 59.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.126 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.28 -173.17 49.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.624 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -89.69 148.05 23.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.17 -1.194 . . . . 0.0 109.843 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.29 -18.15 37.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 108.851 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 59.5 m-85 -139.47 173.71 11.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 220' ' ' GLU . 5.8 mp0 -80.09 -14.42 58.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.48 48.38 1.84 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.253 -0.904 . . . . 0.0 109.596 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -56.54 -46.52 99.81 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 109.808 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.1 Cg_exo -51.5 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.452 2.101 . . . . 0.0 112.108 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.1 -35.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.028 -1.045 . . . . 0.0 109.575 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 18.5 mtt180 -60.19 -41.5 93.08 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -68.04 -31.87 71.83 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.828 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -64.56 -37.16 86.59 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.6 t -69.42 -35.18 65.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.49 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.4 t80 -65.22 -55.27 19.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -63.64 -26.19 68.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.0 tp -77.81 -35.03 51.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.021 -1.049 . . . . 0.0 108.609 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.1 mt -67.14 -36.42 76.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.86 -59.31 6.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -51.67 -34.86 40.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -1.231 . . . . 0.0 108.873 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 235' ' ' LEU . 8.5 mt -60.67 -23.0 64.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.983 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.44 -21.64 61.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.088 . . . . 0.0 108.743 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.3 mt -55.16 3.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.677 -1.264 . . . . 0.0 110.521 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.607 ' HG ' HG13 ' A' ' 260' ' ' VAL . 8.1 mt -80.12 -16.24 55.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.856 -1.152 . . . . 0.0 109.729 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.88 43.4 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.114 -1.041 . . . . 0.0 110.629 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.38 158.14 9.94 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.395 . . . . 0.0 108.921 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -48.74 150.94 5.71 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 121.848 1.699 . . . . 0.0 109.429 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.72 145.35 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 0.0 112.181 -177.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.5 122.2 32.76 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 148.62 174.8 20.62 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.442 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.519 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 18.3 tttt -102.02 146.98 27.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.255 . . . . 0.0 109.986 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 18.3 m-85 -140.56 140.27 35.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 109.927 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -127.12 126.0 42.17 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.0 m -119.62 135.53 54.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 0.0 111.331 -178.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 250' ' ' ARG . 90.9 t80 -116.78 115.22 25.17 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 250' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 249' ' ' PHE . 78.3 mtp85 45.14 47.82 9.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.01 -1.056 . . . . 0.0 108.726 -179.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.83 159.53 28.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.52 -174.56 13.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -60.75 -47.92 84.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -1.125 . . . . 0.0 109.642 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.25 -59.08 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 139' ' ' ILE . 1.3 tp -52.73 -48.39 66.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.731 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 7.2 m-20 -47.41 -45.29 25.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 109.192 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.907 HG21 HG21 ' A' ' 56' ' ' THR . 59.1 t -66.96 -40.14 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 109.986 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 133' ' ' GLU . 8.3 ttpt -63.74 -51.75 63.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 109.378 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 139' ' ' ILE . 47.6 tp -53.95 -48.8 69.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 108.931 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.607 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.5 t -57.81 -53.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.372 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 261' ' ' LYS . . . . . 0.612 ' HE3' HG12 ' A' ' 257' ' ' VAL . 10.7 mtmt -51.1 -40.44 58.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.688 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.82 -50.45 42.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.949 . . . . 0.0 109.841 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.75 -48.7 80.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -68.24 -32.82 73.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 110.114 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 7.7 mmtm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.0 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -55.95 137.61 50.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.959 . . . . 0.0 108.93 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.57 144.19 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.439 -0.788 . . . . 0.0 110.024 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -141.53 -171.34 3.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 30' ' ' PRO . 5.8 m -99.49 137.09 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.013 -1.055 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.43 -25.18 67.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.667 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.28 162.5 40.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 139.97 54.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.92 166.18 12.81 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -136.72 141.7 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.086 -1.009 . . . . 0.0 110.305 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 28' ' ' ILE . 93.4 m-85 -139.25 153.65 47.86 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.52 152.33 21.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.836 -1.165 . . . . 0.0 110.283 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.57 175.71 36.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.4 153.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.551 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 140.98 17.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 19' ' ' HIS . 6.5 tt -61.48 -37.92 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -1.217 . . . . 0.0 111.117 -178.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.405 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 92.3 m-70 -90.52 -49.45 6.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.292 -1.505 . . . . 0.0 110.938 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 p -68.66 -25.71 64.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 111.853 -178.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.71 16.78 47.12 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.065 -1.54 . . . . 0.0 109.456 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.69 153.69 23.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -1.085 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -76.31 135.53 39.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.773 . . . . 0.0 109.602 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.1 t -138.23 145.72 41.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.43 154.44 22.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 96' ' ' ILE . 10.1 mt -134.12 144.13 48.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.74 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.623 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -140.03 114.31 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 13' ' ' PHE . 17.2 mt -99.3 114.59 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.461 -0.775 . . . . 0.0 110.501 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.623 ' NE2' HG22 ' A' ' 27' ' ' ILE . 2.9 m-70 -109.41 140.23 21.87 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.42 -0.8 . . . . 0.0 109.682 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HG3' HG23 ' A' ' 7' ' ' VAL . 15.0 Cg_exo -55.35 168.61 1.36 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.767 1.645 . . . . 0.0 111.183 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 42.0 mm-40 -140.5 179.72 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.0 110.026 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.0 mttt -86.36 152.68 22.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.761 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.442 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 44.5 mt-10 -47.14 143.83 2.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.22 7.87 60.9 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.322 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 44.0 m -69.7 -45.22 68.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.533 -1.569 . . . . 0.0 109.802 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.39 -179.9 30.88 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.613 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -96.86 118.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -142.65 153.7 43.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.716 -1.24 . . . . 0.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -102.43 158.78 15.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -130.94 108.32 9.74 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -135.58 137.04 41.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 111.004 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.492 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 16.5 m120 52.25 31.22 8.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 111.279 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.42 80.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.569 -1.3 . . . . 0.0 109.97 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 121.24 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -1.06 . . . . 0.0 109.108 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.69 129.81 34.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 69' ' ' ILE . 30.9 mt -117.92 93.45 44.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.843 . . . . 0.0 109.618 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -49.04 148.82 9.0 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.317 2.011 . . . . 0.0 111.897 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -85.29 69.88 10.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.183 -0.948 . . . . 0.0 109.965 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -122.54 173.95 7.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 108.957 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 237' ' ' LEU . 1.3 p-80 -74.71 -48.21 27.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.9 mm-40 -47.75 -16.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.807 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' HIS . 27.4 m-85 -95.6 -0.86 51.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.756 -1.215 . . . . 0.0 109.705 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.7 129.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.08 -27.78 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 110.258 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -151.02 131.79 14.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.85 HG21 HG21 ' A' ' 257' ' ' VAL . 40.4 p -124.5 95.44 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.9 t-20 -163.01 128.8 3.25 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.4 m-70 50.4 8.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.132 -0.98 . . . . 0.0 109.027 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER 162.64 140.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.883 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 72' ' ' VAL . 63.7 m -85.51 126.29 33.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -119.83 148.84 42.97 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.65 0.738 . . . . 0.0 110.75 -179.168 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CG ' HG21 ' A' ' 72' ' ' VAL . 8.3 mt -122.92 147.25 46.82 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.97 152.89 23.62 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.561 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -160.59 148.35 16.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -1.023 . . . . 0.0 109.108 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.36 21.68 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.552 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.83 -32.34 7.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.492 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 28.1 mm-40 -60.36 144.64 50.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.071 -1.252 . . . . 0.0 109.469 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -141.64 140.89 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 46' ' ' ILE . 56.9 mt -131.3 122.72 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 29.5 mttm -90.8 158.69 16.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.036 -1.04 . . . . 0.0 111.365 -179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 m 41.58 79.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.426 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 62' ' ' LEU . 15.9 m -107.34 -9.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.6 pm0 -61.7 -26.58 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.674 . . . . 0.0 110.443 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -66.06 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 0.0 108.998 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.34 -49.87 40.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.8 mt -49.14 -51.19 33.68 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.976 -1.078 . . . . 0.0 110.233 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -59.61 -41.63 90.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.16 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.05 -44.54 78.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.038 -1.039 . . . . 0.0 108.912 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.32 -35.21 78.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.362 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -62.78 -35.79 80.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.5 mt -79.63 -38.21 34.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 109.845 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 114' ' ' ILE . 94.6 mt -81.14 1.71 30.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.1 -1.0 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 54.79 40.51 31.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 110.113 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.26 140.47 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 121' ' ' ILE . 64.1 p -126.34 -21.4 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.16 -0.963 . . . . 0.0 111.753 -178.349 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.722 ' O ' HG13 ' A' ' 87' ' ' VAL . 58.8 m-20 -126.02 107.25 10.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.942 -1.099 . . . . 0.0 110.351 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -164.56 147.07 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.16 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 72.3 m -116.29 110.46 18.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.513 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -93.95 101.58 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tt0 -77.35 129.01 35.27 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 108.539 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.41 123.38 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.918 0.866 . . . . 0.0 111.823 -177.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mt -104.6 96.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.55 -155.32 24.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -122.22 -9.04 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' H ' ' A' ' 70' ' ' LYS . 44.2 tt0 -138.86 148.13 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 110.0 -179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.555 HG23 HD11 ' A' ' 26' ' ' LEU . 39.7 mm -71.94 122.81 88.3 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.187 -1.005 . . . . 0.0 108.383 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -42.46 117.4 0.82 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.637 1.558 . . . . 0.0 110.937 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -72.45 -14.38 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.424 HD11 ' CE2' ' A' ' 106' ' ' PHE . 75.1 mt 56.98 -120.41 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.121 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.99 8.45 44.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.868 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.28 62.4 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.901 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -172.1 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.901 . . . . 0.0 109.57 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.23 17.31 8.54 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 57.7 t-105 -57.12 -43.76 82.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 0.0 110.197 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.88 -55.91 16.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 99' ' ' LEU . 12.9 m-85 -51.08 -45.94 61.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 0.0 109.604 -179.539 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.427 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 44.6 t80 -62.69 -52.87 61.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.0 110.829 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.436 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 2.0 mm-40 -61.21 -44.63 96.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.116 -0.99 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.99 19.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.219 -0.926 . . . . 0.0 110.351 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.2 mt -65.11 -32.11 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.423 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 53.2 ttt180 -63.29 -42.31 99.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HG3' HD22 ' A' ' 113' ' ' ASN . 1.6 ptpp? -76.46 7.39 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 110.134 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.42 HD22 ' HG3' ' A' ' 112' ' ' LYS . 17.4 m-80 -137.36 33.97 2.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.024 . . . . 0.0 110.509 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 HD22 ' A' ' 82' ' ' LEU . 50.9 mt -80.68 138.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.945 -1.097 . . . . 0.0 110.247 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -129.41 124.97 35.49 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 142.6 31.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.1 -172.27 2.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.239 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -113.93 69.61 0.71 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.286 -0.884 . . . . 0.0 110.716 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -168.59 131.28 1.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 109.255 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE2' ' C ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -69.8 151.05 46.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 110.08 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 85' ' ' THR . 45.4 mt -95.25 152.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.107 -0.996 . . . . 0.0 110.096 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.32 83.83 4.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 48.0 m-85 -62.5 147.01 50.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.071 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -93.68 102.04 14.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 243' ' ' LYS . 61.4 t -93.9 133.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 0.0 110.647 -177.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.91 116.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -84.63 -29.95 25.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.064 -1.022 . . . . 0.0 110.889 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.25 168.73 13.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 109.901 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 147.92 24.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.862 2.374 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.7 tt -157.36 149.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -0.834 . . . . 0.0 109.043 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.95 146.4 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.93 148.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -133.56 160.72 36.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.71 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 258' ' ' LYS . 19.2 t70 -175.1 105.71 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.301 -0.875 . . . . 0.0 109.823 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.32 51.33 15.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 110.199 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.78 -30.65 3.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -62.13 136.89 58.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.262 . . . . 0.0 108.229 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -145.57 140.09 27.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 110.534 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.644 HG21 HD22 ' A' ' 259' ' ' LEU . 71.2 mt -136.91 127.03 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.717 . . . . 0.0 109.66 179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -114.22 134.03 55.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.42 135.64 54.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.42 150.2 39.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -47.22 142.53 11.86 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.684 2.256 . . . . 0.0 113.409 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.581 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -159.0 147.87 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.689 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -66.39 -32.49 73.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 110.53 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.581 ' O ' ' OG ' ' A' ' 144' ' ' SER . 72.5 p -120.25 -163.23 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.327 -0.858 . . . . 0.0 109.308 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.7 tp -109.25 123.98 50.15 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.7 tt0 -135.37 125.25 25.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 108.466 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG1' HD23 ' A' ' 231' ' ' LEU . 63.5 t -125.87 121.5 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 152.03 27.66 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.623 -0.673 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -140.01 130.59 25.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -122.41 133.86 54.62 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.9 140.81 11.91 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.651 -178.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -101.54 100.47 10.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.71 166.95 13.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 110.707 -178.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -104.29 -20.51 13.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 110.484 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 159' ' ' LEU . 32.4 p-10 -89.08 -171.01 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.761 -1.212 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -52.63 2.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.277 -0.889 . . . . 0.0 111.501 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 157' ' ' ASN . 14.6 mt -82.25 -28.63 31.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.388 -1.445 . . . . 0.0 108.493 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.5 -141.56 38.35 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -100.44 136.23 40.64 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.256 -1.143 . . . . 0.0 109.13 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -143.73 160.81 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.374 -0.829 . . . . 0.0 109.597 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 150.54 31.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 225' ' ' ARG . 49.1 t80 -144.66 140.78 28.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -107.06 122.93 47.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 109.985 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.0 t80 -102.76 111.61 24.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 110.022 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.15 150.74 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.73 138.13 6.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.202 -0.936 . . . . 0.0 108.826 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.09 3.83 69.6 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.83 20.97 15.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.701 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.8 OUTLIER -58.96 -50.86 72.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.361 -0.837 . . . . 0.0 109.196 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.6 -5.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.491 -0.756 . . . . 0.0 109.774 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 171' ' ' GLU . 39.3 mt-10 -104.91 -9.81 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 110.3 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.0 pt -126.85 -27.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.191 -0.943 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.0 m -60.98 -22.88 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.679 -1.263 . . . . 0.0 108.524 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.93 -2.62 58.75 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.35 115.93 10.11 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.355 -0.841 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.3 mtm180 -79.53 172.76 13.35 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 0.0 109.255 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.1 t -79.71 163.87 24.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -148.71 144.46 27.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.244 -1.535 . . . . 0.0 111.37 -179.206 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.06 158.84 43.29 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.262 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.3 m-85 -99.46 144.75 28.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.35 -36.2 20.79 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.31 -0.869 . . . . 0.0 109.578 -179.477 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 8.5 p90 -73.67 -26.38 60.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 109.842 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.3 OUTLIER -76.65 -38.66 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 109.998 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.407 HG22 ' HG3' ' A' ' 190' ' ' LYS . 62.6 mt -48.51 -51.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 186' ' ' ILE . 8.6 tt0 -42.95 -45.38 5.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.953 . . . . 0.0 110.303 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.435 ' O ' HG22 ' A' ' 192' ' ' VAL . 4.5 t60 -75.26 -57.35 3.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 45.6 mt -44.74 -27.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -85.5 -54.37 4.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.772 -1.205 . . . . 0.0 109.506 179.876 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -51.91 -40.22 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.929 . . . . 0.0 110.034 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -75.37 3.37 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.927 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.24 37.72 31.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.0 mt -128.52 169.53 14.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -1.144 . . . . 0.0 109.865 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.42 24.11 61.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -60.4 -21.23 61.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.623 -1.516 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -111.24 24.95 14.76 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.2 125.45 7.79 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.885 -1.362 . . . . 0.0 109.744 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -144.11 164.5 30.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -1.112 . . . . 0.0 110.03 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.568 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 25.3 mt -64.47 -8.99 15.64 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -93.09 -15.99 25.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -136.84 10.99 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 110.17 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -149.16 149.99 31.92 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.043 -1.035 . . . . 0.0 110.287 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.6 tp -100.24 93.34 5.64 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.436 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -86.12 131.33 34.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.768 0.794 . . . . 0.0 109.031 -179.258 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.14 162.66 23.13 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.31 -166.73 12.68 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -31.59 71.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -1.05 . . . . 0.0 109.569 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -153.9 23.79 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.21 -0.931 . . . . 0.0 110.678 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -144.24 151.73 39.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.748 -1.22 . . . . 0.0 110.516 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.56 112.25 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -57.17 -51.88 67.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.015 . . . . 0.0 110.328 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 8.0 m120 -58.0 111.66 3.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.5 -12.42 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.596 1.531 . . . . 0.0 111.821 179.107 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -17.2 59.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.048 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.3 -175.79 48.26 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.619 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.2 mt -87.81 142.07 28.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -1.2 . . . . 0.0 109.86 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -19.92 60.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -142.9 -179.05 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.389 -0.82 . . . . 0.0 109.297 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.567 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 1.9 pm0 -87.17 3.42 46.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.608 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.04 47.57 0.62 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.561 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -58.88 -46.02 99.57 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.011 -1.055 . . . . 0.0 109.933 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 50.7 Cg_exo -52.19 -66.44 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.069 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 225' ' ' ARG . 31.5 m -60.54 -35.94 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 109.568 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 224' ' ' VAL . 62.3 mtt180 -59.27 -41.64 89.33 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 18.1 t60 -68.3 -32.13 72.05 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.147 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.81 -35.5 81.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' ' 166' ' ' PHE . 54.3 t -70.35 -37.85 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -63.33 -49.79 72.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.458 -0.776 . . . . 0.0 108.961 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -67.78 -27.82 67.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 109.755 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.511 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.1 tp -77.33 -34.03 55.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.002 -1.061 . . . . 0.0 108.359 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.1 mt -67.95 -37.74 78.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.22 -56.06 13.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 21.8 m-20 -52.45 -38.36 59.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -1.219 . . . . 0.0 108.982 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 235' ' ' LEU . 15.9 mt -58.23 -23.47 55.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.629 -0.669 . . . . 0.0 110.48 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.83 -22.36 60.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.692 -1.255 . . . . 0.0 108.758 -179.666 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 94.0 mt -52.71 -0.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.635 -1.291 . . . . 0.0 110.356 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.566 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.9 mt -77.96 -14.48 59.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.799 -1.188 . . . . 0.0 109.756 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.39 -1.53 55.97 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.844 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.05 156.7 9.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.742 -1.446 . . . . 0.0 109.174 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.75 150.23 9.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.852 1.701 . . . . 0.0 109.518 178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.42 149.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.999 -1.063 . . . . 0.0 112.115 -177.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 243' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.8 mmtp -129.77 123.55 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.439 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.58 -160.86 30.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.26 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.14 46.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -1.085 . . . . 0.0 108.76 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -133.1 138.22 46.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 110.145 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -123.55 129.72 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 t -123.83 136.24 54.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.378 -177.782 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.36 111.47 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 50.0 45.05 25.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.17 -0.957 . . . . 0.0 108.465 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.78 141.73 17.33 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -115.8 178.75 17.74 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 52.0 m-70 -59.33 -39.14 82.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.137 -1.213 . . . . 0.0 109.595 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -54.74 -58.79 6.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.224 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 255' ' ' LEU . 11.8 tp -56.69 -45.7 81.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.563 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.5 m-20 -47.46 -54.76 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 109.634 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 56' ' ' THR . 99.2 t -60.89 -50.71 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 258' ' ' LYS . . . . . 0.47 ' HZ1' ' HB2' ' A' ' 134' ' ' ASP . 22.2 ttmt -50.49 -52.35 39.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.978 -1.076 . . . . 0.0 108.963 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.644 HD22 HG21 ' A' ' 139' ' ' ILE . 35.5 tp -50.4 -50.85 50.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' A' ' 238' ' ' LEU . 46.8 t -55.27 -52.94 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.889 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.09 -50.16 29.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.148 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.48 -49.32 77.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.1 mt -56.12 -52.47 64.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -26.29 67.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.79 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.935 . . . . 0.0 110.072 -179.442 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.515 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.2 mt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.371 0.605 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 94.6 mt-10 -57.67 137.83 56.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 146.98 47.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.49 -0.756 . . . . 0.0 109.996 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -141.16 -171.7 3.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 30' ' ' PRO . 14.2 m -97.64 135.35 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.036 -1.04 . . . . 0.0 109.269 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.07 -20.75 65.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.16 160.66 40.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 139.11 57.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 109.869 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.3 mt -117.44 163.01 17.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.17 141.02 48.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' LEU . 99.0 m-85 -139.56 147.72 41.56 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.93 151.84 22.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.839 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.14 173.95 36.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.56 149.25 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -1.039 . . . . 0.0 110.108 -179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 140.09 16.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.491 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -58.91 -39.15 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.126 -1.22 . . . . 0.0 110.327 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.474 ' N ' HG23 ' A' ' 18' ' ' ILE . 78.3 m-70 -90.21 -50.38 6.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.718 -1.239 . . . . 0.0 111.168 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -66.6 -23.93 66.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.762 . . . . 0.0 111.242 -178.156 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.69 16.71 17.85 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -112.56 157.93 20.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -1.012 . . . . 0.0 109.401 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.82 134.7 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -136.34 145.29 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.57 157.62 20.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.978 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 96' ' ' ILE . 9.3 mt -138.59 145.02 40.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.491 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -140.56 108.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 108.416 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -92.28 115.24 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 0.0 110.621 -178.725 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 27' ' ' ILE . 47.5 m-70 -108.67 139.77 21.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 0.0 109.393 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' VAL . 27.5 Cg_exo -52.57 168.34 0.46 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.828 1.686 . . . . 0.0 111.737 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HB3' HG21 ' A' ' 35' ' ' THR . 17.7 mm-40 -142.84 174.56 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.668 179.434 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.7 mttt -82.05 149.38 28.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -47.05 149.03 0.98 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.15 -0.969 . . . . 0.0 109.821 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 66.66 4.01 23.62 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.75 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.8 m -67.53 -41.69 83.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.774 -1.427 . . . . 0.0 109.238 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.67 -179.91 34.58 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.398 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 87' ' ' VAL . 24.4 mm -98.92 116.5 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -139.62 155.31 47.51 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.772 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -103.58 156.8 17.5 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -128.69 111.8 13.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.0 108.657 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -135.66 134.35 39.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.699 -178.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 53.74 28.31 8.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 111.362 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.05 18.23 75.16 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.074 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.56 122.99 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.415 -1.05 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -84.39 128.26 34.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.111 -0.993 . . . . 0.0 109.466 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 69' ' ' ILE . 55.7 mt -118.13 91.09 39.37 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.36 152.24 8.75 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.519 2.146 . . . . 0.0 111.826 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 67.4 9.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -121.55 161.86 21.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.83 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.1 p-80 -65.17 -51.6 60.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -43.44 -16.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 110.879 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.1 m-85 -98.56 0.58 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.867 -1.145 . . . . 0.0 110.105 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 50' ' ' HIS . 79.3 t -69.98 131.0 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.63 -30.27 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 110.35 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -151.75 133.3 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.952 -1.093 . . . . 0.0 109.992 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.597 HG21 HG21 ' A' ' 257' ' ' VAL . 41.2 p -123.29 95.51 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 59' ' ' SER . 13.9 t-20 -163.03 129.1 3.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.972 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 36.8 m80 50.83 8.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.065 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.19 144.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.754 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.7 m -87.09 127.18 35.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 109.18 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.78 150.33 42.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.81 0.814 . . . . 0.0 111.046 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mt -126.27 149.71 48.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.23 151.91 23.04 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.193 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -158.04 144.13 17.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -1.092 . . . . 0.0 109.215 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.86 22.04 2.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 109.839 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.14 -33.37 6.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -57.55 141.56 47.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.241 . . . . 0.0 109.153 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -133.89 134.3 42.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.486 -0.758 . . . . 0.0 110.336 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 69' ' ' ILE . 18.8 mt -127.05 122.02 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -102.78 156.17 17.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.0 -1.063 . . . . 0.0 111.357 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 71' ' ' THR . 86.1 m 50.31 73.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 60' ' ' THR . 19.8 m -108.11 -9.22 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.21 -26.2 67.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.537 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.66 -69.02 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.64 -48.02 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.054 -1.029 . . . . 0.0 109.107 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 75' ' ' ILE . 26.1 mt -51.76 -49.19 63.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.0 109.93 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 t -60.95 -42.5 98.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.82 -44.87 79.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 108.823 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -67.74 -34.44 76.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -61.92 -36.81 82.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 108.872 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.1 mt -78.86 -38.14 38.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 114' ' ' ILE . 74.7 mt -80.45 -0.52 37.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.744 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 55.0 40.37 32.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 110.922 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.5 mm -85.82 141.77 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 69.0 p -127.23 -23.18 3.6 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.182 -0.949 . . . . 0.0 111.582 -178.227 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.726 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.4 m-80 -124.33 106.53 10.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.828 -1.17 . . . . 0.0 110.164 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.9 148.27 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.625 0.726 . . . . 0.0 110.295 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.8 m -116.33 114.53 24.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -94.97 100.4 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.367 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.502 ' OE1' HD12 ' A' ' 27' ' ' ILE . 4.9 tt0 -73.55 124.72 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 26' ' ' LEU . 62.1 t -107.39 126.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.82 0.819 . . . . 0.0 111.583 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 92' ' ' ILE . 27.7 mt -111.03 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.39 -156.24 25.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -121.68 -10.68 8.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.11 149.25 42.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 0.0 109.564 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -73.43 121.33 84.86 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.042 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.71 124.03 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.76 1.64 . . . . 0.0 111.405 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -81.19 -12.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 106' ' ' PHE . 8.2 mt 56.05 -116.83 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.84 8.13 45.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.012 -1.055 . . . . 0.0 110.743 -178.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.2 65.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 -172.27 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.741 -0.858 . . . . 0.0 109.339 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.96 14.58 8.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.582 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 52.3 t-105 -56.3 -42.8 78.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 3.8 mp0 -64.96 -57.32 9.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 0.0 110.171 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 99' ' ' LEU . 11.0 m-85 -51.02 -46.2 61.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.223 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.581 ' OH ' ' NH1' ' A' ' 111' ' ' ARG . 89.4 t80 -60.97 -52.35 65.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.669 -0.644 . . . . 0.0 110.884 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.582 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 4.0 mm-40 -62.03 -45.24 94.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.142 -0.974 . . . . 0.0 111.726 -178.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.1 -55.64 17.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.996 -1.065 . . . . 0.0 110.548 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.47 -32.46 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.383 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.581 ' NH1' ' OH ' ' A' ' 107' ' ' TYR . 59.1 ttt85 -63.3 -41.86 98.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.0 109.933 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' C ' HD22 ' A' ' 113' ' ' ASN . 27.6 pttt -77.58 13.37 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.495 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.7 m-80 -143.11 31.32 1.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.898 -1.126 . . . . 0.0 110.79 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 82' ' ' LEU . 73.6 mt -79.07 138.79 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.759 -1.213 . . . . 0.0 109.718 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -129.24 125.32 36.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.32 143.51 35.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.573 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.92 -175.6 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 109.303 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -110.03 67.33 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.633 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.3 ttt85 -162.91 129.55 3.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 109.335 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.96 142.61 52.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.959 -1.088 . . . . 0.0 109.661 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 241' ' ' PRO . 74.0 mt -88.83 151.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.651 -179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.42 84.88 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 70.9 m-85 -61.71 146.69 48.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.517 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -91.63 101.64 14.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -93.63 134.44 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.442 0.639 . . . . 0.0 111.058 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.7 t -73.89 112.93 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.65 -26.94 16.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.277 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.04 150.3 76.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.825 . . . . 0.0 109.278 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.5 149.35 55.78 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.432 2.088 . . . . 0.0 112.037 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.7 tt -152.41 150.65 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 108.965 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.43 141.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.38 146.73 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -135.9 159.22 42.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 109.485 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.57 108.05 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.169 -0.957 . . . . 0.0 110.161 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 48.61 52.94 12.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 110.754 178.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.4 -36.85 3.17 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.484 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.85 126.16 26.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.93 -1.335 . . . . 0.0 108.634 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -138.71 138.85 38.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 110.138 -179.444 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 259' ' ' LEU . 83.6 mt -137.97 130.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.475 -0.766 . . . . 0.0 109.76 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 29.5 tttm -119.24 132.1 55.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.689 -0.632 . . . . 0.0 109.887 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.81 133.82 54.43 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 4.2 pt-20 -145.89 149.11 38.24 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.016 -1.053 . . . . 0.0 109.729 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.0 140.95 9.77 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.561 2.174 . . . . 0.0 113.158 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -154.57 142.8 20.4 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.97 -7.1 3.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.437 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.9 p -149.91 -174.62 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 109.605 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.8 tp -98.75 123.16 42.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.137 -0.977 . . . . 0.0 108.737 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.444 ' N ' HD12 ' A' ' 147' ' ' LEU . 44.8 tt0 -139.28 126.99 21.92 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 108.651 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.428 ' CG1' HD23 ' A' ' 231' ' ' LEU . 93.6 t -125.24 123.7 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.421 -0.799 . . . . 0.0 109.864 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m -113.8 152.73 30.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.608 -0.682 . . . . 0.0 109.849 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -140.44 131.09 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.854 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 10.1 tt0 -122.47 133.75 54.59 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.99 140.76 10.66 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.482 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 97.56 7.03 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.51 167.36 21.4 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.713 . . . . 0.0 110.673 -178.352 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.89 25.3 9.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.507 -0.746 . . . . 0.0 111.092 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 157' ' ' ASN . 20.5 p-10 -137.19 -164.66 1.62 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.864 -1.147 . . . . 0.0 109.996 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -56.62 -4.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.429 -0.794 . . . . 0.0 110.968 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 159' ' ' LEU . 12.2 mt -76.39 -27.01 56.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.59 -1.319 . . . . 0.0 108.036 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.57 -139.49 39.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.2 136.78 41.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -142.75 154.18 44.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.614 -0.679 . . . . 0.0 109.519 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 148.96 31.52 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -145.37 139.01 26.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -0.841 . . . . 0.0 109.836 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 m -107.1 123.87 48.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.474 -0.767 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.475 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.0 t80 -103.17 109.04 20.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.35 150.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 109.676 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -49.5 128.21 16.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 108.787 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' GLY . . . . . 0.459 ' N ' ' OE1' ' A' ' 171' ' ' GLU . . . 106.31 0.97 38.06 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.55 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 16.0 m120 -116.62 20.75 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 109.022 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.1 pm0 -55.62 -49.08 73.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.396 -0.815 . . . . 0.0 110.205 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -50.27 -22.22 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 110.46 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.71 -7.13 58.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.002 -1.061 . . . . 0.0 111.899 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.5 pt -125.51 -28.16 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.84 -1.163 . . . . 0.0 111.247 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.62 -17.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.593 -1.317 . . . . 0.0 109.022 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.56 -4.03 55.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.45 -0.781 . . . . 0.0 108.945 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.465 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.29 115.82 8.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.86 . . . . 0.0 108.937 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.525 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 88.5 mtm180 -78.59 172.7 13.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.232 -0.918 . . . . 0.0 109.264 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.442 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.6 t -79.36 163.3 24.96 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -147.85 148.78 31.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.141 -1.599 . . . . 0.0 111.666 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -145.65 156.7 43.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.402 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 80.3 m-85 -99.75 144.37 28.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.041 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.444 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.35 -36.04 5.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 110.169 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -75.55 -29.27 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.906 -1.121 . . . . 0.0 110.387 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.7 tt0 -75.23 -29.0 60.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.3 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.9 -47.75 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.297 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.29 -41.56 19.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -74.82 -52.18 12.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.321 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.494 HD11 ' OE1' ' A' ' 185' ' ' GLU . 43.1 mt -48.5 -29.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -85.13 -53.54 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.792 -1.192 . . . . 0.0 109.737 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -49.81 -34.76 20.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.385 -179.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 m -85.51 8.87 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.895 -1.128 . . . . 0.0 110.36 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.4 39.71 56.38 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.63 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.3 mt -128.47 171.12 12.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -1.177 . . . . 0.0 109.835 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.19 23.22 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -57.92 -19.65 31.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.598 -1.531 . . . . 0.0 110.031 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.38 3.47 34.85 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.58 125.46 35.41 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.082 -1.246 . . . . 0.0 110.466 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.7 p -147.61 165.24 31.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.373 -1.075 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 24.0 mt -67.85 -8.2 34.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -96.36 -11.91 25.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.793 -0.567 . . . . 0.0 109.702 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.512 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.5 p-10 -137.93 8.89 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.046 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.491 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -147.57 149.08 31.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.071 -1.018 . . . . 0.0 110.006 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.62 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.1 tp -99.58 93.79 6.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 203' ' ' THR . 41.8 t -86.22 131.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.86 0.838 . . . . 0.0 109.109 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.23 165.82 16.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.22 -166.38 11.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -58.56 -36.16 73.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -1.072 . . . . 0.0 109.604 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.62 25.44 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.693 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.59 148.92 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.872 -1.142 . . . . 0.0 110.537 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.24 110.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.52 -46.85 73.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.11 -0.993 . . . . 0.0 109.516 -178.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -66.57 117.42 44.17 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.03 -11.13 29.75 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.362 1.375 . . . . 0.0 111.37 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.55 -17.77 61.69 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.376 -0.827 . . . . 0.0 109.031 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.57 -177.73 46.37 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -86.58 136.94 32.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -1.227 . . . . 0.0 109.644 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -20.29 65.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.3 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' TYR . . . . . 0.467 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.8 m-85 -138.31 -164.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.203 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -97.63 -17.02 19.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.5 48.52 1.93 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -53.11 -48.29 92.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 109.806 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.1 Cg_exo -48.24 -67.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.14 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.2 m -59.59 -36.61 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 93.2 mtt180 -60.84 -40.52 93.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.975 -1.078 . . . . 0.0 108.411 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 13.8 t60 -67.6 -30.87 70.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.251 -0.906 . . . . 0.0 108.732 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -66.11 -36.86 84.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.4 t -67.4 -37.97 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -63.24 -53.68 49.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.52 -0.737 . . . . 0.0 109.067 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.41 -28.77 70.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' LEU . . . . . 0.428 HD23 ' CG1' ' A' ' 149' ' ' VAL . 33.1 tp -76.76 -34.29 58.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.988 -1.07 . . . . 0.0 108.565 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.6 mt -65.29 -38.33 82.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.36 -56.81 10.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.431 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 46.0 m-20 -53.11 -30.95 39.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.203 . . . . 0.0 109.191 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.17 -23.61 67.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 110.339 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.63 -22.37 60.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.744 -1.223 . . . . 0.0 108.96 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -49.76 -5.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.373 -1.454 . . . . 0.0 109.974 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -74.51 -15.85 60.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.42 0.31 61.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.293 178.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 240' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -167.14 146.95 4.66 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.557 -1.554 . . . . 0.0 110.007 179.471 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 121' ' ' ILE . 58.7 Cg_exo -34.66 147.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.699 2.266 . . . . 0.0 111.339 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 83.1 t -115.03 147.76 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.603 -178.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -131.77 124.03 28.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 152.68 174.99 23.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 13.9 tttt -103.89 142.2 34.82 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.8 m-85 -137.41 138.93 40.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.216 -0.927 . . . . 0.0 109.761 -179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 59.7 t80 -125.69 128.26 47.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -124.7 136.23 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 -177.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -118.96 113.91 21.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 55.13 18.89 2.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.353 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.32 155.41 17.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.65 176.36 20.66 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.5 m-70 -58.9 -37.7 77.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.251 . . . . 0.0 109.534 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -58.27 9.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.319 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.509 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.2 tp -60.94 -43.24 98.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 18.4 m-20 -47.57 -54.07 12.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 109.417 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 56' ' ' THR . 82.8 t -62.4 -46.38 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.596 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -54.27 -52.08 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.013 -1.054 . . . . 0.0 108.961 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 139' ' ' ILE . 23.8 tp -50.65 -58.49 5.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.452 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.0 t -49.27 -52.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.196 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -49.18 -49.19 43.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.761 . . . . 0.0 109.704 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 130' ' ' ILE . 28.5 mm-40 -61.83 -48.2 81.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.0 -47.97 79.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.01 -29.72 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 110.08 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 -179.603 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.9 mt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 26.6 mt-10 -53.18 135.19 38.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.173 -0.954 . . . . 0.0 108.783 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 144.55 46.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.618 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -141.86 -169.78 2.99 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -100.83 137.33 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.324 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.35 -27.96 68.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.695 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.42 158.19 43.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.812 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 141.1 58.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -120.39 165.18 15.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.64 143.11 43.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 110.177 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.0 m-85 -139.82 150.73 45.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -158.65 151.57 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 0.0 109.999 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.85 174.06 36.45 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.73 149.01 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.431 -1.041 . . . . 0.0 110.256 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.46 137.86 16.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 203' ' ' THR . 3.8 tt -59.2 -38.15 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.243 . . . . 0.0 110.272 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.448 ' N ' HG23 ' A' ' 18' ' ' ILE . 85.2 m-70 -89.8 -50.63 5.94 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.724 -1.235 . . . . 0.0 111.376 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 p -69.03 -21.62 64.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 111.547 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.56 19.2 26.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -112.41 155.46 24.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.523 -0.987 . . . . 0.0 109.569 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -76.53 134.45 39.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 m -138.36 146.12 41.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.726 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 3.4 ttpp -112.6 157.79 20.77 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.41 -0.806 . . . . 0.0 109.923 -179.347 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 96' ' ' ILE . 8.4 mt -136.86 145.14 44.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -138.74 115.85 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.02 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.62 114.38 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.873 . . . . 0.0 110.994 -178.259 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 27' ' ' ILE . 50.7 m-70 -109.58 138.16 20.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 109.808 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 28.0 Cg_exo -51.99 168.38 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.942 1.761 . . . . 0.0 111.399 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 35' ' ' THR . 15.1 mm-40 -142.91 168.97 18.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 110.131 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 35' ' ' THR . 1.6 mttp -76.82 150.76 36.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.464 -0.773 . . . . 0.0 109.72 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -46.92 146.16 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.867 . . . . 0.0 110.209 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.74 6.04 48.7 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.955 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.536 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 28.5 m -68.66 -43.29 76.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.597 -1.531 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.97 178.2 36.25 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' A' ' 87' ' ' VAL . 15.3 mm -96.07 117.23 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.72 149.83 42.67 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.603 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -100.18 158.26 15.98 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -129.61 112.27 13.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 108.624 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -135.64 132.88 37.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.463 -0.773 . . . . 0.0 110.5 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' N ' HD22 ' A' ' 42' ' ' ASN . 2.8 m120 53.16 31.24 11.09 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 0.0 111.639 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.3 17.8 78.94 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.153 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.6 121.75 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -1.015 . . . . 0.0 109.19 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.6 m-85 -84.19 128.51 34.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mt -117.61 92.64 41.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.26 145.75 14.64 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.462 2.108 . . . . 0.0 111.984 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 71.41 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 6.0 mmt85 -126.23 172.43 10.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.5 p-80 -73.64 -48.67 30.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 110.195 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -43.6 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 0.0 111.25 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 37.4 m-85 -96.92 1.78 50.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.725 -1.234 . . . . 0.0 110.105 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.6 t -63.66 123.59 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.043 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 m -106.55 -29.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 109.979 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -154.11 132.49 11.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.049 -1.032 . . . . 0.0 109.805 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.726 HG21 HG21 ' A' ' 257' ' ' VAL . 61.3 p -123.6 95.23 4.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 45.6 t-20 -163.66 129.01 3.0 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.395 -0.815 . . . . 0.0 108.894 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 31.2 m80 47.76 11.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.065 -1.022 . . . . 0.0 108.973 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.36 141.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.872 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.42 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 34.2 m -90.36 127.76 36.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 109.131 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.71 152.82 38.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.413 -0.805 . . . . 0.0 111.067 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.64 ' CD1' HG21 ' A' ' 72' ' ' VAL . 7.7 mt -128.44 149.01 50.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.76 156.77 28.76 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 118.886 -1.626 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -163.82 151.47 12.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.026 . . . . 0.0 108.849 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 52.53 23.85 2.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.971 . . . . 0.0 109.375 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.96 -31.25 7.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -58.3 145.94 36.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -1.17 . . . . 0.0 108.827 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -145.28 140.04 27.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 110.693 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.26 123.08 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -101.43 158.47 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.074 -1.016 . . . . 0.0 111.408 -177.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 m 48.45 72.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.253 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 62' ' ' LEU . 28.0 m -107.16 -9.4 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.174 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -60.47 -25.33 65.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 110.025 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.41 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.6 m170 -67.33 -68.48 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 109.181 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.14 -47.18 44.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 109.192 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 48' ' ' ALA . 20.9 mt -52.67 -47.57 67.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.948 -1.095 . . . . 0.0 110.1 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.5 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.1 t -61.65 -43.53 98.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.943 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.19 -44.75 80.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.14 -35.25 77.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.284 -0.885 . . . . 0.0 109.208 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -62.39 -33.76 75.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.883 . . . . 0.0 109.269 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 171' ' ' GLU . 62.3 mt -82.13 -38.37 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 107' ' ' TYR . 86.5 mt -80.74 4.18 19.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.547 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 54.22 39.11 30.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.07 139.38 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.642 HG21 HG12 ' A' ' 121' ' ' ILE . 56.6 p -126.02 -20.57 4.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.151 -0.968 . . . . 0.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.627 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.1 m-80 -128.5 108.25 10.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.884 -1.135 . . . . 0.0 111.0 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 86' ' ' ASN . 12.7 m -162.76 147.17 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 178.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 17.5 m -112.76 113.74 25.98 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.502 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.6 mt -97.7 101.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 110.648 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.93 124.26 25.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD21 ' A' ' 26' ' ' LEU . 98.5 t -104.94 129.42 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.87 0.843 . . . . 0.0 111.836 -177.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 33.3 mm -111.7 91.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.7 163.6 10.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -84.51 -3.36 58.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.321 . . . . 0.0 110.852 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -140.01 147.09 39.89 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.836 -1.165 . . . . 0.0 110.214 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 26' ' ' LEU . 47.0 mm -74.35 122.2 86.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 109.02 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -41.4 127.17 3.09 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.762 1.641 . . . . 0.0 111.394 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.1 tp -80.18 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.274 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.605 HD11 ' CE2' ' A' ' 106' ' ' PHE . 35.9 mt 58.74 -122.67 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -95.07 8.3 43.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.926 . . . . 0.0 110.464 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.85 -3.63 65.16 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.119 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.45 -172.44 2.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.792 -0.828 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.06 14.3 10.38 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.549 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 4.7 t-105 -56.98 -42.15 79.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.18 -57.83 7.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.097 -1.002 . . . . 0.0 110.261 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 99' ' ' LEU . 10.2 m-85 -51.45 -45.93 62.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.356 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.442 ' CE1' HD21 ' A' ' 82' ' ' LEU . 40.0 t80 -61.22 -53.93 50.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.665 . . . . 0.0 110.905 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 1.5 mm-40 -60.99 -43.54 98.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 111.473 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -54.74 20.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.013 -1.054 . . . . 0.0 110.449 -179.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.6 mt -66.43 -32.83 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 109.645 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -63.61 -42.45 98.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.656 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -77.06 15.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.654 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -146.31 31.18 1.01 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.659 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 72.9 mt -79.29 138.86 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.776 -1.202 . . . . 0.0 110.328 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.05 120.87 25.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.435 -0.791 . . . . 0.0 109.058 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 142.41 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 0.0 110.148 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -110.37 -170.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 109.48 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -111.53 67.84 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.232 -0.918 . . . . 0.0 110.588 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -164.01 128.7 2.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.044 -1.035 . . . . 0.0 109.314 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.92 142.59 54.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.642 HG12 HG21 ' A' ' 85' ' ' THR . 37.5 mt -86.79 151.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.841 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.03 79.99 3.27 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -58.08 143.41 43.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.557 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -90.08 101.67 14.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.45 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.639 -0.663 . . . . 0.0 110.902 -177.652 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.12 117.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -97.99 -26.73 14.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.456 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.59 149.66 74.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 149.1 56.48 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.41 2.073 . . . . 0.0 112.096 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.5 tt -153.09 149.75 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.03 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.22 143.46 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.94 147.61 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -134.44 161.52 34.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.076 -1.015 . . . . 0.0 110.181 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.48 ' HB2' HD13 ' A' ' 255' ' ' LEU . 7.0 t0 -168.65 101.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.357 -0.839 . . . . 0.0 109.804 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 47.32 62.54 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.528 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.86 -37.29 3.09 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.578 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -61.03 137.72 58.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.888 -1.36 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -146.96 136.78 23.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.935 -1.103 . . . . 0.0 110.082 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.473 HG21 HD22 ' A' ' 259' ' ' LEU . 92.9 mt -136.13 134.48 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.455 -0.778 . . . . 0.0 109.46 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 tttp -124.16 131.63 53.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.504 0.669 . . . . 0.0 109.957 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.41 137.39 54.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.96 155.86 40.59 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.091 -1.006 . . . . 0.0 109.765 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -50.53 142.21 31.43 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.496 2.131 . . . . 0.0 113.421 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -156.69 139.38 15.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -60.91 -5.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 0.0 110.462 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 145' ' ' ASP . 29.2 p -154.18 -177.54 6.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.884 -1.135 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 148' ' ' GLU . 15.1 tp -93.64 120.55 34.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.0 -1.062 . . . . 0.0 109.341 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.561 ' HG3' HG22 ' A' ' 167' ' ' VAL . 12.1 tt0 -134.49 115.7 14.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.94 121.81 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.403 ' OG1' HG23 ' A' ' 165' ' ' THR . 60.4 m -112.82 152.22 29.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.714 -0.616 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -139.6 131.06 26.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.138 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -121.47 130.52 53.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.25 139.11 10.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.682 -1.246 . . . . 0.0 111.556 -178.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -104.33 101.9 11.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -88.46 167.42 13.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.852 -178.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -100.69 -12.86 18.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' LEU . 39.9 p-10 -97.77 -170.8 2.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.979 -1.076 . . . . 0.0 110.355 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -52.86 0.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.492 -0.755 . . . . 0.0 112.019 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.545 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 28.5 mt -81.87 -28.03 33.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.241 -1.537 . . . . 0.0 108.772 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.16 -136.97 41.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -97.48 130.69 44.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 109.791 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -132.96 142.91 49.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.4 pttm -138.09 144.03 40.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.406 -0.809 . . . . 0.0 109.826 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' PHE . . . . . 0.508 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 61.0 t80 -144.99 138.02 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' THR . . . . . 0.403 HG23 ' OG1' ' A' ' 150' ' ' THR . 59.8 m -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.45 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.2 t80 -102.8 110.91 23.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.99 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG22 ' HG3' ' A' ' 148' ' ' GLU . 42.4 t -104.06 152.14 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.836 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -49.51 124.24 9.07 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.336 -0.853 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 0.75 31.08 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -116.93 21.66 13.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.195 -1.179 . . . . 0.0 109.268 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -55.44 -52.74 62.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 109.942 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.8 mt-10 -44.54 -22.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 0.0 110.11 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 171' ' ' GLU . 42.0 mt-10 -86.15 -8.95 57.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 111.753 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.5 pt -123.73 -29.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.801 -1.187 . . . . 0.0 111.225 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.6 m -61.41 -20.75 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.586 -1.321 . . . . 0.0 109.025 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.465 HD22 HH11 ' A' ' 218' ' ' ARG . 6.7 mt -90.31 -1.79 57.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.167 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.49 120.44 16.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.031 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.444 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 83.6 mtm180 -84.45 172.6 11.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.487 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 163.37 25.06 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -148.7 146.01 27.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.303 -1.498 . . . . 0.0 111.628 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.25 157.76 44.11 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 79.5 m-85 -99.19 147.54 25.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.076 -1.015 . . . . 0.0 109.389 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 2.3 p30 -53.27 -33.2 52.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 109.686 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' TRP . . . . . 0.501 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.5 p90 -73.53 -26.36 60.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.906 -1.121 . . . . 0.0 109.55 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.8 mm-40 -77.82 -40.65 39.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.953 . . . . 0.0 109.698 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 183' ' ' ASP . 76.4 mt -45.69 -51.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.136 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -42.65 -45.16 4.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.1 t60 -77.1 -50.93 11.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 109.71 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.5 mt -47.37 -32.24 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -85.04 -52.7 5.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.69 -1.256 . . . . 0.0 108.744 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -50.65 -32.16 18.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.331 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.7 m -86.62 6.27 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.941 -1.1 . . . . 0.0 110.116 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.49 37.55 40.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.6 mt -128.71 171.85 11.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -1.11 . . . . 0.0 109.798 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.55 22.38 52.11 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.78 -19.42 16.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.661 -1.494 . . . . 0.0 110.521 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.27 5.55 28.49 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.36 125.15 26.18 Favored Glycine 0 N--CA 1.491 2.337 0 O-C-N 121.052 -1.263 . . . . 0.0 110.571 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.455 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -147.04 169.46 19.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.562 -0.964 . . . . 0.0 109.421 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 35.2 mt -67.97 -8.36 36.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -93.09 -13.05 29.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 23.8 p30 -139.64 10.72 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.041 -1.037 . . . . 0.0 110.33 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.3 m -148.06 148.49 30.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.911 -1.118 . . . . 0.0 110.49 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.3 tp -98.69 93.41 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -85.88 129.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.4 mt -124.1 164.18 19.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.635 -0.665 . . . . 0.0 109.625 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.25 -166.24 12.55 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -23.25 65.8 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.639 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -157.02 21.77 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.042 -1.036 . . . . 0.0 111.255 -179.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -147.37 156.04 42.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.529 -1.357 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.87 112.79 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -59.21 -51.16 71.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 110.58 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -59.6 112.71 5.66 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -58.05 -11.07 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.704 1.603 . . . . 0.0 112.162 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -19.03 59.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.237 -179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.42 -178.04 50.37 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.8 mt -87.88 131.53 34.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -1.126 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.465 HH11 HD22 ' A' ' 176' ' ' LEU . 6.8 ttm180 -61.14 -20.97 63.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.833 . . . . 0.0 108.875 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -143.43 -173.31 3.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.49 -0.757 . . . . 0.0 109.246 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.05 -16.84 30.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 221' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -134.55 46.25 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.303 -179.952 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.73 -47.11 99.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.751 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 60.2 Cg_exo -50.42 -66.3 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.511 2.141 . . . . 0.0 112.177 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -60.04 -35.62 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 109.636 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ARG . . . . . 0.508 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 60.8 mtt-85 -60.91 -40.62 93.85 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.6 t60 -67.89 -31.99 72.17 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.561 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -65.03 -36.0 82.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.5 t -69.54 -34.52 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.2 t80 -66.14 -52.49 47.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.44 -27.76 68.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.776 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.2 tp -77.76 -33.99 52.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.107 -0.995 . . . . 0.0 108.591 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.9 mt -67.65 -38.11 79.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -55.37 15.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' ASP . . . . . 0.432 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 9.7 m-20 -55.24 -36.82 66.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.293 . . . . 0.0 109.114 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.5 mt -62.27 -24.92 67.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.514 -179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 236' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.1 t80 -73.95 -21.5 60.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.825 -1.172 . . . . 0.0 109.376 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 237' ' ' LEU . 93.2 mt -49.16 -4.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.572 -1.33 . . . . 0.0 110.501 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 238' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 236' ' ' TYR . 11.1 mt -74.09 -14.36 60.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 109.998 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.451 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 96.53 3.19 59.84 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.989 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.59 152.18 11.76 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.489 . . . . 0.0 109.06 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.33 129.36 34.25 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.706 1.604 . . . . 0.0 109.668 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -89.39 151.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.033 -1.042 . . . . 0.0 112.435 -176.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.64 126.65 31.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.77 -165.55 32.61 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.631 ' N ' ' OG ' ' A' ' 144' ' ' SER . 11.9 tptm -124.55 133.71 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -1.092 . . . . 0.0 108.639 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.2 m-85 -132.25 138.05 47.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -125.77 118.21 25.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -112.49 135.31 53.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 111.023 -178.385 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -117.36 107.73 14.72 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 54.39 31.02 13.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.77 157.56 52.62 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.97 -179.91 16.48 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 54.6 m-70 -60.06 -40.15 88.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -58.88 6.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 134' ' ' ASP . 12.6 tp -56.68 -44.77 81.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.025 . . . . 0.0 109.283 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 256' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 19.9 m-20 -47.64 -52.09 19.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.933 -1.104 . . . . 0.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 56' ' ' THR . 81.4 t -61.54 -45.24 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.07 -49.2 77.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 139' ' ' ILE . 22.4 tp -54.61 -51.2 66.09 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.972 . . . . 0.0 108.779 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.446 HG13 ' HG ' ' A' ' 238' ' ' LEU . 11.5 t -57.87 -54.37 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.896 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -48.67 -45.53 38.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.678 . . . . 0.0 109.517 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' A' ' 130' ' ' ILE . 23.3 mm-40 -64.02 -51.68 63.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.862 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.88 -46.86 71.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.908 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.84 66.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 110.41 -179.274 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.79 149.86 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' HD22 ' A' ' 86' ' ' ASN . 33.1 mt-10 -54.16 139.71 34.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 108.54 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -123.26 145.9 48.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -0.853 . . . . 0.0 110.217 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 t -143.2 -169.76 3.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.588 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.3 m -100.51 137.94 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.915 -1.115 . . . . 0.0 109.092 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.669 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -68.33 -19.42 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.972 . . . . 0.0 109.954 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.5 OUTLIER -152.72 157.47 40.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.08 -1.013 . . . . 0.0 109.705 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 138.67 58.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.161 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.46 166.44 13.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.54 144.3 34.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.898 -1.126 . . . . 0.0 110.396 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 81.2 m-85 -138.23 152.08 48.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 6.8 pt-20 -158.99 150.06 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.956 -1.09 . . . . 0.0 110.146 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.33 174.79 36.76 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.2 151.05 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -1.09 . . . . 0.0 110.058 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.61 140.27 16.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 4.2 tt -59.22 -38.88 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 110.321 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 72.2 m-70 -88.75 -50.1 6.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.629 -1.294 . . . . 0.0 111.183 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 -25.06 64.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 111.819 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.88 14.41 23.28 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.319 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -110.32 157.67 19.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.464 -1.021 . . . . 0.0 109.564 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 77.7 t80 -76.02 135.17 39.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -137.27 143.22 42.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.317 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -112.52 156.93 21.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.417 -0.802 . . . . 0.0 109.952 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.627 HD11 HG23 ' A' ' 96' ' ' ILE . 9.5 mt -136.05 146.42 47.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.52 -0.738 . . . . 0.0 109.82 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.59 106.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 108.691 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -91.64 114.83 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.0 110.979 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -108.79 137.03 19.95 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.523 -0.736 . . . . 0.0 109.544 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.8 Cg_exo -52.27 168.41 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.941 1.761 . . . . 0.0 111.993 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.517 ' HB3' HG21 ' A' ' 35' ' ' THR . 35.3 mm-40 -141.95 173.68 11.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.6 mttt -83.51 154.29 23.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.96 147.57 3.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.102 -0.999 . . . . 0.0 109.783 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 70.31 0.19 28.26 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.819 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 31' ' ' GLU . 53.8 m -66.03 -44.7 83.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.565 -1.55 . . . . 0.0 109.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.34 178.81 31.36 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.743 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -98.96 117.79 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -144.33 155.96 44.04 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.12 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -101.89 158.7 15.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -128.56 111.45 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 0.0 108.718 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -135.62 132.6 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.639 ' ND2' ' OE1' ' A' ' 67' ' ' GLN . 21.8 m-20 55.09 28.25 10.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 111.334 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.85 19.42 73.03 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.773 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.15 121.13 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.537 -0.978 . . . . 0.0 109.217 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 46.2 m-85 -83.1 127.58 33.71 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -0.904 . . . . 0.0 109.05 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.44 90.75 35.74 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.625 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.02 148.78 6.41 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.497 2.131 . . . . 0.0 112.075 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.569 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.68 70.23 10.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.064 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -122.76 170.36 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.49 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.573 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p-80 -72.35 -51.67 19.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.363 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -43.59 -16.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.41 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.5 m-85 -96.47 -0.34 49.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.906 -1.121 . . . . 0.0 110.142 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 76.3 t -68.46 130.75 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 108.72 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.2 -30.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -147.18 127.0 13.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.968 -1.082 . . . . 0.0 109.608 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.876 HG21 HG21 ' A' ' 257' ' ' VAL . 38.6 p -120.56 96.23 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 59' ' ' SER . 8.7 t-20 -160.35 129.01 4.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.036 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 59' ' ' SER . 41.8 m80 48.94 11.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 108.928 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.52 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.75 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 237' ' ' LEU . 46.4 m -86.81 128.03 35.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 109.293 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.06 147.18 45.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.655 0.74 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.546 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.5 mt -121.92 149.55 43.26 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.74 156.49 28.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -163.52 150.88 12.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -1.102 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 50.1 21.64 0.79 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.299 -0.876 . . . . 0.0 109.399 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.85 -34.0 6.12 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.639 ' OE1' ' ND2' ' A' ' 42' ' ' ASN . 76.5 mm-40 -59.04 149.42 27.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.283 . . . . 0.0 109.656 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -143.87 137.61 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 110.809 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.25 124.8 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 13.6 mtpp -102.21 157.82 16.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.073 . . . . 0.0 111.461 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.1 m 50.0 73.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.62 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 62' ' ' LEU . 30.1 m -107.34 -9.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 0.0 108.804 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.4 pm0 -61.2 -26.24 67.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.558 -0.714 . . . . 0.0 110.472 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.3 m170 -69.1 -68.12 0.42 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.966 -1.084 . . . . 0.0 109.312 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.27 -48.83 43.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.294 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 75' ' ' ILE . 20.3 mt -54.16 -46.39 72.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.022 -1.049 . . . . 0.0 110.184 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.414 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 29.4 t -60.72 -42.25 96.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.016 -1.053 . . . . 0.0 109.889 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.77 -44.98 87.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.024 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.9 -34.79 78.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.282 -0.886 . . . . 0.0 109.119 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.458 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 5.1 t-160 -62.31 -38.12 88.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' A' ' 171' ' ' GLU . 58.7 mt -77.11 -38.0 53.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.695 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 82' ' ' LEU . 72.6 mt -83.51 -0.79 51.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 109.703 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 5.3 mp0 56.6 43.22 25.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.814 . . . . 0.0 111.506 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 33.4 mm -87.06 144.86 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.81 -1.182 . . . . 0.0 107.952 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.596 HG21 HG12 ' A' ' 121' ' ' ILE . 43.6 p -130.0 -22.01 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.086 -1.009 . . . . 0.0 111.995 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 87' ' ' VAL . 24.1 m-80 -127.72 107.2 9.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.191 . . . . 0.0 110.607 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.4 m -166.01 152.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.512 0.672 . . . . 0.0 109.861 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.8 m -116.57 113.11 22.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -94.89 100.56 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' HD23 ' A' ' 26' ' ' LEU . 16.5 tt0 -75.33 126.74 31.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.42 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 HD21 ' A' ' 26' ' ' LEU . 39.8 t -110.28 127.31 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.899 0.856 . . . . 0.0 111.913 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mm -109.34 96.88 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.55 -155.14 24.0 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 -8.36 8.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.183 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -141.82 149.64 40.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 109.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 26' ' ' LEU . 42.9 mm -74.11 121.81 86.08 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.969 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -41.17 127.9 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.774 1.649 . . . . 0.0 111.366 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.6 tp -79.42 -11.88 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.516 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 106' ' ' PHE . 70.7 mt 56.07 -121.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.052 -1.03 . . . . 0.0 109.6 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.33 9.14 43.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.001 -1.062 . . . . 0.0 111.056 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.54 -3.47 61.28 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.249 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -128.66 -171.95 2.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.887 . . . . 0.0 109.537 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.34 15.6 10.76 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HB2' HD22 ' A' ' 176' ' ' LEU . 15.7 t-105 -58.78 -42.43 89.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -1.131 . . . . 0.0 110.493 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.03 -58.04 7.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' A' ' 99' ' ' LEU . 7.9 m-85 -51.15 -45.65 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.351 -0.843 . . . . 0.0 109.633 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -60.52 -48.97 79.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.623 -0.673 . . . . 0.0 110.974 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 9.1 mm-40 -67.34 -42.6 83.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.087 -1.008 . . . . 0.0 111.701 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.36 -50.36 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 110.395 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.31 -31.92 51.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.989 -1.069 . . . . 0.0 109.291 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -62.96 -42.1 99.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HG3' HD22 ' A' ' 113' ' ' ASN . 12.0 pttp -77.64 12.74 1.52 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.204 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.669 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 3.9 m-80 -143.86 31.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.883 -1.136 . . . . 0.0 110.457 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.515 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 84.0 mt -79.62 141.3 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.957 -1.089 . . . . 0.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LYS . 22.0 tp -129.92 122.46 28.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -79.23 141.53 37.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.145 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -110.17 -174.59 2.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.504 -0.748 . . . . 0.0 109.595 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.23 68.84 0.68 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 110.678 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -167.16 130.38 1.79 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.91 143.81 55.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.596 HG12 HG21 ' A' ' 85' ' ' THR . 55.2 mt -86.22 149.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.11 78.13 5.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -58.65 142.72 48.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 110.041 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -89.44 101.59 14.26 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.8 t -93.88 134.16 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.461 0.648 . . . . 0.0 111.061 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.57 111.91 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.437 ' C ' ' OE1' ' A' ' 128' ' ' GLU . 81.3 mt-10 -90.35 -27.66 19.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -134.21 154.75 80.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.497 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.76 148.11 45.98 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.551 2.167 . . . . 0.0 112.199 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.0 149.05 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mp -140.3 143.37 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 109.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.38 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -133.05 159.63 39.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.15 -0.969 . . . . 0.0 110.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -175.44 105.94 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 52.11 54.95 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -0.813 . . . . 0.0 110.715 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.19 -31.18 3.19 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.109 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -63.09 135.39 57.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.267 . . . . 0.0 108.52 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -146.03 136.61 24.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.897 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.657 HG21 HD22 ' A' ' 259' ' ' LEU . 96.5 mt -135.41 121.64 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.229 -0.919 . . . . 0.0 109.207 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -112.16 131.82 55.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.487 0.66 . . . . 0.0 109.98 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.15 138.47 54.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.83 153.42 33.45 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 109.524 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -49.19 142.38 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.401 2.067 . . . . 0.0 113.49 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.5 t -154.15 142.44 20.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 146' ' ' THR . 55.8 m-20 -60.59 -4.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.314 -0.866 . . . . 0.0 110.726 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 145' ' ' ASP . 17.4 p -157.96 -171.07 3.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.872 -1.143 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 148' ' ' GLU . 14.9 tp -93.98 120.57 34.41 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.118 -0.989 . . . . 0.0 109.018 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.409 ' N ' HD12 ' A' ' 147' ' ' LEU . 77.1 tt0 -136.77 113.01 9.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.36 122.0 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.9 m -112.91 152.31 29.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.96 131.61 27.26 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.938 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.28 140.26 52.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.64 138.67 8.27 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.969 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.36 99.29 9.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -84.42 167.22 16.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.853 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -100.67 -12.07 19.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.9 p-10 -102.69 -172.63 2.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.934 -1.104 . . . . 0.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -49.18 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.466 -0.771 . . . . 0.0 111.532 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' ASN . 18.3 mt -77.31 -27.19 52.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.379 -1.45 . . . . 0.0 108.311 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.46 -139.18 31.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -97.36 134.07 41.12 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.169 -1.194 . . . . 0.0 109.513 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -141.23 152.86 44.92 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 152.76 32.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.214 -0.929 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 53.8 t80 -148.53 146.53 28.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -110.3 124.57 51.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.516 -0.74 . . . . 0.0 110.468 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.456 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.888 . . . . 0.0 110.012 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 t -109.75 156.26 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -50.65 123.37 8.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.973 . . . . 0.0 109.19 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.475 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 103.92 5.95 43.64 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.453 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 82.8 m-20 -119.75 19.03 12.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.367 -1.078 . . . . 0.0 109.212 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.695 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.9 pm0 -59.8 -43.9 94.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -53.89 -6.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 110.021 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 171' ' ' GLU . 89.3 mt-10 -104.8 -8.96 18.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.348 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 pt -123.85 -27.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.231 -0.918 . . . . 0.0 110.575 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.8 m -62.18 -29.23 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.795 -1.191 . . . . 0.0 108.611 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -77.58 -7.53 56.48 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.485 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.28 119.15 12.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.314 -0.866 . . . . 0.0 109.172 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.511 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 72.8 mtm180 -83.25 172.29 12.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.914 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.3 t -77.06 162.37 27.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -147.65 145.17 28.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.302 -1.499 . . . . 0.0 111.333 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.595 ' HB2' ' CE1' ' A' ' 501' ' ' C90 . . . -142.17 157.16 45.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.54 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.6 m-85 -98.72 142.28 30.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 0.0 109.514 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.15 -37.66 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.314 -0.866 . . . . 0.0 109.748 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.0 -27.25 63.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.472 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 7.1 mt-10 -78.61 -40.07 35.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.425 HG21 HB11 ' A' ' 501' ' ' C90 . 13.2 mt -43.22 -54.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 186' ' ' ILE . 1.0 OUTLIER -43.21 -43.12 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.942 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.75 ' O ' HG22 ' A' ' 192' ' ' VAL . 2.3 t60 -74.27 -50.08 20.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 0.0 109.598 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 56.0 mt -52.08 -28.97 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -85.3 -53.32 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.74 -1.225 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -51.77 -33.68 36.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.6 m -83.07 7.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 0.0 109.819 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.67 39.38 55.87 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 54.4 mt -129.48 171.56 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.204 . . . . 0.0 110.134 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.67 24.0 56.28 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -58.22 -19.33 32.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.67 -1.488 . . . . 0.0 110.387 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.454 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.44 6.51 28.31 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.723 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.32 126.19 27.79 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 120.903 -1.351 . . . . 0.0 110.297 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.58 167.03 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.246 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.5 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 78.5 mt -68.75 -8.59 44.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 108.395 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -98.06 -11.17 23.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.712 -0.618 . . . . 0.0 109.54 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.2 p30 -133.21 7.66 3.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.64 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.43 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.43 149.56 31.94 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.645 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.73 93.99 6.11 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.6 129.06 38.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.779 0.8 . . . . 0.0 109.094 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 211' ' ' VAL . 40.9 mt -123.08 170.87 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.651 -0.656 . . . . 0.0 109.562 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.76 -166.22 11.71 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -64.48 -29.66 70.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -1.148 . . . . 0.0 109.611 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -153.26 24.45 0.54 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 111.061 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -149.17 156.82 42.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.515 -1.366 . . . . 0.0 110.925 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 206' ' ' LEU . 84.6 t -104.67 112.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -57.04 -49.32 76.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.902 -1.123 . . . . 0.0 109.856 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.83 112.26 4.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -57.3 -17.94 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 112.598 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.12 -16.34 60.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.915 -1.116 . . . . 0.0 109.98 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.43 -171.96 50.9 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.645 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.0 mt -91.17 137.3 32.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -1.085 . . . . 0.0 109.674 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -74.41 -16.45 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 108.74 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.99 169.36 17.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 2.1 mm-40 -84.56 3.68 35.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.141 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.519 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -151.38 43.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.186 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -56.24 -47.21 99.31 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.2 Cg_exo -50.57 -68.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.447 2.098 . . . . 0.0 112.193 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.1 m -57.13 -35.3 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.012 -1.055 . . . . 0.0 109.644 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.566 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 76.9 mtt-85 -60.7 -41.24 94.79 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.449 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.0 t60 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.986 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.7 t -67.64 -37.06 78.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.414 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 52.7 t80 -65.33 -50.98 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.051 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.539 ' OD2' ' C22' ' A' ' 501' ' ' C90 . 91.8 m-20 -64.11 -30.53 71.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 109.997 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.3 tp -75.49 -32.8 60.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.034 -1.041 . . . . 0.0 108.579 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.27 -39.66 83.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.7 -56.15 16.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.41 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 49.6 m-20 -54.82 -33.98 62.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 235' ' ' LEU . 7.7 mt -61.18 -24.01 66.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.467 -0.771 . . . . 0.0 110.444 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -72.63 -22.1 61.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.892 -1.13 . . . . 0.0 108.611 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 60' ' ' THR . 63.4 mt -50.78 -2.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.0 110.621 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 260' ' ' VAL . 9.5 mt -76.76 -13.38 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.147 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.01 -0.38 58.97 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.04 155.16 8.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.318 . . . . 0.0 108.814 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.53 150.67 5.62 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.745 1.63 . . . . 0.0 109.6 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 145.54 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.076 -1.015 . . . . 0.0 112.361 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.6 mmmp? -126.25 121.32 32.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.3 -175.55 31.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.556 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 26.9 tttt -114.59 147.47 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.075 . . . . 0.0 109.263 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 6.8 m-85 -142.92 140.48 31.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.56 122.12 34.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -114.7 135.25 54.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 111.112 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -118.52 109.68 16.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 54.15 26.82 6.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.69 158.74 52.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.02 168.14 24.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.41 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 68.5 m-70 -47.19 -41.29 17.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -1.187 . . . . 0.0 109.695 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.27 -57.98 9.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.045 -1.034 . . . . 0.0 109.293 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.546 HD23 HG13 ' A' ' 139' ' ' ILE . 6.4 tp -58.15 -44.82 88.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 256' ' ' ASN . 2.7 m-20 -47.95 -50.48 26.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.057 . . . . 0.0 109.391 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 56' ' ' THR . 99.4 t -63.15 -51.12 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.594 -0.691 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -53.0 -51.32 62.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 109.286 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.657 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -51.57 -57.79 8.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.161 -0.962 . . . . 0.0 108.434 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.6 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.2 t -50.78 -56.23 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 108.899 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -49.04 20.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.525 -0.734 . . . . 0.0 109.398 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.435 ' HB3' HD11 ' A' ' 130' ' ' ILE . 1.8 mm-40 -62.07 -48.27 80.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.36 -50.54 71.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.96 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.44 -27.0 65.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.0 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -77.11 -40.3 46.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.908 . . . . 0.0 110.267 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -19.5 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 0.0 109.972 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.83 -47.29 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.052 -1.03 . . . . 0.0 109.739 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 -162.99 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.982 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 109.399 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' C90 . . . . . 0.595 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.569 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 2.0 mt -84.28 156.49 21.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.18 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -51.76 143.29 13.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.55 146.61 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.091 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.96 -168.82 3.03 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.2 m -99.56 134.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 109.526 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -63.9 -16.73 62.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -152.71 -171.63 3.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.381 -0.824 . . . . 0.0 109.246 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 144.01 25.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 11' ' ' LEU . 43.5 mt -120.97 163.31 18.45 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.44 140.41 46.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.6 m-85 -138.48 148.28 44.16 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.13 152.2 26.05 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.809 -1.182 . . . . 0.0 110.209 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.12 173.24 35.9 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.08 150.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.393 -1.063 . . . . 0.0 110.17 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.58 136.63 15.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.6 tt -60.52 -37.78 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 110.445 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 46.3 m-70 -90.68 -51.45 5.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.588 -1.32 . . . . 0.0 111.044 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.7 p -70.54 -22.03 62.65 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.6 -0.688 . . . . 0.0 111.232 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.25 21.37 47.11 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.731 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -110.64 153.07 25.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 109.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -74.86 130.13 38.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.46 -0.775 . . . . 0.0 109.562 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 t -135.41 145.86 47.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.235 -0.916 . . . . 0.0 110.057 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -112.0 156.52 22.02 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.416 0.627 . . . . 0.0 109.333 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.586 HD11 HG23 ' A' ' 96' ' ' ILE . 10.8 mt -135.61 144.92 46.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.553 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -140.19 110.22 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 108.79 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.3 113.62 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 111.094 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' HG22 ' A' ' 27' ' ' ILE . 45.4 m-70 -108.32 138.14 20.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.073 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HG3' HG23 ' A' ' 7' ' ' VAL . 20.6 Cg_exo -51.37 167.98 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.853 1.702 . . . . 0.0 112.279 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.2 mm-40 -140.92 176.21 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 35' ' ' THR . 3.5 mtpp -85.31 152.83 22.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.856 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 146.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.925 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.68 6.32 42.44 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.039 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 24.6 m -69.08 -43.7 74.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.631 -1.511 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.55 -175.67 31.82 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.458 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mm -98.45 117.92 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.03 140.7 38.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.57 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -129.11 110.8 12.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.031 -1.043 . . . . 0.0 109.084 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.19 134.14 39.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.32 28.33 7.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.03 75.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.806 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.49 121.19 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -1.012 . . . . 0.0 108.951 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.5 m-85 -84.34 127.11 33.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.6 mt -115.72 92.65 34.63 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -49.66 144.99 18.33 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.2 67.5 7.15 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -122.16 163.79 18.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -65.63 -52.87 48.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 5.4 mm-40 -43.25 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.724 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' HIS . 15.9 m-85 -95.7 1.73 53.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 50' ' ' HIS . 86.8 t -70.58 130.35 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 108.874 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.46 -31.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 109.744 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.7 136.53 17.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.884 HG21 HG21 ' A' ' 257' ' ' VAL . 35.8 p -125.35 96.3 4.77 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.4 t-20 -162.24 129.49 3.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.808 . . . . 0.0 108.949 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.541 ' O ' ' CB ' ' A' ' 59' ' ' SER . 32.6 m80 51.98 7.9 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.104 -0.998 . . . . 0.0 108.759 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.5 OUTLIER 161.9 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 72' ' ' VAL . 88.0 m -93.88 126.49 39.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 109.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.94 149.02 42.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.612 0.72 . . . . 0.0 110.868 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 72' ' ' VAL . 9.0 mt -124.86 149.07 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.73 153.74 24.43 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.98 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -163.12 148.79 11.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 0.0 109.174 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.89 23.79 4.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.15 -31.72 7.4 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.38 144.55 50.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.235 . . . . 0.0 109.262 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -140.04 139.02 35.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.675 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.3 mt -130.4 123.02 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -101.36 157.33 16.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.95 -1.094 . . . . 0.0 111.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.8 m 49.91 74.57 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.545 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 62' ' ' LEU . 30.5 m -107.65 -9.81 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.938 . . . . 0.0 109.31 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 10.6 pm0 -61.74 -26.09 67.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 110.46 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.0 m170 -66.78 -69.23 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.932 -1.105 . . . . 0.0 109.242 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.02 -48.57 40.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.013 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.589 HD21 ' HB1' ' A' ' 48' ' ' ALA . 14.8 mt -51.55 -49.27 62.34 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.038 -1.039 . . . . 0.0 110.3 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -42.68 96.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.988 -1.07 . . . . 0.0 110.295 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.9 t -56.74 -45.41 82.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.075 -1.015 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.3 -34.69 78.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -61.62 -35.84 79.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 109.035 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 65.1 mt -80.23 -37.65 32.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.257 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.0 9.29 5.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 109.781 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 3.3 mp0 50.2 36.77 13.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.34 136.82 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.034 -1.041 . . . . 0.0 108.282 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.484 HG21 HG12 ' A' ' 121' ' ' ILE . 33.0 p -127.1 -19.81 4.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 111.595 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' VAL . 72.7 m-20 -124.38 107.59 11.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.876 -1.14 . . . . 0.0 110.423 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -163.94 148.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.408 -0.808 . . . . 0.0 110.282 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.8 m -114.69 111.5 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.552 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -95.68 100.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -72.07 127.69 33.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 26' ' ' LEU . 83.3 t -111.9 119.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.937 0.875 . . . . 0.0 111.905 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' ILE . 13.7 mt -109.04 93.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.2 160.4 8.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -7.54 59.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 111.292 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -138.96 147.89 42.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 110.676 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 26' ' ' LEU . 42.0 mm -73.86 125.96 89.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.457 -0.777 . . . . 0.0 108.917 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -44.61 134.2 9.88 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.775 1.65 . . . . 0.0 111.075 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.7 tp -88.17 -14.66 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 110.61 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.7 mt 55.78 -121.98 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -95.82 7.6 45.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.939 -1.101 . . . . 0.0 111.17 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.52 -3.73 63.61 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.281 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.9 p -123.88 -172.65 2.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.724 -0.868 . . . . 0.0 109.556 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.98 10.18 11.14 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 55.5 t-105 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -1.121 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.31 -58.98 6.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.028 -1.045 . . . . 0.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HB3' HG11 ' A' ' 78' ' ' VAL . 11.7 m-85 -51.18 -43.77 61.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.83 0.824 . . . . 0.0 108.885 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.464 ' CE2' ' OE1' ' A' ' 171' ' ' GLU . 56.4 t80 -62.27 -52.19 64.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.663 -0.648 . . . . 0.0 111.18 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.448 ' CG ' ' CZ2' ' A' ' 104' ' ' TRP . 19.5 mm-40 -61.89 -43.2 99.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.956 -1.09 . . . . 0.0 111.195 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.12 2.63 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 110.363 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.44 -35.42 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.635 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 41.8 ttt85 -64.78 -43.55 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.762 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -72.59 10.76 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -145.73 36.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.948 -1.095 . . . . 0.0 110.448 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.7 mt -83.44 139.91 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.98 119.5 23.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.411 ' ND2' ' HD2' ' A' ' 5' ' ' LYS . 2.8 m120 -76.3 143.56 40.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.722 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.19 -175.96 2.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 109.592 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -106.91 67.99 0.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.235 -0.915 . . . . 0.0 110.514 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -164.93 129.64 2.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.22 140.77 57.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 85' ' ' THR . 37.4 mt -81.47 147.0 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.77 88.78 4.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -0.872 . . . . 0.0 108.657 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.71 143.77 56.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -88.47 102.2 14.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.24 134.12 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.556 -0.715 . . . . 0.0 110.792 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.27 117.22 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 127' ' ' GLU . 7.3 tp10 -89.69 -31.62 17.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.961 -1.087 . . . . 0.0 109.99 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.11 154.28 80.06 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.41 158.39 44.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.557 2.172 . . . . 0.0 112.35 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.549 HG13 ' HZ2' ' A' ' 266' ' ' LYS . 3.0 tt -165.09 154.67 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.76 147.06 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.96 147.28 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -132.84 161.56 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -173.66 102.17 0.11 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 0.0 109.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.17 59.25 4.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.436 -0.79 . . . . 0.0 111.002 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.02 -35.56 3.25 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.448 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -63.94 131.38 47.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.265 . . . . 0.0 108.89 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -143.3 139.25 30.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 109.999 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 259' ' ' LEU . 68.5 mt -137.29 128.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.387 -0.821 . . . . 0.0 109.876 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -117.94 132.77 56.37 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.514 0.673 . . . . 0.0 110.146 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.83 134.95 54.89 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -146.46 147.68 31.59 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.54 143.52 8.45 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.617 2.211 . . . . 0.0 113.458 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.73 147.38 18.55 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.77 -37.55 82.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.325 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -120.46 -169.86 1.88 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.9 tp -100.08 122.94 43.72 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.36 130.2 36.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.459 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.9 t -128.73 121.45 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.541 ' OG1' HG23 ' A' ' 165' ' ' THR . 21.4 m -112.43 151.99 29.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.594 -0.691 . . . . 0.0 109.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -140.52 131.4 25.98 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.145 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -121.67 125.42 46.61 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.91 138.87 10.7 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.345 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -102.87 103.14 13.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -93.31 167.44 11.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.664 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -103.65 -12.27 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 110.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.2 p-10 -97.88 -167.13 1.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 110.378 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -53.48 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.259 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 157' ' ' ASN . 13.5 mt -85.59 -30.53 23.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.545 -1.347 . . . . 0.0 109.102 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.85 -140.25 38.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 161' ' ' ARG . 11.5 ttp-105 -98.82 135.91 39.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.193 -1.181 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -137.89 149.72 46.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.484 -0.76 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -140.86 143.99 35.05 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -145.47 140.3 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.541 HG23 ' OG1' ' A' ' 150' ' ' THR . 32.2 m -108.14 123.85 49.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.527 -0.733 . . . . 0.0 109.998 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -102.91 111.73 24.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.959 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 44.5 t -99.8 146.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.954 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -48.25 134.21 14.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.29 -0.881 . . . . 0.0 108.987 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.92 -6.0 43.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -114.03 25.61 11.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -1.132 . . . . 0.0 109.27 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.464 ' OE1' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -53.09 -51.69 61.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.429 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -50.56 -21.28 1.47 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.12 -0.988 . . . . 0.0 110.177 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.26 -7.9 59.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 111.619 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.58 -25.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.852 -1.155 . . . . 0.0 111.121 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.9 m -63.7 -24.44 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.438 -1.414 . . . . 0.0 109.005 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.4 mm? -81.66 -5.62 58.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.468 -0.77 . . . . 0.0 108.99 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.404 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.57 115.52 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.173 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.409 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 49.8 mtm180 -79.41 172.51 13.7 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.201 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.4 t -77.86 163.23 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -147.1 144.46 29.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.207 -1.558 . . . . 0.0 111.716 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.01 156.7 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.86 147.29 25.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 109.662 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -52.94 -35.97 59.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.429 -0.794 . . . . 0.0 109.698 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.2 p90 -72.91 -31.44 64.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.578 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.2 mm-40 -75.36 -35.74 61.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.017 -1.052 . . . . 0.0 109.375 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 183' ' ' ASP . 77.1 mt -46.46 -55.61 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 109.786 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -43.8 -42.0 5.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.858 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.0 t60 -74.44 -48.4 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.988 . . . . 0.0 109.046 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.1 mt -51.09 -30.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.336 -0.852 . . . . 0.0 109.302 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -82.35 -52.02 7.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.782 -1.199 . . . . 0.0 109.143 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -47.29 -47.12 25.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.425 -0.797 . . . . 0.0 110.158 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.7 m -74.67 8.17 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.79 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.08 39.9 62.52 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 194' ' ' LEU . 44.8 mt -126.45 170.91 11.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -1.082 . . . . 0.0 109.676 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.8 21.22 58.16 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -57.2 -21.67 35.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.557 -1.555 . . . . 0.0 109.807 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -113.48 25.19 11.38 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.36 127.53 8.4 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.458 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -141.18 169.4 17.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.124 . . . . 0.0 109.519 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 63.5 mt -70.7 -8.64 53.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -97.38 -12.66 22.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.609 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.458 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 17.9 p30 -132.71 8.67 4.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.492 HG22 HG23 ' A' ' 205' ' ' VAL . 1.0 OUTLIER -149.89 149.76 30.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.967 -1.083 . . . . 0.0 110.481 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.548 ' CG ' HD21 ' A' ' 206' ' ' LEU . 32.0 tp -97.45 93.36 6.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 203' ' ' THR . 45.1 t -87.22 130.34 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.554 -0.716 . . . . 0.0 109.152 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.548 HD21 ' CG ' ' A' ' 204' ' ' LEU . 12.5 mt -124.15 166.26 16.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.159 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.08 -166.15 12.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -1.12 . . . . 0.0 109.366 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 209' ' ' ASP . 47.9 t0 -153.9 24.32 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -143.02 150.6 39.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 79.7 t -103.23 113.32 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -58.61 -49.76 76.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.012 -1.055 . . . . 0.0 110.04 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -58.1 111.81 4.03 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.231 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.54 -12.98 12.35 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.541 1.494 . . . . 0.0 111.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -17.54 59.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 110.035 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.7 -173.78 49.29 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 204' ' ' LEU . 6.7 mt -91.02 136.14 33.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -1.209 . . . . 0.0 109.462 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -75.32 -20.12 59.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 108.824 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.43 159.07 42.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.555 -0.716 . . . . 0.0 109.12 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.5 -12.79 61.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.82 51.17 1.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.28 -47.03 99.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 0.0 109.795 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 63.6 Cg_exo -49.9 -67.08 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.453 2.102 . . . . 0.0 112.342 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 m -59.16 -35.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.121 . . . . 0.0 109.571 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -60.66 -41.1 94.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 108.457 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.2 t60 -68.19 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.301 -0.874 . . . . 0.0 108.947 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -64.45 -37.63 88.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.07 -36.11 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.59 -57.37 9.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.532 -0.73 . . . . 0.0 109.137 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -61.58 -26.01 67.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.354 -0.841 . . . . 0.0 109.885 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.7 tp -78.2 -35.08 48.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 0.0 108.69 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.8 mt -66.0 -36.51 77.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.79 -59.76 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 99.4 m-20 -48.09 -36.1 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.274 . . . . 0.0 108.992 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.9 mt -62.83 -22.78 66.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.547 -0.721 . . . . 0.0 110.317 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.27 -22.63 61.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.777 -1.202 . . . . 0.0 108.999 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.36 -3.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.688 -1.257 . . . . 0.0 110.204 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.5 mt -78.87 -16.34 57.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.906 -1.121 . . . . 0.0 109.695 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 2.63 56.37 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.172 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.66 154.54 9.13 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.747 -1.443 . . . . 0.0 109.287 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.16 128.77 31.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.91 1.74 . . . . 0.0 109.682 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 151.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 112.524 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -131.9 124.74 30.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.48 -158.41 27.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -129.08 132.89 47.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -1.155 . . . . 0.0 108.713 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.5 m-85 -131.92 140.09 48.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -126.76 125.34 41.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 m -120.93 135.44 55.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 111.015 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.403 ' C ' ' N ' ' A' ' 251' ' ' GLY . 30.4 t80 -116.1 114.84 25.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 17.38 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.092 -1.005 . . . . 0.0 109.007 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 249' ' ' PHE . . . -55.68 140.89 40.06 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.2 179.45 17.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.7 m-70 -62.21 -42.26 99.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.203 -1.174 . . . . 0.0 109.875 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.0 t -55.62 -58.92 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.07 -1.019 . . . . 0.0 109.572 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 255' ' ' LEU . 12.8 tp -55.99 -44.56 78.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 109.313 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 34.9 m-20 -47.59 -50.77 23.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.965 -1.085 . . . . 0.0 108.962 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 56' ' ' THR . 86.3 t -61.98 -49.55 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.524 -0.735 . . . . 0.0 109.84 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -54.88 -51.93 64.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.029 -1.044 . . . . 0.0 109.311 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 139' ' ' ILE . 51.9 tp -50.06 -52.79 31.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 108.549 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.503 HG13 ' HG ' ' A' ' 238' ' ' LEU . 34.5 t -55.41 -51.45 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 108.746 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -50.16 -47.01 54.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 109.552 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -64.45 -48.95 73.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.957 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 14.9 mt -57.42 -51.81 67.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.44 -27.3 65.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 110.251 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' HZ1' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -71.72 -63.44 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.549 ' HZ2' HG13 ' A' ' 130' ' ' ILE . 3.1 pttt -71.17 -15.41 62.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.473 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 266' ' ' LYS . 5.6 tp-100 -34.59 -35.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 266' ' ' LYS . 7.7 mmtp -87.37 85.49 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.475 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.506 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.635 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt -100.05 152.55 20.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.445 ' CD ' ' OG1' ' A' ' 85' ' ' THR . 13.5 mm-40 -53.94 137.01 40.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.511 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 143.86 48.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -140.87 -171.96 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.502 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.8 m -97.05 133.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.998 -1.064 . . . . 0.0 109.397 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -64.68 -18.02 64.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.252 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 16.5 pt-20 -155.99 163.99 39.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.287 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 139.36 51.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 113' ' ' ASN . 11.5 mt -117.45 166.85 11.85 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -140.33 142.97 35.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 110.253 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' LEU . 91.6 m-85 -140.11 151.07 45.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.2 pt-20 -157.12 150.83 24.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.893 -1.129 . . . . 0.0 110.036 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.34 175.42 36.63 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.08 154.47 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -1.107 . . . . 0.0 110.003 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.01 140.15 15.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -59.33 -38.67 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 110.396 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.7 m-70 -89.42 -50.49 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.784 -1.198 . . . . 0.0 111.067 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 p -70.41 -23.08 62.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.634 -0.666 . . . . 0.0 111.758 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.2 15.55 15.57 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.63 153.44 22.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 24.9 t80 -74.38 135.53 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.354 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.2 m -139.7 144.77 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.602 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.9 ttpp -110.95 156.23 21.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -135.53 147.67 48.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.42 -0.8 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.6 mt -143.81 114.11 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 108.882 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mt -98.41 114.61 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.372 -0.83 . . . . 0.0 110.774 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 9.3 m-70 -108.49 138.13 20.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.2 Cg_exo -53.23 168.43 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.81 1.674 . . . . 0.0 111.65 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.497 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 58.9 mm-40 -141.22 177.54 8.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.031 -1.043 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' OG1' ' A' ' 35' ' ' THR . 21.0 mttt -84.48 152.44 23.96 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.692 0.758 . . . . 0.0 110.161 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.16 142.82 2.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.167 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 69.53 10.26 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.258 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 33.5 m -69.98 -42.43 73.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.573 -1.545 . . . . 0.0 109.798 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 178.95 35.58 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.351 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 87' ' ' VAL . 41.0 mm -95.44 116.32 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 7.1 ptm180 -141.14 150.26 42.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 110.582 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.31 157.03 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -128.41 111.82 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 108.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 44.4 tttm -134.68 132.62 39.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.534 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.5 m120 52.58 28.27 5.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.795 . . . . 0.0 111.372 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.07 19.64 69.34 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.187 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.81 122.6 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -1.063 . . . . 0.0 109.174 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.453 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 64.5 m-85 -84.73 127.19 33.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 109.729 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.9 mt -116.96 93.88 43.04 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.386 -0.822 . . . . 0.0 109.386 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.95 149.83 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.637 2.224 . . . . 0.0 112.105 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.05 68.48 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 3.9 mmt85 -123.08 175.69 6.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.276 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.8 p-80 -77.78 -51.65 10.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 110.28 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -43.06 -16.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 110.759 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.0 m-85 -98.11 2.96 49.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 110.295 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 50' ' ' HIS . 74.0 t -70.46 128.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.001 -1.062 . . . . 0.0 108.896 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -31.65 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.131 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -151.52 132.01 13.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.733 HG21 HG21 ' A' ' 257' ' ' VAL . 41.4 p -120.88 96.02 4.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.6 t30 -162.65 128.9 3.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.916 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 51.7 m80 52.72 5.37 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 0.0 109.02 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 165.14 155.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.588 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 72' ' ' VAL . 55.1 m -94.64 126.76 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 109.2 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -119.0 148.02 43.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.507 -0.746 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' HG21 ' A' ' 72' ' ' VAL . 11.0 mt -123.51 149.87 44.65 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.78 157.58 28.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.848 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CD2' ' HD3' ' A' ' 65' ' ' LYS . 8.0 t80 -166.03 143.65 5.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 108.738 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HD3' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 53.36 22.13 2.67 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.31 -32.04 7.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 80.4 mm-40 -59.81 148.31 34.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.312 . . . . 0.0 109.613 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.52 138.5 30.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 110.53 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.3 mt -129.67 123.89 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -99.93 155.95 17.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 111.259 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.9 m 49.96 74.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.4 m -107.59 -8.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 108.71 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 60' ' ' THR . 14.3 pm0 -60.86 -28.46 68.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 110.623 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.25 -68.76 0.35 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -51.98 -47.56 41.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 75' ' ' ILE . 85.9 mt -52.32 -47.32 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.84 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 48.5 t -61.13 -42.23 98.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.097 -1.002 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.24 -43.41 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.993 -1.067 . . . . 0.0 109.133 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.3 -34.99 78.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.159 -0.963 . . . . 0.0 109.167 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.18 -38.27 90.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.429 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.1 mt -77.59 -38.87 47.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.855 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 82' ' ' LEU . 68.5 mt -81.81 0.08 40.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 109.411 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 55.93 42.72 28.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.645 -0.66 . . . . 0.0 111.365 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.34 145.32 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.782 -1.198 . . . . 0.0 108.192 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.667 HG21 HG12 ' A' ' 121' ' ' ILE . 82.7 p -129.35 -25.61 2.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.0 111.574 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 87' ' ' VAL . 83.2 m-20 -124.26 106.87 10.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.867 -1.146 . . . . 0.0 110.362 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.0 m -164.36 148.49 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.415 -0.803 . . . . 0.0 110.289 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.497 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 88.8 m -115.88 109.38 17.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.475 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -91.71 100.15 10.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 109.859 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -72.17 125.89 28.42 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 26' ' ' LEU . 92.3 t -107.94 123.55 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.707 0.765 . . . . 0.0 111.364 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.602 HD12 ' HB3' ' A' ' 25' ' ' LYS . 91.7 mt -110.25 96.36 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.25 -156.62 25.73 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -119.67 -11.03 9.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -1.149 . . . . 0.0 110.041 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -141.46 149.65 41.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.977 -1.077 . . . . 0.0 109.661 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.658 HG23 HD11 ' A' ' 26' ' ' LEU . 44.3 mm -72.52 119.55 75.66 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.037 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -40.32 119.89 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.778 1.652 . . . . 0.0 111.378 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -76.02 -13.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 110.098 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.7 mt 56.86 -118.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.25 -0.907 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 1.9 t0 -95.31 6.08 49.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.121 -0.987 . . . . 0.0 110.682 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.08 -0.91 60.62 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.52 -172.53 2.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.698 -0.884 . . . . 0.0 109.627 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.92 17.23 10.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.546 ' CE3' HD21 ' A' ' 176' ' ' LEU . 4.3 t-105 -59.57 -43.53 93.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.456 -1.026 . . . . 0.0 110.08 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 -57.87 8.24 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.062 -1.024 . . . . 0.0 109.852 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.47 -46.69 63.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -61.37 -49.3 77.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 7.2 mm-40 -66.0 -43.83 86.6 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.969 -1.082 . . . . 0.0 111.579 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.84 45.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 110.454 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.53 -31.97 56.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.968 -1.082 . . . . 0.0 109.161 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -63.2 -42.38 99.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 7.4 pttp -79.15 10.44 3.56 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.983 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.524 ' ND2' ' OE2' ' A' ' 9' ' ' GLU . 9.6 m-20 -138.23 32.25 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.051 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.55 137.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 110.855 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.28 118.6 21.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.566 -0.708 . . . . 0.0 109.274 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -79.88 145.8 32.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.028 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.22 -170.74 1.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.775 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 -109.46 68.97 0.69 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 110.361 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.34 128.6 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.152 -0.967 . . . . 0.0 109.207 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.28 142.51 56.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.0 109.506 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.667 HG12 HG21 ' A' ' 85' ' ' THR . 65.9 mt -84.39 149.33 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.2 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.58 87.68 3.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -66.52 145.36 55.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.184 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.439 ' CZ ' ' NE2' ' A' ' 267' ' ' GLN . 45.1 t80 -88.22 101.41 13.81 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.88 133.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.456 0.646 . . . . 0.0 111.027 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.51 112.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.22 -30.12 17.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.959 -1.088 . . . . 0.0 110.534 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.42 81.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.86 148.69 41.26 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.562 2.174 . . . . 0.0 112.083 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 tt -156.8 148.93 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -0.833 . . . . 0.0 109.124 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.27 146.23 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.362 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.8 m -132.57 148.93 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.19 161.16 35.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.869 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -170.28 101.94 0.27 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 109.731 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 48.43 58.02 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.38 -35.52 3.31 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.584 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -62.18 136.3 57.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.339 . . . . 0.0 108.778 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.4 tt -144.53 139.1 27.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.863 -1.148 . . . . 0.0 110.062 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.801 HG21 HD22 ' A' ' 259' ' ' LEU . 23.3 mt -137.85 134.02 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.415 -0.803 . . . . 0.0 109.982 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -122.23 132.64 54.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.455 0.645 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.18 53.98 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.85 151.68 42.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 110.143 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.95 141.88 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.583 2.189 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.11 147.62 19.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -36.46 81.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.3 p -121.9 -169.22 1.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.846 . . . . 0.0 109.956 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.0 tp -98.76 123.71 43.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 108.67 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -136.33 128.09 29.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.2 t -128.3 121.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.843 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.7 m -110.84 151.1 28.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.451 -0.781 . . . . 0.0 109.07 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -139.15 130.22 26.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -120.99 131.05 54.07 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.18 140.0 11.31 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.534 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -106.22 101.12 10.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.55 167.15 13.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.935 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -99.14 -15.56 18.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.624 -0.672 . . . . 0.0 110.911 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.1 p-10 -96.09 -168.63 1.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.803 -1.185 . . . . 0.0 110.084 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -55.85 2.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.0 111.446 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.9 mt -77.61 -27.34 51.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.408 -1.433 . . . . 0.0 108.13 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.38 29.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.4 135.64 42.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -1.123 . . . . 0.0 109.339 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -140.82 158.9 43.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.429 -0.794 . . . . 0.0 109.363 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -147.44 146.23 29.48 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.216 -0.927 . . . . 0.0 109.828 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -145.41 140.13 27.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 110.08 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.9 m -108.21 123.54 48.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 110.03 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.49 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.22 115.46 30.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.56 147.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 5.6 mm-40 -48.73 135.04 15.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.196 -0.94 . . . . 0.0 108.897 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.07 -10.23 36.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 0.6 OUTLIER -116.97 25.85 10.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -1.125 . . . . 0.0 109.15 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.5 pm0 -62.45 -15.87 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 176' ' ' LEU . 1.9 tt0 -78.28 -8.11 57.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 110.887 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' HG2' HG23 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -104.79 -5.07 21.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.993 -1.067 . . . . 0.0 111.302 -178.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 173' ' ' GLU . 41.7 pt -115.65 -30.05 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.192 -0.942 . . . . 0.0 110.355 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 171' ' ' GLU . 10.3 m -60.44 -18.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.017 -1.052 . . . . 0.0 109.25 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.546 HD21 ' CE3' ' A' ' 104' ' ' TRP . 1.4 mp -93.92 0.85 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.008 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.587 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.05 117.39 11.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.922 . . . . 0.0 108.774 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 87.4 mtm180 -80.29 171.72 14.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.453 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.1 t -79.04 163.02 25.49 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -148.2 144.55 27.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.269 -1.519 . . . . 0.0 111.565 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.585 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -142.4 157.73 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.511 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.5 m-85 -99.35 146.56 26.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 109.558 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.99 -35.19 23.54 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.352 -0.842 . . . . 0.0 109.647 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.2 p90 -74.83 -30.32 61.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.983 -1.073 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.8 OUTLIER -73.56 -37.53 65.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.922 . . . . 0.0 109.967 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 187' ' ' GLU . 84.2 mt -48.93 -55.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.037 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -41.53 -41.73 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.062 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.6 t-160 -75.62 -47.31 27.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 109.148 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.17 -25.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.845 . . . . 0.0 109.566 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -85.64 -55.19 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.874 -1.141 . . . . 0.0 109.335 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -48.63 -41.74 32.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 188' ' ' HIS . 33.4 m -76.38 7.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.062 -1.024 . . . . 0.0 110.462 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.71 61.48 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.212 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 194' ' ' LEU . 51.3 mt -128.33 171.96 11.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 109.372 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 59.16 21.98 54.57 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -59.99 -21.16 60.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.476 -1.603 . . . . 0.0 108.945 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -108.6 25.62 18.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.41 7.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' THR . 35.7 m -143.94 165.56 27.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -1.114 . . . . 0.0 109.582 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 27.8 mt -66.51 -8.68 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 17.7 ttpt -95.08 -17.2 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 15.8 p30 -132.24 8.75 4.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.64 149.48 31.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.976 -1.077 . . . . 0.0 110.405 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.8 tp -100.61 93.45 5.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 203' ' ' THR . 44.2 t -85.43 131.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.828 0.823 . . . . 0.0 108.914 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' A' ' 211' ' ' VAL . 60.2 mt -123.25 161.7 24.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.556 -0.715 . . . . 0.0 109.464 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.82 -166.23 12.61 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -64.67 -29.55 70.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 110.051 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.28 24.23 0.63 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.999 . . . . 0.0 111.208 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -150.93 159.3 44.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.309 -1.494 . . . . 0.0 110.839 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 206' ' ' LEU . 43.1 t -104.36 111.86 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -54.83 -48.32 72.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.991 -1.068 . . . . 0.0 109.444 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.43 112.22 5.21 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -57.96 -19.84 41.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.823 1.682 . . . . 0.0 112.69 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.53 -15.49 61.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.056 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.67 -175.58 46.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.59 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.2 mt -84.84 144.26 28.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -76.15 -18.06 59.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 108.759 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.84 -170.26 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.191 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.73 -7.33 37.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.114 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.68 48.84 1.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.246 -0.909 . . . . 0.0 109.612 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.95 -45.47 98.94 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.321 -0.862 . . . . 0.0 110.548 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.2 Cg_exo -54.62 -55.7 3.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.329 2.019 . . . . 0.0 112.876 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 17.2 m -68.31 -39.73 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.883 -1.135 . . . . 0.0 111.749 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -68.89 -32.24 71.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.238 -1.539 . . . . 0.0 108.526 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.587 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 21.8 t60 -66.47 -35.46 80.32 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -64.41 -35.04 79.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 166' ' ' PHE . 79.2 t -66.94 -35.67 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -68.21 -52.24 36.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.76 -30.8 71.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.816 . . . . 0.0 109.642 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.62 -32.44 58.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.135 -0.978 . . . . 0.0 108.755 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.78 -37.35 78.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.82 -55.96 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.555 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -54.36 -35.99 63.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.237 . . . . 0.0 108.936 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.0 mt -60.08 -23.13 63.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.474 -0.766 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.8 -21.77 61.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.043 -1.036 . . . . 0.0 108.659 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 60' ' ' THR . 79.6 mt -49.87 -4.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.641 -1.287 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -76.88 -17.25 59.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.974 -1.078 . . . . 0.0 109.861 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.481 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 100.23 2.17 55.78 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.943 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.47 153.91 10.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.42 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.91 128.54 30.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.013 1.809 . . . . 0.0 110.035 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 t -86.95 152.01 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 112.217 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -135.79 127.67 29.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.76 -158.37 27.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.486 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.4 ttmt -127.29 140.73 52.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 109.137 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.4 m-85 -138.91 140.69 38.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.059 -1.025 . . . . 0.0 110.394 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -124.3 132.58 53.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -129.59 136.1 49.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.062 . . . . 0.0 111.154 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 250' ' ' ARG . 39.3 t80 -117.33 116.81 27.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.1 mtt-85 45.03 48.16 9.53 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.055 -1.028 . . . . 0.0 108.516 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.29 143.94 24.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -124.33 160.96 18.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.404 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 76.6 m-70 -46.4 -36.34 6.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -1.22 . . . . 0.0 109.492 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -58.11 9.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 108.986 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.5 tp -59.14 -44.21 92.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 0.0 109.239 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.3 m-20 -47.63 -54.31 12.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.555 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.733 HG21 HG21 ' A' ' 56' ' ' THR . 74.9 t -61.0 -56.84 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.424 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.533 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -44.53 -49.68 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.96 . . . . 0.0 108.93 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.801 HD22 HG21 ' A' ' 139' ' ' ILE . 24.5 tp -54.09 -61.59 2.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.896 -1.128 . . . . 0.0 108.605 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 238' ' ' LEU . 23.8 t -47.2 -54.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -47.2 -52.83 14.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.345 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -59.1 -49.92 76.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.782 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 16.0 mt -53.15 -52.86 57.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.59 66.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -76.34 -42.38 45.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 268' ' ' LYS . 3.2 pptp? -87.28 -19.64 27.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.439 ' NE2' ' CZ ' ' A' ' 124' ' ' PHE . 0.7 OUTLIER -73.84 30.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 109.382 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 266' ' ' LYS . 11.9 ptmt -177.76 48.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.622 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.441 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.585 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.68 154.94 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -1.111 . . . . 0.0 109.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.505 ' CD ' HD22 ' A' ' 86' ' ' ASN . 76.1 mt-10 -57.55 138.62 55.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.296 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 145.39 48.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.487 -0.758 . . . . 0.0 109.541 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -141.37 -173.95 3.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.9 m -96.19 135.69 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 0.0 109.212 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -66.49 -23.0 66.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.482 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 9.9 pt-20 -150.83 156.08 40.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 142.09 58.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 110.249 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -119.73 163.35 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 p -134.55 142.0 46.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.0 110.183 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 26' ' ' LEU . 96.8 m-85 -139.21 146.32 40.35 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -153.06 150.63 29.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.354 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.16 174.79 36.65 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.5 p -84.06 154.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.254 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -88.81 139.94 15.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.2 tt -60.82 -37.0 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -1.168 . . . . 0.0 110.558 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.579 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 78.0 m-70 -89.58 -51.72 5.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.631 -1.293 . . . . 0.0 111.396 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 p -70.0 -23.25 63.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.701 -0.624 . . . . 0.0 111.653 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.78 20.14 46.34 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.182 -1.485 . . . . 0.0 109.6 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -111.83 154.03 25.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -1.118 . . . . 0.0 109.563 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.24 135.59 42.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.169 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.3 m -139.37 144.52 38.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.03 . . . . 0.0 109.845 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.96 155.7 23.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.448 -0.782 . . . . 0.0 109.668 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.667 HD11 HG23 ' A' ' 96' ' ' ILE . 8.6 mt -135.74 148.26 48.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.58 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.9 mt -143.58 112.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 108.928 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.86 114.91 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.42 -0.8 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.58 ' NE2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -107.83 139.17 20.36 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 26.8 Cg_exo -52.82 168.23 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.849 1.699 . . . . 0.0 111.822 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' OE1' HG21 ' A' ' 35' ' ' THR . 20.1 mm-40 -142.23 174.74 10.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.541 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -85.91 155.11 21.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -49.62 146.95 3.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.961 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 71.03 -0.54 29.72 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.978 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.8 m -65.43 -42.39 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.556 -1.555 . . . . 0.0 109.481 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 93.6 -177.36 37.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mm -99.52 115.31 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -137.5 151.5 48.51 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.993 -1.067 . . . . 0.0 110.498 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.17 157.57 16.48 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -129.99 110.69 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.853 . . . . 0.0 108.995 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -134.69 133.81 40.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.596 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 48.38 34.31 4.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.59 -0.694 . . . . 0.0 111.59 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 17.04 80.26 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.472 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.89 120.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.105 . . . . 0.0 108.836 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 39.8 m-85 -86.84 129.14 35.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.187 -0.946 . . . . 0.0 109.734 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.43 96.97 50.48 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.647 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.25 146.43 31.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.229 1.953 . . . . 0.0 111.623 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -78.97 70.28 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.982 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 49' ' ' ARG . 6.7 mtt-85 -127.22 171.55 11.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 0.0 109.003 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -73.25 -49.17 29.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.591 ' OE1' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mp0 -43.53 -17.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.889 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.4 m-85 -97.89 2.96 49.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.208 . . . . 0.0 109.938 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 50' ' ' HIS . 66.9 t -74.06 129.07 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.372 -0.83 . . . . 0.0 108.781 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.74 -25.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.885 . . . . 0.0 110.281 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 t-80 -150.37 130.02 13.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.692 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.734 HG21 HG21 ' A' ' 257' ' ' VAL . 34.3 p -123.79 96.04 4.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 49.3 t30 -158.42 128.49 5.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 42.1 m80 46.54 13.12 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.89 152.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.796 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.8 m -96.24 128.16 42.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 55' ' ' HIS . 0.9 OUTLIER -120.28 148.67 43.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.652 0.739 . . . . 0.0 110.878 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 72' ' ' VAL . 10.8 mt -125.54 146.81 49.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.84 151.12 22.06 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.01 -1.567 . . . . 0.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -160.0 148.89 17.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.981 . . . . 0.0 109.145 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.09 26.39 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.858 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.53 -32.5 6.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 9.0 mm-40 -57.38 140.25 50.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.149 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 134.09 40.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.849 . . . . 0.0 110.305 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.53 120.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -100.94 157.11 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.046 . . . . 0.0 111.119 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.0 m 48.97 75.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 62' ' ' LEU . 22.7 m -107.72 -10.56 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 109.318 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.0 pm0 -60.79 -24.3 65.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.556 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.414 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -68.68 -68.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.126 -0.984 . . . . 0.0 109.232 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.1 tp -52.1 -48.11 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.7 mt -52.79 -46.92 67.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 22.5 t -61.91 -43.24 99.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.432 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.82 -46.76 83.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.021 -1.05 . . . . 0.0 109.071 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.39 -34.42 78.26 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -63.29 -34.78 78.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.631 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 171' ' ' GLU . 59.3 mt -81.6 -38.82 25.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 110.289 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 82' ' ' LEU . 63.7 mt -81.13 -0.39 39.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 0.0 110.005 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 61.53 39.84 14.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 111.383 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.81 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.698 -1.251 . . . . 0.0 108.026 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -123.73 -24.1 4.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 0.0 111.792 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.708 ' O ' HG13 ' A' ' 87' ' ' VAL . 45.0 m-80 -123.84 107.18 11.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.917 -1.115 . . . . 0.0 110.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -164.35 148.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 110.468 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 99.3 m -115.54 113.04 23.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.481 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -95.36 100.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.184 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' O ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -73.6 126.73 30.95 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.54 128.21 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.98 0.895 . . . . 0.0 111.895 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.81 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.11 -159.78 27.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 -11.3 10.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.25 149.88 41.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.995 -1.066 . . . . 0.0 109.535 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.667 HG23 HD11 ' A' ' 26' ' ' LEU . 43.9 mm -72.96 120.93 83.56 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -40.51 120.45 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.782 1.655 . . . . 0.0 111.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.8 tp -76.62 -14.21 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.913 . . . . 0.0 110.476 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 mt 56.84 -118.43 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.029 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.86 6.75 47.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.23 59.48 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 p -128.76 -172.25 2.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.666 -0.902 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.3 15.2 9.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 2.7 t-105 -57.59 -42.44 83.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.272 -1.134 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.11 -57.2 9.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 110.122 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.42 -46.33 62.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.09 -54.08 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 0.0 110.821 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 2.9 mm-40 -60.44 -43.76 96.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.02 . . . . 0.0 111.53 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.67 -56.91 8.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.252 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.73 -32.83 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.158 -0.963 . . . . 0.0 109.383 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER -64.18 -42.72 96.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.6 13.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 110.041 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' OE2' ' A' ' 9' ' ' GLU . 15.7 m-80 -144.58 33.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 0.0 110.336 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 82' ' ' LEU . 66.2 mt -79.81 138.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.28 123.35 29.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.23 148.3 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.476 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 21.6 mt-30 -115.62 -171.82 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -111.67 69.0 0.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -165.32 130.92 2.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.003 -1.061 . . . . 0.0 109.691 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.53 144.46 53.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.528 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.16 149.37 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.568 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -93.09 78.17 4.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.4 m-85 -58.1 140.67 52.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 109.409 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -88.87 101.44 14.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 243' ' ' LYS . 41.0 t -92.68 134.3 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.528 0.68 . . . . 0.0 110.772 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.52 116.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.42 -27.01 16.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.528 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -130.74 149.76 74.53 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.15 150.0 41.91 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.589 2.192 . . . . 0.0 112.017 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.803 HD12 ' HZ1' ' A' ' 266' ' ' LYS . 1.4 tt -157.37 151.01 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 142.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 0.0 109.513 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.93 145.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -133.25 156.72 47.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.002 . . . . 0.0 110.459 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -166.04 98.91 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.485 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 46.02 65.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 110.848 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.2 -38.02 3.0 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.89 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.9 mtt85 -65.44 133.67 51.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.862 -1.375 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.734 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.7 tt -146.58 138.92 24.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.053 -1.029 . . . . 0.0 109.973 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 255' ' ' LEU . 69.2 mt -135.57 125.87 42.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.458 -0.776 . . . . 0.0 109.523 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -114.3 133.44 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.532 0.682 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.29 133.61 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.08 151.56 48.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.787 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -50.14 143.23 25.94 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.382 2.055 . . . . 0.0 113.392 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.41 145.78 20.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -68.61 -5.01 17.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 110.488 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 p -148.45 -175.24 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.069 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.2 tp -98.32 120.06 38.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.084 -1.01 . . . . 0.0 108.702 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' N ' HD12 ' A' ' 147' ' ' LEU . 38.4 tt0 -137.27 122.84 19.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 108.553 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 231' ' ' LEU . 76.7 t -122.37 122.58 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.723 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -113.52 152.22 30.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -139.64 130.47 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.964 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.56 129.95 54.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.53 141.2 12.52 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.266 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -105.64 104.11 13.77 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -93.65 166.95 11.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -14.89 17.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.734 . . . . 0.0 110.485 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 159' ' ' LEU . 29.9 p-10 -93.96 -171.38 2.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.869 -1.144 . . . . 0.0 110.265 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -52.91 3.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.449 -0.782 . . . . 0.0 111.704 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.9 mt -83.35 -29.36 28.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.321 -1.487 . . . . 0.0 109.06 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.43 -140.67 36.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 134.41 38.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -1.145 . . . . 0.0 109.491 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -138.03 148.72 45.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.296 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -141.26 145.05 35.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.934 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -144.63 139.34 27.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.7 m -109.78 124.63 51.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 110.156 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.537 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.5 t80 -104.08 113.07 26.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.273 -0.892 . . . . 0.0 109.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.53 156.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -50.86 133.12 26.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.266 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.83 3.76 60.62 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 170' ' ' ASN . 3.4 m-20 -117.53 20.25 13.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 109.153 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -55.89 -56.57 18.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.291 -0.881 . . . . 0.0 110.017 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 171' ' ' GLU . 1.8 mt-10 -42.52 -25.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.545 ' O ' ' CZ ' ' A' ' 225' ' ' ARG . 12.5 mt-10 -80.74 -7.85 59.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 111.924 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.74 -25.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.663 -1.273 . . . . 0.0 111.817 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 175' ' ' VAL . 4.5 m -62.77 -15.88 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.456 -1.403 . . . . 0.0 109.175 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.4 mt -92.27 -6.43 50.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.46 -0.775 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.448 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -67.43 116.19 7.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.173 -0.954 . . . . 0.0 108.847 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.507 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 74.5 mtm180 -77.57 172.84 12.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.516 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 t -77.25 162.28 27.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -146.81 149.07 32.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.21 -1.556 . . . . 0.0 111.493 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -148.18 157.06 43.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -98.97 146.97 25.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.537 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.11 -38.11 16.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.488 -0.757 . . . . 0.0 109.86 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -72.29 -28.9 63.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.827 -1.171 . . . . 0.0 109.605 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.0 mt-10 -71.93 -39.9 69.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.638 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.49 HD13 HB11 ' A' ' 500' ' ' C90 . 25.6 mt -47.37 -59.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.553 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 7.7 tp10 -41.81 -40.02 1.94 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.514 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 189' ' ' ILE . 13.3 t-160 -75.28 -60.89 2.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 108.887 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 188' ' ' HIS . 93.7 mt -41.85 -32.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.625 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -80.13 -52.07 8.22 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.764 -1.21 . . . . 0.0 109.193 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -48.17 -40.05 22.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 110.518 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.0 8.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.036 . . . . 0.0 110.522 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.74 39.65 54.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 194' ' ' LEU . 69.3 mt -129.64 172.81 11.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -1.111 . . . . 0.0 109.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.65 20.57 56.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -57.56 -20.55 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.365 -1.668 . . . . 0.0 109.878 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.431 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.55 25.18 11.33 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.22 129.38 9.64 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.99 -1.3 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -143.88 172.75 12.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 109.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.9 mt -71.26 -7.8 49.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -99.35 -11.54 21.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.442 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 17.0 p30 -133.53 8.49 3.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 109.999 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.1 m -150.28 151.52 33.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.0 tp -99.5 93.93 6.14 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -85.34 128.96 38.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.832 0.825 . . . . 0.0 109.119 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 211' ' ' VAL . 15.6 mt -123.53 162.81 22.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.615 -0.678 . . . . 0.0 109.289 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.33 -166.73 13.03 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.77 71.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.491 -1.005 . . . . 0.0 109.458 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.83 21.66 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -147.58 155.88 42.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.64 -1.287 . . . . 0.0 110.355 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 206' ' ' LEU . 51.3 t -105.82 114.56 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -57.97 -47.02 84.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.046 -1.034 . . . . 0.0 109.904 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.86 121.83 61.12 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.139 -0.976 . . . . 0.0 109.768 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.87 -16.22 45.29 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.437 1.424 . . . . 0.0 111.794 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -15.12 59.54 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.63 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.47 -170.32 50.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.617 ' CD2' HD11 ' A' ' 204' ' ' LEU . 6.3 mt -86.78 131.12 34.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -1.213 . . . . 0.0 109.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -63.15 -17.78 62.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.122 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CD2' ' CZ ' ' A' ' 225' ' ' ARG . 62.3 m-85 -144.73 -168.88 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -100.65 -0.24 37.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.247 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 30.49 1.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.034 -1.041 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 mt-10 -46.26 -51.17 35.35 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.026 -1.047 . . . . 0.0 110.013 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 76.4 Cg_exo -47.4 -68.01 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.118 1.878 . . . . 0.0 112.278 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.4 m -57.33 -34.84 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.963 -1.086 . . . . 0.0 109.991 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' CZ ' ' CD2' ' A' ' 219' ' ' TYR . 5.0 mtp180 -60.53 -42.85 97.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 108.381 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 6.9 t60 -65.78 -33.02 74.9 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.88 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 166' ' ' PHE . 51.9 t -69.75 -36.77 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.531 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.4 t80 -65.98 -48.82 69.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.562 -0.711 . . . . 0.0 109.147 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.551 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 86.6 m-20 -65.0 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.804 . . . . 0.0 109.776 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.412 HD23 ' CG1' ' A' ' 149' ' ' VAL . 52.5 tp -75.02 -31.77 61.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.84 -39.37 81.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.95 -54.79 19.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.36 -35.62 67.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.055 -1.262 . . . . 0.0 109.279 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 235' ' ' LEU . 12.1 mt -61.11 -22.79 64.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 110.414 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.8 -22.28 60.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.164 . . . . 0.0 109.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.9 mt -50.93 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.639 -1.288 . . . . 0.0 110.6 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.2 mt -77.46 -14.85 59.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.831 -1.168 . . . . 0.0 109.643 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.78 57.67 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.563 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.16 155.07 10.23 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.374 . . . . 0.0 108.937 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.1 Cg_endo -50.02 151.02 9.25 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.825 1.684 . . . . 0.0 109.566 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.43 140.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 112.044 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.493 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.3 mmtp -121.86 119.12 30.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.9 -163.56 30.95 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.142 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.514 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -123.77 141.64 51.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -1.032 . . . . 0.0 109.078 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -139.6 139.64 36.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -127.02 118.38 24.35 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 133.83 53.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.005 -1.059 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -115.47 112.16 21.84 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.36 28.68 2.44 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.61 149.13 42.99 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -121.78 -174.2 14.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.463 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.2 m-70 -63.74 -41.38 98.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.094 . . . . 0.0 109.741 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -58.63 6.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.032 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.532 HD23 HG13 ' A' ' 139' ' ' ILE . 5.7 tp -55.29 -45.07 76.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.202 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 22.2 m-20 -47.73 -51.56 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.432 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.734 HG21 HG21 ' A' ' 56' ' ' THR . 90.8 t -63.18 -42.27 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -61.41 -52.86 62.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -50.34 -49.63 53.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.091 -1.006 . . . . 0.0 108.423 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.54 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.1 t -58.03 -52.18 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -50.76 -49.52 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -61.54 -51.24 69.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.791 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.98 -48.45 75.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 109.738 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.34 71.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 109.801 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -67.35 -40.26 85.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 108.954 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.803 ' HZ1' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -67.79 -66.21 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.449 -0.782 . . . . 0.0 109.028 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -42.93 -46.27 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.403 -0.811 . . . . 0.0 109.507 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 265' ' ' LYS . 10.4 mmmt -94.07 110.83 22.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 109.529 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.551 ' C22' ' OD2' ' A' ' 230' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 121' ' ' ILE . 84.2 mt -101.67 153.81 19.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -1.11 . . . . 0.0 109.578 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.596 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -53.18 129.02 29.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -120.91 142.07 50.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.182 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 t -141.94 -170.57 3.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.66 136.45 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -62.85 -20.48 65.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -152.15 -171.12 3.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.222 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 142.14 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.09 160.23 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.14 145.2 41.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.996 -1.065 . . . . 0.0 110.698 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 73.3 m-85 -139.83 155.09 47.43 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.05 151.69 19.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.809 -1.182 . . . . 0.0 110.319 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.43 174.77 36.1 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.85 151.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 110.128 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.63 137.98 16.38 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.0 tt -58.95 -39.06 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.105 -1.232 . . . . 0.0 110.452 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' ILE . 79.8 m-70 -90.74 -50.65 5.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.724 -1.235 . . . . 0.0 110.966 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -70.31 -22.68 62.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.68 -0.638 . . . . 0.0 111.091 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.75 17.48 21.22 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.686 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -105.26 151.25 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -1.151 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -74.77 132.87 41.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.177 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 145.31 40.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 5.7 ttmt -113.02 156.42 23.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -133.4 147.01 51.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.594 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.2 mt -141.38 108.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.917 . . . . 0.0 108.738 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.25 115.44 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 111.122 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.594 ' NE2' HG22 ' A' ' 27' ' ' ILE . 33.3 m-70 -111.12 139.81 22.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.578 -0.701 . . . . 0.0 109.689 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -52.57 168.33 0.46 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.048 1.832 . . . . 0.0 111.854 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 16.4 mm-40 -141.02 -178.97 5.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.162 -0.961 . . . . 0.0 109.798 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.6 mttm -89.45 154.4 20.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -47.62 142.46 4.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.329 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.11 11.22 63.44 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.466 -0.874 . . . . 0.0 110.949 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -72.02 -44.87 62.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.605 -1.526 . . . . 0.0 109.752 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -179.88 33.77 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.379 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mm -95.67 117.97 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 148.24 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.86 158.87 15.5 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -129.9 110.58 11.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 0.0 108.874 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' NZ ' ' H ' ' A' ' 93' ' ' GLY . 64.6 tttp -135.06 134.6 40.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 110.737 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.05 29.52 10.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.784 . . . . 0.0 111.341 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.56 17.27 77.94 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.355 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -1.126 . . . . 0.0 109.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -83.66 127.36 33.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.0 mt -115.48 93.81 37.76 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 109.436 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.55 145.8 16.07 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.412 2.075 . . . . 0.0 111.948 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -89.38 79.76 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -134.18 -179.89 5.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -74.99 -55.25 5.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 110.01 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 33.4 mt-10 -43.55 -17.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.795 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' HIS . 35.5 m-85 -95.17 0.62 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.884 -1.135 . . . . 0.0 110.104 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.8 t -68.48 129.46 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.415 -0.803 . . . . 0.0 109.173 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -112.38 -29.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.322 -0.861 . . . . 0.0 109.977 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -152.26 132.98 14.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.036 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 HG21 ' A' ' 257' ' ' VAL . 47.8 p -123.65 95.46 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 59' ' ' SER . 47.7 t-20 -162.95 129.21 3.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 108.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 84.6 m-70 48.97 10.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.056 -1.027 . . . . 0.0 108.711 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 163.0 157.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.9 m -102.86 127.76 49.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -121.33 152.37 39.05 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 111.024 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.9 mt -128.14 152.18 48.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.31 151.86 21.96 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 118.824 -1.655 . . . . 0.0 110.956 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CD2' ' CD ' ' A' ' 65' ' ' LYS . 9.4 t80 -156.51 146.29 20.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -1.03 . . . . 0.0 109.676 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CD ' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 54.73 21.79 3.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.528 -0.732 . . . . 0.0 109.638 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.88 8.17 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -62.96 145.24 55.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.318 . . . . 0.0 109.343 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.91 142.86 34.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 110.333 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.13 125.94 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -100.21 156.67 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.081 . . . . 0.0 111.217 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m 49.27 73.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.071 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 34.4 m -107.78 -8.46 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 108.957 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.4 pm0 -61.02 -26.66 67.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.599 -0.688 . . . . 0.0 110.539 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.1 m170 -68.07 -68.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.941 -1.099 . . . . 0.0 109.46 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -52.14 -47.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.605 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.2 mt -53.4 -48.33 68.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.461 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.6 t -59.66 -41.99 91.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.058 -1.026 . . . . 0.0 110.244 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.8 -44.02 89.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 109.168 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.29 -34.92 79.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -62.91 -38.88 92.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 171' ' ' GLU . 50.2 mt -75.72 -38.07 58.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 114' ' ' ILE . 80.7 mt -83.22 -1.46 53.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.978 . . . . 0.0 109.891 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 41.5 mt-10 55.75 42.24 29.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.385 -0.822 . . . . 0.0 111.121 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 5' ' ' LYS . 46.0 mm -84.87 141.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.946 -1.096 . . . . 0.0 108.096 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 121' ' ' ILE . 72.5 p -123.79 -23.71 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 0.0 112.027 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.675 ' O ' HG13 ' A' ' 87' ' ' VAL . 80.4 m-20 -125.98 107.66 10.66 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.698 -1.251 . . . . 0.0 110.688 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.5 m -162.95 149.14 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.829 0.824 . . . . 0.0 110.442 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 45.2 m -116.71 113.77 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.497 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.7 mt -96.65 100.92 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.467 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 11.7 mt-10 -70.24 124.57 24.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 44.2 t -107.96 119.0 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.587 0.708 . . . . 0.0 111.507 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mt -108.85 93.38 2.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' H ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.63 160.52 8.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -81.05 -5.55 57.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.914 -1.345 . . . . 0.0 111.091 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -142.06 149.11 39.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.602 -1.311 . . . . 0.0 110.276 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 26' ' ' LEU . 46.4 mm -73.89 121.82 86.1 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -41.52 127.81 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.585 1.523 . . . . 0.0 111.282 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.408 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -81.76 -15.94 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.879 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.8 mt 58.1 -120.62 1.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.12 -0.988 . . . . 0.0 110.081 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 46.4 t0 -97.49 5.81 49.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.62 60.11 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.384 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.4 p -127.86 -172.62 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.896 . . . . 0.0 109.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.1 15.83 10.14 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.533 ' HB2' HD22 ' A' ' 176' ' ' LEU . 6.1 t-105 -60.26 -43.56 96.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.48 -1.012 . . . . 0.0 110.317 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.71 -58.59 6.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.024 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.29 -45.16 62.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -61.9 -49.29 76.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 111.22 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CD ' ' CH2' ' A' ' 104' ' ' TRP . 1.6 mm-40 -65.5 -42.36 92.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.019 -1.05 . . . . 0.0 111.236 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.92 -54.2 24.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.017 -1.052 . . . . 0.0 110.286 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.29 -32.56 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -64.42 -42.55 95.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -76.16 12.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.74 32.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.165 . . . . 0.0 110.545 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 HD22 ' A' ' 82' ' ' LEU . 77.5 mt -80.32 138.96 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.932 -1.105 . . . . 0.0 110.265 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.52 125.53 34.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.546 -0.721 . . . . 0.0 109.157 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -78.27 145.42 35.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.352 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -115.06 -173.53 2.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.688 -0.632 . . . . 0.0 109.404 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.55 65.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.293 -0.879 . . . . 0.0 111.268 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.502 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -161.49 129.31 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 0.0 109.043 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -68.38 141.1 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 109.163 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 3' ' ' LEU . 85.4 mt -82.16 147.77 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 110.427 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -95.66 84.12 3.88 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 55.1 m-85 -62.82 143.93 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -90.43 101.96 14.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 243' ' ' LYS . 55.1 t -93.05 133.62 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.699 . . . . 0.0 111.193 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.47 115.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -98.78 -26.81 14.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 110.576 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.02 148.43 65.72 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.36 148.35 38.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.493 2.129 . . . . 0.0 111.899 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.29 152.27 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.957 . . . . 0.0 109.363 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.83 146.45 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.212 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.18 147.09 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -135.19 162.63 31.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.984 -1.072 . . . . 0.0 110.515 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -173.9 103.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 50.58 58.66 5.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 110.725 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.44 -32.59 2.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.517 HH21 ' H ' ' A' ' 252' ' ' GLY . 42.7 mtp180 -61.91 134.12 56.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.245 . . . . 0.0 108.26 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -146.1 137.79 24.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.77 -1.206 . . . . 0.0 110.446 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.727 HG21 HD22 ' A' ' 259' ' ' LEU . 79.6 mt -135.62 131.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.476 -0.765 . . . . 0.0 109.353 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -121.37 131.09 53.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.369 0.604 . . . . 0.0 109.839 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.88 134.62 54.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 151.07 47.31 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.131 -0.981 . . . . 0.0 109.659 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.71 143.27 12.87 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.481 2.121 . . . . 0.0 113.22 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.407 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -157.32 147.08 20.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.61 -6.6 26.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -148.66 178.68 8.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.942 -1.098 . . . . 0.0 109.741 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.4 tp -91.98 120.8 32.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.996 . . . . 0.0 108.709 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 167' ' ' VAL . 2.0 tt0 -135.73 129.72 33.07 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.4 t -129.87 120.73 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.507 ' OG1' HG23 ' A' ' 165' ' ' THR . 47.6 m -112.3 152.29 28.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.461 -0.774 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 228' ' ' VAL . 38.8 t80 -139.46 130.74 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.176 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.444 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 23.2 tt0 -120.84 130.36 53.92 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.22 137.79 9.57 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.465 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -103.06 100.14 10.06 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.21 166.93 13.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.008 . . . . 0.0 110.833 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -99.67 -18.56 17.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.563 -0.711 . . . . 0.0 110.652 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.4 p-10 -92.3 -170.0 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.227 . . . . 0.0 110.22 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -52.77 0.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 111.398 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.1 mt -79.02 -28.01 43.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.401 -1.437 . . . . 0.0 108.734 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.66 -138.48 33.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -101.93 134.64 44.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.233 -1.157 . . . . 0.0 109.671 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -138.53 151.72 47.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -141.09 144.8 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.76 135.29 27.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.507 HG23 ' OG1' ' A' ' 150' ' ' THR . 57.3 m -105.03 121.93 44.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.698 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.7 t80 -102.66 113.12 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.449 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.9 t -104.22 148.75 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.767 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -49.36 131.26 20.35 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.261 -0.899 . . . . 0.0 109.026 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.7 -3.63 39.33 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 1.3 m-20 -114.6 24.46 11.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 0.0 109.183 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 81' ' ' LEU . 1.1 mt-10 -50.87 -56.48 12.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.293 -0.88 . . . . 0.0 109.882 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -44.62 -23.45 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.306 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' GLU . 6.6 mt-10 -83.24 -12.72 56.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 111.537 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.9 pt -121.44 -28.26 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.862 -1.149 . . . . 0.0 111.2 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.1 m -63.66 -27.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.556 -1.34 . . . . 0.0 109.395 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -78.52 -6.0 54.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.414 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.68 124.66 24.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.684 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.475 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -88.71 172.17 9.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -78.57 162.32 26.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.55 146.07 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.125 -1.609 . . . . 0.0 111.836 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.548 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -144.5 157.72 44.1 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.453 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 77.3 m-85 -100.96 147.77 25.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.414 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 22.8 p30 -54.23 -33.29 58.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 110.022 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.551 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 7.0 p90 -72.35 -28.76 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.818 -1.176 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.525 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -81.84 -37.33 27.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.099 -1.001 . . . . 0.0 109.985 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 183' ' ' ASP . 94.3 mt -45.53 -59.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.966 -1.084 . . . . 0.0 109.475 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 14.9 tt0 -41.32 -39.4 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 109.763 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.507 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.7 t-160 -73.94 -44.38 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.769 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 98.2 mt -57.72 -27.59 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.555 -0.716 . . . . 0.0 109.579 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -84.67 -53.59 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.883 -1.136 . . . . 0.0 109.317 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -49.24 -42.48 40.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.1 m -75.68 6.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.978 -1.076 . . . . 0.0 110.294 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.41 39.65 50.32 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 55.0 mt -128.77 172.09 11.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.225 -1.162 . . . . 0.0 109.855 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 62.41 20.79 61.53 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -54.17 -21.51 9.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.636 -1.508 . . . . 0.0 109.85 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -115.35 25.8 9.56 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.07 124.31 7.1 Favored Glycine 0 N--CA 1.491 2.362 0 O-C-N 120.819 -1.401 . . . . 0.0 109.703 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.28 172.74 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.8 mt -69.13 -7.91 40.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 6.2 mmmt -91.58 -12.17 35.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.832 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -143.46 13.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.917 -1.114 . . . . 0.0 110.421 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -148.39 149.65 32.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.857 -1.152 . . . . 0.0 110.82 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.445 HD21 HD22 ' A' ' 217' ' ' LEU . 26.0 tp -99.11 93.51 6.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.436 HG23 HG22 ' A' ' 203' ' ' THR . 47.5 t -86.81 129.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.868 0.842 . . . . 0.0 109.336 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.26 164.76 18.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.19 -166.45 12.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -26.44 68.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.499 -1.0 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.64 21.89 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -143.33 150.82 39.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.755 -1.215 . . . . 0.0 110.518 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.26 111.72 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -57.79 -51.37 69.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 110.236 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -57.62 111.66 3.75 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -58.36 -11.77 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.699 1.599 . . . . 0.0 111.772 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -17.28 59.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 110.2 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.7 -177.79 46.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.9 mt -88.81 143.28 27.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.767 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.596 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 37.1 mtp85 -73.46 -20.01 60.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.602 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 17.2 m-85 -146.83 169.81 18.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -82.28 10.77 6.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 38.11 0.49 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.407 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -55.08 -47.42 98.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.94 -1.1 . . . . 0.0 109.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 54.3 Cg_exo -50.53 -65.37 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.3 m -58.7 -36.34 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.602 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 60.7 mtt180 -60.48 -42.85 97.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.2 t60 -66.42 -32.48 73.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.355 -0.841 . . . . 0.0 108.964 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -65.66 -35.49 80.93 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.6 t -68.64 -36.73 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.461 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 61.6 t80 -65.24 -52.6 53.48 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.501 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 88.1 m-20 -62.93 -29.7 70.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.842 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 149' ' ' VAL . 58.7 tp -74.79 -32.85 62.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.029 -1.044 . . . . 0.0 108.536 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.53 -40.85 85.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.41 -53.92 32.72 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.459 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 24.7 m-20 -56.79 -30.57 63.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.062 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.5 mt -67.11 -24.44 65.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 110.481 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.66 -22.36 60.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.813 -1.18 . . . . 0.0 109.095 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.2 mt -49.16 -6.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.516 -1.365 . . . . 0.0 110.063 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.4 mt -72.28 -16.12 61.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.908 -1.12 . . . . 0.0 109.63 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.63 2.24 60.04 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.794 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.39 153.88 9.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.779 -1.424 . . . . 0.0 108.984 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -49.34 150.5 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.787 1.658 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.48 148.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.009 -1.057 . . . . 0.0 111.861 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.439 ' HB2' HG22 ' A' ' 125' ' ' VAL . 29.2 mmtt -128.92 122.95 31.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.34 -163.86 31.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 144' ' ' SER . 10.3 ttpt -126.07 139.62 53.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 109.652 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 35.1 m-85 -136.4 139.43 42.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.444 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 56.8 t80 -126.19 125.36 42.31 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.3 m -120.36 136.77 54.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 0.0 111.579 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -118.28 113.14 21.02 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 47.59 47.35 17.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.13 150.57 23.95 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 137' ' ' ARG . . . -122.66 178.53 16.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.459 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.9 m-70 -61.92 -38.26 87.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -1.19 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 11.0 m -60.08 -60.01 4.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.023 -1.048 . . . . 0.0 109.004 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.613 ' HG ' HD12 ' A' ' 139' ' ' ILE . 24.4 tp -52.0 -47.59 64.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.09 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 19.7 m-20 -48.02 -50.9 26.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 56' ' ' THR . 73.9 t -60.84 -54.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.997 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.474 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -50.8 -45.33 59.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.668 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.727 HD22 HG21 ' A' ' 139' ' ' ILE . 13.9 tp -54.12 -55.44 27.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.02 . . . . 0.0 108.56 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.2 t -56.81 -55.32 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.077 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 260' ' ' VAL . 0.1 OUTLIER -44.95 -48.51 11.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.1 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.22 -52.76 63.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.403 -0.811 . . . . 0.0 109.485 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.09 -50.09 59.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.28 -27.03 63.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.507 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -73.54 -58.45 3.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 110.663 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -62.45 -37.58 86.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.92 -1.112 . . . . 0.0 109.744 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -48.75 -13.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 266' ' ' LYS . 0.3 OUTLIER -132.79 120.49 21.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 109.372 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.548 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.6 mt -75.63 146.73 40.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.199 -1.177 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -52.5 142.27 18.19 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -123.05 144.73 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.33 -170.55 3.3 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.9 m -98.49 136.63 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.89 -1.131 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -67.57 -19.68 65.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 110.078 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -154.23 156.33 36.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 138.06 58.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 109.809 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -118.77 163.99 16.05 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.48 142.23 48.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.91 150.18 46.85 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 9.6 pt-20 -158.91 151.28 21.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.926 -1.109 . . . . 0.0 109.923 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.55 173.66 35.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.44 148.34 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.232 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.67 137.07 16.21 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' A' ' 98' ' ' ILE . 10.1 tt -59.09 -37.84 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.052 -1.263 . . . . 0.0 110.298 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 70.5 m-70 -88.85 -50.17 6.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.687 -1.258 . . . . 0.0 110.925 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 p -69.69 -20.76 63.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 111.544 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.36 12.88 6.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.15 156.61 18.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -1.018 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 67.4 t80 -74.39 135.11 42.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -138.41 144.09 40.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.88 155.16 24.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG23 ' A' ' 96' ' ' ILE . 9.0 mt -135.87 146.41 47.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.35 -0.844 . . . . 0.0 109.953 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.509 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 mt -141.43 112.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 108.638 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.91 113.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 110.466 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.7 m-70 -107.47 137.72 19.74 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.0 Cg_exo -54.77 168.73 1.02 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.685 1.59 . . . . 0.0 111.515 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 35' ' ' THR . 77.6 mm-40 -141.04 176.09 9.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.955 . . . . 0.0 109.769 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 18.6 mmtp -87.08 155.18 20.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -46.46 141.69 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.769 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 70.85 9.2 65.54 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.27 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.752 ' H ' HD22 ' A' ' 86' ' ' ASN . 53.5 m -71.53 -44.16 65.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.476 -1.602 . . . . 0.0 109.461 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.28 -179.87 35.1 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.512 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 mm -97.69 115.63 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -139.92 154.45 47.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.914 -1.116 . . . . 0.0 110.333 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -102.79 158.36 16.32 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -129.68 111.73 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.296 -0.878 . . . . 0.0 108.981 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -135.41 134.75 40.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.839 . . . . 0.0 110.621 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.495 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.7 m120 50.37 32.74 6.67 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 111.47 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 17.39 79.95 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.427 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -123.22 120.94 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.055 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -82.41 126.81 32.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.443 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.42 92.07 31.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.458 -0.777 . . . . 0.0 109.201 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.81 146.14 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.502 2.135 . . . . 0.0 112.287 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.35 70.24 10.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -122.86 166.89 14.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 109.448 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.6 p-80 -68.94 -53.85 18.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.618 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -44.99 -16.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' HIS . 41.1 m-85 -95.44 3.4 54.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 50' ' ' HIS . 69.1 t -70.47 129.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 108.719 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.53 -29.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.841 . . . . 0.0 110.225 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.12 131.53 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.74 HG21 HG21 ' A' ' 257' ' ' VAL . 45.9 p -123.18 95.12 4.48 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' SER . 48.5 t30 -163.33 130.68 3.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.531 ' O ' ' CB ' ' A' ' 59' ' ' SER . 27.2 m80 50.46 8.8 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.041 -1.037 . . . . 0.0 108.848 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.9 157.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.54 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 36.2 m -100.55 127.71 46.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 109.254 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.78 151.85 41.23 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.799 0.809 . . . . 0.0 111.171 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.4 mt -126.42 151.21 48.01 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.37 156.56 28.4 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.568 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -164.7 151.89 11.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -1.069 . . . . 0.0 109.273 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 53.1 21.66 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.256 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.09 7.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 85.7 mm-40 -60.64 148.15 39.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -1.209 . . . . 0.0 109.451 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.42 HH21 ' HD2' ' A' ' 70' ' ' LYS . 9.6 ttp-105 -144.48 140.81 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.478 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.82 126.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HD2' HH21 ' A' ' 68' ' ' ARG . 15.1 mtpp -101.47 156.19 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.898 -1.126 . . . . 0.0 111.299 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.2 m 50.93 74.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.4 m -108.2 -10.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.579 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.34 -28.56 69.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -64.8 -68.88 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.886 -1.134 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.39 -48.12 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.12 -0.987 . . . . 0.0 109.28 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.623 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.1 mt -50.88 -50.3 57.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.953 -1.092 . . . . 0.0 110.286 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 9.4 t -60.48 -42.81 97.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 110.164 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.71 -45.32 79.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.4 mt -68.16 -35.0 77.35 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.082 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.1 -31.77 72.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.848 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 171' ' ' GLU . 72.2 mt -83.34 -36.92 24.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 107' ' ' TYR . 87.3 mt -80.29 4.44 17.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.733 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 53.8 38.76 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.957 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.0 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 121' ' ' ILE . 72.6 p -126.13 -18.9 4.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.181 -0.949 . . . . 0.0 111.762 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.769 HD21 ' H ' ' A' ' 34' ' ' GLY . 3.0 m120 -126.98 107.9 10.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.843 -1.161 . . . . 0.0 110.956 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.7 m -163.95 148.18 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.377 -0.827 . . . . 0.0 109.971 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 27.9 m -117.06 110.04 17.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.526 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -94.08 103.73 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.6 tt0 -77.33 127.51 32.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.41 128.99 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.98 0.895 . . . . 0.0 111.734 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mm -112.2 95.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.44 -155.83 24.89 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.18 -10.45 9.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -1.107 . . . . 0.0 110.13 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -141.06 149.91 42.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.926 -1.109 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.697 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -72.68 121.66 85.52 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 109.182 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -41.15 127.26 2.83 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.641 1.561 . . . . 0.0 111.175 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -81.27 -12.61 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.5 mt 55.25 -121.15 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.4 9.32 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.927 -1.108 . . . . 0.0 111.192 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.49 -2.98 65.5 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.242 -1.456 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -172.09 2.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.625 -0.926 . . . . 0.0 109.628 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.1 15.72 12.11 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -56.39 -43.83 79.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -1.088 . . . . 0.0 110.232 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -57.46 8.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.089 -1.007 . . . . 0.0 110.143 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -51.68 -47.95 63.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 109.871 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 82' ' ' LEU . 57.9 t80 -61.59 -49.18 77.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 111.214 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.92 -43.02 89.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 111.368 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.77 -54.95 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.939 -1.101 . . . . 0.0 110.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.1 mt -63.45 -34.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 109.477 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -62.81 -41.72 99.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -78.07 12.83 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.822 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -142.54 31.17 1.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.971 -1.08 . . . . 0.0 110.327 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.3 mt -80.05 138.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 110.478 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 8' ' ' LYS . 8.3 tp -129.76 122.49 28.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 147.86 42.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.93 -174.87 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -110.62 66.36 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.137 -0.977 . . . . 0.0 111.222 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.4 129.52 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.865 -1.147 . . . . 0.0 109.379 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.42 141.55 56.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.783 -1.198 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 85' ' ' THR . 85.4 mt -84.2 150.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 110.266 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -97.46 81.89 3.03 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 31.2 m-85 -59.33 142.04 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -88.06 101.3 13.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.01 132.65 35.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.412 0.625 . . . . 0.0 110.643 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.93 111.17 2.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.56 -31.67 26.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.02 -1.05 . . . . 0.0 110.323 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 155.47 75.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.627 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.05 153.5 57.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.529 2.153 . . . . 0.0 112.103 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 tt -159.59 153.07 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -0.789 . . . . 0.0 109.273 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.36 141.89 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.92 150.05 33.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -135.76 158.93 43.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.61 106.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.929 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.9 51.55 15.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.25 3.32 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.146 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -61.61 137.4 58.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.963 -1.316 . . . . 0.0 108.639 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.9 tt -145.03 138.11 26.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 110.251 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 259' ' ' LEU . 48.3 mt -134.97 132.54 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.569 -0.707 . . . . 0.0 109.556 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -121.39 130.82 53.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.696 -0.628 . . . . 0.0 109.948 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.06 137.14 54.92 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -149.28 149.63 29.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.47 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 40.6 Cg_exo -47.74 143.73 12.26 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.491 2.127 . . . . 0.0 113.572 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.405 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -156.4 144.32 19.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -62.85 -5.4 2.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.61 -178.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 145' ' ' ASP . 12.6 p -154.04 -174.89 5.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 109.628 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.1 tp -93.76 122.04 35.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.132 -0.98 . . . . 0.0 108.933 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 mt-10 -135.86 126.63 27.38 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.1 t -129.82 123.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 m -113.68 152.62 30.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.684 -0.635 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -138.95 131.78 29.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.123 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -120.91 135.23 55.24 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 137.06 8.59 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.633 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.81 97.91 7.99 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.95 167.09 16.22 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 110.937 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -100.01 -15.25 18.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.6 p-10 -95.01 -168.18 1.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.125 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -57.16 2.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -0.787 . . . . 0.0 111.296 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.5 mt -79.03 -26.63 43.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.455 -1.403 . . . . 0.0 108.28 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.3 -137.53 37.68 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 131.25 45.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.4 -1.059 . . . . 0.0 109.295 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.22 146.23 44.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -0.792 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HZ2' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -142.26 148.01 37.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.371 -0.83 . . . . 0.0 110.366 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -146.53 140.39 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 110.044 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.1 m -107.21 123.41 48.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 109.732 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.462 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.4 t80 -103.06 112.8 25.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.902 . . . . 0.0 110.312 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.69 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.875 . . . . 0.0 109.673 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -48.16 134.38 14.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.413 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 107.58 -9.12 37.86 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -120.84 26.43 9.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.8 OUTLIER -68.25 -16.01 63.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.74 -8.84 57.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 0.0 109.894 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -106.15 -5.5 19.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.37 -33.38 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.32 -0.862 . . . . 0.0 109.632 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 171' ' ' GLU . 14.4 m -64.11 -23.67 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 108.395 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.75 -7.2 59.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.421 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.05 119.47 12.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -80.62 173.01 13.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 109.514 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.5 t -77.18 162.01 27.74 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -148.25 141.65 25.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.312 -1.492 . . . . 0.0 111.71 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.61 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -139.32 156.72 46.84 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -98.2 143.64 28.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.264 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.3 t0 -47.7 -35.32 9.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -0.85 . . . . 0.0 109.59 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.545 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -73.13 -29.87 63.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.883 -1.136 . . . . 0.0 109.681 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.545 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 4.6 tt0 -75.38 -41.21 56.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.651 HG21 HB21 ' A' ' 500' ' ' C90 . 49.5 mt -46.17 -56.71 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -0.983 . . . . 0.0 110.031 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.6 -40.08 1.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -76.19 -53.79 7.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.875 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.86 -26.8 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.452 -0.78 . . . . 0.0 109.624 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.98 -53.64 5.17 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.785 -1.197 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -47.58 -44.9 26.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 110.217 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.99 8.67 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.9 54.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.818 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 194' ' ' LEU . 50.9 mt -128.04 172.03 11.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -1.196 . . . . 0.0 109.687 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 57.39 24.83 53.41 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -60.14 -19.62 54.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.714 -1.462 . . . . 0.0 110.304 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -106.43 4.33 37.53 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.05 129.99 41.54 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.107 -1.231 . . . . 0.0 110.307 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.63 165.13 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.997 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.81 -8.4 43.1 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -97.09 -10.41 26.11 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.455 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 19.1 p-10 -140.3 9.82 2.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 m -145.27 147.09 31.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.106 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 206' ' ' LEU . 19.4 tp -97.8 93.86 6.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -88.45 130.51 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.569 0.7 . . . . 0.0 109.281 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 204' ' ' LEU . 18.3 mt -123.33 -178.46 4.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 109.605 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.95 -166.13 10.54 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -64.59 -20.75 66.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -1.104 . . . . 0.0 109.401 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.34 22.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.848 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -140.78 148.51 40.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.046 -1.033 . . . . 0.0 110.34 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.38 110.55 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -57.74 -45.22 86.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.987 -1.071 . . . . 0.0 109.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.8 118.82 45.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.642 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.23 -14.52 43.34 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.401 1.401 . . . . 0.0 112.017 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.85 -14.73 60.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.057 -1.027 . . . . 0.0 108.78 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.04 52.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.5 mt -86.14 134.99 33.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -1.206 . . . . 0.0 109.617 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -64.17 -19.58 65.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 108.824 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.663 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.5 m-85 -139.89 -164.16 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.118 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.65 -21.41 17.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.12 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 48.38 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.448 -0.783 . . . . 0.0 109.463 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.515 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -53.8 -47.92 95.19 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.995 . . . . 0.0 109.992 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.7 Cg_exo -48.67 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.164 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 225' ' ' ARG . 17.4 m -59.87 -36.76 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.976 -1.078 . . . . 0.0 109.666 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.663 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 74.8 mtt180 -60.09 -41.74 93.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 108.267 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.421 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 17.2 t60 -68.02 -30.56 69.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.905 . . . . 0.0 108.859 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.75 -36.0 82.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -68.48 -37.72 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.471 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.8 t80 -64.1 -52.1 60.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.546 -0.721 . . . . 0.0 109.175 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.25 -27.31 68.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.429 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.2 tp -76.74 -33.2 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.161 -0.962 . . . . 0.0 108.57 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.66 -38.81 79.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -57.58 9.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.492 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.4 m-20 -54.35 -37.26 64.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -1.211 . . . . 0.0 109.06 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 235' ' ' LEU . 10.3 mt -61.99 -24.68 67.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 0.0 110.271 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.2 t80 -72.85 -20.85 61.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.162 . . . . 0.0 109.35 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 237' ' ' LEU . 83.8 mt -50.67 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.858 -1.151 . . . . 0.0 110.591 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.9 mt -74.59 -14.23 60.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.779 -1.2 . . . . 0.0 109.854 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.17 1.69 59.41 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.575 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.1 m -164.94 153.11 10.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.259 . . . . 0.0 108.751 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.6 Cg_endo -50.06 150.4 10.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.806 1.671 . . . . 0.0 109.48 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.66 142.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.812 -1.18 . . . . 0.0 112.056 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -124.05 119.82 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.96 -165.94 32.33 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.525 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.2 tmtt? -123.39 142.06 51.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -1.022 . . . . 0.0 108.581 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 9.7 m-85 -139.52 142.16 37.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.981 -1.074 . . . . 0.0 110.63 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -126.28 132.56 51.64 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -126.93 137.7 53.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 111.145 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -119.32 116.83 27.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 47.09 28.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.182 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.0 153.31 52.89 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -134.52 170.39 22.71 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.579 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -49.92 -36.52 27.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -1.166 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.84 -58.19 9.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.701 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.414 HD23 ' CD1' ' A' ' 139' ' ' ILE . 8.6 tp -59.21 -45.02 92.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.071 -1.018 . . . . 0.0 109.444 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.5 m-20 -47.77 -51.39 22.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.566 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.74 HG21 HG21 ' A' ' 56' ' ' THR . 84.8 t -62.94 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.339 -0.85 . . . . 0.0 109.404 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -50.97 -51.07 56.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 109.209 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 139' ' ' ILE . 33.0 tp -51.26 -51.62 52.44 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 108.487 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.487 HG13 ' HG ' ' A' ' 238' ' ' LEU . 71.2 t -57.14 -53.86 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.948 . . . . 0.0 109.104 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -46.78 -41.66 15.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -70.98 -50.32 35.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.905 . . . . 0.0 109.802 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 38.2 mt -57.28 -47.64 80.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.05 75.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -68.75 -36.59 78.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.968 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.07 -64.4 0.86 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.327 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.67 -40.92 60.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.56 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 102.06 14.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.651 HB21 HG21 ' A' ' 186' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.05 159.75 18.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -1.131 . . . . 0.0 109.489 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.11 137.52 51.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.088 -1.008 . . . . 0.0 108.473 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -123.23 144.89 49.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -143.41 -168.85 2.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.97 136.31 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.05 -12.96 56.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.39 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 8.5 pt-20 -156.15 -172.71 4.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 141.92 28.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 mt -119.15 166.15 13.3 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.8 144.54 37.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 110.328 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 76.1 m-85 -140.0 156.23 46.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -163.59 149.23 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 109.581 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.95 173.35 35.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 p -79.32 150.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -1.074 . . . . 0.0 110.518 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.63 141.18 15.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.0 tt -60.67 -39.66 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -1.154 . . . . 0.0 111.189 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.2 m-70 -88.14 -49.44 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 111.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -72.18 -21.68 61.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.664 . . . . 0.0 111.842 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.27 16.88 22.29 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.08 -1.533 . . . . 0.0 109.558 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.48 156.14 20.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -1.152 . . . . 0.0 109.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.39 136.68 39.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.88 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -135.64 141.12 45.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.5 ttpt -110.36 155.71 21.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 109.723 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.3 mt -137.89 149.38 46.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.607 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -141.71 109.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.54 116.65 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.165 -0.96 . . . . 0.0 111.049 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.607 ' NE2' HG22 ' A' ' 27' ' ' ILE . 21.4 m-70 -112.77 139.75 23.19 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.442 -0.786 . . . . 0.0 109.542 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -54.26 168.59 0.91 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.895 1.73 . . . . 0.0 111.916 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.4 mm-40 -138.0 178.18 7.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.593 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.9 mtmm -87.16 152.76 22.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.981 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -48.36 146.21 2.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.642 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 68.35 8.49 55.44 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.729 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.733 ' H ' HD22 ' A' ' 86' ' ' ASN . 26.4 m -73.42 -45.84 52.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.608 -1.525 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.66 -178.92 30.2 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.662 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.4 mm -97.9 117.18 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -142.07 150.14 40.84 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' HD13 ' A' ' 89' ' ' ILE . 95.6 m-85 -99.7 157.12 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -129.69 110.72 12.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 108.974 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -135.96 135.97 40.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.582 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m120 51.03 28.17 3.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 111.183 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.23 74.76 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.024 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.95 120.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -1.065 . . . . 0.0 108.946 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.3 m-85 -86.86 129.0 35.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.066 -1.021 . . . . 0.0 109.169 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.129 ' CD1' HE21 ' A' ' 67' ' ' GLN . 52.8 mt -120.12 96.95 49.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.238 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -53.07 149.3 27.71 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.081 1.854 . . . . 0.0 111.101 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.7 72.16 10.36 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -127.55 175.61 8.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -73.19 -50.74 20.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -43.72 -17.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.184 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' HIS . 54.2 m-85 -98.2 0.07 45.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.128 . . . . 0.0 110.258 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.3 t -68.81 130.91 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 108.722 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG21 ' HG2' ' A' ' 68' ' ' ARG . 10.4 m -114.3 -28.7 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.326 -0.859 . . . . 0.0 110.088 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -152.81 131.62 12.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.956 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 257' ' ' VAL . 70.3 p -121.75 95.09 4.53 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.3 t-20 -163.11 128.74 3.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.399 -0.813 . . . . 0.0 109.064 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.523 ' O ' ' CB ' ' A' ' 59' ' ' SER . 27.3 m80 50.25 6.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.962 . . . . 0.0 109.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.573 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.1 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.7 m -81.38 129.18 34.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 0.0 109.247 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.92 150.43 42.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.357 -0.839 . . . . 0.0 111.172 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 72' ' ' VAL . 8.0 mt -126.0 147.66 49.48 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.69 160.41 32.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.248 -1.453 . . . . 0.0 110.243 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.24 149.58 10.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -1.123 . . . . 0.0 109.329 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.65 21.47 3.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.411 -0.805 . . . . 0.0 109.938 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.53 -30.94 8.95 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.681 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 1.129 HE21 ' CD1' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -70.78 145.06 50.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.763 -1.433 . . . . 0.0 108.855 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 4.7 mtt180 -137.46 149.76 47.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.019 -1.051 . . . . 0.0 111.874 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.732 ' CG1' HE22 ' A' ' 67' ' ' GLN . 12.9 mt -129.29 128.45 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -105.14 155.28 19.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.892 -1.13 . . . . 0.0 111.338 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.2 m 51.5 74.57 0.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.894 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.8 m -108.24 -9.58 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.037 -1.039 . . . . 0.0 109.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.0 pm0 -61.13 -26.8 67.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 110.689 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.43 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 25.4 m170 -66.88 -68.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.958 -1.089 . . . . 0.0 109.375 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -51.84 -47.64 40.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.048 -1.033 . . . . 0.0 109.058 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.9 mt -54.13 -47.42 71.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.889 -1.132 . . . . 0.0 110.478 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 25.2 t -60.23 -41.75 93.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.004 -1.06 . . . . 0.0 109.817 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -57.5 -45.81 85.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 108.955 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.97 -35.0 79.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 109.247 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.05 -40.25 97.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 0.0 109.202 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.0 mt -75.68 -38.48 58.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.22 -0.48 45.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.842 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 56.42 41.97 28.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 111.303 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.1 mm -88.33 138.47 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.741 -1.224 . . . . 0.0 108.158 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.433 HG21 HG12 ' A' ' 121' ' ' ILE . 70.7 p -126.56 -20.62 4.31 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.213 -0.929 . . . . 0.0 111.451 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.775 HD21 ' N ' ' A' ' 34' ' ' GLY . 3.3 m120 -124.2 106.45 10.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.02 -1.05 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -166.07 150.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.654 0.74 . . . . 0.0 110.2 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 55.8 m -117.11 114.61 23.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.415 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.3 mt -95.69 100.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.432 -0.792 . . . . 0.0 109.988 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -74.27 122.88 23.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 HD21 ' A' ' 26' ' ' LEU . 19.3 t -108.69 124.75 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.845 0.831 . . . . 0.0 111.906 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 25' ' ' LYS . 8.1 mt -108.4 96.22 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.52 -158.51 27.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -122.19 -11.68 8.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -1.111 . . . . 0.0 110.196 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -140.63 149.38 42.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -73.06 127.24 89.69 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.06 132.32 14.5 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.033 1.822 . . . . 0.0 111.276 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.91 -20.85 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.12 -0.987 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.9 mt 58.64 -119.69 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.91 4.71 49.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.908 -1.12 . . . . 0.0 110.95 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.78 0.04 56.45 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.332 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -172.28 2.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.718 -0.872 . . . . 0.0 109.676 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.84 13.17 9.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 47.9 t-105 -56.0 -40.54 73.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.44 -59.28 4.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 11.0 m-85 -51.3 -45.56 62.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CE2' ' HD2' ' A' ' 111' ' ' ARG . 64.7 t80 -60.68 -49.99 75.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.772 -0.58 . . . . 0.0 110.806 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 19.8 mm-40 -62.99 -43.36 99.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.245 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.05 6.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.703 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.1 -30.28 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.212 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.418 ' HD2' ' CE2' ' A' ' 107' ' ' TYR . 57.9 ttt180 -66.11 -44.37 84.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.412 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HG3' HD22 ' A' ' 113' ' ' ASN . 15.0 ptpt -76.36 8.72 3.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.882 -1.136 . . . . 0.0 110.431 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' OD1' ' OE1' ' A' ' 9' ' ' GLU . 8.0 m-80 -140.58 35.87 1.83 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.945 -1.097 . . . . 0.0 110.267 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.65 143.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.12 . . . . 0.0 110.88 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.9 tp -133.51 129.68 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.429 -0.795 . . . . 0.0 109.431 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.75 138.81 31.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -108.48 -173.53 2.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.73 . . . . 0.0 109.108 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -113.62 70.66 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.958 . . . . 0.0 110.685 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -167.4 129.68 1.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -65.96 140.54 58.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.086 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.433 HG12 HG21 ' A' ' 85' ' ' THR . 56.3 mt -84.42 150.25 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 109.894 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -93.24 76.67 4.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.858 . . . . 0.0 108.792 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -58.21 142.79 46.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.598 ' CE2' ' NE2' ' A' ' 267' ' ' GLN . 51.8 t80 -87.3 101.97 14.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.22 133.64 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.686 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.77 116.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -92.0 -28.71 17.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.65 156.99 78.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.943 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.56 150.15 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.913 2.409 . . . . 0.0 112.39 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.21 151.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.828 . . . . 0.0 109.323 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.82 145.91 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 109.366 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.12 147.98 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -131.78 161.32 33.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.137 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 255' ' ' LEU . 6.6 t70 -170.35 102.21 0.27 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 110.082 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 47.6 59.26 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.805 . . . . 0.0 110.677 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.78 -35.86 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.456 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -62.94 135.98 57.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.362 . . . . 0.0 109.132 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.2 tt -143.08 139.36 30.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 110.148 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.649 HG21 HD22 ' A' ' 259' ' ' LEU . 91.4 mt -137.47 134.13 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 0.0 109.734 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.75 131.48 53.61 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.53 0.681 . . . . 0.0 109.998 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.37 55.22 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.01 150.47 45.84 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.103 -0.998 . . . . 0.0 110.197 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -48.37 142.51 17.02 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.566 2.177 . . . . 0.0 113.35 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.76 147.24 18.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -69.84 -18.07 63.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.3 p -133.51 -173.33 3.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.49 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 16.3 tp -102.43 123.02 45.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.6 ' HG3' HG22 ' A' ' 167' ' ' VAL . 11.2 tt0 -136.83 129.04 29.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.632 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.09 121.34 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.557 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.1 m -112.27 152.15 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -138.83 129.72 26.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.965 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -120.57 131.91 54.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.0 132.3 6.21 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.701 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.24 97.59 9.29 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.57 166.98 19.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.368 -0.832 . . . . 0.0 111.169 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -105.87 23.6 13.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.752 -0.593 . . . . 0.0 110.034 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.4 p-10 -140.53 -169.74 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.053 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -47.15 -4.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.618 -0.676 . . . . 0.0 111.664 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 157' ' ' ASN . 17.5 mt -85.27 -28.63 25.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.334 -1.479 . . . . 0.0 109.111 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.14 -132.47 41.83 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.465 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 4.4 ttm105 -97.02 129.84 44.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.302 . . . . 0.0 109.8 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.478 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -132.81 139.36 47.47 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -137.57 144.05 41.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -143.56 136.12 27.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.724 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.3 m -106.98 124.53 49.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.417 -0.802 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -105.8 118.48 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 148' ' ' GLU . 26.0 t -113.59 158.42 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.75 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 30.9 mt-10 -50.18 125.15 11.71 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 108.92 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.89 6.59 39.94 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -120.31 15.81 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.245 . . . . 0.0 108.698 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -49.63 73.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.404 -0.81 . . . . 0.0 110.034 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -51.2 -22.33 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.12 -6.99 58.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 0.0 111.441 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 8.9 pt -124.95 -27.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.888 -1.133 . . . . 0.0 111.552 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.98 -24.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.528 -1.358 . . . . 0.0 108.694 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -82.31 -5.54 58.64 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.446 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.32 118.5 11.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.189 -0.944 . . . . 0.0 109.005 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 41.3 mtm180 -81.21 171.8 14.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.197 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -77.94 164.16 25.36 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -149.3 146.03 27.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.168 -1.582 . . . . 0.0 111.629 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -144.81 158.93 43.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -101.24 146.03 28.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 9.9 p30 -52.08 -32.91 36.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.233 -0.917 . . . . 0.0 109.935 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.1 p90 -71.8 -26.16 62.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.756 -1.215 . . . . 0.0 109.645 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.449 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 tt0 -83.81 -40.29 18.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.101 -1.0 . . . . 0.0 110.049 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.512 HG21 HB11 ' A' ' 500' ' ' C90 . 67.2 mt -43.17 -59.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.614 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.8 tp10 -42.1 -38.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.597 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.4 t-160 -76.85 -42.81 38.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.137 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.97 -27.6 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.579 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.64 -53.15 5.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.666 -1.271 . . . . 0.0 109.143 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -50.99 -41.17 59.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 110.172 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 188' ' ' HIS . 18.8 m -74.56 4.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.82 38.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 56.2 mt -129.89 171.36 12.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -1.141 . . . . 0.0 109.684 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.94 24.82 58.59 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.487 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.6 -18.48 41.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.425 -1.633 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.24 25.22 10.02 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.09 130.18 9.96 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.8 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.6 t -144.42 171.2 14.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.679 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.426 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 59.5 mt -69.78 -8.41 47.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -98.69 -13.75 20.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.642 -0.661 . . . . 0.0 109.696 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 18.7 p30 -130.33 7.1 4.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -149.19 150.13 32.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 206' ' ' LEU . 12.5 tp -97.96 95.26 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.05 127.87 40.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.985 0.898 . . . . 0.0 109.497 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 204' ' ' LEU . 34.3 mt -123.28 164.89 17.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.613 -0.68 . . . . 0.0 109.303 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.04 -166.63 11.98 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.414 ' HZ2' ' HB2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -60.03 -34.79 73.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.507 -0.996 . . . . 0.0 109.325 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -153.41 23.76 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.926 -1.109 . . . . 0.0 110.74 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -142.12 149.04 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.614 -1.304 . . . . 0.0 110.702 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.4 t -101.49 111.05 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.19 -46.41 85.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.977 -1.077 . . . . 0.0 110.148 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.1 118.28 31.48 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.927 . . . . 0.0 109.827 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -67.6 -17.2 48.15 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.85 -14.32 61.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.296 -0.878 . . . . 0.0 108.99 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.8 -176.98 45.28 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.4 mt -84.37 153.05 23.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -1.208 . . . . 0.0 109.558 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 218' ' ' ARG . 0.0 OUTLIER -82.2 -18.4 42.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.0 m-85 -145.53 -165.14 2.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -0.751 . . . . 0.0 108.998 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.19 -4.84 28.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.309 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.53 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -141.91 40.86 1.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.85 -47.36 97.09 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.876 -1.14 . . . . 0.0 109.584 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.7 Cg_exo -51.8 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.375 2.05 . . . . 0.0 112.076 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.9 m -58.86 -35.06 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 109.624 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NH1' ' CD2' ' A' ' 219' ' ' TYR . 58.2 mtt180 -60.21 -40.66 90.92 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.446 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 11.9 t60 -69.43 -32.1 70.85 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.162 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -64.88 -35.73 82.08 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.72 -40.85 84.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.5 t80 -61.78 -51.46 68.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.611 0.719 . . . . 0.0 109.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.548 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 92.0 m-20 -65.6 -27.48 68.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 110.016 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.6 tp -77.46 -34.24 54.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.094 -1.004 . . . . 0.0 108.777 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 57.9 mt -68.31 -38.5 79.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.92 -56.8 11.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 2.2 m-20 -53.16 -35.06 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.238 . . . . 0.0 108.671 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.0 mt -62.01 -23.51 66.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.639 -0.663 . . . . 0.0 110.325 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.04 -21.8 61.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 108.821 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 237' ' ' LEU . 53.3 mt -51.22 -1.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.619 -1.3 . . . . 0.0 110.416 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.624 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -77.86 -15.61 58.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.903 -1.123 . . . . 0.0 109.526 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.68 58.01 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.14 -1.029 . . . . 0.0 110.605 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.64 153.88 10.13 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.901 -1.352 . . . . 0.0 109.127 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.66 130.22 39.14 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.904 1.736 . . . . 0.0 109.939 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 68.5 t -86.22 147.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 122.204 1.002 . . . . 0.0 112.558 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -131.34 124.71 30.96 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.28 -155.58 26.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -131.8 133.77 45.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.315 -1.109 . . . . 0.0 109.119 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.8 m-85 -135.09 140.01 45.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.459 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.1 t80 -125.34 132.23 52.87 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.2 t -127.62 136.85 52.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.25 112.97 20.8 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 53.41 24.91 4.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.97 153.0 48.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.49 177.5 18.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.585 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 74.8 m-70 -57.72 -36.25 71.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -1.187 . . . . 0.0 109.427 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 29.6 t -58.97 -58.62 7.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 134' ' ' ASP . 9.0 tp -59.53 -44.6 93.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.501 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -47.94 -50.62 26.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 109.286 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 56' ' ' THR . 70.7 t -63.18 -50.44 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.16 -50.9 63.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.06 -1.025 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.649 HD22 HG21 ' A' ' 139' ' ' ILE . 28.8 tp -52.22 -59.36 4.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 108.447 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.624 HG13 ' HG ' ' A' ' 238' ' ' LEU . 43.1 t -48.39 -55.58 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.39 -47.53 18.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.17 -47.02 78.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -59.51 -49.79 76.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -70.76 -32.13 69.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 4.3 mmtp -69.8 -46.84 64.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.945 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -67.1 -52.51 41.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.598 ' NE2' ' CE2' ' A' ' 124' ' ' PHE . 2.3 tt0 -55.94 -8.93 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.807 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 269' ' ' LEU . 0.0 OUTLIER -81.69 114.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 268' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.576 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.1 mt -98.05 155.25 17.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' CD ' HD21 ' A' ' 86' ' ' ASN . 70.8 mt-10 -55.22 139.85 40.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 108.833 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.81 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.907 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -140.55 -172.71 3.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.4 m -97.93 136.38 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.003 -1.06 . . . . 0.0 109.074 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -66.97 -23.29 65.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.549 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 2.5 pt-20 -146.92 170.04 17.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 141.08 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.3 mt -120.03 166.47 13.33 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 143.18 41.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.071 -1.018 . . . . 0.0 110.418 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' ILE . 79.1 m-85 -139.24 154.15 47.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.98 150.8 15.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.875 -1.141 . . . . 0.0 110.019 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.22 174.98 36.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 p -82.81 153.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.115 . . . . 0.0 110.183 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.86 140.11 16.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 ' OG1' ' A' ' 203' ' ' THR . 9.6 tt -61.52 -37.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.916 -1.344 . . . . 0.0 110.379 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 45.8 m-70 -86.77 -51.07 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 111.096 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -73.47 -20.93 60.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.741 -0.599 . . . . 0.0 111.706 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.33 16.41 14.73 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.492 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.22 154.07 21.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 109.598 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.9 134.53 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -138.61 143.03 39.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.398 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -110.87 157.74 19.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.299 -0.876 . . . . 0.0 109.728 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.9 mt -138.2 147.77 44.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.447 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.568 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.9 mt -142.55 112.69 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 108.825 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.45 HD12 ' CE1' ' A' ' 13' ' ' PHE . 55.2 mt -96.09 114.57 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 111.123 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.568 ' NE2' HG22 ' A' ' 27' ' ' ILE . 24.5 m-70 -109.4 139.3 20.97 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 109.669 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.7 Cg_exo -55.12 168.6 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.828 1.686 . . . . 0.0 111.758 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 64.2 mm-40 -141.72 178.22 7.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.993 . . . . 0.0 109.816 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' A' ' 35' ' ' THR . 23.9 mmtm -85.72 152.49 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -46.07 145.08 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.402 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 67.78 9.17 55.52 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.169 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -70.03 -41.67 73.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.63 -1.512 . . . . 0.0 109.49 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.99 179.69 37.14 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.539 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mm -96.61 116.26 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -138.8 144.43 39.34 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.511 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.59 158.34 15.48 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -131.02 110.18 11.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 109.222 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -136.63 134.97 37.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 110.558 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.14 26.95 10.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 111.275 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 17.95 78.49 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.81 122.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -83.98 127.46 33.89 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.191 -0.943 . . . . 0.0 109.243 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.71 94.4 40.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.422 -0.799 . . . . 0.0 109.446 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.12 145.71 33.14 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.0 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -80.6 65.58 5.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -119.49 153.24 35.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.407 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 1.8 p-80 -57.71 -53.67 55.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 109.985 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.0 mm-40 -43.84 -17.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 111.043 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' HIS . 16.0 m-85 -94.13 5.11 52.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.664 -1.272 . . . . 0.0 109.79 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' HIS . 79.8 t -72.66 130.87 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.53 -29.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.345 -0.847 . . . . 0.0 109.894 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.4 t-80 -150.13 131.22 14.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.046 -1.034 . . . . 0.0 109.915 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.822 HG21 HG21 ' A' ' 257' ' ' VAL . 67.7 p -121.98 95.84 4.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 11.6 t-20 -162.38 128.56 3.53 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 59' ' ' SER . 34.3 m80 52.79 5.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.082 -1.011 . . . . 0.0 109.047 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m 165.16 151.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.404 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 31.1 m -91.12 126.54 36.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.241 -0.912 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD2' ' NZ ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -120.29 149.57 42.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.449 -0.782 . . . . 0.0 111.12 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.687 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.4 mt -126.28 147.54 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.52 155.91 27.25 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 118.961 -1.59 . . . . 0.0 110.587 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -160.42 147.64 15.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -1.047 . . . . 0.0 109.095 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 24.18 4.77 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.283 -0.885 . . . . 0.0 109.647 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.52 -31.35 7.89 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 8.3 mm-40 -60.34 144.25 51.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.245 . . . . 0.0 108.916 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -143.06 141.38 31.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 110.475 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.09 123.32 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 13.2 mtpp -99.36 154.63 18.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.966 -1.083 . . . . 0.0 111.128 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.5 m 50.79 74.38 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.338 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.687 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.9 m -106.92 -10.08 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.236 -0.915 . . . . 0.0 108.927 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.9 pm0 -61.34 -26.3 67.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 110.353 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.58 -69.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.91 -1.119 . . . . 0.0 109.47 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.01 -47.37 42.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 108.979 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' ILE . 16.8 mt -52.1 -49.22 64.03 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.04 -1.038 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 t -60.65 -42.82 97.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.105 -0.997 . . . . 0.0 110.247 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -56.04 -48.37 78.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.05 -1.031 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.04 -33.9 76.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.165 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.4 -37.17 86.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.912 . . . . 0.0 109.268 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.29 -38.76 34.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.414 -0.804 . . . . 0.0 109.648 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 107' ' ' TYR . 77.8 mt -80.36 -0.48 37.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.132 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 56.89 42.38 26.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.666 -0.646 . . . . 0.0 111.622 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mm -89.41 144.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.697 -1.252 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.571 HG21 HG12 ' A' ' 121' ' ' ILE . 43.5 p -127.88 -20.81 3.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.192 -0.943 . . . . 0.0 111.815 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG13 ' A' ' 87' ' ' VAL . 33.6 m-80 -124.99 108.12 11.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.838 -1.164 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.75 148.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.363 -0.836 . . . . 0.0 110.421 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.47 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 94.3 m -114.71 113.53 24.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 5.5 mt -97.27 100.77 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 110.412 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.1 tt0 -74.63 124.83 27.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 20.0 t -109.96 131.93 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 122.048 0.928 . . . . 0.0 111.707 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mm -116.15 95.9 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.67 -156.9 26.07 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -121.37 -9.51 9.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.439 -1.036 . . . . 0.0 109.999 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -140.53 148.81 41.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.648 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 26' ' ' LEU . 39.2 mm -72.07 119.37 74.16 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 108.987 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -39.94 120.09 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.739 1.626 . . . . 0.0 111.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -75.04 -10.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 110.774 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.9 mt 54.7 -120.7 1.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.091 -1.006 . . . . 0.0 109.995 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.6 8.22 44.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.66 67.36 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.197 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -172.54 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.768 -0.842 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.0 9.0 9.76 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.407 ' HB2' HD22 ' A' ' 176' ' ' LEU . 33.6 t-105 -55.49 -39.52 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -1.135 . . . . 0.0 110.452 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.12 -59.31 4.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -50.84 -44.83 59.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.209 -0.932 . . . . 0.0 109.38 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 82' ' ' LEU . 36.2 t80 -60.92 -48.05 83.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 110.786 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.82 -42.47 90.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.009 -1.057 . . . . 0.0 111.28 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.49 -52.06 43.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.913 -1.117 . . . . 0.0 110.356 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.05 -32.86 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.943 -1.098 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -63.79 -43.44 96.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 109.822 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.623 ' C ' HD22 ' A' ' 113' ' ' ASN . 1.3 ptpm? -77.81 11.1 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.017 -1.052 . . . . 0.0 109.852 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.623 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.92 33.23 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.29 138.82 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.864 -1.147 . . . . 0.0 111.212 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 8' ' ' LYS . 9.0 tp -132.75 123.56 26.45 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.65 145.15 31.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.343 -0.848 . . . . 0.0 110.221 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -112.61 -173.19 2.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.763 . . . . 0.0 109.352 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -109.34 68.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -164.09 128.76 2.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.007 . . . . 0.0 109.315 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.69 140.58 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.069 . . . . 0.0 109.667 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 85' ' ' THR . 69.3 mt -83.94 150.47 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.843 . . . . 0.0 109.906 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.64 85.94 3.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 108.876 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 241' ' ' PRO . 25.1 m-85 -63.52 142.79 58.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.545 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -87.54 101.38 13.57 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.43 134.16 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.663 -0.648 . . . . 0.0 110.75 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.97 111.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -83.74 -33.5 25.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.944 -1.098 . . . . 0.0 110.725 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.25 156.93 78.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 109.784 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.09 149.0 45.63 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.791 2.327 . . . . 0.0 112.241 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 tt -159.01 151.48 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.19 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 143.51 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.76 148.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.89 157.38 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.466 ' HB3' HD13 ' A' ' 255' ' ' LEU . 10.5 t70 -174.15 106.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 109.796 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 49.58 53.43 12.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 110.803 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.57 -35.68 3.17 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.416 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.581 ' HB3' HD22 ' A' ' 255' ' ' LEU . 0.9 OUTLIER -63.48 131.81 49.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.932 -1.334 . . . . 0.0 108.906 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -143.98 139.79 29.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.986 -1.071 . . . . 0.0 109.891 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HD22 ' A' ' 259' ' ' LEU . 62.6 mt -136.9 127.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.783 . . . . 0.0 109.59 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -112.49 131.76 55.42 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.411 0.624 . . . . 0.0 109.752 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 135.37 54.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.88 149.19 32.44 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.128 -0.983 . . . . 0.0 109.648 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -46.35 143.53 7.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.661 2.241 . . . . 0.0 113.272 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.425 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.92 145.62 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 146' ' ' THR . 44.0 t0 -65.34 -4.71 5.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 110.541 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 145' ' ' ASP . 21.8 p -155.66 -177.78 6.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -92.26 119.35 31.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 167' ' ' VAL . 1.1 tt0 -135.16 110.32 8.91 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.29 122.09 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.7 m -112.32 151.98 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.624 -0.673 . . . . 0.0 109.229 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -139.62 131.71 27.98 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.128 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -122.0 132.98 54.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.4 144.67 16.2 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.747 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.82 105.97 15.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -95.18 166.86 11.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -98.07 -16.69 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.576 -0.703 . . . . 0.0 110.9 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.7 p-10 -94.79 -173.14 2.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.751 -1.218 . . . . 0.0 110.217 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -50.35 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 0.0 111.642 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.2 mt -77.74 -27.8 50.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.343 -1.473 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.76 -140.5 34.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -104.16 137.89 41.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.302 -1.116 . . . . 0.0 109.691 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -143.89 159.14 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.497 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -146.67 147.68 31.27 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -142.86 135.65 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 109.645 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 98.6 m -104.56 122.87 46.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.894 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -104.46 112.34 25.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 148' ' ' GLU . 4.9 t -106.38 152.36 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.758 0.79 . . . . 0.0 109.901 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -49.28 127.04 14.14 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 108.808 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.57 27.35 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -116.69 20.72 13.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.162 -1.199 . . . . 0.0 108.962 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -54.04 -22.78 11.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.445 -0.784 . . . . 0.0 110.542 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -18.21 48.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.041 -1.037 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -84.2 -6.37 59.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 111.476 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 pt -125.19 -26.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.865 -1.147 . . . . 0.0 111.221 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 171' ' ' GLU . 6.5 m -60.5 -24.01 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.623 -1.298 . . . . 0.0 108.716 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.2 mm? -83.56 -3.23 57.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.556 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.99 113.5 7.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.569 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 73.0 mtm180 -79.31 172.36 13.9 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.6 t -77.26 161.13 28.37 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.39 146.06 32.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.282 -1.512 . . . . 0.0 111.439 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.629 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -144.93 154.55 42.71 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.422 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 70.2 m-85 -98.09 145.82 26.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.018 -1.051 . . . . 0.0 109.362 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.61 -36.97 37.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.3 p90 -71.42 -27.19 63.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.843 -1.161 . . . . 0.0 110.039 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.1 tt0 -78.97 -43.18 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.979 -1.076 . . . . 0.0 110.137 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 21.3 mt -41.0 -61.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.903 . . . . 0.0 110.145 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.7 tt0 -40.49 -41.37 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 0.0 110.193 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 192' ' ' VAL . 74.3 t60 -76.24 -46.22 29.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.942 . . . . 0.0 109.402 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.5 -30.86 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -80.65 -52.23 7.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.883 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -48.61 -44.56 37.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 110.334 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.1 m -74.86 6.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 0.0 110.326 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.41 41.79 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.584 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.4 mt -127.73 178.39 6.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -1.185 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 50.83 24.28 7.95 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -61.23 -19.3 61.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.624 -1.516 . . . . 0.0 110.59 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -107.27 4.82 35.49 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.57 125.03 30.44 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 121.136 -1.214 . . . . 0.0 110.296 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.559 ' N ' HD21 ' A' ' 202' ' ' ASN . 3.5 t -135.99 174.22 10.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -1.028 . . . . 0.0 109.456 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 213' ' ' ASN . 2.2 mm? -73.91 -9.14 58.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -102.78 -17.67 15.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.642 -0.662 . . . . 0.0 110.289 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 199' ' ' SER . 18.9 p30 -120.04 7.91 10.93 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.477 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -150.84 151.25 31.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.872 -1.143 . . . . 0.0 110.556 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.2 tp -98.99 93.54 6.06 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -86.08 129.19 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.687 0.756 . . . . 0.0 109.277 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 211' ' ' VAL . 11.9 mt -123.48 162.95 21.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.611 -0.68 . . . . 0.0 109.454 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.41 -166.38 12.91 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -28.26 66.5 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.384 -1.068 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.44 20.98 1.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 111.153 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.6 160.99 43.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.465 -1.397 . . . . 0.0 110.823 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 206' ' ' LEU . 86.9 t -107.59 116.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -60.28 -42.93 96.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.578 ' HA ' HD12 ' A' ' 200' ' ' LEU . 8.9 m120 -65.06 115.61 22.71 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -64.69 -10.53 25.09 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.16 1.24 . . . . 0.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -20.13 59.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.408 -0.807 . . . . 0.0 109.286 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.24 -179.5 45.53 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.5 mt -86.1 133.51 33.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.073 -1.251 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.99 -17.71 64.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.318 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 39.2 m-85 -143.33 -170.46 3.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.71 -4.37 44.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.79 43.61 1.26 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 109.649 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.86 -47.84 95.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.997 -1.065 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.5 Cg_exo -51.37 -65.33 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.487 2.124 . . . . 0.0 112.31 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.39 -35.19 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.986 -1.071 . . . . 0.0 109.461 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -62.72 -39.44 94.07 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 8.5 t60 -68.02 -32.68 73.22 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -64.17 -35.72 81.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.88 -35.48 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.97 -53.01 44.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 109.172 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.437 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 93.1 m-20 -63.98 -28.86 70.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.457 -0.777 . . . . 0.0 109.797 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.12 -34.97 49.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.085 -1.01 . . . . 0.0 109.018 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.55 -38.53 81.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.5 -54.87 17.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -55.27 -30.19 59.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.0 108.825 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.6 mt -65.86 -24.23 66.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.529 -0.732 . . . . 0.0 110.442 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.78 -21.8 61.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.855 -1.153 . . . . 0.0 108.54 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 38.9 mt -48.19 -7.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.762 -1.211 . . . . 0.0 109.905 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 236' ' ' TYR . 7.2 mt -74.03 -16.6 61.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.767 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 95.77 3.83 60.68 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.823 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.79 152.99 10.6 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.763 -1.433 . . . . 0.0 109.301 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.413 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 8.1 Cg_endo -53.91 127.22 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.956 1.771 . . . . 0.0 110.002 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.8 t -86.43 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 112.289 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.57 125.86 29.72 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.51 -160.59 29.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -128.6 133.56 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -1.107 . . . . 0.0 108.951 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.8 m-85 -132.92 141.65 48.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 110.945 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -124.76 124.94 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.2 t -118.83 135.69 54.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.946 -1.096 . . . . 0.0 111.28 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -116.87 114.75 24.33 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 48.41 25.77 0.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.57 164.11 12.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -145.01 173.94 25.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.446 ' O ' HG23 ' A' ' 257' ' ' VAL . 77.4 m-70 -54.41 -43.52 71.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 p -55.37 -58.6 7.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 137' ' ' ARG . 5.9 tp -54.88 -46.23 74.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.0 m-20 -47.43 -48.11 26.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.942 -1.099 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.822 HG21 HG21 ' A' ' 56' ' ' THR . 44.9 t -63.85 -50.03 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 109.96 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -56.31 -50.27 71.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.961 -1.087 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 139' ' ' ILE . 35.6 tp -52.58 -50.53 62.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.063 -1.023 . . . . 0.0 108.636 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.4 t -57.79 -55.28 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.274 -0.891 . . . . 0.0 109.165 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.69 -49.08 14.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.82 -49.53 72.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.278 -0.889 . . . . 0.0 110.109 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.17 -50.94 71.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 0.0 110.38 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -33.16 75.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.123 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -67.6 -38.06 83.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -71.91 -65.28 0.79 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.282 -0.886 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.469 ' O ' ' CB ' ' A' ' 268' ' ' LYS . 11.2 tt0 -59.06 -92.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.771 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 267' ' ' GLN . 10.8 ttpt 166.35 123.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.261 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.629 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.6 mt -98.16 155.61 17.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -1.162 . . . . 0.0 109.574 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.545 ' OE1' ' ND2' ' A' ' 86' ' ' ASN . 73.8 mt-10 -56.04 135.04 52.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.123 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.38 142.67 48.97 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -139.46 -170.34 2.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.8 m -100.32 137.55 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -64.88 -19.87 66.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.857 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.95 157.42 36.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.113 -0.992 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 140.36 58.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.946 . . . . 0.0 109.805 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.07 157.08 28.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 p -127.67 140.13 52.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.2 m-85 -138.04 147.67 44.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.4 pt-20 -156.8 151.98 26.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.16 175.66 36.72 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.06 152.93 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 110.222 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.67 140.07 15.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 11.4 tt -59.31 -39.05 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.039 -1.271 . . . . 0.0 110.269 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 34.0 m-70 -88.43 -50.05 6.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.688 -1.258 . . . . 0.0 110.77 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -70.45 -22.95 62.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.716 . . . . 0.0 111.297 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.24 10.92 4.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.64 156.18 17.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 32.2 t80 -74.82 136.25 41.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -141.04 143.51 34.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -109.77 159.02 17.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.999 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.29 145.12 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.3 mt -142.18 107.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.976 . . . . 0.0 108.867 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mt -90.85 113.77 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.366 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.503 ' NE2' HG22 ' A' ' 27' ' ' ILE . 57.2 m-70 -107.74 137.26 19.69 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 109.4 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG3' HG23 ' A' ' 7' ' ' VAL . 33.2 Cg_exo -50.1 167.72 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.847 1.698 . . . . 0.0 111.532 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HB3' HG21 ' A' ' 35' ' ' THR . 28.0 mm-40 -144.99 160.48 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.886 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.8 mttp -68.0 149.1 50.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -48.41 151.05 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.141 -0.974 . . . . 0.0 110.093 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.542 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.63 -2.12 8.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.51 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 24.6 m -62.21 -42.75 99.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.467 . . . . 0.0 109.558 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 179.45 36.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.415 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 87' ' ' VAL . 14.6 mm -96.58 116.81 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -140.91 147.68 39.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 0.0 110.215 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.34 157.42 15.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -129.06 112.17 13.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 108.976 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -135.58 133.43 38.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.636 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 53.5 26.82 5.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 111.313 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.43 20.26 64.67 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.097 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.5 t -124.46 124.49 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -1.093 . . . . 0.0 109.322 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -86.37 126.75 34.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.78 93.03 36.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.188 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.12 145.5 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.298 1.999 . . . . 0.0 112.044 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.93 70.57 8.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 109.403 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -120.52 174.73 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.159 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.485 ' O ' HG23 ' A' ' 53' ' ' VAL . 16.1 p-80 -78.31 -46.37 20.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -49.95 -16.62 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -93.15 3.97 54.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.754 -1.216 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 50' ' ' HIS . 75.2 t -70.95 127.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG21 ' HD2' ' A' ' 68' ' ' ARG . 26.9 m -106.32 -31.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -155.12 139.83 17.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 257' ' ' VAL . 39.2 p -126.25 95.82 4.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.5 t30 -161.39 128.91 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.769 . . . . 0.0 108.95 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 82.2 m-70 52.95 5.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.247 -0.908 . . . . 0.0 109.178 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.11 142.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' VAL . 34.6 m -81.87 127.3 32.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 108.837 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.82 148.24 43.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.859 0.837 . . . . 0.0 111.071 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.1 mt -126.84 150.06 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.36 155.73 27.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.756 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.92 153.55 12.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -1.012 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 50.75 21.59 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.8 -33.25 6.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.99 141.86 57.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.245 . . . . 0.0 109.245 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -137.33 139.69 41.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 110.364 -179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.3 mt -129.23 121.3 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -99.64 157.54 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 110.926 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.9 m 51.23 73.73 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.932 -0.48 . . . . 0.0 110.694 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG21 ' HG ' ' A' ' 62' ' ' LEU . 12.2 m -107.7 -9.29 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.0 108.9 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 18.2 pm0 -61.04 -28.86 69.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 110.75 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -66.83 -67.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.868 -1.145 . . . . 0.0 109.56 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.15 -46.73 44.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.271 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.0 mt -53.61 -46.91 70.58 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.899 -1.126 . . . . 0.0 110.136 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.56 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.87 -43.18 99.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -0.989 . . . . 0.0 110.063 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.88 -46.05 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.05 -34.47 77.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -62.58 -37.34 85.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.408 HD12 ' CG1' ' A' ' 175' ' ' VAL . 54.8 mt -78.78 -38.73 37.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 114' ' ' ILE . 72.8 mt -79.9 -1.03 37.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.383 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 57.7 43.01 22.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 111.339 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 mm -88.22 143.74 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.887 -1.133 . . . . 0.0 108.688 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.477 HG21 HD13 ' A' ' 121' ' ' ILE . 63.0 p -127.4 -23.44 3.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 111.822 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 54.1 m-80 -124.73 107.49 11.01 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.723 -1.235 . . . . 0.0 110.412 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -163.64 147.0 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 37.9 m -114.23 109.48 18.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.8 mt -92.06 100.52 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -74.48 126.15 30.11 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.512 HG22 HD21 ' A' ' 26' ' ' LEU . 29.4 t -111.74 122.42 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.964 0.887 . . . . 0.0 111.58 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.94 96.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.39 -156.78 26.34 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -120.66 -10.04 9.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -1.095 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -142.82 150.63 40.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.01 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 36.9 mm -72.76 120.94 83.53 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -41.85 123.81 2.5 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.517 1.478 . . . . 0.0 110.987 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.4 tp -76.91 -12.43 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.369 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 mt 56.48 -121.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.29 8.89 40.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 110.666 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.41 -1.96 67.35 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.436 -1.364 . . . . 0.0 109.696 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -172.46 2.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.841 -0.8 . . . . 0.0 109.401 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.74 16.02 9.61 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.4 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 67.0 t-105 -59.55 -43.47 93.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.409 -1.054 . . . . 0.0 110.28 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.8 -57.61 10.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -51.21 -44.87 61.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.078 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 62.2 t80 -61.81 -52.42 64.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.633 -0.667 . . . . 0.0 110.674 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.4 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 16.8 mm-40 -60.53 -44.88 95.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 0.0 111.319 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.71 -58.6 4.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.918 -1.114 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.22 -33.73 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.452 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 13.1 ttt180 -62.37 -43.71 98.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.26 12.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.951 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -143.24 34.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.097 . . . . 0.0 110.329 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 82' ' ' LEU . 46.9 mt -80.75 138.55 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 tp -132.3 128.87 38.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.331 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -87.87 140.5 29.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.694 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.72 -170.85 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.9 69.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.24 -0.913 . . . . 0.0 110.599 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.01 130.12 2.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.959 -1.088 . . . . 0.0 109.708 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.76 145.97 51.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.984 . . . . 0.0 109.817 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 85' ' ' THR . 35.4 mt -90.87 151.48 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -94.06 79.8 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 50.0 m-85 -59.93 143.01 52.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.483 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.553 ' CE1' ' OE1' ' A' ' 267' ' ' GLN . 83.6 t80 -89.1 101.5 14.16 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.78 132.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.707 -0.62 . . . . 0.0 110.785 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -70.12 111.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -88.49 -30.48 19.35 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.104 -0.998 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -133.06 149.29 72.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 109.663 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.32 155.66 55.64 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.372 2.048 . . . . 0.0 112.118 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.646 HD12 ' HD3' ' A' ' 266' ' ' LYS . 4.2 tt -161.71 153.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -139.33 141.04 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.835 . . . . 0.0 109.257 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.42 148.85 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.72 158.28 44.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 135' ' ' GLU . 43.4 t0 -174.51 105.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.933 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 134' ' ' ASP . 5.5 mt-10 49.7 54.74 10.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.7 -36.31 3.14 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.448 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.475 ' HB3' HD22 ' A' ' 255' ' ' LEU . 2.4 mpt_? -61.55 134.36 56.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 108.657 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -147.79 138.52 23.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 255' ' ' LEU . 75.5 mt -135.69 132.13 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.662 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 142' ' ' GLU . 19.0 tttm -117.72 131.05 56.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.707 -0.621 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.79 55.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 140' ' ' LYS . 9.7 pt-20 -148.29 151.65 37.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.774 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -49.42 142.68 22.36 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.439 2.093 . . . . 0.0 113.445 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.44 141.35 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.03 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -60.98 -6.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.836 . . . . 0.0 110.602 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.4 p -152.79 -173.52 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.926 -1.109 . . . . 0.0 109.546 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 148' ' ' GLU . 8.8 tp -96.29 120.45 36.61 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 108.865 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.1 tt0 -136.57 129.41 30.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.21 123.61 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 95.9 m -113.51 152.35 30.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.749 -0.594 . . . . 0.0 109.481 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -141.85 132.39 25.37 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.31 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.18 132.72 54.59 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.27 147.16 19.04 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.184 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.28 98.28 6.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -85.57 167.84 15.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.632 0.729 . . . . 0.0 110.894 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -97.55 -9.94 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 111.302 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' LEU . 30.7 p-10 -102.76 -170.94 1.87 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 111.036 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -48.2 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.806 -0.559 . . . . 0.0 111.509 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.7 mt -80.29 -29.75 38.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.479 -1.388 . . . . 0.0 108.534 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.41 -133.73 46.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.425 HH11 ' HB2' ' A' ' 161' ' ' ARG . 13.0 ttp-105 -107.88 136.27 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -1.075 . . . . 0.0 109.391 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.694 -0.629 . . . . 0.0 109.303 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.13 147.84 29.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.44 -0.788 . . . . 0.0 109.604 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.495 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 9.8 t80 -147.9 143.18 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.084 -1.01 . . . . 0.0 110.3 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.458 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 89.4 m -110.17 123.81 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.798 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.21 116.93 33.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG22 ' CG ' ' A' ' 148' ' ' GLU . 56.0 t -106.57 149.4 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.011 0.91 . . . . 0.0 110.405 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.61 134.44 24.36 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.385 -0.822 . . . . 0.0 109.197 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.11 -9.18 42.68 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.09 28.19 8.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.199 -1.177 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.7 pm0 -60.41 -36.67 78.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.56 -17.0 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.86 -5.99 46.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.835 -1.166 . . . . 0.0 111.517 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.2 pt -121.21 -29.82 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.061 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.9 m -61.99 -15.81 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.626 -1.296 . . . . 0.0 108.803 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.98 -2.85 55.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.48 114.49 7.76 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -77.58 172.93 12.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.4 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.3 t -77.25 162.49 27.31 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.2 143.85 30.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.366 -1.459 . . . . 0.0 111.427 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.79 155.78 44.87 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.44 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 71.4 m-85 -99.38 140.41 33.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.494 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.07 -37.54 9.7 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.369 -0.832 . . . . 0.0 110.345 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.3 p90 -70.16 -26.81 64.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.734 -1.229 . . . . 0.0 110.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.7 OUTLIER -88.5 -35.05 17.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.94 -1.1 . . . . 0.0 110.441 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 205' ' ' VAL . 73.5 mt -48.23 -58.18 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 0.0 109.708 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.9 OUTLIER -42.92 -36.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.16 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.461 ' O ' HG22 ' A' ' 192' ' ' VAL . 19.6 t60 -72.63 -50.22 26.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.752 . . . . 0.0 109.136 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 81.7 mt -52.17 -29.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -80.87 -53.04 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.798 -1.189 . . . . 0.0 109.022 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -48.55 -40.45 27.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.4 m -77.62 6.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.026 -1.046 . . . . 0.0 110.364 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.18 38.79 38.73 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.228 -0.986 . . . . 0.0 110.655 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.413 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.6 mt -130.91 -179.71 5.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -1.155 . . . . 0.0 109.515 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 54.64 23.44 28.68 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.578 -0.701 . . . . 0.0 111.488 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -57.06 -21.13 29.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.602 -1.528 . . . . 0.0 110.435 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.92 5.47 34.49 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.985 -1.103 . . . . 0.0 110.559 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.74 129.3 41.73 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 120.925 -1.338 . . . . 0.0 110.451 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.14 167.0 25.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.353 -1.086 . . . . 0.0 108.822 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 75.4 mt -71.03 -7.71 48.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.492 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.83 -11.46 21.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.528 -0.733 . . . . 0.0 110.309 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.501 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 11.7 p-10 -130.94 9.77 4.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.82 152.22 32.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 110.416 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.4 tp -99.2 95.46 7.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 186' ' ' ILE . 52.6 t -87.49 129.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.672 0.749 . . . . 0.0 109.606 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.5 mt -123.82 164.16 19.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.55 -0.719 . . . . 0.0 109.306 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.55 -166.36 11.97 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.517 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 1.1 tppp? -57.02 -36.83 70.91 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.555 -0.968 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.89 26.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 110.57 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.29 148.44 39.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.696 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.28 112.94 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.69 -49.93 75.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.972 -1.08 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.4 m120 -58.92 112.29 4.84 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 0.0 110.193 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -58.44 -11.73 11.86 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.576 1.517 . . . . 0.0 111.501 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 -18.53 57.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.381 -0.825 . . . . 0.0 109.92 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.32 -173.63 50.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.616 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -89.18 140.35 29.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -1.222 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -78.06 -21.17 51.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.416 -0.803 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -138.58 154.77 48.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.177 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -67.09 -1.88 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.744 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.536 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -148.48 46.14 1.04 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.128 -0.983 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.17 -46.56 99.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.697 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -52.55 -66.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.371 2.047 . . . . 0.0 112.044 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.41 -35.9 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.976 -1.077 . . . . 0.0 109.439 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.536 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 68.4 mtt-85 -60.67 -41.48 95.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -67.1 -31.77 72.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.766 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -65.21 -36.9 85.61 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.6 t -68.55 -35.5 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.56 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 73.1 t80 -66.32 -54.14 28.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.88 -27.08 68.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.933 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.26 -33.76 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 33.7 mt -68.23 -38.93 80.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.76 -57.33 12.67 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.55 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.6 m-20 -54.24 -34.42 60.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 109.274 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.4 mt -60.88 -23.8 65.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 110.219 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.18 -22.31 61.3 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.902 -1.124 . . . . 0.0 108.91 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.424 HD11 HG21 ' A' ' 60' ' ' THR . 95.8 mt -52.58 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.712 -1.243 . . . . 0.0 110.629 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.569 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.05 -13.0 60.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.744 -1.223 . . . . 0.0 109.66 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.84 -0.79 57.83 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.503 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.57 156.28 10.34 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.914 -1.345 . . . . 0.0 108.829 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.6 Cg_endo -49.93 150.68 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.892 1.728 . . . . 0.0 109.552 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.08 148.36 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.988 -1.07 . . . . 0.0 112.125 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -130.97 124.17 30.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.97 -157.32 27.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -131.85 145.11 51.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -1.074 . . . . 0.0 108.951 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.2 m-85 -141.51 142.44 33.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.485 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.34 123.15 37.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.3 m -115.85 134.81 54.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 250' ' ' ARG . 60.5 t80 -116.54 117.01 28.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.3 OUTLIER 45.4 24.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.161 -0.962 . . . . 0.0 109.425 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.57 164.74 45.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.491 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -142.73 171.52 24.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.55 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 60.9 m-70 -51.01 -34.87 31.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -1.225 . . . . 0.0 109.635 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.7 m -60.03 -57.82 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 139' ' ' ILE . 7.0 tp -61.57 -43.8 98.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.008 . . . . 0.0 109.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.5 m-20 -47.33 -46.84 25.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.88 -1.138 . . . . 0.0 108.577 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 56' ' ' THR . 60.5 t -64.15 -50.46 76.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.59 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -55.32 -51.18 67.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.997 -1.065 . . . . 0.0 109.285 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 139' ' ' ILE . 46.9 tp -51.07 -50.7 58.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.152 -0.967 . . . . 0.0 108.588 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.563 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.9 t -57.06 -54.79 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.458 ' NZ ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.89 -55.07 8.65 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 109.597 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.57 -51.29 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.95 -51.91 59.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.81 -25.51 65.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.29 -60.83 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.34 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.646 ' HD3' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.7 -44.96 80.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.08 . . . . 0.0 109.713 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.553 ' OE1' ' CE1' ' A' ' 124' ' ' PHE . 5.3 tt0 -67.72 -75.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 54.7 tttt 52.28 27.45 4.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.455 ' H ' ' HG2' ' A' ' 267' ' ' GLN . 5.1 mt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.558 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.9 mt -90.5 156.55 18.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -1.163 . . . . 0.0 109.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' HD21 ' A' ' 86' ' ' ASN . 1.6 mm-40 -56.43 136.14 53.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.087 -1.008 . . . . 0.0 108.579 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HZ1' ' HB3' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -121.96 143.23 49.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.8 t -141.69 -170.46 3.12 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.8 m -101.6 138.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.483 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 9' ' ' GLU . 7.8 ptmm? -66.96 -25.37 66.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 8.2 pt-20 -148.14 158.4 44.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.993 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 142.32 57.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.481 -0.762 . . . . 0.0 110.133 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 11' ' ' LEU . 20.7 mt -120.68 167.07 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -137.13 142.25 42.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 26' ' ' LEU . 95.0 m-85 -139.26 151.7 46.69 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.48 153.44 19.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.0 110.023 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.44 177.02 36.77 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.83 153.7 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -1.047 . . . . 0.0 110.025 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.97 140.36 15.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.483 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.9 tt -60.46 -38.44 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -1.152 . . . . 0.0 110.807 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 73.8 m-70 -90.02 -51.26 5.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.564 -1.335 . . . . 0.0 110.963 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.1 p -70.11 -22.25 63.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.774 -0.579 . . . . 0.0 111.237 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.6 19.44 27.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -111.44 155.06 23.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -1.059 . . . . 0.0 109.788 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -74.34 137.0 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.647 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -143.16 143.59 31.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.064 -1.022 . . . . 0.0 109.594 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -108.14 160.06 16.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -139.84 145.13 37.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.731 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.466 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.8 mt -140.33 116.26 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 108.972 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.14 111.89 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.466 ' NE2' HG22 ' A' ' 27' ' ' ILE . 61.5 m-70 -107.46 139.89 20.97 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.1 Cg_exo -54.81 168.15 1.26 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.836 1.691 . . . . 0.0 111.495 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -142.12 178.93 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.611 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 mmtm -87.7 153.32 21.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' OE2' ' N ' ' A' ' 118' ' ' ASN . 63.1 mt-10 -47.51 146.43 2.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.496 -0.752 . . . . 0.0 109.939 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.26 4.71 45.09 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.032 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.586 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -67.92 -44.56 76.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.618 -1.519 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -179.26 32.14 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.471 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.76 115.74 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 6.8 ptm180 -140.3 152.09 45.59 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.951 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.03 157.81 16.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.9 111.09 12.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -134.7 133.51 40.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.73 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 53.16 28.33 6.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.577 -0.702 . . . . 0.0 111.401 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 18.88 69.95 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.399 -1.382 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 122.05 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -1.069 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 28.5 m-85 -83.82 127.07 33.56 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 mt -116.54 92.93 38.86 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.242 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.5 149.0 18.85 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.504 2.136 . . . . 0.0 112.086 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.44 69.4 9.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -121.31 170.95 9.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.2 p-80 -74.18 -48.58 28.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.622 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.56 -16.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.47 4.33 53.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.73 -1.231 . . . . 0.0 109.92 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -71.51 141.68 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.17 -29.26 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -0.847 . . . . 0.0 110.114 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -151.67 129.84 11.93 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 109.965 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -120.63 95.36 4.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.7 t-20 -163.28 129.41 3.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 73.3 m-70 49.9 9.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.177 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER 162.48 150.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.706 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -91.22 124.42 35.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 109.288 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.13 148.59 42.9 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.651 0.739 . . . . 0.0 110.637 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 72' ' ' VAL . 10.7 mt -125.48 153.2 43.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.35 154.55 25.35 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 118.974 -1.584 . . . . 0.0 110.747 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -161.37 149.83 15.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -1.017 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.8 mttt 46.36 24.18 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.621 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -34.45 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -54.87 145.57 19.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.255 . . . . 0.0 109.045 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -145.36 135.39 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 110.613 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.16 120.28 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -97.8 159.11 15.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 0.0 111.193 -178.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 71' ' ' THR . 91.7 m 46.52 74.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 62' ' ' LEU . 20.6 m -107.37 -8.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -60.61 -25.19 66.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.152 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.1 m170 -67.97 -69.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.049 . . . . 0.0 109.415 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.4 -47.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.099 -1.001 . . . . 0.0 109.129 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' N ' HG23 ' A' ' 75' ' ' ILE . 19.9 mt -52.08 -50.18 62.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.026 . . . . 0.0 110.137 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 39.2 t -60.32 -41.55 93.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.113 -0.992 . . . . 0.0 110.071 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 106' ' ' PHE . 97.4 t -56.88 -44.95 83.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.051 -1.031 . . . . 0.0 109.217 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.72 -33.76 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -62.89 -40.86 98.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 109.179 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD12 ' CG1' ' A' ' 175' ' ' VAL . 37.5 mt -75.38 -39.09 59.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.852 . . . . 0.0 109.702 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 82' ' ' LEU . 67.8 mt -79.42 -1.07 35.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.94 42.1 26.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 111.414 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 23.1 mm -90.69 139.91 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 108.226 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 73.3 p -126.9 -19.15 4.51 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.745 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.73 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.2 m-80 -124.98 106.25 9.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.827 -1.171 . . . . 0.0 110.274 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -165.86 150.67 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.729 0.776 . . . . 0.0 109.916 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.0 m -116.17 117.84 31.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.575 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.9 mt -100.19 100.36 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.352 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.1 mt-10 -71.77 126.08 28.8 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG22 HD21 ' A' ' 26' ' ' LEU . 19.2 t -112.55 121.02 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.949 0.88 . . . . 0.0 111.807 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mm -107.77 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.72 160.05 8.2 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -83.05 -7.45 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.267 . . . . 0.0 111.219 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -139.35 147.59 41.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.725 -1.234 . . . . 0.0 110.36 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 40.3 mm -73.18 121.28 84.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -41.82 123.83 2.48 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.665 1.577 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.2 tp -76.58 -15.4 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.678 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.7 mt 57.0 -122.09 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 27.0 t70 -93.36 7.3 45.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.024 -1.048 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.84 -3.9 62.94 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.243 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.94 -172.0 2.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.911 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.39 14.53 9.36 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -57.94 -41.76 83.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 0.0 110.284 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.89 -55.7 17.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.019 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' A' ' 78' ' ' VAL . 7.2 m-85 -51.4 -45.81 62.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 108.927 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.96 -54.18 48.12 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.268 0.556 . . . . 0.0 110.62 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.98 -43.69 98.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 111.508 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . . . -65.59 -56.83 10.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.961 -1.087 . . . . 0.0 110.363 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.12 -30.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 109.355 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -65.26 -43.36 91.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.307 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ1' ' HA ' ' A' ' 109' ' ' ALA . 3.7 pttm -76.41 9.88 2.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.892 -1.13 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -140.89 36.45 1.77 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 0.0 109.926 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -85.29 140.68 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 111.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -131.42 122.0 25.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.584 -0.697 . . . . 0.0 109.129 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.506 ' HB3' ' HZ1' ' A' ' 5' ' ' LYS . 6.7 m-80 -79.37 146.32 32.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -111.26 -174.45 2.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.447 -0.783 . . . . 0.0 109.42 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 26.8 t-20 -111.69 70.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.852 . . . . 0.0 110.579 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -168.41 134.69 1.9 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.355 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.39 143.98 51.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.065 -1.022 . . . . 0.0 110.15 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.11 151.43 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 0.0 110.233 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.53 83.78 3.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 108.872 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 15.0 m-85 -63.12 142.13 58.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.291 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -86.94 101.36 13.34 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.7 133.47 33.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 110.75 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.29 111.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.45 -30.1 23.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.138 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.92 155.34 77.89 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.01 149.87 53.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.536 2.158 . . . . 0.0 112.234 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.555 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.77 149.83 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 108.942 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.75 140.93 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.78 145.96 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.63 156.95 47.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -174.3 107.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.851 . . . . 0.0 109.929 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 53.33 52.86 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.51 -31.66 3.22 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -61.77 134.91 57.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.242 . . . . 0.0 108.52 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 138' ' ' LEU . 1.1 tt -147.5 137.12 22.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.854 -1.154 . . . . 0.0 109.901 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.551 HG13 HD23 ' A' ' 255' ' ' LEU . 75.4 mt -136.41 125.51 37.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.454 -0.779 . . . . 0.0 109.451 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -114.21 132.08 56.24 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.511 0.672 . . . . 0.0 109.932 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.05 134.66 54.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.69 149.18 32.94 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.921 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -45.87 143.04 7.22 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.62 2.213 . . . . 0.0 113.447 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.2 t -156.61 144.82 19.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 146' ' ' THR . 53.5 t0 -62.75 -5.6 2.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.898 . . . . 0.0 110.332 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' ASP . 24.6 p -156.15 -167.43 2.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.359 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.0 tp -102.51 121.49 42.47 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -134.5 108.24 8.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.68 122.79 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.07 -1.019 . . . . 0.0 110.206 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 m -112.76 151.13 30.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 38.9 t80 -141.64 130.47 22.97 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.126 -1.029 . . . . 0.0 111.234 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -120.98 133.96 55.29 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.08 142.11 13.49 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.601 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -104.06 99.41 9.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -87.87 167.41 13.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.558 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -105.55 -11.53 16.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.471 -0.768 . . . . 0.0 110.72 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 159' ' ' LEU . 31.1 p-10 -98.53 -164.83 1.17 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.789 -1.195 . . . . 0.0 110.456 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -55.41 0.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 111.161 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 157' ' ' ASN . 16.5 mt -83.61 -30.4 26.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.504 -1.372 . . . . 0.0 108.565 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.27 -138.67 42.8 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -99.91 135.87 40.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -1.151 . . . . 0.0 109.306 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -144.8 159.03 43.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.435 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 149.85 33.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 110.159 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -143.63 140.67 30.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.8 m -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.705 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.548 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.6 t80 -105.2 114.39 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.44 152.95 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -49.8 126.11 13.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.175 -0.953 . . . . 0.0 108.975 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.503 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 106.24 2.11 38.49 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -121.02 21.54 11.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.248 -1.148 . . . . 0.0 109.718 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.1 pm0 -59.32 -54.7 43.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 4.3 mt-10 -41.42 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 0.0 110.085 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 171' ' ' GLU . 67.3 mm-40 -87.59 -6.99 58.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 111.731 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.56 -27.73 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.863 -1.148 . . . . 0.0 111.282 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' A' ' 81' ' ' LEU . 5.0 m -63.32 -17.27 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 108.669 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mt -90.02 -5.89 56.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.266 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.87 119.07 13.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -79.94 173.06 12.97 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.442 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -76.37 162.51 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -146.19 146.87 30.97 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.237 -1.539 . . . . 0.0 111.421 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -146.78 157.8 43.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 81.3 m-85 -100.04 146.48 26.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.94 -1.1 . . . . 0.0 109.092 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -50.14 -33.73 19.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.109 -0.995 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.6 p90 -74.33 -28.31 61.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.786 -1.197 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -75.21 -35.58 61.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 65.0 mt -52.34 -49.93 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -47.34 -41.66 19.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 110.079 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -74.34 -48.34 28.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.131 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.2 mt -52.38 -30.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.44 -53.77 5.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 0.0 109.365 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -48.88 -32.59 9.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.487 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.8 m -87.16 7.66 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.02 . . . . 0.0 110.506 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.73 39.88 54.38 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.083 -1.01 . . . . 0.0 110.725 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.53 174.75 9.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -1.216 . . . . 0.0 109.808 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.7 22.13 52.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -57.97 -19.91 34.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.679 -1.483 . . . . 0.0 109.63 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.32 10.34 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 125.47 7.76 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 120.859 -1.377 . . . . 0.0 109.72 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.4 t -143.27 169.47 17.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -1.146 . . . . 0.0 109.806 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.56 -8.73 36.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -13.26 25.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -136.18 11.32 3.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.14 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.433 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.06 149.28 30.09 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 110.275 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.3 tp -98.94 93.32 5.96 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 203' ' ' THR . 48.8 t -86.1 130.03 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.738 0.78 . . . . 0.0 109.019 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.41 164.92 18.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.632 -0.667 . . . . 0.0 109.365 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -127.03 -166.6 12.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -61.69 -32.43 72.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 109.552 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.6 22.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -142.09 149.17 39.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.808 -1.183 . . . . 0.0 110.688 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.407 HG11 ' HA2' ' A' ' 216' ' ' GLY . 87.6 t -101.96 111.32 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -58.23 -47.01 84.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 110.063 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.16 124.17 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 109.787 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -67.09 -18.07 51.16 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.57 1.514 . . . . 0.0 111.965 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 -15.34 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.923 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.13 -163.53 53.99 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.638 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -91.55 148.35 22.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.207 . . . . 0.0 109.833 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -87.0 -18.36 30.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 108.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.499 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 60.2 m-85 -137.73 178.69 6.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -82.88 -14.18 54.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.68 52.25 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.514 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -58.18 -48.19 97.47 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.039 -1.038 . . . . 0.0 109.89 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.8 Cg_exo -49.79 -68.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 228' ' ' VAL . 20.7 m -58.77 -34.71 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.005 -1.059 . . . . 0.0 109.604 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.499 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 56.2 mtt180 -61.23 -41.18 96.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -67.26 -31.65 72.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.326 -0.95 . . . . 0.0 108.692 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 12.8 mmtp -66.07 -37.33 85.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 166' ' ' PHE . 56.0 t -67.3 -35.87 75.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.1 t80 -65.84 -54.77 22.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.554 0.693 . . . . 0.0 109.236 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.11 -27.91 69.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.753 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.67 -34.08 58.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 108.394 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.79 -39.45 85.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -57.88 8.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.411 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 78.6 m-20 -51.4 -34.65 35.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -1.23 . . . . 0.0 109.001 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.6 mt -62.52 -22.76 66.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.038 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.08 -22.97 60.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.857 -1.152 . . . . 0.0 108.919 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 237' ' ' LEU . 94.6 mt -50.15 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.699 -1.251 . . . . 0.0 109.909 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 236' ' ' TYR . 9.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.478 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 1.42 59.33 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.485 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.95 156.93 10.08 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.012 -1.287 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.36 150.35 8.09 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.966 1.778 . . . . 0.0 109.655 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.07 143.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 112.133 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.01 121.53 33.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.49 175.27 23.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -101.9 135.26 43.77 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.203 -1.175 . . . . 0.0 109.276 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.8 m-85 -130.76 136.52 48.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.288 -0.882 . . . . 0.0 109.596 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -126.17 126.15 43.64 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 m -119.42 133.08 55.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.853 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.539 ' CZ ' ' NE ' ' A' ' 250' ' ' ARG . 74.8 t80 -115.34 112.83 22.96 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.539 ' NE ' ' CZ ' ' A' ' 249' ' ' PHE . 71.4 mtt180 48.41 32.48 3.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.81 165.26 54.71 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -140.33 179.64 18.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.588 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.4 m-70 -59.64 -41.62 90.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -1.203 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.091 -1.006 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 139' ' ' ILE . 5.8 tp -57.94 -45.13 87.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.424 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 11.0 m-20 -47.42 -51.25 20.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.989 -1.07 . . . . 0.0 109.077 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 56' ' ' THR . 71.3 t -62.91 -44.71 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -0.793 . . . . 0.0 109.849 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -58.75 -50.08 75.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 0.0 109.292 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.86 -49.18 69.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 108.695 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 238' ' ' LEU . 17.2 t -60.43 -58.2 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.077 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -43.32 17.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 109.061 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 130' ' ' ILE . 2.8 mm-40 -66.24 -47.12 74.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.32 -49.63 76.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 268' ' ' LYS . . . -70.48 -28.6 65.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.78 -50.7 48.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.023 -1.048 . . . . 0.0 109.859 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -69.97 -45.95 66.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.538 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.74 23.27 3.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 264' ' ' ALA . 24.7 mmtm 48.92 -150.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.302 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.526 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.16 159.66 14.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.601 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 85' ' ' THR . 9.4 mm-40 -54.45 139.65 36.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 108.71 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -122.66 146.27 47.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 110.234 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -143.61 -171.62 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.0 m -99.35 135.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.971 -1.081 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -65.19 -21.61 66.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.778 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.591 ' HG2' HD21 ' A' ' 113' ' ' ASN . 18.7 pt-20 -152.86 158.72 42.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 140.46 58.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.288 -0.883 . . . . 0.0 110.055 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -118.22 164.8 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -131.32 139.87 49.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 110.18 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -138.05 146.23 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.1 154.05 24.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 110.349 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.87 175.21 36.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.33 151.68 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -1.07 . . . . 0.0 110.069 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.75 138.66 15.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CG2' HD13 ' A' ' 98' ' ' ILE . 8.7 tt -59.73 -37.21 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -1.22 . . . . 0.0 110.403 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 29.6 m-70 -89.66 -50.66 5.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.66 -1.275 . . . . 0.0 111.08 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 p -70.66 -24.26 62.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.797 -0.565 . . . . 0.0 111.822 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.21 14.64 26.7 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.146 -1.502 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.07 155.38 19.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -1.142 . . . . 0.0 109.407 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -75.24 134.53 41.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m -137.55 145.84 43.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -114.54 155.26 26.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.451 -0.78 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 96' ' ' ILE . 9.1 mt -136.25 144.19 44.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.643 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' NE2' ' A' ' 29' ' ' HIS . 4.7 mp -139.49 112.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.81 115.76 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.349 -0.845 . . . . 0.0 110.858 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.562 ' NE2' HG22 ' A' ' 27' ' ' ILE . 19.6 m-70 -106.96 139.68 20.64 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.495 -0.753 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.3 Cg_exo -56.46 168.24 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.533 1.489 . . . . 0.0 111.238 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 35' ' ' THR . 50.1 mm-40 -144.51 163.39 34.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 109.629 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -74.55 155.42 37.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 118' ' ' ASN . 5.2 mt-10 -49.96 149.88 2.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.174 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.26 19.52 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.042 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.47 HG21 ' HB3' ' A' ' 31' ' ' GLU . 90.0 m -58.0 -48.53 79.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.555 -1.556 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.68 178.42 35.17 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mm -92.97 116.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -1.033 . . . . 0.0 108.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 35' ' ' THR . 14.1 ptp180 -144.18 151.01 38.92 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.456 -1.297 . . . . 0.0 110.883 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.97 157.06 16.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -129.87 111.83 12.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.413 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -135.19 134.88 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 110.735 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.2 27.39 2.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.608 -0.682 . . . . 0.0 111.247 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.72 66.2 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.04 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.23 120.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 108.808 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -84.77 126.06 33.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.12 -0.987 . . . . 0.0 109.192 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.1 mt -117.01 91.45 36.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.13 148.06 14.4 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.667 2.245 . . . . 0.0 112.077 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.13 70.38 9.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -128.54 174.44 9.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 109.186 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.7 p-80 -71.52 -49.58 39.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -43.19 -17.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 111.496 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.4 m-85 -100.2 -2.47 33.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.684 -1.26 . . . . 0.0 110.163 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.4 t -66.92 121.13 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.185 -0.947 . . . . 0.0 108.576 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.99 -30.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.275 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.32 136.24 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.254 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 257' ' ' VAL . 66.9 p -123.75 95.96 4.78 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.0 t-20 -162.47 129.05 3.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 108.882 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 91.6 m-70 50.19 8.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 108.983 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.26 147.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.851 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 m -90.13 128.29 36.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.322 -0.861 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.75 150.6 41.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.478 -0.763 . . . . 0.0 111.056 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.542 HD12 HG11 ' A' ' 72' ' ' VAL . 9.0 mt -123.89 149.49 45.78 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.02 150.31 20.42 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -162.82 148.17 12.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.423 -1.045 . . . . 0.0 108.965 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.452 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.06 25.93 2.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 109.677 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.92 5.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.549 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 5.3 mm-40 -57.45 145.1 34.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -1.221 . . . . 0.0 109.152 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.58 137.71 26.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 110.407 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 96' ' ' ILE . 55.5 mt -131.18 125.94 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -101.08 156.21 17.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.023 -1.048 . . . . 0.0 111.294 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.0 m 51.79 75.29 0.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 HD12 ' A' ' 62' ' ' LEU . 34.9 m -107.52 -9.06 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.11 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pm0 -61.4 -26.34 67.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 0.0 110.361 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 30.8 m170 -68.2 -69.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.068 -1.02 . . . . 0.0 109.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -51.88 -48.42 39.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.197 -0.939 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.605 ' N ' HG23 ' A' ' 75' ' ' ILE . 13.1 mt -51.86 -48.8 63.87 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.006 -1.058 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -60.26 -43.09 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.119 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 106' ' ' PHE . 94.8 t -56.67 -45.69 82.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 109.193 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 89' ' ' ILE . 25.6 mt -65.97 -34.37 77.96 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.212 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -63.37 -37.0 85.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.316 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 171' ' ' GLU . 78.3 mt -77.13 -38.91 51.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 107' ' ' TYR . 96.1 mt -80.64 6.53 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 110.034 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 52.36 39.73 27.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 110.07 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.69 141.66 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 108.267 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.61 HG21 HG12 ' A' ' 121' ' ' ILE . 54.9 p -128.98 -22.6 3.17 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.114 -0.991 . . . . 0.0 111.873 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.681 ' O ' HG13 ' A' ' 87' ' ' VAL . 76.9 m-20 -124.0 107.72 11.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.874 -1.141 . . . . 0.0 110.278 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.8 142.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.519 -0.738 . . . . 0.0 110.138 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 96.0 m -109.42 111.46 23.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 79' ' ' LEU . 6.5 mt -93.97 100.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 110.311 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -75.08 125.46 28.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.612 HG22 HD21 ' A' ' 26' ' ' LEU . 16.1 t -114.75 118.39 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.947 0.879 . . . . 0.0 111.675 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' ILE . 11.0 mt -105.4 98.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.84 -159.23 27.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 -13.63 8.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -1.135 . . . . 0.0 110.421 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -138.73 146.99 42.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.979 -1.076 . . . . 0.0 109.676 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.68 HG23 HD11 ' A' ' 26' ' ' LEU . 43.5 mm -70.08 119.83 74.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 108.706 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.27 124.49 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.88 1.72 . . . . 0.0 111.62 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.497 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.0 tp -76.39 -15.42 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 110.206 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.7 mt 55.36 -123.14 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -92.66 8.97 36.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.15 -7.87 69.63 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.47 -1.348 . . . . 0.0 109.973 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.2 p -124.02 -172.1 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.61 -0.936 . . . . 0.0 109.16 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.62 13.71 11.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 48.3 t-105 -56.08 -42.33 76.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -1.125 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.27 -54.78 31.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 78' ' ' VAL . 10.3 m-85 -54.85 -46.49 74.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.118 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 82' ' ' LEU . 34.5 t80 -60.69 -56.54 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.731 -0.606 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 13.6 mm-40 -58.88 -44.01 91.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.145 -0.972 . . . . 0.0 111.337 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.6 -51.79 46.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.964 -1.085 . . . . 0.0 110.719 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.7 mt -69.31 -31.87 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.155 . . . . 0.0 109.344 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.46 -43.22 94.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 110.258 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.23 17.05 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.591 HD21 ' HG2' ' A' ' 9' ' ' GLU . 2.3 m120 -144.05 29.04 1.35 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -0.999 . . . . 0.0 110.169 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.7 mt -79.61 141.35 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.607 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.58 123.47 33.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.612 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.97 141.0 37.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.94 . . . . 0.0 110.314 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.85 -175.74 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.394 -0.816 . . . . 0.0 109.26 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.487 ' OD1' ' OE2' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -109.66 70.09 0.72 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.085 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -169.22 134.03 1.48 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.082 -1.011 . . . . 0.0 109.503 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.13 142.56 54.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.61 HG12 HG21 ' A' ' 85' ' ' THR . 35.0 mt -84.79 150.16 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 110.024 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.74 90.0 4.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -68.94 148.03 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.94 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -90.12 101.98 14.69 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.22 134.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.612 -0.68 . . . . 0.0 111.204 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.21 118.72 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.51 -27.04 15.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.522 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.18 152.5 79.66 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 151.52 46.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.64 2.226 . . . . 0.0 112.286 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.46 ' HB ' ' HZ3' ' A' ' 266' ' ' LYS . 7.9 tt -160.04 153.15 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.336 -0.853 . . . . 0.0 109.29 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.11 145.31 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.84 149.29 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 138' ' ' LEU . 28.8 mt-10 -139.85 157.86 45.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.132 -0.98 . . . . 0.0 110.196 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.86 111.35 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.252 -0.905 . . . . 0.0 109.93 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 52.47 48.19 23.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.541 -0.724 . . . . 0.0 110.833 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.6 -33.59 3.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.366 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 1.5 mpt_? -64.31 131.95 48.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.915 -1.344 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -145.03 141.63 29.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 110.357 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 255' ' ' LEU . 92.4 mt -136.88 132.18 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.779 . . . . 0.0 109.859 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.43 133.04 56.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.413 0.625 . . . . 0.0 110.007 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.71 135.33 53.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.727 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.02 149.62 39.51 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.868 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -48.48 142.4 17.73 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.523 2.149 . . . . 0.0 113.382 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.12 145.19 19.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.97 -30.43 70.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -127.01 -171.14 2.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.74 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.467 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 12.3 tp -100.15 123.46 44.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.163 -0.96 . . . . 0.0 108.675 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 tt0 -136.28 118.03 15.07 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.233 -0.917 . . . . 0.0 108.555 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.84 122.2 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.47 ' OG1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 m -113.15 152.05 30.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.479 -0.763 . . . . 0.0 109.679 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 227' ' ' LYS . 39.2 t80 -138.78 130.79 28.08 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.948 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -119.98 130.44 54.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.78 135.64 8.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.645 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -98.55 100.39 11.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.79 167.02 13.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 110.66 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -102.84 -22.53 13.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.912 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' LEU . 26.0 p-10 -88.05 -171.42 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.701 -1.249 . . . . 0.0 109.986 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -52.23 1.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 111.458 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.5 mt -79.44 -28.58 41.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.353 -1.467 . . . . 0.0 108.71 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.05 -142.55 35.15 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -99.6 135.65 40.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.8 mm100 -138.26 153.5 49.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.812 . . . . 0.0 109.41 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -141.22 144.85 34.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.288 -0.882 . . . . 0.0 109.754 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.583 ' CE1' ' NH2' ' A' ' 225' ' ' ARG . 49.2 t80 -142.05 132.89 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.661 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 86.9 m -103.78 122.68 45.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.2 t80 -103.83 114.06 28.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.9 152.79 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.737 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 3.2 mm-40 -49.96 128.19 18.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.69 1.81 43.1 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -117.83 20.29 13.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.15 -51.47 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 5.0 mt-10 -47.76 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 171' ' ' GLU . 9.3 mm-40 -102.94 -6.11 22.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.123 -0.985 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.7 pt -125.16 -26.84 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.959 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 175' ' ' VAL . 5.2 m -62.13 -10.66 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.815 -1.178 . . . . 0.0 109.106 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -98.46 -2.17 39.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 0.0 109.078 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.498 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -65.44 122.2 16.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 0.0 109.283 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 215' ' ' GLU . 52.5 mtm180 -94.23 128.27 40.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.869 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 12.5 t -36.53 158.67 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -145.2 150.0 35.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.51 -1.369 . . . . 0.0 111.49 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.569 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -147.39 157.05 43.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.6 m-85 -97.7 145.52 26.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.442 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.97 -37.11 8.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.363 -0.835 . . . . 0.0 109.278 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -74.29 -29.56 61.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.1 mm-40 -71.52 -31.64 67.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 59.6 mt -57.24 -55.07 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.669 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.8 tt0 -42.85 -38.74 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.13 -0.981 . . . . 0.0 109.302 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 189' ' ' ILE . 9.3 t60 -76.3 -59.34 2.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.051 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 188' ' ' HIS . 82.9 mt -41.75 -36.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.698 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -79.43 -51.83 8.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.875 -1.141 . . . . 0.0 109.226 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -49.35 -27.17 3.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 110.709 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.51 11.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.746 -1.221 . . . . 0.0 110.086 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.44 39.54 69.35 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.433 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.1 mt -129.61 172.59 11.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -1.179 . . . . 0.0 109.998 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.99 21.84 59.54 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -58.93 -21.19 57.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.463 -1.61 . . . . 0.0 109.749 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.56 25.51 11.03 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -87.49 132.94 11.48 Favored Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.923 -1.34 . . . . 0.0 109.921 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.9 174.39 11.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -1.095 . . . . 0.0 109.564 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.18 -7.52 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 108.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -97.51 -19.97 18.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.603 -0.686 . . . . 0.0 110.003 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.8 p30 -125.68 3.35 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -144.54 145.35 31.79 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.636 HD11 HD21 ' A' ' 206' ' ' LEU . 25.8 tp -96.35 96.13 8.54 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.53 128.22 39.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.9 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.636 HD21 HD11 ' A' ' 204' ' ' LEU . 29.7 mt -123.38 162.99 21.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.539 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.2 -166.28 12.74 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -24.54 66.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.457 -1.025 . . . . 0.0 109.966 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.6 24.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -151.97 160.47 43.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.515 -1.365 . . . . 0.0 110.643 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.559 HG11 ' HA2' ' A' ' 216' ' ' GLY . 88.5 t -106.08 114.01 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -57.56 -46.94 83.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 110.46 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 213' ' ' ASN . 1.3 m-20 -59.31 130.39 87.21 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.17 -0.956 . . . . 0.0 110.53 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -67.88 -21.62 43.77 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.682 1.588 . . . . 0.0 111.688 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -80.71 -15.46 56.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.957 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.559 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.51 -157.5 53.29 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.262 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.6 mt -89.19 154.44 20.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -1.138 . . . . 0.0 110.138 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -90.14 -19.54 24.14 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -138.75 -176.5 4.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 19.2 mp0 -83.6 -20.16 34.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 109.529 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.507 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -136.12 54.7 1.89 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -57.59 -46.31 99.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.893 -1.13 . . . . 0.0 109.848 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.6 Cg_exo -52.67 -66.26 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.221 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 225' ' ' ARG . 21.9 m -59.69 -36.07 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 109.512 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.583 ' NH2' ' CE1' ' A' ' 164' ' ' PHE . 74.6 mtt-85 -59.79 -41.21 90.67 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.498 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 7.5 t60 -68.17 -31.64 71.34 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.1 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.511 ' HE2' H211 ' A' ' 500' ' ' C90 . 16.9 mmtt -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 166' ' ' PHE . 64.3 t -69.17 -38.37 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.3 t80 -62.56 -51.34 67.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 108.892 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 91.9 m-20 -64.76 -29.51 70.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.526 -0.733 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.87 -33.77 51.97 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.3 mt -65.76 -37.81 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.22 -56.1 11.29 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.425 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 92.4 m-20 -52.67 -37.14 58.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.246 . . . . 0.0 109.309 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.2 mt -60.04 -24.04 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 110.497 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.592 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -70.66 -21.58 62.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.783 -1.198 . . . . 0.0 108.792 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.13 3.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.56 -1.338 . . . . 0.0 110.318 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 260' ' ' VAL . 7.7 mt -82.98 -16.47 47.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 0.0 109.585 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.17 44.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.913 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.75 158.69 11.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.428 . . . . 0.0 109.297 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.15 128.3 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.874 1.716 . . . . 0.0 109.456 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.1 t -87.86 154.56 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.992 -1.068 . . . . 0.0 112.387 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -136.26 127.57 28.3 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.38 -155.0 25.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.47 ' NZ ' ' OG1' ' A' ' 150' ' ' THR . 19.9 tptt -133.49 127.49 33.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 108.697 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -127.82 140.76 51.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.313 -0.867 . . . . 0.0 110.572 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -123.65 133.91 53.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.5 t -127.26 134.89 50.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.952 -1.092 . . . . 0.0 110.95 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -116.91 115.82 26.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 47.44 24.37 0.47 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.168 -0.957 . . . . 0.0 109.248 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 152.92 37.45 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.58 166.6 22.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.592 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 60.0 m-70 -48.77 -40.68 29.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.131 -1.217 . . . . 0.0 109.531 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -54.91 -58.53 7.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.54 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 139' ' ' ILE . 7.8 tp -57.14 -45.48 83.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.646 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.2 m-20 -47.51 -51.26 21.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.361 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 56' ' ' THR . 87.9 t -62.72 -50.55 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.928 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -52.05 -52.2 52.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.008 . . . . 0.0 109.356 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 139' ' ' ILE . 37.0 tp -51.28 -51.33 55.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 108.533 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.609 HG13 ' HG ' ' A' ' 238' ' ' LEU . 69.0 t -53.93 -50.07 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.918 . . . . 0.0 108.828 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -51.23 -55.16 19.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.515 -0.74 . . . . 0.0 109.732 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.19 -49.91 75.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 110.022 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.5 mt -56.7 -52.11 66.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.1 67.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.272 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -69.03 -57.41 5.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.46 ' HZ3' ' HB ' ' A' ' 130' ' ' ILE . 31.5 pttt -69.43 -36.05 76.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 268' ' ' LYS . 2.2 mm100 -71.07 -9.01 57.31 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.066 -1.021 . . . . 0.0 110.099 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 267' ' ' GLN . 5.8 ptmt 35.39 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.688 -0.632 . . . . 0.0 110.123 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.3 tp . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.569 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' O ' HD11 ' A' ' 121' ' ' ILE . 6.9 mt -101.1 160.23 14.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.437 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -58.0 136.62 57.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 109.063 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.675 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -120.96 141.58 50.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 109.54 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -139.19 -170.12 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 29.8 m -99.57 136.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.022 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -66.47 -16.67 64.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -156.18 159.85 39.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 139.21 57.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 110.228 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 11' ' ' LEU . 57.2 mt -117.66 165.41 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.66 144.51 39.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.957 -1.089 . . . . 0.0 110.483 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.7 m-85 -140.41 155.35 46.77 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -162.11 152.81 17.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.782 -1.199 . . . . 0.0 110.275 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.4 176.83 36.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.53 153.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.179 . . . . 0.0 110.424 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.62 141.13 16.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.1 tt -61.51 -41.29 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 111.026 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.5 m-70 -87.1 -50.49 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.534 -1.354 . . . . 0.0 111.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -70.24 -22.82 62.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 111.363 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.0 20.65 35.01 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.931 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -110.86 154.1 24.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.65 135.4 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -139.67 143.37 37.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -112.38 154.39 25.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.324 -0.86 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 96' ' ' ILE . 7.9 mt -132.43 148.98 52.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.367 -0.833 . . . . 0.0 110.312 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.501 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.0 mt -143.58 110.78 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.52 117.44 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 111.032 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.501 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.0 m-70 -110.65 138.84 21.14 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.458 -0.776 . . . . 0.0 109.701 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.4 Cg_exo -54.28 168.58 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.958 1.772 . . . . 0.0 111.79 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 50.3 mm-40 -140.86 177.49 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.918 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.0 mttt -86.02 153.0 22.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.393 -0.817 . . . . 0.0 110.136 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -47.25 145.67 2.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.089 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.3 7.33 51.58 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.128 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.6 m -69.56 -43.68 72.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.659 -1.495 . . . . 0.0 109.56 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.73 -178.96 32.72 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.359 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.15 116.52 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 8.8 ptm180 -140.26 150.86 44.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.822 -1.174 . . . . 0.0 110.382 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.66 157.4 16.71 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -129.43 110.97 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.181 -0.949 . . . . 0.0 108.877 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.555 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 32.7 tttm -135.64 135.26 40.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.534 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 15.2 m120 52.85 28.88 6.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 111.19 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.27 18.1 78.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.958 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -122.7 122.22 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -1.028 . . . . 0.0 108.808 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 42.1 m-85 -83.84 126.5 33.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.089 -1.007 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -115.39 95.64 43.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.31 145.04 22.04 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.427 2.085 . . . . 0.0 112.081 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.24 74.8 10.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -132.79 -179.91 5.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.381 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.6 p-80 -75.78 -53.26 8.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.129 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -43.28 -17.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.232 -0.918 . . . . 0.0 110.963 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.2 m-85 -97.63 1.31 48.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.735 -1.228 . . . . 0.0 109.837 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' HD23 ' A' ' 62' ' ' LEU . 48.8 t -71.54 131.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.099 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -30.05 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -151.08 133.49 15.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.685 HG21 HG21 ' A' ' 257' ' ' VAL . 76.2 p -124.38 95.44 4.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.207 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 59' ' ' SER . 46.0 t-20 -162.97 128.86 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 47.4 11.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 108.969 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 163.37 141.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.344 -0.847 . . . . 0.0 110.098 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.436 HG21 HD11 ' A' ' 237' ' ' LEU . 86.2 m -90.62 127.97 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.376 -0.828 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.42 151.75 39.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.664 0.745 . . . . 0.0 111.002 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 53' ' ' VAL . 10.8 mt -126.23 148.23 49.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.63 154.14 25.12 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.088 -1.529 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -165.31 152.95 11.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt 50.69 22.26 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.13 -33.48 6.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -56.22 147.34 21.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.229 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.9 135.55 26.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.272 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.36 126.11 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -103.29 156.23 17.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.968 -1.082 . . . . 0.0 111.078 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.8 m 51.64 75.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.943 -0.473 . . . . 0.0 110.818 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.3 m -108.07 -10.32 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.5 pm0 -61.45 -26.8 68.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.906 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.427 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.0 m170 -66.35 -68.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.574 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.8 tp -52.07 -47.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 109.161 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 48' ' ' ALA . 17.5 mt -52.33 -49.15 64.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 17.5 t -59.73 -43.17 94.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.35 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.71 -44.6 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.975 -1.078 . . . . 0.0 109.101 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.56 -36.07 80.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.964 . . . . 0.0 109.588 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.72 -35.58 78.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.579 HD13 ' CB ' ' A' ' 171' ' ' GLU . 68.1 mt -79.47 -36.93 37.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.38 -0.825 . . . . 0.0 109.843 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 114' ' ' ILE . 94.8 mt -83.52 4.12 29.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.084 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 53.59 40.62 31.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.556 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 5' ' ' LYS . 27.3 mm -85.33 142.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 42.5 p -129.81 -22.61 2.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.186 -0.946 . . . . 0.0 111.612 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.698 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -125.2 107.03 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.744 -1.223 . . . . 0.0 110.035 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.9 m -164.3 148.55 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.616 0.722 . . . . 0.0 110.008 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.496 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 57.4 m -117.19 108.19 15.37 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.436 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -90.18 100.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.804 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 26' ' ' LEU . 10.6 tt0 -73.78 125.14 27.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.99 119.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.815 0.817 . . . . 0.0 111.542 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -105.94 97.75 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.56 -158.77 27.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -120.49 -13.03 8.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -139.56 148.23 42.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 109.707 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 HD11 ' A' ' 26' ' ' LEU . 45.7 mm -71.66 120.76 81.81 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 108.943 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.05 120.23 1.45 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.733 1.622 . . . . 0.0 111.629 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.459 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.2 tp -78.38 -15.8 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.8 mt 55.76 -115.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.267 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.82 5.6 50.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.032 -1.043 . . . . 0.0 110.797 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.96 0.7 61.83 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.147 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -126.7 -172.87 2.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.661 -0.905 . . . . 0.0 109.629 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.33 16.7 8.02 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -57.77 -41.73 82.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -1.08 . . . . 0.0 110.086 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -64.54 -57.15 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.105 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 14.7 m-85 -51.57 -46.55 63.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.97 . . . . 0.0 109.348 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -61.03 -51.04 70.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.667 -0.646 . . . . 0.0 110.941 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.18 -42.45 96.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.002 -1.061 . . . . 0.0 111.245 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.91 -58.49 4.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.5 -34.4 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.099 -1.001 . . . . 0.0 109.577 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -63.25 -42.21 99.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.98 . . . . 0.0 109.26 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 11.86 0.81 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.465 ' HA ' ' HZ2' ' A' ' 8' ' ' LYS . 3.5 m-80 -146.24 33.64 0.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.557 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 70.2 mt -78.19 139.59 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.742 -1.224 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 8' ' ' LYS . 31.8 tp -127.7 121.96 31.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -0.779 . . . . 0.0 108.998 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.605 ' ND2' ' HZ1' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -79.04 142.59 36.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.144 -0.972 . . . . 0.0 110.354 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -111.56 -170.61 1.68 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.358 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -116.64 71.22 0.78 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.144 -0.972 . . . . 0.0 111.713 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.572 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 9.4 ttt180 -170.02 132.11 1.07 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.959 -1.088 . . . . 0.0 109.31 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.32 142.11 57.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.959 -1.088 . . . . 0.0 110.238 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 3' ' ' LEU . 89.5 mt -87.6 151.74 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.35 79.3 3.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.284 -0.885 . . . . 0.0 108.813 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 36.4 m-85 -58.78 146.67 36.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.294 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -93.11 101.91 14.22 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.75 132.68 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.359 0.599 . . . . 0.0 110.918 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.3 117.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.06 -27.57 15.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 110.662 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -134.36 150.78 74.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.549 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.98 151.42 62.12 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -157.22 150.69 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.416 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 130' ' ' ILE . 2.7 mp -138.68 136.44 43.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 108.965 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 HD11 ' A' ' 255' ' ' LEU . 29.9 m -124.64 147.48 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -130.0 164.71 23.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 0.0 110.263 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -171.82 102.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.841 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 48.05 57.43 6.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 110.731 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.05 -34.51 3.57 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -63.25 138.28 58.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.252 . . . . 0.0 109.133 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.46 137.89 28.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.082 -1.011 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 255' ' ' LEU . 46.2 mt -135.75 121.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.399 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -110.99 131.69 54.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.436 0.636 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -119.87 132.88 55.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.55 146.92 34.21 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 110.258 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -47.11 141.78 12.37 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.654 2.236 . . . . 0.0 113.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.419 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.02 144.35 19.98 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 146' ' ' THR . 4.0 t0 -66.16 0.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.792 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 145' ' ' ASP . 27.9 p -157.13 173.6 16.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.841 -1.162 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 tp -85.11 118.3 24.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -137.45 126.17 23.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 108.764 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.41 121.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.9 m -111.62 151.7 28.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.642 -0.661 . . . . 0.0 109.292 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.03 130.25 26.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.721 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -120.88 131.66 54.52 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.24 133.91 7.46 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.584 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -100.98 97.72 8.26 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -88.57 167.13 13.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.983 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -98.99 -17.05 18.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.76 -0.587 . . . . 0.0 110.697 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.0 p-10 -92.62 -168.59 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.825 -1.172 . . . . 0.0 110.386 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -55.08 0.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.362 -0.836 . . . . 0.0 111.472 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.537 HD22 ' OE1' ' A' ' 162' ' ' GLN . 11.2 mt -78.55 -27.65 45.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.443 -1.411 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.8 -137.96 34.96 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -100.4 132.3 45.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.202 -1.175 . . . . 0.0 109.682 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.537 ' OE1' HD22 ' A' ' 159' ' ' LEU . 56.4 mt-30 -139.5 155.52 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.125 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -147.93 149.5 32.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.113 -0.992 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -143.46 139.32 29.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.512 -0.742 . . . . 0.0 109.41 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.29 124.82 51.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.509 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.8 t80 -105.12 113.77 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.848 . . . . 0.0 110.327 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.0 153.06 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.316 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.01 125.61 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.248 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 102.73 3.59 49.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -120.24 19.9 12.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.307 -1.114 . . . . 0.0 109.278 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 173' ' ' GLU . 2.2 pm0 -64.88 -46.49 81.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.642 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -47.8 -7.52 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 171' ' ' GLU . 75.0 mt-10 -103.58 -5.89 22.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.482 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.4 pt -123.29 -26.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.217 -0.927 . . . . 0.0 110.558 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -60.79 -23.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.569 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.9 mt -85.27 -2.2 57.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -71.49 119.09 15.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.417 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 42.5 mtm180 -83.53 172.97 11.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.4 163.38 25.7 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -147.78 147.91 30.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.22 -1.55 . . . . 0.0 111.786 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.626 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -147.87 157.88 43.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.443 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.0 m-85 -97.85 146.94 24.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.901 -1.124 . . . . 0.0 109.78 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.52 -37.31 26.22 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.304 -0.872 . . . . 0.0 109.176 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.443 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.0 p90 -71.05 -25.56 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.13 -0.981 . . . . 0.0 109.947 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.434 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 mt-10 -82.39 -22.93 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.977 . . . . 0.0 109.742 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.85 -53.67 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.639 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.88 -38.02 9.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.686 ' O ' HG22 ' A' ' 192' ' ' VAL . 71.3 t60 -76.54 -53.78 7.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.122 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.82 -32.3 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.788 . . . . 0.0 109.533 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -52.61 6.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.039 -1.038 . . . . 0.0 109.226 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -49.84 -40.43 42.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 110.265 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 188' ' ' HIS . 28.0 m -78.55 5.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.006 -1.059 . . . . 0.0 110.218 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.96 37.21 56.71 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 194' ' ' LEU . 35.4 mt -125.39 168.89 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 109.433 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.51 21.77 58.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.74 -20.27 5.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.571 -1.547 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.447 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.67 26.32 9.05 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 128.53 9.19 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.946 -1.326 . . . . 0.0 110.034 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.8 p -144.93 171.97 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -1.056 . . . . 0.0 109.422 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.47 -8.14 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -97.06 -12.73 22.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.772 -0.58 . . . . 0.0 109.515 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.0 p30 -133.13 7.54 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 109.882 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -149.88 151.0 32.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.609 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.8 tp -98.15 95.4 7.4 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.3 t -85.87 127.76 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.788 0.804 . . . . 0.0 109.28 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.562 ' CD2' HG13 ' A' ' 211' ' ' VAL . 52.9 mt -123.24 161.47 24.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.647 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.94 -166.65 12.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -29.73 70.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -1.099 . . . . 0.0 109.672 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.66 23.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -0.944 . . . . 0.0 110.856 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -146.78 154.12 41.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.51 -1.369 . . . . 0.0 110.708 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.562 HG13 ' CD2' ' A' ' 206' ' ' LEU . 45.3 t -104.44 113.45 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -58.69 -45.62 89.06 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 109.832 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.15 116.61 18.2 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.224 -0.923 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.95 -15.4 43.51 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.475 1.45 . . . . 0.0 111.641 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.404 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.9 pm0 -75.01 -15.82 60.64 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.231 -0.918 . . . . 0.0 108.702 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.23 -178.12 47.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.609 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -83.92 145.75 28.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -1.106 . . . . 0.0 109.639 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -77.79 -18.79 56.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 108.811 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.638 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 76.0 m-85 -141.8 178.74 7.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -85.92 -3.49 58.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -146.77 45.55 1.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -55.58 -47.18 99.24 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.861 -1.149 . . . . 0.0 109.756 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.6 Cg_exo -51.37 -66.77 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.429 2.086 . . . . 0.0 112.157 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 225' ' ' ARG . 27.9 m -59.97 -36.79 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.936 -1.102 . . . . 0.0 109.63 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.638 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 75.3 mtt180 -59.77 -42.18 92.76 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.457 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 19.2 t60 -67.09 -31.66 72.29 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.06 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -66.57 -35.76 81.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.0 t -67.73 -37.73 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.449 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 66.9 t80 -64.01 -50.61 67.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.46 -28.02 67.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.3 tp -75.92 -33.02 59.87 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 28.2 mt -67.52 -39.54 82.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.28 -58.2 9.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.438 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 53.8 m-20 -51.55 -40.84 60.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -1.226 . . . . 0.0 109.249 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 235' ' ' LEU . 7.0 mt -57.18 -22.97 44.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.533 -0.729 . . . . 0.0 110.282 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.6 -22.26 61.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.841 -1.162 . . . . 0.0 108.721 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 60' ' ' THR . 92.4 mt -53.08 -1.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.727 -1.233 . . . . 0.0 110.122 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.592 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.6 mt -75.68 -14.45 60.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.052 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.91 57.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.594 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.3 m -166.52 157.2 10.96 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.867 -1.372 . . . . 0.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.5 Cg_endo -49.84 150.55 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.956 1.771 . . . . 0.0 109.712 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.7 147.95 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 111.515 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -130.34 123.97 31.19 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.51 -158.77 28.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.419 ' N ' ' HB2' ' A' ' 144' ' ' SER . 11.6 ttmt -129.55 139.82 51.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -1.128 . . . . 0.0 109.087 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 22.7 m-85 -134.74 139.84 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 110.426 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -123.39 123.29 40.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.6 m -120.54 134.36 55.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.942 -1.099 . . . . 0.0 111.074 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -115.73 115.74 26.86 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 49.71 20.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.972 -1.08 . . . . 0.0 109.054 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -50.28 156.23 2.4 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -139.7 157.28 25.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.468 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -45.32 -43.36 10.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -1.118 . . . . 0.0 110.032 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.9 p -58.46 -41.05 84.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.0 tp -74.2 -43.61 56.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 108.538 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 256' ' ' ASN . 0.8 OUTLIER -50.98 -45.73 61.13 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.092 -1.005 . . . . 0.0 109.051 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 56' ' ' THR . 77.7 t -66.13 -57.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.416 ' HE3' HD12 ' A' ' 255' ' ' LEU . 2.6 ttpt -47.41 -46.16 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.839 -1.163 . . . . 0.0 108.614 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.683 HD22 HG21 ' A' ' 139' ' ' ILE . 44.1 tp -55.04 -53.48 55.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.051 . . . . 0.0 108.791 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.592 HG13 ' HG ' ' A' ' 238' ' ' LEU . 47.6 t -54.49 -53.75 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.528 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -49.32 -46.69 47.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.83 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -64.92 -52.77 54.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.957 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 267' ' ' GLN . 22.6 mt -53.87 -51.82 62.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 110.196 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.14 -27.2 65.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.963 -1.086 . . . . 0.0 110.304 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -64.77 -59.36 4.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 110.149 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.497 ' CE ' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -81.48 -28.81 33.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.321 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.558 ' O ' ' CG ' ' A' ' 268' ' ' LYS . 3.7 tp60 -86.02 56.67 4.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.03 -1.043 . . . . 0.0 109.242 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.592 ' O ' ' NZ ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 160.57 11.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.626 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 121' ' ' ILE . 14.5 mt -117.51 162.35 18.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.988 . . . . 0.0 109.635 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -55.74 129.12 38.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 108.97 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.9 144.27 48.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.501 -0.749 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -143.83 -173.28 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 30' ' ' PRO . 16.1 m -95.44 135.01 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.087 . . . . 0.0 109.503 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.36 -20.43 66.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -154.62 156.12 35.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.435 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.78 139.85 58.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 11' ' ' LEU . 56.4 mt -118.78 168.29 10.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 p -143.64 146.53 33.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.1 m-85 -140.12 150.24 44.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -152.97 148.18 26.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.965 -1.084 . . . . 0.0 109.703 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.58 173.1 36.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.42 153.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.12 . . . . 0.0 110.311 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.57 140.76 15.51 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.4 tt -60.15 -41.52 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 110.659 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' HG23 ' A' ' 18' ' ' ILE . 88.6 m-70 -86.64 -50.8 6.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.686 -1.259 . . . . 0.0 110.875 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 p -70.96 -22.57 62.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.67 -0.644 . . . . 0.0 111.526 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.51 15.61 12.52 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -106.82 154.99 20.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 109.76 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.23 135.44 42.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 3.5 t -138.9 145.43 39.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -111.04 155.21 23.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.616 -0.677 . . . . 0.0 110.019 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 90' ' ' GLU . 9.7 mt -135.4 147.11 48.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 109.969 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 mt -143.45 109.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 108.864 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.68 113.75 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -106.76 140.0 20.92 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.489 -0.757 . . . . 0.0 109.265 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.625 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.6 Cg_exo -54.55 165.77 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.752 1.635 . . . . 0.0 111.952 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.6 mm-40 -141.39 174.39 10.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' OG1' ' A' ' 35' ' ' THR . 75.2 mttt -82.68 152.26 25.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -48.7 151.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.81 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.56 -6.94 3.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 31' ' ' GLU . 32.7 m -59.62 -44.9 93.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.784 -1.421 . . . . 0.0 109.705 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.15 -176.31 30.38 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.57 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 mm -102.52 116.79 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.93 155.13 47.31 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.608 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -102.99 158.67 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -128.88 109.14 11.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 108.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -135.53 134.5 39.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.333 -0.854 . . . . 0.0 110.995 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.7 m120 52.7 29.14 7.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.775 . . . . 0.0 111.325 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.0 18.41 76.84 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.909 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.65 123.26 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -1.062 . . . . 0.0 109.08 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -85.49 127.59 34.46 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.0 mt -116.91 93.7 42.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.69 151.42 19.37 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 111.897 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.42 70.74 10.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.759 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.952 . . . . 0.0 109.035 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.4 p-80 -69.51 -54.12 15.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.56 -17.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 111.087 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.5 m-85 -94.96 3.4 54.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.936 -1.102 . . . . 0.0 109.912 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' HIS . 96.9 t -72.24 138.94 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.19 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.76 -28.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.395 -0.815 . . . . 0.0 109.639 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.37 133.61 12.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.632 HG21 HG21 ' A' ' 257' ' ' VAL . 45.6 p -124.03 95.6 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.124 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.0 t-20 -163.09 128.71 3.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.798 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 59' ' ' SER . 30.4 m80 45.64 13.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.32 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.963 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.468 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 45.2 m -78.68 125.17 29.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 108.869 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 147.73 44.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.841 0.829 . . . . 0.0 111.206 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 15.0 mt -123.77 150.26 44.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.88 151.36 21.09 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.731 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -163.36 152.21 14.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.533 -0.981 . . . . 0.0 109.27 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt 51.3 21.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.89 6.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 13.6 mm-40 -59.26 146.39 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -1.229 . . . . 0.0 109.332 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -142.13 137.31 30.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 110.663 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 122.96 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -101.13 155.16 18.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 111.312 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 m 49.18 73.89 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.78 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 17.2 m -107.78 -8.33 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.05 -27.61 68.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.495 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 29.1 m170 -64.49 -69.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.923 -1.111 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.49 -47.59 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.23 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' N ' HG23 ' A' ' 75' ' ' ILE . 37.5 mt -52.58 -48.28 66.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 109.985 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 t -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.095 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD12 ' A' ' 110' ' ' ILE . 54.0 t -57.04 -45.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 108.981 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.09 -34.98 78.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.255 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -61.52 -36.4 80.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 171' ' ' GLU . 52.3 mt -79.75 -37.02 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.5 mt -79.33 2.07 22.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.015 -1.053 . . . . 0.0 109.802 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 54.48 39.4 31.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.513 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 2.8 mm -86.21 141.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 108.25 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.516 HG21 HG23 ' A' ' 121' ' ' ILE . 57.0 p -124.49 -21.44 4.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.028 -1.045 . . . . 0.0 111.753 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 87' ' ' VAL . 38.8 m-80 -127.24 108.06 10.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.887 -1.133 . . . . 0.0 111.048 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.0 m -162.61 146.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 89.5 m -115.85 113.75 23.79 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.568 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.5 mt -95.9 107.4 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.693 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.4 tt0 -76.75 127.15 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.38 117.51 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.742 0.782 . . . . 0.0 111.442 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.414 ' O ' ' OG ' ' A' ' 24' ' ' SER . 26.1 mm -104.51 95.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.19 -155.4 24.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.21 -10.5 8.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -1.175 . . . . 0.0 110.379 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -139.82 148.95 42.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 26' ' ' LEU . 40.8 mm -72.85 126.41 90.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 108.735 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -45.9 121.18 4.03 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 121.845 1.697 . . . . 0.0 111.004 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.9 tp -75.25 -15.64 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 110.551 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.6 mt 57.33 -120.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.96 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -96.29 6.61 48.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.062 -1.024 . . . . 0.0 110.821 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.3 61.12 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.077 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 p -128.31 -172.31 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.634 -0.921 . . . . 0.0 109.524 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.66 15.5 10.53 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -58.53 -43.27 89.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -1.098 . . . . 0.0 110.003 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.85 -59.19 4.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.008 -1.057 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -51.56 -46.29 63.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.762 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CD1' HG11 ' A' ' 175' ' ' VAL . 53.5 t80 -61.56 -51.99 66.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 110.974 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.36 -43.26 95.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 111.375 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -55.92 13.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 110.611 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.409 HD12 HG11 ' A' ' 78' ' ' VAL . 40.6 mt -63.74 -31.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 0.0 109.446 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -65.0 -41.15 95.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.069 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 113' ' ' ASN . 6.0 pttt -75.55 11.06 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.5 m-80 -139.91 34.6 1.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 110.507 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.15 139.85 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.8 -1.187 . . . . 0.0 110.949 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.2 tp -131.74 126.62 34.91 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.81 146.91 28.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.156 -0.965 . . . . 0.0 110.569 -179.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -114.2 -169.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.121 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -112.65 69.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 111.22 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 21.3 ttm-85 -164.89 132.23 3.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.993 -1.067 . . . . 0.0 109.267 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.82 141.52 55.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.066 -1.021 . . . . 0.0 109.456 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 3' ' ' LEU . 18.9 mt -81.34 146.26 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.333 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.74 81.04 4.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 43.0 m-85 -60.41 140.03 57.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -86.97 100.91 12.94 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.4 t -92.41 134.56 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.418 0.628 . . . . 0.0 111.073 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.84 114.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.7 -25.99 15.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.93 149.21 71.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.19 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.4 152.01 48.8 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.377 2.051 . . . . 0.0 111.942 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -155.2 151.58 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.361 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.54 139.23 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 255' ' ' LEU . 23.1 m -125.78 148.13 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.92 159.03 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.7 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.38 105.42 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.442 -0.786 . . . . 0.0 109.666 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 47.82 56.85 6.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.373 -0.83 . . . . 0.0 110.827 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.09 -36.84 2.87 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.464 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -61.56 129.48 41.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.964 -1.315 . . . . 0.0 108.449 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -143.57 141.01 30.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.864 -1.147 . . . . 0.0 110.242 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 259' ' ' LEU . 68.2 mt -137.62 132.36 44.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.735 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -120.47 130.76 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.373 0.606 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.64 135.76 54.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -145.29 152.63 50.85 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.078 -1.014 . . . . 0.0 109.52 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -49.95 143.17 24.82 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.412 2.075 . . . . 0.0 113.506 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -155.45 144.0 20.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -4.53 4.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.273 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.5 p -151.9 -172.08 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -100.54 121.4 41.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 108.845 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 147' ' ' LEU . 67.5 tt0 -135.05 128.82 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.76 122.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 109.966 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 39.6 m -113.71 151.92 31.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.429 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -139.69 131.12 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.938 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -120.94 133.42 55.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.93 138.49 9.84 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.649 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.03 98.04 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -84.97 167.18 16.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.576 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -104.07 -17.57 14.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 110.64 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.3 p-10 -92.17 -166.65 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.779 -1.2 . . . . 0.0 110.01 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.29 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 111.151 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.4 mt -78.68 -27.11 45.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.459 -1.4 . . . . 0.0 108.2 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.03 -141.52 33.14 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -100.27 134.99 42.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.332 -1.099 . . . . 0.0 109.275 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -139.4 153.89 47.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.51 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -144.23 145.75 32.25 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.41 -0.806 . . . . 0.0 109.545 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.564 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 16.4 t80 -145.03 140.19 27.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.173 -0.955 . . . . 0.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.415 ' OG1' ' NZ ' ' A' ' 163' ' ' LYS . 90.2 m -109.06 123.37 49.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 110.093 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.487 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.4 t80 -102.98 114.06 28.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.01 147.53 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 6.5 mm-40 -49.11 132.34 19.23 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.312 -0.867 . . . . 0.0 108.838 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.4 -9.58 30.78 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.47 25.53 10.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.209 -1.171 . . . . 0.0 109.288 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.665 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.0 OUTLIER -61.33 -15.65 38.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.0 110.496 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -81.54 -10.42 59.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.038 -1.039 . . . . 0.0 110.668 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' CZ ' ' A' ' 164' ' ' PHE . 1.5 pp20? -101.11 -5.26 25.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.052 -1.03 . . . . 0.0 110.623 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.478 HG23 ' OE2' ' A' ' 173' ' ' GLU . 16.7 pt -115.99 -31.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 171' ' ' GLU . 11.7 m -61.7 -15.45 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.842 -1.161 . . . . 0.0 108.776 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.1 mt -94.74 -4.81 46.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.561 -0.712 . . . . 0.0 109.451 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.02 120.52 14.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.006 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -81.07 172.16 14.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.74 163.66 25.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.64 145.44 27.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.252 -1.53 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -142.9 158.03 44.01 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.51 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -99.44 143.94 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.002 -1.061 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.38 -36.47 6.46 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.9 p90 -73.35 -29.81 62.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.947 -1.095 . . . . 0.0 109.889 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.5 tt0 -74.54 -27.64 60.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 109.938 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.44 HG21 HB21 ' A' ' 500' ' ' C90 . 58.5 mt -59.31 -48.76 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -47.77 -40.76 21.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.168 -0.957 . . . . 0.0 109.995 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.1 t60 -77.25 -52.92 8.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.275 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.6 mt -49.42 -27.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.418 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -85.61 -54.74 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.001 -1.062 . . . . 0.0 109.35 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -50.76 -33.78 24.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -84.66 7.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.0 -1.063 . . . . 0.0 110.08 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.93 61.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.1 mt -129.39 171.36 12.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -1.168 . . . . 0.0 110.145 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.39 29.14 62.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -58.2 -56.33 23.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.388 -1.654 . . . . 0.0 109.683 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -67.1 4.68 3.19 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.725 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.99 124.82 34.94 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.876 -1.367 . . . . 0.0 110.523 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.1 t -145.91 164.23 32.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.438 -1.036 . . . . 0.0 109.101 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.513 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 70.7 mt -67.92 -8.01 33.24 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.5 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -98.77 -9.31 24.62 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.758 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 23.6 p30 -134.54 9.66 3.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.72 150.05 30.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.4 tp -99.86 93.18 5.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 203' ' ' THR . 43.0 t -85.85 130.56 36.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.716 0.769 . . . . 0.0 108.973 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 35.2 mt -124.78 165.11 18.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.656 -0.652 . . . . 0.0 109.576 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.19 -166.4 12.23 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -25.21 67.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.747 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -163.21 23.15 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.385 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 146.67 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.016 -1.053 . . . . 0.0 110.342 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.73 109.99 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.48 -49.11 75.63 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.078 -1.014 . . . . 0.0 109.826 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.8 m120 -60.28 112.48 5.55 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.832 . . . . 0.0 110.279 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.26 -23.2 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.796 1.664 . . . . 0.0 112.783 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.61 -14.71 62.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.834 -1.166 . . . . 0.0 109.919 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.24 -168.55 52.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.614 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -90.28 138.67 31.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -75.32 -17.25 60.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.174 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.3 -173.61 3.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.7 -22.43 23.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.94 53.25 1.9 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.543 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -54.63 -47.82 96.92 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.3 Cg_exo -48.45 -64.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.391 2.061 . . . . 0.0 112.102 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.5 m -60.64 -35.8 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.793 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.472 HH11 ' CG ' ' A' ' 225' ' ' ARG . 4.0 mtt85 -60.89 -41.56 96.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.046 -1.033 . . . . 0.0 108.468 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.4 t60 -67.45 -32.3 73.07 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.434 ' HE2' H211 ' A' ' 500' ' ' C90 . 24.1 mmtt -66.53 -36.45 82.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 166' ' ' PHE . 66.2 t -67.53 -37.37 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.98 -51.48 61.51 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -64.55 -28.26 69.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 109.844 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 36.0 tp -75.06 -34.13 61.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.072 -1.018 . . . . 0.0 108.492 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.77 -39.84 84.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.04 -56.0 18.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 26.7 m-20 -54.63 -32.72 59.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.096 -1.238 . . . . 0.0 109.178 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.6 mt -63.68 -23.77 67.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.475 -0.766 . . . . 0.0 110.653 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.73 -21.79 61.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.749 -1.219 . . . . 0.0 109.105 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.9 mt -50.46 -1.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.31 . . . . 0.0 110.607 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -78.44 -15.26 58.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.771 -1.205 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.19 2.93 59.02 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.574 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.8 m -166.46 155.45 10.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.362 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.0 Cg_endo -49.63 150.55 8.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.952 1.768 . . . . 0.0 109.608 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.83 145.96 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 0.0 112.124 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -127.81 121.98 31.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.91 -179.27 30.29 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -109.43 140.7 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -1.131 . . . . 0.0 109.198 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 17.2 m-85 -135.05 138.76 44.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 110.34 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -125.0 124.75 42.67 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 m -120.19 135.78 54.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.971 -1.081 . . . . 0.0 111.429 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 251' ' ' GLY . 75.8 t80 -115.28 117.06 29.41 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' PHE . 63.3 mtp180 45.98 22.37 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.065 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -51.9 159.41 2.61 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -139.1 164.3 25.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 34.1 m-70 -50.28 -42.76 52.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.149 -1.206 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.1 m -56.98 -59.2 5.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.4 tp -53.51 -45.64 69.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.381 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -49.54 -50.53 41.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 0.0 109.666 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 56' ' ' THR . 98.5 t -62.41 -55.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.805 . . . . 0.0 110.197 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 255' ' ' LEU . 1.0 OUTLIER -52.0 -45.2 64.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 108.79 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 139' ' ' ILE . 24.6 tp -52.99 -54.47 34.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.488 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.564 HG13 ' HG ' ' A' ' 238' ' ' LEU . 30.6 t -55.86 -54.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -43.98 33.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.35 -49.99 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 109.861 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 13.9 mt -56.94 -47.59 80.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.34 -30.77 69.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -67.5 -42.8 82.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 109.568 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 268' ' ' LYS . 23.5 mttt -78.54 -54.16 6.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.889 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -70.41 53.26 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 266' ' ' LYS . 26.6 mtmt -60.48 -176.03 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.549 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.4 mt -91.88 157.47 16.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -1.166 . . . . 0.0 109.649 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -54.62 137.35 43.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.083 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 142.72 49.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.495 -0.753 . . . . 0.0 109.717 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -141.51 -171.63 3.35 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 30.3 m -96.86 135.15 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.049 . . . . 0.0 109.162 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -21.26 66.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.585 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -153.0 160.76 43.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 0.0 109.275 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 140.59 54.48 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 0.0 110.022 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.14 163.93 15.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 141.9 46.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.091 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 98.0 m-85 -139.84 146.24 39.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' CG ' ' OH ' ' A' ' 23' ' ' TYR . 3.8 pt-20 -151.88 149.35 28.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 109.908 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.87 172.27 35.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.28 151.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -1.087 . . . . 0.0 110.357 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.37 137.1 15.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' HG21 ' A' ' 179' ' ' THR . 6.7 tt -56.26 -38.74 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 68.8 m-70 -91.07 -49.21 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.845 -1.159 . . . . 0.0 111.105 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 22' ' ' GLU . 2.9 p -69.49 -21.76 63.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 111.416 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.03 8.31 3.05 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 20' ' ' THR . 3.4 mm-40 -102.69 157.34 17.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -1.108 . . . . 0.0 109.672 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' OH ' ' CG ' ' A' ' 14' ' ' GLU . 81.8 t80 -74.66 136.58 41.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.466 -0.771 . . . . 0.0 109.734 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -137.67 142.66 41.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -108.39 151.91 25.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -134.74 144.29 47.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -142.45 110.48 2.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.607 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -94.95 115.92 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 111.168 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.592 ' NE2' HG22 ' A' ' 27' ' ' ILE . 27.8 m-70 -109.41 139.73 21.38 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.482 -0.761 . . . . 0.0 109.585 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.5 Cg_exo -54.43 168.13 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.662 1.574 . . . . 0.0 111.434 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' HB3' HG21 ' A' ' 35' ' ' THR . 73.4 mm-40 -139.99 173.35 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.001 . . . . 0.0 110.04 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.9 mtmt -81.98 149.78 27.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.493 -0.754 . . . . 0.0 109.742 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -46.79 145.43 1.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.341 -0.849 . . . . 0.0 109.823 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 69.77 8.22 60.19 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.312 -0.947 . . . . 0.0 110.878 179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.578 ' H ' HD21 ' A' ' 86' ' ' ASN . 26.5 m -73.61 -43.47 59.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.598 -1.531 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.46 -177.61 33.5 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.603 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.11 117.1 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -140.42 151.69 45.1 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.212 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.62 157.38 16.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.56 110.87 12.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 42.5 tttm -135.23 133.95 39.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 50.7 29.44 4.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.47 -0.769 . . . . 0.0 111.213 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.84 19.14 73.69 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.144 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.9 t -122.47 120.98 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -1.08 . . . . 0.0 109.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.7 m-85 -84.61 127.59 34.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.086 -1.008 . . . . 0.0 109.401 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -117.18 93.99 43.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.523 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.72 148.31 16.24 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.558 2.172 . . . . 0.0 112.206 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.64 69.08 10.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -0.952 . . . . 0.0 109.175 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -118.94 163.98 16.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -0.812 . . . . 0.0 109.291 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.546 ' CD2' ' CD ' ' A' ' 51' ' ' GLU . 1.2 p-80 -68.85 -50.07 53.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 0.0 109.578 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.546 ' CD ' ' CD2' ' A' ' 50' ' ' HIS . 42.8 mp0 -46.19 -16.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.632 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.6 m-85 -95.79 3.53 53.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.851 -1.156 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.7 t -71.15 128.73 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 108.735 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.38 -21.73 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.389 -0.819 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -156.26 125.89 6.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.907 -1.12 . . . . 0.0 110.009 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.836 HG21 HG21 ' A' ' 257' ' ' VAL . 38.5 p -121.03 95.56 4.75 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' SER . 44.7 t30 -162.78 128.74 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 87.9 m-70 51.91 7.22 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.97 . . . . 0.0 108.854 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m 164.22 153.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.0 109.786 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.464 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 30.1 m -94.05 127.37 39.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.21 -0.931 . . . . 0.0 109.215 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.36 149.67 41.96 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.758 0.79 . . . . 0.0 111.064 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.594 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.0 mt -125.35 151.81 45.59 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.68 148.0 15.55 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.802 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -159.27 145.67 16.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.972 . . . . 0.0 108.976 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER 52.94 28.01 6.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.394 -0.817 . . . . 0.0 109.473 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.12 -32.61 5.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.567 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -56.62 143.93 34.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 108.952 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.87 137.02 29.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.268 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.33 123.45 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 70' ' ' LYS . 12.5 mtpp -98.81 157.19 16.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.95 -1.093 . . . . 0.0 110.94 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m 50.77 74.61 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.55 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 62' ' ' LEU . 22.0 m -108.02 -10.39 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.197 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -61.63 -27.41 68.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 110.627 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.5 m170 -65.78 -68.6 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.976 -1.078 . . . . 0.0 109.352 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.44 -47.13 47.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.004 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.602 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.5 mt -52.59 -48.7 66.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.968 -1.082 . . . . 0.0 110.189 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 0.8 OUTLIER -61.0 -43.35 99.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.941 . . . . 0.0 110.241 -179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.69 -44.81 78.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 108.843 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.08 -34.85 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.09 -32.03 73.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' HB2' ' A' ' 171' ' ' GLU . 58.7 mt -83.74 -36.97 23.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.283 -0.886 . . . . 0.0 109.363 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 114' ' ' ILE . 94.7 mt -78.81 5.01 12.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.056 . . . . 0.0 109.513 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 52.84 39.38 28.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 110.188 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.78 138.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 108.493 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 72.6 p -123.77 -18.19 6.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 111.716 -178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 87' ' ' VAL . 2.4 m120 -126.7 107.8 10.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.864 -1.147 . . . . 0.0 111.134 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.9 m -163.5 148.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.285 -0.885 . . . . 0.0 110.054 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 18.9 m -116.38 109.1 16.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.51 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -91.86 100.88 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.333 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -73.41 127.18 31.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 26' ' ' LEU . 62.3 t -110.48 126.1 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.98 0.895 . . . . 0.0 111.925 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.6 mt -111.94 95.84 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 141.59 -156.7 25.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -120.67 -10.77 9.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -1.151 . . . . 0.0 110.449 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -140.39 148.89 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 109.47 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 26' ' ' LEU . 45.0 mm -72.59 121.38 84.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.18 -0.95 . . . . 0.0 108.927 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.96 121.97 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.624 1.549 . . . . 0.0 111.206 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.0 tp -78.66 -12.08 13.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.2 mt 56.04 -118.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -97.87 7.29 46.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.3 -0.47 61.88 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.819 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -127.08 -172.26 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.799 -0.824 . . . . 0.0 109.535 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.56 15.04 9.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 27.6 t-105 -57.59 -42.86 84.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 110.095 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.1 -57.75 8.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.103 -0.998 . . . . 0.0 110.19 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.39 -44.99 62.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.442 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 54.0 t80 -63.58 -51.26 66.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 111.261 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 8.0 mm-40 -62.67 -44.41 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.816 -1.177 . . . . 0.0 111.06 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.49 7.29 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.155 -0.966 . . . . 0.0 110.16 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 mt -62.55 -35.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 57.5 ttt-85 -60.82 -41.72 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.628 ' C ' HD22 ' A' ' 113' ' ' ASN . 2.8 mmmp? -74.87 9.45 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.884 . . . . 0.0 109.89 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.628 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.56 33.76 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.443 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 82' ' ' LEU . 66.4 mt -83.57 138.01 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.63 -1.294 . . . . 0.0 110.824 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.25 127.08 37.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.767 . . . . 0.0 109.206 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -85.92 144.91 27.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.076 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -112.23 -169.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -111.87 68.8 0.67 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.761 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -163.3 127.91 2.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 109.127 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.75 141.35 56.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.886 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 122' ' ' ASP . 94.0 mt -87.71 152.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 121' ' ' ILE . 9.1 t70 -102.23 90.84 4.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 14.4 m-85 -65.33 148.14 52.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.552 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.439 ' CD2' HD13 ' A' ' 238' ' ' LEU . 85.1 t80 -92.58 101.79 14.22 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.79 134.33 31.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 110.74 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.05 116.2 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -92.52 -29.13 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.017 -1.052 . . . . 0.0 110.369 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.91 150.04 75.44 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.36 152.11 43.79 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.551 2.168 . . . . 0.0 112.343 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.24 152.62 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.08 147.35 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.61 148.03 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -131.59 162.43 30.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.533 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.3 OUTLIER -172.41 103.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 50.76 54.89 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.333 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.54 -32.64 3.6 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.451 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.56 ' NH1' ' O ' ' A' ' 250' ' ' ARG . 88.1 mtt-85 -62.52 139.74 58.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.925 -1.338 . . . . 0.0 108.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -145.37 138.89 26.6 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.131 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.748 HG21 HD22 ' A' ' 259' ' ' LEU . 78.8 mt -137.56 125.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.579 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -113.41 132.86 55.46 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.393 0.616 . . . . 0.0 109.995 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 130.21 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.0 149.09 47.96 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.028 -1.045 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.59 142.88 9.35 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.677 2.251 . . . . 0.0 113.546 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -157.18 146.15 19.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.39 -3.36 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 p -149.08 -179.16 6.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.967 -1.083 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.2 tp -97.32 120.38 37.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 147' ' ' LEU . 56.1 tt0 -136.77 134.59 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.5 t -133.37 123.43 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.071 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.1 m -112.63 151.67 29.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.767 . . . . 0.0 109.743 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -138.17 129.37 27.37 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.653 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -120.74 131.06 54.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.22 141.6 12.51 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.753 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -106.38 101.16 10.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.94 167.1 15.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 110.964 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -99.55 -16.25 18.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.627 -0.671 . . . . 0.0 110.706 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.5 p-10 -98.53 -169.25 1.76 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.994 -1.067 . . . . 0.0 110.611 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -52.09 -0.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.502 -0.749 . . . . 0.0 111.531 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -78.04 -26.63 48.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.431 -1.418 . . . . 0.0 108.903 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.96 -140.83 34.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -104.9 134.23 48.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.067 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -138.68 158.76 43.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 109.375 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.04 145.43 31.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.383 -0.823 . . . . 0.0 109.471 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -143.74 137.17 27.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.53 124.88 51.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 110.038 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -105.77 117.78 34.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.79 153.14 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -50.71 126.35 15.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.94 -2.86 28.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -117.76 22.94 12.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.173 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 81' ' ' LEU . 11.2 pt-20 -56.43 -29.95 62.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 0.0 110.18 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.86 -19.7 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.0 -6.5 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 111.241 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.79 -26.33 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.906 -1.122 . . . . 0.0 111.314 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -60.34 -20.8 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.594 -1.316 . . . . 0.0 109.123 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.9 -2.75 58.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.556 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.2 116.48 8.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 108.881 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.521 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.8 mtm180 -81.15 172.06 14.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.8 t -80.66 162.14 24.33 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -147.49 147.08 29.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.246 -1.534 . . . . 0.0 111.527 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.698 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -144.22 158.05 43.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.531 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.4 m-85 -99.55 144.25 28.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.992 -1.067 . . . . 0.0 109.981 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.95 -38.87 53.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.531 -0.73 . . . . 0.0 109.895 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.531 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.3 p90 -66.81 -27.46 67.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 0.0 110.034 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.8 mt-10 -84.05 -43.61 14.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.097 -1.002 . . . . 0.0 109.835 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 205' ' ' VAL . 61.8 mt -40.8 -44.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.245 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.75 -37.72 76.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.995 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 185' ' ' GLU . 4.6 t-80 -76.68 -43.6 37.08 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.66 -29.57 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.504 -0.748 . . . . 0.0 109.036 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -80.98 -52.08 7.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -48.86 -45.67 41.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 110.282 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.415 HG11 ' NE2' ' A' ' 188' ' ' HIS . 19.1 m -74.89 6.49 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.03 . . . . 0.0 110.216 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.78 39.24 48.41 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.126 -0.984 . . . . 0.0 110.726 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.6 mt -126.53 176.1 7.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -1.168 . . . . 0.0 109.56 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 54.43 24.25 30.0 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -58.51 -20.89 49.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.662 -1.493 . . . . 0.0 110.306 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.11 1.74 31.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.46 126.2 35.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.963 -1.316 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' THR . 1.6 t -146.31 167.31 23.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.379 -1.071 . . . . 0.0 109.506 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.589 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 0.6 OUTLIER -68.57 -8.76 44.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 7.6 mmtp -96.67 -13.13 23.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.6 p30 -135.83 7.43 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.627 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.72 152.98 33.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 217' ' ' LEU . 15.3 tp -100.21 97.98 8.72 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 186' ' ' ILE . 53.4 t -85.49 126.86 40.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.0 mt -122.26 161.99 22.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.548 -0.72 . . . . 0.0 109.875 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.85 -166.39 12.38 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -62.89 -26.23 68.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -1.13 . . . . 0.0 109.735 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -161.29 22.77 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 110.565 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.04 147.62 40.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.865 -1.147 . . . . 0.0 110.393 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.32 112.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.29 -45.46 93.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 110.103 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.9 m120 -61.91 121.58 66.16 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 109.792 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.66 -12.62 36.19 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.486 1.457 . . . . 0.0 111.817 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.69 -16.81 56.83 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.273 -0.892 . . . . 0.0 108.945 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.26 -169.21 54.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.58 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -89.25 145.57 25.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -1.2 . . . . 0.0 109.781 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -79.42 -19.26 50.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 221' ' ' ASN . 71.2 m-85 -146.85 152.14 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.467 -0.771 . . . . 0.0 108.987 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.64 6.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -151.11 40.62 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -58.27 -47.24 99.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 109.734 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.3 Cg_exo -51.43 -67.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -58.4 -37.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 109.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 224' ' ' VAL . 44.4 mtt180 -59.96 -41.44 91.93 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.071 -1.018 . . . . 0.0 108.446 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.556 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 11.6 t60 -67.0 -31.8 72.6 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -66.77 -36.44 82.44 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 166' ' ' PHE . 92.7 t -67.15 -39.1 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.9 t80 -61.6 -52.36 64.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.559 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 93.7 m-20 -63.44 -28.37 69.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.06 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.458 HD23 ' CG1' ' A' ' 149' ' ' VAL . 40.6 tp -78.2 -33.54 49.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.945 -1.097 . . . . 0.0 108.738 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.86 -37.69 79.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.37 -55.86 11.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 29.1 m-20 -53.95 -35.48 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -1.174 . . . . 0.0 109.086 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.0 mt -63.96 -24.64 67.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.478 -0.764 . . . . 0.0 110.512 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.3 t80 -75.44 -21.66 57.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.918 -1.114 . . . . 0.0 109.361 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 237' ' ' LEU . 33.0 mt -50.79 -3.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.711 -1.243 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -72.1 -12.85 61.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.94 -1.1 . . . . 0.0 109.962 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 0.51 59.66 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.915 -1.135 . . . . 0.0 110.824 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 154.54 11.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.872 -1.369 . . . . 0.0 108.816 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.4 Cg_endo -47.94 150.04 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.622 1.548 . . . . 0.0 109.416 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.72 146.85 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.979 -1.075 . . . . 0.0 112.056 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.88 124.33 30.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 154.8 179.22 29.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.413 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.5 OUTLIER -110.87 132.53 54.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.6 m-85 -132.9 140.38 47.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.3 t80 -125.0 137.44 54.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.3 t -130.62 137.29 49.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 111.343 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -117.5 115.9 26.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.56 ' O ' ' NH1' ' A' ' 137' ' ' ARG . 5.3 mtp85 47.57 30.41 1.69 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.05 146.12 44.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.75 169.6 15.92 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 59.5 m-70 -52.94 -37.85 61.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.061 -1.258 . . . . 0.0 109.531 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -57.98 8.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.005 . . . . 0.0 109.127 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 134' ' ' ASP . 15.9 tp -61.75 -43.17 99.38 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -47.7 -51.61 21.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.133 . . . . 0.0 109.139 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 56' ' ' THR . 85.3 t -62.6 -52.16 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -51.31 -51.34 55.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 109.083 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 139' ' ' ILE . 39.8 tp -50.78 -54.82 20.37 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.702 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.449 HG13 ' HG ' ' A' ' 238' ' ' LEU . 49.7 t -55.39 -51.16 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 108.895 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -47.77 -50.5 25.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.08 -48.28 79.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.814 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 263' ' ' LEU . 23.4 mt -58.1 -49.58 76.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 268' ' ' LYS . . . -69.82 -32.99 71.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.292 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -65.47 -62.98 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.264 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -48.9 -59.18 3.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -60.61 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.449 -0.782 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 269' ' ' LEU . 19.8 mttt -137.43 93.83 2.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 268' ' ' LYS . 1.2 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.498 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.698 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mt -83.39 156.36 23.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -1.097 . . . . 0.0 109.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.81 138.93 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 108.996 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -122.58 144.9 48.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.21 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.93 -172.72 3.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 30' ' ' PRO . 32.1 m -99.03 137.89 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.865 -1.147 . . . . 0.0 109.132 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -18.24 65.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 109.898 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -155.27 156.25 35.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 109.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.08 139.54 58.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 110.234 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -117.4 160.39 21.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.89 141.98 47.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 110.232 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -140.34 150.76 44.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -161.61 151.98 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.912 -1.117 . . . . 0.0 109.848 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.62 175.71 37.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.57 152.46 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -1.181 . . . . 0.0 110.243 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' C ' ' OE2' ' A' ' 95' ' ' GLU . . . -88.24 140.29 16.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.496 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 6.2 tt -59.99 -38.39 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 111.041 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 72.2 m-70 -91.52 -46.95 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.402 -1.436 . . . . 0.0 111.039 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.594 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 p -72.15 -23.23 61.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.211 -0.931 . . . . 0.0 111.557 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.64 15.67 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.284 -1.436 . . . . 0.0 109.553 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.94 155.24 20.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -1.091 . . . . 0.0 109.748 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.69 134.98 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.429 -0.794 . . . . 0.0 109.466 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 m -137.01 144.24 43.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.37 155.98 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.453 -0.78 . . . . 0.0 109.866 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.64 143.89 39.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -139.35 114.56 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 108.667 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.18 115.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 0.0 111.006 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.567 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.6 m-70 -108.42 137.06 19.85 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.517 -0.739 . . . . 0.0 109.788 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -51.62 168.13 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.032 1.821 . . . . 0.0 111.604 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 66.9 mm-40 -146.52 155.23 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.938 . . . . 0.0 109.975 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -67.39 154.16 42.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.781 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 149.23 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 110.824 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.18 -7.45 22.92 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.26 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.53 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 93.0 m -59.33 -44.97 92.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.557 -1.555 . . . . 0.0 109.861 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.65 -175.82 33.15 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -100.42 116.54 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -141.23 150.97 43.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.764 -1.21 . . . . 0.0 110.983 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.16 157.42 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.17 114.29 15.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.93 . . . . 0.0 109.248 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 45.4 tttm -134.2 134.38 42.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.486 ' CG ' ' O ' ' A' ' 41' ' ' LYS . 7.5 p-10 44.08 42.37 4.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.877 -0.514 . . . . 0.0 112.193 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.93 15.7 78.33 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 120.695 -1.253 . . . . 0.0 110.549 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -121.43 120.65 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -1.141 . . . . 0.0 109.311 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 36.1 m-85 -86.11 127.72 34.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.481 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.87 93.43 41.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.506 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.99 145.99 17.98 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.656 2.237 . . . . 0.0 112.39 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.39 66.01 4.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.98 166.69 12.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p-80 -72.94 -49.96 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.476 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -44.11 -16.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.2 m-85 -96.84 1.94 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 50' ' ' HIS . 58.5 t -69.24 130.36 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 108.7 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.0 m -111.74 -28.94 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -152.1 130.31 11.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.911 -1.118 . . . . 0.0 110.176 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.816 HG21 HG21 ' A' ' 257' ' ' VAL . 32.9 p -120.87 94.6 4.4 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 59' ' ' SER . 38.8 t30 -163.74 129.15 2.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 108.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' SER . 37.1 m80 52.52 6.15 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.128 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.81 143.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.851 . . . . 0.0 109.683 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.457 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 37.6 m -84.72 128.08 34.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -120.73 149.46 42.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.429 -0.794 . . . . 0.0 110.751 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 72' ' ' VAL . 12.2 mt -120.74 154.59 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.98 22.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.976 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -161.78 145.79 12.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.413 -1.051 . . . . 0.0 109.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt 51.61 21.7 1.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.86 . . . . 0.0 109.323 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.26 -33.59 6.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -55.96 149.16 15.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -1.217 . . . . 0.0 109.51 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -145.89 136.32 24.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.553 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.97 128.15 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -101.27 155.51 17.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 111.605 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.8 m 50.35 74.95 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.746 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.565 HG21 ' CD1' ' A' ' 62' ' ' LEU . 18.8 m -108.4 -11.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.99 . . . . 0.0 109.566 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.4 pm0 -60.44 -26.46 66.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.406 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.8 m170 -66.32 -68.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.324 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.6 tp -52.72 -48.03 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.072 -1.018 . . . . 0.0 109.107 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.646 HD21 ' HB1' ' A' ' 48' ' ' ALA . 11.3 mt -52.33 -50.18 62.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.024 -1.048 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.7 t -59.22 -41.54 88.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 106' ' ' PHE . 76.9 t -56.36 -47.1 81.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.121 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.67 -34.05 77.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.323 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -61.95 -39.19 91.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 171' ' ' GLU . 51.1 mt -77.84 -38.51 46.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 82' ' ' LEU . 74.4 mt -80.68 -1.17 41.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 56.87 42.12 26.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.733 -0.604 . . . . 0.0 111.386 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.17 140.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.854 -1.154 . . . . 0.0 107.968 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 121' ' ' ILE . 68.8 p -124.57 -22.47 4.61 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.126 -0.984 . . . . 0.0 111.799 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.709 ' O ' HG13 ' A' ' 87' ' ' VAL . 36.5 m-80 -125.46 107.13 10.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.868 -1.145 . . . . 0.0 110.666 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -164.69 148.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.771 0.796 . . . . 0.0 110.151 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 93.5 m -114.49 113.26 24.22 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.462 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -95.29 100.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 110.345 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' OE2' ' NE2' ' A' ' 29' ' ' HIS . 33.4 mt-10 -73.41 124.84 26.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.108 -0.995 . . . . 0.0 108.361 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 26' ' ' LEU . 48.6 t -106.94 123.79 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 121.677 0.751 . . . . 0.0 111.172 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mm -109.18 96.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.52 -156.04 23.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -123.08 -12.28 7.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.319 -1.107 . . . . 0.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 20' ' ' THR . 29.3 tt0 -132.85 140.19 47.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 109.944 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 26' ' ' LEU . 45.6 mm -70.24 119.32 71.32 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 108.417 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -40.74 122.58 1.45 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.887 1.725 . . . . 0.0 111.466 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -79.0 -12.0 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.711 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.3 mt 56.42 -119.61 1.34 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 110.01 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 27.6 t0 -96.53 10.02 39.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.923 -1.111 . . . . 0.0 111.126 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.26 -1.41 62.55 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.43 -1.367 . . . . 0.0 109.843 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.02 -172.06 2.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.799 -0.824 . . . . 0.0 109.483 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.18 16.08 10.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.41 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 54.1 t-105 -57.83 -42.84 85.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.429 -1.042 . . . . 0.0 110.464 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.46 -58.96 5.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.167 -0.958 . . . . 0.0 110.092 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' HB3' HG11 ' A' ' 78' ' ' VAL . 13.7 m-85 -51.03 -45.96 61.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.382 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.403 ' CE1' ' HD2' ' A' ' 111' ' ' ARG . 36.9 t80 -61.37 -50.36 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.554 -0.716 . . . . 0.0 111.059 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 10.1 mm-40 -63.47 -44.46 94.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.946 -1.096 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.85 -53.56 38.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 0.0 110.646 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -65.04 -30.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.918 -1.114 . . . . 0.0 109.287 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' HD2' ' CE1' ' A' ' 107' ' ' TYR . 63.9 ttt-85 -65.68 -43.89 87.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.407 -0.808 . . . . 0.0 110.274 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -77.78 14.22 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.957 -1.089 . . . . 0.0 110.019 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -144.13 32.47 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 82' ' ' LEU . 78.8 mt -80.87 139.89 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.928 -1.107 . . . . 0.0 110.272 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.14 125.08 32.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.766 . . . . 0.0 109.128 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -80.57 142.29 34.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.334 -0.854 . . . . 0.0 110.169 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -110.36 -172.75 2.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.408 -0.807 . . . . 0.0 109.448 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -110.43 68.27 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 110.58 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.7 131.16 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 109.531 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.24 142.42 54.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.064 -1.022 . . . . 0.0 109.691 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 85' ' ' THR . 70.9 mt -85.44 151.34 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.815 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.71 83.42 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 108.817 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 28.6 m-85 -61.44 143.09 56.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -90.32 101.83 14.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.17 133.73 32.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.62 . . . . 0.0 110.857 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.13 112.45 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.91 -34.18 21.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.979 -1.076 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.9 149.88 72.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.5 147.93 71.89 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.318 2.012 . . . . 0.0 112.089 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -154.27 152.3 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.67 144.73 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.227 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.95 147.68 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -132.83 159.77 38.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.607 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -172.33 101.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.241 -0.912 . . . . 0.0 109.995 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 45.97 59.26 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.753 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.31 -37.92 3.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.485 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 4.5 mpt_? -63.75 130.89 46.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -144.14 139.85 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.992 -1.067 . . . . 0.0 109.769 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.522 HG21 HD22 ' A' ' 259' ' ' LEU . 98.5 mt -137.62 129.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 109.693 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -115.56 131.67 56.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.49 135.88 55.0 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -149.52 148.54 26.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 109.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -46.04 142.17 8.58 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.508 2.139 . . . . 0.0 113.326 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -155.48 143.3 19.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 146' ' ' THR . 24.7 t0 -62.75 -5.17 2.52 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.503 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 244' ' ' GLY . 30.4 p -154.96 179.1 9.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.949 -1.095 . . . . 0.0 109.859 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.25 120.19 29.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.208 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.6 123.58 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 108.646 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -124.41 122.02 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.1 m -112.25 151.94 29.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.369 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 228' ' ' VAL . 39.1 t80 -139.5 130.67 26.59 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.106 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 28.4 tt0 -121.18 131.7 54.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.43 139.19 10.45 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.469 -1.348 . . . . 0.0 111.577 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -103.0 100.66 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -86.33 167.03 15.15 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 110.6 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.57 -15.55 18.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 110.589 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 159' ' ' LEU . 23.0 p-10 -95.21 -168.12 1.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.832 -1.168 . . . . 0.0 110.131 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -56.58 3.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 111.26 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.8 mt -79.67 -28.28 40.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.454 -1.404 . . . . 0.0 108.423 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.01 -138.69 34.56 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 3.9 ttm180 -97.0 131.84 43.41 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.275 -1.133 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.467 ' OE1' ' O ' ' A' ' 161' ' ' ARG . 29.1 mm100 -136.63 147.29 46.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.765 . . . . 0.0 109.108 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -140.52 145.05 36.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.856 . . . . 0.0 110.093 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.515 ' CZ ' ' NH2' ' A' ' 225' ' ' ARG . 89.3 t80 -144.26 140.38 29.19 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 76.8 m -110.82 124.3 51.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 110.295 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.561 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -103.89 117.26 33.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.409 -0.807 . . . . 0.0 109.761 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.31 154.64 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.097 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -50.63 125.22 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 108.977 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.24 -2.44 26.75 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -119.81 21.74 11.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.14 -1.212 . . . . 0.0 109.186 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' HB2' HD13 ' A' ' 81' ' ' LEU . 3.6 pm0 -54.46 -32.12 56.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.379 -0.825 . . . . 0.0 110.621 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.24 -17.47 62.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 110.183 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.554 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 23.2 mm-40 -86.79 -6.83 58.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.172 -0.955 . . . . 0.0 111.495 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 40.2 pt -123.68 -26.05 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.919 -1.113 . . . . 0.0 110.845 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.1 m -65.21 -26.77 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.553 -1.342 . . . . 0.0 109.382 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.54 -5.54 56.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.0 109.335 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.506 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.09 123.43 21.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.977 . . . . 0.0 109.205 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -84.54 172.93 11.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.2 t -77.32 161.48 28.04 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -147.04 144.38 29.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.191 -1.568 . . . . 0.0 111.427 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.555 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -142.71 157.08 45.02 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 90.6 m-85 -97.66 146.89 24.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.602 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.56 -38.71 21.32 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.399 -0.813 . . . . 0.0 109.741 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.13 -25.18 62.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.0 109.644 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.7 mm-40 -79.82 -25.64 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.0 110.044 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.629 HG21 HB11 ' A' ' 500' ' ' C90 . 22.6 mt -60.93 -54.82 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 110.017 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 186' ' ' ILE . 10.9 tt0 -42.1 -39.88 2.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.887 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.763 ' O ' HG22 ' A' ' 192' ' ' VAL . 5.4 t60 -78.76 -54.31 6.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 194' ' ' LEU . 29.1 mt -48.35 -29.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.663 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -85.34 -54.38 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.769 -1.207 . . . . 0.0 109.194 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -50.09 -42.52 50.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.066 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.5 m -74.65 5.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.995 . . . . 0.0 109.854 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.31 37.28 54.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' ILE . 36.0 mt -125.61 166.04 17.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -1.126 . . . . 0.0 109.591 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 64.5 22.98 68.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -56.18 -23.65 36.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.432 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.5 25.91 12.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.24 125.12 7.88 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.945 -1.327 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -145.1 168.07 21.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.064 . . . . 0.0 109.708 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.1 -8.72 25.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 ttmm -93.89 -14.31 26.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 14.7 p30 -136.07 8.14 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.792 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -147.34 149.28 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.047 -1.033 . . . . 0.0 110.702 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 217' ' ' LEU . 27.1 tp -98.87 94.61 6.68 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 203' ' ' THR . 52.2 t -86.81 129.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.635 0.731 . . . . 0.0 109.225 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.07 173.9 6.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.369 -0.832 . . . . 0.0 109.53 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -134.64 -166.41 11.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.95 70.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -1.047 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -158.91 26.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.061 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -145.36 153.27 41.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.841 -1.162 . . . . 0.0 110.421 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.0 t -104.4 113.32 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -57.99 -48.34 80.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.051 -1.03 . . . . 0.0 109.854 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -63.0 112.51 6.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 110.313 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -57.85 -11.12 8.82 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.697 1.598 . . . . 0.0 112.165 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.18 -18.91 58.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.436 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.24 179.65 50.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.7 mt -83.23 121.93 27.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -1.217 . . . . 0.0 109.64 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.0 OUTLIER -49.52 -22.48 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 108.661 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 56.0 m-85 -148.42 178.96 8.15 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -86.87 2.95 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.755 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 45.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.543 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -61.76 -42.69 84.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.911 -1.118 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.6 Cg_exo -58.76 -60.04 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.585 2.19 . . . . 0.0 112.596 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.2 m -66.96 -39.34 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.064 -1.023 . . . . 0.0 111.448 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.554 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 3.3 ptm85 -67.51 -35.52 79.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.561 -1.337 . . . . 0.0 108.595 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.506 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 23.3 t60 -66.02 -34.56 78.37 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -64.59 -35.08 79.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -67.01 -35.99 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -67.41 -50.93 57.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.2 -33.14 72.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.355 -0.84 . . . . 0.0 109.808 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.1 tp -74.97 -32.74 61.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.096 -1.003 . . . . 0.0 108.736 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.4 mt -65.76 -38.6 82.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -53.97 22.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.497 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 6.7 m-20 -56.15 -29.53 60.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -1.201 . . . . 0.0 109.09 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.1 mt -67.09 -23.27 65.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.529 -0.732 . . . . 0.0 110.581 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.47 -22.51 60.15 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.743 -1.223 . . . . 0.0 109.374 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 237' ' ' LEU . 91.7 mt -50.09 -4.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.599 -1.313 . . . . 0.0 110.411 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.6 mt -75.52 -15.46 60.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 109.681 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.02 58.14 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.659 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.36 155.04 9.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.875 -1.368 . . . . 0.0 109.106 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.1 Cg_endo -49.33 150.62 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.956 1.771 . . . . 0.0 109.869 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -109.42 145.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.023 -1.048 . . . . 0.0 111.881 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -130.25 125.18 34.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.47 -160.3 29.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.417 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -130.49 140.43 50.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 109.153 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.8 m-85 -138.62 142.14 39.12 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.175 -0.953 . . . . 0.0 110.331 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.7 t80 -124.91 124.66 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.0 m -117.76 135.0 54.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -115.36 114.92 25.75 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 49.87 20.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.02 -1.05 . . . . 0.0 109.074 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -53.34 156.53 5.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.489 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -138.35 163.0 25.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.577 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 48.4 m-70 -48.68 -40.11 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.187 -1.184 . . . . 0.0 109.817 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -58.4 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.127 -0.983 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 134' ' ' ASP . 13.8 tp -59.63 -44.02 93.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.077 -1.014 . . . . 0.0 109.519 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.2 m-20 -47.73 -48.12 29.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.885 -1.135 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 56' ' ' THR . 73.2 t -62.89 -52.37 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.584 -0.698 . . . . 0.0 109.573 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.484 ' NZ ' ' OD1' ' A' ' 134' ' ' ASP . 31.0 ttmt -52.86 -48.79 66.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.522 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -52.94 -51.75 60.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 108.7 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.538 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.0 t -56.82 -53.75 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.21 -0.932 . . . . 0.0 109.18 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -49.64 -48.23 49.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.91 -48.47 81.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.64 -49.76 74.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.877 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.47 -26.35 66.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.831 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -70.01 -57.29 5.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 110.097 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -34.65 78.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.744 -179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -75.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -84.52 -166.4 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.317 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.429 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.636 ' O22' H212 ' A' ' 500' ' ' C90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.34 154.44 19.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 85' ' ' THR . 3.0 mm-40 -56.88 138.57 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 108.846 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -121.61 144.59 48.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.0 110.272 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -142.5 -174.63 4.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.0 m -98.6 136.96 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.249 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.41 -23.03 66.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 109.945 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.51 159.35 44.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.719 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 139.68 58.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.18 164.39 15.24 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.32 142.65 45.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.85 -1.156 . . . . 0.0 110.566 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.3 m-85 -139.3 154.01 47.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.1 152.6 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.856 -1.153 . . . . 0.0 110.091 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.79 176.49 36.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.7 154.6 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -1.099 . . . . 0.0 110.369 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.64 140.45 15.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.526 ' CD1' HG21 ' A' ' 179' ' ' THR . 4.2 tt -58.83 -40.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -1.169 . . . . 0.0 110.679 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 18' ' ' ILE . 77.9 m-70 -89.53 -49.67 6.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.663 -1.273 . . . . 0.0 111.126 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 p -69.6 -23.1 63.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.662 -0.649 . . . . 0.0 111.262 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.48 15.94 13.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.39 154.37 21.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 109.607 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 14.1 t80 -75.98 135.93 40.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 109.766 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 m -139.39 145.28 38.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.43 154.87 24.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 89' ' ' ILE . 8.7 mt -135.71 148.58 48.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.204 -0.935 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG22 ' NE2' ' A' ' 29' ' ' HIS . 14.6 mt -143.37 113.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.18 115.22 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 110.992 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.546 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -107.71 135.95 19.73 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.476 -0.765 . . . . 0.0 109.692 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 21.0 Cg_exo -52.32 168.18 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.004 1.803 . . . . 0.0 111.94 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 35' ' ' THR . 12.7 mm-40 -144.63 177.52 8.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.35 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.11 156.07 19.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.44 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 1.4 mt-10 -49.6 151.28 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.29 -11.1 2.28 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.997 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.531 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 62.1 m -55.81 -46.65 78.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.652 -1.499 . . . . 0.0 109.986 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.97 -177.71 32.89 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.204 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.66 117.0 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -138.44 147.7 43.57 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.67 156.86 16.35 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -129.08 111.27 12.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 16.2 tttp -135.65 134.97 39.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 110.851 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 49.92 26.59 2.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.969 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.11 19.54 62.6 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.298 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.7 120.45 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.099 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -87.14 129.14 35.06 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.093 -1.004 . . . . 0.0 108.42 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.514 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 73.5 mt -121.31 95.64 48.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 110.466 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.45 150.19 16.12 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.93 1.754 . . . . 0.0 110.995 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.66 72.1 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -123.86 163.38 21.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.774 . . . . 0.0 109.043 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.3 p-80 -66.04 -52.12 52.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 110.141 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -43.83 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.777 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' HIS . 28.3 m-85 -95.2 5.44 51.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.789 -1.194 . . . . 0.0 109.936 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.3 t -76.69 129.82 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.0 108.611 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.74 -24.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 0.0 110.303 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.67 125.18 10.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.012 -1.055 . . . . 0.0 110.009 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -119.58 95.98 5.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.9 t-20 -162.66 128.54 3.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 59' ' ' SER . 35.1 m80 48.02 9.79 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.15 -0.969 . . . . 0.0 109.263 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 165.8 147.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.905 . . . . 0.0 109.868 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.41 ' HG1' ' HD1' ' A' ' 253' ' ' HIS . 86.0 m -90.06 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 109.149 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.11 149.49 42.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.465 -0.772 . . . . 0.0 110.788 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 13.3 mt -120.37 163.17 18.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.117 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.62 151.19 15.58 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.619 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.33 145.41 14.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.669 -0.901 . . . . 0.0 108.691 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 21.35 7.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.04 -28.14 15.22 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.804 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.23 147.46 49.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.699 -1.471 . . . . 0.0 109.402 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 47.2 ttp180 -140.51 147.03 38.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.071 -1.018 . . . . 0.0 111.498 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.23 137.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -105.87 156.07 18.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 112.322 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.0 m 50.18 78.3 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.439 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.33 -8.2 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.005 . . . . 0.0 109.363 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.8 pm0 -62.74 -27.13 69.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 111.106 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.81 -69.09 0.33 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.802 -1.186 . . . . 0.0 109.256 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG23 ' N ' ' A' ' 76' ' ' LEU . 7.1 tp -51.87 -47.7 40.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.6 ' N ' HG23 ' A' ' 75' ' ' ILE . 11.8 mt -52.29 -49.12 64.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.937 -1.102 . . . . 0.0 110.384 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 36.1 t -60.56 -42.12 95.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.19 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 106' ' ' PHE . 82.3 t -57.25 -46.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.942 -1.099 . . . . 0.0 109.194 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.63 -34.2 77.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -64.09 -37.95 89.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' A' ' 171' ' ' GLU . 54.4 mt -77.85 -39.58 43.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.72 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 82' ' ' LEU . 69.3 mt -78.41 -2.53 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.009 . . . . 0.0 109.226 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 58.32 42.44 21.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 111.311 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.1 mm -86.01 146.59 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.871 -1.143 . . . . 0.0 108.169 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG12 ' A' ' 121' ' ' ILE . 61.3 p -128.93 -23.84 3.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 111.514 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 87' ' ' VAL . 51.3 m-80 -124.61 107.85 11.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.851 -1.156 . . . . 0.0 110.75 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.89 147.14 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.851 0.834 . . . . 0.0 110.256 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 24.7 m -114.82 112.04 22.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.478 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -93.82 100.32 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.421 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.494 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.4 tt0 -74.55 125.94 29.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.4 HG22 HD21 ' A' ' 26' ' ' LEU . 40.3 t -107.16 130.01 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.921 0.867 . . . . 0.0 111.998 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.3 mm -110.69 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.82 -154.76 23.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.44 -10.44 8.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.385 -1.068 . . . . 0.0 110.049 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -138.83 148.31 43.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.041 -1.037 . . . . 0.0 109.347 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 26' ' ' LEU . 7.8 mm -74.44 122.17 86.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.317 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -41.82 122.05 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.975 1.783 . . . . 0.0 111.501 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.475 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -74.82 -13.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.101 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 106' ' ' PHE . 25.8 mt 57.27 -122.45 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.496 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.49 8.74 43.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.588 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.52 -3.66 72.06 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.514 -1.327 . . . . 0.0 109.819 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.21 -173.03 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.495 -1.003 . . . . 0.0 109.135 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.24 16.2 11.83 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -58.24 -45.09 88.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.907 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.95 -57.42 9.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.011 . . . . 0.0 109.655 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 99' ' ' LEU . 8.8 m-85 -51.58 -46.03 63.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.058 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 59.6 t80 -61.17 -52.93 62.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.646 . . . . 0.0 111.058 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.1 -43.08 99.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.139 -0.976 . . . . 0.0 111.376 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -56.63 9.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 110.572 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.7 mt -63.54 -32.24 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.97 -1.081 . . . . 0.0 109.661 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.2 ttt180 -65.09 -43.62 91.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -75.83 11.39 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.018 -1.051 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -143.98 35.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.914 -1.116 . . . . 0.0 110.435 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -82.02 141.19 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 0.0 110.57 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.69 120.52 22.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -81.78 140.68 34.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -106.11 -168.57 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.785 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.571 ' O ' ' ND2' ' A' ' 118' ' ' ASN . 0.4 OUTLIER -111.54 71.52 0.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 0.0 110.65 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -170.5 133.77 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.995 . . . . 0.0 109.547 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -69.71 147.68 50.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.707 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.629 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -88.72 151.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -97.99 88.05 4.14 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.3 m-85 -66.46 144.27 56.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.848 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.734 ' CE2' ' NE2' ' A' ' 267' ' ' GLN . 34.5 t80 -88.31 100.98 13.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -90.78 132.61 34.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.657 -0.652 . . . . 0.0 110.799 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.45 114.06 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.87 -30.18 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.961 -1.087 . . . . 0.0 110.313 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.76 149.95 73.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.831 . . . . 0.0 109.463 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.28 149.72 45.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.492 2.128 . . . . 0.0 111.456 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.455 HD12 ' CD ' ' A' ' 266' ' ' LYS . 4.8 tt -157.37 153.82 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.055 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.63 144.51 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.322 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.39 148.24 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -134.96 161.83 34.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB3' HD13 ' A' ' 255' ' ' LEU . 30.6 t70 -174.8 105.81 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.907 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 52.26 53.57 12.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.442 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 -33.0 3.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -60.32 135.51 57.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.019 -1.283 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -145.41 137.72 25.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 110.333 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.575 ' CD1' HD23 ' A' ' 255' ' ' LEU . 90.4 mt -137.04 130.39 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 0.0 109.51 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -117.8 132.09 56.49 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.362 0.601 . . . . 0.0 109.896 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.26 134.21 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.57 153.15 46.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -50.79 143.19 30.49 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.379 2.052 . . . . 0.0 113.428 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.5 143.8 19.03 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.12 -9.66 11.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 110.463 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' GLY . 82.1 p -144.7 -175.29 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 109.547 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 148' ' ' GLU . 10.3 tp -100.19 123.56 44.56 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.198 -0.939 . . . . 0.0 108.567 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.477 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -138.9 135.41 34.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 108.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 231' ' ' LEU . 70.9 t -134.48 123.67 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 165' ' ' THR . 90.9 m -113.75 152.32 30.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -0.775 . . . . 0.0 109.846 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.949 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.97 132.43 54.92 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.03 141.2 11.33 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.338 -1.41 . . . . 0.0 112.07 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.11 101.92 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.43 167.03 13.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 111.144 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -104.54 30.97 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.594 -0.691 . . . . 0.0 110.726 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' LEU . 27.5 p-10 -148.53 -168.35 3.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.771 -1.206 . . . . 0.0 110.118 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -48.22 -4.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 0.0 111.374 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.7 mt -82.99 -31.01 27.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.521 -1.362 . . . . 0.0 108.708 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.55 -135.53 41.48 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.69 132.27 45.14 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.154 -1.203 . . . . 0.0 109.146 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -137.92 149.98 46.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -140.66 144.11 35.5 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -141.78 132.62 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 109.775 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.455 HG23 ' OG1' ' A' ' 150' ' ' THR . 85.5 m -105.89 123.98 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.549 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.9 t80 -105.22 115.74 30.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.49 151.53 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.69 129.63 23.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.01 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.09 -1.99 38.06 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -119.18 23.23 11.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -1.123 . . . . 0.0 109.39 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -56.03 -56.05 25.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 171' ' ' GLU . 3.8 mt-10 -41.81 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.407 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.572 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 2.3 mt-10 -85.11 -7.35 59.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.067 -1.021 . . . . 0.0 111.463 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.565 HG22 ' HB2' ' A' ' 225' ' ' ARG . 9.2 pt -126.36 -27.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.864 -1.147 . . . . 0.0 110.906 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 81' ' ' LEU . 15.8 m -63.89 -17.37 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.739 -1.226 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.4 -3.52 55.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 225' ' ' ARG . . . -68.6 126.32 29.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 179' ' ' THR . 62.4 mtm180 -94.04 130.36 40.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 10.1 t -37.11 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.52 154.24 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.544 -1.348 . . . . 0.0 111.578 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.678 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -152.16 156.36 39.65 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.1 m-85 -97.66 145.49 26.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.83 -1.169 . . . . 0.0 109.692 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.447 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 4.0 t0 -48.8 -37.9 20.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.251 -0.905 . . . . 0.0 109.084 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.532 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.8 p90 -70.16 -25.82 63.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.987 -1.071 . . . . 0.0 109.331 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.3 mm-40 -75.68 -35.66 60.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.403 HD13 ' N4 ' ' A' ' 500' ' ' C90 . 61.8 mt -51.92 -42.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.681 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -58.84 -41.7 87.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 0.0 109.538 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 189' ' ' ILE . 11.7 t60 -75.85 -58.31 3.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.013 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 188' ' ' HIS . 94.4 mt -43.79 -33.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -79.4 -52.51 7.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.1 . . . . 0.0 109.069 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -47.33 -44.82 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.22 7.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.054 -1.029 . . . . 0.0 110.531 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.02 40.0 57.67 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.081 -1.012 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.0 mt -127.72 173.82 9.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.219 -1.166 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.16 26.58 50.11 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -60.26 -19.69 55.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.0 109.868 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.84 3.34 33.92 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.68 128.07 40.14 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.462 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 11.5 p -146.44 164.65 31.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.9 mt -66.72 -7.93 24.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 108.607 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -96.83 -19.09 19.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.601 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.462 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 21.5 p30 -128.04 3.98 5.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.5 m -144.47 146.72 32.59 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.688 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 217' ' ' LEU . 13.7 tp -96.79 96.3 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.09 127.67 39.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.893 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.5 160.95 24.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.577 -0.702 . . . . 0.0 109.438 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.43 -166.15 13.04 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -30.47 70.61 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.134 -1.215 . . . . 0.0 109.658 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.97 23.38 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.089 -1.007 . . . . 0.0 111.264 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -149.97 157.76 43.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.449 -1.407 . . . . 0.0 110.724 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.9 t -105.24 115.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -61.63 -44.06 97.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.387 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.3 m120 -62.43 126.01 87.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.889 -1.132 . . . . 0.0 110.334 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -67.08 -17.17 50.7 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.689 1.593 . . . . 0.0 112.246 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -15.82 56.28 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.964 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.33 -164.93 54.45 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.7 mt -91.83 129.55 37.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -1.208 . . . . 0.0 109.463 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 3.3 mmt85 -67.02 -17.08 64.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.995 -1.066 . . . . 0.0 108.193 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 40.6 m-85 -145.53 160.67 41.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.433 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.9 mp0 -77.86 15.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.708 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.538 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -154.28 39.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.781 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.4 tt0 -57.95 -43.81 98.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.903 -1.123 . . . . 0.0 109.793 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 33.2 Cg_exo -59.59 -66.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.833 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 225' ' ' ARG . 19.6 m -60.37 -40.19 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.133 -0.979 . . . . 0.0 111.428 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.572 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 4.3 ptm180 -67.77 -34.72 77.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.615 -1.303 . . . . 0.0 109.006 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -66.61 -32.35 73.62 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -65.59 -37.61 87.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 166' ' ' PHE . 67.8 t -65.7 -37.2 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 46.1 t80 -64.04 -52.07 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.403 ' OD2' ' N23' ' A' ' 500' ' ' C90 . 82.3 m-20 -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.705 . . . . 0.0 109.565 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.557 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.0 tp -77.51 -33.58 54.32 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 mt -67.41 -38.06 80.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -54.4 22.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 95.4 m-20 -56.52 -33.04 65.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -1.197 . . . . 0.0 109.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 235' ' ' LEU . 9.1 mt -68.09 -25.15 65.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.544 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.4 t80 -75.06 -21.48 58.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.921 -1.112 . . . . 0.0 109.528 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -50.71 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.705 -1.247 . . . . 0.0 110.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 4.3 mt -70.67 -13.55 62.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.048 . . . . 0.0 109.857 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.74 0.91 60.34 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.609 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.05 152.5 11.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.345 . . . . 0.0 108.86 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.9 Cg_endo -53.59 128.04 27.83 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.795 1.663 . . . . 0.0 109.942 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 t -87.48 153.16 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 112.266 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -134.94 126.15 28.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.7 -157.15 27.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.1 OUTLIER -131.2 136.17 48.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 108.87 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.0 m-85 -135.52 140.54 44.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.155 -0.965 . . . . 0.0 110.484 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -126.09 132.15 51.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -125.32 136.37 53.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.121 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -117.3 113.37 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.19 24.43 1.99 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 109.037 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.45 154.08 42.38 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -131.09 178.18 17.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 75.5 m-70 -59.78 -40.92 89.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -1.226 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -58.96 5.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.575 HD23 ' CD1' ' A' ' 139' ' ' ILE . 6.1 tp -55.74 -46.38 77.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 109.62 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.3 -51.73 18.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.889 -1.132 . . . . 0.0 109.323 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 56' ' ' THR . 88.6 t -61.53 -50.26 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.428 -0.795 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -54.09 -52.05 62.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.988 -1.07 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.1 tp -49.79 -50.92 43.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.17 -0.956 . . . . 0.0 108.486 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 238' ' ' LEU . 44.1 t -58.65 -53.16 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -46.9 -49.77 19.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.82 -48.4 74.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.8 mt -55.95 -51.99 65.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.72 -26.44 63.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.397 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -47.78 35.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.514 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.455 ' CD ' HD12 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -71.63 -46.92 57.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 0.0 110.111 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.734 ' NE2' ' CE2' ' A' ' 124' ' ' PHE . 23.0 tt0 -42.74 -72.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.542 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 150.4 20.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.488 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 269' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.678 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mt -99.65 159.43 15.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.34 138.49 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.957 . . . . 0.0 108.862 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.85 145.77 47.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -141.77 -174.83 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.634 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.3 m -97.18 136.95 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.115 . . . . 0.0 109.112 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' HD13 ' A' ' 115' ' ' LEU . 16.7 ptmt -65.47 -29.82 70.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -144.42 156.15 44.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -63.69 141.21 58.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.428 -0.795 . . . . 0.0 110.356 -179.486 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.94 166.22 13.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -137.76 143.18 41.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.085 -1.01 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.1 m-85 -139.37 154.52 47.86 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -163.28 152.59 14.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.837 -1.165 . . . . 0.0 110.177 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.13 176.66 36.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.19 153.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -1.144 . . . . 0.0 110.01 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.28 139.97 15.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 19' ' ' HIS . 5.9 tt -58.54 -41.09 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.249 . . . . 0.0 110.472 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 73.4 m-70 -88.09 -50.52 6.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.694 -1.254 . . . . 0.0 111.116 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 p -66.07 -27.92 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.781 -0.575 . . . . 0.0 111.801 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.74 16.63 46.66 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 118.888 -1.625 . . . . 0.0 109.226 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.85 156.04 22.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -1.058 . . . . 0.0 109.487 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.84 134.45 41.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.5 m -138.21 143.86 40.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.132 -0.98 . . . . 0.0 109.499 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -113.03 156.59 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.255 -0.903 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -136.08 146.94 47.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 110.236 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.3 mp -140.85 115.43 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.93 114.99 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.493 -0.755 . . . . 0.0 110.967 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.547 ' NE2' HG22 ' A' ' 27' ' ' ILE . 13.2 m-70 -109.34 138.06 20.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.427 -0.796 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.634 ' HG3' HG23 ' A' ' 7' ' ' VAL . 29.6 Cg_exo -52.15 168.87 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.959 1.772 . . . . 0.0 111.704 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 35' ' ' THR . 71.9 mm-40 -141.91 173.91 11.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.037 -1.039 . . . . 0.0 109.973 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' A' ' 35' ' ' THR . 31.1 mmtp -83.51 152.26 25.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.769 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 17.7 mt-10 -48.11 146.1 2.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 110.073 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.7 46.27 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.83 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 31' ' ' GLU . 29.0 m -68.51 -42.66 78.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.702 -1.469 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -176.62 32.58 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.367 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.12 118.32 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -141.64 155.95 45.68 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.933 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -104.31 156.91 17.51 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -129.5 109.94 11.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 108.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -135.4 134.97 40.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.422 -0.799 . . . . 0.0 111.006 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 50.69 32.63 7.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 111.578 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.75 17.37 80.12 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.2 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.12 120.81 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.44 -1.036 . . . . 0.0 108.854 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 31.8 m-85 -84.96 128.28 34.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -117.78 93.44 43.9 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.389 -0.819 . . . . 0.0 109.283 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.78 146.7 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.324 2.016 . . . . 0.0 111.925 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 70.93 9.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -122.34 174.82 6.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.2 p-80 -78.1 -52.57 8.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.997 . . . . 0.0 109.61 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -43.7 -16.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' HIS . 39.8 m-85 -96.18 2.74 53.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.06 . . . . 0.0 110.029 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -73.12 132.76 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 108.664 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.64 -30.83 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 110.336 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.68 134.91 18.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 257' ' ' VAL . 73.3 p -123.75 96.07 4.82 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.0 t-20 -162.84 128.7 3.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.3 -0.875 . . . . 0.0 109.121 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.502 ' O ' ' CB ' ' A' ' 59' ' ' SER . 11.9 m80 48.41 9.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.118 -0.989 . . . . 0.0 109.15 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.07 141.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.692 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.1 m -86.22 127.68 34.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.366 -0.834 . . . . 0.0 109.158 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -120.29 149.59 42.06 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.67 0.748 . . . . 0.0 110.944 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 72' ' ' VAL . 12.0 mt -122.16 150.38 42.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.72 151.89 22.7 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.06 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -161.68 147.09 13.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 52.35 21.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.09 6.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -58.42 146.09 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 136.28 34.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.579 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.2 126.47 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -102.96 157.85 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.097 . . . . 0.0 111.582 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.3 m 49.93 74.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 60' ' ' THR . 24.4 m -108.01 -10.86 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 6.7 pm0 -61.71 -25.79 67.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 110.706 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.13 -68.91 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 109.083 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.15 -47.66 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.006 -1.059 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.579 ' N ' HG23 ' A' ' 75' ' ' ILE . 14.4 mt -52.73 -50.03 64.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 110.201 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.9 t -59.75 -42.76 93.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.943 -1.098 . . . . 0.0 110.195 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.2 t -55.06 -48.08 76.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.026 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.49 -33.49 76.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.191 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -62.6 -38.77 91.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 109.416 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.9 mt -76.47 -39.25 53.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 110.155 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 114' ' ' ILE . 65.5 mt -81.8 0.5 38.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.985 -1.072 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.38 43.28 26.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.556 -0.715 . . . . 0.0 111.185 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mm -87.69 146.52 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 108.082 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.592 HG21 HG12 ' A' ' 121' ' ' ILE . 51.0 p -130.53 -20.46 2.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.116 -0.99 . . . . 0.0 111.385 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.728 ' O ' HG13 ' A' ' 87' ' ' VAL . 57.2 m-20 -125.74 107.09 10.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.054 -1.028 . . . . 0.0 110.614 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -165.75 148.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.618 0.723 . . . . 0.0 110.053 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.1 m -115.87 111.47 20.49 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -94.3 101.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.4 tt0 -72.95 126.36 29.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 HD21 ' A' ' 26' ' ' LEU . 71.5 t -108.68 120.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.892 0.854 . . . . 0.0 111.285 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' ILE . 14.2 mt -108.37 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.22 -158.27 27.18 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -118.95 -12.43 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -1.101 . . . . 0.0 110.059 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -141.43 150.77 42.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 109.509 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -74.09 121.26 84.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.991 . . . . 0.0 108.964 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -41.12 122.02 1.5 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.751 1.634 . . . . 0.0 111.345 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.3 tp -77.95 -15.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.536 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt 57.25 -117.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 9.4 t70 -98.25 5.72 48.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.037 -1.039 . . . . 0.0 110.731 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.97 0.9 58.6 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.143 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.0 -172.45 2.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.703 -0.881 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.59 16.64 7.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.554 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 68.8 t-105 -58.38 -42.15 86.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -1.101 . . . . 0.0 110.292 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.0 -56.39 17.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.905 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 78' ' ' VAL . 12.8 m-85 -51.38 -44.09 62.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 108.783 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.415 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 36.3 t80 -62.41 -53.91 48.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.702 -0.624 . . . . 0.0 110.801 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 4.2 mt-10 -59.31 -44.5 92.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 111.133 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.38 -54.87 19.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.992 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.1 mt -67.09 -33.63 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.761 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.8 ttm-85 -62.87 -43.71 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -77.8 14.01 1.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -144.53 32.2 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.964 -1.085 . . . . 0.0 110.333 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 82' ' ' LEU . 79.4 mt -77.76 138.34 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 110.344 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 8' ' ' LYS . 5.1 tp -128.87 120.03 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -80.2 142.99 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.272 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.57 -174.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -109.66 68.95 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -164.77 129.42 2.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.099 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -67.96 141.9 56.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.107 . . . . 0.0 109.478 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.592 HG12 HG21 ' A' ' 85' ' ' THR . 69.9 mt -85.37 150.86 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.128 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p30 -97.76 85.16 3.5 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 32.7 m-85 -62.32 143.49 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.588 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -89.48 101.6 14.28 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.2 133.46 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.43 0.634 . . . . 0.0 110.768 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.16 116.56 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -92.62 -29.93 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.957 -1.089 . . . . 0.0 110.607 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.67 149.7 73.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 109.793 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.17 149.56 46.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.62 2.213 . . . . 0.0 111.779 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -157.02 152.43 7.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.155 -0.966 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.51 141.17 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 109.007 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.83 147.22 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -138.49 157.08 46.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.996 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -175.3 108.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.318 -0.864 . . . . 0.0 109.779 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 53.44 51.53 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -0.828 . . . . 0.0 110.614 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.02 -32.53 3.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.419 ' HB3' HD22 ' A' ' 255' ' ' LEU . 4.8 mtp180 -59.16 136.9 58.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -1.232 . . . . 0.0 108.133 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -149.3 135.64 19.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.77 -1.206 . . . . 0.0 109.709 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.615 ' CD1' HD23 ' A' ' 255' ' ' LEU . 87.4 mt -137.27 128.57 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -114.13 131.88 56.27 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.412 0.625 . . . . 0.0 109.886 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.0 134.26 54.81 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.91 152.86 45.04 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.004 -1.06 . . . . 0.0 110.018 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.68 142.57 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.529 2.153 . . . . 0.0 113.889 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -156.83 147.01 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.3 -29.42 68.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.122 -0.986 . . . . 0.0 110.869 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.534 ' O ' ' OG ' ' A' ' 144' ' ' SER . 12.6 p -119.67 -165.52 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.358 -0.838 . . . . 0.0 109.23 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 148' ' ' GLU . 7.3 tp -107.42 122.38 46.5 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.7 tt0 -138.65 126.25 22.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.979 . . . . 0.0 109.098 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.96 122.2 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 109.83 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 165' ' ' THR . 52.0 m -112.98 151.77 30.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.613 -0.68 . . . . 0.0 109.61 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.76 130.18 25.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.669 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -122.47 135.13 54.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.44 143.13 12.73 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.7 100.64 10.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.11 167.82 13.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.846 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -103.82 24.93 10.49 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.632 -0.668 . . . . 0.0 110.257 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 158' ' ' PHE . 22.6 p-10 -137.71 -170.53 2.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.037 -1.04 . . . . 0.0 110.36 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.59 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 21.2 p90 -49.55 -5.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.608 -0.683 . . . . 0.0 111.638 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.601 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 73.6 mt -82.35 -30.31 30.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.176 -1.578 . . . . 0.0 108.349 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.59 -132.26 43.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 131.04 43.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.158 -1.201 . . . . 0.0 109.192 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 1.6 tp-100 -138.29 144.7 40.59 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.465 -0.772 . . . . 0.0 109.259 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.83 36.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 110.361 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -146.74 141.66 26.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.927 . . . . 0.0 109.942 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 150' ' ' THR . 58.5 m -110.49 124.59 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.491 -0.755 . . . . 0.0 109.822 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -105.37 115.91 31.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.51 151.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.737 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.33 131.56 24.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.167 -0.958 . . . . 0.0 109.166 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.28 -3.03 43.53 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -117.35 22.57 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -1.183 . . . . 0.0 109.002 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -50.97 -54.87 20.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.738 . . . . 0.0 110.011 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 171' ' ' GLU . 71.6 mt-10 -41.79 -23.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' GLU . 64.6 mt-10 -81.54 -12.77 58.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.028 -1.045 . . . . 0.0 111.754 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.15 -28.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.866 -1.146 . . . . 0.0 111.355 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.58 -26.84 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.519 -1.363 . . . . 0.0 108.972 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -84.71 -3.61 58.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.461 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.46 116.82 10.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 108.915 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 54.4 mtm180 -79.95 172.35 13.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.143 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -78.54 162.51 26.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.37 149.17 32.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.218 -1.551 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.513 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -146.24 156.7 43.57 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.441 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 89.9 m-85 -98.15 146.2 25.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.0 109.314 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.44 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.37 -38.3 12.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.897 . . . . 0.0 109.479 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -72.33 -29.37 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 0.0 109.597 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.7 mt-10 -73.16 -33.95 65.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.53 HD13 HB12 ' A' ' 500' ' ' C90 . 71.2 mt -53.8 -54.25 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.3 -41.93 9.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.5 t-160 -74.42 -47.99 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.466 -0.771 . . . . 0.0 109.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 92.9 mt -53.97 -30.56 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -84.36 -53.52 5.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.885 -1.135 . . . . 0.0 109.477 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -49.87 -36.54 27.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.9 m -81.61 8.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.022 . . . . 0.0 109.892 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.2 39.95 71.53 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.5 mt -128.99 172.31 11.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -1.143 . . . . 0.0 109.989 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.5 25.23 57.8 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -58.89 -20.02 47.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.478 -1.601 . . . . 0.0 109.987 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.46 5.47 31.46 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.69 130.71 34.09 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.315 . . . . 0.0 110.437 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.659 ' N ' HD21 ' A' ' 202' ' ' ASN . 8.2 t -144.08 160.9 40.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.44 -1.035 . . . . 0.0 109.235 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 31.8 mt -66.92 -8.99 33.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.419 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -98.15 -13.05 21.13 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.659 HD21 ' N ' ' A' ' 199' ' ' SER . 10.0 p30 -128.66 8.79 5.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 109.256 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.97 153.91 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 110.377 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 217' ' ' LEU . 9.9 tp -101.3 110.65 22.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.79 128.85 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.773 0.797 . . . . 0.0 109.281 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.83 165.79 17.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.706 . . . . 0.0 109.639 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -166.73 11.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -30.44 69.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -1.049 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 209' ' ' ASP . 23.0 p-10 -158.34 21.88 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.274 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -138.15 145.19 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.907 -1.12 . . . . 0.0 110.535 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.3 108.41 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -54.84 -50.58 68.27 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 110.043 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.61 115.29 13.0 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.66 -12.28 35.01 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.418 1.412 . . . . 0.0 111.9 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.72 -15.95 60.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 108.664 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.73 178.27 46.05 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.592 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -82.62 150.12 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -1.08 . . . . 0.0 109.576 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -79.02 -19.0 52.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.15 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -141.94 -165.53 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.6 -8.21 29.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.191 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.07 45.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.914 . . . . 0.0 109.35 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.18 -46.92 99.6 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.925 -1.109 . . . . 0.0 109.86 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 55.4 Cg_exo -51.18 -68.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.42 2.08 . . . . 0.0 112.179 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.6 -35.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.95 -1.094 . . . . 0.0 109.674 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -61.69 -40.7 95.94 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.9 t60 -68.02 -31.41 71.06 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.664 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -65.33 -36.25 83.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -38.14 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 67.5 t80 -64.42 -50.23 68.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 109.17 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.435 ' OD2' ' N23' ' A' ' 500' ' ' C90 . 89.2 m-20 -66.65 -28.35 68.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.06 -32.91 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.104 -0.998 . . . . 0.0 108.391 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.587 HD11 ' CD2' ' A' ' 166' ' ' PHE . 34.4 mt -68.97 -38.9 79.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.58 -53.49 31.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.449 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 80.6 m-20 -56.74 -38.2 72.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.234 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.6 mt -58.59 -21.12 52.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.505 -0.747 . . . . 0.0 110.36 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -75.02 -22.32 58.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.824 -1.172 . . . . 0.0 109.454 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.18 1.08 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.49 -1.381 . . . . 0.0 110.292 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.4 mt -77.93 -16.29 58.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.911 -1.118 . . . . 0.0 109.569 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.9 -0.23 51.88 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.867 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.79 157.41 10.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.736 -1.449 . . . . 0.0 109.118 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.8 Cg_endo -50.22 150.79 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.805 1.67 . . . . 0.0 109.322 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.67 145.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.873 -1.142 . . . . 0.0 112.108 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 122.44 33.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.66 -160.5 30.7 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.444 -1.033 . . . . 0.0 108.888 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -140.66 141.26 35.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 110.401 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -125.52 122.96 38.08 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.8 m -115.22 136.11 53.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 111.198 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 250' ' ' ARG . 91.7 t80 -117.81 116.04 26.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 249' ' ' PHE . 38.0 mtp85 43.55 43.54 4.66 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.219 -0.926 . . . . 0.0 109.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.35 165.42 35.62 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -138.83 -174.57 13.51 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.552 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.4 m-70 -63.01 -39.14 93.86 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER -55.27 -58.68 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.088 -1.007 . . . . 0.0 108.999 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 139' ' ' ILE . 4.1 tp -56.27 -45.08 80.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 109.461 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.46 -50.5 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 109.35 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 56' ' ' THR . 96.1 t -64.95 -39.23 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.732 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -63.97 -51.41 64.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 139' ' ' ILE . 23.6 tp -52.87 -49.13 66.44 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 108.545 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.471 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.4 t -60.01 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -49.29 -48.68 45.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -61.32 -49.07 78.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 109.705 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -57.3 -45.77 83.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 109.641 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.55 63.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.914 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -69.2 -65.62 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 109.76 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 268' ' ' LYS . 4.1 pttm -51.02 -40.19 57.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.074 -1.016 . . . . 0.0 108.97 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -67.63 52.5 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 266' ' ' LYS . 7.2 pttp -39.67 130.21 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.478 -0.763 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.53 HB12 HD13 ' A' ' 186' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.48 155.01 31.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -57.59 141.57 47.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 108.731 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -125.59 147.09 49.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.4 t -141.93 -173.03 3.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.6 m -97.35 136.84 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.868 -1.145 . . . . 0.0 109.035 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -67.27 -21.77 65.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.572 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE2' ' O ' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -152.31 157.82 41.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' O ' ' OE2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -65.8 139.99 58.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.312 -0.867 . . . . 0.0 110.368 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 mt -115.95 163.55 15.72 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.51 142.06 43.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 110.344 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -141.21 161.01 38.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -167.15 152.75 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 109.768 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.27 176.11 36.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.34 155.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -1.128 . . . . 0.0 110.062 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 139.14 15.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 179' ' ' THR . 7.3 tt -58.98 -38.33 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.265 . . . . 0.0 110.354 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 80.2 m-70 -90.86 -50.82 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.674 -1.266 . . . . 0.0 111.026 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.3 p -68.65 -23.64 64.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.76 -0.587 . . . . 0.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.95 17.2 21.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -108.28 153.34 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -1.025 . . . . 0.0 109.651 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -73.3 134.64 44.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.0 109.41 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -140.49 143.83 35.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -108.28 158.58 17.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -137.6 144.61 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.54 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.574 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.5 mt -143.43 110.91 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.9 . . . . 0.0 108.852 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.43 115.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 111.057 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' NE2' HG22 ' A' ' 27' ' ' ILE . 30.1 m-70 -108.5 138.57 20.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 109.422 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -53.82 168.37 0.81 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.753 1.635 . . . . 0.0 111.728 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' OE1' HG21 ' A' ' 35' ' ' THR . 28.1 mm-40 -140.94 173.75 11.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OG1' ' A' ' 35' ' ' THR . 39.7 mttm -85.08 153.06 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.284 -0.885 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.17 147.21 3.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.704 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 71.82 -0.33 37.24 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.903 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.76 ' H ' HD22 ' A' ' 86' ' ' ASN . 51.6 m -67.21 -45.42 76.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.615 -1.52 . . . . 0.0 109.536 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.75 -179.34 31.52 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.774 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.87 117.66 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH2' ' CE1' ' A' ' 45' ' ' TYR . 21.7 ptt180 -144.49 157.73 44.1 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.839 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -103.64 157.86 16.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -128.07 110.83 12.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 108.772 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 15.9 tttp -135.27 132.81 38.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.579 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.17 28.3 6.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.464 -0.772 . . . . 0.0 111.628 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.44 19.67 68.34 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.211 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -124.28 123.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.278 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.447 ' CE1' ' NH2' ' A' ' 38' ' ' ARG . 98.9 m-85 -84.78 127.62 34.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.4 90.99 40.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.69 150.22 4.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.549 2.166 . . . . 0.0 111.926 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.644 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.11 75.99 9.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.982 . . . . 0.0 109.775 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -129.35 173.66 10.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 109.211 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.2 p-80 -71.81 -52.43 17.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -45.48 -16.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.758 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' HIS . 21.0 m-85 -94.9 0.37 54.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.722 -1.236 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -72.82 128.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.04 -28.94 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -151.07 133.03 15.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.945 HG21 HG21 ' A' ' 257' ' ' VAL . 40.8 p -123.93 95.91 4.74 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' SER . 5.7 t-20 -162.61 128.76 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.852 . . . . 0.0 108.805 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' SER . 18.0 m80 50.17 9.45 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.97 146.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.801 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.434 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 31.0 m -89.9 126.92 35.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 0.0 109.174 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.7 m-20 -121.04 150.35 41.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.328 -0.857 . . . . 0.0 111.059 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CG ' HG21 ' A' ' 72' ' ' VAL . 4.5 mt -125.5 150.11 47.68 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.51 154.82 25.91 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.894 -1.622 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -163.22 150.39 12.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -1.033 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt 52.31 22.2 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.13 -32.5 7.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -59.83 145.74 44.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.287 . . . . 0.0 109.478 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.25 139.51 35.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.407 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -130.15 121.96 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -99.04 156.99 16.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.1 m 49.14 74.52 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.879 -0.513 . . . . 0.0 110.739 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.533 HG21 ' CG ' ' A' ' 62' ' ' LEU . 20.6 m -108.0 -9.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.117 -0.989 . . . . 0.0 109.274 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.1 pm0 -60.86 -26.28 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.493 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.01 -69.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -52.56 -47.48 48.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.276 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.644 HD21 ' HB1' ' A' ' 48' ' ' ALA . 26.4 mt -52.02 -48.75 64.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.954 -1.091 . . . . 0.0 110.026 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -61.18 -42.46 98.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.166 -0.959 . . . . 0.0 110.118 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.8 t -56.64 -44.88 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.093 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.24 -35.19 75.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.33 -0.856 . . . . 0.0 109.288 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -62.48 -34.36 76.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 109.189 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 52.2 mt -82.03 -37.97 25.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.619 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 82' ' ' LEU . 70.4 mt -79.62 0.26 30.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.409 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 4.1 mp0 57.13 41.13 27.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.326 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.07 143.67 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.703 -1.248 . . . . 0.0 108.043 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 121' ' ' ILE . 51.5 p -127.52 -21.04 3.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.103 -0.998 . . . . 0.0 111.703 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.76 HD22 ' H ' ' A' ' 35' ' ' THR . 5.4 m120 -127.18 107.0 9.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.937 -1.102 . . . . 0.0 110.609 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -164.94 149.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 109.917 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.45 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 41.7 m -117.21 111.66 19.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.487 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.2 mt -92.61 100.92 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.917 . . . . 0.0 110.269 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.8 tt0 -73.95 127.51 33.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.552 HG22 HD21 ' A' ' 26' ' ' LEU . 21.2 t -115.9 124.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.04 0.924 . . . . 0.0 112.261 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.5 mm -109.48 98.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.548 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 144.36 -159.05 27.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.02 -10.93 9.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -1.163 . . . . 0.0 110.075 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -141.62 150.2 41.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.981 -1.074 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -72.27 120.35 79.91 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.702 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -41.09 120.83 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.69 1.593 . . . . 0.0 111.145 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.3 tp -78.25 -15.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 110.754 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 106' ' ' PHE . 46.2 mt 57.1 -117.78 1.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.051 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 10.3 t0 -97.04 4.48 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 110.588 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.63 1.57 58.87 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.104 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 p -127.58 -172.68 2.73 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.811 . . . . 0.0 109.563 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.7 15.84 7.94 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.403 ' CZ2' ' HG3' ' A' ' 108' ' ' GLU . 42.1 t-105 -56.09 -42.43 76.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -1.046 . . . . 0.0 110.5 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.9 -59.1 5.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.322 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 99' ' ' LEU . 11.2 m-30 -51.16 -45.18 61.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.149 -0.969 . . . . 0.0 109.288 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 48.8 t80 -60.12 -50.72 72.57 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 23.8 mm-40 -63.78 -43.85 95.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.17 -0.956 . . . . 0.0 111.23 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.45 -60.01 2.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.945 -1.097 . . . . 0.0 110.095 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.49 -36.8 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.192 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 39.9 ttt180 -62.12 -43.44 98.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 109.249 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -76.33 13.93 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.614 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -146.08 31.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.069 -1.02 . . . . 0.0 110.453 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.1 mt -80.75 139.12 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.902 -1.124 . . . . 0.0 110.35 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -128.06 119.25 25.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.529 -0.732 . . . . 0.0 109.041 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.62 140.68 48.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -109.54 -178.26 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.701 . . . . 0.0 109.186 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -108.85 68.4 0.68 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.949 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -165.91 131.58 2.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 0.0 109.255 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -67.49 139.02 57.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 109.666 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 HG21 ' A' ' 85' ' ' THR . 47.2 mt -81.35 147.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.103 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.73 84.74 3.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 108.856 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.2 m-85 -64.14 143.84 57.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.438 -0.789 . . . . 0.0 109.851 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -88.27 101.56 13.98 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.17 132.19 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.7 . . . . 0.0 110.777 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.0 114.65 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -86.64 -29.1 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.959 -1.088 . . . . 0.0 110.907 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.77 162.33 51.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.963 -1.086 . . . . 0.0 109.766 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.34 145.56 27.14 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.857 2.371 . . . . 0.0 112.777 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -154.31 149.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.33 143.49 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 109.37 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.5 149.29 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.13 164.72 27.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.4 -0.812 . . . . 0.0 109.859 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.598 ' CG ' HH21 ' A' ' 137' ' ' ARG . 57.6 t0 -173.87 111.77 0.18 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 109.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 58.18 9.54 1.02 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.619 -0.675 . . . . 0.0 109.865 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.18 -26.63 8.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 134' ' ' ASP . 1.2 mpp_? -58.42 144.12 43.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.702 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.3 tt -148.94 139.51 22.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.093 -1.443 . . . . 0.0 111.03 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.23 125.6 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -111.71 131.0 55.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.436 0.636 . . . . 0.0 109.838 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.97 132.37 54.88 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 154.02 52.26 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.995 -1.066 . . . . 0.0 109.959 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.3 139.76 43.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.276 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.93 147.13 22.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.9 -37.54 82.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.4 p -117.75 -171.55 2.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.0 110.051 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 tp -100.95 126.15 47.58 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.98 137.23 34.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.58 ' CG1' HD23 ' A' ' 231' ' ' LEU . 61.8 t -133.98 121.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.0 m -111.29 151.96 27.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.465 -0.772 . . . . 0.0 109.265 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.557 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 34.0 t80 -140.75 130.94 24.88 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.181 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.83 131.66 54.17 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.83 141.33 12.29 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.583 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -103.89 100.81 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.28 167.3 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -100.94 -14.99 17.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.821 . . . . 0.0 110.774 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 p-10 -95.31 -173.56 2.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.784 -1.198 . . . . 0.0 110.587 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.47 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 8.4 p90 -49.3 -0.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.812 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.6 mt -80.76 -28.63 36.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.31 -1.494 . . . . 0.0 108.803 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.12 -137.09 45.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -99.85 135.85 40.65 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -1.188 . . . . 0.0 109.625 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -139.03 146.88 41.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -138.18 144.65 40.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.493 -0.755 . . . . 0.0 109.756 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -143.22 136.16 27.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.7 m -105.85 122.76 46.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.72 ' CD1' ' ND2' ' A' ' 170' ' ' ASN . 7.2 t80 -101.73 110.24 22.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.271 -0.893 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.659 ' O ' ' ND2' ' A' ' 170' ' ' ASN . 3.7 t -105.76 141.02 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 110.054 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 167' ' ' VAL . 9.8 mm-40 -44.06 131.58 5.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 108.819 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.85 -16.52 18.45 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.72 ' ND2' ' CD1' ' A' ' 166' ' ' PHE . 0.3 OUTLIER -115.16 29.36 8.07 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.074 -1.25 . . . . 0.0 109.916 179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -53.75 -38.32 64.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.07 -1.019 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.3 -18.65 50.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -85.66 -7.57 58.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 111.179 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.73 -28.49 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.114 -0.991 . . . . 0.0 110.963 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.8 m -63.5 -24.95 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.736 -1.227 . . . . 0.0 108.882 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.59 -4.72 58.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.511 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.13 120.17 13.9 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 82.3 mtm180 -83.4 172.47 12.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.501 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.9 t -79.14 161.48 26.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -147.85 145.45 28.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.234 -1.541 . . . . 0.0 111.859 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.49 157.43 44.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.5 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.5 m-85 -98.95 145.54 26.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 109.626 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.06 -35.79 26.58 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.344 -0.847 . . . . 0.0 109.864 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -72.8 -28.16 62.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.963 -1.086 . . . . 0.0 109.862 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.6 mm-40 -79.11 -40.62 30.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 110.085 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.53 HG21 HB11 ' A' ' 500' ' ' C90 . 77.5 mt -44.73 -55.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 19.3 tt0 -42.13 -41.73 2.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 192' ' ' VAL . 48.6 t60 -73.26 -55.55 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 88.5 mt -45.4 -26.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.368 -0.832 . . . . 0.0 109.407 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -85.75 -53.71 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.819 -1.176 . . . . 0.0 108.921 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -49.09 -26.77 2.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 188' ' ' HIS . 15.4 m -96.1 18.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 59.25 39.83 95.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 194' ' ' LEU . 62.4 mt -125.45 171.97 10.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -1.071 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.37 22.49 51.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -58.28 -22.79 54.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.7 -1.471 . . . . 0.0 109.534 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -110.28 25.56 15.52 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.33 125.01 7.61 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.416 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -143.89 169.49 17.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -1.118 . . . . 0.0 109.847 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.554 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 55.8 mt -69.08 -8.74 48.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.5 -10.64 24.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.722 -0.611 . . . . 0.0 109.762 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.44 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 13.5 p30 -138.27 8.76 2.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 109.866 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.482 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.72 149.56 31.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.932 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.586 HD11 HD21 ' A' ' 206' ' ' LEU . 21.8 tp -97.95 93.65 6.44 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -87.41 130.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.279 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 204' ' ' LEU . 20.3 mt -123.35 163.05 21.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.528 -0.733 . . . . 0.0 109.164 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.52 -166.79 13.22 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -68.45 -25.74 65.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.261 -1.14 . . . . 0.0 109.665 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.16 21.47 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 0.0 110.778 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -150.1 157.92 43.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.411 -1.43 . . . . 0.0 110.68 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.01 113.94 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -57.38 -50.86 71.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.897 -1.127 . . . . 0.0 109.99 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.34 111.21 3.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.56 -16.47 30.15 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.747 1.631 . . . . 0.0 112.677 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.65 -15.7 60.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.901 -1.125 . . . . 0.0 109.923 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.4 -178.37 47.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.7 mt -84.31 151.41 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 109.735 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.5 OUTLIER -78.55 -18.97 53.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.187 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 52.9 m-85 -144.72 -172.0 3.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.542 -0.724 . . . . 0.0 109.103 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.3 -5.08 53.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.6 43.28 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.196 -0.94 . . . . 0.0 109.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -54.82 -47.52 98.02 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 109.948 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -50.82 -68.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.463 2.108 . . . . 0.0 112.079 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.7 m -58.22 -36.3 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -60.88 -40.88 94.66 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.223 -0.923 . . . . 0.0 108.555 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.511 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 15.3 t60 -68.47 -32.19 72.01 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.253 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.557 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 6.0 mmtp -66.04 -36.03 82.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.9 t -67.63 -37.49 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.03 -52.11 61.01 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 87.4 m-20 -65.38 -27.01 68.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.681 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.58 HD23 ' CG1' ' A' ' 149' ' ' VAL . 59.2 tp -76.92 -32.77 57.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.084 -1.01 . . . . 0.0 108.588 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.85 -38.53 78.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.15 -54.36 24.57 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -56.96 -35.43 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 109.293 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.72 -24.83 67.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 110.512 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.2 t80 -74.98 -21.46 59.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.884 -1.135 . . . . 0.0 109.388 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 237' ' ' LEU . 65.0 mt -48.54 -6.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.86 -1.15 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -69.33 -13.03 62.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.945 -1.097 . . . . 0.0 109.85 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.85 2.92 64.44 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.715 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.74 149.87 11.02 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.872 -1.369 . . . . 0.0 108.904 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.401 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 6.9 Cg_endo -53.04 130.0 35.95 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.639 1.559 . . . . 0.0 110.076 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.88 150.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 112.216 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -130.64 123.37 29.28 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.82 -157.43 27.59 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.8 OUTLIER -129.35 137.03 50.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -1.042 . . . . 0.0 108.857 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.0 m-85 -133.54 140.03 46.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -126.97 123.24 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.06 132.99 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.735 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -114.92 110.79 20.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 56.6 mtp180 46.57 41.25 9.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.249 -0.907 . . . . 0.0 109.087 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.8 163.98 50.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -131.76 -179.05 15.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.519 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 30.7 m-70 -65.15 -46.72 79.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -1.229 . . . . 0.0 110.034 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.6 OUTLIER -53.45 -60.61 3.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.971 -1.081 . . . . 0.0 108.782 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 254' ' ' SER . 12.5 tp -47.76 -49.5 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.03 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 25.8 m-20 -47.74 -49.5 28.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.988 -1.07 . . . . 0.0 109.098 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 56' ' ' THR . 88.2 t -60.94 -44.29 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.473 -0.767 . . . . 0.0 109.755 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -59.4 -49.21 78.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.218 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 32.4 tp -54.19 -49.85 68.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.63 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.555 HG13 ' HG ' ' A' ' 238' ' ' LEU . 22.5 t -58.47 -57.43 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.003 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -47.74 -45.33 28.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.133 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -62.48 -57.4 11.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.365 -0.834 . . . . 0.0 109.213 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.5 mt -48.4 -48.7 36.86 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.141 -0.975 . . . . 0.0 109.512 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.58 67.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -69.81 -50.61 41.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 109.859 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 266' ' ' LYS . 26.2 mmtt -64.08 -45.87 86.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.966 -1.084 . . . . 0.0 108.533 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -86.94 58.2 4.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 0.0 109.367 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -92.6 5.68 50.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.539 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.3 mt -65.91 143.04 57.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -1.132 . . . . 0.0 109.643 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 119' ' ' ARG . 27.9 mt-10 -54.0 142.45 24.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -125.7 142.73 51.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.351 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -142.62 -168.55 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.1 m -103.22 141.19 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.005 -1.059 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -69.92 -26.03 63.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.982 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -145.44 161.79 38.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 110.161 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 139.18 55.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.07 161.27 20.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 p -131.96 141.66 49.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.73 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 91.9 m-85 -138.17 152.5 48.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.24 151.9 19.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.743 -1.223 . . . . 0.0 110.157 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.72 174.28 35.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 151.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.0 136.14 14.81 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.4 tt -56.55 -39.05 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.456 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.8 m-70 -92.35 -49.26 6.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.757 -1.214 . . . . 0.0 111.008 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -28.38 69.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 111.245 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.87 17.63 55.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -112.7 155.12 25.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -1.012 . . . . 0.0 109.325 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.28 135.2 44.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.0 109.421 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 m -138.11 144.34 40.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.784 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.18 154.38 25.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.027 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 7.7 mt -135.74 147.44 48.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 110.162 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.573 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.8 mt -143.87 109.43 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.4 115.15 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.449 -0.782 . . . . 0.0 110.575 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.573 ' NE2' HG22 ' A' ' 27' ' ' ILE . 34.2 m-70 -109.46 141.81 24.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 7' ' ' VAL . 16.5 Cg_exo -55.79 168.89 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.824 1.683 . . . . 0.0 111.477 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' HG21 ' A' ' 35' ' ' THR . 70.7 mm-40 -141.74 175.44 9.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.93 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 13.8 mttt -82.37 152.09 26.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 145.13 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 70.19 5.06 52.59 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.107 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 31' ' ' GLU . 35.2 m -67.31 -44.37 79.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.526 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.36 -179.69 33.54 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.547 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -96.29 116.58 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -143.02 148.84 37.41 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.69 -1.204 . . . . 0.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.82 156.94 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -129.3 109.38 11.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.236 -0.915 . . . . 0.0 108.934 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 tttp -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m120 53.61 27.7 7.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 111.101 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.25 19.67 71.43 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.463 -1.351 . . . . 0.0 109.859 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 t -123.28 123.2 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -85.87 127.46 34.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.04 -1.038 . . . . 0.0 109.287 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mt -118.23 95.03 47.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 109.724 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.4 148.24 11.18 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.476 2.118 . . . . 0.0 112.179 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.674 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.59 78.38 8.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.761 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -134.85 -179.94 5.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 0.0 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.4 p-80 -74.52 -54.76 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.986 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.598 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.4 OUTLIER -43.5 -17.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.845 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 67.2 m-85 -97.23 -0.52 46.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 109.655 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.94 122.36 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.4 -0.813 . . . . 0.0 108.831 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -100.3 -34.11 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -151.21 138.66 19.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.144 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.944 HG21 HG21 ' A' ' 257' ' ' VAL . 55.2 p -125.02 95.86 4.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 59' ' ' SER . 28.0 t-20 -162.53 129.5 3.66 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.4 m-70 49.43 9.57 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.091 -1.006 . . . . 0.0 108.969 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.61 143.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 109.646 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 41.8 m -88.66 129.56 35.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 109.011 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.16 152.34 41.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.288 -0.883 . . . . 0.0 111.164 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.0 mt -126.11 151.77 46.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.04 165.54 34.25 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.021 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -168.71 141.74 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 108.806 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? 52.27 28.59 5.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.741 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.63 5.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -57.64 148.75 23.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.006 -1.291 . . . . 0.0 109.343 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.28 139.99 26.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.699 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.534 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -130.24 124.62 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -98.45 154.19 18.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.272 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.2 m 51.89 75.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.1 m -107.88 -9.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.138 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.58 -27.96 69.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.517 -0.739 . . . . 0.0 110.559 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -65.08 -69.37 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.988 -1.07 . . . . 0.0 109.498 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -51.57 -47.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.154 -0.966 . . . . 0.0 109.023 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.674 HD21 ' HB1' ' A' ' 48' ' ' ALA . 18.6 mt -52.12 -48.37 64.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.076 -1.015 . . . . 0.0 110.134 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.582 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 40.5 t -60.87 -42.77 98.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.45 -44.59 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.0 109.086 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.05 -34.48 77.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -61.96 -40.43 95.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' HB2' ' A' ' 171' ' ' GLU . 55.8 mt -75.0 -37.9 61.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.718 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.23 0.82 34.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 109.543 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 54.41 42.25 31.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 0.0 110.139 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -90.36 137.04 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 108.557 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 HG12 ' A' ' 121' ' ' ILE . 31.4 p -124.53 -19.01 5.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.191 -0.943 . . . . 0.0 112.018 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.732 ' O ' HG13 ' A' ' 87' ' ' VAL . 29.6 m-80 -124.61 107.16 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.806 -1.184 . . . . 0.0 110.407 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.3 m -165.9 147.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.738 0.78 . . . . 0.0 109.913 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 53.3 m -114.03 110.97 20.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.18 100.31 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 110.16 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.92 125.7 28.2 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 69' ' ' ILE . 48.8 t -110.79 120.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.762 0.791 . . . . 0.0 111.725 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt -107.52 96.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.84 -156.61 26.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -121.83 -10.55 8.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -1.169 . . . . 0.0 110.443 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -140.33 148.86 41.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.0 -1.063 . . . . 0.0 109.973 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.7 mm -72.99 117.17 57.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.892 . . . . 0.0 108.804 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' ILE . 75.3 Cg_exo -39.31 130.26 1.57 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.586 1.524 . . . . 0.0 111.418 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.482 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.6 tp -86.21 -14.12 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.08 -117.47 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 0.0 109.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 4.47 51.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.024 -1.047 . . . . 0.0 110.75 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.71 58.77 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.182 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.1 p -126.54 -172.82 2.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.558 -0.966 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.7 15.99 9.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 62.5 t-105 -59.67 -42.73 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -1.064 . . . . 0.0 110.299 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.55 -57.06 11.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.095 -1.003 . . . . 0.0 109.996 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -51.33 -44.92 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.865 . . . . 0.0 109.048 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 46.4 t80 -62.55 -52.51 63.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.726 -0.608 . . . . 0.0 110.931 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 3.8 mm-40 -60.71 -44.13 96.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.08 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.85 3.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.088 -1.007 . . . . 0.0 110.51 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.25 -33.75 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.506 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 36.2 ttt180 -64.64 -41.81 95.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -75.86 11.97 1.23 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 110.024 -179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -142.84 35.68 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.284 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.3 mt -81.41 140.12 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.225 -0.922 . . . . 0.0 110.953 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 8' ' ' LYS . 3.9 tp -132.21 126.94 34.73 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.15 146.03 33.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -117.02 -175.85 2.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.272 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -113.27 67.02 0.66 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.232 -0.917 . . . . 0.0 111.175 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 4' ' ' GLU . 7.6 ttt180 -164.89 128.31 2.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 109.529 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -68.24 142.77 55.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.89 -1.131 . . . . 0.0 109.99 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.528 HG12 HG21 ' A' ' 85' ' ' THR . 70.7 mt -85.95 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -95.94 83.46 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 108.794 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 44.1 m-85 -61.66 145.27 52.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 110.14 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -92.6 102.31 14.74 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.22 133.89 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.384 0.611 . . . . 0.0 110.843 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.69 118.96 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.62 -28.31 16.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.979 -1.075 . . . . 0.0 110.736 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 154.54 80.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.48 151.68 47.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.684 2.256 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -160.23 154.21 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.595 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.37 144.67 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.49 148.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -134.88 159.9 39.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.45 107.9 0.12 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 54.66 49.35 18.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.442 -0.786 . . . . 0.0 110.488 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.65 -29.36 3.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -61.8 137.97 58.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -1.216 . . . . 0.0 108.116 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -146.71 139.38 25.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.691 -1.256 . . . . 0.0 110.223 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.587 ' CD1' HD23 ' A' ' 255' ' ' LEU . 96.7 mt -137.78 126.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.375 -0.828 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -113.34 133.26 55.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.392 0.615 . . . . 0.0 109.999 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.11 136.2 54.89 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.81 150.73 40.3 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.61 141.88 14.57 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.693 2.262 . . . . 0.0 113.62 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.21 144.89 20.16 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.539 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.19 -20.51 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.296 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.9 p -137.45 -174.13 3.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 tp -94.39 121.19 35.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -134.74 120.46 19.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.52 121.45 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.805 . . . . 0.0 109.993 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.0 m -111.31 151.84 27.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.631 -0.668 . . . . 0.0 109.199 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -139.21 130.05 26.22 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -121.23 131.67 54.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.65 138.5 9.49 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.32 -1.419 . . . . 0.0 112.053 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 99.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -83.66 167.01 17.65 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 111.359 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -100.44 23.61 10.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.712 -0.617 . . . . 0.0 110.649 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.0 p-10 -140.08 -172.91 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -49.34 -2.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 111.417 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -77.94 -27.74 49.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.361 -1.462 . . . . 0.0 108.375 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.84 -135.1 43.14 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 133.25 44.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -1.204 . . . . 0.0 109.302 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -135.31 141.4 45.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -136.8 144.11 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.012 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -144.91 137.06 25.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.3 m -105.5 123.55 48.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.701 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.489 ' HB3' HG11 ' A' ' 228' ' ' VAL . 10.2 t80 -103.56 109.0 20.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.984 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.76 149.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.07 131.39 23.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -0.958 . . . . 0.0 109.02 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.53 43.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -115.97 22.95 12.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -1.085 . . . . 0.0 109.226 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.722 ' HB2' HD13 ' A' ' 81' ' ' LEU . 4.9 pt-20 -58.11 -47.24 83.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.376 -0.827 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 171' ' ' GLU . 22.8 mt-10 -52.85 -6.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 110.258 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 171' ' ' GLU . 23.7 mt-10 -102.71 -6.94 22.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.033 . . . . 0.0 110.952 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.1 pt -123.73 -26.46 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.996 -1.065 . . . . 0.0 110.849 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.1 m -63.65 -29.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mt -77.39 -5.65 50.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.537 -0.727 . . . . 0.0 109.165 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.406 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.51 124.51 24.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.113 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.412 HH12 ' HG3' ' A' ' 215' ' ' GLU . 63.3 mtm180 -86.13 172.72 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.778 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.427 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -79.0 162.55 25.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.36 145.63 27.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.216 -1.552 . . . . 0.0 111.875 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.615 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.14 157.94 44.06 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.593 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.5 m-85 -98.61 142.11 30.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.652 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 2.9 t0 -49.22 -35.61 17.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.205 -0.935 . . . . 0.0 109.409 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.593 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.2 p90 -70.55 -26.16 63.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.023 -1.048 . . . . 0.0 109.553 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -86.3 -27.3 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.758 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 205' ' ' VAL . 31.5 mt -60.14 -43.81 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.999 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.6 -39.8 65.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.998 -1.064 . . . . 0.0 109.261 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -75.92 -56.22 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 194' ' ' LEU . 47.8 mt -44.74 -33.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -52.54 7.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.827 -1.171 . . . . 0.0 108.869 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -46.73 -48.33 20.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 110.455 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.6 m -74.24 7.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.002 -1.061 . . . . 0.0 110.409 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 37.85 45.69 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 194' ' ' LEU . 36.8 mt -126.07 169.5 12.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.3 25.38 57.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -61.76 -21.76 64.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.675 -1.486 . . . . 0.0 109.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.44 24.22 22.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.35 124.92 7.43 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.9 OUTLIER -138.64 163.38 32.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -1.154 . . . . 0.0 109.539 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.8 mt -66.91 -8.6 30.49 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.59 -11.83 20.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.3 p30 -133.36 6.4 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.31 149.64 32.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.597 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.456 HD11 HD21 ' A' ' 206' ' ' LEU . 21.3 tp -98.63 95.89 7.58 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 186' ' ' ILE . 62.8 t -86.23 127.83 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.717 0.77 . . . . 0.0 109.323 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 211' ' ' VAL . 28.1 mt -122.27 173.98 7.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.602 -0.686 . . . . 0.0 109.322 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.58 -166.39 10.84 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -30.79 70.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.48 -1.012 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -157.85 25.22 0.27 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -144.21 150.75 38.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.922 -1.111 . . . . 0.0 110.677 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.518 HG22 HD22 ' A' ' 206' ' ' LEU . 51.3 t -103.75 112.31 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -58.89 -45.31 90.54 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.056 -1.027 . . . . 0.0 110.071 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.6 m120 -59.86 117.14 20.61 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.9 -15.3 46.7 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.391 1.394 . . . . 0.0 111.702 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.8 pm0 -76.08 -14.83 60.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.352 -0.842 . . . . 0.0 109.089 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.82 -176.39 51.02 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.8 mt -86.72 140.95 29.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 7.3 ttp180 -71.29 -18.08 62.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.67 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 57.1 m-85 -147.26 165.09 31.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.58 -12.69 60.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.078 . . . . 0.0 109.355 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -131.9 43.63 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -60.62 -46.39 97.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.3 Cg_exo -51.37 -67.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.326 2.018 . . . . 0.0 112.295 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.5 m -58.74 -36.26 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.032 -1.042 . . . . 0.0 109.579 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.67 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 58.5 mtt180 -58.67 -42.08 87.61 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.406 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 17.4 t60 -69.08 -30.94 69.36 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.404 -0.81 . . . . 0.0 109.302 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -65.77 -36.37 83.36 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.8 t -68.49 -39.25 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.582 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 57.6 t80 -62.82 -50.48 70.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.28 -29.4 69.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.057 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.42 -31.16 62.2 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.022 -1.049 . . . . 0.0 108.177 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.4 mt -69.56 -40.17 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.88 47.99 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 m-20 -58.62 -40.81 84.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.262 . . . . 0.0 109.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 13.2 mt -55.09 -21.45 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.683 . . . . 0.0 110.15 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.95 -22.19 60.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.087 . . . . 0.0 108.73 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.31 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.649 -1.282 . . . . 0.0 110.208 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.583 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -76.21 -15.51 60.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.941 -1.099 . . . . 0.0 109.781 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.0 -1.21 55.06 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.48 156.74 9.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.368 . . . . 0.0 108.671 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.422 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.8 Cg_endo -47.88 150.49 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.637 1.558 . . . . 0.0 109.461 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.68 144.92 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.074 -1.016 . . . . 0.0 111.935 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.78 120.34 30.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 -166.8 34.49 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.476 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 2.0 ttmt -126.34 139.25 53.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.405 -1.056 . . . . 0.0 108.934 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -139.26 140.58 37.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 110.546 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.88 124.81 42.86 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 m -116.43 136.39 53.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 111.314 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 250' ' ' ARG . 51.8 t80 -116.54 114.5 24.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 249' ' ' PHE . 5.1 mtp180 44.4 46.8 8.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.021 -1.05 . . . . 0.0 108.836 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -84.99 158.8 33.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -132.15 176.85 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.583 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 55.9 m-70 -58.89 -40.34 84.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.2 t -55.55 -59.53 4.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.833 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 139' ' ' ILE . 5.3 tp -52.33 -47.26 66.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.56 -49.87 25.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.944 HG21 HG21 ' A' ' 56' ' ' THR . 85.4 t -63.62 -51.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 109.805 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.06 -51.56 61.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.045 . . . . 0.0 109.312 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 139' ' ' ILE . 39.7 tp -52.04 -50.2 61.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 108.525 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.583 HG13 ' HG ' ' A' ' 238' ' ' LEU . 41.7 t -57.65 -53.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 108.82 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -48.31 -47.06 36.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.742 . . . . 0.0 109.311 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.24 -51.43 60.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 109.813 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.06 -50.89 69.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 268' ' ' LYS . . . -66.62 -29.46 69.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.083 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -59.06 3.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.88 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.63 -36.49 84.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -80.16 -105.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 264' ' ' ALA . 2.6 tttm -106.41 128.11 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.982 . . . . 0.0 109.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.585 179.951 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.615 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.11 152.33 21.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -1.178 . . . . 0.0 109.596 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 69.0 mt-10 -54.22 141.26 30.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HG2' HG23 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -125.28 143.57 50.89 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 109.76 -178.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -142.16 -168.61 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -102.4 139.32 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -66.91 -30.07 70.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 109.825 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.43 160.11 41.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.73 140.72 56.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.433 -0.792 . . . . 0.0 110.137 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 11' ' ' LEU . 21.0 mt -117.75 166.79 12.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.18 35.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.952 -1.092 . . . . 0.0 110.404 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' LEU . 85.6 m-85 -142.17 158.83 43.29 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -163.32 151.13 13.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.953 -1.092 . . . . 0.0 109.492 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.99 175.24 36.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.85 153.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -1.079 . . . . 0.0 110.266 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.21 140.72 15.6 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.459 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.5 tt -60.32 -38.23 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 110.862 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 18' ' ' ILE . 70.4 m-70 -90.8 -49.93 6.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.496 -1.378 . . . . 0.0 111.237 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.8 p -72.55 -20.44 61.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 0.0 111.233 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.43 15.6 12.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -105.5 154.27 20.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 109.909 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 31.2 t80 -75.57 136.04 40.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -0.76 . . . . 0.0 109.557 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -138.52 145.55 40.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 109.906 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -108.7 154.67 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.537 HD22 ' CG2' ' A' ' 89' ' ' ILE . 10.1 mt -134.64 146.8 49.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.8 mt -143.72 111.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.808 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.87 115.04 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.189 -0.945 . . . . 0.0 110.668 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 25.5 m-70 -110.82 138.55 21.13 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 109.669 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 7' ' ' VAL . 37.9 Cg_exo -50.47 168.42 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.917 1.744 . . . . 0.0 111.627 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' HG21 ' A' ' 35' ' ' THR . 9.3 mm-40 -140.19 173.2 11.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 109.826 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.3 mmtt -83.04 150.95 26.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.584 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -49.11 146.67 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.937 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 67.14 6.68 40.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -71.78 -47.14 55.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.809 -1.407 . . . . 0.0 109.606 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.16 -174.76 24.41 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.771 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 87' ' ' VAL . 24.2 mm -102.33 118.34 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -139.54 151.91 46.48 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.574 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.81 158.09 16.22 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -130.4 113.82 14.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -135.14 133.16 38.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 110.472 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.5 m120 48.98 34.92 5.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.379 -0.825 . . . . 0.0 111.561 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.71 17.43 80.11 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.233 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.18 121.24 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.102 . . . . 0.0 108.901 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.8 m-85 -86.76 128.01 35.01 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.025 -1.047 . . . . 0.0 109.913 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 52' ' ' PHE . 13.4 mt -116.39 92.15 35.64 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.54 -0.725 . . . . 0.0 109.044 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.94 144.99 10.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.47 2.114 . . . . 0.0 112.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.87 63.65 4.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 108.995 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 49' ' ' ARG . 0.3 OUTLIER -114.29 169.88 8.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -75.14 -44.32 47.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 -16.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.436 ' HD2' HG23 ' A' ' 46' ' ' ILE . 24.5 m-85 -95.09 2.05 55.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.815 -1.178 . . . . 0.0 109.949 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.02 126.49 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 108.927 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.4 -30.82 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.888 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.83 141.56 19.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.048 -1.032 . . . . 0.0 109.94 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 HG21 ' A' ' 257' ' ' VAL . 66.0 p -128.56 95.72 4.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 5.9 t-20 -162.86 129.44 3.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 109.061 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 96.3 m-70 50.82 8.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.047 -1.033 . . . . 0.0 108.875 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.13 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 109.591 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.646 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 33.8 m -91.44 126.95 36.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.026 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.59 149.85 42.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.712 0.768 . . . . 0.0 111.14 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CG ' HG21 ' A' ' 72' ' ' VAL . 5.9 mt -125.54 149.13 48.58 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.55 151.52 21.43 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 118.767 -1.682 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -158.36 149.46 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.5 -1.0 . . . . 0.0 109.231 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 59.7 mttt 46.38 33.92 2.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 109.781 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.76 -33.25 4.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -55.58 139.76 43.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -1.19 . . . . 0.0 108.886 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -139.94 135.14 32.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 110.517 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.408 HG23 HG11 ' A' ' 91' ' ' VAL . 51.1 mt -128.84 117.17 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 mtpp -97.27 155.42 16.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.896 -1.127 . . . . 0.0 111.118 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' THR . 66.1 m 52.62 72.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.221 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 62' ' ' LEU . 19.0 m -107.41 -10.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.646 ' CD ' ' H ' ' A' ' 60' ' ' THR . 2.5 pm0 -60.91 -31.47 70.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -0.786 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -61.87 -68.39 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.983 -1.073 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.39 -48.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 109.314 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.4 mt -51.15 -47.61 62.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.875 -1.141 . . . . 0.0 109.744 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.9 t -62.09 -43.31 99.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 106' ' ' PHE . 91.3 t -56.54 -45.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 108.937 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 mt -66.79 -34.67 78.34 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 108.916 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -63.21 -34.48 77.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.203 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 171' ' ' GLU . 66.3 mt -79.42 -38.45 34.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.764 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.13 3.1 21.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.64 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 55.51 40.19 31.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mm -90.26 134.39 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 108.696 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 121' ' ' ILE . 26.5 p -120.96 -16.16 8.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.367 -0.833 . . . . 0.0 111.718 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -127.64 108.15 10.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.876 -1.14 . . . . 0.0 111.242 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -165.36 150.7 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.356 -0.84 . . . . 0.0 110.404 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 35.7 m -118.67 109.67 16.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.537 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -93.3 102.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.666 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.1 mt-10 -71.42 124.49 24.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.408 HG11 HG23 ' A' ' 69' ' ' ILE . 13.7 t -108.66 113.95 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.529 0.681 . . . . 0.0 110.709 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.7 mm -102.08 97.7 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.65 -156.31 25.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.31 -12.32 9.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 109.827 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -138.5 148.86 44.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 109.404 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.17 128.16 86.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 121.95 4.81 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.709 1.606 . . . . 0.0 111.39 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 202' ' ' ASN . 2.4 tp -77.98 -14.83 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.3 mt 57.38 -120.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.275 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 15.7 t70 -95.05 9.0 41.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.983 -1.073 . . . . 0.0 111.117 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.3 64.64 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.148 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -171.62 2.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.812 -0.817 . . . . 0.0 109.43 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.47 15.11 10.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.99 -42.63 85.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.342 -1.093 . . . . 0.0 110.665 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.47 -58.48 7.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.124 -0.985 . . . . 0.0 110.017 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HG11 ' A' ' 78' ' ' VAL . 21.4 m-85 -51.05 -44.03 61.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.19 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 64.6 t80 -60.88 -50.91 71.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.933 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.33 -43.61 90.42 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.967 -1.083 . . . . 0.0 111.469 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.01 -59.52 3.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.958 -1.088 . . . . 0.0 110.277 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.23 -36.17 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 71.6 ttt180 -63.27 -41.52 99.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.595 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -74.13 9.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -143.76 38.65 1.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.148 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.43 HG23 ' HG2' ' A' ' 5' ' ' LYS . 89.4 mt -88.08 141.72 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.097 -1.002 . . . . 0.0 111.585 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.87 134.72 44.97 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -85.4 150.31 24.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 109.931 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -115.98 -173.95 2.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.408 -0.808 . . . . 0.0 109.81 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -113.97 66.8 0.67 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.6 128.61 2.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.051 -1.031 . . . . 0.0 109.291 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.05 139.18 58.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.732 -1.23 . . . . 0.0 109.572 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -82.62 149.31 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.8 81.38 3.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.68 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -60.28 143.53 52.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.672 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -89.36 101.33 14.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -93.39 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.367 0.603 . . . . 0.0 110.778 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.54 114.69 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.89 -28.43 15.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.978 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -129.58 150.18 74.97 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.84 149.59 37.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.478 2.119 . . . . 0.0 112.207 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.95 150.94 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.954 . . . . 0.0 109.265 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.29 143.44 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.58 147.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.24 162.21 35.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -178.07 113.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 54.58 47.38 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 0.0 110.717 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 -30.88 4.26 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -61.55 137.66 58.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.91 -1.347 . . . . 0.0 108.469 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -144.1 138.18 28.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.011 -1.056 . . . . 0.0 109.543 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.768 ' CD1' HD23 ' A' ' 255' ' ' LEU . 78.8 mt -138.85 127.3 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.312 -0.867 . . . . 0.0 110.067 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -117.09 132.01 56.78 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.454 0.645 . . . . 0.0 109.887 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.75 133.66 54.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.72 153.05 46.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.88 -1.138 . . . . 0.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -48.43 141.87 18.48 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.859 2.373 . . . . 0.0 113.836 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.26 148.75 20.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -37.83 82.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.501 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.4 p -124.91 -174.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.317 -0.864 . . . . 0.0 110.385 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -90.86 121.2 32.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.9 . . . . 0.0 109.065 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.476 ' CG ' HG22 ' A' ' 167' ' ' VAL . 3.7 tt0 -134.79 121.7 21.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.473 ' CG1' HD23 ' A' ' 231' ' ' LEU . 59.9 t -121.67 120.97 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -110.6 151.45 27.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.196 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.81 130.18 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.68 130.79 53.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.13 135.11 7.69 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.623 -1.275 . . . . 0.0 111.682 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -101.91 102.34 12.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -86.18 166.95 15.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 111.141 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -103.96 23.36 13.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.771 -0.581 . . . . 0.0 110.294 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.5 p-10 -138.81 -170.7 2.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 110.115 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -50.67 -4.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 111.163 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' ASN . 13.0 mt -78.51 -26.92 46.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.463 -1.398 . . . . 0.0 108.556 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.84 -139.54 32.31 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -99.71 134.76 42.13 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -136.19 144.62 45.04 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.552 -0.717 . . . . 0.0 109.116 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.508 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.21 145.15 38.93 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 110.036 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 165' ' ' THR . 10.1 t80 -147.41 146.11 29.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 92.1 m -113.53 125.39 54.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 110.582 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.434 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.1 t80 -105.01 118.95 37.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.371 -0.83 . . . . 0.0 109.997 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.476 HG22 ' CG ' ' A' ' 148' ' ' GLU . 65.0 t -109.84 150.5 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 134.26 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.35 -7.46 51.25 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -118.95 28.02 8.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.183 -1.187 . . . . 0.0 109.365 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.634 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -63.55 -15.4 57.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.438 -0.789 . . . . 0.0 110.647 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.46 -13.19 61.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 0.0 110.622 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.02 -6.07 36.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.834 -1.167 . . . . 0.0 111.51 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.42 -30.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.149 -0.969 . . . . 0.0 110.426 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 171' ' ' GLU . 12.3 m -61.1 -20.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.772 -1.205 . . . . 0.0 108.683 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.98 -3.35 58.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 0.0 108.969 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.4 117.41 11.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.581 ' NE ' ' OE2' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -82.2 173.22 12.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.665 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.67 162.91 25.88 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -147.8 143.93 27.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.313 -1.492 . . . . 0.0 111.38 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.662 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.09 158.63 43.53 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.488 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.1 m-85 -101.03 146.07 27.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.584 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 7.8 p30 -51.18 -37.7 48.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.102 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.488 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.1 p90 -67.87 -26.1 65.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.788 -1.195 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.6 mm-40 -82.43 -25.5 33.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.943 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.469 HD13 HB11 ' A' ' 500' ' ' C90 . 37.2 mt -58.22 -55.34 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.963 . . . . 0.0 109.659 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -45.3 -39.59 6.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.085 -1.01 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 16.1 t-160 -76.49 -57.46 3.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.151 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 188' ' ' HIS . 84.3 mt -42.04 -32.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.46 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -82.13 -51.31 8.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.071 -1.018 . . . . 0.0 109.102 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -48.35 -45.07 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.89 . . . . 0.0 110.376 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 30.6 m -76.95 8.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.039 -1.038 . . . . 0.0 110.558 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.76 39.74 59.41 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 194' ' ' LEU . 51.7 mt -126.43 170.79 11.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -1.107 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.49 22.28 58.78 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -55.78 -21.6 20.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.641 -1.505 . . . . 0.0 110.231 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.5 3.63 32.72 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.55 124.86 34.14 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.125 -1.221 . . . . 0.0 110.092 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.0 m -145.57 167.4 23.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.267 -1.137 . . . . 0.0 108.956 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.517 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.2 mt -69.94 -8.26 47.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.464 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -95.16 -10.67 29.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.912 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.516 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 12.2 p-10 -138.38 9.81 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.926 -1.109 . . . . 0.0 110.215 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.89 149.3 31.02 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.79 93.68 5.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 203' ' ' THR . 38.6 t -85.7 130.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 66.2 mt -123.05 168.53 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.39 -166.06 11.82 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -63.44 -21.08 66.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -1.107 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.34 22.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -136.66 144.81 44.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.286 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.42 110.25 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -59.76 -47.02 87.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.605 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -62.5 121.28 66.18 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 0.0 109.733 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -67.65 -14.74 42.91 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.474 1.45 . . . . 0.0 112.016 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.2 -16.73 59.78 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.113 -0.992 . . . . 0.0 108.714 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.38 -169.97 54.88 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.247 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -88.98 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 0.0 110.117 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -69.03 -21.34 64.12 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.8 m-85 -147.03 148.01 31.23 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.17 7.6 0.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.201 -0.937 . . . . 0.0 109.769 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.54 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.0 OUTLIER -148.34 37.05 0.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.581 ' OE2' ' NE ' ' A' ' 178' ' ' ARG . 1.1 tt0 -54.92 -47.08 99.26 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.95 -66.98 0.1 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.435 2.09 . . . . 0.0 112.102 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.02 -37.12 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 109.969 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.509 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 56.9 mtt180 -60.95 -40.64 94.11 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.0 t60 -67.47 -32.05 72.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.696 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.87 -35.52 80.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 166' ' ' PHE . 65.1 t -69.14 -37.57 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.575 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 49.8 t80 -64.51 -50.69 66.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.15 -28.74 69.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' CG1' ' A' ' 149' ' ' VAL . 42.9 tp -76.03 -33.66 59.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 108.732 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.34 -40.74 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.85 -52.88 38.16 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.23 -31.8 69.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -1.187 . . . . 0.0 109.314 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 235' ' ' LEU . 6.2 mt -68.86 -24.56 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -76.51 -21.79 55.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.918 -1.114 . . . . 0.0 109.394 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.2 mt -51.23 -0.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.793 -1.192 . . . . 0.0 110.606 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.6 mt -76.59 -11.92 59.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 109.955 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.32 0.6 59.59 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.836 -1.174 . . . . 0.0 110.724 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.56 152.67 13.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.928 -1.337 . . . . 0.0 108.859 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 130.17 39.13 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.869 1.712 . . . . 0.0 110.032 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.55 151.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 112.042 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -136.39 128.82 30.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 151.21 -156.78 26.86 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.453 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.4 OUTLIER -128.9 139.98 51.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -1.102 . . . . 0.0 109.169 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.0 m-85 -139.04 140.04 37.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.104 -0.998 . . . . 0.0 110.329 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -125.56 123.09 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.8 m -118.28 136.55 53.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 111.303 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 250' ' ' ARG . 47.8 t80 -117.32 117.27 29.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 249' ' ' PHE . 10.4 mtp180 45.02 42.49 6.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 108.562 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.08 153.09 35.48 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.13 178.89 17.64 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 86.2 m-70 -59.72 -40.09 86.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -1.044 . . . . 0.0 109.77 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 83.4 p -59.48 -38.78 81.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.798 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.768 HD23 ' CD1' ' A' ' 139' ' ' ILE . 2.1 tp -76.15 -47.18 25.22 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.038 . . . . 0.0 108.984 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . 9.0 m-20 -47.59 -44.5 26.44 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.987 -1.07 . . . . 0.0 108.457 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 56' ' ' THR . 72.1 t -66.71 -54.23 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.541 -0.724 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -49.59 -51.67 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.946 -1.096 . . . . 0.0 109.435 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.723 HD22 HG21 ' A' ' 139' ' ' ILE . 37.2 tp -53.37 -52.88 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.214 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.3 t -56.4 -54.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.034 -1.041 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.02 -52.63 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.96 -50.93 72.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 109.738 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -52.86 -49.87 64.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.29 -26.98 66.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -71.21 -47.81 55.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -34.94 53.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 109.91 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -83.63 56.35 3.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -102.95 12.55 35.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.662 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.37 155.61 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -55.13 138.62 44.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 108.777 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.25 143.43 49.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 110.048 -179.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -141.23 -174.28 3.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG23 ' HG3' ' A' ' 30' ' ' PRO . 26.1 m -96.81 136.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.878 -1.139 . . . . 0.0 109.007 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -67.34 -21.43 65.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.422 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -151.52 156.91 41.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.63 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 141.91 58.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.825 . . . . 0.0 110.297 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.77 164.98 15.77 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.44 140.52 48.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 26' ' ' LEU . 90.6 m-85 -136.92 148.36 46.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.28 150.23 25.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.923 -1.11 . . . . 0.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.39 171.38 34.99 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.47 151.17 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.404 -1.056 . . . . 0.0 109.893 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.15 137.85 15.94 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.0 tt -58.64 -38.52 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -1.222 . . . . 0.0 110.316 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.427 ' N ' HG23 ' A' ' 18' ' ' ILE . 69.5 m-70 -90.94 -50.26 5.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.701 -1.25 . . . . 0.0 110.804 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.3 p -66.93 -24.79 66.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.708 -0.62 . . . . 0.0 111.265 -178.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.17 18.97 29.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -112.69 155.45 24.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -1.059 . . . . 0.0 109.446 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.91 132.18 43.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.242 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -134.9 143.22 46.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.494 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.75 156.62 21.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.421 -0.8 . . . . 0.0 109.728 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.631 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -138.46 147.45 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.509 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.0 mt -141.75 113.34 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 mt -96.34 113.16 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.609 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -106.33 138.9 19.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.656 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.0 Cg_exo -55.29 168.12 1.55 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.652 1.568 . . . . 0.0 111.657 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' OE1' HG21 ' A' ' 35' ' ' THR . 37.0 mm-40 -142.31 171.5 13.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.369 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.0 mttp -83.58 155.82 23.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.73 150.38 4.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.43 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 72.34 -7.63 8.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.54 HG21 ' OE1' ' A' ' 31' ' ' GLU . 95.8 m -62.19 -46.26 89.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.602 -1.528 . . . . 0.0 109.773 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 -179.64 35.59 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.34 115.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.78 151.29 46.95 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.54 158.27 16.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -129.26 108.94 10.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.245 -0.91 . . . . 0.0 108.602 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -135.27 135.55 40.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 53.7 26.78 6.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 178.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.49 17.0 78.53 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.19 122.47 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.443 -1.034 . . . . 0.0 108.706 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.48 128.0 33.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.79 93.64 41.83 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 0.0 109.533 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.61 145.71 16.58 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.407 2.071 . . . . 0.0 111.905 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.86 76.25 10.26 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -132.63 -179.66 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.532 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.9 p-80 -76.0 -55.67 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.008 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -43.75 -16.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.934 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.8 m-85 -98.16 3.62 49.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.74 -1.225 . . . . 0.0 110.337 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.78 138.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 108.607 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.92 -28.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.387 -0.821 . . . . 0.0 110.307 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -150.68 129.08 12.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.012 -1.055 . . . . 0.0 109.612 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.83 HG21 HG21 ' A' ' 257' ' ' VAL . 45.8 p -121.74 95.35 4.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.9 t-20 -163.09 129.82 3.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 108.935 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.539 ' O ' ' CB ' ' A' ' 59' ' ' SER . 50.9 m80 52.01 7.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.025 . . . . 0.0 108.883 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 161.54 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.0 109.689 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.9 m -85.42 129.1 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.177 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.8 m-20 -121.38 150.38 41.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.79 0.805 . . . . 0.0 110.814 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.2 mt -125.66 148.63 48.94 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.72 158.35 30.81 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.027 -1.559 . . . . 0.0 110.415 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -165.75 153.06 10.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -1.012 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt 51.29 21.3 1.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.78 -33.03 6.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.1 mm100 -58.99 148.23 31.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -146.47 140.18 26.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.525 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 91' ' ' VAL . 13.5 mt -129.01 123.34 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 12.6 mtpp -99.32 153.95 18.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.83 -1.169 . . . . 0.0 111.154 -178.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.7 m 50.82 75.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 62' ' ' LEU . 14.2 m -107.82 -9.14 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 109.082 178.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.7 pm0 -60.86 -25.35 66.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.531 -0.731 . . . . 0.0 110.464 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -68.26 -69.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 0.0 109.36 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -51.87 -47.34 40.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.018 -1.051 . . . . 0.0 109.07 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.58 HD21 ' HB1' ' A' ' 48' ' ' ALA . 19.9 mt -52.95 -49.27 66.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 t -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.077 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.78 -46.26 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.174 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.88 -34.28 78.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -63.29 -39.18 93.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.2 -40.43 45.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.788 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.536 HD22 HD11 ' A' ' 114' ' ' ILE . 64.8 mt -77.89 0.04 25.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.998 -1.064 . . . . 0.0 109.357 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 56.9 41.64 27.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.585 -0.697 . . . . 0.0 111.283 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.5 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 17.2 mm -88.53 144.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.773 -1.205 . . . . 0.0 108.434 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.699 HG21 HG12 ' A' ' 121' ' ' ILE . 43.9 p -126.98 -23.25 3.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.29 -0.881 . . . . 0.0 111.901 -178.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.674 ' O ' HG13 ' A' ' 87' ' ' VAL . 8.5 m-80 -125.08 108.16 11.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.866 -1.147 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -163.26 150.11 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.0 110.549 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.44 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.0 m -117.46 114.12 23.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.479 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -96.93 103.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -178.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 26' ' ' LEU . 40.7 mt-10 -74.41 124.68 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 69' ' ' ILE . 13.4 t -110.16 120.7 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.792 0.806 . . . . 0.0 111.23 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.77 96.13 4.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.29 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.07 -158.67 27.5 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -119.37 -11.95 9.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -1.177 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.15 148.26 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.017 -1.052 . . . . 0.0 109.726 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 26' ' ' LEU . 42.5 mm -71.79 119.04 71.93 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 128.45 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.66 1.574 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -82.05 -13.27 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.562 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 mt 55.84 -121.92 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.71 7.61 44.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.45 -10.87 61.41 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.435 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.93 -171.58 2.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.696 -0.885 . . . . 0.0 109.434 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.25 13.59 12.4 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.522 ' HB2' HD22 ' A' ' 176' ' ' LEU . 44.1 t-105 -58.34 -42.22 86.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -1.01 . . . . 0.0 110.635 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.88 -56.05 23.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.849 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -51.47 -42.96 61.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.011 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.489 ' OH ' ' OE2' ' A' ' 171' ' ' GLU . 44.8 t80 -62.62 -53.48 54.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.7 . . . . 0.0 110.558 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -44.52 92.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.67 -59.82 3.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.051 -1.031 . . . . 0.0 110.402 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mt -59.45 -33.34 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.52 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 30.8 ttt180 -64.03 -43.68 94.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -73.73 15.98 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.707 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 5.8 m-80 -149.25 34.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.904 -1.122 . . . . 0.0 110.941 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 HD22 ' A' ' 82' ' ' LEU . 65.8 mt -81.88 136.72 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.763 -1.211 . . . . 0.0 110.294 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.3 tp -130.37 116.27 18.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -71.37 150.18 45.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -114.84 -174.51 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.545 -0.722 . . . . 0.0 109.422 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -107.67 67.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 111.118 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -168.52 135.25 1.94 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.048 . . . . 0.0 109.776 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -69.85 142.14 53.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.647 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 85' ' ' THR . 42.8 mt -83.14 148.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.48 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.16 87.14 3.85 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 47.9 m-85 -65.91 144.35 56.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.891 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -87.64 101.94 14.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.248 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.66 131.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.642 -0.661 . . . . 0.0 110.724 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.93 113.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.52 -31.06 22.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.74 156.84 75.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.018 . . . . 0.0 109.796 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.93 148.61 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.613 2.209 . . . . 0.0 112.149 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.0 tt -157.08 149.29 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.073 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.65 142.77 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.355 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.11 149.64 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.559 ' OE2' HD12 ' A' ' 138' ' ' LEU . 48.8 mt-10 -134.53 161.55 34.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.655 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.415 ' CB ' HD13 ' A' ' 255' ' ' LEU . 34.5 t0 -173.61 108.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.334 -0.854 . . . . 0.0 109.709 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 54.91 49.51 17.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.68 -30.35 3.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.589 HH21 ' CA ' ' A' ' 252' ' ' GLY . 19.3 mtp85 -60.79 140.17 57.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -1.224 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.559 HD12 ' OE2' ' A' ' 133' ' ' GLU . 1.2 tt -145.33 137.08 25.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.981 -1.074 . . . . 0.0 109.953 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.572 ' CD1' HD23 ' A' ' 255' ' ' LEU . 83.2 mt -136.66 128.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.662 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -117.12 133.28 56.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.482 0.658 . . . . 0.0 110.263 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.08 135.64 54.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -149.05 149.46 29.91 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.932 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -48.23 143.8 14.06 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.507 2.138 . . . . 0.0 113.519 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.93 148.6 19.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -36.37 78.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.344 -0.848 . . . . 0.0 110.111 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.1 p -123.89 -165.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 109.67 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 18.7 tp -103.46 124.54 48.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.941 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.694 ' HG3' HG22 ' A' ' 167' ' ' VAL . 33.6 tt0 -135.81 109.52 8.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.088 -1.007 . . . . 0.0 108.711 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.7 t -109.5 121.69 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.237 -0.914 . . . . 0.0 109.82 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.0 m -112.82 152.03 29.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 109.631 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -139.85 130.47 25.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.959 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -120.56 131.37 54.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.01 136.96 8.76 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.57 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 155' ' ' PHE . 10.7 tm-20 -101.93 100.95 11.3 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.405 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 79.9 m-85 -89.44 167.64 12.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.614 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -11.31 19.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.533 -0.73 . . . . 0.0 110.64 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 159' ' ' LEU . 46.5 p-10 -98.0 -166.54 1.39 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.845 -1.159 . . . . 0.0 110.445 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -55.67 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.488 -0.758 . . . . 0.0 111.654 -178.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.522 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 30.8 mt -82.49 -29.26 30.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.384 -1.447 . . . . 0.0 108.789 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.72 -135.22 42.51 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.5 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 5.5 ttm-85 -96.64 131.41 43.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -1.196 . . . . 0.0 109.559 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.522 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.43 143.69 41.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -143.26 135.92 27.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.269 -0.894 . . . . 0.0 109.822 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -105.34 122.56 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -103.68 112.74 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.139 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.694 HG22 ' HG3' ' A' ' 148' ' ' GLU . 30.0 t -105.13 152.73 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 62.3 mt-10 -49.0 123.77 7.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 108.757 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.76 5.26 36.17 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -117.11 18.32 14.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -1.058 . . . . 0.0 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.489 ' OE2' ' OH ' ' A' ' 107' ' ' TYR . 0.2 OUTLIER -52.75 -56.39 15.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.838 . . . . 0.0 110.079 -179.66 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 171' ' ' GLU . 48.1 mt-10 -42.67 -24.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 171' ' ' GLU . 54.9 mt-10 -82.67 -11.38 58.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 111.77 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.9 pt -124.21 -28.12 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.0 111.415 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.4 m -62.15 -29.34 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.427 -1.421 . . . . 0.0 108.942 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -78.31 -0.6 29.48 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.037 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -75.01 113.61 12.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.758 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.575 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -78.97 173.3 12.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.37 -0.831 . . . . 0.0 109.064 179.657 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.441 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -77.62 161.86 27.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -147.67 143.94 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.239 -1.538 . . . . 0.0 111.667 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.03 157.49 44.49 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 83.8 m-85 -97.41 147.15 24.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.467 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.87 -36.38 16.9 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.683 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -74.85 -28.31 60.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 0.0 109.934 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 9.4 tt0 -77.26 -26.23 52.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.103 -0.998 . . . . 0.0 110.339 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.447 HG21 HB21 ' A' ' 500' ' ' C90 . 81.1 mt -60.43 -56.08 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.937 -1.102 . . . . 0.0 110.033 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.18 -41.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 110.144 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.689 ' O ' HG22 ' A' ' 192' ' ' VAL . 3.1 t-160 -73.56 -48.1 35.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 108.801 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.53 -28.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HZ1' ' HC2' ' A' ' 500' ' ' C90 . 4.2 mmtm -85.21 -52.73 5.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 109.281 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -46.98 -35.01 6.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.7 m -88.54 17.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 -179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.485 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 60.26 40.4 97.33 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 194' ' ' LEU . 39.0 mt -125.74 170.76 11.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 61.04 21.94 59.8 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' LYS . . . . . 0.485 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 27.9 mttp -54.5 -20.65 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.598 -1.53 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.83 26.04 9.14 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.01 125.31 7.71 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 120.781 -1.423 . . . . 0.0 109.932 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.66 170.44 16.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.698 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.582 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 38.6 mt -68.68 -8.42 42.3 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -96.46 -13.21 23.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 109.658 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.2 p30 -135.1 7.96 3.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 109.852 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.438 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.5 149.99 32.62 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.017 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.526 HD11 HD21 ' A' ' 206' ' ' LEU . 20.6 tp -98.09 93.6 6.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 203' ' ' THR . 52.7 t -87.06 129.9 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.64 0.733 . . . . 0.0 109.347 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.526 HD21 HD11 ' A' ' 204' ' ' LEU . 22.7 mt -122.35 170.55 9.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.37 -166.36 11.78 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -63.98 -30.37 71.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.55 24.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.672 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.95 153.2 40.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.257 . . . . 0.0 110.561 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.19 112.23 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.99 -50.19 71.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.015 -1.053 . . . . 0.0 109.965 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.03 111.51 4.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.458 -0.776 . . . . 0.0 110.425 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -59.83 -13.95 24.9 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.732 1.621 . . . . 0.0 112.467 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -76.31 -18.09 59.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.062 -1.024 . . . . 0.0 109.723 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.31 -179.08 53.27 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.438 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.0 mt -85.65 149.28 25.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.08 . . . . 0.0 109.852 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.44 -21.36 49.26 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -142.27 170.82 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.7 pm0 -77.21 -12.33 59.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.142 -0.974 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.526 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -135.1 44.16 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.176 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.7 OUTLIER -54.11 -46.91 98.59 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.944 -1.097 . . . . 0.0 109.41 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.64 -67.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.386 2.057 . . . . 0.0 111.996 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.56 -35.57 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.526 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 59.6 mtt-85 -61.45 -40.15 93.43 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.575 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.3 t60 -68.02 -32.85 73.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.002 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -65.47 -36.5 84.08 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -66.06 -39.14 83.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -63.23 -51.58 65.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.523 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 92.1 m-20 -63.83 -27.74 69.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.31 -35.85 47.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.13 -0.981 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -65.18 -38.61 83.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.83 -54.54 17.85 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.477 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 48.0 m-20 -55.59 -31.35 62.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.079 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.0 mt -65.55 -23.81 66.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.697 . . . . 0.0 110.299 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.23 -21.94 61.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.762 -1.211 . . . . 0.0 108.865 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 237' ' ' LEU . 92.0 mt -49.71 -3.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.623 -1.298 . . . . 0.0 110.381 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.6 mt -78.37 -16.77 57.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.18 2.92 56.82 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.08 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.43 153.31 8.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.62 -1.517 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.7 Cg_endo -53.95 129.31 33.61 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.895 1.73 . . . . 0.0 109.938 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.1 t -88.74 153.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.121 0.962 . . . . 0.0 112.295 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -133.34 125.82 30.02 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.32 -154.82 25.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 133.12 43.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -1.152 . . . . 0.0 108.873 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.2 m-85 -131.46 138.12 48.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 110.026 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -124.47 128.1 48.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.8 t -122.72 135.07 54.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.063 . . . . 0.0 111.364 -178.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -115.61 116.23 27.78 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 46.15 28.61 0.68 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.93 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.82 154.5 31.68 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.589 ' CA ' HH21 ' A' ' 137' ' ' ARG . . . -130.48 172.51 20.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 35.9 m-70 -59.13 -40.68 86.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.24 . . . . 0.0 109.547 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.5 t -56.43 -59.28 5.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 108.958 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.572 HD23 ' CD1' ' A' ' 139' ' ' ILE . 10.0 tp -51.34 -47.3 62.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 109.207 179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.6 m-20 -48.26 -51.01 27.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 56' ' ' THR . 89.9 t -61.58 -54.17 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -51.27 -50.01 60.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 109.061 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 139' ' ' ILE . 50.4 tp -51.8 -50.16 61.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.544 HG13 ' HG ' ' A' ' 238' ' ' LEU . 77.4 t -59.12 -53.81 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.182 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -49.35 -43.18 43.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.436 -0.79 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.59 -50.64 64.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.4 mt -57.77 -45.72 85.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.821 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.49 -31.01 65.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.31 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -69.87 -58.95 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.222 -179.237 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -41.83 97.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.916 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -46.2 -27.32 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.404 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -95.23 152.32 18.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.526 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.594 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 19.7 mt -85.31 149.43 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -1.121 . . . . 0.0 109.757 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 70.8 mt-10 -54.89 136.74 46.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.035 -1.041 . . . . 0.0 108.542 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -120.19 142.42 49.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.456 -0.778 . . . . 0.0 109.572 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.28 -168.4 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.0 m -103.81 139.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.988 -1.07 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -67.46 -23.68 65.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -150.02 158.38 44.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.013 . . . . 0.0 109.833 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 141.51 58.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.448 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.43 168.6 10.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -139.63 144.79 37.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.965 -1.085 . . . . 0.0 110.674 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 77.8 m-85 -139.77 156.44 46.76 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -163.35 152.3 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.95 174.94 35.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.18 152.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -1.102 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 139.07 15.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 19' ' ' HIS . 7.2 tt -57.75 -40.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 110.354 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.47 ' N ' HG23 ' A' ' 18' ' ' ILE . 81.8 m-70 -89.37 -49.2 6.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 111.181 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -69.92 -23.85 63.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.547 -0.721 . . . . 0.0 111.692 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.68 11.47 7.9 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.17 -1.49 . . . . 0.0 109.517 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -104.29 155.32 18.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.68 136.49 40.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.845 . . . . 0.0 109.67 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.0 m -137.07 142.73 42.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.562 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.32 151.27 26.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 -179.498 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -132.71 147.59 52.33 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -143.12 110.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 108.755 178.322 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mt -96.35 116.21 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 110.721 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' A' ' 27' ' ' ILE . 67.7 m-70 -110.64 141.55 24.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.537 -0.727 . . . . 0.0 109.781 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.5 Cg_exo -53.97 168.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.868 1.712 . . . . 0.0 111.479 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.3 mm-40 -140.1 176.27 8.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 30.2 mttp -84.76 151.02 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.94 143.88 2.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.543 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.1 9.39 57.01 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.99 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 31' ' ' GLU . 22.9 m -71.31 -44.95 64.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.563 -1.551 . . . . 0.0 109.502 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.99 -176.2 29.26 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.69 117.25 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH2' ' CE2' ' A' ' 45' ' ' TYR . 13.3 ptt180 -142.47 155.72 45.1 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.836 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.84 157.45 17.08 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -128.35 110.94 12.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 108.996 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -135.11 133.83 39.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.6 m120 52.43 26.84 4.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 111.238 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.69 66.41 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.038 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.5 123.88 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -1.083 . . . . 0.0 109.096 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.477 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 16.3 m-85 -88.31 128.81 35.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.174 -0.954 . . . . 0.0 109.797 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.43 112.97 35.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CE1' ' A' ' 52' ' ' PHE . 36.6 Cg_endo -71.86 155.96 57.3 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.81 1.673 . . . . 0.0 112.322 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.91 63.68 7.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.58 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.3 mtt85 -116.84 169.2 9.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.3 p-80 -74.04 -49.89 22.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.517 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -45.93 -16.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' HIS . 55.7 m-85 -97.85 3.93 49.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.872 -1.143 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.7 126.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.29 -30.35 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.34 131.3 13.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.061 -1.024 . . . . 0.0 110.112 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.907 HG21 HG21 ' A' ' 257' ' ' VAL . 56.7 p -120.52 95.09 4.59 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' SER . 35.3 t30 -163.36 130.17 3.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' O ' ' CB ' ' A' ' 59' ' ' SER . 28.6 m80 51.66 7.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.1 -1.0 . . . . 0.0 109.266 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.3 OUTLIER 161.03 140.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 72' ' ' VAL . 27.2 m -80.42 127.36 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.291 -0.881 . . . . 0.0 109.197 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -120.77 147.73 44.94 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.861 0.839 . . . . 0.0 111.113 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.7 mt -120.95 148.21 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.44 153.83 24.78 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.252 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -164.75 150.12 9.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -1.083 . . . . 0.0 109.285 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.3 mttt 51.63 23.9 2.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -33.04 6.32 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -60.49 148.36 37.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.041 -1.27 . . . . 0.0 109.565 -179.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -144.12 139.79 29.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.57 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.65 122.69 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -97.95 155.8 16.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 111.22 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 m 49.12 75.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.094 0.473 . . . . 0.0 110.747 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.5 m -107.78 -8.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.268 -0.895 . . . . 0.0 109.006 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 7.6 pm0 -60.84 -27.25 67.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.67 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.423 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.9 m170 -65.78 -69.03 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.907 -1.12 . . . . 0.0 109.281 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.09 -47.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' N ' HG23 ' A' ' 75' ' ' ILE . 82.0 mt -51.59 -49.27 62.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 110.157 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.49 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 19.5 t -60.99 -42.87 99.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.03 -1.044 . . . . 0.0 110.382 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 106' ' ' PHE . 99.2 t -55.89 -47.54 79.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.96 -34.59 78.46 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.3 -34.95 77.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -80.83 -38.01 29.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.045 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.27 5.58 12.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.026 -1.046 . . . . 0.0 109.581 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 53.87 39.14 30.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.4 mm -89.79 134.48 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 108.716 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.8 p -123.39 -18.68 6.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.259 -0.901 . . . . 0.0 111.686 -178.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.746 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.1 m120 -124.09 106.9 10.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.868 -1.145 . . . . 0.0 110.351 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.9 m -166.41 147.54 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.666 0.746 . . . . 0.0 110.056 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 22.2 m -115.76 110.2 18.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.433 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.3 mt -91.29 100.33 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.028 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' OE2' HD12 ' A' ' 27' ' ' ILE . 2.1 tt0 -75.0 128.58 35.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.098 -1.001 . . . . 0.0 108.417 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.1 128.67 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.06 0.933 . . . . 0.0 111.927 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 31.2 mm -109.66 96.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.28 -153.15 21.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -9.27 8.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -1.087 . . . . 0.0 110.072 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.93 148.31 41.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.042 -1.036 . . . . 0.0 109.727 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 26' ' ' LEU . 45.9 mm -73.48 120.02 78.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -40.0 125.25 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.515 1.477 . . . . 0.0 111.105 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.51 HG21 HD22 ' A' ' 202' ' ' ASN . 2.5 tp -78.16 -11.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.3 mt 54.34 -119.73 1.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.21 7.8 45.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.83 -0.63 64.93 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.765 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.72 -172.66 2.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.801 -0.823 . . . . 0.0 109.315 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.4 16.08 8.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -59.56 -42.86 93.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -1.086 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.74 -56.88 13.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.544 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB3' HG11 ' A' ' 78' ' ' VAL . 9.9 m-85 -51.67 -44.54 63.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.847 . . . . 0.0 109.108 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 72.1 t80 -61.72 -50.63 71.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.577 -0.702 . . . . 0.0 110.916 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.59 -43.0 95.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.091 -1.006 . . . . 0.0 111.24 -178.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.77 -55.68 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 110.735 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.11 -30.82 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 51.5 ttt180 -66.76 -43.43 84.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.842 . . . . 0.0 110.52 -179.141 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -75.72 11.61 1.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 110.196 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.471 ' OD1' ' CG ' ' A' ' 9' ' ' GLU . 2.6 m-80 -142.75 35.01 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.992 -1.068 . . . . 0.0 110.198 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.7 mt -83.02 142.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.949 -1.094 . . . . 0.0 111.186 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 8' ' ' LYS . 6.2 tp -132.98 129.39 38.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -83.79 149.07 26.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -116.47 -174.58 2.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.15 68.3 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.35 -0.844 . . . . 0.0 110.807 -178.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -163.73 129.82 3.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.0 109.298 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.82 138.94 56.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.844 -1.16 . . . . 0.0 109.685 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.5 mt -83.37 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 110.191 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.15 79.53 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 42.5 m-85 -59.92 142.76 53.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.524 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 38.1 t80 -88.87 101.93 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.35 133.31 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.71 -0.619 . . . . 0.0 110.561 -177.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.1 t -70.6 114.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.5 mp0 -82.42 -29.98 30.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.044 -1.035 . . . . 0.0 110.695 -178.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 172.99 5.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.754 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.55 149.47 12.92 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.846 2.364 . . . . 0.0 112.848 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.539 HD12 ' NZ ' ' A' ' 266' ' ' LYS . 11.3 tt -157.0 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.79 140.56 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.98 147.59 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' O ' ' NZ ' ' A' ' 258' ' ' LYS . 3.5 mp0 -136.54 160.99 37.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.014 -1.054 . . . . 0.0 110.523 -178.793 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -174.13 105.48 0.11 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.367 -0.833 . . . . 0.0 109.741 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.09 57.7 6.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.496 -0.752 . . . . 0.0 110.676 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.9 2.83 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.402 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.604 ' NH2' ' H ' ' A' ' 255' ' ' LEU . 46.5 mtp180 -61.96 130.85 47.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.023 -1.281 . . . . 0.0 108.219 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.2 tt -143.12 137.15 28.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 109.984 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.697 ' CD1' HD23 ' A' ' 255' ' ' LEU . 71.2 mt -134.44 127.21 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 109.418 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.91 131.46 56.93 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.514 0.673 . . . . 0.0 109.926 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.98 136.07 54.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.58 149.28 36.52 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.015 -1.053 . . . . 0.0 109.874 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.41 141.42 51.01 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.426 2.084 . . . . 0.0 113.187 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -154.84 147.46 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.925 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.4 -3.91 7.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.299 -0.876 . . . . 0.0 110.619 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.1 p -150.84 -175.61 5.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.872 -1.143 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' A' ' 244' ' ' GLY . 17.2 tp -96.4 122.63 39.5 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.064 -1.022 . . . . 0.0 108.875 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG3' HG13 ' A' ' 167' ' ' VAL . 1.5 mt-10 -137.13 127.14 25.92 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.331 -0.856 . . . . 0.0 108.768 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 65.7 t -126.89 120.68 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 165' ' ' THR . 46.5 m -112.15 152.11 28.72 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.583 -0.698 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -139.69 130.71 26.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.933 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.38 132.86 54.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.37 141.18 12.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.802 -178.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.41 ' O ' ' NH1' ' A' ' 250' ' ' ARG . 5.6 tt0 -105.54 100.1 9.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.31 167.0 15.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -102.5 5.08 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 110.91 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.8 p-10 -119.46 -171.0 2.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.0 110.424 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -47.8 -3.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.595 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -80.24 -29.11 38.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.359 -1.463 . . . . 0.0 109.073 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.95 -139.02 33.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -97.23 131.79 43.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.218 -1.166 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -138.01 147.69 44.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.87 . . . . 0.0 109.456 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.5 146.15 36.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -143.83 137.9 28.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.488 HG23 ' OG1' ' A' ' 150' ' ' THR . 25.4 m -107.18 123.34 48.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.224 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.3 t80 -102.69 109.64 21.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.8 t -102.14 154.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.05 126.79 19.54 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.83 2.49 42.78 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -115.37 20.58 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -1.153 . . . . 0.0 109.079 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 173' ' ' GLU . 1.4 pm0 -58.14 -52.15 66.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.6 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 110.499 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 171' ' ' GLU . 12.6 mm-40 -103.47 -7.16 21.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.957 -1.089 . . . . 0.0 110.552 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.35 -26.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.125 -0.984 . . . . 0.0 110.942 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.1 m -60.84 -22.13 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.646 -1.284 . . . . 0.0 108.76 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.87 -2.74 58.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 109.222 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.15 116.41 10.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 108.764 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -79.65 172.76 13.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.4 t -78.53 163.57 25.43 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -147.51 144.98 28.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.28 -1.512 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.77 157.41 44.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.423 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.2 m-85 -98.98 144.43 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.992 -1.068 . . . . 0.0 109.53 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 t0 -53.07 -35.96 60.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.38 -0.825 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.2 p90 -69.36 -25.38 64.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.77 -1.206 . . . . 0.0 109.902 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.436 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -83.43 -31.14 26.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.032 -1.043 . . . . 0.0 109.92 -179.652 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 189' ' ' ILE . 55.7 mt -50.98 -58.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.532 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.0 tp10 -40.82 -40.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.937 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.2 t60 -74.68 -35.39 62.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 186' ' ' ILE . 91.1 mt -58.92 -38.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.354 -0.841 . . . . 0.0 109.024 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -75.71 -52.52 10.3 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -49.07 -43.12 40.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.433 -0.792 . . . . 0.0 110.678 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 188' ' ' HIS . 21.0 m -79.53 5.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.388 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 40.08 50.64 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.8 178.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 189' ' ' ILE . 39.0 mt -128.13 173.91 9.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.098 -1.236 . . . . 0.0 110.013 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.03 58.58 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -54.7 -20.64 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.479 -1.601 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -117.04 26.02 8.52 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.815 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.5 127.05 8.41 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.665 -1.491 . . . . 0.0 109.886 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.4 m -144.43 174.84 10.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -1.09 . . . . 0.0 109.332 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.5 mt -72.15 -7.77 50.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 108.872 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -96.28 -11.36 26.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.27 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 98' ' ' ILE . 8.3 p-10 -134.75 9.88 3.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.008 . . . . 0.0 110.034 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.444 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -150.65 150.94 31.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 110.339 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.0 tp -100.4 93.88 5.88 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 203' ' ' THR . 52.0 t -86.07 130.12 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.781 0.801 . . . . 0.0 109.318 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.99 165.08 18.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.651 -0.656 . . . . 0.0 109.343 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.31 -166.61 12.05 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -58.4 -36.68 73.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.482 -1.011 . . . . 0.0 109.338 179.8 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.38 23.71 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.026 -1.046 . . . . 0.0 110.469 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -139.0 146.91 41.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 0.0 110.552 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -100.58 111.26 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -57.54 -52.37 65.68 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.322 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -56.16 111.11 2.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.045 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.55 -14.85 17.99 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.741 1.627 . . . . 0.0 111.962 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -15.86 59.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.126 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.28 -173.17 49.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.624 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -89.69 148.05 23.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.17 -1.194 . . . . 0.0 109.843 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.29 -18.15 37.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 108.851 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 59.5 m-85 -139.47 173.71 11.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 220' ' ' GLU . 5.8 mp0 -80.09 -14.42 58.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.48 48.38 1.84 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.253 -0.904 . . . . 0.0 109.596 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -56.54 -46.52 99.81 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 109.808 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.1 Cg_exo -51.5 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.452 2.101 . . . . 0.0 112.108 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.1 -35.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.028 -1.045 . . . . 0.0 109.575 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 18.5 mtt180 -60.19 -41.5 93.08 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -68.04 -31.87 71.83 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.828 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -64.56 -37.16 86.59 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.6 t -69.42 -35.18 65.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.49 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.4 t80 -65.22 -55.27 19.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -63.64 -26.19 68.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.0 tp -77.81 -35.03 51.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.021 -1.049 . . . . 0.0 108.609 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.1 mt -67.14 -36.42 76.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.86 -59.31 6.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -51.67 -34.86 40.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -1.231 . . . . 0.0 108.873 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 235' ' ' LEU . 8.5 mt -60.67 -23.0 64.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.983 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.44 -21.64 61.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.088 . . . . 0.0 108.743 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.3 mt -55.16 3.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.677 -1.264 . . . . 0.0 110.521 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.607 ' HG ' HG13 ' A' ' 260' ' ' VAL . 8.1 mt -80.12 -16.24 55.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.856 -1.152 . . . . 0.0 109.729 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.88 43.4 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.114 -1.041 . . . . 0.0 110.629 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.38 158.14 9.94 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.395 . . . . 0.0 108.921 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -48.74 150.94 5.71 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 121.848 1.699 . . . . 0.0 109.429 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.72 145.35 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 0.0 112.181 -177.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.5 122.2 32.76 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 148.62 174.8 20.62 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.442 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.519 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 18.3 tttt -102.02 146.98 27.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.255 . . . . 0.0 109.986 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 18.3 m-85 -140.56 140.27 35.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 109.927 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -127.12 126.0 42.17 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.0 m -119.62 135.53 54.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 0.0 111.331 -178.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 250' ' ' ARG . 90.9 t80 -116.78 115.22 25.17 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 250' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 249' ' ' PHE . 78.3 mtp85 45.14 47.82 9.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.01 -1.056 . . . . 0.0 108.726 -179.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.83 159.53 28.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.52 -174.56 13.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -60.75 -47.92 84.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -1.125 . . . . 0.0 109.642 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.25 -59.08 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 139' ' ' ILE . 1.3 tp -52.73 -48.39 66.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.731 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 7.2 m-20 -47.41 -45.29 25.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 109.192 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.907 HG21 HG21 ' A' ' 56' ' ' THR . 59.1 t -66.96 -40.14 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 109.986 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 133' ' ' GLU . 8.3 ttpt -63.74 -51.75 63.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 109.378 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 139' ' ' ILE . 47.6 tp -53.95 -48.8 69.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 108.931 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.607 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.5 t -57.81 -53.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.372 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.612 ' HE3' HG12 ' A' ' 257' ' ' VAL . 10.7 mtmt -51.1 -40.44 58.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.688 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.82 -50.45 42.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.949 . . . . 0.0 109.841 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.75 -48.7 80.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -68.24 -32.82 73.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 110.114 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 7.7 mmtm -66.13 -43.84 85.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.542 ' C ' ' H ' ' A' ' 268' ' ' LYS . 12.4 mtmt -66.09 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.548 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.524 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 27.1 tt0 -56.59 -0.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.831 . . . . 0.0 109.979 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 266' ' ' LYS . 9.8 tttt -117.83 138.49 52.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.635 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.67 152.26 21.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -1.158 . . . . 0.0 109.501 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -55.95 137.61 50.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.959 . . . . 0.0 108.93 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.57 144.19 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.439 -0.788 . . . . 0.0 110.024 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -141.53 -171.34 3.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 30' ' ' PRO . 5.8 m -99.49 137.09 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.013 -1.055 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.43 -25.18 67.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.667 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.28 162.5 40.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 139.97 54.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.92 166.18 12.81 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -136.72 141.7 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.086 -1.009 . . . . 0.0 110.305 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 28' ' ' ILE . 93.4 m-85 -139.25 153.65 47.86 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.52 152.33 21.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.836 -1.165 . . . . 0.0 110.283 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.57 175.71 36.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.4 153.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.551 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 140.98 17.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 19' ' ' HIS . 6.5 tt -61.48 -37.92 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -1.217 . . . . 0.0 111.117 -178.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.405 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 92.3 m-70 -90.52 -49.45 6.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.292 -1.505 . . . . 0.0 110.938 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 p -68.66 -25.71 64.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 111.853 -178.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.71 16.78 47.12 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.065 -1.54 . . . . 0.0 109.456 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.69 153.69 23.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -1.085 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -76.31 135.53 39.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.773 . . . . 0.0 109.602 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.1 t -138.23 145.72 41.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.43 154.44 22.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 96' ' ' ILE . 10.1 mt -134.12 144.13 48.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.74 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.623 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -140.03 114.31 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 13' ' ' PHE . 17.2 mt -99.3 114.59 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.461 -0.775 . . . . 0.0 110.501 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.623 ' NE2' HG22 ' A' ' 27' ' ' ILE . 2.9 m-70 -109.41 140.23 21.87 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.42 -0.8 . . . . 0.0 109.682 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HG3' HG23 ' A' ' 7' ' ' VAL . 15.0 Cg_exo -55.35 168.61 1.36 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.767 1.645 . . . . 0.0 111.183 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 42.0 mm-40 -140.5 179.72 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.0 110.026 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.0 mttt -86.36 152.68 22.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.761 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.442 ' HA ' ' ND2' ' A' ' 86' ' ' ASN . 44.5 mt-10 -47.14 143.83 2.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.628 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.22 7.87 60.9 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.322 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 44.0 m -69.7 -45.22 68.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.533 -1.569 . . . . 0.0 109.802 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.39 -179.9 30.88 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.613 179.327 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -96.86 118.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -142.65 153.7 43.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.716 -1.24 . . . . 0.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -102.43 158.78 15.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -130.94 108.32 9.74 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -135.58 137.04 41.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 111.004 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.492 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 16.5 m120 52.25 31.22 8.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 111.279 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.42 80.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.569 -1.3 . . . . 0.0 109.97 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 121.24 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -1.06 . . . . 0.0 109.108 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.69 129.81 34.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 69' ' ' ILE . 30.9 mt -117.92 93.45 44.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.843 . . . . 0.0 109.618 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -49.04 148.82 9.0 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.317 2.011 . . . . 0.0 111.897 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -85.29 69.88 10.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.183 -0.948 . . . . 0.0 109.965 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -122.54 173.95 7.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 108.957 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 237' ' ' LEU . 1.3 p-80 -74.71 -48.21 27.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.9 mm-40 -47.75 -16.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.807 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' HIS . 27.4 m-85 -95.6 -0.86 51.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.756 -1.215 . . . . 0.0 109.705 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.7 129.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.08 -27.78 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 110.258 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -151.02 131.79 14.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.85 HG21 HG21 ' A' ' 257' ' ' VAL . 40.4 p -124.5 95.44 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.9 t-20 -163.01 128.8 3.25 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.4 m-70 50.4 8.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.132 -0.98 . . . . 0.0 109.027 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER 162.64 140.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.883 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 72' ' ' VAL . 63.7 m -85.51 126.29 33.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -119.83 148.84 42.97 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.65 0.738 . . . . 0.0 110.75 -179.168 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CG ' HG21 ' A' ' 72' ' ' VAL . 8.3 mt -122.92 147.25 46.82 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.97 152.89 23.62 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.561 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -160.59 148.35 16.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -1.023 . . . . 0.0 109.108 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.36 21.68 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.552 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.83 -32.34 7.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 28.1 mm-40 -60.36 144.64 50.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.071 -1.252 . . . . 0.0 109.469 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -141.64 140.89 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 46' ' ' ILE . 56.9 mt -131.3 122.72 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 29.5 mttm -90.8 158.69 16.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.036 -1.04 . . . . 0.0 111.365 -179.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 m 41.58 79.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.426 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 62' ' ' LEU . 15.9 m -107.34 -9.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.6 pm0 -61.7 -26.58 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.674 . . . . 0.0 110.443 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -66.06 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 0.0 108.998 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.34 -49.87 40.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.8 mt -49.14 -51.19 33.68 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.976 -1.078 . . . . 0.0 110.233 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -59.61 -41.63 90.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.16 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.05 -44.54 78.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.038 -1.039 . . . . 0.0 108.912 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.32 -35.21 78.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.362 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -62.78 -35.79 80.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.5 mt -79.63 -38.21 34.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 109.845 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 114' ' ' ILE . 94.6 mt -81.14 1.71 30.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.1 -1.0 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 54.79 40.51 31.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 110.113 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.26 140.47 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 121' ' ' ILE . 64.1 p -126.34 -21.4 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.16 -0.963 . . . . 0.0 111.753 -178.349 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.722 ' O ' HG13 ' A' ' 87' ' ' VAL . 58.8 m-20 -126.02 107.25 10.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.942 -1.099 . . . . 0.0 110.351 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -164.56 147.07 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.16 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 72.3 m -116.29 110.46 18.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.513 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -93.95 101.58 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tt0 -77.35 129.01 35.27 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 108.539 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.41 123.38 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.918 0.866 . . . . 0.0 111.823 -177.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mt -104.6 96.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.55 -155.32 24.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -122.22 -9.04 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' H ' ' A' ' 70' ' ' LYS . 44.2 tt0 -138.86 148.13 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 110.0 -179.459 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.555 HG23 HD11 ' A' ' 26' ' ' LEU . 39.7 mm -71.94 122.81 88.3 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.187 -1.005 . . . . 0.0 108.383 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -42.46 117.4 0.82 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.637 1.558 . . . . 0.0 110.937 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -72.45 -14.38 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.424 HD11 ' CE2' ' A' ' 106' ' ' PHE . 75.1 mt 56.98 -120.41 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.121 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.99 8.45 44.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.868 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.28 62.4 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.901 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -172.1 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.901 . . . . 0.0 109.57 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.23 17.31 8.54 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 57.7 t-105 -57.12 -43.76 82.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 0.0 110.197 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.88 -55.91 16.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 99' ' ' LEU . 12.9 m-85 -51.08 -45.94 61.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 0.0 109.604 -179.539 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.427 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 44.6 t80 -62.69 -52.87 61.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.0 110.829 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.436 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 2.0 mm-40 -61.21 -44.63 96.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.116 -0.99 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.99 19.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.219 -0.926 . . . . 0.0 110.351 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.2 mt -65.11 -32.11 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.423 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 53.2 ttt180 -63.29 -42.31 99.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HG3' HD22 ' A' ' 113' ' ' ASN . 1.6 ptpp? -76.46 7.39 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 110.134 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.42 HD22 ' HG3' ' A' ' 112' ' ' LYS . 17.4 m-80 -137.36 33.97 2.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.024 . . . . 0.0 110.509 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 HD22 ' A' ' 82' ' ' LEU . 50.9 mt -80.68 138.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.945 -1.097 . . . . 0.0 110.247 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -129.41 124.97 35.49 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 142.6 31.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.1 -172.27 2.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.239 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -113.93 69.61 0.71 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.286 -0.884 . . . . 0.0 110.716 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -168.59 131.28 1.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 109.255 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE2' ' C ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -69.8 151.05 46.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 110.08 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 85' ' ' THR . 45.4 mt -95.25 152.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.107 -0.996 . . . . 0.0 110.096 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.32 83.83 4.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 48.0 m-85 -62.5 147.01 50.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.071 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -93.68 102.04 14.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 243' ' ' LYS . 61.4 t -93.9 133.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 0.0 110.647 -177.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.91 116.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -84.63 -29.95 25.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.064 -1.022 . . . . 0.0 110.889 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.25 168.73 13.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 109.901 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 147.92 24.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.862 2.374 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.7 tt -157.36 149.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -0.834 . . . . 0.0 109.043 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.95 146.4 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.93 148.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -133.56 160.72 36.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.71 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 258' ' ' LYS . 19.2 t70 -175.1 105.71 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.301 -0.875 . . . . 0.0 109.823 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.32 51.33 15.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 110.199 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.78 -30.65 3.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -62.13 136.89 58.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.262 . . . . 0.0 108.229 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -145.57 140.09 27.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 110.534 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.644 HG21 HD22 ' A' ' 259' ' ' LEU . 71.2 mt -136.91 127.03 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.717 . . . . 0.0 109.66 179.485 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -114.22 134.03 55.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.42 135.64 54.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.42 150.2 39.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -47.22 142.53 11.86 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.684 2.256 . . . . 0.0 113.409 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.581 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -159.0 147.87 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.689 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -66.39 -32.49 73.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 110.53 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.581 ' O ' ' OG ' ' A' ' 144' ' ' SER . 72.5 p -120.25 -163.23 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.327 -0.858 . . . . 0.0 109.308 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.7 tp -109.25 123.98 50.15 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.7 tt0 -135.37 125.25 25.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 108.466 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG1' HD23 ' A' ' 231' ' ' LEU . 63.5 t -125.87 121.5 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 152.03 27.66 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.623 -0.673 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -140.01 130.59 25.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -122.41 133.86 54.62 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.9 140.81 11.91 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.651 -178.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -101.54 100.47 10.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.71 166.95 13.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 110.707 -178.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -104.29 -20.51 13.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 110.484 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 159' ' ' LEU . 32.4 p-10 -89.08 -171.01 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.761 -1.212 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -52.63 2.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.277 -0.889 . . . . 0.0 111.501 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 157' ' ' ASN . 14.6 mt -82.25 -28.63 31.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.388 -1.445 . . . . 0.0 108.493 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.5 -141.56 38.35 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -100.44 136.23 40.64 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.256 -1.143 . . . . 0.0 109.13 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -143.73 160.81 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.374 -0.829 . . . . 0.0 109.597 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 150.54 31.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 225' ' ' ARG . 49.1 t80 -144.66 140.78 28.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -107.06 122.93 47.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 109.985 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.0 t80 -102.76 111.61 24.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 110.022 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.15 150.74 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 179.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.73 138.13 6.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.202 -0.936 . . . . 0.0 108.826 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.09 3.83 69.6 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.83 20.97 15.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.701 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.8 OUTLIER -58.96 -50.86 72.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.361 -0.837 . . . . 0.0 109.196 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.6 -5.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.491 -0.756 . . . . 0.0 109.774 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 171' ' ' GLU . 39.3 mt-10 -104.91 -9.81 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 110.3 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.0 pt -126.85 -27.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.191 -0.943 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.0 m -60.98 -22.88 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.679 -1.263 . . . . 0.0 108.524 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.93 -2.62 58.75 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.35 115.93 10.11 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.355 -0.841 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.3 mtm180 -79.53 172.76 13.35 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 0.0 109.255 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.1 t -79.71 163.87 24.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -148.71 144.46 27.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.244 -1.535 . . . . 0.0 111.37 -179.206 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.658 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.06 158.84 43.29 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.3 m-85 -99.46 144.75 28.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.35 -36.2 20.79 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.31 -0.869 . . . . 0.0 109.578 -179.477 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 8.5 p90 -73.67 -26.38 60.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 109.842 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.3 OUTLIER -76.65 -38.66 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 109.998 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.407 HG22 ' HG3' ' A' ' 190' ' ' LYS . 62.6 mt -48.51 -51.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 186' ' ' ILE . 8.6 tt0 -42.95 -45.38 5.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.953 . . . . 0.0 110.303 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.435 ' O ' HG22 ' A' ' 192' ' ' VAL . 4.5 t60 -75.26 -57.35 3.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 45.6 mt -44.74 -27.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -85.5 -54.37 4.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.772 -1.205 . . . . 0.0 109.506 179.876 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -51.91 -40.22 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.929 . . . . 0.0 110.034 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -75.37 3.37 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.927 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.24 37.72 31.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.0 mt -128.52 169.53 14.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -1.144 . . . . 0.0 109.865 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.42 24.11 61.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -60.4 -21.23 61.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.623 -1.516 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -111.24 24.95 14.76 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.2 125.45 7.79 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.885 -1.362 . . . . 0.0 109.744 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -144.11 164.5 30.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -1.112 . . . . 0.0 110.03 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.568 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 25.3 mt -64.47 -8.99 15.64 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -93.09 -15.99 25.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -136.84 10.99 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 110.17 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -149.16 149.99 31.92 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.043 -1.035 . . . . 0.0 110.287 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.6 tp -100.24 93.34 5.64 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.436 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -86.12 131.33 34.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.768 0.794 . . . . 0.0 109.031 -179.258 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.14 162.66 23.13 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.31 -166.73 12.68 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -31.59 71.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -1.05 . . . . 0.0 109.569 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -153.9 23.79 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.21 -0.931 . . . . 0.0 110.678 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -144.24 151.73 39.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.748 -1.22 . . . . 0.0 110.516 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.56 112.25 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -57.17 -51.88 67.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.015 . . . . 0.0 110.328 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 8.0 m120 -58.0 111.66 3.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.5 -12.42 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.596 1.531 . . . . 0.0 111.821 179.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -17.2 59.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.048 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.3 -175.79 48.26 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.619 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.2 mt -87.81 142.07 28.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -1.2 . . . . 0.0 109.86 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -19.92 60.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -142.9 -179.05 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.389 -0.82 . . . . 0.0 109.297 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.567 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 1.9 pm0 -87.17 3.42 46.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.608 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.04 47.57 0.62 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.561 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -58.88 -46.02 99.57 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.011 -1.055 . . . . 0.0 109.933 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 50.7 Cg_exo -52.19 -66.44 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.069 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 225' ' ' ARG . 31.5 m -60.54 -35.94 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 109.568 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 224' ' ' VAL . 62.3 mtt180 -59.27 -41.64 89.33 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 18.1 t60 -68.3 -32.13 72.05 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.147 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.81 -35.5 81.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' ' 166' ' ' PHE . 54.3 t -70.35 -37.85 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -63.33 -49.79 72.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.458 -0.776 . . . . 0.0 108.961 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -67.78 -27.82 67.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 109.755 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.511 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.1 tp -77.33 -34.03 55.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.002 -1.061 . . . . 0.0 108.359 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.1 mt -67.95 -37.74 78.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.22 -56.06 13.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 21.8 m-20 -52.45 -38.36 59.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -1.219 . . . . 0.0 108.982 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 235' ' ' LEU . 15.9 mt -58.23 -23.47 55.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.629 -0.669 . . . . 0.0 110.48 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.83 -22.36 60.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.692 -1.255 . . . . 0.0 108.758 -179.666 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 94.0 mt -52.71 -0.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.635 -1.291 . . . . 0.0 110.356 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.566 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.9 mt -77.96 -14.48 59.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.799 -1.188 . . . . 0.0 109.756 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.39 -1.53 55.97 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.844 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.05 156.7 9.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.742 -1.446 . . . . 0.0 109.174 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.75 150.23 9.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.852 1.701 . . . . 0.0 109.518 178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.42 149.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.999 -1.063 . . . . 0.0 112.115 -177.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.8 mmtp -129.77 123.55 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.439 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.58 -160.86 30.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.26 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.14 46.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -1.085 . . . . 0.0 108.76 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -133.1 138.22 46.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 110.145 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -123.55 129.72 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 t -123.83 136.24 54.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.378 -177.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.36 111.47 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 50.0 45.05 25.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.17 -0.957 . . . . 0.0 108.465 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.78 141.73 17.33 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -115.8 178.75 17.74 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 52.0 m-70 -59.33 -39.14 82.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.137 -1.213 . . . . 0.0 109.595 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -54.74 -58.79 6.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.224 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 255' ' ' LEU . 11.8 tp -56.69 -45.7 81.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.563 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.5 m-20 -47.46 -54.76 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 109.634 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 56' ' ' THR . 99.2 t -60.89 -50.71 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 258' ' ' LYS . . . . . 0.47 ' HZ1' ' HB2' ' A' ' 134' ' ' ASP . 22.2 ttmt -50.49 -52.35 39.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.978 -1.076 . . . . 0.0 108.963 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.644 HD22 HG21 ' A' ' 139' ' ' ILE . 35.5 tp -50.4 -50.85 50.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' A' ' 238' ' ' LEU . 46.8 t -55.27 -52.94 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.889 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.09 -50.16 29.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.148 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.48 -49.32 77.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.1 mt -56.12 -52.47 64.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -26.29 67.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.79 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -71.29 -64.68 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.935 . . . . 0.0 110.072 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -54.53 -37.35 65.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.951 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -90.31 32.25 0.95 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.966 -1.083 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 268' ' ' LYS . . . . . 0.598 ' CG ' ' H ' ' A' ' 269' ' ' LEU . 2.5 tptm -90.44 -134.91 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.598 ' H ' ' CG ' ' A' ' 268' ' ' LYS . 2.1 pp . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.658 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.515 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.2 mt -100.77 156.65 17.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -1.128 . . . . 0.0 109.654 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 94.6 mt-10 -57.67 137.83 56.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 146.98 47.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.49 -0.756 . . . . 0.0 109.996 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -141.16 -171.7 3.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 30' ' ' PRO . 14.2 m -97.64 135.35 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.036 -1.04 . . . . 0.0 109.269 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.07 -20.75 65.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.16 160.66 40.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 139.11 57.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 109.869 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.3 mt -117.44 163.01 17.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.17 141.02 48.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' LEU . 99.0 m-85 -139.56 147.72 41.56 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.93 151.84 22.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.839 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.14 173.95 36.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.56 149.25 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -1.039 . . . . 0.0 110.108 -179.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 140.09 16.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.491 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -58.91 -39.15 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.126 -1.22 . . . . 0.0 110.327 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.474 ' N ' HG23 ' A' ' 18' ' ' ILE . 78.3 m-70 -90.21 -50.38 6.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.718 -1.239 . . . . 0.0 111.168 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -66.6 -23.93 66.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.762 . . . . 0.0 111.242 -178.156 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.69 16.71 17.85 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -112.56 157.93 20.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -1.012 . . . . 0.0 109.401 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.82 134.7 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -136.34 145.29 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.57 157.62 20.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.978 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 96' ' ' ILE . 9.3 mt -138.59 145.02 40.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.491 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -140.56 108.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 108.416 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -92.28 115.24 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 0.0 110.621 -178.725 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 27' ' ' ILE . 47.5 m-70 -108.67 139.77 21.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 0.0 109.393 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' VAL . 27.5 Cg_exo -52.57 168.34 0.46 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.828 1.686 . . . . 0.0 111.737 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HB3' HG21 ' A' ' 35' ' ' THR . 17.7 mm-40 -142.84 174.56 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.668 179.434 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.7 mttt -82.05 149.38 28.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -47.05 149.03 0.98 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.15 -0.969 . . . . 0.0 109.821 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 66.66 4.01 23.62 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.75 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.8 m -67.53 -41.69 83.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.774 -1.427 . . . . 0.0 109.238 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.67 -179.91 34.58 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.398 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 87' ' ' VAL . 24.4 mm -98.92 116.5 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -139.62 155.31 47.51 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.772 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -103.58 156.8 17.5 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -128.69 111.8 13.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.0 108.657 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -135.66 134.35 39.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.699 -178.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 53.74 28.31 8.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 111.362 178.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.05 18.23 75.16 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.074 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.56 122.99 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.415 -1.05 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -84.39 128.26 34.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.111 -0.993 . . . . 0.0 109.466 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 69' ' ' ILE . 55.7 mt -118.13 91.09 39.37 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.36 152.24 8.75 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.519 2.146 . . . . 0.0 111.826 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 67.4 9.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -121.55 161.86 21.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.83 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.1 p-80 -65.17 -51.6 60.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -43.44 -16.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 110.879 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.1 m-85 -98.56 0.58 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.867 -1.145 . . . . 0.0 110.105 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 50' ' ' HIS . 79.3 t -69.98 131.0 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.271 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.63 -30.27 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 110.35 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -151.75 133.3 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.952 -1.093 . . . . 0.0 109.992 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.597 HG21 HG21 ' A' ' 257' ' ' VAL . 41.2 p -123.29 95.51 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 59' ' ' SER . 13.9 t-20 -163.03 129.1 3.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.972 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 36.8 m80 50.83 8.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.065 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.19 144.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.754 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.7 m -87.09 127.18 35.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 109.18 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.78 150.33 42.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.81 0.814 . . . . 0.0 111.046 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mt -126.27 149.71 48.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.23 151.91 23.04 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.193 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -158.04 144.13 17.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -1.092 . . . . 0.0 109.215 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.86 22.04 2.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 109.839 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.14 -33.37 6.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -57.55 141.56 47.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.241 . . . . 0.0 109.153 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -133.89 134.3 42.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.486 -0.758 . . . . 0.0 110.336 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 69' ' ' ILE . 18.8 mt -127.05 122.02 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -102.78 156.17 17.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.0 -1.063 . . . . 0.0 111.357 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 71' ' ' THR . 86.1 m 50.31 73.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 60' ' ' THR . 19.8 m -108.11 -9.22 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.21 -26.2 67.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.537 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.66 -69.02 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.64 -48.02 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.054 -1.029 . . . . 0.0 109.107 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 75' ' ' ILE . 26.1 mt -51.76 -49.19 63.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.0 109.93 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 t -60.95 -42.5 98.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.82 -44.87 79.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 108.823 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -67.74 -34.44 76.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -61.92 -36.81 82.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 108.872 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.1 mt -78.86 -38.14 38.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 114' ' ' ILE . 74.7 mt -80.45 -0.52 37.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.744 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 55.0 40.37 32.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 110.922 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.5 mm -85.82 141.77 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 69.0 p -127.23 -23.18 3.6 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.182 -0.949 . . . . 0.0 111.582 -178.227 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.726 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.4 m-80 -124.33 106.53 10.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.828 -1.17 . . . . 0.0 110.164 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.9 148.27 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.625 0.726 . . . . 0.0 110.295 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.8 m -116.33 114.53 24.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -94.97 100.4 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.367 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' OE1' HD12 ' A' ' 27' ' ' ILE . 4.9 tt0 -73.55 124.72 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 26' ' ' LEU . 62.1 t -107.39 126.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.82 0.819 . . . . 0.0 111.583 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 92' ' ' ILE . 27.7 mt -111.03 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.39 -156.24 25.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -121.68 -10.68 8.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.11 149.25 42.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 0.0 109.564 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -73.43 121.33 84.86 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.042 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.71 124.03 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.76 1.64 . . . . 0.0 111.405 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -81.19 -12.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 106' ' ' PHE . 8.2 mt 56.05 -116.83 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.84 8.13 45.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.012 -1.055 . . . . 0.0 110.743 -178.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.2 65.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 -172.27 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.741 -0.858 . . . . 0.0 109.339 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.96 14.58 8.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.582 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 52.3 t-105 -56.3 -42.8 78.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 3.8 mp0 -64.96 -57.32 9.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 0.0 110.171 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 99' ' ' LEU . 11.0 m-85 -51.02 -46.2 61.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.223 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.581 ' OH ' ' NH1' ' A' ' 111' ' ' ARG . 89.4 t80 -60.97 -52.35 65.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.669 -0.644 . . . . 0.0 110.884 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.582 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 4.0 mm-40 -62.03 -45.24 94.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.142 -0.974 . . . . 0.0 111.726 -178.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.1 -55.64 17.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.996 -1.065 . . . . 0.0 110.548 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.47 -32.46 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.383 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.581 ' NH1' ' OH ' ' A' ' 107' ' ' TYR . 59.1 ttt85 -63.3 -41.86 98.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.0 109.933 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' C ' HD22 ' A' ' 113' ' ' ASN . 27.6 pttt -77.58 13.37 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.495 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.7 m-80 -143.11 31.32 1.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.898 -1.126 . . . . 0.0 110.79 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 82' ' ' LEU . 73.6 mt -79.07 138.79 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.759 -1.213 . . . . 0.0 109.718 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -129.24 125.32 36.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -79.32 143.51 35.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.573 -179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.92 -175.6 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 109.303 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -110.03 67.33 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.633 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.3 ttt85 -162.91 129.55 3.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 109.335 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.96 142.61 52.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.959 -1.088 . . . . 0.0 109.661 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 241' ' ' PRO . 74.0 mt -88.83 151.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.651 -179.23 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.42 84.88 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 70.9 m-85 -61.71 146.69 48.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.517 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -91.63 101.64 14.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -93.63 134.44 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.442 0.639 . . . . 0.0 111.058 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.7 t -73.89 112.93 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.65 -26.94 16.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.277 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.04 150.3 76.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.825 . . . . 0.0 109.278 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.5 149.35 55.78 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.432 2.088 . . . . 0.0 112.037 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.7 tt -152.41 150.65 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 108.965 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.43 141.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.38 146.73 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -135.9 159.22 42.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 109.485 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.57 108.05 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.169 -0.957 . . . . 0.0 110.161 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 48.61 52.94 12.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 110.754 178.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.4 -36.85 3.17 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.484 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.85 126.16 26.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.93 -1.335 . . . . 0.0 108.634 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -138.71 138.85 38.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 110.138 -179.444 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 259' ' ' LEU . 83.6 mt -137.97 130.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.475 -0.766 . . . . 0.0 109.76 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.414 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 29.5 tttm -119.24 132.1 55.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.689 -0.632 . . . . 0.0 109.887 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.81 133.82 54.43 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 4.2 pt-20 -145.89 149.11 38.24 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.016 -1.053 . . . . 0.0 109.729 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.0 140.95 9.77 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.561 2.174 . . . . 0.0 113.158 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -154.57 142.8 20.4 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.97 -7.1 3.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.437 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.9 p -149.91 -174.62 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 109.605 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.8 tp -98.75 123.16 42.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.137 -0.977 . . . . 0.0 108.737 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.444 ' N ' HD12 ' A' ' 147' ' ' LEU . 44.8 tt0 -139.28 126.99 21.92 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 108.651 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.428 ' CG1' HD23 ' A' ' 231' ' ' LEU . 93.6 t -125.24 123.7 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.421 -0.799 . . . . 0.0 109.864 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m -113.8 152.73 30.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.608 -0.682 . . . . 0.0 109.849 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -140.44 131.09 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.854 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 10.1 tt0 -122.47 133.75 54.59 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.99 140.76 10.66 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.482 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 97.56 7.03 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.51 167.36 21.4 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.713 . . . . 0.0 110.673 -178.352 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.89 25.3 9.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.507 -0.746 . . . . 0.0 111.092 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 157' ' ' ASN . 20.5 p-10 -137.19 -164.66 1.62 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.864 -1.147 . . . . 0.0 109.996 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -56.62 -4.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.429 -0.794 . . . . 0.0 110.968 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 159' ' ' LEU . 12.2 mt -76.39 -27.01 56.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.59 -1.319 . . . . 0.0 108.036 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.57 -139.49 39.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.2 136.78 41.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -142.75 154.18 44.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.614 -0.679 . . . . 0.0 109.519 -179.623 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 148.96 31.52 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -145.37 139.01 26.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -0.841 . . . . 0.0 109.836 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 m -107.1 123.87 48.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.474 -0.767 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.475 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.0 t80 -103.17 109.04 20.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.35 150.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 109.676 179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -49.5 128.21 16.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 108.787 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLY . . . . . 0.459 ' N ' ' OE1' ' A' ' 171' ' ' GLU . . . 106.31 0.97 38.06 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.55 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 16.0 m120 -116.62 20.75 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 109.022 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.1 pm0 -55.62 -49.08 73.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.396 -0.815 . . . . 0.0 110.205 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -50.27 -22.22 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 110.46 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.71 -7.13 58.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.002 -1.061 . . . . 0.0 111.899 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.5 pt -125.51 -28.16 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.84 -1.163 . . . . 0.0 111.247 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.62 -17.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.593 -1.317 . . . . 0.0 109.022 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.56 -4.03 55.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.45 -0.781 . . . . 0.0 108.945 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.492 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.29 115.82 8.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.86 . . . . 0.0 108.937 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.525 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 88.5 mtm180 -78.59 172.7 13.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.232 -0.918 . . . . 0.0 109.264 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.442 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.6 t -79.36 163.3 24.96 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -147.85 148.78 31.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.141 -1.599 . . . . 0.0 111.666 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -145.65 156.7 43.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.402 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 80.3 m-85 -99.75 144.37 28.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.041 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.444 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.35 -36.04 5.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 110.169 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -75.55 -29.27 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.906 -1.121 . . . . 0.0 110.387 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.7 tt0 -75.23 -29.0 60.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.3 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.516 HG21 HB21 ' A' ' 500' ' ' C90 . 62.1 mt -57.9 -47.75 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.297 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.29 -41.56 19.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -74.82 -52.18 12.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.321 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.494 HD11 ' OE1' ' A' ' 185' ' ' GLU . 43.1 mt -48.5 -29.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -85.13 -53.54 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.792 -1.192 . . . . 0.0 109.737 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -49.81 -34.76 20.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.385 -179.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.9 m -85.51 8.87 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.895 -1.128 . . . . 0.0 110.36 -179.248 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.4 39.71 56.38 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.63 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.3 mt -128.47 171.12 12.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -1.177 . . . . 0.0 109.835 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.19 23.22 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -57.92 -19.65 31.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.598 -1.531 . . . . 0.0 110.031 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.38 3.47 34.85 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.58 125.46 35.41 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.082 -1.246 . . . . 0.0 110.466 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.7 p -147.61 165.24 31.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.373 -1.075 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 24.0 mt -67.85 -8.2 34.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -96.36 -11.91 25.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.793 -0.567 . . . . 0.0 109.702 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.512 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.5 p-10 -137.93 8.89 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.046 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.491 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -147.57 149.08 31.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.071 -1.018 . . . . 0.0 110.006 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.62 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.1 tp -99.58 93.79 6.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 203' ' ' THR . 41.8 t -86.22 131.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.86 0.838 . . . . 0.0 109.109 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.23 165.82 16.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.22 -166.38 11.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -58.56 -36.16 73.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -1.072 . . . . 0.0 109.604 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.62 25.44 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.693 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.59 148.92 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.872 -1.142 . . . . 0.0 110.537 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.24 110.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.52 -46.85 73.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.11 -0.993 . . . . 0.0 109.516 -178.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -66.57 117.42 44.17 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.03 -11.13 29.75 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.362 1.375 . . . . 0.0 111.37 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.55 -17.77 61.69 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.376 -0.827 . . . . 0.0 109.031 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.57 -177.73 46.37 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -86.58 136.94 32.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -1.227 . . . . 0.0 109.644 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -20.29 65.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.3 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' TYR . . . . . 0.467 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.8 m-85 -138.31 -164.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.203 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -97.63 -17.02 19.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -138.5 48.52 1.93 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -53.11 -48.29 92.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 109.806 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.1 Cg_exo -48.24 -67.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.14 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.2 m -59.59 -36.61 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 93.2 mtt180 -60.84 -40.52 93.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.975 -1.078 . . . . 0.0 108.411 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 13.8 t60 -67.6 -30.87 70.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.251 -0.906 . . . . 0.0 108.732 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -66.11 -36.86 84.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.4 t -67.4 -37.97 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -63.24 -53.68 49.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.52 -0.737 . . . . 0.0 109.067 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 89.6 m-20 -62.41 -28.77 70.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 110.145 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' LEU . . . . . 0.428 HD23 ' CG1' ' A' ' 149' ' ' VAL . 33.1 tp -76.76 -34.29 58.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.988 -1.07 . . . . 0.0 108.565 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.6 mt -65.29 -38.33 82.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.36 -56.81 10.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.431 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 46.0 m-20 -53.11 -30.95 39.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.203 . . . . 0.0 109.191 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.17 -23.61 67.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 110.339 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.63 -22.37 60.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.744 -1.223 . . . . 0.0 108.96 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -49.76 -5.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.373 -1.454 . . . . 0.0 109.974 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -74.51 -15.85 60.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.42 0.31 61.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.293 178.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -167.14 146.95 4.66 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.557 -1.554 . . . . 0.0 110.007 179.471 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 121' ' ' ILE . 58.7 Cg_exo -34.66 147.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.699 2.266 . . . . 0.0 111.339 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 83.1 t -115.03 147.76 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.603 -178.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -131.77 124.03 28.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 152.68 174.99 23.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 13.9 tttt -103.89 142.2 34.82 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.8 m-85 -137.41 138.93 40.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.216 -0.927 . . . . 0.0 109.761 -179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 59.7 t80 -125.69 128.26 47.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -124.7 136.23 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 -177.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -118.96 113.91 21.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 55.13 18.89 2.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.353 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.32 155.41 17.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.65 176.36 20.66 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.5 m-70 -58.9 -37.7 77.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.251 . . . . 0.0 109.534 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -58.27 9.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.319 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.509 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.2 tp -60.94 -43.24 98.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 18.4 m-20 -47.57 -54.07 12.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 109.417 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 56' ' ' THR . 82.8 t -62.4 -46.38 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.596 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -54.27 -52.08 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.013 -1.054 . . . . 0.0 108.961 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 139' ' ' ILE . 23.8 tp -50.65 -58.49 5.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.452 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.0 t -49.27 -52.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.196 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -49.18 -49.19 43.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.761 . . . . 0.0 109.704 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 130' ' ' ILE . 28.5 mm-40 -61.83 -48.2 81.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.0 -47.97 79.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.01 -29.72 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 110.08 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -67.39 -53.89 25.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 -179.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -62.32 -49.22 76.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.0 109.484 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.22 47.69 0.47 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.681 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -117.98 170.37 8.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.403 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 179.969 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.552 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.9 mt -99.34 153.73 18.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 26.6 mt-10 -53.18 135.19 38.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.173 -0.954 . . . . 0.0 108.783 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 144.55 46.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.618 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -141.86 -169.78 2.99 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -100.83 137.33 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.324 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.35 -27.96 68.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.695 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.42 158.19 43.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.812 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 141.1 58.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -120.39 165.18 15.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.64 143.11 43.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 110.177 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.0 m-85 -139.82 150.73 45.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -158.65 151.57 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 0.0 109.999 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.85 174.06 36.45 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.73 149.01 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.431 -1.041 . . . . 0.0 110.256 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.46 137.86 16.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 203' ' ' THR . 3.8 tt -59.2 -38.15 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.243 . . . . 0.0 110.272 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.448 ' N ' HG23 ' A' ' 18' ' ' ILE . 85.2 m-70 -89.8 -50.63 5.94 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.724 -1.235 . . . . 0.0 111.376 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 p -69.03 -21.62 64.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 111.547 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.56 19.2 26.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -112.41 155.46 24.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.523 -0.987 . . . . 0.0 109.569 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -76.53 134.45 39.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 m -138.36 146.12 41.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.726 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 3.4 ttpp -112.6 157.79 20.77 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.41 -0.806 . . . . 0.0 109.923 -179.347 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 96' ' ' ILE . 8.4 mt -136.86 145.14 44.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -138.74 115.85 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.02 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.62 114.38 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.873 . . . . 0.0 110.994 -178.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 27' ' ' ILE . 50.7 m-70 -109.58 138.16 20.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 109.808 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 28.0 Cg_exo -51.99 168.38 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.942 1.761 . . . . 0.0 111.399 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 35' ' ' THR . 15.1 mm-40 -142.91 168.97 18.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 110.131 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 35' ' ' THR . 1.6 mttp -76.82 150.76 36.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.464 -0.773 . . . . 0.0 109.72 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -46.92 146.16 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.867 . . . . 0.0 110.209 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.74 6.04 48.7 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.955 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.536 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 28.5 m -68.66 -43.29 76.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.597 -1.531 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.97 178.2 36.25 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' A' ' 87' ' ' VAL . 15.3 mm -96.07 117.23 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.72 149.83 42.67 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.603 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -100.18 158.26 15.98 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -129.61 112.27 13.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 108.624 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -135.64 132.88 37.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.463 -0.773 . . . . 0.0 110.5 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' N ' HD22 ' A' ' 42' ' ' ASN . 2.8 m120 53.16 31.24 11.09 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 0.0 111.639 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.3 17.8 78.94 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.153 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.6 121.75 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -1.015 . . . . 0.0 109.19 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.6 m-85 -84.19 128.51 34.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mt -117.61 92.64 41.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.26 145.75 14.64 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.462 2.108 . . . . 0.0 111.984 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 71.41 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 6.0 mmt85 -126.23 172.43 10.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.5 p-80 -73.64 -48.67 30.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 110.195 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -43.6 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 0.0 111.25 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 37.4 m-85 -96.92 1.78 50.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.725 -1.234 . . . . 0.0 110.105 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.6 t -63.66 123.59 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.043 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 m -106.55 -29.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 109.979 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -154.11 132.49 11.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.049 -1.032 . . . . 0.0 109.805 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.726 HG21 HG21 ' A' ' 257' ' ' VAL . 61.3 p -123.6 95.23 4.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 45.6 t-20 -163.66 129.01 3.0 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.395 -0.815 . . . . 0.0 108.894 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 31.2 m80 47.76 11.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.065 -1.022 . . . . 0.0 108.973 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.36 141.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.872 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.42 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 34.2 m -90.36 127.76 36.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 109.131 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.71 152.82 38.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.413 -0.805 . . . . 0.0 111.067 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.64 ' CD1' HG21 ' A' ' 72' ' ' VAL . 7.7 mt -128.44 149.01 50.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.76 156.77 28.76 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 118.886 -1.626 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -163.82 151.47 12.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.026 . . . . 0.0 108.849 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 52.53 23.85 2.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.971 . . . . 0.0 109.375 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.96 -31.25 7.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -58.3 145.94 36.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -1.17 . . . . 0.0 108.827 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -145.28 140.04 27.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 110.693 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.26 123.08 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -101.43 158.47 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.074 -1.016 . . . . 0.0 111.408 -177.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 m 48.45 72.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.253 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 62' ' ' LEU . 28.0 m -107.16 -9.4 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.174 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -60.47 -25.33 65.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 110.025 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.41 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.6 m170 -67.33 -68.48 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 109.181 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.14 -47.18 44.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 109.192 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 48' ' ' ALA . 20.9 mt -52.67 -47.57 67.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.948 -1.095 . . . . 0.0 110.1 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.5 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.1 t -61.65 -43.53 98.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.943 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.19 -44.75 80.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.14 -35.25 77.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.284 -0.885 . . . . 0.0 109.208 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -62.39 -33.76 75.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.883 . . . . 0.0 109.269 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 171' ' ' GLU . 62.3 mt -82.13 -38.37 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 107' ' ' TYR . 86.5 mt -80.74 4.18 19.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.547 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 54.22 39.11 30.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.07 139.38 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.642 HG21 HG12 ' A' ' 121' ' ' ILE . 56.6 p -126.02 -20.57 4.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.151 -0.968 . . . . 0.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.1 m-80 -128.5 108.25 10.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.884 -1.135 . . . . 0.0 111.0 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 86' ' ' ASN . 12.7 m -162.76 147.17 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 178.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 17.5 m -112.76 113.74 25.98 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.502 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.6 mt -97.7 101.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 110.648 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.93 124.26 25.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD21 ' A' ' 26' ' ' LEU . 98.5 t -104.94 129.42 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.87 0.843 . . . . 0.0 111.836 -177.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 33.3 mm -111.7 91.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.7 163.6 10.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -84.51 -3.36 58.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.321 . . . . 0.0 110.852 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -140.01 147.09 39.89 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.836 -1.165 . . . . 0.0 110.214 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 26' ' ' LEU . 47.0 mm -74.35 122.2 86.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 109.02 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -41.4 127.17 3.09 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.762 1.641 . . . . 0.0 111.394 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.1 tp -80.18 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.274 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.605 HD11 ' CE2' ' A' ' 106' ' ' PHE . 35.9 mt 58.74 -122.67 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -95.07 8.3 43.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.926 . . . . 0.0 110.464 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.85 -3.63 65.16 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.119 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.45 -172.44 2.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.792 -0.828 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.06 14.3 10.38 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.549 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 4.7 t-105 -56.98 -42.15 79.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.18 -57.83 7.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.097 -1.002 . . . . 0.0 110.261 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 99' ' ' LEU . 10.2 m-85 -51.45 -45.93 62.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.356 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.442 ' CE1' HD21 ' A' ' 82' ' ' LEU . 40.0 t80 -61.22 -53.93 50.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.665 . . . . 0.0 110.905 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 1.5 mm-40 -60.99 -43.54 98.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 111.473 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -54.74 20.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.013 -1.054 . . . . 0.0 110.449 -179.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.6 mt -66.43 -32.83 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 109.645 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -63.61 -42.45 98.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.656 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -77.06 15.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.654 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -146.31 31.18 1.01 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.659 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 72.9 mt -79.29 138.86 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.776 -1.202 . . . . 0.0 110.328 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.05 120.87 25.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.435 -0.791 . . . . 0.0 109.058 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 142.41 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 0.0 110.148 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -110.37 -170.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 109.48 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -111.53 67.84 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.232 -0.918 . . . . 0.0 110.588 -179.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -164.01 128.7 2.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.044 -1.035 . . . . 0.0 109.314 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.92 142.59 54.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.642 HG12 HG21 ' A' ' 85' ' ' THR . 37.5 mt -86.79 151.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.841 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.03 79.99 3.27 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -58.08 143.41 43.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.557 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -90.08 101.67 14.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.45 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.639 -0.663 . . . . 0.0 110.902 -177.652 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.12 117.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -97.99 -26.73 14.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.456 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.59 149.66 74.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 149.1 56.48 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.41 2.073 . . . . 0.0 112.096 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.5 tt -153.09 149.75 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.03 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.22 143.46 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.94 147.61 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -134.44 161.52 34.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.076 -1.015 . . . . 0.0 110.181 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.48 ' HB2' HD13 ' A' ' 255' ' ' LEU . 7.0 t0 -168.65 101.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.357 -0.839 . . . . 0.0 109.804 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 47.32 62.54 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.528 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.86 -37.29 3.09 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.578 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -61.03 137.72 58.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.888 -1.36 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -146.96 136.78 23.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.935 -1.103 . . . . 0.0 110.082 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.473 HG21 HD22 ' A' ' 259' ' ' LEU . 92.9 mt -136.13 134.48 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.455 -0.778 . . . . 0.0 109.46 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 tttp -124.16 131.63 53.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.504 0.669 . . . . 0.0 109.957 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.41 137.39 54.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.96 155.86 40.59 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.091 -1.006 . . . . 0.0 109.765 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -50.53 142.21 31.43 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.496 2.131 . . . . 0.0 113.421 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -156.69 139.38 15.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -60.91 -5.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 0.0 110.462 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 145' ' ' ASP . 29.2 p -154.18 -177.54 6.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.884 -1.135 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 148' ' ' GLU . 15.1 tp -93.64 120.55 34.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.0 -1.062 . . . . 0.0 109.341 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.561 ' HG3' HG22 ' A' ' 167' ' ' VAL . 12.1 tt0 -134.49 115.7 14.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.94 121.81 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.403 ' OG1' HG23 ' A' ' 165' ' ' THR . 60.4 m -112.82 152.22 29.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.714 -0.616 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -139.6 131.06 26.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.138 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -121.47 130.52 53.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.25 139.11 10.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.682 -1.246 . . . . 0.0 111.556 -178.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -104.33 101.9 11.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -88.46 167.42 13.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.852 -178.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -100.69 -12.86 18.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' LEU . 39.9 p-10 -97.77 -170.8 2.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.979 -1.076 . . . . 0.0 110.355 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -52.86 0.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.492 -0.755 . . . . 0.0 112.019 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.545 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 28.5 mt -81.87 -28.03 33.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.241 -1.537 . . . . 0.0 108.772 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.16 -136.97 41.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -97.48 130.69 44.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 109.791 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -132.96 142.91 49.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.4 pttm -138.09 144.03 40.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.406 -0.809 . . . . 0.0 109.826 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' PHE . . . . . 0.508 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 61.0 t80 -144.99 138.02 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' THR . . . . . 0.403 HG23 ' OG1' ' A' ' 150' ' ' THR . 59.8 m -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.45 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.2 t80 -102.8 110.91 23.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.99 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG22 ' HG3' ' A' ' 148' ' ' GLU . 42.4 t -104.06 152.14 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.836 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -49.51 124.24 9.07 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.336 -0.853 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 0.75 31.08 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -116.93 21.66 13.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.195 -1.179 . . . . 0.0 109.268 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -55.44 -52.74 62.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 109.942 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.8 mt-10 -44.54 -22.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 0.0 110.11 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 171' ' ' GLU . 42.0 mt-10 -86.15 -8.95 57.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 111.753 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.5 pt -123.73 -29.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.801 -1.187 . . . . 0.0 111.225 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.6 m -61.41 -20.75 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.586 -1.321 . . . . 0.0 109.025 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.465 HD22 HH11 ' A' ' 218' ' ' ARG . 6.7 mt -90.31 -1.79 57.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.167 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.434 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.49 120.44 16.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.031 179.689 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.444 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 83.6 mtm180 -84.45 172.6 11.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.487 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 163.37 25.06 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -148.7 146.01 27.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.303 -1.498 . . . . 0.0 111.628 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.589 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -144.25 157.76 44.11 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 79.5 m-85 -99.19 147.54 25.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.076 -1.015 . . . . 0.0 109.389 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 2.3 p30 -53.27 -33.2 52.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 109.686 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' TRP . . . . . 0.501 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.5 p90 -73.53 -26.36 60.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.906 -1.121 . . . . 0.0 109.55 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.8 mm-40 -77.82 -40.65 39.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.953 . . . . 0.0 109.698 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 183' ' ' ASP . 76.4 mt -45.69 -51.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.136 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -42.65 -45.16 4.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.1 t60 -77.1 -50.93 11.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 109.71 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.5 mt -47.37 -32.24 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -85.04 -52.7 5.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.69 -1.256 . . . . 0.0 108.744 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -50.65 -32.16 18.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.331 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.7 m -86.62 6.27 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.941 -1.1 . . . . 0.0 110.116 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.49 37.55 40.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.6 mt -128.71 171.85 11.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -1.11 . . . . 0.0 109.798 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.55 22.38 52.11 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.78 -19.42 16.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.661 -1.494 . . . . 0.0 110.521 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.27 5.55 28.49 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.36 125.15 26.18 Favored Glycine 0 N--CA 1.491 2.337 0 O-C-N 121.052 -1.263 . . . . 0.0 110.571 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.455 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -147.04 169.46 19.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.562 -0.964 . . . . 0.0 109.421 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 35.2 mt -67.97 -8.36 36.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -93.09 -13.05 29.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 23.8 p30 -139.64 10.72 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.041 -1.037 . . . . 0.0 110.33 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.3 m -148.06 148.49 30.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.911 -1.118 . . . . 0.0 110.49 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.3 tp -98.69 93.41 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -85.88 129.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.4 mt -124.1 164.18 19.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.635 -0.665 . . . . 0.0 109.625 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.25 -166.24 12.55 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -23.25 65.8 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.639 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -157.02 21.77 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.042 -1.036 . . . . 0.0 111.255 -179.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -147.37 156.04 42.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.529 -1.357 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.87 112.79 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -59.21 -51.16 71.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 110.58 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -59.6 112.71 5.66 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -58.05 -11.07 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.704 1.603 . . . . 0.0 112.162 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -19.03 59.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.237 -179.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.42 -178.04 50.37 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.8 mt -87.88 131.53 34.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -1.126 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.465 HH11 HD22 ' A' ' 176' ' ' LEU . 6.8 ttm180 -61.14 -20.97 63.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.833 . . . . 0.0 108.875 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -143.43 -173.31 3.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.49 -0.757 . . . . 0.0 109.246 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.05 -16.84 30.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 221' ' ' ASN . . . . . 0.497 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -134.55 46.25 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.303 -179.952 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.73 -47.11 99.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.751 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 60.2 Cg_exo -50.42 -66.3 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.511 2.141 . . . . 0.0 112.177 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -60.04 -35.62 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 109.636 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ARG . . . . . 0.508 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 60.8 mtt-85 -60.91 -40.62 93.85 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.6 t60 -67.89 -31.99 72.17 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.561 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 227' ' ' LYS . . . . . 0.515 ' HE2' H211 ' A' ' 500' ' ' C90 . 17.3 mmtt -65.03 -36.0 82.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.5 t -69.54 -34.52 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.2 t80 -66.14 -52.49 47.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.44 -27.76 68.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.776 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.2 tp -77.76 -33.99 52.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.107 -0.995 . . . . 0.0 108.591 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.9 mt -67.65 -38.11 79.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -55.37 15.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' ASP . . . . . 0.432 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 9.7 m-20 -55.24 -36.82 66.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.293 . . . . 0.0 109.114 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.5 mt -62.27 -24.92 67.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.514 -179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 236' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.1 t80 -73.95 -21.5 60.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.825 -1.172 . . . . 0.0 109.376 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 237' ' ' LEU . 93.2 mt -49.16 -4.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.572 -1.33 . . . . 0.0 110.501 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 238' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 236' ' ' TYR . 11.1 mt -74.09 -14.36 60.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 109.998 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.451 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 96.53 3.19 59.84 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.989 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.59 152.18 11.76 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.489 . . . . 0.0 109.06 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.33 129.36 34.25 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.706 1.604 . . . . 0.0 109.668 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -89.39 151.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.033 -1.042 . . . . 0.0 112.435 -176.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.64 126.65 31.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.77 -165.55 32.61 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.631 ' N ' ' OG ' ' A' ' 144' ' ' SER . 11.9 tptm -124.55 133.71 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -1.092 . . . . 0.0 108.639 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.2 m-85 -132.25 138.05 47.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -125.77 118.21 25.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -112.49 135.31 53.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 111.023 -178.385 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -117.36 107.73 14.72 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 54.39 31.02 13.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.77 157.56 52.62 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.97 -179.91 16.48 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 54.6 m-70 -60.06 -40.15 88.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -58.88 6.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 134' ' ' ASP . 12.6 tp -56.68 -44.77 81.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.025 . . . . 0.0 109.283 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 256' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 19.9 m-20 -47.64 -52.09 19.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.933 -1.104 . . . . 0.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 56' ' ' THR . 81.4 t -61.54 -45.24 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.07 -49.2 77.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 139' ' ' ILE . 22.4 tp -54.61 -51.2 66.09 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.972 . . . . 0.0 108.779 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.446 HG13 ' HG ' ' A' ' 238' ' ' LEU . 11.5 t -57.87 -54.37 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.896 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -48.67 -45.53 38.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.678 . . . . 0.0 109.517 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' A' ' 130' ' ' ILE . 23.3 mm-40 -64.02 -51.68 63.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.862 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.88 -46.86 71.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.908 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.84 66.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -70.29 -59.86 2.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 110.41 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -28.9 69.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.163 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 267' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 269' ' ' LEU . 6.3 tt0 -101.27 42.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.966 -1.084 . . . . 0.0 109.583 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -73.61 15.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.454 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 267' ' ' GLN . 1.6 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 500' ' ' C90 . . . . . 0.589 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 33.1 mt-10 -54.16 139.71 34.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 108.54 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -123.26 145.9 48.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -0.853 . . . . 0.0 110.217 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 t -143.2 -169.76 3.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.588 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.3 m -100.51 137.94 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.915 -1.115 . . . . 0.0 109.092 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.669 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -68.33 -19.42 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.972 . . . . 0.0 109.954 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.5 OUTLIER -152.72 157.47 40.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.08 -1.013 . . . . 0.0 109.705 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 138.67 58.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.161 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.46 166.44 13.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.54 144.3 34.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.898 -1.126 . . . . 0.0 110.396 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 81.2 m-85 -138.23 152.08 48.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 6.8 pt-20 -158.99 150.06 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.956 -1.09 . . . . 0.0 110.146 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.33 174.79 36.76 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.2 151.05 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -1.09 . . . . 0.0 110.058 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.61 140.27 16.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 4.2 tt -59.22 -38.88 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 110.321 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 72.2 m-70 -88.75 -50.1 6.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.629 -1.294 . . . . 0.0 111.183 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 -25.06 64.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 111.819 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.88 14.41 23.28 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.319 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -110.32 157.67 19.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.464 -1.021 . . . . 0.0 109.564 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 77.7 t80 -76.02 135.17 39.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -137.27 143.22 42.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.317 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -112.52 156.93 21.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.417 -0.802 . . . . 0.0 109.952 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.627 HD11 HG23 ' A' ' 96' ' ' ILE . 9.5 mt -136.05 146.42 47.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.52 -0.738 . . . . 0.0 109.82 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.59 106.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 108.691 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -91.64 114.83 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.0 110.979 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -108.79 137.03 19.95 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.523 -0.736 . . . . 0.0 109.544 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.8 Cg_exo -52.27 168.41 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.941 1.761 . . . . 0.0 111.993 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.517 ' HB3' HG21 ' A' ' 35' ' ' THR . 35.3 mm-40 -141.95 173.68 11.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.6 mttt -83.51 154.29 23.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.96 147.57 3.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.102 -0.999 . . . . 0.0 109.783 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.443 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 70.31 0.19 28.26 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.819 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.686 ' N ' HD22 ' A' ' 86' ' ' ASN . 53.8 m -66.03 -44.7 83.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.565 -1.55 . . . . 0.0 109.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.62 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 99.34 178.81 31.36 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.743 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -98.96 117.79 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -144.33 155.96 44.04 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.12 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -101.89 158.7 15.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -128.56 111.45 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 0.0 108.718 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -135.62 132.6 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 42' ' ' ASN . 2.0 m120 55.09 28.25 10.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 111.334 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.85 19.42 73.03 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.773 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.15 121.13 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.537 -0.978 . . . . 0.0 109.217 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 46.2 m-85 -83.1 127.58 33.71 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -0.904 . . . . 0.0 109.05 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.44 90.75 35.74 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.625 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.02 148.78 6.41 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.497 2.131 . . . . 0.0 112.075 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.569 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.68 70.23 10.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.064 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -122.76 170.36 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.49 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.573 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p-80 -72.35 -51.67 19.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.363 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.573 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -43.59 -16.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.41 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.5 m-85 -96.47 -0.34 49.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.906 -1.121 . . . . 0.0 110.142 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 76.3 t -68.46 130.75 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 108.72 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.2 -30.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -147.18 127.0 13.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.968 -1.082 . . . . 0.0 109.608 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.876 HG21 HG21 ' A' ' 257' ' ' VAL . 38.6 p -120.56 96.23 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 59' ' ' SER . 8.7 t-20 -160.35 129.01 4.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.036 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.9 m-70 48.94 11.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 108.928 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.52 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.75 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 237' ' ' LEU . 46.4 m -86.81 128.03 35.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 109.293 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.06 147.18 45.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.655 0.74 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.546 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.5 mt -121.92 149.55 43.26 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.74 156.49 28.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -163.52 150.88 12.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -1.102 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 50.1 21.64 0.79 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.299 -0.876 . . . . 0.0 109.399 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.85 -34.0 6.12 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.489 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 76.5 mm-40 -59.04 149.42 27.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.283 . . . . 0.0 109.656 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -143.87 137.61 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 110.809 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.25 124.8 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 13.6 mtpp -102.21 157.82 16.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.073 . . . . 0.0 111.461 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.1 m 50.0 73.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.62 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 62' ' ' LEU . 30.1 m -107.34 -9.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 0.0 108.804 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.4 pm0 -61.2 -26.24 67.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.558 -0.714 . . . . 0.0 110.472 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.3 m170 -69.1 -68.12 0.42 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.966 -1.084 . . . . 0.0 109.312 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.27 -48.83 43.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.294 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 75' ' ' ILE . 20.3 mt -54.16 -46.39 72.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.022 -1.049 . . . . 0.0 110.184 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.414 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 29.4 t -60.72 -42.25 96.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.016 -1.053 . . . . 0.0 109.889 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.77 -44.98 87.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.024 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.9 -34.79 78.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.282 -0.886 . . . . 0.0 109.119 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.458 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 5.1 t-160 -62.31 -38.12 88.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' A' ' 171' ' ' GLU . 58.7 mt -77.11 -38.0 53.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.695 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 82' ' ' LEU . 72.6 mt -83.51 -0.79 51.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 109.703 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 5.3 mp0 56.6 43.22 25.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.814 . . . . 0.0 111.506 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 33.4 mm -87.06 144.86 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.81 -1.182 . . . . 0.0 107.952 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.596 HG21 HG12 ' A' ' 121' ' ' ILE . 43.6 p -130.0 -22.01 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.086 -1.009 . . . . 0.0 111.995 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.8 m120 -127.72 107.2 9.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.191 . . . . 0.0 110.607 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.4 m -166.01 152.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.512 0.672 . . . . 0.0 109.861 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.8 m -116.57 113.11 22.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -94.89 100.56 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' HD23 ' A' ' 26' ' ' LEU . 16.5 tt0 -75.33 126.74 31.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.42 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 HD21 ' A' ' 26' ' ' LEU . 39.8 t -110.28 127.31 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.899 0.856 . . . . 0.0 111.913 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mm -109.34 96.88 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.55 -155.14 24.0 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 -8.36 8.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.183 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -141.82 149.64 40.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 109.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 26' ' ' LEU . 42.9 mm -74.11 121.81 86.08 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.969 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -41.17 127.9 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.774 1.649 . . . . 0.0 111.366 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.6 tp -79.42 -11.88 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.516 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 106' ' ' PHE . 70.7 mt 56.07 -121.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.052 -1.03 . . . . 0.0 109.6 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.33 9.14 43.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.001 -1.062 . . . . 0.0 111.056 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.54 -3.47 61.28 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.249 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -128.66 -171.95 2.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.887 . . . . 0.0 109.537 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.34 15.6 10.76 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HB2' HD22 ' A' ' 176' ' ' LEU . 15.7 t-105 -58.78 -42.43 89.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -1.131 . . . . 0.0 110.493 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.03 -58.04 7.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' A' ' 99' ' ' LEU . 7.9 m-85 -51.15 -45.65 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.351 -0.843 . . . . 0.0 109.633 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -60.52 -48.97 79.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.623 -0.673 . . . . 0.0 110.974 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 9.1 mm-40 -67.34 -42.6 83.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.087 -1.008 . . . . 0.0 111.701 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.36 -50.36 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 110.395 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.31 -31.92 51.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.989 -1.069 . . . . 0.0 109.291 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -62.96 -42.1 99.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HG3' HD22 ' A' ' 113' ' ' ASN . 12.0 pttp -77.64 12.74 1.52 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.204 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.669 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 3.9 m-80 -143.86 31.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.883 -1.136 . . . . 0.0 110.457 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.515 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 84.0 mt -79.62 141.3 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.957 -1.089 . . . . 0.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LYS . 22.0 tp -129.92 122.46 28.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.778 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.6 OUTLIER -79.23 141.53 37.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.145 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -110.17 -174.59 2.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.504 -0.748 . . . . 0.0 109.595 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.23 68.84 0.68 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 110.678 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -167.16 130.38 1.79 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.91 143.81 55.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.596 HG12 HG21 ' A' ' 85' ' ' THR . 55.2 mt -86.22 149.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.11 78.13 5.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -58.65 142.72 48.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 110.041 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -89.44 101.59 14.26 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.8 t -93.88 134.16 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.461 0.648 . . . . 0.0 111.061 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.57 111.91 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.437 ' C ' ' OE1' ' A' ' 128' ' ' GLU . 81.3 mt-10 -90.35 -27.66 19.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -134.21 154.75 80.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.497 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.76 148.11 45.98 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.551 2.167 . . . . 0.0 112.199 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.0 149.05 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mp -140.3 143.37 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 109.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.38 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -133.05 159.63 39.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.15 -0.969 . . . . 0.0 110.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -175.44 105.94 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 52.11 54.95 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -0.813 . . . . 0.0 110.715 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.19 -31.18 3.19 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.109 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -63.09 135.39 57.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.267 . . . . 0.0 108.52 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -146.03 136.61 24.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.897 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.657 HG21 HD22 ' A' ' 259' ' ' LEU . 96.5 mt -135.41 121.64 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.229 -0.919 . . . . 0.0 109.207 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -112.16 131.82 55.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.487 0.66 . . . . 0.0 109.98 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.15 138.47 54.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.83 153.42 33.45 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 109.524 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -49.19 142.38 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.401 2.067 . . . . 0.0 113.49 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.5 t -154.15 142.44 20.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 146' ' ' THR . 55.8 m-20 -60.59 -4.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.314 -0.866 . . . . 0.0 110.726 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 145' ' ' ASP . 17.4 p -157.96 -171.07 3.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.872 -1.143 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 148' ' ' GLU . 14.9 tp -93.98 120.57 34.41 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.118 -0.989 . . . . 0.0 109.018 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.409 ' N ' HD12 ' A' ' 147' ' ' LEU . 77.1 tt0 -136.77 113.01 9.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.36 122.0 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.9 m -112.91 152.31 29.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.96 131.61 27.26 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.938 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.28 140.26 52.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.64 138.67 8.27 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.969 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.36 99.29 9.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -84.42 167.22 16.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.853 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -100.67 -12.07 19.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.9 p-10 -102.69 -172.63 2.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.934 -1.104 . . . . 0.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -49.18 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.466 -0.771 . . . . 0.0 111.532 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' ASN . 18.3 mt -77.31 -27.19 52.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.379 -1.45 . . . . 0.0 108.311 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.46 -139.18 31.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -97.36 134.07 41.12 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.169 -1.194 . . . . 0.0 109.513 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -141.23 152.86 44.92 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 152.76 32.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.214 -0.929 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 53.8 t80 -148.53 146.53 28.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -110.3 124.57 51.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.516 -0.74 . . . . 0.0 110.468 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.456 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.888 . . . . 0.0 110.012 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 t -109.75 156.26 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -50.65 123.37 8.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.973 . . . . 0.0 109.19 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.475 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 103.92 5.95 43.64 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.453 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 82.8 m-20 -119.75 19.03 12.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.367 -1.078 . . . . 0.0 109.212 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.695 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.9 pm0 -59.8 -43.9 94.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -53.89 -6.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 110.021 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 171' ' ' GLU . 89.3 mt-10 -104.8 -8.96 18.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.348 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 pt -123.85 -27.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.231 -0.918 . . . . 0.0 110.575 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.8 m -62.18 -29.23 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.795 -1.191 . . . . 0.0 108.611 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -77.58 -7.53 56.48 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.403 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.28 119.15 12.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.314 -0.866 . . . . 0.0 109.172 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.511 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 72.8 mtm180 -83.25 172.29 12.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.914 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.3 t -77.06 162.37 27.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -147.65 145.17 28.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.302 -1.499 . . . . 0.0 111.333 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.17 157.16 45.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.54 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.6 m-85 -98.72 142.28 30.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 0.0 109.514 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.15 -37.66 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.314 -0.866 . . . . 0.0 109.748 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.0 -27.25 63.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.472 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 7.1 mt-10 -78.61 -40.07 35.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 185' ' ' GLU . 13.2 mt -43.22 -54.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 186' ' ' ILE . 1.0 OUTLIER -43.21 -43.12 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.942 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.75 ' O ' HG22 ' A' ' 192' ' ' VAL . 2.3 t60 -74.27 -50.08 20.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 0.0 109.598 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 56.0 mt -52.08 -28.97 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -85.3 -53.32 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.74 -1.225 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -51.77 -33.68 36.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.6 m -83.07 7.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 0.0 109.819 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.67 39.38 55.87 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 54.4 mt -129.48 171.56 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.204 . . . . 0.0 110.134 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.67 24.0 56.28 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -58.22 -19.33 32.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.67 -1.488 . . . . 0.0 110.387 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.454 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.44 6.51 28.31 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.723 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.32 126.19 27.79 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 120.903 -1.351 . . . . 0.0 110.297 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.58 167.03 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.246 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.5 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 78.5 mt -68.75 -8.59 44.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 108.395 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -98.06 -11.17 23.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.712 -0.618 . . . . 0.0 109.54 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.2 p30 -133.21 7.66 3.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.64 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.43 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.43 149.56 31.94 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.645 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.73 93.99 6.11 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.6 129.06 38.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.779 0.8 . . . . 0.0 109.094 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 211' ' ' VAL . 40.9 mt -123.08 170.87 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.651 -0.656 . . . . 0.0 109.562 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.76 -166.22 11.71 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -64.48 -29.66 70.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -1.148 . . . . 0.0 109.611 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -153.26 24.45 0.54 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 111.061 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -149.17 156.82 42.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.515 -1.366 . . . . 0.0 110.925 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 206' ' ' LEU . 84.6 t -104.67 112.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -57.04 -49.32 76.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.902 -1.123 . . . . 0.0 109.856 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.83 112.26 4.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -57.3 -17.94 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 112.598 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.12 -16.34 60.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.915 -1.116 . . . . 0.0 109.98 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.43 -171.96 50.9 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.645 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.0 mt -91.17 137.3 32.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -1.085 . . . . 0.0 109.674 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -74.41 -16.45 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 108.74 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.99 169.36 17.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 2.1 mm-40 -84.56 3.68 35.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.141 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.519 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -151.38 43.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.186 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -56.24 -47.21 99.31 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.2 Cg_exo -50.57 -68.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.447 2.098 . . . . 0.0 112.193 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.1 m -57.13 -35.3 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.012 -1.055 . . . . 0.0 109.644 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.566 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 76.9 mtt-85 -60.7 -41.24 94.79 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.449 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.0 t60 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.986 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.7 t -67.64 -37.06 78.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.414 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 52.7 t80 -65.33 -50.98 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.051 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -64.11 -30.53 71.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 109.997 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.3 tp -75.49 -32.8 60.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.034 -1.041 . . . . 0.0 108.579 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.27 -39.66 83.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.7 -56.15 16.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.41 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 49.6 m-20 -54.82 -33.98 62.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 235' ' ' LEU . 7.7 mt -61.18 -24.01 66.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.467 -0.771 . . . . 0.0 110.444 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -72.63 -22.1 61.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.892 -1.13 . . . . 0.0 108.611 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 60' ' ' THR . 63.4 mt -50.78 -2.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.0 110.621 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 260' ' ' VAL . 9.5 mt -76.76 -13.38 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.147 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.01 -0.38 58.97 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.04 155.16 8.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.318 . . . . 0.0 108.814 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.53 150.67 5.62 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.745 1.63 . . . . 0.0 109.6 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 145.54 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.076 -1.015 . . . . 0.0 112.361 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.6 mmmp? -126.25 121.32 32.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.3 -175.55 31.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.556 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 26.9 tttt -114.59 147.47 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.075 . . . . 0.0 109.263 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 6.8 m-85 -142.92 140.48 31.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.56 122.12 34.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -114.7 135.25 54.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 111.112 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -118.52 109.68 16.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 54.15 26.82 6.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.69 158.74 52.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.02 168.14 24.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.41 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 68.5 m-70 -47.19 -41.29 17.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -1.187 . . . . 0.0 109.695 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.27 -57.98 9.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.045 -1.034 . . . . 0.0 109.293 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.546 HD23 HG13 ' A' ' 139' ' ' ILE . 6.4 tp -58.15 -44.82 88.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 256' ' ' ASN . 2.7 m-20 -47.95 -50.48 26.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.057 . . . . 0.0 109.391 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 56' ' ' THR . 99.4 t -63.15 -51.12 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.594 -0.691 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -53.0 -51.32 62.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 109.286 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.657 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -51.57 -57.79 8.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.161 -0.962 . . . . 0.0 108.434 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.6 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.2 t -50.78 -56.23 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 108.899 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -49.04 20.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.525 -0.734 . . . . 0.0 109.398 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.435 ' HB3' HD11 ' A' ' 130' ' ' ILE . 1.8 mm-40 -62.07 -48.27 80.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.36 -50.54 71.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.96 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.44 -27.0 65.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.0 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.908 . . . . 0.0 110.267 -179.276 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.569 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 2.0 mt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -51.76 143.29 13.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.55 146.61 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.091 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.96 -168.82 3.03 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.2 m -99.56 134.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 109.526 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -63.9 -16.73 62.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -152.71 -171.63 3.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.381 -0.824 . . . . 0.0 109.246 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 144.01 25.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 11' ' ' LEU . 43.5 mt -120.97 163.31 18.45 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.44 140.41 46.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.6 m-85 -138.48 148.28 44.16 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.13 152.2 26.05 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.809 -1.182 . . . . 0.0 110.209 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.12 173.24 35.9 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.08 150.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.393 -1.063 . . . . 0.0 110.17 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.58 136.63 15.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.6 tt -60.52 -37.78 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 110.445 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.421 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 46.3 m-70 -90.68 -51.45 5.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.588 -1.32 . . . . 0.0 111.044 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.7 p -70.54 -22.03 62.65 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.6 -0.688 . . . . 0.0 111.232 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.25 21.37 47.11 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.731 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -110.64 153.07 25.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 109.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -74.86 130.13 38.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.46 -0.775 . . . . 0.0 109.562 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 t -135.41 145.86 47.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.235 -0.916 . . . . 0.0 110.057 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -112.0 156.52 22.02 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.416 0.627 . . . . 0.0 109.333 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.586 HD11 HG23 ' A' ' 96' ' ' ILE . 10.8 mt -135.61 144.92 46.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.553 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -140.19 110.22 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 108.79 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.3 113.62 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 111.094 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' HG22 ' A' ' 27' ' ' ILE . 45.4 m-70 -108.32 138.14 20.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.073 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HG3' HG23 ' A' ' 7' ' ' VAL . 20.6 Cg_exo -51.37 167.98 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.853 1.702 . . . . 0.0 112.279 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.2 mm-40 -140.92 176.21 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 35' ' ' THR . 3.5 mtpp -85.31 152.83 22.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.856 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 146.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.925 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.68 6.32 42.44 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.039 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 24.6 m -69.08 -43.7 74.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.631 -1.511 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.55 -175.67 31.82 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.458 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mm -98.45 117.92 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.03 140.7 38.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.57 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -129.11 110.8 12.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.031 -1.043 . . . . 0.0 109.084 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.19 134.14 39.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.32 28.33 7.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.03 75.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.806 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.49 121.19 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -1.012 . . . . 0.0 108.951 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.5 m-85 -84.34 127.11 33.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.6 mt -115.72 92.65 34.63 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -49.66 144.99 18.33 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.2 67.5 7.15 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -122.16 163.79 18.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -65.63 -52.87 48.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 5.4 mm-40 -43.25 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.724 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' HIS . 15.9 m-85 -95.7 1.73 53.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 50' ' ' HIS . 86.8 t -70.58 130.35 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 108.874 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.46 -31.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 109.744 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.7 136.53 17.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.884 HG21 HG21 ' A' ' 257' ' ' VAL . 35.8 p -125.35 96.3 4.77 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.545 HD22 ' CD2' ' A' ' 58' ' ' HIS . 0.5 OUTLIER -162.24 129.49 3.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.808 . . . . 0.0 108.949 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.545 ' CD2' HD22 ' A' ' 57' ' ' ASN . 79.8 m-70 51.98 7.9 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.104 -0.998 . . . . 0.0 108.759 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.5 OUTLIER 161.9 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 72' ' ' VAL . 88.0 m -93.88 126.49 39.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 109.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.94 149.02 42.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.612 0.72 . . . . 0.0 110.868 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 72' ' ' VAL . 9.0 mt -124.86 149.07 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.73 153.74 24.43 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.98 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -163.12 148.79 11.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 0.0 109.174 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.89 23.79 4.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.15 -31.72 7.4 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.38 144.55 50.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.235 . . . . 0.0 109.262 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -140.04 139.02 35.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.675 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.3 mt -130.4 123.02 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -101.36 157.33 16.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.95 -1.094 . . . . 0.0 111.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.8 m 49.91 74.57 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.545 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 62' ' ' LEU . 30.5 m -107.65 -9.81 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.938 . . . . 0.0 109.31 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 10.6 pm0 -61.74 -26.09 67.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 110.46 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.0 m170 -66.78 -69.23 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.932 -1.105 . . . . 0.0 109.242 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.02 -48.57 40.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.013 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.589 HD21 ' HB1' ' A' ' 48' ' ' ALA . 14.8 mt -51.55 -49.27 62.34 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.038 -1.039 . . . . 0.0 110.3 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -42.68 96.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.988 -1.07 . . . . 0.0 110.295 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.9 t -56.74 -45.41 82.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.075 -1.015 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.3 -34.69 78.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -61.62 -35.84 79.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 109.035 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 65.1 mt -80.23 -37.65 32.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.257 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.0 9.29 5.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 109.781 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 3.3 mp0 50.2 36.77 13.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.34 136.82 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.034 -1.041 . . . . 0.0 108.282 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.484 HG21 HG12 ' A' ' 121' ' ' ILE . 33.0 p -127.1 -19.81 4.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 111.595 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' VAL . 72.7 m-20 -124.38 107.59 11.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.876 -1.14 . . . . 0.0 110.423 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -163.94 148.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.408 -0.808 . . . . 0.0 110.282 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.8 m -114.69 111.5 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.552 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -95.68 100.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -72.07 127.69 33.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 26' ' ' LEU . 83.3 t -111.9 119.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.937 0.875 . . . . 0.0 111.905 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' ILE . 13.7 mt -109.04 93.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.2 160.4 8.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -7.54 59.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 111.292 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -138.96 147.89 42.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 110.676 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 26' ' ' LEU . 42.0 mm -73.86 125.96 89.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.457 -0.777 . . . . 0.0 108.917 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -44.61 134.2 9.88 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.775 1.65 . . . . 0.0 111.075 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.7 tp -88.17 -14.66 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 110.61 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.7 mt 55.78 -121.98 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -95.82 7.6 45.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.939 -1.101 . . . . 0.0 111.17 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.52 -3.73 63.61 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.281 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.9 p -123.88 -172.65 2.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.724 -0.868 . . . . 0.0 109.556 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.98 10.18 11.14 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 55.5 t-105 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -1.121 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.31 -58.98 6.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.028 -1.045 . . . . 0.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HB3' HG11 ' A' ' 78' ' ' VAL . 11.7 m-85 -51.18 -43.77 61.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.83 0.824 . . . . 0.0 108.885 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.464 ' CE2' ' OE1' ' A' ' 171' ' ' GLU . 56.4 t80 -62.27 -52.19 64.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.663 -0.648 . . . . 0.0 111.18 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.448 ' CG ' ' CZ2' ' A' ' 104' ' ' TRP . 19.5 mm-40 -61.89 -43.2 99.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.956 -1.09 . . . . 0.0 111.195 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.12 2.63 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 110.363 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.44 -35.42 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.635 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 41.8 ttt85 -64.78 -43.55 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.762 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -72.59 10.76 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -145.73 36.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.948 -1.095 . . . . 0.0 110.448 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.7 mt -83.44 139.91 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.98 119.5 23.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.8 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.5 OUTLIER -76.3 143.56 40.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.722 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.19 -175.96 2.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 109.592 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.547 ' ND2' ' H ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -106.91 67.99 0.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.235 -0.915 . . . . 0.0 110.514 -179.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -164.93 129.64 2.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.22 140.77 57.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 85' ' ' THR . 37.4 mt -81.47 147.0 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.77 88.78 4.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -0.872 . . . . 0.0 108.657 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.71 143.77 56.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -88.47 102.2 14.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.24 134.12 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.556 -0.715 . . . . 0.0 110.792 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.27 117.22 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 127' ' ' GLU . 7.3 tp10 -89.69 -31.62 17.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.961 -1.087 . . . . 0.0 109.99 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.11 154.28 80.06 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.41 158.39 44.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.557 2.172 . . . . 0.0 112.35 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.0 tt -165.09 154.67 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.76 147.06 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.96 147.28 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -132.84 161.56 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -173.66 102.17 0.11 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 0.0 109.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.17 59.25 4.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.436 -0.79 . . . . 0.0 111.002 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.02 -35.56 3.25 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.448 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -63.94 131.38 47.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.265 . . . . 0.0 108.89 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -143.3 139.25 30.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 109.999 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 259' ' ' LEU . 68.5 mt -137.29 128.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.387 -0.821 . . . . 0.0 109.876 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -117.94 132.77 56.37 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.514 0.673 . . . . 0.0 110.146 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.83 134.95 54.89 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -146.46 147.68 31.59 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.54 143.52 8.45 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.617 2.211 . . . . 0.0 113.458 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.73 147.38 18.55 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.77 -37.55 82.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.325 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -120.46 -169.86 1.88 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.9 tp -100.08 122.94 43.72 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.36 130.2 36.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.459 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.9 t -128.73 121.45 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.541 ' OG1' HG23 ' A' ' 165' ' ' THR . 21.4 m -112.43 151.99 29.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.594 -0.691 . . . . 0.0 109.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -140.52 131.4 25.98 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.145 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -121.67 125.42 46.61 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.91 138.87 10.7 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.345 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -102.87 103.14 13.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -93.31 167.44 11.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.664 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -103.65 -12.27 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 110.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.2 p-10 -97.88 -167.13 1.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 110.378 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -53.48 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.259 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 157' ' ' ASN . 13.5 mt -85.59 -30.53 23.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.545 -1.347 . . . . 0.0 109.102 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.85 -140.25 38.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 161' ' ' ARG . 11.5 ttp-105 -98.82 135.91 39.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.193 -1.181 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -137.89 149.72 46.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.484 -0.76 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -140.86 143.99 35.05 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -145.47 140.3 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.541 HG23 ' OG1' ' A' ' 150' ' ' THR . 32.2 m -108.14 123.85 49.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.527 -0.733 . . . . 0.0 109.998 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -102.91 111.73 24.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.959 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 44.5 t -99.8 146.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.954 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -48.25 134.21 14.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.29 -0.881 . . . . 0.0 108.987 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.92 -6.0 43.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -114.03 25.61 11.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -1.132 . . . . 0.0 109.27 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.464 ' OE1' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -53.09 -51.69 61.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.429 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -50.56 -21.28 1.47 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.12 -0.988 . . . . 0.0 110.177 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.26 -7.9 59.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 111.619 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.58 -25.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.852 -1.155 . . . . 0.0 111.121 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.9 m -63.7 -24.44 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.438 -1.414 . . . . 0.0 109.005 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.4 mm? -81.66 -5.62 58.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.468 -0.77 . . . . 0.0 108.99 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.404 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.57 115.52 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.173 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.409 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 49.8 mtm180 -79.41 172.51 13.7 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.201 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.4 t -77.86 163.23 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -147.1 144.46 29.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.207 -1.558 . . . . 0.0 111.716 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.01 156.7 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.86 147.29 25.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 109.662 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -52.94 -35.97 59.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.429 -0.794 . . . . 0.0 109.698 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.2 p90 -72.91 -31.44 64.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.578 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.2 mm-40 -75.36 -35.74 61.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.017 -1.052 . . . . 0.0 109.375 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 183' ' ' ASP . 77.1 mt -46.46 -55.61 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 109.786 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -43.8 -42.0 5.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.858 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.0 t60 -74.44 -48.4 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.988 . . . . 0.0 109.046 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.1 mt -51.09 -30.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.336 -0.852 . . . . 0.0 109.302 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -82.35 -52.02 7.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.782 -1.199 . . . . 0.0 109.143 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -47.29 -47.12 25.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.425 -0.797 . . . . 0.0 110.158 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.7 m -74.67 8.17 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.79 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.08 39.9 62.52 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 194' ' ' LEU . 44.8 mt -126.45 170.91 11.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -1.082 . . . . 0.0 109.676 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.8 21.22 58.16 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -57.2 -21.67 35.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.557 -1.555 . . . . 0.0 109.807 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -113.48 25.19 11.38 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.36 127.53 8.4 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.458 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -141.18 169.4 17.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.124 . . . . 0.0 109.519 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 63.5 mt -70.7 -8.64 53.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -97.38 -12.66 22.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.609 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.458 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 17.9 p30 -132.71 8.67 4.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.492 HG22 HG23 ' A' ' 205' ' ' VAL . 1.0 OUTLIER -149.89 149.76 30.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.967 -1.083 . . . . 0.0 110.481 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.548 ' CG ' HD21 ' A' ' 206' ' ' LEU . 32.0 tp -97.45 93.36 6.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 203' ' ' THR . 45.1 t -87.22 130.34 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.554 -0.716 . . . . 0.0 109.152 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.548 HD21 ' CG ' ' A' ' 204' ' ' LEU . 12.5 mt -124.15 166.26 16.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.159 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.08 -166.15 12.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -1.12 . . . . 0.0 109.366 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 209' ' ' ASP . 47.9 t0 -153.9 24.32 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -143.02 150.6 39.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 79.7 t -103.23 113.32 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -58.61 -49.76 76.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.012 -1.055 . . . . 0.0 110.04 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -58.1 111.81 4.03 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.231 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.54 -12.98 12.35 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.541 1.494 . . . . 0.0 111.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -17.54 59.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 110.035 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.7 -173.78 49.29 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 204' ' ' LEU . 6.7 mt -91.02 136.14 33.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -1.209 . . . . 0.0 109.462 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -75.32 -20.12 59.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 108.824 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.43 159.07 42.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.555 -0.716 . . . . 0.0 109.12 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.5 -12.79 61.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.82 51.17 1.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.28 -47.03 99.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 0.0 109.795 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 63.6 Cg_exo -49.9 -67.08 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.453 2.102 . . . . 0.0 112.342 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 m -59.16 -35.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.121 . . . . 0.0 109.571 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -60.66 -41.1 94.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 108.457 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.2 t60 -68.19 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.301 -0.874 . . . . 0.0 108.947 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -64.45 -37.63 88.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.07 -36.11 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.59 -57.37 9.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.532 -0.73 . . . . 0.0 109.137 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -61.58 -26.01 67.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.354 -0.841 . . . . 0.0 109.885 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.7 tp -78.2 -35.08 48.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 0.0 108.69 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.8 mt -66.0 -36.51 77.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.79 -59.76 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 99.4 m-20 -48.09 -36.1 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.274 . . . . 0.0 108.992 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.9 mt -62.83 -22.78 66.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.547 -0.721 . . . . 0.0 110.317 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.27 -22.63 61.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.777 -1.202 . . . . 0.0 108.999 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.36 -3.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.688 -1.257 . . . . 0.0 110.204 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.5 mt -78.87 -16.34 57.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.906 -1.121 . . . . 0.0 109.695 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 2.63 56.37 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.172 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.66 154.54 9.13 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.747 -1.443 . . . . 0.0 109.287 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.16 128.77 31.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.91 1.74 . . . . 0.0 109.682 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 151.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 112.524 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -131.9 124.74 30.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.48 -158.41 27.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -129.08 132.89 47.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -1.155 . . . . 0.0 108.713 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.5 m-85 -131.92 140.09 48.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -126.76 125.34 41.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 m -120.93 135.44 55.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 111.015 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.403 ' C ' ' N ' ' A' ' 251' ' ' GLY . 30.4 t80 -116.1 114.84 25.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 17.38 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.092 -1.005 . . . . 0.0 109.007 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 249' ' ' PHE . . . -55.68 140.89 40.06 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.2 179.45 17.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.7 m-70 -62.21 -42.26 99.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.203 -1.174 . . . . 0.0 109.875 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.0 t -55.62 -58.92 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.07 -1.019 . . . . 0.0 109.572 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 255' ' ' LEU . 12.8 tp -55.99 -44.56 78.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 109.313 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 34.9 m-20 -47.59 -50.77 23.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.965 -1.085 . . . . 0.0 108.962 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 56' ' ' THR . 86.3 t -61.98 -49.55 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.524 -0.735 . . . . 0.0 109.84 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -54.88 -51.93 64.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.029 -1.044 . . . . 0.0 109.311 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 139' ' ' ILE . 51.9 tp -50.06 -52.79 31.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 108.549 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.503 HG13 ' HG ' ' A' ' 238' ' ' LEU . 34.5 t -55.41 -51.45 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 108.746 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -50.16 -47.01 54.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 109.552 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -64.45 -48.95 73.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.957 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 14.9 mt -57.42 -51.81 67.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.44 -27.3 65.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 110.251 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' HZ1' ' A' ' 265' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.445 ' CD ' ' OG1' ' A' ' 85' ' ' THR . 13.5 mm-40 -53.94 137.01 40.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.511 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 143.86 48.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -140.87 -171.96 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.502 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.8 m -97.05 133.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.998 -1.064 . . . . 0.0 109.397 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -64.68 -18.02 64.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.252 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -155.99 163.99 39.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.287 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 139.36 51.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 113' ' ' ASN . 11.5 mt -117.45 166.85 11.85 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -140.33 142.97 35.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 110.253 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' LEU . 91.6 m-85 -140.11 151.07 45.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.2 pt-20 -157.12 150.83 24.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.893 -1.129 . . . . 0.0 110.036 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.34 175.42 36.63 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.08 154.47 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -1.107 . . . . 0.0 110.003 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.01 140.15 15.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -59.33 -38.67 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 110.396 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.7 m-70 -89.42 -50.49 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.784 -1.198 . . . . 0.0 111.067 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 p -70.41 -23.08 62.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.634 -0.666 . . . . 0.0 111.758 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.2 15.55 15.57 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.63 153.44 22.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 24.9 t80 -74.38 135.53 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.354 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.2 m -139.7 144.77 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.602 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.9 ttpp -110.95 156.23 21.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -135.53 147.67 48.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.42 -0.8 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.6 mt -143.81 114.11 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 108.882 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mt -98.41 114.61 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.372 -0.83 . . . . 0.0 110.774 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 9.3 m-70 -108.49 138.13 20.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.2 Cg_exo -53.23 168.43 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.81 1.674 . . . . 0.0 111.65 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.497 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 58.9 mm-40 -141.22 177.54 8.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.031 -1.043 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' OG1' ' A' ' 35' ' ' THR . 21.0 mttt -84.48 152.44 23.96 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.692 0.758 . . . . 0.0 110.161 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.16 142.82 2.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.167 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 69.53 10.26 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.258 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 33.5 m -69.98 -42.43 73.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.573 -1.545 . . . . 0.0 109.798 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 178.95 35.58 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.351 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 87' ' ' VAL . 41.0 mm -95.44 116.32 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 7.1 ptm180 -141.14 150.26 42.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 110.582 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.31 157.03 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -128.41 111.82 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 108.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 44.4 tttm -134.68 132.62 39.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.534 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.5 m120 52.58 28.27 5.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.795 . . . . 0.0 111.372 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.07 19.64 69.34 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.187 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.81 122.6 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -1.063 . . . . 0.0 109.174 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.453 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 64.5 m-85 -84.73 127.19 33.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 109.729 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.9 mt -116.96 93.88 43.04 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.386 -0.822 . . . . 0.0 109.386 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.95 149.83 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.637 2.224 . . . . 0.0 112.105 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.05 68.48 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 3.9 mmt85 -123.08 175.69 6.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.276 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.8 p-80 -77.78 -51.65 10.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 110.28 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -43.06 -16.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 110.759 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.0 m-85 -98.11 2.96 49.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 110.295 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 50' ' ' HIS . 74.0 t -70.46 128.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.001 -1.062 . . . . 0.0 108.896 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -31.65 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.131 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -151.52 132.01 13.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.733 HG21 HG21 ' A' ' 257' ' ' VAL . 41.4 p -120.88 96.02 4.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.6 t30 -162.65 128.9 3.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.916 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 83.8 m-70 52.72 5.37 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 0.0 109.02 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 165.14 155.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.588 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 72' ' ' VAL . 55.1 m -94.64 126.76 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 109.2 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -119.0 148.02 43.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.507 -0.746 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' HG21 ' A' ' 72' ' ' VAL . 11.0 mt -123.51 149.87 44.65 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.78 157.58 28.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.848 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CD2' ' HD3' ' A' ' 65' ' ' LYS . 8.0 t80 -166.03 143.65 5.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 108.738 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HD3' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 53.36 22.13 2.67 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.31 -32.04 7.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.452 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 80.4 mm-40 -59.81 148.31 34.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.312 . . . . 0.0 109.613 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.52 138.5 30.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 110.53 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.3 mt -129.67 123.89 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -99.93 155.95 17.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 111.259 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.9 m 49.96 74.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.4 m -107.59 -8.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 108.71 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 60' ' ' THR . 14.3 pm0 -60.86 -28.46 68.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 110.623 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.25 -68.76 0.35 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -51.98 -47.56 41.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 75' ' ' ILE . 85.9 mt -52.32 -47.32 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.84 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 48.5 t -61.13 -42.23 98.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.097 -1.002 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.24 -43.41 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.993 -1.067 . . . . 0.0 109.133 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.3 -34.99 78.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.159 -0.963 . . . . 0.0 109.167 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.18 -38.27 90.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.429 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.1 mt -77.59 -38.87 47.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.855 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 82' ' ' LEU . 68.5 mt -81.81 0.08 40.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 109.411 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 55.93 42.72 28.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.645 -0.66 . . . . 0.0 111.365 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.34 145.32 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.782 -1.198 . . . . 0.0 108.192 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.667 HG21 HG12 ' A' ' 121' ' ' ILE . 82.7 p -129.35 -25.61 2.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.0 111.574 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 87' ' ' VAL . 83.2 m-20 -124.26 106.87 10.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.867 -1.146 . . . . 0.0 110.362 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.0 m -164.36 148.49 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.415 -0.803 . . . . 0.0 110.289 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.497 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 88.8 m -115.88 109.38 17.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.475 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -91.71 100.15 10.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 109.859 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -72.17 125.89 28.42 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 26' ' ' LEU . 92.3 t -107.94 123.55 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.707 0.765 . . . . 0.0 111.364 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.602 HD12 ' HB3' ' A' ' 25' ' ' LYS . 91.7 mt -110.25 96.36 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.25 -156.62 25.73 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -119.67 -11.03 9.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -1.149 . . . . 0.0 110.041 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -141.46 149.65 41.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.977 -1.077 . . . . 0.0 109.661 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.658 HG23 HD11 ' A' ' 26' ' ' LEU . 44.3 mm -72.52 119.55 75.66 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.037 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -40.32 119.89 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.778 1.652 . . . . 0.0 111.378 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -76.02 -13.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 110.098 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.7 mt 56.86 -118.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.25 -0.907 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 1.9 t0 -95.31 6.08 49.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.121 -0.987 . . . . 0.0 110.682 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.08 -0.91 60.62 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.52 -172.53 2.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.698 -0.884 . . . . 0.0 109.627 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.92 17.23 10.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.546 ' CE3' HD21 ' A' ' 176' ' ' LEU . 4.3 t-105 -59.57 -43.53 93.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.456 -1.026 . . . . 0.0 110.08 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 -57.87 8.24 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.062 -1.024 . . . . 0.0 109.852 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.47 -46.69 63.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -61.37 -49.3 77.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 7.2 mm-40 -66.0 -43.83 86.6 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.969 -1.082 . . . . 0.0 111.579 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.84 45.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 110.454 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.53 -31.97 56.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.968 -1.082 . . . . 0.0 109.161 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -63.2 -42.38 99.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.61 ' C ' HD22 ' A' ' 113' ' ' ASN . 7.4 pttp -79.15 10.44 3.56 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.983 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.61 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -138.23 32.25 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.55 137.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 110.855 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.28 118.6 21.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.566 -0.708 . . . . 0.0 109.274 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.732 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.0 OUTLIER -79.88 145.8 32.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.028 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.22 -170.74 1.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.775 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.46 68.97 0.69 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 110.361 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.34 128.6 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.152 -0.967 . . . . 0.0 109.207 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.28 142.51 56.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.0 109.506 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.667 HG12 HG21 ' A' ' 85' ' ' THR . 65.9 mt -84.39 149.33 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.2 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.58 87.68 3.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -66.52 145.36 55.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.184 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -88.22 101.41 13.81 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.88 133.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.456 0.646 . . . . 0.0 111.027 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.51 112.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.22 -30.12 17.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.959 -1.088 . . . . 0.0 110.534 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.42 81.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.86 148.69 41.26 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.562 2.174 . . . . 0.0 112.083 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 tt -156.8 148.93 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -0.833 . . . . 0.0 109.124 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.27 146.23 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.362 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.8 m -132.57 148.93 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.19 161.16 35.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.869 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -170.28 101.94 0.27 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 109.731 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 48.43 58.02 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.38 -35.52 3.31 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.584 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -62.18 136.3 57.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.339 . . . . 0.0 108.778 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.4 tt -144.53 139.1 27.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.863 -1.148 . . . . 0.0 110.062 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.801 HG21 HD22 ' A' ' 259' ' ' LEU . 23.3 mt -137.85 134.02 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.415 -0.803 . . . . 0.0 109.982 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -122.23 132.64 54.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.455 0.645 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.18 53.98 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.85 151.68 42.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 110.143 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.95 141.88 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.583 2.189 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.11 147.62 19.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -36.46 81.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.3 p -121.9 -169.22 1.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.846 . . . . 0.0 109.956 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.0 tp -98.76 123.71 43.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 108.67 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -136.33 128.09 29.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.2 t -128.3 121.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.843 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.7 m -110.84 151.1 28.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.451 -0.781 . . . . 0.0 109.07 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -139.15 130.22 26.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -120.99 131.05 54.07 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.18 140.0 11.31 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.534 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -106.22 101.12 10.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.55 167.15 13.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.935 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -99.14 -15.56 18.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.624 -0.672 . . . . 0.0 110.911 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.1 p-10 -96.09 -168.63 1.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.803 -1.185 . . . . 0.0 110.084 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -55.85 2.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.0 111.446 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.9 mt -77.61 -27.34 51.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.408 -1.433 . . . . 0.0 108.13 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.38 29.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.4 135.64 42.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -1.123 . . . . 0.0 109.339 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -140.82 158.9 43.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.429 -0.794 . . . . 0.0 109.363 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -147.44 146.23 29.48 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.216 -0.927 . . . . 0.0 109.828 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -145.41 140.13 27.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 110.08 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.9 m -108.21 123.54 48.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 110.03 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.49 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.22 115.46 30.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.56 147.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 5.6 mm-40 -48.73 135.04 15.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.196 -0.94 . . . . 0.0 108.897 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.07 -10.23 36.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 0.6 OUTLIER -116.97 25.85 10.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -1.125 . . . . 0.0 109.15 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.5 pm0 -62.45 -15.87 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 176' ' ' LEU . 1.9 tt0 -78.28 -8.11 57.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 110.887 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.564 ' HG2' HG23 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -104.79 -5.07 21.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.993 -1.067 . . . . 0.0 111.302 -178.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 173' ' ' GLU . 41.7 pt -115.65 -30.05 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.192 -0.942 . . . . 0.0 110.355 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 171' ' ' GLU . 10.3 m -60.44 -18.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.017 -1.052 . . . . 0.0 109.25 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.546 HD21 ' CE3' ' A' ' 104' ' ' TRP . 1.4 mp -93.92 0.85 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.008 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.492 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -70.05 117.39 11.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.922 . . . . 0.0 108.774 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 87.4 mtm180 -80.29 171.72 14.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.453 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.1 t -79.04 163.02 25.49 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -148.2 144.55 27.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.269 -1.519 . . . . 0.0 111.565 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.4 157.73 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.511 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.5 m-85 -99.35 146.56 26.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 109.558 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.99 -35.19 23.54 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.352 -0.842 . . . . 0.0 109.647 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.2 p90 -74.83 -30.32 61.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.983 -1.073 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.8 OUTLIER -73.56 -37.53 65.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.922 . . . . 0.0 109.967 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 187' ' ' GLU . 84.2 mt -48.93 -55.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.037 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -41.53 -41.73 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.062 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.6 t-160 -75.62 -47.31 27.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 109.148 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.17 -25.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.845 . . . . 0.0 109.566 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -85.64 -55.19 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.874 -1.141 . . . . 0.0 109.335 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -48.63 -41.74 32.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 188' ' ' HIS . 33.4 m -76.38 7.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.062 -1.024 . . . . 0.0 110.462 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.71 61.48 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.212 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 194' ' ' LEU . 51.3 mt -128.33 171.96 11.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 109.372 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 59.16 21.98 54.57 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -59.99 -21.16 60.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.476 -1.603 . . . . 0.0 108.945 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -108.6 25.62 18.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.41 7.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' THR . 35.7 m -143.94 165.56 27.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -1.114 . . . . 0.0 109.582 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 27.8 mt -66.51 -8.68 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 17.7 ttpt -95.08 -17.2 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 15.8 p30 -132.24 8.75 4.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.64 149.48 31.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.976 -1.077 . . . . 0.0 110.405 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.8 tp -100.61 93.45 5.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 203' ' ' THR . 44.2 t -85.43 131.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.828 0.823 . . . . 0.0 108.914 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' A' ' 211' ' ' VAL . 60.2 mt -123.25 161.7 24.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.556 -0.715 . . . . 0.0 109.464 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.82 -166.23 12.61 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -64.67 -29.55 70.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 110.051 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.28 24.23 0.63 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.999 . . . . 0.0 111.208 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -150.93 159.3 44.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.309 -1.494 . . . . 0.0 110.839 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 206' ' ' LEU . 43.1 t -104.36 111.86 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -54.83 -48.32 72.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.991 -1.068 . . . . 0.0 109.444 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.43 112.22 5.21 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -57.96 -19.84 41.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.823 1.682 . . . . 0.0 112.69 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.53 -15.49 61.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.056 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.67 -175.58 46.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.59 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.2 mt -84.84 144.26 28.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -76.15 -18.06 59.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 108.759 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.84 -170.26 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.191 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.73 -7.33 37.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.114 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.68 48.84 1.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.246 -0.909 . . . . 0.0 109.612 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.95 -45.47 98.94 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.321 -0.862 . . . . 0.0 110.548 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.2 Cg_exo -54.62 -55.7 3.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.329 2.019 . . . . 0.0 112.876 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 17.2 m -68.31 -39.73 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.883 -1.135 . . . . 0.0 111.749 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -68.89 -32.24 71.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.238 -1.539 . . . . 0.0 108.526 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.492 ' ND1' ' O ' ' A' ' 177' ' ' ALA . 21.8 t60 -66.47 -35.46 80.32 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -64.41 -35.04 79.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 166' ' ' PHE . 79.2 t -66.94 -35.67 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -68.21 -52.24 36.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.76 -30.8 71.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.816 . . . . 0.0 109.642 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.62 -32.44 58.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.135 -0.978 . . . . 0.0 108.755 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.78 -37.35 78.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.82 -55.96 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.555 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -54.36 -35.99 63.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.237 . . . . 0.0 108.936 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.0 mt -60.08 -23.13 63.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.474 -0.766 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.8 -21.77 61.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.043 -1.036 . . . . 0.0 108.659 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 60' ' ' THR . 79.6 mt -49.87 -4.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.641 -1.287 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -76.88 -17.25 59.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.974 -1.078 . . . . 0.0 109.861 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.481 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 100.23 2.17 55.78 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.943 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.47 153.91 10.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.42 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.91 128.54 30.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.013 1.809 . . . . 0.0 110.035 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 t -86.95 152.01 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 112.217 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -135.79 127.67 29.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.76 -158.37 27.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.486 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.4 ttmt -127.29 140.73 52.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 109.137 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.4 m-85 -138.91 140.69 38.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.059 -1.025 . . . . 0.0 110.394 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -124.3 132.58 53.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -129.59 136.1 49.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.062 . . . . 0.0 111.154 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 250' ' ' ARG . 39.3 t80 -117.33 116.81 27.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.1 mtt-85 45.03 48.16 9.53 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.055 -1.028 . . . . 0.0 108.516 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.29 143.94 24.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -124.33 160.96 18.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.404 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 76.6 m-70 -46.4 -36.34 6.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -1.22 . . . . 0.0 109.492 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -58.11 9.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 108.986 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.5 tp -59.14 -44.21 92.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 0.0 109.239 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.3 m-20 -47.63 -54.31 12.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.555 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.733 HG21 HG21 ' A' ' 56' ' ' THR . 74.9 t -61.0 -56.84 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.424 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.533 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -44.53 -49.68 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.96 . . . . 0.0 108.93 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.801 HD22 HG21 ' A' ' 139' ' ' ILE . 24.5 tp -54.09 -61.59 2.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.896 -1.128 . . . . 0.0 108.605 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 238' ' ' LEU . 23.8 t -47.2 -54.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -47.2 -52.83 14.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.345 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -59.1 -49.92 76.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.782 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 16.0 mt -53.15 -52.86 57.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.59 66.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.213 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 76.1 mt-10 -57.55 138.62 55.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.296 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 145.39 48.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.487 -0.758 . . . . 0.0 109.541 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -141.37 -173.95 3.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.9 m -96.19 135.69 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 0.0 109.212 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -66.49 -23.0 66.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.482 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 9.9 pt-20 -150.83 156.08 40.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 142.09 58.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 110.249 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -119.73 163.35 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 p -134.55 142.0 46.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.0 110.183 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 26' ' ' LEU . 96.8 m-85 -139.21 146.32 40.35 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -153.06 150.63 29.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.354 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.16 174.79 36.65 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.5 p -84.06 154.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.254 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -88.81 139.94 15.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.2 tt -60.82 -37.0 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -1.168 . . . . 0.0 110.558 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.579 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 78.0 m-70 -89.58 -51.72 5.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.631 -1.293 . . . . 0.0 111.396 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 p -70.0 -23.25 63.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.701 -0.624 . . . . 0.0 111.653 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.78 20.14 46.34 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.182 -1.485 . . . . 0.0 109.6 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -111.83 154.03 25.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -1.118 . . . . 0.0 109.563 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.24 135.59 42.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.169 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.3 m -139.37 144.52 38.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.03 . . . . 0.0 109.845 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.96 155.7 23.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.448 -0.782 . . . . 0.0 109.668 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.667 HD11 HG23 ' A' ' 96' ' ' ILE . 8.6 mt -135.74 148.26 48.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.58 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.9 mt -143.58 112.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 108.928 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.86 114.91 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.42 -0.8 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.58 ' NE2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -107.83 139.17 20.36 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 26.8 Cg_exo -52.82 168.23 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.849 1.699 . . . . 0.0 111.822 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.466 ' OE1' HG21 ' A' ' 35' ' ' THR . 20.1 mm-40 -142.23 174.74 10.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.541 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -85.91 155.11 21.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -49.62 146.95 3.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.961 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.426 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 71.03 -0.54 29.72 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.978 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.8 m -65.43 -42.39 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.556 -1.555 . . . . 0.0 109.481 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.787 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 93.6 -177.36 37.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mm -99.52 115.31 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -137.5 151.5 48.51 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.993 -1.067 . . . . 0.0 110.498 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.17 157.57 16.48 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -129.99 110.69 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.853 . . . . 0.0 108.995 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -134.69 133.81 40.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.596 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 48.38 34.31 4.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.59 -0.694 . . . . 0.0 111.59 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 17.04 80.26 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.472 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.89 120.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.105 . . . . 0.0 108.836 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 39.8 m-85 -86.84 129.14 35.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.187 -0.946 . . . . 0.0 109.734 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.43 96.97 50.48 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.647 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.25 146.43 31.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.229 1.953 . . . . 0.0 111.623 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -78.97 70.28 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.982 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 49' ' ' ARG . 6.7 mtt-85 -127.22 171.55 11.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 0.0 109.003 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -73.25 -49.17 29.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.591 ' OE1' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mp0 -43.53 -17.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.889 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.4 m-85 -97.89 2.96 49.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.208 . . . . 0.0 109.938 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 50' ' ' HIS . 66.9 t -74.06 129.07 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.372 -0.83 . . . . 0.0 108.781 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.74 -25.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.885 . . . . 0.0 110.281 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 t-80 -150.37 130.02 13.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.692 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.734 HG21 HG21 ' A' ' 257' ' ' VAL . 34.3 p -123.79 96.04 4.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.1 t-20 -158.42 128.49 5.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.5 m-70 46.54 13.12 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.89 152.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.796 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.8 m -96.24 128.16 42.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 55' ' ' HIS . 0.9 OUTLIER -120.28 148.67 43.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.652 0.739 . . . . 0.0 110.878 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 72' ' ' VAL . 10.8 mt -125.54 146.81 49.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.84 151.12 22.06 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.01 -1.567 . . . . 0.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -160.0 148.89 17.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.981 . . . . 0.0 109.145 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.09 26.39 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.858 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.53 -32.5 6.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -57.38 140.25 50.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.149 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 134.09 40.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.849 . . . . 0.0 110.305 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.53 120.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -100.94 157.11 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.046 . . . . 0.0 111.119 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.0 m 48.97 75.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 62' ' ' LEU . 22.7 m -107.72 -10.56 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 109.318 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.463 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.0 pm0 -60.79 -24.3 65.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.556 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.414 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -68.68 -68.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.126 -0.984 . . . . 0.0 109.232 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.1 tp -52.1 -48.11 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.7 mt -52.79 -46.92 67.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 22.5 t -61.91 -43.24 99.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.432 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.82 -46.76 83.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.021 -1.05 . . . . 0.0 109.071 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.39 -34.42 78.26 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -63.29 -34.78 78.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.631 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 171' ' ' GLU . 59.3 mt -81.6 -38.82 25.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 110.289 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 82' ' ' LEU . 63.7 mt -81.13 -0.39 39.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 0.0 110.005 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 61.53 39.84 14.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 111.383 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.81 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.698 -1.251 . . . . 0.0 108.026 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -123.73 -24.1 4.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 0.0 111.792 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.787 HD22 ' H ' ' A' ' 36' ' ' GLY . 27.7 m120 -123.84 107.18 11.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.917 -1.115 . . . . 0.0 110.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -164.35 148.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 110.468 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 99.3 m -115.54 113.04 23.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.481 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -95.36 100.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.184 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' O ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -73.6 126.73 30.95 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.54 128.21 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.98 0.895 . . . . 0.0 111.895 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.81 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.11 -159.78 27.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 -11.3 10.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.25 149.88 41.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.995 -1.066 . . . . 0.0 109.535 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.667 HG23 HD11 ' A' ' 26' ' ' LEU . 43.9 mm -72.96 120.93 83.56 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -40.51 120.45 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.782 1.655 . . . . 0.0 111.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.8 tp -76.62 -14.21 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.913 . . . . 0.0 110.476 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 mt 56.84 -118.43 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.029 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.86 6.75 47.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.23 59.48 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 p -128.76 -172.25 2.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.666 -0.902 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.3 15.2 9.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 2.7 t-105 -57.59 -42.44 83.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.272 -1.134 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.11 -57.2 9.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 110.122 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.42 -46.33 62.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.09 -54.08 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 0.0 110.821 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 2.9 mm-40 -60.44 -43.76 96.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.02 . . . . 0.0 111.53 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.67 -56.91 8.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.252 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.73 -32.83 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.158 -0.963 . . . . 0.0 109.383 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER -64.18 -42.72 96.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.6 13.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 110.041 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' OE2' ' A' ' 9' ' ' GLU . 15.7 m-80 -144.58 33.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 0.0 110.336 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 82' ' ' LEU . 66.2 mt -79.81 138.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.28 123.35 29.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.23 148.3 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.62 -171.82 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -111.67 69.0 0.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -165.32 130.92 2.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.003 -1.061 . . . . 0.0 109.691 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.53 144.46 53.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.528 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.16 149.37 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.568 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -93.09 78.17 4.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.4 m-85 -58.1 140.67 52.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 109.409 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -88.87 101.44 14.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 243' ' ' LYS . 41.0 t -92.68 134.3 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.528 0.68 . . . . 0.0 110.772 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.52 116.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.42 -27.01 16.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.528 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -130.74 149.76 74.53 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.15 150.0 41.91 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.589 2.192 . . . . 0.0 112.017 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 1.4 tt -157.37 151.01 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 142.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 0.0 109.513 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.93 145.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -133.25 156.72 47.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.002 . . . . 0.0 110.459 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -166.04 98.91 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.485 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 46.02 65.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 110.848 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.2 -38.02 3.0 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.89 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.9 mtt85 -65.44 133.67 51.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.862 -1.375 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.734 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.7 tt -146.58 138.92 24.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.053 -1.029 . . . . 0.0 109.973 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 255' ' ' LEU . 69.2 mt -135.57 125.87 42.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.458 -0.776 . . . . 0.0 109.523 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -114.3 133.44 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.532 0.682 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.29 133.61 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.08 151.56 48.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.787 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -50.14 143.23 25.94 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.382 2.055 . . . . 0.0 113.392 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.41 145.78 20.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -68.61 -5.01 17.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 110.488 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 p -148.45 -175.24 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.069 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.2 tp -98.32 120.06 38.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.084 -1.01 . . . . 0.0 108.702 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.404 ' N ' HD12 ' A' ' 147' ' ' LEU . 38.4 tt0 -137.27 122.84 19.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 108.553 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 231' ' ' LEU . 76.7 t -122.37 122.58 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.723 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -113.52 152.22 30.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -139.64 130.47 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.964 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.56 129.95 54.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.53 141.2 12.52 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.266 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -105.64 104.11 13.77 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -93.65 166.95 11.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -14.89 17.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.734 . . . . 0.0 110.485 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 159' ' ' LEU . 29.9 p-10 -93.96 -171.38 2.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.869 -1.144 . . . . 0.0 110.265 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -52.91 3.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.449 -0.782 . . . . 0.0 111.704 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.9 mt -83.35 -29.36 28.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.321 -1.487 . . . . 0.0 109.06 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.43 -140.67 36.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 134.41 38.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -1.145 . . . . 0.0 109.491 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.03 148.72 45.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -141.26 145.05 35.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.934 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -144.63 139.34 27.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.7 m -109.78 124.63 51.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 110.156 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.537 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.5 t80 -104.08 113.07 26.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.273 -0.892 . . . . 0.0 109.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.53 156.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -50.86 133.12 26.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.266 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.83 3.76 60.62 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 170' ' ' ASN . 3.4 m-20 -117.53 20.25 13.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 109.153 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -55.89 -56.57 18.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.291 -0.881 . . . . 0.0 110.017 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 171' ' ' GLU . 1.8 mt-10 -42.52 -25.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.545 ' O ' ' CZ ' ' A' ' 225' ' ' ARG . 12.5 mt-10 -80.74 -7.85 59.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 111.924 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.74 -25.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.663 -1.273 . . . . 0.0 111.817 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 175' ' ' VAL . 4.5 m -62.77 -15.88 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.456 -1.403 . . . . 0.0 109.175 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.4 mt -92.27 -6.43 50.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.46 -0.775 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.448 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -67.43 116.19 7.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.173 -0.954 . . . . 0.0 108.847 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.507 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 74.5 mtm180 -77.57 172.84 12.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.516 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 t -77.25 162.28 27.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -146.81 149.07 32.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.21 -1.556 . . . . 0.0 111.493 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.06 43.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -98.97 146.97 25.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.537 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.11 -38.11 16.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.488 -0.757 . . . . 0.0 109.86 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -72.29 -28.9 63.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.827 -1.171 . . . . 0.0 109.605 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.0 mt-10 -71.93 -39.9 69.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.638 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 25.6 mt -47.37 -59.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.553 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 7.7 tp10 -41.81 -40.02 1.94 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.514 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 189' ' ' ILE . 13.3 t-160 -75.28 -60.89 2.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 108.887 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 188' ' ' HIS . 93.7 mt -41.85 -32.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.625 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -80.13 -52.07 8.22 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.764 -1.21 . . . . 0.0 109.193 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -48.17 -40.05 22.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 110.518 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.0 8.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.036 . . . . 0.0 110.522 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.74 39.65 54.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 194' ' ' LEU . 69.3 mt -129.64 172.81 11.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -1.111 . . . . 0.0 109.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.65 20.57 56.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -57.56 -20.55 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.365 -1.668 . . . . 0.0 109.878 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.431 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.55 25.18 11.33 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.22 129.38 9.64 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.99 -1.3 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -143.88 172.75 12.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 109.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.9 mt -71.26 -7.8 49.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -99.35 -11.54 21.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.442 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 17.0 p30 -133.53 8.49 3.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 109.999 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.1 m -150.28 151.52 33.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.0 tp -99.5 93.93 6.14 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -85.34 128.96 38.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.832 0.825 . . . . 0.0 109.119 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 211' ' ' VAL . 15.6 mt -123.53 162.81 22.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.615 -0.678 . . . . 0.0 109.289 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.33 -166.73 13.03 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.77 71.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.491 -1.005 . . . . 0.0 109.458 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.83 21.66 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -147.58 155.88 42.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.64 -1.287 . . . . 0.0 110.355 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 206' ' ' LEU . 51.3 t -105.82 114.56 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -57.97 -47.02 84.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.046 -1.034 . . . . 0.0 109.904 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.86 121.83 61.12 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.139 -0.976 . . . . 0.0 109.768 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.87 -16.22 45.29 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.437 1.424 . . . . 0.0 111.794 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -15.12 59.54 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.63 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.47 -170.32 50.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.617 ' CD2' HD11 ' A' ' 204' ' ' LEU . 6.3 mt -86.78 131.12 34.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -1.213 . . . . 0.0 109.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -63.15 -17.78 62.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.122 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CD2' ' CZ ' ' A' ' 225' ' ' ARG . 62.3 m-85 -144.73 -168.88 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -100.65 -0.24 37.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.247 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 30.49 1.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.034 -1.041 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 mt-10 -46.26 -51.17 35.35 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.026 -1.047 . . . . 0.0 110.013 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 76.4 Cg_exo -47.4 -68.01 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.118 1.878 . . . . 0.0 112.278 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.4 m -57.33 -34.84 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.963 -1.086 . . . . 0.0 109.991 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' CZ ' ' CD2' ' A' ' 219' ' ' TYR . 5.0 mtp180 -60.53 -42.85 97.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 108.381 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 6.9 t60 -65.78 -33.02 74.9 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.88 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 166' ' ' PHE . 51.9 t -69.75 -36.77 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.531 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.4 t80 -65.98 -48.82 69.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.562 -0.711 . . . . 0.0 109.147 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -65.0 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.804 . . . . 0.0 109.776 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.412 HD23 ' CG1' ' A' ' 149' ' ' VAL . 52.5 tp -75.02 -31.77 61.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.84 -39.37 81.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.95 -54.79 19.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.36 -35.62 67.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.055 -1.262 . . . . 0.0 109.279 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 235' ' ' LEU . 12.1 mt -61.11 -22.79 64.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 110.414 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.8 -22.28 60.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.164 . . . . 0.0 109.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.9 mt -50.93 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.639 -1.288 . . . . 0.0 110.6 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.2 mt -77.46 -14.85 59.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.831 -1.168 . . . . 0.0 109.643 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.78 57.67 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.563 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.16 155.07 10.23 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.374 . . . . 0.0 108.937 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.1 Cg_endo -50.02 151.02 9.25 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.825 1.684 . . . . 0.0 109.566 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.43 140.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 112.044 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.493 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.3 mmtp -121.86 119.12 30.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.9 -163.56 30.95 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.142 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.514 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -123.77 141.64 51.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -1.032 . . . . 0.0 109.078 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -139.6 139.64 36.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -127.02 118.38 24.35 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 133.83 53.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.005 -1.059 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -115.47 112.16 21.84 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.36 28.68 2.44 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.61 149.13 42.99 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -121.78 -174.2 14.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.463 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.2 m-70 -63.74 -41.38 98.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.094 . . . . 0.0 109.741 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -58.63 6.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.032 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.532 HD23 HG13 ' A' ' 139' ' ' ILE . 5.7 tp -55.29 -45.07 76.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.202 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 22.2 m-20 -47.73 -51.56 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.432 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.734 HG21 HG21 ' A' ' 56' ' ' THR . 90.8 t -63.18 -42.27 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -61.41 -52.86 62.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -50.34 -49.63 53.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.091 -1.006 . . . . 0.0 108.423 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.54 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.1 t -58.03 -52.18 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -50.76 -49.52 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -61.54 -51.24 69.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.791 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.98 -48.45 75.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 109.738 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.34 71.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 109.801 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 108.954 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 121' ' ' ILE . 84.2 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.288 0.566 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.596 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -53.18 129.02 29.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -120.91 142.07 50.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.182 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 t -141.94 -170.57 3.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.66 136.45 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -62.85 -20.48 65.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -152.15 -171.12 3.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.222 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 142.14 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.09 160.23 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.14 145.2 41.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.996 -1.065 . . . . 0.0 110.698 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 73.3 m-85 -139.83 155.09 47.43 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.05 151.69 19.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.809 -1.182 . . . . 0.0 110.319 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.43 174.77 36.1 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.85 151.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 110.128 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.63 137.98 16.38 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.0 tt -58.95 -39.06 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.105 -1.232 . . . . 0.0 110.452 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' ILE . 79.8 m-70 -90.74 -50.65 5.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.724 -1.235 . . . . 0.0 110.966 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -70.31 -22.68 62.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.68 -0.638 . . . . 0.0 111.091 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.75 17.48 21.22 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.686 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -105.26 151.25 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -1.151 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -74.77 132.87 41.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.177 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 145.31 40.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 5.7 ttmt -113.02 156.42 23.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -133.4 147.01 51.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.594 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.2 mt -141.38 108.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.917 . . . . 0.0 108.738 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.25 115.44 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 111.122 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.594 ' NE2' HG22 ' A' ' 27' ' ' ILE . 33.3 m-70 -111.12 139.81 22.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.578 -0.701 . . . . 0.0 109.689 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -52.57 168.33 0.46 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.048 1.832 . . . . 0.0 111.854 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 16.4 mm-40 -141.02 -178.97 5.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.162 -0.961 . . . . 0.0 109.798 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.6 mttm -89.45 154.4 20.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -47.62 142.46 4.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.329 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.11 11.22 63.44 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.466 -0.874 . . . . 0.0 110.949 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -72.02 -44.87 62.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.605 -1.526 . . . . 0.0 109.752 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -179.88 33.77 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.379 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mm -95.67 117.97 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 148.24 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.86 158.87 15.5 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -129.9 110.58 11.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 0.0 108.874 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.536 ' NZ ' ' H ' ' A' ' 93' ' ' GLY . 64.6 tttp -135.06 134.6 40.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 110.737 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.05 29.52 10.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.784 . . . . 0.0 111.341 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.56 17.27 77.94 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.355 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -1.126 . . . . 0.0 109.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -83.66 127.36 33.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.0 mt -115.48 93.81 37.76 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 109.436 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.55 145.8 16.07 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.412 2.075 . . . . 0.0 111.948 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -89.38 79.76 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -134.18 -179.89 5.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -74.99 -55.25 5.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 110.01 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 33.4 mt-10 -43.55 -17.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.795 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' HIS . 35.5 m-85 -95.17 0.62 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.884 -1.135 . . . . 0.0 110.104 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.8 t -68.48 129.46 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.415 -0.803 . . . . 0.0 109.173 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -112.38 -29.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.322 -0.861 . . . . 0.0 109.977 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -152.26 132.98 14.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.036 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 HG21 ' A' ' 257' ' ' VAL . 47.8 p -123.65 95.46 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 59' ' ' SER . 47.7 t-20 -162.95 129.21 3.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 108.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 84.6 m-70 48.97 10.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.056 -1.027 . . . . 0.0 108.711 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 163.0 157.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.9 m -102.86 127.76 49.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -121.33 152.37 39.05 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 111.024 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.9 mt -128.14 152.18 48.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.31 151.86 21.96 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 118.824 -1.655 . . . . 0.0 110.956 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CD2' ' CD ' ' A' ' 65' ' ' LYS . 9.4 t80 -156.51 146.29 20.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -1.03 . . . . 0.0 109.676 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CD ' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 54.73 21.79 3.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.528 -0.732 . . . . 0.0 109.638 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.88 8.17 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.96 145.24 55.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.318 . . . . 0.0 109.343 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.91 142.86 34.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 110.333 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.13 125.94 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -100.21 156.67 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.081 . . . . 0.0 111.217 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m 49.27 73.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.071 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 34.4 m -107.78 -8.46 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 108.957 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.4 pm0 -61.02 -26.66 67.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.599 -0.688 . . . . 0.0 110.539 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.1 m170 -68.07 -68.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.941 -1.099 . . . . 0.0 109.46 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -52.14 -47.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.605 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.2 mt -53.4 -48.33 68.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.461 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.6 t -59.66 -41.99 91.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.058 -1.026 . . . . 0.0 110.244 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.8 -44.02 89.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 109.168 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.29 -34.92 79.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -62.91 -38.88 92.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 171' ' ' GLU . 50.2 mt -75.72 -38.07 58.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 114' ' ' ILE . 80.7 mt -83.22 -1.46 53.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.978 . . . . 0.0 109.891 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.453 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 41.5 mt-10 55.75 42.24 29.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.385 -0.822 . . . . 0.0 111.121 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 5' ' ' LYS . 46.0 mm -84.87 141.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.946 -1.096 . . . . 0.0 108.096 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 121' ' ' ILE . 72.5 p -123.79 -23.71 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 0.0 112.027 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.675 ' O ' HG13 ' A' ' 87' ' ' VAL . 80.4 m-20 -125.98 107.66 10.66 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.698 -1.251 . . . . 0.0 110.688 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.5 m -162.95 149.14 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.829 0.824 . . . . 0.0 110.442 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 45.2 m -116.71 113.77 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.497 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.7 mt -96.65 100.92 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.467 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 11.7 mt-10 -70.24 124.57 24.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 44.2 t -107.96 119.0 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.587 0.708 . . . . 0.0 111.507 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mt -108.85 93.38 2.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.536 ' H ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.63 160.52 8.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -81.05 -5.55 57.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.914 -1.345 . . . . 0.0 111.091 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -142.06 149.11 39.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.602 -1.311 . . . . 0.0 110.276 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 26' ' ' LEU . 46.4 mm -73.89 121.82 86.1 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -41.52 127.81 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.585 1.523 . . . . 0.0 111.282 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.408 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -81.76 -15.94 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.879 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.8 mt 58.1 -120.62 1.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.12 -0.988 . . . . 0.0 110.081 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 46.4 t0 -97.49 5.81 49.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.62 60.11 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.384 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.4 p -127.86 -172.62 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.896 . . . . 0.0 109.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.1 15.83 10.14 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.533 ' HB2' HD22 ' A' ' 176' ' ' LEU . 6.1 t-105 -60.26 -43.56 96.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.48 -1.012 . . . . 0.0 110.317 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.71 -58.59 6.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.024 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.29 -45.16 62.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -61.9 -49.29 76.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 111.22 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CD ' ' CH2' ' A' ' 104' ' ' TRP . 1.6 mm-40 -65.5 -42.36 92.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.019 -1.05 . . . . 0.0 111.236 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.92 -54.2 24.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.017 -1.052 . . . . 0.0 110.286 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.29 -32.56 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -64.42 -42.55 95.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -76.16 12.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.74 32.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.165 . . . . 0.0 110.545 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 HD22 ' A' ' 82' ' ' LEU . 77.5 mt -80.32 138.96 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.932 -1.105 . . . . 0.0 110.265 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.52 125.53 34.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.546 -0.721 . . . . 0.0 109.157 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -78.27 145.42 35.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.352 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -115.06 -173.53 2.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.688 -0.632 . . . . 0.0 109.404 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.55 65.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.293 -0.879 . . . . 0.0 111.268 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.502 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -161.49 129.31 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 0.0 109.043 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -68.38 141.1 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 109.163 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 3' ' ' LEU . 85.4 mt -82.16 147.77 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 110.427 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -95.66 84.12 3.88 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 55.1 m-85 -62.82 143.93 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -90.43 101.96 14.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 243' ' ' LYS . 55.1 t -93.05 133.62 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.699 . . . . 0.0 111.193 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.47 115.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -98.78 -26.81 14.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 110.576 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.02 148.43 65.72 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.36 148.35 38.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.493 2.129 . . . . 0.0 111.899 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.29 152.27 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.957 . . . . 0.0 109.363 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.83 146.45 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.212 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.18 147.09 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -135.19 162.63 31.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.984 -1.072 . . . . 0.0 110.515 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -173.9 103.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 50.58 58.66 5.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 110.725 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.44 -32.59 2.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.517 HH21 ' H ' ' A' ' 252' ' ' GLY . 42.7 mtp180 -61.91 134.12 56.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.245 . . . . 0.0 108.26 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -146.1 137.79 24.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.77 -1.206 . . . . 0.0 110.446 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.727 HG21 HD22 ' A' ' 259' ' ' LEU . 79.6 mt -135.62 131.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.476 -0.765 . . . . 0.0 109.353 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -121.37 131.09 53.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.369 0.604 . . . . 0.0 109.839 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.88 134.62 54.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 151.07 47.31 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.131 -0.981 . . . . 0.0 109.659 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.71 143.27 12.87 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.481 2.121 . . . . 0.0 113.22 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.407 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -157.32 147.08 20.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.61 -6.6 26.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -148.66 178.68 8.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.942 -1.098 . . . . 0.0 109.741 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.4 tp -91.98 120.8 32.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.996 . . . . 0.0 108.709 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 167' ' ' VAL . 2.0 tt0 -135.73 129.72 33.07 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.4 t -129.87 120.73 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.507 ' OG1' HG23 ' A' ' 165' ' ' THR . 47.6 m -112.3 152.29 28.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.461 -0.774 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 228' ' ' VAL . 38.8 t80 -139.46 130.74 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.176 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.444 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 23.2 tt0 -120.84 130.36 53.92 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.22 137.79 9.57 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.465 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -103.06 100.14 10.06 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.21 166.93 13.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.008 . . . . 0.0 110.833 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -99.67 -18.56 17.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.563 -0.711 . . . . 0.0 110.652 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.4 p-10 -92.3 -170.0 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.227 . . . . 0.0 110.22 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -52.77 0.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 111.398 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.1 mt -79.02 -28.01 43.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.401 -1.437 . . . . 0.0 108.734 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.66 -138.48 33.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -101.93 134.64 44.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.233 -1.157 . . . . 0.0 109.671 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -138.53 151.72 47.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -141.09 144.8 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.76 135.29 27.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.507 HG23 ' OG1' ' A' ' 150' ' ' THR . 57.3 m -105.03 121.93 44.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.698 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.7 t80 -102.66 113.12 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.449 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.9 t -104.22 148.75 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.767 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -49.36 131.26 20.35 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.261 -0.899 . . . . 0.0 109.026 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.7 -3.63 39.33 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 1.3 m-20 -114.6 24.46 11.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 0.0 109.183 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 81' ' ' LEU . 1.1 mt-10 -50.87 -56.48 12.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.293 -0.88 . . . . 0.0 109.882 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -44.62 -23.45 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.306 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' GLU . 6.6 mt-10 -83.24 -12.72 56.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 111.537 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.9 pt -121.44 -28.26 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.862 -1.149 . . . . 0.0 111.2 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.1 m -63.66 -27.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.556 -1.34 . . . . 0.0 109.395 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -78.52 -6.0 54.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.66 24.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.684 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.475 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -88.71 172.17 9.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -78.57 162.32 26.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.55 146.07 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.125 -1.609 . . . . 0.0 111.836 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.5 157.72 44.1 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.453 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 77.3 m-85 -100.96 147.77 25.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.414 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 22.8 p30 -54.23 -33.29 58.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 110.022 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.551 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 7.0 p90 -72.35 -28.76 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.818 -1.176 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.525 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -81.84 -37.33 27.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.099 -1.001 . . . . 0.0 109.985 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 183' ' ' ASP . 94.3 mt -45.53 -59.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.966 -1.084 . . . . 0.0 109.475 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 14.9 tt0 -41.32 -39.4 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 109.763 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.507 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.7 t-160 -73.94 -44.38 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.769 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 98.2 mt -57.72 -27.59 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.555 -0.716 . . . . 0.0 109.579 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -84.67 -53.59 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.883 -1.136 . . . . 0.0 109.317 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -49.24 -42.48 40.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.1 m -75.68 6.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.978 -1.076 . . . . 0.0 110.294 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.41 39.65 50.32 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 55.0 mt -128.77 172.09 11.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.225 -1.162 . . . . 0.0 109.855 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 62.41 20.79 61.53 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -54.17 -21.51 9.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.636 -1.508 . . . . 0.0 109.85 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -115.35 25.8 9.56 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.07 124.31 7.1 Favored Glycine 0 N--CA 1.491 2.362 0 O-C-N 120.819 -1.401 . . . . 0.0 109.703 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.28 172.74 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.8 mt -69.13 -7.91 40.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 6.2 mmmt -91.58 -12.17 35.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.832 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -143.46 13.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.917 -1.114 . . . . 0.0 110.421 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -148.39 149.65 32.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.857 -1.152 . . . . 0.0 110.82 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.445 HD21 HD22 ' A' ' 217' ' ' LEU . 26.0 tp -99.11 93.51 6.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.436 HG23 HG22 ' A' ' 203' ' ' THR . 47.5 t -86.81 129.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.868 0.842 . . . . 0.0 109.336 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.26 164.76 18.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.19 -166.45 12.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -26.44 68.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.499 -1.0 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.64 21.89 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -143.33 150.82 39.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.755 -1.215 . . . . 0.0 110.518 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.26 111.72 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -57.79 -51.37 69.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 110.236 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -57.62 111.66 3.75 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -58.36 -11.77 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.699 1.599 . . . . 0.0 111.772 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -17.28 59.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 110.2 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.7 -177.79 46.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.9 mt -88.81 143.28 27.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.767 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.596 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 37.1 mtp85 -73.46 -20.01 60.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.602 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 17.2 m-85 -146.83 169.81 18.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -82.28 10.77 6.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 38.11 0.49 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.407 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -55.08 -47.42 98.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.94 -1.1 . . . . 0.0 109.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 54.3 Cg_exo -50.53 -65.37 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.3 m -58.7 -36.34 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.602 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 60.7 mtt180 -60.48 -42.85 97.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.2 t60 -66.42 -32.48 73.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.355 -0.841 . . . . 0.0 108.964 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -65.66 -35.49 80.93 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.6 t -68.64 -36.73 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.461 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 61.6 t80 -65.24 -52.6 53.48 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.93 -29.7 70.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.842 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 149' ' ' VAL . 58.7 tp -74.79 -32.85 62.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.029 -1.044 . . . . 0.0 108.536 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.53 -40.85 85.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.41 -53.92 32.72 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.459 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 24.7 m-20 -56.79 -30.57 63.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.062 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.5 mt -67.11 -24.44 65.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 110.481 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.66 -22.36 60.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.813 -1.18 . . . . 0.0 109.095 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.2 mt -49.16 -6.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.516 -1.365 . . . . 0.0 110.063 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.4 mt -72.28 -16.12 61.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.908 -1.12 . . . . 0.0 109.63 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.63 2.24 60.04 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.794 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.39 153.88 9.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.779 -1.424 . . . . 0.0 108.984 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -49.34 150.5 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.787 1.658 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.48 148.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.009 -1.057 . . . . 0.0 111.861 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.439 ' HB2' HG22 ' A' ' 125' ' ' VAL . 29.2 mmtt -128.92 122.95 31.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.34 -163.86 31.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 144' ' ' SER . 10.3 ttpt -126.07 139.62 53.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 109.652 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 35.1 m-85 -136.4 139.43 42.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.444 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 56.8 t80 -126.19 125.36 42.31 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.3 m -120.36 136.77 54.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 0.0 111.579 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -118.28 113.14 21.02 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 47.59 47.35 17.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.13 150.57 23.95 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 137' ' ' ARG . . . -122.66 178.53 16.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.459 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.9 m-70 -61.92 -38.26 87.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -1.19 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 11.0 m -60.08 -60.01 4.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.023 -1.048 . . . . 0.0 109.004 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.613 ' HG ' HD12 ' A' ' 139' ' ' ILE . 24.4 tp -52.0 -47.59 64.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.09 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 19.7 m-20 -48.02 -50.9 26.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 56' ' ' THR . 73.9 t -60.84 -54.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.997 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.474 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -50.8 -45.33 59.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.668 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.727 HD22 HG21 ' A' ' 139' ' ' ILE . 13.9 tp -54.12 -55.44 27.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.02 . . . . 0.0 108.56 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.2 t -56.81 -55.32 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.077 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 260' ' ' VAL . 0.1 OUTLIER -44.95 -48.51 11.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.1 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.22 -52.76 63.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.403 -0.811 . . . . 0.0 109.485 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.09 -50.09 59.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.28 -27.03 63.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.507 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 110.663 -178.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.6 mt . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -52.5 142.27 18.19 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -123.05 144.73 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.33 -170.55 3.3 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.9 m -98.49 136.63 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.89 -1.131 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -67.57 -19.68 65.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 110.078 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -154.23 156.33 36.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 138.06 58.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 109.809 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -118.77 163.99 16.05 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.48 142.23 48.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.91 150.18 46.85 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 9.6 pt-20 -158.91 151.28 21.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.926 -1.109 . . . . 0.0 109.923 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.55 173.66 35.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.44 148.34 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.232 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.67 137.07 16.21 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' A' ' 98' ' ' ILE . 10.1 tt -59.09 -37.84 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.052 -1.263 . . . . 0.0 110.298 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.429 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 70.5 m-70 -88.85 -50.17 6.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.687 -1.258 . . . . 0.0 110.925 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 p -69.69 -20.76 63.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 111.544 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.36 12.88 6.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.15 156.61 18.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -1.018 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.447 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 67.4 t80 -74.39 135.11 42.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -138.41 144.09 40.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.88 155.16 24.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG23 ' A' ' 96' ' ' ILE . 9.0 mt -135.87 146.41 47.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.35 -0.844 . . . . 0.0 109.953 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.509 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 mt -141.43 112.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 108.638 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.91 113.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 110.466 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.7 m-70 -107.47 137.72 19.74 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.0 Cg_exo -54.77 168.73 1.02 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.685 1.59 . . . . 0.0 111.515 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 35' ' ' THR . 77.6 mm-40 -141.04 176.09 9.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.955 . . . . 0.0 109.769 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 18.6 mmtp -87.08 155.18 20.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -46.46 141.69 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.769 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 70.85 9.2 65.54 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.27 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.752 ' H ' HD22 ' A' ' 86' ' ' ASN . 53.5 m -71.53 -44.16 65.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.476 -1.602 . . . . 0.0 109.461 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.28 -179.87 35.1 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.512 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 mm -97.69 115.63 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -139.92 154.45 47.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.914 -1.116 . . . . 0.0 110.333 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -102.79 158.36 16.32 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -129.68 111.73 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.296 -0.878 . . . . 0.0 108.981 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -135.41 134.75 40.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.839 . . . . 0.0 110.621 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.495 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.7 m120 50.37 32.74 6.67 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 111.47 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 17.39 79.95 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.427 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -123.22 120.94 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.055 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -82.41 126.81 32.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.443 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.42 92.07 31.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.458 -0.777 . . . . 0.0 109.201 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.81 146.14 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.502 2.135 . . . . 0.0 112.287 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.35 70.24 10.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -122.86 166.89 14.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 109.448 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.6 p-80 -68.94 -53.85 18.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.618 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -44.99 -16.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' HIS . 41.1 m-85 -95.44 3.4 54.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 50' ' ' HIS . 69.1 t -70.47 129.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 108.719 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.53 -29.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.841 . . . . 0.0 110.225 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.12 131.53 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.74 HG21 HG21 ' A' ' 257' ' ' VAL . 45.9 p -123.18 95.12 4.48 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.568 ' ND2' ' CD2' ' A' ' 58' ' ' HIS . 1.1 t-20 -163.33 130.68 3.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.568 ' CD2' ' ND2' ' A' ' 57' ' ' ASN . 73.7 m-70 50.46 8.8 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.041 -1.037 . . . . 0.0 108.848 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.9 157.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.54 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 36.2 m -100.55 127.71 46.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 109.254 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.78 151.85 41.23 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.799 0.809 . . . . 0.0 111.171 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.4 mt -126.42 151.21 48.01 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.37 156.56 28.4 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.568 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -164.7 151.89 11.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -1.069 . . . . 0.0 109.273 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 53.1 21.66 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.256 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.09 7.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.495 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 85.7 mm-40 -60.64 148.15 39.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -1.209 . . . . 0.0 109.451 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' NH1' HD21 ' A' ' 94' ' ' ASN . 9.6 ttp-105 -144.48 140.81 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.478 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.82 126.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HD2' HH21 ' A' ' 68' ' ' ARG . 15.1 mtpp -101.47 156.19 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.898 -1.126 . . . . 0.0 111.299 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.2 m 50.93 74.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.4 m -108.2 -10.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.579 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.34 -28.56 69.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -64.8 -68.88 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.886 -1.134 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.39 -48.12 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.12 -0.987 . . . . 0.0 109.28 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.623 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.1 mt -50.88 -50.3 57.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.953 -1.092 . . . . 0.0 110.286 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 9.4 t -60.48 -42.81 97.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 110.164 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.71 -45.32 79.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.4 mt -68.16 -35.0 77.35 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.082 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.1 -31.77 72.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.848 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 171' ' ' GLU . 72.2 mt -83.34 -36.92 24.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 107' ' ' TYR . 87.3 mt -80.29 4.44 17.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.733 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 53.8 38.76 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.957 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.0 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 121' ' ' ILE . 72.6 p -126.13 -18.9 4.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.181 -0.949 . . . . 0.0 111.762 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.769 HD21 ' H ' ' A' ' 34' ' ' GLY . 3.0 m120 -126.98 107.9 10.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.843 -1.161 . . . . 0.0 110.956 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.7 m -163.95 148.18 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.377 -0.827 . . . . 0.0 109.971 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 27.9 m -117.06 110.04 17.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.526 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -94.08 103.73 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.6 tt0 -77.33 127.51 32.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.41 128.99 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.98 0.895 . . . . 0.0 111.734 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mm -112.2 95.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.44 -155.83 24.89 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.474 HD21 ' NH1' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -120.18 -10.45 9.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -1.107 . . . . 0.0 110.13 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -141.06 149.91 42.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.926 -1.109 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.697 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -72.68 121.66 85.52 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 109.182 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -41.15 127.26 2.83 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.641 1.561 . . . . 0.0 111.175 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -81.27 -12.61 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.5 mt 55.25 -121.15 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.4 9.32 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.927 -1.108 . . . . 0.0 111.192 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.49 -2.98 65.5 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.242 -1.456 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -172.09 2.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.625 -0.926 . . . . 0.0 109.628 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.1 15.72 12.11 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -56.39 -43.83 79.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -1.088 . . . . 0.0 110.232 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -57.46 8.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.089 -1.007 . . . . 0.0 110.143 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -51.68 -47.95 63.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 109.871 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 82' ' ' LEU . 57.9 t80 -61.59 -49.18 77.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 111.214 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.92 -43.02 89.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 111.368 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.77 -54.95 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.939 -1.101 . . . . 0.0 110.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.1 mt -63.45 -34.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 109.477 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -62.81 -41.72 99.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -78.07 12.83 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.822 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -142.54 31.17 1.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.971 -1.08 . . . . 0.0 110.327 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.3 mt -80.05 138.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 110.478 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 8' ' ' LYS . 8.3 tp -129.76 122.49 28.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 147.86 42.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.93 -174.87 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -110.62 66.36 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.137 -0.977 . . . . 0.0 111.222 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.4 129.52 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.865 -1.147 . . . . 0.0 109.379 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.42 141.55 56.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.783 -1.198 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 85' ' ' THR . 85.4 mt -84.2 150.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 110.266 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -97.46 81.89 3.03 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 31.2 m-85 -59.33 142.04 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -88.06 101.3 13.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.01 132.65 35.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.412 0.625 . . . . 0.0 110.643 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.93 111.17 2.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.56 -31.67 26.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.02 -1.05 . . . . 0.0 110.323 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 155.47 75.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.627 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.05 153.5 57.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.529 2.153 . . . . 0.0 112.103 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 tt -159.59 153.07 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -0.789 . . . . 0.0 109.273 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.36 141.89 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.92 150.05 33.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -135.76 158.93 43.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.61 106.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.929 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.9 51.55 15.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.25 3.32 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.146 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -61.61 137.4 58.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.963 -1.316 . . . . 0.0 108.639 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.9 tt -145.03 138.11 26.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 110.251 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 259' ' ' LEU . 48.3 mt -134.97 132.54 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.569 -0.707 . . . . 0.0 109.556 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -121.39 130.82 53.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.696 -0.628 . . . . 0.0 109.948 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.06 137.14 54.92 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -149.28 149.63 29.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.47 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 40.6 Cg_exo -47.74 143.73 12.26 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.491 2.127 . . . . 0.0 113.572 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.405 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -156.4 144.32 19.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -62.85 -5.4 2.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.61 -178.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 145' ' ' ASP . 12.6 p -154.04 -174.89 5.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 109.628 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.1 tp -93.76 122.04 35.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.132 -0.98 . . . . 0.0 108.933 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 mt-10 -135.86 126.63 27.38 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.1 t -129.82 123.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 m -113.68 152.62 30.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.684 -0.635 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -138.95 131.78 29.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.123 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -120.91 135.23 55.24 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 137.06 8.59 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.633 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.81 97.91 7.99 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.95 167.09 16.22 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 110.937 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -100.01 -15.25 18.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.6 p-10 -95.01 -168.18 1.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.125 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -57.16 2.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -0.787 . . . . 0.0 111.296 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.5 mt -79.03 -26.63 43.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.455 -1.403 . . . . 0.0 108.28 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.3 -137.53 37.68 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 131.25 45.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.4 -1.059 . . . . 0.0 109.295 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.22 146.23 44.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -0.792 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HZ2' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -142.26 148.01 37.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.371 -0.83 . . . . 0.0 110.366 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -146.53 140.39 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 110.044 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.1 m -107.21 123.41 48.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 109.732 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.462 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.4 t80 -103.06 112.8 25.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.902 . . . . 0.0 110.312 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.69 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.875 . . . . 0.0 109.673 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -48.16 134.38 14.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.413 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 107.58 -9.12 37.86 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -120.84 26.43 9.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.8 OUTLIER -68.25 -16.01 63.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.74 -8.84 57.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 0.0 109.894 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -106.15 -5.5 19.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.37 -33.38 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.32 -0.862 . . . . 0.0 109.632 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 171' ' ' GLU . 14.4 m -64.11 -23.67 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 108.395 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.75 -7.2 59.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.421 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.05 119.47 12.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -80.62 173.01 13.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 109.514 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.5 t -77.18 162.01 27.74 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -148.25 141.65 25.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.312 -1.492 . . . . 0.0 111.71 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -139.32 156.72 46.84 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -98.2 143.64 28.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.264 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.3 t0 -47.7 -35.32 9.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -0.85 . . . . 0.0 109.59 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.545 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -73.13 -29.87 63.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.883 -1.136 . . . . 0.0 109.681 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.545 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 4.6 tt0 -75.38 -41.21 56.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.447 ' O ' ' C ' ' A' ' 187' ' ' GLU . 49.5 mt -46.17 -56.71 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -0.983 . . . . 0.0 110.031 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.6 -40.08 1.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -76.19 -53.79 7.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.875 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.86 -26.8 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.452 -0.78 . . . . 0.0 109.624 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.98 -53.64 5.17 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.785 -1.197 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -47.58 -44.9 26.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 110.217 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.99 8.67 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.9 54.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.818 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 194' ' ' LEU . 50.9 mt -128.04 172.03 11.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -1.196 . . . . 0.0 109.687 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 57.39 24.83 53.41 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -60.14 -19.62 54.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.714 -1.462 . . . . 0.0 110.304 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -106.43 4.33 37.53 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.05 129.99 41.54 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.107 -1.231 . . . . 0.0 110.307 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.63 165.13 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.997 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.81 -8.4 43.1 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -97.09 -10.41 26.11 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.455 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 19.1 p-10 -140.3 9.82 2.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 m -145.27 147.09 31.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.106 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 206' ' ' LEU . 19.4 tp -97.8 93.86 6.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -88.45 130.51 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.569 0.7 . . . . 0.0 109.281 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 204' ' ' LEU . 18.3 mt -123.33 -178.46 4.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 109.605 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.95 -166.13 10.54 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -64.59 -20.75 66.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -1.104 . . . . 0.0 109.401 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.34 22.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.848 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -140.78 148.51 40.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.046 -1.033 . . . . 0.0 110.34 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.38 110.55 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -57.74 -45.22 86.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.987 -1.071 . . . . 0.0 109.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.8 118.82 45.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.642 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.23 -14.52 43.34 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.401 1.401 . . . . 0.0 112.017 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.85 -14.73 60.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.057 -1.027 . . . . 0.0 108.78 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.04 52.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.5 mt -86.14 134.99 33.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -1.206 . . . . 0.0 109.617 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -64.17 -19.58 65.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 108.824 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.663 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.5 m-85 -139.89 -164.16 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.118 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.65 -21.41 17.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.12 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 48.38 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.448 -0.783 . . . . 0.0 109.463 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.515 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -53.8 -47.92 95.19 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.995 . . . . 0.0 109.992 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.7 Cg_exo -48.67 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.164 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 225' ' ' ARG . 17.4 m -59.87 -36.76 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.976 -1.078 . . . . 0.0 109.666 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.663 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 74.8 mtt180 -60.09 -41.74 93.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 108.267 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.421 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 17.2 t60 -68.02 -30.56 69.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.905 . . . . 0.0 108.859 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.75 -36.0 82.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -68.48 -37.72 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.471 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.8 t80 -64.1 -52.1 60.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.546 -0.721 . . . . 0.0 109.175 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.25 -27.31 68.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.429 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.2 tp -76.74 -33.2 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.161 -0.962 . . . . 0.0 108.57 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.66 -38.81 79.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -57.58 9.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.492 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.4 m-20 -54.35 -37.26 64.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -1.211 . . . . 0.0 109.06 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 235' ' ' LEU . 10.3 mt -61.99 -24.68 67.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 0.0 110.271 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.2 t80 -72.85 -20.85 61.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.162 . . . . 0.0 109.35 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 237' ' ' LEU . 83.8 mt -50.67 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.858 -1.151 . . . . 0.0 110.591 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.9 mt -74.59 -14.23 60.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.779 -1.2 . . . . 0.0 109.854 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.17 1.69 59.41 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.575 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.1 m -164.94 153.11 10.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.259 . . . . 0.0 108.751 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.6 Cg_endo -50.06 150.4 10.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.806 1.671 . . . . 0.0 109.48 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.66 142.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.812 -1.18 . . . . 0.0 112.056 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -124.05 119.82 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.96 -165.94 32.33 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.525 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.2 tmtt? -123.39 142.06 51.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -1.022 . . . . 0.0 108.581 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 9.7 m-85 -139.52 142.16 37.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.981 -1.074 . . . . 0.0 110.63 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -126.28 132.56 51.64 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -126.93 137.7 53.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 111.145 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -119.32 116.83 27.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 47.09 28.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.182 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.0 153.31 52.89 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -134.52 170.39 22.71 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.579 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -49.92 -36.52 27.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -1.166 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.84 -58.19 9.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.701 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.414 HD23 ' CD1' ' A' ' 139' ' ' ILE . 8.6 tp -59.21 -45.02 92.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.071 -1.018 . . . . 0.0 109.444 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.5 m-20 -47.77 -51.39 22.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.566 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.74 HG21 HG21 ' A' ' 56' ' ' THR . 84.8 t -62.94 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.339 -0.85 . . . . 0.0 109.404 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -50.97 -51.07 56.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 109.209 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 139' ' ' ILE . 33.0 tp -51.26 -51.62 52.44 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 108.487 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.487 HG13 ' HG ' ' A' ' 238' ' ' LEU . 71.2 t -57.14 -53.86 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.948 . . . . 0.0 109.104 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -46.78 -41.66 15.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -70.98 -50.32 35.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.905 . . . . 0.0 109.802 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 38.2 mt -57.28 -47.64 80.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.05 75.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.968 179.799 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.11 137.52 51.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.088 -1.008 . . . . 0.0 108.473 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -123.23 144.89 49.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -143.41 -168.85 2.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.97 136.31 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.05 -12.96 56.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.39 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 8.5 pt-20 -156.15 -172.71 4.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 141.92 28.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 mt -119.15 166.15 13.3 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.8 144.54 37.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 110.328 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 76.1 m-85 -140.0 156.23 46.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -163.59 149.23 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 109.581 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.95 173.35 35.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 p -79.32 150.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -1.074 . . . . 0.0 110.518 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.63 141.18 15.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.0 tt -60.67 -39.66 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -1.154 . . . . 0.0 111.189 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.2 m-70 -88.14 -49.44 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 111.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -72.18 -21.68 61.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.664 . . . . 0.0 111.842 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.27 16.88 22.29 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.08 -1.533 . . . . 0.0 109.558 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.48 156.14 20.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -1.152 . . . . 0.0 109.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.39 136.68 39.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.88 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -135.64 141.12 45.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.5 ttpt -110.36 155.71 21.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 109.723 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.3 mt -137.89 149.38 46.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.607 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -141.71 109.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.54 116.65 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.165 -0.96 . . . . 0.0 111.049 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.607 ' NE2' HG22 ' A' ' 27' ' ' ILE . 21.4 m-70 -112.77 139.75 23.19 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.442 -0.786 . . . . 0.0 109.542 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -54.26 168.59 0.91 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.895 1.73 . . . . 0.0 111.916 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.4 mm-40 -138.0 178.18 7.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.593 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.9 mtmm -87.16 152.76 22.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.981 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -48.36 146.21 2.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.642 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 68.35 8.49 55.44 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.729 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.733 ' H ' HD22 ' A' ' 86' ' ' ASN . 26.4 m -73.42 -45.84 52.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.608 -1.525 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.66 -178.92 30.2 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.662 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.4 mm -97.9 117.18 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -142.07 150.14 40.84 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' HD13 ' A' ' 89' ' ' ILE . 95.6 m-85 -99.7 157.12 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -129.69 110.72 12.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 108.974 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.666 ' NZ ' ' NE2' ' A' ' 67' ' ' GLN . 17.5 tttm -135.96 135.97 40.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.582 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m120 51.03 28.17 3.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 111.183 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.23 74.76 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.024 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.95 120.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -1.065 . . . . 0.0 108.946 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.3 m-85 -86.86 129.0 35.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.066 -1.021 . . . . 0.0 109.169 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 52.8 mt -120.12 96.95 49.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.238 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -53.07 149.3 27.71 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.081 1.854 . . . . 0.0 111.101 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.7 72.16 10.36 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -127.55 175.61 8.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -73.19 -50.74 20.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -43.72 -17.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.184 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' HIS . 54.2 m-85 -98.2 0.07 45.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.128 . . . . 0.0 110.258 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.3 t -68.81 130.91 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 108.722 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.512 HG21 ' HG2' ' A' ' 68' ' ' ARG . 10.4 m -114.3 -28.7 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.326 -0.859 . . . . 0.0 110.088 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -152.81 131.62 12.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.956 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 257' ' ' VAL . 70.3 p -121.75 95.09 4.53 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.3 t-20 -163.11 128.74 3.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.399 -0.813 . . . . 0.0 109.064 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 76.9 m-70 50.25 6.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.962 . . . . 0.0 109.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.573 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.1 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.7 m -81.38 129.18 34.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 0.0 109.247 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.92 150.43 42.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.357 -0.839 . . . . 0.0 111.172 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 72' ' ' VAL . 8.0 mt -126.0 147.66 49.48 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.69 160.41 32.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.248 -1.453 . . . . 0.0 110.243 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.24 149.58 10.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -1.123 . . . . 0.0 109.329 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.65 21.47 3.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.411 -0.805 . . . . 0.0 109.938 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.53 -30.94 8.95 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.681 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.693 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.78 145.06 50.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.763 -1.433 . . . . 0.0 108.855 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.693 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 4.7 mtt180 -137.46 149.76 47.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.019 -1.051 . . . . 0.0 111.874 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.29 128.45 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -105.14 155.28 19.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.892 -1.13 . . . . 0.0 111.338 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.2 m 51.5 74.57 0.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.894 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.8 m -108.24 -9.58 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.037 -1.039 . . . . 0.0 109.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.0 pm0 -61.13 -26.8 67.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 110.689 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.43 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 25.4 m170 -66.88 -68.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.958 -1.089 . . . . 0.0 109.375 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -51.84 -47.64 40.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.048 -1.033 . . . . 0.0 109.058 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.9 mt -54.13 -47.42 71.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.889 -1.132 . . . . 0.0 110.478 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 25.2 t -60.23 -41.75 93.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.004 -1.06 . . . . 0.0 109.817 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -57.5 -45.81 85.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 108.955 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.97 -35.0 79.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 109.247 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.05 -40.25 97.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 0.0 109.202 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.0 mt -75.68 -38.48 58.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.22 -0.48 45.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.842 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 56.42 41.97 28.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 111.303 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.1 mm -88.33 138.47 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.741 -1.224 . . . . 0.0 108.158 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.433 HG21 HG12 ' A' ' 121' ' ' ILE . 70.7 p -126.56 -20.62 4.31 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.213 -0.929 . . . . 0.0 111.451 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.775 HD21 ' N ' ' A' ' 34' ' ' GLY . 3.3 m120 -124.2 106.45 10.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.02 -1.05 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -166.07 150.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.654 0.74 . . . . 0.0 110.2 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 55.8 m -117.11 114.61 23.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.415 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.3 mt -95.69 100.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.432 -0.792 . . . . 0.0 109.988 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -74.27 122.88 23.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 HD21 ' A' ' 26' ' ' LEU . 19.3 t -108.69 124.75 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.845 0.831 . . . . 0.0 111.906 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 25' ' ' LYS . 8.1 mt -108.4 96.22 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.52 -158.51 27.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -122.19 -11.68 8.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -1.111 . . . . 0.0 110.196 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -140.63 149.38 42.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -73.06 127.24 89.69 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.06 132.32 14.5 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.033 1.822 . . . . 0.0 111.276 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.91 -20.85 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.12 -0.987 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.9 mt 58.64 -119.69 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.91 4.71 49.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.908 -1.12 . . . . 0.0 110.95 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.78 0.04 56.45 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.332 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -172.28 2.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.718 -0.872 . . . . 0.0 109.676 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.84 13.17 9.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 47.9 t-105 -56.0 -40.54 73.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.44 -59.28 4.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 11.0 m-85 -51.3 -45.56 62.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CE2' ' HD2' ' A' ' 111' ' ' ARG . 64.7 t80 -60.68 -49.99 75.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.772 -0.58 . . . . 0.0 110.806 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 19.8 mm-40 -62.99 -43.36 99.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.245 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.05 6.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.703 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.1 -30.28 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.212 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.418 ' HD2' ' CE2' ' A' ' 107' ' ' TYR . 57.9 ttt180 -66.11 -44.37 84.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.412 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HG3' HD22 ' A' ' 113' ' ' ASN . 15.0 ptpt -76.36 8.72 3.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.882 -1.136 . . . . 0.0 110.431 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' OD1' ' OE1' ' A' ' 9' ' ' GLU . 8.0 m-80 -140.58 35.87 1.83 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.945 -1.097 . . . . 0.0 110.267 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.65 143.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.12 . . . . 0.0 110.88 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.9 tp -133.51 129.68 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.429 -0.795 . . . . 0.0 109.431 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.75 138.81 31.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -108.48 -173.53 2.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.73 . . . . 0.0 109.108 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.62 70.66 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.958 . . . . 0.0 110.685 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -167.4 129.68 1.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -65.96 140.54 58.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.086 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.433 HG12 HG21 ' A' ' 85' ' ' THR . 56.3 mt -84.42 150.25 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 109.894 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -93.24 76.67 4.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.858 . . . . 0.0 108.792 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -58.21 142.79 46.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -87.3 101.97 14.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.22 133.64 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.686 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.77 116.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -92.0 -28.71 17.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.65 156.99 78.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.943 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.56 150.15 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.913 2.409 . . . . 0.0 112.39 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.21 151.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.828 . . . . 0.0 109.323 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.82 145.91 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 109.366 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.12 147.98 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -131.78 161.32 33.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.137 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 255' ' ' LEU . 6.6 t70 -170.35 102.21 0.27 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 110.082 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 47.6 59.26 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.805 . . . . 0.0 110.677 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.78 -35.86 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.456 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -62.94 135.98 57.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.362 . . . . 0.0 109.132 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.2 tt -143.08 139.36 30.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 110.148 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.649 HG21 HD22 ' A' ' 259' ' ' LEU . 91.4 mt -137.47 134.13 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 0.0 109.734 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.75 131.48 53.61 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.53 0.681 . . . . 0.0 109.998 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.37 55.22 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.01 150.47 45.84 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.103 -0.998 . . . . 0.0 110.197 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -48.37 142.51 17.02 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.566 2.177 . . . . 0.0 113.35 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.76 147.24 18.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -69.84 -18.07 63.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.3 p -133.51 -173.33 3.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.49 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 16.3 tp -102.43 123.02 45.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.6 ' HG3' HG22 ' A' ' 167' ' ' VAL . 11.2 tt0 -136.83 129.04 29.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.632 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.09 121.34 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.557 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.1 m -112.27 152.15 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -138.83 129.72 26.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.965 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -120.57 131.91 54.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.0 132.3 6.21 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.701 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.24 97.59 9.29 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.57 166.98 19.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.368 -0.832 . . . . 0.0 111.169 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -105.87 23.6 13.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.752 -0.593 . . . . 0.0 110.034 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.4 p-10 -140.53 -169.74 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.053 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -47.15 -4.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.618 -0.676 . . . . 0.0 111.664 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 17.5 mt -85.27 -28.63 25.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.334 -1.479 . . . . 0.0 109.111 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.14 -132.47 41.83 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.615 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 4.4 ttm105 -97.02 129.84 44.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.302 . . . . 0.0 109.8 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.628 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -132.81 139.36 47.47 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -137.57 144.05 41.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -143.56 136.12 27.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.724 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.3 m -106.98 124.53 49.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.417 -0.802 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -105.8 118.48 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 148' ' ' GLU . 26.0 t -113.59 158.42 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.75 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 30.9 mt-10 -50.18 125.15 11.71 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 108.92 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.89 6.59 39.94 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -120.31 15.81 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.245 . . . . 0.0 108.698 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -49.63 73.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.404 -0.81 . . . . 0.0 110.034 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -51.2 -22.33 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.12 -6.99 58.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 0.0 111.441 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 8.9 pt -124.95 -27.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.888 -1.133 . . . . 0.0 111.552 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.98 -24.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.528 -1.358 . . . . 0.0 108.694 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -82.31 -5.54 58.64 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.32 118.5 11.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.189 -0.944 . . . . 0.0 109.005 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 41.3 mtm180 -81.21 171.8 14.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.197 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -77.94 164.16 25.36 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -149.3 146.03 27.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.168 -1.582 . . . . 0.0 111.629 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.81 158.93 43.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -101.24 146.03 28.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 9.9 p30 -52.08 -32.91 36.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.233 -0.917 . . . . 0.0 109.935 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.1 p90 -71.8 -26.16 62.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.756 -1.215 . . . . 0.0 109.645 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.449 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 tt0 -83.81 -40.29 18.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.101 -1.0 . . . . 0.0 110.049 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 67.2 mt -43.17 -59.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.614 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.8 tp10 -42.1 -38.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.597 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.4 t-160 -76.85 -42.81 38.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.137 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.97 -27.6 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.579 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.64 -53.15 5.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.666 -1.271 . . . . 0.0 109.143 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -50.99 -41.17 59.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 110.172 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 188' ' ' HIS . 18.8 m -74.56 4.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.82 38.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 56.2 mt -129.89 171.36 12.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -1.141 . . . . 0.0 109.684 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.94 24.82 58.59 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.487 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.6 -18.48 41.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.425 -1.633 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.24 25.22 10.02 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.09 130.18 9.96 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.8 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.6 t -144.42 171.2 14.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.679 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.426 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 59.5 mt -69.78 -8.41 47.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -98.69 -13.75 20.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.642 -0.661 . . . . 0.0 109.696 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 18.7 p30 -130.33 7.1 4.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -149.19 150.13 32.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 206' ' ' LEU . 12.5 tp -97.96 95.26 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.05 127.87 40.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.985 0.898 . . . . 0.0 109.497 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 204' ' ' LEU . 34.3 mt -123.28 164.89 17.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.613 -0.68 . . . . 0.0 109.303 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.04 -166.63 11.98 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.414 ' HZ2' ' HB2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -60.03 -34.79 73.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.507 -0.996 . . . . 0.0 109.325 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -153.41 23.76 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.926 -1.109 . . . . 0.0 110.74 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -142.12 149.04 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.614 -1.304 . . . . 0.0 110.702 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.4 t -101.49 111.05 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.19 -46.41 85.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.977 -1.077 . . . . 0.0 110.148 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.1 118.28 31.48 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.927 . . . . 0.0 109.827 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -67.6 -17.2 48.15 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.85 -14.32 61.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.296 -0.878 . . . . 0.0 108.99 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.8 -176.98 45.28 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.4 mt -84.37 153.05 23.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -1.208 . . . . 0.0 109.558 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 218' ' ' ARG . 0.0 OUTLIER -82.2 -18.4 42.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.0 m-85 -145.53 -165.14 2.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -0.751 . . . . 0.0 108.998 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.19 -4.84 28.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.309 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -141.91 40.86 1.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.85 -47.36 97.09 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.876 -1.14 . . . . 0.0 109.584 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.7 Cg_exo -51.8 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.375 2.05 . . . . 0.0 112.076 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.9 m -58.86 -35.06 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 109.624 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NH1' ' CD2' ' A' ' 219' ' ' TYR . 58.2 mtt180 -60.21 -40.66 90.92 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.9 t60 -69.43 -32.1 70.85 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.162 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -64.88 -35.73 82.08 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.72 -40.85 84.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.5 t80 -61.78 -51.46 68.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.611 0.719 . . . . 0.0 109.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -65.6 -27.48 68.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 110.016 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.6 tp -77.46 -34.24 54.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.094 -1.004 . . . . 0.0 108.777 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 57.9 mt -68.31 -38.5 79.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.92 -56.8 11.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 2.2 m-20 -53.16 -35.06 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.238 . . . . 0.0 108.671 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.0 mt -62.01 -23.51 66.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.639 -0.663 . . . . 0.0 110.325 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.04 -21.8 61.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 108.821 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 237' ' ' LEU . 53.3 mt -51.22 -1.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.619 -1.3 . . . . 0.0 110.416 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.624 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -77.86 -15.61 58.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.903 -1.123 . . . . 0.0 109.526 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.68 58.01 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.14 -1.029 . . . . 0.0 110.605 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.64 153.88 10.13 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.901 -1.352 . . . . 0.0 109.127 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.66 130.22 39.14 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.904 1.736 . . . . 0.0 109.939 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 68.5 t -86.22 147.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 122.204 1.002 . . . . 0.0 112.558 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -131.34 124.71 30.96 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.28 -155.58 26.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -131.8 133.77 45.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.315 -1.109 . . . . 0.0 109.119 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.8 m-85 -135.09 140.01 45.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.459 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.1 t80 -125.34 132.23 52.87 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.2 t -127.62 136.85 52.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.25 112.97 20.8 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 53.41 24.91 4.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.97 153.0 48.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.49 177.5 18.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.585 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 74.8 m-70 -57.72 -36.25 71.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -1.187 . . . . 0.0 109.427 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 29.6 t -58.97 -58.62 7.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 134' ' ' ASP . 9.0 tp -59.53 -44.6 93.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.501 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -47.94 -50.62 26.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 109.286 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 56' ' ' THR . 70.7 t -63.18 -50.44 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.16 -50.9 63.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.06 -1.025 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.649 HD22 HG21 ' A' ' 139' ' ' ILE . 28.8 tp -52.22 -59.36 4.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 108.447 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.624 HG13 ' HG ' ' A' ' 238' ' ' LEU . 43.1 t -48.39 -55.58 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.39 -47.53 18.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.17 -47.02 78.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -59.51 -49.79 76.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -70.76 -32.13 69.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 4.3 mmtp . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.945 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.472 ' CD ' HD21 ' A' ' 86' ' ' ASN . 70.8 mt-10 -55.22 139.85 40.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 108.833 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.81 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.907 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -140.55 -172.71 3.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.4 m -97.93 136.38 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.003 -1.06 . . . . 0.0 109.074 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -66.97 -23.29 65.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.549 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 2.5 pt-20 -146.92 170.04 17.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 141.08 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.3 mt -120.03 166.47 13.33 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 143.18 41.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.071 -1.018 . . . . 0.0 110.418 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' ILE . 79.1 m-85 -139.24 154.15 47.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.98 150.8 15.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.875 -1.141 . . . . 0.0 110.019 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.22 174.98 36.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 p -82.81 153.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.115 . . . . 0.0 110.183 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.86 140.11 16.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 ' OG1' ' A' ' 203' ' ' THR . 9.6 tt -61.52 -37.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.916 -1.344 . . . . 0.0 110.379 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 45.8 m-70 -86.77 -51.07 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 111.096 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -73.47 -20.93 60.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.741 -0.599 . . . . 0.0 111.706 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.33 16.41 14.73 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.492 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.22 154.07 21.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 109.598 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.9 134.53 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -138.61 143.03 39.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.398 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -110.87 157.74 19.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.299 -0.876 . . . . 0.0 109.728 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.9 mt -138.2 147.77 44.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.447 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.568 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.9 mt -142.55 112.69 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 108.825 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.45 HD12 ' CE1' ' A' ' 13' ' ' PHE . 55.2 mt -96.09 114.57 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 111.123 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.568 ' NE2' HG22 ' A' ' 27' ' ' ILE . 24.5 m-70 -109.4 139.3 20.97 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 109.669 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.7 Cg_exo -55.12 168.6 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.828 1.686 . . . . 0.0 111.758 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 64.2 mm-40 -141.72 178.22 7.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.993 . . . . 0.0 109.816 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' A' ' 35' ' ' THR . 23.9 mmtm -85.72 152.49 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -46.07 145.08 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.402 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 67.78 9.17 55.52 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.169 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -70.03 -41.67 73.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.63 -1.512 . . . . 0.0 109.49 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.99 179.69 37.14 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.539 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mm -96.61 116.26 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -138.8 144.43 39.34 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.511 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.59 158.34 15.48 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -131.02 110.18 11.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 109.222 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -136.63 134.97 37.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 110.558 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.14 26.95 10.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 111.275 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 17.95 78.49 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.81 122.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -83.98 127.46 33.89 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.191 -0.943 . . . . 0.0 109.243 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.71 94.4 40.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.422 -0.799 . . . . 0.0 109.446 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.12 145.71 33.14 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.0 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -80.6 65.58 5.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -119.49 153.24 35.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.407 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.508 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 1.8 p-80 -57.71 -53.67 55.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 109.985 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.508 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.0 mm-40 -43.84 -17.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 111.043 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' HIS . 16.0 m-85 -94.13 5.11 52.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.664 -1.272 . . . . 0.0 109.79 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' HIS . 79.8 t -72.66 130.87 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.53 -29.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.345 -0.847 . . . . 0.0 109.894 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.4 t-80 -150.13 131.22 14.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.046 -1.034 . . . . 0.0 109.915 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.822 HG21 HG21 ' A' ' 257' ' ' VAL . 67.7 p -121.98 95.84 4.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.38 128.56 3.53 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 59' ' ' SER . 72.6 m-70 52.79 5.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.082 -1.011 . . . . 0.0 109.047 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m 165.16 151.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.404 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 31.1 m -91.12 126.54 36.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.241 -0.912 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD2' ' NZ ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -120.29 149.57 42.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.449 -0.782 . . . . 0.0 111.12 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.687 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.4 mt -126.28 147.54 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.52 155.91 27.25 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 118.961 -1.59 . . . . 0.0 110.587 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -160.42 147.64 15.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -1.047 . . . . 0.0 109.095 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 24.18 4.77 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.283 -0.885 . . . . 0.0 109.647 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.52 -31.35 7.89 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 8.3 mm-40 -60.34 144.25 51.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.245 . . . . 0.0 108.916 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -143.06 141.38 31.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 110.475 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.09 123.32 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 13.2 mtpp -99.36 154.63 18.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.966 -1.083 . . . . 0.0 111.128 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.5 m 50.79 74.38 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.338 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.687 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.9 m -106.92 -10.08 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.236 -0.915 . . . . 0.0 108.927 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.9 pm0 -61.34 -26.3 67.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 110.353 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.58 -69.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.91 -1.119 . . . . 0.0 109.47 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.01 -47.37 42.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 108.979 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' ILE . 16.8 mt -52.1 -49.22 64.03 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.04 -1.038 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 t -60.65 -42.82 97.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.105 -0.997 . . . . 0.0 110.247 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -56.04 -48.37 78.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.05 -1.031 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.04 -33.9 76.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.165 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.4 -37.17 86.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.912 . . . . 0.0 109.268 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.29 -38.76 34.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.414 -0.804 . . . . 0.0 109.648 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 107' ' ' TYR . 77.8 mt -80.36 -0.48 37.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.132 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 56.89 42.38 26.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.666 -0.646 . . . . 0.0 111.622 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mm -89.41 144.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.697 -1.252 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.571 HG21 HG12 ' A' ' 121' ' ' ILE . 43.5 p -127.88 -20.81 3.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.192 -0.943 . . . . 0.0 111.815 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG13 ' A' ' 87' ' ' VAL . 33.6 m-80 -124.99 108.12 11.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.838 -1.164 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.75 148.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.363 -0.836 . . . . 0.0 110.421 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.47 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 94.3 m -114.71 113.53 24.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 5.5 mt -97.27 100.77 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 110.412 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.1 tt0 -74.63 124.83 27.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 20.0 t -109.96 131.93 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 122.048 0.928 . . . . 0.0 111.707 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mm -116.15 95.9 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.67 -156.9 26.07 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -121.37 -9.51 9.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.439 -1.036 . . . . 0.0 109.999 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -140.53 148.81 41.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.648 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 26' ' ' LEU . 39.2 mm -72.07 119.37 74.16 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 108.987 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -39.94 120.09 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.739 1.626 . . . . 0.0 111.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -75.04 -10.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 110.774 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.9 mt 54.7 -120.7 1.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.091 -1.006 . . . . 0.0 109.995 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.6 8.22 44.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.66 67.36 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.197 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -172.54 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.768 -0.842 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.0 9.0 9.76 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.407 ' HB2' HD22 ' A' ' 176' ' ' LEU . 33.6 t-105 -55.49 -39.52 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -1.135 . . . . 0.0 110.452 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.12 -59.31 4.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -50.84 -44.83 59.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.209 -0.932 . . . . 0.0 109.38 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 82' ' ' LEU . 36.2 t80 -60.92 -48.05 83.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 110.786 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.82 -42.47 90.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.009 -1.057 . . . . 0.0 111.28 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.49 -52.06 43.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.913 -1.117 . . . . 0.0 110.356 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.05 -32.86 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.943 -1.098 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -63.79 -43.44 96.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 109.822 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.623 ' C ' HD22 ' A' ' 113' ' ' ASN . 1.3 ptpm? -77.81 11.1 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.017 -1.052 . . . . 0.0 109.852 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.623 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.92 33.23 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.29 138.82 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.864 -1.147 . . . . 0.0 111.212 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 8' ' ' LYS . 9.0 tp -132.75 123.56 26.45 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.65 145.15 31.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.343 -0.848 . . . . 0.0 110.221 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -112.61 -173.19 2.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.763 . . . . 0.0 109.352 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -109.34 68.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -164.09 128.76 2.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.007 . . . . 0.0 109.315 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.69 140.58 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.069 . . . . 0.0 109.667 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 85' ' ' THR . 69.3 mt -83.94 150.47 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.843 . . . . 0.0 109.906 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.64 85.94 3.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 108.876 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 241' ' ' PRO . 25.1 m-85 -63.52 142.79 58.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.545 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -87.54 101.38 13.57 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.43 134.16 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.663 -0.648 . . . . 0.0 110.75 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.97 111.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -83.74 -33.5 25.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.944 -1.098 . . . . 0.0 110.725 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.25 156.93 78.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 109.784 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.09 149.0 45.63 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.791 2.327 . . . . 0.0 112.241 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 tt -159.01 151.48 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.19 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 143.51 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.76 148.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.89 157.38 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.466 ' HB3' HD13 ' A' ' 255' ' ' LEU . 10.5 t70 -174.15 106.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 109.796 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 49.58 53.43 12.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 110.803 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.57 -35.68 3.17 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.416 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.581 ' HB3' HD22 ' A' ' 255' ' ' LEU . 0.9 OUTLIER -63.48 131.81 49.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.932 -1.334 . . . . 0.0 108.906 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -143.98 139.79 29.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.986 -1.071 . . . . 0.0 109.891 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HD22 ' A' ' 259' ' ' LEU . 62.6 mt -136.9 127.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.783 . . . . 0.0 109.59 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -112.49 131.76 55.42 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.411 0.624 . . . . 0.0 109.752 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 135.37 54.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.88 149.19 32.44 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.128 -0.983 . . . . 0.0 109.648 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -46.35 143.53 7.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.661 2.241 . . . . 0.0 113.272 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.425 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.92 145.62 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 146' ' ' THR . 44.0 t0 -65.34 -4.71 5.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 110.541 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 145' ' ' ASP . 21.8 p -155.66 -177.78 6.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -92.26 119.35 31.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 167' ' ' VAL . 1.1 tt0 -135.16 110.32 8.91 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.29 122.09 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.7 m -112.32 151.98 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.624 -0.673 . . . . 0.0 109.229 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -139.62 131.71 27.98 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.128 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -122.0 132.98 54.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.4 144.67 16.2 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.747 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.82 105.97 15.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -95.18 166.86 11.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -98.07 -16.69 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.576 -0.703 . . . . 0.0 110.9 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.7 p-10 -94.79 -173.14 2.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.751 -1.218 . . . . 0.0 110.217 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -50.35 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 0.0 111.642 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.2 mt -77.74 -27.8 50.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.343 -1.473 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.76 -140.5 34.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -104.16 137.89 41.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.302 -1.116 . . . . 0.0 109.691 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -143.89 159.14 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.497 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -146.67 147.68 31.27 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -142.86 135.65 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 109.645 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 98.6 m -104.56 122.87 46.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.894 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -104.46 112.34 25.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 148' ' ' GLU . 4.9 t -106.38 152.36 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.758 0.79 . . . . 0.0 109.901 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -49.28 127.04 14.14 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 108.808 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.57 27.35 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -116.69 20.72 13.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.162 -1.199 . . . . 0.0 108.962 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -54.04 -22.78 11.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.445 -0.784 . . . . 0.0 110.542 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -18.21 48.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.041 -1.037 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -84.2 -6.37 59.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 111.476 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 pt -125.19 -26.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.865 -1.147 . . . . 0.0 111.221 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 171' ' ' GLU . 6.5 m -60.5 -24.01 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.623 -1.298 . . . . 0.0 108.716 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.2 mm? -83.56 -3.23 57.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.506 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -69.99 113.5 7.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.569 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 73.0 mtm180 -79.31 172.36 13.9 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.6 t -77.26 161.13 28.37 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.39 146.06 32.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.282 -1.512 . . . . 0.0 111.439 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.93 154.55 42.71 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.422 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 70.2 m-85 -98.09 145.82 26.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.018 -1.051 . . . . 0.0 109.362 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.61 -36.97 37.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.3 p90 -71.42 -27.19 63.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.843 -1.161 . . . . 0.0 110.039 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.1 tt0 -78.97 -43.18 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.979 -1.076 . . . . 0.0 110.137 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 21.3 mt -41.0 -61.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.903 . . . . 0.0 110.145 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.7 tt0 -40.49 -41.37 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 0.0 110.193 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 192' ' ' VAL . 74.3 t60 -76.24 -46.22 29.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.942 . . . . 0.0 109.402 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.5 -30.86 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -80.65 -52.23 7.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.883 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -48.61 -44.56 37.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 110.334 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.1 m -74.86 6.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 0.0 110.326 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.41 41.79 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.584 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.4 mt -127.73 178.39 6.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -1.185 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 50.83 24.28 7.95 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -61.23 -19.3 61.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.624 -1.516 . . . . 0.0 110.59 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -107.27 4.82 35.49 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.57 125.03 30.44 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 121.136 -1.214 . . . . 0.0 110.296 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.559 ' N ' HD21 ' A' ' 202' ' ' ASN . 3.5 t -135.99 174.22 10.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -1.028 . . . . 0.0 109.456 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 213' ' ' ASN . 2.2 mm? -73.91 -9.14 58.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -102.78 -17.67 15.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.642 -0.662 . . . . 0.0 110.289 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 199' ' ' SER . 18.9 p30 -120.04 7.91 10.93 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.477 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -150.84 151.25 31.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.872 -1.143 . . . . 0.0 110.556 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.2 tp -98.99 93.54 6.06 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -86.08 129.19 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.687 0.756 . . . . 0.0 109.277 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 211' ' ' VAL . 11.9 mt -123.48 162.95 21.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.611 -0.68 . . . . 0.0 109.454 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.41 -166.38 12.91 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -28.26 66.5 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.384 -1.068 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.44 20.98 1.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 111.153 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.6 160.99 43.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.465 -1.397 . . . . 0.0 110.823 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 206' ' ' LEU . 86.9 t -107.59 116.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -60.28 -42.93 96.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.578 ' HA ' HD12 ' A' ' 200' ' ' LEU . 8.9 m120 -65.06 115.61 22.71 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -64.69 -10.53 25.09 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.16 1.24 . . . . 0.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -20.13 59.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.408 -0.807 . . . . 0.0 109.286 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.24 -179.5 45.53 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.5 mt -86.1 133.51 33.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.073 -1.251 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.99 -17.71 64.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.318 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 39.2 m-85 -143.33 -170.46 3.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.71 -4.37 44.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.79 43.61 1.26 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 109.649 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.86 -47.84 95.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.997 -1.065 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.5 Cg_exo -51.37 -65.33 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.487 2.124 . . . . 0.0 112.31 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.39 -35.19 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.986 -1.071 . . . . 0.0 109.461 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -62.72 -39.44 94.07 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 8.5 t60 -68.02 -32.68 73.22 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -64.17 -35.72 81.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.88 -35.48 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.97 -53.01 44.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 109.172 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -63.98 -28.86 70.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.457 -0.777 . . . . 0.0 109.797 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.12 -34.97 49.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.085 -1.01 . . . . 0.0 109.018 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.55 -38.53 81.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.5 -54.87 17.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -55.27 -30.19 59.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.0 108.825 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.6 mt -65.86 -24.23 66.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.529 -0.732 . . . . 0.0 110.442 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.78 -21.8 61.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.855 -1.153 . . . . 0.0 108.54 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 38.9 mt -48.19 -7.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.762 -1.211 . . . . 0.0 109.905 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 236' ' ' TYR . 7.2 mt -74.03 -16.6 61.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.767 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 95.77 3.83 60.68 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.823 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.79 152.99 10.6 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.763 -1.433 . . . . 0.0 109.301 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.413 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 8.1 Cg_endo -53.91 127.22 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.956 1.771 . . . . 0.0 110.002 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.8 t -86.43 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 112.289 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.57 125.86 29.72 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.51 -160.59 29.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -128.6 133.56 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -1.107 . . . . 0.0 108.951 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.8 m-85 -132.92 141.65 48.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 110.945 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -124.76 124.94 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.2 t -118.83 135.69 54.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.946 -1.096 . . . . 0.0 111.28 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -116.87 114.75 24.33 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 48.41 25.77 0.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.57 164.11 12.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -145.01 173.94 25.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.446 ' O ' HG23 ' A' ' 257' ' ' VAL . 77.4 m-70 -54.41 -43.52 71.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 p -55.37 -58.6 7.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 137' ' ' ARG . 5.9 tp -54.88 -46.23 74.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.0 m-20 -47.43 -48.11 26.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.942 -1.099 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.822 HG21 HG21 ' A' ' 56' ' ' THR . 44.9 t -63.85 -50.03 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 109.96 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -56.31 -50.27 71.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.961 -1.087 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 139' ' ' ILE . 35.6 tp -52.58 -50.53 62.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.063 -1.023 . . . . 0.0 108.636 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.4 t -57.79 -55.28 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.274 -0.891 . . . . 0.0 109.165 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.69 -49.08 14.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.82 -49.53 72.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.278 -0.889 . . . . 0.0 110.109 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.17 -50.94 71.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 0.0 110.38 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -33.16 75.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.123 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 109.374 179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 73.8 mt-10 -56.04 135.04 52.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.123 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.38 142.67 48.97 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -139.46 -170.34 2.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.8 m -100.32 137.55 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -64.88 -19.87 66.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.857 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.95 157.42 36.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.113 -0.992 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 140.36 58.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.946 . . . . 0.0 109.805 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.07 157.08 28.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 p -127.67 140.13 52.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.2 m-85 -138.04 147.67 44.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.4 pt-20 -156.8 151.98 26.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.16 175.66 36.72 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.06 152.93 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 110.222 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.67 140.07 15.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 11.4 tt -59.31 -39.05 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.039 -1.271 . . . . 0.0 110.269 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 34.0 m-70 -88.43 -50.05 6.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.688 -1.258 . . . . 0.0 110.77 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -70.45 -22.95 62.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.716 . . . . 0.0 111.297 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.24 10.92 4.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.64 156.18 17.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.458 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 32.2 t80 -74.82 136.25 41.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -141.04 143.51 34.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -109.77 159.02 17.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.999 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.29 145.12 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.3 mt -142.18 107.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.976 . . . . 0.0 108.867 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mt -90.85 113.77 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.366 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.503 ' NE2' HG22 ' A' ' 27' ' ' ILE . 57.2 m-70 -107.74 137.26 19.69 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 109.4 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG3' HG23 ' A' ' 7' ' ' VAL . 33.2 Cg_exo -50.1 167.72 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.847 1.698 . . . . 0.0 111.532 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HB3' HG21 ' A' ' 35' ' ' THR . 28.0 mm-40 -144.99 160.48 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.886 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.8 mttp -68.0 149.1 50.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -48.41 151.05 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.141 -0.974 . . . . 0.0 110.093 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.563 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 68.63 -2.12 8.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.66 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 24.6 m -62.21 -42.75 99.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.467 . . . . 0.0 109.558 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.689 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 95.86 179.45 36.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.415 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 87' ' ' VAL . 14.6 mm -96.58 116.81 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -140.91 147.68 39.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 0.0 110.215 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.34 157.42 15.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -129.06 112.17 13.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 108.976 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -135.58 133.43 38.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.636 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 53.5 26.82 5.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 111.313 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.43 20.26 64.67 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.097 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.5 t -124.46 124.49 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -1.093 . . . . 0.0 109.322 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -86.37 126.75 34.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.78 93.03 36.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.188 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.12 145.5 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.298 1.999 . . . . 0.0 112.044 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.93 70.57 8.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 109.403 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -120.52 174.73 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.159 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.485 ' O ' HG23 ' A' ' 53' ' ' VAL . 16.1 p-80 -78.31 -46.37 20.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -49.95 -16.62 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -93.15 3.97 54.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.754 -1.216 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 50' ' ' HIS . 75.2 t -70.95 127.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.508 HG21 ' HD2' ' A' ' 68' ' ' ARG . 26.9 m -106.32 -31.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -155.12 139.83 17.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 257' ' ' VAL . 39.2 p -126.25 95.82 4.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.5 t30 -161.39 128.91 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.769 . . . . 0.0 108.95 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 82.2 m-70 52.95 5.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.247 -0.908 . . . . 0.0 109.178 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.11 142.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' VAL . 34.6 m -81.87 127.3 32.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 108.837 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.82 148.24 43.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.859 0.837 . . . . 0.0 111.071 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.1 mt -126.84 150.06 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.36 155.73 27.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.756 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.92 153.55 12.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -1.012 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 50.75 21.59 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.8 -33.25 6.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.99 141.86 57.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.245 . . . . 0.0 109.245 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -137.33 139.69 41.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 110.364 -179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.3 mt -129.23 121.3 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -99.64 157.54 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 110.926 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.9 m 51.23 73.73 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.932 -0.48 . . . . 0.0 110.694 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG21 ' HG ' ' A' ' 62' ' ' LEU . 12.2 m -107.7 -9.29 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.0 108.9 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 18.2 pm0 -61.04 -28.86 69.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 110.75 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -66.83 -67.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.868 -1.145 . . . . 0.0 109.56 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.15 -46.73 44.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.271 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.0 mt -53.61 -46.91 70.58 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.899 -1.126 . . . . 0.0 110.136 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.56 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.87 -43.18 99.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -0.989 . . . . 0.0 110.063 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.88 -46.05 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.05 -34.47 77.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -62.58 -37.34 85.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.408 HD12 ' CG1' ' A' ' 175' ' ' VAL . 54.8 mt -78.78 -38.73 37.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 114' ' ' ILE . 72.8 mt -79.9 -1.03 37.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.383 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 57.7 43.01 22.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 111.339 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 mm -88.22 143.74 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.887 -1.133 . . . . 0.0 108.688 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.477 HG21 HD13 ' A' ' 121' ' ' ILE . 63.0 p -127.4 -23.44 3.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 111.822 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 29.4 m120 -124.73 107.49 11.01 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.723 -1.235 . . . . 0.0 110.412 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -163.64 147.0 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 37.9 m -114.23 109.48 18.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.8 mt -92.06 100.52 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -74.48 126.15 30.11 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.512 HG22 HD21 ' A' ' 26' ' ' LEU . 29.4 t -111.74 122.42 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.964 0.887 . . . . 0.0 111.58 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.94 96.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.39 -156.78 26.34 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -120.66 -10.04 9.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -1.095 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -142.82 150.63 40.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.01 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 36.9 mm -72.76 120.94 83.53 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -41.85 123.81 2.5 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.517 1.478 . . . . 0.0 110.987 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.4 tp -76.91 -12.43 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.369 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 mt 56.48 -121.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.29 8.89 40.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 110.666 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.41 -1.96 67.35 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.436 -1.364 . . . . 0.0 109.696 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -172.46 2.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.841 -0.8 . . . . 0.0 109.401 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.74 16.02 9.61 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.4 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 67.0 t-105 -59.55 -43.47 93.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.409 -1.054 . . . . 0.0 110.28 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.8 -57.61 10.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -51.21 -44.87 61.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.078 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 62.2 t80 -61.81 -52.42 64.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.633 -0.667 . . . . 0.0 110.674 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.4 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 16.8 mm-40 -60.53 -44.88 95.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 0.0 111.319 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.71 -58.6 4.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.918 -1.114 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.22 -33.73 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.452 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 13.1 ttt180 -62.37 -43.71 98.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.26 12.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.951 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -143.24 34.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.097 . . . . 0.0 110.329 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 82' ' ' LEU . 46.9 mt -80.75 138.55 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 tp -132.3 128.87 38.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.331 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -87.87 140.5 29.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.694 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.72 -170.85 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.9 69.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.24 -0.913 . . . . 0.0 110.599 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.01 130.12 2.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.959 -1.088 . . . . 0.0 109.708 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.76 145.97 51.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.984 . . . . 0.0 109.817 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 85' ' ' THR . 35.4 mt -90.87 151.48 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -94.06 79.8 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 50.0 m-85 -59.93 143.01 52.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.483 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -89.1 101.5 14.16 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.78 132.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.707 -0.62 . . . . 0.0 110.785 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -70.12 111.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -88.49 -30.48 19.35 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.104 -0.998 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -133.06 149.29 72.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 109.663 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.32 155.66 55.64 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.372 2.048 . . . . 0.0 112.118 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.2 tt -161.71 153.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -139.33 141.04 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.835 . . . . 0.0 109.257 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.42 148.85 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.72 158.28 44.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 135' ' ' GLU . 43.4 t0 -174.51 105.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.933 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 134' ' ' ASP . 5.5 mt-10 49.7 54.74 10.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.7 -36.31 3.14 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.448 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.475 ' HB3' HD22 ' A' ' 255' ' ' LEU . 2.4 mpt_? -61.55 134.36 56.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 108.657 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -147.79 138.52 23.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 255' ' ' LEU . 75.5 mt -135.69 132.13 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.662 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 142' ' ' GLU . 19.0 tttm -117.72 131.05 56.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.707 -0.621 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.79 55.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 140' ' ' LYS . 9.7 pt-20 -148.29 151.65 37.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.774 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -49.42 142.68 22.36 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.439 2.093 . . . . 0.0 113.445 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.44 141.35 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.03 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -60.98 -6.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.836 . . . . 0.0 110.602 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.4 p -152.79 -173.52 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.926 -1.109 . . . . 0.0 109.546 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 148' ' ' GLU . 8.8 tp -96.29 120.45 36.61 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 108.865 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.1 tt0 -136.57 129.41 30.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.21 123.61 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 95.9 m -113.51 152.35 30.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.749 -0.594 . . . . 0.0 109.481 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -141.85 132.39 25.37 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.31 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.18 132.72 54.59 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.27 147.16 19.04 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.184 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.28 98.28 6.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -85.57 167.84 15.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.632 0.729 . . . . 0.0 110.894 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -97.55 -9.94 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 111.302 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' LEU . 30.7 p-10 -102.76 -170.94 1.87 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 111.036 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -48.2 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.806 -0.559 . . . . 0.0 111.509 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.7 mt -80.29 -29.75 38.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.479 -1.388 . . . . 0.0 108.534 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.41 -133.73 46.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.425 HH11 ' HB2' ' A' ' 161' ' ' ARG . 13.0 ttp-105 -107.88 136.27 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -1.075 . . . . 0.0 109.391 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.694 -0.629 . . . . 0.0 109.303 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.13 147.84 29.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.44 -0.788 . . . . 0.0 109.604 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.495 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 9.8 t80 -147.9 143.18 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.084 -1.01 . . . . 0.0 110.3 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.458 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 89.4 m -110.17 123.81 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.798 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.21 116.93 33.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.414 HG22 ' CG ' ' A' ' 148' ' ' GLU . 56.0 t -106.57 149.4 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.011 0.91 . . . . 0.0 110.405 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.61 134.44 24.36 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.385 -0.822 . . . . 0.0 109.197 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.11 -9.18 42.68 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.09 28.19 8.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.199 -1.177 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.7 pm0 -60.41 -36.67 78.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.56 -17.0 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.86 -5.99 46.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.835 -1.166 . . . . 0.0 111.517 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.2 pt -121.21 -29.82 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.061 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.9 m -61.99 -15.81 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.626 -1.296 . . . . 0.0 108.803 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.98 -2.85 55.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.48 114.49 7.76 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -77.58 172.93 12.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.4 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.3 t -77.25 162.49 27.31 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.2 143.85 30.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.366 -1.459 . . . . 0.0 111.427 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.79 155.78 44.87 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.44 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 71.4 m-85 -99.38 140.41 33.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.494 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.07 -37.54 9.7 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.369 -0.832 . . . . 0.0 110.345 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.3 p90 -70.16 -26.81 64.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.734 -1.229 . . . . 0.0 110.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.7 OUTLIER -88.5 -35.05 17.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.94 -1.1 . . . . 0.0 110.441 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 205' ' ' VAL . 73.5 mt -48.23 -58.18 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 0.0 109.708 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.9 OUTLIER -42.92 -36.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.16 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.461 ' O ' HG22 ' A' ' 192' ' ' VAL . 19.6 t60 -72.63 -50.22 26.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.752 . . . . 0.0 109.136 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 81.7 mt -52.17 -29.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -80.87 -53.04 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.798 -1.189 . . . . 0.0 109.022 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -48.55 -40.45 27.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.4 m -77.62 6.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.026 -1.046 . . . . 0.0 110.364 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.18 38.79 38.73 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.228 -0.986 . . . . 0.0 110.655 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.413 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.6 mt -130.91 -179.71 5.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -1.155 . . . . 0.0 109.515 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 54.64 23.44 28.68 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.578 -0.701 . . . . 0.0 111.488 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -57.06 -21.13 29.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.602 -1.528 . . . . 0.0 110.435 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.92 5.47 34.49 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.985 -1.103 . . . . 0.0 110.559 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.74 129.3 41.73 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 120.925 -1.338 . . . . 0.0 110.451 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.14 167.0 25.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.353 -1.086 . . . . 0.0 108.822 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 75.4 mt -71.03 -7.71 48.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.492 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.83 -11.46 21.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.528 -0.733 . . . . 0.0 110.309 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.501 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 11.7 p-10 -130.94 9.77 4.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.82 152.22 32.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 110.416 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.4 tp -99.2 95.46 7.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 186' ' ' ILE . 52.6 t -87.49 129.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.672 0.749 . . . . 0.0 109.606 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.5 mt -123.82 164.16 19.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.55 -0.719 . . . . 0.0 109.306 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.55 -166.36 11.97 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.517 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 1.1 tppp? -57.02 -36.83 70.91 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.555 -0.968 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.89 26.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 110.57 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.29 148.44 39.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.696 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.28 112.94 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.69 -49.93 75.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.972 -1.08 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.4 m120 -58.92 112.29 4.84 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 0.0 110.193 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -58.44 -11.73 11.86 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.576 1.517 . . . . 0.0 111.501 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 -18.53 57.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.381 -0.825 . . . . 0.0 109.92 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.32 -173.63 50.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.616 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -89.18 140.35 29.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -1.222 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -78.06 -21.17 51.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.416 -0.803 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -138.58 154.77 48.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.177 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -67.09 -1.88 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.744 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.536 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -148.48 46.14 1.04 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.128 -0.983 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.17 -46.56 99.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.697 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -52.55 -66.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.371 2.047 . . . . 0.0 112.044 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.41 -35.9 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.976 -1.077 . . . . 0.0 109.439 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.536 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 68.4 mtt-85 -60.67 -41.48 95.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -67.1 -31.77 72.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.766 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -65.21 -36.9 85.61 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.6 t -68.55 -35.5 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.56 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 73.1 t80 -66.32 -54.14 28.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.88 -27.08 68.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.933 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.26 -33.76 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 33.7 mt -68.23 -38.93 80.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.76 -57.33 12.67 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.55 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.6 m-20 -54.24 -34.42 60.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 109.274 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.4 mt -60.88 -23.8 65.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 110.219 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.18 -22.31 61.3 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.902 -1.124 . . . . 0.0 108.91 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.424 HD11 HG21 ' A' ' 60' ' ' THR . 95.8 mt -52.58 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.712 -1.243 . . . . 0.0 110.629 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.569 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.05 -13.0 60.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.744 -1.223 . . . . 0.0 109.66 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.84 -0.79 57.83 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.503 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.57 156.28 10.34 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.914 -1.345 . . . . 0.0 108.829 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.6 Cg_endo -49.93 150.68 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.892 1.728 . . . . 0.0 109.552 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.08 148.36 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.988 -1.07 . . . . 0.0 112.125 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -130.97 124.17 30.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.97 -157.32 27.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.53 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -131.85 145.11 51.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -1.074 . . . . 0.0 108.951 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.2 m-85 -141.51 142.44 33.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.485 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.34 123.15 37.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.3 m -115.85 134.81 54.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 250' ' ' ARG . 60.5 t80 -116.54 117.01 28.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.3 OUTLIER 45.4 24.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.161 -0.962 . . . . 0.0 109.425 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.57 164.74 45.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.491 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -142.73 171.52 24.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.55 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 60.9 m-70 -51.01 -34.87 31.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -1.225 . . . . 0.0 109.635 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.7 m -60.03 -57.82 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 139' ' ' ILE . 7.0 tp -61.57 -43.8 98.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.008 . . . . 0.0 109.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.5 m-20 -47.33 -46.84 25.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.88 -1.138 . . . . 0.0 108.577 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 56' ' ' THR . 60.5 t -64.15 -50.46 76.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.59 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -55.32 -51.18 67.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.997 -1.065 . . . . 0.0 109.285 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 139' ' ' ILE . 46.9 tp -51.07 -50.7 58.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.152 -0.967 . . . . 0.0 108.588 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.563 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.9 t -57.06 -54.79 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.458 ' NZ ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.89 -55.07 8.65 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 109.597 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.57 -51.29 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.95 -51.91 59.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.81 -25.51 65.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.34 -179.232 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.9 mt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.219 0.533 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' HD21 ' A' ' 86' ' ' ASN . 1.6 mm-40 -56.43 136.14 53.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.087 -1.008 . . . . 0.0 108.579 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HZ1' ' HB3' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -121.96 143.23 49.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.8 t -141.69 -170.46 3.12 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.8 m -101.6 138.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.483 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 9' ' ' GLU . 7.8 ptmm? -66.96 -25.37 66.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 8.2 pt-20 -148.14 158.4 44.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.993 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 142.32 57.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.481 -0.762 . . . . 0.0 110.133 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 11' ' ' LEU . 20.7 mt -120.68 167.07 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -137.13 142.25 42.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 26' ' ' LEU . 95.0 m-85 -139.26 151.7 46.69 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.48 153.44 19.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.0 110.023 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.44 177.02 36.77 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.83 153.7 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -1.047 . . . . 0.0 110.025 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.97 140.36 15.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.483 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.9 tt -60.46 -38.44 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -1.152 . . . . 0.0 110.807 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 73.8 m-70 -90.02 -51.26 5.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.564 -1.335 . . . . 0.0 110.963 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.1 p -70.11 -22.25 63.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.774 -0.579 . . . . 0.0 111.237 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.6 19.44 27.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -111.44 155.06 23.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -1.059 . . . . 0.0 109.788 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -74.34 137.0 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.647 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -143.16 143.59 31.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.064 -1.022 . . . . 0.0 109.594 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -108.14 160.06 16.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -139.84 145.13 37.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.731 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.466 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.8 mt -140.33 116.26 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 108.972 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.14 111.89 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.466 ' NE2' HG22 ' A' ' 27' ' ' ILE . 61.5 m-70 -107.46 139.89 20.97 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.1 Cg_exo -54.81 168.15 1.26 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.836 1.691 . . . . 0.0 111.495 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -142.12 178.93 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.611 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 mmtm -87.7 153.32 21.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.496 ' OE2' ' N ' ' A' ' 118' ' ' ASN . 63.1 mt-10 -47.51 146.43 2.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.496 -0.752 . . . . 0.0 109.939 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.26 4.71 45.09 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.032 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.586 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -67.92 -44.56 76.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.618 -1.519 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -179.26 32.14 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.471 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.76 115.74 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 6.8 ptm180 -140.3 152.09 45.59 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.951 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.03 157.81 16.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.9 111.09 12.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -134.7 133.51 40.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.73 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 53.16 28.33 6.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.577 -0.702 . . . . 0.0 111.401 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 18.88 69.95 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.399 -1.382 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 122.05 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -1.069 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 28.5 m-85 -83.82 127.07 33.56 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 mt -116.54 92.93 38.86 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.242 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.5 149.0 18.85 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.504 2.136 . . . . 0.0 112.086 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.44 69.4 9.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -121.31 170.95 9.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.2 p-80 -74.18 -48.58 28.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.622 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.56 -16.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.47 4.33 53.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.73 -1.231 . . . . 0.0 109.92 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -71.51 141.68 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.17 -29.26 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -0.847 . . . . 0.0 110.114 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -151.67 129.84 11.93 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 109.965 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -120.63 95.36 4.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.7 t-20 -163.28 129.41 3.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 73.3 m-70 49.9 9.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.177 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER 162.48 150.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.706 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -91.22 124.42 35.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 109.288 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.13 148.59 42.9 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.651 0.739 . . . . 0.0 110.637 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 72' ' ' VAL . 10.7 mt -125.48 153.2 43.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.35 154.55 25.35 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 118.974 -1.584 . . . . 0.0 110.747 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -161.37 149.83 15.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -1.017 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.8 mttt 46.36 24.18 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.621 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -34.45 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -54.87 145.57 19.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.255 . . . . 0.0 109.045 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -145.36 135.39 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 110.613 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.16 120.28 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -97.8 159.11 15.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 0.0 111.193 -178.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 71' ' ' THR . 91.7 m 46.52 74.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 62' ' ' LEU . 20.6 m -107.37 -8.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -60.61 -25.19 66.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.152 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.1 m170 -67.97 -69.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.049 . . . . 0.0 109.415 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.4 -47.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.099 -1.001 . . . . 0.0 109.129 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' N ' HG23 ' A' ' 75' ' ' ILE . 19.9 mt -52.08 -50.18 62.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.026 . . . . 0.0 110.137 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 39.2 t -60.32 -41.55 93.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.113 -0.992 . . . . 0.0 110.071 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 106' ' ' PHE . 97.4 t -56.88 -44.95 83.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.051 -1.031 . . . . 0.0 109.217 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.72 -33.76 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -62.89 -40.86 98.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 109.179 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD12 ' CG1' ' A' ' 175' ' ' VAL . 37.5 mt -75.38 -39.09 59.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.852 . . . . 0.0 109.702 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 82' ' ' LEU . 67.8 mt -79.42 -1.07 35.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.94 42.1 26.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 111.414 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 23.1 mm -90.69 139.91 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 108.226 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 73.3 p -126.9 -19.15 4.51 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.745 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.73 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.2 m-80 -124.98 106.25 9.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.827 -1.171 . . . . 0.0 110.274 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -165.86 150.67 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.729 0.776 . . . . 0.0 109.916 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.0 m -116.17 117.84 31.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.575 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.9 mt -100.19 100.36 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.352 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.1 mt-10 -71.77 126.08 28.8 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG22 HD21 ' A' ' 26' ' ' LEU . 19.2 t -112.55 121.02 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.949 0.88 . . . . 0.0 111.807 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mm -107.77 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.72 160.05 8.2 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -83.05 -7.45 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.267 . . . . 0.0 111.219 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -139.35 147.59 41.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.725 -1.234 . . . . 0.0 110.36 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 40.3 mm -73.18 121.28 84.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -41.82 123.83 2.48 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.665 1.577 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.2 tp -76.58 -15.4 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.678 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.7 mt 57.0 -122.09 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 27.0 t70 -93.36 7.3 45.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.024 -1.048 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.84 -3.9 62.94 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.243 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.94 -172.0 2.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.911 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.39 14.53 9.36 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -57.94 -41.76 83.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 0.0 110.284 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.89 -55.7 17.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.019 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' A' ' 78' ' ' VAL . 7.2 m-85 -51.4 -45.81 62.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 108.927 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.96 -54.18 48.12 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.268 0.556 . . . . 0.0 110.62 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.98 -43.69 98.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 111.508 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . . . -65.59 -56.83 10.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.961 -1.087 . . . . 0.0 110.363 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.12 -30.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 109.355 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -65.26 -43.36 91.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.307 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ1' ' HA ' ' A' ' 109' ' ' ALA . 3.7 pttm -76.41 9.88 2.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.892 -1.13 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -140.89 36.45 1.77 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 0.0 109.926 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -85.29 140.68 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 111.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -131.42 122.0 25.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.584 -0.697 . . . . 0.0 109.129 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.506 ' HB3' ' HZ1' ' A' ' 5' ' ' LYS . 6.7 m-80 -79.37 146.32 32.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -111.26 -174.45 2.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.447 -0.783 . . . . 0.0 109.42 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 26.8 t-20 -111.69 70.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.852 . . . . 0.0 110.579 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -168.41 134.69 1.9 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.355 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.39 143.98 51.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.065 -1.022 . . . . 0.0 110.15 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.11 151.43 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 0.0 110.233 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.53 83.78 3.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 108.872 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 15.0 m-85 -63.12 142.13 58.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.291 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -86.94 101.36 13.34 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.7 133.47 33.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 110.75 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.29 111.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.45 -30.1 23.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.138 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.92 155.34 77.89 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.01 149.87 53.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.536 2.158 . . . . 0.0 112.234 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.555 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.77 149.83 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 108.942 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.75 140.93 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.78 145.96 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.63 156.95 47.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -174.3 107.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.851 . . . . 0.0 109.929 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 53.33 52.86 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.51 -31.66 3.22 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -61.77 134.91 57.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.242 . . . . 0.0 108.52 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 138' ' ' LEU . 1.1 tt -147.5 137.12 22.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.854 -1.154 . . . . 0.0 109.901 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.551 HG13 HD23 ' A' ' 255' ' ' LEU . 75.4 mt -136.41 125.51 37.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.454 -0.779 . . . . 0.0 109.451 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -114.21 132.08 56.24 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.511 0.672 . . . . 0.0 109.932 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.05 134.66 54.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.69 149.18 32.94 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.921 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -45.87 143.04 7.22 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.62 2.213 . . . . 0.0 113.447 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.2 t -156.61 144.82 19.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 146' ' ' THR . 53.5 t0 -62.75 -5.6 2.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.898 . . . . 0.0 110.332 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' ASP . 24.6 p -156.15 -167.43 2.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.359 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.0 tp -102.51 121.49 42.47 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -134.5 108.24 8.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.68 122.79 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.07 -1.019 . . . . 0.0 110.206 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 m -112.76 151.13 30.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 38.9 t80 -141.64 130.47 22.97 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.126 -1.029 . . . . 0.0 111.234 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -120.98 133.96 55.29 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.08 142.11 13.49 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.601 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -104.06 99.41 9.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -87.87 167.41 13.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.558 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -105.55 -11.53 16.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.471 -0.768 . . . . 0.0 110.72 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 159' ' ' LEU . 31.1 p-10 -98.53 -164.83 1.17 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.789 -1.195 . . . . 0.0 110.456 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -55.41 0.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 111.161 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 157' ' ' ASN . 16.5 mt -83.61 -30.4 26.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.504 -1.372 . . . . 0.0 108.565 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.27 -138.67 42.8 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -99.91 135.87 40.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -1.151 . . . . 0.0 109.306 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.43 ' NE2' HD22 ' A' ' 159' ' ' LEU . 25.1 mt-30 -144.8 159.03 43.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.435 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 149.85 33.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 110.159 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -143.63 140.67 30.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.8 m -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.705 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.548 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.6 t80 -105.2 114.39 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.44 152.95 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -49.8 126.11 13.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.175 -0.953 . . . . 0.0 108.975 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.503 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 106.24 2.11 38.49 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -121.02 21.54 11.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.248 -1.148 . . . . 0.0 109.718 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.1 pm0 -59.32 -54.7 43.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 4.3 mt-10 -41.42 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 0.0 110.085 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 171' ' ' GLU . 67.3 mm-40 -87.59 -6.99 58.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 111.731 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.56 -27.73 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.863 -1.148 . . . . 0.0 111.282 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' A' ' 81' ' ' LEU . 5.0 m -63.32 -17.27 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 108.669 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mt -90.02 -5.89 56.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.266 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.87 119.07 13.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -79.94 173.06 12.97 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.442 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -76.37 162.51 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -146.19 146.87 30.97 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.237 -1.539 . . . . 0.0 111.421 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.78 157.8 43.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 81.3 m-85 -100.04 146.48 26.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.94 -1.1 . . . . 0.0 109.092 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -50.14 -33.73 19.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.109 -0.995 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.6 p90 -74.33 -28.31 61.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.786 -1.197 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -75.21 -35.58 61.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 65.0 mt -52.34 -49.93 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -47.34 -41.66 19.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 110.079 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -74.34 -48.34 28.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.131 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.2 mt -52.38 -30.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.44 -53.77 5.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 0.0 109.365 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -48.88 -32.59 9.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.487 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.8 m -87.16 7.66 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.02 . . . . 0.0 110.506 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.73 39.88 54.38 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.083 -1.01 . . . . 0.0 110.725 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.53 174.75 9.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -1.216 . . . . 0.0 109.808 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.7 22.13 52.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -57.97 -19.91 34.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.679 -1.483 . . . . 0.0 109.63 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.32 10.34 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 125.47 7.76 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 120.859 -1.377 . . . . 0.0 109.72 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.4 t -143.27 169.47 17.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -1.146 . . . . 0.0 109.806 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.56 -8.73 36.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -13.26 25.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -136.18 11.32 3.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.14 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.433 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.06 149.28 30.09 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 110.275 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.3 tp -98.94 93.32 5.96 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 203' ' ' THR . 48.8 t -86.1 130.03 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.738 0.78 . . . . 0.0 109.019 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.41 164.92 18.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.632 -0.667 . . . . 0.0 109.365 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -127.03 -166.6 12.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -61.69 -32.43 72.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 109.552 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.6 22.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -142.09 149.17 39.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.808 -1.183 . . . . 0.0 110.688 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.407 HG11 ' HA2' ' A' ' 216' ' ' GLY . 87.6 t -101.96 111.32 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -58.23 -47.01 84.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 110.063 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.16 124.17 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 109.787 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -67.09 -18.07 51.16 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.57 1.514 . . . . 0.0 111.965 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 -15.34 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.923 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.13 -163.53 53.99 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.638 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -91.55 148.35 22.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.207 . . . . 0.0 109.833 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -87.0 -18.36 30.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 108.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.499 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 60.2 m-85 -137.73 178.69 6.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -82.88 -14.18 54.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.68 52.25 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.514 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -58.18 -48.19 97.47 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.039 -1.038 . . . . 0.0 109.89 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.8 Cg_exo -49.79 -68.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 228' ' ' VAL . 20.7 m -58.77 -34.71 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.005 -1.059 . . . . 0.0 109.604 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.499 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 56.2 mtt180 -61.23 -41.18 96.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -67.26 -31.65 72.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.326 -0.95 . . . . 0.0 108.692 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 12.8 mmtp -66.07 -37.33 85.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 166' ' ' PHE . 56.0 t -67.3 -35.87 75.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.1 t80 -65.84 -54.77 22.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.554 0.693 . . . . 0.0 109.236 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.11 -27.91 69.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.753 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.67 -34.08 58.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 108.394 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.79 -39.45 85.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -57.88 8.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.411 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 78.6 m-20 -51.4 -34.65 35.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -1.23 . . . . 0.0 109.001 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.6 mt -62.52 -22.76 66.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.038 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.08 -22.97 60.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.857 -1.152 . . . . 0.0 108.919 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 237' ' ' LEU . 94.6 mt -50.15 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.699 -1.251 . . . . 0.0 109.909 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 236' ' ' TYR . 9.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.478 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 1.42 59.33 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.485 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.95 156.93 10.08 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.012 -1.287 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.36 150.35 8.09 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.966 1.778 . . . . 0.0 109.655 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.07 143.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 112.133 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.01 121.53 33.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.49 175.27 23.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -101.9 135.26 43.77 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.203 -1.175 . . . . 0.0 109.276 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.8 m-85 -130.76 136.52 48.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.288 -0.882 . . . . 0.0 109.596 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -126.17 126.15 43.64 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 m -119.42 133.08 55.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.853 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.539 ' CZ ' ' NE ' ' A' ' 250' ' ' ARG . 74.8 t80 -115.34 112.83 22.96 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.539 ' NE ' ' CZ ' ' A' ' 249' ' ' PHE . 71.4 mtt180 48.41 32.48 3.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.81 165.26 54.71 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -140.33 179.64 18.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.588 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.4 m-70 -59.64 -41.62 90.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -1.203 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.091 -1.006 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 139' ' ' ILE . 5.8 tp -57.94 -45.13 87.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.424 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 11.0 m-20 -47.42 -51.25 20.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.989 -1.07 . . . . 0.0 109.077 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 56' ' ' THR . 71.3 t -62.91 -44.71 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -0.793 . . . . 0.0 109.849 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -58.75 -50.08 75.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 0.0 109.292 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.86 -49.18 69.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 108.695 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 238' ' ' LEU . 17.2 t -60.43 -58.2 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.077 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -43.32 17.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 109.061 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 130' ' ' ILE . 2.8 mm-40 -66.24 -47.12 74.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.32 -49.63 76.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.423 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -70.48 -28.6 65.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.023 -1.048 . . . . 0.0 109.859 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.229 0.538 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 85' ' ' THR . 9.4 mm-40 -54.45 139.65 36.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 108.71 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -122.66 146.27 47.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 110.234 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -143.61 -171.62 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.0 m -99.35 135.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.971 -1.081 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -65.19 -21.61 66.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.778 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -152.86 158.72 42.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 140.46 58.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.288 -0.883 . . . . 0.0 110.055 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -118.22 164.8 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -131.32 139.87 49.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 110.18 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -138.05 146.23 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.1 154.05 24.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 110.349 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.87 175.21 36.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.33 151.68 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -1.07 . . . . 0.0 110.069 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.75 138.66 15.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CG2' HD13 ' A' ' 98' ' ' ILE . 8.7 tt -59.73 -37.21 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -1.22 . . . . 0.0 110.403 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 29.6 m-70 -89.66 -50.66 5.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.66 -1.275 . . . . 0.0 111.08 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 p -70.66 -24.26 62.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.797 -0.565 . . . . 0.0 111.822 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.21 14.64 26.7 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.146 -1.502 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.07 155.38 19.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -1.142 . . . . 0.0 109.407 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -75.24 134.53 41.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m -137.55 145.84 43.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -114.54 155.26 26.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.451 -0.78 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 96' ' ' ILE . 9.1 mt -136.25 144.19 44.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.643 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' NE2' ' A' ' 29' ' ' HIS . 4.7 mp -139.49 112.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.81 115.76 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.349 -0.845 . . . . 0.0 110.858 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.562 ' NE2' HG22 ' A' ' 27' ' ' ILE . 19.6 m-70 -106.96 139.68 20.64 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.495 -0.753 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.3 Cg_exo -56.46 168.24 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.533 1.489 . . . . 0.0 111.238 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 35' ' ' THR . 50.1 mm-40 -144.51 163.39 34.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 109.629 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -74.55 155.42 37.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 118' ' ' ASN . 5.2 mt-10 -49.96 149.88 2.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.174 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.26 19.52 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.042 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.47 HG21 ' HB3' ' A' ' 31' ' ' GLU . 90.0 m -58.0 -48.53 79.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.555 -1.556 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.68 178.42 35.17 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mm -92.97 116.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -1.033 . . . . 0.0 108.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 35' ' ' THR . 14.1 ptp180 -144.18 151.01 38.92 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.456 -1.297 . . . . 0.0 110.883 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.97 157.06 16.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -129.87 111.83 12.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.413 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -135.19 134.88 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 110.735 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.2 27.39 2.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.608 -0.682 . . . . 0.0 111.247 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.72 66.2 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.04 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.23 120.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 108.808 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -84.77 126.06 33.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.12 -0.987 . . . . 0.0 109.192 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.1 mt -117.01 91.45 36.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.13 148.06 14.4 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.667 2.245 . . . . 0.0 112.077 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.13 70.38 9.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -128.54 174.44 9.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 109.186 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.7 p-80 -71.52 -49.58 39.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -43.19 -17.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 111.496 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.4 m-85 -100.2 -2.47 33.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.684 -1.26 . . . . 0.0 110.163 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.4 t -66.92 121.13 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.185 -0.947 . . . . 0.0 108.576 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.99 -30.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.275 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.32 136.24 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.254 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 257' ' ' VAL . 66.9 p -123.75 95.96 4.78 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.0 t-20 -162.47 129.05 3.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 108.882 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 91.6 m-70 50.19 8.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 108.983 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.26 147.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.851 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 m -90.13 128.29 36.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.322 -0.861 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.75 150.6 41.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.478 -0.763 . . . . 0.0 111.056 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.542 HD12 HG11 ' A' ' 72' ' ' VAL . 9.0 mt -123.89 149.49 45.78 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.02 150.31 20.42 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -162.82 148.17 12.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.423 -1.045 . . . . 0.0 108.965 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.452 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.06 25.93 2.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 109.677 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.92 5.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.549 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 5.3 mm-40 -57.45 145.1 34.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -1.221 . . . . 0.0 109.152 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.58 137.71 26.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 110.407 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 96' ' ' ILE . 55.5 mt -131.18 125.94 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -101.08 156.21 17.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.023 -1.048 . . . . 0.0 111.294 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.0 m 51.79 75.29 0.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 HD12 ' A' ' 62' ' ' LEU . 34.9 m -107.52 -9.06 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.11 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pm0 -61.4 -26.34 67.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 0.0 110.361 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 30.8 m170 -68.2 -69.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.068 -1.02 . . . . 0.0 109.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -51.88 -48.42 39.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.197 -0.939 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.605 ' N ' HG23 ' A' ' 75' ' ' ILE . 13.1 mt -51.86 -48.8 63.87 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.006 -1.058 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -60.26 -43.09 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.119 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 106' ' ' PHE . 94.8 t -56.67 -45.69 82.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 109.193 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 89' ' ' ILE . 25.6 mt -65.97 -34.37 77.96 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.212 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -63.37 -37.0 85.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.316 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 171' ' ' GLU . 78.3 mt -77.13 -38.91 51.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 107' ' ' TYR . 96.1 mt -80.64 6.53 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 110.034 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 52.36 39.73 27.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 110.07 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.69 141.66 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 108.267 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.61 HG21 HG12 ' A' ' 121' ' ' ILE . 54.9 p -128.98 -22.6 3.17 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.114 -0.991 . . . . 0.0 111.873 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.681 ' O ' HG13 ' A' ' 87' ' ' VAL . 76.9 m-20 -124.0 107.72 11.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.874 -1.141 . . . . 0.0 110.278 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.8 142.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.519 -0.738 . . . . 0.0 110.138 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 96.0 m -109.42 111.46 23.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 79' ' ' LEU . 6.5 mt -93.97 100.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 110.311 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -75.08 125.46 28.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.612 HG22 HD21 ' A' ' 26' ' ' LEU . 16.1 t -114.75 118.39 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.947 0.879 . . . . 0.0 111.675 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' ILE . 11.0 mt -105.4 98.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.84 -159.23 27.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 -13.63 8.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -1.135 . . . . 0.0 110.421 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -138.73 146.99 42.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.979 -1.076 . . . . 0.0 109.676 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.68 HG23 HD11 ' A' ' 26' ' ' LEU . 43.5 mm -70.08 119.83 74.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 108.706 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.27 124.49 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.88 1.72 . . . . 0.0 111.62 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.497 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.0 tp -76.39 -15.42 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 110.206 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.7 mt 55.36 -123.14 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -92.66 8.97 36.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.15 -7.87 69.63 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.47 -1.348 . . . . 0.0 109.973 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.2 p -124.02 -172.1 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.61 -0.936 . . . . 0.0 109.16 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.62 13.71 11.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 48.3 t-105 -56.08 -42.33 76.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -1.125 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.27 -54.78 31.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 78' ' ' VAL . 10.3 m-85 -54.85 -46.49 74.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.118 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 82' ' ' LEU . 34.5 t80 -60.69 -56.54 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.731 -0.606 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 13.6 mm-40 -58.88 -44.01 91.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.145 -0.972 . . . . 0.0 111.337 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.6 -51.79 46.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.964 -1.085 . . . . 0.0 110.719 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.7 mt -69.31 -31.87 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.155 . . . . 0.0 109.344 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.46 -43.22 94.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 110.258 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.23 17.05 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -144.05 29.04 1.35 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -0.999 . . . . 0.0 110.169 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.7 mt -79.61 141.35 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.607 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.58 123.47 33.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.612 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.97 141.0 37.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.94 . . . . 0.0 110.314 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.85 -175.74 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.394 -0.816 . . . . 0.0 109.26 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.487 ' OD1' ' OE2' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -109.66 70.09 0.72 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -169.22 134.03 1.48 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.082 -1.011 . . . . 0.0 109.503 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.13 142.56 54.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.61 HG12 HG21 ' A' ' 85' ' ' THR . 35.0 mt -84.79 150.16 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 110.024 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.74 90.0 4.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -68.94 148.03 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.94 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -90.12 101.98 14.69 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.22 134.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.612 -0.68 . . . . 0.0 111.204 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.21 118.72 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.51 -27.04 15.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.522 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.18 152.5 79.66 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 151.52 46.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.64 2.226 . . . . 0.0 112.286 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 7.9 tt -160.04 153.15 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.336 -0.853 . . . . 0.0 109.29 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.11 145.31 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.84 149.29 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 138' ' ' LEU . 28.8 mt-10 -139.85 157.86 45.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.132 -0.98 . . . . 0.0 110.196 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.86 111.35 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.252 -0.905 . . . . 0.0 109.93 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 52.47 48.19 23.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.541 -0.724 . . . . 0.0 110.833 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.6 -33.59 3.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.366 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 1.5 mpt_? -64.31 131.95 48.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.915 -1.344 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -145.03 141.63 29.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 110.357 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 255' ' ' LEU . 92.4 mt -136.88 132.18 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.779 . . . . 0.0 109.859 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.43 133.04 56.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.413 0.625 . . . . 0.0 110.007 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.71 135.33 53.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.727 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.02 149.62 39.51 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.868 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -48.48 142.4 17.73 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.523 2.149 . . . . 0.0 113.382 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.12 145.19 19.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.97 -30.43 70.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -127.01 -171.14 2.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.74 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.467 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 12.3 tp -100.15 123.46 44.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.163 -0.96 . . . . 0.0 108.675 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.449 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 tt0 -136.28 118.03 15.07 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.233 -0.917 . . . . 0.0 108.555 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.84 122.2 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.47 ' OG1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 m -113.15 152.05 30.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.479 -0.763 . . . . 0.0 109.679 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 227' ' ' LYS . 39.2 t80 -138.78 130.79 28.08 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.948 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -119.98 130.44 54.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.78 135.64 8.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.645 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -98.55 100.39 11.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.79 167.02 13.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 110.66 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -102.84 -22.53 13.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.912 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' LEU . 26.0 p-10 -88.05 -171.42 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.701 -1.249 . . . . 0.0 109.986 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -52.23 1.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 111.458 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.5 mt -79.44 -28.58 41.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.353 -1.467 . . . . 0.0 108.71 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.05 -142.55 35.15 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -99.6 135.65 40.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -138.26 153.5 49.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.812 . . . . 0.0 109.41 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -141.22 144.85 34.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.288 -0.882 . . . . 0.0 109.754 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.583 ' CE1' ' NH2' ' A' ' 225' ' ' ARG . 49.2 t80 -142.05 132.89 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.661 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 86.9 m -103.78 122.68 45.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.2 t80 -103.83 114.06 28.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.9 152.79 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.737 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 3.2 mm-40 -49.96 128.19 18.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.69 1.81 43.1 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -117.83 20.29 13.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.15 -51.47 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 5.0 mt-10 -47.76 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 171' ' ' GLU . 9.3 mm-40 -102.94 -6.11 22.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.123 -0.985 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.7 pt -125.16 -26.84 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.959 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 175' ' ' VAL . 5.2 m -62.13 -10.66 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.815 -1.178 . . . . 0.0 109.106 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -98.46 -2.17 39.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 0.0 109.078 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.44 122.2 16.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 215' ' ' GLU . 52.5 mtm180 -94.23 128.27 40.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.869 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 12.5 t -36.53 158.67 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -145.2 150.0 35.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.51 -1.369 . . . . 0.0 111.49 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.39 157.05 43.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.6 m-85 -97.7 145.52 26.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.442 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.97 -37.11 8.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.363 -0.835 . . . . 0.0 109.278 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -74.29 -29.56 61.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.1 mm-40 -71.52 -31.64 67.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 59.6 mt -57.24 -55.07 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.669 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.8 tt0 -42.85 -38.74 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.13 -0.981 . . . . 0.0 109.302 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 189' ' ' ILE . 9.3 t60 -76.3 -59.34 2.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.051 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 188' ' ' HIS . 82.9 mt -41.75 -36.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.698 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -79.43 -51.83 8.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.875 -1.141 . . . . 0.0 109.226 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -49.35 -27.17 3.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 110.709 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.51 11.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.746 -1.221 . . . . 0.0 110.086 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.44 39.54 69.35 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.433 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.1 mt -129.61 172.59 11.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -1.179 . . . . 0.0 109.998 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.99 21.84 59.54 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -58.93 -21.19 57.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.463 -1.61 . . . . 0.0 109.749 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.405 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.56 25.51 11.03 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -87.49 132.94 11.48 Favored Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.923 -1.34 . . . . 0.0 109.921 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.9 174.39 11.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -1.095 . . . . 0.0 109.564 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.18 -7.52 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 108.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -97.51 -19.97 18.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.603 -0.686 . . . . 0.0 110.003 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.8 p30 -125.68 3.35 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -144.54 145.35 31.79 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.636 HD11 HD21 ' A' ' 206' ' ' LEU . 25.8 tp -96.35 96.13 8.54 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.53 128.22 39.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.9 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.636 HD21 HD11 ' A' ' 204' ' ' LEU . 29.7 mt -123.38 162.99 21.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.539 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.2 -166.28 12.74 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -24.54 66.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.457 -1.025 . . . . 0.0 109.966 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.6 24.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -151.97 160.47 43.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.515 -1.365 . . . . 0.0 110.643 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.559 HG11 ' HA2' ' A' ' 216' ' ' GLY . 88.5 t -106.08 114.01 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -57.56 -46.94 83.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 110.46 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 213' ' ' ASN . 1.3 m-20 -59.31 130.39 87.21 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.17 -0.956 . . . . 0.0 110.53 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -67.88 -21.62 43.77 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.682 1.588 . . . . 0.0 111.688 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -80.71 -15.46 56.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.957 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.559 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.51 -157.5 53.29 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.262 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.6 mt -89.19 154.44 20.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -1.138 . . . . 0.0 110.138 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -90.14 -19.54 24.14 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -138.75 -176.5 4.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 19.2 mp0 -83.6 -20.16 34.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 109.529 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.649 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -136.12 54.7 1.89 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -57.59 -46.31 99.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.893 -1.13 . . . . 0.0 109.848 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.6 Cg_exo -52.67 -66.26 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.221 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 225' ' ' ARG . 21.9 m -59.69 -36.07 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 109.512 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.583 ' NH2' ' CE1' ' A' ' 164' ' ' PHE . 74.6 mtt-85 -59.79 -41.21 90.67 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -68.17 -31.64 71.34 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.1 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.4 ' HB3' ' CD2' ' A' ' 151' ' ' TYR . 16.9 mmtt -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 166' ' ' PHE . 64.3 t -69.17 -38.37 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.3 t80 -62.56 -51.34 67.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 108.892 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -64.76 -29.51 70.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.526 -0.733 . . . . 0.0 110.016 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.87 -33.77 51.97 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.3 mt -65.76 -37.81 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.22 -56.1 11.29 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.425 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 92.4 m-20 -52.67 -37.14 58.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.246 . . . . 0.0 109.309 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.2 mt -60.04 -24.04 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 110.497 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.592 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -70.66 -21.58 62.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.783 -1.198 . . . . 0.0 108.792 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.13 3.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.56 -1.338 . . . . 0.0 110.318 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 260' ' ' VAL . 7.7 mt -82.98 -16.47 47.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 0.0 109.585 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.17 44.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.913 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.75 158.69 11.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.428 . . . . 0.0 109.297 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.15 128.3 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.874 1.716 . . . . 0.0 109.456 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.1 t -87.86 154.56 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.992 -1.068 . . . . 0.0 112.387 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -136.26 127.57 28.3 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.38 -155.0 25.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.47 ' NZ ' ' OG1' ' A' ' 150' ' ' THR . 19.9 tptt -133.49 127.49 33.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 108.697 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -127.82 140.76 51.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.313 -0.867 . . . . 0.0 110.572 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -123.65 133.91 53.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.5 t -127.26 134.89 50.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.952 -1.092 . . . . 0.0 110.95 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -116.91 115.82 26.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 47.44 24.37 0.47 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.168 -0.957 . . . . 0.0 109.248 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 152.92 37.45 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.58 166.6 22.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.592 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 60.0 m-70 -48.77 -40.68 29.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.131 -1.217 . . . . 0.0 109.531 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -54.91 -58.53 7.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.54 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 139' ' ' ILE . 7.8 tp -57.14 -45.48 83.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.646 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.2 m-20 -47.51 -51.26 21.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.361 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 56' ' ' THR . 87.9 t -62.72 -50.55 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.928 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -52.05 -52.2 52.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.008 . . . . 0.0 109.356 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 139' ' ' ILE . 37.0 tp -51.28 -51.33 55.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 108.533 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.609 HG13 ' HG ' ' A' ' 238' ' ' LEU . 69.0 t -53.93 -50.07 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.918 . . . . 0.0 108.828 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -51.23 -55.16 19.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.515 -0.74 . . . . 0.0 109.732 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.19 -49.91 75.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 110.022 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.5 mt -56.7 -52.11 66.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.1 67.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.272 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.196 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.522 ' O ' HD11 ' A' ' 121' ' ' ILE . 6.9 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.58 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -58.0 136.62 57.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 109.063 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.675 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -120.96 141.58 50.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 109.54 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -139.19 -170.12 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 29.8 m -99.57 136.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.022 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -66.47 -16.67 64.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -156.18 159.85 39.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 139.21 57.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 110.228 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 11' ' ' LEU . 57.2 mt -117.66 165.41 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.66 144.51 39.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.957 -1.089 . . . . 0.0 110.483 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.7 m-85 -140.41 155.35 46.77 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -162.11 152.81 17.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.782 -1.199 . . . . 0.0 110.275 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.4 176.83 36.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.53 153.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.179 . . . . 0.0 110.424 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.62 141.13 16.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.1 tt -61.51 -41.29 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 111.026 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.5 m-70 -87.1 -50.49 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.534 -1.354 . . . . 0.0 111.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -70.24 -22.82 62.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 111.363 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.0 20.65 35.01 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.931 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -110.86 154.1 24.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.65 135.4 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -139.67 143.37 37.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -112.38 154.39 25.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.324 -0.86 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 96' ' ' ILE . 7.9 mt -132.43 148.98 52.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.367 -0.833 . . . . 0.0 110.312 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.501 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.0 mt -143.58 110.78 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.52 117.44 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 111.032 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.501 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.0 m-70 -110.65 138.84 21.14 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.458 -0.776 . . . . 0.0 109.701 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.4 Cg_exo -54.28 168.58 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.958 1.772 . . . . 0.0 111.79 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 50.3 mm-40 -140.86 177.49 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.918 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.0 mttt -86.02 153.0 22.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.393 -0.817 . . . . 0.0 110.136 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -47.25 145.67 2.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.089 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.3 7.33 51.58 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.128 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.6 m -69.56 -43.68 72.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.659 -1.495 . . . . 0.0 109.56 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.73 -178.96 32.72 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.359 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.15 116.52 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 8.8 ptm180 -140.26 150.86 44.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.822 -1.174 . . . . 0.0 110.382 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.66 157.4 16.71 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -129.43 110.97 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.181 -0.949 . . . . 0.0 108.877 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.555 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 32.7 tttm -135.64 135.26 40.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.534 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.555 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 15.2 m120 52.85 28.88 6.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 111.19 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.27 18.1 78.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.958 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -122.7 122.22 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -1.028 . . . . 0.0 108.808 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 42.1 m-85 -83.84 126.5 33.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.089 -1.007 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -115.39 95.64 43.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.31 145.04 22.04 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.427 2.085 . . . . 0.0 112.081 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.24 74.8 10.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -132.79 -179.91 5.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.381 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.6 p-80 -75.78 -53.26 8.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.129 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -43.28 -17.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.232 -0.918 . . . . 0.0 110.963 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.2 m-85 -97.63 1.31 48.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.735 -1.228 . . . . 0.0 109.837 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' HD23 ' A' ' 62' ' ' LEU . 48.8 t -71.54 131.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.099 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -30.05 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -151.08 133.49 15.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.685 HG21 HG21 ' A' ' 257' ' ' VAL . 76.2 p -124.38 95.44 4.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.207 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 59' ' ' SER . 46.0 t-20 -162.97 128.86 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 47.4 11.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 108.969 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 163.37 141.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.344 -0.847 . . . . 0.0 110.098 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.436 HG21 HD11 ' A' ' 237' ' ' LEU . 86.2 m -90.62 127.97 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.376 -0.828 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.42 151.75 39.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.664 0.745 . . . . 0.0 111.002 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 53' ' ' VAL . 10.8 mt -126.23 148.23 49.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.63 154.14 25.12 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.088 -1.529 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -165.31 152.95 11.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt 50.69 22.26 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.13 -33.48 6.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 9.0 mm-40 -56.22 147.34 21.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.229 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.9 135.55 26.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.272 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.36 126.11 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -103.29 156.23 17.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.968 -1.082 . . . . 0.0 111.078 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.8 m 51.64 75.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.943 -0.473 . . . . 0.0 110.818 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.3 m -108.07 -10.32 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.5 pm0 -61.45 -26.8 68.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.906 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.427 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.0 m170 -66.35 -68.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.574 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.8 tp -52.07 -47.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 109.161 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 48' ' ' ALA . 17.5 mt -52.33 -49.15 64.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 17.5 t -59.73 -43.17 94.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.35 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.71 -44.6 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.975 -1.078 . . . . 0.0 109.101 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.56 -36.07 80.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.964 . . . . 0.0 109.588 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.72 -35.58 78.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.579 HD13 ' CB ' ' A' ' 171' ' ' GLU . 68.1 mt -79.47 -36.93 37.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.38 -0.825 . . . . 0.0 109.843 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 114' ' ' ILE . 94.8 mt -83.52 4.12 29.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.084 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 53.59 40.62 31.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.556 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 5' ' ' LYS . 27.3 mm -85.33 142.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 42.5 p -129.81 -22.61 2.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.186 -0.946 . . . . 0.0 111.612 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.698 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -125.2 107.03 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.744 -1.223 . . . . 0.0 110.035 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.9 m -164.3 148.55 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.616 0.722 . . . . 0.0 110.008 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.496 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 57.4 m -117.19 108.19 15.37 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.436 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -90.18 100.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.804 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 26' ' ' LEU . 10.6 tt0 -73.78 125.14 27.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.99 119.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.815 0.817 . . . . 0.0 111.542 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -105.94 97.75 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.56 -158.77 27.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -120.49 -13.03 8.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -139.56 148.23 42.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 109.707 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 HD11 ' A' ' 26' ' ' LEU . 45.7 mm -71.66 120.76 81.81 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 108.943 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.05 120.23 1.45 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.733 1.622 . . . . 0.0 111.629 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.459 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.2 tp -78.38 -15.8 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.8 mt 55.76 -115.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.267 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.82 5.6 50.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.032 -1.043 . . . . 0.0 110.797 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.96 0.7 61.83 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.147 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -126.7 -172.87 2.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.661 -0.905 . . . . 0.0 109.629 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.33 16.7 8.02 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -57.77 -41.73 82.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -1.08 . . . . 0.0 110.086 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -64.54 -57.15 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.105 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 14.7 m-85 -51.57 -46.55 63.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.97 . . . . 0.0 109.348 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -61.03 -51.04 70.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.667 -0.646 . . . . 0.0 110.941 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.18 -42.45 96.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.002 -1.061 . . . . 0.0 111.245 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.91 -58.49 4.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.5 -34.4 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.099 -1.001 . . . . 0.0 109.577 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -63.25 -42.21 99.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.98 . . . . 0.0 109.26 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 11.86 0.81 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.465 ' HA ' ' HZ2' ' A' ' 8' ' ' LYS . 3.5 m-80 -146.24 33.64 0.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.557 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 70.2 mt -78.19 139.59 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.742 -1.224 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 8' ' ' LYS . 31.8 tp -127.7 121.96 31.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -0.779 . . . . 0.0 108.998 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.605 ' ND2' ' HZ1' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -79.04 142.59 36.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.144 -0.972 . . . . 0.0 110.354 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -111.56 -170.61 1.68 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.358 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -116.64 71.22 0.78 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.144 -0.972 . . . . 0.0 111.713 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.572 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 9.4 ttt180 -170.02 132.11 1.07 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.959 -1.088 . . . . 0.0 109.31 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.32 142.11 57.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.959 -1.088 . . . . 0.0 110.238 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 3' ' ' LEU . 89.5 mt -87.6 151.74 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.35 79.3 3.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.284 -0.885 . . . . 0.0 108.813 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 36.4 m-85 -58.78 146.67 36.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.294 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -93.11 101.91 14.22 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.75 132.68 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.359 0.599 . . . . 0.0 110.918 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.3 117.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -95.06 -27.57 15.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 110.662 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -134.36 150.78 74.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.549 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.98 151.42 62.12 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -157.22 150.69 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.416 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 130' ' ' ILE . 2.7 mp -138.68 136.44 43.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 108.965 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 HD11 ' A' ' 255' ' ' LEU . 29.9 m -124.64 147.48 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -130.0 164.71 23.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 0.0 110.263 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -171.82 102.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.841 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 48.05 57.43 6.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 110.731 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.05 -34.51 3.57 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -63.25 138.28 58.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.252 . . . . 0.0 109.133 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.46 137.89 28.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.082 -1.011 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 255' ' ' LEU . 46.2 mt -135.75 121.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.399 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -110.99 131.69 54.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.436 0.636 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -119.87 132.88 55.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.55 146.92 34.21 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 110.258 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -47.11 141.78 12.37 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.654 2.236 . . . . 0.0 113.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.419 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.02 144.35 19.98 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 146' ' ' THR . 4.0 t0 -66.16 0.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.792 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 145' ' ' ASP . 27.9 p -157.13 173.6 16.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.841 -1.162 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 tp -85.11 118.3 24.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -137.45 126.17 23.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 108.764 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.41 121.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.9 m -111.62 151.7 28.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.642 -0.661 . . . . 0.0 109.292 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.03 130.25 26.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.721 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -120.88 131.66 54.52 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.24 133.91 7.46 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.584 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -100.98 97.72 8.26 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -88.57 167.13 13.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.983 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -98.99 -17.05 18.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.76 -0.587 . . . . 0.0 110.697 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.0 p-10 -92.62 -168.59 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.825 -1.172 . . . . 0.0 110.386 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -55.08 0.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.362 -0.836 . . . . 0.0 111.472 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.537 HD22 ' OE1' ' A' ' 162' ' ' GLN . 11.2 mt -78.55 -27.65 45.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.443 -1.411 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.8 -137.96 34.96 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -100.4 132.3 45.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.202 -1.175 . . . . 0.0 109.682 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.537 ' OE1' HD22 ' A' ' 159' ' ' LEU . 56.4 mt-30 -139.5 155.52 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.125 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -147.93 149.5 32.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.113 -0.992 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -143.46 139.32 29.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.512 -0.742 . . . . 0.0 109.41 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.29 124.82 51.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.509 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.8 t80 -105.12 113.77 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.848 . . . . 0.0 110.327 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.0 153.06 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.316 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.01 125.61 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.248 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 102.73 3.59 49.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -120.24 19.9 12.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.307 -1.114 . . . . 0.0 109.278 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 173' ' ' GLU . 2.2 pm0 -64.88 -46.49 81.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.642 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -47.8 -7.52 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 171' ' ' GLU . 75.0 mt-10 -103.58 -5.89 22.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.482 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.4 pt -123.29 -26.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.217 -0.927 . . . . 0.0 110.558 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -60.79 -23.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.569 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.9 mt -85.27 -2.2 57.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -71.49 119.09 15.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.417 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 42.5 mtm180 -83.53 172.97 11.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.4 163.38 25.7 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -147.78 147.91 30.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.22 -1.55 . . . . 0.0 111.786 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -147.87 157.88 43.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.443 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.0 m-85 -97.85 146.94 24.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.901 -1.124 . . . . 0.0 109.78 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.52 -37.31 26.22 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.304 -0.872 . . . . 0.0 109.176 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.443 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.0 p90 -71.05 -25.56 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.13 -0.981 . . . . 0.0 109.947 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.434 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 mt-10 -82.39 -22.93 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.977 . . . . 0.0 109.742 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.85 -53.67 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.639 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.88 -38.02 9.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.686 ' O ' HG22 ' A' ' 192' ' ' VAL . 71.3 t60 -76.54 -53.78 7.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.122 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.82 -32.3 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.788 . . . . 0.0 109.533 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -52.61 6.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.039 -1.038 . . . . 0.0 109.226 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -49.84 -40.43 42.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 110.265 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 188' ' ' HIS . 28.0 m -78.55 5.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.006 -1.059 . . . . 0.0 110.218 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.96 37.21 56.71 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 194' ' ' LEU . 35.4 mt -125.39 168.89 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 109.433 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.51 21.77 58.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.74 -20.27 5.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.571 -1.547 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.447 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.67 26.32 9.05 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 128.53 9.19 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.946 -1.326 . . . . 0.0 110.034 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.8 p -144.93 171.97 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -1.056 . . . . 0.0 109.422 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.47 -8.14 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -97.06 -12.73 22.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.772 -0.58 . . . . 0.0 109.515 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.0 p30 -133.13 7.54 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 109.882 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -149.88 151.0 32.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.609 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.8 tp -98.15 95.4 7.4 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.3 t -85.87 127.76 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.788 0.804 . . . . 0.0 109.28 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.562 ' CD2' HG13 ' A' ' 211' ' ' VAL . 52.9 mt -123.24 161.47 24.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.647 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.94 -166.65 12.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -29.73 70.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -1.099 . . . . 0.0 109.672 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.66 23.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -0.944 . . . . 0.0 110.856 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -146.78 154.12 41.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.51 -1.369 . . . . 0.0 110.708 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.562 HG13 ' CD2' ' A' ' 206' ' ' LEU . 45.3 t -104.44 113.45 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -58.69 -45.62 89.06 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 109.832 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.15 116.61 18.2 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.224 -0.923 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.95 -15.4 43.51 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.475 1.45 . . . . 0.0 111.641 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.404 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.9 pm0 -75.01 -15.82 60.64 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.231 -0.918 . . . . 0.0 108.702 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.23 -178.12 47.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.609 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -83.92 145.75 28.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -1.106 . . . . 0.0 109.639 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -77.79 -18.79 56.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 108.811 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.638 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 76.0 m-85 -141.8 178.74 7.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -85.92 -3.49 58.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.705 HD22 ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -146.77 45.55 1.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -55.58 -47.18 99.24 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.861 -1.149 . . . . 0.0 109.756 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.6 Cg_exo -51.37 -66.77 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.429 2.086 . . . . 0.0 112.157 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 225' ' ' ARG . 27.9 m -59.97 -36.79 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.936 -1.102 . . . . 0.0 109.63 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.705 ' NE ' HD22 ' A' ' 221' ' ' ASN . 75.3 mtt180 -59.77 -42.18 92.76 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.414 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.2 t60 -67.09 -31.66 72.29 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.06 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -66.57 -35.76 81.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.0 t -67.73 -37.73 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.449 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 66.9 t80 -64.01 -50.61 67.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.46 -28.02 67.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.3 tp -75.92 -33.02 59.87 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 28.2 mt -67.52 -39.54 82.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.28 -58.2 9.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.438 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 53.8 m-20 -51.55 -40.84 60.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -1.226 . . . . 0.0 109.249 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 235' ' ' LEU . 7.0 mt -57.18 -22.97 44.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.533 -0.729 . . . . 0.0 110.282 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.6 -22.26 61.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.841 -1.162 . . . . 0.0 108.721 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 60' ' ' THR . 92.4 mt -53.08 -1.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.727 -1.233 . . . . 0.0 110.122 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.592 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.6 mt -75.68 -14.45 60.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.052 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.91 57.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.594 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.3 m -166.52 157.2 10.96 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.867 -1.372 . . . . 0.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.5 Cg_endo -49.84 150.55 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.956 1.771 . . . . 0.0 109.712 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.7 147.95 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 111.515 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -130.34 123.97 31.19 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.51 -158.77 28.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.419 ' N ' ' HB2' ' A' ' 144' ' ' SER . 11.6 ttmt -129.55 139.82 51.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -1.128 . . . . 0.0 109.087 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 22.7 m-85 -134.74 139.84 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 110.426 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -123.39 123.29 40.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.6 m -120.54 134.36 55.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.942 -1.099 . . . . 0.0 111.074 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -115.73 115.74 26.86 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 49.71 20.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.972 -1.08 . . . . 0.0 109.054 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -50.28 156.23 2.4 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -139.7 157.28 25.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.468 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -45.32 -43.36 10.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -1.118 . . . . 0.0 110.032 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.9 p -58.46 -41.05 84.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.0 tp -74.2 -43.61 56.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 108.538 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 256' ' ' ASN . 0.8 OUTLIER -50.98 -45.73 61.13 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.092 -1.005 . . . . 0.0 109.051 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 56' ' ' THR . 77.7 t -66.13 -57.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.416 ' HE3' HD12 ' A' ' 255' ' ' LEU . 2.6 ttpt -47.41 -46.16 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.839 -1.163 . . . . 0.0 108.614 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.683 HD22 HG21 ' A' ' 139' ' ' ILE . 44.1 tp -55.04 -53.48 55.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.051 . . . . 0.0 108.791 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.592 HG13 ' HG ' ' A' ' 238' ' ' LEU . 47.6 t -54.49 -53.75 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.528 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -49.32 -46.69 47.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.83 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -64.92 -52.77 54.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.957 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 263' ' ' LEU . 22.6 mt -53.87 -51.82 62.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 110.196 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.14 -27.2 65.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.963 -1.086 . . . . 0.0 110.304 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 110.149 -179.314 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 121' ' ' ILE . 14.5 mt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.402 0.62 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -55.74 129.12 38.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 108.97 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.9 144.27 48.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.501 -0.749 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -143.83 -173.28 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 30' ' ' PRO . 16.1 m -95.44 135.01 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.087 . . . . 0.0 109.503 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.36 -20.43 66.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -154.62 156.12 35.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.435 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.78 139.85 58.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 11' ' ' LEU . 56.4 mt -118.78 168.29 10.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 p -143.64 146.53 33.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.1 m-85 -140.12 150.24 44.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -152.97 148.18 26.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.965 -1.084 . . . . 0.0 109.703 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.58 173.1 36.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.42 153.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.12 . . . . 0.0 110.311 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.57 140.76 15.51 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.4 tt -60.15 -41.52 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 110.659 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' HG23 ' A' ' 18' ' ' ILE . 88.6 m-70 -86.64 -50.8 6.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.686 -1.259 . . . . 0.0 110.875 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 p -70.96 -22.57 62.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.67 -0.644 . . . . 0.0 111.526 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.51 15.61 12.52 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -106.82 154.99 20.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 109.76 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.23 135.44 42.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 3.5 t -138.9 145.43 39.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -111.04 155.21 23.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.616 -0.677 . . . . 0.0 110.019 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 90' ' ' GLU . 9.7 mt -135.4 147.11 48.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 109.969 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 mt -143.45 109.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 108.864 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.68 113.75 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -106.76 140.0 20.92 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.489 -0.757 . . . . 0.0 109.265 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.625 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.6 Cg_exo -54.55 165.77 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.752 1.635 . . . . 0.0 111.952 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.6 mm-40 -141.39 174.39 10.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' OG1' ' A' ' 35' ' ' THR . 75.2 mttt -82.68 152.26 25.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -48.7 151.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.81 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.56 -6.94 3.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 31' ' ' GLU . 32.7 m -59.62 -44.9 93.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.784 -1.421 . . . . 0.0 109.705 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.15 -176.31 30.38 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.57 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 mm -102.52 116.79 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.93 155.13 47.31 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.608 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -102.99 158.67 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -128.88 109.14 11.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 108.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -135.53 134.5 39.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.333 -0.854 . . . . 0.0 110.995 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 52.7 29.14 7.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.775 . . . . 0.0 111.325 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.0 18.41 76.84 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.909 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.65 123.26 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -1.062 . . . . 0.0 109.08 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -85.49 127.59 34.46 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.0 mt -116.91 93.7 42.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.69 151.42 19.37 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 111.897 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.42 70.74 10.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.759 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.952 . . . . 0.0 109.035 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.4 p-80 -69.51 -54.12 15.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.56 -17.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 111.087 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.5 m-85 -94.96 3.4 54.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.936 -1.102 . . . . 0.0 109.912 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' HIS . 96.9 t -72.24 138.94 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.19 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.76 -28.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.395 -0.815 . . . . 0.0 109.639 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.37 133.61 12.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.632 HG21 HG21 ' A' ' 257' ' ' VAL . 45.6 p -124.03 95.6 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.124 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.0 t-20 -163.09 128.71 3.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.798 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.9 m-70 45.64 13.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.32 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.963 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.468 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 45.2 m -78.68 125.17 29.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 108.869 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 147.73 44.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.841 0.829 . . . . 0.0 111.206 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 15.0 mt -123.77 150.26 44.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.88 151.36 21.09 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.731 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -163.36 152.21 14.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.533 -0.981 . . . . 0.0 109.27 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt 51.3 21.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.89 6.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 13.6 mm-40 -59.26 146.39 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -1.229 . . . . 0.0 109.332 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -142.13 137.31 30.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 110.663 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 122.96 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -101.13 155.16 18.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 111.312 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 m 49.18 73.89 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.78 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 17.2 m -107.78 -8.33 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.05 -27.61 68.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.495 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 29.1 m170 -64.49 -69.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.923 -1.111 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.49 -47.59 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.23 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' N ' HG23 ' A' ' 75' ' ' ILE . 37.5 mt -52.58 -48.28 66.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 109.985 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 t -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.095 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD12 ' A' ' 110' ' ' ILE . 54.0 t -57.04 -45.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 108.981 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.09 -34.98 78.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.255 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -61.52 -36.4 80.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 171' ' ' GLU . 52.3 mt -79.75 -37.02 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.5 mt -79.33 2.07 22.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.015 -1.053 . . . . 0.0 109.802 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 54.48 39.4 31.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.513 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 2.8 mm -86.21 141.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 108.25 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.516 HG21 HG23 ' A' ' 121' ' ' ILE . 57.0 p -124.49 -21.44 4.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.028 -1.045 . . . . 0.0 111.753 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 87' ' ' VAL . 38.8 m-80 -127.24 108.06 10.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.887 -1.133 . . . . 0.0 111.048 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.0 m -162.61 146.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 89.5 m -115.85 113.75 23.79 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.568 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.5 mt -95.9 107.4 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.693 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.4 tt0 -76.75 127.15 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.38 117.51 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.742 0.782 . . . . 0.0 111.442 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.414 ' O ' ' OG ' ' A' ' 24' ' ' SER . 26.1 mm -104.51 95.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.19 -155.4 24.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.21 -10.5 8.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -1.175 . . . . 0.0 110.379 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -139.82 148.95 42.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 26' ' ' LEU . 40.8 mm -72.85 126.41 90.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 108.735 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -45.9 121.18 4.03 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 121.845 1.697 . . . . 0.0 111.004 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.9 tp -75.25 -15.64 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 110.551 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.6 mt 57.33 -120.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.96 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -96.29 6.61 48.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.062 -1.024 . . . . 0.0 110.821 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.3 61.12 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.077 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 p -128.31 -172.31 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.634 -0.921 . . . . 0.0 109.524 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.66 15.5 10.53 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -58.53 -43.27 89.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -1.098 . . . . 0.0 110.003 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.85 -59.19 4.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.008 -1.057 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -51.56 -46.29 63.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.762 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CD1' HG11 ' A' ' 175' ' ' VAL . 53.5 t80 -61.56 -51.99 66.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 110.974 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.36 -43.26 95.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 111.375 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -55.92 13.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 110.611 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.409 HD12 HG11 ' A' ' 78' ' ' VAL . 40.6 mt -63.74 -31.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 0.0 109.446 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -65.0 -41.15 95.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.069 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 113' ' ' ASN . 6.0 pttt -75.55 11.06 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.5 m-80 -139.91 34.6 1.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 110.507 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.15 139.85 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.8 -1.187 . . . . 0.0 110.949 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.2 tp -131.74 126.62 34.91 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 116' ' ' ASN . 2.1 p30 -82.81 146.91 28.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.156 -0.965 . . . . 0.0 110.569 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -114.2 -169.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.121 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -112.65 69.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 111.22 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 21.3 ttm-85 -164.89 132.23 3.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.993 -1.067 . . . . 0.0 109.267 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.82 141.52 55.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.066 -1.021 . . . . 0.0 109.456 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 3' ' ' LEU . 18.9 mt -81.34 146.26 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.333 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.74 81.04 4.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 43.0 m-85 -60.41 140.03 57.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -86.97 100.91 12.94 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.4 t -92.41 134.56 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.418 0.628 . . . . 0.0 111.073 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.84 114.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.7 -25.99 15.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.93 149.21 71.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.19 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.4 152.01 48.8 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.377 2.051 . . . . 0.0 111.942 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -155.2 151.58 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.361 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.54 139.23 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 255' ' ' LEU . 23.1 m -125.78 148.13 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.92 159.03 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.7 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.38 105.42 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.442 -0.786 . . . . 0.0 109.666 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 47.82 56.85 6.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.373 -0.83 . . . . 0.0 110.827 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.09 -36.84 2.87 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.464 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -61.56 129.48 41.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.964 -1.315 . . . . 0.0 108.449 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -143.57 141.01 30.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.864 -1.147 . . . . 0.0 110.242 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 259' ' ' LEU . 68.2 mt -137.62 132.36 44.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.735 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -120.47 130.76 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.373 0.606 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.64 135.76 54.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -145.29 152.63 50.85 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.078 -1.014 . . . . 0.0 109.52 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -49.95 143.17 24.82 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.412 2.075 . . . . 0.0 113.506 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -155.45 144.0 20.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -4.53 4.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.273 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.5 p -151.9 -172.08 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -100.54 121.4 41.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 108.845 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 147' ' ' LEU . 67.5 tt0 -135.05 128.82 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.76 122.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 109.966 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 39.6 m -113.71 151.92 31.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.429 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -139.69 131.12 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.938 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -120.94 133.42 55.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.93 138.49 9.84 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.649 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.03 98.04 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -84.97 167.18 16.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.576 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -104.07 -17.57 14.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 110.64 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.3 p-10 -92.17 -166.65 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.779 -1.2 . . . . 0.0 110.01 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.29 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 111.151 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.4 mt -78.68 -27.11 45.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.459 -1.4 . . . . 0.0 108.2 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.03 -141.52 33.14 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -100.27 134.99 42.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.332 -1.099 . . . . 0.0 109.275 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.4 153.89 47.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.51 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -144.23 145.75 32.25 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.41 -0.806 . . . . 0.0 109.545 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.564 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 16.4 t80 -145.03 140.19 27.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.173 -0.955 . . . . 0.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.415 ' OG1' ' NZ ' ' A' ' 163' ' ' LYS . 90.2 m -109.06 123.37 49.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 110.093 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.487 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.4 t80 -102.98 114.06 28.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.01 147.53 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 6.5 mm-40 -49.11 132.34 19.23 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.312 -0.867 . . . . 0.0 108.838 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.4 -9.58 30.78 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.47 25.53 10.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.209 -1.171 . . . . 0.0 109.288 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.665 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.0 OUTLIER -61.33 -15.65 38.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.0 110.496 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -81.54 -10.42 59.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.038 -1.039 . . . . 0.0 110.668 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' CZ ' ' A' ' 164' ' ' PHE . 1.5 pp20? -101.11 -5.26 25.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.052 -1.03 . . . . 0.0 110.623 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.478 HG23 ' OE2' ' A' ' 173' ' ' GLU . 16.7 pt -115.99 -31.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 171' ' ' GLU . 11.7 m -61.7 -15.45 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.842 -1.161 . . . . 0.0 108.776 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.1 mt -94.74 -4.81 46.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.561 -0.712 . . . . 0.0 109.451 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.02 120.52 14.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.006 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -81.07 172.16 14.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.74 163.66 25.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.64 145.44 27.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.252 -1.53 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.9 158.03 44.01 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.51 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -99.44 143.94 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.002 -1.061 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.38 -36.47 6.46 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.9 p90 -73.35 -29.81 62.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.947 -1.095 . . . . 0.0 109.889 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.5 tt0 -74.54 -27.64 60.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 109.938 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.5 mt -59.31 -48.76 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -47.77 -40.76 21.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.168 -0.957 . . . . 0.0 109.995 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.1 t60 -77.25 -52.92 8.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.275 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.6 mt -49.42 -27.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.418 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -85.61 -54.74 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.001 -1.062 . . . . 0.0 109.35 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -50.76 -33.78 24.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -84.66 7.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.0 -1.063 . . . . 0.0 110.08 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.93 61.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.1 mt -129.39 171.36 12.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -1.168 . . . . 0.0 110.145 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.39 29.14 62.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -58.2 -56.33 23.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.388 -1.654 . . . . 0.0 109.683 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -67.1 4.68 3.19 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.725 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.99 124.82 34.94 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.876 -1.367 . . . . 0.0 110.523 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.1 t -145.91 164.23 32.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.438 -1.036 . . . . 0.0 109.101 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.513 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 70.7 mt -67.92 -8.01 33.24 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.5 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -98.77 -9.31 24.62 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.758 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 23.6 p30 -134.54 9.66 3.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.72 150.05 30.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.4 tp -99.86 93.18 5.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 203' ' ' THR . 43.0 t -85.85 130.56 36.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.716 0.769 . . . . 0.0 108.973 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 35.2 mt -124.78 165.11 18.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.656 -0.652 . . . . 0.0 109.576 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.19 -166.4 12.23 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -25.21 67.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.747 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -163.21 23.15 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.385 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 146.67 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.016 -1.053 . . . . 0.0 110.342 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.73 109.99 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.48 -49.11 75.63 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.078 -1.014 . . . . 0.0 109.826 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.8 m120 -60.28 112.48 5.55 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.832 . . . . 0.0 110.279 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.26 -23.2 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.796 1.664 . . . . 0.0 112.783 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.61 -14.71 62.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.834 -1.166 . . . . 0.0 109.919 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.24 -168.55 52.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.614 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -90.28 138.67 31.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -75.32 -17.25 60.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.174 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.3 -173.61 3.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.7 -22.43 23.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.549 HD22 ' NH1' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -136.94 53.25 1.9 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.543 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -54.63 -47.82 96.92 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.3 Cg_exo -48.45 -64.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.391 2.061 . . . . 0.0 112.102 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.5 m -60.64 -35.8 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.793 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.549 ' NH1' HD22 ' A' ' 221' ' ' ASN . 4.0 mtt85 -60.89 -41.56 96.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.046 -1.033 . . . . 0.0 108.468 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.4 t60 -67.45 -32.3 73.07 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -66.53 -36.45 82.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 166' ' ' PHE . 66.2 t -67.53 -37.37 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.98 -51.48 61.51 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -64.55 -28.26 69.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 109.844 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 36.0 tp -75.06 -34.13 61.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.072 -1.018 . . . . 0.0 108.492 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.77 -39.84 84.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.04 -56.0 18.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 26.7 m-20 -54.63 -32.72 59.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.096 -1.238 . . . . 0.0 109.178 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.6 mt -63.68 -23.77 67.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.475 -0.766 . . . . 0.0 110.653 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.73 -21.79 61.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.749 -1.219 . . . . 0.0 109.105 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.9 mt -50.46 -1.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.31 . . . . 0.0 110.607 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -78.44 -15.26 58.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.771 -1.205 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.19 2.93 59.02 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.574 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.8 m -166.46 155.45 10.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.362 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.0 Cg_endo -49.63 150.55 8.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.952 1.768 . . . . 0.0 109.608 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.83 145.96 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 0.0 112.124 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -127.81 121.98 31.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.91 -179.27 30.29 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -109.43 140.7 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -1.131 . . . . 0.0 109.198 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 17.2 m-85 -135.05 138.76 44.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 110.34 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -125.0 124.75 42.67 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 m -120.19 135.78 54.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.971 -1.081 . . . . 0.0 111.429 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 251' ' ' GLY . 75.8 t80 -115.28 117.06 29.41 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' PHE . 63.3 mtp180 45.98 22.37 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.065 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -51.9 159.41 2.61 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -139.1 164.3 25.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 34.1 m-70 -50.28 -42.76 52.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.149 -1.206 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.1 m -56.98 -59.2 5.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.4 tp -53.51 -45.64 69.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.381 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -49.54 -50.53 41.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 0.0 109.666 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 56' ' ' THR . 98.5 t -62.41 -55.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.805 . . . . 0.0 110.197 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 255' ' ' LEU . 1.0 OUTLIER -52.0 -45.2 64.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 108.79 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 139' ' ' ILE . 24.6 tp -52.99 -54.47 34.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.488 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.564 HG13 ' HG ' ' A' ' 238' ' ' LEU . 30.6 t -55.86 -54.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -43.98 33.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.35 -49.99 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 109.861 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 13.9 mt -56.94 -47.59 80.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.34 -30.77 69.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 109.568 -179.674 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.291 0.567 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB3' HD21 ' A' ' 86' ' ' ASN . 32.4 mt-10 -54.62 137.35 43.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.083 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 142.72 49.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.495 -0.753 . . . . 0.0 109.717 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -141.51 -171.63 3.35 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 30.3 m -96.86 135.15 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.049 . . . . 0.0 109.162 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -21.26 66.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.585 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -153.0 160.76 43.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 0.0 109.275 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 140.59 54.48 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 0.0 110.022 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.14 163.93 15.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 141.9 46.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.091 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 98.0 m-85 -139.84 146.24 39.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' CG ' ' OH ' ' A' ' 23' ' ' TYR . 3.8 pt-20 -151.88 149.35 28.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 109.908 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.87 172.27 35.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.28 151.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -1.087 . . . . 0.0 110.357 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.37 137.1 15.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' HG21 ' A' ' 179' ' ' THR . 6.7 tt -56.26 -38.74 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 68.8 m-70 -91.07 -49.21 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.845 -1.159 . . . . 0.0 111.105 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 22' ' ' GLU . 2.9 p -69.49 -21.76 63.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 111.416 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.03 8.31 3.05 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 20' ' ' THR . 3.4 mm-40 -102.69 157.34 17.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -1.108 . . . . 0.0 109.672 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' OH ' ' CG ' ' A' ' 14' ' ' GLU . 81.8 t80 -74.66 136.58 41.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.466 -0.771 . . . . 0.0 109.734 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -137.67 142.66 41.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -108.39 151.91 25.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -134.74 144.29 47.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -142.45 110.48 2.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.607 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -94.95 115.92 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 111.168 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.592 ' NE2' HG22 ' A' ' 27' ' ' ILE . 27.8 m-70 -109.41 139.73 21.38 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.482 -0.761 . . . . 0.0 109.585 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.5 Cg_exo -54.43 168.13 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.662 1.574 . . . . 0.0 111.434 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.482 ' HB3' HG21 ' A' ' 35' ' ' THR . 73.4 mm-40 -139.99 173.35 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.001 . . . . 0.0 110.04 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.9 mtmt -81.98 149.78 27.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.493 -0.754 . . . . 0.0 109.742 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -46.79 145.43 1.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.341 -0.849 . . . . 0.0 109.823 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.77 8.22 60.19 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.312 -0.947 . . . . 0.0 110.878 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.5 m -73.61 -43.47 59.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.598 -1.531 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.46 -177.61 33.5 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.603 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.11 117.1 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -140.42 151.69 45.1 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.212 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.62 157.38 16.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.56 110.87 12.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.456 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 42.5 tttm -135.23 133.95 39.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.7 29.44 4.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.47 -0.769 . . . . 0.0 111.213 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.84 19.14 73.69 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.144 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.9 t -122.47 120.98 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -1.08 . . . . 0.0 109.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.7 m-85 -84.61 127.59 34.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.086 -1.008 . . . . 0.0 109.401 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -117.18 93.99 43.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.523 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.72 148.31 16.24 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.558 2.172 . . . . 0.0 112.206 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.64 69.08 10.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -0.952 . . . . 0.0 109.175 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -118.94 163.98 16.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -0.812 . . . . 0.0 109.291 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.546 ' CD2' ' CD ' ' A' ' 51' ' ' GLU . 1.2 p-80 -68.85 -50.07 53.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 0.0 109.578 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.546 ' CD ' ' CD2' ' A' ' 50' ' ' HIS . 42.8 mp0 -46.19 -16.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.632 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.6 m-85 -95.79 3.53 53.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.851 -1.156 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.7 t -71.15 128.73 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 108.735 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.38 -21.73 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.389 -0.819 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -156.26 125.89 6.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.907 -1.12 . . . . 0.0 110.009 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.836 HG21 HG21 ' A' ' 257' ' ' VAL . 38.5 p -121.03 95.56 4.75 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.3 t-20 -162.78 128.74 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 87.9 m-70 51.91 7.22 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.97 . . . . 0.0 108.854 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m 164.22 153.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.0 109.786 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.464 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 30.1 m -94.05 127.37 39.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.21 -0.931 . . . . 0.0 109.215 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.36 149.67 41.96 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.758 0.79 . . . . 0.0 111.064 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.594 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.0 mt -125.35 151.81 45.59 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.68 148.0 15.55 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.802 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -159.27 145.67 16.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.972 . . . . 0.0 108.976 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER 52.94 28.01 6.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.394 -0.817 . . . . 0.0 109.473 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.12 -32.61 5.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.567 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -56.62 143.93 34.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 108.952 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.87 137.02 29.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.268 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.33 123.45 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 70' ' ' LYS . 12.5 mtpp -98.81 157.19 16.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.95 -1.093 . . . . 0.0 110.94 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m 50.77 74.61 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.55 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 62' ' ' LEU . 22.0 m -108.02 -10.39 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.197 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -61.63 -27.41 68.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 110.627 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.5 m170 -65.78 -68.6 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.976 -1.078 . . . . 0.0 109.352 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.44 -47.13 47.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.004 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.602 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.5 mt -52.59 -48.7 66.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.968 -1.082 . . . . 0.0 110.189 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 0.8 OUTLIER -61.0 -43.35 99.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.941 . . . . 0.0 110.241 -179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.69 -44.81 78.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 108.843 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.08 -34.85 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.09 -32.03 73.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' HB2' ' A' ' 171' ' ' GLU . 58.7 mt -83.74 -36.97 23.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.283 -0.886 . . . . 0.0 109.363 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 114' ' ' ILE . 94.7 mt -78.81 5.01 12.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.056 . . . . 0.0 109.513 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 52.84 39.38 28.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 110.188 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.78 138.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 108.493 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.585 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 72.6 p -123.77 -18.19 6.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 111.716 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -126.7 107.8 10.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.864 -1.147 . . . . 0.0 111.134 -179.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.9 m -163.5 148.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.285 -0.885 . . . . 0.0 110.054 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 18.9 m -116.38 109.1 16.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.51 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -91.86 100.88 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.333 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -73.41 127.18 31.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 26' ' ' LEU . 62.3 t -110.48 126.1 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.98 0.895 . . . . 0.0 111.925 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.6 mt -111.94 95.84 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 141.59 -156.7 25.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -120.67 -10.77 9.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -1.151 . . . . 0.0 110.449 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -140.39 148.89 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 109.47 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 26' ' ' LEU . 45.0 mm -72.59 121.38 84.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.18 -0.95 . . . . 0.0 108.927 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.96 121.97 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.624 1.549 . . . . 0.0 111.206 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.0 tp -78.66 -12.08 13.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.2 mt 56.04 -118.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -97.87 7.29 46.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.3 -0.47 61.88 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.819 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -127.08 -172.26 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.799 -0.824 . . . . 0.0 109.535 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.56 15.04 9.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 27.6 t-105 -57.59 -42.86 84.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 110.095 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.1 -57.75 8.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.103 -0.998 . . . . 0.0 110.19 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.39 -44.99 62.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.442 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 54.0 t80 -63.58 -51.26 66.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 111.261 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 8.0 mm-40 -62.67 -44.41 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.816 -1.177 . . . . 0.0 111.06 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.49 7.29 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.155 -0.966 . . . . 0.0 110.16 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 mt -62.55 -35.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 57.5 ttt-85 -60.82 -41.72 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.628 ' C ' HD22 ' A' ' 113' ' ' ASN . 2.8 mmmp? -74.87 9.45 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.884 . . . . 0.0 109.89 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.628 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.56 33.76 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 82' ' ' LEU . 66.4 mt -83.57 138.01 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.63 -1.294 . . . . 0.0 110.824 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.25 127.08 37.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.767 . . . . 0.0 109.206 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.92 144.91 27.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.076 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -112.23 -169.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -111.87 68.8 0.67 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.761 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -163.3 127.91 2.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 109.127 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.75 141.35 56.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.886 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 122' ' ' ASP . 94.0 mt -87.71 152.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 121' ' ' ILE . 9.1 t70 -102.23 90.84 4.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 14.4 m-85 -65.33 148.14 52.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.552 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.439 ' CD2' HD13 ' A' ' 238' ' ' LEU . 85.1 t80 -92.58 101.79 14.22 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.79 134.33 31.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 110.74 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.05 116.2 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -92.52 -29.13 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.017 -1.052 . . . . 0.0 110.369 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.91 150.04 75.44 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.36 152.11 43.79 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.551 2.168 . . . . 0.0 112.343 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.24 152.62 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.08 147.35 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.61 148.03 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -131.59 162.43 30.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.533 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.3 OUTLIER -172.41 103.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 50.76 54.89 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.333 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.54 -32.64 3.6 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.451 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.56 ' NH1' ' O ' ' A' ' 250' ' ' ARG . 88.1 mtt-85 -62.52 139.74 58.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.925 -1.338 . . . . 0.0 108.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -145.37 138.89 26.6 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.131 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.748 HG21 HD22 ' A' ' 259' ' ' LEU . 78.8 mt -137.56 125.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.579 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -113.41 132.86 55.46 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.393 0.616 . . . . 0.0 109.995 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 130.21 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.0 149.09 47.96 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.028 -1.045 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.59 142.88 9.35 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.677 2.251 . . . . 0.0 113.546 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -157.18 146.15 19.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.39 -3.36 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 p -149.08 -179.16 6.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.967 -1.083 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.2 tp -97.32 120.38 37.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 147' ' ' LEU . 56.1 tt0 -136.77 134.59 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.5 t -133.37 123.43 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.071 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.1 m -112.63 151.67 29.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.767 . . . . 0.0 109.743 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -138.17 129.37 27.37 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.653 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -120.74 131.06 54.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.22 141.6 12.51 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.753 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -106.38 101.16 10.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.94 167.1 15.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 110.964 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -99.55 -16.25 18.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.627 -0.671 . . . . 0.0 110.706 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.5 p-10 -98.53 -169.25 1.76 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.994 -1.067 . . . . 0.0 110.611 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -52.09 -0.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.502 -0.749 . . . . 0.0 111.531 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -78.04 -26.63 48.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.431 -1.418 . . . . 0.0 108.903 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.96 -140.83 34.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -104.9 134.23 48.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.067 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -138.68 158.76 43.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 109.375 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.04 145.43 31.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.383 -0.823 . . . . 0.0 109.471 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -143.74 137.17 27.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.53 124.88 51.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 110.038 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.414 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -105.77 117.78 34.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.79 153.14 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -50.71 126.35 15.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.94 -2.86 28.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -117.76 22.94 12.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.173 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 81' ' ' LEU . 11.2 pt-20 -56.43 -29.95 62.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 0.0 110.18 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.86 -19.7 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.0 -6.5 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 111.241 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.79 -26.33 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.906 -1.122 . . . . 0.0 111.314 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -60.34 -20.8 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.594 -1.316 . . . . 0.0 109.123 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.9 -2.75 58.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.466 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.2 116.48 8.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 108.881 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.521 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.8 mtm180 -81.15 172.06 14.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.8 t -80.66 162.14 24.33 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -147.49 147.08 29.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.246 -1.534 . . . . 0.0 111.527 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.22 158.05 43.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.531 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.4 m-85 -99.55 144.25 28.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.992 -1.067 . . . . 0.0 109.981 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.95 -38.87 53.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.531 -0.73 . . . . 0.0 109.895 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.531 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.3 p90 -66.81 -27.46 67.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 0.0 110.034 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.8 mt-10 -84.05 -43.61 14.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.097 -1.002 . . . . 0.0 109.835 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 205' ' ' VAL . 61.8 mt -40.8 -44.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.245 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.75 -37.72 76.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.995 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 185' ' ' GLU . 4.6 t-80 -76.68 -43.6 37.08 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.66 -29.57 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.504 -0.748 . . . . 0.0 109.036 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -80.98 -52.08 7.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -48.86 -45.67 41.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 110.282 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.415 HG11 ' NE2' ' A' ' 188' ' ' HIS . 19.1 m -74.89 6.49 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.03 . . . . 0.0 110.216 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.78 39.24 48.41 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.126 -0.984 . . . . 0.0 110.726 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.6 mt -126.53 176.1 7.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -1.168 . . . . 0.0 109.56 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 54.43 24.25 30.0 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -58.51 -20.89 49.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.662 -1.493 . . . . 0.0 110.306 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.11 1.74 31.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.46 126.2 35.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.963 -1.316 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' THR . 1.6 t -146.31 167.31 23.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.379 -1.071 . . . . 0.0 109.506 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.589 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 0.6 OUTLIER -68.57 -8.76 44.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 7.6 mmtp -96.67 -13.13 23.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.6 p30 -135.83 7.43 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.627 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.72 152.98 33.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 217' ' ' LEU . 15.3 tp -100.21 97.98 8.72 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 186' ' ' ILE . 53.4 t -85.49 126.86 40.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.0 mt -122.26 161.99 22.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.548 -0.72 . . . . 0.0 109.875 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.85 -166.39 12.38 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -62.89 -26.23 68.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -1.13 . . . . 0.0 109.735 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -161.29 22.77 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 110.565 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.04 147.62 40.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.865 -1.147 . . . . 0.0 110.393 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.32 112.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.29 -45.46 93.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 110.103 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.9 m120 -61.91 121.58 66.16 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 109.792 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.66 -12.62 36.19 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.486 1.457 . . . . 0.0 111.817 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.69 -16.81 56.83 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.273 -0.892 . . . . 0.0 108.945 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.26 -169.21 54.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.58 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -89.25 145.57 25.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -1.2 . . . . 0.0 109.781 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -79.42 -19.26 50.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 221' ' ' ASN . 71.2 m-85 -146.85 152.14 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.467 -0.771 . . . . 0.0 108.987 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.64 6.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -151.11 40.62 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -58.27 -47.24 99.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 109.734 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.3 Cg_exo -51.43 -67.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -58.4 -37.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 109.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 224' ' ' VAL . 44.4 mtt180 -59.96 -41.44 91.93 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.071 -1.018 . . . . 0.0 108.446 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.6 t60 -67.0 -31.8 72.6 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -66.77 -36.44 82.44 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 166' ' ' PHE . 92.7 t -67.15 -39.1 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.9 t80 -61.6 -52.36 64.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -63.44 -28.37 69.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.06 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.458 HD23 ' CG1' ' A' ' 149' ' ' VAL . 40.6 tp -78.2 -33.54 49.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.945 -1.097 . . . . 0.0 108.738 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.86 -37.69 79.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.37 -55.86 11.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 29.1 m-20 -53.95 -35.48 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -1.174 . . . . 0.0 109.086 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.0 mt -63.96 -24.64 67.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.478 -0.764 . . . . 0.0 110.512 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.3 t80 -75.44 -21.66 57.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.918 -1.114 . . . . 0.0 109.361 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 237' ' ' LEU . 33.0 mt -50.79 -3.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.711 -1.243 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -72.1 -12.85 61.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.94 -1.1 . . . . 0.0 109.962 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 0.51 59.66 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.915 -1.135 . . . . 0.0 110.824 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 154.54 11.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.872 -1.369 . . . . 0.0 108.816 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.4 Cg_endo -47.94 150.04 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.622 1.548 . . . . 0.0 109.416 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.72 146.85 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.979 -1.075 . . . . 0.0 112.056 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.88 124.33 30.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 154.8 179.22 29.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.413 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.5 OUTLIER -110.87 132.53 54.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.6 m-85 -132.9 140.38 47.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.3 t80 -125.0 137.44 54.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.3 t -130.62 137.29 49.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 111.343 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -117.5 115.9 26.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.56 ' O ' ' NH1' ' A' ' 137' ' ' ARG . 5.3 mtp85 47.57 30.41 1.69 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.05 146.12 44.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.75 169.6 15.92 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 59.5 m-70 -52.94 -37.85 61.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.061 -1.258 . . . . 0.0 109.531 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -57.98 8.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.005 . . . . 0.0 109.127 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 134' ' ' ASP . 15.9 tp -61.75 -43.17 99.38 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -47.7 -51.61 21.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.133 . . . . 0.0 109.139 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 56' ' ' THR . 85.3 t -62.6 -52.16 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -51.31 -51.34 55.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 109.083 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 139' ' ' ILE . 39.8 tp -50.78 -54.82 20.37 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.702 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.449 HG13 ' HG ' ' A' ' 238' ' ' LEU . 49.7 t -55.39 -51.16 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 108.895 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -47.77 -50.5 25.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.08 -48.28 79.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.814 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 263' ' ' LEU . 23.4 mt -58.1 -49.58 76.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.415 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -69.82 -32.99 71.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.292 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.264 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.81 138.93 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 108.996 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -122.58 144.9 48.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.21 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.93 -172.72 3.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 30' ' ' PRO . 32.1 m -99.03 137.89 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.865 -1.147 . . . . 0.0 109.132 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -18.24 65.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 109.898 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -155.27 156.25 35.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 109.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.08 139.54 58.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 110.234 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -117.4 160.39 21.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.89 141.98 47.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 110.232 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -140.34 150.76 44.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -161.61 151.98 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.912 -1.117 . . . . 0.0 109.848 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.62 175.71 37.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.57 152.46 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -1.181 . . . . 0.0 110.243 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.452 ' C ' ' OE2' ' A' ' 95' ' ' GLU . . . -88.24 140.29 16.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.496 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 6.2 tt -59.99 -38.39 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 111.041 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 72.2 m-70 -91.52 -46.95 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.402 -1.436 . . . . 0.0 111.039 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.594 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 p -72.15 -23.23 61.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.211 -0.931 . . . . 0.0 111.557 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.64 15.67 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.284 -1.436 . . . . 0.0 109.553 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.94 155.24 20.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -1.091 . . . . 0.0 109.748 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.69 134.98 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.429 -0.794 . . . . 0.0 109.466 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 m -137.01 144.24 43.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.37 155.98 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.453 -0.78 . . . . 0.0 109.866 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.64 143.89 39.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -139.35 114.56 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 108.667 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.18 115.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 0.0 111.006 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.567 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.6 m-70 -108.42 137.06 19.85 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.517 -0.739 . . . . 0.0 109.788 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -51.62 168.13 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.032 1.821 . . . . 0.0 111.604 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 66.9 mm-40 -146.52 155.23 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.938 . . . . 0.0 109.975 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -67.39 154.16 42.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.781 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 149.23 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 110.824 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.674 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 75.18 -7.45 22.92 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.26 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.739 ' N ' HD22 ' A' ' 86' ' ' ASN . 93.0 m -59.33 -44.97 92.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.557 -1.555 . . . . 0.0 109.861 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.481 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 95.65 -175.82 33.15 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -100.42 116.54 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -141.23 150.97 43.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.764 -1.21 . . . . 0.0 110.983 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.16 157.42 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.17 114.29 15.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.93 . . . . 0.0 109.248 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 45.4 tttm -134.2 134.38 42.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.486 ' CG ' ' O ' ' A' ' 41' ' ' LYS . 7.5 p-10 44.08 42.37 4.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.877 -0.514 . . . . 0.0 112.193 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.93 15.7 78.33 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 120.695 -1.253 . . . . 0.0 110.549 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -121.43 120.65 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -1.141 . . . . 0.0 109.311 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 36.1 m-85 -86.11 127.72 34.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.481 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.87 93.43 41.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.506 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.99 145.99 17.98 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.656 2.237 . . . . 0.0 112.39 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.39 66.01 4.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.98 166.69 12.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p-80 -72.94 -49.96 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.476 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -44.11 -16.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.2 m-85 -96.84 1.94 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 50' ' ' HIS . 58.5 t -69.24 130.36 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 108.7 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.0 m -111.74 -28.94 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -152.1 130.31 11.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.911 -1.118 . . . . 0.0 110.176 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.816 HG21 HG21 ' A' ' 257' ' ' VAL . 32.9 p -120.87 94.6 4.4 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.6 t-20 -163.74 129.15 2.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 108.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' SER . 86.5 m-70 52.52 6.15 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.128 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.81 143.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.851 . . . . 0.0 109.683 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.457 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 37.6 m -84.72 128.08 34.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -120.73 149.46 42.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.429 -0.794 . . . . 0.0 110.751 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 72' ' ' VAL . 12.2 mt -120.74 154.59 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.98 22.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.976 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -161.78 145.79 12.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.413 -1.051 . . . . 0.0 109.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt 51.61 21.7 1.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.86 . . . . 0.0 109.323 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.26 -33.59 6.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -55.96 149.16 15.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -1.217 . . . . 0.0 109.51 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -145.89 136.32 24.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.553 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.97 128.15 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -101.27 155.51 17.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 111.605 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.8 m 50.35 74.95 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.746 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.565 HG21 ' CD1' ' A' ' 62' ' ' LEU . 18.8 m -108.4 -11.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.99 . . . . 0.0 109.566 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.4 pm0 -60.44 -26.46 66.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.406 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.8 m170 -66.32 -68.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.324 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.6 tp -52.72 -48.03 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.072 -1.018 . . . . 0.0 109.107 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.646 HD21 ' HB1' ' A' ' 48' ' ' ALA . 11.3 mt -52.33 -50.18 62.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.024 -1.048 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.7 t -59.22 -41.54 88.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 106' ' ' PHE . 76.9 t -56.36 -47.1 81.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.121 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.67 -34.05 77.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.323 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -61.95 -39.19 91.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 171' ' ' GLU . 51.1 mt -77.84 -38.51 46.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 82' ' ' LEU . 74.4 mt -80.68 -1.17 41.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 56.87 42.12 26.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.733 -0.604 . . . . 0.0 111.386 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.17 140.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.854 -1.154 . . . . 0.0 107.968 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 121' ' ' ILE . 68.8 p -124.57 -22.47 4.61 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.126 -0.984 . . . . 0.0 111.799 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.739 HD22 ' N ' ' A' ' 35' ' ' THR . 18.0 m120 -125.46 107.13 10.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.868 -1.145 . . . . 0.0 110.666 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -164.69 148.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.771 0.796 . . . . 0.0 110.151 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 93.5 m -114.49 113.26 24.22 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.462 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -95.29 100.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 110.345 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' OE2' ' NE2' ' A' ' 29' ' ' HIS . 33.4 mt-10 -73.41 124.84 26.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.108 -0.995 . . . . 0.0 108.361 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 26' ' ' LEU . 48.6 t -106.94 123.79 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 121.677 0.751 . . . . 0.0 111.172 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mm -109.18 96.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.52 -156.04 23.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -123.08 -12.28 7.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.319 -1.107 . . . . 0.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 20' ' ' THR . 29.3 tt0 -132.85 140.19 47.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 109.944 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 26' ' ' LEU . 45.6 mm -70.24 119.32 71.32 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 108.417 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -40.74 122.58 1.45 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.887 1.725 . . . . 0.0 111.466 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -79.0 -12.0 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.711 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.3 mt 56.42 -119.61 1.34 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 110.01 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 27.6 t0 -96.53 10.02 39.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.923 -1.111 . . . . 0.0 111.126 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.26 -1.41 62.55 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.43 -1.367 . . . . 0.0 109.843 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.02 -172.06 2.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.799 -0.824 . . . . 0.0 109.483 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.18 16.08 10.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.41 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 54.1 t-105 -57.83 -42.84 85.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.429 -1.042 . . . . 0.0 110.464 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.46 -58.96 5.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.167 -0.958 . . . . 0.0 110.092 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.402 ' HB3' HG11 ' A' ' 78' ' ' VAL . 13.7 m-85 -51.03 -45.96 61.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.382 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.403 ' CE1' ' HD2' ' A' ' 111' ' ' ARG . 36.9 t80 -61.37 -50.36 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.554 -0.716 . . . . 0.0 111.059 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 10.1 mm-40 -63.47 -44.46 94.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.946 -1.096 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.85 -53.56 38.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 0.0 110.646 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -65.04 -30.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.918 -1.114 . . . . 0.0 109.287 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.403 ' HD2' ' CE1' ' A' ' 107' ' ' TYR . 63.9 ttt-85 -65.68 -43.89 87.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.407 -0.808 . . . . 0.0 110.274 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -77.78 14.22 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.957 -1.089 . . . . 0.0 110.019 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -144.13 32.47 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 82' ' ' LEU . 78.8 mt -80.87 139.89 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.928 -1.107 . . . . 0.0 110.272 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.14 125.08 32.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.766 . . . . 0.0 109.128 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -80.57 142.29 34.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.334 -0.854 . . . . 0.0 110.169 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -110.36 -172.75 2.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.408 -0.807 . . . . 0.0 109.448 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -110.43 68.27 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 110.58 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.7 131.16 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 109.531 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.24 142.42 54.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.064 -1.022 . . . . 0.0 109.691 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 85' ' ' THR . 70.9 mt -85.44 151.34 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.815 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.71 83.42 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 108.817 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 28.6 m-85 -61.44 143.09 56.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -90.32 101.83 14.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.17 133.73 32.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.62 . . . . 0.0 110.857 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.13 112.45 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.91 -34.18 21.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.979 -1.076 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.9 149.88 72.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.627 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.5 147.93 71.89 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.318 2.012 . . . . 0.0 112.089 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -154.27 152.3 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.67 144.73 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.227 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.95 147.68 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -132.83 159.77 38.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.607 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -172.33 101.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.241 -0.912 . . . . 0.0 109.995 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 45.97 59.26 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.753 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.31 -37.92 3.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.485 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 4.5 mpt_? -63.75 130.89 46.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -144.14 139.85 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.992 -1.067 . . . . 0.0 109.769 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.522 HG21 HD22 ' A' ' 259' ' ' LEU . 98.5 mt -137.62 129.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 109.693 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -115.56 131.67 56.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.49 135.88 55.0 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -149.52 148.54 26.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 109.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -46.04 142.17 8.58 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.508 2.139 . . . . 0.0 113.326 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -155.48 143.3 19.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 146' ' ' THR . 24.7 t0 -62.75 -5.17 2.52 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.503 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 244' ' ' GLY . 30.4 p -154.96 179.1 9.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.949 -1.095 . . . . 0.0 109.859 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.25 120.19 29.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.208 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.6 123.58 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 108.646 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -124.41 122.02 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.1 m -112.25 151.94 29.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.369 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 228' ' ' VAL . 39.1 t80 -139.5 130.67 26.59 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.106 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 28.4 tt0 -121.18 131.7 54.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.43 139.19 10.45 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.469 -1.348 . . . . 0.0 111.577 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -103.0 100.66 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -86.33 167.03 15.15 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 110.6 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.57 -15.55 18.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 110.589 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 159' ' ' LEU . 23.0 p-10 -95.21 -168.12 1.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.832 -1.168 . . . . 0.0 110.131 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -56.58 3.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 111.26 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.8 mt -79.67 -28.28 40.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.454 -1.404 . . . . 0.0 108.423 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.01 -138.69 34.56 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 3.9 ttm180 -97.0 131.84 43.41 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.275 -1.133 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.467 ' OE1' ' O ' ' A' ' 161' ' ' ARG . 29.1 mm100 -136.63 147.29 46.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.765 . . . . 0.0 109.108 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -140.52 145.05 36.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.856 . . . . 0.0 110.093 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.515 ' CZ ' ' NH2' ' A' ' 225' ' ' ARG . 89.3 t80 -144.26 140.38 29.19 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 76.8 m -110.82 124.3 51.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 110.295 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.561 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -103.89 117.26 33.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.409 -0.807 . . . . 0.0 109.761 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.31 154.64 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.097 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -50.63 125.22 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 108.977 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.24 -2.44 26.75 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -119.81 21.74 11.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.14 -1.212 . . . . 0.0 109.186 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.476 ' HB2' HD13 ' A' ' 81' ' ' LEU . 3.6 pm0 -54.46 -32.12 56.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.379 -0.825 . . . . 0.0 110.621 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.24 -17.47 62.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 110.183 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.554 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 23.2 mm-40 -86.79 -6.83 58.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.172 -0.955 . . . . 0.0 111.495 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 40.2 pt -123.68 -26.05 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.919 -1.113 . . . . 0.0 110.845 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.1 m -65.21 -26.77 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.553 -1.342 . . . . 0.0 109.382 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.54 -5.54 56.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.0 109.335 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 225' ' ' ARG . . . -70.09 123.43 21.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.977 . . . . 0.0 109.205 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -84.54 172.93 11.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.2 t -77.32 161.48 28.04 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -147.04 144.38 29.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.191 -1.568 . . . . 0.0 111.427 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.71 157.08 45.02 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 90.6 m-85 -97.66 146.89 24.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.602 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.56 -38.71 21.32 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.399 -0.813 . . . . 0.0 109.741 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.13 -25.18 62.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.0 109.644 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.7 mm-40 -79.82 -25.64 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.0 110.044 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.428 ' O ' ' C ' ' A' ' 187' ' ' GLU . 22.6 mt -60.93 -54.82 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 110.017 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 186' ' ' ILE . 10.9 tt0 -42.1 -39.88 2.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.887 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.763 ' O ' HG22 ' A' ' 192' ' ' VAL . 5.4 t60 -78.76 -54.31 6.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 194' ' ' LEU . 29.1 mt -48.35 -29.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.663 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -85.34 -54.38 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.769 -1.207 . . . . 0.0 109.194 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -50.09 -42.52 50.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.066 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.5 m -74.65 5.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.995 . . . . 0.0 109.854 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.31 37.28 54.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' ILE . 36.0 mt -125.61 166.04 17.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -1.126 . . . . 0.0 109.591 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 64.5 22.98 68.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -56.18 -23.65 36.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.432 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.464 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.5 25.91 12.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.24 125.12 7.88 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.945 -1.327 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -145.1 168.07 21.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.064 . . . . 0.0 109.708 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.1 -8.72 25.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 ttmm -93.89 -14.31 26.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 14.7 p30 -136.07 8.14 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.792 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -147.34 149.28 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.047 -1.033 . . . . 0.0 110.702 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 217' ' ' LEU . 27.1 tp -98.87 94.61 6.68 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 203' ' ' THR . 52.2 t -86.81 129.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.635 0.731 . . . . 0.0 109.225 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.07 173.9 6.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.369 -0.832 . . . . 0.0 109.53 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -134.64 -166.41 11.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.95 70.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -1.047 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -158.91 26.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.061 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -145.36 153.27 41.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.841 -1.162 . . . . 0.0 110.421 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.0 t -104.4 113.32 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -57.99 -48.34 80.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.051 -1.03 . . . . 0.0 109.854 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -63.0 112.51 6.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 110.313 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -57.85 -11.12 8.82 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.697 1.598 . . . . 0.0 112.165 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.18 -18.91 58.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.436 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.24 179.65 50.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.7 mt -83.23 121.93 27.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -1.217 . . . . 0.0 109.64 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.0 OUTLIER -49.52 -22.48 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 108.661 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 56.0 m-85 -148.42 178.96 8.15 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -86.87 2.95 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.755 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 45.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.543 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -61.76 -42.69 84.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.911 -1.118 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.6 Cg_exo -58.76 -60.04 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.585 2.19 . . . . 0.0 112.596 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.2 m -66.96 -39.34 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.064 -1.023 . . . . 0.0 111.448 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.554 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 3.3 ptm85 -67.51 -35.52 79.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.561 -1.337 . . . . 0.0 108.595 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -66.02 -34.56 78.37 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -64.59 -35.08 79.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -67.01 -35.99 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -67.41 -50.93 57.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.2 -33.14 72.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.355 -0.84 . . . . 0.0 109.808 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.1 tp -74.97 -32.74 61.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.096 -1.003 . . . . 0.0 108.736 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.4 mt -65.76 -38.6 82.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -53.97 22.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.497 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 6.7 m-20 -56.15 -29.53 60.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -1.201 . . . . 0.0 109.09 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.1 mt -67.09 -23.27 65.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.529 -0.732 . . . . 0.0 110.581 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.47 -22.51 60.15 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.743 -1.223 . . . . 0.0 109.374 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 237' ' ' LEU . 91.7 mt -50.09 -4.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.599 -1.313 . . . . 0.0 110.411 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.6 mt -75.52 -15.46 60.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 109.681 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.02 58.14 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.659 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.36 155.04 9.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.875 -1.368 . . . . 0.0 109.106 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.1 Cg_endo -49.33 150.62 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.956 1.771 . . . . 0.0 109.869 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -109.42 145.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.023 -1.048 . . . . 0.0 111.881 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -130.25 125.18 34.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.47 -160.3 29.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.417 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -130.49 140.43 50.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 109.153 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.8 m-85 -138.62 142.14 39.12 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.175 -0.953 . . . . 0.0 110.331 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.7 t80 -124.91 124.66 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.0 m -117.76 135.0 54.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -115.36 114.92 25.75 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 49.87 20.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.02 -1.05 . . . . 0.0 109.074 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -53.34 156.53 5.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.489 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -138.35 163.0 25.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.577 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 48.4 m-70 -48.68 -40.11 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.187 -1.184 . . . . 0.0 109.817 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -58.4 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.127 -0.983 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 134' ' ' ASP . 13.8 tp -59.63 -44.02 93.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.077 -1.014 . . . . 0.0 109.519 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.2 m-20 -47.73 -48.12 29.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.885 -1.135 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 56' ' ' THR . 73.2 t -62.89 -52.37 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.584 -0.698 . . . . 0.0 109.573 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.484 ' NZ ' ' OD1' ' A' ' 134' ' ' ASP . 31.0 ttmt -52.86 -48.79 66.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.522 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -52.94 -51.75 60.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 108.7 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.538 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.0 t -56.82 -53.75 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.21 -0.932 . . . . 0.0 109.18 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -49.64 -48.23 49.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.91 -48.47 81.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.64 -49.76 74.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.877 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.47 -26.35 66.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.831 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 110.097 -179.531 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 85' ' ' THR . 3.0 mm-40 -56.88 138.57 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 108.846 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -121.61 144.59 48.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.0 110.272 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -142.5 -174.63 4.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.0 m -98.6 136.96 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.249 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.41 -23.03 66.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 109.945 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.51 159.35 44.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.719 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 139.68 58.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.18 164.39 15.24 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.32 142.65 45.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.85 -1.156 . . . . 0.0 110.566 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.3 m-85 -139.3 154.01 47.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.1 152.6 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.856 -1.153 . . . . 0.0 110.091 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.79 176.49 36.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.7 154.6 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -1.099 . . . . 0.0 110.369 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.64 140.45 15.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.526 ' CD1' HG21 ' A' ' 179' ' ' THR . 4.2 tt -58.83 -40.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -1.169 . . . . 0.0 110.679 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 18' ' ' ILE . 77.9 m-70 -89.53 -49.67 6.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.663 -1.273 . . . . 0.0 111.126 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 p -69.6 -23.1 63.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.662 -0.649 . . . . 0.0 111.262 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.48 15.94 13.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.39 154.37 21.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 109.607 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 14.1 t80 -75.98 135.93 40.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 109.766 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 m -139.39 145.28 38.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.43 154.87 24.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 89' ' ' ILE . 8.7 mt -135.71 148.58 48.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.204 -0.935 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG22 ' NE2' ' A' ' 29' ' ' HIS . 14.6 mt -143.37 113.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.18 115.22 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 110.992 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.546 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -107.71 135.95 19.73 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.476 -0.765 . . . . 0.0 109.692 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 21.0 Cg_exo -52.32 168.18 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.004 1.803 . . . . 0.0 111.94 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 35' ' ' THR . 12.7 mm-40 -144.63 177.52 8.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.35 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.11 156.07 19.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -49.6 151.28 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.737 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 70.29 -11.1 2.28 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.997 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.68 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 62.1 m -55.81 -46.65 78.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.652 -1.499 . . . . 0.0 109.986 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 96.97 -177.71 32.89 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.204 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.66 117.0 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -138.44 147.7 43.57 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.67 156.86 16.35 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -129.08 111.27 12.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 16.2 tttp -135.65 134.97 39.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 110.851 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 49.92 26.59 2.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.969 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.11 19.54 62.6 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.298 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.7 120.45 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.099 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -87.14 129.14 35.06 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.093 -1.004 . . . . 0.0 108.42 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.514 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 73.5 mt -121.31 95.64 48.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 110.466 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.45 150.19 16.12 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.93 1.754 . . . . 0.0 110.995 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.66 72.1 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -123.86 163.38 21.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.774 . . . . 0.0 109.043 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.3 p-80 -66.04 -52.12 52.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 110.141 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -43.83 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.777 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' HIS . 28.3 m-85 -95.2 5.44 51.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.789 -1.194 . . . . 0.0 109.936 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.3 t -76.69 129.82 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.0 108.611 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.74 -24.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 0.0 110.303 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.67 125.18 10.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.012 -1.055 . . . . 0.0 110.009 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -119.58 95.98 5.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.9 t-20 -162.66 128.54 3.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 88.0 m-70 48.02 9.79 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.15 -0.969 . . . . 0.0 109.263 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 165.8 147.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.905 . . . . 0.0 109.868 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.41 ' HG1' ' HD1' ' A' ' 253' ' ' HIS . 86.0 m -90.06 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 109.149 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.11 149.49 42.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.465 -0.772 . . . . 0.0 110.788 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 13.3 mt -120.37 163.17 18.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.117 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.62 151.19 15.58 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.619 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.33 145.41 14.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.669 -0.901 . . . . 0.0 108.691 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 21.35 7.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.04 -28.14 15.22 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.804 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.23 147.46 49.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.699 -1.471 . . . . 0.0 109.402 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 47.2 ttp180 -140.51 147.03 38.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.071 -1.018 . . . . 0.0 111.498 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.23 137.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -105.87 156.07 18.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 112.322 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.0 m 50.18 78.3 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.439 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.33 -8.2 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.005 . . . . 0.0 109.363 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.8 pm0 -62.74 -27.13 69.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 111.106 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.81 -69.09 0.33 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.802 -1.186 . . . . 0.0 109.256 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.6 HG23 ' N ' ' A' ' 76' ' ' LEU . 7.1 tp -51.87 -47.7 40.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.6 ' N ' HG23 ' A' ' 75' ' ' ILE . 11.8 mt -52.29 -49.12 64.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.937 -1.102 . . . . 0.0 110.384 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 36.1 t -60.56 -42.12 95.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.19 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 106' ' ' PHE . 82.3 t -57.25 -46.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.942 -1.099 . . . . 0.0 109.194 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.63 -34.2 77.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -64.09 -37.95 89.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' A' ' 171' ' ' GLU . 54.4 mt -77.85 -39.58 43.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.72 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 82' ' ' LEU . 69.3 mt -78.41 -2.53 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.009 . . . . 0.0 109.226 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 58.32 42.44 21.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 111.311 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.1 mm -86.01 146.59 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.871 -1.143 . . . . 0.0 108.169 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG12 ' A' ' 121' ' ' ILE . 61.3 p -128.93 -23.84 3.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 111.514 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.737 HD21 ' N ' ' A' ' 34' ' ' GLY . 27.6 m120 -124.61 107.85 11.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.851 -1.156 . . . . 0.0 110.75 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.89 147.14 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.851 0.834 . . . . 0.0 110.256 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 24.7 m -114.82 112.04 22.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.478 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -93.82 100.32 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.421 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.494 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.4 tt0 -74.55 125.94 29.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.4 HG22 HD21 ' A' ' 26' ' ' LEU . 40.3 t -107.16 130.01 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.921 0.867 . . . . 0.0 111.998 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.3 mm -110.69 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.82 -154.76 23.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.44 -10.44 8.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.385 -1.068 . . . . 0.0 110.049 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -138.83 148.31 43.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.041 -1.037 . . . . 0.0 109.347 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 26' ' ' LEU . 7.8 mm -74.44 122.17 86.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.317 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -41.82 122.05 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.975 1.783 . . . . 0.0 111.501 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.475 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -74.82 -13.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.101 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 106' ' ' PHE . 25.8 mt 57.27 -122.45 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.496 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.49 8.74 43.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.588 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.52 -3.66 72.06 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.514 -1.327 . . . . 0.0 109.819 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.21 -173.03 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.495 -1.003 . . . . 0.0 109.135 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.24 16.2 11.83 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -58.24 -45.09 88.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.907 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.95 -57.42 9.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.011 . . . . 0.0 109.655 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 99' ' ' LEU . 8.8 m-85 -51.58 -46.03 63.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.058 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 59.6 t80 -61.17 -52.93 62.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.646 . . . . 0.0 111.058 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.1 -43.08 99.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.139 -0.976 . . . . 0.0 111.376 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -56.63 9.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 110.572 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.7 mt -63.54 -32.24 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.97 -1.081 . . . . 0.0 109.661 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.2 ttt180 -65.09 -43.62 91.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -75.83 11.39 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.018 -1.051 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -143.98 35.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.914 -1.116 . . . . 0.0 110.435 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -82.02 141.19 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 0.0 110.57 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.69 120.52 22.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.709 ' H ' HD22 ' A' ' 116' ' ' ASN . 1.0 OUTLIER -81.78 140.68 34.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -106.11 -168.57 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.785 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 118' ' ' ASN . 16.3 p30 -111.54 71.52 0.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 0.0 110.65 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -170.5 133.77 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.995 . . . . 0.0 109.547 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -69.71 147.68 50.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.707 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.629 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -88.72 151.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -97.99 88.05 4.14 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.3 m-85 -66.46 144.27 56.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.848 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -88.31 100.98 13.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -90.78 132.61 34.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.657 -0.652 . . . . 0.0 110.799 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.45 114.06 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.87 -30.18 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.961 -1.087 . . . . 0.0 110.313 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.76 149.95 73.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.831 . . . . 0.0 109.463 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.28 149.72 45.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.492 2.128 . . . . 0.0 111.456 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 4.8 tt -157.37 153.82 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.055 . . . . 0.0 109.565 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.63 144.51 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.322 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.39 148.24 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -134.96 161.83 34.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB3' HD13 ' A' ' 255' ' ' LEU . 30.6 t70 -174.8 105.81 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.907 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 52.26 53.57 12.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.442 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 -33.0 3.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -60.32 135.51 57.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.019 -1.283 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -145.41 137.72 25.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 110.333 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.575 ' CD1' HD23 ' A' ' 255' ' ' LEU . 90.4 mt -137.04 130.39 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 0.0 109.51 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -117.8 132.09 56.49 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.362 0.601 . . . . 0.0 109.896 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.26 134.21 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.57 153.15 46.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -50.79 143.19 30.49 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.379 2.052 . . . . 0.0 113.428 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.5 143.8 19.03 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.12 -9.66 11.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 110.463 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' GLY . 82.1 p -144.7 -175.29 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 109.547 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 148' ' ' GLU . 10.3 tp -100.19 123.56 44.56 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.198 -0.939 . . . . 0.0 108.567 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.477 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -138.9 135.41 34.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 108.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 231' ' ' LEU . 70.9 t -134.48 123.67 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 165' ' ' THR . 90.9 m -113.75 152.32 30.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -0.775 . . . . 0.0 109.846 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.949 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.97 132.43 54.92 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.03 141.2 11.33 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.338 -1.41 . . . . 0.0 112.07 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.11 101.92 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.43 167.03 13.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 111.144 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -104.54 30.97 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.594 -0.691 . . . . 0.0 110.726 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' LEU . 27.5 p-10 -148.53 -168.35 3.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.771 -1.206 . . . . 0.0 110.118 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -48.22 -4.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 0.0 111.374 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.7 mt -82.99 -31.01 27.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.521 -1.362 . . . . 0.0 108.708 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.55 -135.53 41.48 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.69 132.27 45.14 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.154 -1.203 . . . . 0.0 109.146 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -137.92 149.98 46.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -140.66 144.11 35.5 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -141.78 132.62 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 109.775 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.455 HG23 ' OG1' ' A' ' 150' ' ' THR . 85.5 m -105.89 123.98 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.549 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.9 t80 -105.22 115.74 30.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.49 151.53 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.69 129.63 23.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.01 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.09 -1.99 38.06 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -119.18 23.23 11.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -1.123 . . . . 0.0 109.39 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -56.03 -56.05 25.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 171' ' ' GLU . 3.8 mt-10 -41.81 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.407 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.572 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 2.3 mt-10 -85.11 -7.35 59.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.067 -1.021 . . . . 0.0 111.463 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.565 HG22 ' HB2' ' A' ' 225' ' ' ARG . 9.2 pt -126.36 -27.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.864 -1.147 . . . . 0.0 110.906 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 81' ' ' LEU . 15.8 m -63.89 -17.37 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.739 -1.226 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.4 -3.52 55.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 225' ' ' ARG . . . -68.6 126.32 29.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 179' ' ' THR . 62.4 mtm180 -94.04 130.36 40.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 10.1 t -37.11 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.52 154.24 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.544 -1.348 . . . . 0.0 111.578 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -152.16 156.36 39.65 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.1 m-85 -97.66 145.49 26.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.83 -1.169 . . . . 0.0 109.692 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.447 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 4.0 t0 -48.8 -37.9 20.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.251 -0.905 . . . . 0.0 109.084 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.532 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.8 p90 -70.16 -25.82 63.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.987 -1.071 . . . . 0.0 109.331 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.3 mm-40 -75.68 -35.66 60.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 61.8 mt -51.92 -42.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.681 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -58.84 -41.7 87.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 0.0 109.538 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 189' ' ' ILE . 11.7 t60 -75.85 -58.31 3.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.013 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 188' ' ' HIS . 94.4 mt -43.79 -33.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -79.4 -52.51 7.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.1 . . . . 0.0 109.069 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -47.33 -44.82 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.22 7.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.054 -1.029 . . . . 0.0 110.531 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.02 40.0 57.67 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.081 -1.012 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.0 mt -127.72 173.82 9.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.219 -1.166 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.16 26.58 50.11 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -60.26 -19.69 55.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.0 109.868 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.84 3.34 33.92 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.68 128.07 40.14 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.462 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 11.5 p -146.44 164.65 31.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.9 mt -66.72 -7.93 24.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 108.607 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -96.83 -19.09 19.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.601 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.462 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 21.5 p30 -128.04 3.98 5.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.5 m -144.47 146.72 32.59 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.688 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 217' ' ' LEU . 13.7 tp -96.79 96.3 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.09 127.67 39.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.893 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.5 160.95 24.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.577 -0.702 . . . . 0.0 109.438 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.43 -166.15 13.04 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -30.47 70.61 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.134 -1.215 . . . . 0.0 109.658 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.97 23.38 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.089 -1.007 . . . . 0.0 111.264 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -149.97 157.76 43.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.449 -1.407 . . . . 0.0 110.724 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.9 t -105.24 115.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -61.63 -44.06 97.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.387 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.3 m120 -62.43 126.01 87.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.889 -1.132 . . . . 0.0 110.334 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -67.08 -17.17 50.7 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.689 1.593 . . . . 0.0 112.246 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -15.82 56.28 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.964 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.33 -164.93 54.45 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.7 mt -91.83 129.55 37.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -1.208 . . . . 0.0 109.463 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 3.3 mmt85 -67.02 -17.08 64.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.995 -1.066 . . . . 0.0 108.193 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 40.6 m-85 -145.53 160.67 41.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.433 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.9 mp0 -77.86 15.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.708 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.538 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -154.28 39.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.781 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.4 tt0 -57.95 -43.81 98.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.903 -1.123 . . . . 0.0 109.793 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 33.2 Cg_exo -59.59 -66.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.833 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 225' ' ' ARG . 19.6 m -60.37 -40.19 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.133 -0.979 . . . . 0.0 111.428 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.572 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 4.3 ptm180 -67.77 -34.72 77.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.615 -1.303 . . . . 0.0 109.006 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -66.61 -32.35 73.62 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -65.59 -37.61 87.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 166' ' ' PHE . 67.8 t -65.7 -37.2 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 46.1 t80 -64.04 -52.07 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.705 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.557 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.0 tp -77.51 -33.58 54.32 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 mt -67.41 -38.06 80.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -54.4 22.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 95.4 m-20 -56.52 -33.04 65.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -1.197 . . . . 0.0 109.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 235' ' ' LEU . 9.1 mt -68.09 -25.15 65.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.544 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.4 t80 -75.06 -21.48 58.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.921 -1.112 . . . . 0.0 109.528 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -50.71 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.705 -1.247 . . . . 0.0 110.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 4.3 mt -70.67 -13.55 62.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.048 . . . . 0.0 109.857 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.74 0.91 60.34 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.609 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.05 152.5 11.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.345 . . . . 0.0 108.86 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.9 Cg_endo -53.59 128.04 27.83 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.795 1.663 . . . . 0.0 109.942 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 t -87.48 153.16 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 112.266 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -134.94 126.15 28.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.7 -157.15 27.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.1 OUTLIER -131.2 136.17 48.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 108.87 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.0 m-85 -135.52 140.54 44.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.155 -0.965 . . . . 0.0 110.484 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -126.09 132.15 51.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -125.32 136.37 53.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.121 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -117.3 113.37 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.19 24.43 1.99 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 109.037 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.45 154.08 42.38 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -131.09 178.18 17.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 75.5 m-70 -59.78 -40.92 89.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -1.226 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -58.96 5.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.575 HD23 ' CD1' ' A' ' 139' ' ' ILE . 6.1 tp -55.74 -46.38 77.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 109.62 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.3 -51.73 18.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.889 -1.132 . . . . 0.0 109.323 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 56' ' ' THR . 88.6 t -61.53 -50.26 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.428 -0.795 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -54.09 -52.05 62.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.988 -1.07 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.1 tp -49.79 -50.92 43.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.17 -0.956 . . . . 0.0 108.486 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 238' ' ' LEU . 44.1 t -58.65 -53.16 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -46.9 -49.77 19.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.82 -48.4 74.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.8 mt -55.95 -51.99 65.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.72 -26.44 63.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.397 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.514 -179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.34 138.49 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.957 . . . . 0.0 108.862 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.85 145.77 47.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -141.77 -174.83 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.634 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.3 m -97.18 136.95 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.115 . . . . 0.0 109.112 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' HD13 ' A' ' 115' ' ' LEU . 16.7 ptmt -65.47 -29.82 70.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -144.42 156.15 44.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -63.69 141.21 58.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.428 -0.795 . . . . 0.0 110.356 -179.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.94 166.22 13.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -137.76 143.18 41.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.085 -1.01 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.1 m-85 -139.37 154.52 47.86 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -163.28 152.59 14.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.837 -1.165 . . . . 0.0 110.177 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.13 176.66 36.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.19 153.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -1.144 . . . . 0.0 110.01 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.28 139.97 15.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 19' ' ' HIS . 5.9 tt -58.54 -41.09 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.249 . . . . 0.0 110.472 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 73.4 m-70 -88.09 -50.52 6.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.694 -1.254 . . . . 0.0 111.116 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 p -66.07 -27.92 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.781 -0.575 . . . . 0.0 111.801 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.74 16.63 46.66 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 118.888 -1.625 . . . . 0.0 109.226 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.85 156.04 22.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -1.058 . . . . 0.0 109.487 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.84 134.45 41.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.5 m -138.21 143.86 40.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.132 -0.98 . . . . 0.0 109.499 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -113.03 156.59 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.255 -0.903 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -136.08 146.94 47.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 110.236 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.3 mp -140.85 115.43 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.93 114.99 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.493 -0.755 . . . . 0.0 110.967 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.547 ' NE2' HG22 ' A' ' 27' ' ' ILE . 13.2 m-70 -109.34 138.06 20.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.427 -0.796 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.634 ' HG3' HG23 ' A' ' 7' ' ' VAL . 29.6 Cg_exo -52.15 168.87 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.959 1.772 . . . . 0.0 111.704 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 35' ' ' THR . 71.9 mm-40 -141.91 173.91 11.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.037 -1.039 . . . . 0.0 109.973 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' A' ' 35' ' ' THR . 31.1 mmtp -83.51 152.26 25.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.769 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.11 146.1 2.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 110.073 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.7 46.27 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.83 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 31' ' ' GLU . 29.0 m -68.51 -42.66 78.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.702 -1.469 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.82 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 96.6 -176.62 32.58 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.367 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.12 118.32 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -141.64 155.95 45.68 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.933 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -104.31 156.91 17.51 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -129.5 109.94 11.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 108.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -135.4 134.97 40.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.422 -0.799 . . . . 0.0 111.006 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.69 32.63 7.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 111.578 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.75 17.37 80.12 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.2 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.12 120.81 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.44 -1.036 . . . . 0.0 108.854 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 31.8 m-85 -84.96 128.28 34.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -117.78 93.44 43.9 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.389 -0.819 . . . . 0.0 109.283 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.78 146.7 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.324 2.016 . . . . 0.0 111.925 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 70.93 9.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -122.34 174.82 6.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.2 p-80 -78.1 -52.57 8.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.997 . . . . 0.0 109.61 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -43.7 -16.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' HIS . 39.8 m-85 -96.18 2.74 53.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.06 . . . . 0.0 110.029 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -73.12 132.76 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 108.664 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.64 -30.83 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 110.336 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.68 134.91 18.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 257' ' ' VAL . 73.3 p -123.75 96.07 4.82 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -162.84 128.7 3.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.3 -0.875 . . . . 0.0 109.121 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.502 ' O ' ' CB ' ' A' ' 59' ' ' SER . 33.6 m-70 48.41 9.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.118 -0.989 . . . . 0.0 109.15 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.07 141.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.692 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.1 m -86.22 127.68 34.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.366 -0.834 . . . . 0.0 109.158 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -120.29 149.59 42.06 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.67 0.748 . . . . 0.0 110.944 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 72' ' ' VAL . 12.0 mt -122.16 150.38 42.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.72 151.89 22.7 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.06 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -161.68 147.09 13.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 52.35 21.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.09 6.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -58.42 146.09 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 136.28 34.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.579 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.2 126.47 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -102.96 157.85 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.097 . . . . 0.0 111.582 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.3 m 49.93 74.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 60' ' ' THR . 24.4 m -108.01 -10.86 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.552 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 6.7 pm0 -61.71 -25.79 67.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 110.706 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.13 -68.91 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 109.083 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.15 -47.66 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.006 -1.059 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.579 ' N ' HG23 ' A' ' 75' ' ' ILE . 14.4 mt -52.73 -50.03 64.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 110.201 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.9 t -59.75 -42.76 93.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.943 -1.098 . . . . 0.0 110.195 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.2 t -55.06 -48.08 76.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.026 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.49 -33.49 76.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.191 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -62.6 -38.77 91.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 109.416 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.9 mt -76.47 -39.25 53.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 110.155 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 114' ' ' ILE . 65.5 mt -81.8 0.5 38.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.985 -1.072 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.38 43.28 26.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.556 -0.715 . . . . 0.0 111.185 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mm -87.69 146.52 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 108.082 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.592 HG21 HG12 ' A' ' 121' ' ' ILE . 51.0 p -130.53 -20.46 2.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.116 -0.99 . . . . 0.0 111.385 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.82 HD22 ' H ' ' A' ' 36' ' ' GLY . 11.5 m120 -125.74 107.09 10.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.054 -1.028 . . . . 0.0 110.614 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -165.75 148.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.618 0.723 . . . . 0.0 110.053 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.1 m -115.87 111.47 20.49 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -94.3 101.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.4 tt0 -72.95 126.36 29.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 HD21 ' A' ' 26' ' ' LEU . 71.5 t -108.68 120.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.892 0.854 . . . . 0.0 111.285 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' ILE . 14.2 mt -108.37 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.22 -158.27 27.18 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -118.95 -12.43 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -1.101 . . . . 0.0 110.059 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -141.43 150.77 42.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 109.509 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -74.09 121.26 84.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.991 . . . . 0.0 108.964 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -41.12 122.02 1.5 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.751 1.634 . . . . 0.0 111.345 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.3 tp -77.95 -15.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.536 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt 57.25 -117.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 9.4 t70 -98.25 5.72 48.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.037 -1.039 . . . . 0.0 110.731 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.97 0.9 58.6 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.143 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.0 -172.45 2.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.703 -0.881 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.59 16.64 7.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.554 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 68.8 t-105 -58.38 -42.15 86.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -1.101 . . . . 0.0 110.292 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.0 -56.39 17.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.905 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 78' ' ' VAL . 12.8 m-85 -51.38 -44.09 62.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 108.783 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.415 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 36.3 t80 -62.41 -53.91 48.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.702 -0.624 . . . . 0.0 110.801 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 4.2 mt-10 -59.31 -44.5 92.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 111.133 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.38 -54.87 19.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.992 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.1 mt -67.09 -33.63 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.761 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.8 ttm-85 -62.87 -43.71 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -77.8 14.01 1.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -144.53 32.2 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.964 -1.085 . . . . 0.0 110.333 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 82' ' ' LEU . 79.4 mt -77.76 138.34 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 110.344 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 8' ' ' LYS . 5.1 tp -128.87 120.03 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -80.2 142.99 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.272 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.57 -174.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.66 68.95 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -164.77 129.42 2.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.099 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -67.96 141.9 56.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.107 . . . . 0.0 109.478 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.592 HG12 HG21 ' A' ' 85' ' ' THR . 69.9 mt -85.37 150.86 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.128 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p30 -97.76 85.16 3.5 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 32.7 m-85 -62.32 143.49 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.588 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -89.48 101.6 14.28 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.2 133.46 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.43 0.634 . . . . 0.0 110.768 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.16 116.56 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -92.62 -29.93 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.957 -1.089 . . . . 0.0 110.607 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.67 149.7 73.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 109.793 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.17 149.56 46.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.62 2.213 . . . . 0.0 111.779 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -157.02 152.43 7.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.155 -0.966 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.51 141.17 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 109.007 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.83 147.22 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -138.49 157.08 46.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.996 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -175.3 108.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.318 -0.864 . . . . 0.0 109.779 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 53.44 51.53 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -0.828 . . . . 0.0 110.614 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.02 -32.53 3.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.419 ' HB3' HD22 ' A' ' 255' ' ' LEU . 4.8 mtp180 -59.16 136.9 58.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -1.232 . . . . 0.0 108.133 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -149.3 135.64 19.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.77 -1.206 . . . . 0.0 109.709 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.615 ' CD1' HD23 ' A' ' 255' ' ' LEU . 87.4 mt -137.27 128.57 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -114.13 131.88 56.27 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.412 0.625 . . . . 0.0 109.886 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.0 134.26 54.81 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.91 152.86 45.04 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.004 -1.06 . . . . 0.0 110.018 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.68 142.57 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.529 2.153 . . . . 0.0 113.889 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -156.83 147.01 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.3 -29.42 68.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.122 -0.986 . . . . 0.0 110.869 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.534 ' O ' ' OG ' ' A' ' 144' ' ' SER . 12.6 p -119.67 -165.52 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.358 -0.838 . . . . 0.0 109.23 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 148' ' ' GLU . 7.3 tp -107.42 122.38 46.5 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.49 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.7 tt0 -138.65 126.25 22.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.979 . . . . 0.0 109.098 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.96 122.2 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 109.83 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 165' ' ' THR . 52.0 m -112.98 151.77 30.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.613 -0.68 . . . . 0.0 109.61 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.76 130.18 25.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.669 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -122.47 135.13 54.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.44 143.13 12.73 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.7 100.64 10.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.11 167.82 13.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.846 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -103.82 24.93 10.49 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.632 -0.668 . . . . 0.0 110.257 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 158' ' ' PHE . 22.6 p-10 -137.71 -170.53 2.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.037 -1.04 . . . . 0.0 110.36 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.59 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 21.2 p90 -49.55 -5.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.608 -0.683 . . . . 0.0 111.638 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.601 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 73.6 mt -82.35 -30.31 30.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.176 -1.578 . . . . 0.0 108.349 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.59 -132.26 43.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 131.04 43.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.158 -1.201 . . . . 0.0 109.192 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 1.6 tp-100 -138.29 144.7 40.59 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.465 -0.772 . . . . 0.0 109.259 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.83 36.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 110.361 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -146.74 141.66 26.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.927 . . . . 0.0 109.942 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 150' ' ' THR . 58.5 m -110.49 124.59 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.491 -0.755 . . . . 0.0 109.822 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -105.37 115.91 31.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.51 151.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.737 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.33 131.56 24.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.167 -0.958 . . . . 0.0 109.166 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.28 -3.03 43.53 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -117.35 22.57 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -1.183 . . . . 0.0 109.002 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -50.97 -54.87 20.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.738 . . . . 0.0 110.011 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 171' ' ' GLU . 71.6 mt-10 -41.79 -23.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' GLU . 64.6 mt-10 -81.54 -12.77 58.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.028 -1.045 . . . . 0.0 111.754 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.15 -28.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.866 -1.146 . . . . 0.0 111.355 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.58 -26.84 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.519 -1.363 . . . . 0.0 108.972 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -84.71 -3.61 58.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.427 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -69.46 116.82 10.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 108.915 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 54.4 mtm180 -79.95 172.35 13.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.143 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -78.54 162.51 26.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.37 149.17 32.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.218 -1.551 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -146.24 156.7 43.57 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.441 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 89.9 m-85 -98.15 146.2 25.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.0 109.314 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.44 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.37 -38.3 12.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.897 . . . . 0.0 109.479 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -72.33 -29.37 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 0.0 109.597 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.7 mt-10 -73.16 -33.95 65.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 71.2 mt -53.8 -54.25 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.792 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.3 -41.93 9.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.5 t-160 -74.42 -47.99 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.466 -0.771 . . . . 0.0 109.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 92.9 mt -53.97 -30.56 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -84.36 -53.52 5.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.885 -1.135 . . . . 0.0 109.477 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -49.87 -36.54 27.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.9 m -81.61 8.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.022 . . . . 0.0 109.892 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.2 39.95 71.53 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.5 mt -128.99 172.31 11.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -1.143 . . . . 0.0 109.989 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.5 25.23 57.8 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -58.89 -20.02 47.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.478 -1.601 . . . . 0.0 109.987 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.46 5.47 31.46 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.69 130.71 34.09 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.315 . . . . 0.0 110.437 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.659 ' N ' HD21 ' A' ' 202' ' ' ASN . 8.2 t -144.08 160.9 40.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.44 -1.035 . . . . 0.0 109.235 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 31.8 mt -66.92 -8.99 33.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.419 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -98.15 -13.05 21.13 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.659 HD21 ' N ' ' A' ' 199' ' ' SER . 10.0 p30 -128.66 8.79 5.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 109.256 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.97 153.91 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 110.377 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 217' ' ' LEU . 9.9 tp -101.3 110.65 22.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.79 128.85 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.773 0.797 . . . . 0.0 109.281 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.83 165.79 17.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.706 . . . . 0.0 109.639 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -166.73 11.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -30.44 69.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -1.049 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 209' ' ' ASP . 23.0 p-10 -158.34 21.88 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.274 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -138.15 145.19 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.907 -1.12 . . . . 0.0 110.535 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.3 108.41 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -54.84 -50.58 68.27 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 110.043 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.61 115.29 13.0 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.66 -12.28 35.01 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.418 1.412 . . . . 0.0 111.9 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.72 -15.95 60.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 108.664 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.73 178.27 46.05 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.592 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -82.62 150.12 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -1.08 . . . . 0.0 109.576 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -79.02 -19.0 52.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.15 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -141.94 -165.53 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.6 -8.21 29.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.191 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.07 45.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.914 . . . . 0.0 109.35 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.18 -46.92 99.6 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.925 -1.109 . . . . 0.0 109.86 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 55.4 Cg_exo -51.18 -68.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.42 2.08 . . . . 0.0 112.179 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.6 -35.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.95 -1.094 . . . . 0.0 109.674 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -61.69 -40.7 95.94 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.9 t60 -68.02 -31.41 71.06 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.664 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -65.33 -36.25 83.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -38.14 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 67.5 t80 -64.42 -50.23 68.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 109.17 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -66.65 -28.35 68.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.06 -32.91 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.104 -0.998 . . . . 0.0 108.391 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.587 HD11 ' CD2' ' A' ' 166' ' ' PHE . 34.4 mt -68.97 -38.9 79.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.58 -53.49 31.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.449 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 80.6 m-20 -56.74 -38.2 72.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.234 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.6 mt -58.59 -21.12 52.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.505 -0.747 . . . . 0.0 110.36 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -75.02 -22.32 58.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.824 -1.172 . . . . 0.0 109.454 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.18 1.08 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.49 -1.381 . . . . 0.0 110.292 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.4 mt -77.93 -16.29 58.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.911 -1.118 . . . . 0.0 109.569 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.9 -0.23 51.88 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.867 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.79 157.41 10.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.736 -1.449 . . . . 0.0 109.118 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.8 Cg_endo -50.22 150.79 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.805 1.67 . . . . 0.0 109.322 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.67 145.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.873 -1.142 . . . . 0.0 112.108 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 122.44 33.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.66 -160.5 30.7 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.444 -1.033 . . . . 0.0 108.888 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -140.66 141.26 35.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 110.401 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -125.52 122.96 38.08 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.8 m -115.22 136.11 53.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 111.198 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 250' ' ' ARG . 91.7 t80 -117.81 116.04 26.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 249' ' ' PHE . 38.0 mtp85 43.55 43.54 4.66 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.219 -0.926 . . . . 0.0 109.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.35 165.42 35.62 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -138.83 -174.57 13.51 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.552 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.4 m-70 -63.01 -39.14 93.86 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER -55.27 -58.68 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.088 -1.007 . . . . 0.0 108.999 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 139' ' ' ILE . 4.1 tp -56.27 -45.08 80.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 109.461 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.46 -50.5 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 109.35 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 56' ' ' THR . 96.1 t -64.95 -39.23 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.732 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -63.97 -51.41 64.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 139' ' ' ILE . 23.6 tp -52.87 -49.13 66.44 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 108.545 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.471 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.4 t -60.01 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -49.29 -48.68 45.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -61.32 -49.07 78.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 109.705 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -57.3 -45.77 83.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 109.641 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.55 63.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.914 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 109.76 -179.644 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 mt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -57.59 141.57 47.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 108.731 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -125.59 147.09 49.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.4 t -141.93 -173.03 3.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.6 m -97.35 136.84 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.868 -1.145 . . . . 0.0 109.035 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -67.27 -21.77 65.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.572 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE2' ' O ' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -152.31 157.82 41.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.417 ' O ' ' OE2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -65.8 139.99 58.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.312 -0.867 . . . . 0.0 110.368 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 mt -115.95 163.55 15.72 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.51 142.06 43.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 110.344 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -141.21 161.01 38.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -167.15 152.75 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 109.768 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.27 176.11 36.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.34 155.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -1.128 . . . . 0.0 110.062 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 139.14 15.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 179' ' ' THR . 7.3 tt -58.98 -38.33 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.265 . . . . 0.0 110.354 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 80.2 m-70 -90.86 -50.82 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.674 -1.266 . . . . 0.0 111.026 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.3 p -68.65 -23.64 64.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.76 -0.587 . . . . 0.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.95 17.2 21.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -108.28 153.34 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -1.025 . . . . 0.0 109.651 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -73.3 134.64 44.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.0 109.41 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -140.49 143.83 35.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -108.28 158.58 17.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -137.6 144.61 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.54 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.574 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.5 mt -143.43 110.91 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.9 . . . . 0.0 108.852 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.43 115.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 111.057 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.574 ' NE2' HG22 ' A' ' 27' ' ' ILE . 30.1 m-70 -108.5 138.57 20.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 109.422 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -53.82 168.37 0.81 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.753 1.635 . . . . 0.0 111.728 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.504 ' OE1' HG21 ' A' ' 35' ' ' THR . 28.1 mm-40 -140.94 173.75 11.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OG1' ' A' ' 35' ' ' THR . 39.7 mttm -85.08 153.06 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.284 -0.885 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.17 147.21 3.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.704 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 71.82 -0.33 37.24 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.903 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.76 ' H ' HD22 ' A' ' 86' ' ' ASN . 51.6 m -67.21 -45.42 76.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.615 -1.52 . . . . 0.0 109.536 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.75 -179.34 31.52 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.774 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.87 117.66 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH2' ' CE1' ' A' ' 45' ' ' TYR . 21.7 ptt180 -144.49 157.73 44.1 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.839 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -103.64 157.86 16.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -128.07 110.83 12.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 108.772 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.548 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 15.9 tttp -135.27 132.81 38.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.579 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.17 28.3 6.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.464 -0.772 . . . . 0.0 111.628 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.44 19.67 68.34 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.211 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -124.28 123.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.278 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.447 ' CE1' ' NH2' ' A' ' 38' ' ' ARG . 98.9 m-85 -84.78 127.62 34.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.4 90.99 40.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.69 150.22 4.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.549 2.166 . . . . 0.0 111.926 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.644 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.11 75.99 9.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.982 . . . . 0.0 109.775 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -129.35 173.66 10.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 109.211 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.2 p-80 -71.81 -52.43 17.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -45.48 -16.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.758 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' HIS . 21.0 m-85 -94.9 0.37 54.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.722 -1.236 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -72.82 128.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.04 -28.94 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -151.07 133.03 15.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.945 HG21 HG21 ' A' ' 257' ' ' VAL . 40.8 p -123.93 95.91 4.74 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' SER . 5.7 t-20 -162.61 128.76 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.852 . . . . 0.0 108.805 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' SER . 50.9 m-70 50.17 9.45 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.97 146.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.801 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.434 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 31.0 m -89.9 126.92 35.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 0.0 109.174 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.7 m-20 -121.04 150.35 41.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.328 -0.857 . . . . 0.0 111.059 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CG ' HG21 ' A' ' 72' ' ' VAL . 4.5 mt -125.5 150.11 47.68 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.51 154.82 25.91 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.894 -1.622 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -163.22 150.39 12.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -1.033 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt 52.31 22.2 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.13 -32.5 7.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -59.83 145.74 44.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.287 . . . . 0.0 109.478 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.25 139.51 35.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.407 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -130.15 121.96 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -99.04 156.99 16.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.1 m 49.14 74.52 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.879 -0.513 . . . . 0.0 110.739 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.533 HG21 ' CG ' ' A' ' 62' ' ' LEU . 20.6 m -108.0 -9.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.117 -0.989 . . . . 0.0 109.274 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.1 pm0 -60.86 -26.28 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.493 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.01 -69.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -52.56 -47.48 48.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.276 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.644 HD21 ' HB1' ' A' ' 48' ' ' ALA . 26.4 mt -52.02 -48.75 64.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.954 -1.091 . . . . 0.0 110.026 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -61.18 -42.46 98.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.166 -0.959 . . . . 0.0 110.118 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.8 t -56.64 -44.88 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.093 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.24 -35.19 75.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.33 -0.856 . . . . 0.0 109.288 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -62.48 -34.36 76.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 109.189 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 52.2 mt -82.03 -37.97 25.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.619 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 82' ' ' LEU . 70.4 mt -79.62 0.26 30.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.409 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 4.1 mp0 57.13 41.13 27.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.326 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.07 143.67 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.703 -1.248 . . . . 0.0 108.043 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 121' ' ' ILE . 51.5 p -127.52 -21.04 3.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.103 -0.998 . . . . 0.0 111.703 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.76 HD22 ' H ' ' A' ' 35' ' ' THR . 5.4 m120 -127.18 107.0 9.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.937 -1.102 . . . . 0.0 110.609 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -164.94 149.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 109.917 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.45 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 41.7 m -117.21 111.66 19.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.487 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.2 mt -92.61 100.92 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.917 . . . . 0.0 110.269 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.8 tt0 -73.95 127.51 33.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.552 HG22 HD21 ' A' ' 26' ' ' LEU . 21.2 t -115.9 124.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.04 0.924 . . . . 0.0 112.261 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.5 mm -109.48 98.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.548 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 144.36 -159.05 27.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.02 -10.93 9.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -1.163 . . . . 0.0 110.075 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -141.62 150.2 41.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.981 -1.074 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -72.27 120.35 79.91 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.702 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -41.09 120.83 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.69 1.593 . . . . 0.0 111.145 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.3 tp -78.25 -15.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 110.754 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 106' ' ' PHE . 46.2 mt 57.1 -117.78 1.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.051 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 10.3 t0 -97.04 4.48 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 110.588 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.63 1.57 58.87 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.104 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 p -127.58 -172.68 2.73 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.811 . . . . 0.0 109.563 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.7 15.84 7.94 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.403 ' CZ2' ' HG3' ' A' ' 108' ' ' GLU . 42.1 t-105 -56.09 -42.43 76.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -1.046 . . . . 0.0 110.5 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.9 -59.1 5.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.322 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 99' ' ' LEU . 11.2 m-30 -51.16 -45.18 61.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.149 -0.969 . . . . 0.0 109.288 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 48.8 t80 -60.12 -50.72 72.57 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 23.8 mm-40 -63.78 -43.85 95.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.17 -0.956 . . . . 0.0 111.23 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.45 -60.01 2.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.945 -1.097 . . . . 0.0 110.095 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.49 -36.8 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.192 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 39.9 ttt180 -62.12 -43.44 98.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 109.249 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -76.33 13.93 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.614 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -146.08 31.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.069 -1.02 . . . . 0.0 110.453 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.1 mt -80.75 139.12 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.902 -1.124 . . . . 0.0 110.35 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -128.06 119.25 25.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.529 -0.732 . . . . 0.0 109.041 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.62 140.68 48.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -109.54 -178.26 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.701 . . . . 0.0 109.186 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -108.85 68.4 0.68 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.949 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -165.91 131.58 2.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 0.0 109.255 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -67.49 139.02 57.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 109.666 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 HG21 ' A' ' 85' ' ' THR . 47.2 mt -81.35 147.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.103 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.73 84.74 3.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 108.856 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.2 m-85 -64.14 143.84 57.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.438 -0.789 . . . . 0.0 109.851 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -88.27 101.56 13.98 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.17 132.19 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.7 . . . . 0.0 110.777 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.0 114.65 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -86.64 -29.1 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.959 -1.088 . . . . 0.0 110.907 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.77 162.33 51.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.963 -1.086 . . . . 0.0 109.766 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.34 145.56 27.14 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.857 2.371 . . . . 0.0 112.777 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -154.31 149.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.33 143.49 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 109.37 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.5 149.29 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.13 164.72 27.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.4 -0.812 . . . . 0.0 109.859 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.598 ' CG ' HH21 ' A' ' 137' ' ' ARG . 57.6 t0 -173.87 111.77 0.18 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 109.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 58.18 9.54 1.02 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.619 -0.675 . . . . 0.0 109.865 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.18 -26.63 8.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 134' ' ' ASP . 1.2 mpp_? -58.42 144.12 43.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.702 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.3 tt -148.94 139.51 22.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.093 -1.443 . . . . 0.0 111.03 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.23 125.6 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -111.71 131.0 55.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.436 0.636 . . . . 0.0 109.838 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.97 132.37 54.88 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 154.02 52.26 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.995 -1.066 . . . . 0.0 109.959 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.3 139.76 43.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.276 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.93 147.13 22.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.9 -37.54 82.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.4 p -117.75 -171.55 2.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.0 110.051 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 tp -100.95 126.15 47.58 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.98 137.23 34.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.58 ' CG1' HD23 ' A' ' 231' ' ' LEU . 61.8 t -133.98 121.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.0 m -111.29 151.96 27.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.465 -0.772 . . . . 0.0 109.265 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.557 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 34.0 t80 -140.75 130.94 24.88 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.181 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.83 131.66 54.17 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.83 141.33 12.29 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.583 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -103.89 100.81 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.28 167.3 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -100.94 -14.99 17.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.821 . . . . 0.0 110.774 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 p-10 -95.31 -173.56 2.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.784 -1.198 . . . . 0.0 110.587 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.47 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 8.4 p90 -49.3 -0.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.812 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.6 mt -80.76 -28.63 36.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.31 -1.494 . . . . 0.0 108.803 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.12 -137.09 45.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -99.85 135.85 40.65 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -1.188 . . . . 0.0 109.625 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -139.03 146.88 41.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -138.18 144.65 40.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.493 -0.755 . . . . 0.0 109.756 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -143.22 136.16 27.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.7 m -105.85 122.76 46.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CD1' ' OD1' ' A' ' 170' ' ' ASN . 7.2 t80 -101.73 110.24 22.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.271 -0.893 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.684 ' H ' HD21 ' A' ' 170' ' ' ASN . 3.7 t -105.76 141.02 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 110.054 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 167' ' ' VAL . 9.8 mm-40 -44.06 131.58 5.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 108.819 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.85 -16.52 18.45 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.684 HD21 ' H ' ' A' ' 167' ' ' VAL . 1.9 p30 -115.16 29.36 8.07 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.074 -1.25 . . . . 0.0 109.916 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -53.75 -38.32 64.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.07 -1.019 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.3 -18.65 50.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -85.66 -7.57 58.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 111.179 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.73 -28.49 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.114 -0.991 . . . . 0.0 110.963 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.8 m -63.5 -24.95 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.736 -1.227 . . . . 0.0 108.882 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.59 -4.72 58.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.13 120.17 13.9 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 82.3 mtm180 -83.4 172.47 12.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.501 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.9 t -79.14 161.48 26.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -147.85 145.45 28.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.234 -1.541 . . . . 0.0 111.859 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.49 157.43 44.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.5 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.5 m-85 -98.95 145.54 26.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 109.626 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.06 -35.79 26.58 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.344 -0.847 . . . . 0.0 109.864 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -72.8 -28.16 62.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.963 -1.086 . . . . 0.0 109.862 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.6 mm-40 -79.11 -40.62 30.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 110.085 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.443 ' O ' ' C ' ' A' ' 187' ' ' GLU . 77.5 mt -44.73 -55.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 19.3 tt0 -42.13 -41.73 2.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 192' ' ' VAL . 48.6 t60 -73.26 -55.55 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 88.5 mt -45.4 -26.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.368 -0.832 . . . . 0.0 109.407 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -85.75 -53.71 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.819 -1.176 . . . . 0.0 108.921 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -49.09 -26.77 2.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 188' ' ' HIS . 15.4 m -96.1 18.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 59.25 39.83 95.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 194' ' ' LEU . 62.4 mt -125.45 171.97 10.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -1.071 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.37 22.49 51.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -58.28 -22.79 54.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.7 -1.471 . . . . 0.0 109.534 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -110.28 25.56 15.52 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.33 125.01 7.61 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.416 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -143.89 169.49 17.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -1.118 . . . . 0.0 109.847 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.554 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 55.8 mt -69.08 -8.74 48.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.5 -10.64 24.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.722 -0.611 . . . . 0.0 109.762 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.44 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 13.5 p30 -138.27 8.76 2.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 109.866 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.482 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.72 149.56 31.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.932 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.586 HD11 HD21 ' A' ' 206' ' ' LEU . 21.8 tp -97.95 93.65 6.44 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -87.41 130.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.279 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 204' ' ' LEU . 20.3 mt -123.35 163.05 21.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.528 -0.733 . . . . 0.0 109.164 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.52 -166.79 13.22 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -68.45 -25.74 65.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.261 -1.14 . . . . 0.0 109.665 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.16 21.47 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 0.0 110.778 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -150.1 157.92 43.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.411 -1.43 . . . . 0.0 110.68 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.01 113.94 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -57.38 -50.86 71.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.897 -1.127 . . . . 0.0 109.99 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.34 111.21 3.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.56 -16.47 30.15 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.747 1.631 . . . . 0.0 112.677 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.65 -15.7 60.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.901 -1.125 . . . . 0.0 109.923 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.4 -178.37 47.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.7 mt -84.31 151.41 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 109.735 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.5 OUTLIER -78.55 -18.97 53.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.187 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 52.9 m-85 -144.72 -172.0 3.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.542 -0.724 . . . . 0.0 109.103 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.3 -5.08 53.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.6 43.28 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.196 -0.94 . . . . 0.0 109.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -54.82 -47.52 98.02 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 109.948 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -50.82 -68.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.463 2.108 . . . . 0.0 112.079 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.7 m -58.22 -36.3 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -60.88 -40.88 94.66 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.223 -0.923 . . . . 0.0 108.555 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.479 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 15.3 t60 -68.47 -32.19 72.01 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.253 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . 0.557 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 6.0 mmtp -66.04 -36.03 82.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.9 t -67.63 -37.49 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.03 -52.11 61.01 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 87.4 m-20 -65.38 -27.01 68.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.681 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.58 HD23 ' CG1' ' A' ' 149' ' ' VAL . 59.2 tp -76.92 -32.77 57.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.084 -1.01 . . . . 0.0 108.588 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.85 -38.53 78.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.15 -54.36 24.57 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -56.96 -35.43 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 109.293 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.72 -24.83 67.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 110.512 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.2 t80 -74.98 -21.46 59.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.884 -1.135 . . . . 0.0 109.388 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 237' ' ' LEU . 65.0 mt -48.54 -6.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.86 -1.15 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -69.33 -13.03 62.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.945 -1.097 . . . . 0.0 109.85 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.85 2.92 64.44 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.715 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.74 149.87 11.02 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.872 -1.369 . . . . 0.0 108.904 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.401 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 6.9 Cg_endo -53.04 130.0 35.95 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.639 1.559 . . . . 0.0 110.076 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.88 150.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 112.216 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -130.64 123.37 29.28 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.82 -157.43 27.59 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.8 OUTLIER -129.35 137.03 50.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -1.042 . . . . 0.0 108.857 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.0 m-85 -133.54 140.03 46.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -126.97 123.24 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.06 132.99 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.735 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -114.92 110.79 20.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 56.6 mtp180 46.57 41.25 9.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.249 -0.907 . . . . 0.0 109.087 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.8 163.98 50.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -131.76 -179.05 15.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.519 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 30.7 m-70 -65.15 -46.72 79.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -1.229 . . . . 0.0 110.034 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.6 OUTLIER -53.45 -60.61 3.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.971 -1.081 . . . . 0.0 108.782 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 254' ' ' SER . 12.5 tp -47.76 -49.5 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.03 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 25.8 m-20 -47.74 -49.5 28.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.988 -1.07 . . . . 0.0 109.098 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 56' ' ' THR . 88.2 t -60.94 -44.29 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.473 -0.767 . . . . 0.0 109.755 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -59.4 -49.21 78.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.218 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 32.4 tp -54.19 -49.85 68.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.63 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.555 HG13 ' HG ' ' A' ' 238' ' ' LEU . 22.5 t -58.47 -57.43 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.003 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -47.74 -45.33 28.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.133 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -62.48 -57.4 11.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.365 -0.834 . . . . 0.0 109.213 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.5 mt -48.4 -48.7 36.86 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.141 -0.975 . . . . 0.0 109.512 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.58 67.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 109.859 -179.537 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.3 mt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.266 0.555 . . . . 0.0 109.643 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 119' ' ' ARG . 27.9 mt-10 -54.0 142.45 24.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -125.7 142.73 51.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.351 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -142.62 -168.55 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.1 m -103.22 141.19 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.005 -1.059 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -69.92 -26.03 63.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.982 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -145.44 161.79 38.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 110.161 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 139.18 55.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.07 161.27 20.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 p -131.96 141.66 49.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.73 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 91.9 m-85 -138.17 152.5 48.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.24 151.9 19.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.743 -1.223 . . . . 0.0 110.157 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.72 174.28 35.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 151.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.0 136.14 14.81 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.4 tt -56.55 -39.05 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.456 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.8 m-70 -92.35 -49.26 6.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.757 -1.214 . . . . 0.0 111.008 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -28.38 69.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 111.245 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.87 17.63 55.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -112.7 155.12 25.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -1.012 . . . . 0.0 109.325 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.28 135.2 44.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.0 109.421 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 m -138.11 144.34 40.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.784 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.18 154.38 25.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.027 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 7.7 mt -135.74 147.44 48.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 110.162 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.573 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.8 mt -143.87 109.43 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.4 115.15 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.449 -0.782 . . . . 0.0 110.575 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.573 ' NE2' HG22 ' A' ' 27' ' ' ILE . 34.2 m-70 -109.46 141.81 24.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 7' ' ' VAL . 16.5 Cg_exo -55.79 168.89 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.824 1.683 . . . . 0.0 111.477 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' HG21 ' A' ' 35' ' ' THR . 70.7 mm-40 -141.74 175.44 9.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.93 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 13.8 mttt -82.37 152.09 26.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 145.13 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.4 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 70.19 5.06 52.59 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.107 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 31' ' ' GLU . 35.2 m -67.31 -44.37 79.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.526 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.811 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 97.36 -179.69 33.54 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.547 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -96.29 116.58 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -143.02 148.84 37.41 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.69 -1.204 . . . . 0.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.82 156.94 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -129.3 109.38 11.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.236 -0.915 . . . . 0.0 108.934 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 tttp -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m120 53.61 27.7 7.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 111.101 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.25 19.67 71.43 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.463 -1.351 . . . . 0.0 109.859 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 t -123.28 123.2 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -85.87 127.46 34.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.04 -1.038 . . . . 0.0 109.287 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mt -118.23 95.03 47.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 109.724 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.4 148.24 11.18 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.476 2.118 . . . . 0.0 112.179 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.674 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.59 78.38 8.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.761 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -134.85 -179.94 5.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 0.0 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.4 p-80 -74.52 -54.76 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.986 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.598 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.4 OUTLIER -43.5 -17.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.845 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 67.2 m-85 -97.23 -0.52 46.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 109.655 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.94 122.36 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.4 -0.813 . . . . 0.0 108.831 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -100.3 -34.11 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -151.21 138.66 19.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.144 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.944 HG21 HG21 ' A' ' 257' ' ' VAL . 55.2 p -125.02 95.86 4.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 59' ' ' SER . 28.0 t-20 -162.53 129.5 3.66 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.4 m-70 49.43 9.57 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.091 -1.006 . . . . 0.0 108.969 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.61 143.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 109.646 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 41.8 m -88.66 129.56 35.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 109.011 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.16 152.34 41.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.288 -0.883 . . . . 0.0 111.164 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.0 mt -126.11 151.77 46.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.04 165.54 34.25 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.021 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -168.71 141.74 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 108.806 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? 52.27 28.59 5.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.741 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.63 5.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -57.64 148.75 23.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.006 -1.291 . . . . 0.0 109.343 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.28 139.99 26.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.699 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.534 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -130.24 124.62 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -98.45 154.19 18.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.272 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.2 m 51.89 75.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.1 m -107.88 -9.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.138 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.58 -27.96 69.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.517 -0.739 . . . . 0.0 110.559 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -65.08 -69.37 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.988 -1.07 . . . . 0.0 109.498 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -51.57 -47.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.154 -0.966 . . . . 0.0 109.023 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.674 HD21 ' HB1' ' A' ' 48' ' ' ALA . 18.6 mt -52.12 -48.37 64.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.076 -1.015 . . . . 0.0 110.134 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.582 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 40.5 t -60.87 -42.77 98.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.45 -44.59 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.0 109.086 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.05 -34.48 77.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -61.96 -40.43 95.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' HB2' ' A' ' 171' ' ' GLU . 55.8 mt -75.0 -37.9 61.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.718 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.23 0.82 34.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 109.543 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 54.41 42.25 31.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 0.0 110.139 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -90.36 137.04 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 108.557 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 HG12 ' A' ' 121' ' ' ILE . 31.4 p -124.53 -19.01 5.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.191 -0.943 . . . . 0.0 112.018 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.811 HD22 ' H ' ' A' ' 36' ' ' GLY . 19.2 m120 -124.61 107.16 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.806 -1.184 . . . . 0.0 110.407 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.3 m -165.9 147.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.738 0.78 . . . . 0.0 109.913 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 53.3 m -114.03 110.97 20.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.18 100.31 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 110.16 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.92 125.7 28.2 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 69' ' ' ILE . 48.8 t -110.79 120.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.762 0.791 . . . . 0.0 111.725 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt -107.52 96.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.84 -156.61 26.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -121.83 -10.55 8.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -1.169 . . . . 0.0 110.443 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -140.33 148.86 41.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.0 -1.063 . . . . 0.0 109.973 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.7 mm -72.99 117.17 57.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.892 . . . . 0.0 108.804 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' ILE . 75.3 Cg_exo -39.31 130.26 1.57 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.586 1.524 . . . . 0.0 111.418 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.482 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.6 tp -86.21 -14.12 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.08 -117.47 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 0.0 109.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 4.47 51.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.024 -1.047 . . . . 0.0 110.75 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.71 58.77 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.182 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.1 p -126.54 -172.82 2.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.558 -0.966 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.7 15.99 9.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 62.5 t-105 -59.67 -42.73 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -1.064 . . . . 0.0 110.299 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.55 -57.06 11.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.095 -1.003 . . . . 0.0 109.996 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -51.33 -44.92 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.865 . . . . 0.0 109.048 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 46.4 t80 -62.55 -52.51 63.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.726 -0.608 . . . . 0.0 110.931 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 3.8 mm-40 -60.71 -44.13 96.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.08 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.85 3.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.088 -1.007 . . . . 0.0 110.51 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.25 -33.75 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.506 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 36.2 ttt180 -64.64 -41.81 95.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' C ' HD22 ' A' ' 113' ' ' ASN . 20.3 mmtt -75.86 11.97 1.23 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 110.024 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.454 HD22 ' C ' ' A' ' 112' ' ' LYS . 2.7 m-80 -142.84 35.68 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.284 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.3 mt -81.41 140.12 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.225 -0.922 . . . . 0.0 110.953 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 8' ' ' LYS . 3.9 tp -132.21 126.94 34.73 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.15 146.03 33.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.02 -175.85 2.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.272 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -113.27 67.02 0.66 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.232 -0.917 . . . . 0.0 111.175 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 4' ' ' GLU . 7.6 ttt180 -164.89 128.31 2.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 109.529 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -68.24 142.77 55.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.89 -1.131 . . . . 0.0 109.99 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.528 HG12 HG21 ' A' ' 85' ' ' THR . 70.7 mt -85.95 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -95.94 83.46 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 108.794 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 44.1 m-85 -61.66 145.27 52.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 110.14 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -92.6 102.31 14.74 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.22 133.89 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.384 0.611 . . . . 0.0 110.843 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.69 118.96 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.62 -28.31 16.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.979 -1.075 . . . . 0.0 110.736 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 154.54 80.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.48 151.68 47.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.684 2.256 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -160.23 154.21 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.595 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.37 144.67 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.49 148.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -134.88 159.9 39.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.45 107.9 0.12 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 54.66 49.35 18.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.442 -0.786 . . . . 0.0 110.488 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.65 -29.36 3.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -61.8 137.97 58.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -1.216 . . . . 0.0 108.116 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -146.71 139.38 25.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.691 -1.256 . . . . 0.0 110.223 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.587 ' CD1' HD23 ' A' ' 255' ' ' LEU . 96.7 mt -137.78 126.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.375 -0.828 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -113.34 133.26 55.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.392 0.615 . . . . 0.0 109.999 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.11 136.2 54.89 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.81 150.73 40.3 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.61 141.88 14.57 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.693 2.262 . . . . 0.0 113.62 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.21 144.89 20.16 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.19 -20.51 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.296 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.9 p -137.45 -174.13 3.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 tp -94.39 121.19 35.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -134.74 120.46 19.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.52 121.45 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.805 . . . . 0.0 109.993 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.0 m -111.31 151.84 27.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.631 -0.668 . . . . 0.0 109.199 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -139.21 130.05 26.22 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -121.23 131.67 54.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.65 138.5 9.49 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.32 -1.419 . . . . 0.0 112.053 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 99.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -83.66 167.01 17.65 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 111.359 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -100.44 23.61 10.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.712 -0.617 . . . . 0.0 110.649 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.0 p-10 -140.08 -172.91 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -49.34 -2.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 111.417 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -77.94 -27.74 49.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.361 -1.462 . . . . 0.0 108.375 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.84 -135.1 43.14 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 133.25 44.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -1.204 . . . . 0.0 109.302 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -135.31 141.4 45.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -136.8 144.11 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.012 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -144.91 137.06 25.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.3 m -105.5 123.55 48.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.701 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.489 ' HB3' HG11 ' A' ' 228' ' ' VAL . 10.2 t80 -103.56 109.0 20.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.984 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.76 149.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.07 131.39 23.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -0.958 . . . . 0.0 109.02 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.53 43.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -115.97 22.95 12.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -1.085 . . . . 0.0 109.226 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.722 ' HB2' HD13 ' A' ' 81' ' ' LEU . 4.9 pt-20 -58.11 -47.24 83.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.376 -0.827 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 171' ' ' GLU . 22.8 mt-10 -52.85 -6.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 110.258 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 171' ' ' GLU . 23.7 mt-10 -102.71 -6.94 22.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.033 . . . . 0.0 110.952 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.1 pt -123.73 -26.46 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.996 -1.065 . . . . 0.0 110.849 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.1 m -63.65 -29.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mt -77.39 -5.65 50.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.537 -0.727 . . . . 0.0 109.165 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.51 124.51 24.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.113 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.412 HH12 ' HG3' ' A' ' 215' ' ' GLU . 63.3 mtm180 -86.13 172.72 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.778 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.427 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -79.0 162.55 25.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.36 145.63 27.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.216 -1.552 . . . . 0.0 111.875 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.14 157.94 44.06 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.593 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.5 m-85 -98.61 142.11 30.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.652 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 2.9 t0 -49.22 -35.61 17.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.205 -0.935 . . . . 0.0 109.409 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.593 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.2 p90 -70.55 -26.16 63.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.023 -1.048 . . . . 0.0 109.553 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -86.3 -27.3 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.758 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 205' ' ' VAL . 31.5 mt -60.14 -43.81 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.999 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.6 -39.8 65.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.998 -1.064 . . . . 0.0 109.261 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -75.92 -56.22 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 194' ' ' LEU . 47.8 mt -44.74 -33.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -52.54 7.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.827 -1.171 . . . . 0.0 108.869 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -46.73 -48.33 20.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 110.455 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.6 m -74.24 7.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.002 -1.061 . . . . 0.0 110.409 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 37.85 45.69 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 194' ' ' LEU . 36.8 mt -126.07 169.5 12.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.3 25.38 57.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -61.76 -21.76 64.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.675 -1.486 . . . . 0.0 109.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.44 24.22 22.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.35 124.92 7.43 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.9 OUTLIER -138.64 163.38 32.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -1.154 . . . . 0.0 109.539 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.8 mt -66.91 -8.6 30.49 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.59 -11.83 20.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.3 p30 -133.36 6.4 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.31 149.64 32.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.597 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.456 HD11 HD21 ' A' ' 206' ' ' LEU . 21.3 tp -98.63 95.89 7.58 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 186' ' ' ILE . 62.8 t -86.23 127.83 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.717 0.77 . . . . 0.0 109.323 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 211' ' ' VAL . 28.1 mt -122.27 173.98 7.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.602 -0.686 . . . . 0.0 109.322 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.58 -166.39 10.84 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -30.79 70.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.48 -1.012 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -157.85 25.22 0.27 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -144.21 150.75 38.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.922 -1.111 . . . . 0.0 110.677 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.518 HG22 HD22 ' A' ' 206' ' ' LEU . 51.3 t -103.75 112.31 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -58.89 -45.31 90.54 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.056 -1.027 . . . . 0.0 110.071 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.6 m120 -59.86 117.14 20.61 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.9 -15.3 46.7 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.391 1.394 . . . . 0.0 111.702 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.8 pm0 -76.08 -14.83 60.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.352 -0.842 . . . . 0.0 109.089 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.82 -176.39 51.02 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.8 mt -86.72 140.95 29.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 7.3 ttp180 -71.29 -18.08 62.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.67 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 57.1 m-85 -147.26 165.09 31.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.58 -12.69 60.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.078 . . . . 0.0 109.355 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -131.9 43.63 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -60.62 -46.39 97.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.3 Cg_exo -51.37 -67.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.326 2.018 . . . . 0.0 112.295 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.5 m -58.74 -36.26 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.032 -1.042 . . . . 0.0 109.579 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.67 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 58.5 mtt180 -58.67 -42.08 87.61 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -69.08 -30.94 69.36 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.404 -0.81 . . . . 0.0 109.302 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -65.77 -36.37 83.36 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.8 t -68.49 -39.25 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.582 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 57.6 t80 -62.82 -50.48 70.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.28 -29.4 69.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.057 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.42 -31.16 62.2 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.022 -1.049 . . . . 0.0 108.177 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.4 mt -69.56 -40.17 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.88 47.99 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 m-20 -58.62 -40.81 84.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.262 . . . . 0.0 109.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 13.2 mt -55.09 -21.45 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.683 . . . . 0.0 110.15 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.95 -22.19 60.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.087 . . . . 0.0 108.73 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.31 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.649 -1.282 . . . . 0.0 110.208 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.583 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -76.21 -15.51 60.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.941 -1.099 . . . . 0.0 109.781 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.0 -1.21 55.06 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.48 156.74 9.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.368 . . . . 0.0 108.671 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.422 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.8 Cg_endo -47.88 150.49 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.637 1.558 . . . . 0.0 109.461 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.68 144.92 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.074 -1.016 . . . . 0.0 111.935 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.78 120.34 30.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 -166.8 34.49 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.476 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 2.0 ttmt -126.34 139.25 53.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.405 -1.056 . . . . 0.0 108.934 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -139.26 140.58 37.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 110.546 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.88 124.81 42.86 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 m -116.43 136.39 53.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 111.314 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 250' ' ' ARG . 51.8 t80 -116.54 114.5 24.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 249' ' ' PHE . 5.1 mtp180 44.4 46.8 8.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.021 -1.05 . . . . 0.0 108.836 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -84.99 158.8 33.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -132.15 176.85 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.583 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 55.9 m-70 -58.89 -40.34 84.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.2 t -55.55 -59.53 4.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.833 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 139' ' ' ILE . 5.3 tp -52.33 -47.26 66.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.56 -49.87 25.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.944 HG21 HG21 ' A' ' 56' ' ' THR . 85.4 t -63.62 -51.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 109.805 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.06 -51.56 61.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.045 . . . . 0.0 109.312 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 139' ' ' ILE . 39.7 tp -52.04 -50.2 61.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 108.525 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.583 HG13 ' HG ' ' A' ' 238' ' ' LEU . 41.7 t -57.65 -53.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 108.82 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -48.31 -47.06 36.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.742 . . . . 0.0 109.311 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.24 -51.43 60.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 109.813 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.06 -50.89 69.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.448 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -66.62 -29.46 69.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.083 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.88 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.8 mt . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.224 0.535 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 69.0 mt-10 -54.22 141.26 30.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HG2' HG23 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -125.28 143.57 50.89 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 109.76 -178.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -142.16 -168.61 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -102.4 139.32 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -66.91 -30.07 70.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 109.825 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.43 160.11 41.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.73 140.72 56.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.433 -0.792 . . . . 0.0 110.137 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 11' ' ' LEU . 21.0 mt -117.75 166.79 12.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.18 35.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.952 -1.092 . . . . 0.0 110.404 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' LEU . 85.6 m-85 -142.17 158.83 43.29 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -163.32 151.13 13.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.953 -1.092 . . . . 0.0 109.492 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.99 175.24 36.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.85 153.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -1.079 . . . . 0.0 110.266 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.21 140.72 15.6 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.459 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.5 tt -60.32 -38.23 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 110.862 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 18' ' ' ILE . 70.4 m-70 -90.8 -49.93 6.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.496 -1.378 . . . . 0.0 111.237 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.8 p -72.55 -20.44 61.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 0.0 111.233 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.43 15.6 12.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -105.5 154.27 20.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 109.909 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 31.2 t80 -75.57 136.04 40.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -0.76 . . . . 0.0 109.557 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -138.52 145.55 40.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 109.906 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -108.7 154.67 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.537 HD22 ' CG2' ' A' ' 89' ' ' ILE . 10.1 mt -134.64 146.8 49.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.8 mt -143.72 111.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.808 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.87 115.04 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.189 -0.945 . . . . 0.0 110.668 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 25.5 m-70 -110.82 138.55 21.13 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 109.669 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 7' ' ' VAL . 37.9 Cg_exo -50.47 168.42 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.917 1.744 . . . . 0.0 111.627 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' HG21 ' A' ' 35' ' ' THR . 9.3 mm-40 -140.19 173.2 11.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 109.826 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.3 mmtt -83.04 150.95 26.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.584 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -49.11 146.67 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.937 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 67.14 6.68 40.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -71.78 -47.14 55.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.809 -1.407 . . . . 0.0 109.606 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.16 -174.76 24.41 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.771 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 87' ' ' VAL . 24.2 mm -102.33 118.34 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -139.54 151.91 46.48 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.574 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.81 158.09 16.22 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -130.4 113.82 14.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -135.14 133.16 38.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 110.472 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 42' ' ' ASN . 1.7 m-80 48.98 34.92 5.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.379 -0.825 . . . . 0.0 111.561 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.71 17.43 80.11 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.233 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.18 121.24 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.102 . . . . 0.0 108.901 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.8 m-85 -86.76 128.01 35.01 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.025 -1.047 . . . . 0.0 109.913 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 52' ' ' PHE . 13.4 mt -116.39 92.15 35.64 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.54 -0.725 . . . . 0.0 109.044 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.94 144.99 10.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.47 2.114 . . . . 0.0 112.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.87 63.65 4.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 108.995 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 49' ' ' ARG . 0.3 OUTLIER -114.29 169.88 8.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -75.14 -44.32 47.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 -16.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.436 ' HD2' HG23 ' A' ' 46' ' ' ILE . 24.5 m-85 -95.09 2.05 55.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.815 -1.178 . . . . 0.0 109.949 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.02 126.49 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 108.927 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.4 -30.82 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.888 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.83 141.56 19.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.048 -1.032 . . . . 0.0 109.94 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 HG21 ' A' ' 257' ' ' VAL . 66.0 p -128.56 95.72 4.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.86 129.44 3.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 109.061 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 96.3 m-70 50.82 8.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.047 -1.033 . . . . 0.0 108.875 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.13 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 109.591 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.646 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 33.8 m -91.44 126.95 36.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.026 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.59 149.85 42.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.712 0.768 . . . . 0.0 111.14 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CG ' HG21 ' A' ' 72' ' ' VAL . 5.9 mt -125.54 149.13 48.58 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.55 151.52 21.43 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 118.767 -1.682 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -158.36 149.46 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.5 -1.0 . . . . 0.0 109.231 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 59.7 mttt 46.38 33.92 2.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 109.781 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.76 -33.25 4.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -55.58 139.76 43.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -1.19 . . . . 0.0 108.886 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -139.94 135.14 32.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 110.517 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.408 HG23 HG11 ' A' ' 91' ' ' VAL . 51.1 mt -128.84 117.17 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 mtpp -97.27 155.42 16.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.896 -1.127 . . . . 0.0 111.118 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' THR . 66.1 m 52.62 72.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.221 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 62' ' ' LEU . 19.0 m -107.41 -10.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.646 ' CD ' ' H ' ' A' ' 60' ' ' THR . 2.5 pm0 -60.91 -31.47 70.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -0.786 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -61.87 -68.39 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.983 -1.073 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.39 -48.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 109.314 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.4 mt -51.15 -47.61 62.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.875 -1.141 . . . . 0.0 109.744 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.9 t -62.09 -43.31 99.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 106' ' ' PHE . 91.3 t -56.54 -45.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 108.937 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 mt -66.79 -34.67 78.34 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 108.916 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -63.21 -34.48 77.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.203 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 171' ' ' GLU . 66.3 mt -79.42 -38.45 34.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.764 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.13 3.1 21.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.64 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 55.51 40.19 31.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mm -90.26 134.39 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 108.696 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 121' ' ' ILE . 26.5 p -120.96 -16.16 8.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.367 -0.833 . . . . 0.0 111.718 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -127.64 108.15 10.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.876 -1.14 . . . . 0.0 111.242 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -165.36 150.7 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.356 -0.84 . . . . 0.0 110.404 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 35.7 m -118.67 109.67 16.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.537 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -93.3 102.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.666 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.1 mt-10 -71.42 124.49 24.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.408 HG11 HG23 ' A' ' 69' ' ' ILE . 13.7 t -108.66 113.95 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.529 0.681 . . . . 0.0 110.709 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.7 mm -102.08 97.7 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.65 -156.31 25.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.31 -12.32 9.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 109.827 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -138.5 148.86 44.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 109.404 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.17 128.16 86.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 121.95 4.81 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.709 1.606 . . . . 0.0 111.39 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 202' ' ' ASN . 2.4 tp -77.98 -14.83 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.3 mt 57.38 -120.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.275 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 15.7 t70 -95.05 9.0 41.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.983 -1.073 . . . . 0.0 111.117 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.3 64.64 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.148 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -171.62 2.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.812 -0.817 . . . . 0.0 109.43 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.47 15.11 10.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.99 -42.63 85.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.342 -1.093 . . . . 0.0 110.665 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.47 -58.48 7.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.124 -0.985 . . . . 0.0 110.017 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HG11 ' A' ' 78' ' ' VAL . 21.4 m-85 -51.05 -44.03 61.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.19 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 64.6 t80 -60.88 -50.91 71.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.933 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.33 -43.61 90.42 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.967 -1.083 . . . . 0.0 111.469 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.01 -59.52 3.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.958 -1.088 . . . . 0.0 110.277 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.23 -36.17 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 71.6 ttt180 -63.27 -41.52 99.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.595 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -74.13 9.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -143.76 38.65 1.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.148 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.43 HG23 ' HG2' ' A' ' 5' ' ' LYS . 89.4 mt -88.08 141.72 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.097 -1.002 . . . . 0.0 111.585 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.87 134.72 44.97 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -85.4 150.31 24.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 109.931 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -115.98 -173.95 2.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.408 -0.808 . . . . 0.0 109.81 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.426 ' ND2' ' C ' ' A' ' 118' ' ' ASN . 0.9 OUTLIER -113.97 66.8 0.67 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 -178.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.6 128.61 2.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.051 -1.031 . . . . 0.0 109.291 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.05 139.18 58.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.732 -1.23 . . . . 0.0 109.572 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -82.62 149.31 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.8 81.38 3.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.68 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -60.28 143.53 52.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.672 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -89.36 101.33 14.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -93.39 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.367 0.603 . . . . 0.0 110.778 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.54 114.69 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.89 -28.43 15.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.978 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -129.58 150.18 74.97 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.84 149.59 37.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.478 2.119 . . . . 0.0 112.207 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.95 150.94 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.954 . . . . 0.0 109.265 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.29 143.44 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.58 147.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.24 162.21 35.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -178.07 113.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 54.58 47.38 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 0.0 110.717 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 -30.88 4.26 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -61.55 137.66 58.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.91 -1.347 . . . . 0.0 108.469 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -144.1 138.18 28.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.011 -1.056 . . . . 0.0 109.543 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.768 ' CD1' HD23 ' A' ' 255' ' ' LEU . 78.8 mt -138.85 127.3 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.312 -0.867 . . . . 0.0 110.067 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -117.09 132.01 56.78 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.454 0.645 . . . . 0.0 109.887 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.75 133.66 54.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.72 153.05 46.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.88 -1.138 . . . . 0.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -48.43 141.87 18.48 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.859 2.373 . . . . 0.0 113.836 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.26 148.75 20.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -37.83 82.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.501 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.4 p -124.91 -174.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.317 -0.864 . . . . 0.0 110.385 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -90.86 121.2 32.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.9 . . . . 0.0 109.065 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.476 ' CG ' HG22 ' A' ' 167' ' ' VAL . 3.7 tt0 -134.79 121.7 21.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.473 ' CG1' HD23 ' A' ' 231' ' ' LEU . 59.9 t -121.67 120.97 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -110.6 151.45 27.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.196 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.81 130.18 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.68 130.79 53.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.13 135.11 7.69 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.623 -1.275 . . . . 0.0 111.682 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -101.91 102.34 12.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -86.18 166.95 15.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 111.141 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -103.96 23.36 13.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.771 -0.581 . . . . 0.0 110.294 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.5 p-10 -138.81 -170.7 2.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 110.115 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -50.67 -4.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 111.163 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' ASN . 13.0 mt -78.51 -26.92 46.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.463 -1.398 . . . . 0.0 108.556 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.84 -139.54 32.31 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -99.71 134.76 42.13 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -136.19 144.62 45.04 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.552 -0.717 . . . . 0.0 109.116 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.508 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.21 145.15 38.93 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 110.036 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 165' ' ' THR . 10.1 t80 -147.41 146.11 29.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 92.1 m -113.53 125.39 54.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 110.582 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.434 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.1 t80 -105.01 118.95 37.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.371 -0.83 . . . . 0.0 109.997 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.476 HG22 ' CG ' ' A' ' 148' ' ' GLU . 65.0 t -109.84 150.5 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 134.26 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.35 -7.46 51.25 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -118.95 28.02 8.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.183 -1.187 . . . . 0.0 109.365 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.634 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -63.55 -15.4 57.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.438 -0.789 . . . . 0.0 110.647 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.46 -13.19 61.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 0.0 110.622 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.02 -6.07 36.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.834 -1.167 . . . . 0.0 111.51 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.42 -30.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.149 -0.969 . . . . 0.0 110.426 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 171' ' ' GLU . 12.3 m -61.1 -20.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.772 -1.205 . . . . 0.0 108.683 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.98 -3.35 58.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 0.0 108.969 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.4 117.41 11.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.581 ' NE ' ' OE2' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -82.2 173.22 12.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.665 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.67 162.91 25.88 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -147.8 143.93 27.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.313 -1.492 . . . . 0.0 111.38 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.09 158.63 43.53 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.488 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.1 m-85 -101.03 146.07 27.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.584 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 7.8 p30 -51.18 -37.7 48.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.102 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.488 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.1 p90 -67.87 -26.1 65.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.788 -1.195 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.6 mm-40 -82.43 -25.5 33.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.943 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 186' ' ' ILE . 37.2 mt -58.22 -55.34 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.963 . . . . 0.0 109.659 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -45.3 -39.59 6.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.085 -1.01 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 16.1 t-160 -76.49 -57.46 3.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.151 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 188' ' ' HIS . 84.3 mt -42.04 -32.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.46 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -82.13 -51.31 8.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.071 -1.018 . . . . 0.0 109.102 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -48.35 -45.07 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.89 . . . . 0.0 110.376 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 30.6 m -76.95 8.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.039 -1.038 . . . . 0.0 110.558 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.76 39.74 59.41 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 194' ' ' LEU . 51.7 mt -126.43 170.79 11.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -1.107 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.49 22.28 58.78 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -55.78 -21.6 20.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.641 -1.505 . . . . 0.0 110.231 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.5 3.63 32.72 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.55 124.86 34.14 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.125 -1.221 . . . . 0.0 110.092 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.0 m -145.57 167.4 23.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.267 -1.137 . . . . 0.0 108.956 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.517 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.2 mt -69.94 -8.26 47.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.464 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -95.16 -10.67 29.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.912 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.516 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 12.2 p-10 -138.38 9.81 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.926 -1.109 . . . . 0.0 110.215 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.89 149.3 31.02 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.79 93.68 5.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 203' ' ' THR . 38.6 t -85.7 130.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 66.2 mt -123.05 168.53 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.39 -166.06 11.82 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -63.44 -21.08 66.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -1.107 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.34 22.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -136.66 144.81 44.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.286 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.42 110.25 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -59.76 -47.02 87.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.605 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -62.5 121.28 66.18 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 0.0 109.733 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -67.65 -14.74 42.91 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.474 1.45 . . . . 0.0 112.016 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.2 -16.73 59.78 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.113 -0.992 . . . . 0.0 108.714 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.38 -169.97 54.88 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.247 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -88.98 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 0.0 110.117 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -69.03 -21.34 64.12 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.8 m-85 -147.03 148.01 31.23 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.17 7.6 0.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.201 -0.937 . . . . 0.0 109.769 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.659 ' ND2' ' NE ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -148.34 37.05 0.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.581 ' OE2' ' NE ' ' A' ' 178' ' ' ARG . 1.1 tt0 -54.92 -47.08 99.26 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.95 -66.98 0.1 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.435 2.09 . . . . 0.0 112.102 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.02 -37.12 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 109.969 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.659 ' NE ' ' ND2' ' A' ' 221' ' ' ASN . 56.9 mtt180 -60.95 -40.64 94.11 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.0 t60 -67.47 -32.05 72.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.696 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.87 -35.52 80.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 166' ' ' PHE . 65.1 t -69.14 -37.57 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.575 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 49.8 t80 -64.51 -50.69 66.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.15 -28.74 69.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' CG1' ' A' ' 149' ' ' VAL . 42.9 tp -76.03 -33.66 59.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 108.732 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.34 -40.74 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.85 -52.88 38.16 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.23 -31.8 69.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -1.187 . . . . 0.0 109.314 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 235' ' ' LEU . 6.2 mt -68.86 -24.56 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -76.51 -21.79 55.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.918 -1.114 . . . . 0.0 109.394 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.2 mt -51.23 -0.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.793 -1.192 . . . . 0.0 110.606 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.6 mt -76.59 -11.92 59.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 109.955 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.32 0.6 59.59 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.836 -1.174 . . . . 0.0 110.724 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.56 152.67 13.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.928 -1.337 . . . . 0.0 108.859 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 130.17 39.13 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.869 1.712 . . . . 0.0 110.032 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.55 151.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 112.042 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -136.39 128.82 30.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 151.21 -156.78 26.86 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.453 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.4 OUTLIER -128.9 139.98 51.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -1.102 . . . . 0.0 109.169 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.0 m-85 -139.04 140.04 37.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.104 -0.998 . . . . 0.0 110.329 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -125.56 123.09 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.8 m -118.28 136.55 53.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 111.303 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 250' ' ' ARG . 47.8 t80 -117.32 117.27 29.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 249' ' ' PHE . 10.4 mtp180 45.02 42.49 6.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 108.562 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.08 153.09 35.48 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.13 178.89 17.64 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 86.2 m-70 -59.72 -40.09 86.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -1.044 . . . . 0.0 109.77 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 83.4 p -59.48 -38.78 81.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.798 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.768 HD23 ' CD1' ' A' ' 139' ' ' ILE . 2.1 tp -76.15 -47.18 25.22 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.038 . . . . 0.0 108.984 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . 9.0 m-20 -47.59 -44.5 26.44 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.987 -1.07 . . . . 0.0 108.457 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 56' ' ' THR . 72.1 t -66.71 -54.23 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.541 -0.724 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -49.59 -51.67 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.946 -1.096 . . . . 0.0 109.435 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.723 HD22 HG21 ' A' ' 139' ' ' ILE . 37.2 tp -53.37 -52.88 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.214 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.3 t -56.4 -54.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.034 -1.041 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.02 -52.63 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.96 -50.93 72.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 109.738 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -52.86 -49.87 64.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.29 -26.98 66.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.658 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -55.13 138.62 44.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 108.777 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.25 143.43 49.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 110.048 -179.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -141.23 -174.28 3.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.656 HG23 ' HG3' ' A' ' 30' ' ' PRO . 26.1 m -96.81 136.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.878 -1.139 . . . . 0.0 109.007 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.707 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -67.34 -21.43 65.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.422 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -151.52 156.91 41.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.63 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 141.91 58.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.825 . . . . 0.0 110.297 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.77 164.98 15.77 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.44 140.52 48.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 26' ' ' LEU . 90.6 m-85 -136.92 148.36 46.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.28 150.23 25.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.923 -1.11 . . . . 0.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.39 171.38 34.99 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.47 151.17 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.404 -1.056 . . . . 0.0 109.893 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.15 137.85 15.94 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.0 tt -58.64 -38.52 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -1.222 . . . . 0.0 110.316 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.427 ' N ' HG23 ' A' ' 18' ' ' ILE . 69.5 m-70 -90.94 -50.26 5.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.701 -1.25 . . . . 0.0 110.804 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.3 p -66.93 -24.79 66.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.708 -0.62 . . . . 0.0 111.265 -178.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.17 18.97 29.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -112.69 155.45 24.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -1.059 . . . . 0.0 109.446 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.91 132.18 43.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.242 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -134.9 143.22 46.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.494 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.75 156.62 21.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.421 -0.8 . . . . 0.0 109.728 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.631 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -138.46 147.45 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.509 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.0 mt -141.75 113.34 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 mt -96.34 113.16 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.609 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -106.33 138.9 19.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.656 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.0 Cg_exo -55.29 168.12 1.55 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.652 1.568 . . . . 0.0 111.657 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.54 ' OE1' HG21 ' A' ' 35' ' ' THR . 37.0 mm-40 -142.31 171.5 13.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.369 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.0 mttp -83.58 155.82 23.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.73 150.38 4.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.768 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 72.34 -7.63 8.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.681 ' H ' HD22 ' A' ' 86' ' ' ASN . 95.8 m -62.19 -46.26 89.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.602 -1.528 . . . . 0.0 109.773 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 -179.64 35.59 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.34 115.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.78 151.29 46.95 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.54 158.27 16.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -129.26 108.94 10.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.245 -0.91 . . . . 0.0 108.602 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -135.27 135.55 40.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 53.7 26.78 6.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.49 17.0 78.53 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.19 122.47 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.443 -1.034 . . . . 0.0 108.706 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.48 128.0 33.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.79 93.64 41.83 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 0.0 109.533 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.61 145.71 16.58 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.407 2.071 . . . . 0.0 111.905 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.86 76.25 10.26 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -132.63 -179.66 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.532 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.9 p-80 -76.0 -55.67 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.008 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -43.75 -16.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.934 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.8 m-85 -98.16 3.62 49.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.74 -1.225 . . . . 0.0 110.337 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.78 138.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 108.607 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.92 -28.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.387 -0.821 . . . . 0.0 110.307 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -150.68 129.08 12.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.012 -1.055 . . . . 0.0 109.612 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.83 HG21 HG21 ' A' ' 257' ' ' VAL . 45.8 p -121.74 95.35 4.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.581 ' OD1' ' CD2' ' A' ' 58' ' ' HIS . 64.9 t-20 -163.09 129.82 3.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 108.935 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.581 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 99.7 m-70 52.01 7.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.025 . . . . 0.0 108.883 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 161.54 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.0 109.689 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.9 m -85.42 129.1 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.177 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.8 m-20 -121.38 150.38 41.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.79 0.805 . . . . 0.0 110.814 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.2 mt -125.66 148.63 48.94 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.72 158.35 30.81 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.027 -1.559 . . . . 0.0 110.415 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -165.75 153.06 10.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -1.012 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt 51.29 21.3 1.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.78 -33.03 6.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.1 mm100 -58.99 148.23 31.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -146.47 140.18 26.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.525 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 91' ' ' VAL . 13.5 mt -129.01 123.34 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 12.6 mtpp -99.32 153.95 18.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.83 -1.169 . . . . 0.0 111.154 -178.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.7 m 50.82 75.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 62' ' ' LEU . 14.2 m -107.82 -9.14 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 109.082 178.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.7 pm0 -60.86 -25.35 66.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.531 -0.731 . . . . 0.0 110.464 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -68.26 -69.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 0.0 109.36 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -51.87 -47.34 40.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.018 -1.051 . . . . 0.0 109.07 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.58 HD21 ' HB1' ' A' ' 48' ' ' ALA . 19.9 mt -52.95 -49.27 66.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 t -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.077 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.78 -46.26 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.174 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.88 -34.28 78.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -63.29 -39.18 93.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.2 -40.43 45.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.788 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.536 HD22 HD11 ' A' ' 114' ' ' ILE . 64.8 mt -77.89 0.04 25.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.998 -1.064 . . . . 0.0 109.357 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 56.9 41.64 27.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.585 -0.697 . . . . 0.0 111.283 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.5 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 17.2 mm -88.53 144.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.773 -1.205 . . . . 0.0 108.434 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.699 HG21 HG12 ' A' ' 121' ' ' ILE . 43.9 p -126.98 -23.25 3.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.29 -0.881 . . . . 0.0 111.901 -178.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.768 HD21 ' N ' ' A' ' 34' ' ' GLY . 8.9 m120 -125.08 108.16 11.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.866 -1.147 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -163.26 150.11 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.0 110.549 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.44 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.0 m -117.46 114.12 23.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.479 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -96.93 103.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -178.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 26' ' ' LEU . 40.7 mt-10 -74.41 124.68 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 69' ' ' ILE . 13.4 t -110.16 120.7 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.792 0.806 . . . . 0.0 111.23 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.77 96.13 4.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.07 -158.67 27.5 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -119.37 -11.95 9.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -1.177 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.15 148.26 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.017 -1.052 . . . . 0.0 109.726 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 26' ' ' LEU . 42.5 mm -71.79 119.04 71.93 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 128.45 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.66 1.574 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -82.05 -13.27 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.562 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 mt 55.84 -121.92 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.71 7.61 44.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.45 -10.87 61.41 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.435 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.93 -171.58 2.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.696 -0.885 . . . . 0.0 109.434 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.25 13.59 12.4 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.522 ' HB2' HD22 ' A' ' 176' ' ' LEU . 44.1 t-105 -58.34 -42.22 86.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -1.01 . . . . 0.0 110.635 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.88 -56.05 23.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.849 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -51.47 -42.96 61.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.011 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.489 ' OH ' ' OE2' ' A' ' 171' ' ' GLU . 44.8 t80 -62.62 -53.48 54.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.7 . . . . 0.0 110.558 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -44.52 92.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.67 -59.82 3.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.051 -1.031 . . . . 0.0 110.402 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mt -59.45 -33.34 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.52 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 30.8 ttt180 -64.03 -43.68 94.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -73.73 15.98 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.707 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 5.8 m-80 -149.25 34.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.904 -1.122 . . . . 0.0 110.941 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 HD22 ' A' ' 82' ' ' LEU . 65.8 mt -81.88 136.72 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.763 -1.211 . . . . 0.0 110.294 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.3 tp -130.37 116.27 18.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.413 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.6 OUTLIER -71.37 150.18 45.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -114.84 -174.51 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.545 -0.722 . . . . 0.0 109.422 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.67 67.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 111.118 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -168.52 135.25 1.94 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.048 . . . . 0.0 109.776 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -69.85 142.14 53.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.647 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 85' ' ' THR . 42.8 mt -83.14 148.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.48 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.16 87.14 3.85 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 47.9 m-85 -65.91 144.35 56.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.891 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -87.64 101.94 14.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.66 131.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.642 -0.661 . . . . 0.0 110.724 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.93 113.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.52 -31.06 22.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.74 156.84 75.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.018 . . . . 0.0 109.796 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.93 148.61 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.613 2.209 . . . . 0.0 112.149 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.0 tt -157.08 149.29 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.073 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.65 142.77 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.355 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.11 149.64 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.559 ' OE2' HD12 ' A' ' 138' ' ' LEU . 48.8 mt-10 -134.53 161.55 34.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.655 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.415 ' CB ' HD13 ' A' ' 255' ' ' LEU . 34.5 t0 -173.61 108.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.334 -0.854 . . . . 0.0 109.709 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 54.91 49.51 17.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.68 -30.35 3.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.589 HH21 ' CA ' ' A' ' 252' ' ' GLY . 19.3 mtp85 -60.79 140.17 57.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -1.224 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.559 HD12 ' OE2' ' A' ' 133' ' ' GLU . 1.2 tt -145.33 137.08 25.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.981 -1.074 . . . . 0.0 109.953 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.572 ' CD1' HD23 ' A' ' 255' ' ' LEU . 83.2 mt -136.66 128.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.662 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -117.12 133.28 56.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.482 0.658 . . . . 0.0 110.263 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.08 135.64 54.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -149.05 149.46 29.91 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.932 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -48.23 143.8 14.06 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.507 2.138 . . . . 0.0 113.519 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.93 148.6 19.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -36.37 78.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.344 -0.848 . . . . 0.0 110.111 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.1 p -123.89 -165.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 109.67 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 18.7 tp -103.46 124.54 48.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.941 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.694 ' HG3' HG22 ' A' ' 167' ' ' VAL . 33.6 tt0 -135.81 109.52 8.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.088 -1.007 . . . . 0.0 108.711 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.7 t -109.5 121.69 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.237 -0.914 . . . . 0.0 109.82 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.0 m -112.82 152.03 29.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 109.631 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -139.85 130.47 25.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.959 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -120.56 131.37 54.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.01 136.96 8.76 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.57 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 155' ' ' PHE . 10.7 tm-20 -101.93 100.95 11.3 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.405 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 79.9 m-85 -89.44 167.64 12.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.614 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -11.31 19.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.533 -0.73 . . . . 0.0 110.64 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 159' ' ' LEU . 46.5 p-10 -98.0 -166.54 1.39 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.845 -1.159 . . . . 0.0 110.445 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -55.67 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.488 -0.758 . . . . 0.0 111.654 -178.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.522 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 30.8 mt -82.49 -29.26 30.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.384 -1.447 . . . . 0.0 108.789 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.72 -135.22 42.51 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.5 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 5.5 ttm-85 -96.64 131.41 43.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -1.196 . . . . 0.0 109.559 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.522 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.43 143.69 41.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -143.26 135.92 27.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.269 -0.894 . . . . 0.0 109.822 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -105.34 122.56 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -103.68 112.74 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.139 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.694 HG22 ' HG3' ' A' ' 148' ' ' GLU . 30.0 t -105.13 152.73 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 62.3 mt-10 -49.0 123.77 7.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 108.757 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.76 5.26 36.17 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -117.11 18.32 14.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -1.058 . . . . 0.0 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.489 ' OE2' ' OH ' ' A' ' 107' ' ' TYR . 0.2 OUTLIER -52.75 -56.39 15.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.838 . . . . 0.0 110.079 -179.66 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 171' ' ' GLU . 48.1 mt-10 -42.67 -24.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 171' ' ' GLU . 54.9 mt-10 -82.67 -11.38 58.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 111.77 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.9 pt -124.21 -28.12 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.0 111.415 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.4 m -62.15 -29.34 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.427 -1.421 . . . . 0.0 108.942 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -78.31 -0.6 29.48 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -75.01 113.61 12.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.758 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.575 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -78.97 173.3 12.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.37 -0.831 . . . . 0.0 109.064 179.657 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.441 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -77.62 161.86 27.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -147.67 143.94 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.239 -1.538 . . . . 0.0 111.667 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -143.03 157.49 44.49 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 83.8 m-85 -97.41 147.15 24.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.467 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.87 -36.38 16.9 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.683 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -74.85 -28.31 60.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 0.0 109.934 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 9.4 tt0 -77.26 -26.23 52.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.103 -0.998 . . . . 0.0 110.339 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.445 ' O ' ' C ' ' A' ' 187' ' ' GLU . 81.1 mt -60.43 -56.08 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.937 -1.102 . . . . 0.0 110.033 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.18 -41.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 110.144 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.689 ' O ' HG22 ' A' ' 192' ' ' VAL . 3.1 t-160 -73.56 -48.1 35.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 108.801 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.53 -28.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.409 ' HZ3' ' CG2' ' A' ' 186' ' ' ILE . 4.2 mmtm -85.21 -52.73 5.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 109.281 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -46.98 -35.01 6.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.7 m -88.54 17.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 -179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.485 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 60.26 40.4 97.33 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 194' ' ' LEU . 39.0 mt -125.74 170.76 11.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 61.04 21.94 59.8 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . 0.485 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 27.9 mttp -54.5 -20.65 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.598 -1.53 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.83 26.04 9.14 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.01 125.31 7.71 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 120.781 -1.423 . . . . 0.0 109.932 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.66 170.44 16.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.698 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.582 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 38.6 mt -68.68 -8.42 42.3 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -96.46 -13.21 23.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 109.658 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.2 p30 -135.1 7.96 3.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 109.852 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.438 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.5 149.99 32.62 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.017 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.526 HD11 HD21 ' A' ' 206' ' ' LEU . 20.6 tp -98.09 93.6 6.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 203' ' ' THR . 52.7 t -87.06 129.9 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.64 0.733 . . . . 0.0 109.347 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.526 HD21 HD11 ' A' ' 204' ' ' LEU . 22.7 mt -122.35 170.55 9.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.37 -166.36 11.78 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -63.98 -30.37 71.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.55 24.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.672 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.95 153.2 40.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.257 . . . . 0.0 110.561 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.19 112.23 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.99 -50.19 71.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.015 -1.053 . . . . 0.0 109.965 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.03 111.51 4.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.458 -0.776 . . . . 0.0 110.425 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -59.83 -13.95 24.9 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.732 1.621 . . . . 0.0 112.467 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -76.31 -18.09 59.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.062 -1.024 . . . . 0.0 109.723 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.31 -179.08 53.27 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.438 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.0 mt -85.65 149.28 25.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.08 . . . . 0.0 109.852 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.44 -21.36 49.26 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -142.27 170.82 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.7 pm0 -77.21 -12.33 59.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.142 -0.974 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.526 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -135.1 44.16 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.176 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.7 OUTLIER -54.11 -46.91 98.59 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.944 -1.097 . . . . 0.0 109.41 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.64 -67.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.386 2.057 . . . . 0.0 111.996 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.56 -35.57 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.526 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 59.6 mtt-85 -61.45 -40.15 93.43 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.575 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.3 t60 -68.02 -32.85 73.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.002 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -65.47 -36.5 84.08 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -66.06 -39.14 83.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -63.23 -51.58 65.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.83 -27.74 69.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.31 -35.85 47.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.13 -0.981 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -65.18 -38.61 83.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.83 -54.54 17.85 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.477 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 48.0 m-20 -55.59 -31.35 62.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.079 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.0 mt -65.55 -23.81 66.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.697 . . . . 0.0 110.299 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.23 -21.94 61.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.762 -1.211 . . . . 0.0 108.865 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 237' ' ' LEU . 92.0 mt -49.71 -3.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.623 -1.298 . . . . 0.0 110.381 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.6 mt -78.37 -16.77 57.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.18 2.92 56.82 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.08 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.43 153.31 8.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.62 -1.517 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.7 Cg_endo -53.95 129.31 33.61 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.895 1.73 . . . . 0.0 109.938 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.1 t -88.74 153.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.121 0.962 . . . . 0.0 112.295 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -133.34 125.82 30.02 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.32 -154.82 25.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 133.12 43.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -1.152 . . . . 0.0 108.873 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.2 m-85 -131.46 138.12 48.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 110.026 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -124.47 128.1 48.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.8 t -122.72 135.07 54.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.063 . . . . 0.0 111.364 -178.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -115.61 116.23 27.78 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 46.15 28.61 0.68 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.93 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.82 154.5 31.68 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.589 ' CA ' HH21 ' A' ' 137' ' ' ARG . . . -130.48 172.51 20.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 35.9 m-70 -59.13 -40.68 86.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.24 . . . . 0.0 109.547 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.5 t -56.43 -59.28 5.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 108.958 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.572 HD23 ' CD1' ' A' ' 139' ' ' ILE . 10.0 tp -51.34 -47.3 62.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 109.207 179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.6 m-20 -48.26 -51.01 27.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 56' ' ' THR . 89.9 t -61.58 -54.17 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -51.27 -50.01 60.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 109.061 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 139' ' ' ILE . 50.4 tp -51.8 -50.16 61.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.544 HG13 ' HG ' ' A' ' 238' ' ' LEU . 77.4 t -59.12 -53.81 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.182 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -49.35 -43.18 43.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.436 -0.79 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.59 -50.64 64.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.4 mt -57.77 -45.72 85.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.821 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.49 -31.01 65.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.31 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.222 -179.237 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.594 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 19.7 mt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.304 0.573 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 70.8 mt-10 -54.89 136.74 46.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.035 -1.041 . . . . 0.0 108.542 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -120.19 142.42 49.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.456 -0.778 . . . . 0.0 109.572 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.28 -168.4 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.0 m -103.81 139.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.988 -1.07 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -67.46 -23.68 65.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -150.02 158.38 44.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.013 . . . . 0.0 109.833 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 141.51 58.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.448 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.43 168.6 10.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -139.63 144.79 37.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.965 -1.085 . . . . 0.0 110.674 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 77.8 m-85 -139.77 156.44 46.76 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -163.35 152.3 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.95 174.94 35.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.18 152.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -1.102 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 139.07 15.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 19' ' ' HIS . 7.2 tt -57.75 -40.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 110.354 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.47 ' N ' HG23 ' A' ' 18' ' ' ILE . 81.8 m-70 -89.37 -49.2 6.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 111.181 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -69.92 -23.85 63.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.547 -0.721 . . . . 0.0 111.692 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.68 11.47 7.9 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.17 -1.49 . . . . 0.0 109.517 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -104.29 155.32 18.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.68 136.49 40.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.845 . . . . 0.0 109.67 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.0 m -137.07 142.73 42.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.562 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.32 151.27 26.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 -179.498 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -132.71 147.59 52.33 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -143.12 110.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 108.755 178.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mt -96.35 116.21 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 110.721 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' A' ' 27' ' ' ILE . 67.7 m-70 -110.64 141.55 24.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.537 -0.727 . . . . 0.0 109.781 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.5 Cg_exo -53.97 168.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.868 1.712 . . . . 0.0 111.479 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.3 mm-40 -140.1 176.27 8.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 30.2 mttp -84.76 151.02 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.94 143.88 2.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.543 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.1 9.39 57.01 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.99 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 31' ' ' GLU . 22.9 m -71.31 -44.95 64.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.563 -1.551 . . . . 0.0 109.502 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.99 -176.2 29.26 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.69 117.25 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH2' ' CE2' ' A' ' 45' ' ' TYR . 13.3 ptt180 -142.47 155.72 45.1 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.836 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.84 157.45 17.08 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -128.35 110.94 12.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 108.996 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -135.11 133.83 39.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 52.43 26.84 4.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 111.238 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.69 66.41 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.038 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.5 123.88 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -1.083 . . . . 0.0 109.096 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.477 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 16.3 m-85 -88.31 128.81 35.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.174 -0.954 . . . . 0.0 109.797 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.43 112.97 35.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CE1' ' A' ' 52' ' ' PHE . 36.6 Cg_endo -71.86 155.96 57.3 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.81 1.673 . . . . 0.0 112.322 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.91 63.68 7.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.58 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.3 mtt85 -116.84 169.2 9.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.3 p-80 -74.04 -49.89 22.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.517 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -45.93 -16.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' HIS . 55.7 m-85 -97.85 3.93 49.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.872 -1.143 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.7 126.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.29 -30.35 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.34 131.3 13.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.061 -1.024 . . . . 0.0 110.112 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.907 HG21 HG21 ' A' ' 257' ' ' VAL . 56.7 p -120.52 95.09 4.59 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' SER . 35.3 t30 -163.36 130.17 3.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.544 ' O ' ' CB ' ' A' ' 59' ' ' SER . 76.8 m-70 51.66 7.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.1 -1.0 . . . . 0.0 109.266 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.3 OUTLIER 161.03 140.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 72' ' ' VAL . 27.2 m -80.42 127.36 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.291 -0.881 . . . . 0.0 109.197 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -120.77 147.73 44.94 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.861 0.839 . . . . 0.0 111.113 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.7 mt -120.95 148.21 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.44 153.83 24.78 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.252 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -164.75 150.12 9.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -1.083 . . . . 0.0 109.285 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.3 mttt 51.63 23.9 2.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -33.04 6.32 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -60.49 148.36 37.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.041 -1.27 . . . . 0.0 109.565 -179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -144.12 139.79 29.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.57 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.65 122.69 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -97.95 155.8 16.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 111.22 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 m 49.12 75.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.094 0.473 . . . . 0.0 110.747 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.5 m -107.78 -8.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.268 -0.895 . . . . 0.0 109.006 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 7.6 pm0 -60.84 -27.25 67.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.67 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.423 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.9 m170 -65.78 -69.03 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.907 -1.12 . . . . 0.0 109.281 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.09 -47.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.568 ' N ' HG23 ' A' ' 75' ' ' ILE . 82.0 mt -51.59 -49.27 62.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 110.157 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.49 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 19.5 t -60.99 -42.87 99.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.03 -1.044 . . . . 0.0 110.382 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 106' ' ' PHE . 99.2 t -55.89 -47.54 79.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.96 -34.59 78.46 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.3 -34.95 77.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -80.83 -38.01 29.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.045 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.27 5.58 12.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.026 -1.046 . . . . 0.0 109.581 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 53.87 39.14 30.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.4 mm -89.79 134.48 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 108.716 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.8 p -123.39 -18.68 6.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.259 -0.901 . . . . 0.0 111.686 -178.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.746 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.1 m120 -124.09 106.9 10.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.868 -1.145 . . . . 0.0 110.351 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.9 m -166.41 147.54 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.666 0.746 . . . . 0.0 110.056 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 22.2 m -115.76 110.2 18.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.433 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.3 mt -91.29 100.33 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.028 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.495 ' OE2' HD12 ' A' ' 27' ' ' ILE . 2.1 tt0 -75.0 128.58 35.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.098 -1.001 . . . . 0.0 108.417 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.1 128.67 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.06 0.933 . . . . 0.0 111.927 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 31.2 mm -109.66 96.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.28 -153.15 21.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -9.27 8.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -1.087 . . . . 0.0 110.072 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.93 148.31 41.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.042 -1.036 . . . . 0.0 109.727 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 26' ' ' LEU . 45.9 mm -73.48 120.02 78.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -40.0 125.25 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.515 1.477 . . . . 0.0 111.105 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.51 HG21 HD22 ' A' ' 202' ' ' ASN . 2.5 tp -78.16 -11.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.3 mt 54.34 -119.73 1.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.21 7.8 45.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.83 -0.63 64.93 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.765 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.72 -172.66 2.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.801 -0.823 . . . . 0.0 109.315 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.4 16.08 8.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -59.56 -42.86 93.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -1.086 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.74 -56.88 13.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.544 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB3' HG11 ' A' ' 78' ' ' VAL . 9.9 m-85 -51.67 -44.54 63.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.847 . . . . 0.0 109.108 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 72.1 t80 -61.72 -50.63 71.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.577 -0.702 . . . . 0.0 110.916 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.59 -43.0 95.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.091 -1.006 . . . . 0.0 111.24 -178.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.77 -55.68 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 110.735 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.11 -30.82 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 51.5 ttt180 -66.76 -43.43 84.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.842 . . . . 0.0 110.52 -179.141 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -75.72 11.61 1.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 110.196 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.471 ' OD1' ' CG ' ' A' ' 9' ' ' GLU . 2.6 m-80 -142.75 35.01 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.992 -1.068 . . . . 0.0 110.198 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.7 mt -83.02 142.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.949 -1.094 . . . . 0.0 111.186 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 8' ' ' LYS . 6.2 tp -132.98 129.39 38.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -83.79 149.07 26.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -116.47 -174.58 2.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.15 68.3 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.35 -0.844 . . . . 0.0 110.807 -178.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -163.73 129.82 3.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.0 109.298 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.82 138.94 56.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.844 -1.16 . . . . 0.0 109.685 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.5 mt -83.37 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 110.191 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.15 79.53 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 42.5 m-85 -59.92 142.76 53.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -88.87 101.93 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.716 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.35 133.31 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.71 -0.619 . . . . 0.0 110.561 -177.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.1 t -70.6 114.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.5 mp0 -82.42 -29.98 30.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.044 -1.035 . . . . 0.0 110.695 -178.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 172.99 5.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.754 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.55 149.47 12.92 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.846 2.364 . . . . 0.0 112.848 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.3 tt -157.0 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.79 140.56 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.98 147.59 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.408 ' O ' ' NZ ' ' A' ' 258' ' ' LYS . 3.5 mp0 -136.54 160.99 37.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.014 -1.054 . . . . 0.0 110.523 -178.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -174.13 105.48 0.11 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.367 -0.833 . . . . 0.0 109.741 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.09 57.7 6.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.496 -0.752 . . . . 0.0 110.676 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.9 2.83 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.402 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.604 ' NH2' ' H ' ' A' ' 255' ' ' LEU . 46.5 mtp180 -61.96 130.85 47.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.023 -1.281 . . . . 0.0 108.219 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.2 tt -143.12 137.15 28.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 109.984 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.697 ' CD1' HD23 ' A' ' 255' ' ' LEU . 71.2 mt -134.44 127.21 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 109.418 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.91 131.46 56.93 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.514 0.673 . . . . 0.0 109.926 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.98 136.07 54.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.58 149.28 36.52 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.015 -1.053 . . . . 0.0 109.874 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.41 141.42 51.01 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.426 2.084 . . . . 0.0 113.187 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -154.84 147.46 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.4 -3.91 7.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.299 -0.876 . . . . 0.0 110.619 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.1 p -150.84 -175.61 5.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.872 -1.143 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' A' ' 244' ' ' GLY . 17.2 tp -96.4 122.63 39.5 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.064 -1.022 . . . . 0.0 108.875 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG3' HG13 ' A' ' 167' ' ' VAL . 1.5 mt-10 -137.13 127.14 25.92 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.331 -0.856 . . . . 0.0 108.768 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 65.7 t -126.89 120.68 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 165' ' ' THR . 46.5 m -112.15 152.11 28.72 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.583 -0.698 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -139.69 130.71 26.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.933 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.38 132.86 54.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.37 141.18 12.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.802 -178.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.41 ' O ' ' NH1' ' A' ' 250' ' ' ARG . 5.6 tt0 -105.54 100.1 9.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.31 167.0 15.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -102.5 5.08 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 110.91 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.8 p-10 -119.46 -171.0 2.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.0 110.424 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -47.8 -3.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.595 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -80.24 -29.11 38.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.359 -1.463 . . . . 0.0 109.073 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.95 -139.02 33.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -97.23 131.79 43.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.218 -1.166 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -138.01 147.69 44.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.87 . . . . 0.0 109.456 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.5 146.15 36.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -143.83 137.9 28.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.488 HG23 ' OG1' ' A' ' 150' ' ' THR . 25.4 m -107.18 123.34 48.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.224 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.3 t80 -102.69 109.64 21.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.8 t -102.14 154.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.05 126.79 19.54 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.83 2.49 42.78 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -115.37 20.58 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -1.153 . . . . 0.0 109.079 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 173' ' ' GLU . 1.4 pm0 -58.14 -52.15 66.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.6 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 110.499 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 171' ' ' GLU . 12.6 mm-40 -103.47 -7.16 21.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.957 -1.089 . . . . 0.0 110.552 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.35 -26.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.125 -0.984 . . . . 0.0 110.942 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.1 m -60.84 -22.13 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.646 -1.284 . . . . 0.0 108.76 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.87 -2.74 58.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 109.222 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.15 116.41 10.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 108.764 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -79.65 172.76 13.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.4 t -78.53 163.57 25.43 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -147.51 144.98 28.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.28 -1.512 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.77 157.41 44.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.489 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.423 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.2 m-85 -98.98 144.43 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.992 -1.068 . . . . 0.0 109.53 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 t0 -53.07 -35.96 60.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.38 -0.825 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.2 p90 -69.36 -25.38 64.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.77 -1.206 . . . . 0.0 109.902 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.436 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -83.43 -31.14 26.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.032 -1.043 . . . . 0.0 109.92 -179.652 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 189' ' ' ILE . 55.7 mt -50.98 -58.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.532 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.0 tp10 -40.82 -40.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.937 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.2 t60 -74.68 -35.39 62.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 186' ' ' ILE . 91.1 mt -58.92 -38.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.354 -0.841 . . . . 0.0 109.024 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -75.71 -52.52 10.3 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -49.07 -43.12 40.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.433 -0.792 . . . . 0.0 110.678 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 188' ' ' HIS . 21.0 m -79.53 5.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.388 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 40.08 50.64 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.8 178.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 189' ' ' ILE . 39.0 mt -128.13 173.91 9.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.098 -1.236 . . . . 0.0 110.013 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.03 58.58 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -54.7 -20.64 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.479 -1.601 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -117.04 26.02 8.52 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.815 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.5 127.05 8.41 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.665 -1.491 . . . . 0.0 109.886 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.4 m -144.43 174.84 10.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -1.09 . . . . 0.0 109.332 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.5 mt -72.15 -7.77 50.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 108.872 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -96.28 -11.36 26.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.27 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 98' ' ' ILE . 8.3 p-10 -134.75 9.88 3.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.008 . . . . 0.0 110.034 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.444 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -150.65 150.94 31.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 110.339 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.0 tp -100.4 93.88 5.88 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 203' ' ' THR . 52.0 t -86.07 130.12 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.781 0.801 . . . . 0.0 109.318 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.99 165.08 18.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.651 -0.656 . . . . 0.0 109.343 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.31 -166.61 12.05 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -58.4 -36.68 73.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.482 -1.011 . . . . 0.0 109.338 179.8 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.38 23.71 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.026 -1.046 . . . . 0.0 110.469 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -139.0 146.91 41.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 0.0 110.552 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -100.58 111.26 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -57.54 -52.37 65.68 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.322 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -56.16 111.11 2.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.045 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.55 -14.85 17.99 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.741 1.627 . . . . 0.0 111.962 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -15.86 59.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.126 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.28 -173.17 49.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.624 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -89.69 148.05 23.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.17 -1.194 . . . . 0.0 109.843 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.29 -18.15 37.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 108.851 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 59.5 m-85 -139.47 173.71 11.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 220' ' ' GLU . 5.8 mp0 -80.09 -14.42 58.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.48 48.38 1.84 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.253 -0.904 . . . . 0.0 109.596 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -56.54 -46.52 99.81 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 109.808 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.1 Cg_exo -51.5 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.452 2.101 . . . . 0.0 112.108 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.1 -35.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.028 -1.045 . . . . 0.0 109.575 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 18.5 mtt180 -60.19 -41.5 93.08 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -68.04 -31.87 71.83 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.828 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -64.56 -37.16 86.59 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.6 t -69.42 -35.18 65.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.49 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.4 t80 -65.22 -55.27 19.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -63.64 -26.19 68.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.0 tp -77.81 -35.03 51.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.021 -1.049 . . . . 0.0 108.609 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.1 mt -67.14 -36.42 76.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.86 -59.31 6.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -51.67 -34.86 40.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -1.231 . . . . 0.0 108.873 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 235' ' ' LEU . 8.5 mt -60.67 -23.0 64.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.983 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.44 -21.64 61.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.088 . . . . 0.0 108.743 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.3 mt -55.16 3.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.677 -1.264 . . . . 0.0 110.521 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.607 ' HG ' HG13 ' A' ' 260' ' ' VAL . 8.1 mt -80.12 -16.24 55.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.856 -1.152 . . . . 0.0 109.729 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.88 43.4 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.114 -1.041 . . . . 0.0 110.629 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.38 158.14 9.94 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.395 . . . . 0.0 108.921 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -48.74 150.94 5.71 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 121.848 1.699 . . . . 0.0 109.429 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.72 145.35 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 0.0 112.181 -177.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.5 122.2 32.76 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 148.62 174.8 20.62 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.519 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 18.3 tttt -102.02 146.98 27.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.255 . . . . 0.0 109.986 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 18.3 m-85 -140.56 140.27 35.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 109.927 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -127.12 126.0 42.17 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.0 m -119.62 135.53 54.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 0.0 111.331 -178.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 250' ' ' ARG . 90.9 t80 -116.78 115.22 25.17 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 249' ' ' PHE . 78.3 mtp85 45.14 47.82 9.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.01 -1.056 . . . . 0.0 108.726 -179.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.83 159.53 28.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.52 -174.56 13.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -60.75 -47.92 84.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -1.125 . . . . 0.0 109.642 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.25 -59.08 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 139' ' ' ILE . 1.3 tp -52.73 -48.39 66.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.731 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 7.2 m-20 -47.41 -45.29 25.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 109.192 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.907 HG21 HG21 ' A' ' 56' ' ' THR . 59.1 t -66.96 -40.14 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 109.986 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 133' ' ' GLU . 8.3 ttpt -63.74 -51.75 63.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 109.378 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 139' ' ' ILE . 47.6 tp -53.95 -48.8 69.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 108.931 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.607 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.5 t -57.81 -53.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.372 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . 0.612 ' HE3' HG12 ' A' ' 257' ' ' VAL . 10.7 mtmt -51.1 -40.44 58.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.688 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.82 -50.45 42.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.949 . . . . 0.0 109.841 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.75 -48.7 80.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -68.24 -32.82 73.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 110.114 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 7.7 mmtm . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.0 mt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -55.95 137.61 50.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.959 . . . . 0.0 108.93 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.57 144.19 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.439 -0.788 . . . . 0.0 110.024 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -141.53 -171.34 3.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 30' ' ' PRO . 5.8 m -99.49 137.09 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.013 -1.055 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.43 -25.18 67.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.667 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.28 162.5 40.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 139.97 54.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.92 166.18 12.81 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -136.72 141.7 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.086 -1.009 . . . . 0.0 110.305 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 28' ' ' ILE . 93.4 m-85 -139.25 153.65 47.86 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.52 152.33 21.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.836 -1.165 . . . . 0.0 110.283 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.57 175.71 36.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.4 153.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.551 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 140.98 17.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 19' ' ' HIS . 6.5 tt -61.48 -37.92 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -1.217 . . . . 0.0 111.117 -178.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.405 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 92.3 m-70 -90.52 -49.45 6.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.292 -1.505 . . . . 0.0 110.938 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 p -68.66 -25.71 64.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 111.853 -178.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.71 16.78 47.12 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.065 -1.54 . . . . 0.0 109.456 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.69 153.69 23.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -1.085 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -76.31 135.53 39.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.773 . . . . 0.0 109.602 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.1 t -138.23 145.72 41.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.43 154.44 22.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 96' ' ' ILE . 10.1 mt -134.12 144.13 48.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.74 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.623 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -140.03 114.31 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 13' ' ' PHE . 17.2 mt -99.3 114.59 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.461 -0.775 . . . . 0.0 110.501 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.623 ' NE2' HG22 ' A' ' 27' ' ' ILE . 2.9 m-70 -109.41 140.23 21.87 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.42 -0.8 . . . . 0.0 109.682 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HG3' HG23 ' A' ' 7' ' ' VAL . 15.0 Cg_exo -55.35 168.61 1.36 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.767 1.645 . . . . 0.0 111.183 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 42.0 mm-40 -140.5 179.72 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.0 110.026 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.0 mttt -86.36 152.68 22.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.761 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.14 143.83 2.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.22 7.87 60.9 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.322 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 44.0 m -69.7 -45.22 68.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.533 -1.569 . . . . 0.0 109.802 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.826 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 99.39 -179.9 30.88 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.613 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -96.86 118.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -142.65 153.7 43.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.716 -1.24 . . . . 0.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -102.43 158.78 15.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -130.94 108.32 9.74 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -135.58 137.04 41.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 111.004 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.492 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 16.5 m120 52.25 31.22 8.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 111.279 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.42 80.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.569 -1.3 . . . . 0.0 109.97 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 121.24 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -1.06 . . . . 0.0 109.108 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.69 129.81 34.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 69' ' ' ILE . 30.9 mt -117.92 93.45 44.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.843 . . . . 0.0 109.618 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -49.04 148.82 9.0 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.317 2.011 . . . . 0.0 111.897 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -85.29 69.88 10.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.183 -0.948 . . . . 0.0 109.965 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -122.54 173.95 7.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 108.957 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 237' ' ' LEU . 1.3 p-80 -74.71 -48.21 27.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.9 mm-40 -47.75 -16.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.807 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' HIS . 27.4 m-85 -95.6 -0.86 51.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.756 -1.215 . . . . 0.0 109.705 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.7 129.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.08 -27.78 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 110.258 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -151.02 131.79 14.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.85 HG21 HG21 ' A' ' 257' ' ' VAL . 40.4 p -124.5 95.44 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.9 t-20 -163.01 128.8 3.25 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.4 m-70 50.4 8.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.132 -0.98 . . . . 0.0 109.027 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER 162.64 140.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.883 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 72' ' ' VAL . 63.7 m -85.51 126.29 33.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -119.83 148.84 42.97 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.65 0.738 . . . . 0.0 110.75 -179.168 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CG ' HG21 ' A' ' 72' ' ' VAL . 8.3 mt -122.92 147.25 46.82 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.97 152.89 23.62 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.561 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -160.59 148.35 16.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -1.023 . . . . 0.0 109.108 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.36 21.68 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.552 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.83 -32.34 7.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.492 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 28.1 mm-40 -60.36 144.64 50.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.071 -1.252 . . . . 0.0 109.469 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -141.64 140.89 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 46' ' ' ILE . 56.9 mt -131.3 122.72 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 29.5 mttm -90.8 158.69 16.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.036 -1.04 . . . . 0.0 111.365 -179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 m 41.58 79.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.426 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 62' ' ' LEU . 15.9 m -107.34 -9.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.6 pm0 -61.7 -26.58 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.674 . . . . 0.0 110.443 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -66.06 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 0.0 108.998 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.34 -49.87 40.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.8 mt -49.14 -51.19 33.68 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.976 -1.078 . . . . 0.0 110.233 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -59.61 -41.63 90.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.16 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.05 -44.54 78.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.038 -1.039 . . . . 0.0 108.912 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.32 -35.21 78.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.362 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -62.78 -35.79 80.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.5 mt -79.63 -38.21 34.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 109.845 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 114' ' ' ILE . 94.6 mt -81.14 1.71 30.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.1 -1.0 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 54.79 40.51 31.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 110.113 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.26 140.47 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 121' ' ' ILE . 64.1 p -126.34 -21.4 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.16 -0.963 . . . . 0.0 111.753 -178.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.826 HD22 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -126.02 107.25 10.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.942 -1.099 . . . . 0.0 110.351 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -164.56 147.07 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.16 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 72.3 m -116.29 110.46 18.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.513 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -93.95 101.58 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tt0 -77.35 129.01 35.27 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 108.539 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.41 123.38 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.918 0.866 . . . . 0.0 111.823 -177.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mt -104.6 96.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.55 -155.32 24.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -122.22 -9.04 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' H ' ' A' ' 70' ' ' LYS . 44.2 tt0 -138.86 148.13 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 110.0 -179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.555 HG23 HD11 ' A' ' 26' ' ' LEU . 39.7 mm -71.94 122.81 88.3 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.187 -1.005 . . . . 0.0 108.383 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -42.46 117.4 0.82 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.637 1.558 . . . . 0.0 110.937 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -72.45 -14.38 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.424 HD11 ' CE2' ' A' ' 106' ' ' PHE . 75.1 mt 56.98 -120.41 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.121 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.99 8.45 44.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.868 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.28 62.4 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.901 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -172.1 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.901 . . . . 0.0 109.57 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.23 17.31 8.54 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.436 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 57.7 t-105 -57.12 -43.76 82.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 0.0 110.197 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.88 -55.91 16.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 99' ' ' LEU . 12.9 m-85 -51.08 -45.94 61.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 0.0 109.604 -179.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.427 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 44.6 t80 -62.69 -52.87 61.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.0 110.829 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.436 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 2.0 mm-40 -61.21 -44.63 96.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.116 -0.99 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.99 19.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.219 -0.926 . . . . 0.0 110.351 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.2 mt -65.11 -32.11 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.423 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 53.2 ttt180 -63.29 -42.31 99.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HG3' HD22 ' A' ' 113' ' ' ASN . 1.6 ptpp? -76.46 7.39 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 110.134 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.42 HD22 ' HG3' ' A' ' 112' ' ' LYS . 17.4 m-80 -137.36 33.97 2.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.024 . . . . 0.0 110.509 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 HD22 ' A' ' 82' ' ' LEU . 50.9 mt -80.68 138.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.945 -1.097 . . . . 0.0 110.247 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -129.41 124.97 35.49 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 142.6 31.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.1 -172.27 2.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.239 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -113.93 69.61 0.71 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.286 -0.884 . . . . 0.0 110.716 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -168.59 131.28 1.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 109.255 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE2' ' C ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -69.8 151.05 46.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 110.08 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 85' ' ' THR . 45.4 mt -95.25 152.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.107 -0.996 . . . . 0.0 110.096 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.32 83.83 4.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 48.0 m-85 -62.5 147.01 50.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.071 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -93.68 102.04 14.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 243' ' ' LYS . 61.4 t -93.9 133.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 0.0 110.647 -177.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.91 116.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -84.63 -29.95 25.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.064 -1.022 . . . . 0.0 110.889 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.25 168.73 13.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 109.901 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 147.92 24.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.862 2.374 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.7 tt -157.36 149.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -0.834 . . . . 0.0 109.043 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.95 146.4 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.93 148.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -133.56 160.72 36.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.71 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 258' ' ' LYS . 19.2 t70 -175.1 105.71 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.301 -0.875 . . . . 0.0 109.823 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.32 51.33 15.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 110.199 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.78 -30.65 3.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -62.13 136.89 58.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.262 . . . . 0.0 108.229 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -145.57 140.09 27.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 110.534 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.644 HG21 HD22 ' A' ' 259' ' ' LEU . 71.2 mt -136.91 127.03 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.717 . . . . 0.0 109.66 179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -114.22 134.03 55.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.42 135.64 54.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.42 150.2 39.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -47.22 142.53 11.86 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.684 2.256 . . . . 0.0 113.409 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.581 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -159.0 147.87 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.689 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -66.39 -32.49 73.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 110.53 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.581 ' O ' ' OG ' ' A' ' 144' ' ' SER . 72.5 p -120.25 -163.23 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.327 -0.858 . . . . 0.0 109.308 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.7 tp -109.25 123.98 50.15 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.7 tt0 -135.37 125.25 25.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 108.466 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG1' HD23 ' A' ' 231' ' ' LEU . 63.5 t -125.87 121.5 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 152.03 27.66 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.623 -0.673 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -140.01 130.59 25.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -122.41 133.86 54.62 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.9 140.81 11.91 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.651 -178.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -101.54 100.47 10.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.71 166.95 13.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 110.707 -178.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -104.29 -20.51 13.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 110.484 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 159' ' ' LEU . 32.4 p-10 -89.08 -171.01 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.761 -1.212 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -52.63 2.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.277 -0.889 . . . . 0.0 111.501 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 157' ' ' ASN . 14.6 mt -82.25 -28.63 31.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.388 -1.445 . . . . 0.0 108.493 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.5 -141.56 38.35 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -100.44 136.23 40.64 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.256 -1.143 . . . . 0.0 109.13 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -143.73 160.81 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.374 -0.829 . . . . 0.0 109.597 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 150.54 31.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 225' ' ' ARG . 49.1 t80 -144.66 140.78 28.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -107.06 122.93 47.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 109.985 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.0 t80 -102.76 111.61 24.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 110.022 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.535 ' H ' HD22 ' A' ' 170' ' ' ASN . 13.1 t -103.15 150.74 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.73 138.13 6.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.202 -0.936 . . . . 0.0 108.826 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.09 3.83 69.6 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.535 HD22 ' H ' ' A' ' 167' ' ' VAL . 98.7 m-20 -113.83 20.97 15.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.18 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.701 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.8 OUTLIER -58.96 -50.86 72.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.361 -0.837 . . . . 0.0 109.196 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.6 -5.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.491 -0.756 . . . . 0.0 109.774 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 171' ' ' GLU . 39.3 mt-10 -104.91 -9.81 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 110.3 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.0 pt -126.85 -27.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.191 -0.943 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.0 m -60.98 -22.88 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.679 -1.263 . . . . 0.0 108.524 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.93 -2.62 58.75 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.35 115.93 10.11 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.355 -0.841 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.3 mtm180 -79.53 172.76 13.35 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 0.0 109.255 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.1 t -79.71 163.87 24.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -148.71 144.46 27.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.244 -1.535 . . . . 0.0 111.37 -179.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.06 158.84 43.29 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.3 m-85 -99.46 144.75 28.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.35 -36.2 20.79 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.31 -0.869 . . . . 0.0 109.578 -179.477 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 8.5 p90 -73.67 -26.38 60.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 109.842 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.3 OUTLIER -76.65 -38.66 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 109.998 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.407 HG22 ' HG3' ' A' ' 190' ' ' LYS . 62.6 mt -48.51 -51.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 186' ' ' ILE . 8.6 tt0 -42.95 -45.38 5.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.953 . . . . 0.0 110.303 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.435 ' O ' HG22 ' A' ' 192' ' ' VAL . 4.5 t60 -75.26 -57.35 3.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 45.6 mt -44.74 -27.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -85.5 -54.37 4.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.772 -1.205 . . . . 0.0 109.506 179.876 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -51.91 -40.22 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.929 . . . . 0.0 110.034 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -75.37 3.37 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.927 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.24 37.72 31.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.0 mt -128.52 169.53 14.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -1.144 . . . . 0.0 109.865 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.42 24.11 61.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -60.4 -21.23 61.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.623 -1.516 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -111.24 24.95 14.76 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.2 125.45 7.79 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.885 -1.362 . . . . 0.0 109.744 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -144.11 164.5 30.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -1.112 . . . . 0.0 110.03 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.568 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 25.3 mt -64.47 -8.99 15.64 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -93.09 -15.99 25.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -136.84 10.99 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 110.17 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -149.16 149.99 31.92 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.043 -1.035 . . . . 0.0 110.287 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.6 tp -100.24 93.34 5.64 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -86.12 131.33 34.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.768 0.794 . . . . 0.0 109.031 -179.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.14 162.66 23.13 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.31 -166.73 12.68 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -31.59 71.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -1.05 . . . . 0.0 109.569 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -153.9 23.79 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.21 -0.931 . . . . 0.0 110.678 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -144.24 151.73 39.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.748 -1.22 . . . . 0.0 110.516 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.56 112.25 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -57.17 -51.88 67.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.015 . . . . 0.0 110.328 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 8.0 m120 -58.0 111.66 3.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.5 -12.42 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.596 1.531 . . . . 0.0 111.821 179.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -17.2 59.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.048 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.3 -175.79 48.26 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.619 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.2 mt -87.81 142.07 28.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -1.2 . . . . 0.0 109.86 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -19.92 60.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -142.9 -179.05 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.389 -0.82 . . . . 0.0 109.297 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.567 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 1.9 pm0 -87.17 3.42 46.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.608 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.474 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -154.04 47.57 0.62 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.818 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.561 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -58.88 -46.02 99.57 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.011 -1.055 . . . . 0.0 109.933 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 50.7 Cg_exo -52.19 -66.44 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.069 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 225' ' ' ARG . 31.5 m -60.54 -35.94 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 109.568 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 224' ' ' VAL . 62.3 mtt180 -59.27 -41.64 89.33 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 18.1 t60 -68.3 -32.13 72.05 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.147 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.81 -35.5 81.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' ' 166' ' ' PHE . 54.3 t -70.35 -37.85 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -63.33 -49.79 72.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.458 -0.776 . . . . 0.0 108.961 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -67.78 -27.82 67.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 109.755 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.511 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.1 tp -77.33 -34.03 55.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.002 -1.061 . . . . 0.0 108.359 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.1 mt -67.95 -37.74 78.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.22 -56.06 13.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 21.8 m-20 -52.45 -38.36 59.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -1.219 . . . . 0.0 108.982 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 235' ' ' LEU . 15.9 mt -58.23 -23.47 55.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.629 -0.669 . . . . 0.0 110.48 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.83 -22.36 60.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.692 -1.255 . . . . 0.0 108.758 -179.666 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 94.0 mt -52.71 -0.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.635 -1.291 . . . . 0.0 110.356 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.566 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.9 mt -77.96 -14.48 59.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.799 -1.188 . . . . 0.0 109.756 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.39 -1.53 55.97 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.844 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.05 156.7 9.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.742 -1.446 . . . . 0.0 109.174 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.75 150.23 9.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.852 1.701 . . . . 0.0 109.518 178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.42 149.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.999 -1.063 . . . . 0.0 112.115 -177.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.8 mmtp -129.77 123.55 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.439 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.58 -160.86 30.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.14 46.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -1.085 . . . . 0.0 108.76 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -133.1 138.22 46.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 110.145 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -123.55 129.72 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 t -123.83 136.24 54.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.378 -177.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.36 111.47 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 50.0 45.05 25.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.17 -0.957 . . . . 0.0 108.465 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.78 141.73 17.33 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -115.8 178.75 17.74 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 52.0 m-70 -59.33 -39.14 82.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.137 -1.213 . . . . 0.0 109.595 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -54.74 -58.79 6.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.224 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 255' ' ' LEU . 11.8 tp -56.69 -45.7 81.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.563 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.5 m-20 -47.46 -54.76 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 109.634 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 56' ' ' THR . 99.2 t -60.89 -50.71 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . 0.47 ' HZ1' ' HB2' ' A' ' 134' ' ' ASP . 22.2 ttmt -50.49 -52.35 39.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.978 -1.076 . . . . 0.0 108.963 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.644 HD22 HG21 ' A' ' 139' ' ' ILE . 35.5 tp -50.4 -50.85 50.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' A' ' 238' ' ' LEU . 46.8 t -55.27 -52.94 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.889 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.09 -50.16 29.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.148 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.48 -49.32 77.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.1 mt -56.12 -52.47 64.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -26.29 67.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.79 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.935 . . . . 0.0 110.072 -179.442 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.515 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.2 mt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.371 0.605 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 94.6 mt-10 -57.67 137.83 56.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 146.98 47.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.49 -0.756 . . . . 0.0 109.996 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -141.16 -171.7 3.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 30' ' ' PRO . 14.2 m -97.64 135.35 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.036 -1.04 . . . . 0.0 109.269 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.07 -20.75 65.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.16 160.66 40.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 139.11 57.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 109.869 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.3 mt -117.44 163.01 17.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.17 141.02 48.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' LEU . 99.0 m-85 -139.56 147.72 41.56 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.93 151.84 22.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.839 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.14 173.95 36.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.56 149.25 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -1.039 . . . . 0.0 110.108 -179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 140.09 16.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.491 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -58.91 -39.15 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.126 -1.22 . . . . 0.0 110.327 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.474 ' N ' HG23 ' A' ' 18' ' ' ILE . 78.3 m-70 -90.21 -50.38 6.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.718 -1.239 . . . . 0.0 111.168 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -66.6 -23.93 66.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.762 . . . . 0.0 111.242 -178.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.69 16.71 17.85 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -112.56 157.93 20.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -1.012 . . . . 0.0 109.401 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.82 134.7 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -136.34 145.29 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.57 157.62 20.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.978 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 96' ' ' ILE . 9.3 mt -138.59 145.02 40.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.491 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.533 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -140.56 108.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 108.416 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -92.28 115.24 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 0.0 110.621 -178.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 27' ' ' ILE . 47.5 m-70 -108.67 139.77 21.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 0.0 109.393 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' VAL . 27.5 Cg_exo -52.57 168.34 0.46 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.828 1.686 . . . . 0.0 111.737 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HB3' HG21 ' A' ' 35' ' ' THR . 17.7 mm-40 -142.84 174.56 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.668 179.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.7 mttt -82.05 149.38 28.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -47.05 149.03 0.98 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.15 -0.969 . . . . 0.0 109.821 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 66.66 4.01 23.62 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.75 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.8 m -67.53 -41.69 83.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.774 -1.427 . . . . 0.0 109.238 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.67 -179.91 34.58 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.398 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 87' ' ' VAL . 24.4 mm -98.92 116.5 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -139.62 155.31 47.51 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.772 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -103.58 156.8 17.5 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -128.69 111.8 13.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.0 108.657 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -135.66 134.35 39.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.699 -178.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 42' ' ' ASN . 1.0 OUTLIER 53.74 28.31 8.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 111.362 178.455 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.05 18.23 75.16 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.074 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.56 122.99 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.415 -1.05 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -84.39 128.26 34.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.111 -0.993 . . . . 0.0 109.466 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 69' ' ' ILE . 55.7 mt -118.13 91.09 39.37 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.36 152.24 8.75 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.519 2.146 . . . . 0.0 111.826 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 67.4 9.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -121.55 161.86 21.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.83 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.1 p-80 -65.17 -51.6 60.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -43.44 -16.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 110.879 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.1 m-85 -98.56 0.58 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.867 -1.145 . . . . 0.0 110.105 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 50' ' ' HIS . 79.3 t -69.98 131.0 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.63 -30.27 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 110.35 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -151.75 133.3 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.952 -1.093 . . . . 0.0 109.992 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.597 HG21 HG21 ' A' ' 257' ' ' VAL . 41.2 p -123.29 95.51 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 59' ' ' SER . 13.9 t-20 -163.03 129.1 3.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.972 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 80.7 m-70 50.83 8.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.065 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.19 144.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.754 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.7 m -87.09 127.18 35.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 109.18 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.78 150.33 42.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.81 0.814 . . . . 0.0 111.046 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mt -126.27 149.71 48.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.23 151.91 23.04 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.193 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -158.04 144.13 17.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -1.092 . . . . 0.0 109.215 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.86 22.04 2.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 109.839 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.14 -33.37 6.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -57.55 141.56 47.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.241 . . . . 0.0 109.153 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -133.89 134.3 42.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.486 -0.758 . . . . 0.0 110.336 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 69' ' ' ILE . 18.8 mt -127.05 122.02 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -102.78 156.17 17.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.0 -1.063 . . . . 0.0 111.357 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 71' ' ' THR . 86.1 m 50.31 73.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 60' ' ' THR . 19.8 m -108.11 -9.22 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.21 -26.2 67.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.537 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.66 -69.02 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.64 -48.02 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.054 -1.029 . . . . 0.0 109.107 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 75' ' ' ILE . 26.1 mt -51.76 -49.19 63.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.0 109.93 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 t -60.95 -42.5 98.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.82 -44.87 79.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 108.823 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -67.74 -34.44 76.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -61.92 -36.81 82.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 108.872 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.1 mt -78.86 -38.14 38.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 114' ' ' ILE . 74.7 mt -80.45 -0.52 37.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.744 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 55.0 40.37 32.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 110.922 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.5 mm -85.82 141.77 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 69.0 p -127.23 -23.18 3.6 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.182 -0.949 . . . . 0.0 111.582 -178.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.726 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.4 m-80 -124.33 106.53 10.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.828 -1.17 . . . . 0.0 110.164 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.9 148.27 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.625 0.726 . . . . 0.0 110.295 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.8 m -116.33 114.53 24.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -94.97 100.4 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.367 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.502 ' OE1' HD12 ' A' ' 27' ' ' ILE . 4.9 tt0 -73.55 124.72 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 26' ' ' LEU . 62.1 t -107.39 126.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.82 0.819 . . . . 0.0 111.583 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 92' ' ' ILE . 27.7 mt -111.03 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.39 -156.24 25.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -121.68 -10.68 8.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.11 149.25 42.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 0.0 109.564 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -73.43 121.33 84.86 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.042 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.71 124.03 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.76 1.64 . . . . 0.0 111.405 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -81.19 -12.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 106' ' ' PHE . 8.2 mt 56.05 -116.83 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.84 8.13 45.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.012 -1.055 . . . . 0.0 110.743 -178.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.2 65.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 -172.27 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.741 -0.858 . . . . 0.0 109.339 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.96 14.58 8.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.582 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 52.3 t-105 -56.3 -42.8 78.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 3.8 mp0 -64.96 -57.32 9.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 0.0 110.171 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 99' ' ' LEU . 11.0 m-85 -51.02 -46.2 61.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.223 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.581 ' OH ' ' NH1' ' A' ' 111' ' ' ARG . 89.4 t80 -60.97 -52.35 65.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.669 -0.644 . . . . 0.0 110.884 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.582 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 4.0 mm-40 -62.03 -45.24 94.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.142 -0.974 . . . . 0.0 111.726 -178.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.1 -55.64 17.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.996 -1.065 . . . . 0.0 110.548 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.47 -32.46 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.383 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.581 ' NH1' ' OH ' ' A' ' 107' ' ' TYR . 59.1 ttt85 -63.3 -41.86 98.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.0 109.933 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' C ' HD22 ' A' ' 113' ' ' ASN . 27.6 pttt -77.58 13.37 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.495 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.7 m-80 -143.11 31.32 1.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.898 -1.126 . . . . 0.0 110.79 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 82' ' ' LEU . 73.6 mt -79.07 138.79 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.759 -1.213 . . . . 0.0 109.718 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -129.24 125.32 36.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.32 143.51 35.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.573 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.92 -175.6 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 109.303 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -110.03 67.33 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.633 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.3 ttt85 -162.91 129.55 3.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 109.335 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.96 142.61 52.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.959 -1.088 . . . . 0.0 109.661 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 241' ' ' PRO . 74.0 mt -88.83 151.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.651 -179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.42 84.88 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 70.9 m-85 -61.71 146.69 48.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.517 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -91.63 101.64 14.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -93.63 134.44 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.442 0.639 . . . . 0.0 111.058 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.7 t -73.89 112.93 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.65 -26.94 16.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.277 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.04 150.3 76.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.825 . . . . 0.0 109.278 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.5 149.35 55.78 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.432 2.088 . . . . 0.0 112.037 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.7 tt -152.41 150.65 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 108.965 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.43 141.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.38 146.73 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -135.9 159.22 42.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 109.485 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.57 108.05 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.169 -0.957 . . . . 0.0 110.161 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 48.61 52.94 12.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 110.754 178.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.4 -36.85 3.17 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.484 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.85 126.16 26.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.93 -1.335 . . . . 0.0 108.634 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -138.71 138.85 38.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 110.138 -179.444 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 259' ' ' LEU . 83.6 mt -137.97 130.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.475 -0.766 . . . . 0.0 109.76 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.414 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 29.5 tttm -119.24 132.1 55.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.689 -0.632 . . . . 0.0 109.887 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.81 133.82 54.43 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 4.2 pt-20 -145.89 149.11 38.24 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.016 -1.053 . . . . 0.0 109.729 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.0 140.95 9.77 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.561 2.174 . . . . 0.0 113.158 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -154.57 142.8 20.4 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.97 -7.1 3.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.437 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.9 p -149.91 -174.62 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 109.605 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.8 tp -98.75 123.16 42.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.137 -0.977 . . . . 0.0 108.737 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.444 ' N ' HD12 ' A' ' 147' ' ' LEU . 44.8 tt0 -139.28 126.99 21.92 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 108.651 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.428 ' CG1' HD23 ' A' ' 231' ' ' LEU . 93.6 t -125.24 123.7 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.421 -0.799 . . . . 0.0 109.864 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m -113.8 152.73 30.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.608 -0.682 . . . . 0.0 109.849 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -140.44 131.09 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.854 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 10.1 tt0 -122.47 133.75 54.59 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.99 140.76 10.66 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.482 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 97.56 7.03 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.51 167.36 21.4 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.713 . . . . 0.0 110.673 -178.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.89 25.3 9.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.507 -0.746 . . . . 0.0 111.092 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 157' ' ' ASN . 20.5 p-10 -137.19 -164.66 1.62 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.864 -1.147 . . . . 0.0 109.996 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -56.62 -4.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.429 -0.794 . . . . 0.0 110.968 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.416 HD22 ' NE2' ' A' ' 162' ' ' GLN . 12.2 mt -76.39 -27.01 56.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.59 -1.319 . . . . 0.0 108.036 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.57 -139.49 39.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.2 136.78 41.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.416 ' NE2' HD22 ' A' ' 159' ' ' LEU . 25.1 mt-30 -142.75 154.18 44.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.614 -0.679 . . . . 0.0 109.519 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 148.96 31.52 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -145.37 139.01 26.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -0.841 . . . . 0.0 109.836 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 m -107.1 123.87 48.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.474 -0.767 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.475 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.0 t80 -103.17 109.04 20.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.526 ' H ' HD22 ' A' ' 170' ' ' ASN . 2.4 t -100.35 150.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 109.676 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -49.5 128.21 16.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 108.787 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . 0.459 ' N ' ' OE1' ' A' ' 171' ' ' GLU . . . 106.31 0.97 38.06 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.55 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 91.4 m-20 -116.62 20.75 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 109.022 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.1 pm0 -55.62 -49.08 73.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.396 -0.815 . . . . 0.0 110.205 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -50.27 -22.22 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 110.46 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.71 -7.13 58.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.002 -1.061 . . . . 0.0 111.899 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.5 pt -125.51 -28.16 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.84 -1.163 . . . . 0.0 111.247 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.62 -17.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.593 -1.317 . . . . 0.0 109.022 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.56 -4.03 55.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.45 -0.781 . . . . 0.0 108.945 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.465 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -68.29 115.82 8.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.86 . . . . 0.0 108.937 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.525 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 88.5 mtm180 -78.59 172.7 13.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.232 -0.918 . . . . 0.0 109.264 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.442 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.6 t -79.36 163.3 24.96 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -147.85 148.78 31.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.141 -1.599 . . . . 0.0 111.666 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -145.65 156.7 43.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.402 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 80.3 m-85 -99.75 144.37 28.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.041 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.444 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.35 -36.04 5.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 110.169 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -75.55 -29.27 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.906 -1.121 . . . . 0.0 110.387 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.7 tt0 -75.23 -29.0 60.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.3 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.9 -47.75 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.297 -179.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.29 -41.56 19.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.42 ' CE1' ' CG1' ' A' ' 192' ' ' VAL . 8.6 t60 -74.82 -52.18 12.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.494 HD11 ' OE1' ' A' ' 185' ' ' GLU . 43.1 mt -48.5 -29.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -85.13 -53.54 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.792 -1.192 . . . . 0.0 109.737 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -49.81 -34.76 20.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.385 -179.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.42 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 15.9 m -85.51 8.87 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.895 -1.128 . . . . 0.0 110.36 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.4 39.71 56.38 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.63 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.3 mt -128.47 171.12 12.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -1.177 . . . . 0.0 109.835 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.19 23.22 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -57.92 -19.65 31.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.598 -1.531 . . . . 0.0 110.031 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.38 3.47 34.85 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.58 125.46 35.41 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.082 -1.246 . . . . 0.0 110.466 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.7 p -147.61 165.24 31.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.373 -1.075 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 24.0 mt -67.85 -8.2 34.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -96.36 -11.91 25.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.793 -0.567 . . . . 0.0 109.702 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.512 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.5 p-10 -137.93 8.89 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.046 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.491 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -147.57 149.08 31.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.071 -1.018 . . . . 0.0 110.006 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.62 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.1 tp -99.58 93.79 6.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 203' ' ' THR . 41.8 t -86.22 131.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.86 0.838 . . . . 0.0 109.109 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.23 165.82 16.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.22 -166.38 11.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -58.56 -36.16 73.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -1.072 . . . . 0.0 109.604 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.62 25.44 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.693 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.59 148.92 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.872 -1.142 . . . . 0.0 110.537 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.24 110.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.52 -46.85 73.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.11 -0.993 . . . . 0.0 109.516 -178.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -66.57 117.42 44.17 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.03 -11.13 29.75 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.362 1.375 . . . . 0.0 111.37 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.55 -17.77 61.69 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.376 -0.827 . . . . 0.0 109.031 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.57 -177.73 46.37 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -86.58 136.94 32.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -1.227 . . . . 0.0 109.644 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -20.29 65.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.3 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . 0.467 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.8 m-85 -138.31 -164.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.203 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -97.63 -17.02 19.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -138.5 48.52 1.93 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -53.11 -48.29 92.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 109.806 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.1 Cg_exo -48.24 -67.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.14 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.2 m -59.59 -36.61 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 93.2 mtt180 -60.84 -40.52 93.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.975 -1.078 . . . . 0.0 108.411 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 13.8 t60 -67.6 -30.87 70.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.251 -0.906 . . . . 0.0 108.732 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -66.11 -36.86 84.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.4 t -67.4 -37.97 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -63.24 -53.68 49.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.52 -0.737 . . . . 0.0 109.067 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.41 -28.77 70.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 110.145 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . 0.428 HD23 ' CG1' ' A' ' 149' ' ' VAL . 33.1 tp -76.76 -34.29 58.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.988 -1.07 . . . . 0.0 108.565 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.6 mt -65.29 -38.33 82.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.36 -56.81 10.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.431 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 46.0 m-20 -53.11 -30.95 39.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.203 . . . . 0.0 109.191 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.17 -23.61 67.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 110.339 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.63 -22.37 60.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.744 -1.223 . . . . 0.0 108.96 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -49.76 -5.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.373 -1.454 . . . . 0.0 109.974 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -74.51 -15.85 60.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.42 0.31 61.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.293 178.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -167.14 146.95 4.66 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.557 -1.554 . . . . 0.0 110.007 179.471 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 121' ' ' ILE . 58.7 Cg_exo -34.66 147.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.699 2.266 . . . . 0.0 111.339 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 83.1 t -115.03 147.76 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.603 -178.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -131.77 124.03 28.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 152.68 174.99 23.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 13.9 tttt -103.89 142.2 34.82 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.8 m-85 -137.41 138.93 40.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.216 -0.927 . . . . 0.0 109.761 -179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 59.7 t80 -125.69 128.26 47.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -124.7 136.23 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 -177.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -118.96 113.91 21.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 55.13 18.89 2.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.353 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.32 155.41 17.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.65 176.36 20.66 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.5 m-70 -58.9 -37.7 77.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.251 . . . . 0.0 109.534 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -58.27 9.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.319 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.509 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.2 tp -60.94 -43.24 98.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 18.4 m-20 -47.57 -54.07 12.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 109.417 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 56' ' ' THR . 82.8 t -62.4 -46.38 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.596 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -54.27 -52.08 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.013 -1.054 . . . . 0.0 108.961 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 139' ' ' ILE . 23.8 tp -50.65 -58.49 5.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.452 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.0 t -49.27 -52.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.196 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -49.18 -49.19 43.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.761 . . . . 0.0 109.704 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 130' ' ' ILE . 28.5 mm-40 -61.83 -48.2 81.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.0 -47.97 79.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.01 -29.72 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 110.08 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 -179.603 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.9 mt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 26.6 mt-10 -53.18 135.19 38.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.173 -0.954 . . . . 0.0 108.783 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 144.55 46.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.618 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -141.86 -169.78 2.99 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -100.83 137.33 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.324 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.35 -27.96 68.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.695 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.42 158.19 43.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.812 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 141.1 58.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -120.39 165.18 15.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.64 143.11 43.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 110.177 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.0 m-85 -139.82 150.73 45.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -158.65 151.57 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 0.0 109.999 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.85 174.06 36.45 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.73 149.01 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.431 -1.041 . . . . 0.0 110.256 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.46 137.86 16.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 203' ' ' THR . 3.8 tt -59.2 -38.15 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.243 . . . . 0.0 110.272 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.448 ' N ' HG23 ' A' ' 18' ' ' ILE . 85.2 m-70 -89.8 -50.63 5.94 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.724 -1.235 . . . . 0.0 111.376 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 p -69.03 -21.62 64.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 111.547 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.56 19.2 26.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -112.41 155.46 24.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.523 -0.987 . . . . 0.0 109.569 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -76.53 134.45 39.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 m -138.36 146.12 41.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.726 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 3.4 ttpp -112.6 157.79 20.77 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.41 -0.806 . . . . 0.0 109.923 -179.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 96' ' ' ILE . 8.4 mt -136.86 145.14 44.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -138.74 115.85 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.62 114.38 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.873 . . . . 0.0 110.994 -178.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 27' ' ' ILE . 50.7 m-70 -109.58 138.16 20.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 109.808 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 28.0 Cg_exo -51.99 168.38 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.942 1.761 . . . . 0.0 111.399 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 35' ' ' THR . 15.1 mm-40 -142.91 168.97 18.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 110.131 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 35' ' ' THR . 1.6 mttp -76.82 150.76 36.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.464 -0.773 . . . . 0.0 109.72 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -46.92 146.16 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.867 . . . . 0.0 110.209 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.74 6.04 48.7 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.955 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.536 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 28.5 m -68.66 -43.29 76.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.597 -1.531 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.97 178.2 36.25 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' A' ' 87' ' ' VAL . 15.3 mm -96.07 117.23 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.72 149.83 42.67 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.603 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -100.18 158.26 15.98 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -129.61 112.27 13.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 108.624 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -135.64 132.88 37.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.463 -0.773 . . . . 0.0 110.5 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.451 ' N ' HD22 ' A' ' 42' ' ' ASN . 2.8 m120 53.16 31.24 11.09 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 0.0 111.639 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.3 17.8 78.94 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.153 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.6 121.75 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -1.015 . . . . 0.0 109.19 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.6 m-85 -84.19 128.51 34.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mt -117.61 92.64 41.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.26 145.75 14.64 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.462 2.108 . . . . 0.0 111.984 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 71.41 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 6.0 mmt85 -126.23 172.43 10.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.5 p-80 -73.64 -48.67 30.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 110.195 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -43.6 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 0.0 111.25 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 37.4 m-85 -96.92 1.78 50.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.725 -1.234 . . . . 0.0 110.105 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.6 t -63.66 123.59 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.043 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 m -106.55 -29.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 109.979 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -154.11 132.49 11.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.049 -1.032 . . . . 0.0 109.805 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.726 HG21 HG21 ' A' ' 257' ' ' VAL . 61.3 p -123.6 95.23 4.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 45.6 t-20 -163.66 129.01 3.0 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.395 -0.815 . . . . 0.0 108.894 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 71.4 m-70 47.76 11.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.065 -1.022 . . . . 0.0 108.973 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.36 141.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.872 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.42 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 34.2 m -90.36 127.76 36.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 109.131 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.71 152.82 38.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.413 -0.805 . . . . 0.0 111.067 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.64 ' CD1' HG21 ' A' ' 72' ' ' VAL . 7.7 mt -128.44 149.01 50.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.76 156.77 28.76 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 118.886 -1.626 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -163.82 151.47 12.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.026 . . . . 0.0 108.849 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 52.53 23.85 2.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.971 . . . . 0.0 109.375 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.96 -31.25 7.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -58.3 145.94 36.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -1.17 . . . . 0.0 108.827 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -145.28 140.04 27.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 110.693 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.26 123.08 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -101.43 158.47 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.074 -1.016 . . . . 0.0 111.408 -177.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 m 48.45 72.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.253 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 62' ' ' LEU . 28.0 m -107.16 -9.4 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.174 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -60.47 -25.33 65.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 110.025 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.41 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.6 m170 -67.33 -68.48 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 109.181 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.14 -47.18 44.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 109.192 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 48' ' ' ALA . 20.9 mt -52.67 -47.57 67.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.948 -1.095 . . . . 0.0 110.1 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.5 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.1 t -61.65 -43.53 98.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.943 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.19 -44.75 80.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.14 -35.25 77.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.284 -0.885 . . . . 0.0 109.208 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -62.39 -33.76 75.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.883 . . . . 0.0 109.269 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 171' ' ' GLU . 62.3 mt -82.13 -38.37 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 107' ' ' TYR . 86.5 mt -80.74 4.18 19.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.547 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 54.22 39.11 30.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.07 139.38 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.642 HG21 HG12 ' A' ' 121' ' ' ILE . 56.6 p -126.02 -20.57 4.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.151 -0.968 . . . . 0.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.627 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.1 m-80 -128.5 108.25 10.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.884 -1.135 . . . . 0.0 111.0 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 86' ' ' ASN . 12.7 m -162.76 147.17 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 178.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 17.5 m -112.76 113.74 25.98 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.502 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.6 mt -97.7 101.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 110.648 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.93 124.26 25.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD21 ' A' ' 26' ' ' LEU . 98.5 t -104.94 129.42 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.87 0.843 . . . . 0.0 111.836 -177.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 33.3 mm -111.7 91.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.7 163.6 10.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -84.51 -3.36 58.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.321 . . . . 0.0 110.852 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -140.01 147.09 39.89 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.836 -1.165 . . . . 0.0 110.214 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 26' ' ' LEU . 47.0 mm -74.35 122.2 86.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 109.02 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -41.4 127.17 3.09 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.762 1.641 . . . . 0.0 111.394 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.1 tp -80.18 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.274 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.605 HD11 ' CE2' ' A' ' 106' ' ' PHE . 35.9 mt 58.74 -122.67 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -95.07 8.3 43.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.926 . . . . 0.0 110.464 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.85 -3.63 65.16 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.119 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.45 -172.44 2.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.792 -0.828 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.06 14.3 10.38 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.549 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 4.7 t-105 -56.98 -42.15 79.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.18 -57.83 7.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.097 -1.002 . . . . 0.0 110.261 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 99' ' ' LEU . 10.2 m-85 -51.45 -45.93 62.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.356 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.442 ' CE1' HD21 ' A' ' 82' ' ' LEU . 40.0 t80 -61.22 -53.93 50.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.665 . . . . 0.0 110.905 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 1.5 mm-40 -60.99 -43.54 98.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 111.473 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -54.74 20.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.013 -1.054 . . . . 0.0 110.449 -179.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.6 mt -66.43 -32.83 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 109.645 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -63.61 -42.45 98.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.656 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -77.06 15.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.654 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -146.31 31.18 1.01 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.659 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 72.9 mt -79.29 138.86 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.776 -1.202 . . . . 0.0 110.328 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.05 120.87 25.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.435 -0.791 . . . . 0.0 109.058 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 142.41 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 0.0 110.148 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -110.37 -170.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 109.48 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.542 ' C ' HD22 ' A' ' 118' ' ' ASN . 0.3 OUTLIER -111.53 67.84 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.232 -0.918 . . . . 0.0 110.588 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -164.01 128.7 2.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.044 -1.035 . . . . 0.0 109.314 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.92 142.59 54.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.642 HG12 HG21 ' A' ' 85' ' ' THR . 37.5 mt -86.79 151.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.841 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.03 79.99 3.27 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -58.08 143.41 43.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.557 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -90.08 101.67 14.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.45 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.639 -0.663 . . . . 0.0 110.902 -177.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.12 117.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -97.99 -26.73 14.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.456 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.59 149.66 74.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 149.1 56.48 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.41 2.073 . . . . 0.0 112.096 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.5 tt -153.09 149.75 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.03 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.22 143.46 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.94 147.61 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -134.44 161.52 34.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.076 -1.015 . . . . 0.0 110.181 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.48 ' HB2' HD13 ' A' ' 255' ' ' LEU . 7.0 t0 -168.65 101.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.357 -0.839 . . . . 0.0 109.804 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 47.32 62.54 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.528 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.86 -37.29 3.09 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.578 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -61.03 137.72 58.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.888 -1.36 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -146.96 136.78 23.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.935 -1.103 . . . . 0.0 110.082 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.473 HG21 HD22 ' A' ' 259' ' ' LEU . 92.9 mt -136.13 134.48 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.455 -0.778 . . . . 0.0 109.46 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 tttp -124.16 131.63 53.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.504 0.669 . . . . 0.0 109.957 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.41 137.39 54.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.96 155.86 40.59 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.091 -1.006 . . . . 0.0 109.765 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -50.53 142.21 31.43 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.496 2.131 . . . . 0.0 113.421 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -156.69 139.38 15.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -60.91 -5.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 0.0 110.462 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 145' ' ' ASP . 29.2 p -154.18 -177.54 6.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.884 -1.135 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 148' ' ' GLU . 15.1 tp -93.64 120.55 34.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.0 -1.062 . . . . 0.0 109.341 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.561 ' HG3' HG22 ' A' ' 167' ' ' VAL . 12.1 tt0 -134.49 115.7 14.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.94 121.81 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.403 ' OG1' HG23 ' A' ' 165' ' ' THR . 60.4 m -112.82 152.22 29.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.714 -0.616 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -139.6 131.06 26.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.138 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -121.47 130.52 53.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.25 139.11 10.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.682 -1.246 . . . . 0.0 111.556 -178.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -104.33 101.9 11.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -88.46 167.42 13.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.852 -178.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -100.69 -12.86 18.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' LEU . 39.9 p-10 -97.77 -170.8 2.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.979 -1.076 . . . . 0.0 110.355 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -52.86 0.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.492 -0.755 . . . . 0.0 112.019 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.545 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 28.5 mt -81.87 -28.03 33.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.241 -1.537 . . . . 0.0 108.772 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.16 -136.97 41.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -97.48 130.69 44.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 109.791 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -132.96 142.91 49.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.4 pttm -138.09 144.03 40.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.406 -0.809 . . . . 0.0 109.826 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' PHE . . . . . 0.508 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 61.0 t80 -144.99 138.02 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' THR . . . . . 0.403 HG23 ' OG1' ' A' ' 150' ' ' THR . 59.8 m -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.45 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.2 t80 -102.8 110.91 23.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.99 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.561 HG22 ' HG3' ' A' ' 148' ' ' GLU . 42.4 t -104.06 152.14 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.836 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -49.51 124.24 9.07 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.336 -0.853 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 0.75 31.08 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -116.93 21.66 13.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.195 -1.179 . . . . 0.0 109.268 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -55.44 -52.74 62.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 109.942 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.8 mt-10 -44.54 -22.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 0.0 110.11 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 171' ' ' GLU . 42.0 mt-10 -86.15 -8.95 57.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 111.753 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.5 pt -123.73 -29.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.801 -1.187 . . . . 0.0 111.225 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.6 m -61.41 -20.75 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.586 -1.321 . . . . 0.0 109.025 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.465 HD22 HH11 ' A' ' 218' ' ' ARG . 6.7 mt -90.31 -1.79 57.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.49 120.44 16.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.031 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.444 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 83.6 mtm180 -84.45 172.6 11.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.487 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 163.37 25.06 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -148.7 146.01 27.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.303 -1.498 . . . . 0.0 111.628 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -144.25 157.76 44.11 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 79.5 m-85 -99.19 147.54 25.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.076 -1.015 . . . . 0.0 109.389 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 2.3 p30 -53.27 -33.2 52.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 109.686 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' TRP . . . . . 0.501 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.5 p90 -73.53 -26.36 60.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.906 -1.121 . . . . 0.0 109.55 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.8 mm-40 -77.82 -40.65 39.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.953 . . . . 0.0 109.698 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 183' ' ' ASP . 76.4 mt -45.69 -51.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.136 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -42.65 -45.16 4.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.1 t60 -77.1 -50.93 11.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 109.71 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.5 mt -47.37 -32.24 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -85.04 -52.7 5.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.69 -1.256 . . . . 0.0 108.744 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -50.65 -32.16 18.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.331 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.7 m -86.62 6.27 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.941 -1.1 . . . . 0.0 110.116 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.49 37.55 40.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.6 mt -128.71 171.85 11.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -1.11 . . . . 0.0 109.798 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.55 22.38 52.11 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.78 -19.42 16.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.661 -1.494 . . . . 0.0 110.521 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.27 5.55 28.49 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.36 125.15 26.18 Favored Glycine 0 N--CA 1.491 2.337 0 O-C-N 121.052 -1.263 . . . . 0.0 110.571 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.455 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -147.04 169.46 19.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.562 -0.964 . . . . 0.0 109.421 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 35.2 mt -67.97 -8.36 36.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -93.09 -13.05 29.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 23.8 p30 -139.64 10.72 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.041 -1.037 . . . . 0.0 110.33 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.3 m -148.06 148.49 30.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.911 -1.118 . . . . 0.0 110.49 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.3 tp -98.69 93.41 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -85.88 129.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.4 mt -124.1 164.18 19.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.635 -0.665 . . . . 0.0 109.625 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.25 -166.24 12.55 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -23.25 65.8 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.639 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -157.02 21.77 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.042 -1.036 . . . . 0.0 111.255 -179.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -147.37 156.04 42.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.529 -1.357 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.87 112.79 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -59.21 -51.16 71.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 110.58 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -59.6 112.71 5.66 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -58.05 -11.07 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.704 1.603 . . . . 0.0 112.162 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -19.03 59.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.237 -179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.42 -178.04 50.37 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.8 mt -87.88 131.53 34.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -1.126 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.465 HH11 HD22 ' A' ' 176' ' ' LEU . 6.8 ttm180 -61.14 -20.97 63.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.833 . . . . 0.0 108.875 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -143.43 -173.31 3.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.49 -0.757 . . . . 0.0 109.246 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.05 -16.84 30.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' ASN . . . . . 0.786 HD22 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -134.55 46.25 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.303 -179.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.73 -47.11 99.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.751 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 60.2 Cg_exo -50.42 -66.3 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.511 2.141 . . . . 0.0 112.177 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -60.04 -35.62 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 109.636 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . 0.786 ' HE ' HD22 ' A' ' 221' ' ' ASN . 60.8 mtt-85 -60.91 -40.62 93.85 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.6 t60 -67.89 -31.99 72.17 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.561 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -65.03 -36.0 82.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.5 t -69.54 -34.52 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.2 t80 -66.14 -52.49 47.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.44 -27.76 68.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.776 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.2 tp -77.76 -33.99 52.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.107 -0.995 . . . . 0.0 108.591 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.9 mt -67.65 -38.11 79.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -55.37 15.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' ASP . . . . . 0.432 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 9.7 m-20 -55.24 -36.82 66.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.293 . . . . 0.0 109.114 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.5 mt -62.27 -24.92 67.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.514 -179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.1 t80 -73.95 -21.5 60.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.825 -1.172 . . . . 0.0 109.376 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 237' ' ' LEU . 93.2 mt -49.16 -4.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.572 -1.33 . . . . 0.0 110.501 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 236' ' ' TYR . 11.1 mt -74.09 -14.36 60.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 109.998 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.451 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 96.53 3.19 59.84 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.989 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.59 152.18 11.76 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.489 . . . . 0.0 109.06 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.33 129.36 34.25 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.706 1.604 . . . . 0.0 109.668 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -89.39 151.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.033 -1.042 . . . . 0.0 112.435 -176.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.64 126.65 31.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.77 -165.55 32.61 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.631 ' N ' ' OG ' ' A' ' 144' ' ' SER . 11.9 tptm -124.55 133.71 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -1.092 . . . . 0.0 108.639 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.2 m-85 -132.25 138.05 47.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -125.77 118.21 25.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -112.49 135.31 53.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 111.023 -178.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -117.36 107.73 14.72 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 54.39 31.02 13.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.77 157.56 52.62 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.97 -179.91 16.48 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 54.6 m-70 -60.06 -40.15 88.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -58.88 6.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 134' ' ' ASP . 12.6 tp -56.68 -44.77 81.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.025 . . . . 0.0 109.283 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 256' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 19.9 m-20 -47.64 -52.09 19.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.933 -1.104 . . . . 0.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 56' ' ' THR . 81.4 t -61.54 -45.24 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.07 -49.2 77.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 139' ' ' ILE . 22.4 tp -54.61 -51.2 66.09 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.972 . . . . 0.0 108.779 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.446 HG13 ' HG ' ' A' ' 238' ' ' LEU . 11.5 t -57.87 -54.37 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.896 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -48.67 -45.53 38.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.678 . . . . 0.0 109.517 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' A' ' 130' ' ' ILE . 23.3 mm-40 -64.02 -51.68 63.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.862 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.88 -46.86 71.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.908 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.84 66.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 110.41 -179.274 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.2 mt -96.79 149.86 21.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -1.181 . . . . 0.0 109.419 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 33.1 mt-10 -54.16 139.71 34.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.061 -1.024 . . . . 0.0 108.54 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -123.26 145.9 48.3 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.335 -0.853 . . . . 0.0 110.217 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.6 t -143.2 -169.76 3.11 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.588 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.3 m -100.51 137.94 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.915 -1.115 . . . . 0.0 109.092 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.669 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -68.33 -19.42 64.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.146 -0.972 . . . . 0.0 109.954 -179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.5 OUTLIER -152.72 157.47 40.92 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.08 -1.013 . . . . 0.0 109.705 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.68 138.67 58.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 110.161 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.46 166.44 13.09 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.54 144.3 34.23 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.898 -1.126 . . . . 0.0 110.396 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 81.2 m-85 -138.23 152.08 48.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 6.8 pt-20 -158.99 150.06 20.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.956 -1.09 . . . . 0.0 110.146 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.33 174.79 36.76 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -81.2 151.05 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -1.09 . . . . 0.0 110.058 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.61 140.27 16.5 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 4.2 tt -59.22 -38.88 77.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 110.321 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 72.2 m-70 -88.75 -50.1 6.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.629 -1.294 . . . . 0.0 111.183 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.4 p -68.43 -25.06 64.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 111.819 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.88 14.41 23.28 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.082 -1.532 . . . . 0.0 109.319 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -110.32 157.67 19.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.464 -1.021 . . . . 0.0 109.564 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 77.7 t80 -76.02 135.17 39.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 0.0 109.735 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -137.27 143.22 42.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.955 . . . . 0.0 109.317 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -112.52 156.93 21.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.417 -0.802 . . . . 0.0 109.952 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.627 HD11 HG23 ' A' ' 96' ' ' ILE . 9.5 mt -136.05 146.42 47.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.52 -0.738 . . . . 0.0 109.82 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.1 mt -141.59 106.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.176 -0.952 . . . . 0.0 108.691 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.6 mt -91.64 114.83 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.0 110.979 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -108.79 137.03 19.95 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.523 -0.736 . . . . 0.0 109.544 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.588 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.8 Cg_exo -52.27 168.41 0.41 Allowed 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 121.941 1.761 . . . . 0.0 111.993 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.517 ' HB3' HG21 ' A' ' 35' ' ' THR . 35.3 mm-40 -141.95 173.68 11.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' O ' ' OG1' ' A' ' 35' ' ' THR . 5.6 mttt -83.51 154.29 23.95 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.96 147.57 3.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.102 -0.999 . . . . 0.0 109.783 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.443 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 70.31 0.19 28.26 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.234 -0.984 . . . . 0.0 110.819 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.686 ' N ' HD22 ' A' ' 86' ' ' ASN . 53.8 m -66.03 -44.7 83.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.565 -1.55 . . . . 0.0 109.31 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.62 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 99.34 178.81 31.36 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.743 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 mm -98.96 117.79 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -144.33 155.96 44.04 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.12 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -101.89 158.7 15.94 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -128.56 111.45 13.25 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.134 -0.979 . . . . 0.0 108.718 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -135.62 132.6 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.348 -0.845 . . . . 0.0 110.554 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 42' ' ' ASN . 2.0 m120 55.09 28.25 10.62 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.368 -0.833 . . . . 0.0 111.334 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.85 19.42 73.03 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.773 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.7 t -124.15 121.13 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.537 -0.978 . . . . 0.0 109.217 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.411 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 46.2 m-85 -83.1 127.58 33.71 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.254 -0.904 . . . . 0.0 109.05 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.8 mt -117.44 90.75 35.74 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.625 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -48.02 148.78 6.41 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 122.497 2.131 . . . . 0.0 112.075 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.569 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.68 70.23 10.29 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.321 -0.862 . . . . 0.0 109.064 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -122.76 170.36 10.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.49 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.573 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 3.2 p-80 -72.35 -51.67 19.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 109.363 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.573 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -43.59 -16.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.362 -0.836 . . . . 0.0 110.41 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' A' ' 50' ' ' HIS . 52.5 m-85 -96.47 -0.34 49.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.906 -1.121 . . . . 0.0 110.142 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.411 ' HA ' HD23 ' A' ' 62' ' ' LEU . 76.3 t -68.46 130.75 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.177 -0.952 . . . . 0.0 108.72 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.4 m -118.2 -30.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.375 -0.828 . . . . 0.0 110.341 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -147.18 127.0 13.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.968 -1.082 . . . . 0.0 109.608 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.876 HG21 HG21 ' A' ' 257' ' ' VAL . 38.6 p -120.56 96.23 5.04 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 59' ' ' SER . 8.7 t-20 -160.35 129.01 4.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.325 -0.859 . . . . 0.0 109.036 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.53 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.9 m-70 48.94 11.02 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.194 -0.941 . . . . 0.0 108.928 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.52 146.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.383 -0.823 . . . . 0.0 109.75 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 237' ' ' LEU . 46.4 m -86.81 128.03 35.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.262 -0.899 . . . . 0.0 109.293 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -120.06 147.18 45.15 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.655 0.74 . . . . 0.0 111.14 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.546 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.5 mt -121.92 149.55 43.26 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.74 156.49 28.21 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.434 -1.365 . . . . 0.0 109.904 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -163.52 150.88 12.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -1.102 . . . . 0.0 109.564 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt 50.1 21.64 0.79 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.299 -0.876 . . . . 0.0 109.399 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.85 -34.0 6.12 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.489 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 76.5 mm-40 -59.04 149.42 27.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.019 -1.283 . . . . 0.0 109.656 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.8 mtp85 -143.87 137.61 28.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 110.809 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.25 124.8 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 13.6 mtpp -102.21 157.82 16.62 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.984 -1.073 . . . . 0.0 111.461 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.1 m 50.0 73.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.62 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 62' ' ' LEU . 30.1 m -107.34 -9.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.237 -0.914 . . . . 0.0 108.804 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.42 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.4 pm0 -61.2 -26.24 67.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.558 -0.714 . . . . 0.0 110.472 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.42 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.3 m170 -69.1 -68.12 0.42 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.966 -1.084 . . . . 0.0 109.312 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.595 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.27 -48.83 43.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.185 -0.947 . . . . 0.0 109.294 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.595 ' N ' HG23 ' A' ' 75' ' ' ILE . 20.3 mt -54.16 -46.39 72.29 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.022 -1.049 . . . . 0.0 110.184 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.414 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 29.4 t -60.72 -42.25 96.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.016 -1.053 . . . . 0.0 109.889 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.77 -44.98 87.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.024 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.9 -34.79 78.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.282 -0.886 . . . . 0.0 109.119 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.458 ' O ' ' OE2' ' A' ' 83' ' ' GLU . 5.1 t-160 -62.31 -38.12 88.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.159 -0.963 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' A' ' 171' ' ' GLU . 58.7 mt -77.11 -38.0 53.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.695 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 82' ' ' LEU . 72.6 mt -83.51 -0.79 51.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.022 -1.049 . . . . 0.0 109.703 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.495 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 5.3 mp0 56.6 43.22 25.97 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.814 . . . . 0.0 111.506 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 33.4 mm -87.06 144.86 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.81 -1.182 . . . . 0.0 107.952 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.596 HG21 HG12 ' A' ' 121' ' ' ILE . 43.6 p -130.0 -22.01 2.93 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.086 -1.009 . . . . 0.0 111.995 -178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.737 ' O ' HG13 ' A' ' 87' ' ' VAL . 13.8 m120 -127.72 107.2 9.69 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.795 -1.191 . . . . 0.0 110.607 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.4 m -166.01 152.57 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.512 0.672 . . . . 0.0 109.861 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.8 m -116.57 113.11 22.28 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.516 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -94.89 100.56 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 110.007 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' HD23 ' A' ' 26' ' ' LEU . 16.5 tt0 -75.33 126.74 31.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.078 -1.014 . . . . 0.0 108.42 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.544 HG22 HD21 ' A' ' 26' ' ' LEU . 39.8 t -110.28 127.31 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.899 0.856 . . . . 0.0 111.913 -178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.7 mm -109.34 96.88 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.55 -155.14 24.0 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.07 -8.36 8.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -1.132 . . . . 0.0 110.183 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -141.82 149.64 40.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.916 -1.115 . . . . 0.0 109.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.627 HG23 HD11 ' A' ' 26' ' ' LEU . 42.9 mm -74.11 121.81 86.08 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 108.969 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -41.17 127.9 2.95 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.774 1.649 . . . . 0.0 111.366 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.6 tp -79.42 -11.88 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.189 -0.944 . . . . 0.0 110.516 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 106' ' ' PHE . 70.7 mt 56.07 -121.47 1.63 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.052 -1.03 . . . . 0.0 109.6 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.33 9.14 43.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.001 -1.062 . . . . 0.0 111.056 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.54 -3.47 61.28 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 119.426 -1.369 . . . . 0.0 110.249 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -128.66 -171.95 2.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.692 -0.887 . . . . 0.0 109.537 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.34 15.6 10.76 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.49 ' HB2' HD22 ' A' ' 176' ' ' LEU . 15.7 t-105 -58.78 -42.43 89.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -1.131 . . . . 0.0 110.493 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.03 -58.04 7.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.04 -1.037 . . . . 0.0 110.236 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' A' ' 99' ' ' LEU . 7.9 m-85 -51.15 -45.65 61.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.351 -0.843 . . . . 0.0 109.633 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -60.52 -48.97 79.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.623 -0.673 . . . . 0.0 110.974 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 9.1 mm-40 -67.34 -42.6 83.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.087 -1.008 . . . . 0.0 111.701 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.36 -50.36 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 110.395 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.3 mt -69.31 -31.92 51.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 120.989 -1.069 . . . . 0.0 109.291 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -62.96 -42.1 99.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.431 -0.793 . . . . 0.0 109.805 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.425 ' HG3' HD22 ' A' ' 113' ' ' ASN . 12.0 pttp -77.64 12.74 1.52 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.204 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.669 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 3.9 m-80 -143.86 31.7 1.28 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.883 -1.136 . . . . 0.0 110.457 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.515 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 84.0 mt -79.62 141.3 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.957 -1.089 . . . . 0.0 110.572 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 8' ' ' LYS . 22.0 tp -129.92 122.46 28.63 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.778 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.6 OUTLIER -79.23 141.53 37.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.191 -0.943 . . . . 0.0 110.145 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -110.17 -174.59 2.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.504 -0.748 . . . . 0.0 109.595 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -112.23 68.84 0.68 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 110.678 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.5 ttt85 -167.16 130.38 1.79 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.092 -1.005 . . . . 0.0 109.371 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -67.91 143.81 55.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.596 HG12 HG21 ' A' ' 85' ' ' THR . 55.2 mt -86.22 149.32 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 0.0 110.131 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -92.11 78.13 5.25 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -58.65 142.72 48.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.49 -0.756 . . . . 0.0 110.041 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -89.44 101.59 14.26 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 243' ' ' LYS . 46.8 t -93.88 134.16 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 CA-C-O 121.461 0.648 . . . . 0.0 111.061 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.6 t -73.57 111.91 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.437 ' C ' ' OE1' ' A' ' 128' ' ' GLU . 81.3 mt-10 -90.35 -27.66 19.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.136 -0.977 . . . . 0.0 110.151 -179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.437 ' OE1' ' C ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -134.21 154.75 80.2 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.349 -0.844 . . . . 0.0 109.497 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.76 148.11 45.98 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.551 2.167 . . . . 0.0 112.199 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.548 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.0 149.05 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.0 mp -140.3 143.37 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.292 -0.88 . . . . 0.0 109.767 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.38 145.64 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -133.05 159.63 39.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.15 -0.969 . . . . 0.0 110.001 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -175.44 105.94 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.304 -0.872 . . . . 0.0 110.091 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 52.11 54.95 9.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.4 -0.813 . . . . 0.0 110.715 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.19 -31.18 3.19 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.109 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 44.4 mtt85 -63.09 135.39 57.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.046 -1.267 . . . . 0.0 108.52 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -146.03 136.61 24.14 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.897 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.657 HG21 HD22 ' A' ' 259' ' ' LEU . 96.5 mt -135.41 121.64 32.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.229 -0.919 . . . . 0.0 109.207 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -112.16 131.82 55.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.487 0.66 . . . . 0.0 109.98 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -121.15 138.47 54.19 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.83 153.42 33.45 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.149 -0.97 . . . . 0.0 109.524 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -49.19 142.38 21.45 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.401 2.067 . . . . 0.0 113.49 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.5 t -154.15 142.44 20.51 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.553 ' O ' HG23 ' A' ' 146' ' ' THR . 55.8 m-20 -60.59 -4.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.314 -0.866 . . . . 0.0 110.726 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 145' ' ' ASP . 17.4 p -157.96 -171.07 3.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.872 -1.143 . . . . 0.0 109.507 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 148' ' ' GLU . 14.9 tp -93.98 120.57 34.41 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.118 -0.989 . . . . 0.0 109.018 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.409 ' N ' HD12 ' A' ' 147' ' ' LEU . 77.1 tt0 -136.77 113.01 9.84 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.643 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.36 122.0 68.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 0.0 110.008 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.9 m -112.91 152.31 29.46 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -139.96 131.61 27.26 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.938 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.28 140.26 52.84 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.64 138.67 8.27 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.969 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -100.36 99.29 9.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -84.42 167.22 16.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.173 -0.954 . . . . 0.0 110.853 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -100.67 -12.07 19.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 0.0 110.707 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.9 p-10 -102.69 -172.63 2.16 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.934 -1.104 . . . . 0.0 110.486 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -49.18 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.466 -0.771 . . . . 0.0 111.532 -178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 157' ' ' ASN . 18.3 mt -77.31 -27.19 52.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.379 -1.45 . . . . 0.0 108.311 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.46 -139.18 31.34 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.678 -1.769 . . . . 0.0 108.678 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.8 ttp180 -97.36 134.07 41.12 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.169 -1.194 . . . . 0.0 109.513 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.0 mm-40 -141.23 152.86 44.92 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.524 -0.735 . . . . 0.0 109.174 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.13 152.76 32.72 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.214 -0.929 . . . . 0.0 110.446 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.566 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 53.8 t80 -148.53 146.53 28.36 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.236 -0.915 . . . . 0.0 109.879 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 85.5 m -110.3 124.57 51.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.516 -0.74 . . . . 0.0 110.468 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.456 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -104.19 115.73 30.92 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.28 -0.888 . . . . 0.0 110.012 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.5 t -109.75 156.26 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 109.821 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -50.65 123.37 8.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.144 -0.973 . . . . 0.0 109.19 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.475 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 103.92 5.95 43.64 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.453 ' N ' ' OE2' ' A' ' 171' ' ' GLU . 82.8 m-20 -119.75 19.03 12.58 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.367 -1.078 . . . . 0.0 109.212 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.695 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.9 pm0 -59.8 -43.9 94.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -53.89 -6.09 0.08 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.432 -0.792 . . . . 0.0 110.021 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.471 ' H ' ' C ' ' A' ' 171' ' ' GLU . 89.3 mt-10 -104.8 -8.96 18.4 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.348 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 1.9 pt -123.85 -27.52 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.231 -0.918 . . . . 0.0 110.575 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.8 m -62.18 -29.23 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.795 -1.191 . . . . 0.0 108.611 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.49 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -77.58 -7.53 56.48 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.485 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.28 119.15 12.35 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.314 -0.866 . . . . 0.0 109.172 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.511 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 72.8 mtm180 -83.25 172.29 12.74 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.914 . . . . 0.0 109.515 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.3 t -77.06 162.37 27.56 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -147.65 145.17 28.84 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.302 -1.499 . . . . 0.0 111.333 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.595 ' HB2' ' CE1' ' A' ' 501' ' ' C90 . . . -142.17 157.16 45.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.54 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.6 m-85 -98.72 142.28 30.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.07 -1.019 . . . . 0.0 109.514 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.15 -37.66 10.4 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.314 -0.866 . . . . 0.0 109.748 -179.576 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.0 -27.25 63.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.472 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 7.1 mt-10 -78.61 -40.07 35.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.977 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.425 HG21 HB11 ' A' ' 501' ' ' C90 . 13.2 mt -43.22 -54.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.137 -0.977 . . . . 0.0 109.831 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 186' ' ' ILE . 1.0 OUTLIER -43.21 -43.12 4.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.194 -0.941 . . . . 0.0 109.942 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.75 ' O ' HG22 ' A' ' 192' ' ' VAL . 2.3 t60 -74.27 -50.08 20.46 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 0.0 109.598 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 56.0 mt -52.08 -28.97 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.25 -0.906 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -85.3 -53.32 5.3 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.74 -1.225 . . . . 0.0 109.48 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -51.77 -33.68 36.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.241 -0.912 . . . . 0.0 110.147 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.75 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.6 m -83.07 7.07 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.989 -1.07 . . . . 0.0 109.819 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.67 39.38 55.87 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 54.4 mt -129.48 171.56 12.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.154 -1.204 . . . . 0.0 110.134 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.419 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.67 24.0 56.28 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -58.22 -19.33 32.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.67 -1.488 . . . . 0.0 110.387 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.454 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.44 6.51 28.31 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 120.031 -1.08 . . . . 0.0 110.723 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.32 126.19 27.79 Favored Glycine 0 N--CA 1.493 2.498 0 O-C-N 120.903 -1.351 . . . . 0.0 110.297 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.58 167.03 23.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.379 -1.071 . . . . 0.0 109.246 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.5 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 78.5 mt -68.75 -8.59 44.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.121 -0.987 . . . . 0.0 108.395 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -98.06 -11.17 23.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.712 -0.618 . . . . 0.0 109.54 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.454 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.2 p30 -133.21 7.66 3.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 0.0 109.64 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.43 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.43 149.56 31.94 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.115 -0.991 . . . . 0.0 110.365 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.645 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.73 93.99 6.11 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.0 t -85.6 129.06 38.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.779 0.8 . . . . 0.0 109.094 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.438 HD22 HG22 ' A' ' 211' ' ' VAL . 40.9 mt -123.08 170.87 9.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.651 -0.656 . . . . 0.0 109.562 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.76 -166.22 11.71 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -64.48 -29.66 70.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -1.148 . . . . 0.0 109.611 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -153.26 24.45 0.54 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 111.061 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -149.17 156.82 42.74 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.515 -1.366 . . . . 0.0 110.925 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.438 HG22 HD22 ' A' ' 206' ' ' LEU . 84.6 t -104.67 112.24 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -57.04 -49.32 76.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.902 -1.123 . . . . 0.0 109.856 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.83 112.26 4.78 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.418 -0.801 . . . . 0.0 110.385 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -57.3 -17.94 28.48 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 112.598 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.12 -16.34 60.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.915 -1.116 . . . . 0.0 109.98 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.43 -171.96 50.9 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.645 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.0 mt -91.17 137.3 32.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.356 -1.085 . . . . 0.0 109.674 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -74.41 -16.45 60.88 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 0.0 108.74 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.99 169.36 17.94 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.495 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 2.1 mm-40 -84.56 3.68 35.58 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.141 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.519 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -151.38 43.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 109.186 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -56.24 -47.21 99.31 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.869 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.2 Cg_exo -50.57 -68.24 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.447 2.098 . . . . 0.0 112.193 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.427 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.1 m -57.13 -35.3 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.012 -1.055 . . . . 0.0 109.644 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.566 ' NH1' ' CZ ' ' A' ' 164' ' ' PHE . 76.9 mtt-85 -60.7 -41.24 94.79 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.144 -0.973 . . . . 0.0 108.449 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 11.0 t60 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.986 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.456 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.7 t -67.64 -37.06 78.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.414 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 52.7 t80 -65.33 -50.98 63.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.495 -0.753 . . . . 0.0 109.051 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.539 ' OD2' ' C22' ' A' ' 501' ' ' C90 . 91.8 m-20 -64.11 -30.53 71.59 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.372 -0.83 . . . . 0.0 109.997 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 42.3 tp -75.49 -32.8 60.68 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.034 -1.041 . . . . 0.0 108.579 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.27 -39.66 83.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.7 -56.15 16.37 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.41 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 49.6 m-20 -54.82 -33.98 62.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.15 -1.206 . . . . 0.0 109.256 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 235' ' ' LEU . 7.7 mt -61.18 -24.01 66.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.467 -0.771 . . . . 0.0 110.444 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.574 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.1 OUTLIER -72.63 -22.1 61.0 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.892 -1.13 . . . . 0.0 108.611 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.475 HD11 HG21 ' A' ' 60' ' ' THR . 63.4 mt -50.78 -2.39 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.719 -1.238 . . . . 0.0 110.621 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.6 ' HG ' HG13 ' A' ' 260' ' ' VAL . 9.5 mt -76.76 -13.38 60.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.864 -1.147 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.01 -0.38 58.97 Favored Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.983 -1.103 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -167.04 155.16 8.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.96 -1.318 . . . . 0.0 108.814 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -48.53 150.67 5.62 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.745 1.63 . . . . 0.0 109.6 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.74 145.54 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.076 -1.015 . . . . 0.0 112.361 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.505 ' HB2' HG22 ' A' ' 125' ' ' VAL . 3.6 mmmp? -126.25 121.32 32.35 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.3 -175.55 31.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.556 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 26.9 tttt -114.59 147.47 39.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.372 -1.075 . . . . 0.0 109.263 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.556 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 6.8 m-85 -142.92 140.48 31.17 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -126.56 122.12 34.19 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.8 m -114.7 135.25 54.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -0.978 . . . . 0.0 111.112 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -118.52 109.68 16.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 54.15 26.82 6.99 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.18 -0.95 . . . . 0.0 109.382 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.69 158.74 52.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -137.02 168.14 24.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.41 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 68.5 m-70 -47.19 -41.29 17.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -1.187 . . . . 0.0 109.695 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.27 -57.98 9.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.045 -1.034 . . . . 0.0 109.293 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.546 HD23 HG13 ' A' ' 139' ' ' ILE . 6.4 tp -58.15 -44.82 88.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 0.0 109.502 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 256' ' ' ASN . 2.7 m-20 -47.95 -50.48 26.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.008 -1.057 . . . . 0.0 109.391 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.876 HG21 HG21 ' A' ' 56' ' ' THR . 99.4 t -63.15 -51.12 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.594 -0.691 . . . . 0.0 109.704 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -53.0 -51.32 62.03 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.108 -0.995 . . . . 0.0 109.286 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.657 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -51.57 -57.79 8.13 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.161 -0.962 . . . . 0.0 108.434 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.6 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.2 t -50.78 -56.23 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 108.899 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.83 -49.04 20.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.525 -0.734 . . . . 0.0 109.398 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.435 ' HB3' HD11 ' A' ' 130' ' ' ILE . 1.8 mm-40 -62.07 -48.27 80.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.36 -50.54 71.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 109.96 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.44 -27.0 65.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.13 -0.981 . . . . 0.0 110.0 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -77.11 -40.3 46.36 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.908 . . . . 0.0 110.267 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -19.5 30.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 0.0 109.972 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -90.83 -47.29 7.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.052 -1.03 . . . . 0.0 109.739 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.23 -162.99 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.13 -0.982 . . . . 0.0 109.487 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.484 -0.76 . . . . 0.0 109.399 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' C90 . . . . . 0.595 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.569 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 2.0 mt -84.28 156.49 21.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -1.18 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -51.76 143.29 13.24 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.152 -0.967 . . . . 0.0 108.729 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -123.55 146.61 47.98 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.091 -179.172 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.1 t -144.96 -168.82 3.03 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.2 m -99.56 134.92 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.012 -1.055 . . . . 0.0 109.526 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 ptmt -63.9 -16.73 62.13 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.862 . . . . 0.0 109.168 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -152.71 -171.63 3.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.381 -0.824 . . . . 0.0 109.246 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.53 144.01 25.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 11' ' ' LEU . 43.5 mt -120.97 163.31 18.45 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.44 140.41 46.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.291 -0.881 . . . . 0.0 109.774 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.6 m-85 -138.48 148.28 44.16 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.13 152.2 26.05 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.809 -1.182 . . . . 0.0 110.209 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.12 173.24 35.9 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.08 150.82 4.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.393 -1.063 . . . . 0.0 110.17 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.58 136.63 15.21 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.6 tt -60.52 -37.78 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 110.445 -179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.421 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 46.3 m-70 -90.68 -51.45 5.37 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.588 -1.32 . . . . 0.0 111.044 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.7 p -70.54 -22.03 62.65 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.6 -0.688 . . . . 0.0 111.232 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.25 21.37 47.11 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.42 -1.371 . . . . 0.0 109.731 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -110.64 153.07 25.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -1.145 . . . . 0.0 109.92 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -74.86 130.13 38.89 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.46 -0.775 . . . . 0.0 109.562 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.5 t -135.41 145.86 47.71 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.235 -0.916 . . . . 0.0 110.057 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -112.0 156.52 22.02 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.416 0.627 . . . . 0.0 109.333 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.586 HD11 HG23 ' A' ' 96' ' ' ILE . 10.8 mt -135.61 144.92 46.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.277 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.553 HG22 ' NE2' ' A' ' 29' ' ' HIS . 8.3 mt -140.19 110.22 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 108.79 178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 38.3 mt -95.3 113.62 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.398 -0.814 . . . . 0.0 111.094 -178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.553 ' NE2' HG22 ' A' ' 27' ' ' ILE . 45.4 m-70 -108.32 138.14 20.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.073 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HG3' HG23 ' A' ' 7' ' ' VAL . 20.6 Cg_exo -51.37 167.98 0.32 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 C-N-CA 121.853 1.702 . . . . 0.0 112.279 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.2 mm-40 -140.92 176.21 8.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.34 -0.85 . . . . 0.0 109.479 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.488 ' O ' ' OG1' ' A' ' 35' ' ' THR . 3.5 mtpp -85.31 152.83 22.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.856 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.19 146.97 1.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.925 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.68 6.32 42.44 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.039 178.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 24.6 m -69.08 -43.7 74.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.631 -1.511 . . . . 0.0 109.778 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.55 -175.67 31.82 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.458 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.9 mm -98.45 117.92 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -139.03 140.7 38.19 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.858 -1.137 . . . . 0.0 110.57 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.33 156.57 16.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -129.11 110.8 12.33 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.031 -1.043 . . . . 0.0 109.084 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -135.19 134.14 39.79 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 110.571 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.32 28.33 7.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.493 -0.754 . . . . 0.0 111.384 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.33 19.03 75.08 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.425 -1.369 . . . . 0.0 109.806 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.2 t -122.49 121.19 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -1.012 . . . . 0.0 108.951 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.5 m-85 -84.34 127.11 33.79 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 77.6 mt -115.72 92.65 34.63 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.431 -0.793 . . . . 0.0 109.33 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -49.66 144.99 18.33 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.569 2.179 . . . . 0.0 112.108 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.2 67.5 7.15 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.0 mmt180 -122.16 163.79 18.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.433 -0.792 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.549 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -65.63 -52.87 48.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 5.4 mm-40 -43.25 -16.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.724 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.549 ' N ' ' O ' ' A' ' 50' ' ' HIS . 15.9 m-85 -95.7 1.73 53.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.757 -1.214 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 50' ' ' HIS . 86.8 t -70.58 130.35 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.333 -0.855 . . . . 0.0 108.874 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.46 -31.75 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.873 . . . . 0.0 109.744 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -151.7 136.53 17.19 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.186 -0.946 . . . . 0.0 109.666 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.884 HG21 HG21 ' A' ' 257' ' ' VAL . 35.8 p -125.35 96.3 4.77 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.545 HD22 ' CD2' ' A' ' 58' ' ' HIS . 0.5 OUTLIER -162.24 129.49 3.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.808 . . . . 0.0 108.949 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.545 ' CD2' HD22 ' A' ' 57' ' ' ASN . 79.8 m-70 51.98 7.9 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.104 -0.998 . . . . 0.0 108.759 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.541 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.5 OUTLIER 161.9 153.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.817 . . . . 0.0 109.658 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 72' ' ' VAL . 88.0 m -93.88 126.49 39.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.212 -0.93 . . . . 0.0 109.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -118.94 149.02 42.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.612 0.72 . . . . 0.0 110.868 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.561 HD11 HG21 ' A' ' 72' ' ' VAL . 9.0 mt -124.86 149.07 47.89 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.73 153.74 24.43 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.88 -1.629 . . . . 0.0 110.98 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -163.12 148.79 11.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.53 -0.982 . . . . 0.0 109.174 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.89 23.79 4.12 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.334 -0.854 . . . . 0.0 109.626 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.15 -31.72 7.4 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -60.38 144.55 50.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -1.235 . . . . 0.0 109.262 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -140.04 139.02 35.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.251 -0.906 . . . . 0.0 110.675 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 51.3 mt -130.4 123.02 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -101.36 157.33 16.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.95 -1.094 . . . . 0.0 111.511 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.8 m 49.91 74.57 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.545 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 62' ' ' LEU . 30.5 m -107.65 -9.81 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.2 -0.938 . . . . 0.0 109.31 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 10.6 pm0 -61.74 -26.09 67.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.403 -0.811 . . . . 0.0 110.46 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.0 m170 -66.78 -69.23 0.32 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.932 -1.105 . . . . 0.0 109.242 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.02 -48.57 40.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.013 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.589 HD21 ' HB1' ' A' ' 48' ' ' ALA . 14.8 mt -51.55 -49.27 62.34 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.038 -1.039 . . . . 0.0 110.3 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.4 t -60.47 -42.68 96.73 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.988 -1.07 . . . . 0.0 110.295 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.9 t -56.74 -45.41 82.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.075 -1.015 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.8 mt -66.3 -34.69 78.56 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -61.62 -35.84 79.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 109.035 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.493 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 65.1 mt -80.23 -37.65 32.65 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.326 -0.859 . . . . 0.0 110.257 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.5 mt -80.0 9.29 5.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.034 -1.041 . . . . 0.0 109.781 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 3.3 mp0 50.2 36.77 13.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.33 -0.856 . . . . 0.0 109.394 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.34 136.82 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.034 -1.041 . . . . 0.0 108.282 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.484 HG21 HG12 ' A' ' 121' ' ' ILE . 33.0 p -127.1 -19.81 4.28 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 111.595 -178.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.686 ' O ' HG13 ' A' ' 87' ' ' VAL . 72.7 m-20 -124.38 107.59 11.28 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.876 -1.14 . . . . 0.0 110.423 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -163.94 148.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.408 -0.808 . . . . 0.0 110.282 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.8 m -114.69 111.5 21.4 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.552 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -95.68 100.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 110.126 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -72.07 127.69 33.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 26' ' ' LEU . 83.3 t -111.9 119.54 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.937 0.875 . . . . 0.0 111.905 -177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 92' ' ' ILE . 13.7 mt -109.04 93.55 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.2 160.4 8.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.41 -7.54 59.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.997 -1.296 . . . . 0.0 111.292 -178.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -138.96 147.89 42.81 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 110.676 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.586 HG23 HD11 ' A' ' 26' ' ' LEU . 42.0 mm -73.86 125.96 89.88 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.457 -0.777 . . . . 0.0 108.917 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -44.61 134.2 9.88 Favored 'Trans proline' 0 C--N 1.315 -1.227 0 C-N-CA 121.775 1.65 . . . . 0.0 111.075 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.7 tp -88.17 -14.66 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.16 -0.963 . . . . 0.0 110.61 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 97.7 mt 55.78 -121.98 1.74 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.102 -0.999 . . . . 0.0 109.991 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -95.82 7.6 45.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.939 -1.101 . . . . 0.0 111.17 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.52 -3.73 63.61 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.281 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.9 p -123.88 -172.65 2.58 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.724 -0.868 . . . . 0.0 109.556 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.98 10.18 11.14 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 55.5 t-105 -58.57 -40.58 83.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -1.121 . . . . 0.0 110.381 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -61.31 -58.98 6.04 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.028 -1.045 . . . . 0.0 109.38 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HB3' HG11 ' A' ' 78' ' ' VAL . 11.7 m-85 -51.18 -43.77 61.4 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.83 0.824 . . . . 0.0 108.885 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.464 ' CE2' ' OE1' ' A' ' 171' ' ' GLU . 56.4 t80 -62.27 -52.19 64.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.663 -0.648 . . . . 0.0 111.18 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.448 ' CG ' ' CZ2' ' A' ' 104' ' ' TRP . 19.5 mm-40 -61.89 -43.2 99.34 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.956 -1.09 . . . . 0.0 111.195 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.12 2.63 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.144 -0.972 . . . . 0.0 110.363 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mt -58.44 -35.42 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 0.0 109.635 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 41.8 ttt85 -64.78 -43.55 92.9 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.343 -0.848 . . . . 0.0 109.762 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -72.59 10.76 0.76 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.339 -0.851 . . . . 0.0 110.154 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -145.73 36.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.948 -1.095 . . . . 0.0 110.448 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 72.7 mt -83.44 139.91 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 0.0 110.897 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tp -129.98 119.5 23.29 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.8 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.5 OUTLIER -76.3 143.56 40.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.722 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.19 -175.96 2.9 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.446 -0.784 . . . . 0.0 109.592 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.547 ' ND2' ' H ' ' A' ' 118' ' ' ASN . 0.3 OUTLIER -106.91 67.99 0.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.235 -0.915 . . . . 0.0 110.514 -179.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -164.93 129.64 2.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.163 -0.96 . . . . 0.0 109.148 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -67.22 140.77 57.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.849 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.484 HG12 HG21 ' A' ' 85' ' ' THR . 37.4 mt -81.47 147.0 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 0.0 110.321 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.77 88.78 4.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.304 -0.872 . . . . 0.0 108.657 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -66.71 143.77 56.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.195 -0.941 . . . . 0.0 109.849 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -88.47 102.2 14.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 51.7 t -92.24 134.12 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.556 -0.715 . . . . 0.0 110.792 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.2 t -70.27 117.22 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 127' ' ' GLU . 7.3 tp10 -89.69 -31.62 17.4 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.961 -1.087 . . . . 0.0 109.99 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.11 154.28 80.06 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.187 -0.946 . . . . 0.0 109.504 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.41 158.39 44.46 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.557 2.172 . . . . 0.0 112.35 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.549 HG13 ' HZ2' ' A' ' 266' ' ' LYS . 3.0 tt -165.09 154.67 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 0.0 109.474 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.76 147.06 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.425 -0.797 . . . . 0.0 109.692 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.2 m -131.96 147.28 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -132.84 161.56 33.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -0.968 . . . . 0.0 110.194 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -173.66 102.17 0.11 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.427 -0.796 . . . . 0.0 109.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 47.17 59.25 4.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.436 -0.79 . . . . 0.0 111.002 179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.02 -35.56 3.25 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.929 -1.129 . . . . 0.0 110.448 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -63.94 131.38 47.51 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.049 -1.265 . . . . 0.0 108.89 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.675 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -143.3 139.25 30.05 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 109.999 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 259' ' ' LEU . 68.5 mt -137.29 128.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.387 -0.821 . . . . 0.0 109.876 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -117.94 132.77 56.37 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.514 0.673 . . . . 0.0 110.146 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.83 134.95 54.89 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -146.46 147.68 31.59 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.111 -0.993 . . . . 0.0 110.04 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.54 143.52 8.45 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.617 2.211 . . . . 0.0 113.458 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.73 147.38 18.55 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.77 -37.55 82.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.325 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -120.46 -169.86 1.88 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 11.9 tp -100.08 122.94 43.72 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.36 130.2 36.58 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.459 ' CG1' HD23 ' A' ' 231' ' ' LEU . 54.9 t -128.73 121.45 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.541 ' OG1' HG23 ' A' ' 165' ' ' THR . 21.4 m -112.43 151.99 29.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.594 -0.691 . . . . 0.0 109.433 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -140.52 131.4 25.98 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.113 -1.035 . . . . 0.0 111.145 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 65.6 tt0 -121.67 125.42 46.61 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.91 138.87 10.7 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.345 -178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 67.1 tt0 -102.87 103.14 13.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -93.31 167.44 11.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 110.664 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 9.4 tttp -103.65 -12.27 17.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.586 -0.696 . . . . 0.0 110.921 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.2 p-10 -97.88 -167.13 1.47 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 0.0 110.378 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -53.48 3.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.614 -0.679 . . . . 0.0 111.259 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 157' ' ' ASN . 13.5 mt -85.59 -30.53 23.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.545 -1.347 . . . . 0.0 109.102 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.85 -140.25 38.62 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 161' ' ' ARG . 11.5 ttp-105 -98.82 135.91 39.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.193 -1.181 . . . . 0.0 109.457 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -137.89 149.72 46.49 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.484 -0.76 . . . . 0.0 109.456 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -140.86 143.99 35.05 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -145.47 140.3 27.45 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.762 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.541 HG23 ' OG1' ' A' ' 150' ' ' THR . 32.2 m -108.14 123.85 49.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.527 -0.733 . . . . 0.0 109.998 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -102.91 111.73 24.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.959 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 44.5 t -99.8 146.26 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.954 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -48.25 134.21 14.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.29 -0.881 . . . . 0.0 108.987 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.92 -6.0 43.25 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -114.03 25.61 11.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.275 -1.132 . . . . 0.0 109.27 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.464 ' OE1' ' CE2' ' A' ' 107' ' ' TYR . 0.0 OUTLIER -53.09 -51.69 61.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.306 -0.871 . . . . 0.0 110.429 -179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -50.56 -21.28 1.47 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.12 -0.988 . . . . 0.0 110.177 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -82.26 -7.9 59.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 111.619 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 29.8 pt -125.58 -25.23 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.852 -1.155 . . . . 0.0 111.121 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 14.9 m -63.7 -24.44 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.438 -1.414 . . . . 0.0 109.005 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.4 mm? -81.66 -5.62 58.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.468 -0.77 . . . . 0.0 108.99 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.404 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.57 115.52 8.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.174 -0.954 . . . . 0.0 109.173 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.409 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 49.8 mtm180 -79.41 172.51 13.7 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.214 -0.929 . . . . 0.0 109.201 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.4 t -77.86 163.23 26.23 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.2 p90 -147.1 144.46 29.06 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.207 -1.558 . . . . 0.0 111.716 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.01 156.7 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -98.86 147.29 25.09 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 109.662 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.543 ' HA ' HD12 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -52.94 -35.97 59.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.429 -0.794 . . . . 0.0 109.698 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.578 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.2 p90 -72.91 -31.44 64.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.95 -1.094 . . . . 0.0 109.898 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.578 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.2 mm-40 -75.36 -35.74 61.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.017 -1.052 . . . . 0.0 109.375 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 183' ' ' ASP . 77.1 mt -46.46 -55.61 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.321 -0.862 . . . . 0.0 109.786 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -43.8 -42.0 5.33 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 109.858 -179.589 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.639 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.0 t60 -74.44 -48.4 27.8 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.12 -0.988 . . . . 0.0 109.046 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 97.1 mt -51.09 -30.15 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.336 -0.852 . . . . 0.0 109.302 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -82.35 -52.02 7.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.782 -1.199 . . . . 0.0 109.143 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 tttm -47.29 -47.12 25.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.425 -0.797 . . . . 0.0 110.158 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.7 m -74.67 8.17 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.182 -0.949 . . . . 0.0 110.79 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.08 39.9 62.52 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 194' ' ' LEU . 44.8 mt -126.45 170.91 11.49 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -1.082 . . . . 0.0 109.676 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.421 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.8 21.22 58.16 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -57.2 -21.67 35.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.557 -1.555 . . . . 0.0 109.807 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -113.48 25.19 11.38 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -86.36 127.53 8.4 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.458 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -141.18 169.4 17.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.29 -1.124 . . . . 0.0 109.519 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.407 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 63.5 mt -70.7 -8.64 53.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 15.0 mttp -97.38 -12.66 22.52 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.569 -0.707 . . . . 0.0 109.609 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.458 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 17.9 p30 -132.71 8.67 4.19 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 110.154 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.492 HG22 HG23 ' A' ' 205' ' ' VAL . 1.0 OUTLIER -149.89 149.76 30.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.967 -1.083 . . . . 0.0 110.481 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.548 ' CG ' HD21 ' A' ' 206' ' ' LEU . 32.0 tp -97.45 93.36 6.42 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 203' ' ' THR . 45.1 t -87.22 130.34 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.554 -0.716 . . . . 0.0 109.152 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.548 HD21 ' CG ' ' A' ' 204' ' ' LEU . 12.5 mt -124.15 166.26 16.12 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.518 -0.739 . . . . 0.0 109.159 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.08 -166.15 12.18 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -33.05 73.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.296 -1.12 . . . . 0.0 109.366 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.412 ' O ' ' CG ' ' A' ' 209' ' ' ASP . 47.9 t0 -153.9 24.32 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 110.305 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -143.02 150.6 39.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.871 -1.143 . . . . 0.0 110.33 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 79.7 t -103.23 113.32 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -58.61 -49.76 76.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.012 -1.055 . . . . 0.0 110.04 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -58.1 111.81 4.03 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.231 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -57.54 -12.98 12.35 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.541 1.494 . . . . 0.0 111.466 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.45 -17.54 59.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.407 -0.808 . . . . 0.0 110.035 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.7 -173.78 49.29 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.457 HD22 HD21 ' A' ' 204' ' ' LEU . 6.7 mt -91.02 136.14 33.28 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.145 -1.209 . . . . 0.0 109.462 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.4 mtm180 -75.32 -20.12 59.25 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 108.824 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -134.43 159.07 42.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.555 -0.716 . . . . 0.0 109.12 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -69.5 -12.79 61.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.82 51.17 1.53 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.169 -0.957 . . . . 0.0 109.656 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.28 -47.03 99.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 0.0 109.795 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 63.6 Cg_exo -49.9 -67.08 0.11 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.453 2.102 . . . . 0.0 112.342 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 20.0 m -59.16 -35.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.121 . . . . 0.0 109.571 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -60.66 -41.1 94.36 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 108.457 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.406 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.2 t60 -68.19 -32.4 72.61 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.301 -0.874 . . . . 0.0 108.947 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -64.45 -37.63 88.19 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.07 -36.11 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.59 -57.37 9.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.532 -0.73 . . . . 0.0 109.137 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -61.58 -26.01 67.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.354 -0.841 . . . . 0.0 109.885 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.459 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.7 tp -78.2 -35.08 48.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.059 -1.025 . . . . 0.0 108.69 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 37.8 mt -66.0 -36.51 77.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.79 -59.76 5.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.1 -1.6 . . . . 0.0 109.1 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.454 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 99.4 m-20 -48.09 -36.1 12.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.274 . . . . 0.0 108.992 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.9 mt -62.83 -22.78 66.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.547 -0.721 . . . . 0.0 110.317 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.27 -22.63 61.19 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.777 -1.202 . . . . 0.0 108.999 -179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 57.8 mt -50.36 -3.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.688 -1.257 . . . . 0.0 110.204 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.5 mt -78.87 -16.34 57.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.906 -1.121 . . . . 0.0 109.695 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 2.63 56.37 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.172 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.66 154.54 9.13 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.747 -1.443 . . . . 0.0 109.287 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.16 128.77 31.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.91 1.74 . . . . 0.0 109.682 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -87.68 151.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.113 -0.992 . . . . 0.0 112.524 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.8 mmtp -131.9 124.74 30.1 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.48 -158.41 27.99 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -129.08 132.89 47.49 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -1.155 . . . . 0.0 108.713 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.5 m-85 -131.92 140.09 48.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.223 -0.923 . . . . 0.0 110.33 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -126.76 125.34 41.59 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.1 m -120.93 135.44 55.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.063 -1.023 . . . . 0.0 111.015 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.403 ' C ' ' N ' ' A' ' 251' ' ' GLY . 30.4 t80 -116.1 114.84 25.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 17.38 0.73 Allowed 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.092 -1.005 . . . . 0.0 109.007 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.403 ' N ' ' C ' ' A' ' 249' ' ' PHE . . . -55.68 140.89 40.06 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -118.2 179.45 17.05 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.454 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.7 m-70 -62.21 -42.26 99.13 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.203 -1.174 . . . . 0.0 109.875 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.0 t -55.62 -58.92 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.07 -1.019 . . . . 0.0 109.572 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.452 HD12 ' HA ' ' A' ' 255' ' ' LEU . 12.8 tp -55.99 -44.56 78.72 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.064 -1.022 . . . . 0.0 109.313 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.442 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 34.9 m-20 -47.59 -50.77 23.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.965 -1.085 . . . . 0.0 108.962 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 56' ' ' THR . 86.3 t -61.98 -49.55 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.524 -0.735 . . . . 0.0 109.84 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -54.88 -51.93 64.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.029 -1.044 . . . . 0.0 109.311 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 139' ' ' ILE . 51.9 tp -50.06 -52.79 31.6 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.082 -1.011 . . . . 0.0 108.549 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.503 HG13 ' HG ' ' A' ' 238' ' ' LEU . 34.5 t -55.41 -51.45 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.21 -0.931 . . . . 0.0 108.746 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -50.16 -47.01 54.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.592 -0.692 . . . . 0.0 109.552 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -64.45 -48.95 73.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 109.957 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 263' ' ' LEU . 14.9 mt -57.42 -51.81 67.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 110.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.44 -27.3 65.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.86 . . . . 0.0 110.251 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' HZ1' ' A' ' 265' ' ' LYS . 0.0 OUTLIER -71.72 -63.44 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.12 -0.987 . . . . 0.0 110.225 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.549 ' HZ2' HG13 ' A' ' 130' ' ' ILE . 3.1 pttt -71.17 -15.41 62.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -0.93 . . . . 0.0 110.473 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.496 ' C ' ' O ' ' A' ' 266' ' ' LYS . 5.6 tp-100 -34.59 -35.52 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.47 -0.769 . . . . 0.0 110.208 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 266' ' ' LYS . 7.7 mmtp -87.37 85.49 7.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.178 -0.951 . . . . 0.0 109.475 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.344 -0.847 . . . . 0.0 109.506 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.635 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 80.5 mt -100.05 152.55 20.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.268 -1.136 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.445 ' CD ' ' OG1' ' A' ' 85' ' ' THR . 13.5 mm-40 -53.94 137.01 40.14 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.07 -1.019 . . . . 0.0 108.511 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.25 143.86 48.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.442 -0.786 . . . . 0.0 110.068 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -140.87 -171.96 3.36 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.502 HG23 ' HG3' ' A' ' 30' ' ' PRO . 3.8 m -97.05 133.89 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.998 -1.064 . . . . 0.0 109.397 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -64.68 -18.02 64.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.252 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -155.99 163.99 39.03 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.287 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.73 139.36 51.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 109.754 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 113' ' ' ASN . 11.5 mt -117.45 166.85 11.85 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.1 p -140.33 142.97 35.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 110.253 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 26' ' ' LEU . 91.6 m-85 -140.11 151.07 45.04 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.2 pt-20 -157.12 150.83 24.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.893 -1.129 . . . . 0.0 110.036 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.34 175.42 36.63 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.7 p -83.08 154.47 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.318 -1.107 . . . . 0.0 110.003 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.01 140.15 15.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -59.33 -38.67 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.036 -1.273 . . . . 0.0 110.396 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.462 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.7 m-70 -89.42 -50.49 6.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.784 -1.198 . . . . 0.0 111.067 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 p -70.41 -23.08 62.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.634 -0.666 . . . . 0.0 111.758 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.2 15.55 15.57 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.181 -1.485 . . . . 0.0 109.487 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -106.63 153.44 22.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -1.132 . . . . 0.0 109.609 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 24.9 t80 -74.38 135.53 42.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.354 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.2 m -139.7 144.77 37.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.117 -0.989 . . . . 0.0 109.704 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.602 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.9 ttpp -110.95 156.23 21.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 0.0 109.528 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.658 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -135.53 147.67 48.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.42 -0.8 . . . . 0.0 109.826 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.6 mt -143.81 114.11 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 108.882 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mt -98.41 114.61 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.372 -0.83 . . . . 0.0 110.774 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 9.3 m-70 -108.49 138.13 20.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 0.0 109.586 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.502 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.2 Cg_exo -53.23 168.43 0.59 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.81 1.674 . . . . 0.0 111.65 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.497 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 58.9 mm-40 -141.22 177.54 8.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.031 -1.043 . . . . 0.0 110.28 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.457 ' O ' ' OG1' ' A' ' 35' ' ' THR . 21.0 mttt -84.48 152.44 23.96 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.692 0.758 . . . . 0.0 110.161 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -46.16 142.82 2.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.167 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 69.53 10.26 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.258 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 33.5 m -69.98 -42.43 73.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.573 -1.545 . . . . 0.0 109.798 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.33 178.95 35.58 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.351 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.42 HD13 HG22 ' A' ' 87' ' ' VAL . 41.0 mm -95.44 116.32 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 7.1 ptm180 -141.14 150.26 42.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 110.582 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.31 157.03 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -128.41 111.82 13.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.273 -0.892 . . . . 0.0 108.991 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' NZ ' ' OE1' ' A' ' 67' ' ' GLN . 44.4 tttm -134.68 132.62 39.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 110.534 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.5 m120 52.58 28.27 5.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.427 -0.795 . . . . 0.0 111.372 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.07 19.64 69.34 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 119.522 -1.323 . . . . 0.0 110.187 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.8 t -123.81 122.6 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.393 -1.063 . . . . 0.0 109.174 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.453 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 64.5 m-85 -84.73 127.19 33.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.121 -0.987 . . . . 0.0 109.729 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.9 mt -116.96 93.88 43.04 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.386 -0.822 . . . . 0.0 109.386 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.95 149.83 19.62 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.637 2.224 . . . . 0.0 112.105 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.05 68.48 9.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.732 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 3.9 mmt85 -123.08 175.69 6.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.38 -0.825 . . . . 0.0 109.276 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.558 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.8 p-80 -77.78 -51.65 10.18 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.293 -0.88 . . . . 0.0 110.28 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -43.06 -16.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 110.759 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.558 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.0 m-85 -98.11 2.96 49.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 110.295 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 50' ' ' HIS . 74.0 t -70.46 128.05 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.001 -1.062 . . . . 0.0 108.896 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -31.65 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.888 . . . . 0.0 110.131 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -151.52 132.01 13.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.733 HG21 HG21 ' A' ' 257' ' ' VAL . 41.4 p -120.88 96.02 4.94 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 59' ' ' SER . 20.6 t30 -162.65 128.9 3.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.41 -0.806 . . . . 0.0 108.916 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 83.8 m-70 52.72 5.37 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 0.0 109.02 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.549 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 165.14 155.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.19 -0.944 . . . . 0.0 109.588 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.482 ' O ' HG22 ' A' ' 72' ' ' VAL . 55.1 m -94.64 126.76 40.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.877 . . . . 0.0 109.2 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.6 OUTLIER -119.0 148.02 43.45 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.507 -0.746 . . . . 0.0 110.774 -179.158 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' CD1' HG21 ' A' ' 72' ' ' VAL . 11.0 mt -123.51 149.87 44.65 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.78 157.58 28.1 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.537 -1.316 . . . . 0.0 109.848 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CD2' ' HD3' ' A' ' 65' ' ' LYS . 8.0 t80 -166.03 143.65 5.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -1.18 . . . . 0.0 108.738 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.406 ' HD3' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 53.36 22.13 2.67 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.31 -32.04 7.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.452 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 80.4 mm-40 -59.81 148.31 34.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.97 -1.312 . . . . 0.0 109.613 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.52 138.5 30.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 110.53 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.3 mt -129.67 123.89 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 mtpp -99.93 155.95 17.41 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.966 -1.084 . . . . 0.0 111.259 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.9 m 49.96 74.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.503 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.502 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.4 m -107.59 -8.44 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 108.71 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 60' ' ' THR . 14.3 pm0 -60.86 -28.46 68.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.519 -0.738 . . . . 0.0 110.623 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.25 -68.76 0.35 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.897 -1.127 . . . . 0.0 109.642 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.59 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -51.98 -47.56 41.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 75' ' ' ILE . 85.9 mt -52.32 -47.32 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.84 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.57 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 48.5 t -61.13 -42.23 98.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.097 -1.002 . . . . 0.0 110.16 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -58.24 -43.41 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.993 -1.067 . . . . 0.0 109.133 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.4 mt -67.3 -34.99 78.54 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.159 -0.963 . . . . 0.0 109.167 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.18 -38.27 90.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.377 -0.827 . . . . 0.0 109.429 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 62.1 mt -77.59 -38.87 47.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.306 -0.871 . . . . 0.0 109.855 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 82' ' ' LEU . 68.5 mt -81.81 0.08 40.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.103 -0.998 . . . . 0.0 109.411 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 55.93 42.72 28.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.645 -0.66 . . . . 0.0 111.365 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.34 145.32 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.782 -1.198 . . . . 0.0 108.192 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.667 HG21 HG12 ' A' ' 121' ' ' ILE . 82.7 p -129.35 -25.61 2.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.138 -0.976 . . . . 0.0 111.574 -178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.712 ' O ' HG13 ' A' ' 87' ' ' VAL . 83.2 m-20 -124.26 106.87 10.62 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.867 -1.146 . . . . 0.0 110.362 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.0 m -164.36 148.49 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.415 -0.803 . . . . 0.0 110.289 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.497 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 88.8 m -115.88 109.38 17.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.475 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -91.71 100.15 10.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.352 -0.842 . . . . 0.0 109.859 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -72.17 125.89 28.42 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.498 HG22 HD21 ' A' ' 26' ' ' LEU . 92.3 t -107.94 123.55 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.707 0.765 . . . . 0.0 111.364 -178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.602 HD12 ' HB3' ' A' ' 25' ' ' LYS . 91.7 mt -110.25 96.36 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.25 -156.62 25.73 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -119.67 -11.03 9.47 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.247 -1.149 . . . . 0.0 110.041 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -141.46 149.65 41.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.977 -1.077 . . . . 0.0 109.661 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.658 HG23 HD11 ' A' ' 26' ' ' LEU . 44.3 mm -72.52 119.55 75.66 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.037 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -40.32 119.89 0.79 Allowed 'Trans proline' 0 C--N 1.317 -1.092 0 C-N-CA 121.778 1.652 . . . . 0.0 111.378 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -76.02 -13.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.142 -0.974 . . . . 0.0 110.098 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.7 mt 56.86 -118.54 1.17 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.25 -0.907 . . . . 0.0 110.257 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.409 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 1.9 t0 -95.31 6.08 49.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.121 -0.987 . . . . 0.0 110.682 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.08 -0.91 60.62 Favored Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.422 -1.37 . . . . 0.0 110.218 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.52 -172.53 2.69 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.698 -0.884 . . . . 0.0 109.627 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.92 17.23 10.06 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.546 ' CE3' HD21 ' A' ' 176' ' ' LEU . 4.3 t-105 -59.57 -43.53 93.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.456 -1.026 . . . . 0.0 110.08 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.21 -57.87 8.24 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.062 -1.024 . . . . 0.0 109.852 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -51.47 -46.69 63.21 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.207 -0.933 . . . . 0.0 109.565 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -61.37 -49.3 77.51 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.571 -0.706 . . . . 0.0 111.013 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.401 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 7.2 mm-40 -66.0 -43.83 86.6 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.969 -1.082 . . . . 0.0 111.579 -178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.01 -52.84 45.6 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.114 -0.991 . . . . 0.0 110.454 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.3 mt -65.53 -31.97 56.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.968 -1.082 . . . . 0.0 109.161 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -63.2 -42.38 99.31 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 0.0 109.732 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.61 ' C ' HD22 ' A' ' 113' ' ' ASN . 7.4 pttp -79.15 10.44 3.56 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.044 -1.062 . . . . 0.0 109.983 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.61 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -138.23 32.25 2.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 0.0 110.051 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 67.6 mt -81.55 137.47 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.852 -1.155 . . . . 0.0 110.855 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.28 118.6 21.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.566 -0.708 . . . . 0.0 109.274 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.732 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.0 OUTLIER -79.88 145.8 32.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.028 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -112.22 -170.74 1.72 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.461 -0.775 . . . . 0.0 109.506 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.46 68.97 0.69 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 110.361 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.34 128.6 2.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.152 -0.967 . . . . 0.0 109.207 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -67.28 142.51 56.84 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.0 109.506 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.667 HG12 HG21 ' A' ' 85' ' ' THR . 65.9 mt -84.39 149.33 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.856 . . . . 0.0 110.2 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.58 87.68 3.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -66.52 145.36 55.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.291 -0.881 . . . . 0.0 110.184 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -88.22 101.41 13.81 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -92.88 133.24 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 121.456 0.646 . . . . 0.0 111.027 -177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.51 112.25 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.22 -30.12 17.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.959 -1.088 . . . . 0.0 110.534 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.81 154.42 81.43 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 109.59 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.86 148.69 41.26 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.562 2.174 . . . . 0.0 112.083 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.2 tt -156.8 148.93 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -0.833 . . . . 0.0 109.124 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mt -137.27 146.23 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.172 -0.955 . . . . 0.0 109.362 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 28.8 m -132.57 148.93 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.19 161.16 35.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -0.875 . . . . 0.0 109.869 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -170.28 101.94 0.27 Allowed 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.3 -0.875 . . . . 0.0 109.731 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 48.43 58.02 5.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 0.0 110.51 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.38 -35.52 3.31 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.584 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -62.18 136.3 57.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.339 . . . . 0.0 108.778 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.4 tt -144.53 139.1 27.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.863 -1.148 . . . . 0.0 110.062 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.801 HG21 HD22 ' A' ' 259' ' ' LEU . 23.3 mt -137.85 134.02 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.415 -0.803 . . . . 0.0 109.982 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -122.23 132.64 54.53 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.455 0.645 . . . . 0.0 109.859 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.42 134.18 53.98 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.85 151.68 42.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.087 -1.008 . . . . 0.0 110.143 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -47.95 141.88 16.2 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.583 2.189 . . . . 0.0 113.727 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.408 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.11 147.62 19.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.84 -36.46 81.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.263 -0.898 . . . . 0.0 110.373 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.3 p -121.9 -169.22 1.84 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.846 . . . . 0.0 109.956 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.0 tp -98.76 123.71 43.16 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.188 -0.945 . . . . 0.0 108.67 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.455 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -136.33 128.09 29.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 31.2 t -128.3 121.41 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 109.843 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 81.7 m -110.84 151.1 28.23 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.451 -0.781 . . . . 0.0 109.07 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -139.15 130.22 26.55 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.264 -0.974 . . . . 0.0 110.812 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -120.99 131.05 54.07 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.18 140.0 11.31 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.534 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -106.22 101.12 10.62 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -89.55 167.15 13.18 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.317 -0.864 . . . . 0.0 110.935 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -99.14 -15.56 18.92 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.624 -0.672 . . . . 0.0 110.911 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.483 ' C ' ' H ' ' A' ' 159' ' ' LEU . 26.1 p-10 -96.09 -168.63 1.78 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.803 -1.185 . . . . 0.0 110.084 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -55.85 2.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.374 -0.829 . . . . 0.0 111.446 -178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.9 mt -77.61 -27.34 51.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.408 -1.433 . . . . 0.0 108.13 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.02 -143.38 29.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -101.4 135.64 42.56 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -1.123 . . . . 0.0 109.339 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -140.82 158.9 43.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.429 -0.794 . . . . 0.0 109.363 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.0 pttt -147.44 146.23 29.48 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.216 -0.927 . . . . 0.0 109.828 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -145.41 140.13 27.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.152 -0.967 . . . . 0.0 110.08 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.9 m -108.21 123.54 48.91 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 110.03 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.49 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.22 115.46 30.44 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 14.3 t -108.56 147.25 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.214 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 5.6 mm-40 -48.73 135.04 15.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.196 -0.94 . . . . 0.0 108.897 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 108.07 -10.23 36.99 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 0.6 OUTLIER -116.97 25.85 10.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -1.125 . . . . 0.0 109.15 179.369 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.5 pm0 -62.45 -15.87 52.07 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.486 ' O ' ' CD1' ' A' ' 176' ' ' LEU . 1.9 tt0 -78.28 -8.11 57.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.173 -0.954 . . . . 0.0 110.887 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' HG2' HG23 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -104.79 -5.07 21.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.993 -1.067 . . . . 0.0 111.302 -178.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.564 HG23 ' HG2' ' A' ' 173' ' ' GLU . 41.7 pt -115.65 -30.05 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.192 -0.942 . . . . 0.0 110.355 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 171' ' ' GLU . 10.3 m -60.44 -18.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.017 -1.052 . . . . 0.0 109.25 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.546 HD21 ' CE3' ' A' ' 104' ' ' TRP . 1.4 mp -93.92 0.85 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.008 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.587 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.05 117.39 11.56 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.226 -0.922 . . . . 0.0 108.774 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 87.4 mtm180 -80.29 171.72 14.7 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.143 -0.973 . . . . 0.0 109.394 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.453 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.1 t -79.04 163.02 25.49 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -148.2 144.55 27.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.269 -1.519 . . . . 0.0 111.565 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.585 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -142.4 157.73 44.47 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.511 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.5 m-85 -99.35 146.56 26.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.001 -1.062 . . . . 0.0 109.558 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.99 -35.19 23.54 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.352 -0.842 . . . . 0.0 109.647 -179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.554 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.2 p90 -74.83 -30.32 61.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.983 -1.073 . . . . 0.0 109.784 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.554 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.8 OUTLIER -73.56 -37.53 65.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.922 . . . . 0.0 109.967 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.433 ' O ' ' C ' ' A' ' 187' ' ' GLU . 84.2 mt -48.93 -55.81 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 110.037 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.433 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.3 OUTLIER -41.53 -41.73 2.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.178 -0.951 . . . . 0.0 110.062 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.612 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.6 t-160 -75.62 -47.31 27.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 109.148 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.17 -25.05 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.845 . . . . 0.0 109.566 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -85.64 -55.19 4.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.874 -1.141 . . . . 0.0 109.335 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -48.63 -41.74 32.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 188' ' ' HIS . 33.4 m -76.38 7.97 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.062 -1.024 . . . . 0.0 110.462 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.34 39.71 61.48 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.212 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 194' ' ' LEU . 51.3 mt -128.33 171.96 11.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -1.115 . . . . 0.0 109.372 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.401 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 59.16 21.98 54.57 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -59.99 -21.16 60.92 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.476 -1.603 . . . . 0.0 108.945 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.434 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -108.6 25.62 18.82 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -90.3 125.41 7.89 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.411 ' O ' ' N ' ' A' ' 203' ' ' THR . 35.7 m -143.94 165.56 27.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.306 -1.114 . . . . 0.0 109.582 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.481 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 27.8 mt -66.51 -8.68 28.19 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.409 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 17.7 ttpt -95.08 -17.2 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.444 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 15.8 p30 -132.24 8.75 4.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.438 -0.789 . . . . 0.0 109.966 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.64 149.48 31.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.976 -1.077 . . . . 0.0 110.405 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.59 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.8 tp -100.61 93.45 5.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 203' ' ' THR . 44.2 t -85.43 131.3 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.828 0.823 . . . . 0.0 108.914 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.471 ' CD2' HG13 ' A' ' 211' ' ' VAL . 60.2 mt -123.25 161.7 24.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.556 -0.715 . . . . 0.0 109.464 -178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.82 -166.23 12.61 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -64.67 -29.55 70.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 110.051 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -152.28 24.23 0.63 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.102 -0.999 . . . . 0.0 111.208 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -150.93 159.3 44.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.309 -1.494 . . . . 0.0 110.839 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.471 HG13 ' CD2' ' A' ' 206' ' ' LEU . 43.1 t -104.36 111.86 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -54.83 -48.32 72.98 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.991 -1.068 . . . . 0.0 109.444 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.43 112.22 5.21 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 110.093 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -57.96 -19.84 41.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.823 1.682 . . . . 0.0 112.69 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.53 -15.49 61.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.029 -1.044 . . . . 0.0 110.056 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.67 -175.58 46.8 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.59 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.2 mt -84.84 144.26 28.54 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.279 -1.13 . . . . 0.0 109.809 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -76.15 -18.06 59.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.893 . . . . 0.0 108.759 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -136.84 -170.26 2.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.388 -0.82 . . . . 0.0 109.191 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.73 -7.33 37.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 109.114 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.68 48.84 1.08 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.246 -0.909 . . . . 0.0 109.612 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.553 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.9 tt0 -53.95 -45.47 98.94 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.321 -0.862 . . . . 0.0 110.548 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.2 Cg_exo -54.62 -55.7 3.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.329 2.019 . . . . 0.0 112.876 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 228' ' ' VAL . 17.2 m -68.31 -39.73 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 120.883 -1.135 . . . . 0.0 111.749 -178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 225' ' ' ARG . 0.8 OUTLIER -68.89 -32.24 71.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.238 -1.539 . . . . 0.0 108.526 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.587 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 21.8 t60 -66.47 -35.46 80.32 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 27.0 mmtt -64.41 -35.04 79.63 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.49 HG11 ' HB3' ' A' ' 166' ' ' PHE . 79.2 t -66.94 -35.67 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 52.6 t80 -68.21 -52.24 36.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -62.76 -30.8 71.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -0.816 . . . . 0.0 109.642 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 58.3 tp -76.62 -32.44 58.04 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.135 -0.978 . . . . 0.0 108.755 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.0 mt -67.78 -37.35 78.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.82 -55.96 10.25 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.555 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -54.36 -35.99 63.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.237 . . . . 0.0 108.936 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.0 mt -60.08 -23.13 63.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.474 -0.766 . . . . 0.0 110.03 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.582 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.8 -21.77 61.66 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.043 -1.036 . . . . 0.0 108.659 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 60' ' ' THR . 79.6 mt -49.87 -4.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.641 -1.287 . . . . 0.0 110.329 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -76.88 -17.25 59.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.974 -1.078 . . . . 0.0 109.861 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.481 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 100.23 2.17 55.78 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.943 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.47 153.91 10.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 120.786 -1.42 . . . . 0.0 109.214 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.91 128.54 30.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.013 1.809 . . . . 0.0 110.035 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 26.0 t -86.95 152.01 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.039 -1.038 . . . . 0.0 112.217 -177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -135.79 127.67 29.39 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 151.76 -158.37 27.73 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.486 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.4 ttmt -127.29 140.73 52.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.325 -1.103 . . . . 0.0 109.137 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.4 m-85 -138.91 140.69 38.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.059 -1.025 . . . . 0.0 110.394 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -124.3 132.58 53.57 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 12.3 t -129.59 136.1 49.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.062 . . . . 0.0 111.154 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.435 ' O ' ' C ' ' A' ' 250' ' ' ARG . 39.3 t80 -117.33 116.81 27.96 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 249' ' ' PHE . 1.1 mtt-85 45.03 48.16 9.53 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.055 -1.028 . . . . 0.0 108.516 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -81.29 143.94 24.23 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -124.33 160.96 18.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.404 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 76.6 m-70 -46.4 -36.34 6.39 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.126 -1.22 . . . . 0.0 109.492 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.22 -58.11 9.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.17 -0.956 . . . . 0.0 108.986 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.563 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.5 tp -59.14 -44.21 92.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.95 . . . . 0.0 109.239 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.3 m-20 -47.63 -54.31 12.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 109.555 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.733 HG21 HG21 ' A' ' 56' ' ' THR . 74.9 t -61.0 -56.84 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.335 -0.853 . . . . 0.0 109.424 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.533 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -44.53 -49.68 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.96 . . . . 0.0 108.93 179.741 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.801 HD22 HG21 ' A' ' 139' ' ' ILE . 24.5 tp -54.09 -61.59 2.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.896 -1.128 . . . . 0.0 108.605 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 238' ' ' LEU . 23.8 t -47.2 -54.69 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 109.312 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -47.2 -52.83 14.68 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.345 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -59.1 -49.92 76.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.916 . . . . 0.0 109.782 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 16.0 mt -53.15 -52.86 57.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.335 -0.853 . . . . 0.0 110.075 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.59 66.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.221 -0.924 . . . . 0.0 110.252 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -76.34 -42.38 45.11 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.152 -0.967 . . . . 0.0 110.6 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 268' ' ' LYS . 3.2 pptp? -87.28 -19.64 27.99 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.134 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -73.84 30.83 0.08 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 109.382 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.496 ' H ' ' C ' ' A' ' 266' ' ' LYS . 11.9 ptmt -177.76 48.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.622 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.892 . . . . 0.0 109.441 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.585 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -96.68 154.94 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -1.111 . . . . 0.0 109.401 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 76.1 mt-10 -57.55 138.62 55.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.296 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.53 145.39 48.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.487 -0.758 . . . . 0.0 109.541 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.7 t -141.37 -173.95 3.89 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.9 m -96.19 135.69 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.065 . . . . 0.0 109.212 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.1 ptmt -66.49 -23.0 66.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.526 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.482 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 9.9 pt-20 -150.83 156.08 40.53 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.288 -0.882 . . . . 0.0 109.463 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 142.09 58.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.859 . . . . 0.0 110.249 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 90.4 mt -119.73 163.35 17.57 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.0 p -134.55 142.0 46.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.0 110.183 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 26' ' ' LEU . 96.8 m-85 -139.21 146.32 40.35 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -153.06 150.63 29.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.961 -1.087 . . . . 0.0 110.354 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.16 174.79 36.65 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 17' ' ' GLY . 7.5 p -84.06 154.48 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -1.142 . . . . 0.0 110.254 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.411 ' N ' HG22 ' A' ' 16' ' ' VAL . . . -88.81 139.94 15.62 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.2 tt -60.82 -37.0 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.215 -1.168 . . . . 0.0 110.558 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.579 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 78.0 m-70 -89.58 -51.72 5.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.631 -1.293 . . . . 0.0 111.396 -178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.2 p -70.0 -23.25 63.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.701 -0.624 . . . . 0.0 111.653 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.78 20.14 46.34 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.182 -1.485 . . . . 0.0 109.6 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -111.83 154.03 25.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.299 -1.118 . . . . 0.0 109.563 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -74.24 135.59 42.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.358 -0.839 . . . . 0.0 109.169 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 74.3 m -139.37 144.52 38.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.03 . . . . 0.0 109.845 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -111.96 155.7 23.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.448 -0.782 . . . . 0.0 109.668 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.667 HD11 HG23 ' A' ' 96' ' ' ILE . 8.6 mt -135.74 148.26 48.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.875 . . . . 0.0 110.064 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.58 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.9 mt -143.58 112.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.27 -0.894 . . . . 0.0 108.928 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 mt -96.86 114.91 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.42 -0.8 . . . . 0.0 110.876 -178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.58 ' NE2' HG22 ' A' ' 27' ' ' ILE . 16.3 m-70 -107.83 139.17 20.36 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.415 -0.803 . . . . 0.0 109.532 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 26.8 Cg_exo -52.82 168.23 0.51 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.849 1.699 . . . . 0.0 111.822 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.466 ' OE1' HG21 ' A' ' 35' ' ' THR . 20.1 mm-40 -142.23 174.74 10.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.171 -0.956 . . . . 0.0 109.541 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -85.91 155.11 21.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.764 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -49.62 146.95 3.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 109.961 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.426 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 71.03 -0.54 29.72 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 120.392 -0.909 . . . . 0.0 110.978 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 67.8 m -65.43 -42.39 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.556 -1.555 . . . . 0.0 109.481 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.787 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 93.6 -177.36 37.39 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.6 mm -99.52 115.31 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -137.5 151.5 48.51 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.993 -1.067 . . . . 0.0 110.498 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.17 157.57 16.48 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -129.99 110.69 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.853 . . . . 0.0 108.995 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -134.69 133.81 40.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 110.596 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 48.38 34.31 4.59 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.59 -0.694 . . . . 0.0 111.59 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.05 17.04 80.26 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.472 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.9 t -121.89 120.96 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.322 -1.105 . . . . 0.0 108.836 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 39.8 m-85 -86.84 129.14 35.0 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.187 -0.946 . . . . 0.0 109.734 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.9 mt -118.43 96.97 50.48 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.647 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.25 146.43 31.61 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.229 1.953 . . . . 0.0 111.623 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -78.97 70.28 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.982 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' CG ' HH11 ' A' ' 49' ' ' ARG . 6.7 mtt-85 -127.22 171.55 11.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 0.0 109.003 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.591 ' CD2' ' OE1' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -73.25 -49.17 29.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.591 ' OE1' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mp0 -43.53 -17.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.023 -1.048 . . . . 0.0 110.889 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 50' ' ' HIS . 50.4 m-85 -97.89 2.96 49.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.768 -1.208 . . . . 0.0 109.938 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG23 ' HA ' ' A' ' 50' ' ' HIS . 66.9 t -74.06 129.07 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.372 -0.83 . . . . 0.0 108.781 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.4 m -111.74 -25.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.283 -0.885 . . . . 0.0 110.281 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 1.1 t-80 -150.37 130.02 13.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.028 -1.045 . . . . 0.0 109.692 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.734 HG21 HG21 ' A' ' 257' ' ' VAL . 34.3 p -123.79 96.04 4.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.559 -0.713 . . . . 0.0 109.135 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.1 t-20 -158.42 128.49 5.97 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.5 m-70 46.54 13.12 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.103 -0.998 . . . . 0.0 108.882 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.89 152.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.38 -0.825 . . . . 0.0 109.796 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 58.8 m -96.24 128.16 42.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.301 -0.874 . . . . 0.0 109.233 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 55' ' ' HIS . 0.9 OUTLIER -120.28 148.67 43.42 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.652 0.739 . . . . 0.0 110.878 -178.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.483 HD11 HG21 ' A' ' 72' ' ' VAL . 10.8 mt -125.54 146.81 49.51 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.84 151.12 22.06 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.01 -1.567 . . . . 0.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -160.0 148.89 17.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.532 -0.981 . . . . 0.0 109.145 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.09 26.39 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.858 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.53 -32.5 6.69 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.539 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -57.38 140.25 50.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 0.0 109.149 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 134.09 40.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.341 -0.849 . . . . 0.0 110.305 -179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 mt -128.53 120.36 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -100.94 157.11 16.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.026 -1.046 . . . . 0.0 111.119 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 26.0 m 48.97 75.32 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.639 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.483 HG21 HD11 ' A' ' 62' ' ' LEU . 22.7 m -107.72 -10.56 10.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.17 -0.956 . . . . 0.0 109.318 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.463 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.0 pm0 -60.79 -24.3 65.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.431 -0.793 . . . . 0.0 110.556 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.414 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -68.68 -68.87 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.126 -0.984 . . . . 0.0 109.232 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.1 tp -52.1 -48.11 42.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.108 -0.995 . . . . 0.0 109.083 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.665 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.7 mt -52.79 -46.92 67.84 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.531 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 22.5 t -61.91 -43.24 99.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.2 -0.938 . . . . 0.0 110.432 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.2 t -56.82 -46.76 83.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.021 -1.05 . . . . 0.0 109.071 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.3 mt -65.39 -34.42 78.26 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.306 -0.871 . . . . 0.0 109.095 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -63.29 -34.78 78.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.358 -0.839 . . . . 0.0 109.631 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.741 HD13 ' HB3' ' A' ' 171' ' ' GLU . 59.3 mt -81.6 -38.82 25.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.0 110.289 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 82' ' ' LEU . 63.7 mt -81.13 -0.39 39.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 0.0 110.005 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 61.53 39.84 14.35 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.508 -0.745 . . . . 0.0 111.383 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.7 mm -85.81 138.72 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.698 -1.251 . . . . 0.0 108.026 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.6 p -123.73 -24.1 4.57 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.142 -0.974 . . . . 0.0 111.792 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.787 HD22 ' H ' ' A' ' 36' ' ' GLY . 27.7 m120 -123.84 107.18 11.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.917 -1.115 . . . . 0.0 110.486 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.708 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -164.35 148.17 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.367 -0.833 . . . . 0.0 110.468 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.436 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 99.3 m -115.54 113.04 23.1 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.481 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -95.36 100.21 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 110.184 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' O ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -73.6 126.73 30.95 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 t -111.54 128.21 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.98 0.895 . . . . 0.0 111.895 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -114.81 95.6 3.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 145.11 -159.78 27.94 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.17 -11.3 10.15 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.313 -1.11 . . . . 0.0 110.071 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -141.25 149.88 41.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.995 -1.066 . . . . 0.0 109.535 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.667 HG23 HD11 ' A' ' 26' ' ' LEU . 43.9 mm -72.96 120.93 83.56 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -40.51 120.45 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 C-N-CA 121.782 1.655 . . . . 0.0 111.532 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.444 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.8 tp -76.62 -14.21 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.24 -0.913 . . . . 0.0 110.476 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.9 mt 56.84 -118.43 1.16 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.156 -0.965 . . . . 0.0 110.029 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.86 6.75 47.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.033 -1.042 . . . . 0.0 110.784 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.51 0.23 59.48 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.7 p -128.76 -172.25 2.67 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.666 -0.902 . . . . 0.0 109.574 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.3 15.2 9.34 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' C ' ' A' ' 104' ' ' TRP . 2.7 t-105 -57.59 -42.44 83.2 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.272 -1.134 . . . . 0.0 110.168 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -65.11 -57.2 9.2 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 110.122 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -51.42 -46.33 62.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.208 -0.932 . . . . 0.0 109.225 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -61.09 -54.08 49.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 0.0 110.821 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 2.9 mm-40 -60.44 -43.76 96.48 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.068 -1.02 . . . . 0.0 111.53 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.67 -56.91 8.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.95 -1.094 . . . . 0.0 110.252 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.6 mt -61.73 -32.83 55.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.158 -0.963 . . . . 0.0 109.383 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.411 ' CG ' HH11 ' A' ' 111' ' ' ARG . 0.5 OUTLIER -64.18 -42.72 96.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.359 -0.838 . . . . 0.0 109.719 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -76.6 13.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 0.0 110.041 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.482 ' OD1' ' OE2' ' A' ' 9' ' ' GLU . 15.7 m-80 -144.58 33.72 1.16 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.929 -1.107 . . . . 0.0 110.336 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.421 HD11 HD22 ' A' ' 82' ' ' LEU . 66.2 mt -79.81 138.61 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.029 -1.044 . . . . 0.0 110.429 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.28 123.35 29.86 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.23 148.3 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.18 -0.95 . . . . 0.0 110.452 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.62 -171.82 2.04 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -111.67 69.0 0.68 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.2 ttm180 -165.32 130.92 2.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.003 -1.061 . . . . 0.0 109.691 179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -69.53 144.46 53.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.097 -1.002 . . . . 0.0 109.528 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 73.5 mt -87.16 149.37 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.568 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -93.09 78.17 4.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.416 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 30.4 m-85 -58.1 140.67 52.21 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.336 -0.853 . . . . 0.0 109.409 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -88.87 101.44 14.05 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.493 HG22 ' HB2' ' A' ' 243' ' ' LYS . 41.0 t -92.68 134.3 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.528 0.68 . . . . 0.0 110.772 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.52 116.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.42 -27.01 16.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 110.323 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.528 ' N ' ' CD ' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -130.74 149.76 74.53 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.345 -0.847 . . . . 0.0 109.585 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.15 150.0 41.91 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.589 2.192 . . . . 0.0 112.017 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.803 HD12 ' HZ1' ' A' ' 266' ' ' LYS . 1.4 tt -157.37 151.01 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.224 -0.923 . . . . 0.0 109.232 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 142.61 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.373 -0.83 . . . . 0.0 109.513 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 m -123.93 145.43 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -133.25 156.72 47.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.096 -1.002 . . . . 0.0 110.459 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -166.04 98.91 0.64 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.533 -0.73 . . . . 0.0 109.485 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 46.02 65.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -0.82 . . . . 0.0 110.848 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.2 -38.02 3.0 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.777 -1.201 . . . . 0.0 110.89 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 42.9 mtt85 -65.44 133.67 51.8 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.862 -1.375 . . . . 0.0 108.873 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.734 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.7 tt -146.58 138.92 24.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.053 -1.029 . . . . 0.0 109.973 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.532 HG13 HD23 ' A' ' 255' ' ' LEU . 69.2 mt -135.57 125.87 42.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.458 -0.776 . . . . 0.0 109.523 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -114.3 133.44 55.66 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.532 0.682 . . . . 0.0 110.419 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.29 133.61 54.68 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.08 151.56 48.89 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.001 -1.062 . . . . 0.0 109.787 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -50.14 143.23 25.94 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.382 2.055 . . . . 0.0 113.392 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -156.41 145.78 20.67 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -68.61 -5.01 17.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.389 -0.819 . . . . 0.0 110.488 -179.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.2 p -148.45 -175.24 4.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.99 -1.069 . . . . 0.0 109.605 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.2 tp -98.32 120.06 38.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.084 -1.01 . . . . 0.0 108.702 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.404 ' N ' HD12 ' A' ' 147' ' ' LEU . 38.4 tt0 -137.27 122.84 19.72 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.06 -1.025 . . . . 0.0 108.553 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.412 ' CG1' HD23 ' A' ' 231' ' ' LEU . 76.7 t -122.37 122.58 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.553 -0.717 . . . . 0.0 109.723 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.6 m -113.52 152.22 30.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.623 -0.673 . . . . 0.0 109.535 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -139.64 130.47 26.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.964 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -120.56 129.95 54.01 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.53 141.2 12.52 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.266 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -105.64 104.11 13.77 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -93.65 166.95 11.98 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.01 -14.89 17.66 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.734 . . . . 0.0 110.485 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 159' ' ' LEU . 29.9 p-10 -93.96 -171.38 2.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.869 -1.144 . . . . 0.0 110.265 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -52.91 3.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.449 -0.782 . . . . 0.0 111.704 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.525 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.9 mt -83.35 -29.36 28.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.321 -1.487 . . . . 0.0 109.06 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.43 -140.67 36.25 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.251 -1.54 . . . . 0.0 109.251 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.8 134.41 38.78 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -1.145 . . . . 0.0 109.491 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.03 148.72 45.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.429 -0.795 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -141.26 145.05 35.06 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.934 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -144.63 139.34 27.98 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.284 -0.885 . . . . 0.0 109.954 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 35.7 m -109.78 124.63 51.61 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.427 -0.795 . . . . 0.0 110.156 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.537 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.5 t80 -104.08 113.07 26.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.273 -0.892 . . . . 0.0 109.961 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.53 156.63 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 110.129 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -50.86 133.12 26.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.397 -0.814 . . . . 0.0 109.266 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.83 3.76 60.62 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 170' ' ' ASN . 3.4 m-20 -117.53 20.25 13.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -1.218 . . . . 0.0 109.153 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.741 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -55.89 -56.57 18.99 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.291 -0.881 . . . . 0.0 110.017 -179.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 171' ' ' GLU . 1.8 mt-10 -42.52 -25.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.784 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.545 ' O ' ' CZ ' ' A' ' 225' ' ' ARG . 12.5 mt-10 -80.74 -7.85 59.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.159 -0.963 . . . . 0.0 111.924 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 19.1 pt -130.74 -25.4 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.663 -1.273 . . . . 0.0 111.817 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 175' ' ' VAL . 4.5 m -62.77 -15.88 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.456 -1.403 . . . . 0.0 109.175 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.4 mt -92.27 -6.43 50.42 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.46 -0.775 . . . . 0.0 109.285 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.448 ' O ' ' ND1' ' A' ' 226' ' ' HIS . . . -67.43 116.19 7.9 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.173 -0.954 . . . . 0.0 108.847 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.507 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 74.5 mtm180 -77.57 172.84 12.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.32 -0.863 . . . . 0.0 109.516 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.4 t -77.25 162.28 27.47 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -146.81 149.07 32.6 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.21 -1.556 . . . . 0.0 111.493 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -148.18 157.06 43.28 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -98.97 146.97 25.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.537 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.441 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.11 -38.11 16.93 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.488 -0.757 . . . . 0.0 109.86 -179.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.522 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -72.29 -28.9 63.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.827 -1.171 . . . . 0.0 109.605 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.522 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.0 mt-10 -71.93 -39.9 69.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.638 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.49 HD13 HB11 ' A' ' 500' ' ' C90 . 25.6 mt -47.37 -59.63 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.161 -0.962 . . . . 0.0 109.553 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 7.7 tp10 -41.81 -40.02 1.94 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.37 -0.831 . . . . 0.0 109.514 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 189' ' ' ILE . 13.3 t-160 -75.28 -60.89 2.1 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.27 -0.894 . . . . 0.0 108.887 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 188' ' ' HIS . 93.7 mt -41.85 -32.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.422 -0.799 . . . . 0.0 109.625 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 12.6 mmtt -80.13 -52.07 8.22 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.764 -1.21 . . . . 0.0 109.193 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -48.17 -40.05 22.71 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.351 -0.843 . . . . 0.0 110.518 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.0 m -81.0 8.9 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.043 -1.036 . . . . 0.0 110.522 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.74 39.65 54.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 194' ' ' LEU . 69.3 mt -129.64 172.81 11.21 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.311 -1.111 . . . . 0.0 109.874 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.65 20.57 56.61 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -57.56 -20.55 32.94 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.365 -1.668 . . . . 0.0 109.878 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.431 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.55 25.18 11.33 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.22 129.38 9.64 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 120.99 -1.3 . . . . 0.0 110.07 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -143.88 172.75 12.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.381 -1.07 . . . . 0.0 109.892 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 66.9 mt -71.26 -7.8 49.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -99.35 -11.54 21.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.682 -0.636 . . . . 0.0 109.654 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.442 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 17.0 p30 -133.53 8.49 3.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.152 -0.968 . . . . 0.0 109.999 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.432 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.1 m -150.28 151.52 33.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.617 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.0 tp -99.5 93.93 6.14 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 52.9 t -85.34 128.96 38.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.832 0.825 . . . . 0.0 109.119 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.621 HD23 HG13 ' A' ' 211' ' ' VAL . 15.6 mt -123.53 162.81 22.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.615 -0.678 . . . . 0.0 109.289 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.33 -166.73 13.03 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.5 -30.77 71.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.491 -1.005 . . . . 0.0 109.458 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -149.83 21.66 0.89 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 110.732 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mttp -147.58 155.88 42.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.64 -1.287 . . . . 0.0 110.355 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.621 HG13 HD23 ' A' ' 206' ' ' LEU . 51.3 t -105.82 114.56 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -57.97 -47.02 84.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.046 -1.034 . . . . 0.0 109.904 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -59.86 121.83 61.12 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.139 -0.976 . . . . 0.0 109.768 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.87 -16.22 45.29 Favored 'Trans proline' 0 N--CA 1.488 1.165 0 C-N-CA 121.437 1.424 . . . . 0.0 111.794 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.38 -15.12 59.54 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.307 -0.957 . . . . 0.0 108.63 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.47 -170.32 50.8 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.617 ' CD2' HD11 ' A' ' 204' ' ' LEU . 6.3 mt -86.78 131.12 34.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.137 -1.213 . . . . 0.0 109.668 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.2 mtp85 -63.15 -17.78 62.74 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.395 -0.815 . . . . 0.0 109.122 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CD2' ' CZ ' ' A' ' 225' ' ' ARG . 62.3 m-85 -144.73 -168.88 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.43 -0.794 . . . . 0.0 109.352 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -100.65 -0.24 37.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.247 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.8 30.49 1.08 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.034 -1.041 . . . . 0.0 109.397 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 mt-10 -46.26 -51.17 35.35 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.026 -1.047 . . . . 0.0 110.013 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 76.4 Cg_exo -47.4 -68.01 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.118 1.878 . . . . 0.0 112.278 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.4 m -57.33 -34.84 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.963 -1.086 . . . . 0.0 109.991 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' CZ ' ' CD2' ' A' ' 219' ' ' TYR . 5.0 mtp180 -60.53 -42.85 97.32 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.072 -1.018 . . . . 0.0 108.381 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.507 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 6.9 t60 -65.78 -33.02 74.9 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.88 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -64.98 -36.61 84.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 166' ' ' PHE . 51.9 t -69.75 -36.77 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.531 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 69.4 t80 -65.98 -48.82 69.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.562 -0.711 . . . . 0.0 109.147 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.551 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 86.6 m-20 -65.0 -31.93 73.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.804 . . . . 0.0 109.776 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.412 HD23 ' CG1' ' A' ' 149' ' ' VAL . 52.5 tp -75.02 -31.77 61.43 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.061 -1.024 . . . . 0.0 108.816 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.0 mt -67.84 -39.37 81.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.95 -54.79 19.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.36 -35.62 67.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.055 -1.262 . . . . 0.0 109.279 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 235' ' ' LEU . 12.1 mt -61.11 -22.79 64.98 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.563 -0.711 . . . . 0.0 110.414 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.564 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.8 -22.28 60.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.164 . . . . 0.0 109.078 -179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.9 mt -50.93 -2.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.639 -1.288 . . . . 0.0 110.6 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.2 mt -77.46 -14.85 59.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.831 -1.168 . . . . 0.0 109.643 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.56 1.78 57.67 Favored Glycine 0 N--CA 1.492 2.413 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.563 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.16 155.07 10.23 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.864 -1.374 . . . . 0.0 108.937 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.1 Cg_endo -50.02 151.02 9.25 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.825 1.684 . . . . 0.0 109.566 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 84.5 t -106.43 140.53 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.986 -1.071 . . . . 0.0 112.044 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.493 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.3 mmtp -121.86 119.12 30.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.9 -163.56 30.95 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.142 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.514 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -123.77 141.64 51.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.445 -1.032 . . . . 0.0 109.078 -179.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.3 m-85 -139.6 139.64 36.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.157 -0.964 . . . . 0.0 110.081 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -127.02 118.38 24.35 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 133.83 53.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.005 -1.059 . . . . 0.0 110.676 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -115.47 112.16 21.84 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.36 28.68 2.44 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.175 -0.953 . . . . 0.0 109.48 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.61 149.13 42.99 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.469 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -121.78 -174.2 14.65 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.463 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.2 m-70 -63.74 -41.38 98.05 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.341 -1.094 . . . . 0.0 109.741 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -54.47 -58.63 6.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 0.0 109.032 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.532 HD23 HG13 ' A' ' 139' ' ' ILE . 5.7 tp -55.29 -45.07 76.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 109.202 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 22.2 m-20 -47.73 -51.56 21.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.989 -1.069 . . . . 0.0 109.432 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.734 HG21 HG21 ' A' ' 56' ' ' THR . 90.8 t -63.18 -42.27 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.407 -0.808 . . . . 0.0 109.744 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -61.41 -52.86 62.81 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.05 -1.031 . . . . 0.0 109.264 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 22.4 tp -50.34 -49.63 53.45 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.091 -1.006 . . . . 0.0 108.423 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.54 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.1 t -58.03 -52.18 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.875 . . . . 0.0 108.861 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -50.76 -49.52 57.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.582 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -61.54 -51.24 69.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.791 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.2 mt -55.98 -48.45 75.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -0.96 . . . . 0.0 109.738 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.85 -31.34 71.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.464 -0.773 . . . . 0.0 109.801 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 268' ' ' LYS . 0.1 OUTLIER -67.35 -40.26 85.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.185 -0.947 . . . . 0.0 108.954 179.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.803 ' HZ1' HD12 ' A' ' 130' ' ' ILE . 0.1 OUTLIER -67.79 -66.21 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.449 -0.782 . . . . 0.0 109.028 179.487 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -42.93 -46.27 5.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.403 -0.811 . . . . 0.0 109.507 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 265' ' ' LYS . 10.4 mmmt -94.07 110.83 22.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.147 -0.97 . . . . 0.0 109.529 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.932 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.551 ' C22' ' OD2' ' A' ' 230' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.473 ' O ' HD11 ' A' ' 121' ' ' ILE . 84.2 mt -101.67 153.81 19.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.312 -1.11 . . . . 0.0 109.578 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.596 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -53.18 129.02 29.92 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.432 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -120.91 142.07 50.05 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.182 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.7 t -141.94 -170.57 3.17 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -98.66 136.45 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 109.229 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -62.85 -20.48 65.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -152.15 -171.12 3.84 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.267 -0.896 . . . . 0.0 109.222 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.54 142.14 28.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.224 -0.922 . . . . 0.0 109.488 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -121.09 160.23 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.14 145.2 41.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.996 -1.065 . . . . 0.0 110.698 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.456 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 73.3 m-85 -139.83 155.09 47.43 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -160.05 151.69 19.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.809 -1.182 . . . . 0.0 110.319 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.43 174.77 36.1 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.85 151.67 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -1.123 . . . . 0.0 110.128 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.63 137.98 16.38 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 19' ' ' HIS . 12.0 tt -58.95 -39.06 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.105 -1.232 . . . . 0.0 110.452 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.44 ' N ' HG23 ' A' ' 18' ' ' ILE . 79.8 m-70 -90.74 -50.65 5.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.724 -1.235 . . . . 0.0 110.966 -178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 p -70.31 -22.68 62.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.68 -0.638 . . . . 0.0 111.091 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.75 17.48 21.22 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.378 -1.391 . . . . 0.0 109.686 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -105.26 151.25 24.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.243 -1.151 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -74.77 132.87 41.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 109.177 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.9 m -138.73 145.31 40.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.093 -1.004 . . . . 0.0 109.763 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' CG ' ' N ' ' A' ' 26' ' ' LEU . 5.7 ttmt -113.02 156.42 23.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.342 -0.849 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 96' ' ' ILE . 8.0 mt -133.4 147.01 51.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.594 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.2 mt -141.38 108.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.917 . . . . 0.0 108.738 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.25 115.44 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 111.122 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.594 ' NE2' HG22 ' A' ' 27' ' ' ILE . 33.3 m-70 -111.12 139.81 22.2 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.578 -0.701 . . . . 0.0 109.689 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -52.57 168.33 0.46 Allowed 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 122.048 1.832 . . . . 0.0 111.854 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 16.4 mm-40 -141.02 -178.97 5.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.162 -0.961 . . . . 0.0 109.798 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.6 mttm -89.45 154.4 20.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 0.0 110.331 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -47.62 142.46 4.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.329 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.11 11.22 63.44 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.466 -0.874 . . . . 0.0 110.949 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.499 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 22.9 m -72.02 -44.87 62.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.605 -1.526 . . . . 0.0 109.752 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -179.88 33.77 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.379 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.5 mm -95.67 117.97 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.03 148.24 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.498 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -99.86 158.87 15.5 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.1 t80 -129.9 110.58 11.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.158 -0.964 . . . . 0.0 108.874 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.536 ' NZ ' ' H ' ' A' ' 93' ' ' GLY . 64.6 tttp -135.06 134.6 40.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.415 -0.803 . . . . 0.0 110.737 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 54.05 29.52 10.36 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.446 -0.784 . . . . 0.0 111.341 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.56 17.27 77.94 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.355 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 10.0 t -124.21 124.63 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.286 -1.126 . . . . 0.0 109.339 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -83.66 127.36 33.71 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 51.0 mt -115.48 93.81 37.76 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.808 . . . . 0.0 109.436 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -49.55 145.8 16.07 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.412 2.075 . . . . 0.0 111.948 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -89.38 79.76 6.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.185 -0.947 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -134.18 -179.89 5.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 0.0 109.414 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' PHE . 13.9 p-80 -74.99 -55.25 5.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.182 -0.949 . . . . 0.0 110.01 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 33.4 mt-10 -43.55 -17.0 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.795 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' HIS . 35.5 m-85 -95.17 0.62 54.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.884 -1.135 . . . . 0.0 110.104 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.427 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.8 t -68.48 129.46 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.415 -0.803 . . . . 0.0 109.173 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.5 m -112.38 -29.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.322 -0.861 . . . . 0.0 109.977 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -152.26 132.98 14.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.114 -0.991 . . . . 0.0 110.036 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 HG21 ' A' ' 257' ' ' VAL . 47.8 p -123.65 95.46 4.59 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 59' ' ' SER . 47.7 t-20 -162.95 129.21 3.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 108.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 84.6 m-70 48.97 10.52 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.056 -1.027 . . . . 0.0 108.711 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.571 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.9 OUTLIER 163.0 157.56 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.63 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.9 m -102.86 127.76 49.91 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 109.245 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -121.33 152.37 39.05 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 111.024 -179.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.9 mt -128.14 152.18 48.33 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.31 151.86 21.96 Favored Glycine 0 N--CA 1.496 2.692 0 C-N-CA 118.824 -1.655 . . . . 0.0 110.956 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.423 ' CD2' ' CD ' ' A' ' 65' ' ' LYS . 9.4 t80 -156.51 146.29 20.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.449 -1.03 . . . . 0.0 109.676 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.423 ' CD ' ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 54.73 21.79 3.74 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.528 -0.732 . . . . 0.0 109.638 179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.85 -31.88 8.17 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -62.96 145.24 55.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.959 -1.318 . . . . 0.0 109.343 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -140.91 142.86 34.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 110.333 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 76.6 mt -130.13 125.94 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -100.21 156.67 17.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.97 -1.081 . . . . 0.0 111.217 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m 49.27 73.74 0.22 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.071 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 34.4 m -107.78 -8.46 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 0.0 108.957 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.4 pm0 -61.02 -26.66 67.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.599 -0.688 . . . . 0.0 110.539 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.1 m170 -68.07 -68.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.941 -1.099 . . . . 0.0 109.46 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.554 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -52.14 -47.07 44.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.605 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.2 mt -53.4 -48.33 68.77 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 110.09 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.461 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.6 t -59.66 -41.99 91.84 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.058 -1.026 . . . . 0.0 110.244 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -58.8 -44.02 89.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.074 -1.016 . . . . 0.0 109.168 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -66.29 -34.92 79.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.187 -0.946 . . . . 0.0 109.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -62.91 -38.88 92.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.26 -0.9 . . . . 0.0 109.222 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' A' ' 171' ' ' GLU . 50.2 mt -75.72 -38.07 58.86 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.33 -0.856 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 114' ' ' ILE . 80.7 mt -83.22 -1.46 53.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.134 -0.978 . . . . 0.0 109.891 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' OE1' ' OH ' ' A' ' 123' ' ' TYR . 41.5 mt-10 55.75 42.24 29.43 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.385 -0.822 . . . . 0.0 111.121 178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.405 HD13 ' HB3' ' A' ' 5' ' ' LYS . 46.0 mm -84.87 141.35 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.946 -1.096 . . . . 0.0 108.096 178.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.416 HG21 HG12 ' A' ' 121' ' ' ILE . 72.5 p -123.79 -23.71 4.63 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.057 -1.027 . . . . 0.0 112.027 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.675 ' O ' HG13 ' A' ' 87' ' ' VAL . 80.4 m-20 -125.98 107.66 10.66 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.698 -1.251 . . . . 0.0 110.688 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.5 m -162.95 149.14 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.829 0.824 . . . . 0.0 110.442 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.473 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 45.2 m -116.71 113.77 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.497 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.7 mt -96.65 100.92 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 110.467 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.506 ' O ' HD23 ' A' ' 26' ' ' LEU . 11.7 mt-10 -70.24 124.57 24.46 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 44.2 t -107.96 119.0 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 CA-C-O 121.587 0.708 . . . . 0.0 111.507 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.0 mt -108.85 93.38 2.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.536 ' H ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.63 160.52 8.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -81.05 -5.55 57.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.914 -1.345 . . . . 0.0 111.091 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.6 tt0 -142.06 149.11 39.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.602 -1.311 . . . . 0.0 110.276 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.62 HG23 HD11 ' A' ' 26' ' ' LEU . 46.4 mm -73.89 121.82 86.1 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 108.677 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -41.52 127.81 3.35 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.585 1.523 . . . . 0.0 111.282 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.408 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -81.76 -15.94 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 110.879 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 49.8 mt 58.1 -120.62 1.23 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.12 -0.988 . . . . 0.0 110.081 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 46.4 t0 -97.49 5.81 49.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.161 -0.962 . . . . 0.0 110.972 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.95 0.62 60.11 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.384 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.4 p -127.86 -172.62 2.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.676 -0.896 . . . . 0.0 109.551 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.1 15.83 10.14 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.533 ' HB2' HD22 ' A' ' 176' ' ' LEU . 6.1 t-105 -60.26 -43.56 96.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.48 -1.012 . . . . 0.0 110.317 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -63.71 -58.59 6.41 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.062 -1.024 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.456 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.2 m-85 -51.29 -45.16 62.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 109.479 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -61.9 -49.29 76.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.641 -0.662 . . . . 0.0 111.22 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.453 ' CD ' ' CH2' ' A' ' 104' ' ' TRP . 1.6 mm-40 -65.5 -42.36 92.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.019 -1.05 . . . . 0.0 111.236 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.92 -54.2 24.38 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.017 -1.052 . . . . 0.0 110.286 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.5 mt -65.29 -32.56 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.177 -0.952 . . . . 0.0 109.5 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -64.42 -42.55 95.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.286 -0.884 . . . . 0.0 109.408 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.7 mmtm -76.16 12.86 1.03 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.085 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.74 32.98 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.837 -1.165 . . . . 0.0 110.545 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 HD22 ' A' ' 82' ' ' LEU . 77.5 mt -80.32 138.96 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.932 -1.105 . . . . 0.0 110.265 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.1 tp -130.52 125.53 34.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.546 -0.721 . . . . 0.0 109.157 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -78.27 145.42 35.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.352 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -115.06 -173.53 2.33 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.688 -0.632 . . . . 0.0 109.404 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.55 65.08 0.61 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.293 -0.879 . . . . 0.0 111.268 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.502 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -161.49 129.31 4.18 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 0.0 109.043 178.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -68.38 141.1 55.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.869 -1.144 . . . . 0.0 109.163 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.473 HD11 ' O ' ' A' ' 3' ' ' LEU . 85.4 mt -82.16 147.77 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 110.427 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -95.66 84.12 3.88 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' OH ' ' OE1' ' A' ' 83' ' ' GLU . 55.1 m-85 -62.82 143.93 57.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.252 -0.905 . . . . 0.0 110.241 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -90.43 101.96 14.69 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 243' ' ' LYS . 55.1 t -93.05 133.62 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.581 -0.699 . . . . 0.0 111.193 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.47 115.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -98.78 -26.81 14.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.052 -1.03 . . . . 0.0 110.576 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.02 148.43 65.72 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.36 148.35 38.28 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.493 2.129 . . . . 0.0 111.899 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.1 tt -157.29 152.27 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.957 . . . . 0.0 109.363 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -139.83 146.45 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.429 -0.794 . . . . 0.0 109.212 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -131.18 147.09 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -135.19 162.63 31.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.984 -1.072 . . . . 0.0 110.515 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -173.9 103.55 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.557 -0.714 . . . . 0.0 109.881 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 50.58 58.66 5.27 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 110.725 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.44 -32.59 2.83 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.517 HH21 ' H ' ' A' ' 252' ' ' GLY . 42.7 mtp180 -61.91 134.12 56.27 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.245 . . . . 0.0 108.26 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.731 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -146.1 137.79 24.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.77 -1.206 . . . . 0.0 110.446 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.727 HG21 HD22 ' A' ' 259' ' ' LEU . 79.6 mt -135.62 131.93 51.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.476 -0.765 . . . . 0.0 109.353 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -121.37 131.09 53.98 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.369 0.604 . . . . 0.0 109.839 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.88 134.62 54.37 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.17 151.07 47.31 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.131 -0.981 . . . . 0.0 109.659 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -47.71 143.27 12.87 Favored 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.481 2.121 . . . . 0.0 113.22 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.407 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -157.32 147.08 20.48 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.61 -6.6 26.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.917 . . . . 0.0 110.464 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -148.66 178.68 8.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.942 -1.098 . . . . 0.0 109.741 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.4 tp -91.98 120.8 32.97 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.106 -0.996 . . . . 0.0 108.709 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' HG3' HG13 ' A' ' 167' ' ' VAL . 2.0 tt0 -135.73 129.72 33.07 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.43 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.4 t -129.87 120.73 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 109.9 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.507 ' OG1' HG23 ' A' ' 165' ' ' THR . 47.6 m -112.3 152.29 28.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.461 -0.774 . . . . 0.0 109.358 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.402 ' HB2' HG22 ' A' ' 228' ' ' VAL . 38.8 t80 -139.46 130.74 26.75 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.176 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.444 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 23.2 tt0 -120.84 130.36 53.92 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.22 137.79 9.57 Favored Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.519 -1.324 . . . . 0.0 111.465 -178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -103.06 100.14 10.06 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -89.21 166.93 13.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.088 -1.008 . . . . 0.0 110.833 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -99.67 -18.56 17.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.563 -0.711 . . . . 0.0 110.652 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.508 ' C ' ' H ' ' A' ' 159' ' ' LEU . 27.4 p-10 -92.3 -170.0 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.738 -1.227 . . . . 0.0 110.22 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -52.77 0.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.384 -0.822 . . . . 0.0 111.398 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.1 mt -79.02 -28.01 43.29 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.401 -1.437 . . . . 0.0 108.734 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.66 -138.48 33.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -101.93 134.64 44.81 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.233 -1.157 . . . . 0.0 109.671 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -138.53 151.72 47.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.481 -0.762 . . . . 0.0 109.249 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -141.09 144.8 35.11 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -142.76 135.29 27.74 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.387 -0.821 . . . . 0.0 109.659 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.507 HG23 ' OG1' ' A' ' 150' ' ' THR . 57.3 m -105.03 121.93 44.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.38 -0.825 . . . . 0.0 109.698 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.494 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.7 t80 -102.66 113.12 26.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.268 -0.895 . . . . 0.0 110.062 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.449 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.9 t -104.22 148.75 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 109.767 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -49.36 131.26 20.35 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.261 -0.899 . . . . 0.0 109.026 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 105.7 -3.63 39.33 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 170' ' ' ASN . 1.3 m-20 -114.6 24.46 11.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.206 -1.173 . . . . 0.0 109.183 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.529 ' HB3' HD13 ' A' ' 81' ' ' LEU . 1.1 mt-10 -50.87 -56.48 12.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.293 -0.88 . . . . 0.0 109.882 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -44.62 -23.45 0.13 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.418 -0.801 . . . . 0.0 110.306 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 171' ' ' GLU . 6.6 mt-10 -83.24 -12.72 56.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.993 -1.067 . . . . 0.0 111.537 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.9 pt -121.44 -28.26 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.862 -1.149 . . . . 0.0 111.2 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.1 m -63.66 -27.06 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 120.556 -1.34 . . . . 0.0 109.395 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -78.52 -6.0 54.24 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.402 -0.811 . . . . 0.0 109.129 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.414 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.68 124.66 24.23 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.173 -0.955 . . . . 0.0 109.684 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.475 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -88.71 172.17 9.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.337 -0.852 . . . . 0.0 109.342 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.8 t -78.57 162.32 26.37 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -148.55 146.07 28.13 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.125 -1.609 . . . . 0.0 111.836 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.548 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -144.5 157.72 44.1 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.453 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 77.3 m-85 -100.96 147.77 25.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.414 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 22.8 p30 -54.23 -33.29 58.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.181 -0.949 . . . . 0.0 110.022 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.551 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 7.0 p90 -72.35 -28.76 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.818 -1.176 . . . . 0.0 109.591 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.525 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -81.84 -37.33 27.17 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.099 -1.001 . . . . 0.0 109.985 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 183' ' ' ASP . 94.3 mt -45.53 -59.51 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.966 -1.084 . . . . 0.0 109.475 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 14.9 tt0 -41.32 -39.4 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 109.763 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.507 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.7 t-160 -73.94 -44.38 55.15 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.302 -0.874 . . . . 0.0 108.769 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 98.2 mt -57.72 -27.59 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.555 -0.716 . . . . 0.0 109.579 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.2 mttp -84.67 -53.59 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.883 -1.136 . . . . 0.0 109.317 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -49.24 -42.48 40.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 110.269 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.1 m -75.68 6.25 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.978 -1.076 . . . . 0.0 110.294 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.41 39.65 50.32 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 55.0 mt -128.77 172.09 11.61 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.225 -1.162 . . . . 0.0 109.855 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 62.41 20.79 61.53 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -54.17 -21.51 9.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.636 -1.508 . . . . 0.0 109.85 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -115.35 25.8 9.56 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.07 124.31 7.1 Favored Glycine 0 N--CA 1.491 2.362 0 O-C-N 120.819 -1.401 . . . . 0.0 109.703 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.28 172.74 13.39 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.8 mt -69.13 -7.91 40.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.49 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 6.2 mmmt -91.58 -12.17 35.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.832 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -143.46 13.04 1.75 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.917 -1.114 . . . . 0.0 110.421 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.436 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -148.39 149.65 32.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.857 -1.152 . . . . 0.0 110.82 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.445 HD21 HD22 ' A' ' 217' ' ' LEU . 26.0 tp -99.11 93.51 6.02 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.436 HG23 HG22 ' A' ' 203' ' ' THR . 47.5 t -86.81 129.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 121.868 0.842 . . . . 0.0 109.336 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.7 mt -123.26 164.76 18.14 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.19 -166.45 12.48 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.979 -1.649 . . . . 0.0 108.979 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -26.44 68.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.499 -1.0 . . . . 0.0 109.473 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -157.64 21.89 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 110.548 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -143.33 150.82 39.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.755 -1.215 . . . . 0.0 110.518 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.5 t -102.26 111.72 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -57.79 -51.37 69.87 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 110.236 -178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -57.62 111.66 3.75 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.216 -0.928 . . . . 0.0 110.196 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -58.36 -11.77 11.74 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.699 1.599 . . . . 0.0 111.772 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.34 -17.28 59.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.371 -0.831 . . . . 0.0 110.2 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.7 -177.79 46.67 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.9 mt -88.81 143.28 27.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.14 -1.212 . . . . 0.0 109.767 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.596 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 37.1 mtp85 -73.46 -20.01 60.81 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.602 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 17.2 m-85 -146.83 169.81 18.32 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -82.28 10.77 6.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -153.29 38.11 0.49 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.291 -0.881 . . . . 0.0 109.407 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.536 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.2 tt0 -55.08 -47.42 98.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.94 -1.1 . . . . 0.0 109.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 54.3 Cg_exo -50.53 -65.37 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.414 2.076 . . . . 0.0 112.361 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 228' ' ' VAL . 16.3 m -58.7 -36.34 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.031 -1.043 . . . . 0.0 109.689 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.602 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 60.7 mtt180 -60.48 -42.85 97.13 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.2 t60 -66.42 -32.48 73.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.355 -0.841 . . . . 0.0 108.964 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -65.66 -35.49 80.93 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.494 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.6 t -68.64 -36.73 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.461 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 61.6 t80 -65.24 -52.6 53.48 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.501 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 88.1 m-20 -62.93 -29.7 70.99 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.842 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 149' ' ' VAL . 58.7 tp -74.79 -32.85 62.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.029 -1.044 . . . . 0.0 108.536 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 36.2 mt -67.53 -40.85 85.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.41 -53.92 32.72 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.459 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 24.7 m-20 -56.79 -30.57 63.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -1.183 . . . . 0.0 109.062 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.5 mt -67.11 -24.44 65.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.551 -0.718 . . . . 0.0 110.481 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.66 -22.36 60.94 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.813 -1.18 . . . . 0.0 109.095 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.2 mt -49.16 -6.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.516 -1.365 . . . . 0.0 110.063 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.4 mt -72.28 -16.12 61.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.908 -1.12 . . . . 0.0 109.63 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.63 2.24 60.04 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.794 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.39 153.88 9.06 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.779 -1.424 . . . . 0.0 108.984 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -49.34 150.5 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.787 1.658 . . . . 0.0 109.618 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 42.4 t -111.48 148.64 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.009 -1.057 . . . . 0.0 111.861 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.439 ' HB2' HG22 ' A' ' 125' ' ' VAL . 29.2 mmtt -128.92 122.95 31.36 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.34 -163.86 31.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 144' ' ' SER . 10.3 ttpt -126.07 139.62 53.25 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.338 -1.095 . . . . 0.0 109.652 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 35.1 m-85 -136.4 139.43 42.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.29 -0.881 . . . . 0.0 110.243 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.444 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 56.8 t80 -126.19 125.36 42.31 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 9.3 m -120.36 136.77 54.6 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.006 -1.059 . . . . 0.0 111.579 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -118.28 113.14 21.02 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 47.59 47.35 17.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -86.13 150.57 23.95 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.517 ' H ' HH21 ' A' ' 137' ' ' ARG . . . -122.66 178.53 16.35 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.459 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 46.9 m-70 -61.92 -38.26 87.73 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.176 -1.19 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 11.0 m -60.08 -60.01 4.5 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.023 -1.048 . . . . 0.0 109.004 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.613 ' HG ' HD12 ' A' ' 139' ' ' ILE . 24.4 tp -52.0 -47.59 64.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.179 -0.951 . . . . 0.0 109.09 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 19.7 m-20 -48.02 -50.9 26.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.961 -1.087 . . . . 0.0 109.445 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.68 HG21 HG21 ' A' ' 56' ' ' THR . 73.9 t -60.84 -54.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.478 -0.764 . . . . 0.0 109.997 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.474 ' HE2' HD12 ' A' ' 255' ' ' LEU . 0.0 OUTLIER -50.8 -45.33 59.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 108.668 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.727 HD22 HG21 ' A' ' 139' ' ' ILE . 13.9 tp -54.12 -55.44 27.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.067 -1.02 . . . . 0.0 108.56 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.458 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.2 t -56.81 -55.32 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.285 -0.884 . . . . 0.0 109.077 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 260' ' ' VAL . 0.1 OUTLIER -44.95 -48.51 11.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.525 -0.734 . . . . 0.0 109.1 179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -61.22 -52.76 63.45 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.403 -0.811 . . . . 0.0 109.485 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.7 mt -51.09 -50.09 59.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.342 -0.849 . . . . 0.0 110.25 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.28 -27.03 63.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.301 -0.874 . . . . 0.0 110.507 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -73.54 -58.45 3.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 110.663 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER -62.45 -37.58 86.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.92 -1.112 . . . . 0.0 109.744 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -48.75 -13.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 266' ' ' LYS . 0.3 OUTLIER -132.79 120.49 21.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 0.0 109.372 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.43 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.548 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 3' ' ' LEU . 95.6 mt -75.63 146.73 40.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.199 -1.177 . . . . 0.0 109.33 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -52.5 142.27 18.19 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -123.05 144.73 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.196 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.33 -170.55 3.3 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.9 m -98.49 136.63 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.89 -1.131 . . . . 0.0 109.314 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -67.57 -19.68 65.3 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.408 -0.807 . . . . 0.0 110.078 -179.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -154.23 156.33 36.86 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.007 -1.058 . . . . 0.0 109.603 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.71 138.06 58.17 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.297 -0.877 . . . . 0.0 109.809 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 28.3 mt -118.77 163.99 16.05 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.48 142.23 48.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 110.294 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -137.91 150.18 46.85 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' CD ' ' OH ' ' A' ' 23' ' ' TYR . 9.6 pt-20 -158.91 151.28 21.48 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.926 -1.109 . . . . 0.0 109.923 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.55 173.66 35.88 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -80.44 148.34 5.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.34 -1.094 . . . . 0.0 110.232 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.67 137.07 16.21 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' CG2' HD13 ' A' ' 98' ' ' ILE . 10.1 tt -59.09 -37.84 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.052 -1.263 . . . . 0.0 110.298 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.429 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 70.5 m-70 -88.85 -50.17 6.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.687 -1.258 . . . . 0.0 110.925 -178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.0 p -69.69 -20.76 63.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.549 -0.719 . . . . 0.0 111.544 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.36 12.88 6.53 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.15 156.61 18.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.47 -1.018 . . . . 0.0 109.853 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.447 ' OH ' ' CD ' ' A' ' 14' ' ' GLU . 67.4 t80 -74.39 135.11 42.42 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.464 -0.772 . . . . 0.0 109.529 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -138.41 144.09 40.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.083 -1.011 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.88 155.16 24.09 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.369 -0.832 . . . . 0.0 109.917 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.697 HD11 HG23 ' A' ' 96' ' ' ILE . 9.0 mt -135.87 146.41 47.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.35 -0.844 . . . . 0.0 109.953 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.509 ' CG2' ' NE2' ' A' ' 29' ' ' HIS . 8.8 mt -141.43 112.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 108.638 178.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.9 mt -94.91 113.27 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.32 -0.862 . . . . 0.0 110.466 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' ' CG2' ' A' ' 27' ' ' ILE . 34.7 m-70 -107.47 137.72 19.74 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.498 -0.751 . . . . 0.0 109.468 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.0 Cg_exo -54.77 168.73 1.02 Allowed 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.685 1.59 . . . . 0.0 111.515 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 35' ' ' THR . 77.6 mm-40 -141.04 176.09 9.09 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.173 -0.955 . . . . 0.0 109.769 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 35' ' ' THR . 18.6 mmtp -87.08 155.18 20.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -46.46 141.69 3.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.452 -0.78 . . . . 0.0 110.287 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.769 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 70.85 9.2 65.54 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.27 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.752 ' H ' HD22 ' A' ' 86' ' ' ASN . 53.5 m -71.53 -44.16 65.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.476 -1.602 . . . . 0.0 109.461 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.28 -179.87 35.1 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.512 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.2 mm -97.69 115.63 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -139.92 154.45 47.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.914 -1.116 . . . . 0.0 110.333 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -102.79 158.36 16.32 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -129.68 111.73 12.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.296 -0.878 . . . . 0.0 108.981 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -135.41 134.75 40.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.358 -0.839 . . . . 0.0 110.621 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.495 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 13.7 m120 50.37 32.74 6.67 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.56 -0.712 . . . . 0.0 111.47 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.58 17.39 79.95 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.427 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.9 t -123.22 120.94 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.055 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -82.41 126.81 32.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.443 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 70.2 mt -115.42 92.07 31.18 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.458 -0.777 . . . . 0.0 109.201 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.81 146.14 16.71 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.502 2.135 . . . . 0.0 112.287 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.35 70.24 10.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.217 -0.927 . . . . 0.0 109.327 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.9 mmm-85 -122.86 166.89 14.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.357 -0.84 . . . . 0.0 109.448 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.618 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.6 p-80 -68.94 -53.85 18.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.28 -0.887 . . . . 0.0 109.79 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.618 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.4 mt-10 -44.99 -16.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.495 ' N ' ' O ' ' A' ' 50' ' ' HIS . 41.1 m-85 -95.44 3.4 54.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 50' ' ' HIS . 69.1 t -70.47 129.07 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 108.719 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.53 -29.53 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.355 -0.841 . . . . 0.0 110.225 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.12 131.53 12.93 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 110.089 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.74 HG21 HG21 ' A' ' 257' ' ' VAL . 45.9 p -123.18 95.12 4.48 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.568 ' ND2' ' CD2' ' A' ' 58' ' ' HIS . 1.1 t-20 -163.33 130.68 3.51 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.568 ' CD2' ' ND2' ' A' ' 57' ' ' ASN . 73.7 m-70 50.46 8.8 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.041 -1.037 . . . . 0.0 108.848 -179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.9 157.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.326 -0.859 . . . . 0.0 109.54 -179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 36.2 m -100.55 127.71 46.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 109.254 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -122.78 151.85 41.23 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.799 0.809 . . . . 0.0 111.171 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.689 ' CD1' HG21 ' A' ' 72' ' ' VAL . 4.4 mt -126.42 151.21 48.01 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.37 156.56 28.4 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.067 -1.539 . . . . 0.0 110.568 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -164.7 151.89 11.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.383 -1.069 . . . . 0.0 109.273 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.0 mmtt 53.1 21.66 2.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.287 -0.883 . . . . 0.0 109.256 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.09 7.5 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.495 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 85.7 mm-40 -60.64 148.15 39.4 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.144 -1.209 . . . . 0.0 109.451 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' NH1' HD21 ' A' ' 94' ' ' ASN . 9.6 ttp-105 -144.48 140.81 29.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.212 -0.93 . . . . 0.0 110.478 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.3 mt -129.82 126.34 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.42 ' HD2' HH21 ' A' ' 68' ' ' ARG . 15.1 mtpp -101.47 156.19 17.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.898 -1.126 . . . . 0.0 111.299 -178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.2 m 50.93 74.39 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.801 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.4 m -108.2 -10.02 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.579 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.34 -28.56 69.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 110.691 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.422 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -64.8 -68.88 0.32 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.886 -1.134 . . . . 0.0 109.228 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.578 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.39 -48.12 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.12 -0.987 . . . . 0.0 109.28 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.623 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.1 mt -50.88 -50.3 57.4 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.953 -1.092 . . . . 0.0 110.286 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.471 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 9.4 t -60.48 -42.81 97.05 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.093 -1.005 . . . . 0.0 110.164 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.2 t -55.71 -45.32 79.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.4 mt -68.16 -35.0 77.35 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.387 -0.821 . . . . 0.0 109.082 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -63.1 -31.77 72.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.342 -0.848 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 171' ' ' GLU . 72.2 mt -83.34 -36.92 24.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.558 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.41 HD21 ' CE2' ' A' ' 107' ' ' TYR . 87.3 mt -80.29 4.44 17.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.181 -0.949 . . . . 0.0 109.733 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 53.8 38.76 29.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.791 . . . . 0.0 109.957 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.4 mm -87.0 140.15 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 121' ' ' ILE . 72.6 p -126.13 -18.9 4.88 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.181 -0.949 . . . . 0.0 111.762 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.769 HD21 ' H ' ' A' ' 34' ' ' GLY . 3.0 m120 -126.98 107.9 10.47 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.843 -1.161 . . . . 0.0 110.956 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 86' ' ' ASN . 6.7 m -163.95 148.18 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.377 -0.827 . . . . 0.0 109.971 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 27.9 m -117.06 110.04 17.73 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.526 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -94.08 103.73 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 110.377 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.404 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.6 tt0 -77.33 127.51 32.69 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.41 128.99 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.98 0.895 . . . . 0.0 111.734 -177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.9 mm -112.2 95.65 4.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.44 -155.83 24.89 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.474 HD21 ' NH1' ' A' ' 68' ' ' ARG . 0.8 OUTLIER -120.18 -10.45 9.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.318 -1.107 . . . . 0.0 110.13 -179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -141.06 149.91 42.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.926 -1.109 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.697 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -72.68 121.66 85.52 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.178 -0.951 . . . . 0.0 109.182 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -41.15 127.26 2.83 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 121.641 1.561 . . . . 0.0 111.175 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -81.27 -12.61 12.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.156 -0.965 . . . . 0.0 110.416 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.5 mt 55.25 -121.15 1.7 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.745 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -93.4 9.32 36.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.927 -1.108 . . . . 0.0 111.192 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.49 -2.98 65.5 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.242 -1.456 . . . . 0.0 109.855 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.49 -172.09 2.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.625 -0.926 . . . . 0.0 109.628 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.1 15.72 12.11 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -56.39 -43.83 79.63 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -1.088 . . . . 0.0 110.232 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.75 -57.46 8.9 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.089 -1.007 . . . . 0.0 110.143 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -51.68 -47.95 63.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.328 -0.858 . . . . 0.0 109.871 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.41 ' CE2' HD21 ' A' ' 82' ' ' LEU . 57.9 t80 -61.59 -49.18 77.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.436 -0.79 . . . . 0.0 111.214 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -65.92 -43.02 89.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.034 -1.041 . . . . 0.0 111.368 -178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.77 -54.95 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.939 -1.101 . . . . 0.0 110.097 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.1 mt -63.45 -34.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.075 -1.016 . . . . 0.0 109.477 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -62.81 -41.72 99.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 0.0 109.178 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -78.07 12.83 1.65 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.341 -0.85 . . . . 0.0 109.822 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -142.54 31.17 1.49 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.971 -1.08 . . . . 0.0 110.327 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 78.3 mt -80.05 138.72 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 110.478 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 8' ' ' LYS . 8.3 tp -129.76 122.49 28.94 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.23 147.86 42.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.909 . . . . 0.0 110.353 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -115.93 -174.87 2.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -110.62 66.36 0.63 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.137 -0.977 . . . . 0.0 111.222 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -165.4 129.52 2.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.865 -1.147 . . . . 0.0 109.379 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -67.42 141.55 56.98 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.783 -1.198 . . . . 0.0 109.802 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.573 HG12 HG21 ' A' ' 85' ' ' THR . 85.4 mt -84.2 150.18 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.33 -0.856 . . . . 0.0 110.266 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -97.46 81.89 3.03 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 31.2 m-85 -59.33 142.04 53.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.26 -0.9 . . . . 0.0 109.61 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -88.06 101.3 13.65 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.3 t -92.01 132.65 35.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.412 0.625 . . . . 0.0 110.643 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.93 111.17 2.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -83.56 -31.67 26.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.02 -1.05 . . . . 0.0 110.323 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.18 155.47 75.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.627 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.05 153.5 57.54 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.529 2.153 . . . . 0.0 112.103 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 3.9 tt -159.59 153.07 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.437 -0.789 . . . . 0.0 109.273 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.36 141.89 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.053 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.92 150.05 33.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -135.76 158.93 43.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.205 -0.934 . . . . 0.0 109.79 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -173.61 106.75 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.347 -0.846 . . . . 0.0 109.929 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 52.9 51.55 15.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.391 -0.818 . . . . 0.0 110.293 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.17 -32.25 3.32 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.146 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.6 mtt-85 -61.61 137.4 58.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.963 -1.316 . . . . 0.0 108.639 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.733 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.9 tt -145.03 138.11 26.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 110.251 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.714 HG21 HD22 ' A' ' 259' ' ' LEU . 48.3 mt -134.97 132.54 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.569 -0.707 . . . . 0.0 109.556 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -121.39 130.82 53.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.696 -0.628 . . . . 0.0 109.948 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.06 137.14 54.92 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.47 ' OE1' ' O ' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -149.28 149.63 29.74 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.509 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.47 ' O ' ' OE1' ' A' ' 142' ' ' GLU . 40.6 Cg_exo -47.74 143.73 12.26 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.491 2.127 . . . . 0.0 113.572 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.405 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -156.4 144.32 19.52 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.423 ' O ' HG23 ' A' ' 146' ' ' THR . 1.0 OUTLIER -62.85 -5.4 2.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -0.884 . . . . 0.0 110.61 -178.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.423 HG23 ' O ' ' A' ' 145' ' ' ASP . 12.6 p -154.04 -174.89 5.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.969 -1.082 . . . . 0.0 109.628 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.441 HD12 ' N ' ' A' ' 148' ' ' GLU . 13.1 tp -93.76 122.04 35.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.132 -0.98 . . . . 0.0 108.933 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.4 mt-10 -135.86 126.63 27.38 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.429 ' CG1' HD23 ' A' ' 231' ' ' LEU . 58.1 t -129.82 123.43 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 110.074 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.1 m -113.68 152.62 30.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.684 -0.635 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -138.95 131.78 29.24 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.305 -0.958 . . . . 0.0 111.123 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -120.91 135.23 55.24 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.79 137.06 8.59 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.633 -178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.81 97.91 7.99 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.95 167.09 16.22 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.378 -0.826 . . . . 0.0 110.937 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -100.01 -15.25 18.33 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.654 -0.654 . . . . 0.0 110.573 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.6 p-10 -95.01 -168.18 1.76 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.761 -1.212 . . . . 0.0 110.125 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -57.16 2.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.441 -0.787 . . . . 0.0 111.296 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.5 mt -79.03 -26.63 43.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.455 -1.403 . . . . 0.0 108.28 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.3 -137.53 37.68 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.78 131.25 45.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.4 -1.059 . . . . 0.0 109.295 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -137.22 146.23 44.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -0.792 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.424 ' HZ2' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -142.26 148.01 37.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.371 -0.83 . . . . 0.0 110.366 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -146.53 140.39 26.12 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.268 -0.895 . . . . 0.0 110.044 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 16.1 m -107.21 123.41 48.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.441 -0.787 . . . . 0.0 109.732 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.462 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.4 t80 -103.06 112.8 25.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.256 -0.902 . . . . 0.0 110.312 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.7 t -103.69 145.78 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.301 -0.875 . . . . 0.0 109.673 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -48.16 134.38 14.34 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.292 -0.88 . . . . 0.0 109.013 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.413 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 107.58 -9.12 37.86 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -120.84 26.43 9.09 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.159 -1.201 . . . . 0.0 109.369 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.8 OUTLIER -68.25 -16.01 63.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.293 -0.879 . . . . 0.0 110.472 -179.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -73.74 -8.84 57.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.997 -1.064 . . . . 0.0 109.894 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -106.15 -5.5 19.28 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.225 -0.922 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.1 pt -111.37 -33.38 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.32 -0.862 . . . . 0.0 109.632 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 171' ' ' GLU . 14.4 m -64.11 -23.67 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 108.395 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.75 -7.2 59.57 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.421 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.05 119.47 12.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.321 -0.862 . . . . 0.0 108.963 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -80.62 173.01 13.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 109.514 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.421 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.5 t -77.18 162.01 27.74 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -148.25 141.65 25.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.312 -1.492 . . . . 0.0 111.71 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.61 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -139.32 156.72 46.84 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.497 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -98.2 143.64 28.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.117 -0.989 . . . . 0.0 109.264 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.486 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.3 t0 -47.7 -35.32 9.47 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -0.85 . . . . 0.0 109.59 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.545 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.1 p90 -73.13 -29.87 63.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.883 -1.136 . . . . 0.0 109.681 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.545 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 4.6 tt0 -75.38 -41.21 56.83 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.281 -0.887 . . . . 0.0 110.071 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.651 HG21 HB21 ' A' ' 500' ' ' C90 . 49.5 mt -46.17 -56.71 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.128 -0.983 . . . . 0.0 110.031 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.6 -40.08 1.8 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.287 -0.883 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -76.19 -53.79 7.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.299 -0.875 . . . . 0.0 109.173 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.86 -26.8 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.452 -0.78 . . . . 0.0 109.624 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -84.98 -53.64 5.17 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.785 -1.197 . . . . 0.0 109.284 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -47.58 -44.9 26.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 110.217 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.99 8.67 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 0.0 110.558 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.6 39.9 54.94 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.995 -1.098 . . . . 0.0 110.818 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 194' ' ' LEU . 50.9 mt -128.04 172.03 11.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -1.196 . . . . 0.0 109.687 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 57.39 24.83 53.41 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -60.14 -19.62 54.5 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.714 -1.462 . . . . 0.0 110.304 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -106.43 4.33 37.53 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.05 129.99 41.54 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.107 -1.231 . . . . 0.0 110.307 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.63 165.13 31.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.997 . . . . 0.0 109.305 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 10.6 mt -68.81 -8.4 43.1 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -97.09 -10.41 26.11 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.82 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.455 ' OD1' ' C ' ' A' ' 202' ' ' ASN . 19.1 p-10 -140.3 9.82 2.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.008 -1.057 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 m -145.27 147.09 31.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.106 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 206' ' ' LEU . 19.4 tp -97.8 93.86 6.6 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.6 t -88.45 130.51 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.569 0.7 . . . . 0.0 109.281 -179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 204' ' ' LEU . 18.3 mt -123.33 -178.46 4.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.453 -0.779 . . . . 0.0 109.605 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.95 -166.13 10.54 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -64.59 -20.75 66.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -1.104 . . . . 0.0 109.401 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.34 22.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.347 -0.846 . . . . 0.0 109.848 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt -140.78 148.51 40.77 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.046 -1.033 . . . . 0.0 110.34 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.7 t -102.38 110.55 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -57.74 -45.22 86.14 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.987 -1.071 . . . . 0.0 109.941 -178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.8 118.82 45.58 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.197 -0.939 . . . . 0.0 109.642 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -67.23 -14.52 43.34 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 121.401 1.401 . . . . 0.0 112.017 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.85 -14.73 60.29 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.057 -1.027 . . . . 0.0 108.78 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.64 -174.04 52.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.5 mt -86.14 134.99 33.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.15 -1.206 . . . . 0.0 109.617 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 6.5 tpt180 -64.17 -19.58 65.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 108.824 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.663 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.5 m-85 -139.89 -164.16 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.292 -0.88 . . . . 0.0 109.118 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -97.65 -21.41 17.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.12 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.12 48.38 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.448 -0.783 . . . . 0.0 109.463 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.515 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -53.8 -47.92 95.19 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.109 -0.995 . . . . 0.0 109.992 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.7 Cg_exo -48.67 -65.71 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.344 2.03 . . . . 0.0 112.164 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 225' ' ' ARG . 17.4 m -59.87 -36.76 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.976 -1.078 . . . . 0.0 109.666 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.663 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 74.8 mtt180 -60.09 -41.74 93.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.068 -1.02 . . . . 0.0 108.267 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.421 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 17.2 t60 -68.02 -30.56 69.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.253 -0.905 . . . . 0.0 108.859 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.3 mmtt -65.75 -36.0 82.31 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.462 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -68.48 -37.72 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.471 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 66.8 t80 -64.1 -52.1 60.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.546 -0.721 . . . . 0.0 109.175 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.25 -27.31 68.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.0 109.714 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.429 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.2 tp -76.74 -33.2 58.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.161 -0.962 . . . . 0.0 108.57 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.1 mt -68.66 -38.81 79.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -57.58 9.73 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.492 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.4 m-20 -54.35 -37.26 64.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.141 -1.211 . . . . 0.0 109.06 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 235' ' ' LEU . 10.3 mt -61.99 -24.68 67.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.553 -0.717 . . . . 0.0 110.271 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.579 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.2 t80 -72.85 -20.85 61.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.84 -1.162 . . . . 0.0 109.35 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.406 ' HA ' HD23 ' A' ' 237' ' ' LEU . 83.8 mt -50.67 -1.52 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.858 -1.151 . . . . 0.0 110.591 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.9 mt -74.59 -14.23 60.75 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.779 -1.2 . . . . 0.0 109.854 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.17 1.69 59.41 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.575 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.1 m -164.94 153.11 10.46 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.059 -1.259 . . . . 0.0 108.751 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.415 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.6 Cg_endo -50.06 150.4 10.31 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.806 1.671 . . . . 0.0 109.48 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 92.5 t -105.66 142.67 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.812 -1.18 . . . . 0.0 112.056 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.3 tptm -124.05 119.82 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.96 -165.94 32.33 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.525 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 1.2 tmtt? -123.39 142.06 51.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -1.022 . . . . 0.0 108.581 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.525 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 9.7 m-85 -139.52 142.16 37.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.981 -1.074 . . . . 0.0 110.63 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -126.28 132.56 51.64 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.6 t -126.93 137.7 53.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 111.145 -178.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -119.32 116.83 27.02 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 47.09 28.9 1.0 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.272 -0.892 . . . . 0.0 109.182 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -68.0 153.31 52.89 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.497 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -134.52 170.39 22.71 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.579 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -49.92 -36.52 27.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -1.166 . . . . 0.0 109.569 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.84 -58.19 9.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.239 -0.913 . . . . 0.0 109.701 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.414 HD23 ' CD1' ' A' ' 139' ' ' ILE . 8.6 tp -59.21 -45.02 92.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.071 -1.018 . . . . 0.0 109.444 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.497 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.5 m-20 -47.77 -51.39 22.5 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.114 -0.991 . . . . 0.0 109.566 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.74 HG21 HG21 ' A' ' 56' ' ' THR . 84.8 t -62.94 -51.75 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.339 -0.85 . . . . 0.0 109.404 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -50.97 -51.07 56.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 109.209 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 139' ' ' ILE . 33.0 tp -51.26 -51.62 52.44 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.161 -0.962 . . . . 0.0 108.487 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.487 HG13 ' HG ' ' A' ' 238' ' ' LEU . 71.2 t -57.14 -53.86 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.948 . . . . 0.0 109.104 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -46.78 -41.66 15.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -70.98 -50.32 35.72 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.251 -0.905 . . . . 0.0 109.802 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 38.2 mt -57.28 -47.64 80.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.237 -0.914 . . . . 0.0 109.717 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.62 -34.05 75.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.423 -0.798 . . . . 0.0 109.764 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -68.75 -36.59 78.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 108.968 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -67.07 -64.4 0.86 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.327 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -51.67 -40.92 60.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 0.0 109.56 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.75 102.06 14.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 109.592 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.651 HB21 HG21 ' A' ' 186' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 43.8 mt -88.05 159.75 18.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -1.131 . . . . 0.0 109.489 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -56.11 137.52 51.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.088 -1.008 . . . . 0.0 108.473 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -123.23 144.89 49.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.41 -0.806 . . . . 0.0 109.914 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -143.41 -168.85 2.92 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 m -99.97 136.31 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.05 -12.96 56.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.39 -179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 8.5 pt-20 -156.15 -172.71 4.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -0.872 . . . . 0.0 109.179 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 141.92 28.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 mt -119.15 166.15 13.3 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.8 144.54 37.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.062 -1.024 . . . . 0.0 110.328 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 76.1 m-85 -140.0 156.23 46.73 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -163.59 149.23 11.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.914 -1.116 . . . . 0.0 109.581 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.95 173.35 35.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 p -79.32 150.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.373 -1.074 . . . . 0.0 110.518 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.63 141.18 15.98 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.0 tt -60.67 -39.66 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -1.154 . . . . 0.0 111.189 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.512 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.2 m-70 -88.14 -49.44 7.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 111.146 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -72.18 -21.68 61.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.637 -0.664 . . . . 0.0 111.842 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.27 16.88 22.29 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.08 -1.533 . . . . 0.0 109.558 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.48 156.14 20.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.241 -1.152 . . . . 0.0 109.575 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.39 136.68 39.49 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.291 -0.88 . . . . 0.0 109.579 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -135.64 141.12 45.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.566 ' HB3' HD12 ' A' ' 92' ' ' ILE . 1.5 ttpt -110.36 155.71 21.76 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.257 -0.902 . . . . 0.0 109.723 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.3 mt -137.89 149.38 46.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 110.817 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.607 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -141.71 109.87 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.54 116.65 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.165 -0.96 . . . . 0.0 111.049 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.607 ' NE2' HG22 ' A' ' 27' ' ' ILE . 21.4 m-70 -112.77 139.75 23.19 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.442 -0.786 . . . . 0.0 109.542 179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -54.26 168.59 0.91 Allowed 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.895 1.73 . . . . 0.0 111.916 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.519 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.4 mm-40 -138.0 178.18 7.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.313 -0.867 . . . . 0.0 109.593 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.483 ' O ' ' OG1' ' A' ' 35' ' ' THR . 17.9 mtmm -87.16 152.76 22.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.981 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -48.36 146.21 2.96 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.642 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.775 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 68.35 8.49 55.44 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.236 -0.983 . . . . 0.0 110.729 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.733 ' H ' HD22 ' A' ' 86' ' ' ASN . 26.4 m -73.42 -45.84 52.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.608 -1.525 . . . . 0.0 109.585 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.66 -178.92 30.2 Favored Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.662 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.4 mm -97.9 117.18 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -142.07 150.14 40.84 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.466 -1.293 . . . . 0.0 110.954 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.406 ' CE2' HD13 ' A' ' 89' ' ' ILE . 95.6 m-85 -99.7 157.12 16.7 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -129.69 110.72 12.01 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.123 -0.986 . . . . 0.0 108.974 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.666 ' NZ ' ' NE2' ' A' ' 67' ' ' GLN . 17.5 tttm -135.96 135.97 40.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.385 -0.822 . . . . 0.0 110.582 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m120 51.03 28.17 3.72 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.451 -0.781 . . . . 0.0 111.183 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.22 18.23 74.76 Favored Glycine 0 N--CA 1.492 2.384 0 C-N-CA 119.609 -1.282 . . . . 0.0 110.024 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.9 t -119.95 120.76 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.389 -1.065 . . . . 0.0 108.946 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.432 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.3 m-85 -86.86 129.0 35.06 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.066 -1.021 . . . . 0.0 109.169 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.526 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 52.8 mt -120.12 96.95 49.37 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.364 -0.835 . . . . 0.0 110.238 -179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -53.07 149.3 27.71 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.081 1.854 . . . . 0.0 111.101 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.553 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.7 72.16 10.36 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.147 -0.97 . . . . 0.0 109.658 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 38.7 mtm-85 -127.55 175.61 8.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.507 -0.746 . . . . 0.0 109.18 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' O ' ' N ' ' A' ' 52' ' ' PHE . 2.4 p-80 -73.19 -50.74 20.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.168 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -43.72 -17.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 111.184 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' A' ' 50' ' ' HIS . 54.2 m-85 -98.2 0.07 45.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.896 -1.128 . . . . 0.0 110.258 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 62' ' ' LEU . 79.3 t -68.81 130.91 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 108.722 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.512 HG21 ' HG2' ' A' ' 68' ' ' ARG . 10.4 m -114.3 -28.7 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.326 -0.859 . . . . 0.0 110.088 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -152.81 131.62 12.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.097 -1.002 . . . . 0.0 109.956 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 257' ' ' VAL . 70.3 p -121.75 95.09 4.53 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.573 ' C ' ' H ' ' A' ' 59' ' ' SER . 6.3 t-20 -163.11 128.74 3.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.399 -0.813 . . . . 0.0 109.064 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.531 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 76.9 m-70 50.25 6.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.16 -0.962 . . . . 0.0 109.288 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.573 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.1 137.65 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.7 m -81.38 129.18 34.52 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.228 -0.92 . . . . 0.0 109.247 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.92 150.43 42.0 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.357 -0.839 . . . . 0.0 111.172 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 72' ' ' VAL . 8.0 mt -126.0 147.66 49.48 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.69 160.41 32.31 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.248 -1.453 . . . . 0.0 110.243 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -164.24 149.58 10.42 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.291 -1.123 . . . . 0.0 109.329 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 54.65 21.47 3.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.411 -0.805 . . . . 0.0 109.938 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.53 -30.94 8.95 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.681 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.693 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.78 145.06 50.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.763 -1.433 . . . . 0.0 108.855 -179.357 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 4.7 mtt180 -137.46 149.76 47.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.019 -1.051 . . . . 0.0 111.874 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.9 mt -129.29 128.45 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.6 mtpp -105.14 155.28 19.17 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.892 -1.13 . . . . 0.0 111.338 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.2 m 51.5 74.57 0.24 Allowed 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.894 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.8 m -108.24 -9.58 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.037 -1.039 . . . . 0.0 109.63 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.0 pm0 -61.13 -26.8 67.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 110.689 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.43 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 25.4 m170 -66.88 -68.54 0.37 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.958 -1.089 . . . . 0.0 109.375 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.575 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -51.84 -47.64 40.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.048 -1.033 . . . . 0.0 109.058 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.575 ' N ' HG23 ' A' ' 75' ' ' ILE . 12.9 mt -54.13 -47.42 71.88 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 120.889 -1.132 . . . . 0.0 110.478 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 25.2 t -60.23 -41.75 93.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.004 -1.06 . . . . 0.0 109.817 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.9 t -57.5 -45.81 85.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 108.955 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.5 mt -64.97 -35.0 79.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.407 -0.808 . . . . 0.0 109.247 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -63.05 -40.25 97.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.154 -0.966 . . . . 0.0 109.202 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 49.0 mt -75.68 -38.48 58.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.313 -0.867 . . . . 0.0 109.518 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.8 mt -82.22 -0.48 45.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.842 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 56.42 41.97 28.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 111.303 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 37.1 mm -88.33 138.47 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.741 -1.224 . . . . 0.0 108.158 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.433 HG21 HG12 ' A' ' 121' ' ' ILE . 70.7 p -126.56 -20.62 4.31 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.213 -0.929 . . . . 0.0 111.451 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.775 HD21 ' N ' ' A' ' 34' ' ' GLY . 3.3 m120 -124.2 106.45 10.31 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.02 -1.05 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.6 m -166.07 150.24 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-O 121.654 0.74 . . . . 0.0 110.2 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 55.8 m -117.11 114.61 23.96 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.415 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.3 mt -95.69 100.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.432 -0.792 . . . . 0.0 109.988 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -74.27 122.88 23.55 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.447 HG22 HD21 ' A' ' 26' ' ' LEU . 19.3 t -108.69 124.75 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.845 0.831 . . . . 0.0 111.906 -177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 25' ' ' LYS . 8.1 mt -108.4 96.22 4.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.52 -158.51 27.33 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.9 m-80 -122.19 -11.68 8.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.311 -1.111 . . . . 0.0 110.196 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 tt0 -140.63 149.38 42.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.0 -1.063 . . . . 0.0 109.873 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mm -73.06 127.24 89.69 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -46.06 132.32 14.5 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 C-N-CA 122.033 1.822 . . . . 0.0 111.276 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 tp -85.91 -20.85 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.12 -0.987 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 71.9 mt 58.64 -119.69 1.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.194 -0.941 . . . . 0.0 109.952 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.91 4.71 49.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.908 -1.12 . . . . 0.0 110.95 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.78 0.04 56.45 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.332 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.66 -172.28 2.6 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.718 -0.872 . . . . 0.0 109.676 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.84 13.17 9.24 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.45 ' HB2' HD22 ' A' ' 176' ' ' LEU . 47.9 t-105 -56.0 -40.54 73.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -1.113 . . . . 0.0 110.742 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.44 -59.28 4.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 11.0 m-85 -51.3 -45.56 62.22 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.343 -0.848 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.418 ' CE2' ' HD2' ' A' ' 111' ' ' ARG . 64.7 t80 -60.68 -49.99 75.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.772 -0.58 . . . . 0.0 110.806 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 19.8 mm-40 -62.99 -43.36 99.0 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.102 -0.999 . . . . 0.0 111.245 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.03 -58.05 6.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -0.936 . . . . 0.0 110.703 -178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 27.9 mt -61.1 -30.28 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.212 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.418 ' HD2' ' CE2' ' A' ' 107' ' ' TYR . 57.9 ttt180 -66.11 -44.37 84.53 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.419 -0.801 . . . . 0.0 110.412 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' HG3' HD22 ' A' ' 113' ' ' ASN . 15.0 ptpt -76.36 8.72 3.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.882 -1.136 . . . . 0.0 110.431 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' OD1' ' OE1' ' A' ' 9' ' ' GLU . 8.0 m-80 -140.58 35.87 1.83 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.945 -1.097 . . . . 0.0 110.267 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 53.9 mt -82.65 143.0 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.907 -1.12 . . . . 0.0 110.88 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.576 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.9 tp -133.51 129.68 37.47 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.429 -0.795 . . . . 0.0 109.431 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.75 138.81 31.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.422 -0.799 . . . . 0.0 110.434 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -108.48 -173.53 2.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.533 -0.73 . . . . 0.0 109.108 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.62 70.66 0.73 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.168 -0.958 . . . . 0.0 110.685 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -167.4 129.68 1.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.111 -0.993 . . . . 0.0 109.401 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -65.96 140.54 58.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 0.0 110.086 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.433 HG12 HG21 ' A' ' 85' ' ' THR . 56.3 mt -84.42 150.25 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.437 -0.789 . . . . 0.0 109.894 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 122' ' ' ASP . 0.3 OUTLIER -93.24 76.67 4.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.858 . . . . 0.0 108.792 179.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -58.21 142.79 46.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.508 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.596 ' CZ ' ' NE2' ' A' ' 267' ' ' GLN . 51.8 t80 -87.3 101.97 14.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 24.4 t -94.22 133.64 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.584 -0.698 . . . . 0.0 110.686 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.77 116.16 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -92.0 -28.71 17.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.966 -1.084 . . . . 0.0 110.296 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.65 156.99 78.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.192 -0.943 . . . . 0.0 109.931 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.56 150.15 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.913 2.409 . . . . 0.0 112.39 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 5.3 tt -159.21 151.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.376 -0.828 . . . . 0.0 109.323 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.82 145.91 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.842 . . . . 0.0 109.366 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.9 m -132.12 147.98 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -131.78 161.32 33.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.245 -0.909 . . . . 0.0 110.137 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.634 ' HB3' HD13 ' A' ' 255' ' ' LEU . 6.6 t70 -170.35 102.21 0.27 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.23 -0.919 . . . . 0.0 110.082 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.472 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 47.6 59.26 4.26 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.413 -0.805 . . . . 0.0 110.677 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.78 -35.86 3.19 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.456 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -62.94 135.98 57.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.885 -1.362 . . . . 0.0 109.132 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.697 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.2 tt -143.08 139.36 30.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 110.148 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.649 HG21 HD22 ' A' ' 259' ' ' LEU . 91.4 mt -137.47 134.13 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.415 -0.803 . . . . 0.0 109.734 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.6 tttt -123.75 131.48 53.61 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.53 0.681 . . . . 0.0 109.998 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.17 134.37 55.22 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -145.01 150.47 45.84 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.103 -0.998 . . . . 0.0 110.197 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -48.37 142.51 17.02 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.566 2.177 . . . . 0.0 113.35 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.76 147.24 18.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 0.5 OUTLIER -69.84 -18.07 63.42 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.407 -0.808 . . . . 0.0 110.238 -179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.3 p -133.51 -173.33 3.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.199 -0.938 . . . . 0.0 109.49 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.526 ' N ' ' OE2' ' A' ' 168' ' ' GLU . 16.3 tp -102.43 123.02 45.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.095 -1.003 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.6 ' HG3' HG22 ' A' ' 167' ' ' VAL . 11.2 tt0 -136.83 129.04 29.73 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 108.632 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 41.2 t -129.09 121.34 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 109.557 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 88.1 m -112.27 152.15 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.639 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -138.83 129.72 26.46 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.965 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -120.57 131.91 54.89 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.0 132.3 6.21 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.701 -178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.24 97.59 9.29 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.157 -1.424 . . . . 0.0 107.157 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -81.57 166.98 19.76 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.368 -0.832 . . . . 0.0 111.169 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 6.9 mttm -105.87 23.6 13.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.752 -0.593 . . . . 0.0 110.034 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 159' ' ' LEU . 35.4 p-10 -140.53 -169.74 2.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.016 -1.053 . . . . 0.0 110.635 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -47.15 -4.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.618 -0.676 . . . . 0.0 111.664 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 17.5 mt -85.27 -28.63 25.2 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.334 -1.479 . . . . 0.0 109.111 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.14 -132.47 41.83 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.615 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 4.4 ttm105 -97.02 129.84 44.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.987 -1.302 . . . . 0.0 109.8 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.628 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -132.81 139.36 47.47 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -137.57 144.05 41.86 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 110.131 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -143.56 136.12 27.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.278 -0.889 . . . . 0.0 109.724 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 5.3 m -106.98 124.53 49.76 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.417 -0.802 . . . . 0.0 110.037 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -105.8 118.48 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.336 -0.853 . . . . 0.0 110.378 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.6 HG22 ' HG3' ' A' ' 148' ' ' GLU . 26.0 t -113.59 158.42 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.75 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.526 ' OE2' ' N ' ' A' ' 147' ' ' LEU . 30.9 mt-10 -50.18 125.15 11.71 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.301 -0.875 . . . . 0.0 108.92 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.89 6.59 39.94 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -120.31 15.81 12.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.083 -1.245 . . . . 0.0 108.698 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.31 -49.63 73.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.404 -0.81 . . . . 0.0 110.034 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -51.2 -22.33 2.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -0.906 . . . . 0.0 110.087 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -86.12 -6.99 58.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 0.0 111.441 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 8.9 pt -124.95 -27.68 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 120.888 -1.133 . . . . 0.0 111.552 -178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 5.8 m -61.98 -24.27 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.528 -1.358 . . . . 0.0 108.694 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.45 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -82.31 -5.54 58.64 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.446 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.32 118.5 11.49 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.189 -0.944 . . . . 0.0 109.005 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 41.3 mtm180 -81.21 171.8 14.42 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.192 -0.943 . . . . 0.0 109.197 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.8 t -77.94 164.16 25.36 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -149.3 146.03 27.34 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.168 -1.582 . . . . 0.0 111.629 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.576 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -144.81 158.93 43.61 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 85.6 m-85 -101.24 146.03 28.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.109 -0.994 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 9.9 p30 -52.08 -32.91 36.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.233 -0.917 . . . . 0.0 109.935 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.1 p90 -71.8 -26.16 62.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.756 -1.215 . . . . 0.0 109.645 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.449 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.5 tt0 -83.81 -40.29 18.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.101 -1.0 . . . . 0.0 110.049 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.512 HG21 HB11 ' A' ' 500' ' ' C90 . 67.2 mt -43.17 -59.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.075 -1.016 . . . . 0.0 109.614 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.8 tp10 -42.1 -38.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.743 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.597 ' O ' HG22 ' A' ' 192' ' ' VAL . 12.4 t-160 -76.85 -42.81 38.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.137 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 71.6 mt -60.97 -27.6 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.417 -0.802 . . . . 0.0 109.579 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -85.64 -53.15 5.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.666 -1.271 . . . . 0.0 109.143 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -50.99 -41.17 59.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 110.172 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 188' ' ' HIS . 18.8 m -74.56 4.9 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.2 38.82 38.53 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 194' ' ' LEU . 56.2 mt -129.89 171.36 12.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -1.141 . . . . 0.0 109.684 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.406 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.94 24.82 58.59 Favored Glycine 0 N--CA 1.492 2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.487 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -59.6 -18.48 41.7 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.425 -1.633 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.407 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.24 25.22 10.02 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.09 130.18 9.96 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.8 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.6 t -144.42 171.2 14.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -1.138 . . . . 0.0 109.679 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.426 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 59.5 mt -69.78 -8.41 47.96 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -98.69 -13.75 20.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.642 -0.661 . . . . 0.0 109.696 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 18.7 p30 -130.33 7.1 4.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.311 -0.868 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.3 m -149.19 150.13 32.13 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.092 -1.005 . . . . 0.0 110.105 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.684 HD11 HD21 ' A' ' 206' ' ' LEU . 12.5 tp -97.96 95.26 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 48.6 t -87.05 127.87 40.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.985 0.898 . . . . 0.0 109.497 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.684 HD21 HD11 ' A' ' 204' ' ' LEU . 34.3 mt -123.28 164.89 17.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.613 -0.68 . . . . 0.0 109.303 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.04 -166.63 11.98 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.414 ' HZ2' ' HB2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -60.03 -34.79 73.85 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.507 -0.996 . . . . 0.0 109.325 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -153.41 23.76 0.54 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.926 -1.109 . . . . 0.0 110.74 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -142.12 149.04 39.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.614 -1.304 . . . . 0.0 110.702 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 88.4 t -101.49 111.05 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.19 -46.41 85.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.977 -1.077 . . . . 0.0 110.148 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.1 118.28 31.48 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.216 -0.927 . . . . 0.0 109.827 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -67.6 -17.2 48.15 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -73.85 -14.32 61.06 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.296 -0.878 . . . . 0.0 108.99 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.8 -176.98 45.28 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.4 mt -84.37 153.05 23.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.147 -1.208 . . . . 0.0 109.558 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.568 ' CG ' HH11 ' A' ' 218' ' ' ARG . 0.0 OUTLIER -82.2 -18.4 42.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.375 -0.828 . . . . 0.0 108.839 179.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.564 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 33.0 m-85 -145.53 -165.14 2.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -0.751 . . . . 0.0 108.998 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -100.19 -4.84 28.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.137 -0.977 . . . . 0.0 109.309 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.675 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -141.91 40.86 1.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.242 -0.912 . . . . 0.0 109.544 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.85 -47.36 97.09 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.876 -1.14 . . . . 0.0 109.584 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.7 Cg_exo -51.8 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.375 2.05 . . . . 0.0 112.076 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.9 m -58.86 -35.06 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.067 -1.021 . . . . 0.0 109.624 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.466 ' NH1' ' CD2' ' A' ' 219' ' ' TYR . 58.2 mtt180 -60.21 -40.66 90.92 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.446 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 11.9 t60 -69.43 -32.1 70.85 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.162 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -64.88 -35.73 82.08 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.72 -40.85 84.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 63.5 t80 -61.78 -51.46 68.22 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.611 0.719 . . . . 0.0 109.13 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.548 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 92.0 m-20 -65.6 -27.48 68.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 110.016 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.6 tp -77.46 -34.24 54.48 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.094 -1.004 . . . . 0.0 108.777 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 57.9 mt -68.31 -38.5 79.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.92 -56.8 11.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 2.2 m-20 -53.16 -35.06 59.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.096 -1.238 . . . . 0.0 108.671 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.0 mt -62.01 -23.51 66.48 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.639 -0.663 . . . . 0.0 110.325 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.578 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.04 -21.8 61.48 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.835 -1.166 . . . . 0.0 108.821 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 237' ' ' LEU . 53.3 mt -51.22 -1.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.619 -1.3 . . . . 0.0 110.416 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.624 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -77.86 -15.61 58.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.903 -1.123 . . . . 0.0 109.526 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.68 58.01 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.14 -1.029 . . . . 0.0 110.605 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.64 153.88 10.13 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 120.901 -1.352 . . . . 0.0 109.127 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.66 130.22 39.14 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.904 1.736 . . . . 0.0 109.939 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 68.5 t -86.22 147.56 5.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-O 122.204 1.002 . . . . 0.0 112.558 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 16.7 mmtt -131.34 124.71 30.96 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.28 -155.58 26.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 7.2 tptm -131.8 133.77 45.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.315 -1.109 . . . . 0.0 109.119 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 11.8 m-85 -135.09 140.01 45.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 110.391 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.459 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.1 t80 -125.34 132.23 52.87 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.2 t -127.62 136.85 52.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.989 -1.069 . . . . 0.0 111.12 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -118.25 112.97 20.8 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.8 mtp85 53.41 24.91 4.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.291 -0.88 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -63.97 153.0 48.21 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.49 177.5 18.75 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.585 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 74.8 m-70 -57.72 -36.25 71.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -1.187 . . . . 0.0 109.427 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 29.6 t -58.97 -58.62 7.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 109.589 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 134' ' ' ASP . 9.0 tp -59.53 -44.6 93.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.501 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -47.94 -50.62 26.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 109.286 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.757 HG21 HG21 ' A' ' 56' ' ' THR . 70.7 t -63.18 -50.44 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.16 -50.9 63.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.06 -1.025 . . . . 0.0 109.32 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.649 HD22 HG21 ' A' ' 139' ' ' ILE . 28.8 tp -52.22 -59.36 4.49 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.123 -0.986 . . . . 0.0 108.447 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.624 HG13 ' HG ' ' A' ' 238' ' ' LEU . 43.1 t -48.39 -55.58 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 257' ' ' VAL . 0.0 OUTLIER -46.39 -47.53 18.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.682 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -65.17 -47.02 78.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.223 -0.923 . . . . 0.0 109.775 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -59.51 -49.79 76.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 110.16 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.572 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -70.76 -32.13 69.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.37 -0.831 . . . . 0.0 110.406 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.443 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 4.3 mmtp -69.8 -46.84 64.82 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.946 . . . . 0.0 109.945 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -67.1 -52.51 41.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 0.0 109.73 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.596 ' NE2' ' CZ ' ' A' ' 124' ' ' PHE . 4.9 tt0 -55.94 -8.93 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 109.807 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 269' ' ' LEU . 0.0 OUTLIER -81.69 114.76 20.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.097 -1.002 . . . . 0.0 109.471 -179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 268' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.576 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.1 mt -98.05 155.25 17.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.351 -1.088 . . . . 0.0 109.427 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.472 ' CD ' HD21 ' A' ' 86' ' ' ASN . 70.8 mt-10 -55.22 139.85 40.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -0.874 . . . . 0.0 108.833 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.02 142.81 49.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 109.907 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -140.55 -172.71 3.5 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.4 m -97.93 136.38 29.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.003 -1.06 . . . . 0.0 109.074 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -66.97 -23.29 65.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 0.0 109.549 -179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 2.5 pt-20 -146.92 170.04 17.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.269 -0.894 . . . . 0.0 109.446 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.73 141.08 38.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.3 mt -120.03 166.47 13.33 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.67 143.18 41.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.071 -1.018 . . . . 0.0 110.418 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.45 ' CE1' HD12 ' A' ' 28' ' ' ILE . 79.1 m-85 -139.24 154.15 47.95 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -161.98 150.8 15.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.875 -1.141 . . . . 0.0 110.019 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.22 174.98 36.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 p -82.81 153.55 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -1.115 . . . . 0.0 110.183 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.86 140.11 16.24 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.457 HD11 ' OG1' ' A' ' 203' ' ' THR . 9.6 tt -61.52 -37.89 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.916 -1.344 . . . . 0.0 110.379 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 45.8 m-70 -86.77 -51.07 6.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.634 -1.291 . . . . 0.0 111.096 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -73.47 -20.93 60.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.741 -0.599 . . . . 0.0 111.706 -177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.33 16.41 14.73 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.114 -1.517 . . . . 0.0 109.492 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -106.22 154.07 21.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -1.114 . . . . 0.0 109.598 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -74.9 134.53 41.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.374 -0.829 . . . . 0.0 109.929 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 71.0 m -138.61 143.03 39.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.22 -0.925 . . . . 0.0 109.398 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -110.87 157.74 19.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.299 -0.876 . . . . 0.0 109.728 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.498 HD23 ' O ' ' A' ' 90' ' ' GLU . 7.9 mt -138.2 147.77 44.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.447 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.568 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.9 mt -142.55 112.69 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 108.825 178.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.45 HD12 ' CE1' ' A' ' 13' ' ' PHE . 55.2 mt -96.09 114.57 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.318 -0.864 . . . . 0.0 111.123 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.568 ' NE2' HG22 ' A' ' 27' ' ' ILE . 24.5 m-70 -109.4 139.3 20.97 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 109.669 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 22.7 Cg_exo -55.12 168.6 1.22 Allowed 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.828 1.686 . . . . 0.0 111.758 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 64.2 mm-40 -141.72 178.22 7.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.993 . . . . 0.0 109.816 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.455 ' O ' ' OG1' ' A' ' 35' ' ' THR . 23.9 mmtm -85.72 152.49 23.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.32 -0.863 . . . . 0.0 109.934 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -46.07 145.08 1.67 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 110.187 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.402 ' N ' ' OE1' ' A' ' 4' ' ' GLU . . . 67.78 9.17 55.52 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.169 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -70.03 -41.67 73.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.63 -1.512 . . . . 0.0 109.49 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 94.99 179.69 37.14 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.815 -1.183 . . . . 0.0 110.539 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.1 mm -96.61 116.26 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -138.8 144.43 39.34 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.511 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -96.59 158.34 15.48 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -131.02 110.18 11.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 109.222 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -136.63 134.97 37.9 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.475 -0.765 . . . . 0.0 110.558 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.14 26.95 10.83 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 111.275 178.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.46 17.95 78.49 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.81 122.11 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.474 -1.015 . . . . 0.0 109.049 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -83.98 127.46 33.89 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.191 -0.943 . . . . 0.0 109.243 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.4 mt -115.71 94.4 40.53 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.422 -0.799 . . . . 0.0 109.446 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.12 145.71 33.14 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.594 2.196 . . . . 0.0 112.0 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.574 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -80.6 65.58 5.79 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.157 -0.964 . . . . 0.0 109.302 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -119.49 153.24 35.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.407 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 1.8 p-80 -57.71 -53.67 55.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.203 -0.936 . . . . 0.0 109.985 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.508 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 6.0 mm-40 -43.84 -17.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.232 -0.917 . . . . 0.0 111.043 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 50' ' ' HIS . 16.0 m-85 -94.13 5.11 52.77 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.664 -1.272 . . . . 0.0 109.79 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 50' ' ' HIS . 79.8 t -72.66 130.87 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.3 m -112.53 -29.04 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.345 -0.847 . . . . 0.0 109.894 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.429 ' O ' ' OD1' ' A' ' 61' ' ' ASP . 2.4 t-80 -150.13 131.22 14.41 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.046 -1.034 . . . . 0.0 109.915 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.822 HG21 HG21 ' A' ' 257' ' ' VAL . 67.7 p -121.98 95.84 4.82 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.38 128.56 3.53 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 59' ' ' SER . 72.6 m-70 52.79 5.81 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.082 -1.011 . . . . 0.0 109.047 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.1 m 165.16 151.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.215 -0.928 . . . . 0.0 109.872 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.404 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 31.1 m -91.12 126.54 36.23 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.241 -0.912 . . . . 0.0 109.366 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' OD2' ' NZ ' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -120.29 149.57 42.09 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.449 -0.782 . . . . 0.0 111.12 -178.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.687 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.4 mt -126.28 147.54 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.52 155.91 27.25 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 118.961 -1.59 . . . . 0.0 110.587 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -160.42 147.64 15.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -1.047 . . . . 0.0 109.095 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.21 24.18 4.77 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.283 -0.885 . . . . 0.0 109.647 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.52 -31.35 7.89 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 8.3 mm-40 -60.34 144.25 51.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.245 . . . . 0.0 108.916 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -143.06 141.38 31.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -0.961 . . . . 0.0 110.475 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.09 123.32 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' NZ ' ' OD2' ' A' ' 61' ' ' ASP . 13.2 mtpp -99.36 154.63 18.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.966 -1.083 . . . . 0.0 111.128 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.5 m 50.79 74.38 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.338 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.687 HG21 ' CD1' ' A' ' 62' ' ' LEU . 35.9 m -106.92 -10.08 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.236 -0.915 . . . . 0.0 108.927 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 8.9 pm0 -61.34 -26.3 67.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.586 -0.696 . . . . 0.0 110.353 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.2 m170 -66.58 -69.38 0.31 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.91 -1.119 . . . . 0.0 109.47 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.01 -47.37 42.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.131 -0.981 . . . . 0.0 108.979 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.587 ' N ' HG23 ' A' ' 75' ' ' ILE . 16.8 mt -52.1 -49.22 64.03 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.04 -1.038 . . . . 0.0 110.254 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.4 t -60.65 -42.82 97.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.105 -0.997 . . . . 0.0 110.247 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 76.6 t -56.04 -48.37 78.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.05 -1.031 . . . . 0.0 109.145 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 mt -64.04 -33.9 76.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.165 179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -63.4 -37.17 86.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.912 . . . . 0.0 109.268 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 74.8 mt -79.29 -38.76 34.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.414 -0.804 . . . . 0.0 109.648 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 107' ' ' TYR . 77.8 mt -80.36 -0.48 37.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.292 -0.88 . . . . 0.0 109.132 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 56.89 42.38 26.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.666 -0.646 . . . . 0.0 111.622 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 17.4 mm -89.41 144.24 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.697 -1.252 . . . . 0.0 108.574 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.571 HG21 HG12 ' A' ' 121' ' ' ILE . 43.5 p -127.88 -20.81 3.79 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.192 -0.943 . . . . 0.0 111.815 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.684 ' O ' HG13 ' A' ' 87' ' ' VAL . 33.6 m-80 -124.99 108.12 11.52 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.838 -1.164 . . . . 0.0 110.66 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.75 148.23 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.363 -0.836 . . . . 0.0 110.421 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.47 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 94.3 m -114.71 113.53 24.42 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 5.5 mt -97.27 100.77 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 110.412 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.1 tt0 -74.63 124.83 27.41 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.442 HG22 HD21 ' A' ' 26' ' ' LEU . 20.0 t -109.96 131.93 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 122.048 0.928 . . . . 0.0 111.707 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 mm -116.15 95.9 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.67 -156.9 26.07 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -121.37 -9.51 9.03 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.439 -1.036 . . . . 0.0 109.999 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -140.53 148.81 41.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.012 -1.055 . . . . 0.0 109.648 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.417 HG23 HD11 ' A' ' 26' ' ' LEU . 39.2 mm -72.07 119.37 74.16 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 108.987 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -39.94 120.09 0.73 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 121.739 1.626 . . . . 0.0 111.29 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.443 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -75.04 -10.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 110.774 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 95.9 mt 54.7 -120.7 1.68 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.091 -1.006 . . . . 0.0 109.995 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.6 8.22 44.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.044 -1.035 . . . . 0.0 110.783 -178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.96 -3.66 67.36 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.446 -1.359 . . . . 0.0 110.197 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.18 -172.54 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.768 -0.842 . . . . 0.0 109.486 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.0 9.0 9.76 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.407 ' HB2' HD22 ' A' ' 176' ' ' LEU . 33.6 t-105 -55.49 -39.52 70.55 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -1.135 . . . . 0.0 110.452 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -64.12 -59.31 4.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -50.84 -44.83 59.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.209 -0.932 . . . . 0.0 109.38 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 82' ' ' LEU . 36.2 t80 -60.92 -48.05 83.58 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.541 -0.724 . . . . 0.0 110.786 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -65.82 -42.47 90.56 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.009 -1.057 . . . . 0.0 111.28 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.49 -52.06 43.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.913 -1.117 . . . . 0.0 110.356 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.05 -32.86 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.943 -1.098 . . . . 0.0 109.444 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -63.79 -43.44 96.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 0.0 109.822 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.623 ' C ' HD22 ' A' ' 113' ' ' ASN . 1.3 ptpm? -77.81 11.1 2.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.017 -1.052 . . . . 0.0 109.852 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.623 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.92 33.23 1.97 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 109.827 -179.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.29 138.82 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.864 -1.147 . . . . 0.0 111.212 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 8' ' ' LYS . 9.0 tp -132.75 123.56 26.45 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.65 145.15 31.79 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.343 -0.848 . . . . 0.0 110.221 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -112.61 -173.19 2.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.763 . . . . 0.0 109.352 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -109.34 68.6 0.68 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 55.1 ttm-85 -164.09 128.76 2.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.088 -1.007 . . . . 0.0 109.315 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -67.69 140.58 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.99 -1.069 . . . . 0.0 109.667 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.571 HG12 HG21 ' A' ' 85' ' ' THR . 69.3 mt -83.94 150.47 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.843 . . . . 0.0 109.906 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.64 85.94 3.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.366 -0.834 . . . . 0.0 108.876 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 241' ' ' PRO . 25.1 m-85 -63.52 142.79 58.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.251 -0.906 . . . . 0.0 109.545 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -87.54 101.38 13.57 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.43 134.16 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.663 -0.648 . . . . 0.0 110.75 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 90.5 t -68.97 111.69 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -83.74 -33.5 25.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.944 -1.098 . . . . 0.0 110.725 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.25 156.93 78.58 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.175 -0.953 . . . . 0.0 109.784 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.09 149.0 45.63 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.791 2.327 . . . . 0.0 112.241 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.0 tt -159.01 151.48 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.322 -0.861 . . . . 0.0 109.19 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.38 143.51 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 8.1 m -125.76 148.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.89 157.38 46.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.466 ' HB3' HD13 ' A' ' 255' ' ' LEU . 10.5 t70 -174.15 106.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.221 -0.924 . . . . 0.0 109.796 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 49.58 53.43 12.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.438 -0.789 . . . . 0.0 110.803 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.57 -35.68 3.17 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.416 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.581 ' HB3' HD22 ' A' ' 255' ' ' LEU . 0.9 OUTLIER -63.48 131.81 49.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.932 -1.334 . . . . 0.0 108.906 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -143.98 139.79 29.26 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.986 -1.071 . . . . 0.0 109.891 -179.768 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.568 HG21 HD22 ' A' ' 259' ' ' LEU . 62.6 mt -136.9 127.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.448 -0.783 . . . . 0.0 109.59 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -112.49 131.76 55.42 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.411 0.624 . . . . 0.0 109.752 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.1 135.37 54.8 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.88 149.19 32.44 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.128 -0.983 . . . . 0.0 109.648 179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -46.35 143.53 7.96 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 122.661 2.241 . . . . 0.0 113.272 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.425 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.92 145.62 19.89 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 146' ' ' THR . 44.0 t0 -65.34 -4.71 5.82 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.362 -0.836 . . . . 0.0 110.541 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 145' ' ' ASP . 21.8 p -155.66 -177.78 6.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.888 -1.132 . . . . 0.0 109.755 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.9 tp -92.26 119.35 31.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.24 -0.912 . . . . 0.0 109.048 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' HG22 ' A' ' 167' ' ' VAL . 1.1 tt0 -135.16 110.32 8.91 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 47.0 t -111.29 122.09 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.32 -0.863 . . . . 0.0 110.079 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 70.7 m -112.32 151.98 29.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.624 -0.673 . . . . 0.0 109.229 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -139.62 131.71 27.98 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.128 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -122.0 132.98 54.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.4 144.67 16.2 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.747 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -109.82 105.97 15.39 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -95.18 166.86 11.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.158 -0.964 . . . . 0.0 110.786 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -98.07 -16.69 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.576 -0.703 . . . . 0.0 110.9 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.557 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.7 p-10 -94.79 -173.14 2.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.751 -1.218 . . . . 0.0 110.217 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -50.35 0.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.431 -0.793 . . . . 0.0 111.642 -178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.557 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.2 mt -77.74 -27.8 50.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.343 -1.473 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.76 -140.5 34.05 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -104.16 137.89 41.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.302 -1.116 . . . . 0.0 109.691 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -143.89 159.14 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.427 -0.796 . . . . 0.0 109.497 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -146.67 147.68 31.27 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.419 -0.8 . . . . 0.0 109.865 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -142.86 135.65 27.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.326 -0.859 . . . . 0.0 109.645 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 98.6 m -104.56 122.87 46.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 109.894 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -104.46 112.34 25.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.275 -0.891 . . . . 0.0 109.81 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 148' ' ' GLU . 4.9 t -106.38 152.36 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 CA-C-O 121.758 0.79 . . . . 0.0 109.901 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -49.28 127.04 14.14 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.248 -0.907 . . . . 0.0 108.808 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 111.86 -3.57 27.35 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -116.69 20.72 13.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.162 -1.199 . . . . 0.0 108.962 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.444 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -54.04 -22.78 11.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.445 -0.784 . . . . 0.0 110.542 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -18.21 48.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.041 -1.037 . . . . 0.0 109.99 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -84.2 -6.37 59.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.1 -1.0 . . . . 0.0 111.476 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 26.0 pt -125.19 -26.21 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.865 -1.147 . . . . 0.0 111.221 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 171' ' ' GLU . 6.5 m -60.5 -24.01 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 120.623 -1.298 . . . . 0.0 108.716 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.407 HD22 ' HB2' ' A' ' 104' ' ' TRP . 1.2 mm? -83.56 -3.23 57.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.556 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.99 113.5 7.26 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.183 -0.948 . . . . 0.0 109.345 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.569 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 73.0 mtm180 -79.31 172.36 13.9 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.322 -0.861 . . . . 0.0 109.254 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.6 t -77.26 161.13 28.37 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -144.39 146.06 32.29 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.282 -1.512 . . . . 0.0 111.439 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.629 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -144.93 154.55 42.71 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.422 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 70.2 m-85 -98.09 145.82 26.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.018 -1.051 . . . . 0.0 109.362 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.61 -36.97 37.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.364 -0.835 . . . . 0.0 109.989 -179.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.3 p90 -71.42 -27.19 63.12 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.843 -1.161 . . . . 0.0 110.039 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.1 tt0 -78.97 -43.18 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.979 -1.076 . . . . 0.0 110.137 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.45 ' O ' ' C ' ' A' ' 187' ' ' GLU . 21.3 mt -41.0 -61.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.256 -0.903 . . . . 0.0 110.145 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.7 tt0 -40.49 -41.37 1.42 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 0.0 110.193 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.457 ' O ' HG22 ' A' ' 192' ' ' VAL . 74.3 t60 -76.24 -46.22 29.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.192 -0.942 . . . . 0.0 109.402 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 74.7 mt -56.5 -30.86 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -80.65 -52.23 7.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.826 -1.171 . . . . 0.0 108.883 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -48.61 -44.56 37.23 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.852 . . . . 0.0 110.334 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.1 m -74.86 6.32 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.073 -1.017 . . . . 0.0 110.326 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.41 41.79 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 120.177 -1.011 . . . . 0.0 110.584 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.4 mt -127.73 178.39 6.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.186 -1.185 . . . . 0.0 109.455 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 50.83 24.28 7.95 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -61.23 -19.3 61.5 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.624 -1.516 . . . . 0.0 110.59 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.47 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -107.27 4.82 35.49 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -64.57 125.03 30.44 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 121.136 -1.214 . . . . 0.0 110.296 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.559 ' N ' HD21 ' A' ' 202' ' ' ASN . 3.5 t -135.99 174.22 10.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -1.028 . . . . 0.0 109.456 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 213' ' ' ASN . 2.2 mm? -73.91 -9.14 58.34 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -102.78 -17.67 15.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.642 -0.662 . . . . 0.0 110.289 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 199' ' ' SER . 18.9 p30 -120.04 7.91 10.93 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.286 -0.884 . . . . 0.0 110.666 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.477 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -150.84 151.25 31.99 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.872 -1.143 . . . . 0.0 110.556 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.2 tp -98.99 93.54 6.06 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.477 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -86.08 129.19 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.687 0.756 . . . . 0.0 109.277 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 211' ' ' VAL . 11.9 mt -123.48 162.95 21.85 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.611 -0.68 . . . . 0.0 109.454 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -121.41 -166.38 12.91 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.92 -28.26 66.5 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.384 -1.068 . . . . 0.0 109.588 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -148.44 20.98 1.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 111.153 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.6 160.99 43.17 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.465 -1.397 . . . . 0.0 110.823 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 206' ' ' LEU . 86.9 t -107.59 116.35 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -60.28 -42.93 96.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.578 ' HA ' HD12 ' A' ' 200' ' ' LEU . 8.9 m120 -65.06 115.61 22.71 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.158 -0.964 . . . . 0.0 109.799 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -64.69 -10.53 25.09 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 121.16 1.24 . . . . 0.0 111.205 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -74.97 -20.13 59.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.408 -0.807 . . . . 0.0 109.286 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.24 -179.5 45.53 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.5 mt -86.1 133.51 33.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.073 -1.251 . . . . 0.0 109.312 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.6 OUTLIER -64.99 -17.71 64.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.341 -0.85 . . . . 0.0 109.318 179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.509 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 39.2 m-85 -143.33 -170.46 3.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.71 -4.37 44.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 109.762 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.79 43.61 1.26 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.213 -0.93 . . . . 0.0 109.649 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.3 tt0 -53.86 -47.84 95.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.997 -1.065 . . . . 0.0 109.833 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.521 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.5 Cg_exo -51.37 -65.33 0.15 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.487 2.124 . . . . 0.0 112.31 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.39 -35.19 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.986 -1.071 . . . . 0.0 109.461 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -62.72 -39.44 94.07 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.569 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 8.5 t60 -68.02 -32.68 73.22 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -64.17 -35.72 81.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.88 -35.48 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -65.97 -53.01 44.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 109.172 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.437 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 93.1 m-20 -63.98 -28.86 70.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.457 -0.777 . . . . 0.0 109.797 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.12 -34.97 49.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.085 -1.01 . . . . 0.0 109.018 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.9 mt -66.55 -38.53 81.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.5 -54.87 17.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -55.27 -30.19 59.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.0 108.825 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 235' ' ' LEU . 11.6 mt -65.86 -24.23 66.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.529 -0.732 . . . . 0.0 110.442 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.78 -21.8 61.67 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.855 -1.153 . . . . 0.0 108.54 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.406 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 38.9 mt -48.19 -7.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.762 -1.211 . . . . 0.0 109.905 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 236' ' ' TYR . 7.2 mt -74.03 -16.6 61.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.767 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 95.77 3.83 60.68 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.823 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.79 152.99 10.6 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.763 -1.433 . . . . 0.0 109.301 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.413 ' HB2' ' CE2' ' A' ' 123' ' ' TYR . 8.1 Cg_endo -53.91 127.22 24.71 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 121.956 1.771 . . . . 0.0 110.002 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.8 t -86.43 150.61 3.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.15 -0.969 . . . . 0.0 112.289 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.57 125.86 29.72 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.51 -160.59 29.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -128.6 133.56 48.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -1.107 . . . . 0.0 108.951 -179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.8 m-85 -132.92 141.65 48.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 110.945 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -124.76 124.94 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.2 t -118.83 135.69 54.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.946 -1.096 . . . . 0.0 111.28 -178.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -116.87 114.75 24.33 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 69.6 mtp180 48.41 25.77 0.98 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.193 -0.942 . . . . 0.0 109.415 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.57 164.11 12.34 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.488 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -145.01 173.94 25.27 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.446 ' O ' HG23 ' A' ' 257' ' ' VAL . 77.4 m-70 -54.41 -43.52 71.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.258 -1.142 . . . . 0.0 109.728 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 p -55.37 -58.6 7.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.131 -0.981 . . . . 0.0 109.489 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 137' ' ' ARG . 5.9 tp -54.88 -46.23 74.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 109.383 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.0 m-20 -47.43 -48.11 26.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.942 -1.099 . . . . 0.0 109.046 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.822 HG21 HG21 ' A' ' 56' ' ' THR . 44.9 t -63.85 -50.03 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 109.96 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -56.31 -50.27 71.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.961 -1.087 . . . . 0.0 109.542 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.568 HD22 HG21 ' A' ' 139' ' ' ILE . 35.6 tp -52.58 -50.53 62.8 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.063 -1.023 . . . . 0.0 108.636 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.576 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.4 t -57.79 -55.28 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.274 -0.891 . . . . 0.0 109.165 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.69 -49.08 14.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.53 -0.731 . . . . 0.0 109.838 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.82 -49.53 72.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.278 -0.889 . . . . 0.0 110.109 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 34.2 mt -58.17 -50.94 71.78 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 0.0 110.38 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -33.16 75.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.123 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 16.5 mmtt -67.6 -38.06 83.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.08 -1.012 . . . . 0.0 109.374 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -71.91 -65.28 0.79 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.282 -0.886 . . . . 0.0 109.645 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.469 ' O ' ' CB ' ' A' ' 268' ' ' LYS . 11.2 tt0 -59.06 -92.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.771 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 267' ' ' GLN . 10.8 ttpt 166.35 123.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 0.0 109.261 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.95 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.629 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.6 mt -98.16 155.61 17.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.225 -1.162 . . . . 0.0 109.574 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 73.8 mt-10 -56.04 135.04 52.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.123 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -120.38 142.67 48.97 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.777 0.799 . . . . 0.0 109.773 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -139.46 -170.34 2.88 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.8 m -100.32 137.55 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.33 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -64.88 -19.87 66.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 109.857 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -155.95 157.42 36.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.113 -0.992 . . . . 0.0 109.694 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 140.36 58.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.946 . . . . 0.0 109.805 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.8 mt -119.07 157.08 28.55 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.1 p -127.67 140.13 52.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.945 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.43 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.2 m-85 -138.04 147.67 44.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' OE2' ' OH ' ' A' ' 23' ' ' TYR . 4.4 pt-20 -156.8 151.98 26.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.74 -1.225 . . . . 0.0 110.228 -179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.16 175.66 36.72 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.6 p -82.06 152.93 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 110.222 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.67 140.07 15.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 19' ' ' HIS . 11.4 tt -59.31 -39.05 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.039 -1.271 . . . . 0.0 110.269 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.449 ' N ' HG23 ' A' ' 18' ' ' ILE . 34.0 m-70 -88.43 -50.05 6.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.688 -1.258 . . . . 0.0 110.77 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -70.45 -22.95 62.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.555 -0.716 . . . . 0.0 111.297 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.24 10.92 4.37 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -103.64 156.18 17.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -1.109 . . . . 0.0 109.636 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.458 ' OH ' ' OE2' ' A' ' 14' ' ' GLU . 32.2 t80 -74.82 136.25 41.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.374 -0.829 . . . . 0.0 109.741 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -141.04 143.51 34.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.601 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -109.77 159.02 17.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.895 . . . . 0.0 109.999 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.29 145.12 40.87 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.626 -0.671 . . . . 0.0 109.475 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.503 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.3 mt -142.18 107.29 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.139 -0.976 . . . . 0.0 108.867 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mt -90.85 113.77 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.356 -0.84 . . . . 0.0 110.366 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.503 ' NE2' HG22 ' A' ' 27' ' ' ILE . 57.2 m-70 -107.74 137.26 19.69 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.438 -0.789 . . . . 0.0 109.4 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG3' HG23 ' A' ' 7' ' ' VAL . 33.2 Cg_exo -50.1 167.72 0.21 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.847 1.698 . . . . 0.0 111.532 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.498 ' HB3' HG21 ' A' ' 35' ' ' THR . 28.0 mm-40 -144.99 160.48 41.28 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.264 -0.975 . . . . 0.0 109.886 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.487 ' O ' ' OG1' ' A' ' 35' ' ' THR . 43.8 mttp -68.0 149.1 50.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -48.41 151.05 1.15 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.141 -0.974 . . . . 0.0 110.093 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.563 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 68.63 -2.12 8.46 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.66 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 24.6 m -62.21 -42.75 99.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.467 . . . . 0.0 109.558 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.689 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 95.86 179.45 36.02 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.415 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 87' ' ' VAL . 14.6 mm -96.58 116.81 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -140.91 147.68 39.25 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 0.0 110.215 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -95.34 157.42 15.9 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -129.06 112.17 13.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 108.976 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.7 tttm -135.58 133.43 38.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.0 110.636 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 53.5 26.82 5.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 0.0 111.313 178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.43 20.26 64.67 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.097 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 67.5 t -124.46 124.49 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -1.093 . . . . 0.0 109.322 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -86.37 126.75 34.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.162 -0.961 . . . . 0.0 109.375 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.0 mt -115.78 93.03 36.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.188 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.12 145.5 14.33 Favored 'Trans proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.298 1.999 . . . . 0.0 112.044 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.567 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.93 70.57 8.87 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 109.403 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -120.52 174.73 6.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.483 -0.761 . . . . 0.0 109.159 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.485 ' O ' HG23 ' A' ' 53' ' ' VAL . 16.1 p-80 -78.31 -46.37 20.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.695 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -49.95 -16.62 0.29 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.246 -0.909 . . . . 0.0 110.783 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -93.15 3.97 54.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.754 -1.216 . . . . 0.0 109.825 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 50' ' ' HIS . 75.2 t -70.95 127.76 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.508 HG21 ' HD2' ' A' ' 68' ' ' ARG . 26.9 m -106.32 -31.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.626 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -155.12 139.83 17.07 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.213 -0.929 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.93 HG21 HG21 ' A' ' 257' ' ' VAL . 39.2 p -126.25 95.82 4.51 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 59' ' ' SER . 64.5 t30 -161.39 128.91 4.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.47 -0.769 . . . . 0.0 108.95 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 82.2 m-70 52.95 5.29 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.247 -0.908 . . . . 0.0 109.178 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.558 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.1 OUTLIER 164.11 142.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.694 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' VAL . 34.6 m -81.87 127.3 32.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.0 108.837 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -119.82 148.24 43.69 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.859 0.837 . . . . 0.0 111.071 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.489 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.1 mt -126.84 150.06 49.4 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.36 155.73 27.26 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 118.838 -1.649 . . . . 0.0 110.756 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -164.92 153.55 12.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.479 -1.012 . . . . 0.0 109.7 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.6 mmtt 50.75 21.59 0.95 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.704 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.8 -33.25 6.4 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -61.99 141.86 57.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.083 -1.245 . . . . 0.0 109.245 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.508 ' HD2' HG21 ' A' ' 54' ' ' VAL . 0.5 OUTLIER -137.33 139.69 41.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 110.364 -179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.3 mt -129.23 121.3 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -99.64 157.54 16.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.888 -1.133 . . . . 0.0 110.926 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.9 m 51.23 73.73 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.932 -0.48 . . . . 0.0 110.694 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG21 ' HG ' ' A' ' 62' ' ' LEU . 12.2 m -107.7 -9.29 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.0 108.9 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 18.2 pm0 -61.04 -28.86 69.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 110.75 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.7 m170 -66.83 -67.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.868 -1.145 . . . . 0.0 109.56 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.561 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.15 -46.73 44.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.006 -1.059 . . . . 0.0 109.271 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.567 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.0 mt -53.61 -46.91 70.58 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 120.899 -1.126 . . . . 0.0 110.136 -179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.56 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.6 t -61.87 -43.18 99.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -0.989 . . . . 0.0 110.063 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 89.0 t -56.88 -46.05 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.191 -0.943 . . . . 0.0 109.332 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.05 -34.47 77.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.6 t-160 -62.58 -37.34 85.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.091 -1.006 . . . . 0.0 109.281 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.408 HD12 ' CG1' ' A' ' 175' ' ' VAL . 54.8 mt -78.78 -38.73 37.72 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.286 -0.884 . . . . 0.0 109.904 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 114' ' ' ILE . 72.8 mt -79.9 -1.03 37.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.383 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 57.7 43.01 22.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.725 -0.609 . . . . 0.0 111.339 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.5 mm -88.22 143.74 10.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.887 -1.133 . . . . 0.0 108.688 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.477 HG21 HD13 ' A' ' 121' ' ' ILE . 63.0 p -127.4 -23.44 3.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.24 -0.913 . . . . 0.0 111.822 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.691 ' O ' HG13 ' A' ' 87' ' ' VAL . 29.4 m120 -124.73 107.49 11.01 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.723 -1.235 . . . . 0.0 110.412 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -163.64 147.0 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 0.0 110.33 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 37.9 m -114.23 109.48 18.44 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.8 mt -92.06 100.52 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.1 tt0 -74.48 126.15 30.11 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.512 HG22 HD21 ' A' ' 26' ' ' LEU . 29.4 t -111.74 122.42 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.964 0.887 . . . . 0.0 111.58 -178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 29.1 mm -107.94 96.92 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 142.39 -156.78 26.34 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.901 -1.679 . . . . 0.0 108.901 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -120.66 -10.04 9.26 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -1.095 . . . . 0.0 110.472 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -142.82 150.63 40.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.88 -1.138 . . . . 0.0 110.01 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 36.9 mm -72.76 120.94 83.53 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.245 -0.909 . . . . 0.0 109.117 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -41.85 123.81 2.5 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.517 1.478 . . . . 0.0 110.987 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.4 tp -76.91 -12.43 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 110.369 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.6 mt 56.48 -121.95 1.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.858 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.29 8.89 40.22 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 110.666 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.41 -1.96 67.35 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.436 -1.364 . . . . 0.0 109.696 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.85 -172.46 2.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.841 -0.8 . . . . 0.0 109.401 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.74 16.02 9.61 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.4 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 67.0 t-105 -59.55 -43.47 93.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.409 -1.054 . . . . 0.0 110.28 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.8 -57.61 10.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.175 -0.953 . . . . 0.0 109.824 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -51.21 -44.87 61.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.078 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 62.2 t80 -61.81 -52.42 64.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.633 -0.667 . . . . 0.0 110.674 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.4 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 16.8 mm-40 -60.53 -44.88 95.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 0.0 111.319 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.71 -58.6 4.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.918 -1.114 . . . . 0.0 110.283 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.5 mt -60.22 -33.73 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.09 -1.006 . . . . 0.0 109.452 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.448 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 13.1 ttt180 -62.37 -43.71 98.19 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -76.26 12.51 1.17 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.951 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -143.24 34.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.946 -1.097 . . . . 0.0 110.329 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 82' ' ' LEU . 46.9 mt -80.75 138.55 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.7 tp -132.3 128.87 38.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.331 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -87.87 140.5 29.44 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 0.0 110.694 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -109.72 -170.85 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.575 -0.703 . . . . 0.0 109.16 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -112.9 69.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.24 -0.913 . . . . 0.0 110.599 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -166.01 130.12 2.2 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.959 -1.088 . . . . 0.0 109.708 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -69.76 145.97 51.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.125 -0.984 . . . . 0.0 109.817 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.477 HD13 HG21 ' A' ' 85' ' ' THR . 35.4 mt -90.87 151.48 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 0.0 110.353 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -94.06 79.8 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 50.0 m-85 -59.93 143.01 52.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.383 -0.823 . . . . 0.0 109.483 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.553 ' CE1' ' OE1' ' A' ' 267' ' ' GLN . 83.6 t80 -89.1 101.5 14.16 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.78 132.74 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.707 -0.62 . . . . 0.0 110.785 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.3 t -70.12 111.45 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -88.49 -30.48 19.35 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.104 -0.998 . . . . 0.0 110.233 -178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -133.06 149.29 72.36 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 109.663 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.32 155.66 55.64 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.372 2.048 . . . . 0.0 112.118 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.646 HD12 ' HD3' ' A' ' 266' ' ' LYS . 4.2 tt -161.71 153.76 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.864 . . . . 0.0 109.404 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.9 mp -139.33 141.04 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -0.835 . . . . 0.0 109.257 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 m -123.42 148.85 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -135.72 158.28 44.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.4 ' OD1' ' OE1' ' A' ' 135' ' ' GLU . 43.4 t0 -174.51 105.1 0.1 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.258 -0.901 . . . . 0.0 109.933 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' OE1' ' OD1' ' A' ' 134' ' ' ASP . 5.5 mt-10 49.7 54.74 10.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.265 -0.897 . . . . 0.0 110.538 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.7 -36.31 3.14 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.448 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.475 ' HB3' HD22 ' A' ' 255' ' ' LEU . 2.4 mpt_? -61.55 134.36 56.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.354 . . . . 0.0 108.657 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -147.79 138.52 23.23 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.611 HG13 HD23 ' A' ' 255' ' ' LEU . 75.5 mt -135.69 132.13 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.436 -0.79 . . . . 0.0 109.662 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 142' ' ' GLU . 19.0 tttm -117.72 131.05 56.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.707 -0.621 . . . . 0.0 109.874 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.2 135.79 55.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 140' ' ' LYS . 9.7 pt-20 -148.29 151.65 37.43 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.774 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -49.42 142.68 22.36 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.439 2.093 . . . . 0.0 113.445 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.44 141.35 19.2 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.0 109.03 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -60.98 -6.63 1.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.362 -0.836 . . . . 0.0 110.602 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.4 p -152.79 -173.52 4.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.926 -1.109 . . . . 0.0 109.546 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 148' ' ' GLU . 8.8 tp -96.29 120.45 36.61 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.137 -0.977 . . . . 0.0 108.865 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.1 tt0 -136.57 129.41 30.84 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.21 123.61 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.354 -0.841 . . . . 0.0 110.321 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 95.9 m -113.51 152.35 30.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.749 -0.594 . . . . 0.0 109.481 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -141.85 132.39 25.37 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.31 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -122.18 132.72 54.59 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.27 147.16 19.04 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.184 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.28 98.28 6.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -85.57 167.84 15.02 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.632 0.729 . . . . 0.0 110.894 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -97.55 -9.94 26.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.628 -0.67 . . . . 0.0 111.302 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.583 ' O ' ' N ' ' A' ' 159' ' ' LEU . 30.7 p-10 -102.76 -170.94 1.87 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.905 -1.122 . . . . 0.0 111.036 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -48.2 -2.06 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.806 -0.559 . . . . 0.0 111.509 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.7 mt -80.29 -29.75 38.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.479 -1.388 . . . . 0.0 108.534 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.41 -133.73 46.18 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.425 HH11 ' HB2' ' A' ' 161' ' ' ARG . 13.0 ttp-105 -107.88 136.27 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -1.075 . . . . 0.0 109.391 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -142.2 157.36 44.95 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.694 -0.629 . . . . 0.0 109.303 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.13 147.84 29.94 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.44 -0.788 . . . . 0.0 109.604 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.495 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 9.8 t80 -147.9 143.18 27.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.084 -1.01 . . . . 0.0 110.3 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.458 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 89.4 m -110.17 123.81 50.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.5 -0.75 . . . . 0.0 109.798 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.543 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -104.21 116.93 33.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.334 -0.854 . . . . 0.0 109.961 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.414 HG22 ' CG ' ' A' ' 148' ' ' GLU . 56.0 t -106.57 149.4 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.011 0.91 . . . . 0.0 110.405 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -50.61 134.44 24.36 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.385 -0.822 . . . . 0.0 109.197 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.11 -9.18 42.68 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -117.09 28.19 8.66 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.199 -1.177 . . . . 0.0 109.718 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.545 ' O ' HG22 ' A' ' 175' ' ' VAL . 1.7 pm0 -60.41 -36.67 78.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 0.0 110.262 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.56 -17.0 7.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.174 -0.954 . . . . 0.0 110.587 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -93.86 -5.99 46.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.835 -1.166 . . . . 0.0 111.517 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.2 pt -121.21 -29.82 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.002 -1.061 . . . . 0.0 111.032 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.9 m -61.99 -15.81 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.626 -1.296 . . . . 0.0 108.803 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.2 mt -92.98 -2.85 55.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.48 114.49 7.76 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -77.58 172.93 12.61 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.4 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.3 t -77.25 162.49 27.31 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.2 143.85 30.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.366 -1.459 . . . . 0.0 111.427 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.558 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.79 155.78 44.87 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.44 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 71.4 m-85 -99.38 140.41 33.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.16 -0.963 . . . . 0.0 109.494 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.07 -37.54 9.7 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.369 -0.832 . . . . 0.0 110.345 -179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.3 p90 -70.16 -26.81 64.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.734 -1.229 . . . . 0.0 110.352 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.7 OUTLIER -88.5 -35.05 17.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.94 -1.1 . . . . 0.0 110.441 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 205' ' ' VAL . 73.5 mt -48.23 -58.18 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.068 . . . . 0.0 109.708 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 186' ' ' ILE . 0.9 OUTLIER -42.92 -36.66 1.6 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.16 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.461 ' O ' HG22 ' A' ' 192' ' ' VAL . 19.6 t60 -72.63 -50.22 26.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.496 -0.752 . . . . 0.0 109.136 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 81.7 mt -52.17 -29.44 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -80.87 -53.04 6.82 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.798 -1.189 . . . . 0.0 109.022 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -48.55 -40.45 27.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.439 -0.788 . . . . 0.0 110.293 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.461 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.4 m -77.62 6.34 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.026 -1.046 . . . . 0.0 110.364 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.18 38.79 38.73 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 120.228 -0.986 . . . . 0.0 110.655 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.413 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.6 mt -130.91 -179.71 5.48 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.236 -1.155 . . . . 0.0 109.515 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 54.64 23.44 28.68 Favored Glycine 0 N--CA 1.494 2.522 0 O-C-N 121.578 -0.701 . . . . 0.0 111.488 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -57.06 -21.13 29.08 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.602 -1.528 . . . . 0.0 110.435 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.92 5.47 34.49 Favored Glycine 0 N--CA 1.496 2.696 0 C-N-CA 119.985 -1.103 . . . . 0.0 110.559 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.74 129.3 41.73 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 120.925 -1.338 . . . . 0.0 110.451 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.14 167.0 25.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.353 -1.086 . . . . 0.0 108.822 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 75.4 mt -71.03 -7.71 48.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 108.492 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -98.83 -11.46 21.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.528 -0.733 . . . . 0.0 110.309 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.501 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 11.7 p-10 -130.94 9.77 4.94 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.081 -1.012 . . . . 0.0 110.048 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.82 152.22 32.35 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.031 -1.043 . . . . 0.0 110.416 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.616 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.4 tp -99.2 95.46 7.1 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.627 HG22 HD11 ' A' ' 186' ' ' ILE . 52.6 t -87.49 129.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-O 121.672 0.749 . . . . 0.0 109.606 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.5 mt -123.82 164.16 19.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.55 -0.719 . . . . 0.0 109.306 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.55 -166.36 11.97 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.517 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 1.1 tppp? -57.02 -36.83 70.91 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.555 -0.968 . . . . 0.0 109.427 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -154.89 26.06 0.43 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 110.57 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.29 148.44 39.79 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.848 -1.157 . . . . 0.0 110.696 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.4 t -102.28 112.94 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -59.69 -49.93 75.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.972 -1.08 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.4 m120 -58.92 112.29 4.84 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.219 -0.926 . . . . 0.0 110.193 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -58.44 -11.73 11.86 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.576 1.517 . . . . 0.0 111.501 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.23 -18.53 57.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.381 -0.825 . . . . 0.0 109.92 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.32 -173.63 50.89 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.616 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -89.18 140.35 29.55 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -1.222 . . . . 0.0 109.803 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -78.06 -21.17 51.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.416 -0.803 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -138.58 154.77 48.72 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.177 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -67.09 -1.88 4.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.148 -0.97 . . . . 0.0 109.744 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.536 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -148.48 46.14 1.04 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.128 -0.983 . . . . 0.0 109.509 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -57.17 -46.56 99.83 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.972 -1.08 . . . . 0.0 109.697 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -52.55 -66.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.371 2.047 . . . . 0.0 112.044 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.41 -35.9 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.976 -1.077 . . . . 0.0 109.439 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.536 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 68.4 mtt-85 -60.67 -41.48 95.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -67.1 -31.77 72.47 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.395 -0.922 . . . . 0.0 108.766 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 13.9 mmtt -65.21 -36.9 85.61 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.543 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.6 t -68.55 -35.5 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.56 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 73.1 t80 -66.32 -54.14 28.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.604 -0.685 . . . . 0.0 109.327 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -64.88 -27.08 68.61 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.38 -0.825 . . . . 0.0 109.933 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 26.3 tp -76.26 -33.76 59.15 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 33.7 mt -68.23 -38.93 80.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.76 -57.33 12.67 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.55 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 2.6 m-20 -54.24 -34.42 60.67 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.184 -1.186 . . . . 0.0 109.274 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.4 mt -60.88 -23.8 65.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.517 -0.739 . . . . 0.0 110.219 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.569 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.18 -22.31 61.3 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.902 -1.124 . . . . 0.0 108.91 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.424 HD11 HG21 ' A' ' 60' ' ' THR . 95.8 mt -52.58 0.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.712 -1.243 . . . . 0.0 110.629 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.569 ' H ' ' C ' ' A' ' 236' ' ' TYR . 6.8 mt -78.05 -13.0 60.03 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.744 -1.223 . . . . 0.0 109.66 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.84 -0.79 57.83 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.503 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.57 156.28 10.34 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.914 -1.345 . . . . 0.0 108.829 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.6 Cg_endo -49.93 150.68 9.47 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.892 1.728 . . . . 0.0 109.552 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.08 148.36 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.988 -1.07 . . . . 0.0 112.125 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -130.97 124.17 30.41 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.97 -157.32 27.24 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.53 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.3 OUTLIER -131.85 145.11 51.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.374 -1.074 . . . . 0.0 108.951 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 7.2 m-85 -141.51 142.44 33.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.485 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -126.34 123.15 37.36 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 1.3 m -115.85 134.81 54.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 0.0 110.878 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.412 ' O ' ' C ' ' A' ' 250' ' ' ARG . 60.5 t80 -116.54 117.01 28.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.412 ' C ' ' O ' ' A' ' 249' ' ' PHE . 0.3 OUTLIER 45.4 24.94 0.19 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.161 -0.962 . . . . 0.0 109.425 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -67.57 164.74 45.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.491 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -142.73 171.52 24.78 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.346 -1.502 . . . . 0.0 109.346 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.55 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 60.9 m-70 -51.01 -34.87 31.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.118 -1.225 . . . . 0.0 109.635 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.7 m -60.03 -57.82 11.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.959 . . . . 0.0 109.456 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.611 HD23 HG13 ' A' ' 139' ' ' ILE . 7.0 tp -61.57 -43.8 98.2 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.088 -1.008 . . . . 0.0 109.193 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.5 m-20 -47.33 -46.84 25.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.88 -1.138 . . . . 0.0 108.577 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 56' ' ' THR . 60.5 t -64.15 -50.46 76.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.612 -0.68 . . . . 0.0 109.59 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -55.32 -51.18 67.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.997 -1.065 . . . . 0.0 109.285 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.492 HD22 HG21 ' A' ' 139' ' ' ILE . 46.9 tp -51.07 -50.7 58.19 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.152 -0.967 . . . . 0.0 108.588 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.563 HG13 ' HG ' ' A' ' 238' ' ' LEU . 37.9 t -57.06 -54.79 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.183 -0.948 . . . . 0.0 108.758 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.458 ' NZ ' HG13 ' A' ' 257' ' ' VAL . 0.1 OUTLIER -46.89 -55.07 8.65 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.561 -0.712 . . . . 0.0 109.597 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -57.57 -51.29 70.09 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.345 -0.847 . . . . 0.0 110.059 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 15.6 mt -52.95 -51.91 59.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.344 -0.847 . . . . 0.0 110.215 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.81 -25.51 65.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.209 -0.932 . . . . 0.0 110.197 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -69.29 -60.83 2.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 110.34 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.646 ' HD3' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -66.7 -44.96 80.27 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.972 -1.08 . . . . 0.0 109.713 -179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.553 ' OE1' ' CE1' ' A' ' 124' ' ' PHE . 5.3 tt0 -67.72 -75.42 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.42 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 54.7 tttt 52.28 27.45 4.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.923 . . . . 0.0 109.541 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.455 ' H ' ' HG2' ' A' ' 267' ' ' GLN . 5.1 mt . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.537 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.558 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 47.9 mt -90.5 156.55 18.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -1.163 . . . . 0.0 109.615 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.606 ' CD ' HD21 ' A' ' 86' ' ' ASN . 1.6 mm-40 -56.43 136.14 53.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.087 -1.008 . . . . 0.0 108.579 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.506 ' HZ1' ' HB3' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -121.96 143.23 49.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 -179.064 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.8 t -141.69 -170.46 3.12 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 30' ' ' PRO . 9.8 m -101.6 138.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.483 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 9' ' ' GLU . 7.8 ptmm? -66.96 -25.37 66.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.156 -0.965 . . . . 0.0 109.806 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 8.2 pt-20 -148.14 158.4 44.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.073 -1.017 . . . . 0.0 109.993 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.36 142.32 57.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.481 -0.762 . . . . 0.0 110.133 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 11' ' ' LEU . 20.7 mt -120.68 167.07 12.84 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.6 p -137.13 142.25 42.26 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.193 -0.942 . . . . 0.0 110.026 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' A' ' 26' ' ' LEU . 95.0 m-85 -139.26 151.7 46.69 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -161.48 153.44 19.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.861 -1.149 . . . . 0.0 110.023 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.44 177.02 36.77 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.2 p -81.83 153.7 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.421 -1.047 . . . . 0.0 110.025 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.97 140.36 15.49 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.483 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.9 tt -60.46 -38.44 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -1.152 . . . . 0.0 110.807 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.438 ' N ' HG23 ' A' ' 18' ' ' ILE . 73.8 m-70 -90.02 -51.26 5.56 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.564 -1.335 . . . . 0.0 110.963 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 28.1 p -70.11 -22.25 63.03 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.774 -0.579 . . . . 0.0 111.237 -178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.6 19.44 27.43 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -111.44 155.06 23.76 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -1.059 . . . . 0.0 109.788 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -74.34 137.0 42.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.372 -0.83 . . . . 0.0 109.647 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.2 m -143.16 143.59 31.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.064 -1.022 . . . . 0.0 109.594 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -108.14 160.06 16.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 0.0 109.982 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -139.84 145.13 37.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.731 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.466 HG22 ' NE2' ' A' ' 29' ' ' HIS . 11.8 mt -140.33 116.26 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.0 108.972 178.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.4 mt -101.14 111.89 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.301 -0.874 . . . . 0.0 110.369 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.466 ' NE2' HG22 ' A' ' 27' ' ' ILE . 61.5 m-70 -107.46 139.89 20.97 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.393 -0.817 . . . . 0.0 109.419 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.1 Cg_exo -54.81 168.15 1.26 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.836 1.691 . . . . 0.0 111.495 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 28.1 mm-40 -142.12 178.93 7.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.611 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.4 mmtm -87.7 153.32 21.46 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.684 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.496 ' OE2' ' N ' ' A' ' 118' ' ' ASN . 63.1 mt-10 -47.51 146.43 2.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.496 -0.752 . . . . 0.0 109.939 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.26 4.71 45.09 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 120.366 -0.921 . . . . 0.0 111.032 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.586 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 29.4 m -67.92 -44.56 76.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.618 -1.519 . . . . 0.0 109.683 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.27 -179.26 32.14 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.827 -1.178 . . . . 0.0 110.471 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.76 115.74 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.443 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 6.8 ptm180 -140.3 152.09 45.59 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 118.576 -1.25 . . . . 0.0 110.951 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.03 157.81 16.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -129.9 111.09 12.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.271 -0.893 . . . . 0.0 109.284 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -134.7 133.51 40.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 110.73 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 53.16 28.33 6.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.577 -0.702 . . . . 0.0 111.401 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.49 18.88 69.95 Favored Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.399 -1.382 . . . . 0.0 110.021 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.9 t -124.14 122.05 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -1.069 . . . . 0.0 109.295 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 28.5 m-85 -83.82 127.07 33.56 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.188 -0.945 . . . . 0.0 109.364 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.9 mt -116.54 92.93 38.86 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.318 -0.864 . . . . 0.0 109.242 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.5 149.0 18.85 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.504 2.136 . . . . 0.0 112.086 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.44 69.4 9.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.202 -0.936 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 17.5 mmm-85 -121.31 170.95 9.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.145 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.55 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.2 p-80 -74.18 -48.58 28.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.622 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.56 -16.86 0.13 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 111.111 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -95.47 4.33 53.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.73 -1.231 . . . . 0.0 109.92 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 50' ' ' HIS . 91.5 t -71.51 141.68 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.17 -29.26 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.344 -0.847 . . . . 0.0 110.114 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.7 t60 -151.67 129.84 11.93 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.103 -0.998 . . . . 0.0 109.965 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -120.63 95.36 4.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 59' ' ' SER . 3.7 t-20 -163.28 129.41 3.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.319 -0.863 . . . . 0.0 109.196 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 73.3 m-70 49.9 9.73 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.177 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.54 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.9 OUTLIER 162.48 150.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 109.706 179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.427 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 86.2 m -91.22 124.42 35.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.204 -0.935 . . . . 0.0 109.288 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -119.13 148.59 42.9 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.651 0.739 . . . . 0.0 110.637 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.505 HD11 HG21 ' A' ' 72' ' ' VAL . 10.7 mt -125.48 153.2 43.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.35 154.55 25.35 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 118.974 -1.584 . . . . 0.0 110.747 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 16.0 t80 -161.37 149.83 15.76 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.471 -1.017 . . . . 0.0 109.37 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.8 mttt 46.36 24.18 0.27 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.621 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -34.45 5.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -54.87 145.57 19.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.255 . . . . 0.0 109.045 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -145.36 135.39 23.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.168 -0.958 . . . . 0.0 110.613 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.16 120.28 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' NZ ' ' HB3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -97.8 159.11 15.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.858 -1.151 . . . . 0.0 111.193 -178.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 71' ' ' THR . 91.7 m 46.52 74.31 0.15 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.429 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 62' ' ' LEU . 20.6 m -107.37 -8.48 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.366 -0.834 . . . . 0.0 109.088 178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.588 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -60.61 -25.19 66.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.449 -0.782 . . . . 0.0 110.152 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.1 m170 -67.97 -69.4 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.049 . . . . 0.0 109.415 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.582 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.4 -47.63 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.099 -1.001 . . . . 0.0 109.129 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' N ' HG23 ' A' ' 75' ' ' ILE . 19.9 mt -52.08 -50.18 62.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.059 -1.026 . . . . 0.0 110.137 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.48 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 39.2 t -60.32 -41.55 93.76 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.113 -0.992 . . . . 0.0 110.071 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 106' ' ' PHE . 97.4 t -56.88 -44.95 83.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.051 -1.031 . . . . 0.0 109.217 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.72 -33.76 75.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.39 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -62.89 -40.86 98.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.122 -0.986 . . . . 0.0 109.179 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD12 ' CG1' ' A' ' 175' ' ' VAL . 37.5 mt -75.38 -39.09 59.54 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.852 . . . . 0.0 109.702 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 82' ' ' LEU . 67.8 mt -79.42 -1.07 35.55 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.191 -0.943 . . . . 0.0 109.138 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 56.94 42.1 26.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.632 -0.667 . . . . 0.0 111.414 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.414 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 23.1 mm -90.69 139.91 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.784 -1.197 . . . . 0.0 108.226 178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.424 ' OG1' ' OE2' ' A' ' 4' ' ' GLU . 73.3 p -126.9 -19.15 4.51 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.745 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.73 ' O ' HG13 ' A' ' 87' ' ' VAL . 70.2 m-80 -124.98 106.25 9.82 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.827 -1.171 . . . . 0.0 110.274 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -165.86 150.67 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.729 0.776 . . . . 0.0 109.916 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.0 m -116.17 117.84 31.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.575 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.9 mt -100.19 100.36 10.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 110.352 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' O ' HD23 ' A' ' 26' ' ' LEU . 7.1 mt-10 -71.77 126.08 28.8 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG22 HD21 ' A' ' 26' ' ' LEU . 19.2 t -112.55 121.02 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.949 0.88 . . . . 0.0 111.807 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.4 mm -107.77 93.82 2.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 139.72 160.05 8.2 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -83.05 -7.45 59.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.046 -1.267 . . . . 0.0 111.219 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -139.35 147.59 41.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.725 -1.234 . . . . 0.0 110.36 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 40.3 mm -73.18 121.28 84.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -41.82 123.83 2.48 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.665 1.577 . . . . 0.0 111.301 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.483 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.2 tp -76.58 -15.4 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 110.678 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.7 mt 57.0 -122.09 1.58 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.146 -0.971 . . . . 0.0 110.261 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 27.0 t70 -93.36 7.3 45.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.024 -1.048 . . . . 0.0 111.176 -178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.84 -3.9 62.94 Favored Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.243 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.94 -172.0 2.58 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.651 -0.911 . . . . 0.0 109.45 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.39 14.53 9.36 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -57.94 -41.76 83.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 0.0 110.284 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.89 -55.7 17.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.082 -1.012 . . . . 0.0 110.019 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.445 ' HB3' HG11 ' A' ' 78' ' ' VAL . 7.2 m-85 -51.4 -45.81 62.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 108.927 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.96 -54.18 48.12 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.268 0.556 . . . . 0.0 110.62 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.98 -43.69 98.43 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.203 -0.936 . . . . 0.0 111.508 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.46 ' HA ' ' HZ1' ' A' ' 112' ' ' LYS . . . -65.59 -56.83 10.12 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.961 -1.087 . . . . 0.0 110.363 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 39.8 mt -62.12 -30.98 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.161 -0.962 . . . . 0.0 109.355 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.8 ttt180 -65.26 -43.36 91.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.381 -0.825 . . . . 0.0 110.307 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ1' ' HA ' ' A' ' 109' ' ' ALA . 3.7 pttm -76.41 9.88 2.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.892 -1.13 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -140.89 36.45 1.77 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 0.0 109.926 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 89.3 mt -85.29 140.68 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 111.286 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tp -131.42 122.0 25.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.584 -0.697 . . . . 0.0 109.129 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.506 ' HB3' ' HZ1' ' A' ' 5' ' ' LYS . 6.7 m-80 -79.37 146.32 32.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.337 -0.852 . . . . 0.0 109.959 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -111.26 -174.45 2.47 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.447 -0.783 . . . . 0.0 109.42 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' N ' ' OE2' ' A' ' 33' ' ' GLU . 26.8 t-20 -111.69 70.55 0.72 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.338 -0.852 . . . . 0.0 110.579 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -168.41 134.69 1.9 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.142 -0.974 . . . . 0.0 109.355 179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -70.39 143.98 51.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.065 -1.022 . . . . 0.0 110.15 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -88.11 151.43 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.391 -0.818 . . . . 0.0 110.233 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -96.53 83.78 3.57 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.368 -0.832 . . . . 0.0 108.872 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 15.0 m-85 -63.12 142.13 58.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.268 -0.895 . . . . 0.0 109.291 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -86.94 101.36 13.34 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.5 t -91.7 133.47 33.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.658 -0.651 . . . . 0.0 110.75 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t -70.29 111.65 4.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.45 -30.1 23.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.0 -1.063 . . . . 0.0 110.138 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.92 155.34 77.89 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.608 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.01 149.87 53.63 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.536 2.158 . . . . 0.0 112.234 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.555 HG22 ' HB3' ' A' ' 141' ' ' ALA . 5.2 tt -152.77 149.83 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 108.942 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.75 140.93 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.29 -0.881 . . . . 0.0 109.398 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.4 m -126.78 145.96 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.63 156.95 47.82 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -174.3 107.35 0.12 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.338 -0.851 . . . . 0.0 109.929 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 53.33 52.86 12.71 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 0.0 110.712 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.51 -31.66 3.22 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -61.77 134.91 57.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.242 . . . . 0.0 108.52 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.402 ' O ' HD23 ' A' ' 138' ' ' LEU . 1.1 tt -147.5 137.12 22.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.854 -1.154 . . . . 0.0 109.901 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.551 HG13 HD23 ' A' ' 255' ' ' LEU . 75.4 mt -136.41 125.51 37.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 O-C-N 121.454 -0.779 . . . . 0.0 109.451 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -114.21 132.08 56.24 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.511 0.672 . . . . 0.0 109.932 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.05 134.66 54.78 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -147.69 149.18 32.94 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.98 -1.075 . . . . 0.0 109.921 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -45.87 143.04 7.22 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.62 2.213 . . . . 0.0 113.447 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 1.2 t -156.61 144.82 19.64 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 146' ' ' THR . 53.5 t0 -62.75 -5.6 2.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.262 -0.898 . . . . 0.0 110.332 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 145' ' ' ASP . 24.6 p -156.15 -167.43 2.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.048 -1.032 . . . . 0.0 109.359 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 17.0 tp -102.51 121.49 42.47 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -134.5 108.24 8.0 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -107.68 122.79 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.07 -1.019 . . . . 0.0 110.206 -178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 m -112.76 151.13 30.67 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.575 -0.703 . . . . 0.0 109.667 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.595 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 38.9 t80 -141.64 130.47 22.97 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.126 -1.029 . . . . 0.0 111.234 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -120.98 133.96 55.29 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.08 142.11 13.49 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.66 -1.257 . . . . 0.0 111.601 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -104.06 99.41 9.16 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -87.87 167.41 13.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.558 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -105.55 -11.53 16.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.471 -0.768 . . . . 0.0 110.72 -178.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 159' ' ' LEU . 31.1 p-10 -98.53 -164.83 1.17 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.789 -1.195 . . . . 0.0 110.456 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -55.41 0.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 111.161 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' H ' ' C ' ' A' ' 157' ' ' ASN . 16.5 mt -83.61 -30.4 26.97 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.504 -1.372 . . . . 0.0 108.565 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.27 -138.67 42.8 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -99.91 135.87 40.68 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.243 -1.151 . . . . 0.0 109.306 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.43 ' NE2' HD22 ' A' ' 159' ' ' LEU . 25.1 mt-30 -144.8 159.03 43.53 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.369 -0.832 . . . . 0.0 109.435 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.74 149.85 33.18 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 110.159 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -143.63 140.67 30.24 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.332 -0.855 . . . . 0.0 109.584 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 62.8 m -111.97 125.32 53.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.295 -0.878 . . . . 0.0 110.705 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.548 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.6 t80 -105.2 114.39 28.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.44 152.95 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.529 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -49.8 126.11 13.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.175 -0.953 . . . . 0.0 108.975 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.503 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 106.24 2.11 38.49 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -121.02 21.54 11.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.248 -1.148 . . . . 0.0 109.718 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.1 pm0 -59.32 -54.7 43.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.232 -0.917 . . . . 0.0 109.966 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 171' ' ' GLU . 4.3 mt-10 -41.42 -22.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.305 -0.872 . . . . 0.0 110.085 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 171' ' ' GLU . 67.3 mm-40 -87.59 -6.99 58.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.201 -0.937 . . . . 0.0 111.731 -178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 3.7 pt -125.56 -27.73 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.863 -1.148 . . . . 0.0 111.282 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' A' ' 81' ' ' LEU . 5.0 m -63.32 -17.27 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.575 -1.328 . . . . 0.0 108.669 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mt -90.02 -5.89 56.16 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.586 -0.696 . . . . 0.0 109.266 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -69.87 119.07 13.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 108.963 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -79.94 173.06 12.97 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.222 -0.924 . . . . 0.0 109.442 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 t -76.37 162.51 27.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -146.19 146.87 30.97 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.237 -1.539 . . . . 0.0 111.421 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -146.78 157.8 43.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.478 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 81.3 m-85 -100.04 146.48 26.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.94 -1.1 . . . . 0.0 109.092 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -50.14 -33.73 19.9 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.109 -0.995 . . . . 0.0 110.148 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.484 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 8.6 p90 -74.33 -28.31 61.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.786 -1.197 . . . . 0.0 109.446 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.484 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.2 tt0 -75.21 -35.58 61.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.307 -0.871 . . . . 0.0 109.975 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 65.0 mt -52.34 -49.93 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.802 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -47.34 -41.66 19.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 110.079 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -74.34 -48.34 28.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 109.131 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.2 mt -52.38 -30.79 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.844 . . . . 0.0 109.798 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.6 mmtm -83.44 -53.77 5.46 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 0.0 109.365 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.2 tttt -48.88 -32.59 9.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -0.93 . . . . 0.0 110.487 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.8 m -87.16 7.66 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.02 . . . . 0.0 110.506 -179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.73 39.88 54.38 Favored Glycine 0 N--CA 1.494 2.54 0 O-C-N 121.083 -1.01 . . . . 0.0 110.725 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 61.6 mt -130.53 174.75 9.59 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.133 -1.216 . . . . 0.0 109.808 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.7 22.13 52.44 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 6.7 mttm -57.97 -19.91 34.08 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.679 -1.483 . . . . 0.0 109.63 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.32 10.34 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.439 -1.064 . . . . 0.0 110.439 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 125.47 7.76 Favored Glycine 0 N--CA 1.493 2.467 0 O-C-N 120.859 -1.377 . . . . 0.0 109.72 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.4 t -143.27 169.47 17.58 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.252 -1.146 . . . . 0.0 109.806 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 54.2 mt -67.56 -8.73 36.5 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.67 -13.26 25.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 120.278 -0.569 . . . . 0.0 109.473 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 19.4 p30 -136.18 11.32 3.3 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -0.947 . . . . 0.0 110.14 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.433 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.06 149.28 30.09 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.968 -1.083 . . . . 0.0 110.275 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.638 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.3 tp -98.94 93.32 5.96 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.433 HG23 HG22 ' A' ' 203' ' ' THR . 48.8 t -86.1 130.03 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 CA-C-O 121.738 0.78 . . . . 0.0 109.019 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 15.9 mt -124.41 164.92 18.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.632 -0.667 . . . . 0.0 109.365 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -127.03 -166.6 12.18 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 10.4 mmmt -61.69 -32.43 72.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -1.103 . . . . 0.0 109.552 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.6 22.65 0.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -142.09 149.17 39.52 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.808 -1.183 . . . . 0.0 110.688 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.407 HG11 ' HA2' ' A' ' 216' ' ' GLY . 87.6 t -101.96 111.32 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -58.23 -47.01 84.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.125 -0.984 . . . . 0.0 110.063 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -60.16 124.17 76.24 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.052 -1.03 . . . . 0.0 109.787 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -67.09 -18.07 51.16 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.57 1.514 . . . . 0.0 111.965 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.28 -15.34 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.385 -0.926 . . . . 0.0 108.923 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.407 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.13 -163.53 53.99 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.638 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -91.55 148.35 22.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.149 -1.207 . . . . 0.0 109.833 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.5 ttt85 -87.0 -18.36 30.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -0.862 . . . . 0.0 108.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.499 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 60.2 m-85 -137.73 178.69 6.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -82.88 -14.18 54.74 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.121 -0.987 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -141.68 52.25 1.52 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.242 -0.911 . . . . 0.0 109.516 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.514 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -58.18 -48.19 97.47 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.039 -1.038 . . . . 0.0 109.89 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.8 Cg_exo -49.79 -68.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.399 2.066 . . . . 0.0 112.265 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 228' ' ' VAL . 20.7 m -58.77 -34.71 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.005 -1.059 . . . . 0.0 109.604 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.499 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 56.2 mtt180 -61.23 -41.18 96.42 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 21.4 t60 -67.26 -31.65 72.13 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.326 -0.95 . . . . 0.0 108.692 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.595 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 12.8 mmtp -66.07 -37.33 85.56 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.548 HG11 ' HB3' ' A' ' 166' ' ' PHE . 56.0 t -67.3 -35.87 75.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.48 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 54.1 t80 -65.84 -54.77 22.37 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.554 0.693 . . . . 0.0 109.236 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -62.11 -27.91 69.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.753 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.67 -34.08 58.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 108.394 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.1 mt -64.79 -39.45 85.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -57.88 8.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.411 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 78.6 m-20 -51.4 -34.65 35.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -1.23 . . . . 0.0 109.001 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.6 mt -62.52 -22.76 66.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 110.038 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.57 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.08 -22.97 60.49 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.857 -1.152 . . . . 0.0 108.919 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 237' ' ' LEU . 94.6 mt -50.15 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.699 -1.251 . . . . 0.0 109.909 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 236' ' ' TYR . 9.7 mt -72.02 -15.53 62.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.478 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 1.42 59.33 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.485 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.95 156.93 10.08 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.012 -1.287 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.36 150.35 8.09 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 121.966 1.778 . . . . 0.0 109.655 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 45.8 t -110.07 143.63 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.996 -1.065 . . . . 0.0 112.133 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.01 121.53 33.3 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 152.49 175.27 23.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.442 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -101.9 135.26 43.77 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.203 -1.175 . . . . 0.0 109.276 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 13.8 m-85 -130.76 136.52 48.8 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.288 -0.882 . . . . 0.0 109.596 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -126.17 126.15 43.64 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 2.2 m -119.42 133.08 55.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 110.853 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.539 ' CZ ' ' NE ' ' A' ' 250' ' ' ARG . 74.8 t80 -115.34 112.83 22.96 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.539 ' NE ' ' CZ ' ' A' ' 249' ' ' PHE . 71.4 mtt180 48.41 32.48 3.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.175 -0.953 . . . . 0.0 109.233 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.81 165.26 54.71 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.473 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -140.33 179.64 18.87 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.588 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 58.4 m-70 -59.64 -41.62 90.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.156 -1.203 . . . . 0.0 109.772 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.5 -58.11 8.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.091 -1.006 . . . . 0.0 109.382 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.551 HD23 HG13 ' A' ' 139' ' ' ILE . 5.8 tp -57.94 -45.13 87.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -0.961 . . . . 0.0 109.424 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 11.0 m-20 -47.42 -51.25 20.55 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.989 -1.07 . . . . 0.0 109.077 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.492 HG21 HG21 ' A' ' 56' ' ' THR . 71.3 t -62.91 -44.71 99.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.432 -0.793 . . . . 0.0 109.849 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -58.75 -50.08 75.24 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.108 -0.995 . . . . 0.0 109.292 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.86 -49.18 69.07 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 108.695 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 238' ' ' LEU . 17.2 t -60.43 -58.2 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.381 -0.824 . . . . 0.0 109.077 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -43.32 17.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.421 -0.799 . . . . 0.0 109.061 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.407 ' HB3' HD11 ' A' ' 130' ' ' ILE . 2.8 mm-40 -66.24 -47.12 74.82 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.32 -49.63 76.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.269 -0.895 . . . . 0.0 109.993 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 268' ' ' LYS . . . -70.48 -28.6 65.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.241 -0.912 . . . . 0.0 110.092 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.78 -50.7 48.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.023 -1.048 . . . . 0.0 109.859 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 7.2 mtpt -69.97 -45.95 66.26 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.207 -0.933 . . . . 0.0 109.538 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -90.74 23.27 3.16 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.198 -0.939 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 264' ' ' ALA . 24.7 mmtm 48.92 -150.45 0.17 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.14 -0.975 . . . . 0.0 109.302 179.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.526 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.16 159.66 14.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -1.135 . . . . 0.0 109.601 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' OE1' ' OG1' ' A' ' 85' ' ' THR . 9.4 mm-40 -54.45 139.65 36.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 108.71 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tptt -122.66 146.27 47.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.38 -0.825 . . . . 0.0 110.234 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.5 t -143.61 -171.62 3.56 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.0 m -99.35 135.86 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.971 -1.081 . . . . 0.0 109.378 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -65.19 -21.61 66.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.778 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -152.86 158.72 42.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.27 -0.894 . . . . 0.0 109.331 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 140.46 58.07 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.288 -0.883 . . . . 0.0 110.055 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 11.3 mt -118.22 164.8 14.63 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -131.32 139.87 49.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 110.18 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -138.05 146.23 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -159.1 154.05 24.97 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.848 -1.157 . . . . 0.0 110.349 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.87 175.21 36.12 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.7 p -81.33 151.68 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.381 -1.07 . . . . 0.0 110.069 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.75 138.66 15.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.497 ' CG2' HD13 ' A' ' 98' ' ' ILE . 8.7 tt -59.73 -37.21 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.126 -1.22 . . . . 0.0 110.403 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' HA ' ' H ' ' A' ' 195' ' ' GLY . 29.6 m-70 -89.66 -50.66 5.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.66 -1.275 . . . . 0.0 111.08 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.8 p -70.66 -24.26 62.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.797 -0.565 . . . . 0.0 111.822 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.21 14.64 26.7 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.146 -1.502 . . . . 0.0 109.611 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -107.07 155.38 19.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -1.142 . . . . 0.0 109.407 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -75.24 134.53 41.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.24 -0.912 . . . . 0.0 109.432 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.0 m -137.55 145.84 43.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.154 -0.966 . . . . 0.0 109.51 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -114.54 155.26 26.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.451 -0.78 . . . . 0.0 109.933 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 96' ' ' ILE . 9.1 mt -136.25 144.19 44.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.549 -0.719 . . . . 0.0 109.643 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.562 HG22 ' NE2' ' A' ' 29' ' ' HIS . 4.7 mp -139.49 112.06 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 8.7 mt -94.81 115.76 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.349 -0.845 . . . . 0.0 110.858 -178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.562 ' NE2' HG22 ' A' ' 27' ' ' ILE . 19.6 m-70 -106.96 139.68 20.64 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.495 -0.753 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HG3' HG23 ' A' ' 7' ' ' VAL . 17.3 Cg_exo -56.46 168.24 2.27 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.533 1.489 . . . . 0.0 111.238 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HB3' HG21 ' A' ' 35' ' ' THR . 50.1 mm-40 -144.51 163.39 34.01 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 109.629 179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -74.55 155.42 37.92 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.4 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.487 ' OE2' ' OD1' ' A' ' 118' ' ' ASN . 5.2 mt-10 -49.96 149.88 2.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 110.174 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.26 19.52 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 120.361 -0.923 . . . . 0.0 111.042 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.47 HG21 ' HB3' ' A' ' 31' ' ' GLU . 90.0 m -58.0 -48.53 79.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.555 -1.556 . . . . 0.0 110.03 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.68 178.42 35.17 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.676 -1.25 . . . . 0.0 110.332 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 35.6 mm -92.97 116.01 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -1.033 . . . . 0.0 108.259 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 35' ' ' THR . 14.1 ptp180 -144.18 151.01 38.92 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.456 -1.297 . . . . 0.0 110.883 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -98.97 157.06 16.58 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -129.87 111.83 12.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.268 -0.895 . . . . 0.0 109.413 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -135.19 134.88 40.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.355 -0.841 . . . . 0.0 110.735 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.2 27.39 2.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.608 -0.682 . . . . 0.0 111.247 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.26 19.72 66.2 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.04 179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.1 t -121.23 120.5 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 108.808 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -84.77 126.06 33.09 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.12 -0.987 . . . . 0.0 109.192 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.1 mt -117.01 91.45 36.16 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.422 -0.799 . . . . 0.0 109.488 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.13 148.06 14.4 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.667 2.245 . . . . 0.0 112.077 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.598 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -82.13 70.38 9.04 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.494 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -128.54 174.44 9.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.143 -0.973 . . . . 0.0 109.186 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.7 p-80 -71.52 -49.58 39.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.242 -0.912 . . . . 0.0 110.103 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -43.19 -17.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 111.496 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.4 m-85 -100.2 -2.47 33.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.684 -1.26 . . . . 0.0 110.163 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 62' ' ' LEU . 52.4 t -66.92 121.13 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.185 -0.947 . . . . 0.0 108.576 179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 m -102.99 -30.5 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.157 -0.964 . . . . 0.0 110.275 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -152.32 136.24 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.97 -1.081 . . . . 0.0 110.254 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 257' ' ' VAL . 66.9 p -123.75 95.96 4.78 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.556 ' O ' ' N ' ' A' ' 59' ' ' SER . 15.0 t-20 -162.47 129.05 3.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 108.882 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 91.6 m-70 50.19 8.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 108.983 -179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.2 OUTLIER 162.26 147.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.374 -0.829 . . . . 0.0 109.851 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.9 m -90.13 128.29 36.3 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.322 -0.861 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.75 150.6 41.59 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.478 -0.763 . . . . 0.0 111.056 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.542 HD12 HG11 ' A' ' 72' ' ' VAL . 9.0 mt -123.89 149.49 45.78 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.02 150.31 20.42 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.165 -1.493 . . . . 0.0 110.517 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -162.82 148.17 12.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.423 -1.045 . . . . 0.0 108.965 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.452 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER 51.06 25.93 2.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.441 -0.787 . . . . 0.0 109.677 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.21 -33.92 5.3 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.549 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 5.3 mm-40 -57.45 145.1 34.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -1.221 . . . . 0.0 109.152 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -144.58 137.71 26.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 0.0 110.407 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.427 HG21 HD11 ' A' ' 96' ' ' ILE . 55.5 mt -131.18 125.94 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -101.08 156.21 17.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.023 -1.048 . . . . 0.0 111.294 -178.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.0 m 51.79 75.29 0.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG11 HD12 ' A' ' 62' ' ' LEU . 34.9 m -107.52 -9.06 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.172 -0.955 . . . . 0.0 109.11 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.592 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.0 pm0 -61.4 -26.34 67.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 0.0 110.361 -179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.421 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 30.8 m170 -68.2 -69.06 0.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.068 -1.02 . . . . 0.0 109.193 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.605 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -51.88 -48.42 39.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.197 -0.939 . . . . 0.0 108.987 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.605 ' N ' HG23 ' A' ' 75' ' ' ILE . 13.1 mt -51.86 -48.8 63.87 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.006 -1.058 . . . . 0.0 110.026 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.407 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 31.0 t -60.26 -43.09 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 110.119 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 106' ' ' PHE . 94.8 t -56.67 -45.69 82.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 121.026 -1.046 . . . . 0.0 109.193 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.514 HD11 HD11 ' A' ' 89' ' ' ILE . 25.6 mt -65.97 -34.37 77.96 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.326 -0.859 . . . . 0.0 109.212 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -63.37 -37.0 85.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.18 -0.95 . . . . 0.0 109.316 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 171' ' ' GLU . 78.3 mt -77.13 -38.91 51.07 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.332 -0.855 . . . . 0.0 110.195 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.402 HD21 ' CE1' ' A' ' 107' ' ' TYR . 96.1 mt -80.64 6.53 12.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.976 -1.078 . . . . 0.0 110.034 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 52.36 39.73 27.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.323 -0.861 . . . . 0.0 110.07 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.69 141.66 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.032 -1.043 . . . . 0.0 108.267 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.61 HG21 HG12 ' A' ' 121' ' ' ILE . 54.9 p -128.98 -22.6 3.17 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.114 -0.991 . . . . 0.0 111.873 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.681 ' O ' HG13 ' A' ' 87' ' ' VAL . 76.9 m-20 -124.0 107.72 11.62 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.874 -1.141 . . . . 0.0 110.278 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.1 m -163.8 142.6 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.519 -0.738 . . . . 0.0 110.138 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 96.0 m -109.42 111.46 23.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.514 HD11 HD11 ' A' ' 79' ' ' LEU . 6.5 mt -93.97 100.2 10.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.364 -0.835 . . . . 0.0 110.311 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' O ' HD23 ' A' ' 26' ' ' LEU . 3.9 tt0 -75.08 125.46 28.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.612 HG22 HD21 ' A' ' 26' ' ' LEU . 16.1 t -114.75 118.39 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.947 0.879 . . . . 0.0 111.675 -178.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 92' ' ' ILE . 11.0 mt -105.4 98.98 7.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 177.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.84 -159.23 27.8 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.31 -13.63 8.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.27 -1.135 . . . . 0.0 110.421 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -138.73 146.99 42.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.979 -1.076 . . . . 0.0 109.676 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.68 HG23 HD11 ' A' ' 26' ' ' LEU . 43.5 mm -70.08 119.83 74.21 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.228 -0.92 . . . . 0.0 108.706 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -40.27 124.49 1.65 Allowed 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.88 1.72 . . . . 0.0 111.62 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.497 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.0 tp -76.39 -15.42 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.243 -0.911 . . . . 0.0 110.206 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.7 mt 55.36 -123.14 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -92.66 8.97 36.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.993 -1.067 . . . . 0.0 111.119 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.15 -7.87 69.63 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 119.47 -1.348 . . . . 0.0 109.973 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 77.2 p -124.02 -172.1 2.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.61 -0.936 . . . . 0.0 109.16 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.62 13.71 11.85 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 48.3 t-105 -56.08 -42.33 76.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.287 -1.125 . . . . 0.0 110.001 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -63.27 -54.78 31.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.205 -0.934 . . . . 0.0 109.645 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 78' ' ' VAL . 10.3 m-85 -54.85 -46.49 74.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.118 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.402 ' CE1' HD21 ' A' ' 82' ' ' LEU . 34.5 t80 -60.69 -56.54 20.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.731 -0.606 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 13.6 mm-40 -58.88 -44.01 91.03 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.145 -0.972 . . . . 0.0 111.337 -178.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.6 -51.79 46.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.964 -1.085 . . . . 0.0 110.719 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.7 mt -69.31 -31.87 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 120.853 -1.155 . . . . 0.0 109.344 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.46 -43.22 94.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.42 -0.8 . . . . 0.0 110.258 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.23 17.05 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.82 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -144.05 29.04 1.35 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.101 -0.999 . . . . 0.0 110.169 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.7 mt -79.61 141.35 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.112 -0.993 . . . . 0.0 110.607 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -128.58 123.47 33.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.612 ' N ' ' OD1' ' A' ' 116' ' ' ASN . 0.0 OUTLIER -78.97 141.0 37.89 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.195 -0.94 . . . . 0.0 110.314 -179.069 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -107.85 -175.74 2.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.394 -0.816 . . . . 0.0 109.26 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.487 ' OD1' ' OE2' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -109.66 70.09 0.72 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.289 -0.882 . . . . 0.0 110.688 -179.085 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -169.22 134.03 1.48 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.082 -1.011 . . . . 0.0 109.503 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -69.13 142.56 54.37 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 0.0 110.171 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.61 HG12 HG21 ' A' ' 85' ' ' THR . 35.0 mt -84.79 150.16 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.396 -0.815 . . . . 0.0 110.024 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -100.74 90.0 4.08 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -68.94 148.03 50.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.417 -0.802 . . . . 0.0 109.94 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -90.12 101.98 14.69 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.22 134.15 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.612 -0.68 . . . . 0.0 111.204 -177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.21 118.72 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HG3' HE22 ' A' ' 267' ' ' GLN . 2.6 mt-10 -96.51 -27.04 15.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.079 -1.013 . . . . 0.0 110.522 -178.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.18 152.5 79.66 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.76 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 151.52 46.96 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.64 2.226 . . . . 0.0 112.286 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.46 ' HB ' ' HZ3' ' A' ' 266' ' ' LYS . 7.9 tt -160.04 153.15 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.336 -0.853 . . . . 0.0 109.29 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.8 mp -141.11 145.31 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 m -128.84 149.29 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' OE2' HD12 ' A' ' 138' ' ' LEU . 28.8 mt-10 -139.85 157.86 45.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.132 -0.98 . . . . 0.0 110.196 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.86 111.35 0.07 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.252 -0.905 . . . . 0.0 109.93 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 52.47 48.19 23.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.541 -0.724 . . . . 0.0 110.833 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.6 -33.59 3.45 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.366 179.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.439 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 1.5 mpt_? -64.31 131.95 48.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.915 -1.344 . . . . 0.0 108.528 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -145.03 141.63 29.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.036 -1.04 . . . . 0.0 110.357 -179.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.517 HG13 HD23 ' A' ' 255' ' ' LEU . 92.4 mt -136.88 132.18 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.453 -0.779 . . . . 0.0 109.859 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -118.43 133.04 56.2 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.413 0.625 . . . . 0.0 110.007 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.71 135.33 53.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.538 -0.727 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.02 149.62 39.51 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 0.0 109.868 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -48.48 142.4 17.73 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.523 2.149 . . . . 0.0 113.382 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.12 145.19 19.29 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.97 -30.43 70.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.348 -0.845 . . . . 0.0 110.219 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.0 p -127.01 -171.14 2.34 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.401 -0.812 . . . . 0.0 109.74 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.467 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 12.3 tp -100.15 123.46 44.41 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.163 -0.96 . . . . 0.0 108.675 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.449 ' N ' HD12 ' A' ' 147' ' ' LEU . 11.3 tt0 -136.28 118.03 15.07 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.233 -0.917 . . . . 0.0 108.555 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.6 t -117.84 122.2 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.335 -0.853 . . . . 0.0 109.982 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.47 ' OG1' ' NZ ' ' A' ' 245' ' ' LYS . 54.6 m -113.15 152.05 30.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.479 -0.763 . . . . 0.0 109.679 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.4 ' CD2' ' HB3' ' A' ' 227' ' ' LYS . 39.2 t80 -138.78 130.79 28.08 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.266 -0.973 . . . . 0.0 110.948 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -119.98 130.44 54.76 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -133.78 135.64 8.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.585 -1.293 . . . . 0.0 111.645 -178.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -98.55 100.39 11.63 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.79 167.02 13.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 110.66 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.0 tttp -102.84 -22.53 13.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.405 -0.809 . . . . 0.0 110.912 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.533 ' O ' ' N ' ' A' ' 159' ' ' LEU . 26.0 p-10 -88.05 -171.42 3.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.701 -1.249 . . . . 0.0 109.986 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -52.23 1.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 111.458 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.533 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.5 mt -79.44 -28.58 41.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.353 -1.467 . . . . 0.0 108.71 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.05 -142.55 35.15 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.5 ttp-105 -99.6 135.65 40.7 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.269 -1.136 . . . . 0.0 109.289 179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -138.26 153.5 49.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.812 . . . . 0.0 109.41 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -141.22 144.85 34.96 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.288 -0.882 . . . . 0.0 109.754 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.583 ' CE1' ' NH2' ' A' ' 225' ' ' ARG . 49.2 t80 -142.05 132.89 25.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.661 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 86.9 m -103.78 122.68 45.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.364 -0.835 . . . . 0.0 109.804 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.2 t80 -103.83 114.06 28.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 0.0 110.099 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.9 152.79 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.323 -0.86 . . . . 0.0 109.737 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.467 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 3.2 mm-40 -49.96 128.19 18.1 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.69 1.81 43.1 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -117.83 20.29 13.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.354 -1.086 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.622 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -60.15 -51.47 69.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.39 -0.819 . . . . 0.0 109.637 -179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.495 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 5.0 mt-10 -47.76 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.403 -0.81 . . . . 0.0 110.291 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.586 ' N ' ' O ' ' A' ' 171' ' ' GLU . 9.3 mm-40 -102.94 -6.11 22.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.123 -0.985 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.7 pt -125.16 -26.84 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.959 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 175' ' ' VAL . 5.2 m -62.13 -10.66 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.815 -1.178 . . . . 0.0 109.106 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.2 mt -98.46 -2.17 39.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.349 -0.845 . . . . 0.0 109.078 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.498 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -65.44 122.2 16.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.94 . . . . 0.0 109.283 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.585 HH12 ' CD ' ' A' ' 215' ' ' GLU . 52.5 mtm180 -94.23 128.27 40.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.309 -0.869 . . . . 0.0 109.422 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 12.5 t -36.53 158.67 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -178.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -145.2 150.0 35.95 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.51 -1.369 . . . . 0.0 111.49 -178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.569 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -147.39 157.05 43.42 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.463 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.6 m-85 -97.7 145.52 26.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.048 -1.033 . . . . 0.0 109.493 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.442 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.97 -37.11 8.55 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.363 -0.835 . . . . 0.0 109.278 -179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.54 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -74.29 -29.56 61.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.069 -1.019 . . . . 0.0 109.514 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.54 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.1 mm-40 -71.52 -31.64 67.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 0.0 109.547 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.441 ' O ' ' C ' ' A' ' 187' ' ' GLU . 59.6 mt -57.24 -55.07 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.888 . . . . 0.0 109.669 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.8 tt0 -42.85 -38.74 2.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.13 -0.981 . . . . 0.0 109.302 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 189' ' ' ILE . 9.3 t60 -76.3 -59.34 2.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.051 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.437 ' C ' ' O ' ' A' ' 188' ' ' HIS . 82.9 mt -41.75 -36.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.563 -0.711 . . . . 0.0 109.698 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -79.43 -51.83 8.86 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.875 -1.141 . . . . 0.0 109.226 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -49.35 -27.17 3.72 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.0 110.709 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.8 m -95.51 11.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.746 -1.221 . . . . 0.0 110.086 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.44 39.54 69.35 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.433 ' HB3' ' ND1' ' A' ' 19' ' ' HIS . 89.1 mt -129.61 172.59 11.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.196 -1.179 . . . . 0.0 109.998 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.444 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.99 21.84 59.54 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -58.93 -21.19 57.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.463 -1.61 . . . . 0.0 109.749 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.405 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -113.56 25.51 11.03 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -87.49 132.94 11.48 Favored Glycine 0 N--CA 1.491 2.344 0 O-C-N 120.923 -1.34 . . . . 0.0 109.921 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.9 174.39 11.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.338 -1.095 . . . . 0.0 109.564 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 43.2 mt -71.18 -7.52 47.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.147 -0.971 . . . . 0.0 108.954 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -97.51 -19.97 18.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.603 -0.686 . . . . 0.0 110.003 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.428 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 21.8 p30 -125.68 3.35 7.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.106 -0.996 . . . . 0.0 109.666 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.423 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -144.54 145.35 31.79 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.996 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.636 HD11 HD21 ' A' ' 206' ' ' LEU . 25.8 tp -96.35 96.13 8.54 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.53 128.22 39.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.9 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.636 HD21 HD11 ' A' ' 204' ' ' LEU . 29.7 mt -123.38 162.99 21.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.539 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.2 -166.28 12.74 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.83 -24.54 66.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.457 -1.025 . . . . 0.0 109.966 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -156.6 24.53 0.34 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.991 -1.068 . . . . 0.0 111.265 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -151.97 160.47 43.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.515 -1.365 . . . . 0.0 110.643 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.559 HG11 ' HA2' ' A' ' 216' ' ' GLY . 88.5 t -106.08 114.01 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -57.56 -46.94 83.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.112 -0.992 . . . . 0.0 110.46 -178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.4 ' OD1' ' N ' ' A' ' 213' ' ' ASN . 1.3 m-20 -59.31 130.39 87.21 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.17 -0.956 . . . . 0.0 110.53 -178.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -67.88 -21.62 43.77 Favored 'Trans proline' 0 C--N 1.316 -1.15 0 C-N-CA 121.682 1.588 . . . . 0.0 111.688 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.585 ' CD ' HH12 ' A' ' 178' ' ' ARG . 0.0 OUTLIER -80.71 -15.46 56.45 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.957 179.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.559 ' HA2' HG11 ' A' ' 211' ' ' VAL . . . 71.51 -157.5 53.29 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.262 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.481 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.6 mt -89.19 154.44 20.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.266 -1.138 . . . . 0.0 110.138 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -90.14 -19.54 24.14 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -138.75 -176.5 4.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.534 ' N ' ' OE1' ' A' ' 220' ' ' GLU . 19.2 mp0 -83.6 -20.16 34.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.135 -0.978 . . . . 0.0 109.529 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.649 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -136.12 54.7 1.89 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.7 tt0 -57.59 -46.31 99.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.893 -1.13 . . . . 0.0 109.848 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.6 Cg_exo -52.67 -66.26 0.12 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.401 2.068 . . . . 0.0 112.221 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 225' ' ' ARG . 21.9 m -59.69 -36.07 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.986 -1.071 . . . . 0.0 109.512 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.583 ' NH2' ' CE1' ' A' ' 164' ' ' PHE . 74.6 mtt-85 -59.79 -41.21 90.67 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.498 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 7.5 t60 -68.17 -31.64 71.34 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.669 -0.812 . . . . 0.0 109.1 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.511 ' HE2' H211 ' A' ' 500' ' ' C90 . 16.9 mmtt -65.32 -36.97 85.67 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 166' ' ' PHE . 64.3 t -69.17 -38.37 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.407 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 55.3 t80 -62.56 -51.34 67.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.398 -0.814 . . . . 0.0 108.892 179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 91.9 m-20 -64.76 -29.51 70.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.526 -0.733 . . . . 0.0 110.016 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 55.2 tp -77.87 -33.77 51.97 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.892 -1.13 . . . . 0.0 108.728 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.3 mt -65.76 -37.81 80.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.22 -56.1 11.29 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.425 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 92.4 m-20 -52.67 -37.14 58.22 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.083 -1.246 . . . . 0.0 109.309 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.2 mt -60.04 -24.04 64.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.549 -0.719 . . . . 0.0 110.497 -179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.592 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -70.66 -21.58 62.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.783 -1.198 . . . . 0.0 108.792 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 96.3 mt -55.13 3.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.56 -1.338 . . . . 0.0 110.318 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 260' ' ' VAL . 7.7 mt -82.98 -16.47 47.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 0.0 109.585 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 103.93 -1.17 44.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.913 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.75 158.69 11.2 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.772 -1.428 . . . . 0.0 109.297 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -56.15 128.3 29.63 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.874 1.716 . . . . 0.0 109.456 178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.1 t -87.86 154.56 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.992 -1.068 . . . . 0.0 112.387 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 10.2 mmtt -136.26 127.57 28.3 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.38 -155.0 25.91 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.47 ' NZ ' ' OG1' ' A' ' 150' ' ' THR . 19.9 tptt -133.49 127.49 33.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.221 -1.164 . . . . 0.0 108.697 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.5 m-85 -127.82 140.76 51.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.313 -0.867 . . . . 0.0 110.572 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -123.65 133.91 53.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 33.5 t -127.26 134.89 50.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.952 -1.092 . . . . 0.0 110.95 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -116.91 115.82 26.22 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.4 mtp180 47.44 24.37 0.47 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.168 -0.957 . . . . 0.0 109.248 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -60.53 152.92 37.45 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.479 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.58 166.6 22.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.592 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 60.0 m-70 -48.77 -40.68 29.72 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.131 -1.217 . . . . 0.0 109.531 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 12.8 t -54.91 -58.53 7.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 0.0 109.54 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.517 HD23 HG13 ' A' ' 139' ' ' ILE . 7.8 tp -57.14 -45.48 83.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.084 -1.01 . . . . 0.0 109.646 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 1.2 m-20 -47.51 -51.26 21.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.031 -1.043 . . . . 0.0 109.361 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 56' ' ' THR . 87.9 t -62.72 -50.55 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.216 -0.928 . . . . 0.0 109.547 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -52.05 -52.2 52.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.088 -1.008 . . . . 0.0 109.356 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 139' ' ' ILE . 37.0 tp -51.28 -51.33 55.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.113 -0.992 . . . . 0.0 108.533 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.609 HG13 ' HG ' ' A' ' 238' ' ' LEU . 69.0 t -53.93 -50.07 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.918 . . . . 0.0 108.828 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -51.23 -55.16 19.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.515 -0.74 . . . . 0.0 109.732 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.19 -49.91 75.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.295 -0.878 . . . . 0.0 110.022 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.5 mt -56.7 -52.11 66.22 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.38 -28.1 67.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.304 -0.873 . . . . 0.0 110.272 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -69.03 -57.41 5.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.16 -0.962 . . . . 0.0 110.337 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.46 ' HZ3' ' HB ' ' A' ' 130' ' ' ILE . 31.5 pttt -69.43 -36.05 76.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.508 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.487 ' O ' ' C ' ' A' ' 268' ' ' LYS . 2.6 mm-40 -71.07 -9.01 57.31 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.066 -1.021 . . . . 0.0 110.099 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.487 ' C ' ' O ' ' A' ' 267' ' ' GLN . 5.8 ptmt 35.39 -155.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.688 -0.632 . . . . 0.0 110.123 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.3 tp . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.569 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' O ' HD11 ' A' ' 121' ' ' ILE . 6.9 mt -101.1 160.23 14.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -1.176 . . . . 0.0 109.437 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.58 ' OE1' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -58.0 136.62 57.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.025 . . . . 0.0 109.063 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.675 ' HB3' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -120.96 141.58 50.56 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.46 -0.775 . . . . 0.0 109.54 -179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -139.19 -170.12 2.81 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 29.8 m -99.57 136.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.016 -1.053 . . . . 0.0 109.022 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 114' ' ' ILE . 0.0 OUTLIER -66.47 -16.67 64.3 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.089 -1.007 . . . . 0.0 109.434 -179.614 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -156.18 159.85 39.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.151 -0.968 . . . . 0.0 109.565 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.23 139.21 57.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.355 -0.84 . . . . 0.0 110.228 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 11' ' ' LEU . 57.2 mt -117.66 165.41 13.63 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.66 144.51 39.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.957 -1.089 . . . . 0.0 110.483 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.408 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.7 m-85 -140.41 155.35 46.77 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -162.11 152.81 17.45 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.782 -1.199 . . . . 0.0 110.275 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.4 176.83 36.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.53 153.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.195 -1.179 . . . . 0.0 110.424 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.62 141.13 16.39 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 19' ' ' HIS . 14.1 tt -61.51 -41.29 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -1.158 . . . . 0.0 111.026 -178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' N ' HG23 ' A' ' 18' ' ' ILE . 59.5 m-70 -87.1 -50.49 6.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.534 -1.354 . . . . 0.0 111.102 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -70.24 -22.82 62.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.625 -0.672 . . . . 0.0 111.363 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.0 20.65 35.01 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.931 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -110.86 154.1 24.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.51 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -74.65 135.4 41.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 109.309 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 75.0 m -139.67 143.37 37.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.136 -0.977 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -112.38 154.39 25.83 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.324 -0.86 . . . . 0.0 109.484 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.509 HD11 HG23 ' A' ' 96' ' ' ILE . 7.9 mt -132.43 148.98 52.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.367 -0.833 . . . . 0.0 110.312 -179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.501 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.0 mt -143.58 110.78 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.5 mt -96.52 117.44 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.347 -0.846 . . . . 0.0 111.032 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.501 ' NE2' HG22 ' A' ' 27' ' ' ILE . 22.0 m-70 -110.65 138.84 21.14 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.458 -0.776 . . . . 0.0 109.701 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.4 Cg_exo -54.28 168.58 0.91 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.958 1.772 . . . . 0.0 111.79 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 50.3 mm-40 -140.86 177.49 8.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.961 . . . . 0.0 109.918 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 15.0 mttt -86.02 153.0 22.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.393 -0.817 . . . . 0.0 110.136 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -47.25 145.67 2.22 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.354 -0.841 . . . . 0.0 110.089 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.3 7.33 51.58 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.128 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.6 m -69.56 -43.68 72.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.659 -1.495 . . . . 0.0 109.56 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.73 -178.96 32.72 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.359 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.15 116.52 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HE ' ' HB3' ' A' ' 45' ' ' TYR . 8.8 ptm180 -140.26 150.86 44.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.822 -1.174 . . . . 0.0 110.382 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -100.66 157.4 16.71 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -129.43 110.97 12.32 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.181 -0.949 . . . . 0.0 108.877 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.555 ' NZ ' ' OD1' ' A' ' 42' ' ' ASN . 32.7 tttm -135.64 135.26 40.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.875 . . . . 0.0 110.534 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.555 ' OD1' ' NZ ' ' A' ' 41' ' ' LYS . 15.2 m120 52.85 28.88 6.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.5 -0.75 . . . . 0.0 111.19 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.27 18.1 78.63 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.958 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 56.9 t -122.7 122.22 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.453 -1.028 . . . . 0.0 108.808 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' HB3' ' HE ' ' A' ' 38' ' ' ARG . 42.1 m-85 -83.84 126.5 33.01 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.089 -1.007 . . . . 0.0 109.659 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.6 mt -115.39 95.64 43.47 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.464 -0.773 . . . . 0.0 109.258 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.31 145.04 22.04 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.427 2.085 . . . . 0.0 112.081 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.24 74.8 10.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.822 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -132.79 -179.91 5.76 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.347 -0.846 . . . . 0.0 109.381 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.536 ' O ' ' N ' ' A' ' 52' ' ' PHE . 9.6 p-80 -75.78 -53.26 8.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.917 . . . . 0.0 110.129 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -43.28 -17.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.232 -0.918 . . . . 0.0 110.963 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 50' ' ' HIS . 45.2 m-85 -97.63 1.31 48.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.735 -1.228 . . . . 0.0 109.837 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' HD23 ' A' ' 62' ' ' LEU . 48.8 t -71.54 131.33 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.099 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -30.05 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.324 -0.86 . . . . 0.0 109.869 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -151.08 133.49 15.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.865 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.685 HG21 HG21 ' A' ' 257' ' ' VAL . 76.2 p -124.38 95.44 4.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.521 -0.737 . . . . 0.0 109.207 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.585 ' O ' ' N ' ' A' ' 59' ' ' SER . 46.0 t-20 -162.97 128.86 3.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.8 m-70 47.4 11.69 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.063 -1.023 . . . . 0.0 108.969 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.585 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 163.37 141.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.344 -0.847 . . . . 0.0 110.098 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.436 HG21 HD11 ' A' ' 237' ' ' LEU . 86.2 m -90.62 127.97 36.45 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.376 -0.828 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.6 m-20 -121.42 151.75 39.84 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.664 0.745 . . . . 0.0 111.002 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 53' ' ' VAL . 10.8 mt -126.23 148.23 49.51 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.63 154.14 25.12 Favored Glycine 0 N--CA 1.492 2.407 0 C-N-CA 119.088 -1.529 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -165.31 152.95 11.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.326 -1.102 . . . . 0.0 109.577 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt 50.69 22.26 1.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 0.0 109.175 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.13 -33.48 6.11 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.546 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 9.0 mm-40 -56.22 147.34 21.01 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.213 -1.169 . . . . 0.0 109.229 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.9 135.55 26.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.291 -0.881 . . . . 0.0 110.272 -179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 16.3 mt -129.36 126.11 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -103.29 156.23 17.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.968 -1.082 . . . . 0.0 111.078 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.8 m 51.64 75.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.943 -0.473 . . . . 0.0 110.818 179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 29.3 m -108.07 -10.32 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.169 -0.957 . . . . 0.0 109.344 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.5 pm0 -61.45 -26.8 68.12 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.814 . . . . 0.0 110.906 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.427 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.0 m170 -66.35 -68.72 0.35 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.977 -1.077 . . . . 0.0 109.196 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.574 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.8 tp -52.07 -47.05 43.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 109.161 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 48' ' ' ALA . 17.5 mt -52.33 -49.15 64.84 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.993 -1.067 . . . . 0.0 110.068 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.449 ' OG ' ' CD1' ' A' ' 229' ' ' PHE . 17.5 t -59.73 -43.17 94.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 0.0 110.35 -179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -56.71 -44.6 81.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 O-C-N 120.975 -1.078 . . . . 0.0 109.101 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 mt -67.56 -36.07 80.25 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.157 -0.964 . . . . 0.0 109.588 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -61.72 -35.58 78.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -0.975 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.579 HD13 ' CB ' ' A' ' 171' ' ' GLU . 68.1 mt -79.47 -36.93 37.96 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.38 -0.825 . . . . 0.0 109.843 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.515 HD22 HD11 ' A' ' 114' ' ' ILE . 94.8 mt -83.52 4.12 29.36 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.114 -0.991 . . . . 0.0 110.084 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 73.3 mt-10 53.59 40.62 31.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -0.887 . . . . 0.0 110.556 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.675 HD13 ' HB3' ' A' ' 5' ' ' LYS . 27.3 mm -85.33 142.92 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.553 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 42.5 p -129.81 -22.61 2.92 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.186 -0.946 . . . . 0.0 111.612 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.698 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -125.2 107.03 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.744 -1.223 . . . . 0.0 110.035 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.9 m -164.3 148.55 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.616 0.722 . . . . 0.0 110.008 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.496 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 57.4 m -117.19 108.19 15.37 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.436 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.4 mt -90.18 100.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 0.0 109.804 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' O ' HD23 ' A' ' 26' ' ' LEU . 10.6 tt0 -73.78 125.14 27.44 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.0 t -110.99 119.66 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.815 0.817 . . . . 0.0 111.542 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 51.0 mt -105.94 97.75 6.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.56 -158.77 27.64 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.741 -1.743 . . . . 0.0 108.741 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -120.49 -13.03 8.86 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.305 -1.114 . . . . 0.0 110.227 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -139.56 148.23 42.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.992 -1.068 . . . . 0.0 109.707 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.509 HG23 HD11 ' A' ' 26' ' ' LEU . 45.7 mm -71.66 120.76 81.81 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 108.943 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -42.05 120.23 1.45 Allowed 'Trans proline' 0 C--N 1.314 -1.256 0 C-N-CA 121.733 1.622 . . . . 0.0 111.629 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.459 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.2 tp -78.38 -15.8 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 110.346 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.8 mt 55.76 -115.6 0.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.0 110.267 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.82 5.6 50.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.032 -1.043 . . . . 0.0 110.797 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.96 0.7 61.83 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.439 -1.362 . . . . 0.0 110.147 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.3 p -126.7 -172.87 2.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.661 -0.905 . . . . 0.0 109.629 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.33 16.7 8.02 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -57.77 -41.73 82.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -1.08 . . . . 0.0 110.086 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -64.54 -57.15 9.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.063 -1.023 . . . . 0.0 110.105 -179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 14.7 m-85 -51.57 -46.55 63.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.147 -0.97 . . . . 0.0 109.348 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -61.03 -51.04 70.88 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.667 -0.646 . . . . 0.0 110.941 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -64.18 -42.45 96.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.002 -1.061 . . . . 0.0 111.245 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.91 -58.49 4.47 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.948 -1.095 . . . . 0.0 110.576 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.7 mt -60.5 -34.4 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.099 -1.001 . . . . 0.0 109.577 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -63.25 -42.21 99.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.131 -0.98 . . . . 0.0 109.26 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.99 11.86 0.81 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.212 -0.93 . . . . 0.0 110.161 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.465 ' HA ' ' HZ2' ' A' ' 8' ' ' LYS . 3.5 m-80 -146.24 33.64 0.98 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.732 -1.23 . . . . 0.0 110.983 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.557 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 70.2 mt -78.19 139.59 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.742 -1.224 . . . . 0.0 110.373 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 8' ' ' LYS . 31.8 tp -127.7 121.96 31.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.453 -0.779 . . . . 0.0 108.998 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.605 ' ND2' ' HZ1' ' A' ' 5' ' ' LYS . 0.6 OUTLIER -79.04 142.59 36.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.144 -0.972 . . . . 0.0 110.354 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -111.56 -170.61 1.68 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.454 -0.779 . . . . 0.0 109.358 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -116.64 71.22 0.78 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.144 -0.972 . . . . 0.0 111.713 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.572 ' N ' ' OE1' ' A' ' 4' ' ' GLU . 9.4 ttt180 -170.02 132.11 1.07 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.959 -1.088 . . . . 0.0 109.31 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -66.32 142.11 57.76 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.959 -1.088 . . . . 0.0 110.238 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 3' ' ' LEU . 89.5 mt -87.6 151.74 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.413 -0.804 . . . . 0.0 110.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.35 79.3 3.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.284 -0.885 . . . . 0.0 108.813 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 36.4 m-85 -58.78 146.67 36.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.876 . . . . 0.0 109.294 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -93.11 101.91 14.22 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.7 t -92.75 132.68 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.359 0.599 . . . . 0.0 110.918 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.3 117.56 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.407 ' H ' ' NE2' ' A' ' 267' ' ' GLN . 4.8 mt-10 -95.06 -27.57 15.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.984 -1.073 . . . . 0.0 110.662 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -134.36 150.78 74.85 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 109.549 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -70.98 151.42 62.12 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.502 2.135 . . . . 0.0 112.255 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.541 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.9 tt -157.22 150.69 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.925 . . . . 0.0 109.416 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.408 ' N ' HG12 ' A' ' 130' ' ' ILE . 2.7 mp -138.68 136.44 43.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.385 -0.822 . . . . 0.0 108.965 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.584 HG23 HD11 ' A' ' 255' ' ' LEU . 29.9 m -124.64 147.48 29.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -130.0 164.71 23.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 0.0 110.263 -178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -171.82 102.12 0.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.397 -0.814 . . . . 0.0 109.841 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' CD ' ' N ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER 48.05 57.43 6.1 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.373 -0.829 . . . . 0.0 110.731 179.312 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.05 -34.51 3.57 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.887 -1.149 . . . . 0.0 110.469 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -63.25 138.28 58.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.252 . . . . 0.0 109.133 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.46 137.89 28.89 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.082 -1.011 . . . . 0.0 109.726 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.705 HD12 ' HG ' ' A' ' 255' ' ' LEU . 46.2 mt -135.75 121.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.406 -0.809 . . . . 0.0 109.399 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 tttp -110.99 131.69 54.83 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.436 0.636 . . . . 0.0 109.634 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.541 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -119.87 132.88 55.69 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -144.55 146.92 34.21 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.057 -1.027 . . . . 0.0 110.258 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -47.11 141.78 12.37 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 122.654 2.236 . . . . 0.0 113.492 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.419 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.02 144.35 19.98 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 146' ' ' THR . 4.0 t0 -66.16 0.6 1.9 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.34 -0.85 . . . . 0.0 110.792 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 145' ' ' ASP . 27.9 p -157.13 173.6 16.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.841 -1.162 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 tp -85.11 118.3 24.59 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.204 -0.935 . . . . 0.0 109.424 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -137.45 126.17 23.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 108.764 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.3 t -125.41 121.41 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.371 -0.831 . . . . 0.0 110.029 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 98.9 m -111.62 151.7 28.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.642 -0.661 . . . . 0.0 109.292 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -139.03 130.25 26.79 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.721 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -120.88 131.66 54.52 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -131.24 133.91 7.46 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.584 -178.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -100.98 97.72 8.26 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -88.57 167.13 13.66 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 110.983 -178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 16.1 tttm -98.99 -17.05 18.49 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.76 -0.587 . . . . 0.0 110.697 -178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.0 p-10 -92.62 -168.59 1.99 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.825 -1.172 . . . . 0.0 110.386 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.4 p90 -55.08 0.28 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.362 -0.836 . . . . 0.0 111.472 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.537 HD22 ' OE1' ' A' ' 162' ' ' GLN . 11.2 mt -78.55 -27.65 45.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.443 -1.411 . . . . 0.0 108.839 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.8 -137.96 34.96 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.3 ttm105 -100.4 132.3 45.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.202 -1.175 . . . . 0.0 109.682 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.537 ' OE1' HD22 ' A' ' 159' ' ' LEU . 56.4 mt-30 -139.5 155.52 47.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.329 -0.857 . . . . 0.0 109.125 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -147.93 149.5 32.33 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.113 -0.992 . . . . 0.0 110.585 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -143.46 139.32 29.83 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.512 -0.742 . . . . 0.0 109.41 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.29 124.82 51.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.162 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.509 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.8 t80 -105.12 113.77 27.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.848 . . . . 0.0 110.327 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.5 t -107.0 153.06 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.316 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.01 125.61 10.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.101 -1.0 . . . . 0.0 109.248 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.541 ' CA ' ' OE2' ' A' ' 171' ' ' GLU . . . 102.73 3.59 49.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -120.24 19.9 12.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.307 -1.114 . . . . 0.0 109.278 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 173' ' ' GLU . 2.2 pm0 -64.88 -46.49 81.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.25 -0.906 . . . . 0.0 109.642 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -47.8 -7.52 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.359 -0.838 . . . . 0.0 110.1 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.588 ' N ' ' O ' ' A' ' 171' ' ' GLU . 75.0 mt-10 -103.58 -5.89 22.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.106 -0.996 . . . . 0.0 110.482 -179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.4 pt -123.29 -26.96 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.217 -0.927 . . . . 0.0 110.558 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.2 m -60.79 -23.6 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.569 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.9 mt -85.27 -2.2 57.79 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -71.49 119.09 15.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -0.845 . . . . 0.0 109.082 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.417 ' NH2' ' OE1' ' A' ' 222' ' ' GLU . 42.5 mtm180 -83.53 172.97 11.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.453 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.4 163.38 25.7 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -147.78 147.91 30.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.22 -1.55 . . . . 0.0 111.786 -179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.626 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -147.87 157.88 43.76 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.443 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.0 m-85 -97.85 146.94 24.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.901 -1.124 . . . . 0.0 109.78 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.52 -37.31 26.22 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.304 -0.872 . . . . 0.0 109.176 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.443 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.0 p90 -71.05 -25.56 62.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.13 -0.981 . . . . 0.0 109.947 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.434 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.4 mt-10 -82.39 -22.93 35.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.138 -0.977 . . . . 0.0 109.742 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . . . . . . . . . 58.8 mt -60.85 -53.67 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.204 -0.935 . . . . 0.0 109.639 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.88 -38.02 9.75 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.145 -0.972 . . . . 0.0 109.579 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.686 ' O ' HG22 ' A' ' 192' ' ' VAL . 71.3 t60 -76.54 -53.78 7.6 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.122 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.1 mt -46.82 -32.3 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.788 . . . . 0.0 109.533 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.84 -52.61 6.57 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.039 -1.038 . . . . 0.0 109.226 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.2 tttp -49.84 -40.43 42.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.871 . . . . 0.0 110.265 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.686 HG22 ' O ' ' A' ' 188' ' ' HIS . 28.0 m -78.55 5.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.006 -1.059 . . . . 0.0 110.218 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.96 37.21 56.71 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 194' ' ' LEU . 35.4 mt -125.39 168.89 12.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.357 -1.084 . . . . 0.0 109.433 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.51 21.77 58.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -53.74 -20.27 5.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.571 -1.547 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.447 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.67 26.32 9.05 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.92 128.53 9.19 Favored Glycine 0 N--CA 1.491 2.325 0 O-C-N 120.946 -1.326 . . . . 0.0 110.034 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 7.8 p -144.93 171.97 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.406 -1.056 . . . . 0.0 109.422 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 18.5 mt -70.47 -8.14 48.79 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt -97.06 -12.73 22.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.772 -0.58 . . . . 0.0 109.515 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 18.0 p30 -133.13 7.54 3.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 109.882 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.8 m -149.88 151.0 32.75 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.89 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.609 HD11 ' CD2' ' A' ' 217' ' ' LEU . 10.8 tp -98.15 95.4 7.4 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.3 t -85.87 127.76 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.788 0.804 . . . . 0.0 109.28 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.562 ' CD2' HG13 ' A' ' 211' ' ' VAL . 52.9 mt -123.24 161.47 24.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.647 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -122.94 -166.65 12.71 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -29.73 70.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -1.099 . . . . 0.0 109.672 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.66 23.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.19 -0.944 . . . . 0.0 110.856 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -146.78 154.12 41.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.51 -1.369 . . . . 0.0 110.708 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.562 HG13 ' CD2' ' A' ' 206' ' ' LEU . 45.3 t -104.44 113.45 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -58.69 -45.62 89.06 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 109.832 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.15 116.61 18.2 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.224 -0.923 . . . . 0.0 109.73 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.95 -15.4 43.51 Favored 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 121.475 1.45 . . . . 0.0 111.641 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.404 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.9 pm0 -75.01 -15.82 60.64 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.231 -0.918 . . . . 0.0 108.702 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.23 -178.12 47.58 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.609 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -83.92 145.75 28.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.32 -1.106 . . . . 0.0 109.639 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -77.79 -18.79 56.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 0.0 108.811 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.638 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 76.0 m-85 -141.8 178.74 7.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.502 -0.749 . . . . 0.0 109.203 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -85.92 -3.49 58.94 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.145 -0.972 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.705 HD22 ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -146.77 45.55 1.19 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.544 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -55.58 -47.18 99.24 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.861 -1.149 . . . . 0.0 109.756 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.544 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.6 Cg_exo -51.37 -66.77 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.429 2.086 . . . . 0.0 112.157 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 225' ' ' ARG . 27.9 m -59.97 -36.79 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.936 -1.102 . . . . 0.0 109.63 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.705 ' NE ' HD22 ' A' ' 221' ' ' ASN . 75.3 mtt180 -59.77 -42.18 92.76 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.457 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 19.2 t60 -67.09 -31.66 72.29 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.06 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -66.57 -35.76 81.01 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.509 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.0 t -67.73 -37.73 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.449 ' CD1' ' OG ' ' A' ' 77' ' ' SER . 66.9 t80 -64.01 -50.61 67.82 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -67.46 -28.02 67.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.454 -0.779 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 23.3 tp -75.92 -33.02 59.87 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 28.2 mt -67.52 -39.54 82.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.28 -58.2 9.16 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.456 -1.457 . . . . 0.0 109.456 179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.438 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 53.8 m-20 -51.55 -40.84 60.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.116 -1.226 . . . . 0.0 109.249 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' A' ' 235' ' ' LEU . 7.0 mt -57.18 -22.97 44.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.533 -0.729 . . . . 0.0 110.282 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.557 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.6 -22.26 61.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.841 -1.162 . . . . 0.0 108.721 -179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 60' ' ' THR . 92.4 mt -53.08 -1.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.727 -1.233 . . . . 0.0 110.122 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.592 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.6 mt -75.68 -14.45 60.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.016 -1.052 . . . . 0.0 109.598 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.64 -1.91 57.09 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.594 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 1.3 m -166.52 157.2 10.96 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.867 -1.372 . . . . 0.0 109.208 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 5.5 Cg_endo -49.84 150.55 9.37 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 121.956 1.771 . . . . 0.0 109.712 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.1 t -110.7 147.95 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 111.515 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.7 tppt? -130.34 123.97 31.19 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.491 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.51 -158.77 28.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.419 ' N ' ' HB2' ' A' ' 144' ' ' SER . 11.6 ttmt -129.55 139.82 51.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.282 -1.128 . . . . 0.0 109.087 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 22.7 m-85 -134.74 139.84 45.48 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.317 -0.865 . . . . 0.0 110.426 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -123.39 123.29 40.35 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.6 m -120.54 134.36 55.29 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.942 -1.099 . . . . 0.0 111.074 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -115.73 115.74 26.86 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 9.0 mtp180 49.71 20.75 0.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.972 -1.08 . . . . 0.0 109.054 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -50.28 156.23 2.4 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -139.7 157.28 25.17 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.468 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 80.9 m-70 -45.32 -43.36 10.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.3 -1.118 . . . . 0.0 110.032 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.9 p -58.46 -41.05 84.3 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.705 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.0 tp -74.2 -43.61 56.52 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.084 -1.01 . . . . 0.0 108.538 179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 256' ' ' ASN . 0.8 OUTLIER -50.98 -45.73 61.13 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.092 -1.005 . . . . 0.0 109.051 179.122 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 56' ' ' THR . 77.7 t -66.13 -57.43 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.503 -0.748 . . . . 0.0 109.81 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.416 ' HE3' HD12 ' A' ' 255' ' ' LEU . 2.6 ttpt -47.41 -46.16 26.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.839 -1.163 . . . . 0.0 108.614 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.683 HD22 HG21 ' A' ' 139' ' ' ILE . 44.1 tp -55.04 -53.48 55.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.051 . . . . 0.0 108.791 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.592 HG13 ' HG ' ' A' ' 238' ' ' LEU . 47.6 t -54.49 -53.75 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.154 -0.966 . . . . 0.0 109.528 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -49.32 -46.69 47.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -0.823 . . . . 0.0 109.83 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -64.92 -52.77 54.6 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.163 -0.961 . . . . 0.0 109.957 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.441 ' O ' ' CB ' ' A' ' 267' ' ' GLN . 22.6 mt -53.87 -51.82 62.41 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.52 -0.738 . . . . 0.0 110.196 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.14 -27.2 65.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.963 -1.086 . . . . 0.0 110.304 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -64.77 -59.36 4.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.074 -1.016 . . . . 0.0 110.149 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.497 ' CE ' HD12 ' A' ' 130' ' ' ILE . 0.0 OUTLIER -81.48 -28.81 33.94 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.026 -1.046 . . . . 0.0 110.321 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.558 ' O ' ' CG ' ' A' ' 268' ' ' LYS . 1.6 tp-100 -86.02 56.67 4.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.03 -1.043 . . . . 0.0 109.242 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.592 ' O ' ' NZ ' ' A' ' 268' ' ' LYS . 0.0 OUTLIER 160.57 11.69 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.406 ' H ' ' H ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 0.0 109.445 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.626 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.634 ' O ' HD11 ' A' ' 121' ' ' ILE . 14.5 mt -117.51 162.35 18.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.52 -0.988 . . . . 0.0 109.635 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' OE1' ' O ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -55.74 129.12 38.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 0.0 108.97 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.9 144.27 48.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.501 -0.749 . . . . 0.0 109.301 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.8 t -143.83 -173.28 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.625 HG23 ' HG3' ' A' ' 30' ' ' PRO . 16.1 m -95.44 135.01 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.96 -1.087 . . . . 0.0 109.503 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HB3' HD13 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -65.36 -20.43 66.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.305 -0.872 . . . . 0.0 109.664 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -154.62 156.12 35.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.196 -0.94 . . . . 0.0 109.435 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.78 139.85 58.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.326 -0.859 . . . . 0.0 110.112 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 11' ' ' LEU . 56.4 mt -118.78 168.29 10.88 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.5 p -143.64 146.53 33.32 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.916 -1.115 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 97.1 m-85 -140.12 150.24 44.03 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -152.97 148.18 26.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.965 -1.084 . . . . 0.0 109.703 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.58 173.1 36.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.42 153.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -1.12 . . . . 0.0 110.311 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.57 140.76 15.51 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.503 HG23 ' N ' ' A' ' 19' ' ' HIS . 15.4 tt -60.15 -41.52 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -1.216 . . . . 0.0 110.659 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.503 ' N ' HG23 ' A' ' 18' ' ' ILE . 88.6 m-70 -86.64 -50.8 6.54 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.686 -1.259 . . . . 0.0 110.875 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.6 p -70.96 -22.57 62.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.67 -0.644 . . . . 0.0 111.526 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.51 15.61 12.52 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -106.82 154.99 20.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -1.159 . . . . 0.0 109.76 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -74.23 135.44 42.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 92' ' ' ILE . 3.5 t -138.9 145.43 39.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.91 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 ttpt -111.04 155.21 23.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.616 -0.677 . . . . 0.0 110.019 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 90' ' ' GLU . 9.7 mt -135.4 147.11 48.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 109.969 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.6 mt -143.45 109.62 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.056 -1.027 . . . . 0.0 108.864 177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.68 113.75 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.279 -0.888 . . . . 0.0 110.444 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -106.76 140.0 20.92 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.489 -0.757 . . . . 0.0 109.265 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.625 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.6 Cg_exo -54.55 165.77 2.22 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.752 1.635 . . . . 0.0 111.952 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' HG21 ' A' ' 35' ' ' THR . 5.6 mm-40 -141.39 174.39 10.59 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.257 -0.902 . . . . 0.0 109.241 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.471 ' O ' ' OG1' ' A' ' 35' ' ' THR . 75.2 mttt -82.68 152.26 25.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.556 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -48.7 151.93 1.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.81 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.56 -6.94 3.07 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 31' ' ' GLU . 32.7 m -59.62 -44.9 93.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.784 -1.421 . . . . 0.0 109.705 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.15 -176.31 30.38 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.57 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.5 mm -102.52 116.79 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.93 155.13 47.31 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.056 -1.058 . . . . 0.0 110.608 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -102.99 158.67 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -128.88 109.14 11.01 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.247 -0.908 . . . . 0.0 108.875 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -135.53 134.5 39.51 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.333 -0.854 . . . . 0.0 110.995 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.3 m-80 52.7 29.14 7.0 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.461 -0.775 . . . . 0.0 111.325 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.0 18.41 76.84 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.909 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.65 123.26 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.395 -1.062 . . . . 0.0 109.08 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -85.49 127.59 34.46 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.115 -0.991 . . . . 0.0 109.405 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.0 mt -116.91 93.7 42.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.207 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.69 151.42 19.37 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 111.897 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.42 70.74 10.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.129 -0.982 . . . . 0.0 109.759 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.176 -0.952 . . . . 0.0 109.035 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.578 ' O ' HG23 ' A' ' 53' ' ' VAL . 2.4 p-80 -69.51 -54.12 15.75 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.816 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -43.56 -17.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.37 -0.831 . . . . 0.0 111.087 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.5 m-85 -94.96 3.4 54.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.936 -1.102 . . . . 0.0 109.912 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 50' ' ' HIS . 96.9 t -72.24 138.94 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.19 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.76 -28.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.395 -0.815 . . . . 0.0 109.639 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -154.37 133.61 12.56 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.093 -1.004 . . . . 0.0 109.658 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.632 HG21 HG21 ' A' ' 257' ' ' VAL . 45.6 p -124.03 95.6 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.51 -0.744 . . . . 0.0 109.124 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.586 ' O ' ' N ' ' A' ' 59' ' ' SER . 6.0 t-20 -163.09 128.71 3.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.798 . . . . 0.0 109.097 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 59' ' ' SER . 79.9 m-70 45.64 13.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.153 -0.967 . . . . 0.0 109.491 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.586 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.32 130.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.15 -0.969 . . . . 0.0 109.963 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.468 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 45.2 m -78.68 125.17 29.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.184 -0.948 . . . . 0.0 108.869 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.02 147.73 44.44 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.841 0.829 . . . . 0.0 111.206 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.486 HD23 ' HA ' ' A' ' 53' ' ' VAL . 15.0 mt -123.77 150.26 44.64 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.88 151.36 21.09 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.907 -1.616 . . . . 0.0 110.731 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -163.36 152.21 14.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.533 -0.981 . . . . 0.0 109.27 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt 51.3 21.83 1.24 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.28 -0.888 . . . . 0.0 109.528 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 99.0 -32.89 6.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.518 ' NE2' ' N ' ' A' ' 67' ' ' GLN . 13.6 mm-40 -59.26 146.39 39.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -1.229 . . . . 0.0 109.332 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 ttm-85 -142.13 137.31 30.83 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -0.923 . . . . 0.0 110.663 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 122.96 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -101.13 155.16 18.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.876 -1.14 . . . . 0.0 111.312 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 m 49.18 73.89 0.21 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.78 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 17.2 m -107.78 -8.33 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.237 -0.915 . . . . 0.0 109.531 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.593 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.05 -27.61 68.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.362 -0.837 . . . . 0.0 110.495 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 29.1 m170 -64.49 -69.04 0.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.923 -1.111 . . . . 0.0 109.349 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.56 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.49 -47.59 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.031 -1.043 . . . . 0.0 109.23 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' N ' HG23 ' A' ' 75' ' ' ILE . 37.5 mt -52.58 -48.28 66.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.927 -1.108 . . . . 0.0 109.985 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 29.6 t -60.47 -41.85 95.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.099 -1.001 . . . . 0.0 110.095 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG11 HD12 ' A' ' 110' ' ' ILE . 54.0 t -57.04 -45.41 83.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.99 -1.069 . . . . 0.0 108.981 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.09 -34.98 78.8 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.12 -0.988 . . . . 0.0 109.255 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -61.52 -36.4 80.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.613 HD13 ' HB2' ' A' ' 171' ' ' GLU . 52.3 mt -79.75 -37.02 36.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.35 -0.844 . . . . 0.0 109.835 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 81.5 mt -79.33 2.07 22.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.015 -1.053 . . . . 0.0 109.802 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 54.48 39.4 31.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.997 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.513 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 2.8 mm -86.21 141.8 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.975 -1.078 . . . . 0.0 108.25 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.516 HG21 HG23 ' A' ' 121' ' ' ILE . 57.0 p -124.49 -21.44 4.89 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.028 -1.045 . . . . 0.0 111.753 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.658 ' O ' HG13 ' A' ' 87' ' ' VAL . 38.8 m-80 -127.24 108.06 10.55 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.887 -1.133 . . . . 0.0 111.048 -178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.0 m -162.61 146.52 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.322 -0.861 . . . . 0.0 110.199 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.485 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 89.5 m -115.85 113.75 23.79 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.568 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.5 mt -95.9 107.4 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.693 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.579 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.4 tt0 -76.75 127.15 32.22 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.38 117.51 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 CA-C-O 121.742 0.782 . . . . 0.0 111.442 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.414 ' O ' ' OG ' ' A' ' 24' ' ' SER . 26.1 mm -104.51 95.98 4.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.19 -155.4 24.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.21 -10.5 8.52 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.203 -1.175 . . . . 0.0 110.379 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -139.82 148.95 42.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.031 -1.043 . . . . 0.0 109.923 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.505 HG23 HD11 ' A' ' 26' ' ' LEU . 40.8 mm -72.85 126.41 90.61 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.347 -0.846 . . . . 0.0 108.735 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -45.9 121.18 4.03 Favored 'Trans proline' 0 N--CA 1.487 1.144 0 C-N-CA 121.845 1.697 . . . . 0.0 111.004 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.9 tp -75.25 -15.64 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.157 -0.964 . . . . 0.0 110.551 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.6 mt 57.33 -120.63 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.96 . . . . 0.0 109.923 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -96.29 6.61 48.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.062 -1.024 . . . . 0.0 110.821 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.64 -0.3 61.12 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.077 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.2 p -128.31 -172.31 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.634 -0.921 . . . . 0.0 109.524 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.66 15.5 10.53 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -58.53 -43.27 89.16 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.334 -1.098 . . . . 0.0 110.003 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -63.85 -59.19 4.85 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.008 -1.057 . . . . 0.0 109.837 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -51.56 -46.29 63.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.266 -0.896 . . . . 0.0 109.762 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.458 ' CD1' HG11 ' A' ' 175' ' ' VAL . 53.5 t80 -61.56 -51.99 66.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.58 -0.7 . . . . 0.0 110.974 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.36 -43.26 95.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.189 -0.944 . . . . 0.0 111.375 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.51 -55.92 13.3 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 110.611 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.409 HD12 HG11 ' A' ' 78' ' ' VAL . 40.6 mt -63.74 -31.93 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.114 -0.991 . . . . 0.0 109.446 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -65.0 -41.15 95.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.359 -0.838 . . . . 0.0 110.069 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 113' ' ' ASN . 6.0 pttt -75.55 11.06 1.4 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.604 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.5 m-80 -139.91 34.6 1.96 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.98 -1.075 . . . . 0.0 110.507 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.0 mt -84.15 139.85 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.8 -1.187 . . . . 0.0 110.949 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.555 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.2 tp -131.74 126.62 34.91 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.576 ' ND2' ' H ' ' A' ' 116' ' ' ASN . 2.1 p30 -82.81 146.91 28.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.156 -0.965 . . . . 0.0 110.569 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -114.2 -169.42 1.52 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.553 -0.717 . . . . 0.0 109.121 179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -112.65 69.33 0.69 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 111.22 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.498 ' O ' ' OE1' ' A' ' 4' ' ' GLU . 21.3 ttm-85 -164.89 132.23 3.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.993 -1.067 . . . . 0.0 109.267 178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -68.82 141.52 55.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.066 -1.021 . . . . 0.0 109.456 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.634 HD11 ' O ' ' A' ' 3' ' ' LEU . 18.9 mt -81.34 146.26 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.937 . . . . 0.0 110.333 -179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.74 81.04 4.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 43.0 m-85 -60.41 140.03 57.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -86.97 100.91 12.94 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.4 t -92.41 134.56 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-O 121.418 0.628 . . . . 0.0 111.073 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.84 114.69 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.7 -25.99 15.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.073 -1.017 . . . . 0.0 109.978 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -128.93 149.21 71.78 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 109.19 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.4 152.01 48.8 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.377 2.051 . . . . 0.0 111.942 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -155.2 151.58 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.118 -0.989 . . . . 0.0 109.361 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.54 139.23 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.547 HG23 HD11 ' A' ' 255' ' ' LEU . 23.1 m -125.78 148.13 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.92 159.03 42.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.7 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -173.38 105.42 0.13 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.442 -0.786 . . . . 0.0 109.666 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 47.82 56.85 6.63 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.373 -0.83 . . . . 0.0 110.827 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.09 -36.84 2.87 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.839 -1.172 . . . . 0.0 110.464 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -61.56 129.48 41.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.964 -1.315 . . . . 0.0 108.449 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.592 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -143.57 141.01 30.5 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.864 -1.147 . . . . 0.0 110.242 -179.562 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.717 HG21 HD22 ' A' ' 259' ' ' LEU . 68.2 mt -137.62 132.36 44.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.543 -0.723 . . . . 0.0 109.735 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -120.47 130.76 54.43 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.373 0.606 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.64 135.76 54.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -145.29 152.63 50.85 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.078 -1.014 . . . . 0.0 109.52 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -49.95 143.17 24.82 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.412 2.075 . . . . 0.0 113.506 -179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.6 OUTLIER -155.45 144.0 20.38 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 178.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.6 -4.53 4.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.251 -0.906 . . . . 0.0 110.273 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.5 p -151.9 -172.08 4.12 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.049 -1.032 . . . . 0.0 109.279 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -100.54 121.4 41.51 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.077 -1.014 . . . . 0.0 108.845 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 147' ' ' LEU . 67.5 tt0 -135.05 128.82 33.02 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.76 122.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -0.9 . . . . 0.0 109.966 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 39.6 m -113.71 151.92 31.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.594 -0.691 . . . . 0.0 109.429 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -139.69 131.12 26.92 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.938 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -120.94 133.42 55.28 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.93 138.49 9.84 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.649 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -102.03 98.04 8.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -84.97 167.18 16.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 110.576 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -104.07 -17.57 14.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 0.0 110.64 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.45 ' C ' ' H ' ' A' ' 159' ' ' LEU . 24.3 p-10 -92.17 -166.65 1.59 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.779 -1.2 . . . . 0.0 110.01 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -57.29 0.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.91 . . . . 0.0 111.151 -178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 157' ' ' ASN . 12.4 mt -78.68 -27.11 45.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.459 -1.4 . . . . 0.0 108.2 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.03 -141.52 33.14 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 55.7 ttp85 -100.27 134.99 42.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.332 -1.099 . . . . 0.0 109.275 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -139.4 153.89 47.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.559 -0.713 . . . . 0.0 109.484 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.51 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -144.23 145.75 32.25 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.41 -0.806 . . . . 0.0 109.545 179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.564 ' CZ ' ' OE2' ' A' ' 173' ' ' GLU . 16.4 t80 -145.03 140.19 27.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.173 -0.955 . . . . 0.0 109.846 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.415 ' OG1' ' NZ ' ' A' ' 163' ' ' LYS . 90.2 m -109.06 123.37 49.05 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.486 -0.759 . . . . 0.0 110.093 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.487 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.4 t80 -102.98 114.06 28.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.01 147.53 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 6.5 mm-40 -49.11 132.34 19.23 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.312 -0.867 . . . . 0.0 108.838 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.4 -9.58 30.78 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -116.47 25.53 10.55 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.209 -1.171 . . . . 0.0 109.288 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.665 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.0 OUTLIER -61.33 -15.65 38.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.265 -0.897 . . . . 0.0 110.496 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -81.54 -10.42 59.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.038 -1.039 . . . . 0.0 110.668 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' CZ ' ' A' ' 164' ' ' PHE . 1.5 pp20? -101.11 -5.26 25.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.052 -1.03 . . . . 0.0 110.623 -178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.478 HG23 ' OE2' ' A' ' 173' ' ' GLU . 16.7 pt -115.99 -31.15 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.207 -0.933 . . . . 0.0 110.193 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 171' ' ' GLU . 11.7 m -61.7 -15.45 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.842 -1.161 . . . . 0.0 108.776 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.1 mt -94.74 -4.81 46.69 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.561 -0.712 . . . . 0.0 109.451 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.02 120.52 14.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.006 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 86.7 mtm180 -81.07 172.16 14.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.945 . . . . 0.0 109.577 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.74 163.66 25.21 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -148.64 145.44 27.76 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.252 -1.53 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.549 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -142.9 158.03 44.01 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.51 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 88.2 m-85 -99.44 143.94 29.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.002 -1.061 . . . . 0.0 109.412 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.38 -36.47 6.46 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.3 -0.875 . . . . 0.0 109.643 -179.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.524 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.9 p90 -73.35 -29.81 62.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.947 -1.095 . . . . 0.0 109.889 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.524 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.5 tt0 -74.54 -27.64 60.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 0.0 109.938 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.44 HG21 HB21 ' A' ' 500' ' ' C90 . 58.5 mt -59.31 -48.76 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 110.026 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -47.77 -40.76 21.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.168 -0.957 . . . . 0.0 109.995 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.1 t60 -77.25 -52.92 8.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.964 . . . . 0.0 109.275 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 67.6 mt -49.42 -27.06 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 0.0 109.418 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -85.61 -54.74 4.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.001 -1.062 . . . . 0.0 109.35 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -50.76 -33.78 24.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.294 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -84.66 7.16 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.0 -1.063 . . . . 0.0 110.08 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.38 39.93 61.03 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.1 mt -129.39 171.36 12.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.214 -1.168 . . . . 0.0 110.145 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 58.39 29.14 62.96 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 29.8 mttt -58.2 -56.33 23.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.388 -1.654 . . . . 0.0 109.683 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.494 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -67.1 4.68 3.19 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 120.104 -1.045 . . . . 0.0 110.725 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.99 124.82 34.94 Favored Glycine 0 N--CA 1.495 2.569 0 O-C-N 120.876 -1.367 . . . . 0.0 110.523 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.1 t -145.91 164.23 32.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.438 -1.036 . . . . 0.0 109.101 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.513 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 70.7 mt -67.92 -8.01 33.24 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.5 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -98.77 -9.31 24.62 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.758 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 23.6 p30 -134.54 9.66 3.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.106 -0.996 . . . . 0.0 110.113 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 205' ' ' VAL . 1.3 m -150.72 150.05 30.57 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.114 -0.991 . . . . 0.0 110.194 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.614 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.4 tp -99.86 93.18 5.65 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.411 HG23 HG22 ' A' ' 203' ' ' THR . 43.0 t -85.85 130.56 36.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.716 0.769 . . . . 0.0 108.973 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 35.2 mt -124.78 165.11 18.57 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.656 -0.652 . . . . 0.0 109.576 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -126.19 -166.4 12.23 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.57 -25.21 67.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 109.747 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -163.21 23.15 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 110.385 -179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.13 146.67 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.016 -1.053 . . . . 0.0 110.342 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 91.3 t -100.73 109.99 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -56.48 -49.11 75.63 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.078 -1.014 . . . . 0.0 109.826 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.8 m120 -60.28 112.48 5.55 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.37 -0.832 . . . . 0.0 110.279 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -56.26 -23.2 44.54 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 121.796 1.664 . . . . 0.0 112.783 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.61 -14.71 62.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.834 -1.166 . . . . 0.0 109.919 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.24 -168.55 52.25 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.614 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -90.28 138.67 31.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -1.166 . . . . 0.0 109.763 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -75.32 -17.25 60.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.158 -0.964 . . . . 0.0 109.174 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -135.3 -173.61 3.38 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -88.7 -22.43 23.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.549 HD22 ' NH1' ' A' ' 225' ' ' ARG . 0.1 OUTLIER -136.94 53.25 1.9 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.295 -0.878 . . . . 0.0 109.543 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.519 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -54.63 -47.82 96.92 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 0.0 109.917 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.519 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.3 Cg_exo -48.45 -64.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 122.391 2.061 . . . . 0.0 112.102 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 15.5 m -60.64 -35.8 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.064 -1.022 . . . . 0.0 109.793 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.549 ' NH1' HD22 ' A' ' 221' ' ' ASN . 4.0 mtt85 -60.89 -41.56 96.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.046 -1.033 . . . . 0.0 108.468 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.457 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.4 t60 -67.45 -32.3 73.07 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.296 -0.878 . . . . 0.0 109.064 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.434 ' HE2' H211 ' A' ' 500' ' ' C90 . 24.1 mmtt -66.53 -36.45 82.71 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 166' ' ' PHE . 66.2 t -67.53 -37.37 78.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -64.98 -51.48 61.51 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -64.55 -28.26 69.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.373 -0.83 . . . . 0.0 109.844 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 36.0 tp -75.06 -34.13 61.79 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.072 -1.018 . . . . 0.0 108.492 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 43.5 mt -66.77 -39.84 84.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.04 -56.0 18.61 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.405 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 26.7 m-20 -54.63 -32.72 59.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.096 -1.238 . . . . 0.0 109.178 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.6 mt -63.68 -23.77 67.51 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.475 -0.766 . . . . 0.0 110.653 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.576 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.73 -21.79 61.71 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.749 -1.219 . . . . 0.0 109.105 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 237' ' ' LEU . 83.9 mt -50.46 -1.93 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.604 -1.31 . . . . 0.0 110.607 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -78.44 -15.26 58.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.771 -1.205 . . . . 0.0 109.574 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.19 2.93 59.02 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.574 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 2.8 m -166.46 155.45 10.0 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.884 -1.362 . . . . 0.0 109.163 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.0 Cg_endo -49.63 150.55 8.71 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 121.952 1.768 . . . . 0.0 109.608 179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -109.83 145.96 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 0.0 112.124 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -127.81 121.98 31.53 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 153.91 -179.27 30.29 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 246' ' ' PHE . 0.0 OUTLIER -109.43 140.7 42.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.277 -1.131 . . . . 0.0 109.198 -179.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 17.2 m-85 -135.05 138.76 44.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.156 -0.965 . . . . 0.0 110.34 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -125.0 124.75 42.67 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 44.8 m -120.19 135.78 54.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.971 -1.081 . . . . 0.0 111.429 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.429 ' O ' ' N ' ' A' ' 251' ' ' GLY . 75.8 t80 -115.28 117.06 29.41 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 249' ' ' PHE . 63.3 mtp180 45.98 22.37 0.13 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.073 -1.017 . . . . 0.0 109.065 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 249' ' ' PHE . . . -51.9 159.41 2.61 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -139.1 164.3 25.86 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.593 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 34.1 m-70 -50.28 -42.76 52.87 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.149 -1.206 . . . . 0.0 109.809 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.1 m -56.98 -59.2 5.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.675 ' HG ' HD12 ' A' ' 139' ' ' ILE . 26.4 tp -53.51 -45.64 69.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.173 -0.954 . . . . 0.0 109.381 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -49.54 -50.53 41.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 0.0 109.666 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.632 HG21 HG21 ' A' ' 56' ' ' THR . 98.5 t -62.41 -55.22 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.413 -0.805 . . . . 0.0 110.197 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.457 ' HE3' HD12 ' A' ' 255' ' ' LEU . 1.0 OUTLIER -52.0 -45.2 64.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 108.79 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 139' ' ' ILE . 24.6 tp -52.99 -54.47 34.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.488 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.564 HG13 ' HG ' ' A' ' 238' ' ' LEU . 30.6 t -55.86 -54.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.89 . . . . 0.0 109.37 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.35 -43.98 33.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.5 -0.75 . . . . 0.0 109.735 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.35 -49.99 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.125 -0.984 . . . . 0.0 109.861 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 13.9 mt -56.94 -47.59 80.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 109.86 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -68.34 -30.77 69.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.203 -0.936 . . . . 0.0 110.159 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.8 mmtt -67.5 -42.8 82.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 109.568 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 268' ' ' LYS . 23.5 mttt -78.54 -54.16 6.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 109.889 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -70.41 53.26 0.14 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 0.0 109.661 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 266' ' ' LYS . 26.6 mtmt -60.48 -176.03 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.214 -0.929 . . . . 0.0 109.532 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.549 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 79.4 mt -91.88 157.47 16.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.218 -1.166 . . . . 0.0 109.649 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.409 ' HB3' HD21 ' A' ' 86' ' ' ASN . 32.4 mt-10 -54.62 137.35 43.83 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.083 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.66 142.72 49.87 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.495 -0.753 . . . . 0.0 109.717 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.4 t -141.51 -171.63 3.35 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.654 HG23 ' HG3' ' A' ' 30' ' ' PRO . 30.3 m -96.86 135.15 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.022 -1.049 . . . . 0.0 109.162 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.91 -21.26 66.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.585 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -153.0 160.76 43.04 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.228 -0.92 . . . . 0.0 109.275 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 140.59 54.48 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.322 -0.861 . . . . 0.0 110.022 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 52.2 mt -118.14 163.93 15.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.64 141.9 46.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.111 -0.993 . . . . 0.0 110.091 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.42 ' O ' ' N ' ' A' ' 26' ' ' LEU . 98.0 m-85 -139.84 146.24 39.1 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' CG ' ' OH ' ' A' ' 23' ' ' TYR . 3.8 pt-20 -151.88 149.35 28.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.992 -1.067 . . . . 0.0 109.908 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.87 172.27 35.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.28 151.53 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -1.087 . . . . 0.0 110.357 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.37 137.1 15.03 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' HG21 ' A' ' 179' ' ' THR . 6.7 tt -56.26 -38.74 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.139 -1.212 . . . . 0.0 110.283 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 68.8 m-70 -91.07 -49.21 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.845 -1.159 . . . . 0.0 111.105 -178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.402 ' C ' ' H ' ' A' ' 22' ' ' GLU . 2.9 p -69.49 -21.76 63.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 111.416 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.03 8.31 3.05 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 20' ' ' THR . 3.4 mm-40 -102.69 157.34 17.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -1.108 . . . . 0.0 109.672 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' OH ' ' CG ' ' A' ' 14' ' ' GLU . 81.8 t80 -74.66 136.58 41.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.466 -0.771 . . . . 0.0 109.734 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.6 m -137.67 142.66 41.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.115 -0.99 . . . . 0.0 109.805 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -108.39 151.91 25.38 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.493 -0.755 . . . . 0.0 110.043 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.69 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -134.74 144.29 47.64 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.273 -0.892 . . . . 0.0 109.608 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.592 HG22 ' NE2' ' A' ' 29' ' ' HIS . 5.0 mt -142.45 110.48 2.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.113 -0.992 . . . . 0.0 108.607 178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.5 mt -94.95 115.92 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.488 -0.758 . . . . 0.0 111.168 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.592 ' NE2' HG22 ' A' ' 27' ' ' ILE . 27.8 m-70 -109.41 139.73 21.38 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.482 -0.761 . . . . 0.0 109.585 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.654 ' HG3' HG23 ' A' ' 7' ' ' VAL . 23.5 Cg_exo -54.43 168.13 1.12 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.662 1.574 . . . . 0.0 111.434 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.482 ' HB3' HG21 ' A' ' 35' ' ' THR . 73.4 mm-40 -139.99 173.35 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.099 -1.001 . . . . 0.0 110.04 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 35' ' ' THR . 12.9 mtmt -81.98 149.78 27.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.493 -0.754 . . . . 0.0 109.742 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -46.79 145.43 1.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.341 -0.849 . . . . 0.0 109.823 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.77 8.22 60.19 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.312 -0.947 . . . . 0.0 110.878 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 26.5 m -73.61 -43.47 59.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.598 -1.531 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.46 -177.61 33.5 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.603 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.7 mm -99.11 117.1 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -140.42 151.69 45.1 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.212 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -98.62 157.38 16.29 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.56 110.87 12.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.199 -0.938 . . . . 0.0 109.061 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.456 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 42.5 tttm -135.23 133.95 39.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.317 -0.864 . . . . 0.0 110.684 -178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.7 m120 50.7 29.44 4.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.47 -0.769 . . . . 0.0 111.213 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.84 19.14 73.69 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.144 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.9 t -122.47 120.98 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.364 -1.08 . . . . 0.0 109.029 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 18.7 m-85 -84.61 127.59 34.15 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.086 -1.008 . . . . 0.0 109.401 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.1 mt -117.18 93.99 43.85 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.401 -0.812 . . . . 0.0 109.523 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.72 148.31 16.24 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 122.558 2.172 . . . . 0.0 112.206 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.602 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.64 69.08 10.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.176 -0.952 . . . . 0.0 109.175 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -118.94 163.98 16.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.4 -0.812 . . . . 0.0 109.291 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.546 ' CD2' ' CD ' ' A' ' 51' ' ' GLU . 1.2 p-80 -68.85 -50.07 53.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.069 -1.02 . . . . 0.0 109.578 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.546 ' CD ' ' CD2' ' A' ' 50' ' ' HIS . 42.8 mp0 -46.19 -16.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 110.632 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 50' ' ' HIS . 29.6 m-85 -95.79 3.53 53.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.851 -1.156 . . . . 0.0 110.019 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.437 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.7 t -71.15 128.73 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 108.735 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.0 m -114.38 -21.73 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.389 -0.819 . . . . 0.0 110.355 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -156.26 125.89 6.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.907 -1.12 . . . . 0.0 110.009 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.836 HG21 HG21 ' A' ' 257' ' ' VAL . 38.5 p -121.03 95.56 4.75 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.3 t-20 -162.78 128.74 3.35 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.503 ' O ' ' CB ' ' A' ' 59' ' ' SER . 87.9 m-70 51.91 7.22 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.97 . . . . 0.0 108.854 -179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 57' ' ' ASN . 1.3 m 164.22 153.77 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 0.0 109.786 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.464 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 30.1 m -94.05 127.37 39.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.21 -0.931 . . . . 0.0 109.215 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.36 149.67 41.96 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.758 0.79 . . . . 0.0 111.064 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.594 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.0 mt -125.35 151.81 45.59 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.68 148.0 15.55 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.802 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -159.27 145.67 16.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.547 -0.972 . . . . 0.0 108.976 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.408 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 0.6 OUTLIER 52.94 28.01 6.14 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.394 -0.817 . . . . 0.0 109.473 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.12 -32.61 5.56 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.567 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.7 OUTLIER -56.62 143.93 34.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.162 -1.199 . . . . 0.0 108.952 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.87 137.02 29.26 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.263 -0.898 . . . . 0.0 110.268 -179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.0 mt -131.33 123.45 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 70' ' ' LYS . 12.5 mtpp -98.81 157.19 16.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.95 -1.093 . . . . 0.0 110.94 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.4 m 50.77 74.61 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.55 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.594 HG21 ' CD1' ' A' ' 62' ' ' LEU . 22.0 m -108.02 -10.39 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 0.0 109.197 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -61.63 -27.41 68.64 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 110.627 -179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.425 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.5 m170 -65.78 -68.6 0.35 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.976 -1.078 . . . . 0.0 109.352 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -52.44 -47.13 47.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.093 -1.004 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.602 HD21 ' HB1' ' A' ' 48' ' ' ALA . 16.5 mt -52.59 -48.7 66.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.968 -1.082 . . . . 0.0 110.189 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.507 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 0.8 OUTLIER -61.0 -43.35 99.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.195 -0.941 . . . . 0.0 110.241 -179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.69 -44.81 78.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 121.232 -0.917 . . . . 0.0 108.843 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.8 mt -69.08 -34.85 75.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.0 t-160 -63.09 -32.03 73.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 109.3 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD13 ' HB2' ' A' ' 171' ' ' GLU . 58.7 mt -83.74 -36.97 23.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.283 -0.886 . . . . 0.0 109.363 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD22 HD11 ' A' ' 114' ' ' ILE . 94.7 mt -78.81 5.01 12.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.011 -1.056 . . . . 0.0 109.513 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 52.84 39.38 28.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -0.874 . . . . 0.0 110.188 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -89.78 138.14 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 108.493 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.585 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 72.6 p -123.77 -18.19 6.13 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.181 -0.949 . . . . 0.0 111.716 -178.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.659 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -126.7 107.8 10.5 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.864 -1.147 . . . . 0.0 111.134 -179.168 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.9 m -163.5 148.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.285 -0.885 . . . . 0.0 110.054 178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 18.9 m -116.38 109.1 16.89 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.51 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -91.86 100.88 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 110.333 -178.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -73.41 127.18 31.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.106 -0.996 . . . . 0.0 108.409 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 HD21 ' A' ' 26' ' ' LEU . 62.3 t -110.48 126.1 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.98 0.895 . . . . 0.0 111.925 -177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 92' ' ' ILE . 4.6 mt -111.94 95.84 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.456 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 141.59 -156.7 25.93 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -120.67 -10.77 9.14 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.243 -1.151 . . . . 0.0 110.449 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -140.39 148.89 41.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 109.47 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.69 HG23 HD11 ' A' ' 26' ' ' LEU . 45.0 mm -72.59 121.38 84.74 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.18 -0.95 . . . . 0.0 108.927 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.96 121.97 1.41 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.624 1.549 . . . . 0.0 111.206 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.44 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.0 tp -78.66 -12.08 13.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 -179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 81.2 mt 56.04 -118.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.173 -0.954 . . . . 0.0 110.146 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 0.4 OUTLIER -97.87 7.29 46.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.144 -0.973 . . . . 0.0 110.539 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.3 -0.47 61.88 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.523 -1.322 . . . . 0.0 109.819 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -127.08 -172.26 2.61 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.799 -0.824 . . . . 0.0 109.535 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.56 15.04 9.2 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 27.6 t-105 -57.59 -42.86 84.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.269 -1.136 . . . . 0.0 110.095 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -64.1 -57.75 8.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.103 -0.998 . . . . 0.0 110.19 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -51.39 -44.99 62.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.442 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 54.0 t80 -63.58 -51.26 66.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.583 -0.698 . . . . 0.0 111.261 -178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 8.0 mm-40 -62.67 -44.41 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.816 -1.177 . . . . 0.0 111.06 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.4 -57.49 7.29 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.155 -0.966 . . . . 0.0 110.16 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.4 mt -62.55 -35.28 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -0.901 . . . . 0.0 109.573 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 57.5 ttt-85 -60.82 -41.72 96.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.213 -0.929 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.628 ' C ' HD22 ' A' ' 113' ' ' ASN . 2.8 mmmp? -74.87 9.45 1.88 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.285 -0.884 . . . . 0.0 109.89 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.628 HD22 ' C ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER -139.56 33.76 2.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.999 -1.063 . . . . 0.0 110.52 -179.443 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.493 HD11 HD22 ' A' ' 82' ' ' LEU . 66.4 mt -83.57 138.01 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 120.63 -1.294 . . . . 0.0 110.824 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.2 tp -131.25 127.08 37.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.767 . . . . 0.0 109.206 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.92 144.91 27.4 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.076 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -112.23 -169.07 1.4 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.427 -0.796 . . . . 0.0 109.466 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -111.87 68.8 0.67 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.334 -0.854 . . . . 0.0 110.761 -179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt85 -163.3 127.91 2.96 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.108 -0.995 . . . . 0.0 109.127 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.75 141.35 56.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 0.0 109.886 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 122' ' ' ASP . 94.0 mt -87.71 152.25 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.402 -0.811 . . . . 0.0 110.247 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 121' ' ' ILE . 9.1 t70 -102.23 90.84 4.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 14.4 m-85 -65.33 148.14 52.22 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.552 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.439 ' CD2' HD13 ' A' ' 238' ' ' LEU . 85.1 t80 -92.58 101.79 14.22 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 31.1 t -93.79 134.33 31.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-O 121.404 0.621 . . . . 0.0 110.74 -177.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.05 116.2 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -92.52 -29.13 16.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.017 -1.052 . . . . 0.0 110.369 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.91 150.04 75.44 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.23 -0.919 . . . . 0.0 109.693 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.36 152.11 43.79 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.551 2.168 . . . . 0.0 112.343 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.7 tt -161.24 152.62 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.08 147.35 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.364 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.61 148.03 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -131.59 162.43 30.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 0.0 109.73 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.533 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.3 OUTLIER -172.41 103.54 0.16 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 50.76 54.89 10.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.331 -0.856 . . . . 0.0 110.333 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.54 -32.64 3.6 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.451 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.56 ' NH1' ' O ' ' A' ' 250' ' ' ARG . 88.1 mtt-85 -62.52 139.74 58.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.925 -1.338 . . . . 0.0 108.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -145.37 138.89 26.6 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.131 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.748 HG21 HD22 ' A' ' 259' ' ' LEU . 78.8 mt -137.56 125.13 30.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.35 -0.844 . . . . 0.0 109.579 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -113.41 132.86 55.46 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 121.393 0.616 . . . . 0.0 109.995 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.41 130.21 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.0 149.09 47.96 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.028 -1.045 . . . . 0.0 109.881 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.59 142.88 9.35 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 C-N-CA 122.677 2.251 . . . . 0.0 113.546 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.413 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.4 OUTLIER -157.18 146.15 19.94 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.654 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -69.39 -3.36 13.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 110.474 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 p -149.08 -179.16 6.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.967 -1.083 . . . . 0.0 109.467 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.458 HD12 ' N ' ' A' ' 148' ' ' GLU . 11.2 tp -97.32 120.38 37.59 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.052 -1.03 . . . . 0.0 108.938 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 147' ' ' LEU . 56.1 tt0 -136.77 134.59 37.24 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 231' ' ' LEU . 60.5 t -133.37 123.43 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.174 -0.954 . . . . 0.0 110.071 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 73.1 m -112.63 151.67 29.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.767 . . . . 0.0 109.743 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -138.17 129.37 27.37 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.653 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -120.74 131.06 54.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.22 141.6 12.51 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.41 -1.376 . . . . 0.0 111.753 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -106.38 101.16 10.64 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.94 167.1 15.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.218 -0.926 . . . . 0.0 110.964 -178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -99.55 -16.25 18.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.627 -0.671 . . . . 0.0 110.706 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 159' ' ' LEU . 28.5 p-10 -98.53 -169.25 1.76 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.994 -1.067 . . . . 0.0 110.611 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -52.09 -0.07 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.502 -0.749 . . . . 0.0 111.531 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.506 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.5 mt -78.04 -26.63 48.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.431 -1.418 . . . . 0.0 108.903 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.96 -140.83 34.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -104.9 134.23 48.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.387 -1.067 . . . . 0.0 109.75 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -138.68 158.76 43.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.581 -0.699 . . . . 0.0 109.375 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.04 145.43 31.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.383 -0.823 . . . . 0.0 109.471 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -143.74 137.17 27.93 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.082 -1.011 . . . . 0.0 110.102 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 88.9 m -109.53 124.88 51.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.482 -0.761 . . . . 0.0 110.038 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.414 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.6 t80 -105.77 117.78 34.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.39 -0.819 . . . . 0.0 109.948 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.79 153.14 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -50.71 126.35 15.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.381 -0.824 . . . . 0.0 109.03 179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 110.94 -2.86 28.66 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -117.76 22.94 12.02 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.173 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.518 ' HB2' HD13 ' A' ' 81' ' ' LEU . 11.2 pt-20 -56.43 -29.95 62.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.301 -0.875 . . . . 0.0 110.18 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -69.86 -19.7 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.726 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -84.0 -6.5 59.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 111.241 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 32.9 pt -124.79 -26.33 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.906 -1.122 . . . . 0.0 111.314 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 11.7 m -60.34 -20.8 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.594 -1.316 . . . . 0.0 109.123 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.9 -2.75 58.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.452 -0.78 . . . . 0.0 109.363 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.556 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.2 116.48 8.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.193 -0.942 . . . . 0.0 108.881 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.521 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.8 mtm180 -81.15 172.06 14.13 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.237 -0.914 . . . . 0.0 109.419 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.444 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.8 t -80.66 162.14 24.33 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -147.49 147.08 29.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.246 -1.534 . . . . 0.0 111.527 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.698 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -144.22 158.05 43.95 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.531 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 85.4 m-85 -99.55 144.25 28.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.992 -1.067 . . . . 0.0 109.981 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.95 -38.87 53.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.531 -0.73 . . . . 0.0 109.895 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.531 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.3 p90 -66.81 -27.46 67.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 0.0 110.034 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.479 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.8 mt-10 -84.05 -43.61 14.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.097 -1.002 . . . . 0.0 109.835 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.639 HD11 HG22 ' A' ' 205' ' ' VAL . 61.8 mt -40.8 -44.7 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 110.245 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.75 -37.72 76.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.107 -0.995 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.452 ' N ' ' O ' ' A' ' 185' ' ' GLU . 4.6 t-80 -76.68 -43.6 37.08 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 96.5 mt -57.66 -29.57 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.504 -0.748 . . . . 0.0 109.036 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -80.98 -52.08 7.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.079 -1.013 . . . . 0.0 108.922 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -48.86 -45.67 41.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 110.282 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.415 HG11 ' NE2' ' A' ' 188' ' ' HIS . 19.1 m -74.89 6.49 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.052 -1.03 . . . . 0.0 110.216 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.78 39.24 48.41 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.126 -0.984 . . . . 0.0 110.726 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.6 mt -126.53 176.1 7.43 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.215 -1.168 . . . . 0.0 109.56 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 54.43 24.25 30.0 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -58.51 -20.89 49.69 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.662 -1.493 . . . . 0.0 110.306 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.482 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.11 1.74 31.41 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -63.46 126.2 35.06 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.963 -1.316 . . . . 0.0 110.416 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 203' ' ' THR . 1.6 t -146.31 167.31 23.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.379 -1.071 . . . . 0.0 109.506 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.589 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 0.6 OUTLIER -68.57 -8.76 44.6 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.331 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.405 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 7.6 mmtp -96.67 -13.13 23.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.668 -0.645 . . . . 0.0 109.478 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.6 p30 -135.83 7.43 3.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.627 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -151.72 152.98 33.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.269 -0.894 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.58 HD11 ' CD2' ' A' ' 217' ' ' LEU . 15.3 tp -100.21 97.98 8.72 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.639 HG22 HD11 ' A' ' 186' ' ' ILE . 53.4 t -85.49 126.86 40.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 43.0 mt -122.26 161.99 22.26 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.548 -0.72 . . . . 0.0 109.875 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -124.85 -166.39 12.38 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -62.89 -26.23 68.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.28 -1.13 . . . . 0.0 109.735 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -161.29 22.77 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 110.565 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -140.04 147.62 40.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.865 -1.147 . . . . 0.0 110.393 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.32 112.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -60.29 -45.46 93.27 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.084 . . . . 0.0 110.103 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.9 m120 -61.91 121.58 66.16 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.018 -1.051 . . . . 0.0 109.792 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -67.66 -12.62 36.19 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 C-N-CA 121.486 1.457 . . . . 0.0 111.817 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.69 -16.81 56.83 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.273 -0.892 . . . . 0.0 108.945 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.26 -169.21 54.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.58 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.4 mt -89.25 145.57 25.31 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.159 -1.2 . . . . 0.0 109.781 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -79.42 -19.26 50.42 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 221' ' ' ASN . 71.2 m-85 -146.85 152.14 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.467 -0.771 . . . . 0.0 108.987 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -66.64 6.57 0.45 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.63 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.47 ' H ' ' C ' ' A' ' 219' ' ' TYR . 0.2 OUTLIER -151.11 40.62 0.72 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.542 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -58.27 -47.24 99.17 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 120.857 -1.152 . . . . 0.0 109.734 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.3 Cg_exo -51.43 -67.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.425 2.083 . . . . 0.0 112.199 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -58.4 -37.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.964 -1.085 . . . . 0.0 109.858 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 224' ' ' VAL . 44.4 mtt180 -59.96 -41.44 91.93 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.071 -1.018 . . . . 0.0 108.446 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.556 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 11.6 t60 -67.0 -31.8 72.6 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.363 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -66.77 -36.44 82.44 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 166' ' ' PHE . 92.7 t -67.15 -39.1 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.507 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 62.9 t80 -61.6 -52.36 64.71 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.559 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 93.7 m-20 -63.44 -28.37 69.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.06 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.458 HD23 ' CG1' ' A' ' 149' ' ' VAL . 40.6 tp -78.2 -33.54 49.96 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.945 -1.097 . . . . 0.0 108.738 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.3 mt -66.86 -37.69 79.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.37 -55.86 11.53 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.513 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 29.1 m-20 -53.95 -35.48 61.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -1.174 . . . . 0.0 109.086 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 235' ' ' LEU . 17.0 mt -63.96 -24.64 67.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.478 -0.764 . . . . 0.0 110.512 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.3 t80 -75.44 -21.66 57.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.918 -1.114 . . . . 0.0 109.361 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 237' ' ' LEU . 33.0 mt -50.79 -3.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.711 -1.243 . . . . 0.0 110.203 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.572 ' H ' ' C ' ' A' ' 236' ' ' TYR . 8.2 mt -72.1 -12.85 61.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.94 -1.1 . . . . 0.0 109.962 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.3 0.51 59.66 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.915 -1.135 . . . . 0.0 110.824 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.84 154.54 11.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 120.872 -1.369 . . . . 0.0 108.816 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.424 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.4 Cg_endo -47.94 150.04 5.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.622 1.548 . . . . 0.0 109.416 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.72 146.85 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.979 -1.075 . . . . 0.0 112.056 -177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -130.88 124.33 30.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 154.8 179.22 29.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.413 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.5 OUTLIER -110.87 132.53 54.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 -179.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 6.6 m-85 -132.9 140.38 47.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 110.125 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.47 ' C ' ' CD1' ' A' ' 247' ' ' TYR . 4.3 t80 -125.0 137.44 54.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 32.3 t -130.62 137.29 49.54 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.947 -1.096 . . . . 0.0 111.343 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -117.5 115.9 26.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.56 ' O ' ' NH1' ' A' ' 137' ' ' ARG . 5.3 mtp85 47.57 30.41 1.69 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -69.05 146.12 44.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -123.75 169.6 15.92 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 59.5 m-70 -52.94 -37.85 61.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.061 -1.258 . . . . 0.0 109.531 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -57.98 8.99 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.091 -1.005 . . . . 0.0 109.127 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 134' ' ' ASP . 15.9 tp -61.75 -43.17 99.38 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.257 -0.902 . . . . 0.0 109.297 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -47.7 -51.61 21.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.888 -1.133 . . . . 0.0 109.139 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.836 HG21 HG21 ' A' ' 56' ' ' THR . 85.3 t -62.6 -52.16 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -51.31 -51.34 55.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.078 -1.014 . . . . 0.0 109.083 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.748 HD22 HG21 ' A' ' 139' ' ' ILE . 39.8 tp -50.78 -54.82 20.37 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 108.702 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.449 HG13 ' HG ' ' A' ' 238' ' ' LEU . 49.7 t -55.39 -51.16 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.139 -0.976 . . . . 0.0 108.895 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -47.77 -50.5 25.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 0.0 109.48 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -63.08 -48.28 79.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.814 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 263' ' ' LEU . 23.4 mt -58.1 -49.58 76.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.279 -0.888 . . . . 0.0 110.095 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 268' ' ' LYS . . . -69.82 -32.99 71.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.292 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -65.47 -62.98 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.264 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 266' ' ' LYS . 0.1 OUTLIER -48.9 -59.18 3.8 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.37 -0.831 . . . . 0.0 109.174 179.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -60.61 -83.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.449 -0.782 . . . . 0.0 109.856 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.478 ' O ' ' O ' ' A' ' 269' ' ' LEU . 19.8 mttt -137.43 93.83 2.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.24 -0.913 . . . . 0.0 109.416 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 268' ' ' LYS . 1.2 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.498 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.698 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.6 mt -83.39 156.36 23.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -1.097 . . . . 0.0 109.534 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -57.81 138.93 55.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 0.0 108.996 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -122.58 144.9 48.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.412 -0.805 . . . . 0.0 110.21 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.9 t -139.93 -172.72 3.46 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 30' ' ' PRO . 32.1 m -99.03 137.89 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.865 -1.147 . . . . 0.0 109.132 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -18.24 65.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.844 . . . . 0.0 109.898 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.501 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -155.27 156.25 35.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.092 -1.005 . . . . 0.0 109.711 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -61.08 139.54 58.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.866 . . . . 0.0 110.234 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 87.3 mt -117.4 160.39 21.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.89 141.98 47.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.015 -1.053 . . . . 0.0 110.232 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.442 ' O ' ' N ' ' A' ' 26' ' ' LEU . 92.9 m-85 -140.34 150.76 44.37 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -161.61 151.98 17.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.912 -1.117 . . . . 0.0 109.848 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.62 175.71 37.08 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.2 p -81.57 152.46 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.192 -1.181 . . . . 0.0 110.243 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.452 ' C ' ' OE2' ' A' ' 95' ' ' GLU . . . -88.24 140.29 16.14 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.496 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 6.2 tt -59.99 -38.39 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -1.205 . . . . 0.0 111.041 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' N ' ' OE2' ' A' ' 95' ' ' GLU . 72.2 m-70 -91.52 -46.95 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.402 -1.436 . . . . 0.0 111.039 -178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.594 ' N ' ' OE1' ' A' ' 95' ' ' GLU . 3.5 p -72.15 -23.23 61.26 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.211 -0.931 . . . . 0.0 111.557 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 59.64 15.67 34.24 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 119.284 -1.436 . . . . 0.0 109.553 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -107.94 155.24 20.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.345 -1.091 . . . . 0.0 109.748 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.69 134.98 41.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.429 -0.794 . . . . 0.0 109.466 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 37.7 m -137.01 144.24 43.16 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.089 -1.007 . . . . 0.0 109.788 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.37 155.98 22.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.453 -0.78 . . . . 0.0 109.866 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.597 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -138.64 143.89 39.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.759 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.567 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -139.35 114.56 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.159 -0.963 . . . . 0.0 108.667 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -98.18 115.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.299 -0.876 . . . . 0.0 111.006 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.567 ' NE2' HG22 ' A' ' 27' ' ' ILE . 15.6 m-70 -108.42 137.06 19.85 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.517 -0.739 . . . . 0.0 109.788 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.55 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -51.62 168.13 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 122.032 1.821 . . . . 0.0 111.604 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 66.9 mm-40 -146.52 155.23 42.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.198 -0.938 . . . . 0.0 109.975 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -67.39 154.16 42.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 109.781 179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -49.49 149.23 2.38 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.147 -0.971 . . . . 0.0 110.824 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.674 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 75.18 -7.45 22.92 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 120.535 -0.841 . . . . 0.0 111.26 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.739 ' N ' HD22 ' A' ' 86' ' ' ASN . 93.0 m -59.33 -44.97 92.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.557 -1.555 . . . . 0.0 109.861 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.481 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 95.65 -175.82 33.15 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -100.42 116.54 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -141.23 150.97 43.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.764 -1.21 . . . . 0.0 110.983 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -99.16 157.42 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -130.17 114.29 15.52 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.93 . . . . 0.0 109.248 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 42' ' ' ASN . 45.4 tttm -134.2 134.38 42.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.415 -0.803 . . . . 0.0 110.23 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.486 ' CG ' ' O ' ' A' ' 41' ' ' LYS . 7.5 p-10 44.08 42.37 4.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.877 -0.514 . . . . 0.0 112.193 178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.93 15.7 78.33 Favored Glycine 0 N--CA 1.493 2.489 0 O-C-N 120.695 -1.253 . . . . 0.0 110.549 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 78.5 t -121.43 120.65 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.26 -1.141 . . . . 0.0 109.311 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.42 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 36.1 m-85 -86.11 127.72 34.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.481 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 mt -116.87 93.43 41.51 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.506 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -49.99 145.99 17.98 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 122.656 2.237 . . . . 0.0 112.39 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.646 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.39 66.01 4.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.443 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.98 166.69 12.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.441 -0.787 . . . . 0.0 109.278 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.533 ' O ' ' N ' ' A' ' 52' ' ' PHE . 3.2 p-80 -72.94 -49.96 26.3 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.476 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -44.11 -16.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.149 -0.969 . . . . 0.0 110.476 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 26.2 m-85 -96.84 1.94 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 50' ' ' HIS . 58.5 t -69.24 130.36 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.882 . . . . 0.0 108.7 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 20.0 m -111.74 -28.94 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.305 -0.872 . . . . 0.0 110.296 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -152.1 130.31 11.98 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.911 -1.118 . . . . 0.0 110.176 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.816 HG21 HG21 ' A' ' 257' ' ' VAL . 32.9 p -120.87 94.6 4.4 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 59' ' ' SER . 3.6 t-20 -163.74 129.15 2.99 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.449 -0.782 . . . . 0.0 108.933 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' SER . 86.5 m-70 52.52 6.15 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.128 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.81 143.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.851 . . . . 0.0 109.683 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.457 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 37.6 m -84.72 128.08 34.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -120.73 149.46 42.5 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.429 -0.794 . . . . 0.0 110.751 -179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' CD1' HG21 ' A' ' 72' ' ' VAL . 12.2 mt -120.74 154.59 35.43 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.98 22.1 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.976 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -161.78 145.79 12.61 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.413 -1.051 . . . . 0.0 109.126 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.6 mmtt 51.61 21.7 1.38 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.325 -0.86 . . . . 0.0 109.323 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.26 -33.59 6.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.513 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.8 mm100 -55.96 149.16 15.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -1.217 . . . . 0.0 109.51 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 ttm180 -145.89 136.32 24.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.884 . . . . 0.0 110.553 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.5 mt -129.97 128.15 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp -101.27 155.51 17.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.887 -1.133 . . . . 0.0 111.605 -177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.8 m 50.35 74.95 0.19 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.746 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.565 HG21 ' CD1' ' A' ' 62' ' ' LEU . 18.8 m -108.4 -11.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.117 -0.99 . . . . 0.0 109.566 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.4 pm0 -60.44 -26.46 66.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.406 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.8 m170 -66.32 -68.1 0.4 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.028 -1.045 . . . . 0.0 109.324 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 76' ' ' LEU . 5.6 tp -52.72 -48.03 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.072 -1.018 . . . . 0.0 109.107 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.646 HD21 ' HB1' ' A' ' 48' ' ' ALA . 11.3 mt -52.33 -50.18 62.81 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.024 -1.048 . . . . 0.0 110.371 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 28.7 t -59.22 -41.54 88.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG11 ' HB3' ' A' ' 106' ' ' PHE . 76.9 t -56.36 -47.1 81.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.192 -0.943 . . . . 0.0 109.121 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -65.67 -34.05 77.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.323 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -61.95 -39.19 91.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB2' ' A' ' 171' ' ' GLU . 51.1 mt -77.84 -38.51 46.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.39 -0.819 . . . . 0.0 110.05 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' A' ' 82' ' ' LEU . 74.4 mt -80.68 -1.17 41.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 56.87 42.12 26.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.733 -0.604 . . . . 0.0 111.386 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 38.1 mm -87.17 140.81 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.854 -1.154 . . . . 0.0 107.968 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.658 HG21 HG12 ' A' ' 121' ' ' ILE . 68.8 p -124.57 -22.47 4.61 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.126 -0.984 . . . . 0.0 111.799 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.739 HD22 ' N ' ' A' ' 35' ' ' THR . 18.0 m120 -125.46 107.13 10.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.868 -1.145 . . . . 0.0 110.666 -179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -164.69 148.64 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.771 0.796 . . . . 0.0 110.151 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.447 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 93.5 m -114.49 113.26 24.22 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.462 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -95.29 100.76 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.901 . . . . 0.0 110.345 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' OE2' ' NE2' ' A' ' 29' ' ' HIS . 33.4 mt-10 -73.41 124.84 26.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.108 -0.995 . . . . 0.0 108.361 178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.443 HG22 HD21 ' A' ' 26' ' ' LEU . 48.6 t -106.94 123.79 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 CA-C-O 121.677 0.751 . . . . 0.0 111.172 -178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.0 mm -109.18 96.61 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 138.52 -156.04 23.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -123.08 -12.28 7.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.319 -1.107 . . . . 0.0 110.04 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.594 ' OE1' ' N ' ' A' ' 20' ' ' THR . 29.3 tt0 -132.85 140.19 47.81 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 109.944 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.597 HG23 HD11 ' A' ' 26' ' ' LEU . 45.6 mm -70.24 119.32 71.32 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.033 -1.042 . . . . 0.0 108.417 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -40.74 122.58 1.45 Allowed 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 121.887 1.725 . . . . 0.0 111.466 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.427 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.6 tp -79.0 -12.0 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.711 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.3 mt 56.42 -119.61 1.34 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 110.01 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 201' ' ' LYS . 27.6 t0 -96.53 10.02 39.66 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.923 -1.111 . . . . 0.0 111.126 -178.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.26 -1.41 62.55 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.43 -1.367 . . . . 0.0 109.843 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.02 -172.06 2.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.799 -0.824 . . . . 0.0 109.483 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.18 16.08 10.82 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.41 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 54.1 t-105 -57.83 -42.84 85.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.429 -1.042 . . . . 0.0 110.464 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.46 -58.96 5.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.167 -0.958 . . . . 0.0 110.092 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.402 ' HB3' HG11 ' A' ' 78' ' ' VAL . 13.7 m-85 -51.03 -45.96 61.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 109.382 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.403 ' CE1' ' HD2' ' A' ' 111' ' ' ARG . 36.9 t80 -61.37 -50.36 73.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.554 -0.716 . . . . 0.0 111.059 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.41 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 10.1 mm-40 -63.47 -44.46 94.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.946 -1.096 . . . . 0.0 111.377 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.85 -53.56 38.28 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.115 -0.991 . . . . 0.0 110.646 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 37.7 mt -65.04 -30.59 50.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.918 -1.114 . . . . 0.0 109.287 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' HD2' ' CE1' ' A' ' 107' ' ' TYR . 63.9 ttt-85 -65.68 -43.89 87.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.407 -0.808 . . . . 0.0 110.274 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 pttt -77.78 14.22 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.957 -1.089 . . . . 0.0 110.019 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -144.13 32.47 1.23 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.088 -1.008 . . . . 0.0 110.269 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.41 HD11 HD22 ' A' ' 82' ' ' LEU . 78.8 mt -80.87 139.89 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.928 -1.107 . . . . 0.0 110.272 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.14 125.08 32.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.475 -0.766 . . . . 0.0 109.128 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.45 ' OD1' ' N ' ' A' ' 116' ' ' ASN . 0.2 OUTLIER -80.57 142.29 34.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.334 -0.854 . . . . 0.0 110.169 -179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -110.36 -172.75 2.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.408 -0.807 . . . . 0.0 109.448 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -110.43 68.27 0.66 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.294 -0.879 . . . . 0.0 110.58 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -166.7 131.16 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 109.531 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -69.24 142.42 54.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.064 -1.022 . . . . 0.0 109.691 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.658 HG12 HG21 ' A' ' 85' ' ' THR . 70.9 mt -85.44 151.34 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.308 -0.87 . . . . 0.0 109.815 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.71 83.42 3.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.0 108.817 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 28.6 m-85 -61.44 143.09 56.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.529 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -90.32 101.83 14.55 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.8 t -92.17 133.73 32.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.709 -0.62 . . . . 0.0 110.857 -177.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 84.8 t -68.13 112.45 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -85.91 -34.18 21.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.979 -1.076 . . . . 0.0 111.086 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' HG3' ' HZ3' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -133.9 149.88 72.97 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.627 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.5 147.93 71.89 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.318 2.012 . . . . 0.0 112.089 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 13.2 tt -154.27 152.3 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.325 -0.859 . . . . 0.0 109.317 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.67 144.73 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.497 -0.752 . . . . 0.0 109.227 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.95 147.68 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -132.83 159.77 38.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.253 -0.904 . . . . 0.0 109.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.607 ' HB2' HD13 ' A' ' 255' ' ' LEU . 0.1 OUTLIER -172.33 101.35 0.16 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.241 -0.912 . . . . 0.0 109.995 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 45.97 59.26 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.444 -0.785 . . . . 0.0 110.753 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.31 -37.92 3.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.944 -1.122 . . . . 0.0 110.485 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.454 ' HD2' ' H ' ' A' ' 137' ' ' ARG . 4.5 mpt_? -63.75 130.89 46.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.869 -1.371 . . . . 0.0 108.984 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.4 OUTLIER -144.14 139.85 29.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.992 -1.067 . . . . 0.0 109.769 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.522 HG21 HD22 ' A' ' 259' ' ' LEU . 98.5 mt -137.62 129.52 40.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.353 -0.842 . . . . 0.0 109.693 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -115.56 131.67 56.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.355 0.598 . . . . 0.0 109.679 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -121.49 135.88 55.0 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -149.52 148.54 26.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.019 . . . . 0.0 109.788 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -46.04 142.17 8.58 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.508 2.139 . . . . 0.0 113.326 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -155.48 143.3 19.81 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' O ' HG23 ' A' ' 146' ' ' THR . 24.7 t0 -62.75 -5.17 2.52 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.4 -0.813 . . . . 0.0 110.503 -178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 244' ' ' GLY . 30.4 p -154.96 179.1 9.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.949 -1.095 . . . . 0.0 109.859 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 15.6 tp -88.25 120.19 29.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.938 . . . . 0.0 109.208 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -136.6 123.58 21.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.194 -0.941 . . . . 0.0 108.646 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 80.3 t -124.41 122.02 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.1 m -112.25 151.94 29.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.555 -0.716 . . . . 0.0 109.369 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.4 ' HB2' HG22 ' A' ' 228' ' ' VAL . 39.1 t80 -139.5 130.67 26.59 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.183 -1.007 . . . . 0.0 111.106 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 28.4 tt0 -121.18 131.7 54.4 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 177.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.43 139.19 10.45 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.469 -1.348 . . . . 0.0 111.577 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -103.0 100.66 10.62 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -86.33 167.03 15.15 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 110.6 -178.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -99.57 -15.55 18.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.464 -0.773 . . . . 0.0 110.589 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 159' ' ' LEU . 23.0 p-10 -95.21 -168.12 1.74 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.832 -1.168 . . . . 0.0 110.131 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -56.58 3.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.543 -0.723 . . . . 0.0 111.26 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 157' ' ' ASN . 11.8 mt -79.67 -28.28 40.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.454 -1.404 . . . . 0.0 108.423 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.01 -138.69 34.56 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.467 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 3.9 ttm180 -97.0 131.84 43.41 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.275 -1.133 . . . . 0.0 109.494 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.467 ' OE1' ' O ' ' A' ' 161' ' ' ARG . 29.1 mm100 -136.63 147.29 46.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.475 -0.765 . . . . 0.0 109.108 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.1 pttt -140.52 145.05 36.33 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.33 -0.856 . . . . 0.0 110.093 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.515 ' CZ ' ' NH2' ' A' ' 225' ' ' ARG . 89.3 t80 -144.26 140.38 29.19 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 109.761 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 76.8 m -110.82 124.3 51.75 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 110.295 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.561 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.3 t80 -103.89 117.26 33.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.409 -0.807 . . . . 0.0 109.761 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.3 t -112.31 154.64 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.857 . . . . 0.0 110.097 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -50.63 125.22 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 108.977 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 112.24 -2.44 26.75 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -119.81 21.74 11.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.14 -1.212 . . . . 0.0 109.186 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.476 ' HB2' HD13 ' A' ' 81' ' ' LEU . 3.6 pm0 -54.46 -32.12 56.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.379 -0.825 . . . . 0.0 110.621 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.24 -17.47 62.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 110.183 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.554 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 23.2 mm-40 -86.79 -6.83 58.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.172 -0.955 . . . . 0.0 111.495 -178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 40.2 pt -123.68 -26.05 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 120.919 -1.113 . . . . 0.0 110.845 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.1 m -65.21 -26.77 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.553 -1.342 . . . . 0.0 109.382 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.54 -5.54 56.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.0 109.335 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.506 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.09 123.43 21.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.136 -0.977 . . . . 0.0 109.205 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -84.54 172.93 11.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.409 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.2 t -77.32 161.48 28.04 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 177.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -147.04 144.38 29.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.191 -1.568 . . . . 0.0 111.427 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.555 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -142.71 157.08 45.02 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 90.6 m-85 -97.66 146.89 24.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.049 -1.032 . . . . 0.0 109.602 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.56 -38.71 21.32 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.399 -0.813 . . . . 0.0 109.741 -179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.7 p90 -71.13 -25.18 62.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.97 -1.081 . . . . 0.0 109.644 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.7 mm-40 -79.82 -25.64 40.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.0 110.044 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.629 HG21 HB11 ' A' ' 500' ' ' C90 . 22.6 mt -60.93 -54.82 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.066 -1.021 . . . . 0.0 110.017 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 186' ' ' ILE . 10.9 tt0 -42.1 -39.88 2.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 109.887 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.763 ' O ' HG22 ' A' ' 192' ' ' VAL . 5.4 t60 -78.76 -54.31 6.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.601 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 194' ' ' LEU . 29.1 mt -48.35 -29.85 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.663 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -85.34 -54.38 4.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.769 -1.207 . . . . 0.0 109.194 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -50.09 -42.52 50.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.333 -0.854 . . . . 0.0 110.066 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.763 HG22 ' O ' ' A' ' 188' ' ' HIS . 34.5 m -74.65 5.78 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.995 . . . . 0.0 109.854 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.31 37.28 54.61 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 189' ' ' ILE . 36.0 mt -125.61 166.04 17.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -1.126 . . . . 0.0 109.591 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.412 ' H ' ' HA ' ' A' ' 19' ' ' HIS . . . 64.5 22.98 68.25 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -56.18 -23.65 36.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.766 -1.432 . . . . 0.0 109.36 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.464 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.5 25.91 12.79 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.24 125.12 7.88 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.945 -1.327 . . . . 0.0 109.83 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -145.1 168.07 21.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -1.064 . . . . 0.0 109.708 -179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 31.6 mt -66.1 -8.72 25.37 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . 0.491 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 9.8 ttmm -93.89 -14.31 26.2 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 14.7 p30 -136.07 8.14 3.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.225 -0.922 . . . . 0.0 109.792 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.429 HG22 HG23 ' A' ' 205' ' ' VAL . 1.2 m -147.34 149.28 32.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.047 -1.033 . . . . 0.0 110.702 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.463 HD21 HD22 ' A' ' 217' ' ' LEU . 27.1 tp -98.87 94.61 6.68 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.429 HG23 HG22 ' A' ' 203' ' ' THR . 52.2 t -86.81 129.46 38.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-O 121.635 0.731 . . . . 0.0 109.225 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 17.7 mt -121.07 173.9 6.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.369 -0.832 . . . . 0.0 109.53 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -134.64 -166.41 11.16 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -29.95 70.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -1.047 . . . . 0.0 109.505 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -158.91 26.0 0.21 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.061 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -145.36 153.27 41.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.841 -1.162 . . . . 0.0 110.421 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.0 t -104.4 113.32 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -57.99 -48.34 80.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.051 -1.03 . . . . 0.0 109.854 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -63.0 112.51 6.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 110.313 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -57.85 -11.12 8.82 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.697 1.598 . . . . 0.0 112.165 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.18 -18.91 58.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.189 -0.944 . . . . 0.0 110.436 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.24 179.65 50.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.7 mt -83.23 121.93 27.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.131 -1.217 . . . . 0.0 109.64 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.525 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 1.0 OUTLIER -49.52 -22.48 1.25 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 108.661 179.45 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.525 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 56.0 m-85 -148.42 178.96 8.15 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -86.87 2.95 47.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.139 -0.976 . . . . 0.0 109.755 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.74 45.15 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.946 . . . . 0.0 109.543 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.618 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -61.76 -42.69 84.52 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.911 -1.118 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 39.6 Cg_exo -58.76 -60.04 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.585 2.19 . . . . 0.0 112.596 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 228' ' ' VAL . 28.2 m -66.96 -39.34 83.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.064 -1.023 . . . . 0.0 111.448 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.554 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 3.3 ptm85 -67.51 -35.52 79.28 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.561 -1.337 . . . . 0.0 108.595 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.506 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 23.3 t60 -66.02 -34.56 78.37 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 43.6 mmtt -64.59 -35.08 79.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.9 t -67.01 -35.99 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -67.41 -50.93 57.33 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -61.2 -33.14 72.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.355 -0.84 . . . . 0.0 109.808 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 25.1 tp -74.97 -32.74 61.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.096 -1.003 . . . . 0.0 108.736 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.4 mt -65.76 -38.6 82.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -53.97 22.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.497 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 6.7 m-20 -56.15 -29.53 60.9 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.158 -1.201 . . . . 0.0 109.09 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.1 mt -67.09 -23.27 65.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.529 -0.732 . . . . 0.0 110.581 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.47 -22.51 60.15 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.743 -1.223 . . . . 0.0 109.374 -179.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 237' ' ' LEU . 91.7 mt -50.09 -4.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.599 -1.313 . . . . 0.0 110.411 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 10.6 mt -75.52 -15.46 60.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.842 -1.161 . . . . 0.0 109.681 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 98.14 2.02 58.14 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.659 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.36 155.04 9.91 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 120.875 -1.368 . . . . 0.0 109.106 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.1 Cg_endo -49.33 150.62 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.956 1.771 . . . . 0.0 109.869 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 97.6 t -109.42 145.76 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.023 -1.048 . . . . 0.0 111.881 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -130.25 125.18 34.2 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 153.47 -160.3 29.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.417 ' N ' ' HB2' ' A' ' 144' ' ' SER . 0.3 OUTLIER -130.49 140.43 50.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.187 -1.184 . . . . 0.0 109.153 179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.8 m-85 -138.62 142.14 39.12 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.175 -0.953 . . . . 0.0 110.331 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 44.7 t80 -124.91 124.66 42.53 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 5.0 m -117.76 135.0 54.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.088 -1.008 . . . . 0.0 111.097 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -115.36 114.92 25.75 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 49.87 20.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.02 -1.05 . . . . 0.0 109.074 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -53.34 156.53 5.41 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.489 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -138.35 163.0 25.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.577 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 48.4 m-70 -48.68 -40.11 26.94 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.187 -1.184 . . . . 0.0 109.817 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 1.4 m -56.97 -58.4 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.127 -0.983 . . . . 0.0 109.494 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.607 HD13 ' HB2' ' A' ' 134' ' ' ASP . 13.8 tp -59.63 -44.02 93.63 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.077 -1.014 . . . . 0.0 109.519 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 2.2 m-20 -47.73 -48.12 29.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.885 -1.135 . . . . 0.0 108.78 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.816 HG21 HG21 ' A' ' 56' ' ' THR . 73.2 t -62.89 -52.37 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.584 -0.698 . . . . 0.0 109.573 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.484 ' NZ ' ' OD1' ' A' ' 134' ' ' ASP . 31.0 ttmt -52.86 -48.79 66.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 109.269 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.522 HD22 HG21 ' A' ' 139' ' ' ILE . 42.7 tp -52.94 -51.75 60.32 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 108.7 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.538 HG13 ' HG ' ' A' ' 238' ' ' LEU . 39.0 t -56.82 -53.75 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.21 -0.932 . . . . 0.0 109.18 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -49.64 -48.23 49.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -60.91 -48.47 81.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.27 -0.894 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 28.3 mt -56.64 -49.76 74.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.877 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.47 -26.35 66.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.126 -0.984 . . . . 0.0 109.831 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.1 mmtm -70.01 -57.29 5.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 110.097 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.419 ' HZ3' ' HG3' ' A' ' 128' ' ' GLU . 0.0 OUTLIER -66.32 -34.65 78.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 109.744 -179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.96 -75.31 0.09 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.331 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -84.52 -166.4 1.45 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.317 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 mp . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.971 . . . . 0.0 109.429 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.636 ' O22' H212 ' A' ' 500' ' ' C90 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 19.2 mt -104.34 154.44 19.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -1.126 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 85' ' ' THR . 3.0 mm-40 -56.88 138.57 53.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.156 -0.965 . . . . 0.0 108.846 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -121.61 144.59 48.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.27 -0.893 . . . . 0.0 110.272 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.4 t -142.5 -174.63 4.19 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 30' ' ' PRO . 33.0 m -98.6 136.96 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.922 -1.111 . . . . 0.0 109.249 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -65.41 -23.03 66.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 0.0 109.945 -179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.51 159.35 44.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.195 -0.941 . . . . 0.0 109.719 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.53 139.68 58.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.88 . . . . 0.0 110.352 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.18 164.39 15.24 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.32 142.65 45.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.85 -1.156 . . . . 0.0 110.566 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.3 m-85 -139.3 154.01 47.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -163.1 152.6 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.856 -1.153 . . . . 0.0 110.091 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 164.79 176.49 36.55 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.7 154.6 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.331 -1.099 . . . . 0.0 110.369 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.64 140.45 15.62 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.526 ' CD1' HG21 ' A' ' 179' ' ' THR . 4.2 tt -58.83 -40.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.212 -1.169 . . . . 0.0 110.679 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.482 ' N ' HG23 ' A' ' 18' ' ' ILE . 77.9 m-70 -89.53 -49.67 6.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.663 -1.273 . . . . 0.0 111.126 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.5 p -69.6 -23.1 63.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.662 -0.649 . . . . 0.0 111.262 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.48 15.94 13.68 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -107.39 154.37 21.41 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -1.12 . . . . 0.0 109.607 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.475 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 14.1 t80 -75.98 135.93 40.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.421 -0.799 . . . . 0.0 109.766 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.1 m -139.39 145.28 38.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.156 -0.965 . . . . 0.0 109.656 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.43 154.87 24.03 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.478 HD22 ' CG2' ' A' ' 89' ' ' ILE . 8.7 mt -135.71 148.58 48.92 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.204 -0.935 . . . . 0.0 110.364 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG22 ' NE2' ' A' ' 29' ' ' HIS . 14.6 mt -143.37 113.74 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.7 mt -97.18 115.22 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.359 -0.838 . . . . 0.0 110.992 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.546 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -107.71 135.95 19.73 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.476 -0.765 . . . . 0.0 109.692 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.577 ' HG3' HG23 ' A' ' 7' ' ' VAL . 21.0 Cg_exo -52.32 168.18 0.45 Allowed 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.004 1.803 . . . . 0.0 111.94 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' CD ' HG21 ' A' ' 35' ' ' THR . 12.7 mm-40 -144.63 177.52 8.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.35 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 0.0 OUTLIER -89.11 156.07 19.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -49.6 151.28 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.737 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 70.29 -11.1 2.28 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.482 -0.866 . . . . 0.0 110.997 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.68 ' N ' ' ND2' ' A' ' 86' ' ' ASN . 62.1 m -55.81 -46.65 78.02 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.652 -1.499 . . . . 0.0 109.986 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' H ' ' ND2' ' A' ' 86' ' ' ASN . . . 96.97 -177.71 32.89 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.204 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 12.6 mm -100.66 117.0 45.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -138.44 147.7 43.57 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.909 -1.117 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -97.67 156.86 16.35 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -129.08 111.27 12.78 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.27 -0.894 . . . . 0.0 108.714 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.569 ' NZ ' ' O ' ' A' ' 93' ' ' GLY . 16.2 tttp -135.65 134.97 39.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 110.851 -178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 49.92 26.59 2.04 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.481 -0.762 . . . . 0.0 110.969 178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.11 19.54 62.6 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.298 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -119.7 120.45 63.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -1.136 . . . . 0.0 109.099 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -87.14 129.14 35.06 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.093 -1.004 . . . . 0.0 108.42 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.514 ' CD1' ' OE1' ' A' ' 67' ' ' GLN . 73.5 mt -121.31 95.64 48.39 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.306 -0.871 . . . . 0.0 110.466 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -51.45 150.19 16.12 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.93 1.754 . . . . 0.0 110.995 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.531 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -83.66 72.1 10.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.158 -0.964 . . . . 0.0 109.642 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.1 mtm180 -123.86 163.38 21.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.462 -0.774 . . . . 0.0 109.043 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.3 p-80 -66.04 -52.12 52.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.237 -0.914 . . . . 0.0 110.141 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -43.83 -16.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 110.777 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 50' ' ' HIS . 28.3 m-85 -95.2 5.44 51.78 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.789 -1.194 . . . . 0.0 109.936 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.422 ' HA ' HD23 ' A' ' 62' ' ' LEU . 75.3 t -76.69 129.82 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.0 108.611 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.1 m -114.74 -24.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 0.0 110.303 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -149.67 125.18 10.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.012 -1.055 . . . . 0.0 110.009 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 HG21 ' A' ' 257' ' ' VAL . 63.5 p -119.58 95.98 5.01 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 18.9 t-20 -162.66 128.54 3.38 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.513 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 88.0 m-70 48.02 9.79 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.15 -0.969 . . . . 0.0 109.263 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 165.8 147.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.253 -0.905 . . . . 0.0 109.868 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.41 ' HG1' ' HD1' ' A' ' 253' ' ' HIS . 86.0 m -90.06 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 109.149 179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.11 149.49 42.12 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.465 -0.772 . . . . 0.0 110.788 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 53' ' ' VAL . 13.3 mt -120.37 163.17 18.27 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.459 -0.776 . . . . 0.0 109.117 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.62 151.19 15.58 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.619 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -160.33 145.41 14.76 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.669 -0.901 . . . . 0.0 108.691 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.82 21.35 7.42 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.32 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.04 -28.14 15.22 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.033 -1.08 . . . . 0.0 110.804 179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.69 ' NE2' ' N ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -70.23 147.46 49.75 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.699 -1.471 . . . . 0.0 109.402 -179.27 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' NE2' ' A' ' 67' ' ' GLN . 47.2 ttp180 -140.51 147.03 38.94 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.071 -1.018 . . . . 0.0 111.498 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.23 137.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -105.87 156.07 18.7 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.086 -1.009 . . . . 0.0 112.322 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 86.0 m 50.18 78.3 0.1 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.439 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -108.33 -8.2 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.093 -1.005 . . . . 0.0 109.363 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.8 pm0 -62.74 -27.13 69.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.42 -0.8 . . . . 0.0 111.106 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.81 -69.09 0.33 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.802 -1.186 . . . . 0.0 109.256 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.6 HG23 ' N ' ' A' ' 76' ' ' LEU . 7.1 tp -51.87 -47.7 40.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.6 ' N ' HG23 ' A' ' 75' ' ' ILE . 11.8 mt -52.29 -49.12 64.8 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.937 -1.102 . . . . 0.0 110.384 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 36.1 t -60.56 -42.12 95.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.041 -1.037 . . . . 0.0 110.19 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 106' ' ' PHE . 82.3 t -57.25 -46.63 85.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.942 -1.099 . . . . 0.0 109.194 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.6 mt -65.63 -34.2 77.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.295 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -64.09 -37.95 89.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.197 -0.939 . . . . 0.0 109.364 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' A' ' 171' ' ' GLU . 54.4 mt -77.85 -39.58 43.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.224 -0.922 . . . . 0.0 109.72 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 82' ' ' LEU . 69.3 mt -78.41 -2.53 38.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.085 -1.009 . . . . 0.0 109.226 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 58.32 42.44 21.58 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.739 -0.601 . . . . 0.0 111.311 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.1 mm -86.01 146.59 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.871 -1.143 . . . . 0.0 108.169 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 HG12 ' A' ' 121' ' ' ILE . 61.3 p -128.93 -23.84 3.01 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.137 -0.977 . . . . 0.0 111.514 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.737 HD21 ' N ' ' A' ' 34' ' ' GLY . 27.6 m120 -124.61 107.85 11.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.851 -1.156 . . . . 0.0 110.75 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.712 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.89 147.14 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.851 0.834 . . . . 0.0 110.256 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.443 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 24.7 m -114.82 112.04 22.16 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.478 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.1 mt -93.82 100.32 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 110.421 -178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.494 ' OE1' HD12 ' A' ' 27' ' ' ILE . 3.4 tt0 -74.55 125.94 29.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.4 HG22 HD21 ' A' ' 26' ' ' LEU . 40.3 t -107.16 130.01 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 CA-C-O 121.921 0.867 . . . . 0.0 111.998 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 22.3 mm -110.69 95.61 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 178.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' ' NZ ' ' A' ' 41' ' ' LYS . . . 138.82 -154.76 23.38 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.44 -10.44 8.43 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.385 -1.068 . . . . 0.0 110.049 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -138.83 148.31 43.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.041 -1.037 . . . . 0.0 109.347 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 26' ' ' LEU . 7.8 mm -74.44 122.17 86.9 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.317 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -41.82 122.05 1.91 Allowed 'Trans proline' 0 C--N 1.315 -1.224 0 C-N-CA 121.975 1.783 . . . . 0.0 111.501 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.475 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.5 tp -74.82 -13.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.101 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.493 HD11 ' CE2' ' A' ' 106' ' ' PHE . 25.8 mt 57.27 -122.45 1.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.496 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -96.49 8.74 43.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.141 -0.974 . . . . 0.0 110.588 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.52 -3.66 72.06 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.514 -1.327 . . . . 0.0 109.819 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.21 -173.03 2.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.495 -1.003 . . . . 0.0 109.135 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.24 16.2 11.83 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -58.24 -45.09 88.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.907 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.95 -57.42 9.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.011 . . . . 0.0 109.655 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 99' ' ' LEU . 8.8 m-85 -51.58 -46.03 63.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.248 -0.907 . . . . 0.0 109.058 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.405 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 59.6 t80 -61.17 -52.93 62.75 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.646 . . . . 0.0 111.058 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -62.1 -43.08 99.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.139 -0.976 . . . . 0.0 111.376 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.81 -56.63 9.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 110.572 -178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 33.7 mt -63.54 -32.24 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.97 -1.081 . . . . 0.0 109.661 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.2 ttt180 -65.09 -43.62 91.49 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.869 . . . . 0.0 110.1 -179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.1 ptpp? -75.83 11.39 1.4 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.018 -1.051 . . . . 0.0 110.337 -179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -143.98 35.1 1.24 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.914 -1.116 . . . . 0.0 110.435 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 82.9 mt -82.02 141.19 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.931 -1.106 . . . . 0.0 110.57 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tp -131.69 120.52 22.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.709 ' H ' HD22 ' A' ' 116' ' ' ASN . 1.0 OUTLIER -81.78 140.68 34.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.879 . . . . 0.0 110.154 -179.465 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -106.11 -168.57 1.45 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.445 -0.785 . . . . 0.0 109.624 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.444 ' O ' ' OD1' ' A' ' 118' ' ' ASN . 16.3 p30 -111.54 71.52 0.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.905 . . . . 0.0 110.65 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 -170.5 133.77 1.06 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.107 -0.995 . . . . 0.0 109.547 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -69.71 147.68 50.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.197 -0.939 . . . . 0.0 109.707 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.629 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -88.72 151.3 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.161 -0.962 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -97.99 88.05 4.14 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.3 m-85 -66.46 144.27 56.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.848 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.635 ' CZ ' ' NE2' ' A' ' 267' ' ' GLN . 34.5 t80 -88.31 100.98 13.42 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 47.3 t -90.78 132.61 34.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.657 -0.652 . . . . 0.0 110.799 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 95.4 t -70.45 114.06 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.87 -30.18 16.31 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.961 -1.087 . . . . 0.0 110.313 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.76 149.95 73.57 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.37 -0.831 . . . . 0.0 109.463 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.28 149.72 45.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.492 2.128 . . . . 0.0 111.456 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.455 HD12 ' CD ' ' A' ' 266' ' ' LYS . 4.8 tt -157.37 153.82 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.055 . . . . 0.0 109.565 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.63 144.51 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.471 -0.768 . . . . 0.0 109.322 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 m -130.39 148.24 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -134.96 161.83 34.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.217 -0.927 . . . . 0.0 109.909 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.479 ' HB3' HD13 ' A' ' 255' ' ' LEU . 30.6 t70 -174.8 105.81 0.1 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.233 -0.917 . . . . 0.0 109.907 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 52.26 53.57 12.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.346 -0.846 . . . . 0.0 110.442 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.34 -33.0 3.24 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.0 mtt85 -60.32 135.51 57.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.019 -1.283 . . . . 0.0 108.45 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.676 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.7 OUTLIER -145.41 137.72 25.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.977 -1.077 . . . . 0.0 110.333 -179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.575 ' CD1' HD23 ' A' ' 255' ' ' LEU . 90.4 mt -137.04 130.39 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.358 -0.839 . . . . 0.0 109.51 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -117.8 132.09 56.49 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.362 0.601 . . . . 0.0 109.896 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -123.26 134.21 54.11 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.57 153.15 46.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.108 -0.995 . . . . 0.0 109.513 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -50.79 143.19 30.49 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.379 2.052 . . . . 0.0 113.428 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.5 143.8 19.03 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.12 -9.66 11.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.361 -0.837 . . . . 0.0 110.463 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 244' ' ' GLY . 82.1 p -144.7 -175.29 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.013 -1.054 . . . . 0.0 109.547 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 148' ' ' GLU . 10.3 tp -100.19 123.56 44.56 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.198 -0.939 . . . . 0.0 108.567 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.477 ' N ' HD12 ' A' ' 147' ' ' LEU . 52.3 tt0 -138.9 135.41 34.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.183 -0.948 . . . . 0.0 108.751 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.557 ' CG1' HD23 ' A' ' 231' ' ' LEU . 70.9 t -134.48 123.67 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.267 -0.896 . . . . 0.0 109.711 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.455 ' OG1' HG23 ' A' ' 165' ' ' THR . 90.9 m -113.75 152.32 30.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -0.775 . . . . 0.0 109.846 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -137.67 130.64 30.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.949 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.97 132.43 54.92 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.03 141.2 11.33 Favored Glycine 0 N--CA 1.494 2.524 0 C-N-CA 119.338 -1.41 . . . . 0.0 112.07 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -104.11 101.92 11.67 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -88.43 167.03 13.82 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 111.144 -177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -104.54 30.97 4.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.594 -0.691 . . . . 0.0 110.726 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.575 ' O ' ' N ' ' A' ' 159' ' ' LEU . 27.5 p-10 -148.53 -168.35 3.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.771 -1.206 . . . . 0.0 110.118 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -48.22 -4.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 0.0 111.374 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.575 ' N ' ' O ' ' A' ' 157' ' ' ASN . 12.7 mt -82.99 -31.01 27.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.521 -1.362 . . . . 0.0 108.708 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.55 -135.53 41.48 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.69 132.27 45.14 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.154 -1.203 . . . . 0.0 109.146 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -137.92 149.98 46.67 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.1 pttm -140.66 144.11 35.5 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.342 -0.849 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -141.78 132.62 25.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 109.775 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.455 HG23 ' OG1' ' A' ' 150' ' ' THR . 85.5 m -105.89 123.98 48.83 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.428 -0.795 . . . . 0.0 109.84 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.549 ' HB3' HG11 ' A' ' 228' ' ' VAL . 7.9 t80 -105.22 115.74 30.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.821 . . . . 0.0 110.237 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.49 151.53 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -0.922 . . . . 0.0 109.589 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.69 129.63 23.11 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.283 -0.886 . . . . 0.0 109.01 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.09 -1.99 38.06 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -119.18 23.23 11.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.29 -1.123 . . . . 0.0 109.39 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.742 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -56.03 -56.05 25.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.249 -0.907 . . . . 0.0 110.12 -179.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 171' ' ' GLU . 3.8 mt-10 -41.81 -20.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.297 -0.877 . . . . 0.0 110.407 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.572 ' O ' ' NE ' ' A' ' 225' ' ' ARG . 2.3 mt-10 -85.11 -7.35 59.13 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.067 -1.021 . . . . 0.0 111.463 -178.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.565 HG22 ' HB2' ' A' ' 225' ' ' ARG . 9.2 pt -126.36 -27.73 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.864 -1.147 . . . . 0.0 110.906 -179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.45 ' CG1' HD12 ' A' ' 81' ' ' LEU . 15.8 m -63.89 -17.37 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 120.739 -1.226 . . . . 0.0 109.346 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.8 mt -92.4 -3.52 55.16 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.378 -0.826 . . . . 0.0 109.516 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.432 ' HB2' ' HG3' ' A' ' 225' ' ' ARG . . . -68.6 126.32 29.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.336 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.532 ' O ' ' O ' ' A' ' 179' ' ' THR . 62.4 mtm180 -94.04 130.36 40.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.642 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 178' ' ' ARG . 10.1 t -37.11 159.25 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -143.52 154.24 43.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.544 -1.348 . . . . 0.0 111.578 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.678 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -152.16 156.36 39.65 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.532 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 87.1 m-85 -97.66 145.49 26.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.83 -1.169 . . . . 0.0 109.692 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.447 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 4.0 t0 -48.8 -37.9 20.5 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.251 -0.905 . . . . 0.0 109.084 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.532 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.8 p90 -70.16 -25.82 63.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.987 -1.071 . . . . 0.0 109.331 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.445 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.3 mm-40 -75.68 -35.66 60.29 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.403 HD13 ' N4 ' ' A' ' 500' ' ' C90 . 61.8 mt -51.92 -42.21 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.942 . . . . 0.0 109.681 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -58.84 -41.7 87.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.151 -0.968 . . . . 0.0 109.538 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.415 ' O ' ' C ' ' A' ' 189' ' ' ILE . 11.7 t60 -75.85 -58.31 3.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.277 -0.889 . . . . 0.0 109.013 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.415 ' C ' ' O ' ' A' ' 188' ' ' HIS . 94.4 mt -43.79 -33.43 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 109.419 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 35.5 mttt -79.4 -52.51 7.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.939 -1.1 . . . . 0.0 109.069 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -47.33 -44.82 24.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.22 7.14 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.054 -1.029 . . . . 0.0 110.531 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.02 40.0 57.67 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 121.081 -1.012 . . . . 0.0 110.677 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 194' ' ' LEU . 44.0 mt -127.72 173.82 9.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.219 -1.166 . . . . 0.0 109.93 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 56.16 26.58 50.11 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -60.26 -19.69 55.81 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.0 109.868 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.84 3.34 33.92 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.68 128.07 40.14 Favored Glycine 0 N--CA 1.493 2.463 0 O-C-N 120.995 -1.297 . . . . 0.0 110.04 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.462 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 11.5 p -146.44 164.65 31.8 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.435 -1.038 . . . . 0.0 109.322 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.594 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.9 mt -66.72 -7.93 24.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.124 -0.985 . . . . 0.0 108.607 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -96.83 -19.09 19.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.583 -0.698 . . . . 0.0 109.601 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.462 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 21.5 p30 -128.04 3.98 5.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.287 -0.883 . . . . 0.0 109.392 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.5 m -144.47 146.72 32.59 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.455 -0.898 . . . . 0.0 109.688 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.604 HD11 ' CD2' ' A' ' 217' ' ' LEU . 13.7 tp -96.79 96.3 8.48 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.1 t -85.09 127.67 39.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.893 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 29.1 mt -122.5 160.95 24.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.577 -0.702 . . . . 0.0 109.438 -178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.43 -166.15 13.04 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.95 -30.47 70.61 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.134 -1.215 . . . . 0.0 109.658 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -148.97 23.38 0.96 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.089 -1.007 . . . . 0.0 111.264 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -149.97 157.76 43.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.449 -1.407 . . . . 0.0 110.724 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.9 t -105.24 115.09 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -61.63 -44.06 97.68 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.091 -1.006 . . . . 0.0 110.387 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 7.3 m120 -62.43 126.01 87.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 120.889 -1.132 . . . . 0.0 110.334 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -67.08 -17.17 50.7 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 C-N-CA 121.689 1.593 . . . . 0.0 112.246 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 -15.82 56.28 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.964 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 72.33 -164.93 54.45 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.604 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.7 mt -91.83 129.55 37.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.146 -1.208 . . . . 0.0 109.463 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.494 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 3.3 mmt85 -67.02 -17.08 64.75 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.995 -1.066 . . . . 0.0 108.193 178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.494 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 40.6 m-85 -145.53 160.67 41.29 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.433 ' C ' ' OD1' ' A' ' 221' ' ' ASN . 3.9 mp0 -77.86 15.83 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.167 -0.958 . . . . 0.0 109.708 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.538 ' ND2' ' NH1' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -154.28 39.55 0.46 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.781 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 2.4 tt0 -57.95 -43.81 98.84 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.903 -1.123 . . . . 0.0 109.793 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 33.2 Cg_exo -59.59 -66.78 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 122.605 2.203 . . . . 0.0 112.833 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 225' ' ' ARG . 19.6 m -60.37 -40.19 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.133 -0.979 . . . . 0.0 111.428 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.572 ' NE ' ' O ' ' A' ' 173' ' ' GLU . 4.3 ptm180 -67.77 -34.72 77.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.615 -1.303 . . . . 0.0 109.006 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -66.61 -32.35 73.62 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 16.8 mmtp -65.59 -37.61 87.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.549 HG11 ' HB3' ' A' ' 166' ' ' PHE . 67.8 t -65.7 -37.2 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.468 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 46.1 t80 -64.04 -52.07 61.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.403 ' OD2' ' N23' ' A' ' 500' ' ' C90 . 82.3 m-20 -65.09 -26.6 68.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.571 -0.705 . . . . 0.0 109.565 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.557 HD23 ' CG1' ' A' ' 149' ' ' VAL . 57.0 tp -77.51 -33.58 54.32 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.5 mt -67.41 -38.06 80.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.7 -54.4 22.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.415 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 95.4 m-20 -56.52 -33.04 65.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.166 -1.197 . . . . 0.0 109.316 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HA ' HD23 ' A' ' 235' ' ' LEU . 9.1 mt -68.09 -25.15 65.18 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 0.0 110.544 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.4 t80 -75.06 -21.48 58.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.921 -1.112 . . . . 0.0 109.528 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.7 mt -50.71 -3.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.705 -1.247 . . . . 0.0 110.136 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 236' ' ' TYR . 4.3 mt -70.67 -13.55 62.12 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.024 -1.048 . . . . 0.0 109.857 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.74 0.91 60.34 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.941 -1.124 . . . . 0.0 110.609 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.05 152.5 11.34 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 120.913 -1.345 . . . . 0.0 108.86 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.9 Cg_endo -53.59 128.04 27.83 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.795 1.663 . . . . 0.0 109.942 179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 18.1 t -87.48 153.16 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.135 -0.978 . . . . 0.0 112.266 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -134.94 126.15 28.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 146' ' ' THR . . . 154.7 -157.15 27.37 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.425 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.1 OUTLIER -131.2 136.17 48.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -1.173 . . . . 0.0 108.87 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.0 m-85 -135.52 140.54 44.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.155 -0.965 . . . . 0.0 110.484 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -126.09 132.15 51.96 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 43.0 t -125.32 136.37 53.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.038 -1.039 . . . . 0.0 111.121 -178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -117.3 113.37 22.06 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.4 mtt180 51.19 24.43 1.99 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.192 -0.943 . . . . 0.0 109.037 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -62.45 154.08 42.38 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -131.09 178.18 17.94 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.573 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 75.5 m-70 -59.78 -40.92 89.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -1.226 . . . . 0.0 109.531 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.09 -58.96 5.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.24 -0.913 . . . . 0.0 109.432 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.575 HD23 ' CD1' ' A' ' 139' ' ' ILE . 6.1 tp -55.74 -46.38 77.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.023 -1.048 . . . . 0.0 109.62 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.3 -51.73 18.34 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.889 -1.132 . . . . 0.0 109.323 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 56' ' ' THR . 88.6 t -61.53 -50.26 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.428 -0.795 . . . . 0.0 109.725 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -54.09 -52.05 62.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.988 -1.07 . . . . 0.0 109.375 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 35.1 tp -49.79 -50.92 43.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.17 -0.956 . . . . 0.0 108.486 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 238' ' ' LEU . 44.1 t -58.65 -53.16 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.239 -0.913 . . . . 0.0 108.935 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -46.9 -49.77 19.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.633 -0.667 . . . . 0.0 109.431 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -64.82 -48.4 74.53 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.8 mt -55.95 -51.99 65.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.255 -0.903 . . . . 0.0 110.197 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -70.72 -26.44 63.39 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 0.0 110.397 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -47.78 35.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -0.979 . . . . 0.0 110.514 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.455 ' CD ' HD12 ' A' ' 130' ' ' ILE . 0.3 OUTLIER -71.63 -46.92 57.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.1 -1.0 . . . . 0.0 110.111 -179.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.635 ' NE2' ' CZ ' ' A' ' 124' ' ' PHE . 22.7 tt0 -42.74 -72.43 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.179 -0.95 . . . . 0.0 109.542 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.16 150.4 20.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 0.0 109.488 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 269' ' ' LEU . 2.3 mm? . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.875 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.678 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.2 mt -99.65 159.43 15.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -1.168 . . . . 0.0 109.482 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.34 138.49 39.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.17 -0.957 . . . . 0.0 108.862 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.85 145.77 47.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.4 t -141.77 -174.83 4.18 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.634 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.3 m -97.18 136.95 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.916 -1.115 . . . . 0.0 109.112 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' HB3' HD13 ' A' ' 115' ' ' LEU . 16.7 ptmt -65.47 -29.82 70.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 109.744 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -144.42 156.15 44.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 179.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.497 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -63.69 141.21 58.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.428 -0.795 . . . . 0.0 110.356 -179.486 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.3 mt -118.94 166.22 13.12 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -137.76 143.18 41.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.085 -1.01 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 89.1 m-85 -139.37 154.52 47.86 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -163.28 152.59 14.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.837 -1.165 . . . . 0.0 110.177 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.13 176.66 36.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.6 p -82.19 153.44 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -1.144 . . . . 0.0 110.01 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.28 139.97 15.93 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 19' ' ' HIS . 5.9 tt -58.54 -41.09 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.077 -1.249 . . . . 0.0 110.472 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.484 ' HE2' ' HG ' ' A' ' 59' ' ' SER . 73.4 m-70 -88.09 -50.52 6.34 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.694 -1.254 . . . . 0.0 111.116 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 p -66.07 -27.92 68.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.781 -0.575 . . . . 0.0 111.801 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.74 16.63 46.66 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 118.888 -1.625 . . . . 0.0 109.226 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -111.85 156.04 22.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.401 -1.058 . . . . 0.0 109.487 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -74.84 134.45 41.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.49 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.5 m -138.21 143.86 40.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.132 -0.98 . . . . 0.0 109.499 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -113.03 156.59 22.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.255 -0.903 . . . . 0.0 109.821 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD11 HG23 ' A' ' 96' ' ' ILE . 8.7 mt -136.08 146.94 47.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.365 -0.834 . . . . 0.0 110.236 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 27' ' ' ILE . 2.3 mp -140.85 115.43 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.19 -0.944 . . . . 0.0 108.711 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.7 mt -98.93 114.99 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.493 -0.755 . . . . 0.0 110.967 -178.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.547 ' NE2' HG22 ' A' ' 27' ' ' ILE . 13.2 m-70 -109.34 138.06 20.41 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.427 -0.796 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.634 ' HG3' HG23 ' A' ' 7' ' ' VAL . 29.6 Cg_exo -52.15 168.87 0.34 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.959 1.772 . . . . 0.0 111.704 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.509 ' HB3' HG21 ' A' ' 35' ' ' THR . 71.9 mm-40 -141.91 173.91 11.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.037 -1.039 . . . . 0.0 109.973 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' A' ' 35' ' ' THR . 31.1 mmtp -83.51 152.26 25.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.347 -0.846 . . . . 0.0 109.769 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.11 146.1 2.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 110.073 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.65 5.7 46.27 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.383 -0.913 . . . . 0.0 110.83 178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 31' ' ' GLU . 29.0 m -68.51 -42.66 78.23 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.702 -1.469 . . . . 0.0 109.428 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.82 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 96.6 -176.62 32.58 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.91 -1.138 . . . . 0.0 110.367 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.2 mm -101.12 118.32 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -141.64 155.95 45.68 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 118.662 -1.215 . . . . 0.0 110.933 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -104.31 156.91 17.51 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -129.5 109.94 11.46 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 108.914 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -135.4 134.97 40.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.422 -0.799 . . . . 0.0 111.006 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 50.69 32.63 7.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.51 -0.744 . . . . 0.0 111.578 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.75 17.37 80.12 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.2 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.12 120.81 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.44 -1.036 . . . . 0.0 108.854 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 31.8 m-85 -84.96 128.28 34.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.21 -0.931 . . . . 0.0 109.314 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -117.78 93.44 43.9 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.389 -0.819 . . . . 0.0 109.283 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -48.78 146.7 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.324 2.016 . . . . 0.0 111.925 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.576 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 70.93 9.0 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.141 -0.975 . . . . 0.0 109.277 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtt180 -122.34 174.82 6.77 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.25 -0.906 . . . . 0.0 109.545 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.543 ' O ' ' N ' ' A' ' 52' ' ' PHE . 15.2 p-80 -78.1 -52.57 8.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.106 -0.997 . . . . 0.0 109.61 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -43.7 -16.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 110.435 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.543 ' N ' ' O ' ' A' ' 50' ' ' HIS . 39.8 m-85 -96.18 2.74 53.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.004 -1.06 . . . . 0.0 110.029 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.8 t -73.12 132.76 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 108.664 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -112.64 -30.83 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 110.336 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -149.68 134.91 18.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.942 -1.099 . . . . 0.0 109.973 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 257' ' ' VAL . 73.3 p -123.75 96.07 4.82 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.587 ' O ' ' N ' ' A' ' 59' ' ' SER . 0.3 OUTLIER -162.84 128.7 3.32 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.3 -0.875 . . . . 0.0 109.121 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.502 ' O ' ' CB ' ' A' ' 59' ' ' SER . 33.6 m-70 48.41 9.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.118 -0.989 . . . . 0.0 109.15 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 164.07 141.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.692 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.433 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.1 m -86.22 127.68 34.78 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.366 -0.834 . . . . 0.0 109.158 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.5 m-20 -120.29 149.59 42.06 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.67 0.748 . . . . 0.0 110.944 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.412 ' HG ' HG21 ' A' ' 72' ' ' VAL . 12.0 mt -122.16 150.38 42.31 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.72 151.89 22.7 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.06 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -161.68 147.09 13.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.374 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt 52.35 21.59 1.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.16 -0.962 . . . . 0.0 109.451 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.14 -33.09 6.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 88.6 mm-40 -58.42 146.09 36.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.119 -1.224 . . . . 0.0 109.759 -179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.35 136.28 34.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.376 -0.828 . . . . 0.0 110.579 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 71.6 mt -130.2 126.47 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -102.96 157.85 16.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.944 -1.097 . . . . 0.0 111.582 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.3 m 49.93 74.66 0.2 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.703 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 60' ' ' THR . 24.4 m -108.01 -10.86 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.246 -0.909 . . . . 0.0 109.587 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.552 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 6.7 pm0 -61.71 -25.79 67.64 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 110.706 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.13 -68.91 0.33 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.857 -1.152 . . . . 0.0 109.083 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.579 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.6 tp -52.15 -47.66 43.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.006 -1.059 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.579 ' N ' HG23 ' A' ' 75' ' ' ILE . 14.4 mt -52.73 -50.03 64.24 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 110.201 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.563 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 15.9 t -59.75 -42.76 93.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.943 -1.098 . . . . 0.0 110.195 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 106' ' ' PHE . 98.2 t -55.06 -48.08 76.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.091 -1.006 . . . . 0.0 109.026 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.4 mt -64.49 -33.49 76.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 109.191 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -62.6 -38.77 91.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 0.0 109.416 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.462 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.9 mt -76.47 -39.25 53.76 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 110.155 -179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.646 HD22 HD11 ' A' ' 114' ' ' ILE . 65.5 mt -81.8 0.5 38.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.985 -1.072 . . . . 0.0 109.502 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 56.38 43.28 26.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.556 -0.715 . . . . 0.0 111.185 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 20.0 mm -87.69 146.52 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 108.082 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.592 HG21 HG12 ' A' ' 121' ' ' ILE . 51.0 p -130.53 -20.46 2.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.116 -0.99 . . . . 0.0 111.385 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.82 HD22 ' H ' ' A' ' 36' ' ' GLY . 11.5 m120 -125.74 107.09 10.2 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.054 -1.028 . . . . 0.0 110.614 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.8 m -165.75 148.21 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 CA-C-O 121.618 0.723 . . . . 0.0 110.053 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.471 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 53.1 m -115.87 111.47 20.49 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.439 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -94.3 101.21 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.385 -0.822 . . . . 0.0 109.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' O ' HD23 ' A' ' 26' ' ' LEU . 23.4 tt0 -72.95 126.36 29.75 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.436 HG22 HD21 ' A' ' 26' ' ' LEU . 71.5 t -108.68 120.12 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 CA-C-O 121.892 0.854 . . . . 0.0 111.285 -178.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.536 HG22 ' O ' ' A' ' 92' ' ' ILE . 14.2 mt -108.37 96.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.22 -158.27 27.18 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -118.95 -12.43 9.56 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.329 -1.101 . . . . 0.0 110.059 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -141.43 150.77 42.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 109.509 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.686 HG23 HD11 ' A' ' 26' ' ' LEU . 44.5 mm -74.09 121.26 84.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.115 -0.991 . . . . 0.0 108.964 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -41.12 122.02 1.5 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.751 1.634 . . . . 0.0 111.345 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.3 tp -77.95 -15.44 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 110.536 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.1 mt 57.25 -117.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.089 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.437 ' O ' ' CG ' ' A' ' 100' ' ' ASP . 9.4 t70 -98.25 5.72 48.11 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.037 -1.039 . . . . 0.0 110.731 -178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.97 0.9 58.6 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.352 -1.404 . . . . 0.0 110.143 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.0 -172.45 2.69 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.703 -0.881 . . . . 0.0 109.527 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.59 16.64 7.9 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.554 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 68.8 t-105 -58.38 -42.15 86.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.328 -1.101 . . . . 0.0 110.292 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.0 -56.39 17.45 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.087 -1.008 . . . . 0.0 109.905 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 78' ' ' VAL . 12.8 m-85 -51.38 -44.09 62.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.327 -0.858 . . . . 0.0 108.783 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.415 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 36.3 t80 -62.41 -53.91 48.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.702 -0.624 . . . . 0.0 110.801 -179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 4.2 mt-10 -59.31 -44.5 92.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 111.133 -178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.38 -54.87 19.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -0.992 . . . . 0.0 110.616 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 34.1 mt -67.09 -33.63 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.116 -0.99 . . . . 0.0 109.761 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 7.8 ttm-85 -62.87 -43.71 98.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.8 mmtm -77.8 14.01 1.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.86 . . . . 0.0 109.863 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -144.53 32.2 1.18 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.964 -1.085 . . . . 0.0 110.333 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.646 HD11 HD22 ' A' ' 82' ' ' LEU . 79.4 mt -77.76 138.34 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.165 -0.959 . . . . 0.0 110.344 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.413 HD13 ' HB3' ' A' ' 8' ' ' LYS . 5.1 tp -128.87 120.03 25.5 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.538 ' O ' ' ND2' ' A' ' 116' ' ' ASN . 0.4 OUTLIER -80.2 142.99 34.16 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.32 -0.862 . . . . 0.0 110.272 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.57 -174.06 2.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.377 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -109.66 68.95 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.201 -0.937 . . . . 0.0 110.234 -179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -164.77 129.42 2.58 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 109.099 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -67.96 141.9 56.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.107 . . . . 0.0 109.478 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.592 HG12 HG21 ' A' ' 85' ' ' THR . 69.9 mt -85.37 150.86 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 110.128 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 12.7 p30 -97.76 85.16 3.5 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.41 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 32.7 m-85 -62.32 143.49 56.88 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.588 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -89.48 101.6 14.28 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.2 133.46 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 121.43 0.634 . . . . 0.0 110.768 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 94.7 t -71.16 116.56 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -92.62 -29.93 15.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.957 -1.089 . . . . 0.0 110.607 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -129.67 149.7 73.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.216 -0.928 . . . . 0.0 109.793 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.17 149.56 46.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.62 2.213 . . . . 0.0 111.779 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.3 tt -157.02 152.43 7.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.155 -0.966 . . . . 0.0 109.536 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.1 mp -138.51 141.17 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.397 -0.814 . . . . 0.0 109.007 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.83 147.22 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 28.8 mp0 -138.49 157.08 46.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.09 -1.006 . . . . 0.0 109.996 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -175.3 108.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.318 -0.864 . . . . 0.0 109.779 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 53.44 51.53 15.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -0.828 . . . . 0.0 110.614 179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.02 -32.53 3.49 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.419 ' HB3' HD22 ' A' ' 255' ' ' LEU . 4.8 mtp180 -59.16 136.9 58.1 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -1.232 . . . . 0.0 108.133 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -149.3 135.64 19.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.77 -1.206 . . . . 0.0 109.709 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.615 ' CD1' HD23 ' A' ' 255' ' ' LEU . 87.4 mt -137.27 128.57 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.657 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.3 tttp -114.13 131.88 56.27 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.412 0.625 . . . . 0.0 109.886 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.0 134.26 54.81 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.91 152.86 45.04 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.004 -1.06 . . . . 0.0 110.018 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -49.68 142.57 24.42 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.529 2.153 . . . . 0.0 113.889 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.534 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -156.83 147.01 21.12 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 178.072 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -68.3 -29.42 68.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.122 -0.986 . . . . 0.0 110.869 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.534 ' O ' ' OG ' ' A' ' 144' ' ' SER . 12.6 p -119.67 -165.52 1.17 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.358 -0.838 . . . . 0.0 109.23 -179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 148' ' ' GLU . 7.3 tp -107.42 122.38 46.5 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.49 ' N ' HD12 ' A' ' 147' ' ' LEU . 1.7 tt0 -138.65 126.25 22.01 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.133 -0.979 . . . . 0.0 109.098 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 52.4 t -124.96 122.2 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 109.83 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.458 ' OG1' HG23 ' A' ' 165' ' ' THR . 52.0 m -112.98 151.77 30.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.613 -0.68 . . . . 0.0 109.61 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -139.76 130.18 25.49 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.669 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -122.47 135.13 54.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.44 143.13 12.73 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.351 -1.404 . . . . 0.0 111.978 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -105.7 100.64 10.2 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -87.11 167.82 13.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 110.846 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -103.82 24.93 10.49 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.632 -0.668 . . . . 0.0 110.257 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.59 ' ND2' ' CE1' ' A' ' 158' ' ' PHE . 22.6 p-10 -137.71 -170.53 2.78 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.037 -1.04 . . . . 0.0 110.36 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.59 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 21.2 p90 -49.55 -5.14 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.608 -0.683 . . . . 0.0 111.638 -178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.601 ' O ' ' NE2' ' A' ' 162' ' ' GLN . 73.6 mt -82.35 -30.31 30.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.176 -1.578 . . . . 0.0 108.349 179.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.59 -132.26 43.39 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.6 131.04 43.64 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.158 -1.201 . . . . 0.0 109.192 179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 159' ' ' LEU . 1.6 tp-100 -138.29 144.7 40.59 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.465 -0.772 . . . . 0.0 109.259 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.64 147.83 36.41 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.373 -0.829 . . . . 0.0 110.361 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -146.74 141.66 26.99 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.218 -0.927 . . . . 0.0 109.942 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.458 HG23 ' OG1' ' A' ' 150' ' ' THR . 58.5 m -110.49 124.59 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.491 -0.755 . . . . 0.0 109.822 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 232' ' ' ILE . 8.7 t80 -105.37 115.91 31.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 110.196 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.51 151.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.42 -0.8 . . . . 0.0 109.737 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.33 131.56 24.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.167 -0.958 . . . . 0.0 109.166 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.28 -3.03 43.53 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -117.35 22.57 12.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.19 -1.183 . . . . 0.0 109.002 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -50.97 -54.87 20.55 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.518 -0.738 . . . . 0.0 110.011 -179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 171' ' ' GLU . 71.6 mt-10 -41.79 -23.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 110.193 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 171' ' ' GLU . 64.6 mt-10 -81.54 -12.77 58.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.028 -1.045 . . . . 0.0 111.754 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 24.8 pt -125.15 -28.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 120.866 -1.146 . . . . 0.0 111.355 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.58 -26.84 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.519 -1.363 . . . . 0.0 108.972 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -84.71 -3.61 58.64 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.461 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.46 116.82 10.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.289 -0.882 . . . . 0.0 108.915 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 54.4 mtm180 -79.95 172.35 13.9 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.279 -0.888 . . . . 0.0 109.143 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 7.0 t -78.54 162.51 26.26 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.37 149.17 32.25 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.218 -1.551 . . . . 0.0 111.445 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.513 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -146.24 156.7 43.57 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.441 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 89.9 m-85 -98.15 146.2 25.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.0 109.314 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.44 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -47.37 -38.3 12.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.266 -0.897 . . . . 0.0 109.479 -179.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.526 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -72.33 -29.37 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.999 -1.063 . . . . 0.0 109.597 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 2.7 mt-10 -73.16 -33.95 65.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.59 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.53 HD13 HB12 ' A' ' 500' ' ' C90 . 71.2 mt -53.8 -54.25 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.28 -0.887 . . . . 0.0 109.792 -179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -45.3 -41.93 9.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.787 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.5 t-160 -74.42 -47.99 30.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.466 -0.771 . . . . 0.0 109.615 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 92.9 mt -53.97 -30.56 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.687 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -84.36 -53.52 5.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.885 -1.135 . . . . 0.0 109.477 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -49.87 -36.54 27.51 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.285 -0.884 . . . . 0.0 110.258 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 188' ' ' HIS . 27.9 m -81.61 8.65 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.066 -1.022 . . . . 0.0 109.892 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 70.2 39.95 71.53 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.5 mt -128.99 172.31 11.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.257 -1.143 . . . . 0.0 109.989 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.5 25.23 57.8 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -58.89 -20.02 47.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.478 -1.601 . . . . 0.0 109.987 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.492 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -109.46 5.47 31.46 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.69 130.71 34.09 Favored Glycine 0 N--CA 1.495 2.62 0 O-C-N 120.965 -1.315 . . . . 0.0 110.437 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.659 ' N ' HD21 ' A' ' 202' ' ' ASN . 8.2 t -144.08 160.9 40.1 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.44 -1.035 . . . . 0.0 109.235 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.467 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 31.8 mt -66.92 -8.99 33.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.026 -1.046 . . . . 0.0 108.419 179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -98.15 -13.05 21.13 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.659 HD21 ' N ' ' A' ' 199' ' ' SER . 10.0 p30 -128.66 8.79 5.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.437 -0.789 . . . . 0.0 109.256 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.97 153.91 32.84 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 110.377 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.592 HD11 ' CD2' ' A' ' 217' ' ' LEU . 9.9 tp -101.3 110.65 22.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 53.9 t -99.79 128.85 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.773 0.797 . . . . 0.0 109.281 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 21.7 mt -124.83 165.79 17.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.571 -0.706 . . . . 0.0 109.639 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.26 -166.73 11.88 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -30.44 69.64 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.417 -1.049 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 209' ' ' ASP . 23.0 p-10 -158.34 21.88 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 110.274 -179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -138.15 145.19 41.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.907 -1.12 . . . . 0.0 110.535 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.3 108.41 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -54.84 -50.58 68.27 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 110.043 -178.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.467 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.7 m120 -60.61 115.29 13.0 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.447 -0.783 . . . . 0.0 109.897 -179.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -67.66 -12.28 35.01 Favored 'Trans proline' 0 N--CA 1.489 1.212 0 C-N-CA 121.418 1.412 . . . . 0.0 111.9 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -75.72 -15.95 60.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.236 -0.915 . . . . 0.0 108.664 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.73 178.27 46.05 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.592 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.9 mt -82.62 150.12 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.364 -1.08 . . . . 0.0 109.576 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -79.02 -19.0 52.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.15 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -141.94 -165.53 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.6 -8.21 29.46 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.226 -0.921 . . . . 0.0 109.191 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.07 45.93 1.44 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.237 -0.914 . . . . 0.0 109.35 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.535 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.18 -46.92 99.6 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.925 -1.109 . . . . 0.0 109.86 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 55.4 Cg_exo -51.18 -68.17 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.42 2.08 . . . . 0.0 112.179 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.2 m -58.6 -35.06 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.95 -1.094 . . . . 0.0 109.674 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -61.69 -40.7 95.94 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.9 t60 -68.02 -31.41 71.06 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.664 179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 18.4 mmtm -65.33 -36.25 83.46 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.36 -38.14 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 67.5 t80 -64.42 -50.23 68.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.522 -0.736 . . . . 0.0 109.17 179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.435 ' OD2' ' N23' ' A' ' 500' ' ' C90 . 89.2 m-20 -66.65 -28.35 68.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 109.899 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 31.9 tp -76.06 -32.91 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.104 -0.998 . . . . 0.0 108.391 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.587 HD11 ' CD2' ' A' ' 166' ' ' PHE . 34.4 mt -68.97 -38.9 79.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -65.58 -53.49 31.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.449 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 80.6 m-20 -56.74 -38.2 72.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.101 -1.234 . . . . 0.0 109.151 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 235' ' ' LEU . 10.6 mt -58.59 -21.12 52.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.505 -0.747 . . . . 0.0 110.36 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.588 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -75.02 -22.32 58.54 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.824 -1.172 . . . . 0.0 109.454 -179.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.18 1.08 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.49 -1.381 . . . . 0.0 110.292 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 236' ' ' TYR . 7.4 mt -77.93 -16.29 58.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.911 -1.118 . . . . 0.0 109.569 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.9 -0.23 51.88 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.936 -1.126 . . . . 0.0 110.867 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.79 157.41 10.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.736 -1.449 . . . . 0.0 109.118 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.41 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 4.8 Cg_endo -50.22 150.79 10.22 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 121.805 1.67 . . . . 0.0 109.322 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 71.7 t -109.67 145.54 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.873 -1.142 . . . . 0.0 112.108 -177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 122.44 33.55 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.66 -160.5 30.7 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -133.22 141.05 47.86 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.444 -1.033 . . . . 0.0 108.888 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 9.7 m-85 -140.66 141.26 35.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.978 . . . . 0.0 110.401 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -125.52 122.96 38.08 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 178.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.8 m -115.22 136.11 53.46 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.026 -1.046 . . . . 0.0 111.198 -178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.436 ' O ' ' C ' ' A' ' 250' ' ' ARG . 91.7 t80 -117.81 116.04 26.2 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 249' ' ' PHE . 38.0 mtp85 43.55 43.54 4.66 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.219 -0.926 . . . . 0.0 109.193 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.35 165.42 35.62 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -138.83 -174.57 13.51 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.552 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 61.4 m-70 -63.01 -39.14 93.86 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 109.509 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER -55.27 -58.68 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.088 -1.007 . . . . 0.0 108.999 179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.615 HD23 ' CD1' ' A' ' 139' ' ' ILE . 4.1 tp -56.27 -45.08 80.25 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 109.461 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -47.46 -50.5 22.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.043 -1.036 . . . . 0.0 109.35 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 56' ' ' THR . 96.1 t -64.95 -39.23 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.732 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -63.97 -51.41 64.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 0.0 109.268 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 139' ' ' ILE . 23.6 tp -52.87 -49.13 66.44 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.215 -0.928 . . . . 0.0 108.545 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.471 HG13 ' HG ' ' A' ' 238' ' ' LEU . 15.4 t -60.01 -53.19 51.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 108.826 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -49.29 -48.68 45.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.53 -0.732 . . . . 0.0 109.475 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -61.32 -49.07 78.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 109.705 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 18.1 mt -57.3 -45.77 83.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 109.641 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.39 -29.55 63.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.914 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -69.2 -65.62 0.68 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.176 -0.953 . . . . 0.0 109.76 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 268' ' ' LYS . 4.1 pttm -51.02 -40.19 57.63 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.074 -1.016 . . . . 0.0 108.97 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.458 ' O ' ' C ' ' A' ' 268' ' ' LYS . 0.8 OUTLIER -67.63 52.5 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -0.853 . . . . 0.0 109.126 179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.547 ' N ' ' O ' ' A' ' 266' ' ' LYS . 7.2 pttp -39.67 130.21 1.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.478 -0.763 . . . . 0.0 109.84 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.53 HB12 HD13 ' A' ' 186' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.48 155.01 31.98 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -1.147 . . . . 0.0 109.504 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -57.59 141.57 47.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 108.731 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -125.59 147.09 49.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 110.433 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.4 t -141.93 -173.03 3.69 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.645 HG23 ' HG3' ' A' ' 30' ' ' PRO . 19.6 m -97.35 136.84 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.868 -1.145 . . . . 0.0 109.035 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -67.27 -21.77 65.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.572 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' OE2' ' O ' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -152.31 157.82 41.89 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.417 ' O ' ' OE2' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -65.8 139.99 58.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.312 -0.867 . . . . 0.0 110.368 -179.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.9 mt -115.95 163.55 15.72 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.51 142.06 43.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.103 -0.998 . . . . 0.0 110.344 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -141.21 161.01 38.89 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -167.15 152.75 7.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.929 -1.107 . . . . 0.0 109.768 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.27 176.11 36.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 6.2 p -82.34 155.54 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -1.128 . . . . 0.0 110.062 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.44 139.14 15.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.501 ' CD1' HG21 ' A' ' 179' ' ' THR . 7.3 tt -58.98 -38.33 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.05 -1.265 . . . . 0.0 110.354 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' N ' HG23 ' A' ' 18' ' ' ILE . 80.2 m-70 -90.86 -50.82 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.674 -1.266 . . . . 0.0 111.026 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.3 p -68.65 -23.64 64.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.76 -0.587 . . . . 0.0 111.244 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.95 17.2 21.41 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -108.28 153.34 23.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.458 -1.025 . . . . 0.0 109.651 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -73.3 134.64 44.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 0.0 109.41 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 73.9 m -140.49 143.83 35.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.008 -1.058 . . . . 0.0 109.754 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.6 tttt -108.28 158.58 17.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 8.9 mt -137.6 144.61 42.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.824 . . . . 0.0 109.54 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.574 HG22 ' NE2' ' A' ' 29' ' ' HIS . 6.5 mt -143.43 110.91 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.9 . . . . 0.0 108.852 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -94.43 115.1 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.495 -0.753 . . . . 0.0 111.057 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.574 ' NE2' HG22 ' A' ' 27' ' ' ILE . 30.1 m-70 -108.5 138.57 20.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.559 -0.713 . . . . 0.0 109.422 179.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HG3' HG23 ' A' ' 7' ' ' VAL . 24.0 Cg_exo -53.82 168.37 0.81 Allowed 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 121.753 1.635 . . . . 0.0 111.728 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.504 ' OE1' HG21 ' A' ' 35' ' ' THR . 28.1 mm-40 -140.94 173.75 11.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 109.55 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.484 ' O ' ' OG1' ' A' ' 35' ' ' THR . 39.7 mttm -85.08 153.06 22.95 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.284 -0.885 . . . . 0.0 109.441 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -49.17 147.21 3.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.704 ' H ' HD21 ' A' ' 86' ' ' ASN . . . 71.82 -0.33 37.24 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.903 179.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.76 ' H ' HD22 ' A' ' 86' ' ' ASN . 51.6 m -67.21 -45.42 76.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.615 -1.52 . . . . 0.0 109.536 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.75 -179.34 31.52 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.802 -1.19 . . . . 0.0 110.774 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 mm -97.87 117.66 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH2' ' CE1' ' A' ' 45' ' ' TYR . 21.7 ptt180 -144.49 157.73 44.1 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.591 -1.244 . . . . 0.0 110.839 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -103.64 157.86 16.77 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -128.07 110.83 12.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.364 -0.835 . . . . 0.0 108.772 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.548 ' CE ' ' O ' ' A' ' 93' ' ' GLY . 15.9 tttp -135.27 132.81 38.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.0 110.579 -178.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 53.17 28.3 6.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.464 -0.772 . . . . 0.0 111.628 178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.44 19.67 68.34 Favored Glycine 0 N--CA 1.493 2.446 0 C-N-CA 119.449 -1.358 . . . . 0.0 110.211 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.9 t -124.28 123.0 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -1.112 . . . . 0.0 109.278 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.447 ' CE1' ' NH2' ' A' ' 38' ' ' ARG . 98.9 m-85 -84.78 127.62 34.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.215 -0.928 . . . . 0.0 109.255 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -118.4 90.99 40.16 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.846 . . . . 0.0 109.707 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -47.69 150.22 4.36 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.549 2.166 . . . . 0.0 111.926 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.644 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.11 75.99 9.36 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.982 . . . . 0.0 109.775 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -129.35 173.66 10.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.99 . . . . 0.0 109.211 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.2 p-80 -71.81 -52.43 17.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.572 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -45.48 -16.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.18 -0.95 . . . . 0.0 110.758 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' HIS . 21.0 m-85 -94.9 0.37 54.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.722 -1.236 . . . . 0.0 109.676 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.0 t -72.82 128.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 m -110.04 -28.94 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.17 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -151.07 133.03 15.13 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.906 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.945 HG21 HG21 ' A' ' 257' ' ' VAL . 40.8 p -123.93 95.91 4.74 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 59' ' ' SER . 5.7 t-20 -162.61 128.76 3.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.336 -0.852 . . . . 0.0 108.805 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' SER . 50.9 m-70 50.17 9.45 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.115 -0.99 . . . . 0.0 108.791 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 162.97 146.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.391 -0.818 . . . . 0.0 109.801 179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.434 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 31.0 m -89.9 126.92 35.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.283 -0.886 . . . . 0.0 109.174 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.401 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.7 m-20 -121.04 150.35 41.29 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.328 -0.857 . . . . 0.0 111.059 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CG ' HG21 ' A' ' 72' ' ' VAL . 4.5 mt -125.5 150.11 47.68 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.51 154.82 25.91 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.894 -1.622 . . . . 0.0 110.6 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -163.22 150.39 12.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.443 -1.033 . . . . 0.0 109.522 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtt 52.31 22.2 1.94 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.13 -32.5 7.24 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -59.83 145.74 44.44 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.013 -1.287 . . . . 0.0 109.478 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.25 139.51 35.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 0.0 110.407 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mt -130.15 121.96 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -99.04 156.99 16.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.902 -1.124 . . . . 0.0 111.108 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.1 m 49.14 74.52 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.879 -0.513 . . . . 0.0 110.739 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.533 HG21 ' CG ' ' A' ' 62' ' ' LEU . 20.6 m -108.0 -9.99 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.117 -0.989 . . . . 0.0 109.274 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 5.1 pm0 -60.86 -26.28 67.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.393 -0.817 . . . . 0.0 110.493 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 23.6 m170 -66.01 -69.52 0.29 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.931 -1.106 . . . . 0.0 109.373 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.4 tp -52.56 -47.48 48.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.284 -0.885 . . . . 0.0 109.276 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.644 HD21 ' HB1' ' A' ' 48' ' ' ALA . 26.4 mt -52.02 -48.75 64.35 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.954 -1.091 . . . . 0.0 110.026 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -61.18 -42.46 98.61 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.166 -0.959 . . . . 0.0 110.118 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.8 t -56.64 -44.88 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.068 -1.02 . . . . 0.0 109.093 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.1 mt -69.24 -35.19 75.89 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.33 -0.856 . . . . 0.0 109.288 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -62.48 -34.36 76.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.265 -0.897 . . . . 0.0 109.189 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.473 ' O ' ' OE1' ' A' ' 83' ' ' GLU . 52.2 mt -82.03 -37.97 25.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.619 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 82' ' ' LEU . 70.4 mt -79.62 0.26 30.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.113 -0.992 . . . . 0.0 109.409 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' OE1' ' O ' ' A' ' 81' ' ' LEU . 4.1 mp0 57.13 41.13 27.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.611 -0.681 . . . . 0.0 111.326 178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 39.9 mm -88.07 143.67 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.703 -1.248 . . . . 0.0 108.043 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.696 HG21 HG12 ' A' ' 121' ' ' ILE . 51.5 p -127.52 -21.04 3.88 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.103 -0.998 . . . . 0.0 111.703 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.76 HD22 ' H ' ' A' ' 35' ' ' THR . 5.4 m120 -127.18 107.0 9.63 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.937 -1.102 . . . . 0.0 110.609 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -164.94 149.63 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.507 -0.745 . . . . 0.0 109.917 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.45 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 41.7 m -117.21 111.66 19.74 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.487 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.2 mt -92.61 100.92 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.232 -0.917 . . . . 0.0 110.269 -179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' O ' HD23 ' A' ' 26' ' ' LEU . 2.8 tt0 -73.95 127.51 33.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.11 -0.994 . . . . 0.0 108.573 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.552 HG22 HD21 ' A' ' 26' ' ' LEU . 21.2 t -115.9 124.0 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.04 0.924 . . . . 0.0 112.261 -177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.5 mm -109.48 98.32 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.548 ' O ' ' CE ' ' A' ' 41' ' ' LYS . . . 144.36 -159.05 27.67 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -119.02 -10.93 9.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.223 -1.163 . . . . 0.0 110.075 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -141.62 150.2 41.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.981 -1.074 . . . . 0.0 109.683 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -72.27 120.35 79.91 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.244 -0.91 . . . . 0.0 108.702 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -41.09 120.83 1.2 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 121.69 1.593 . . . . 0.0 111.145 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.498 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.3 tp -78.25 -15.39 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 110.754 -178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.696 HD11 ' CE1' ' A' ' 106' ' ' PHE . 46.2 mt 57.1 -117.78 1.08 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.051 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 10.3 t0 -97.04 4.48 51.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.188 -0.945 . . . . 0.0 110.588 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.63 1.57 58.87 Favored Glycine 0 N--CA 1.491 2.331 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.104 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.7 p -127.58 -172.68 2.73 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.822 -0.811 . . . . 0.0 109.563 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.7 15.84 7.94 Favored Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.403 ' CZ2' ' HG3' ' A' ' 108' ' ' GLU . 42.1 t-105 -56.09 -42.43 76.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -1.046 . . . . 0.0 110.5 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -62.9 -59.1 5.3 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.05 -1.031 . . . . 0.0 110.322 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.696 ' CE1' HD11 ' A' ' 99' ' ' LEU . 11.2 m-30 -51.16 -45.18 61.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.149 -0.969 . . . . 0.0 109.288 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.434 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 48.8 t80 -60.12 -50.72 72.57 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.403 ' HG3' ' CZ2' ' A' ' 104' ' ' TRP . 23.8 mm-40 -63.78 -43.85 95.15 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.17 -0.956 . . . . 0.0 111.23 -178.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.45 -60.01 2.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.945 -1.097 . . . . 0.0 110.095 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.4 mt -56.49 -36.8 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.256 -0.902 . . . . 0.0 109.192 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 39.9 ttt180 -62.12 -43.44 98.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.37 -0.831 . . . . 0.0 109.249 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -76.33 13.93 0.84 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.348 -0.845 . . . . 0.0 109.614 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -146.08 31.47 1.03 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.069 -1.02 . . . . 0.0 110.453 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.1 mt -80.75 139.12 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.902 -1.124 . . . . 0.0 110.35 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.5 tp -128.06 119.25 25.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.529 -0.732 . . . . 0.0 109.041 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.62 140.68 48.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.0 109.972 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -109.54 -178.26 3.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.701 . . . . 0.0 109.186 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -108.85 68.4 0.68 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.949 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -165.91 131.58 2.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.193 -0.942 . . . . 0.0 109.255 179.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -67.49 139.02 57.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 109.666 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.696 HG12 HG21 ' A' ' 85' ' ' THR . 47.2 mt -81.35 147.99 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.296 -0.877 . . . . 0.0 110.103 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -96.73 84.74 3.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.283 -0.886 . . . . 0.0 108.856 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 49.2 m-85 -64.14 143.84 57.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.438 -0.789 . . . . 0.0 109.851 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -88.27 101.56 13.98 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 30.6 t -91.17 132.19 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.579 -0.7 . . . . 0.0 110.777 -177.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.0 114.65 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -86.64 -29.1 22.78 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.959 -1.088 . . . . 0.0 110.907 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -139.77 162.33 51.4 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 120.963 -1.086 . . . . 0.0 109.766 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.34 145.56 27.14 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.857 2.371 . . . . 0.0 112.777 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 2.7 tt -154.31 149.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -139.33 143.49 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.0 109.37 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.4 m -125.5 149.29 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -135.13 164.72 27.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.4 -0.812 . . . . 0.0 109.859 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.598 ' CG ' HH21 ' A' ' 137' ' ' ARG . 57.6 t0 -173.87 111.77 0.18 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.183 -0.948 . . . . 0.0 109.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 58.18 9.54 1.02 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.619 -0.675 . . . . 0.0 109.865 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.18 -26.63 8.14 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.598 HH21 ' CG ' ' A' ' 134' ' ' ASP . 1.2 mpp_? -58.42 144.12 43.05 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.702 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.3 tt -148.94 139.51 22.6 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.093 -1.443 . . . . 0.0 111.03 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 63.5 mt -134.23 125.6 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -111.71 131.0 55.6 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.436 0.636 . . . . 0.0 109.838 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -120.97 132.37 54.88 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.5 154.02 52.26 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 120.995 -1.066 . . . . 0.0 109.959 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.3 139.76 43.93 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.742 2.295 . . . . 0.0 113.276 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.93 147.13 22.47 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -60.9 -37.54 82.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.928 . . . . 0.0 110.128 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.4 p -117.75 -171.55 2.08 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.409 -0.807 . . . . 0.0 110.051 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.7 tp -100.95 126.15 47.58 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -139.98 137.23 34.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.21 -0.931 . . . . 0.0 109.101 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.58 ' CG1' HD23 ' A' ' 231' ' ' LEU . 61.8 t -133.98 121.04 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.312 -0.867 . . . . 0.0 109.281 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 75.0 m -111.29 151.96 27.76 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.465 -0.772 . . . . 0.0 109.265 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.557 ' OH ' ' NZ ' ' A' ' 227' ' ' LYS . 34.0 t80 -140.75 130.94 24.88 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.041 -1.063 . . . . 0.0 111.181 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -121.83 131.66 54.17 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.83 141.33 12.29 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.552 -1.308 . . . . 0.0 111.583 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -103.89 100.81 10.61 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -88.28 167.3 13.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 110.274 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -100.94 -14.99 17.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.821 . . . . 0.0 110.774 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.563 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.4 p-10 -95.31 -173.56 2.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.784 -1.198 . . . . 0.0 110.587 -179.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.47 ' CE1' ' ND2' ' A' ' 157' ' ' ASN . 8.4 p90 -49.3 -0.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.812 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.563 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.6 mt -80.76 -28.63 36.38 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.31 -1.494 . . . . 0.0 108.803 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.12 -137.09 45.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -99.85 135.85 40.65 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.181 -1.188 . . . . 0.0 109.625 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -139.03 146.88 41.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.499 -0.75 . . . . 0.0 109.632 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 5.0 tttp -138.18 144.65 40.8 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.493 -0.755 . . . . 0.0 109.756 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -143.22 136.16 27.81 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.333 -0.854 . . . . 0.0 109.55 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 57.7 m -105.85 122.76 46.76 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.409 -0.807 . . . . 0.0 110.085 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.567 ' CD1' ' OD1' ' A' ' 170' ' ' ASN . 7.2 t80 -101.73 110.24 22.18 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.271 -0.893 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.684 ' H ' HD21 ' A' ' 170' ' ' ASN . 3.7 t -105.76 141.02 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 110.054 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 167' ' ' VAL . 9.8 mm-40 -44.06 131.58 5.82 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.23 -0.919 . . . . 0.0 108.819 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 114.85 -16.52 18.45 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.684 HD21 ' H ' ' A' ' 167' ' ' VAL . 1.9 p30 -115.16 29.36 8.07 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.074 -1.25 . . . . 0.0 109.916 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.414 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.5 pm0 -53.75 -38.32 64.26 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.07 -1.019 . . . . 0.0 109.806 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.3 -18.65 50.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.149 -0.969 . . . . 0.0 109.89 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -85.66 -7.57 58.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.092 -1.005 . . . . 0.0 111.179 -178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.73 -28.49 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.114 -0.991 . . . . 0.0 110.963 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 171' ' ' GLU . 15.8 m -63.5 -24.95 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.736 -1.227 . . . . 0.0 108.882 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.59 -4.72 58.11 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.511 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.13 120.17 13.9 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.374 -0.829 . . . . 0.0 109.262 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.479 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 82.3 mtm180 -83.4 172.47 12.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.247 -0.908 . . . . 0.0 109.484 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.501 HG21 ' CD1' ' A' ' 18' ' ' ILE . 5.9 t -79.14 161.48 26.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -147.85 145.45 28.71 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.234 -1.541 . . . . 0.0 111.859 -178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.539 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.49 157.43 44.45 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.5 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.5 m-85 -98.95 145.54 26.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.993 -1.067 . . . . 0.0 109.626 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.451 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -50.06 -35.79 26.58 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.344 -0.847 . . . . 0.0 109.864 -179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.7 p90 -72.8 -28.16 62.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.963 -1.086 . . . . 0.0 109.862 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.6 mm-40 -79.11 -40.62 30.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.119 -0.988 . . . . 0.0 110.085 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.53 HG21 HB11 ' A' ' 500' ' ' C90 . 77.5 mt -44.73 -55.48 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.095 -1.003 . . . . 0.0 109.807 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.443 ' C ' ' O ' ' A' ' 186' ' ' ILE . 19.3 tt0 -42.13 -41.73 2.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 0.0 109.703 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.671 ' O ' HG22 ' A' ' 192' ' ' VAL . 48.6 t60 -73.26 -55.55 6.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 88.5 mt -45.4 -26.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.368 -0.832 . . . . 0.0 109.407 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -85.75 -53.71 4.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.819 -1.176 . . . . 0.0 108.921 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 13.9 tttp -49.09 -26.77 2.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.283 -0.886 . . . . 0.0 110.0 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 188' ' ' HIS . 15.4 m -96.1 18.37 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 59.25 39.83 95.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 194' ' ' LEU . 62.4 mt -125.45 171.97 10.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -1.071 . . . . 0.0 109.448 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.37 22.49 51.28 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 10.9 mtpt -58.28 -22.79 54.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.7 -1.471 . . . . 0.0 109.534 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.42 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -110.28 25.56 15.52 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.33 125.01 7.61 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.416 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.9 OUTLIER -143.89 169.49 17.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -1.118 . . . . 0.0 109.847 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.554 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 55.8 mt -69.08 -8.74 48.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.5 -10.64 24.93 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.722 -0.611 . . . . 0.0 109.762 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.44 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 13.5 p30 -138.27 8.76 2.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.061 -1.024 . . . . 0.0 109.866 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.482 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -148.72 149.56 31.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.932 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.586 HD11 HD21 ' A' ' 206' ' ' LEU . 21.8 tp -97.95 93.65 6.44 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.437 HG23 HG22 ' A' ' 203' ' ' THR . 50.7 t -87.41 130.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.279 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.586 HD21 HD11 ' A' ' 204' ' ' LEU . 20.3 mt -123.35 163.05 21.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.528 -0.733 . . . . 0.0 109.164 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -120.52 -166.79 13.22 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.718 -1.753 . . . . 0.0 108.718 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -68.45 -25.74 65.15 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.261 -1.14 . . . . 0.0 109.665 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.16 21.47 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.134 -0.979 . . . . 0.0 110.778 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 21.5 mttp -150.1 157.92 43.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.411 -1.43 . . . . 0.0 110.68 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 90.3 t -104.01 113.94 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -57.38 -50.86 71.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.897 -1.127 . . . . 0.0 109.99 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.554 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.9 m120 -58.34 111.21 3.28 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.364 -0.835 . . . . 0.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -58.56 -16.47 30.15 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 121.747 1.631 . . . . 0.0 112.677 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -74.65 -15.7 60.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.901 -1.125 . . . . 0.0 109.923 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.4 -178.37 47.59 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.7 mt -84.31 151.41 24.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 109.735 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.411 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 0.5 OUTLIER -78.55 -18.97 53.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.187 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.411 ' CD1' ' O ' ' A' ' 218' ' ' ARG . 52.9 m-85 -144.72 -172.0 3.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.542 -0.724 . . . . 0.0 109.103 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -92.3 -5.08 53.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.114 -0.991 . . . . 0.0 109.587 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.6 43.28 1.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.196 -0.94 . . . . 0.0 109.828 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -54.82 -47.52 98.02 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 109.948 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 53.0 Cg_exo -50.82 -68.01 0.09 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.463 2.108 . . . . 0.0 112.079 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 228' ' ' VAL . 18.7 m -58.22 -36.3 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 57.7 mtt180 -60.88 -40.88 94.66 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.223 -0.923 . . . . 0.0 108.555 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.511 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 15.3 t60 -68.47 -32.19 72.01 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.253 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.557 ' NZ ' ' OH ' ' A' ' 151' ' ' TYR . 6.0 mmtp -66.04 -36.03 82.15 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.474 HG11 ' HB3' ' A' ' 166' ' ' PHE . 60.9 t -67.63 -37.49 78.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -64.03 -52.11 61.01 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 234' ' ' ASP . 87.4 m-20 -65.38 -27.01 68.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.681 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.58 HD23 ' CG1' ' A' ' 149' ' ' VAL . 59.2 tp -76.92 -32.77 57.6 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.084 -1.01 . . . . 0.0 108.588 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.85 -38.53 78.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -66.15 -54.36 24.57 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.079 -1.608 . . . . 0.0 109.079 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.561 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 0.9 OUTLIER -56.96 -35.43 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -1.137 . . . . 0.0 109.293 179.65 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.72 -24.83 67.07 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.562 -0.711 . . . . 0.0 110.512 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.2 t80 -74.98 -21.46 59.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.884 -1.135 . . . . 0.0 109.388 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.415 ' HA ' HD23 ' A' ' 237' ' ' LEU . 65.0 mt -48.54 -6.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.86 -1.15 . . . . 0.0 110.19 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 236' ' ' TYR . 6.8 mt -69.33 -13.03 62.16 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.945 -1.097 . . . . 0.0 109.85 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 93.85 2.92 64.44 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.958 -1.115 . . . . 0.0 110.715 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.74 149.87 11.02 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.872 -1.369 . . . . 0.0 108.904 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.401 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 6.9 Cg_endo -53.04 130.0 35.95 Favored 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 121.639 1.559 . . . . 0.0 110.076 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.88 150.11 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 112.216 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -130.64 123.37 29.28 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.82 -157.43 27.59 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.427 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.8 OUTLIER -129.35 137.03 50.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -1.042 . . . . 0.0 108.857 -179.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 14.0 m-85 -133.54 140.03 46.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 110.512 -178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -126.97 123.24 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.06 132.99 56.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.058 -1.026 . . . . 0.0 110.735 -178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -114.92 110.79 20.18 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 137' ' ' ARG . 56.6 mtp180 46.57 41.25 9.53 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.249 -0.907 . . . . 0.0 109.087 -179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -78.8 163.98 50.05 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.438 ' O ' ' CG ' ' A' ' 256' ' ' ASN . . . -131.76 -179.05 15.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.519 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 30.7 m-70 -65.15 -46.72 79.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -1.229 . . . . 0.0 110.034 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 255' ' ' LEU . 0.6 OUTLIER -53.45 -60.61 3.08 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.971 -1.081 . . . . 0.0 108.782 -179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.504 ' N ' ' OG ' ' A' ' 254' ' ' SER . 12.5 tp -47.76 -49.5 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.118 -0.989 . . . . 0.0 109.03 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 252' ' ' GLY . 25.8 m-20 -47.74 -49.5 28.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.988 -1.07 . . . . 0.0 109.098 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.945 HG21 HG21 ' A' ' 56' ' ' THR . 88.2 t -60.94 -44.29 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.473 -0.767 . . . . 0.0 109.755 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -59.4 -49.21 78.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.153 -0.967 . . . . 0.0 109.218 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 32.4 tp -54.19 -49.85 68.42 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.105 -0.997 . . . . 0.0 108.63 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.555 HG13 ' HG ' ' A' ' 238' ' ' LEU . 22.5 t -58.47 -57.43 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.003 179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -47.74 -45.33 28.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.133 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -62.48 -57.4 11.33 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.365 -0.834 . . . . 0.0 109.213 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.5 mt -48.4 -48.7 36.86 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.141 -0.975 . . . . 0.0 109.512 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -66.45 -27.58 67.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.903 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -69.81 -50.61 41.32 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -0.985 . . . . 0.0 109.859 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 266' ' ' LYS . 26.2 mmtt -64.08 -45.87 86.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.966 -1.084 . . . . 0.0 108.533 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -86.94 58.2 4.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.566 -0.709 . . . . 0.0 109.367 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 24.5 tttt -92.6 5.68 50.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.539 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 3' ' ' LEU . 96.3 mt -65.91 143.04 57.67 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -1.132 . . . . 0.0 109.643 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 119' ' ' ARG . 27.9 mt-10 -54.0 142.45 24.88 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -125.7 142.73 51.36 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.205 -0.934 . . . . 0.0 110.351 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -142.62 -168.55 2.78 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.1 m -103.22 141.19 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.005 -1.059 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -69.92 -26.03 63.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.0 109.982 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -145.44 161.79 38.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.974 -1.079 . . . . 0.0 110.161 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.34 139.18 55.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.49 -0.756 . . . . 0.0 109.842 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.07 161.27 20.11 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.2 p -131.96 141.66 49.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 110.73 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.44 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 91.9 m-85 -138.17 152.5 48.73 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -160.24 151.9 19.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.743 -1.223 . . . . 0.0 110.157 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.72 174.28 35.85 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -82.1 151.54 4.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.276 -1.132 . . . . 0.0 110.15 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.0 136.14 14.81 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' CG2' HD13 ' A' ' 98' ' ' ILE . 5.4 tt -56.55 -39.05 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -1.164 . . . . 0.0 110.397 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.456 ' N ' HG23 ' A' ' 18' ' ' ILE . 75.8 m-70 -92.35 -49.26 6.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.757 -1.214 . . . . 0.0 111.008 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -28.38 69.47 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.615 -0.678 . . . . 0.0 111.245 -178.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.87 17.63 55.14 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -112.7 155.12 25.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.48 -1.012 . . . . 0.0 109.325 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -73.28 135.2 44.41 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.31 -0.869 . . . . 0.0 109.421 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.1 m -138.11 144.34 40.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.784 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.18 154.38 25.61 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.42 -0.8 . . . . 0.0 110.027 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.671 HD11 HG23 ' A' ' 96' ' ' ILE . 7.7 mt -135.74 147.44 48.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 110.162 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.573 HG22 ' NE2' ' A' ' 29' ' ' HIS . 7.8 mt -143.87 109.43 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.302 -0.874 . . . . 0.0 109.011 178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.8 mt -94.4 115.15 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.449 -0.782 . . . . 0.0 110.575 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.573 ' NE2' HG22 ' A' ' 27' ' ' ILE . 34.2 m-70 -109.46 141.81 24.36 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.429 -0.794 . . . . 0.0 109.774 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.601 ' HG3' HG23 ' A' ' 7' ' ' VAL . 16.5 Cg_exo -55.79 168.89 1.49 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.824 1.683 . . . . 0.0 111.477 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' HG21 ' A' ' 35' ' ' THR . 70.7 mm-40 -141.74 175.44 9.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.053 -1.029 . . . . 0.0 109.93 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' O ' ' OG1' ' A' ' 35' ' ' THR . 13.8 mttt -82.37 152.09 26.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.87 145.13 3.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.398 -0.814 . . . . 0.0 110.132 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.4 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 70.19 5.06 52.59 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.107 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 31' ' ' GLU . 35.2 m -67.31 -44.37 79.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.526 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.811 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 97.36 -179.69 33.54 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.953 -1.118 . . . . 0.0 110.547 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.4 mm -96.29 116.58 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -143.02 148.84 37.41 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 118.69 -1.204 . . . . 0.0 110.873 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -96.82 156.94 16.13 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -129.3 109.38 11.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.236 -0.915 . . . . 0.0 108.934 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 tttp -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 110.81 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.3 m120 53.61 27.7 7.04 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 111.101 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.25 19.67 71.43 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 119.463 -1.351 . . . . 0.0 109.859 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.5 t -123.28 123.2 67.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -1.064 . . . . 0.0 109.229 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -85.87 127.46 34.59 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.04 -1.038 . . . . 0.0 109.287 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.0 mt -118.23 95.03 47.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.293 -0.879 . . . . 0.0 109.724 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -49.4 148.24 11.18 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.476 2.118 . . . . 0.0 112.179 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.674 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -87.59 78.38 8.55 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -0.903 . . . . 0.0 109.761 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.4 mtt180 -134.85 -179.94 5.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.993 -1.067 . . . . 0.0 109.371 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' A' ' 51' ' ' GLU . 2.4 p-80 -74.52 -54.76 6.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.986 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.598 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.4 OUTLIER -43.5 -17.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 110.845 -179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.533 ' N ' ' O ' ' A' ' 50' ' ' HIS . 67.2 m-85 -97.23 -0.52 46.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 109.655 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.94 122.36 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.4 -0.813 . . . . 0.0 108.831 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -100.3 -34.11 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -151.21 138.66 19.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.051 -1.031 . . . . 0.0 110.144 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.944 HG21 HG21 ' A' ' 257' ' ' VAL . 55.2 p -125.02 95.86 4.65 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 59' ' ' SER . 28.0 t-20 -162.53 129.5 3.66 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.54 ' O ' ' CB ' ' A' ' 59' ' ' SER . 89.4 m-70 49.43 9.57 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.091 -1.006 . . . . 0.0 108.969 -179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.561 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.5 OUTLIER 161.61 143.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.305 -0.872 . . . . 0.0 109.646 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.44 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 41.8 m -88.66 129.56 35.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.959 . . . . 0.0 109.011 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -123.16 152.34 41.27 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.288 -0.883 . . . . 0.0 111.164 -178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' A' ' 72' ' ' VAL . 5.0 mt -126.11 151.77 46.79 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.04 165.54 34.25 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.537 -1.316 . . . . 0.0 110.021 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -168.71 141.74 2.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -1.185 . . . . 0.0 108.806 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? 52.27 28.59 5.77 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.298 -0.876 . . . . 0.0 109.741 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.56 -33.63 5.72 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -57.64 148.75 23.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.006 -1.291 . . . . 0.0 109.343 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.28 139.99 26.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -0.944 . . . . 0.0 110.699 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.534 HD13 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -130.24 124.62 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -98.45 154.19 18.04 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.892 -1.13 . . . . 0.0 111.272 -178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.2 m 51.89 75.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.745 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.1 m -107.88 -9.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.138 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.5 pm0 -61.58 -27.96 69.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.517 -0.739 . . . . 0.0 110.559 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -65.08 -69.37 0.3 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.988 -1.07 . . . . 0.0 109.498 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.58 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.0 tp -51.57 -47.15 37.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.154 -0.966 . . . . 0.0 109.023 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.674 HD21 ' HB1' ' A' ' 48' ' ' ALA . 18.6 mt -52.12 -48.37 64.85 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.076 -1.015 . . . . 0.0 110.134 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.582 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 40.5 t -60.87 -42.77 98.56 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.104 -0.997 . . . . 0.0 110.324 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.5 t -57.45 -44.59 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.057 -1.027 . . . . 0.0 109.086 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.3 mt -67.05 -34.48 77.77 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -61.96 -40.43 95.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.201 -0.937 . . . . 0.0 109.343 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.722 HD13 ' HB2' ' A' ' 171' ' ' GLU . 55.8 mt -75.0 -37.9 61.74 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.389 -0.819 . . . . 0.0 109.718 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.23 0.82 34.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 109.543 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 54.41 42.25 31.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 0.0 110.139 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.6 mm -90.36 137.04 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.1 -1.0 . . . . 0.0 108.557 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 HG12 ' A' ' 121' ' ' ILE . 31.4 p -124.53 -19.01 5.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.191 -0.943 . . . . 0.0 112.018 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.811 HD22 ' H ' ' A' ' 36' ' ' GLY . 19.2 m120 -124.61 107.16 10.72 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.806 -1.184 . . . . 0.0 110.407 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.732 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.3 m -165.9 147.25 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.738 0.78 . . . . 0.0 109.913 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.459 ' HG1' ' CD ' ' A' ' 31' ' ' GLU . 53.3 m -114.03 110.97 20.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.7 mt -92.18 100.31 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.372 -0.83 . . . . 0.0 110.16 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -72.92 125.7 28.2 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG21 HD13 ' A' ' 69' ' ' ILE . 48.8 t -110.79 120.36 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 CA-C-O 121.762 0.791 . . . . 0.0 111.725 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.6 mt -107.52 96.53 4.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.84 -156.61 26.0 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -121.83 -10.55 8.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.213 -1.169 . . . . 0.0 110.443 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -140.33 148.86 41.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.0 -1.063 . . . . 0.0 109.973 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.671 HG23 HD11 ' A' ' 26' ' ' LEU . 43.7 mm -72.99 117.17 57.62 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.892 . . . . 0.0 108.804 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.402 ' C ' ' O ' ' A' ' 96' ' ' ILE . 75.3 Cg_exo -39.31 130.26 1.57 Allowed 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 121.586 1.524 . . . . 0.0 111.418 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.482 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.6 tp -86.21 -14.12 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.247 -0.908 . . . . 0.0 110.228 -179.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.5 mt 56.08 -117.47 1.11 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.952 . . . . 0.0 109.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 4.47 51.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.024 -1.047 . . . . 0.0 110.75 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.9 0.71 58.77 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.458 -1.353 . . . . 0.0 110.182 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.1 p -126.54 -172.82 2.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.558 -0.966 . . . . 0.0 109.526 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -121.7 15.99 9.01 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 108' ' ' GLU . 62.5 t-105 -59.67 -42.73 93.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -1.064 . . . . 0.0 110.299 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -63.55 -57.06 11.34 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.095 -1.003 . . . . 0.0 109.996 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' CE1' ' CG ' ' A' ' 13' ' ' PHE . 10.3 m-85 -51.33 -44.92 62.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.315 -0.865 . . . . 0.0 109.048 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.424 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 46.4 t80 -62.55 -52.51 63.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.726 -0.608 . . . . 0.0 110.931 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.406 ' HG3' ' CE2' ' A' ' 104' ' ' TRP . 3.8 mm-40 -60.71 -44.13 96.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.973 -1.08 . . . . 0.0 111.144 -178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.54 -59.85 3.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.088 -1.007 . . . . 0.0 110.51 -179.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 35.9 mt -59.25 -33.75 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.14 -0.975 . . . . 0.0 109.506 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 36.2 ttt180 -64.64 -41.81 95.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' C ' HD22 ' A' ' 113' ' ' ASN . 20.3 mmtt -75.86 11.97 1.23 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.159 -0.963 . . . . 0.0 110.024 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.454 HD22 ' C ' ' A' ' 112' ' ' LYS . 2.7 m-80 -142.84 35.68 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.941 -1.099 . . . . 0.0 110.284 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.3 mt -81.41 140.12 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.225 -0.922 . . . . 0.0 110.953 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.419 HD13 ' HB3' ' A' ' 8' ' ' LYS . 3.9 tp -132.21 126.94 34.73 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.15 146.03 33.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.212 -0.93 . . . . 0.0 110.434 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -117.02 -175.85 2.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 109.272 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -113.27 67.02 0.66 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.232 -0.917 . . . . 0.0 111.175 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 4' ' ' GLU . 7.6 ttt180 -164.89 128.31 2.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.897 -1.127 . . . . 0.0 109.529 179.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -68.24 142.77 55.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.89 -1.131 . . . . 0.0 109.99 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.528 HG12 HG21 ' A' ' 85' ' ' THR . 70.7 mt -85.95 150.79 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -95.94 83.46 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 108.794 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 44.1 m-85 -61.66 145.27 52.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 0.0 110.14 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -92.6 102.31 14.74 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 17.8 t -94.22 133.89 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 CA-C-O 121.384 0.611 . . . . 0.0 110.843 -177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 96.3 t -72.69 118.96 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -93.62 -28.31 16.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.979 -1.075 . . . . 0.0 110.736 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.15 154.54 80.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.48 151.68 47.95 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.684 2.256 . . . . 0.0 112.117 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.436 HG22 ' HB3' ' A' ' 141' ' ' ALA . 1.5 tt -160.23 154.21 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.595 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.1 mp -140.37 144.67 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.484 -0.76 . . . . 0.0 109.382 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.49 148.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -134.88 159.9 39.95 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.089 -1.007 . . . . 0.0 110.251 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -174.45 107.9 0.12 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 109.85 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 54.66 49.35 18.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.442 -0.786 . . . . 0.0 110.488 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.65 -29.36 3.7 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 -61.8 137.97 58.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -1.216 . . . . 0.0 108.116 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -146.71 139.38 25.13 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.691 -1.256 . . . . 0.0 110.223 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.587 ' CD1' HD23 ' A' ' 255' ' ' LEU . 96.7 mt -137.78 126.19 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.375 -0.828 . . . . 0.0 109.767 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -113.34 133.26 55.23 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.392 0.615 . . . . 0.0 109.999 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.436 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.11 136.2 54.89 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.81 150.73 40.3 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 109.819 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -47.61 141.88 14.57 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.693 2.262 . . . . 0.0 113.62 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.417 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -156.21 144.89 20.16 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -65.19 -20.51 66.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.972 . . . . 0.0 110.296 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 66.9 p -137.45 -174.13 3.67 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.198 -0.939 . . . . 0.0 109.64 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 14.8 tp -94.39 121.19 35.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.134 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -134.74 120.46 19.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 90.9 t -122.52 121.45 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.411 -0.805 . . . . 0.0 109.993 -179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 16.0 m -111.31 151.84 27.91 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.631 -0.668 . . . . 0.0 109.199 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -139.21 130.05 26.22 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.921 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -121.23 131.67 54.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -138.65 138.5 9.49 Favored Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.32 -1.419 . . . . 0.0 112.053 -178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.33 99.38 9.22 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -83.66 167.01 17.65 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 111.359 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -100.44 23.61 10.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.712 -0.617 . . . . 0.0 110.649 -178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.0 p-10 -140.08 -172.91 3.51 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.898 -1.126 . . . . 0.0 110.118 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -49.34 -2.96 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.395 -0.815 . . . . 0.0 111.417 -178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -77.94 -27.74 49.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.361 -1.462 . . . . 0.0 108.375 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.84 -135.1 43.14 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.151 -1.58 . . . . 0.0 109.151 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.93 133.25 44.57 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -1.204 . . . . 0.0 109.302 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -135.31 141.4 45.63 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 9.8 ptmt -136.8 144.11 43.53 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.012 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -144.91 137.06 25.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.239 -0.913 . . . . 0.0 109.813 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 96.3 m -105.5 123.55 48.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.488 -0.758 . . . . 0.0 109.701 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.489 ' HB3' HG11 ' A' ' 228' ' ' VAL . 10.2 t80 -103.56 109.0 20.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 109.984 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.8 t -100.76 149.56 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.325 -0.859 . . . . 0.0 109.665 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -50.07 131.39 23.2 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.167 -0.958 . . . . 0.0 109.02 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.23 -2.53 43.71 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -115.97 22.95 12.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.355 -1.085 . . . . 0.0 109.226 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.722 ' HB2' HD13 ' A' ' 81' ' ' LEU . 4.9 pt-20 -58.11 -47.24 83.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.376 -0.827 . . . . 0.0 109.726 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.425 ' N ' ' CG ' ' A' ' 171' ' ' GLU . 22.8 mt-10 -52.85 -6.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.483 -0.76 . . . . 0.0 110.258 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 171' ' ' GLU . 23.7 mt-10 -102.71 -6.94 22.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.048 -1.033 . . . . 0.0 110.952 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 9.1 pt -123.73 -26.46 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.996 -1.065 . . . . 0.0 110.849 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.1 m -63.65 -29.91 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.567 -1.333 . . . . 0.0 109.079 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.2 mt -77.39 -5.65 50.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.537 -0.727 . . . . 0.0 109.165 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.406 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -69.51 124.51 24.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.113 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.412 HH12 ' HG3' ' A' ' 215' ' ' GLU . 63.3 mtm180 -86.13 172.72 10.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.288 -0.882 . . . . 0.0 109.778 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.427 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -79.0 162.55 25.86 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -149.36 145.63 27.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.216 -1.552 . . . . 0.0 111.875 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.615 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.14 157.94 44.06 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.593 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 87.5 m-85 -98.61 142.11 30.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.047 -1.033 . . . . 0.0 109.652 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 2.9 t0 -49.22 -35.61 17.86 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.205 -0.935 . . . . 0.0 109.409 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.593 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.2 p90 -70.55 -26.16 63.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.023 -1.048 . . . . 0.0 109.553 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.459 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.2 OUTLIER -86.3 -27.3 24.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.758 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.793 HD11 HG22 ' A' ' 205' ' ' VAL . 31.5 mt -60.14 -43.81 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.999 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -53.6 -39.8 65.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.998 -1.064 . . . . 0.0 109.261 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -75.92 -56.22 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.439 -0.788 . . . . 0.0 109.252 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.411 HG22 ' O ' ' A' ' 194' ' ' LEU . 47.8 mt -44.74 -33.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.348 -0.845 . . . . 0.0 109.591 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -52.54 7.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.827 -1.171 . . . . 0.0 108.869 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -46.73 -48.33 20.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.424 -0.798 . . . . 0.0 110.455 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.6 m -74.24 7.66 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.002 -1.061 . . . . 0.0 110.409 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 74.52 37.85 45.69 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 194' ' ' LEU . 36.8 mt -126.07 169.5 12.71 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.192 -1.181 . . . . 0.0 109.402 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.3 25.38 57.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 33.8 mttt -61.76 -21.76 64.83 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.675 -1.486 . . . . 0.0 109.131 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.44 24.22 22.86 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.35 124.92 7.43 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.441 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.9 OUTLIER -138.64 163.38 32.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.238 -1.154 . . . . 0.0 109.539 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.447 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 13.8 mt -66.91 -8.6 30.49 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.59 -11.83 20.63 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.451 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.3 p30 -133.36 6.4 3.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.328 -0.857 . . . . 0.0 109.398 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.441 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -148.31 149.64 32.2 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.597 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.456 HD11 HD21 ' A' ' 206' ' ' LEU . 21.3 tp -98.63 95.89 7.58 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.793 HG22 HD11 ' A' ' 186' ' ' ILE . 62.8 t -86.23 127.83 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.717 0.77 . . . . 0.0 109.323 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 211' ' ' VAL . 28.1 mt -122.27 173.98 7.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.602 -0.686 . . . . 0.0 109.322 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -136.58 -166.39 10.84 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -30.79 70.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.48 -1.012 . . . . 0.0 109.455 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -157.85 25.22 0.27 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.271 -0.893 . . . . 0.0 110.471 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -144.21 150.75 38.48 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.922 -1.111 . . . . 0.0 110.677 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.518 HG22 HD22 ' A' ' 206' ' ' LEU . 51.3 t -103.75 112.31 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -58.89 -45.31 90.54 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.056 -1.027 . . . . 0.0 110.071 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 5.6 m120 -59.86 117.14 20.61 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -66.9 -15.3 46.7 Favored 'Trans proline' 0 N--CA 1.489 1.24 0 C-N-CA 121.391 1.394 . . . . 0.0 111.702 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.412 ' HG3' HH12 ' A' ' 178' ' ' ARG . 1.8 pm0 -76.08 -14.83 60.19 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.352 -0.842 . . . . 0.0 109.089 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 75.82 -176.39 51.02 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 217' ' ' LEU . 6.8 mt -86.72 140.95 29.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.231 -1.158 . . . . 0.0 109.671 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 219' ' ' TYR . 7.3 ttp180 -71.29 -18.08 62.43 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.67 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 57.1 m-85 -147.26 165.09 31.14 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.58 -12.69 60.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.976 -1.078 . . . . 0.0 109.355 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.433 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -131.9 43.63 3.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.6 tt0 -60.62 -46.39 97.21 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.164 -0.96 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.3 Cg_exo -51.37 -67.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.326 2.018 . . . . 0.0 112.295 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.416 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.5 m -58.74 -36.26 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.032 -1.042 . . . . 0.0 109.579 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.67 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 58.5 mtt180 -58.67 -42.08 87.61 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.406 ' HD1' ' C ' ' A' ' 177' ' ' ALA . 17.4 t60 -69.08 -30.94 69.36 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.404 -0.81 . . . . 0.0 109.302 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -65.77 -36.37 83.36 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.489 HG11 ' HB3' ' A' ' 166' ' ' PHE . 58.8 t -68.49 -39.25 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.582 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 57.6 t80 -62.82 -50.48 70.79 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 109.323 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -66.28 -29.4 69.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.372 -0.83 . . . . 0.0 110.057 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.42 -31.16 62.2 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.022 -1.049 . . . . 0.0 108.177 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 20.4 mt -69.56 -40.17 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.88 47.99 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 234' ' ' ASP . 1.5 m-20 -58.62 -40.81 84.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.055 -1.262 . . . . 0.0 109.146 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 235' ' ' LEU . 13.2 mt -55.09 -21.45 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.608 -0.683 . . . . 0.0 110.15 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.563 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.95 -22.19 60.75 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.962 -1.087 . . . . 0.0 108.73 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.31 -1.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.649 -1.282 . . . . 0.0 110.208 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.583 ' HG ' HG13 ' A' ' 260' ' ' VAL . 6.9 mt -76.21 -15.51 60.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.941 -1.099 . . . . 0.0 109.781 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 101.0 -1.21 55.06 Favored Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.937 -1.125 . . . . 0.0 110.622 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.48 156.74 9.21 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.875 -1.368 . . . . 0.0 108.671 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.422 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 1.8 Cg_endo -47.88 150.49 4.5 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.637 1.558 . . . . 0.0 109.461 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 44.1 t -108.68 144.92 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.074 -1.016 . . . . 0.0 111.935 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.78 120.34 30.32 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 158.65 -166.8 34.49 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.476 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 2.0 ttmt -126.34 139.25 53.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.405 -1.056 . . . . 0.0 108.934 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 4.8 m-85 -139.26 140.58 37.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.988 . . . . 0.0 110.546 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -124.88 124.81 42.86 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.3 m -116.43 136.39 53.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.085 -1.009 . . . . 0.0 111.314 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 250' ' ' ARG . 51.8 t80 -116.54 114.5 24.25 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 249' ' ' PHE . 5.1 mtp180 44.4 46.8 8.0 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.021 -1.05 . . . . 0.0 108.836 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -84.99 158.8 33.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.456 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -132.15 176.85 19.11 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.583 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 55.9 m-70 -58.89 -40.34 84.16 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.24 -1.153 . . . . 0.0 109.513 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 2.2 t -55.55 -59.53 4.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.833 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.587 HD23 ' CD1' ' A' ' 139' ' ' ILE . 5.3 tp -52.33 -47.26 66.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.425 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.2 m-20 -47.56 -49.87 25.37 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.093 -1.004 . . . . 0.0 109.321 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.944 HG21 HG21 ' A' ' 56' ' ' THR . 85.4 t -63.62 -51.23 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 109.805 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 13.4 ttmm -53.06 -51.56 61.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.027 -1.045 . . . . 0.0 109.312 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.515 HD22 HG21 ' A' ' 139' ' ' ILE . 39.7 tp -52.04 -50.2 61.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 108.525 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.583 HG13 ' HG ' ' A' ' 238' ' ' LEU . 41.7 t -57.65 -53.02 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.099 -1.001 . . . . 0.0 108.82 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -48.31 -47.06 36.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.742 . . . . 0.0 109.311 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.24 -51.43 60.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.322 -0.861 . . . . 0.0 109.813 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.06 -50.89 69.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 109.972 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.469 ' O ' ' O ' ' A' ' 268' ' ' LYS . . . -66.62 -29.46 69.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 110.083 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -59.06 3.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.0 109.88 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -64.63 -36.49 84.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.001 . . . . 0.0 109.771 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.16 -105.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -0.943 . . . . 0.0 109.257 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.469 ' O ' ' O ' ' A' ' 264' ' ' ALA . 2.6 tttm -106.41 128.11 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.128 -0.982 . . . . 0.0 109.591 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.288 -0.882 . . . . 0.0 109.585 179.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.615 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 20.8 mt -90.11 152.33 21.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.198 -1.178 . . . . 0.0 109.596 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 69.0 mt-10 -54.22 141.26 30.03 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.43 ' HG2' HG23 ' A' ' 114' ' ' ILE . 0.0 OUTLIER -125.28 143.57 50.89 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.37 -0.831 . . . . 0.0 109.76 -178.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.0 t -142.16 -168.61 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.597 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -102.4 139.32 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.175 -0.953 . . . . 0.0 109.556 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.1 ptmm? -66.91 -30.07 70.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 109.825 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -143.43 160.11 41.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.138 -0.976 . . . . 0.0 109.89 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.73 140.72 56.73 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.433 -0.792 . . . . 0.0 110.137 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 11' ' ' LEU . 21.0 mt -117.75 166.79 12.02 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.4 145.18 35.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.952 -1.092 . . . . 0.0 110.404 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' O ' ' N ' ' A' ' 26' ' ' LEU . 85.6 m-85 -142.17 158.83 43.29 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -163.32 151.13 13.24 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.953 -1.092 . . . . 0.0 109.492 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.99 175.24 36.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.2 p -81.85 153.26 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.366 -1.079 . . . . 0.0 110.266 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -90.21 140.72 15.6 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.459 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.5 tt -60.32 -38.23 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 110.862 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.433 ' N ' HG23 ' A' ' 18' ' ' ILE . 70.4 m-70 -90.8 -49.93 6.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.496 -1.378 . . . . 0.0 111.237 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 19.8 p -72.55 -20.44 61.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 0.0 111.233 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.43 15.6 12.17 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -105.5 154.27 20.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.315 -1.109 . . . . 0.0 109.909 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD1' ' C ' ' A' ' 23' ' ' TYR . 31.2 t80 -75.57 136.04 40.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -0.76 . . . . 0.0 109.557 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -138.52 145.55 40.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 0.0 109.906 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -108.7 154.67 21.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.636 -0.665 . . . . 0.0 109.61 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.537 HD22 ' CG2' ' A' ' 89' ' ' ILE . 10.1 mt -134.64 146.8 49.88 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.274 -0.891 . . . . 0.0 110.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.8 mt -143.72 111.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.298 -0.961 . . . . 0.0 108.808 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.87 115.04 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.189 -0.945 . . . . 0.0 110.668 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.564 ' NE2' HG22 ' A' ' 27' ' ' ILE . 25.5 m-70 -110.82 138.55 21.13 Favored Pre-proline 0 N--CA 1.496 1.83 0 O-C-N 121.441 -0.787 . . . . 0.0 109.669 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.597 ' HG3' HG23 ' A' ' 7' ' ' VAL . 37.9 Cg_exo -50.47 168.42 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.917 1.744 . . . . 0.0 111.627 179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HB3' HG21 ' A' ' 35' ' ' THR . 9.3 mm-40 -140.19 173.2 11.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.135 -0.978 . . . . 0.0 109.826 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.496 ' O ' ' OG1' ' A' ' 35' ' ' THR . 29.3 mmtt -83.04 150.95 26.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.358 -0.839 . . . . 0.0 109.584 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -49.11 146.67 3.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.396 -0.815 . . . . 0.0 109.937 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 67.14 6.68 40.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 21.3 m -71.78 -47.14 55.56 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.809 -1.407 . . . . 0.0 109.606 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.16 -174.76 24.41 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.798 -1.191 . . . . 0.0 110.771 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 87' ' ' VAL . 24.2 mm -102.33 118.34 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -139.54 151.91 46.48 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 118.906 -1.118 . . . . 0.0 110.574 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.81 158.09 16.22 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -130.4 113.82 14.8 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -135.14 133.16 38.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.343 -0.848 . . . . 0.0 110.472 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 42' ' ' ASN . 1.7 m-80 48.98 34.92 5.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.379 -0.825 . . . . 0.0 111.561 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.71 17.43 80.11 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.233 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.18 121.24 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.326 -1.102 . . . . 0.0 108.901 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 28.8 m-85 -86.76 128.01 35.01 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.025 -1.047 . . . . 0.0 109.913 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.436 HG23 ' HD2' ' A' ' 52' ' ' PHE . 13.4 mt -116.39 92.15 35.64 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.54 -0.725 . . . . 0.0 109.044 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.94 144.99 10.91 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.47 2.114 . . . . 0.0 112.308 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -79.87 63.65 4.48 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.213 -0.929 . . . . 0.0 108.995 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 49' ' ' ARG . 0.3 OUTLIER -114.29 169.88 8.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -75.14 -44.32 47.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.423 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 -16.37 0.38 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.384 -0.823 . . . . 0.0 110.811 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.436 ' HD2' HG23 ' A' ' 46' ' ' ILE . 24.5 m-85 -95.09 2.05 55.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.815 -1.178 . . . . 0.0 109.949 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.8 t -70.02 126.49 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 0.0 108.927 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.0 m -103.4 -30.82 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.253 -0.905 . . . . 0.0 109.888 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -154.83 141.56 19.0 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.048 -1.032 . . . . 0.0 109.94 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 HG21 ' A' ' 257' ' ' VAL . 66.0 p -128.56 95.72 4.2 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 59' ' ' SER . 0.2 OUTLIER -162.86 129.44 3.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 109.061 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.518 ' O ' ' CB ' ' A' ' 59' ' ' SER . 96.3 m-70 50.82 8.17 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.047 -1.033 . . . . 0.0 108.875 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.556 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.13 146.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.441 -0.787 . . . . 0.0 109.591 -179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.646 ' H ' ' CD ' ' A' ' 73' ' ' GLU . 33.8 m -91.44 126.95 36.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 109.026 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -121.59 149.85 42.55 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.712 0.768 . . . . 0.0 111.14 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' CG ' HG21 ' A' ' 72' ' ' VAL . 5.9 mt -125.54 149.13 48.58 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.55 151.52 21.43 Favored Glycine 0 N--CA 1.494 2.562 0 C-N-CA 118.767 -1.682 . . . . 0.0 110.892 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -158.36 149.46 20.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.5 -1.0 . . . . 0.0 109.231 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' O ' ' OE1' ' A' ' 67' ' ' GLN . 59.7 mttt 46.38 33.92 2.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.943 . . . . 0.0 109.781 -179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.76 -33.25 4.91 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.559 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -55.58 139.76 43.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -1.19 . . . . 0.0 108.886 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -139.94 135.14 32.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.116 -0.99 . . . . 0.0 110.517 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.408 HG23 HG11 ' A' ' 91' ' ' VAL . 51.1 mt -128.84 117.17 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.447 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 10.3 mtpp -97.27 155.42 16.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.896 -1.127 . . . . 0.0 111.118 -178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' THR . 66.1 m 52.62 72.75 0.39 Allowed 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.221 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.518 HG21 ' CG ' ' A' ' 62' ' ' LEU . 19.0 m -107.41 -10.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.646 ' CD ' ' H ' ' A' ' 60' ' ' THR . 2.5 pm0 -60.91 -31.47 70.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.442 -0.786 . . . . 0.0 110.323 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -61.87 -68.39 0.33 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.983 -1.073 . . . . 0.0 109.352 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.558 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.39 -48.29 45.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 109.314 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 48' ' ' ALA . 15.4 mt -51.15 -47.61 62.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.875 -1.141 . . . . 0.0 109.744 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.575 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 12.9 t -62.09 -43.31 99.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 110.224 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 106' ' ' PHE . 91.3 t -56.54 -45.94 82.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.98 -1.075 . . . . 0.0 108.937 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.1 mt -66.79 -34.67 78.34 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.328 -0.857 . . . . 0.0 108.916 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -63.21 -34.48 77.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 109.203 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.634 HD13 ' HB3' ' A' ' 171' ' ' GLU . 66.3 mt -79.42 -38.45 34.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.764 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.5 mt -80.13 3.1 21.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.253 -0.904 . . . . 0.0 109.64 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 55.51 40.19 31.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.313 -0.867 . . . . 0.0 110.1 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mm -90.26 134.39 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 108.696 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.609 HG21 HG12 ' A' ' 121' ' ' ILE . 26.5 p -120.96 -16.16 8.13 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.367 -0.833 . . . . 0.0 111.718 -178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -127.64 108.15 10.52 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.876 -1.14 . . . . 0.0 111.242 -178.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.3 m -165.36 150.7 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.356 -0.84 . . . . 0.0 110.404 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.461 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 35.7 m -118.67 109.67 16.4 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.537 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.1 mt -93.3 102.46 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.276 -0.89 . . . . 0.0 110.666 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 26' ' ' LEU . 12.1 mt-10 -71.42 124.49 24.72 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.408 HG11 HG23 ' A' ' 69' ' ' ILE . 13.7 t -108.66 113.95 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 CA-C-O 121.529 0.681 . . . . 0.0 110.709 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.7 mm -102.08 97.7 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.65 -156.31 25.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.31 -12.32 9.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.242 -1.152 . . . . 0.0 109.827 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -138.5 148.86 44.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.174 -0.954 . . . . 0.0 109.404 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mm -74.17 128.16 86.69 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.336 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -46.0 121.95 4.81 Favored 'Trans proline' 0 N--CA 1.489 1.211 0 C-N-CA 121.709 1.606 . . . . 0.0 111.39 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.466 HG21 HD22 ' A' ' 202' ' ' ASN . 2.4 tp -77.98 -14.83 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.0 110.562 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.3 mt 57.38 -120.92 1.38 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.22 -0.925 . . . . 0.0 110.275 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' ' 100' ' ' ASP . 15.7 t70 -95.05 9.0 41.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.983 -1.073 . . . . 0.0 111.117 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.3 64.64 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.376 -1.393 . . . . 0.0 110.148 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.17 -171.62 2.34 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.812 -0.817 . . . . 0.0 109.43 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -119.47 15.11 10.73 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.99 -42.63 85.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.342 -1.093 . . . . 0.0 110.665 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -61.47 -58.48 7.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.124 -0.985 . . . . 0.0 110.017 -179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' HB3' HG11 ' A' ' 78' ' ' VAL . 21.4 m-85 -51.05 -44.03 61.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.19 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 64.6 t80 -60.88 -50.91 71.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.563 -0.711 . . . . 0.0 110.933 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -65.33 -43.61 90.42 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.967 -1.083 . . . . 0.0 111.469 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.01 -59.52 3.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.958 -1.088 . . . . 0.0 110.277 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.1 mt -58.23 -36.17 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.685 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 71.6 ttt180 -63.27 -41.52 99.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.399 -0.813 . . . . 0.0 109.595 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtt -74.13 9.93 1.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.251 -0.906 . . . . 0.0 110.37 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -143.76 38.65 1.35 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.864 -1.148 . . . . 0.0 110.054 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.43 HG23 ' HG2' ' A' ' 5' ' ' LYS . 89.4 mt -88.08 141.72 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.097 -1.002 . . . . 0.0 111.585 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.5 tp -132.87 134.72 44.97 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 50.7 m-20 -85.4 150.31 24.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.255 -0.903 . . . . 0.0 109.931 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -115.98 -173.95 2.45 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.408 -0.808 . . . . 0.0 109.81 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.426 ' ND2' ' C ' ' A' ' 118' ' ' ASN . 0.9 OUTLIER -113.97 66.8 0.67 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.32 -0.863 . . . . 0.0 111.052 -178.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.6 128.61 2.52 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.051 -1.031 . . . . 0.0 109.291 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -66.05 139.18 58.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.732 -1.23 . . . . 0.0 109.572 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.609 HG12 HG21 ' A' ' 85' ' ' THR . 68.1 mt -82.62 149.31 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 110.008 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.8 81.38 3.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.68 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -60.28 143.53 52.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.441 -0.787 . . . . 0.0 109.672 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -89.36 101.33 14.0 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 45.7 t -93.39 135.05 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.367 0.603 . . . . 0.0 110.778 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.7 t -73.54 114.69 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -94.89 -28.43 15.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.978 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -129.58 150.18 74.97 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.374 -0.829 . . . . 0.0 109.496 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.84 149.59 37.73 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.478 2.119 . . . . 0.0 112.207 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 15.9 tt -156.95 150.94 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -0.954 . . . . 0.0 109.265 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.29 143.44 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.58 147.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -139.24 162.21 35.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -178.07 113.5 0.07 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.296 -0.878 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 54.58 47.38 22.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.512 -0.743 . . . . 0.0 110.717 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.27 -30.88 4.26 Favored Glycine 0 N--CA 1.49 2.288 0 C-N-CA 119.875 -1.155 . . . . 0.0 110.278 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -61.55 137.66 58.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.91 -1.347 . . . . 0.0 108.469 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.449 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -144.1 138.18 28.05 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.011 -1.056 . . . . 0.0 109.543 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.768 ' CD1' HD23 ' A' ' 255' ' ' LEU . 78.8 mt -138.85 127.3 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.312 -0.867 . . . . 0.0 110.067 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -117.09 132.01 56.78 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.454 0.645 . . . . 0.0 109.887 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -122.75 133.66 54.47 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.72 153.05 46.21 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 120.88 -1.138 . . . . 0.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -48.43 141.87 18.48 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.859 2.373 . . . . 0.0 113.836 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.403 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.2 OUTLIER -158.26 148.75 20.35 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -37.83 82.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.933 . . . . 0.0 110.501 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 49.4 p -124.91 -174.06 2.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.317 -0.864 . . . . 0.0 110.385 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 148' ' ' GLU . 9.5 tp -90.86 121.2 32.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.9 . . . . 0.0 109.065 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.476 ' CG ' HG22 ' A' ' 167' ' ' VAL . 3.7 tt0 -134.79 121.7 21.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.473 ' CG1' HD23 ' A' ' 231' ' ' LEU . 59.9 t -121.67 120.97 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 57.1 m -110.6 151.45 27.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.481 -0.762 . . . . 0.0 109.196 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -139.81 130.18 25.43 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.156 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -121.68 130.79 53.71 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.13 135.11 7.69 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 119.623 -1.275 . . . . 0.0 111.682 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 58.6 tt0 -101.91 102.34 12.89 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -86.18 166.95 15.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.229 -0.919 . . . . 0.0 111.141 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -103.96 23.36 13.03 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.771 -0.581 . . . . 0.0 110.294 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 159' ' ' LEU . 24.5 p-10 -138.81 -170.7 2.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.919 -1.113 . . . . 0.0 110.115 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -50.67 -4.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.834 . . . . 0.0 111.163 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.509 ' N ' ' O ' ' A' ' 157' ' ' ASN . 13.0 mt -78.51 -26.92 46.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.463 -1.398 . . . . 0.0 108.556 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.84 -139.54 32.31 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.0 ttp180 -99.71 134.76 42.13 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.749 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 -136.19 144.62 45.04 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.552 -0.717 . . . . 0.0 109.116 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.508 ' C ' ' CD ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -139.21 145.15 38.93 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.344 -0.848 . . . . 0.0 110.036 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 165' ' ' THR . 10.1 t80 -147.41 146.11 29.47 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.153 -0.967 . . . . 0.0 110.034 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.506 ' N ' ' CD1' ' A' ' 164' ' ' PHE . 92.1 m -113.53 125.39 54.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.391 -0.818 . . . . 0.0 110.582 -179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.434 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.1 t80 -105.01 118.95 37.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.371 -0.83 . . . . 0.0 109.997 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.476 HG22 ' CG ' ' A' ' 148' ' ' GLU . 65.0 t -109.84 150.5 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 109.827 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -50.69 134.26 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.364 -0.835 . . . . 0.0 109.55 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 103.35 -7.46 51.25 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -118.95 28.02 8.53 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.183 -1.187 . . . . 0.0 109.365 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.634 ' HB3' HD13 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -63.55 -15.4 57.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.438 -0.789 . . . . 0.0 110.647 -179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -73.46 -13.19 61.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.975 -1.078 . . . . 0.0 110.622 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -97.02 -6.07 36.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.834 -1.167 . . . . 0.0 111.51 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.7 pt -118.42 -30.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.149 -0.969 . . . . 0.0 110.426 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 171' ' ' GLU . 12.3 m -61.1 -20.71 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.772 -1.205 . . . . 0.0 108.683 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.6 mt -89.98 -3.35 58.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 0.0 108.969 179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.4 117.41 11.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.224 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.581 ' NE ' ' OE2' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -82.2 173.22 12.31 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.197 -0.94 . . . . 0.0 109.665 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 6.2 t -78.67 162.91 25.88 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -147.8 143.93 27.85 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.313 -1.492 . . . . 0.0 111.38 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.662 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.09 158.63 43.53 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.488 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 84.1 m-85 -101.03 146.07 27.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.079 -1.013 . . . . 0.0 109.584 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 184' ' ' TRP . 7.8 p30 -51.18 -37.7 48.04 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.227 -0.92 . . . . 0.0 110.102 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.488 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 7.1 p90 -67.87 -26.1 65.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.788 -1.195 . . . . 0.0 109.4 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.46 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 3.6 mm-40 -82.43 -25.5 33.59 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.943 . . . . 0.0 109.85 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.469 HD13 HB11 ' A' ' 500' ' ' C90 . 37.2 mt -58.22 -55.34 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.16 -0.963 . . . . 0.0 109.659 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -45.3 -39.59 6.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.085 -1.01 . . . . 0.0 109.743 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.443 ' O ' HG22 ' A' ' 192' ' ' VAL . 16.1 t-160 -76.49 -57.46 3.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.151 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 188' ' ' HIS . 84.3 mt -42.04 -32.12 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.409 -0.807 . . . . 0.0 109.46 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -82.13 -51.31 8.11 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.071 -1.018 . . . . 0.0 109.102 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -48.35 -45.07 34.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.89 . . . . 0.0 110.376 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 188' ' ' HIS . 30.6 m -76.95 8.21 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.039 -1.038 . . . . 0.0 110.558 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 71.76 39.74 59.41 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 194' ' ' LEU . 51.7 mt -126.43 170.79 11.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -1.107 . . . . 0.0 109.884 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 60.49 22.28 58.78 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -55.78 -21.6 20.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.641 -1.505 . . . . 0.0 110.231 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -108.5 3.63 32.72 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.55 124.86 34.14 Favored Glycine 0 N--CA 1.492 2.389 0 O-C-N 121.125 -1.221 . . . . 0.0 110.092 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 37.0 m -145.57 167.4 23.12 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.267 -1.137 . . . . 0.0 108.956 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.517 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.2 mt -69.94 -8.26 47.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.98 -1.075 . . . . 0.0 108.464 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -95.16 -10.67 29.86 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.912 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.516 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 12.2 p-10 -138.38 9.81 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.926 -1.109 . . . . 0.0 110.215 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.481 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.89 149.3 31.02 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.138 -0.976 . . . . 0.0 110.358 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 217' ' ' LEU . 12.6 tp -99.79 93.68 5.93 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 203' ' ' THR . 38.6 t -85.7 130.44 36.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 66.2 mt -123.05 168.53 12.24 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.735 -0.603 . . . . 0.0 109.812 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -129.39 -166.06 11.82 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -63.44 -21.08 66.09 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -1.107 . . . . 0.0 109.345 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -168.34 22.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.146 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -136.66 144.81 44.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.923 . . . . 0.0 110.286 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.5 t -100.42 110.25 27.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -59.76 -47.02 87.33 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.145 -0.972 . . . . 0.0 110.605 -178.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -62.5 121.28 66.18 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.995 -1.066 . . . . 0.0 109.733 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -67.65 -14.74 42.91 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 121.474 1.45 . . . . 0.0 112.016 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -76.2 -16.73 59.78 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.113 -0.992 . . . . 0.0 108.714 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.38 -169.97 54.88 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.829 -1.177 . . . . 0.0 110.247 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.618 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -88.98 136.3 33.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.455 -1.027 . . . . 0.0 110.117 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -69.03 -21.34 64.12 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 221' ' ' ASN . 70.8 m-85 -147.03 148.01 31.23 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.17 7.6 0.09 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.201 -0.937 . . . . 0.0 109.769 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.659 ' ND2' ' NE ' ' A' ' 225' ' ' ARG . 0.2 OUTLIER -148.34 37.05 0.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.157 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.581 ' OE2' ' NE ' ' A' ' 178' ' ' ARG . 1.1 tt0 -54.92 -47.08 99.26 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.218 -0.926 . . . . 0.0 109.682 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.95 -66.98 0.1 Allowed 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.435 2.09 . . . . 0.0 112.102 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.0 m -61.02 -37.12 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.136 -0.978 . . . . 0.0 109.969 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.659 ' NE ' ' ND2' ' A' ' 221' ' ' ASN . 56.9 mtt180 -60.95 -40.64 94.11 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.496 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 19.0 t60 -67.47 -32.05 72.62 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.696 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -65.87 -35.52 80.87 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.434 HG11 ' HB3' ' A' ' 166' ' ' PHE . 65.1 t -69.14 -37.57 76.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.575 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 49.8 t80 -64.51 -50.69 66.39 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.15 -28.74 69.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.383 -0.823 . . . . 0.0 109.656 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.473 HD23 ' CG1' ' A' ' 149' ' ' VAL . 42.9 tp -76.03 -33.66 59.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.22 -0.925 . . . . 0.0 108.732 179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.2 mt -68.34 -40.74 82.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -64.85 -52.88 38.16 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -59.23 -31.8 69.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -1.187 . . . . 0.0 109.314 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 235' ' ' LEU . 6.2 mt -68.86 -24.56 64.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.585 ' C ' ' H ' ' A' ' 238' ' ' LEU . 1.1 t80 -76.51 -21.79 55.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.918 -1.114 . . . . 0.0 109.394 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 19.2 mt -51.23 -0.88 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.793 -1.192 . . . . 0.0 110.606 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.585 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.6 mt -76.59 -11.92 59.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.931 -1.106 . . . . 0.0 109.955 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 97.32 0.6 59.59 Favored Glycine 0 N--CA 1.493 2.492 0 C-N-CA 119.836 -1.174 . . . . 0.0 110.724 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.56 152.67 13.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 120.928 -1.337 . . . . 0.0 108.859 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 130.17 39.13 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.869 1.712 . . . . 0.0 110.032 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.55 151.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 112.042 -177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 3.2 mttm -136.39 128.82 30.26 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.416 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 151.21 -156.78 26.86 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.453 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 0.4 OUTLIER -128.9 139.98 51.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.327 -1.102 . . . . 0.0 109.169 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 10.0 m-85 -139.04 140.04 37.99 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.104 -0.998 . . . . 0.0 110.329 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -125.56 123.09 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 17.8 m -118.28 136.55 53.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.182 -0.949 . . . . 0.0 111.303 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.428 ' O ' ' C ' ' A' ' 250' ' ' ARG . 47.8 t80 -117.32 117.27 29.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 249' ' ' PHE . 10.4 mtp180 45.02 42.49 6.44 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.158 -0.964 . . . . 0.0 108.562 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -80.08 153.09 35.48 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -132.13 178.89 17.64 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 86.2 m-70 -59.72 -40.09 86.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.426 -1.044 . . . . 0.0 109.77 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 83.4 p -59.48 -38.78 81.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.798 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.768 HD23 ' CD1' ' A' ' 139' ' ' ILE . 2.1 tp -76.15 -47.18 25.22 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.04 -1.038 . . . . 0.0 108.984 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 255' ' ' LEU . 9.0 m-20 -47.59 -44.5 26.44 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.987 -1.07 . . . . 0.0 108.457 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 56' ' ' THR . 72.1 t -66.71 -54.23 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.541 -0.724 . . . . 0.0 109.321 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.0 ttpt -49.59 -51.67 35.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.946 -1.096 . . . . 0.0 109.435 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.723 HD22 HG21 ' A' ' 139' ' ' ILE . 37.2 tp -53.37 -52.88 57.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 109.214 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.496 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.3 t -56.4 -54.74 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.034 -1.041 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.02 -52.63 14.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.339 -0.851 . . . . 0.0 109.403 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -58.96 -50.93 72.19 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.252 -0.905 . . . . 0.0 109.738 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 263' ' ' LEU . 18.1 mt -52.86 -49.87 64.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.198 -0.939 . . . . 0.0 109.755 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -67.29 -26.98 66.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -71.21 -47.81 55.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.169 -0.957 . . . . 0.0 109.97 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -34.94 53.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 109.91 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -83.63 56.35 3.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.6 pttt -102.95 12.55 35.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.395 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.458 -0.776 . . . . 0.0 109.355 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.662 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 12.8 mt -100.37 155.61 17.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.26 -1.141 . . . . 0.0 109.394 -179.841 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -55.13 138.62 44.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.15 -0.969 . . . . 0.0 108.777 179.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.25 143.43 49.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.377 -0.827 . . . . 0.0 110.048 -179.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t -141.23 -174.28 3.97 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.656 HG23 ' HG3' ' A' ' 30' ' ' PRO . 26.1 m -96.81 136.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.878 -1.139 . . . . 0.0 109.007 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.707 ' HZ2' ' C ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -67.34 -21.43 65.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.01 -1.056 . . . . 0.0 109.878 -179.422 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -151.52 156.91 41.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.63 179.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.79 141.91 58.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.379 -0.825 . . . . 0.0 110.297 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.9 mt -120.77 164.98 15.77 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.44 140.52 48.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 110.073 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.419 ' O ' ' N ' ' A' ' 26' ' ' LEU . 90.6 m-85 -136.92 148.36 46.95 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.28 150.23 25.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.923 -1.11 . . . . 0.0 109.943 -179.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 169.39 171.38 34.99 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.47 151.17 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.404 -1.056 . . . . 0.0 109.893 -179.578 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.15 137.85 15.94 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.456 ' CG2' HD13 ' A' ' 98' ' ' ILE . 7.0 tt -58.64 -38.52 71.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -1.222 . . . . 0.0 110.316 -179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.427 ' N ' HG23 ' A' ' 18' ' ' ILE . 69.5 m-70 -90.94 -50.26 5.97 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.701 -1.25 . . . . 0.0 110.804 -178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.3 p -66.93 -24.79 66.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.708 -0.62 . . . . 0.0 111.265 -178.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.17 18.97 29.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 -179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -112.69 155.45 24.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -1.059 . . . . 0.0 109.446 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -72.91 132.18 43.16 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 109.242 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.5 m -134.9 143.22 46.82 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.255 -0.903 . . . . 0.0 109.494 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.75 156.62 21.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.421 -0.8 . . . . 0.0 109.728 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.631 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -138.46 147.45 43.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.353 -0.842 . . . . 0.0 109.987 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.509 HG22 ' NE2' ' A' ' 29' ' ' HIS . 9.0 mt -141.75 113.34 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 9.2 mt -96.34 113.16 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.609 -178.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.509 ' NE2' HG22 ' A' ' 27' ' ' ILE . 18.0 m-70 -106.33 138.9 19.85 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.511 -0.743 . . . . 0.0 109.44 179.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.656 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.0 Cg_exo -55.29 168.12 1.55 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.652 1.568 . . . . 0.0 111.657 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.54 ' OE1' HG21 ' A' ' 35' ' ' THR . 37.0 mm-40 -142.31 171.5 13.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.172 -0.955 . . . . 0.0 109.369 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 4.0 mttp -83.58 155.82 23.06 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.295 -0.878 . . . . 0.0 109.437 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.73 150.38 4.02 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.768 ' N ' HD21 ' A' ' 86' ' ' ASN . . . 72.34 -7.63 8.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.296 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.681 ' H ' HD22 ' A' ' 86' ' ' ASN . 95.8 m -62.19 -46.26 89.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.602 -1.528 . . . . 0.0 109.773 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.86 -179.64 35.59 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.52 179.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.0 mm -96.34 115.48 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.78 151.29 46.95 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.226 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -100.54 158.27 16.05 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.59 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -129.26 108.94 10.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.245 -0.91 . . . . 0.0 108.602 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -135.27 135.55 40.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 -178.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 53.7 26.78 6.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.534 -0.729 . . . . 0.0 110.905 178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.49 17.0 78.53 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -122.19 122.47 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.443 -1.034 . . . . 0.0 108.706 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -82.48 128.0 33.85 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.108 -0.995 . . . . 0.0 109.637 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 79.6 mt -116.79 93.64 41.83 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 0.0 109.533 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -49.61 145.71 16.58 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.407 2.071 . . . . 0.0 111.905 179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.58 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -84.86 76.25 10.26 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.731 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -132.63 -179.66 5.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.438 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.532 ' O ' ' N ' ' A' ' 52' ' ' PHE . 1.9 p-80 -76.0 -55.67 5.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 110.008 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -43.75 -16.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.934 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 50' ' ' HIS . 59.8 m-85 -98.16 3.62 49.06 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.74 -1.225 . . . . 0.0 110.337 -179.437 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.78 138.13 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.227 -0.92 . . . . 0.0 108.607 179.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.92 -28.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.387 -0.821 . . . . 0.0 110.307 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -150.68 129.08 12.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.012 -1.055 . . . . 0.0 109.612 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.83 HG21 HG21 ' A' ' 257' ' ' VAL . 45.8 p -121.74 95.35 4.63 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.505 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.581 ' OD1' ' CD2' ' A' ' 58' ' ' HIS . 64.9 t-20 -163.09 129.82 3.43 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 108.935 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.581 ' CD2' ' OD1' ' A' ' 57' ' ' ASN . 99.7 m-70 52.01 7.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.059 -1.025 . . . . 0.0 108.883 -179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.539 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 161.54 144.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.505 -0.747 . . . . 0.0 109.689 179.99 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.412 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.9 m -85.42 129.1 34.89 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 0.0 109.177 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.8 m-20 -121.38 150.38 41.57 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.79 0.805 . . . . 0.0 110.814 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.473 ' HG ' HG21 ' A' ' 72' ' ' VAL . 7.2 mt -125.66 148.63 48.94 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.075 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.72 158.35 30.81 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.027 -1.559 . . . . 0.0 110.415 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -165.75 153.06 10.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.48 -1.012 . . . . 0.0 109.287 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt 51.29 21.3 1.11 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 109.363 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.78 -33.03 6.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.524 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 2.1 mm100 -58.99 148.23 31.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.167 -1.196 . . . . 0.0 109.15 -179.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -146.47 140.18 26.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 110.525 -179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 91' ' ' VAL . 13.5 mt -129.01 123.34 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.449 ' HZ2' ' HB3' ' A' ' 70' ' ' LYS . 12.6 mtpp -99.32 153.95 18.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.83 -1.169 . . . . 0.0 111.154 -178.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 28.7 m 50.82 75.42 0.19 Allowed 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.939 178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 HG21 ' HG ' ' A' ' 62' ' ' LEU . 14.2 m -107.82 -9.14 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.205 -0.934 . . . . 0.0 109.082 178.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 16.7 pm0 -60.86 -25.35 66.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.531 -0.731 . . . . 0.0 110.464 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.409 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -68.26 -69.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 0.0 109.36 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.7 tp -51.87 -47.34 40.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.018 -1.051 . . . . 0.0 109.07 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.58 HD21 ' HB1' ' A' ' 48' ' ' ALA . 19.9 mt -52.95 -49.27 66.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 -179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.8 t -59.96 -41.79 92.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.969 -1.082 . . . . 0.0 110.077 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 85.7 t -57.78 -46.26 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.081 -1.012 . . . . 0.0 109.174 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.88 -34.28 78.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 179.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.2 t-160 -63.29 -39.18 93.87 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 52.7 mt -77.2 -40.43 45.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -0.881 . . . . 0.0 109.788 -179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.536 HD22 HD11 ' A' ' 114' ' ' ILE . 64.8 mt -77.89 0.04 25.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.998 -1.064 . . . . 0.0 109.357 179.845 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 56.9 41.64 27.57 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.585 -0.697 . . . . 0.0 111.283 178.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.5 ' O ' ' OH ' ' A' ' 236' ' ' TYR . 17.2 mm -88.53 144.08 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.773 -1.205 . . . . 0.0 108.434 178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.699 HG21 HG12 ' A' ' 121' ' ' ILE . 43.9 p -126.98 -23.25 3.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.29 -0.881 . . . . 0.0 111.901 -178.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.768 HD21 ' N ' ' A' ' 34' ' ' GLY . 8.9 m120 -125.08 108.16 11.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.866 -1.147 . . . . 0.0 110.718 -179.002 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 86' ' ' ASN . 5.8 m -163.26 150.11 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.256 -0.903 . . . . 0.0 110.549 179.013 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.44 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 52.0 m -117.46 114.12 23.04 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.479 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -96.93 103.94 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 110.747 -178.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' HD23 ' A' ' 26' ' ' LEU . 40.7 mt-10 -74.41 124.68 26.98 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG21 HD13 ' A' ' 69' ' ' ILE . 13.4 t -110.16 120.7 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 CA-C-O 121.792 0.806 . . . . 0.0 111.23 -178.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.77 96.13 4.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.29 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 144.07 -158.67 27.5 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -119.37 -11.95 9.45 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -1.177 . . . . 0.0 110.169 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -140.15 148.26 41.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.017 -1.052 . . . . 0.0 109.726 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.631 HG23 HD11 ' A' ' 26' ' ' LEU . 42.5 mm -71.79 119.04 71.93 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 108.874 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -38.81 128.45 1.25 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.66 1.574 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.456 HD13 ' CG2' ' A' ' 18' ' ' ILE . 2.8 tp -82.05 -13.27 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.311 -0.868 . . . . 0.0 110.562 -179.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.4 mt 55.84 -121.92 1.72 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.196 -0.94 . . . . 0.0 110.159 -179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.71 7.61 44.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.046 -1.034 . . . . 0.0 111.246 -178.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.45 -10.87 61.41 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.435 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.93 -171.58 2.22 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.696 -0.885 . . . . 0.0 109.434 179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -118.25 13.59 12.4 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.522 ' HB2' HD22 ' A' ' 176' ' ' LEU . 44.1 t-105 -58.34 -42.22 86.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -1.01 . . . . 0.0 110.635 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.88 -56.05 23.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.041 -1.037 . . . . 0.0 109.849 -179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -51.47 -42.96 61.98 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.335 -0.853 . . . . 0.0 109.011 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.489 ' OH ' ' OE2' ' A' ' 171' ' ' GLU . 44.8 t80 -62.62 -53.48 54.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.581 -0.7 . . . . 0.0 110.558 -179.284 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -59.29 -44.52 92.49 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.081 -1.012 . . . . 0.0 111.193 -178.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.67 -59.82 3.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.051 -1.031 . . . . 0.0 110.402 -178.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mt -59.45 -33.34 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.033 -1.042 . . . . 0.0 109.52 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 30.8 ttt180 -64.03 -43.68 94.82 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.25 -0.906 . . . . 0.0 109.312 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -73.73 15.98 0.24 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.329 -0.857 . . . . 0.0 109.742 -179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.707 ' C ' ' HZ2' ' A' ' 8' ' ' LYS . 5.8 m-80 -149.25 34.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.904 -1.122 . . . . 0.0 110.941 -179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 HD22 ' A' ' 82' ' ' LEU . 65.8 mt -81.88 136.72 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.763 -1.211 . . . . 0.0 110.294 179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.587 HD13 ' HB3' ' A' ' 8' ' ' LYS . 7.3 tp -130.37 116.27 18.06 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.413 ' H ' HD22 ' A' ' 116' ' ' ASN . 0.6 OUTLIER -71.37 150.18 45.29 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.265 -0.897 . . . . 0.0 109.968 -179.613 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -114.84 -174.51 2.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.545 -0.722 . . . . 0.0 109.422 179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -107.67 67.85 0.7 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.162 -0.961 . . . . 0.0 111.118 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -168.52 135.25 1.94 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.022 -1.048 . . . . 0.0 109.776 179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -69.85 142.14 53.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.149 -0.969 . . . . 0.0 109.647 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 85' ' ' THR . 42.8 mt -83.14 148.26 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.883 . . . . 0.0 110.48 -179.535 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -98.16 87.14 3.85 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.404 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 47.9 m-85 -65.91 144.35 56.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.404 -0.81 . . . . 0.0 109.891 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -87.64 101.94 14.14 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 177.248 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 29.7 t -90.66 131.78 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.642 -0.661 . . . . 0.0 110.724 -177.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 83.8 t -68.93 113.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -85.52 -31.06 22.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.964 -1.085 . . . . 0.0 110.634 -178.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -136.74 156.84 75.89 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.072 -1.018 . . . . 0.0 109.796 -179.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.93 148.61 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.613 2.209 . . . . 0.0 112.149 179.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.412 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.0 tt -157.08 149.29 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 0.0 109.073 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.7 mp -138.65 142.77 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.355 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.11 149.64 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.559 ' OE2' HD12 ' A' ' 138' ' ' LEU . 48.8 mt-10 -134.53 161.55 34.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 0.0 109.655 -179.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.415 ' CB ' HD13 ' A' ' 255' ' ' LEU . 34.5 t0 -173.61 108.84 0.15 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.334 -0.854 . . . . 0.0 109.709 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 54.91 49.51 17.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.461 -0.774 . . . . 0.0 110.358 179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 84.68 -30.35 3.85 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.589 HH21 ' CA ' ' A' ' 252' ' ' GLY . 19.3 mtp85 -60.79 140.17 57.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.12 -1.224 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.559 HD12 ' OE2' ' A' ' 133' ' ' GLU . 1.2 tt -145.33 137.08 25.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.981 -1.074 . . . . 0.0 109.953 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.572 ' CD1' HD23 ' A' ' 255' ' ' LEU . 83.2 mt -136.66 128.83 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.308 -0.87 . . . . 0.0 109.662 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 11.9 ttpt -117.12 133.28 56.19 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.482 0.658 . . . . 0.0 110.263 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.412 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.08 135.64 54.48 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.585 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -149.05 149.46 29.91 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.055 -1.028 . . . . 0.0 109.932 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -48.23 143.8 14.06 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.507 2.138 . . . . 0.0 113.519 -179.631 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.93 148.6 19.08 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.42 -36.37 78.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.344 -0.848 . . . . 0.0 110.111 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.1 p -123.89 -165.39 1.34 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.324 -0.86 . . . . 0.0 109.67 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.425 ' H ' ' HG3' ' A' ' 168' ' ' GLU . 18.7 tp -103.46 124.54 48.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.941 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.694 ' HG3' HG22 ' A' ' 167' ' ' VAL . 33.6 tt0 -135.81 109.52 8.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.088 -1.007 . . . . 0.0 108.711 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 16.7 t -109.5 121.69 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.237 -0.914 . . . . 0.0 109.82 -179.314 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 96.0 m -112.82 152.03 29.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.473 -0.767 . . . . 0.0 109.631 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -139.85 130.47 25.74 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.959 179.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -120.56 131.37 54.64 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -136.01 136.96 8.76 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.57 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 155' ' ' PHE . 10.7 tm-20 -101.93 100.95 11.3 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.548 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.405 ' O ' ' OE2' ' A' ' 154' ' ' GLU . 79.9 m-85 -89.44 167.64 12.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 110.614 -178.621 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 -11.31 19.45 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.533 -0.73 . . . . 0.0 110.64 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 159' ' ' LEU . 46.5 p-10 -98.0 -166.54 1.39 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.845 -1.159 . . . . 0.0 110.445 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -55.67 0.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.488 -0.758 . . . . 0.0 111.654 -178.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.522 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 30.8 mt -82.49 -29.26 30.64 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.384 -1.447 . . . . 0.0 108.789 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 53.72 -135.22 42.51 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.5 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 5.5 ttm-85 -96.64 131.41 43.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -1.196 . . . . 0.0 109.559 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.522 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -134.33 141.31 46.86 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.43 143.69 41.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.433 -0.792 . . . . 0.0 109.815 -179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -143.26 135.92 27.51 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.269 -0.894 . . . . 0.0 109.822 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 6.7 m -105.34 122.56 46.21 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -103.68 112.74 25.81 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.306 -0.871 . . . . 0.0 110.139 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.694 HG22 ' HG3' ' A' ' 148' ' ' GLU . 30.0 t -105.13 152.73 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 147' ' ' LEU . 62.3 mt-10 -49.0 123.77 7.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.25 -0.906 . . . . 0.0 108.757 179.445 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 106.76 5.26 36.17 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.144 -1.582 . . . . 0.0 109.144 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -117.11 18.32 14.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.401 -1.058 . . . . 0.0 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.489 ' OE2' ' OH ' ' A' ' 107' ' ' TYR . 0.2 OUTLIER -52.75 -56.39 15.95 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.358 -0.838 . . . . 0.0 110.079 -179.66 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 171' ' ' GLU . 48.1 mt-10 -42.67 -24.31 0.06 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.198 -0.939 . . . . 0.0 109.979 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 171' ' ' GLU . 54.9 mt-10 -82.67 -11.38 58.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 111.77 -178.161 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 12.9 pt -124.21 -28.12 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.0 111.415 -178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.4 m -62.15 -29.34 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.427 -1.421 . . . . 0.0 108.942 179.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.522 HD22 ' HB2' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -78.31 -0.6 29.48 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.037 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.457 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -75.01 113.61 12.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.341 -0.849 . . . . 0.0 109.758 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.575 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -78.97 173.3 12.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.37 -0.831 . . . . 0.0 109.064 179.657 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.441 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.3 t -77.62 161.86 27.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -147.67 143.94 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.239 -1.538 . . . . 0.0 111.667 -178.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.526 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -143.03 157.49 44.49 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.446 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 83.8 m-85 -97.41 147.15 24.5 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.074 -1.016 . . . . 0.0 109.467 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -48.87 -36.38 16.9 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.327 -0.858 . . . . 0.0 109.683 -179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.52 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -74.85 -28.31 60.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.137 -0.977 . . . . 0.0 109.934 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 9.4 tt0 -77.26 -26.23 52.29 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.103 -0.998 . . . . 0.0 110.339 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.447 HG21 HB21 ' A' ' 500' ' ' C90 . 81.1 mt -60.43 -56.08 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.937 -1.102 . . . . 0.0 110.033 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 186' ' ' ILE . 2.6 tp10 -41.18 -41.17 1.75 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 110.144 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.689 ' O ' HG22 ' A' ' 192' ' ' VAL . 3.1 t-160 -73.56 -48.1 35.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.133 -0.979 . . . . 0.0 108.801 179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 87.1 mt -49.53 -28.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.408 -0.807 . . . . 0.0 109.197 179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.402 ' HZ1' ' HC2' ' A' ' 500' ' ' C90 . 4.2 mmtm -85.21 -52.73 5.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.916 -1.115 . . . . 0.0 109.281 179.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -46.98 -35.01 6.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 188' ' ' HIS . 20.7 m -88.54 17.29 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.149 -0.969 . . . . 0.0 110.363 -179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.485 ' O ' ' NZ ' ' A' ' 196' ' ' LYS . . . 60.26 40.4 97.33 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 194' ' ' LEU . 39.0 mt -125.74 170.76 11.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 61.04 21.94 59.8 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . 0.485 ' NZ ' ' O ' ' A' ' 193' ' ' GLY . 27.9 mttp -54.5 -20.65 8.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.598 -1.53 . . . . 0.0 109.385 -179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -115.83 26.04 9.14 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.01 125.31 7.71 Favored Glycine 0 N--CA 1.49 2.243 0 O-C-N 120.781 -1.423 . . . . 0.0 109.932 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.66 170.44 16.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 0.0 109.698 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.582 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 38.6 mt -68.68 -8.42 42.3 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 6.1 mmmt -96.46 -13.21 23.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.509 -0.744 . . . . 0.0 109.658 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 197' ' ' GLY . 20.2 p30 -135.1 7.96 3.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.091 -1.006 . . . . 0.0 109.852 -179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.438 HG22 HG23 ' A' ' 205' ' ' VAL . 1.1 m -148.5 149.99 32.62 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.086 -1.009 . . . . 0.0 110.017 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.526 HD11 HD21 ' A' ' 206' ' ' LEU . 20.6 tp -98.09 93.6 6.37 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.438 HG23 HG22 ' A' ' 203' ' ' THR . 52.7 t -87.06 129.9 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.64 0.733 . . . . 0.0 109.347 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.526 HD21 HD11 ' A' ' 204' ' ' LEU . 22.7 mt -122.35 170.55 9.82 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.503 -0.748 . . . . 0.0 109.507 -179.486 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.37 -166.36 11.78 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 179.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -63.98 -30.37 71.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.449 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.55 24.5 0.46 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 110.672 -179.058 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -145.95 153.2 40.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.257 . . . . 0.0 110.561 -179.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 47.1 t -103.19 112.23 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -55.99 -50.19 71.51 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.015 -1.053 . . . . 0.0 109.965 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.582 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.2 m120 -60.03 111.51 4.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.458 -0.776 . . . . 0.0 110.425 -179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -59.83 -13.95 24.9 Favored 'Trans proline' 0 N--CA 1.493 1.481 0 C-N-CA 121.732 1.621 . . . . 0.0 112.467 179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -76.31 -18.09 59.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.062 -1.024 . . . . 0.0 109.723 -179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 79.31 -179.08 53.27 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 120.02 -1.086 . . . . 0.0 110.438 179.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.539 HD23 ' N ' ' A' ' 217' ' ' LEU . 5.0 mt -85.65 149.28 25.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.365 -1.08 . . . . 0.0 109.852 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.44 -21.36 49.26 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -142.27 170.82 14.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 220' ' ' GLU . 2.7 pm0 -77.21 -12.33 59.93 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.142 -0.974 . . . . 0.0 109.329 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.526 ' OD1' ' NE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -135.1 44.16 2.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.49 -0.757 . . . . 0.0 109.176 179.999 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.548 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 0.7 OUTLIER -54.11 -46.91 98.59 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.944 -1.097 . . . . 0.0 109.41 179.857 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 51.4 Cg_exo -51.64 -67.2 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.386 2.057 . . . . 0.0 111.996 -179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.4 m -58.56 -35.57 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.937 -1.102 . . . . 0.0 109.567 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.526 ' NE ' ' OD1' ' A' ' 221' ' ' ASN . 59.6 mtt-85 -61.45 -40.15 93.43 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.575 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 14.3 t60 -68.02 -32.85 73.52 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.002 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 9.2 mmtm -65.47 -36.5 84.08 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 7.9 t -66.06 -39.14 83.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -63.23 -51.58 65.69 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.523 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 92.1 m-20 -63.83 -27.74 69.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.367 -0.833 . . . . 0.0 109.841 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 43.7 tp -78.31 -35.85 47.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.13 -0.981 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 41.9 mt -65.18 -38.61 83.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.83 -54.54 17.85 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.477 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 48.0 m-20 -55.59 -31.35 62.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.079 179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 235' ' ' LEU . 9.0 mt -65.55 -23.81 66.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.584 -0.697 . . . . 0.0 110.299 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.23 -21.94 61.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.762 -1.211 . . . . 0.0 108.865 -179.721 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 237' ' ' LEU . 92.0 mt -49.71 -3.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.623 -1.298 . . . . 0.0 110.381 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 236' ' ' TYR . 13.6 mt -78.37 -16.77 57.33 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.903 -1.123 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 99.18 2.92 56.82 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.789 -1.196 . . . . 0.0 111.08 178.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.43 153.31 8.61 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.62 -1.517 . . . . 0.0 109.429 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.404 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 8.7 Cg_endo -53.95 129.31 33.61 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.895 1.73 . . . . 0.0 109.938 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.1 t -88.74 153.08 3.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.121 0.962 . . . . 0.0 112.295 -177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -133.34 125.82 30.02 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 154.32 -154.82 25.77 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.6 133.12 43.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -1.152 . . . . 0.0 108.873 -179.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 12.2 m-85 -131.46 138.12 48.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.232 -0.918 . . . . 0.0 110.026 -179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -124.47 128.1 48.47 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 13.8 t -122.72 135.07 54.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.063 . . . . 0.0 111.364 -178.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -115.61 116.23 27.78 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 46.15 28.61 0.68 Allowed 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.93 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -59.82 154.5 31.68 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.589 ' CA ' HH21 ' A' ' 137' ' ' ARG . . . -130.48 172.51 20.36 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.477 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 35.9 m-70 -59.13 -40.68 86.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.24 . . . . 0.0 109.547 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.5 t -56.43 -59.28 5.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.007 -1.058 . . . . 0.0 108.958 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.572 HD23 ' CD1' ' A' ' 139' ' ' ILE . 10.0 tp -51.34 -47.3 62.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 0.0 109.207 179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 5.6 m-20 -48.26 -51.01 27.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.147 -0.97 . . . . 0.0 109.534 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.83 HG21 HG21 ' A' ' 56' ' ' THR . 89.9 t -61.58 -54.17 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -51.27 -50.01 60.08 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -0.964 . . . . 0.0 109.061 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.571 HD22 HG21 ' A' ' 139' ' ' ILE . 50.4 tp -51.8 -50.16 61.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.009 . . . . 0.0 108.649 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.544 HG13 ' HG ' ' A' ' 238' ' ' LEU . 77.4 t -59.12 -53.81 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.19 -0.944 . . . . 0.0 109.182 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 28.2 mttt -49.35 -43.18 43.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.436 -0.79 . . . . 0.0 109.543 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -65.59 -50.64 64.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.257 -0.902 . . . . 0.0 109.67 179.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 17.4 mt -57.77 -45.72 85.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.821 -179.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -72.49 -31.01 65.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 110.31 -179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 6.3 mmtp -69.87 -58.95 3.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.2 -0.937 . . . . 0.0 110.222 -179.237 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.01 -41.83 97.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.916 -179.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -46.2 -27.32 0.96 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.404 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -95.23 152.32 18.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.166 -0.959 . . . . 0.0 109.479 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.429 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.526 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.594 ' O ' ' NZ ' ' A' ' 5' ' ' LYS . 19.7 mt -85.31 149.43 25.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.294 -1.121 . . . . 0.0 109.757 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 70.8 mt-10 -54.89 136.74 46.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.035 -1.041 . . . . 0.0 108.542 179.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -120.19 142.42 49.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.456 -0.778 . . . . 0.0 109.572 -179.139 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.1 t -143.28 -168.4 2.8 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 30' ' ' PRO . 27.0 m -103.81 139.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.988 -1.07 . . . . 0.0 109.4 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' HD13 ' A' ' 115' ' ' LEU . 1.2 ptpm? -67.46 -23.68 65.53 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 109.894 -179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CG ' ' OD1' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -150.02 158.38 44.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.013 . . . . 0.0 109.833 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.07 141.51 58.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.825 . . . . 0.0 110.448 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.4 mt -118.43 168.6 10.49 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -139.63 144.79 37.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.965 -1.085 . . . . 0.0 110.674 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.428 ' CG ' ' CE1' ' A' ' 106' ' ' PHE . 77.8 m-85 -139.77 156.44 46.76 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -163.35 152.3 14.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.852 -1.155 . . . . 0.0 110.086 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.95 174.94 35.93 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.3 p -82.18 152.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.326 -1.102 . . . . 0.0 110.155 -179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 139.07 15.87 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 179.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.47 HG23 ' N ' ' A' ' 19' ' ' HIS . 7.2 tt -57.75 -40.03 73.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -1.173 . . . . 0.0 110.354 -179.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.47 ' N ' HG23 ' A' ' 18' ' ' ILE . 81.8 m-70 -89.37 -49.2 6.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.713 -1.242 . . . . 0.0 111.181 -178.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -69.92 -23.85 63.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.547 -0.721 . . . . 0.0 111.692 -177.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 57.68 11.47 7.9 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.17 -1.49 . . . . 0.0 109.517 -179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -104.29 155.32 18.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.223 -1.163 . . . . 0.0 109.36 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.68 136.49 40.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.349 -0.845 . . . . 0.0 109.67 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.0 m -137.07 142.73 42.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.142 -0.974 . . . . 0.0 109.562 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -109.32 151.27 26.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.818 . . . . 0.0 109.547 -179.498 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HG23 ' A' ' 96' ' ' ILE . 8.3 mt -132.71 147.59 52.33 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.283 -0.885 . . . . 0.0 109.996 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -143.12 110.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 108.755 178.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 6.1 mt -96.35 116.21 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.164 -0.96 . . . . 0.0 110.721 -178.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.537 ' NE2' HG22 ' A' ' 27' ' ' ILE . 67.7 m-70 -110.64 141.55 24.29 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.537 -0.727 . . . . 0.0 109.781 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG3' HG23 ' A' ' 7' ' ' VAL . 19.5 Cg_exo -53.97 168.67 0.79 Allowed 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.868 1.712 . . . . 0.0 111.479 179.081 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HB3' HG21 ' A' ' 35' ' ' THR . 14.3 mm-40 -140.1 176.27 8.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.185 -0.947 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.499 ' O ' ' OG1' ' A' ' 35' ' ' THR . 30.2 mttp -84.76 151.02 24.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.416 -0.802 . . . . 0.0 109.957 -179.522 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -45.94 143.88 2.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.075 -179.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.543 ' H ' ' CD ' ' A' ' 4' ' ' GLU . . . 68.1 9.39 57.01 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.305 -0.95 . . . . 0.0 110.99 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 31' ' ' GLU . 22.9 m -71.31 -44.95 64.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.563 -1.551 . . . . 0.0 109.502 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.99 -176.2 29.26 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.545 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mm -99.69 117.25 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' NH2' ' CE2' ' A' ' 45' ' ' TYR . 13.3 ptt180 -142.47 155.72 45.1 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.836 -179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -103.84 157.45 17.08 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -128.35 110.94 12.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.412 -0.805 . . . . 0.0 108.996 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.0 tttm -135.11 133.83 39.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.356 -0.84 . . . . 0.0 110.651 -179.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 52.43 26.84 4.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.535 -0.728 . . . . 0.0 111.238 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.19 19.69 66.41 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.038 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.3 t -122.5 123.88 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.359 -1.083 . . . . 0.0 109.096 179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.477 ' CE2' ' NH2' ' A' ' 38' ' ' ARG . 16.3 m-85 -88.31 128.81 35.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.174 -0.954 . . . . 0.0 109.797 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.4 mt -119.43 112.97 35.34 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HG2' ' CE1' ' A' ' 52' ' ' PHE . 36.6 Cg_endo -71.86 155.96 57.3 Favored 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.81 1.673 . . . . 0.0 112.322 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.91 63.68 7.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.58 -179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.3 mtt85 -116.84 169.2 9.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 0.0 109.461 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.464 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.3 p-80 -74.04 -49.89 22.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.517 -179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -45.93 -16.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.843 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' HIS . 55.7 m-85 -97.85 3.93 49.76 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.872 -1.143 . . . . 0.0 110.107 -179.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -73.7 126.2 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.9 m -105.29 -30.35 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.251 -0.906 . . . . 0.0 110.233 -179.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -151.34 131.3 13.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.061 -1.024 . . . . 0.0 110.112 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.907 HG21 HG21 ' A' ' 257' ' ' VAL . 56.7 p -120.52 95.09 4.59 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.161 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.526 ' C ' ' H ' ' A' ' 59' ' ' SER . 35.3 t30 -163.36 130.17 3.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.297 -0.877 . . . . 0.0 109.139 -179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.544 ' O ' ' CB ' ' A' ' 59' ' ' SER . 76.8 m-70 51.66 7.3 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.1 -1.0 . . . . 0.0 109.266 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' A' ' 58' ' ' HIS . 0.3 OUTLIER 161.03 140.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 179.858 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 72' ' ' VAL . 27.2 m -80.42 127.36 32.31 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.291 -0.881 . . . . 0.0 109.197 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -120.77 147.73 44.94 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.861 0.839 . . . . 0.0 111.113 -178.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' A' ' 72' ' ' VAL . 10.7 mt -120.95 148.21 44.4 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.44 153.83 24.78 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.146 -1.502 . . . . 0.0 110.252 -179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -164.75 150.12 9.88 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.359 -1.083 . . . . 0.0 109.285 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.3 mttt 51.63 23.9 2.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.46 -33.04 6.32 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -60.49 148.36 37.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.041 -1.27 . . . . 0.0 109.565 -179.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -144.12 139.79 29.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.57 -179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 63.1 mt -129.65 122.69 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.5 mtpp -97.95 155.8 16.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.898 -1.126 . . . . 0.0 111.22 -178.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 m 49.12 75.34 0.15 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.094 0.473 . . . . 0.0 110.747 178.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG21 ' CD1' ' A' ' 62' ' ' LEU . 16.5 m -107.78 -8.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.268 -0.895 . . . . 0.0 109.006 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 7.6 pm0 -60.84 -27.25 67.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.341 -0.849 . . . . 0.0 110.67 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.423 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 26.9 m170 -65.78 -69.03 0.32 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.907 -1.12 . . . . 0.0 109.281 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.09 -47.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.403 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.568 ' N ' HG23 ' A' ' 75' ' ' ILE . 82.0 mt -51.59 -49.27 62.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.98 -1.075 . . . . 0.0 110.157 -179.577 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.49 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 19.5 t -60.99 -42.87 99.24 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.03 -1.044 . . . . 0.0 110.382 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 106' ' ' PHE . 99.2 t -55.89 -47.54 79.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.127 -0.983 . . . . 0.0 109.272 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.96 -34.59 78.46 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 109.35 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 -62.3 -34.95 77.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.418 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.5 mt -80.83 -38.01 29.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 110.045 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.6 mt -79.27 5.58 12.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.026 -1.046 . . . . 0.0 109.581 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 53.87 39.14 30.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.42 -0.8 . . . . 0.0 109.944 179.551 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.4 mm -89.79 134.48 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 108.716 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 46.8 p -123.39 -18.68 6.15 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.259 -0.901 . . . . 0.0 111.686 -178.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.746 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.1 m120 -124.09 106.9 10.72 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.868 -1.145 . . . . 0.0 110.351 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 86' ' ' ASN . 3.9 m -166.41 147.54 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.666 0.746 . . . . 0.0 110.056 179.036 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.441 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 22.2 m -115.76 110.2 18.75 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.433 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.3 mt -91.29 100.33 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 110.028 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' OE2' HD12 ' A' ' 27' ' ' ILE . 2.1 tt0 -75.0 128.58 35.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.098 -1.001 . . . . 0.0 108.417 179.143 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.8 t -108.1 128.67 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.06 0.933 . . . . 0.0 111.927 -178.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 31.2 mm -109.66 96.71 4.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.27 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 136.28 -153.15 21.41 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.994 -1.642 . . . . 0.0 108.994 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.88 -9.27 8.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -1.087 . . . . 0.0 110.072 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -139.93 148.31 41.79 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.042 -1.036 . . . . 0.0 109.727 -179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.677 HG23 HD11 ' A' ' 26' ' ' LEU . 45.9 mm -73.48 120.02 78.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.249 -0.907 . . . . 0.0 108.772 179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -40.0 125.25 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.237 0 C-N-CA 121.515 1.477 . . . . 0.0 111.105 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.51 HG21 HD22 ' A' ' 202' ' ' ASN . 2.5 tp -78.16 -11.47 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.076 -1.015 . . . . 0.0 110.1 -179.099 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 76.3 mt 54.34 -119.73 1.52 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -99.21 7.8 45.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.15 -0.969 . . . . 0.0 110.774 -178.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.83 -0.63 64.93 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.411 -1.376 . . . . 0.0 109.765 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.72 -172.66 2.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.801 -0.823 . . . . 0.0 109.315 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -123.4 16.08 8.05 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 57.8 t-105 -59.56 -42.86 93.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -1.086 . . . . 0.0 110.073 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -62.74 -56.88 13.6 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.113 -0.992 . . . . 0.0 109.544 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB3' HG11 ' A' ' 78' ' ' VAL . 9.9 m-85 -51.67 -44.54 63.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.344 -0.847 . . . . 0.0 109.108 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.422 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 72.1 t80 -61.72 -50.63 71.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.577 -0.702 . . . . 0.0 110.916 -179.063 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -64.59 -43.0 95.23 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.091 -1.006 . . . . 0.0 111.24 -178.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.77 -55.68 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.079 -1.013 . . . . 0.0 110.735 -178.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.11 -30.82 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.422 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 51.5 ttt180 -66.76 -43.43 84.1 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.352 -0.842 . . . . 0.0 110.52 -179.141 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -75.72 11.61 1.3 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.995 -1.066 . . . . 0.0 110.196 -179.145 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.471 ' OD1' ' CG ' ' A' ' 9' ' ' GLU . 2.6 m-80 -142.75 35.01 1.41 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.992 -1.068 . . . . 0.0 110.198 -179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 83.7 mt -83.02 142.7 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.949 -1.094 . . . . 0.0 111.186 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 8' ' ' LYS . 6.2 tp -132.98 129.39 38.15 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -83.79 149.07 26.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.066 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -116.47 -174.58 2.59 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.4 -0.813 . . . . 0.0 109.37 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -113.15 68.3 0.68 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.35 -0.844 . . . . 0.0 110.807 -178.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -163.73 129.82 3.14 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.991 -1.068 . . . . 0.0 109.298 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -67.82 138.94 56.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.844 -1.16 . . . . 0.0 109.685 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 96.5 mt -83.37 148.91 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.36 -0.837 . . . . 0.0 110.191 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -94.15 79.53 4.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.42 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 42.5 m-85 -59.92 142.76 53.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.524 ' CE2' ' OE1' ' A' ' 267' ' ' GLN . 38.1 t80 -88.87 101.93 14.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 177.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.35 133.31 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.71 -0.619 . . . . 0.0 110.561 -177.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.1 t -70.6 114.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' CD ' ' H ' ' A' ' 127' ' ' GLU . 1.5 mp0 -82.42 -29.98 30.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.044 -1.035 . . . . 0.0 110.695 -178.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -141.4 172.99 5.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.001 -1.062 . . . . 0.0 109.754 -179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -83.55 149.47 12.92 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.846 2.364 . . . . 0.0 112.848 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.539 HD12 ' NZ ' ' A' ' 266' ' ' LYS . 11.3 tt -157.0 152.43 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -0.769 . . . . 0.0 109.23 179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.79 140.56 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.397 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.4 m -124.98 147.59 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 178.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' O ' ' NZ ' ' A' ' 258' ' ' LYS . 3.5 mp0 -136.54 160.99 37.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.014 -1.054 . . . . 0.0 110.523 -178.793 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -174.13 105.48 0.11 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.367 -0.833 . . . . 0.0 109.741 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 50.09 57.7 6.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.496 -0.752 . . . . 0.0 110.676 179.315 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.9 2.83 Favored Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.866 -1.159 . . . . 0.0 110.402 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.604 ' NH2' ' H ' ' A' ' 255' ' ' LEU . 46.5 mtp180 -61.96 130.85 47.53 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.023 -1.281 . . . . 0.0 108.219 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.75 HD23 ' C ' ' A' ' 138' ' ' LEU . 3.2 tt -143.12 137.15 28.91 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.929 -1.107 . . . . 0.0 109.984 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.697 ' CD1' HD23 ' A' ' 255' ' ' LEU . 71.2 mt -134.44 127.21 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.499 -0.751 . . . . 0.0 109.418 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -115.91 131.46 56.93 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.514 0.673 . . . . 0.0 109.926 -179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -118.98 136.07 54.29 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -146.58 149.28 36.52 Favored Pre-proline 0 C--N 1.303 -1.437 0 O-C-N 121.015 -1.053 . . . . 0.0 109.874 -179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.41 141.42 51.01 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 122.426 2.084 . . . . 0.0 113.187 -179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.41 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.3 OUTLIER -154.84 147.46 24.23 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.4 -3.91 7.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.299 -0.876 . . . . 0.0 110.619 -178.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.1 p -150.84 -175.61 5.2 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.872 -1.143 . . . . 0.0 109.51 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.447 ' HA ' ' H ' ' A' ' 244' ' ' GLY . 17.2 tp -96.4 122.63 39.5 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.064 -1.022 . . . . 0.0 108.875 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HG3' HG13 ' A' ' 167' ' ' VAL . 1.5 mt-10 -137.13 127.14 25.92 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.331 -0.856 . . . . 0.0 108.768 -179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 65.7 t -126.89 120.68 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 0.0 109.435 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.488 ' OG1' HG23 ' A' ' 165' ' ' THR . 46.5 m -112.15 152.11 28.72 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.583 -0.698 . . . . 0.0 109.279 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -139.69 130.71 26.33 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.155 -1.018 . . . . 0.0 110.933 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -122.38 132.86 54.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.075 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.37 141.18 12.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.802 -178.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.41 ' O ' ' NH1' ' A' ' 250' ' ' ARG . 5.6 tt0 -105.54 100.1 9.68 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -86.31 167.0 15.19 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 110.574 -178.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 15.2 mtmt -102.5 5.08 39.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.519 -0.738 . . . . 0.0 110.91 -178.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.595 ' O ' ' N ' ' A' ' 159' ' ' LEU . 28.8 p-10 -119.46 -171.0 2.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.062 -1.024 . . . . 0.0 110.424 -179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -47.8 -3.17 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.465 -0.772 . . . . 0.0 111.553 -178.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.595 ' N ' ' O ' ' A' ' 157' ' ' ASN . 11.3 mt -80.24 -29.11 38.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.359 -1.463 . . . . 0.0 109.073 179.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 52.95 -139.02 33.72 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -97.23 131.79 43.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.218 -1.166 . . . . 0.0 109.637 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -138.01 147.69 44.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -0.87 . . . . 0.0 109.456 179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.5 146.15 36.05 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 110.077 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -143.83 137.9 28.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.139 -0.976 . . . . 0.0 109.79 179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.488 HG23 ' OG1' ' A' ' 150' ' ' THR . 25.4 m -107.18 123.34 48.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.408 -0.807 . . . . 0.0 110.224 -179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.486 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.3 t80 -102.69 109.64 21.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.33 -0.856 . . . . 0.0 110.234 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.487 HG13 ' HG3' ' A' ' 148' ' ' GLU . 2.8 t -102.14 154.03 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.05 126.79 19.54 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.71 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 104.83 2.49 42.78 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -115.37 20.58 14.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.24 -1.153 . . . . 0.0 109.079 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 173' ' ' GLU . 1.4 pm0 -58.14 -52.15 66.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.184 -0.947 . . . . 0.0 109.396 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.6 -6.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.434 -0.791 . . . . 0.0 110.499 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' A' ' 171' ' ' GLU . 12.6 mm-40 -103.47 -7.16 21.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.957 -1.089 . . . . 0.0 110.552 -179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 7.6 pt -125.35 -26.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.125 -0.984 . . . . 0.0 110.942 -179.048 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 6.1 m -60.84 -22.13 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.646 -1.284 . . . . 0.0 108.76 179.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.87 -2.74 58.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.481 -0.762 . . . . 0.0 109.222 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.15 116.41 10.48 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.161 -0.962 . . . . 0.0 108.764 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 70.8 mtm180 -79.65 172.76 13.35 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 -179.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.4 t -78.53 163.57 25.43 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 177.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -147.51 144.98 28.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.28 -1.512 . . . . 0.0 111.386 -179.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.635 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.77 157.41 44.66 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.423 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.2 m-85 -98.98 144.43 28.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.992 -1.068 . . . . 0.0 109.53 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 183' ' ' ASP . 3.9 t0 -53.07 -35.96 60.13 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.38 -0.825 . . . . 0.0 109.77 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 6.2 p90 -69.36 -25.38 64.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.77 -1.206 . . . . 0.0 109.902 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.436 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.0 OUTLIER -83.43 -31.14 26.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.032 -1.043 . . . . 0.0 109.92 -179.652 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.637 ' HA ' HD12 ' A' ' 189' ' ' ILE . 55.7 mt -50.98 -58.96 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.532 -179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 186' ' ' ILE . 6.0 tp10 -40.82 -40.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.937 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.577 ' O ' HG22 ' A' ' 192' ' ' VAL . 11.2 t60 -74.68 -35.39 62.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.231 -0.918 . . . . 0.0 109.017 179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' A' ' 186' ' ' ILE . 91.1 mt -58.92 -38.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.354 -0.841 . . . . 0.0 109.024 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -75.71 -52.52 10.3 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.035 -1.041 . . . . 0.0 109.228 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -49.07 -43.12 40.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.433 -0.792 . . . . 0.0 110.678 -179.058 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.577 HG22 ' O ' ' A' ' 188' ' ' HIS . 21.0 m -79.53 5.85 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.899 -1.126 . . . . 0.0 110.388 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 73.23 40.08 50.64 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 120.032 -1.08 . . . . 0.0 110.8 178.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 189' ' ' ILE . 39.0 mt -128.13 173.91 9.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.098 -1.236 . . . . 0.0 110.013 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 59.89 23.03 58.58 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -54.7 -20.64 8.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.479 -1.601 . . . . 0.0 109.508 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -117.04 26.02 8.52 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.815 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -88.5 127.05 8.41 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.665 -1.491 . . . . 0.0 109.886 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.4 m -144.43 174.84 10.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -1.09 . . . . 0.0 109.332 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.509 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 54.5 mt -72.15 -7.77 50.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.17 -0.956 . . . . 0.0 108.872 179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -96.28 -11.36 26.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.556 -0.715 . . . . 0.0 110.27 -179.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 98' ' ' ILE . 8.3 p-10 -134.75 9.88 3.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.008 . . . . 0.0 110.034 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.444 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -150.65 150.94 31.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.057 -1.027 . . . . 0.0 110.339 -179.136 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.0 tp -100.4 93.88 5.88 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 203' ' ' THR . 52.0 t -86.07 130.12 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 CA-C-O 121.781 0.801 . . . . 0.0 109.318 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 38.8 mt -123.99 165.08 18.06 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.651 -0.656 . . . . 0.0 109.343 -179.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -128.31 -166.61 12.05 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 208' ' ' LYS . 0.9 OUTLIER -58.4 -36.68 73.92 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.482 -1.011 . . . . 0.0 109.338 179.8 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.38 23.71 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.026 -1.046 . . . . 0.0 110.469 -179.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -139.0 146.91 41.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.99 -1.069 . . . . 0.0 110.552 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -100.58 111.26 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -57.54 -52.37 65.68 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.322 -178.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -56.16 111.11 2.82 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.138 -0.976 . . . . 0.0 110.045 -179.735 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -57.55 -14.85 17.99 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.741 1.627 . . . . 0.0 111.962 179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -15.86 59.85 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.338 -0.851 . . . . 0.0 110.126 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 73.28 -173.17 49.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.624 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.3 mt -89.69 148.05 23.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.17 -1.194 . . . . 0.0 109.843 -179.732 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.29 -18.15 37.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 108.851 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.66 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 59.5 m-85 -139.47 173.71 11.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.499 ' N ' ' CD ' ' A' ' 220' ' ' GLU . 5.8 mp0 -80.09 -14.42 58.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.192 -0.943 . . . . 0.0 109.455 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -139.48 48.38 1.84 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.253 -0.904 . . . . 0.0 109.596 -179.746 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.4 tt0 -56.54 -46.52 99.81 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.871 -1.143 . . . . 0.0 109.808 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 52.1 Cg_exo -51.5 -67.18 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.452 2.101 . . . . 0.0 112.108 179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 17.3 m -59.1 -35.25 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.028 -1.045 . . . . 0.0 109.575 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 18.5 mtt180 -60.19 -41.5 93.08 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -68.04 -31.87 71.83 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.828 179.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 19.9 mmtt -64.56 -37.16 86.59 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.6 t -69.42 -35.18 65.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.49 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.4 t80 -65.22 -55.27 19.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -63.64 -26.19 68.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.718 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 39.0 tp -77.81 -35.03 51.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.021 -1.049 . . . . 0.0 108.609 179.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.1 mt -67.14 -36.42 76.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.729 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -68.86 -59.31 6.08 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -51.67 -34.86 40.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -1.231 . . . . 0.0 108.873 179.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 235' ' ' LEU . 8.5 mt -60.67 -23.0 64.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.628 -0.67 . . . . 0.0 109.983 -179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.576 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -71.44 -21.64 61.95 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.959 -1.088 . . . . 0.0 108.743 -179.719 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 92.3 mt -55.16 3.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.677 -1.264 . . . . 0.0 110.521 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.607 ' HG ' HG13 ' A' ' 260' ' ' VAL . 8.1 mt -80.12 -16.24 55.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.856 -1.152 . . . . 0.0 109.729 179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 104.46 -3.88 43.4 Favored Glycine 0 N--CA 1.493 2.488 0 C-N-CA 120.114 -1.041 . . . . 0.0 110.629 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.38 158.14 9.94 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.829 -1.395 . . . . 0.0 108.921 179.467 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 2.3 Cg_endo -48.74 150.94 5.71 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 121.848 1.699 . . . . 0.0 109.429 178.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.72 145.35 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.991 -1.068 . . . . 0.0 112.181 -177.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.5 122.2 32.76 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 148.62 174.8 20.62 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.442 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.519 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 18.3 tttt -102.02 146.98 27.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.066 -1.255 . . . . 0.0 109.986 -179.609 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 245' ' ' LYS . 18.3 m-85 -140.56 140.27 35.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.346 -0.846 . . . . 0.0 109.927 -179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -127.12 126.0 42.17 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 38.0 m -119.62 135.53 54.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.009 -1.057 . . . . 0.0 111.331 -178.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.423 ' O ' ' C ' ' A' ' 250' ' ' ARG . 90.9 t80 -116.78 115.22 25.17 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 249' ' ' PHE . 78.3 mtp85 45.14 47.82 9.89 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.01 -1.056 . . . . 0.0 108.726 -179.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -89.83 159.53 28.03 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.477 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.52 -174.56 13.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -60.75 -47.92 84.13 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.287 -1.125 . . . . 0.0 109.642 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -49.25 -59.08 4.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 139' ' ' ILE . 1.3 tp -52.73 -48.39 66.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.132 -0.98 . . . . 0.0 109.731 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 7.2 m-20 -47.41 -45.29 25.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.064 -1.022 . . . . 0.0 109.192 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.907 HG21 HG21 ' A' ' 56' ' ' THR . 59.1 t -66.96 -40.14 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.543 -0.723 . . . . 0.0 109.986 -179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.408 ' NZ ' ' O ' ' A' ' 133' ' ' GLU . 8.3 ttpt -63.74 -51.75 63.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 109.378 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 139' ' ' ILE . 47.6 tp -53.95 -48.8 69.9 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 108.931 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.607 HG13 ' HG ' ' A' ' 238' ' ' LEU . 59.5 t -57.81 -53.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.101 -0.999 . . . . 0.0 109.372 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.612 ' HE3' HG12 ' A' ' 257' ' ' VAL . 10.7 mtmt -51.1 -40.44 58.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.501 -0.75 . . . . 0.0 109.688 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -69.82 -50.45 42.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.181 -0.949 . . . . 0.0 109.841 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.0 mt -58.75 -48.7 80.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.96 -179.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 238' ' ' LEU . . . -68.24 -32.82 73.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 0.0 110.114 -179.283 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.417 ' CG ' ' O ' ' A' ' 261' ' ' LYS . 7.7 mmtm -66.13 -43.84 85.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.826 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.542 ' C ' ' H ' ' A' ' 268' ' ' LYS . 12.4 mtmt -66.09 -63.97 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.548 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.524 ' OE1' ' CE2' ' A' ' 124' ' ' PHE . 27.1 tt0 -56.59 -0.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -0.831 . . . . 0.0 109.979 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 266' ' ' LYS . 9.8 tttt -117.83 138.49 52.05 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.852 . . . . 0.0 109.621 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.635 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 46.0 mt -88.67 152.26 21.92 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -1.158 . . . . 0.0 109.501 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -55.95 137.61 50.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -0.959 . . . . 0.0 108.93 179.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.57 144.19 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.439 -0.788 . . . . 0.0 110.024 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t -141.53 -171.34 3.29 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 30' ' ' PRO . 5.8 m -99.49 137.09 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.013 -1.055 . . . . 0.0 109.437 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.43 -25.18 67.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.371 -0.831 . . . . 0.0 109.667 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.28 162.5 40.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.18 -0.95 . . . . 0.0 109.602 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.07 139.97 54.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.354 -0.841 . . . . 0.0 110.043 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 mt -117.92 166.18 12.81 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.346 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.4 p -136.72 141.7 43.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.086 -1.009 . . . . 0.0 110.305 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 28' ' ' ILE . 93.4 m-85 -139.25 153.65 47.86 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.52 152.33 21.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.836 -1.165 . . . . 0.0 110.283 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.57 175.71 36.37 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.8 p -84.4 153.21 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.293 -1.122 . . . . 0.0 110.551 -179.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.54 140.98 17.03 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 19' ' ' HIS . 6.5 tt -61.48 -37.92 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.132 -1.217 . . . . 0.0 111.117 -178.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.405 ' HA ' ' N ' ' A' ' 195' ' ' GLY . 92.3 m-70 -90.52 -49.45 6.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.292 -1.505 . . . . 0.0 110.938 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.8 p -68.66 -25.71 64.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.615 -0.678 . . . . 0.0 111.853 -178.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 60.71 16.78 47.12 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.065 -1.54 . . . . 0.0 109.456 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -108.69 153.69 23.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -1.085 . . . . 0.0 109.816 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -76.31 135.53 39.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.464 -0.773 . . . . 0.0 109.602 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.1 t -138.23 145.72 41.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.43 154.44 22.61 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.555 HD11 HG23 ' A' ' 96' ' ' ILE . 10.1 mt -134.12 144.13 48.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.0 109.74 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.623 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -140.03 114.31 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 HD12 ' CE1' ' A' ' 13' ' ' PHE . 17.2 mt -99.3 114.59 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.461 -0.775 . . . . 0.0 110.501 -178.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.623 ' NE2' HG22 ' A' ' 27' ' ' ILE . 2.9 m-70 -109.41 140.23 21.87 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.42 -0.8 . . . . 0.0 109.682 179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HG3' HG23 ' A' ' 7' ' ' VAL . 15.0 Cg_exo -55.35 168.61 1.36 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.767 1.645 . . . . 0.0 111.183 178.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' OE2' ' OG1' ' A' ' 88' ' ' THR . 42.0 mm-40 -140.5 179.72 6.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.0 110.026 179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.504 ' O ' ' OG1' ' A' ' 35' ' ' THR . 7.0 mttt -86.36 152.68 22.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.761 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -47.14 143.83 2.97 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 110.129 -179.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.22 7.87 60.9 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.322 178.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 44.0 m -69.7 -45.22 68.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.533 -1.569 . . . . 0.0 109.802 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.826 ' H ' HD22 ' A' ' 86' ' ' ASN . . . 99.39 -179.9 30.88 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.613 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.9 mm -96.86 118.16 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -142.65 153.7 43.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.716 -1.24 . . . . 0.0 110.818 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -102.43 158.78 15.97 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -130.94 108.32 9.74 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -135.58 137.04 41.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.447 -0.783 . . . . 0.0 111.004 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.492 ' OD1' ' OE1' ' A' ' 67' ' ' GLN . 16.5 m120 52.25 31.22 8.92 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.541 -0.724 . . . . 0.0 111.279 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.42 80.68 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.569 -1.3 . . . . 0.0 109.97 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.86 121.24 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -1.06 . . . . 0.0 109.108 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -84.69 129.81 34.78 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.136 -0.978 . . . . 0.0 109.382 179.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.409 HD12 HD11 ' A' ' 69' ' ' ILE . 30.9 mt -117.92 93.45 44.27 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.843 . . . . 0.0 109.618 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -49.04 148.82 9.0 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.317 2.011 . . . . 0.0 111.897 179.677 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -85.29 69.88 10.78 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.183 -0.948 . . . . 0.0 109.965 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.0 mmm-85 -122.54 173.95 7.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.364 -0.835 . . . . 0.0 108.957 179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 237' ' ' LEU . 1.3 p-80 -74.71 -48.21 27.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.088 -1.007 . . . . 0.0 109.604 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 4.9 mm-40 -47.75 -16.77 0.08 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.0 110.807 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 50' ' ' HIS . 27.4 m-85 -95.6 -0.86 51.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.756 -1.215 . . . . 0.0 109.705 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 37.7 t -70.7 129.25 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.08 -27.78 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -0.872 . . . . 0.0 110.258 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -151.02 131.79 14.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.942 -1.099 . . . . 0.0 109.778 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.85 HG21 HG21 ' A' ' 257' ' ' VAL . 40.4 p -124.5 95.44 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.547 ' O ' ' N ' ' A' ' 59' ' ' SER . 1.9 t-20 -163.01 128.8 3.25 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.532 ' O ' ' CB ' ' A' ' 59' ' ' SER . 95.4 m-70 50.4 8.77 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.132 -0.98 . . . . 0.0 109.027 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.7 OUTLIER 162.64 140.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.293 -0.88 . . . . 0.0 109.883 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 72' ' ' VAL . 63.7 m -85.51 126.29 33.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -119.83 148.84 42.97 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.65 0.738 . . . . 0.0 110.75 -179.168 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CG ' HG21 ' A' ' 72' ' ' VAL . 8.3 mt -122.92 147.25 46.82 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.97 152.89 23.62 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.987 -1.578 . . . . 0.0 110.561 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -160.59 148.35 16.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.461 -1.023 . . . . 0.0 109.108 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.7 mttt 52.36 21.68 1.79 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.191 -0.943 . . . . 0.0 109.552 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.83 -32.34 7.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 110.054 -1.219 . . . . 0.0 110.054 179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' OE1' ' OD1' ' A' ' 42' ' ' ASN . 28.1 mm-40 -60.36 144.64 50.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.071 -1.252 . . . . 0.0 109.469 -179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 10.5 mtp85 -141.64 140.89 33.38 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 110.109 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 46' ' ' ILE . 56.9 mt -131.3 122.72 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' H ' ' HA ' ' A' ' 95' ' ' GLU . 29.5 mttm -90.8 158.69 16.69 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.036 -1.04 . . . . 0.0 111.365 -179.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.1 m 41.58 79.36 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.426 178.207 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG21 ' CG ' ' A' ' 62' ' ' LEU . 15.9 m -107.34 -9.83 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 74' ' ' HIS . 13.6 pm0 -61.7 -26.58 68.13 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.621 -0.674 . . . . 0.0 110.443 -179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 27.8 m170 -66.06 -69.22 0.31 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 0.0 108.998 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.587 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.2 tp -52.34 -49.87 40.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.229 -0.92 . . . . 0.0 109.119 179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD21 ' HB1' ' A' ' 48' ' ' ALA . 13.8 mt -49.14 -51.19 33.68 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.976 -1.078 . . . . 0.0 110.233 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 48.4 t -59.61 -41.63 90.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.234 -0.916 . . . . 0.0 110.16 -179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.1 t -56.05 -44.54 78.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.038 -1.039 . . . . 0.0 108.912 179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.9 mt -67.32 -35.21 78.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.41 -0.806 . . . . 0.0 109.362 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.4 t-160 -62.78 -35.79 80.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 109.217 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.671 HD13 ' HB3' ' A' ' 171' ' ' GLU . 68.5 mt -79.63 -38.21 34.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 109.845 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.573 HD22 HD11 ' A' ' 114' ' ' ILE . 94.6 mt -81.14 1.71 30.68 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.1 -1.0 . . . . 0.0 109.633 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 54.79 40.51 31.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 110.113 179.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mm -86.26 140.47 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 121' ' ' ILE . 64.1 p -126.34 -21.4 4.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.16 -0.963 . . . . 0.0 111.753 -178.349 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.826 HD22 ' H ' ' A' ' 36' ' ' GLY . 11.6 m120 -126.02 107.25 10.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.942 -1.099 . . . . 0.0 110.351 -179.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.1 m -164.56 147.07 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.685 0.755 . . . . 0.0 110.16 179.371 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.467 ' OG1' ' OE2' ' A' ' 31' ' ' GLU . 72.3 m -116.29 110.46 18.77 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.513 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.0 mt -93.95 101.58 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.267 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.409 ' O ' HD23 ' A' ' 26' ' ' LEU . 9.5 tt0 -77.35 129.01 35.27 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.039 -1.038 . . . . 0.0 108.539 179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.41 123.38 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.918 0.866 . . . . 0.0 111.823 -177.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.6 mt -104.6 96.64 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 140.55 -155.32 24.69 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -122.22 -9.04 8.67 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.259 -1.142 . . . . 0.0 110.223 -179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.412 ' HA ' ' H ' ' A' ' 70' ' ' LYS . 44.2 tt0 -138.86 148.13 43.29 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.974 -1.079 . . . . 0.0 110.0 -179.459 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.555 HG23 HD11 ' A' ' 26' ' ' LEU . 39.7 mm -71.94 122.81 88.3 Favored Pre-proline 0 N--CA 1.487 1.39 0 C-N-CA 119.187 -1.005 . . . . 0.0 108.383 179.179 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -42.46 117.4 0.82 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 121.637 1.558 . . . . 0.0 110.937 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.1 tp -72.45 -14.38 17.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.214 -0.929 . . . . 0.0 110.129 -178.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.424 HD11 ' CE2' ' A' ' 106' ' ' PHE . 75.1 mt 56.98 -120.41 1.38 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.899 . . . . 0.0 110.121 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -96.99 8.45 44.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.064 -1.023 . . . . 0.0 110.868 -178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.62 -2.28 62.4 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.901 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.94 -172.1 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.669 -0.901 . . . . 0.0 109.57 -179.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.23 17.31 8.54 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.436 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 57.7 t-105 -57.12 -43.76 82.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -1.109 . . . . 0.0 110.197 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -64.88 -55.91 16.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.17 -0.956 . . . . 0.0 110.313 -179.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.424 ' CE2' HD11 ' A' ' 99' ' ' LEU . 12.9 m-85 -51.08 -45.94 61.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.19 -0.944 . . . . 0.0 109.604 -179.539 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.427 ' O ' ' CB ' ' A' ' 111' ' ' ARG . 44.6 t80 -62.69 -52.87 61.6 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.647 -0.658 . . . . 0.0 110.829 -179.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.436 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 2.0 mm-40 -61.21 -44.63 96.97 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.116 -0.99 . . . . 0.0 111.367 -178.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.65 -54.99 19.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.219 -0.926 . . . . 0.0 110.351 -179.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 44.2 mt -65.11 -32.11 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.423 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 107' ' ' TYR . 53.2 ttt180 -63.29 -42.31 99.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.398 -0.814 . . . . 0.0 110.008 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.42 ' HG3' HD22 ' A' ' 113' ' ' ASN . 1.6 ptpp? -76.46 7.39 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.057 -1.027 . . . . 0.0 110.134 -179.583 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.42 HD22 ' HG3' ' A' ' 112' ' ' LYS . 17.4 m-80 -137.36 33.97 2.52 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.061 -1.024 . . . . 0.0 110.509 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 HD22 ' A' ' 82' ' ' LEU . 50.9 mt -80.68 138.55 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.945 -1.097 . . . . 0.0 110.247 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tp -129.41 124.97 35.49 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.69 142.6 31.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.459 -179.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -110.1 -172.27 2.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.556 -0.715 . . . . 0.0 109.239 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -113.93 69.61 0.71 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.286 -0.884 . . . . 0.0 110.716 -179.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -168.59 131.28 1.39 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.125 -0.984 . . . . 0.0 109.255 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.45 ' OE2' ' C ' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -69.8 151.05 46.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.045 -1.034 . . . . 0.0 110.08 -179.446 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 85' ' ' THR . 45.4 mt -95.25 152.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.107 -0.996 . . . . 0.0 110.096 -179.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -94.32 83.83 4.28 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 48.0 m-85 -62.5 147.01 50.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.897 . . . . 0.0 110.071 -179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -93.68 102.04 14.19 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 243' ' ' LYS . 61.4 t -93.9 133.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.376 0.607 . . . . 0.0 110.647 -177.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.91 116.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -84.63 -29.95 25.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.064 -1.022 . . . . 0.0 110.889 -178.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.25 168.73 13.16 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.897 -1.127 . . . . 0.0 109.901 -179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.92 147.92 24.57 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.862 2.374 . . . . 0.0 112.555 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.47 HG22 ' HB3' ' A' ' 141' ' ' ALA . 2.7 tt -157.36 149.47 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.366 -0.834 . . . . 0.0 109.043 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.95 146.4 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.221 -0.924 . . . . 0.0 109.516 179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.0 m -128.93 148.68 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -133.56 160.72 36.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.908 . . . . 0.0 109.71 -179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 258' ' ' LYS . 19.2 t70 -175.1 105.71 0.09 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.301 -0.875 . . . . 0.0 109.823 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 53.32 51.33 15.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.817 . . . . 0.0 110.199 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.78 -30.65 3.15 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -62.13 136.89 58.14 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.055 -1.262 . . . . 0.0 108.229 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.71 HD23 ' C ' ' A' ' 138' ' ' LEU . 1.1 tt -145.57 140.09 27.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.82 -1.175 . . . . 0.0 110.534 -179.4 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.644 HG21 HD22 ' A' ' 259' ' ' LEU . 71.2 mt -136.91 127.03 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.552 -0.717 . . . . 0.0 109.66 179.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -114.22 134.03 55.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.542 -0.724 . . . . 0.0 110.124 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.42 135.64 54.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -146.42 150.2 39.98 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -47.22 142.53 11.86 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.684 2.256 . . . . 0.0 113.409 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.581 ' OG ' ' O ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -159.0 147.87 18.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.689 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -66.39 -32.49 73.9 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 110.53 -178.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.581 ' O ' ' OG ' ' A' ' 144' ' ' SER . 72.5 p -120.25 -163.23 0.99 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.327 -0.858 . . . . 0.0 109.308 -179.601 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.7 tp -109.25 123.98 50.15 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 147' ' ' LEU . 2.7 tt0 -135.37 125.25 25.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.087 -1.008 . . . . 0.0 108.466 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.511 ' CG1' HD23 ' A' ' 231' ' ' LEU . 63.5 t -125.87 121.5 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.868 . . . . 0.0 109.779 -179.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.6 m -111.28 152.03 27.66 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.623 -0.673 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -140.01 130.59 25.65 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -122.41 133.86 54.62 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.9 140.81 11.91 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.651 -178.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -101.54 100.47 10.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -88.71 166.95 13.73 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.183 -0.948 . . . . 0.0 110.707 -178.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 13.8 mmtp -104.29 -20.51 13.74 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.527 -0.733 . . . . 0.0 110.484 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 159' ' ' LEU . 32.4 p-10 -89.08 -171.01 3.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.761 -1.212 . . . . 0.0 110.174 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -52.63 2.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.277 -0.889 . . . . 0.0 111.501 -178.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 157' ' ' ASN . 14.6 mt -82.25 -28.63 31.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.388 -1.445 . . . . 0.0 108.493 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 55.5 -141.56 38.35 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.039 -1.625 . . . . 0.0 109.039 -179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 24.7 ttp-105 -100.44 136.23 40.64 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.256 -1.143 . . . . 0.0 109.13 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -143.73 160.81 40.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.374 -0.829 . . . . 0.0 109.597 -179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.42 150.54 31.49 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.294 -0.879 . . . . 0.0 110.243 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.402 ' CD2' ' HG2' ' A' ' 225' ' ' ARG . 49.1 t80 -144.66 140.78 28.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 109.544 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 24.4 m -107.06 122.93 47.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.449 -0.782 . . . . 0.0 109.985 -179.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.6 ' HB3' HG11 ' A' ' 228' ' ' VAL . 6.0 t80 -102.76 111.61 24.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.315 -0.865 . . . . 0.0 110.022 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.535 ' H ' HD22 ' A' ' 170' ' ' ASN . 13.1 t -103.15 150.74 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -46.73 138.13 6.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.202 -0.936 . . . . 0.0 108.826 179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 91.09 3.83 69.6 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.535 HD22 ' H ' ' A' ' 167' ' ' VAL . 98.7 m-20 -113.83 20.97 15.38 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.18 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.701 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.8 OUTLIER -58.96 -50.86 72.48 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.361 -0.837 . . . . 0.0 109.196 179.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.6 -5.85 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.491 -0.756 . . . . 0.0 109.774 179.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 171' ' ' GLU . 39.3 mt-10 -104.91 -9.81 17.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.141 -0.974 . . . . 0.0 110.3 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 5.0 pt -126.85 -27.24 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.191 -0.943 . . . . 0.0 110.739 -179.229 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.701 HG22 ' O ' ' A' ' 171' ' ' GLU . 5.0 m -60.98 -22.88 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.679 -1.263 . . . . 0.0 108.524 179.275 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.93 -2.62 58.75 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -70.35 115.93 10.11 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.355 -0.841 . . . . 0.0 109.168 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 64.3 mtm180 -79.53 172.76 13.35 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 0.0 109.255 -179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.1 t -79.71 163.87 24.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 177.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -148.71 144.46 27.11 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.244 -1.535 . . . . 0.0 111.37 -179.206 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.658 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -142.06 158.84 43.29 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.508 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 86.3 m-85 -99.46 144.75 28.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 0.0 109.739 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.449 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -49.35 -36.2 20.79 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.31 -0.869 . . . . 0.0 109.578 -179.477 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.508 ' CE2' ' CB ' ' A' ' 182' ' ' PHE . 8.5 p90 -73.67 -26.38 60.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.026 -1.046 . . . . 0.0 109.842 -179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.453 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 0.3 OUTLIER -76.65 -38.66 54.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.076 -1.015 . . . . 0.0 109.998 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.407 HG22 ' HG3' ' A' ' 190' ' ' LYS . 62.6 mt -48.51 -51.68 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 110.21 -179.383 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 186' ' ' ILE . 8.6 tt0 -42.95 -45.38 5.0 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.953 . . . . 0.0 110.303 -179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.435 ' O ' HG22 ' A' ' 192' ' ' VAL . 4.5 t60 -75.26 -57.35 3.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.432 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 45.6 mt -44.74 -27.95 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.247 -0.908 . . . . 0.0 109.662 179.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . 0.407 ' HG3' HG22 ' A' ' 186' ' ' ILE . 0.0 OUTLIER -85.5 -54.37 4.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.772 -1.205 . . . . 0.0 109.506 179.876 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 21.1 tttm -51.91 -40.22 60.38 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.213 -0.929 . . . . 0.0 110.034 -179.418 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 188' ' ' HIS . 16.3 m -75.37 3.37 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.004 -1.06 . . . . 0.0 109.927 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 77.24 37.72 31.33 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 194' ' ' LEU . 57.0 mt -128.52 169.53 14.26 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.255 -1.144 . . . . 0.0 109.865 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.42 24.11 61.14 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -60.4 -21.23 61.97 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.623 -1.516 . . . . 0.0 109.598 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -111.24 24.95 14.76 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -89.2 125.45 7.79 Favored Glycine 0 N--CA 1.491 2.329 0 O-C-N 120.885 -1.362 . . . . 0.0 109.744 179.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -144.11 164.5 30.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.31 -1.112 . . . . 0.0 110.03 -179.842 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.568 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 25.3 mt -64.47 -8.99 15.64 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.257 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -93.09 -15.99 25.46 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -136.84 10.99 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.496 -0.753 . . . . 0.0 110.17 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 199' ' ' SER . 1.2 m -149.16 149.99 31.92 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.043 -1.035 . . . . 0.0 110.287 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.619 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.6 tp -100.24 93.34 5.64 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.436 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -86.12 131.33 34.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.768 0.794 . . . . 0.0 109.031 -179.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 33.3 mt -124.14 162.66 23.13 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.31 -166.73 12.68 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 179.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -31.59 71.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.416 -1.05 . . . . 0.0 109.569 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -153.9 23.79 0.51 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.21 -0.931 . . . . 0.0 110.678 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -144.24 151.73 39.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.748 -1.22 . . . . 0.0 110.516 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.6 t -102.56 112.25 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -57.17 -51.88 67.56 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.077 -1.015 . . . . 0.0 110.328 -178.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 8.0 m120 -58.0 111.66 3.82 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.13 -0.981 . . . . 0.0 110.24 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.5 -12.42 13.88 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.596 1.531 . . . . 0.0 111.821 179.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.93 -17.2 59.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.237 -0.914 . . . . 0.0 110.048 -179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.3 -175.79 48.26 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.619 ' CD2' HD11 ' A' ' 204' ' ' LEU . 8.2 mt -87.81 142.07 28.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.161 -1.2 . . . . 0.0 109.86 -179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -19.92 60.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.15 179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -142.9 -179.05 6.12 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.389 -0.82 . . . . 0.0 109.297 -179.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.567 ' OE2' ' N ' ' A' ' 220' ' ' GLU . 1.9 pm0 -87.17 3.42 46.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.188 -0.945 . . . . 0.0 109.608 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.474 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -154.04 47.57 0.62 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.255 -179.818 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.561 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -58.88 -46.02 99.57 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.011 -1.055 . . . . 0.0 109.933 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 50.7 Cg_exo -52.19 -66.44 0.11 Allowed 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.591 2.194 . . . . 0.0 112.069 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 225' ' ' ARG . 31.5 m -60.54 -35.94 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.05 -1.031 . . . . 0.0 109.568 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 224' ' ' VAL . 62.3 mtt180 -59.27 -41.64 89.33 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 18.1 t60 -68.3 -32.13 72.05 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.147 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -64.81 -35.5 81.31 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.6 HG11 ' HB3' ' A' ' 166' ' ' PHE . 54.3 t -70.35 -37.85 72.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -63.33 -49.79 72.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.458 -0.776 . . . . 0.0 108.961 179.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -67.78 -27.82 67.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.416 -0.802 . . . . 0.0 109.755 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.511 HD23 ' CG1' ' A' ' 149' ' ' VAL . 61.1 tp -77.33 -34.03 55.39 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.002 -1.061 . . . . 0.0 108.359 179.075 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.1 mt -67.95 -37.74 78.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.22 -56.06 13.58 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.18 -1.568 . . . . 0.0 109.18 179.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.465 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 21.8 m-20 -52.45 -38.36 59.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.128 -1.219 . . . . 0.0 108.982 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 235' ' ' LEU . 15.9 mt -58.23 -23.47 55.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.629 -0.669 . . . . 0.0 110.48 -179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.566 ' C ' ' H ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -72.83 -22.36 60.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.692 -1.255 . . . . 0.0 108.758 -179.666 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.47 ' O ' ' ND1' ' A' ' 50' ' ' HIS . 94.0 mt -52.71 -0.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.635 -1.291 . . . . 0.0 110.356 -179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.566 ' H ' ' C ' ' A' ' 236' ' ' TYR . 9.9 mt -77.96 -14.48 59.51 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.799 -1.188 . . . . 0.0 109.756 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 100.39 -1.53 55.97 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 120.002 -1.094 . . . . 0.0 110.844 179.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.05 156.7 9.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 120.742 -1.446 . . . . 0.0 109.174 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.409 ' HB2' ' CD2' ' A' ' 123' ' ' TYR . 3.6 Cg_endo -49.75 150.23 9.56 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 121.852 1.701 . . . . 0.0 109.518 178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 57.2 t -112.42 149.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 120.999 -1.063 . . . . 0.0 112.115 -177.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . 0.503 ' HB2' HG22 ' A' ' 125' ' ' VAL . 5.8 mmtp -129.77 123.55 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.439 ' C ' ' OG ' ' A' ' 144' ' ' SER . . . 157.58 -160.86 30.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.26 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 135.14 46.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.356 -1.085 . . . . 0.0 108.76 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.545 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 8.2 m-85 -133.1 138.22 46.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 110.145 -179.337 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -123.55 129.72 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 16.3 t -123.83 136.24 54.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.982 -1.074 . . . . 0.0 111.378 -177.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -119.36 111.47 18.22 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 50.0 45.05 25.61 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.17 -0.957 . . . . 0.0 108.465 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -87.78 141.73 17.33 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -115.8 178.75 17.74 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.465 ' ND1' ' OD2' ' A' ' 234' ' ' ASP . 52.0 m-70 -59.33 -39.14 82.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.137 -1.213 . . . . 0.0 109.595 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 4.9 m -54.74 -58.79 6.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.224 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 255' ' ' LEU . 11.8 tp -56.69 -45.7 81.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.151 -0.968 . . . . 0.0 109.563 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 6.5 m-20 -47.46 -54.76 10.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 109.634 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 56' ' ' THR . 99.2 t -60.89 -50.71 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.28 -0.888 . . . . 0.0 109.669 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . 0.47 ' HZ1' ' HB2' ' A' ' 134' ' ' ASP . 22.2 ttmt -50.49 -52.35 39.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.978 -1.076 . . . . 0.0 108.963 179.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.644 HD22 HG21 ' A' ' 139' ' ' ILE . 35.5 tp -50.4 -50.85 50.56 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.548 HG13 ' HG ' ' A' ' 238' ' ' LEU . 46.8 t -55.27 -52.94 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.476 -0.89 . . . . 0.0 108.889 179.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.09 -50.16 29.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.414 -0.804 . . . . 0.0 109.148 179.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -61.48 -49.32 77.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.59 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 21.1 mt -56.12 -52.47 64.21 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.241 -0.912 . . . . 0.0 109.957 -179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -65.4 -26.29 67.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.945 . . . . 0.0 109.79 -179.538 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -71.29 -64.68 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.935 . . . . 0.0 110.072 -179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.3 ptmm? -54.53 -37.35 65.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.09 -1.006 . . . . 0.0 109.951 -179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -90.31 32.25 0.95 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.966 -1.083 . . . . 0.0 109.286 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . 0.598 ' CG ' ' H ' ' A' ' 269' ' ' LEU . 2.5 tptm -90.44 -134.91 0.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.598 ' H ' ' CG ' ' A' ' 268' ' ' LYS . 2.1 pp . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.658 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.515 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.2 mt -100.77 156.65 17.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.283 -1.128 . . . . 0.0 109.654 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 94.6 mt-10 -57.67 137.83 56.04 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.2 179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.07 146.98 47.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.49 -0.756 . . . . 0.0 109.996 -179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.0 t -141.16 -171.7 3.33 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 30' ' ' PRO . 14.2 m -97.64 135.35 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.036 -1.04 . . . . 0.0 109.269 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -63.07 -20.75 65.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.16 160.66 40.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 139.11 57.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.441 -0.787 . . . . 0.0 109.869 -179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 11' ' ' LEU . 28.3 mt -117.44 163.01 17.03 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.251 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.17 141.02 48.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 110.15 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 26' ' ' LEU . 99.0 m-85 -139.56 147.72 41.56 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.022 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -158.93 151.84 22.13 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.94 -1.1 . . . . 0.0 109.839 -179.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.14 173.95 36.55 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 p -79.56 149.25 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -1.039 . . . . 0.0 110.108 -179.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.17 140.09 16.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.491 HD11 ' OG1' ' A' ' 203' ' ' THR . 5.0 tt -58.91 -39.15 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.126 -1.22 . . . . 0.0 110.327 -179.179 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.474 ' N ' HG23 ' A' ' 18' ' ' ILE . 78.3 m-70 -90.21 -50.38 6.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.718 -1.239 . . . . 0.0 111.168 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.2 p -66.6 -23.93 66.26 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.48 -0.762 . . . . 0.0 111.242 -178.156 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.69 16.71 17.85 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -112.56 157.93 20.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.479 -1.012 . . . . 0.0 109.401 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -76.82 134.7 38.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.298 -0.876 . . . . 0.0 109.472 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.9 m -136.34 145.29 45.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.219 -0.925 . . . . 0.0 109.49 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.57 157.62 20.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.978 -179.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.683 HD11 HG23 ' A' ' 96' ' ' ILE . 9.3 mt -138.59 145.02 40.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.457 -0.777 . . . . 0.0 109.491 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.533 HG22 ' NE2' ' A' ' 29' ' ' HIS . 10.3 mt -140.56 108.38 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.164 -0.96 . . . . 0.0 108.416 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mt -92.28 115.24 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.894 . . . . 0.0 110.621 -178.725 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 27' ' ' ILE . 47.5 m-70 -108.67 139.77 21.17 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 0.0 109.393 179.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' VAL . 27.5 Cg_exo -52.57 168.34 0.46 Allowed 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.828 1.686 . . . . 0.0 111.737 179.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.49 ' HB3' HG21 ' A' ' 35' ' ' THR . 17.7 mm-40 -142.84 174.56 10.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -0.974 . . . . 0.0 109.668 179.434 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 35' ' ' THR . 26.7 mttt -82.05 149.38 28.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.556 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -47.05 149.03 0.98 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.15 -0.969 . . . . 0.0 109.821 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.59 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 66.66 4.01 23.62 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 110.75 179.062 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 32' ' ' LYS . 19.8 m -67.53 -41.69 83.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.774 -1.427 . . . . 0.0 109.238 179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.67 -179.91 34.58 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.673 -1.251 . . . . 0.0 110.398 179.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 87' ' ' VAL . 24.4 mm -98.92 116.5 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.104 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -139.62 155.31 47.51 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.772 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -103.58 156.8 17.5 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -128.69 111.8 13.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.138 -0.976 . . . . 0.0 108.657 179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -135.66 134.35 39.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.396 -0.815 . . . . 0.0 110.699 -178.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 42' ' ' ASN . 1.0 OUTLIER 53.74 28.31 8.01 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 111.362 178.455 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.05 18.23 75.16 Favored Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.074 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.8 t -123.56 122.99 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.415 -1.05 . . . . 0.0 109.154 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -84.39 128.26 34.48 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.111 -0.993 . . . . 0.0 109.466 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 69' ' ' ILE . 55.7 mt -118.13 91.09 39.37 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.402 -0.811 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.36 152.24 8.75 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.519 2.146 . . . . 0.0 111.826 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.61 67.4 9.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -121.55 161.86 21.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.371 -0.83 . . . . 0.0 109.302 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.537 ' O ' ' N ' ' A' ' 52' ' ' PHE . 5.1 p-80 -65.17 -51.6 60.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.353 -0.842 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -43.44 -16.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.194 -0.941 . . . . 0.0 110.879 -179.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 50' ' ' HIS . 30.1 m-85 -98.56 0.58 45.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.867 -1.145 . . . . 0.0 110.105 -179.574 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG23 ' HA ' ' A' ' 50' ' ' HIS . 79.3 t -69.98 131.0 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.271 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 m -111.63 -30.27 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.276 -0.89 . . . . 0.0 110.35 -179.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -151.75 133.3 14.7 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.952 -1.093 . . . . 0.0 109.992 -179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.597 HG21 HG21 ' A' ' 257' ' ' VAL . 41.2 p -123.29 95.51 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.551 ' C ' ' H ' ' A' ' 59' ' ' SER . 13.9 t-20 -163.03 129.1 3.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.972 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' O ' ' CB ' ' A' ' 59' ' ' SER . 80.7 m-70 50.83 8.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.159 -0.963 . . . . 0.0 109.065 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.551 ' H ' ' C ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.19 144.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.35 -0.844 . . . . 0.0 109.754 179.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 72' ' ' VAL . 85.7 m -87.09 127.18 35.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.165 -0.959 . . . . 0.0 109.18 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 1.3 m-20 -121.78 150.33 42.02 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.81 0.814 . . . . 0.0 111.046 -178.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mt -126.27 149.71 48.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.23 151.91 23.04 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.184 -1.484 . . . . 0.0 110.193 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -158.04 144.13 17.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.343 -1.092 . . . . 0.0 109.215 -179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 52.86 22.04 2.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.518 -0.739 . . . . 0.0 109.839 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.14 -33.37 6.64 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 179.642 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -57.55 141.56 47.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.241 . . . . 0.0 109.153 -179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 2.0 tpp85 -133.89 134.3 42.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.486 -0.758 . . . . 0.0 110.336 -179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 69' ' ' ILE . 18.8 mt -127.05 122.02 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -102.78 156.17 17.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.0 -1.063 . . . . 0.0 111.357 -178.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 71' ' ' THR . 86.1 m 50.31 73.74 0.25 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.707 179.037 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 60' ' ' THR . 19.8 m -108.11 -9.22 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 109.601 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.596 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 4.7 pm0 -61.21 -26.2 67.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 110.537 -179.214 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.408 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.2 m170 -66.66 -69.02 0.33 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.915 -1.116 . . . . 0.0 109.37 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.596 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.5 tp -52.64 -48.02 48.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.054 -1.029 . . . . 0.0 109.107 179.743 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.596 ' N ' HG23 ' A' ' 75' ' ' ILE . 26.1 mt -51.76 -49.19 63.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.0 109.93 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.1 t -60.95 -42.5 98.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.143 -179.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 67.7 t -55.82 -44.87 79.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.118 -0.989 . . . . 0.0 108.823 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -67.74 -34.44 76.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -61.92 -36.81 82.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 0.0 108.872 179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 70.1 mt -78.86 -38.14 38.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.539 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 114' ' ' ILE . 74.7 mt -80.45 -0.52 37.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.248 -0.908 . . . . 0.0 109.744 -179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 55.0 40.37 32.0 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 110.922 178.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.5 mm -85.82 141.77 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.587 ' OG1' ' ND2' ' A' ' 86' ' ' ASN . 69.0 p -127.23 -23.18 3.6 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.182 -0.949 . . . . 0.0 111.582 -178.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.726 ' O ' HG13 ' A' ' 87' ' ' VAL . 3.4 m-80 -124.33 106.53 10.32 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.828 -1.17 . . . . 0.0 110.164 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 86' ' ' ASN . 4.5 m -164.9 148.27 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 CA-C-O 121.625 0.726 . . . . 0.0 110.295 179.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 30.8 m -116.33 114.53 24.45 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.529 ' CG2' HD22 ' A' ' 26' ' ' LEU . 4.2 mt -94.97 100.4 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.367 -179.013 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' OE1' HD12 ' A' ' 27' ' ' ILE . 4.9 tt0 -73.55 124.72 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 26' ' ' LEU . 62.1 t -107.39 126.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-O 121.82 0.819 . . . . 0.0 111.583 -178.058 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 92' ' ' ILE . 27.7 mt -111.03 95.17 3.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 141.39 -156.24 25.6 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.887 -1.685 . . . . 0.0 108.887 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -121.68 -10.68 8.73 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.32 -1.106 . . . . 0.0 110.359 -179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -140.11 149.25 42.84 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.023 -1.048 . . . . 0.0 109.564 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.683 HG23 HD11 ' A' ' 26' ' ' LEU . 43.1 mm -73.43 121.33 84.86 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.163 -0.96 . . . . 0.0 109.042 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -40.71 124.03 1.78 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.76 1.64 . . . . 0.0 111.405 179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.448 HD13 ' CG2' ' A' ' 18' ' ' ILE . 1.5 tp -81.19 -12.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 110.191 -179.255 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.428 HD11 ' CE2' ' A' ' 106' ' ' PHE . 8.2 mt 56.05 -116.83 1.04 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.302 -0.874 . . . . 0.0 110.117 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.84 8.13 45.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.012 -1.055 . . . . 0.0 110.743 -178.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.2 65.68 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.08 -172.27 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.741 -0.858 . . . . 0.0 109.339 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -122.96 14.58 8.41 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.582 ' CH2' ' OE2' ' A' ' 108' ' ' GLU . 52.3 t-105 -56.3 -42.8 78.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -1.125 . . . . 0.0 110.173 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' A' ' 105' ' ' GLU . 3.8 mp0 -64.96 -57.32 9.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.152 -0.967 . . . . 0.0 110.171 -179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.428 ' CE2' HD11 ' A' ' 99' ' ' LEU . 11.0 m-85 -51.02 -46.2 61.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 0.0 109.223 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.581 ' OH ' ' NH1' ' A' ' 111' ' ' ARG . 89.4 t80 -60.97 -52.35 65.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.669 -0.644 . . . . 0.0 110.884 -179.122 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.582 ' OE2' ' CH2' ' A' ' 104' ' ' TRP . 4.0 mm-40 -62.03 -45.24 94.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.142 -0.974 . . . . 0.0 111.726 -178.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.1 -55.64 17.61 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.996 -1.065 . . . . 0.0 110.548 -178.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mt -63.47 -32.46 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.383 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.581 ' NH1' ' OH ' ' A' ' 107' ' ' TYR . 59.1 ttt85 -63.3 -41.86 98.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.355 -0.841 . . . . 0.0 109.933 -179.603 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' C ' HD22 ' A' ' 113' ' ' ASN . 27.6 pttt -77.58 13.37 1.29 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.495 HD22 ' C ' ' A' ' 112' ' ' LYS . 1.7 m-80 -143.11 31.32 1.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.898 -1.126 . . . . 0.0 110.79 -179.58 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 82' ' ' LEU . 73.6 mt -79.07 138.79 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 120.759 -1.213 . . . . 0.0 109.718 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -129.24 125.32 36.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.32 143.51 35.11 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 110.573 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -112.92 -175.6 2.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.559 -0.713 . . . . 0.0 109.303 179.572 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -110.03 67.33 0.64 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.288 -0.883 . . . . 0.0 110.633 -179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.3 ttt85 -162.91 129.55 3.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.941 -1.099 . . . . 0.0 109.335 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.96 142.61 52.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.959 -1.088 . . . . 0.0 109.661 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.536 HG21 ' HG2' ' A' ' 241' ' ' PRO . 74.0 mt -88.83 151.53 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 0.0 110.651 -179.23 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.42 84.88 3.06 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.519 ' CD2' ' HB2' ' A' ' 241' ' ' PRO . 70.9 m-85 -61.71 146.69 48.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.313 -0.867 . . . . 0.0 109.517 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -91.63 101.64 14.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 13.1 t -93.63 134.44 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.442 0.639 . . . . 0.0 111.058 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 80.7 t -73.89 112.93 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -93.65 -26.94 16.84 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 110.277 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -131.04 150.3 76.21 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.379 -0.825 . . . . 0.0 109.278 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.5 149.35 55.78 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.432 2.088 . . . . 0.0 112.037 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.55 HG22 ' HB3' ' A' ' 141' ' ' ALA . 11.7 tt -152.41 150.65 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.27 -0.894 . . . . 0.0 108.965 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.43 141.15 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 31.0 m -128.38 146.73 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -135.9 159.22 42.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.145 -0.972 . . . . 0.0 109.485 -179.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.57 108.05 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.169 -0.957 . . . . 0.0 110.161 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 48.61 52.94 12.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 110.754 178.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.4 -36.85 3.17 Favored Glycine 0 N--CA 1.491 2.365 0 C-N-CA 119.714 -1.231 . . . . 0.0 110.484 178.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.85 126.16 26.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.93 -1.335 . . . . 0.0 108.634 179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -138.71 138.85 38.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 110.138 -179.444 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 259' ' ' LEU . 83.6 mt -137.97 130.27 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.475 -0.766 . . . . 0.0 109.76 179.567 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.414 ' NZ ' ' OE1' ' A' ' 142' ' ' GLU . 29.5 tttm -119.24 132.1 55.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.689 -0.632 . . . . 0.0 109.887 -179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -122.81 133.82 54.43 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.414 ' OE1' ' NZ ' ' A' ' 140' ' ' LYS . 4.2 pt-20 -145.89 149.11 38.24 Favored Pre-proline 0 N--CA 1.487 1.416 0 O-C-N 121.016 -1.053 . . . . 0.0 109.729 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -46.0 140.95 9.77 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.561 2.174 . . . . 0.0 113.158 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.414 ' HB2' ' N ' ' A' ' 245' ' ' LYS . 0.5 OUTLIER -154.57 142.8 20.4 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -61.97 -7.1 3.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.395 -0.816 . . . . 0.0 110.437 -179.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 71.9 p -149.91 -174.62 4.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.951 -1.093 . . . . 0.0 109.605 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 148' ' ' GLU . 12.8 tp -98.75 123.16 42.8 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.137 -0.977 . . . . 0.0 108.737 179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.444 ' N ' HD12 ' A' ' 147' ' ' LEU . 44.8 tt0 -139.28 126.99 21.92 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.28 -0.887 . . . . 0.0 108.651 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.428 ' CG1' HD23 ' A' ' 231' ' ' LEU . 93.6 t -125.24 123.7 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.421 -0.799 . . . . 0.0 109.864 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m -113.8 152.73 30.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.608 -0.682 . . . . 0.0 109.849 -179.769 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -140.44 131.09 25.62 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.854 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' OE1' ' OH ' ' A' ' 247' ' ' TYR . 10.1 tt0 -122.47 133.75 54.59 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -140.99 140.76 10.66 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.577 -1.297 . . . . 0.0 111.482 -178.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.04 97.56 7.03 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -78.51 167.36 21.4 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 121.596 0.713 . . . . 0.0 110.673 -178.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.89 25.3 9.48 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.507 -0.746 . . . . 0.0 111.092 -178.583 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 157' ' ' ASN . 20.5 p-10 -137.19 -164.66 1.62 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.864 -1.147 . . . . 0.0 109.996 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -56.62 -4.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.429 -0.794 . . . . 0.0 110.968 -178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.416 HD22 ' NE2' ' A' ' 162' ' ' GLN . 12.2 mt -76.39 -27.01 56.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.59 -1.319 . . . . 0.0 108.036 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.57 -139.49 39.0 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -102.2 136.78 41.43 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.405 -1.056 . . . . 0.0 109.545 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.416 ' NE2' HD22 ' A' ' 159' ' ' LEU . 25.1 mt-30 -142.75 154.18 44.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.614 -0.679 . . . . 0.0 109.519 -179.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.75 148.96 31.52 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.425 -0.797 . . . . 0.0 109.836 179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -145.37 139.01 26.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.354 -0.841 . . . . 0.0 109.836 -179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . . . . . . . . . 31.3 m -107.1 123.87 48.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.474 -0.767 . . . . 0.0 109.574 -179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.475 ' HB3' HG11 ' A' ' 228' ' ' VAL . 9.0 t80 -103.17 109.04 20.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.26 -0.9 . . . . 0.0 110.007 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.526 ' H ' HD22 ' A' ' 170' ' ' ASN . 2.4 t -100.35 150.0 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.323 -0.86 . . . . 0.0 109.676 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -49.5 128.21 16.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.247 -0.908 . . . . 0.0 108.787 179.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . 0.459 ' N ' ' OE1' ' A' ' 171' ' ' GLU . . . 106.31 0.97 38.06 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.55 ' N ' ' OE1' ' A' ' 171' ' ' GLU . 91.4 m-20 -116.62 20.75 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -1.118 . . . . 0.0 109.022 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 1.1 pm0 -55.62 -49.08 73.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.396 -0.815 . . . . 0.0 110.205 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -50.27 -22.22 1.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 110.46 -179.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -86.71 -7.13 58.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.002 -1.061 . . . . 0.0 111.899 -177.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 21.5 pt -125.51 -28.16 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 120.84 -1.163 . . . . 0.0 111.247 -178.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.3 m -61.62 -17.43 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.593 -1.317 . . . . 0.0 109.022 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.3 mt -91.56 -4.03 55.82 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.45 -0.781 . . . . 0.0 108.945 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.492 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -68.29 115.82 8.17 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.323 -0.86 . . . . 0.0 108.937 179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.525 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 88.5 mtm180 -78.59 172.7 13.31 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.232 -0.918 . . . . 0.0 109.264 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.442 HG21 ' CD1' ' A' ' 18' ' ' ILE . 6.6 t -79.36 163.3 24.96 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 177.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -147.85 148.78 31.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.141 -1.599 . . . . 0.0 111.666 -178.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.552 ' HB2' ' CE1' ' A' ' 500' ' ' C90 . . . -145.65 156.7 43.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.402 ' CB ' ' CE2' ' A' ' 184' ' ' TRP . 80.3 m-85 -99.75 144.37 28.89 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.034 -1.041 . . . . 0.0 109.487 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.444 ' OD1' ' C ' ' A' ' 183' ' ' ASP . 0.0 OUTLIER -46.35 -36.04 5.98 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.427 -0.796 . . . . 0.0 110.169 -179.171 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.519 ' CD1' ' N ' ' A' ' 185' ' ' GLU . 7.6 p90 -75.55 -29.27 59.34 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.906 -1.121 . . . . 0.0 110.387 -179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.519 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.7 tt0 -75.23 -29.0 60.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.996 -1.065 . . . . 0.0 110.3 -179.123 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.516 HG21 HB21 ' A' ' 500' ' ' C90 . 62.1 mt -57.9 -47.75 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.161 -0.962 . . . . 0.0 110.297 -179.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -47.29 -41.56 19.21 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.269 -0.894 . . . . 0.0 110.09 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.42 ' CE1' ' CG1' ' A' ' 192' ' ' VAL . 8.6 t60 -74.82 -52.18 12.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.221 -0.925 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.494 HD11 ' OE1' ' A' ' 185' ' ' GLU . 43.1 mt -48.5 -29.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.423 -0.798 . . . . 0.0 109.68 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.7 mmtm -85.13 -53.54 5.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.792 -1.192 . . . . 0.0 109.737 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -49.81 -34.76 20.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.947 . . . . 0.0 110.385 -179.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.42 ' CG1' ' CE1' ' A' ' 188' ' ' HIS . 15.9 m -85.51 8.87 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.895 -1.128 . . . . 0.0 110.36 -179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 72.4 39.71 56.38 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.181 -1.009 . . . . 0.0 110.63 178.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 194' ' ' LEU . 46.3 mt -128.47 171.12 12.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.199 -1.177 . . . . 0.0 109.835 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.404 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 60.19 23.22 59.48 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -57.92 -19.65 31.54 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.598 -1.531 . . . . 0.0 110.031 -179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -107.38 3.47 34.85 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.58 125.46 35.41 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.082 -1.246 . . . . 0.0 110.466 -179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.7 p -147.61 165.24 31.01 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.373 -1.075 . . . . 0.0 109.236 179.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.499 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 24.0 mt -67.85 -8.2 34.33 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -96.36 -11.91 25.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.793 -0.567 . . . . 0.0 109.702 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.512 ' C ' ' OD1' ' A' ' 202' ' ' ASN . 8.5 p-10 -137.93 8.89 2.78 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.046 -179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.491 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.2 m -147.57 149.08 31.89 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.071 -1.018 . . . . 0.0 110.006 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.62 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.1 tp -99.58 93.79 6.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.487 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 203' ' ' THR . 41.8 t -86.22 131.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 121.86 0.838 . . . . 0.0 109.109 -179.289 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.23 165.82 16.94 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.428 -0.795 . . . . 0.0 109.419 -178.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -130.22 -166.38 11.8 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? -58.56 -36.16 73.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.378 -1.072 . . . . 0.0 109.604 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -153.62 25.44 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.129 -0.982 . . . . 0.0 110.693 -178.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.59 148.92 38.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.872 -1.142 . . . . 0.0 110.537 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.2 t -100.24 110.26 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -54.52 -46.85 73.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.11 -0.993 . . . . 0.0 109.516 -178.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.5 m120 -66.57 117.42 44.17 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.122 -0.986 . . . . 0.0 109.178 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.03 -11.13 29.75 Favored 'Trans proline' 0 N--CA 1.487 1.109 0 C-N-CA 121.362 1.375 . . . . 0.0 111.37 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.55 -17.77 61.69 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.376 -0.827 . . . . 0.0 109.031 179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 74.57 -177.73 46.37 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.62 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.6 mt -86.58 136.94 32.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.114 -1.227 . . . . 0.0 109.644 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.27 -20.29 65.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.3 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . 0.467 ' CG ' ' NH1' ' A' ' 225' ' ' ARG . 58.8 m-85 -138.31 -164.22 1.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.31 -0.869 . . . . 0.0 109.203 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -97.63 -17.02 19.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.391 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 221' ' ' ASN . 0.0 OUTLIER -138.5 48.52 1.93 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.325 -0.86 . . . . 0.0 109.452 -179.859 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.51 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -53.11 -48.29 92.65 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.065 -1.022 . . . . 0.0 109.806 179.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.51 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 75.1 Cg_exo -48.24 -67.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.4 2.066 . . . . 0.0 112.14 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 18.2 m -59.59 -36.61 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.062 -1.024 . . . . 0.0 109.837 179.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.467 ' NH1' ' CG ' ' A' ' 219' ' ' TYR . 93.2 mtt180 -60.84 -40.52 93.13 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.975 -1.078 . . . . 0.0 108.411 179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 13.8 t60 -67.6 -30.87 70.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.251 -0.906 . . . . 0.0 108.732 179.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . . . . . . . . . 38.0 mmtt -66.11 -36.86 84.29 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.475 HG11 ' HB3' ' A' ' 166' ' ' PHE . 57.4 t -67.4 -37.97 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -63.24 -53.68 49.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.52 -0.737 . . . . 0.0 109.067 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . 0.542 ' OD2' ' C22' ' A' ' 500' ' ' C90 . 89.6 m-20 -62.41 -28.77 70.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.49 -0.756 . . . . 0.0 110.145 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . 0.428 HD23 ' CG1' ' A' ' 149' ' ' VAL . 33.1 tp -76.76 -34.29 58.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.988 -1.07 . . . . 0.0 108.565 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.6 mt -65.29 -38.33 82.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.36 -56.81 10.55 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.431 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 46.0 m-20 -53.11 -30.95 39.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.203 . . . . 0.0 109.191 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 235' ' ' LEU . 11.2 mt -65.17 -23.61 67.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.388 -0.82 . . . . 0.0 110.339 -179.534 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.588 ' O ' ' N ' ' A' ' 238' ' ' LEU . 0.2 OUTLIER -73.63 -22.37 60.01 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.744 -1.223 . . . . 0.0 108.96 -179.796 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 20.6 mt -49.76 -5.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.373 -1.454 . . . . 0.0 109.974 -179.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 236' ' ' TYR . 8.4 mt -74.51 -15.85 60.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.992 -1.068 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 96.42 0.31 61.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.994 -1.098 . . . . 0.0 111.293 178.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 241' ' ' PRO . 0.4 OUTLIER -167.14 146.95 4.66 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.557 -1.554 . . . . 0.0 110.007 179.471 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.536 ' HG2' HG21 ' A' ' 121' ' ' ILE . 58.7 Cg_exo -34.66 147.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.699 2.266 . . . . 0.0 111.339 178.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 83.1 t -115.03 147.76 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.603 -178.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 6.9 mmtp -131.77 124.03 28.87 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 147' ' ' LEU . . . 152.68 174.99 23.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.462 ' C ' ' CD1' ' A' ' 246' ' ' PHE . 13.9 tttt -103.89 142.2 34.82 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.151 -1.205 . . . . 0.0 109.541 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.8 m-85 -137.41 138.93 40.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.216 -0.927 . . . . 0.0 109.761 -179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 152' ' ' GLU . 59.7 t80 -125.69 128.26 47.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -124.7 136.23 53.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.091 -1.006 . . . . 0.0 111.211 -177.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -118.96 113.91 21.74 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 178.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 55.13 18.89 2.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.353 -179.193 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -57.32 155.41 17.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -137.65 176.36 20.66 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.596 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 68.5 m-70 -58.9 -37.7 77.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.251 . . . . 0.0 109.534 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.9 -58.27 9.11 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.139 -0.976 . . . . 0.0 109.319 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.509 ' HG ' HD12 ' A' ' 139' ' ' ILE . 20.2 tp -60.94 -43.24 98.96 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.096 -1.002 . . . . 0.0 109.331 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 18.4 m-20 -47.57 -54.07 12.78 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.14 -0.975 . . . . 0.0 109.417 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 56' ' ' THR . 82.8 t -62.4 -46.38 96.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.365 -0.834 . . . . 0.0 109.596 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -54.27 -52.08 62.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.013 -1.054 . . . . 0.0 108.961 179.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.66 HD22 HG21 ' A' ' 139' ' ' ILE . 23.8 tp -50.65 -58.49 5.73 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.452 HG13 ' HG ' ' A' ' 238' ' ' LEU . 14.0 t -49.27 -52.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.196 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -49.18 -49.19 43.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.761 . . . . 0.0 109.704 -179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.493 ' HB3' HD11 ' A' ' 130' ' ' ILE . 28.5 mm-40 -61.83 -48.2 81.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.274 -0.891 . . . . 0.0 109.699 179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 22.8 mt -57.0 -47.97 79.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.692 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -71.01 -29.72 65.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.375 -0.828 . . . . 0.0 110.08 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 mmtt -67.39 -53.89 25.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.095 -1.003 . . . . 0.0 109.787 -179.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 19.1 mtpt -62.32 -49.22 76.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.0 109.484 -179.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -76.22 47.69 0.47 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -0.905 . . . . 0.0 109.681 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 23.2 tttm -117.98 170.37 8.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.384 -0.823 . . . . 0.0 109.403 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.527 179.969 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.552 ' CE1' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.427 ' O ' HD11 ' A' ' 121' ' ' ILE . 9.9 mt -99.34 153.73 18.74 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -1.114 . . . . 0.0 109.502 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 34' ' ' GLY . 26.6 mt-10 -53.18 135.19 38.4 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.173 -0.954 . . . . 0.0 108.783 179.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.26 144.55 46.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 109.618 -179.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.3 t -141.86 -169.78 2.99 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 30' ' ' PRO . 34.7 m -100.83 137.33 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 109.324 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -66.35 -27.96 68.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.323 -0.861 . . . . 0.0 109.695 -179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -145.42 158.19 43.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.157 -0.964 . . . . 0.0 109.812 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.28 141.1 58.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.421 -0.799 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.5 mt -120.39 165.18 15.26 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -136.64 143.11 43.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 110.177 -179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' O ' ' N ' ' A' ' 26' ' ' LEU . 94.0 m-85 -139.82 150.73 45.05 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -158.65 151.57 22.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.889 -1.132 . . . . 0.0 109.999 -179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 167.85 174.06 36.45 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.316 -1.513 . . . . 0.0 109.316 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.0 p -81.73 149.01 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.431 -1.041 . . . . 0.0 110.256 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -83.46 137.86 16.89 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.979 -1.648 . . . . 0.0 108.979 179.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 203' ' ' THR . 3.8 tt -59.2 -38.15 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.088 -1.243 . . . . 0.0 110.272 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.448 ' N ' HG23 ' A' ' 18' ' ' ILE . 85.2 m-70 -89.8 -50.63 5.94 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.724 -1.235 . . . . 0.0 111.376 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.5 p -69.03 -21.62 64.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.557 -0.714 . . . . 0.0 111.547 -178.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 56.56 19.2 26.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -112.41 155.46 24.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.523 -0.987 . . . . 0.0 109.569 -179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -76.53 134.45 39.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.315 -0.866 . . . . 0.0 109.589 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.4 m -138.36 146.12 41.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.905 . . . . 0.0 109.726 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.503 ' H ' ' HB ' ' A' ' 92' ' ' ILE . 3.4 ttpp -112.6 157.79 20.77 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.41 -0.806 . . . . 0.0 109.923 -179.347 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.679 HD11 HG23 ' A' ' 96' ' ' ILE . 8.4 mt -136.86 145.14 44.04 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.356 -0.84 . . . . 0.0 109.866 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.495 HG22 ' NE2' ' A' ' 29' ' ' HIS . 3.7 mp -138.74 115.85 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.0 mt -101.62 114.38 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.304 -0.873 . . . . 0.0 110.994 -178.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.495 ' NE2' HG22 ' A' ' 27' ' ' ILE . 50.7 m-70 -109.58 138.16 20.53 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 121.484 -0.76 . . . . 0.0 109.808 179.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG3' HG23 ' A' ' 7' ' ' VAL . 28.0 Cg_exo -51.99 168.38 0.37 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.942 1.761 . . . . 0.0 111.399 178.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.5 ' HB3' HG21 ' A' ' 35' ' ' THR . 15.1 mm-40 -142.91 168.97 18.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 110.131 179.58 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 35' ' ' THR . 1.6 mttp -76.82 150.76 36.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.464 -0.773 . . . . 0.0 109.72 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -46.92 146.16 1.77 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.867 . . . . 0.0 110.209 -179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' A' ' 86' ' ' ASN . . . 68.74 6.04 48.7 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.415 -0.898 . . . . 0.0 110.955 178.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.536 ' N ' ' OD1' ' A' ' 86' ' ' ASN . 28.5 m -68.66 -43.29 76.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.597 -1.531 . . . . 0.0 109.439 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.97 178.2 36.25 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.806 -1.188 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' A' ' 87' ' ' VAL . 15.3 mm -96.07 117.23 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.72 149.83 42.67 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 118.796 -1.162 . . . . 0.0 110.603 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -100.18 158.26 15.98 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -129.61 112.27 13.53 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.262 -0.899 . . . . 0.0 108.624 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.8 tttm -135.64 132.88 37.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.463 -0.773 . . . . 0.0 110.5 -178.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.451 ' N ' HD22 ' A' ' 42' ' ' ASN . 2.8 m120 53.16 31.24 11.09 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 0.0 111.639 178.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.3 17.8 78.94 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.153 179.183 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.6 121.75 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.475 -1.015 . . . . 0.0 109.19 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 32.6 m-85 -84.19 128.51 34.61 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.984 . . . . 0.0 109.546 179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 mt -117.61 92.64 41.55 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 0.0 109.376 179.696 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -49.26 145.75 14.64 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 122.462 2.108 . . . . 0.0 111.984 -179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 76' ' ' LEU . . . -81.99 71.41 9.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.222 -0.924 . . . . 0.0 109.881 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.451 ' HE ' ' HA3' ' A' ' 239' ' ' GLY . 6.0 mmt85 -126.23 172.43 10.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.401 -0.812 . . . . 0.0 109.153 179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 52' ' ' PHE . 7.5 p-80 -73.64 -48.67 30.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.325 -0.859 . . . . 0.0 110.195 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -43.6 -17.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 0.0 111.25 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 50' ' ' HIS . 37.4 m-85 -96.92 1.78 50.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.725 -1.234 . . . . 0.0 110.105 -179.647 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 50' ' ' HIS . 72.6 t -63.66 123.59 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.043 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 m -106.55 -29.1 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.298 -0.876 . . . . 0.0 109.979 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -154.11 132.49 11.98 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.049 -1.032 . . . . 0.0 109.805 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.726 HG21 HG21 ' A' ' 257' ' ' VAL . 61.3 p -123.6 95.23 4.5 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' O ' ' N ' ' A' ' 59' ' ' SER . 45.6 t-20 -163.66 129.01 3.0 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.395 -0.815 . . . . 0.0 108.894 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.515 ' O ' ' CB ' ' A' ' 59' ' ' SER . 71.4 m-70 47.76 11.27 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.065 -1.022 . . . . 0.0 108.973 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.588 ' N ' ' O ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 163.36 141.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.872 -179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.42 ' OG1' ' ND1' ' A' ' 253' ' ' HIS . 34.2 m -90.36 127.76 36.27 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.302 -0.874 . . . . 0.0 109.131 179.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.71 152.82 38.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.413 -0.805 . . . . 0.0 111.067 -178.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.64 ' CD1' HG21 ' A' ' 72' ' ' VAL . 7.7 mt -128.44 149.01 50.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.76 156.77 28.76 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 118.886 -1.626 . . . . 0.0 110.866 -179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -163.82 151.47 12.63 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.455 -1.026 . . . . 0.0 108.849 179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt 52.53 23.85 2.77 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.146 -0.971 . . . . 0.0 109.375 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.96 -31.25 7.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' N ' ' CD ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -58.3 145.94 36.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.211 -1.17 . . . . 0.0 108.827 179.771 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -145.28 140.04 27.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 110.693 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.3 mt -130.26 123.08 55.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -101.43 158.47 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.074 -1.016 . . . . 0.0 111.408 -177.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 53.6 m 48.45 72.29 0.29 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.253 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.64 HG21 ' CD1' ' A' ' 62' ' ' LEU . 28.0 m -107.16 -9.4 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.215 -0.928 . . . . 0.0 109.174 179.104 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' OE2' ' CE1' ' A' ' 253' ' ' HIS . 3.7 pm0 -60.47 -25.33 65.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 110.025 -179.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.41 ' N ' ' HG2' ' A' ' 73' ' ' GLU . 24.6 m170 -67.33 -68.48 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 109.181 -179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 76' ' ' LEU . 6.3 tp -52.14 -47.18 44.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.127 -0.983 . . . . 0.0 109.192 179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 48' ' ' ALA . 20.9 mt -52.67 -47.57 67.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.948 -1.095 . . . . 0.0 110.1 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.5 ' OG ' ' CE1' ' A' ' 229' ' ' PHE . 13.1 t -61.65 -43.53 98.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.192 -0.943 . . . . 0.0 110.113 -179.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 73.6 t -56.19 -44.75 80.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 mt -68.14 -35.25 77.78 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.284 -0.885 . . . . 0.0 109.208 179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -62.39 -33.76 75.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.286 -0.883 . . . . 0.0 109.269 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 171' ' ' GLU . 62.3 mt -82.13 -38.37 24.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 107' ' ' TYR . 86.5 mt -80.74 4.18 19.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.547 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 54.22 39.11 30.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.527 -0.733 . . . . 0.0 110.163 179.427 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mm -86.07 139.38 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.642 HG21 HG12 ' A' ' 121' ' ' ILE . 56.6 p -126.02 -20.57 4.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.151 -0.968 . . . . 0.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' O ' HG13 ' A' ' 87' ' ' VAL . 1.1 m-80 -128.5 108.25 10.38 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.884 -1.135 . . . . 0.0 111.0 -178.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 86' ' ' ASN . 12.7 m -162.76 147.17 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.57 -0.706 . . . . 0.0 109.891 178.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.453 ' OG1' ' CD ' ' A' ' 31' ' ' GLU . 17.5 m -112.76 113.74 25.98 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.502 ' CG2' HD22 ' A' ' 26' ' ' LEU . 3.6 mt -97.7 101.56 12.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 110.648 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.93 124.26 25.83 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 178.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG22 HD21 ' A' ' 26' ' ' LEU . 98.5 t -104.94 129.42 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.87 0.843 . . . . 0.0 111.836 -177.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.503 ' HB ' ' H ' ' A' ' 25' ' ' LYS . 33.3 mm -111.7 91.53 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 134.7 163.6 10.24 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 -84.51 -3.36 58.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.954 -1.321 . . . . 0.0 110.852 -178.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -140.01 147.09 39.89 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.836 -1.165 . . . . 0.0 110.214 -179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 26' ' ' LEU . 47.0 mm -74.35 122.2 86.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 0.0 109.02 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -41.4 127.17 3.09 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 121.762 1.641 . . . . 0.0 111.394 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.432 HD13 ' CG2' ' A' ' 18' ' ' ILE . 3.1 tp -80.18 -14.16 13.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 110.274 -179.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.605 HD11 ' CE2' ' A' ' 106' ' ' PHE . 35.9 mt 58.74 -122.67 1.28 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 110.067 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -95.07 8.3 43.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.218 -0.926 . . . . 0.0 110.464 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.85 -3.63 65.16 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.365 -1.398 . . . . 0.0 110.119 179.729 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.45 -172.44 2.63 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.792 -0.828 . . . . 0.0 109.43 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -120.06 14.3 10.38 Favored Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.549 ' CZ2' ' CD ' ' A' ' 108' ' ' GLU . 4.7 t-105 -56.98 -42.15 79.69 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.279 -1.13 . . . . 0.0 110.205 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.18 -57.83 7.55 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.097 -1.002 . . . . 0.0 110.261 -179.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.605 ' CE2' HD11 ' A' ' 99' ' ' LEU . 10.2 m-85 -51.45 -45.93 62.88 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 0.0 109.356 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.442 ' CE1' HD21 ' A' ' 82' ' ' LEU . 40.0 t80 -61.22 -53.93 50.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.635 -0.665 . . . . 0.0 110.905 -179.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' CD ' ' CZ2' ' A' ' 104' ' ' TRP . 1.5 mm-40 -60.99 -43.54 98.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 0.0 111.473 -178.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.55 -54.74 20.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.013 -1.054 . . . . 0.0 110.449 -179.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.6 mt -66.43 -32.83 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.165 -0.959 . . . . 0.0 109.645 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -63.61 -42.45 98.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.166 -0.959 . . . . 0.0 109.656 -179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -77.06 15.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.654 -179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -146.31 31.18 1.01 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.659 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 HD22 ' A' ' 82' ' ' LEU . 72.9 mt -79.29 138.86 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.776 -1.202 . . . . 0.0 110.328 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.05 120.87 25.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.435 -0.791 . . . . 0.0 109.058 179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.2 142.41 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.392 -0.817 . . . . 0.0 110.148 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -110.37 -170.14 1.59 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.506 -0.746 . . . . 0.0 109.48 179.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.542 ' C ' HD22 ' A' ' 118' ' ' ASN . 0.3 OUTLIER -111.53 67.84 0.65 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.232 -0.918 . . . . 0.0 110.588 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -164.01 128.7 2.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.044 -1.035 . . . . 0.0 109.314 179.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -68.92 142.59 54.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.983 -1.073 . . . . 0.0 109.79 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.642 HG12 HG21 ' A' ' 85' ' ' THR . 37.5 mt -86.79 151.47 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.841 -179.826 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -96.03 79.99 3.27 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -58.08 143.41 43.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.343 -0.848 . . . . 0.0 109.557 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -90.08 101.67 14.38 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 177.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 16.1 t -93.45 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.639 -0.663 . . . . 0.0 110.902 -177.652 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.12 117.74 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -97.99 -26.73 14.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.07 -1.019 . . . . 0.0 110.456 -179.074 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.59 149.66 74.16 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 109.479 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.32 149.1 56.48 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 122.41 2.073 . . . . 0.0 112.096 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 141' ' ' ALA . 6.5 tt -153.09 149.75 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.263 -0.898 . . . . 0.0 109.03 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.5 mp -140.22 143.46 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.452 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.0 m -131.94 147.61 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.715 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -134.44 161.52 34.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.076 -1.015 . . . . 0.0 110.181 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.48 ' HB2' HD13 ' A' ' 255' ' ' LEU . 7.0 t0 -168.65 101.11 0.4 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.357 -0.839 . . . . 0.0 109.804 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 47.32 62.54 2.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -0.865 . . . . 0.0 110.528 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 85.86 -37.29 3.09 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.906 -1.14 . . . . 0.0 110.578 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.7 mtt180 -61.03 137.72 58.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.888 -1.36 . . . . 0.0 109.14 -179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.781 HD23 ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -146.96 136.78 23.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.935 -1.103 . . . . 0.0 110.082 -179.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.473 HG21 HD22 ' A' ' 259' ' ' LEU . 92.9 mt -136.13 134.48 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.455 -0.778 . . . . 0.0 109.46 179.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.6 tttp -124.16 131.63 53.55 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.504 0.669 . . . . 0.0 109.957 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.495 ' HB3' HG22 ' A' ' 130' ' ' ILE . . . -123.41 137.39 54.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -148.96 155.86 40.59 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.091 -1.006 . . . . 0.0 109.765 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -50.53 142.21 31.43 Favored 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.496 2.131 . . . . 0.0 113.421 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.631 ' OG ' ' N ' ' A' ' 245' ' ' LYS . 0.7 OUTLIER -156.69 139.38 15.09 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.042 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 146' ' ' THR . 0.7 OUTLIER -60.91 -5.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 0.0 110.462 -179.297 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 145' ' ' ASP . 29.2 p -154.18 -177.54 6.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.884 -1.135 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 148' ' ' GLU . 15.1 tp -93.64 120.55 34.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.0 -1.062 . . . . 0.0 109.341 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.561 ' HG3' HG22 ' A' ' 167' ' ' VAL . 12.1 tt0 -134.49 115.7 14.24 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.94 121.81 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 -179.112 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.403 ' OG1' HG23 ' A' ' 165' ' ' THR . 60.4 m -112.82 152.22 29.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.714 -0.616 . . . . 0.0 109.452 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -139.6 131.06 26.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.138 179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -121.47 130.52 53.61 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.181 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -135.25 139.11 10.52 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 119.682 -1.246 . . . . 0.0 111.556 -178.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -104.33 101.9 11.6 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -88.46 167.42 13.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.336 -0.853 . . . . 0.0 110.852 -178.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -100.69 -12.86 18.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.567 -0.708 . . . . 0.0 110.572 -179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.466 ' O ' ' N ' ' A' ' 159' ' ' LEU . 39.9 p-10 -97.77 -170.8 2.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.979 -1.076 . . . . 0.0 110.355 -179.402 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -52.86 0.76 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.492 -0.755 . . . . 0.0 112.019 -178.396 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.545 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 28.5 mt -81.87 -28.03 33.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.241 -1.537 . . . . 0.0 108.772 179.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 54.16 -136.97 41.87 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.508 ' O ' ' OE1' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -97.48 130.69 44.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.188 . . . . 0.0 109.791 179.944 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.545 ' OE1' ' O ' ' A' ' 159' ' ' LEU . 0.4 OUTLIER -132.96 142.91 49.12 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 8.4 pttm -138.09 144.03 40.7 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.406 -0.809 . . . . 0.0 109.826 179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . 0.508 ' CZ ' ' NH1' ' A' ' 225' ' ' ARG . 61.0 t80 -144.99 138.02 26.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.249 -0.907 . . . . 0.0 109.908 -179.811 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' THR . . . . . 0.403 HG23 ' OG1' ' A' ' 150' ' ' THR . 59.8 m -106.64 122.9 47.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 0.0 109.994 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.45 ' HB3' HG11 ' A' ' 228' ' ' VAL . 8.2 t80 -102.8 110.91 23.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 109.99 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.561 HG22 ' HG3' ' A' ' 148' ' ' GLU . 42.4 t -104.06 152.14 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.836 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -49.51 124.24 9.07 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.336 -0.853 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 109.42 0.75 31.08 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -116.93 21.66 13.14 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.195 -1.179 . . . . 0.0 109.268 179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -55.44 -52.74 62.6 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.195 -0.94 . . . . 0.0 109.942 -179.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.573 ' H ' ' CD ' ' A' ' 171' ' ' GLU . 2.8 mt-10 -44.54 -22.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.147 -0.97 . . . . 0.0 110.11 -179.495 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 171' ' ' GLU . 42.0 mt-10 -86.15 -8.95 57.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.018 -1.051 . . . . 0.0 111.753 -178.353 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 4.5 pt -123.73 -29.25 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 120.801 -1.187 . . . . 0.0 111.225 -178.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 171' ' ' GLU . 4.6 m -61.41 -20.75 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.586 -1.321 . . . . 0.0 109.025 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.465 HD22 HH11 ' A' ' 218' ' ' ARG . 6.7 mt -90.31 -1.79 57.95 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.434 ' C ' ' HD1' ' A' ' 226' ' ' HIS . . . -70.49 120.44 16.14 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.303 -0.873 . . . . 0.0 109.031 179.689 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.444 ' O ' ' ND1' ' A' ' 226' ' ' HIS . 83.6 mtm180 -84.45 172.6 11.56 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.487 -179.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -79.21 163.37 25.06 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -148.7 146.01 27.93 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.303 -1.498 . . . . 0.0 111.628 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.589 ' HB2' ' CE2' ' A' ' 500' ' ' C90 . . . -144.25 157.76 44.11 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.501 ' CG ' ' CZ2' ' A' ' 184' ' ' TRP . 79.5 m-85 -99.19 147.54 25.02 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.076 -1.015 . . . . 0.0 109.389 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 2.3 p30 -53.27 -33.2 52.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.137 -0.977 . . . . 0.0 109.686 -179.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' TRP . . . . . 0.501 ' CZ2' ' CG ' ' A' ' 182' ' ' PHE . 7.5 p90 -73.53 -26.36 60.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.906 -1.121 . . . . 0.0 109.55 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.452 ' N ' ' CD1' ' A' ' 184' ' ' TRP . 1.8 mm-40 -77.82 -40.65 39.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.174 -0.953 . . . . 0.0 109.698 -179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 183' ' ' ASP . 76.4 mt -45.69 -51.07 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 110.136 -179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -42.65 -45.16 4.56 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.269 -0.895 . . . . 0.0 110.245 -179.671 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 192' ' ' VAL . 9.1 t60 -77.1 -50.93 11.93 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.19 -0.944 . . . . 0.0 109.71 -179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 64.5 mt -47.37 -32.24 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.271 -0.893 . . . . 0.0 109.6 -179.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 32.5 mttt -85.04 -52.7 5.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.69 -1.256 . . . . 0.0 108.744 179.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -50.65 -32.16 18.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.89 . . . . 0.0 110.331 -179.442 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 188' ' ' HIS . 24.7 m -86.62 6.27 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.941 -1.1 . . . . 0.0 110.116 -179.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 75.49 37.55 40.65 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.325 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 194' ' ' LEU . 58.6 mt -128.71 171.85 11.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.312 -1.11 . . . . 0.0 109.798 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.428 ' N ' ' HA ' ' A' ' 19' ' ' HIS . . . 58.55 22.38 52.11 Favored Glycine 0 N--CA 1.495 2.631 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.437 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' LYS . . . . . . . . . . . . . 15.5 mtpp -56.78 -19.42 16.98 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.661 -1.494 . . . . 0.0 110.521 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 202' ' ' ASN . . . -111.27 5.55 28.49 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -66.36 125.15 26.18 Favored Glycine 0 N--CA 1.491 2.337 0 O-C-N 121.052 -1.263 . . . . 0.0 110.571 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.455 ' OG ' ' ND2' ' A' ' 202' ' ' ASN . 0.2 OUTLIER -147.04 169.46 19.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.562 -0.964 . . . . 0.0 109.421 179.598 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.455 ' O ' ' ND2' ' A' ' 213' ' ' ASN . 35.2 mt -67.97 -8.36 36.55 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -93.09 -13.05 29.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.651 -0.656 . . . . 0.0 109.647 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.455 ' ND2' ' OG ' ' A' ' 199' ' ' SER . 23.8 p30 -139.64 10.72 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.041 -1.037 . . . . 0.0 110.33 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 18' ' ' ILE . 1.3 m -148.06 148.49 30.72 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.911 -1.118 . . . . 0.0 110.49 -179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.63 HD11 ' CD2' ' A' ' 217' ' ' LEU . 11.3 tp -98.69 93.41 6.08 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 178.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 203' ' ' THR . 42.1 t -85.88 129.77 37.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.036 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 32.4 mt -124.1 164.18 19.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.635 -0.665 . . . . 0.0 109.625 -179.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -123.25 -166.24 12.55 Favored Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.673 -1.771 . . . . 0.0 108.673 179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -23.25 65.8 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.639 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -157.02 21.77 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.042 -1.036 . . . . 0.0 111.255 -179.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -147.37 156.04 42.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.529 -1.357 . . . . 0.0 110.639 -179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 95.6 t -104.87 112.79 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -59.21 -51.16 71.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.112 -0.992 . . . . 0.0 110.58 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 200' ' ' LEU . 6.0 m120 -59.6 112.71 5.66 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.156 -0.965 . . . . 0.0 110.464 -179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -58.05 -11.07 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.704 1.603 . . . . 0.0 112.162 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.94 -19.03 59.11 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.135 -0.978 . . . . 0.0 110.237 -179.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 76.42 -178.04 50.37 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.63 ' CD2' HD11 ' A' ' 204' ' ' LEU . 7.8 mt -87.88 131.53 34.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.287 -1.126 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.465 HH11 HD22 ' A' ' 176' ' ' LEU . 6.8 ttm180 -61.14 -20.97 63.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.833 . . . . 0.0 108.875 179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -143.43 -173.31 3.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.49 -0.757 . . . . 0.0 109.246 179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.05 -16.84 30.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 109.397 179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' ASN . . . . . 0.786 HD22 ' HE ' ' A' ' 225' ' ' ARG . 0.0 OUTLIER -134.55 46.25 2.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.303 -179.952 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.538 ' N ' ' CD ' ' A' ' 223' ' ' PRO . 1.5 tt0 -55.73 -47.11 99.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.095 -1.003 . . . . 0.0 109.751 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 222' ' ' GLU . 60.2 Cg_exo -50.42 -66.3 0.13 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.511 2.141 . . . . 0.0 112.177 -179.934 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 225' ' ' ARG . 22.3 m -60.04 -35.62 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.066 -1.021 . . . . 0.0 109.636 179.593 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . 0.786 ' HE ' HD22 ' A' ' 221' ' ' ASN . 60.8 mtt-85 -60.91 -40.62 93.85 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 178' ' ' ARG . 16.6 t60 -67.89 -31.99 72.17 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.389 -0.924 . . . . 0.0 108.561 178.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' LYS . . . . . 0.515 ' HE2' H211 ' A' ' 500' ' ' C90 . 17.3 mmtt -65.03 -36.0 82.97 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.45 HG11 ' HB3' ' A' ' 166' ' ' PHE . 61.5 t -69.54 -34.52 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.5 ' CE1' ' OG ' ' A' ' 77' ' ' SER . 58.2 t80 -66.14 -52.49 47.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.06 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -65.44 -27.76 68.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.473 -0.767 . . . . 0.0 109.776 179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 45.2 tp -77.76 -33.99 52.57 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.107 -0.995 . . . . 0.0 108.591 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 32.9 mt -67.65 -38.11 79.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -67.29 -55.37 15.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' ASP . . . . . 0.432 ' OD2' ' ND1' ' A' ' 253' ' ' HIS . 9.7 m-20 -55.24 -36.82 66.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.002 -1.293 . . . . 0.0 109.114 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.426 ' HA ' HD23 ' A' ' 235' ' ' LEU . 13.5 mt -62.27 -24.92 67.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.514 -179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 238' ' ' LEU . 1.1 t80 -73.95 -21.5 60.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.825 -1.172 . . . . 0.0 109.376 -179.297 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 237' ' ' LEU . 93.2 mt -49.16 -4.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.572 -1.33 . . . . 0.0 110.501 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . 0.587 ' N ' ' O ' ' A' ' 236' ' ' TYR . 11.1 mt -74.09 -14.36 60.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.94 -1.1 . . . . 0.0 109.998 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.451 ' HA3' ' HE ' ' A' ' 49' ' ' ARG . . . 96.53 3.19 59.84 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.926 -1.13 . . . . 0.0 110.989 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -163.59 152.18 11.76 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.668 -1.489 . . . . 0.0 109.06 179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.33 129.36 34.25 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.706 1.604 . . . . 0.0 109.668 179.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 28.0 t -89.39 151.94 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.033 -1.042 . . . . 0.0 112.435 -176.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.64 126.65 31.3 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 155.77 -165.55 32.61 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -178.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.631 ' N ' ' OG ' ' A' ' 144' ' ' SER . 11.9 tptm -124.55 133.71 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -1.092 . . . . 0.0 108.639 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 246' ' ' PHE . 15.2 m-85 -132.25 138.05 47.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.169 -0.957 . . . . 0.0 110.079 -179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -125.77 118.21 25.07 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 178.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 3.4 m -112.49 135.31 53.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.118 -0.989 . . . . 0.0 111.023 -178.385 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -117.36 107.73 14.72 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.097 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 54.39 31.02 13.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.216 -0.927 . . . . 0.0 109.603 -179.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -72.77 157.56 52.62 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.449 ' O ' ' OD1' ' A' ' 256' ' ' ASN . . . -130.97 -179.91 16.48 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.599 ' CE1' ' OE2' ' A' ' 73' ' ' GLU . 54.6 m-70 -60.06 -40.15 88.49 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.225 -1.162 . . . . 0.0 109.59 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -58.88 6.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.178 -0.951 . . . . 0.0 109.365 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 134' ' ' ASP . 12.6 tp -56.68 -44.77 81.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.061 -1.025 . . . . 0.0 109.283 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' ASN . . . . . 0.449 ' OD1' ' O ' ' A' ' 252' ' ' GLY . 19.9 m-20 -47.64 -52.09 19.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.933 -1.104 . . . . 0.0 109.208 179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.726 HG21 HG21 ' A' ' 56' ' ' THR . 81.4 t -61.54 -45.24 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.594 -0.691 . . . . 0.0 109.797 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' LYS . . . . . . . . . . . . . 4.9 ttmm -58.07 -49.2 77.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.993 -1.067 . . . . 0.0 109.379 179.808 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.473 HD22 HG21 ' A' ' 139' ' ' ILE . 22.4 tp -54.61 -51.2 66.09 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.972 . . . . 0.0 108.779 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.446 HG13 ' HG ' ' A' ' 238' ' ' LEU . 11.5 t -57.87 -54.37 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.896 179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -48.67 -45.53 38.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.678 . . . . 0.0 109.517 179.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.46 ' HB3' HD11 ' A' ' 130' ' ' ILE . 23.3 mm-40 -64.02 -51.68 63.06 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.862 . . . . 0.0 109.854 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 263' ' ' LEU . . . . . . . . . . . . . 12.5 mt -53.88 -46.86 71.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.983 . . . . 0.0 109.908 -179.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -69.39 -28.84 66.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.261 -0.899 . . . . 0.0 110.059 -179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp -70.29 -59.86 2.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.93 . . . . 0.0 110.41 -179.274 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -28.9 69.81 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.163 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 267' ' ' GLN . . . . . 0.453 ' C ' ' H ' ' A' ' 269' ' ' LEU . 6.3 tt0 -101.27 42.37 1.13 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.966 -1.084 . . . . 0.0 109.583 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 268' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -73.61 15.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.3 -0.875 . . . . 0.0 109.454 179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.453 ' H ' ' C ' ' A' ' 267' ' ' GLN . 1.6 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.391 -179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 336' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 500' ' ' C90 . . . . . 0.589 ' CE2' ' HB2' ' A' ' 181' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_